PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Koplan, JP; Brownell, KD				Koplan, Jeffrey P.; Brownell, Kelly D.			Response of the Food and Beverage Industry to the Obesity Threat	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Koplan, Jeffrey P.] Emory Univ, Emory Global Hlth Inst, Atlanta, GA 30322 USA; [Brownell, Kelly D.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT USA	Emory University; Yale University	Koplan, JP (corresponding author), Emory Univ, Emory Global Hlth Inst, 1599 Clifton Rd NE,Ste 6-101, Atlanta, GA 30322 USA.	jkoplan@emory.edu						[Anonymous], PREV CHILDH OB HLTH; Brandt AM., 2007, CIGARETTE CENTURY RI; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Cashore Benjamin, 2004, GOVERNING MARKETS FO; *COC COL CO, COC COL CO 2009 4 QU; *I MED, 2009, LOC GOV ACT PREV CHI; Institute of Medicine, 2006, FOOD MARK CHILDR YOU; Sharma LL, 2010, AM J PUBLIC HEALTH, V100, P240, DOI 10.2105/AJPH.2009.160960; World Health Organization, 2006, MARK FOOD NON BEV CH	9	54	54	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1487	1488		10.1001/jama.2010.1436	http://dx.doi.org/10.1001/jama.2010.1436			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	658SO	20924016				2022-12-24	WOS:000282509900026
J	Middleton, A; Niruban, A; Girling, G; Myint, PK				Middleton, Anna; Niruban, Alagaratnam; Girling, Gill; Myint, Phyo Kyaw			Practice Pointer Communicating in a healthcare setting with people who have hearing loss	BRITISH MEDICAL JOURNAL			English	Editorial Material							OLDER-ADULTS; DEAF; IMPAIRMENT		[Niruban, Alagaratnam; Myint, Phyo Kyaw] Norfolk & Norwich Univ Hosp, Acad Dept Med Elderly, Norwich NR4 7UY, Norfolk, England; [Middleton, Anna] Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; [Girling, Gill] Norfolk Deaf Assoc, Norwich NR3 4TL, Norfolk, England; [Myint, Phyo Kyaw] Univ E Anglia, Sch Med, Fac Hlth, Hlth & Social Sci Res Inst, Norwich NR4 7TJ, Norfolk, England; [Myint, Phyo Kyaw] Univ Cambridge, Sch Clin Med, Dept Public Hlth & Primary Care, Clin Gerontol Unit, Cambridge CB2 0QQ, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Cardiff University; University of East Anglia; University of Cambridge	Myint, PK (corresponding author), Norfolk & Norwich Univ Hosp, Acad Dept Med Elderly, Norwich NR4 7UY, Norfolk, England.	Phyo.K.Myint@uea.ac.uk		Middleton, Anna/0000-0003-3103-8098				Baker Holly, 2007, Psychol Health Med, V12, P380, DOI 10.1080/13548500601133466; Barnett S, 2002, FAM MED, V34, P376; Brink P, 2007, GERONTOLOGIST, V47, P633, DOI 10.1093/geront/47.5.633; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; Davidhizar Ruth, 2008, J Pract Nurs, V58, P12; Department of Health, 2005, MENT HLTH DEAFN EQ A; FORTNUM H, 2006, EFFECTS GENETIC HEAR, P29; Harmer L, 1999, J Deaf Stud Deaf Educ, V4, P73, DOI 10.1093/deafed/4.2.73; Hickson Louise, 2007, Seminars in Speech and Language, V28, P283, DOI 10.1055/s-2007-986525; Hines J, 2000, Nurs Stand, V14, P33; Iezzoni LI, 2004, ANN INTERN MED, V140, P356, DOI 10.7326/0003-4819-140-5-200403020-00011; JONES B, 1998, EBM, V1, P131; Ladd P., 2003, MULTILINGUAL MATTERS; Mackenzie I, 2009, ANN TROP MED PARASIT, V103, P565, DOI 10.1179/000349809X12459740922372; Mann W J, 1994, Md Med J, V43, P509; Middleton A., 2010, WORKING DEAF PEOPLE; Middleton A, 2010, J EVAL CLIN PRACT, V16, P811, DOI 10.1111/j.1365-2753.2009.01207.x; Middleton A, 2010, SIGN LANG STUD, V10, P170, DOI 10.1353/sls.0.0038; NHS Quality Improvement Scotland, 2005, MAX COMM OLD PEOPL W; *ROYAL NAT I DEAF, 2004, SIMPL CUR; Royal National Institute for the Deaf, 2006, FACTS FIG DEAFN TINN; SAUNDERS GH, 2007, TRENDS AMPLIF, V11, P227; Slaven Antoinette, 2003, Nurs Stand, V18, P39; Steinberg AG, 2006, J GEN INTERN MED, V21, P260, DOI 10.1111/j.1525-1497.2006.00340.x; Steinberg AG, 2002, J WOMEN HEALTH GEN-B, V11, P729, DOI 10.1089/15409990260363689; Stephens D., 2005, IMPACT GENETIC HEARI, P54; Traynor Noel, 2004, Nurs Times, V100, P32; WHO, 2001, WHO INT CLASS FUNCT; WITTE TN, 2000, J AM BOARD FAM PRACT, V13, P81; Zazove P, 2006, J AM BOARD FAM MED, V19, P141, DOI 10.3122/jabfm.19.2.141	30	16	16	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 29	2010	341								c4672	10.1136/bmj.c4672	http://dx.doi.org/10.1136/bmj.c4672			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659ND	20880905				2022-12-24	WOS:000282572400008
J	Desser, AS; Gyrd-Hansen, D; Olsen, JA; Grepperud, S; Kristiansen, IS				Desser, Arna S.; Gyrd-Hansen, Dorte; Olsen, Jan Abel; Grepperud, Sverre; Kristiansen, Ivar Sonbo			Societal views on orphan drugs: cross sectional survey of Norwegians aged 40 to 67	BRITISH MEDICAL JOURNAL			English	Article							CHOICE	Objective To determine whether a general societal preference for prioritising treatment of rare diseases over common ones exists and could provide a justification for accepting higher cost effectiveness thresholds for orphan drugs. Design Cross sectional survey using a web based questionnaire. Setting Norway. Participants Random sample of 1547 Norwegians aged 40-67. Main outcome measure Choice between funding treatment for a rare disease versus a common disease and how funds should be allocated if it were not possible to treat all patients, for each of two scenarios: identical treatment costs per patient and higher costs for the rare disease. Respondents rated five statements concerning attitudes to equity on a five point Likert scale (5=completely agree). Results For the equal cost scenario, 11.2% (9.6% to 12.8%) of respondents favoured treating the rare disease, 24.9% (21.7% to 26.0%) the common disease, and 64.9% (62.6% to 67.3%) were indifferent. When the rare disease was four times more costly to treat, the results were, respectively, 7.4% (6.1% to 8.7%), 45.3% (42.8% to 47.8%), and 47.3% (44.8% to 49.8%). Rankings for attitude on a Likert scale indicated strong support for the statements "rare disease patients should have the right to treatment even if more expensive" (mean score 4.5, SD 0.86) and "resources should be used to provide the greatest possible health benefits" (3.9, 1.23). Conclusions Despite strong general support for statements expressing a desire for equal treatment rights for patients with rare diseases, there was little evidence that a societal preference for rarity exists if treatment of patients with rare diseases is at the expense of treatment of those with common diseases.	[Desser, Arna S.; Grepperud, Sverre; Kristiansen, Ivar Sonbo] Univ Oslo, Dept Hlth Mgmt & Hlth Econ, N-0317 Oslo, Norway; [Gyrd-Hansen, Dorte; Kristiansen, Ivar Sonbo] Univ So Denmark, Inst Publ Hlth, Odense, Denmark; [Olsen, Jan Abel] Univ Tromso, Dept Community Med, Tromso, Norway	University of Oslo; University of Southern Denmark; UiT The Arctic University of Tromso	Desser, AS (corresponding author), Univ Oslo, Dept Hlth Mgmt & Hlth Econ, PO Box 1089,Blindern, N-0317 Oslo, Norway.	a.s.desser@medisin.uio.no	Gyrd-Hansen, Dorte/A-3161-2011	Grepperud, Sverre Ole/0000-0002-8658-7345; Gyrd-Hansen, Dorte/0000-0003-1137-2304	Norwegian Research Council; University of Oslo	Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Oslo	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and all authors want to declare (1) Financial support for the submitted work from the Norwegian Research Council and the Health Economics Research Programme (HERO) at the University of Oslo. ISK (2) has received gifts, travel funds, honorariums, consultancy fees or salary from a wide range of public institutions, not for profit organisations or for profit organisations that may have an interest in orphan drug issues. The other authors declare no interests under (2), and all authors declare that they have (3) No spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; (4) No non-financial interests that may be relevant to the submitted work.	DENIS A, 2010, J MED EC; Drummond MF, 2007, INT J TECHNOL ASSESS, V23, P36, DOI 10.1017/S0266462307051550; *EUROQOL, 2010, EQ 5D; *HELS OG OMS, 1987, 198723 NOU HELS OG O; Hughes DA, 2005, QJM-INT J MED, V98, P829, DOI 10.1093/qjmed/hci128; McCabe C, 2006, QJM-INT J MED, V99, P341, DOI 10.1093/qjmed/hcl033; McCabe C, 2005, BRIT MED J, V331, P1016, DOI 10.1136/bmj.331.7523.1016; McCabe C, 2007, INT J TECHNOL ASSESS, V23, P397; McKie J, 2003, SOC SCI MED, V56, P2407, DOI 10.1016/S0277-9536(02)00244-7; National Institute for Clinical Excellence, 2004, CIT COUNC REP ULTR D CIT COUNC REP ULTR D; NORD E, 1995, SOC SCI MED, V41, P1429, DOI 10.1016/0277-9536(95)00121-M; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1992, PSYCHOL SCI, V3, P358, DOI 10.1111/j.1467-9280.1992.tb00047.x; Ubel PA, 1996, NEW ENGL J MED, V334, P1174, DOI 10.1056/NEJM199605023341807	14	67	67	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 22	2010	341								c4715	10.1136/bmj.c4715	http://dx.doi.org/10.1136/bmj.c4715			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	655TK	20861122	Green Submitted, hybrid, Green Published			2022-12-24	WOS:000282272200023
J	Sekulic, N; Bassett, EA; Rogers, DJ; Black, BE				Sekulic, Nikolina; Bassett, Emily A.; Rogers, Danielle J.; Black, Ben E.			The structure of (CENP-A-H4)(2) reveals physical features that mark centromeres	NATURE			English	Article							NUCLEOSOME CORE PARTICLE; SMALL-ANGLE SCATTERING; CENP-A NUCLEOSOMES; ANGSTROM RESOLUTION; CHROMATIN; DNA; HISTONES; SYSTEM; DOMAIN; CRYSTALLOGRAPHY	Centromeres are specified epigenetically, and the histone H3 variant CENP-A is assembled into the chromatin of all active centromeres(1). Divergence from H3 raises the possibility that CENP-A generates unique chromatin features to mark physically centromere location. Here we report the crystal structure of a subnucleosomal heterotetramer, human (CENP-A-H4)(2), that reveals three distinguishing properties encoded by the residues that comprise the CENP-A targeting domain (CATD; ref. 2): (1) a CENP-A-CENP-A interface that is substantially rotated relative to the H3-H3 interface; (2) a protruding loop L1 of the opposite charge as that on H3; and (3) strong hydrophobic contacts that rigidify the CENP-A-H4 interface. Residues involved in the CENP-A-CENP-A rotation are required for efficient incorporation into centromeric chromatin, indicating specificity for an unconventional nucleosome shape. DNA topological analysis indicates that CENP-A-containing nucleosomes are octameric with conventional left-handed DNA wrapping, in contrast to other recent proposals(3-6). Our results indicate that CENP-A marks centromere location by restructuring the nucleosome from within its folded histone core.	[Sekulic, Nikolina; Bassett, Emily A.; Rogers, Danielle J.; Black, Ben E.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Bassett, Emily A.; Black, Ben E.] Univ Penn, Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Black, BE (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	blackbe@mail.med.upenn.edu	Sekulic, Nikolina/N-5550-2016; Sekulic, Nikolina/F-8911-2013	Sekulic, Nikolina/0000-0001-7555-3222; 	NIH [GM82989, GM08275]; Burroughs Wellcome Fund; Rita Allen Foundation; American Cancer Society; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008275, R01GM082989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Rita Allen Foundation; American Cancer Society(American Cancer Society); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Cleveland for plasmids and steadfast encouragement to pursue a physical understanding of the centromere; S. Wood for generating cleaved histone H2A; K. Gupta for help with collecting data and technical suggestions; and K. Ferguson, G. Van Duyne, M. Lemmon, J. Shorter, L. Jansen, D. Foltz, J. Shah, D. Alvarado, K. Moravcevic and T. Panchenko for discussions and comments on the manuscript. This work was supported by the NIH research grant GM82989, a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund, and a Rita Allen Foundation Scholar Award to B.E.B.N.S. is supported by a postdoctoral fellowship from the American Cancer Society and E.A.B. has been supported by the Penn Structural Biology Training Grant (NIH GM08275) and a predoctoral fellowship from the American Heart Association.	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Bassett EA, 2010, J CELL BIOL, V190, P177, DOI 10.1083/jcb.201001035; BINASTEIN M, 1977, CELL, V11, P609, DOI 10.1016/0092-8674(77)90078-2; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Carruthers LM, 1999, METHOD ENZYMOL, V304, P19; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; Erhardt S, 2008, J CELL BIOL, V183, P805, DOI 10.1083/jcb.200806038; ESPOSITO F, 1987, NUCLEIC ACIDS RES, V15, P5105, DOI 10.1093/nar/15.13.5105; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Fyodorov DV, 2003, METHOD ENZYMOL, V371, P499; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lusser A, 2004, NAT METHODS, V1, P19, DOI 10.1038/nmeth709; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Smith MM, 2002, CURR OPIN CELL BIOL, V14, P279, DOI 10.1016/S0955-0674(02)00331-9; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3	41	164	169	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2010	467	7313					347	U132		10.1038/nature09323	http://dx.doi.org/10.1038/nature09323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20739937	Green Accepted			2022-12-24	WOS:000281824900043
J	Poulsen, H; Khandelia, H; Morth, JP; Bublitz, M; Mouritsen, OG; Egebjerg, J; Nissen, P				Poulsen, Hanne; Khandelia, Himanshu; Morth, J. Preben; Bublitz, Maike; Mouritsen, Ole G.; Egebjerg, Jan; Nissen, Poul			Neurological disease mutations compromise a C-terminal ion pathway in the Na+/K+-ATPase	NATURE			English	Article							SITE-DIRECTED MUTAGENESIS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; AMINO-ACID; NA,K-ATPASE; NA+,K+-ATPASE; PUMP; SUBSTITUTIONS; TRANSPORT	The Na+/K+-ATPase pumps three sodium ions out of and two potassium ions into the cell for each ATP molecule that is split, thereby generating the chemical and electrical gradients across the plasma membrane that are essential in, for example, signalling, secondary transport and volume regulation in animal cells. Crystal structures of the potassium-bound form of the pump revealed an intimate docking of the alpha-subunit carboxy terminus at the transmembrane domain(1,2). Here we show that this element is a key regulator of a previously unrecognized ion pathway. Current models of P-type ATPases operate with a single ion conduit through the pump(3-5), but our data suggest an additional pathway in the Na+/K+-ATPase between the ion-binding sites and the cytoplasm. The C-terminal pathway allows a cytoplasmic proton to enter and stabilize site III when empty in the potassium-bound state, and when potassium is released the proton will also return to the cytoplasm, thus allowing an overall asymmetric stoichiometry of the transported ions. The C terminus controls the gate to the pathway. Its structure is crucial for pump function, as demonstrated by at least eight mutations in the region that cause severe neurological diseases(6,7). This novel model for ion transport by the Na+/K+-ATPase is established by electrophysiological studies of C-terminal mutations in familial hemiplegic migraine 2 (FHM2) and is further substantiated by molecular dynamics simulations. A similar ion regulation is likely to apply to the H+/K+-ATPase and the Ca2+-ATPase.	[Poulsen, Hanne; Morth, J. Preben; Bublitz, Maike; Nissen, Poul] Aarhus Univ, Dept Mol Biol, Danish Natl Res Fdn, PUMPKIN Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus C, Denmark; [Khandelia, Himanshu; Mouritsen, Ole G.] Univ So Denmark, Dept Chem & Phys, Danish Natl Res Fdn, MEMPHYS Ctr Biomembrane Phys, DK-5230 Odense M, Denmark; [Egebjerg, Jan] H Lundbeck & Co AS, DK-2500 Copenhagen, Denmark	Aarhus University; Danmarks Grundforskningsfond; Danmarks Grundforskningsfond; University of Southern Denmark; Lundbeck Corporation	Poulsen, H (corresponding author), Aarhus Univ, Dept Mol Biol, Danish Natl Res Fdn, PUMPKIN Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus C, Denmark.	hp@mb.au.dk; pn@mb.au.dk	Morth, Jens Preben/G-4450-2013; Morth, Jens Preben/AAP-7834-2021; Nissen, Poul/D-5774-2014	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Nissen, Poul/0000-0003-0948-6628; Bublitz, Maike/0000-0003-3161-418X; Mouritsen, Ole G./0000-0002-4258-8960; Khandelia, Himanshu/0000-0001-9913-6394	European Molecular Biology Organisation; Carlsberg Foundation; Lundbeck Foundation; Danish Ministry of Science and Innovation; Novo Nordisk Foundation; Lundbeck Foundation [R34-2009-3616] Funding Source: researchfish	European Molecular Biology Organisation; Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden); Danish Ministry of Science and Innovation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden)	We acknowledge the Danish Center for Scientific Computing at the University of Southern Denmark, Odense, for computing resources. We thank D. Gadsby, N. Vedovato and A. Gulyas-Kovacs at the Rockefeller University, New York City, for technical advice and discussion, A. Skov Kristensen and M. H. Poulsen (University of Copenhagen) for supplies of oocytes, and M. J. Clausen, G. Hartvigsen and A. M. Nielsen for assistance with experimental procedures. We are grateful to C. Slayman and F. Ashcroft for discussions on electrogenic transport. H. P. was supported by a short-term travel fellowship from the European Molecular Biology Organisation, J. P. M. was supported by grants from the Carlsberg Foundation and the Lundbeck Foundation, and P. N. was supported by an Elite Researcher grant of the Danish Ministry of Science and Innovation and a Hallas-Moller stipend from the Novo Nordisk Foundation.	Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; Burnay M, 2003, J BIOL CHEM, V278, P19237, DOI 10.1074/jbc.M300946200; Holmgren M, 2000, NATURE, V403, P898, DOI 10.1038/35002599; Jen JC, 2007, J NEUROL NEUROSUR PS, V78, P523, DOI 10.1136/jnnp.2006.103267; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; Li CM, 2006, J MEMBRANE BIOL, V213, P1, DOI 10.1007/s00232-006-0035-0; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; Riant F, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9361; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKOU JC, 1980, BIOCHIM BIOPHYS ACTA, V601, P386, DOI 10.1016/0005-2736(80)90543-X; Takeuchi A, 2008, NATURE, V456, P413, DOI 10.1038/nature07350; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Vasilyev A, 2004, J MEMBRANE BIOL, V198, P65, DOI 10.1007/s00232-004-0660-4; Yamamoto S, 1996, J PHYSIOL-LONDON, V495, P733, DOI 10.1113/jphysiol.1996.sp021629; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106; Zanotti-Fregonara P, 2008, J NEUROL SCI, V273, P148, DOI 10.1016/j.jns.2008.06.033	28	97	100	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2010	467	7311					99	102		10.1038/nature09309	http://dx.doi.org/10.1038/nature09309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20720542				2022-12-24	WOS:000281461200043
J	Jones, R				Jones, Rachel			Biomarkers: casting the net wide	NATURE			English	Editorial Material							PARKINSONS-DISEASE; HUMAN PLASMA											Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Booij J, 1997, EUR J NUCL MED, V24, P68, DOI 10.1007/BF01728311; COLLINGWOOD JF, 2008, MOV DIS S1, V23; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Oakley AE, 2007, NEUROLOGY, V68, P1820, DOI 10.1212/01.wnl.0000262033.01945.9a; POSNEN MM, 2004, ANN NEUROL, V56, P173	7	18	18	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					S11	S12		10.1038/466S11a	http://dx.doi.org/10.1038/466S11a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20739930				2022-12-24	WOS:000281203600061
J	Safren, SA; Sprich, S; Mimiaga, MJ; Surman, C; Knouse, L; Groves, M; Otto, MW				Safren, Steven A.; Sprich, Susan; Mimiaga, Matthew J.; Surman, Craig; Knouse, Laura; Groves, Meghan; Otto, Michael W.			Cognitive Behavioral Therapy vs Relaxation With Educational Support for Medication-Treated Adults With ADHD and Persistent Symptoms A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; PLACEBO	Context Attention-deficit/hyperactivity disorder (ADHD) in adulthood is a prevalent, distressing, and impairing condition that is not fully treated by pharmacotherapy alone and lacks evidence-based psychosocial treatments. Objective To test cognitive behavioral therapy for ADHD in adults treated with medication but who still have clinically significant symptoms. Design, Setting, and Patients Randomized controlled trial assessing the efficacy of cognitive behavioral therapy for 86 symptomatic adults with ADHD who were already being treated with medication. The study was conducted at a US hospital between November 2004 and June 2008 (follow-up was conducted through July 2009). Of the 86 patients randomized, 79 completed treatment and 70 completed the follow-up assessments. Interventions Patients were randomized to 12 individual sessions of either cognitive behavioral therapy or relaxation with educational support (which is an attention-matched comparison). Main Outcome Measures The primary measures were ADHD symptoms rated by an assessor (ADHD rating scale and Clinical Global Impression scale) at baseline, post-treatment, and at 6- and 12-month follow-up. The assessor was blinded to treatment condition assignment. The secondary outcome measure was self-report of ADHD symptoms. Results Cognitive behavioral therapy achieved lower posttreatment scores on both the Clinical Global Impression scale (magnitude -0.0531; 95% confidence interval [CI], -1.01 to -0.05; P=.03) and the ADHD rating scale (magnitude -4.631; 95% CI, -8.30 to -0.963; P=.02) compared with relaxation with educational support. Throughout treatment, self-reported symptoms were also significantly more improved for cognitive behavioral therapy (beta=-0.41; 95% Cl, -0.64 to -0.17; P<001), and there were more treatment responders in cognitive behavioral therapy for both the Clinical Global Impression scale (53% vs 23%; odds ratio [OR], 3.80; 95% CI, 1.50 to 9.59; P=.01) and the ADHD rating scale (67% vs 33%; OR, 4.29; 95% Cl, 1.74 to 10.58; P=.002). Responders and partial responders in the cognitive behavioral therapy condition maintained their gains over 6 and 12 months. Conclusion Among adults with persistent ADHD symptoms treated with medication, the use of cognitive behavioral therapy compared with relaxation with educational support resulted in improved ADHD symptoms, which were maintained at 12 months.	[Safren, Steven A.; Sprich, Susan; Mimiaga, Matthew J.; Surman, Craig; Knouse, Laura; Groves, Meghan; Otto, Michael W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Safren, Steven A.; Sprich, Susan; Mimiaga, Matthew J.; Surman, Craig; Knouse, Laura] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Otto, Michael W.] Boston Univ, Dept Psychol, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Boston University	Safren, SA (corresponding author), Massachusetts Gen Hosp Behav Med, 1 Bowdoin Sq,7th Floor, Boston, MA 02114 USA.	ssafren@partners.org		Otto, Michael/0000-0002-8915-7578	Abbott; Alza; Cephalon; Eli Lilly; ElMinda the Hilda and Preston Davis Foundation; McNeil; Merck; New River; National Institutes of Health; Organon; Pfizer; Shire; Takeda; Jazz Pharmaceuticals; Organon (Schering-Plough); Sanofi-Aventis; National Institutes of Health [5R01MH69812]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069812] Funding Source: NIH RePORTER	Abbott(Abbott Laboratories); Alza; Cephalon; Eli Lilly(Eli Lilly); ElMinda the Hilda and Preston Davis Foundation; McNeil; Merck(Merck & Company); New River; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Organon; Pfizer(Pfizer); Shire; Takeda(Takeda Pharmaceutical Company Ltd); Jazz Pharmaceuticals(Jazz Pharmaceuticals); Organon (Schering-Plough)(Merck & CompanySchering Plough Corporation); Sanofi-Aventis(Sanofi-Aventis); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Drs Safren, Sprich, and Otto reported receiving royalty payments from Oxford University Press. Dr Surman reported receiving research support from Abbott, Alza, Cephalon, Eli Lilly, ElMinda the Hilda and Preston Davis Foundation, McNeil, Merck, New River, National Institutes of Health, Organon, Pfizer, Shire, and Takeda; being a speaker for Janssen-Ortho, McNeil, Novartis, Shire, and MGH Academy/Reed Medical Education (which receives funding from multiple pharmaceutical companies); and being a consultant or advisor for McNeil, Shire, and Takeda. Dr Knouse reported receiving consulting income from Eli Lilly. Dr Otto reported receiving consulting income from Jazz Pharmaceuticals, Organon (Schering-Plough), Pfizer, and Sanofi-Aventis; research support from Organon (Schering-Plough); and royalty payments for use of the SIGH-A from Lilly.; This study was funded by National Institutes of Health grant 5R01MH69812.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barkley R.A, 2006, ATTENTION DEFICIT HY, V3rd; Biederman J, 2006, ATTENTION DEFICIT HY, P704; DuPaul G. J., 1998, ADHD RATING SCALE 4; Faries DE., 2016, J ATTEN DISORD, V5, P107, DOI [DOI 10.1177/108705470100500204, 10.1177/108705470100500204]; First M. B., 2002, STRUCTURED CLIN INTE; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Knouse Laura E, 2008, Expert Rev Neurother, V8, P1537, DOI 10.1586/14737175.8.10.1537; National Institute of Mental Health, 1985, PSYCHOPHARMACOL BULL, V21, P839; ORVASCHEL H, 1985, PSYCHOPHARMACOL BULL, V21, P737; Safren S. A., 2005, MASTERING YOUR ADULT; Safren SA, 2005, BEHAV RES THER, V43, P831, DOI 10.1016/j.brat.2004.07.001; Solanto MV, 2010, AM J PSYCHIAT, V167, P958, DOI 10.1176/appi.ajp.2009.09081123; SPENCER T, 1995, ARCH GEN PSYCHIAT, V52, P434; Steele M, 2006, CLIN THER, V28, P1892, DOI 10.1016/j.clinthera.2006.11.006; Wilens TE, 1996, AM J PSYCHIAT, V153, P1147; Zylowska L, 2008, J ATTEN DISORD, V11, P737, DOI 10.1177/1087054707308502	17	213	219	0	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2010	304	8					875	880		10.1001/jama.2010.1192	http://dx.doi.org/10.1001/jama.2010.1192			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644OY	20736471	Bronze, Green Accepted			2022-12-24	WOS:000281389900025
J	Cates, W				Cates, Willard, Jr.			After CAPRISA 004: time to re-evaluate the HIV lexicon	LANCET			English	Editorial Material							PREVENT		FHI, Res Triangle Pk, NC 27709 USA		Cates, W (corresponding author), FHI, Res Triangle Pk, NC 27709 USA.	wcates@fhi.org						Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; *IAVI, 2010, E002 IAVI; *IAVI, 2010, E001 IAVI; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; *VOICE, 2010, MTN003 VOICE	7	24	24	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 14	2010	376	9740					495	496		10.1016/S0140-6736(10)61200-7	http://dx.doi.org/10.1016/S0140-6736(10)61200-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643BE	20709216				2022-12-24	WOS:000281266800008
J	Gonzalez-Suarez, E; Jacob, AP; Jones, J; Miller, R; Roudier-Meyer, MP; Erwert, R; Pinkas, J; Branstetter, D; Dougall, WC				Gonzalez-Suarez, Eva; Jacob, Allison P.; Jones, Jon; Miller, Robert; Roudier-Meyer, Martine P.; Erwert, Ryan; Pinkas, Jan; Branstetter, Dan; Dougall, William C.			RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis	NATURE			English	Article							HORMONE REPLACEMENT THERAPY; HUMAN BREAST-TUMORS; GLAND DEVELOPMENT; TRANSGENIC MICE; MEDROXYPROGESTERONE ACETATE; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN-LIGAND; CELL FUNCTION; RECEPTOR; EXPRESSION	RANK ligand (RANKL), a TNF-related molecule, is essential for osteoclast formation, function and survival through interaction with its receptor RANK(1,2). Mammary glands of RANK-and RANKL-deficient mice develop normally during sexual maturation, but fail to form lobuloalveolar structures during pregnancy because of defective proliferation and increased apoptosis of mammary epithelium(3). It has been shown that RANKL is responsible for the major proliferative response of mouse mammary epithelium to progesterone during mammary lactational morphogenesis(4), and in mouse models, manipulated to induce activation of the RANK/RANKL pathway in the absence of strict hormonal control, inappropriate mammary proliferation is observed(5,6). However, there is no evidence so far of a functional contribution of RANKL to tumorigenesis. Here we show that RANK and RANKL are expressed within normal, pre-malignant and neoplastic mammary epithelium, and using complementary gain-of-function (mouse mammary tumour virus (MMTV)-RANK transgenic mice) and loss-of function (pharmacological inhibition of RANKL) approaches, define a direct contribution of this pathway in mammary tumorigenesis. Accelerated pre-neoplasias and increased mammary tumour formation were observed in MMTV-RANK transgenic mice after multiparity or treatment with carcinogen and hormone (progesterone). Reciprocally, selective pharmacological inhibition of RANKL attenuated mammary tumour development not only in hormone-and carcinogen-treated MMTV-RANK and wild-type mice, but also in the MMTV-neu transgenic spontaneous tumour model. The reduction in tumorigenesis upon RANKL inhibition was preceded by a reduction in pre-neoplasias as well as rapid and sustained reductions in hormone-and carcinogen-induced mammary epithelial proliferation and cyclin D1 levels. Collectively, our results indicate that RANKL inhibition is acting directly on hormone-induced mammary epithelium at early stages in tumorigenesis, and the permissive contribution of progesterone to increased mammary cancer incidence is due to RANKL-dependent proliferative changes in the mammary epithelium. The current study highlights a potential role for RANKL inhibition in the management of proliferative breast disease.	[Gonzalez-Suarez, Eva; Jacob, Allison P.; Jones, Jon; Miller, Robert; Erwert, Ryan; Dougall, William C.] Amgen Inc, Dept Hematol Oncol Res, Seattle, WA 98119 USA; [Roudier-Meyer, Martine P.; Branstetter, Dan] Amgen Inc, Dept Pathol, Seattle, WA 98119 USA; [Pinkas, Jan] Amgen Inc, Dept Hematol Oncol Res, Cambridge, MA 02139 USA	Amgen; Amgen; Amgen	Dougall, WC (corresponding author), Amgen Inc, Dept Hematol Oncol Res, Seattle, WA 98119 USA.	dougallw@amgen.com	Gonzalez-Suarez, Eva/L-6298-2014	Gonzalez-Suarez, Eva/0000-0003-0858-8171; Dougall, William/0000-0001-9487-251X				Aldaz CM, 1996, CARCINOGENESIS, V17, P2069, DOI 10.1093/carcin/17.9.2069; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Aupperlee Mark, 2005, Breast Dis, V24, P37; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fernandez-Valdivia R, 2009, DEV BIOL, V328, P127, DOI 10.1016/j.ydbio.2009.01.019; Gonzalez-Suarez E, 2007, MOL CELL BIOL, V27, P1442, DOI 10.1128/MCB.01298-06; Greendale GA, 2003, J NATL CANCER I, V95, P30, DOI 10.1093/jnci/95.1.30; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hewitt SC, 2002, CANCER RES, V62, P2798; Hofseth LJ, 1999, J CLIN ENDOCR METAB, V84, P4559, DOI 10.1210/jc.84.12.4559; Holmberg L, 2008, JNCI-J NATL CANCER I, V100, P475, DOI 10.1093/jnci/djn058; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Ismail PM, 2003, STEROIDS, V68, P779, DOI 10.1016/S0039-128X(03)00133-8; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Klijn JGM, 2000, STEROIDS, V65, P825, DOI 10.1016/S0039-128X(00)00195-1; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Van Poznak C, 2006, J CLIN PATHOL, V59, P56, DOI 10.1136/jcp.2005.026534; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0	28	396	408	0	43	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					103	+		10.1038/nature09495	http://dx.doi.org/10.1038/nature09495			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20881963				2022-12-24	WOS:000283786900044
J	Lansdorp-Vogelaar, I; Kuntz, KM; Knudsen, AB; Wilschut, JA; Zauber, AG; van Ballegooijen, M				Lansdorp-Vogelaar, Iris; Kuntz, Karen M.; Knudsen, Amy B.; Wilschut, Janneke A.; Zauber, Ann G.; van Ballegooijen, Marjolein			Stool DNA Testing to Screen for Colorectal Cancer in the Medicare Population A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							FECAL OCCULT-BLOOD; LARGE-INTESTINE; LARGE-BOWEL; COLONOSCOPY; POLYPS; SURVEILLANCE; GUIDELINES; SOCIETY; PATIENT; UPDATE	Background: The Centers for Medicare & Medicaid Services considered whether to reimburse stool DNA testing for colorectal cancer screening among Medicare enrollees. Objective: To evaluate the conditions under which stool DNA testing could be cost-effective compared with the colorectal cancer screening tests currently reimbursed by the Centers for Medicare & Medicaid Services. Design: Comparative microsimulation modeling study using 2 independently developed models. Data Sources: Derived from literature. Target Population: A cohort of persons aged 65 years. A sensitivity analysis was also conducted, in which a cohort of persons aged 50 years was studied. Time Horizon: Lifetime. Perspective: Third-party payer. Intervention: Stool DNA test every 3 or 5 years in comparison with currently recommended colorectal cancer screening strategies. Outcome Measures: Life expectancy, lifetime costs, incremental cost-effectiveness ratios, and threshold costs. Results of Base-Case Analysis: Assuming a cost of $350 per test, strategies of stool DNA testing every 3 or 5 years yielded fewer life-years and higher costs than the currently recommended colorectal cancer screening strategies. Screening with the stool DNA test would be cost-effective at a per-test cost of $40 to $60 for stool DNA testing every 3 years, depending on the simulation model used. There were no levels of sensitivity and specificity for which stool DNA testing would be cost-effective at its current cost of $350 per test. Stool DNA testing every 3 years would be cost-effective at a cost of $350 per test if the relative adherence to stool DNA testing were at least 50% better than that with other screening tests. Results of Sensitivity Analysis: None of the results changed substantially when a cohort of persons aged 50 years was considered. Limitation: No pathways other than the traditional adenoma-carcinoma sequence were modeled. Conclusion: Stool DNA testing could be a cost-effective alternative for colorectal cancer screening if the cost of the test substantially decreased or if its availability would entice a large fraction of otherwise unscreened persons to receive screening.	[Lansdorp-Vogelaar, Iris; Wilschut, Janneke A.; van Ballegooijen, Marjolein] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Lansdorp-Vogelaar, I (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	i.vogelaar@erasmusmc.nl		Wilschut, Janneke/0000-0002-4921-227X	Agency for Healthcare Research and Quality [HHSP233200700123P, HHSP233200700196P, HHSP233200700350P]; National Cancer Institute [U01-CA-088204, U01-CA-097426, U01-CA-115953]; NATIONAL CANCER INSTITUTE [U01CA115953, P30CA008748, U01CA097426, U01CA088204] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the Agency for Healthcare Research and Quality (HHSP233200700123P, HHSP233200700196P, HHSP233200700350P) and the National Cancer Institute (U01-CA-088204, U01-CA-097426, and U01-CA-115953).	Ahlquist DA, 2008, ANN INTERN MED, V149, P441, DOI 10.7326/0003-4819-149-7-200810070-00004; Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; ARMINSKI T. C., 1964, DIS COLON RECTUM, V7, P249, DOI 10.1007/BF02630528; Blatt LJ., 1961, DIS COLON RECTUM, V4, P277; BOMBI JA, 1988, CANCER-AM CANCER SOC, V61, P1472, DOI 10.1002/1097-0142(19880401)61:7<1472::AID-CNCR2820610734>3.0.CO;2-E; CHAPMAN I, 1963, ANN SURG, V157, P223, DOI 10.1097/00000658-196302000-00007; Chung DC, 2008, ANN INTERN MED, V149, P509, DOI 10.7326/0003-4819-149-7-200810070-00013; CLARK JC, 1985, INT J CANCER, V36, P179, DOI 10.1002/ijc.2910360209; EIDE TJ, 1986, INT J CANCER, V38, P173, DOI 10.1002/ijc.2910380205; *EX SCI CORP, 2010, EX SCI CORP ANN REP; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Gold MR, 1996, COST EFFECTIVENESS H; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Itzkowitz S, 2008, AM J GASTROENTEROL, V103, P2862, DOI 10.1111/j.1572-0241.2008.02088.x; Itzkowitz SH, 2007, CLIN GASTROENTEROL H, V5, P111, DOI 10.1016/j.cgh.2006.10.006; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; JASS JR, 1992, GUT, V33, P1508, DOI 10.1136/gut.33.11.1508; JOHANNSEN LGK, 1989, SCAND J GASTROENTERO, V24, P799, DOI 10.3109/00365528909089217; KNUDSEN A, 2005, THESIS HARVARD U; Lansdorp-Vogelaar I, 2009, CANCER-AM CANCER SOC, V115, P2410, DOI 10.1002/cncr.24256; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Levin TR, 2002, GASTROENTEROLOGY, V123, P1786, DOI 10.1053/gast.2002.37064; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Loeve F, 1999, COMPUT BIOMED RES, V32, P13, DOI 10.1006/cbmr.1998.1498; Loeve F, 2000, J NATL CANCER I, V92, P557, DOI 10.1093/jnci/92.7.557; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Mark DH, 2002, JAMA-J AM MED ASSOC, V287, P2428, DOI 10.1001/jama.287.18.2428; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Morikawa T, 2007, AM J GASTROENTEROL, V102, P2259, DOI 10.1111/j.1572-0241.2007.01404.x; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; PERRONE M, 2007, GOVT OFFICIALS WILL; Pox C, 2007, ENDOSCOPY, V39, P168, DOI 10.1055/s-2007-966182; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; RICKERT RR, 1979, CANCER-AM CANCER SOC, V43, P1847, DOI 10.1002/1097-0142(197905)43:5<1847::AID-CNCR2820430538>3.0.CO;2-L; Schroy PC, 2007, AM J MANAG CARE, V13, P393; Schroy PC, 2005, AM J PREV MED, V28, P208, DOI 10.1016/j.amepre.2004.10.008; Shapiro JA, 2008, CANCER EPIDEM BIOMAR, V17, P1623, DOI 10.1158/1055-9965.EPI-07-2838; Smith RA, 2006, CA-CANCER J CLIN, V56, P11, DOI 10.3322/canjclin.56.1.11; Song K, 2004, GASTROENTEROLOGY, V126, P1270, DOI 10.1053/j.gastro.2004.02.016; Syngal S, 2006, CANCER, V106, P277, DOI 10.1002/cncr.21558; Tagore Kuldeep S, 2003, Clin Colorectal Cancer, V3, P47, DOI 10.3816/CCC.2003.n.011; *US CENS BUR, 2010, US POP PROJ; *US PREV SERV TASK, 2008, ANN INT MED, V149; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; VANBALLEGOOIJEN M, 2008, REPORT AGENCY HEALTH; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Whitney D, 2004, J MOL DIAGN, V6, P386, DOI 10.1016/S1525-1578(10)60536-3; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Wu GHM, 2006, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-136; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; ZAUBER A, 2000, EFFECTIVENESS DNA ST; 2002, 59100 FED REG	57	58	58	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2010	153	6					368	377		10.7326/0003-4819-153-6-201009210-00004	http://dx.doi.org/10.7326/0003-4819-153-6-201009210-00004			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652WY	20855801				2022-12-24	WOS:000282043100003
J	Boyd, K; Murray, SA				Boyd, Kirsty; Murray, Scott A.			Spotlight: Palliative Care Beyond Cancer Recognising and managing key transitions in end of life care	BRITISH MEDICAL JOURNAL			English	Article							HEART-FAILURE; PREDICTION; DISEASE; INDEX		[Boyd, Kirsty; Murray, Scott A.] Univ Edinburgh, Ctr Pop Hlth Sci, Primary Palliat Care Res Grp, Edinburgh, Scotland	University of Edinburgh	Boyd, K (corresponding author), Univ Edinburgh, Ctr Pop Hlth Sci, Primary Palliat Care Res Grp, Edinburgh, Scotland.	Kirsty.Boyd@luht.scot.nhs.uk		Boyd, Kirsty/0000-0002-5526-1078				Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Department of Health, 2008, END LIF CAR STRAT AD; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Glare PA, 2008, J PALLIAT MED, V11, P84, DOI 10.1089/jpm.2008.9992; Larson AM, 2006, JAMA-J AM MED ASSOC, V295, P2168, DOI 10.1001/jama.295.18.2168; Lau F, 2009, J PAIN SYMPTOM MANAG, V38, P134, DOI 10.1016/j.jpainsymman.2008.05.017; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Luhrs CA, 2005, J PAIN SYMPTOM MANAG, V29, P544, DOI 10.1016/j.jpainsymman.2005.02.010; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Munday D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2391; Murray SA, 2008, FAM PRACT, V25, P78, DOI 10.1093/fampra/cmn011; National Gold Standards Framework Centre, 2008, PROGN IND GUID PAP; NORTON SA, PROACTIVE PALLIATIVE; *ROYAL COLL PHYS, 2008, ADV CAR PLANN CONC E; *ROYAL COLL PHYS L, 2007, PALL CAR SERV M NEED; *SCOTT GOV HLTH DE, 2008, LIV DYING WELL NAT A; Selman L, 2007, HEART, V93, P963, DOI 10.1136/hrt.2006.106518; Shipman C, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1720; Stone CA, 2008, J PAIN SYMPTOM MANAG, V35, P617, DOI 10.1016/j.jpainsymman.2007.07.006	21	126	127	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 16	2010	341								c4863	10.1136/bmj.c4863	http://dx.doi.org/10.1136/bmj.c4863			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653MO	20847023				2022-12-24	WOS:000282095800011
J	Kim, HJ; Verbinnen, B; Tang, XL; Lu, LR; Cantor, H				Kim, Hye-Jung; Verbinnen, Bert; Tang, Xiaolei; Lu, Linrong; Cantor, Harvey			Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance	NATURE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOIMMUNE-DISEASE; B-CELLS; SUPPRESSION; T-HELPER-2; GENERATION; EXPANSION; IL-15; IL-21; MICE	The ability to produce vigorous immune responses that spare self tissues and organs depends on the elimination of autoreactive T and B cells. However, purging of immature and mature self-reactive T and B cells is incomplete and may also require the involvement of cells programmed to suppress immune responses(1). Regulatory T cells (T-reg) belonging to the CD4(+) T-cell subset may have a role in preventing untoward inflammatory responses, but T-cell subsets programmed to inhibit the development of autoantibody formation and systemic-lupus-erythematosus-like disease have not yet been defined(2). Here we delineate a CD8(+) regulatory T-cell lineage that is essential for the maintenance of self tolerance and prevention of murine autoimmune disease. Genetic disruption of the inhibitory interaction between these CD8(+) T cells and their target Qa-1(+) follicular T-helper cells results in the development of a lethal systemic-lupus-erythematosus-like autoimmune disease. These findings define a sublineage of CD8 T cells programmed to suppress rather than activate immunity that represents an essential regulatory element of the immune response and a guarantor of self tolerance.	[Kim, Hye-Jung; Verbinnen, Bert; Tang, Xiaolei; Cantor, Harvey] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Kim, Hye-Jung; Verbinnen, Bert; Tang, Xiaolei; Cantor, Harvey] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Lu, Linrong] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Zhejiang University	Cantor, H (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	Harvey_Cantor@dfci.harvard.edu	Lu, Linrong/A-1429-2013	Lu, Linrong/0000-0002-0171-4115; Tang, Xiaoren/0000-0002-2402-3659	NIH [AI 037562]; Lupus Research Institute; Schecter Research Foundation; National Research Service [DFCI/NCI T32 CA070083, HSPH/NCI T32 CA009382]; Belgian American Educational Foundation; NATIONAL CANCER INSTITUTE [T32CA070083, T32CA009382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037562] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Institute; Schecter Research Foundation; National Research Service; Belgian American Educational Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Bronson (DF/HCC Rodent Histopathology Core) for histology analysis, R. Gelman and J. Yang for help with statistical analyses, C. Daniel and T. Kreslavsky for cytometry support and critical discussions, M. Iannacone and U. von Andrian for LCMV, X. Wang for technical assistance, M. Call, D. A. Alvarez Arias, T. Kadakia and A. Angel for manuscript and figure preparation. This work was supported in part by NIH Research Grant AI 037562, the Lupus Research Institute and a gift from the Schecter Research Foundation to H.C.; National Research Service Award Fellowships (DFCI/NCI T32 CA070083) to H.-J.K. and (HSPH/NCI T32 CA009382) to X.T.; and a Belgian American Educational Foundation Fellowship to B.V.	Bubier JA, 2009, P NATL ACAD SCI USA, V106, P1518, DOI 10.1073/pnas.0807309106; Cantor H, 2004, NAT IMMUNOL, V5, P347, DOI 10.1038/ni0404-347; Cantor H, 2000, ADV IMMUNOL, V75, P209, DOI 10.1016/S0065-2776(00)75005-X; Chen WL, 2007, P NATL ACAD SCI USA, V104, P20472, DOI 10.1073/pnas.0709878104; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; Hunziker L, 2003, NAT IMMUNOL, V4, P343, DOI 10.1038/ni911; JIANG H, 1992, SCIENCE, V256, P1213, DOI 10.1126/science.256.5060.1213; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Linterman MA, 2009, J EXP MED, V206, P561, DOI 10.1084/jem.20081886; Lu LR, 2007, IMMUNITY, V26, P593, DOI 10.1016/j.immuni.2007.03.017; Lu LR, 2008, CELL MOL IMMUNOL, V5, P401, DOI 10.1038/cmi.2008.50; Lu LR, 2008, P NATL ACAD SCI USA, V105, P19420, DOI 10.1073/pnas.0810383105; Mitchell DM, 2010, J IMMUNOL, V184, P6719, DOI 10.4049/jimmunol.0904089; Noble A, 1998, J IMMUNOL, V160, P566; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Panoutsakopoulou V, 2001, IMMUNITY, V15, P137, DOI 10.1016/S1074-7613(01)00172-8; Ray SK, 1996, P NATL ACAD SCI USA, V93, P2019, DOI 10.1073/pnas.93.5.2019; Sangster MY, 2000, J IMMUNOL, V164, P1820, DOI 10.4049/jimmunol.164.4.1820; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Yurasov S, 2007, CURR OPIN RHEUMATOL, V19, P421, DOI 10.1097/BOR.0b013e328277ef3b; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057	23	254	280	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2010	467	7313					328	U107		10.1038/nature09370	http://dx.doi.org/10.1038/nature09370			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20844537	Green Accepted			2022-12-24	WOS:000281824900039
J	Niles, PB; Boynton, WV; Hoffman, JH; Ming, DW; Hamara, D				Niles, Paul B.; Boynton, William V.; Hoffman, John H.; Ming, Douglas W.; Hamara, Dave			Stable Isotope Measurements of Martian Atmospheric CO2 at the Phoenix Landing Site	SCIENCE			English	Article							ALLAN HILLS 84001; SNC METEORITES; WEATHERING PRODUCTS; VOLATILE EVOLUTION; CALCIUM-CARBONATE; MARS; OXYGEN; EETA-79001; ALH84001; RATIOS	Carbon dioxide is a primary component of the martian atmosphere and reacts readily with water and silicate rocks. Thus, the stable isotopic composition of CO2 can reveal much about the history of volatiles on the planet. The Mars Phoenix spacecraft measurements of carbon isotopes [referenced to the Vienna Pee Dee belemnite (VPDB)] [delta C-13(VPDB) = -2.5 +/- 4.3 per mil (parts per thousand)] and oxygen isotopes [referenced to the Vienna standard mean ocean water (VSMOW)] (delta O-18(VSMOW) = 31.0 +/- 5.7 parts per thousand), reported here, indicate that CO2 is heavily influenced by modern volcanic degassing and equilibration with liquid water. When combined with data from the martian meteorites, a general model can be constructed that constrains the history of water, volcanism, atmospheric evolution, and weathering on Mars. This suggests that low-temperature water-rock interaction has been dominant throughout martian history, carbonate formation is active and ongoing, and recent volcanic degassing has played a substantial role in the composition of the modern atmosphere.	[Niles, Paul B.; Ming, Douglas W.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Boynton, William V.; Hamara, Dave] Univ Arizona, Dept Planetary Sci, Tucson, AZ 85721 USA; [Hoffman, John H.] Univ Texas Dallas, Dept Phys, Dallas, TX 75080 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Arizona; University of Texas System; University of Texas Dallas	Niles, PB (corresponding author), NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA.	paul.b.niles@nasa.gov						Borg LE, 1999, SCIENCE, V286, P90, DOI 10.1126/science.286.5437.90; Boynton WV, 2009, SCIENCE, V325, P61, DOI 10.1126/science.1172768; CARR RH, 1985, NATURE, V314, P248, DOI 10.1038/314248a0; CLAYTON RN, 1988, GEOCHIM COSMOCHIM AC, V52, P925, DOI 10.1016/0016-7037(88)90363-8; Encrenaz T, 2005, ICARUS, V179, P43, DOI 10.1016/j.icarus.2005.06.022; Faure G., 1986, PRINCIPLES ISOTOPE G, V2nd; GOODING JL, 1988, GEOCHIM COSMOCHIM AC, V52, P909, DOI 10.1016/0016-7037(88)90361-4; Hoffman JH, 2008, J AM SOC MASS SPECTR, V19, P1377, DOI 10.1016/j.jasms.2008.07.015; Holland G, 2005, GEOCHIM COSMOCHIM AC, V69, P1359, DOI 10.1016/j.gca.2004.08.023; HUNTEN DM, 1987, ICARUS, V69, P532, DOI 10.1016/0019-1035(87)90022-4; JAKOSKY BM, 1991, ICARUS, V94, P14, DOI 10.1016/0019-1035(91)90138-J; Jakosky BM, 1999, ORIGINS LIFE EVOL B, V29, P47, DOI 10.1023/A:1006586319129; Jull AJT, 2000, GEOCHIM COSMOCHIM AC, V64, P3763, DOI 10.1016/S0016-7037(00)00458-0; Jull AJT, 1998, SCIENCE, V279, P366, DOI 10.1126/science.279.5349.366; JULL AJT, 1995, METEORITICS, V30, P311, DOI 10.1111/j.1945-5100.1995.tb01129.x; Jull AJT, 1997, J GEOPHYS RES-PLANET, V102, P1663, DOI 10.1029/96JE03111; Krasnopolsky VA, 1996, ICARUS, V124, P553, DOI 10.1006/icar.1996.0230; Krasnopolsky VA, 2007, ICARUS, V192, P396, DOI 10.1016/j.icarus.2007.08.013; NIER AO, 1976, SCIENCE, V194, P68, DOI 10.1126/science.194.4260.68; Niles PB, 2005, GEOCHIM COSMOCHIM AC, V69, P2931, DOI 10.1016/j.gca.2004.12.012; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; Owen T., 1977, J GEOPHYS RES, V82, P4635, DOI DOI 10.1029/JS082I028P04635; Rao MN, 1999, GEOPHYS RES LETT, V26, P3265, DOI 10.1029/1999GL005388; ROMANEK CS, 1994, NATURE, V372, P655, DOI 10.1038/372655a0; SCHREY U, 1986, ASTRON ASTROPHYS, V155, P200; Swindle TD, 2000, METEORIT PLANET SCI, V35, P107, DOI 10.1111/j.1945-5100.2000.tb01978.x; WALKER JCG, 1989, GEOPHYS RES LETT, V16, P323, DOI 10.1029/GL016i004p00323; WRIGHT IP, 1990, J GEOPHYS RES-SOLID, V95, P14789, DOI 10.1029/JB095iB09p14789; WRIGHT IP, 1988, GEOCHIM COSMOCHIM AC, V52, P917, DOI 10.1016/0016-7037(88)90362-6; WRIGHT IP, 1992, GEOCHIM COSMOCHIM AC, V56, P817, DOI 10.1016/0016-7037(92)90100-W	30	49	51	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1334	1337		10.1126/science.1192863	http://dx.doi.org/10.1126/science.1192863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829484				2022-12-24	WOS:000281657300036
J	Gandhi, TK; Lee, TH				Gandhi, Tejal K.; Lee, Thomas H.			Patient Safety beyond the Hospital	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gandhi, Tejal K.; Lee, Thomas H.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Gandhi, Tejal K.; Lee, Thomas H.] Partners Healthcare Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Gandhi, TK (corresponding author), Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA.							Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; McKinsey and Company Global Institute, 2008, ACC COST US HEALTHC; National Center for Health Statistics, FASTSTATS A Z; Roy CL, 2005, ANN INTERN MED, V143, P121, DOI 10.7326/0003-4819-143-2-200507190-00011; Wachter RM, 2006, ANN INTERN MED, V145, P547, DOI 10.7326/0003-4819-145-7-200610030-00014	5	72	72	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					1001	1003		10.1056/NEJMp1003294	http://dx.doi.org/10.1056/NEJMp1003294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	647HS	20825311				2022-12-24	WOS:000281609700003
J	Kaveri, SV; Mouthon, L; Bayry, J				Kaveri, Srini V.; Mouthon, Luc; Bayry, Jagadeesh			Basophils and Nephritis in Lupus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ERYTHEMATOSUS		[Kaveri, Srini V.; Bayry, Jagadeesh] Univ Paris 06, INSERM, Ctr Rech Cordeliers, Paris, France; [Mouthon, Luc] Univ Paris 05, INSERM, Inst Cochin & Pole Med Interne, AP HP, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bayry, J (corresponding author), Univ Paris 06, INSERM, Ctr Rech Cordeliers, Paris, France.		Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Kaveri, Srini/0000-0002-0837-4053				Atta AM, 2010, INT ARCH ALLERGY IMM, V152, P401, DOI 10.1159/000288293; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297	4	25	27	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					1080	1082		10.1056/NEJMcibr1006936	http://dx.doi.org/10.1056/NEJMcibr1006936			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647HS	20825323				2022-12-24	WOS:000281609700015
J	Lim, WA; Pawson, T				Lim, Wendell A.; Pawson, Tony			Phosphotyrosine Signaling: Evolving a New Cellular Communication System	CELL			English	Article							PROTEIN-TYROSINE PHOSPHATASES; MONOSIGA-BREVICOLLIS; ANIMAL DEVELOPMENT; EVOLUTION; DICTYOSTELIUM; KINASE; DOMAIN; METAZOAN; GENOME; SH2		[Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Lim, WA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu; pawson@lunenfeld.ca	Pawson, Tony J/E-4578-2013		Howard Hughes Medical Institute; National Institutes of health [GM55040, GM62583, GM081879, EY016546]; Packard Foundation; National Science Foundation Synthetic Biology Engineering Research Center; Canadian Institutes for Health Research [MOP-6849]; Genome Canada; Canadian Cancer Society Research Institute; NATIONAL EYE INSTITUTE [PN2EY016546, PN1EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062583, R01GM055040, P50GM081879] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation Synthetic Biology Engineering Research Center; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Pincus, B. Mayer, P. Beltrao, O. Hoeller, R. Linding, G. Superti-Furga, N.King, N.Helman, L. Holt, A. Horwitz, T. Miller, G. Manning, T. Hunter, D. Morgan, J. Williams, H. Bourne, and I. Ernberg for helpful comments. This work was supported by the Howard Hughes Medical Institute (W.L.), the National Institutes of health (GM55040, GM62583, GM081879, and EY016546-W.L.), the Packard Foundation (W.L.), the National Science Foundation Synthetic Biology Engineering Research Center (W. L.), the Canadian Institutes for Health Research (T.P.-MOP-6849), Genome Canada (T.P.), and the Canadian Cancer Society Research Institute (T.P.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alwayn V., 2004, OPTICAL NETWORK DESI; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Dengl S, 2009, J MOL BIOL, V389, P211, DOI 10.1016/j.jmb.2009.04.016; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Jin J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000546; Kawata T, 1997, CELL, V89, P909, DOI 10.1016/S0092-8674(00)80276-7; Kay RR, 1997, CURR BIOL, V7, pR723, DOI 10.1016/S0960-9822(06)00366-6; Kennelly PJ, 2001, CHEM REV, V101, P2291, DOI 10.1021/cr0002543; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; King N, 2004, DEV CELL, V7, P313, DOI 10.1016/j.devcel.2004.08.010; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Langenick J, 2008, J CELL SCI, V121, P3524, DOI 10.1242/jcs.036798; Lee DC, 2009, TRENDS BIOCHEM SCI, V34, P351, DOI 10.1016/j.tibs.2009.03.003; Li WQ, 2009, BIOCHEMISTRY-US, V48, P5180, DOI 10.1021/bi9000672; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Moniakis J, 2001, GENE DEV, V15, P687, DOI 10.1101/gad.871001; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; PAWSON T, 1993, PHILOS T R SOC B, V340, P279, DOI 10.1098/rstb.1993.0069; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Pincus D, 2008, P NATL ACAD SCI USA, V105, P9680, DOI 10.1073/pnas.0803161105; Rokas A, 2008, ANNU REV GENET, V42, P235, DOI 10.1146/annurev.genet.42.110807.091513; SCHIEVEN G, 1986, SCIENCE, V231, P390, DOI 10.1126/science.2417318; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Sugden C, 2010, J BIOL CHEM, V285, P22925, DOI 10.1074/jbc.M110.139733; Tan CSH, 2009, SCIENCE, V325, P1686, DOI 10.1126/science.1174301; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4	31	244	249	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 3	2010	142	5					661	667		10.1016/j.cell.2010.08.023	http://dx.doi.org/10.1016/j.cell.2010.08.023			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813250	Bronze, Green Accepted			2022-12-24	WOS:000281523200005
J	Wijffels, RH; Barbosa, MJ				Wijffels, Rene H.; Barbosa, Maria J.			An Outlook on Microalgal Biofuels	SCIENCE			English	Editorial Material							GENOME REVEALS; BIODIESEL; EVOLUTION	Microalgae are considered one of the most promising feedstocks for biofuels. The productivity of these photosynthetic microorganisms in converting carbon dioxide into carbon-rich lipids, only a step or two away from biodiesel, greatly exceeds that of agricultural oleaginous crops, without competing for arable land. Worldwide, research and demonstration programs are being carried out to develop the technology needed to expand algal lipid production from a craft to a major industrial process. Although microalgae are not yet produced at large scale for bulk applications, recent advances-particularly in the methods of systems biology, genetic engineering, and biorefining-present opportunities to develop this process in a sustainable and economical way within the next 10 to 15 years.	[Wijffels, Rene H.] Wageningen Univ, NL-6700 EV Wageningen, Netherlands; [Barbosa, Maria J.] Univ Wageningen & Res Ctr, NL-6700 AA Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Wijffels, RH (corresponding author), Wageningen Univ, POB 8129, NL-6700 EV Wageningen, Netherlands.	rene.wijffels@wur.nl; maria.barbosa@wur.nl	Barbosa, Maria/K-7574-2018	Barbosa, Maria/0000-0002-8246-0777; Wijffels, Rene/0000-0001-7630-4295				Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; Benemann JR, 2000, J APPL PHYCOL, V12, P291, DOI 10.1023/A:1008175112704; Bosma R, 2010, INT SUGAR J, V112, P74; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; de Fraiture C, 2008, WATER POLICY, V10, P67, DOI 10.2166/wp.2008.054; Deng MD, 1999, APPL ENVIRON MICROB, V65, P523; *EUR ENV AG, 2008, 5 EEA; Hersbach G.J.M., 1984, BIOTECHNOLOGY IND AN, VVolume 22, P45; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; International Energy Agency (IEA), 2010, OIL MARK REP; Kliphuis AMJ, 2010, BIOTECHNOL PROGR, V26, P687, DOI 10.1002/btpr.379; Lardon L, 2009, ENVIRON SCI TECHNOL, V43, P6475, DOI 10.1021/es900705j; Lestari S, 2009, CHEMSUSCHEM, V2, P1109, DOI 10.1002/cssc.200900107; Melis A, 2009, PLANT SCI, V177, P272, DOI 10.1016/j.plantsci.2009.06.005; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; OSWALD WILLIAM J., 1960, ADVANCES APPL MICROBIOL, V2, P223, DOI 10.1016/S0065-2164(08)70127-8; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; Qiang H, 1996, J APPL PHYCOL, V8, P139, DOI 10.1007/BF02186317; Reijnders L, 2008, TRENDS BIOTECHNOL, V26, P349, DOI 10.1016/j.tibtech.2008.04.001; Sheehan J., 1998, LOOK BACK US DEP ENE; Tredici MR, 2010, BIOFUELS-UK, V1, P143, DOI 10.4155/BFS.09.10; Usui N, 1997, ENERG CONVERS MANAGE, V38, pS487, DOI 10.1016/S0196-8904(96)00315-9; van Egmond K, 2002, AMBIO, V31, P72, DOI 10.1639/0044-7447(2002)031[0072:TENC]2.0.CO;2; Walker TL, 2005, J PHYCOL, V41, P1077, DOI 10.1111/j.1529-8817.2005.00133.x; Wijffels RH, 2010, BIOFUEL BIOPROD BIOR, V4, P287, DOI 10.1002/bbb.215; Zijffers JWF, 2010, MAR BIOTECHNOL, V12, P708, DOI 10.1007/s10126-010-9258-2	28	1324	1392	10	779	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					796	799		10.1126/science.1189003	http://dx.doi.org/10.1126/science.1189003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705853				2022-12-24	WOS:000280809900039
J	Liu, T; Ghosal, G; Yuan, JS; Chen, JJ; Huang, J				Liu, Ting; Ghosal, Gargi; Yuan, Jingsong; Chen, Junjie; Huang, Jun			FAN1 Acts with FANCI-FANCD2 to Promote DNA Interstrand Cross-Link Repair	SCIENCE			English	Article							FANCONI-ANEMIA PATHWAY; DAMAGE RESPONSE; PROTEIN; IDENTIFICATION; FANCD2; BREAKS; BRCA1	Fanconi anemia (FA) is caused by mutations in 13 Fanc genes and renders cells hypersensitive to DNA interstrand cross-linking (ICL) agents. A central event in the FA pathway is mono-ubiquitylation of the FANCI-FANCD2 (ID) protein complex. Here, we characterize a previously unrecognized nuclease, Fanconi anemia-associated nuclease 1 (FAN1), that promotes ICL repair in a manner strictly dependent on its ability to accumulate at or near sites of DNA damage and that relies on mono-ubiquitylation of the ID complex. Thus, the mono-ubiquitylated ID complex recruits the downstream repair protein FAN1 and facilitates the repair of DNA interstrand cross-links.	[Liu, Ting; Huang, Jun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Ghosal, Gargi; Yuan, Jingsong; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	Zhejiang University; University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org; jhuang@zju.edu.cn	Yuan, Jingsong/G-4527-2011	Ghosal, Gargi/0000-0001-8399-5354	Life Sciences Institute, Zhejiang University; Fundamental Research Funds for the Central Universities, China; NIH; U.S. Department of Defense	Life Sciences Institute, Zhejiang University; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense)	This work was supported in part by grants from Startup Fund (Life Sciences Institute, Zhejiang University to J.H.), the Fundamental Research Funds for the Central Universities, China (to J.H.), and the NIH (to J.C.). We thank L. Li, X. Shen, and Y. Zhang for reagents. J.H. would like to thank J.C. for his continuous support and mentoring. J.C. is a recipient of an Era of Hope Scholar award from the U.S. Department of Defense and is a member of M.D. Anderson Cancer Center.	Alpi AF, 2009, DNA REPAIR, V8, P430, DOI 10.1016/j.dnarep.2009.01.019; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Moldovan GL, 2009, CELL, V139, P1222, DOI 10.1016/j.cell.2009.12.006; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159	22	195	201	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					693	696		10.1126/science.1192656	http://dx.doi.org/10.1126/science.1192656			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20671156				2022-12-24	WOS:000280602700042
J	Ton-Hoang, B; Pastemak, C; Siguier, P; Guynet, C; Hickman, AB; Dyda, F; Sommer, S; Chandler, M				Ton-Hoang, Bao; Pastemak, Cecile; Siguier, Patricia; Guynet, Catherine; Hickman, Alison Burgess; Dyda, Fred; Sommer, Suzanne; Chandler, Michael			Single-Stranded DNA Transposition Is Coupled to Host Replication	CELL			English	Article							ESCHERICHIA-COLI MUTANTS; YERSINIA-PESTIS; INSERTION-SEQUENCE; GENOME SEQUENCE; PROTEIN; ARREST; TRANSCRIPTION; RECONSTITUTION; TERMINATION; MECHANISM	DNA transposition has contributed significantly to evolution of eukaryotes and prokaryotes. Insertion sequences (ISs) are the simplest prokaryotic trans-posons and are divided into families on the basis of their organization and transposition mechanism. Here, we describe a link between transposition of IS608 and ISDra2, both members of the IS200/IS605 family, which uses obligatory single-stranded DNA intermediates, and the host replication fork. Replication direction through the IS plays a crucial role in excision: activity is maximal when the "top'' IS strand is located on the lagging-strand template. Excision is stimulated upon transient inactivation of replicative helicase function or inhibition of Okazaki fragment synthesis. IS608 insertions also exhibit an orientation preference for the lagging-strand template and insertion can be specifically directed to stalled replication forks. An in silico genomic approach provides evidence that dissemination of other IS200/IS605 family members is also linked to host replication.	[Ton-Hoang, Bao; Siguier, Patricia; Guynet, Catherine; Chandler, Michael] CNRS, Lab Microbiol & Genet Mol, UMR 5100, F-31062 Toulouse, France; [Pastemak, Cecile; Sommer, Suzanne] Univ Paris 11, CNRS, Inst Genet & Microbiol,UMR 8621, Lab Rech Correspondant Commissariat Energie Atom, F-91405 Orsay, France; [Hickman, Alison Burgess; Dyda, Fred] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ton-Hoang, B (corresponding author), CNRS, Lab Microbiol & Genet Mol, UMR 5100, 118 Route Narbonne, F-31062 Toulouse, France.	bao.tonhoang@ibcg.biotoul.fr; michael.chandler@ibcg.biotoul.fr	Guynet, Catherine/A-4815-2011; Guynet, Catherine/GPX-0917-2022	Chandler, Michael/0000-0002-0292-6662; Pasternak, Cecile/0000-0002-7884-2422; Siguier, Patricia/0000-0003-1620-6495	Centre National de Recherche Scientifique (France); ANR; European contract [LSHM-CT-2005-019023]; Commissariat a l'Energie Atomique and Electricite de France (France); National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036154] Funding Source: NIH RePORTER	Centre National de Recherche Scientifique (France); ANR(French National Research Agency (ANR)); European contract; Commissariat a l'Energie Atomique and Electricite de France (France); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank members of the "Mobile Genetic Elements'' group, A. Bailone, P. Polard, and D. Lane for discussions, G. Coste and B. Marty for expert technical assistance, L. Lavatine for guiding us through the mysteries of statistics, A. Varani for identifying a representative oligonucleotide sequence used in the PCR mapping for the D. radiodurans genome, and the Institut Curie for the use of the <SUP>137</SUP>Cs irradiation system. This work was supported by: intramural funding from the Centre National de Recherche Scientifique (France), in its later stages by ANR grant Mobigen (M.C. and S.S.), European contract LSHM-CT-2005-019023 (M.C.), and the Commissariat a l'Energie Atomique and Electricite de France (France; S.S.). At the National Institutes of Health, this work was supported by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases.	Bao TH, 2005, EMBO J, V24, P3325, DOI 10.1038/sj.emboj.7600787; Barabas O, 2008, CELL, V132, P208, DOI 10.1016/j.cell.2007.12.029; Belle JJ, 2007, J BACTERIOL, V189, P5452, DOI 10.1128/JB.00408-07; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; BIERNE H, 1994, J BACTERIOL, V176, P4165, DOI 10.1128/JB.176.13.4165-4167.1994; BIERNE H, 1994, MOL MICROBIOL, V13, P17, DOI 10.1111/j.1365-2958.1994.tb00398.x; CARL PL, 1970, MOL GEN GENET, V109, P107, DOI 10.1007/BF00269647; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chandler M, 2009, CELL, V138, P621, DOI 10.1016/j.cell.2009.08.003; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; DODSON KW, 1989, GENE, V76, P207, DOI 10.1016/0378-1119(89)90161-3; EliasArnanz M, 1997, EMBO J, V16, P5775, DOI 10.1093/emboj/16.18.5775; FOUSER L, 1983, J BACTERIOL, V154, P1174, DOI 10.1128/JB.154.3.1174-1183.1983; GALAS DJ, 1982, J MOL BIOL, V154, P245, DOI 10.1016/0022-2836(82)90063-8; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Guynet C, 2008, MOL CELL, V29, P302, DOI 10.1016/j.molcel.2007.12.008; Guynet C, 2009, MOL CELL, V34, P612, DOI 10.1016/j.molcel.2009.05.017; Hendrickson H, 2006, J MOL EVOL, V62, P615, DOI 10.1007/s00239-005-0192-2; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Hu WY, 1998, J BACTERIOL, V180, P3039, DOI 10.1128/JB.180.12.3039-3048.1998; Islam MS, 2003, GENES GENET SYST, V78, P319, DOI 10.1266/ggs.78.319; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kaplan DL, 2009, MOL MICROBIOL, V72, P279, DOI 10.1111/j.1365-2958.2009.06656.x; Karpinets TV, 2010, FUNCT INTEGR GENOMIC, V10, P97, DOI 10.1007/s10142-009-0142-y; Kersulyte D, 2002, J BACTERIOL, V184, P992, DOI 10.1128/jb.184.4.992-1002.2002; Kornberg A., 1992, DNA REPLICATION; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; LOUARN JM, 1974, MOL GEN GENET, V133, P193, DOI 10.1007/BF00267668; Mennecier S, 2006, MOL MICROBIOL, V59, P317, DOI 10.1111/j.1365-2958.2005.04936.x; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Mirkin EV, 2006, P NATL ACAD SCI USA, V103, P7276, DOI 10.1073/pnas.0601127103; Mohanty BK, 1998, J BIOL CHEM, V273, P3051, DOI 10.1074/jbc.273.5.3051; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Parks AR, 2009, CELL, V138, P685, DOI 10.1016/j.cell.2009.06.011; Pasternak C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000799; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; ROBERTS D, 1985, CELL, V43, P117, DOI 10.1016/0092-8674(85)90017-0; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; Sanders GM, 2010, MOL CELL, V37, P273, DOI 10.1016/j.molcel.2009.12.025; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Turlan C, 2000, TRENDS MICROBIOL, V8, P268, DOI 10.1016/S0966-842X(00)01757-1; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; WECHSLER JA, 1971, MOL GEN GENET, V113, P273, DOI 10.1007/BF00339547; YIN JCP, 1988, J MOL BIOL, V199, P35, DOI 10.1016/0022-2836(88)90377-4; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; ZECHNER EL, 1992, J BIOL CHEM, V267, P4045	52	46	49	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					398	408		10.1016/j.cell.2010.06.034	http://dx.doi.org/10.1016/j.cell.2010.06.034			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691900	Green Accepted, Bronze			2022-12-24	WOS:000280609100017
J	Williamson, CE; Rose, KC				Williamson, Craig E.; Rose, Kevin C.			When UV Meets Fresh Water	SCIENCE			English	Editorial Material							ULTRAVIOLET-RADIATION; INFECTIVITY; MIGRATION; PATTERNS; LAKES		[Williamson, Craig E.; Rose, Kevin C.] Miami Univ, Dept Zool, Oxford, OH 45056 USA	University System of Ohio; Miami University	Williamson, CE (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	craig.williamson@muohio.edu; rosekc@muohio.edu						Andrady A, 2010, PHOTOCH PHOTOBIO SCI, V9, P275, DOI 10.1039/b923342n; Connelly SJ, 2007, ENVIRON SCI TECHNOL, V41, P7101, DOI 10.1021/es071324r; Cooke SL, 2008, CAN J FISH AQUAT SCI, V65, P1144, DOI 10.1139/F08-039; Jordan R, 2006, J FISH BIOL, V68, P1291, DOI 10.1111/j.0022-1112.2006.00992.x; King BJ, 2008, J APPL MICROBIOL, V104, P1311, DOI 10.1111/j.1365-2672.2007.03658.x; Kodric-Brown A, 2002, ANIM BEHAV, V63, P391, DOI 10.1006/anbe.2001.1917; Leech DM, 2009, LIMNOL OCEANOGR, V54, P1152, DOI 10.4319/lo.2009.54.4.1152; McKenzie RL, 2009, PHOTOCHEM PHOTOBIOL, V85, P88, DOI 10.1111/j.1751-1097.2008.00400.x; ROBERTS L, 1989, SCIENCE, V244, P288, DOI 10.1126/science.244.4902.288; Rose KC, 2009, PHOTOCH PHOTOBIO SCI, V8, P1244, DOI 10.1039/b905616e; Rose KC, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000816; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Siebeck UE, 2010, CURR BIOL, V20, P407, DOI 10.1016/j.cub.2009.12.047; Tucker AJ, 2010, ECOLOGY, V91, P882, DOI 10.1890/09-0554.1; Zhang J, 2010, LIMNOL OCEANOGR, V55, P30, DOI 10.4319/lo.2010.55.1.0030	15	49	51	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2010	329	5992					637	639		10.1126/science.1191192	http://dx.doi.org/10.1126/science.1191192			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689007				2022-12-24	WOS:000280602700025
J	Onodera, T; Sakai, T; Hsu, JC; Matsumoto, K; Chiorini, JA; Yamada, KM				Onodera, Tomohiro; Sakai, Takayoshi; Hsu, Jeff Chi-feng; Matsumoto, Kazue; Chiorini, John A.; Yamada, Kenneth M.			Btbd7 Regulates Epithelial Cell Dynamics and Branching Morphogenesis	SCIENCE			English	Article							FIBRONECTIN; TUBULOGENESIS; LUNG; POLARITY; DOMAIN; ROLES	During embryonic development, many organs form by extensive branching of epithelia through the formation of clefts and buds. In cleft formation, buds are delineated by the conversion of epithelial cell-cell adhesions to cell-matrix adhesions, but the mechanisms of cleft formation are not clear. We have identified Btbd7 as a dynamic regulator of branching morphogenesis. Btbd7 provides a mechanistic link between the extracellular matrix and cleft propagation through its highly focal expression leading to local regulation of Snail2 (Slug), E-cadherin, and epithelial cell motility. Inhibition experiments show that Btbd7 is required for branching of embryonic mammalian salivary glands and lungs. Hence, Btbd7 is a regulatory gene that promotes epithelial tissue remodeling and formation of branched organs.	[Onodera, Tomohiro; Sakai, Takayoshi; Hsu, Jeff Chi-feng; Matsumoto, Kazue; Yamada, Kenneth M.] Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Sakai, Takayoshi] Osaka Univ, Grad Sch Dent, Dept Oral Facial Disorders, Suita, Osaka 5650871, Japan; [Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Osaka University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Sakai, T (corresponding author), Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA.	sakai@dent.osaka-u.ac.jp; kyamada@mail.nih.gov	Sakai, Takayoshi/L-1456-2019; Onodera, Tomohiro/G-1686-2012	Sakai, Takayoshi/0000-0003-4348-4896; Yamada, Kenneth/0000-0003-1512-6805	Japan Society for the Promotion of Science (JSPS) [21390534]; NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000695, ZIADE000525] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank M. Hoffman, M. Larsen, and K. Musselmann for advice. T.O. was supported by a fellowship from the Japan Society for the Promotion of Science (JSPS). This work was supported in part by the Intramural Research Program of the NIH, NIDCR, and by Grants-in-Aid for Scientific Research (B) (21390534) from the JSPS to T. S. The SAGE data sets are available at the Gene Expression Omnibus (GEO) database under accession number GSE22374.	Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Daley WP, 2009, DEV BIOL, V336, P169, DOI 10.1016/j.ydbio.2009.09.037; Davies JA, 2002, BIOESSAYS, V24, P937, DOI 10.1002/bies.10161; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; Gill SE, 2006, DEV BIOL, V298, P540, DOI 10.1016/j.ydbio.2006.07.004; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GROBSTEIN C, 1953, NATURE, V172, P869, DOI 10.1038/172869a0; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Larsen M, 2006, J CELL SCI, V119, P3376, DOI 10.1242/jcs.03079; Leroy P, 2007, MOL BIOL CELL, V18, P1943, DOI 10.1091/mbc.E06-09-0823; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Que JW, 2006, DIFFERENTIATION, V74, P422, DOI 10.1111/j.1432-0436.2006.00096.x; Roman J, 1997, EXP LUNG RES, V23, P147, DOI 10.3109/01902149709074027; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Shah MM, 2004, DEVELOPMENT, V131, P1449, DOI 10.1242/dev.01089; Spooner B S, 1986, Dev Biol (N Y 1985), V3, P225; Walker JL, 2008, DEV DYNAM, V237, P3128, DOI 10.1002/dvdy.21717; Widelitz RB, 2007, SEMIN CELL DEV BIOL, V18, P255, DOI 10.1016/j.semcdb.2007.02.005; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	25	114	117	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					562	565		10.1126/science.1191880	http://dx.doi.org/10.1126/science.1191880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671187	Green Accepted			2022-12-24	WOS:000280483500036
J	Reeves, GK; Travis, RC; Green, J; Bull, D; Tipper, S; Baker, K; Beral, V; Peto, R; Bell, J; Zelenika, D; Lathrop, M				Reeves, Gillian K.; Travis, Ruth C.; Green, Jane; Bull, Diana; Tipper, Sarah; Baker, Krys; Beral, Valerie; Peto, Richard; Bell, John; Zelenika, Diana; Lathrop, Mark		Million Women Study Collaborators	Incidence of Breast Cancer and Its Subtypes in Relation to Individual and Multiple Low-Penetrance Genetic Susceptibility Loci	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; CONFER SUSCEPTIBILITY; COMMON VARIANTS; RISK; ALLELES; FGFR2; WOMEN	Context There is limited evidence on how the risk of breast cancer and its subtypes depend on low-penetrance susceptibility loci, individually or in combination. Objective To analyze breast cancer risk, overall and by tumor subtype, in relation to 14 individual single-nucleotide polymorphisms (SNPs) previously linked to the disease, and in relation to a polygenic risk score. Design, Setting, and Participants Study of 10 306 women with breast cancer (mean age at diagnosis, 58 years) and 10 393 women without breast cancer who in 2005-2008 provided blood samples for genotyping in a large prospective study of UK women; and meta-analysis of these results and of other published results. Main Outcome Measures Estimated per-allele odds ratio (OR) for individual SNPs, and cumulative incidence of breast cancer to age 70 years in relation to a polygenic risk score based on the 4, 7, or 10 SNPs most strongly associated with risk. Results Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803662 and, for these 2 SNPs, were significantly greater for estrogen receptor (ER)-positive than for ER-negative disease, both in our data and in meta-analyses of all published data (pooled per-allele ORs [95% confidence intervals] for ER-positive vs ER-negative disease: 1.30 [1.26-1.33] vs 1.05 [1.01-1.10] for FGFR2; interaction P<.001; and 1.24 [1.21-1.28] vs 1.12 [1.07-1.17] for TNRC9; interaction P<.001). The next strongest association was for 2q-rs13387042, for which the per-allele OR was significantly greater for bilateral than unilateral disease (1.39 [1.21-1.60] vs 1.15 [1.11-1.20]; interaction P=.008) and for lobular than ductal tumors (1.35 [1.23-1.49] vs 1.10 [1.05-1.15]; interaction P<.001). The estimated cumulative incidence (95% confidence interval) of breast cancer to age 70 years among women in the top and bottom fifths of a polygenic risk score based on 7 SNPs was 8.8% (8.3%-9.4%) and 4.4% (4.2%-4.8%), respectively. For ER-positive disease the corresponding risks were 7.4% (6.9%-8.0%) and 3.4% (3.1%-3.8%), respectively; while for ER-negative disease they were 1.4% (1.2%-1.6%) and 1.0% (0.8%-1.2%). The findings did not differ materially according to the number of SNPs included in the polygenic risk model. Conclusions The polygenic risk score was substantially more predictive of ER-positive than of ER-negative breast cancer, particularly for absolute risk. JAMA. 2010; 304(4): 426-434	[Reeves, Gillian K.; Travis, Ruth C.; Green, Jane; Bull, Diana; Tipper, Sarah; Baker, Krys; Beral, Valerie] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England; [Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Peto, Richard] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford OX3 7LF, England; [Bell, John] Univ Oxford, Dept Regius Prof Med, Oxford OX3 7LF, England; [Zelenika, Diana; Lathrop, Mark] CEA, Ctr Natl Genotypage 1G, Paris, France; [Zelenika, Diana; Lathrop, Mark] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, Paris, France	University of Oxford; University of Oxford; University of Oxford; University of Oxford; CEA; Foundation Jean Dausset-CEPH	Reeves, GK (corresponding author), Univ Oxford, Canc Epidemiol Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	gill.reeves@ceu.ox.ac.uk		Balkwill, Angela/0000-0002-6327-6245	UK Medical Research Council; Cancer Research UK; MRC [MC_U137686850, G0700474] Funding Source: UKRI; Medical Research Council [G0700474, G1000800b, MC_U137686850] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Million Women Study is supported by the UK Medical Research Council and Cancer Research UK. Genotyping of blood samples was supported by the Institut National du Cancer, France.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; CURADO MP, 2007, SCI PUBLICATION, V160; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Garcia-Closas M, 2008, CLIN CANCER RES, V14, P8000, DOI 10.1158/1078-0432.CCR-08-0975; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Milne RL, 2009, JNCI-J NATL CANCER I, V101, P1012, DOI 10.1093/jnci/djp167; *NAT CANC INT NETW, ALL BREAST CANC REP; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Rebbeck TR, 2009, CARCINOGENESIS, V30, P269, DOI 10.1093/carcin/bgn247; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Townsend PP., 1988, HLTH DEPRIVATION INE; Travis RC, 2010, LANCET, V375, P2143, DOI 10.1016/S0140-6736(10)60636-8; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; *WHO, 2000, INT CLSAS DIS ONC; World Health Organization, 1992, INT STAT CLASS DIS R; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	23	87	92	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					426	434		10.1001/jama.2010.1042	http://dx.doi.org/10.1001/jama.2010.1042			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664043	Bronze			2022-12-24	WOS:000280350100026
J	Hacein-Bey-Abina, S; Hauer, J; Lim, A; Picard, C; Wang, GP; Berry, CC; Martinache, C; Rieux-Laucat, F; Latour, S; Belohradsky, BH; Leiva, L; Sorensen, R; Debre, M; Casanova, JL; Blanche, S; Durandy, A; Bushman, FD; Fischer, A; Cavazzana-Calvo, M				Hacein-Bey-Abina, Salima; Hauer, Julia; Lim, Annick; Picard, Capucine; Wang, Gary P.; Berry, Charles C.; Martinache, Chantal; Rieux-Laucat, Frederic; Latour, Sylvain; Belohradsky, Bernd H.; Leiva, Lily; Sorensen, Ricardo; Debre, Marianne; Casanova, Jean Laurent; Blanche, Stephane; Durandy, Anne; Bushman, Frederic D.; Fischer, Alain; Cavazzana-Calvo, Marina			Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; INTERLEUKIN-2-RECEPTOR GAMMA-CHAIN; INSERTIONAL MUTAGENESIS; B-CELLS; SCID-X1; RECEPTOR; DISEASE; HUMANS	BACKGROUND The outcomes of gene therapy to correct congenital immunodeficiencies are unknown. We reviewed long-term outcomes after gene therapy in nine patients with X-linked severe combined immunodeficiency (SCID-X1), which is characterized by the absence of the cytokine receptor common gamma chain. METHODS The nine patients, who lacked an HLA-identical donor, underwent ex vivo retrovirus-mediated transfer of gamma chain to autologous CD34+ bone marrow cells between 1999 and 2002. We assessed clinical events and immune function on long-term follow-up. RESULTS Eight patients were alive after a median follow-up period of 9 years (range, 8 to 11). Gene therapy was initially successful at correcting immune dysfunction in eight of the nine patients. However, acute leukemia developed in four patients, and one died. Transduced T cells were detected for up to 10.7 years after gene therapy. Seven patients, including the three survivors of leukemia, had sustained immune reconstitution; three patients required immunoglobulin-replacement therapy. Sustained thymopoiesis was established by the persistent presence of naive T cells, even after chemotherapy in three patients. The T-cell-receptor repertoire was diverse in all patients. Transduced B cells were not detected. Correction of the immunodeficiency improved the patients' health. CONCLUSIONS After nearly 10 years of follow-up, gene therapy was shown to have corrected the immunodeficiency associated with SCID-X1. Gene therapy may be an option for patients who do not have an HLA-identical donor for hematopoietic stem-cell transplantation and for whom the risks are deemed acceptable. This treatment is associated with a risk of acute leukemia.	[Hacein-Bey-Abina, Salima; Martinache, Chantal; Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, Dept Biotherapy, F-75015 Paris, France; [Hacein-Bey-Abina, Salima; Hauer, Julia; Rieux-Laucat, Frederic; Latour, Sylvain; Durandy, Anne; Fischer, Alain; Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, INSERM, U768, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, Ctr Etud Deficits Immunitaires, F-75015 Paris, France; [Hacein-Bey-Abina, Salima; Martinache, Chantal; Cavazzana-Calvo, Marina] Grp Hosp Univ Ouest, AP HP, Clin Invest Ctr Biotherapy, Paris, France; [Hacein-Bey-Abina, Salima; Picard, Capucine; Casanova, Jean Laurent; Blanche, Stephane; Fischer, Alain; Cavazzana-Calvo, Marina] Paris Descartes Univ, Paris, France; [Lim, Annick] Inst Pasteur, Unite Dev Lymphocytes, Paris, France; [Lim, Annick] INSERM, U668, Paris, France; [Casanova, Jean Laurent] INSERM, Lab Human Genet Infect Dis, Necker Branch, U550, Paris, France; [Wang, Gary P.; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Berry, Charles C.] Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Belohradsky, Bernd H.] Univ Childrens Hosp, Dept Immunol & Infect Dis, Munich, Germany; [Leiva, Lily; Sorensen, Ricardo] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Casanova, Jean Laurent] Rockefeller Univ, Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; University of California System; University of California San Diego; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Rockefeller University	Hacein-Bey-Abina, S (corresponding author), Hop Necker Enfants Malad, Dept Biotherapy, 149 Rue Sevres, F-75015 Paris, France.	salima.hacein-bey@nck.ap-hop-paris.fr	Casanova, Jean-Laurent/I-3418-2017; Rieux-Laucat, Frédéric/A-7916-2017; Durandy, Anne/H-7475-2017; Picard, Capucine/H-3914-2017; Latour, Sylvain/H-3652-2017	Rieux-Laucat, Frédéric/0000-0001-7858-7866; Durandy, Anne/0000-0001-7706-8466; Picard, Capucine/0000-0001-8788-5056; Bushman, Frederic/0000-0003-4740-4056; Cavazzana, Marina/0000-0002-0264-0891; Casanova, Jean-Laurent/0000-0002-7782-4169; Latour, Sylvain/0000-0001-8238-4391	INSERM; Association Francaise contre les Myopathies [AT0203]; European Commission [QLK3-CT-1999-00859]; Concerted Safety and Efficiency Evaluation of Retroviral Transgenesis in Gene Therapy of Inherited Diseases [005242]; Gene Therapy of Hematopoietic Stem Cells for Inherited Diseases [QLK3-CT-2001-00427]; Agence Nationale de la Recherche [05-MRAR-004]; Programme Hospitalier de Recherche Clinique of the Health Ministry [PHRC AOM 08064-P071204]; Assistance Publique-Hopitaux de Paris; Fondation de l'Avenir; Institut Pasteur and College de France; National Institutes of Health [AI52845, AI082020]; Akademie der Naturforscher Leopoldina [BMBF-LPD 9901/8-149]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082020, R01AI052845] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); European Commission(European CommissionEuropean Commission Joint Research Centre); Concerted Safety and Efficiency Evaluation of Retroviral Transgenesis in Gene Therapy of Inherited Diseases; Gene Therapy of Hematopoietic Stem Cells for Inherited Diseases; Agence Nationale de la Recherche(French National Research Agency (ANR)); Programme Hospitalier de Recherche Clinique of the Health Ministry; Assistance Publique-Hopitaux de Paris; Fondation de l'Avenir; Institut Pasteur and College de France; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Akademie der Naturforscher Leopoldina; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from INSERM, Association Francaise contre les Myopathies (AT0203), the European Commission (QLK3-CT-1999-00859), the Concerted Safety and Efficiency Evaluation of Retroviral Transgenesis in Gene Therapy of Inherited Diseases (005242), Gene Therapy of Hematopoietic Stem Cells for Inherited Diseases (QLK3-CT-2001-00427), Agence Nationale de la Recherche (05-MRAR-004), Programme Hospitalier de Recherche Clinique of the Health Ministry (PHRC AOM 08064-P071204), Assistance Publique-Hopitaux de Paris, Fondation de l'Avenir, Institut Pasteur and College de France, and the National Institutes of Health (AI52845 and AI082020, to Dr. Bushman). Dr. Hauer was supported by a scholarship from the Akademie der Naturforscher Leopoldina (BMBF-LPD 9901/8-149).	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Baum C, 2007, CURR OPIN HEMATOL, V14, P337, DOI 10.1097/MOH.0b013e3281900f01; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cavazzana-Calvo M, 2007, BLOOD, V109, P4575, DOI 10.1182/blood-2006-07-029090; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; GENNERY AR, J ALLERGY C IN PRESS; Ginn SL, 2005, MED J AUSTRALIA, V182, P458, DOI 10.5694/j.1326-5377.2005.tb06785.x; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Neven B, 2009, BLOOD, V113, P4114, DOI 10.1182/blood-2008-09-177923; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Sarzotti-Kelsoe M, 2009, BLOOD, V114, P1445, DOI 10.1182/blood-2009-01-199323; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; TANNER JM, 1986, CLIN ENDOCRINOL META, V15, P411, DOI 10.1016/S0300-595X(86)80005-6; WANG GP, 2010, BLOOD           0312; Weerkamp F, 2006, BLOOD, V107, P3131, DOI 10.1182/blood-2005-08-3412	23	427	451	0	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					355	364		10.1056/NEJMoa1000164	http://dx.doi.org/10.1056/NEJMoa1000164			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628RU	20660403	Green Accepted			2022-12-24	WOS:000280139300008
J	Feng, MY; Grice, DM; Faddy, HM; Nguyen, N; Leitch, S; Wang, YY; Muend, S; Kenny, PA; Sukumar, S; Roberts-Thomson, SJ; Monteith, GR; Rao, R				Feng, Mingye; Grice, Desma M.; Faddy, Helen M.; Nguyen, Nguyen; Leitch, Sharon; Wang, Yingyu; Muend, Sabina; Kenny, Paraic A.; Sukumar, Saraswati; Roberts-Thomson, Sarah J.; Monteith, Gregory R.; Rao, Rajini			Store-Independent Activation of Orai1 by SPCA2 in Mammary Tumors	CELL			English	Article							GENE-EXPRESSION SIGNATURE; YEAST SECRETORY PATHWAY; BREAST-CANCER; CELL-PROLIFERATION; PLASMA-MEMBRANE; CRAC CHANNEL; CALCIUM-TRANSPORT; ION SELECTIVITY; I-CRAC; CA2+	Ca(2+) is an essential and ubiquitous second messenger. Changes in cytosolic Ca(2+) trigger events critical for tumorigenesis, such as cellular motility, proliferation, and apoptosis. Weshow that an isoform of Secretory Pathway Ca(2+)-ATPase, SPCA2, is upregulated in breast cancer-derived cells and human breast tumors, and suppression of SPCA2 attenuates basal Ca(2+) levels and tumorigenicity. Contrary to its conventional role in Golgi Ca(2+) sequestration, expression of SPCA2 increased Ca(2+) influx by a mechanism dependent on the store-operated Ca(2+) channel Orai1. Unexpectedly, SPCA2-Orai1 signaling was independent of ER Ca(2+) stores or STIM1 and STIM2 sensors and uncoupled from Ca(2+)-ATPase activity of SPCA2. Binding of the SPCA2 amino terminus to Orai1 enabled access of its carboxyl terminus to Orai1 and activation of Ca(2+) influx. Our findings reveal a signaling pathway in which the Orai1-SPCA2 complex elicits constitutive store-independent Ca(2+) signaling that promotes tumorigenesis.	[Feng, Mingye; Leitch, Sharon; Muend, Sabina; Rao, Rajini] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Nguyen, Nguyen; Sukumar, Saraswati] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Grice, Desma M.; Faddy, Helen M.; Roberts-Thomson, Sarah J.; Monteith, Gregory R.] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia; [Kenny, Paraic A.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Wang, Yingyu] Johns Hopkins Univ, Dept Mech Engn, Whiting Sch Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; University of Queensland; Yeshiva University; Albert Einstein College of Medicine; Johns Hopkins University	Rao, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA.	rrao@jhmi.edu	Grice, Desma M/A-7730-2011; Monteith, Gregory/B-1626-2008; Feng, Mingye/E-2302-2013; Faddy, Helen M/A-6541-2015; Roberts-Thomson, Sarah J/B-4282-2011; Roberts-Thomson, Sarah/W-5676-2019	Monteith, Gregory/0000-0002-4345-530X; Roberts-Thomson, Sarah J/0000-0001-8202-5786; Roberts-Thomson, Sarah/0000-0001-8202-5786; Faddy, Helen/0000-0002-3446-8248	National Institution of Health [GM62142]; National Health and Medical Research [569644]; Cancer Council Queensland; Department of Defense-Center of Excellence [W81XWH-04-1-0595]; Albert Einstein College of Medicine; American Heart Association [0815058E]; American Psychological Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062142] Funding Source: NIH RePORTER	National Institution of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research; Cancer Council Queensland(Cancer Council Queensland); Department of Defense-Center of Excellence(United States Department of Defense); Albert Einstein College of Medicine; American Heart Association(American Heart Association); American Psychological Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Paul Worley and Dr. Guo Huang (Johns Hopkins University) for kind gifts of plasmids expressing Orai1, STIM1, and NFAT. This work was supported by grant GM62142 from the National Institution of Health to R.R., 569644 from the National Health and Medical Research and Cancer Council Queensland to G.R.M. and S.J.R.-T., Department of Defense-Center of Excellence Grant W81XWH-04-1-0595 to S.S., laboratory startup funds from the Albert Einstein College of Medicine to P.A.K., American Heart Association Pre-doctoral fellowship 0815058E to M.F., and American Psychological Association scholarship to H.M.F. and D.M.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BOS JL, 1989, CANCER RES, V49, P4682; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clementi E, 1996, CELL CALCIUM, V19, P269, DOI 10.1016/S0143-4160(96)90068-8; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Cook SJ, 2006, CELL CALCIUM, V39, P101, DOI 10.1016/j.ceca.2005.10.014; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Donovan S, 2002, BBA-REV CANCER, V1602, P23, DOI 10.1016/S0304-419X(01)00041-5; Downward J, 1996, CANCER SURV, V27, P87; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; GARSIDE VC, 2010, EXP CELL RES, DOI DOI 10.10.106/J.YEXCR.2010.06.014; Gwack Y, 2007, CELL CALCIUM, V42, P145, DOI 10.1016/j.ceca.2007.03.007; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Huster D, 2003, J BIOL CHEM, V278, P32212, DOI 10.1074/jbc.M305408200; Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f; Lee WJ, 2006, BBA-REV CANCER, V1765, P235, DOI 10.1016/j.bbcan.2005.12.001; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Mamillapalli R, 2008, J BIOL CHEM, V283, P24435, DOI 10.1074/jbc.M801738200; Matsumoto Y, 2002, SCIENCE, V295, P499, DOI 10.1126/science.1065693; Missiaen L, 2007, CELL CALCIUM, V41, P405, DOI 10.1016/j.ceca.2006.11.001; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Morgan MP, 2005, J MAMMARY GLAND BIOL, V10, P181, DOI 10.1007/s10911-005-5400-6; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vanoevelen J, 2005, J BIOL CHEM, V280, P22800, DOI 10.1074/jbc.M501026200; Vig M, 2007, CELL CALCIUM, V42, P157, DOI 10.1016/j.ceca.2007.03.008; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wei Y, 1999, BIOCHEMISTRY-US, V38, P14534, DOI 10.1021/bi9911233; Wei Y, 2000, J BIOL CHEM, V275, P23927, DOI 10.1074/jbc.M002618200; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Xiang MH, 2005, J BIOL CHEM, V280, P11608, DOI 10.1074/jbc.M413116200; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108	50	206	208	1	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					84	98		10.1016/j.cell.2010.08.040	http://dx.doi.org/10.1016/j.cell.2010.08.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887894	Bronze, Green Accepted			2022-12-24	WOS:000282362000016
J	Weber, TS; Deutsch, C				Weber, Thomas S.; Deutsch, Curtis			Ocean nutrient ratios governed by plankton biogeography	NATURE			English	Article							ANTARCTIC CIRCUMPOLAR CURRENT; GLACIAL SOUTHERN-OCEAN; ELEMENTAL STOICHIOMETRY; MARINE-PHYTOPLANKTON; COMMUNITY STRUCTURE; NITROGEN-FIXATION; PACIFIC-OCEAN; CO2; DENITRIFICATION; PHOSPHORUS	The major nutrients nitrate and phosphate have one of the strongest correlations in the sea, with a slope similar to the average nitrogen (N) to phosphorus (P) content of plankton biomass (N/P = 16:1). The processes through which this global relationship emerges despite the wide range of N/P ratios at the organism level are not known. Here we use an ocean circulation model and observed nutrient distributions to show that the N/P ratio of biological nutrient removal varies across latitude in Southern Ocean surface waters, from 12: 1 in the polar ocean to 20: 1 in the sub-Antarctic zone. These variations are governed by regional differences in the species composition of the plankton community. The covariation of dissolved nitrate and phosphate is maintained by ocean circulation, which mixes the shallow subsurface nutrients between distinct biogeographic provinces. Climate-driven shifts in these marine biomes may alter the mean N/P ratio and the associated carbon export by Southern Ocean ecosystems.	[Weber, Thomas S.; Deutsch, Curtis] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Weber, TS (corresponding author), Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA.	tweber@atmos.ucla.edu	Deutsch, Curtis A/D-1703-2011		National Science Foundation; Gordon and Betty Moore Foundation; UCLA	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); UCLA	We thank S. Khatiwala for providing the transport matrix. This work was funded by grants from the National Science Foundation and the Gordon and Betty Moore Foundation. Additional support for T.S.W. was provided by a Pauley Fellowship from UCLA.	ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; CODISPOTI LA, 1989, LIFE SCI R, V44, P377; Dentener F, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002672; Elderfield H, 2000, NATURE, V405, P305, DOI 10.1038/35012507; Falkowski PG, 2000, J PHYCOL, V36, P3, DOI 10.1046/j.1529-8817.2000.99161.x; Finkel ZV, 2006, LIMNOL OCEANOGR, V51, P2690, DOI 10.4319/lo.2006.51.6.2690; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; Garcia H. E., 2006, WORLD OCEAN ATLAS 20; Geider RJ, 2002, EUR J PHYCOL, V37, P1, DOI 10.1017/S0967026201003456; Green SE, 2006, DEEP-SEA RES PT II, V53, P620, DOI 10.1016/j.dsr2.2006.01.022; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Jin X, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002532; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; KARL DM, 2001, ENCY OCEAN SCI, P1876; Khatiwala S, 2005, OCEAN MODEL, V9, P51, DOI 10.1016/j.ocemod.2004.04.002; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; KOPCZYNSKA EE, 1986, POLAR BIOL, V6, P161, DOI 10.1007/BF00274879; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Longhurst A, 1995, PROG OCEANOGR, V36, P77, DOI 10.1016/0079-6611(95)00015-1; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Price NM, 2005, LIMNOL OCEANOGR, V50, P1159, DOI 10.4319/lo.2005.50.4.1159; Quigg A, 2003, NATURE, V425, P291, DOI 10.1038/nature01953; REDFIELD AC, 1958, AM SCI, V46, P205; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; Schlitzer R, 2002, DEEP-SEA RES PT II, V49, P1623, DOI 10.1016/S0967-0645(02)00004-8; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, P80; TAKAHASHI T, 1985, J GEOPHYS RES-OCEANS, V90, P6907, DOI 10.1029/JC090iC04p06907; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Wu JF, 2000, SCIENCE, V289, P759, DOI 10.1126/science.289.5480.759	35	192	198	5	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP	2010	467	7315					550	554		10.1038/nature09403	http://dx.doi.org/10.1038/nature09403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20882009				2022-12-24	WOS:000282273100030
J	Anderson, T				Anderson, Tatum			Pain control The politics of pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OPIOIDS; INDIA					tatumnanderson@gmail.com						Adams Vanessa, 2008, J Pain Palliat Care Pharmacother, V22, P101; CLEARY JF, 2010, EUROPE PALLIAT MED, V24, P109; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; Hojsted J, 2007, EUR J PAIN, V11, P490, DOI 10.1016/j.ejpain.2006.08.004; Human Rights Watch, 2009, ACC PAIN TREATM HUM; *INT NARC CONTR BO, 1961, SINGL CONV NARC DRUG; International Narcotics Control Board, REP INT NARC CONTR B; Rajagopal MR, 2007, J PAIN SYMPTOM MANAG, V33, P615, DOI 10.1016/j.jpainsymman.2007.02.028; Rajagopal MR, 2001, LANCET, V358, P139, DOI 10.1016/S0140-6736(01)05322-3; *UN EC SOC COUNC, 2010, COMM NARC DRUGS; *WHO, NARC PSYCH DRUGS ACH; WHO, ACC CONTR MED PROGR	12	10	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2010	341								c3800	10.1136/bmj.c3800	http://dx.doi.org/10.1136/bmj.c3800			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	640DR	20702554				2022-12-24	WOS:000281028900004
J	Stolfi, A; Gainous, TB; Young, JJ; Mori, A; Levine, M; Christiaen, L				Stolfi, Alberto; Gainous, T. Blair; Young, John J.; Mori, Alessandro; Levine, Michael; Christiaen, Lionel			Early Chordate Origins of the Vertebrate Second Heart Field	SCIENCE			English	Article							ASCIDIAN CIONA-INTESTINALIS; MUSCLE DEVELOPMENT; MYOCARDIAL-CELLS; GENE-EXPRESSION; SPECIFICATION; MIGRATION; MESODERM; MESP	The vertebrate heart is formed from diverse embryonic territories, including the first and second heart fields. The second heart field (SHF) gives rise to the right ventricle and outflow tract, yet its evolutionary origins are unclear. We found that heart progenitor cells of the simple chordate Ciona intestinalis also generate precursors of the atrial siphon muscles (ASMs). These precursors express Islet and Tbx1/10, evocative of the splanchnic mesoderm that produces the lower jaw muscles and SHF of vertebrates. Evidence is presented that the transcription factor COE is a critical determinant of ASM fate. We propose that the last common ancestor of tunicates and vertebrates possessed multipotent cardiopharyngeal muscle precursors, and that their reallocation might have contributed to the emergence of the SHF.	[Stolfi, Alberto; Gainous, T. Blair; Young, John J.; Mori, Alessandro; Levine, Michael; Christiaen, Lionel] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet Genom & Dev, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Christiaen, Lionel] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA	University of California System; University of California Berkeley; New York University	Levine, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet Genom & Dev, Ctr Integrat Genom, Berkeley, CA 94720 USA.	mlevine@berkeley.edu; lc121@nyu.edu	Stolfi, Alberto/AAS-8031-2021	Gainous, T. Blair/0000-0002-8987-3195; Levine, Michael/0000-0001-7629-0081; Christiaen, Lionel/0000-0001-5930-5667	NSF [IOB 0445470]; NIH [0745322]; New York University Faculty of Arts and Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076542] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Faculty of Arts and Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Hendrix for computational analysis, A. Cooc for technical assistance, and R. Harland, I. Philipp, and T. J. Park for advice. Supported by NSF grant IOB 0445470 (M.L.), NIH training grant 0745322 (T.B.G.), and a New York University Faculty of Arts and Science start-up package (L.C.).	Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; Beh J, 2007, DEVELOPMENT, V134, P3297, DOI 10.1242/dev.010140; Brade T, 2007, DEV BIOL, V311, P297, DOI 10.1016/j.ydbio.2007.08.004; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; Christiaen L, 2008, SCIENCE, V320, P1349, DOI 10.1126/science.1158170; Christiaen L, 2009, DEV BIOL, V328, P552, DOI 10.1016/j.ydbio.2009.01.033; Crozatier M, 1999, DEVELOPMENT, V126, P1495; Davidson B, 2005, DEVELOPMENT, V132, P4811, DOI 10.1242/dev.02051; Davidson B, 2007, SEMIN CELL DEV BIOL, V18, P16, DOI 10.1016/j.semcdb.2006.12.007; Davidson B, 2006, GENE DEV, V20, P2728, DOI 10.1101/gad.1467706; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Gessert S, 2009, DEV BIOL, V334, P395, DOI 10.1016/j.ydbio.2009.07.037; Giuliano P, 1998, MECH DEVELOP, V78, P199, DOI 10.1016/S0925-4773(98)00143-9; Hirano T, 1997, DEV BIOL, V192, P199, DOI 10.1006/dbio.1997.8772; Kang J, 2009, DEV BIOL, V334, P513, DOI 10.1016/j.ydbio.2009.06.041; Kokubo N, 2010, EVOL DEV, V12, P34, DOI 10.1111/j.1525-142X.2009.00389.x; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Nathan E, 2008, DEVELOPMENT, V135, P647, DOI 10.1242/dev.007989; Ogasawara M, 2002, DEV GENES EVOL, V212, P173, DOI 10.1007/s00427-002-0230-7; Okkema PG, 1997, DEVELOPMENT, V124, P3965; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Perez-Pomares JM, 2009, INT J DEV BIOL, V53, P1427, DOI 10.1387/ijdb.072409jp; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Satou Y, 2004, DEVELOPMENT, V131, P2533, DOI 10.1242/dev.01145; Takatori N, 2004, DEV DYNAM, V230, P743, DOI 10.1002/dvdy.20082; Tzahor E, 2009, DEV BIOL, V327, P273, DOI 10.1016/j.ydbio.2008.12.035	29	123	124	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					565	568		10.1126/science.1190181	http://dx.doi.org/10.1126/science.1190181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671188	Green Accepted			2022-12-24	WOS:000280483500037
J	Jones, S; Wang, TL; Shih, IM; Mao, TL; Nakayama, K; Roden, R; Glas, R; Slamon, D; Diaz, LA; Vogelstein, B; Kinzler, KW; Velculescu, VE; Papadopoulos, N				Jones, Sian; Wang, Tian-Li; Shih, Ie-Ming; Mao, Tsui-Lien; Nakayama, Kentaro; Roden, Richard; Glas, Ruth; Slamon, Dennis; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.; Papadopoulos, Nickolas			Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma	SCIENCE			English	Article							PHOSPHATASE 2A; HUMAN BREAST; ENDOMETRIOSIS; PATHWAYS; PATTERNS; DISTINCT	Ovarian clear cell carcinoma (OCCC) is an aggressive human cancer that is generally resistant to therapy. To explore the genetic origin of OCCC, we determined the exomic sequences of eight tumors after immunoaffinity purification of cancer cells. Through comparative analyses of normal cells from the same patients, we identified four genes that were mutated in at least two tumors. PIK3CA, which encodes a subunit of phosphatidylinositol-3 kinase, and KRAS, which encodes a well-known oncoprotein, had previously been implicated in OCCC. The other two mutated genes were previously unknown to be involved in OCCC: PPP2R1A encodes a regulatory subunit of serine/threonine phosphatase 2, and ARID1A encodes adenine-thymine (AT)-rich interactive domain-containing protein 1A, which participates in chromatin remodeling. The nature and pattern of the mutations suggest that PPP2R1A functions as an oncogene and ARID1A as a tumor-suppressor gene. In a total of 42 OCCCs, 7% had mutations in PPP2R1A and 57% had mutations in ARID1A. These results suggest that aberrant chromatin remodeling contributes to the pathogenesis of OCCC.	[Jones, Sian; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.; Papadopoulos, Nickolas] Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [Jones, Sian; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Velculescu, Victor E.; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Wang, Tian-Li] Johns Hopkins Med Inst, Dept Gynecol & Obstet & Oncol, Baltimore, MD 21231 USA; [Shih, Ie-Ming; Roden, Richard] Johns Hopkins Med Inst, Dept Pathol Oncol Gynecol & Obstet, Baltimore, MD 21231 USA; [Mao, Tsui-Lien] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei 100, Taiwan; [Nakayama, Kentaro] Shimane Univ, Sch Med, Dept Obstet & Gynecol, Izumo, Shimane 6938501, Japan; [Glas, Ruth; Slamon, Dennis] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Taiwan University; Shimane University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kinzler, KW (corresponding author), Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	kinzlke@jhmi.edu; velculescu@jhmi.edu; npapado1@jhmi.edu	Papadopoulos, Nickolas/K-7272-2012; Velculescu, Victor/ABF-4846-2020; Jones, Sian/A-5050-2012; sdsd, shihieih/ABE-6190-2020	Velculescu, Victor/0000-0003-1195-438X; Diaz, Luis/0000-0002-7079-8914	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; American Association for Cancer Research, The Virginia; U.S. Department of Defense [OC0400600]; NIH [CA121113, CA57345, CA129080, CA103937, CA122581]; NATIONAL CANCER INSTITUTE [R37CA057345, R01CA121113, R01CA103937, R01CA057345, R01CA122581, R01CA129080] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; American Association for Cancer Research, The Virginia; U.S. Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Y. He for technical advice and M. Whalen, J. Ptak, and N. Silliman for expert technical assistance. Funded by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, American Association for Cancer Research Stand Up To Cancer-Dream Team Translational Cancer Research Grant, The Virginia and D. K. Ludwig Fund for Cancer Research, U.S. Department of Defense grant OC0400600 (T.-L. W.), and NIH grants CA121113, CA57345, CA129080, CA103937 (IMS), and CA122581 (R. R.). N. P., B. V., L. D., V. V., and K. W. K. are members of the Scientific Advisory Board of Inostics, a company that is developing technologies for the molecular diagnosis of cancer. N. P., B. V., L. D., V. V., and K. W. K. also own stock in Inostics. The authors are entitled to a share of the royalties received by the university on sales of products related to genes described in this manuscript. The terms of these arrangements are being managed by the university in accordance with their conflict of interest policies. V. V., B. V., K. W. K., and Johns Hopkins University also own stock in Genzyme and Exact Sciences, which are managed under similar arrangements.	Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Erzen M, 2001, GYNECOL ONCOL, V83, P100, DOI 10.1006/gyno.2001.6382; Fukunaga M, 1997, HISTOPATHOLOGY, V30, P249, DOI 10.1046/j.1365-2559.1997.d01-592.x; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Huang JM, 2007, GENE CHROMOSOME CANC, V46, P745, DOI 10.1002/gcc.20459; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kuo KT, 2010, CLIN CANCER RES, V16, P1997, DOI 10.1158/1078-0432.CCR-09-2105; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Sato N, 2000, CANCER RES, V60, P7052; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tang ZY, 2006, DEV CELL, V10, P575, DOI 10.1016/j.devcel.2006.03.010; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Veras E, 2009, AM J SURG PATHOL, V33, P844, DOI 10.1097/PAS.0b013e31819c4271; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009	28	877	921	0	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2010	330	6001					228	231		10.1126/science.1196333	http://dx.doi.org/10.1126/science.1196333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20826764	Green Accepted			2022-12-24	WOS:000282644600044
J	Howard, A; Wilson, M				Howard, Andrew; Wilson, Mary			Easily Missed? Septic arthritis in children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSIENT SYNOVITIS; HIP; DIFFERENTIATION; CHILDHOOD; SEQUELAE		[Howard, Andrew] Hosp Sick Children, Div Orthopaed Surg, Toronto, ON M5G 1X8, Canada; [Wilson, Mary] Marathon Family Hlth Team, Marathon, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Howard, A (corresponding author), Hosp Sick Children, Div Orthopaed Surg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	andrew.howard@sickkids.ca		Howard, Andrew/0000-0001-7226-6471				Baskett A, 2009, PEDIATR EMERG CARE, V25, P78, DOI 10.1097/PEC.0b013e318196ea43; Caird MS, 2006, J BONE JOINT SURG AM, V88A, P1251, DOI 10.2106/JBJS.E.00216; Choi IH, 2005, CLIN ORTHOP RELAT R, P102, DOI 10.1097/01.blo.0000162412.93473.68; Forlin E, 2008, J PEDIATR ORTHOPED, V28, P524, DOI 10.1097/BPO.0b013e31817bb079; Givon U, 2004, J PEDIATR ORTHOPED, V24, P266, DOI 10.1097/01241398-200405000-00006; Goergens ED, 2005, J PAEDIATR CHILD H, V41, P59, DOI 10.1111/j.1440-1754.2005.00538.x; Gordon JE, 2002, J PEDIATR ORTHOPED, V22, P312, DOI 10.1097/00004694-200205000-00008; Kocher MS, 2004, J BONE JOINT SURG AM, V86A, P1629, DOI 10.2106/00004623-200408000-00005; Kocher MS, 1999, J BONE JOINT SURG AM, V81A, P1662, DOI 10.2106/00004623-199912000-00002; Luhmann SJ, 2004, J BONE JOINT SURG AM, V86A, P956, DOI 10.2106/00004623-200405000-00011; Nunn TR, 2007, J BONE JOINT SURG BR, V89B, P100, DOI 10.1302/0301-620X.89B1.17940; Peltola H, 2009, CLIN INFECT DIS, V48, P1201, DOI 10.1086/597582; Riise OR, 2008, PEDIATRICS, V121, pE299, DOI 10.1542/peds.2007-0291	13	3	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2010	341								c4407	10.1136/bmj.c4407	http://dx.doi.org/10.1136/bmj.c4407			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663JJ	20801999				2022-12-24	WOS:000282880500008
J	del Zoppo, GJ; Hawkins, BT				del Zoppo, Gregory J.; Hawkins, Brian T.			Throwing Out the Thromboemboli	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PLASMINOGEN-ACTIVATOR		[del Zoppo, Gregory J.; Hawkins, Brian T.] Univ Washington, Sch Med, Div Hematol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	del Zoppo, GJ (corresponding author), Univ Washington, Sch Med, Div Hematol, Seattle, WA 98195 USA.			Hawkins, Brian/0000-0001-6719-5402				Hosomi N, 2001, STROKE, V32, P1341, DOI 10.1161/01.STR.32.6.1341; Lam CK, 2010, NATURE, V465, P478, DOI 10.1038/nature09001; LEVIN EG, 1994, AM J PATHOL, V144, P855; Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555, DOI 10.1056/NEJM199905203402007; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637	5	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2010	363	13					1282	1284		10.1056/NEJMcibr1006572	http://dx.doi.org/10.1056/NEJMcibr1006572			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652ZA	20860513				2022-12-24	WOS:000282050000016
J	Schulze, S; Koster, S; Geldmacher, U; van Scheltinga, ACT; Kuhlbrandt, W				Schulze, Sabrina; Koester, Stefan; Geldmacher, Ulrike; van Scheltinga, Anke C. Terwisscha; Kuehlbrandt, Werner			Structural basis of Na+-independent and cooperative substrate/product antiport in CaiT	NATURE			English	Article							SOLUTES GLYCINE BETAINE; CATION-PI INTERACTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CARNITINE TRANSPORTER; PROLINE BETAINE; BINDING-SITE; MECHANISM; DETERMINANTS; SYMPORTER	Transport of solutes across biological membranes is performed by specialized secondary transport proteins in the lipid bilayer(1), and is essential for life. Here we report the structures of the sodium-independent carnitine/butyrobetaine antiporter CaiT from Proteus mirabilis (PmCaiT) at 2.3-angstrom and from Escherichia coli (EcCaiT) at 3.5-angstrom resolution. CaiT belongs to the family of betaine/carnitine/choline transporters (BCCT), which are mostly Na+ or H+ dependent, whereas EcCaiT is Na+ and H+ independent(2). The three-dimensional architecture of CaiT resembles that of the Na+-dependent transporters LeuT(3) and BetP(4), but in CaiT a methionine sulphur takes the place of the Na+ ion to coordinate the substrate in the central transport site, accounting for Na+-independent transport. Both CaiT structures show the fully open, inward-facing conformation, and thus complete the set of functional states that describe the alternating access mechanism(5). EcCaiT contains two bound butyrobetaine substrate molecules, one in the central transport site, the other in an extracellular binding pocket. In the structure of PmCaiT, a tryptophan side chain occupies the transport site, and access to the extracellular site is blocked. Binding of both substrates to CaiT reconstituted into proteoliposomes is cooperative, with Hill coefficients up to 1.7, indicating that the extracellular site is regulatory. We propose a mechanism whereby the occupied regulatory site increases the binding affinity of the transport site and initiates substrate translocation.	[Schulze, Sabrina; Koester, Stefan; Geldmacher, Ulrike; van Scheltinga, Anke C. Terwisscha; Kuehlbrandt, Werner] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	Max Planck Society	Kuhlbrandt, W (corresponding author), Max Planck Inst Biophys, Dept Biol Struct, Max von Laue Str 3, D-60438 Frankfurt, Germany.	werner.kuehlbrandt@biophys.mpg.de		Kuhlbrandt, Werner/0000-0002-2013-4810				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; CSAKY TZ, 1965, ANNU REV PHYSIOL, V27, P415, DOI 10.1146/annurev.ph.27.030165.002215; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diallinas G, 2008, SCIENCE, V322, P1644, DOI 10.1126/science.1168107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; FARWICK M, 1995, J BACTERIOL, V177, P4690, DOI 10.1128/jb.177.16.4690-4695.1995; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horn C, 2006, J MOL BIOL, V357, P592, DOI 10.1016/j.jmb.2005.12.085; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung H, 2002, J BIOL CHEM, V277, P39251, DOI 10.1074/jbc.M206319200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Padgett CL, 2007, J NEUROSCI, V27, P886, DOI 10.1523/JNEUROSCI.4791-06.2007; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; RICARD J, 1987, EUR J BIOCHEM, V166, P255, DOI 10.1111/j.1432-1033.1987.tb13510.x; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Sevilla A, 2005, BIOTECHNOL PROGR, V21, P329, DOI 10.1021/bp0497583; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Tang L, 2010, NAT STRUCT MOL BIOL, V17, P492, DOI 10.1038/nsmb.1788; Terwilliger TC, 2004, ACTA CRYSTALLOGR D, V60, P2144, DOI 10.1107/S0907444904019535; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Torrice MM, 2009, P NATL ACAD SCI USA, V106, P11919, DOI 10.1073/pnas.0903260106; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	36	98	99	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2010	467	7312					233	U129		10.1038/nature09310	http://dx.doi.org/10.1038/nature09310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829798	Green Submitted, Green Published			2022-12-24	WOS:000281616300040
J	Rehani, M; Frush, D				Rehani, Madan; Frush, Donald			Tracking radiation exposure of patients	LANCET			English	Editorial Material							CT		[Rehani, Madan] IAEA, A-1400 Vienna, Austria; [Frush, Donald] Duke Radiol, Durham, NC USA	International Atomic Energy Agency	Rehani, M (corresponding author), IAEA, A-1400 Vienna, Austria.	m.rehani@iaea.org	Rehani, Madan/A-5198-2010	Rehani, Madan/0000-0003-3519-1516				Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; [Anonymous], ALLIANCE RAD SAFETY; [Anonymous], 2009, 160 NCRP; BERRINGTON DE, 2007, ARCH INTERN MED, V169, P2071; Birnbaum Steven, 2008, J Am Coll Radiol, V5, P714, DOI 10.1016/j.jacr.2008.02.016; FDA, 2010, FDA UNV IN RED UNN R; FDA, 2009, SAF INV CT BRAIN PER; *IAEA, IAEA SMART CARD SMAR; Neumann RD, 2010, J AM COLL RADIOL, V7, P87, DOI 10.1016/j.jacr.2009.07.012; Oikarinen H, 2009, EUR RADIOL, V19, P1161, DOI 10.1007/s00330-008-1256-7; Rehani MM, 2009, IAEA B, V50; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296	12	36	36	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 4	2010	376	9743					754	755		10.1016/S0140-6736(10)60657-5	http://dx.doi.org/10.1016/S0140-6736(10)60657-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650EC	20816532				2022-12-24	WOS:000281831000010
J	Verdino, P; Witherden, DA; Havran, WL; Wilson, IA				Verdino, Petra; Witherden, Deborah A.; Havran, Wendy L.; Wilson, Ian A.			The Molecular Interaction of CAR and JAML Recruits the Central Cell Signal Transducer PI3K	SCIENCE			English	Article							JUNCTIONAL ADHESION MOLECULE; GROUP-B COXSACKIEVIRUSES; ADENOVIRUS RECEPTOR; T-CELLS; PROTEIN; BINDING; CD28; ACTIVATION; MIGRATION; 3-KINASE	Coxsackie and adenovirus receptor (CAR) is the primary cellular receptor for group B coxsackieviruses and most adenovirus serotypes and plays a crucial role in adenoviral gene therapy. Recent discovery of the interaction between junctional adhesion molecule-like protein (JAML) and CAR uncovered important functional roles in immunity, inflammation, and tissue homeostasis. Crystal structures of JAML ectodomain (2.2 angstroms) and its complex with CAR (2.8 angstroms) reveal an unusual immunoglobulin-domain assembly for JAML and a charged interface that confers high specificity. Biochemical and mutagenesis studies illustrate how CAR-mediated clustering of JAML recruits phosphoinositide 3-kinase (PI3K) to a JAML intracellular sequence motif as delineated for the ab T cell costimulatory receptor CD28. Thus, CAR and JAML are cell signaling receptors of the immune system with implications for asthma, cancer, and chronic nonhealing wounds.	[Verdino, Petra; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Witherden, Deborah A.; Havran, Wendy L.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu			NIH [AI42266, CA58896, AI52257, AI064811]; Austrian Science Fund; Skaggs Institute.; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042266, R01AI036964, R37AI042266, R01AI052257, R01AI064811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080301] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); Skaggs Institute.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Schiefner for help with the structure solution; S. Ferguson, H. Lindermuth, and J. Vanhasny for technical support; L. Teyton for providing cell lines; J. G. Luz, M. A. Adams-Cioaba, J. Stevens, D. A. Shore, A. L. Corper, R. L. Stanfield, and E. Ollmann Saphire for helpful discussions; and X. Dai and K. Saikatendu for assistance on synchrotron trips. We acknowledge the Advanced Light Source, Stanford Synchrotron Radiation Lightsource, and the Advanced Photon Source for use of their synchrotron facilities. This work was supported by NIH grants AI42266, CA58896 to I. A. W., and AI52257 and AI064811 to W. L. H., an Erwin-Schrodinger Fellowship of the Austrian Science Fund to P. V., and the Skaggs Institute. Atomic coordinates and structure factors for JAML and the CAR-JAML complex have been deposited in the Protein Data Bank with accession numbers 3MJ6 and 3MJ7 respectively. This is manuscript 18641-MB from The Scripps Research Institute.	Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Bewley MC, 1999, SCIENCE, V286, P1579, DOI 10.1126/science.286.5444.1579; Bromley SK, 2001, NAT IMMUNOL, V2, P1159, DOI 10.1038/ni737; Carson SD, 2001, REV MED VIROL, V11, P219, DOI 10.1002/rmv.318; Davis SJ, 2003, NAT IMMUNOL, V4, P217, DOI 10.1038/ni0303-217; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Dustin ML, 2001, ANNU REV CELL DEV BI, V17, P133, DOI 10.1146/annurev.cellbio.17.1.133; Freimuth P, 2008, CURR TOP MICROBIOL, V323, P67; Guo YL, 2009, ARTERIOSCL THROM VAS, V29, P75, DOI 10.1161/ATVBAHA.108.177717; He YN, 2001, NAT STRUCT BIOL, V8, P874, DOI 10.1038/nsb1001-874; Howitt J, 2003, CURR TOP MICROBIOL, V272, P331; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jiang SK, 2007, PROTEIN SCI, V16, P539, DOI 10.1110/ps.062643507; Kanerva A, 2005, ANN MED, V37, P33, DOI 10.1080/07853890410018934; Luissint AC, 2008, J CELL BIOL, V183, P1159, DOI 10.1083/jcb.200805061; Moog-Lutz C, 2003, BLOOD, V102, P3371, DOI 10.1182/blood-2002-11-3462; PAGES F, 1994, NATURE, V369, P327, DOI 10.1038/369327a0; RAAB M, 1995, P NATL ACAD SCI USA, V92, P8891, DOI 10.1073/pnas.92.19.8891; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; Verma IM, 2005, ANNU REV BIOCHEM, V74, P711, DOI 10.1146/annurev.biochem.74.050304.091637; Wang J, 1999, CELL, V97, P791, DOI 10.1016/S0092-8674(00)80790-4; WITHERDEN DA, 2010, SCIENCE, V329, pR30; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	25	91	100	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1210	1214		10.1126/science.1187996	http://dx.doi.org/10.1126/science.1187996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20813955	Green Accepted			2022-12-24	WOS:000281485600037
J	Beal, MF				Beal, M. Flint			Parkinson's disease: a model dilemma	NATURE			English	Editorial Material							ALPHA-SYNUCLEIN; TRANSGENIC MICE; MUTATION		[Beal, M. Flint] Weill Med Coll, Dept Neurol & Neurosci, New York, NY USA; [Beal, M. Flint] New York Presbyterian Cornell Campus, Neurol Serv, New York, NY USA	Cornell University	Beal, MF (corresponding author), Weill Med Coll, Dept Neurol & Neurosci, New York, NY USA.							Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Li XT, 2010, J NEUROSCI, V30, P1788, DOI 10.1523/JNEUROSCI.5604-09.2010; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lin X, 2009, NEURON, V64, P807, DOI 10.1016/j.neuron.2009.11.006; Lu XH, 2009, J NEUROSCI, V29, P1962, DOI 10.1523/JNEUROSCI.5351-08.2009; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106	9	77	80	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					S8	S10		10.1038/466S8a	http://dx.doi.org/10.1038/466S8a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20739935	Bronze			2022-12-24	WOS:000281203600060
J	Smith, K				Smith, Kerri			Treatment frontiers	NATURE			English	Editorial Material							GENOME-WIDE ASSOCIATION; PARKINSONS-DISEASE; BRAIN-STIMULATION; RISK-FACTORS; TRANSPLANTATION; NEURONS											BACKLUND EO, 1985, J NEUROSURG, V62, P169, DOI 10.3171/jns.1985.62.2.0169; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Fregni F, 2005, J NEUROL NEUROSUR PS, V76, P1614, DOI 10.1136/jnnp.2005.069849; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lozano AM, 2008, BIOL PSYCHIAT, V64, P461, DOI 10.1016/j.biopsych.2008.05.034; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Rakovic A, 2010, HUM MOL GENET, V19, P3124, DOI 10.1093/hmg/ddq215; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105	17	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					S15	S18		10.1038/466S15a	http://dx.doi.org/10.1038/466S15a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20739932	Bronze			2022-12-24	WOS:000281203600063
J	Hobbs, RM; Seandel, M; Falciatori, I; Rafii, S; Pandolfi, PP				Hobbs, Robin M.; Seandel, Marco; Falciatori, Ilaria; Rafii, Shahin; Pandolfi, Pier Paolo			Plzf Regulates Germline Progenitor Self-Renewal by Opposing mTORC1	CELL			English	Article							SPERMATOGONIAL STEM-CELLS; ACUTE PROMYELOCYTIC LEUKEMIA; UNDIFFERENTIATED SPERMATOGONIA; RETINOIC ACID; MOUSE TESTIS; ZINC-FINGER; BONE-MARROW; MAMMALIAN TARGET; INITIATING CELLS; LIFE-SPAN	Hyperactivity of mTORC1, a key mediator of cell growth, leads to stem cell depletion, although the underlying mechanisms are poorly defined. Using spermatogonial progenitor cells (SPCs) as a model system, we show that mTORC1 impairs stem cell maintenance by a negative feedback from mTORC1 to receptors required to transduce niche-derived signals. We find that SPCs lacking Plzf, a transcription factor essential for SPC maintenance, have enhanced mTORC1 activity. Aberrant mTORC1 activation in Plzf(-/-) SPCs inhibits their response to GDNF, a growth factor critical for SPC self-renewal, via negative feedback at the level of the GDNF receptor. Plzf opposes mTORC1 activity by inducing expression of the mTORC1 inhibitor Redd1. Thus, we identify the mTORC1-Plzf functional interaction as a critical rheostat for maintenance of the spermatogonial pool and propose a model whereby negative feedback from mTORC1 to the GDNF receptor balances SPC growth with self-renewal.	[Hobbs, Robin M.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02115 USA; [Seandel, Marco] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Falciatori, Ilaria; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, Howard Hughes Med Inst, New York, NY 10065 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Cornell University; Cornell University; Howard Hughes Medical Institute	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Hobbs, Robin/I-2577-2014	Hobbs, Robin/0000-0002-3853-2614	NIH; NATIONAL CANCER INSTITUTE [R01CA102142] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank current and past members of the Pandolfi lab and in particular Takahiro Maeda and Rosa Bernardi for helpful discussion and advice. We would also like to thank Antonella Papa for generating luciferase reporters, Sharmila Fagoonee for experimental help, Leif Ellisen for Redd1 promoter constructs, and the flow cytometry facilities of BIDMC and MSKCC for expert support. M.S. is a Stanley and Fiona Druckenmiller Fellow of the New York Stem Cell Foundation. This work was supported by NIH grants to P.P.P.	Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Costoya JA, 2008, ONCOGENE, V27, P3789, DOI 10.1038/onc.2008.7; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; De Rooij DG, 2000, J ANDROL, V21, P776; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fischer S, 2008, J MED GENET, V45, P731, DOI 10.1136/jmg.2008.059451; Gan B, 2009, CELL CYCLE, V8, P1003, DOI 10.4161/cc.8.7.8045; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gery S, 2007, EXP HEMATOL, V35, P572, DOI 10.1016/j.exphem.2007.01.049; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; He LZ, 2000, MOL CELL, V6, P1131, DOI 10.1016/S1097-2765(00)00111-8; Hennige AM, 2000, MOL CELL ENDOCRINOL, V167, P69, DOI 10.1016/S0303-7207(00)00283-5; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Ito K, 2009, CURR OPIN GENET DEV, V19, P51, DOI 10.1016/j.gde.2009.01.004; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Hamra FK, 2007, J BIOL CHEM, V282, P721, DOI 10.1074/jbc.M608398200; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Labbaye C, 2002, ONCOGENE, V21, P6669, DOI 10.1038/sj.onc.1205884; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martelli AM, 2007, CURR MED CHEM, V14, P2009; McConnell MJ, 2007, CURR TOP MICROBIOL, V313, P31; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nishioka C, 2009, INT J CANCER, V125, P1710, DOI 10.1002/ijc.24472; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; VIRTANEN I, 1986, ANAT RECORD, V215, P10, DOI 10.1002/ar.1092150103; Wu X, 2010, BIOL REPROD, V82, P1103, DOI 10.1095/biolreprod.109.083097; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang XF, 2006, BIOL REPROD, V74, P119, DOI 10.1095/biolreprod.105.045591	76	184	197	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					468	479		10.1016/j.cell.2010.06.041	http://dx.doi.org/10.1016/j.cell.2010.06.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691905	Green Accepted, Bronze			2022-12-24	WOS:000280609100023
J	Pletcher, MJ; Bibbins-Domingo, K; Liu, KA; Sidney, S; Lin, F; Vittinghoff, E; Hulley, SB				Pletcher, Mark J.; Bibbins-Domingo, Kirsten; Liu, Kiang; Sidney, Steve; Lin, Feng; Vittinghoff, Eric; Hulley, Stephen B.			Nonoptimal Lipids Commonly Present in Young Adults and Coronary Calcium Later in Life: The CARDIA (Coronary Artery Risk Development in Young Adults) Study	ANNALS OF INTERNAL MEDICINE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK; HEART-DISEASE; BLOOD-PRESSURE; COMPUTED-TOMOGRAPHY; SERUM-CHOLESTEROL; FOLLOW-UP; ATHEROSCLEROSIS; CHILDHOOD	Background: Dyslipidemia causes coronary heart disease in middle-aged and elderly adults, but the consequences of lipid exposure during young adulthood are unclear. Objective: To assess whether nonoptimal lipid levels during young adulthood cause atherosclerotic changes that persist into middle age. Design: Prospective cohort study. Setting: 4 cities in the United States. Participants: 3258 participants from the 5115 black and white men and women recruited at age 18 to 30 years in 1985 to 1986 for the CARDIA (Coronary Artery Risk Development in Young Adults) study. Measurements: Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, triglycerides, and coronary calcium. Time-averaged cumulative exposures to lipids between age 20 and 35 years were estimated by using repeated serum lipid measurements over 20 years in the CARDIA study; these measurements were then related to coronary calcium scores assessed later in life (45 years [SD, 4]). Results: 2824 participants (87%) had nonoptimal levels of LDL cholesterol (>= 2.59 mmol/L [>= 100 mg/dL]), HDL cholesterol (<1.55 mmol/L [<60 mg/dL]), or triglycerides (>= 1.70 mmol/L [>= 150 mg/dL]) during young adulthood. Coronary calcium prevalence 2 decades later was 8% in participants who maintained optimal LDL levels (<1.81 mmol/L [<70 mg/dL]), and 44% in participants with LDL cholesterol levels of 4.14 mmol/L (160 mg/dL) or greater (P < 0.001). The association was similar across race and sex and strongly graded, with odds ratios for coronary calcium of 1.5 (95% CI, 0.7 to 3.3) for LDL cholesterol levels of 1.81 to 2.56 mmol/L (70 to 99 mg/dL), 2.4 (CI, 1.1 to 5.3) for levels of 2.59 to 3.34 mmol/L (100 to 129 mg/dL), 3.3 (CI, 1.3 to 7.8) for levels of 3.37 to 4.12 mmol/L (130 to 159 mg/dL), and 5.6 (CI, 2.0 to 16) for levels of 4.14 mmol/L (160 mg/dL) or greater, compared with levels less than 1.81 mmol/L (<70 mg/dL), after adjustment for lipid exposure after age 35 years and other coronary risk factors. Both LDL and HDL cholesterol levels were independently associated with coronary calcium after participants who were receiving lipid-lowering medications or had clinically abnormal lipid levels were excluded. Limitation: Coronary calcium, although a strong predictor of future coronary heart disease, is not a clinical outcome. Conclusion: Nonoptimal levels of LDL and HDL cholesterol during young adulthood are independently associated with coronary atherosclerosis 2 decades later.	[Pletcher, Mark J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; Kaiser Permanente, Div Res, Oakland, CA USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of California System; University of California San Francisco; Kaiser Permanente; Northwestern University; Feinberg School of Medicine	Pletcher, MJ (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 185 Berry St,Suite 5700, San Francisco, CA 94107 USA.	mpletcher@epi.ucsf.edu			National Heart, Lung, and Blood Institute [N01-HC-45204]; University of Alabama at Birmingham Coordinating Center [N01-HC-95095]; University of Alabama at Birmingham Field Center [N01-HC-48047]; University of Minnesota Field Center and Diet Reading Center [N01-HC-48048]; Northwestern University Field Center [N01-HC-48049]; Kaiser Foundation Research Institute [N01-HC-48050]; University of California, Irvine, Echocardiography Reading Center [N01-HC-45134]; Harbor-University of California, Los Angeles, Research Education Institute, Computed Tomography Reading Center [N01-HC-05187]; Wake Forest University [N01-HC-45205]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC045134, N01HC048048, N01HC005187, N01HC048049, N01HC048047, N01HC048050, N01HC095095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048050, R29HL048048, R01HL048049, R01HL048048] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham Coordinating Center; University of Alabama at Birmingham Field Center; University of Minnesota Field Center and Diet Reading Center(University of Minnesota System); Northwestern University Field Center; Kaiser Foundation Research Institute; University of California, Irvine, Echocardiography Reading Center(University of California System); Harbor-University of California, Los Angeles, Research Education Institute, Computed Tomography Reading Center; Wake Forest University; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.; By the University of Alabama at Birmingham Coordinating Center (grant N01-HC-95095); University of Alabama at Birmingham Field Center (grant N01-HC-48047); University of Minnesota Field Center and Diet Reading Center (year 20 examination) (grant N01-HC-48048); Northwestern University Field Center (grant N01-HC-48049); Kaiser Foundation Research Institute (grant N01-HC-48050); University of California, Irvine, Echocardiography Reading Center (years 5 and 10) (grant N01-HC-45134); Harbor-University of California, Los Angeles, Research Education Institute, Computed Tomography Reading Center (year 15 examination) (grant N01-HC-05187); Wake Forest University (year 20 examination) (grant N01-HC-45205); and New England Medical Center (year 20 examination) (grant N01-HC-45204 from the National Heart, Lung and Blood Institute).	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; ANDERSON KM, 1987, JAMA-J AM MED ASSOC, V257, P2176, DOI 10.1001/jama.257.16.2176; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bao WH, 1996, ARCH INTERN MED, V156, P1315, DOI 10.1001/archinte.156.12.1315; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bild DE, 1996, ANN EPIDEMIOL, V6, P235, DOI 10.1016/1047-2797(96)00005-1; Blaha M, 2009, JACC-CARDIOVASC IMAG, V2, P692, DOI 10.1016/j.jcmg.2009.03.009; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Carr JJ, 2000, AM J ROENTGENOL, V174, P915, DOI 10.2214/ajr.174.4.1740915; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Chhatriwalla AK, 2009, J AM COLL CARDIOL, V53, P1110, DOI 10.1016/j.jacc.2008.09.065; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; DAWBER T. R., 1957, AMER JOUR PUBL HEALTH, V47, P4, DOI 10.2105/AJPH.47.4_Pt_2.4; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; HULLEY SB, 1980, NEW ENGL J MED, V302, P1383, DOI 10.1056/NEJM198006193022503; HULLEY SB, 1992, BRIT MED J, V304, P394, DOI 10.1136/bmj.304.6824.394; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; Knoflach M, 2003, CIRCULATION, V108, P1064, DOI 10.1161/01.CIR.0000085996.95532.FF; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; McGill HC, 1997, ARTERIOSCL THROM VAS, V17, P95, DOI 10.1161/01.ATV.17.1.95; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; *NAT CHOL ED PROGR, 2004, DET EV TREATM HIGH B; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; Nieto FJ, 1999, J CLIN EPIDEMIOL, V52, P559, DOI 10.1016/S0895-4356(99)00030-X; Pletcher MJ, 2008, ANN INTERN MED, V149, P91, DOI 10.7326/0003-4819-149-2-200807150-00005; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sanchez A, 2000, ATHEROSCLEROSIS, V152, P265, DOI 10.1016/S0021-9150(00)00532-3; Sarwar A, 2009, JACC-CARDIOVASC IMAG, V2, P675, DOI 10.1016/j.jcmg.2008.12.031; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Tonstad S, 1996, ARTERIOSCL THROM VAS, V16, P984, DOI 10.1161/01.ATV.16.8.984; *US PREV SERV TASK, 2008, SCREEN LIP DIS AD; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802	46	80	83	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2010	153	3					137	U18		10.7326/0003-4819-153-3-201008030-00004	http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634CR	20679558	Green Accepted			2022-12-24	WOS:000280557600001
J	Unroe, M; Kahn, JM; Carson, SS; Govert, JA; Martinu, T; Sathy, SJ; Clay, AS; Chia, J; Gray, A; Tulsky, JA; Cox, CE				Unroe, Mark; Kahn, Jeremy M.; Carson, Shannon S.; Govert, Joseph A.; Martinu, Tereza; Sathy, Shailaja J.; Clay, Alison S.; Chia, Jessica; Gray, Alice; Tulsky, James A.; Cox, Christopher E.			One-Year Trajectories of Care and Resource Utilization for Recipients of Prolonged Mechanical Ventilation A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							LENGTH-OF-STAY; INTENSIVE-CARE; ECONOMIC-EVALUATION; TRACHEOSTOMY; OUTCOMES; ILLNESS; SURVIVORS; BURDEN; COST; ICU	Background: Growing numbers of critically ill patients receive prolonged mechanical ventilation. Little is known about the patterns of care as patients transition from acute care hospitals to postacute care facilities or about the associated resource utilization. Objective: To describe 1-year trajectories of care and resource utilization for patients receiving prolonged mechanical ventilation. Design: 1-year prospective cohort study. Setting: 5 intensive care units at Duke University Medical Center, Durham, North Carolina. Participants: 126 patients receiving prolonged mechanical ventilation (defined as ventilation for >= 4 days with tracheostomy placement or ventilation for >= 21 days without tracheostomy), as well as their 126 surrogates and 54 intensive care unit physicians, enrolled consecutively over 1 year. Measurements: Patients and surrogates were interviewed in the hospital, as well as 3 and 12 months after discharge, to determine patient survival, functional status, and facility type and duration of postdischarge care. Physicians were interviewed in the hospital to elicit prognoses. Institutional billing records were used to assign costs for acute care, outpatient care, and interfacility transportation. Medicare claims data were used to assign costs for postacute care. Results: 103 (82%) hospital survivors had 457 separate transitions in postdischarge care location (median, 4 transitions [interquartile range, 3 to 5 transitions]), including 68 patients (67%) who were readmitted at least once. Patients spent an average of 74% (95% CI, 68% to 80%) of all days alive in a hospital or postacute care facility or receiving home health care. At 1 year, 11 patients (9%) had a good outcome (alive with no functional dependency), 33 (26%) had a fair outcome (alive with moderate dependency), and 82 (65%) had a poor outcome (either alive with complete functional dependency [4 patients; 21%] or dead [56 patients; 44%]). Patients with poor outcomes were older, had more comorbid conditions, and were more frequently discharged to a postacute care facility than patients with either fair or good outcomes (P < 0.05 for all). The mean cost per patient was $306 135 (SD, $285 467), and total cohort cost was $38.1 million, for an estimated $3.5 million per independently functioning survivor at 1 year. Limitation: The results of this single-center study may not be applicable to other centers. Conclusion: Patients receiving prolonged mechanical ventilation have multiple transitions of care, resulting in substantial health care costs and persistent, profound disability. The optimism of surrogate decision makers should be balanced by discussions of these outcomes when considering a course of prolonged life support.	[Cox, Christopher E.] Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC 27710 USA; Univ N Carolina, Chapel Hill, NC USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania	Cox, CE (corresponding author), Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Box 102043, Durham, NC 27710 USA.	christopher.cox@duke.edu	Cox, Christopher/ABH-7957-2020	Cox, Christopher/0000-0002-4486-0681; Kahn, Jeremy/0000-0001-9688-5576	National Institutes of Health [K23 HL081048, K23 HL082650, K23 HL067068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL067068, K23HL081048, K23HL082650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the National Institutes of Health (grants K23 HL081048, K23 HL082650, and K23 HL067068).	Angus DC, 2001, AM J RESP CRIT CARE, V163, P1389, DOI 10.1164/ajrccm.163.6.2005123; Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Carson SS, 2008, CRIT CARE MED, V36, P2061, DOI 10.1097/CCM.0b013e31817b8925; Carson SS, 2002, CRIT CARE CLIN, V18, P461, DOI 10.1016/S0749-0704(02)00015-5; Carson SS, 2001, CHEST, V120, P928, DOI 10.1378/chest.120.3.928; Centers for Medicare & Medicaid Services, OV PROSP PAYM SYST; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Chudgar SM, 2009, CRIT CARE MED, V37, P49, DOI 10.1097/CCM.0b013e31819265c8; Cooper LM, 2004, CRIT CARE MED, V32, P2247, DOI 10.1097/01.CCM.0000146301.47334.BD; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; Cox CE, 2007, CRIT CARE MED, V35, P1918, DOI 10.1097/01.CCM.0000275391.35834.10; Cox CE, 2007, CRIT CARE, V11, DOI 10.1186/cc5667; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; Davis K, 2007, NEW ENGL J MED, V356, P1166, DOI 10.1056/NEJMe078007; Dewar DM, 1999, CRIT CARE MED, V27, P2640, DOI 10.1097/00003246-199912000-00006; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; El-Jawahri A, 2010, J CLIN ONCOL, V28, P305, DOI 10.1200/JCO.2009.24.7502; ELLIS SG, 1995, CIRCULATION, V92, P741, DOI 10.1161/01.CIR.92.4.741; Engoren M, 2004, CHEST, V125, P220, DOI 10.1378/chest.125.1.220; Evans LR, 2009, AM J RESP CRIT CARE, V179, P48, DOI 10.1164/rccm.200806-969OC; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Griffiths J, 2005, BMJ-BRIT MED J, V330, P1243, DOI 10.1136/bmj.38467.485671.E0; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Heyland DK, 1998, CHEST, V114, P192, DOI 10.1378/chest.114.1.192; Kahn JM, 2008, MED CARE, V46, P1226, DOI 10.1097/MLR.0b013e31817d9342; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kind P., 1999, 172 U YORK YORK HLTH; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Luo N, 2005, MED CARE, V43, P1078, DOI 10.1097/01.mlr.0000182493.57090.c1; MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937; Nasraway SA, 2000, CRIT CARE MED, V28, P19, DOI 10.1097/00003246-200001000-00004; Nathens AB, 2006, CRIT CARE MED, V34, P2919, DOI 10.1097/01.CCM.0000243800.28251.AE; Nelson JE, 2004, CRIT CARE MED, V32, P1527, DOI 10.1097/01.CCM.0000129485.08835.5A; Nelson JE, 2007, ARCH INTERN MED, V167, P2509, DOI 10.1001/archinte.167.22.2509; Nelson JE, 2006, ARCH INTERN MED, V166, P1993, DOI 10.1001/archinte.166.18.1993; Rapoport J, 2003, MED CARE, V41, P386, DOI 10.1097/00005650-200303000-00007; *RTI INT, POST CAR PAYM REF DE; Taira DA, 2003, AM HEART J, V145, P452, DOI 10.1067/mhj.2003.3; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Van Pelt DC, 2007, AM J RESP CRIT CARE, V175, P167, DOI 10.1164/rccm.200604-493OC; White DB, 2007, ARCH INTERN MED, V167, P461, DOI 10.1001/archinte.167.5.461; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; Zilberberg MD, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-242	46	309	317	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2010	153	3					167	U62		10.7326/0003-4819-153-3-201008030-00007	http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00007			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634CR	20679561	Green Accepted			2022-12-24	WOS:000280557600005
J	Schmidt, AC				Schmidt, Alexander C.			Response to Dengue Fever -- The Good, the Bad, and the Ugly?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INFECTION; VACCINE		NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schmidt, AC (corresponding author), NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.							Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690	5	35	38	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2010	363	5					484	487		10.1056/NEJMcibr1005904	http://dx.doi.org/10.1056/NEJMcibr1005904			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632GS	20818870				2022-12-24	WOS:000280411300016
J	Wang, BX; Yang, W; Wen, W; Sun, J; Su, B; Liu, B; Ma, DL; Lv, D; Wen, YR; Qu, T; Chen, M; Sun, MA; Shen, Y; Zhang, X				Wang, Baoxi; Yang, Wei; Wen, Wen; Sun, Jing; Su, Bin; Liu, Bo; Ma, Donglai; Lv, Dan; Wen, Yaran; Qu, Tao; Chen, Min; Sun, Miao; Shen, Yan; Zhang, Xue			gamma-Secretase Gene Mutations in Familial Acne Inversa	SCIENCE			English	Article							HIDRADENITIS-SUPPURATIVA; DISEASE		[Yang, Wei; Sun, Jing; Lv, Dan; Wen, Yaran; Sun, Miao; Shen, Yan; Zhang, Xue] Peking Union Med Coll, Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100021, Peoples R China; [Wang, Baoxi; Su, Bin; Ma, Donglai; Qu, Tao] Peking Union Med Coll, Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China; [Wen, Wen; Zhang, Xue] China Med Univ, Shenyang, Peoples R China; [Liu, Bo; Shen, Yan] Chinese Natl Human Genome Ctr Beijing, Beijing, Peoples R China; [Chen, Min] Peking Union Med Coll, Chinese Acad Med Sci, Inst Dermatol, Nanjing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; China Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Peking Union Medical College	Shen, Y (corresponding author), Peking Union Med Coll, Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing 100021, Peoples R China.	shen.yan@imicams.ac.cn; xuezhang@pumc.edu.cn	miao, sun/E-2834-2018; Wen, Yaran/D-4453-2012	Wen, Yaran/0000-0001-6346-8653; Wang, Baoxi/0000-0002-9514-5098				Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; Gao M, 2006, J INVEST DERMATOL, V126, P1302, DOI 10.1038/sj.jid.5700272; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Prokop S, 2005, J NEUROCHEM, V94, P57, DOI 10.1111/j.1471-4159.2005.03165.x; Revuz J, 2009, J EUR ACAD DERMATOL, V23, P985, DOI 10.1111/j.1468-3083.2009.03356.x; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shuster S, 2008, BRIT J DERMATOL, V158, P1, DOI 10.1111/j.1365-2133.2007.08282.x	7	276	310	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1065	1065		10.1126/science.1196284	http://dx.doi.org/10.1126/science.1196284			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20929727				2022-12-24	WOS:000284374700032
J	Moretti, A; Bellin, M; Welling, A; Jung, CB; Lam, JT; Bott-Flugel, L; Dorn, T; Goedel, A; Hohnke, C; Hofmann, F; Seyfarth, M; Sinnecker, D; Schomig, A; Laugwitz, KL				Moretti, Alessandra; Bellin, Milena; Welling, Andrea; Jung, Christian Billy; Lam, Jason T.; Bott-Fluegel, Lorenz; Dorn, Tatjana; Goedel, Alexander; Hoehnke, Christian; Hofmann, Franz; Seyfarth, Melchior; Sinnecker, Daniel; Schoemig, Albert; Laugwitz, Karl-Ludwig			Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOMYOCYTES; GENERATION; MUTATIONS; KVLQT1; PATHOGENESIS; PROGENITORS; CHANNELS; HEART	Background: Long-QT syndromes are heritable diseases associated with prolongation of the QT interval on an electrocardiogram and a high risk of sudden cardiac death due to ventricular tachyarrhythmia. In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier I(sub Ks) current. Methods: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene. We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells. With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes. Results: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes. Individual cells showed a ``ventricular,'' ``atrial,'' or ``nodal'' phenotype, as evidenced by the expression of cell-type-specific markers and as seen in recordings of the action potentials in single cells. The duration of the action potential was markedly prolonged in ``ventricular'' and ``atrial'' cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects. Further characterization of the role of the R190Q-KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant negative trafficking defect associated with a 70 to 80% reduction in I(sub Ks) current and altered channel activation and deactivation properties. Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype. Conclusions: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes. The patient-derived cells recapitulated the electrophysiological features of the disorder. (Funded by the European Research Council and others.) N Engl J Med 2010;363:1397-1409.	[Moretti, Alessandra; Bellin, Milena; Jung, Christian Billy; Lam, Jason T.; Bott-Fluegel, Lorenz; Dorn, Tatjana; Goedel, Alexander; Seyfarth, Melchior; Sinnecker, Daniel; Schoemig, Albert; Laugwitz, Karl-Ludwig] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 1, Div Cardiol, D-81675 Munich, Germany; [Hoehnke, Christian] Tech Univ Munich, Klinikum Rechts Isar, Dept Plast Surg, D-81675 Munich, Germany; [Moretti, Alessandra; Bellin, Milena; Jung, Christian Billy; Lam, Jason T.; Bott-Fluegel, Lorenz; Dorn, Tatjana; Goedel, Alexander; Seyfarth, Melchior; Sinnecker, Daniel; Schoemig, Albert; Laugwitz, Karl-Ludwig] Tech Univ Munich, German Heart Ctr Munich, Dept Cardiol, D-81675 Munich, Germany; [Welling, Andrea; Hofmann, Franz] Tech Univ Munich, Inst Pharmacol & Toxicol, D-81675 Munich, Germany	Technical University of Munich; Technical University of Munich; German Heart Centre Munich; Technical University of Munich; Technical University of Munich	Laugwitz, KL (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 1, Div Cardiol, Ismaninger Str 22, D-81675 Munich, Germany.	klaugwitz@med1.med.tum.de	Moretti, Alessandra/O-9271-2015; Bellin, Milena/M-2311-2014; Dorn, Tatjana/O-6817-2015; Goedel, Alexander/AAX-3900-2020; Welling, Andrea/K-6674-2017	Moretti, Alessandra/0000-0001-5782-7832; Bellin, Milena/0000-0001-5380-6743; Goedel, Alexander/0000-0002-5980-2257; Welling, Andrea/0000-0002-5364-4980; Bott-Flugel, Lorenz/0000-0003-0932-1241; Sinnecker, Daniel/0000-0002-8116-9750	European Research Council (Marie Curie Excellence Team) [MEXT-23208]; German Research Foundation [923, La 1238 3-1/4-1]; German Ministry for Education and Research [01 GN 0826]	European Research Council (Marie Curie Excellence Team)(European Research Council (ERC)European Commission); German Research Foundation(German Research Foundation (DFG)); German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	Supported by grants from the European Research Council (Marie Curie Excellence Team Grant, MEXT-23208), the German Research Foundation (Research Unit 923 and La 1238 3-1/4-1), and the German Ministry for Education and Research (01 GN 0826).	Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Chouabe C, 2000, CARDIOVASC RES, V45, P971, DOI 10.1016/S0008-6363(99)00411-3; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Freund C, 2010, NETH HEART J, V18, P51; Gai H, 2009, CELL BIOL INT, V33, P1184, DOI 10.1016/j.cellbi.2009.08.008; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; Imredy JP, 2008, AM J PHYSIOL-HEART C, V295, pH1867, DOI 10.1152/ajpheart.433.2008; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Laugwitz KL, 2007, NATURE, V446, P934, DOI 10.1038/nature05790; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lerche C, 2007, MOL PHARMACOL, V72, P796; Lerche C, 2007, MOL PHARMACOL, V71, P1503, DOI 10.1124/mol.106.031682; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moretti A, 2010, FASEB J, V24, P700, DOI 10.1096/fj.09-139477; Moss AJ, 2007, CIRCULATION, V115, P2481, DOI 10.1161/CIRCULATIONAHA.106.665406; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Pan N, 2009, CELL SIGNAL, V21, P349, DOI 10.1016/j.cellsig.2008.11.006; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Priori SG, 2001, EUROPACE, V3, P16, DOI 10.1053/eupc.2000.0141; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Roden DM, 2008, NEW ENGL J MED, V358, P169, DOI 10.1056/NEJMcp0706513; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Vyas H, 2006, CIRCULATION, V113, P1385, DOI 10.1161/CIRCULATIONAHA.105.600445; Wang Z, 1999, J CARDIOVASC ELECTR, V10, P817, DOI 10.1111/j.1540-8167.1999.tb00262.x; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Yokoo N, 2009, BIOCHEM BIOPH RES CO, V387, P482, DOI 10.1016/j.bbrc.2009.07.052; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	41	868	899	0	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1397	1409		10.1056/NEJMoa0908679	http://dx.doi.org/10.1056/NEJMoa0908679			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659NV	20660394	Green Published			2022-12-24	WOS:000282575100005
J	Nishikawa, S; Arimoto, I; Ikezaki, K; Sugawa, M; Ueno, H; Komori, T; Iwane, AH; Yanagida, T				Nishikawa, So; Arimoto, Ikuo; Ikezaki, Keigo; Sugawa, Mitsuhiro; Ueno, Hiroshi; Komori, Tomotaka; Iwane, Atsuko H.; Yanagida, Toshio			Switch between Large Hand-Over-Hand and Small Inchworm-like Steps in Myosin VI	CELL			English	Article							LEVER ARM; ACTIN-FILAMENTS; UNIQUE INSERT; POWER STROKE; MOTOR; MECHANISM; WALKS; DIRECTIONALITY; MICROSCOPY; SIZE	Many biological motor molecules move within cells using stepsizes predictable from their structures. Myosin VI, however, has much larger and more broadly distributed stepsizes than those predicted from its short lever arms. We explain the discrepancy by monitoring Qdots and gold nanoparticles attached to the myosin-VI motor domains using high-sensitivity nanoimaging. The large stepsizes were attributed to an extended and relatively rigid lever arm; their variability to two stepsizes, one large (72 nm) and one small (44 nm). These results suggest that there exist two tilt angles during myosin-VI stepping, which correspond to the pre- and postpowerstroke states and regulate the leading head. The large steps are consistent with the previously reported hand-over-hand mechanism, while the small steps follow an inchworm-like mechanism and increase in frequency with ADP. Switching between these two mechanisms in a strain-sensitive, ADP-dependent manner allows myosin VI to fulfill its multiple cellular tasks including vesicle transport and membrane anchoring.	[Nishikawa, So; Arimoto, Ikuo; Ikezaki, Keigo; Sugawa, Mitsuhiro; Komori, Tomotaka; Iwane, Atsuko H.; Yanagida, Toshio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Ueno, Hiroshi] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Yanagida, Toshio] Osaka Univ, Immunol Frontier Res Ctr, WPI, Osaka 5670047, Japan; [Yanagida, Toshio] RIKEN, Suita, Osaka 5650871, Japan; [Yanagida, Toshio] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan	Osaka University; Osaka University; Osaka University; RIKEN; National Institute of Information & Communications Technology (NICT) - Japan	Yanagida, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yanagida@phys1.med.osaka-u.ac.jp		SUGAWA, MITSUHIRO/0000-0002-3188-1547; Iwane, Atsuko/0000-0003-2641-2268	Ministry of Education, Science, Sports and Culture [20770121]	Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study is supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Young Scientists (B), 20770121, 2008-2009 (to S.N.), for Scientific Research on Priority Areas, 60402997, 2007-2008 (to S.N.), by the Yuragi Project of the Japanese Ministry of Education, Culture, Sports, Science and Technology (to T.Y.). We thank member of Yanagida Lab., Noji Lab. and Kinosita Lab. for valuable discussion. We especially thank M. A. Zulliger, R. Iino, K. V. Tabata, S. Sakakihara, S. Furuike; Y. Arai, T. Mimuro-Ichinose and R. Ogawa, for technical help; P. Karagiannis for helpful discussions and comments on the manuscript.	Ali MY, 2004, BIOPHYS J, V86, P3804, DOI 10.1529/biophysj.103.037416; Altman D, 2004, CELL, V116, P737, DOI 10.1016/S0092-8674(04)00211-9; Altman D, 2007, PLOS BIOL, V5, P1712, DOI 10.1371/journal.pbio.0050210; Bahloul A, 2004, P NATL ACAD SCI USA, V101, P4787, DOI 10.1073/pnas.0306892101; Balci H, 2005, BIOPHYS J, V89, P413, DOI 10.1529/biophysj.105.060608; Bryant Z, 2007, P NATL ACAD SCI USA, V104, P772, DOI 10.1073/pnas.0610144104; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; CHURCHMAN LS, 2007, COLOCALIZATION FLUOR, P73; DE LA CRUZ EM, 2001, J BIOL CHEM, V276, P32373; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; GOLDMAN YE, 1987, ANNU REV PHYSIOL, V49, P637, DOI 10.1146/annurev.ph.49.030187.003225; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; Iwaki M, 2009, NAT CHEM BIOL, V5, P403, DOI 10.1038/nchembio.171; KINOSITA K, 1991, J CELL BIOL, V115, P67, DOI 10.1083/jcb.115.1.67; Lan GH, 2006, BIOPHYS J, V91, P4002, DOI 10.1529/biophysj.106.089888; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Menetrey J, 2008, EMBO J, V27, P244, DOI 10.1038/sj.emboj.7601937; Mukherjea M, 2009, MOL CELL, V35, P305, DOI 10.1016/j.molcel.2009.07.010; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Okten Z, 2004, NAT STRUCT MOL BIOL, V11, P884, DOI 10.1038/nsmb815; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Park H, 2007, P NATL ACAD SCI USA, V104, P778, DOI 10.1073/pnas.0610066104; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Reifenberger JG, 2009, P NATL ACAD SCI USA, V106, P18255, DOI 10.1073/pnas.0900005106; Rock RS, 2005, MOL CELL, V17, P603, DOI 10.1016/j.molcel.2005.01.015; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Shiroguchi K, 2007, SCIENCE, V316, P1208, DOI 10.1126/science.1140468; Sivaramakrishnan S, 2009, J CELL BIOL, V187, P53, DOI 10.1083/jcb.200906133; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Spudich JA, 2010, NAT REV MOL CELL BIO, V11, P128, DOI 10.1038/nrm2833; Sun YJ, 2007, MOL CELL, V28, P954, DOI 10.1016/j.molcel.2007.10.029; Sweeney HL, 2007, CURR OPIN CELL BIOL, V19, P57, DOI 10.1016/j.ceb.2006.12.005; Taniguchi Y, 2005, NAT CHEM BIOL, V1, P342, DOI 10.1038/nchembio741; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Warshaw DM, 2005, BIOPHYS J, V88, pL30, DOI 10.1529/biophysj.105.061903; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yildiz A, 2004, J BIOL CHEM, V279, P37223, DOI 10.1074/jbc.C400252200; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	42	51	51	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 17	2010	142	6					879	888		10.1016/j.cell.2010.08.033	http://dx.doi.org/10.1016/j.cell.2010.08.033			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850010	Bronze			2022-12-24	WOS:000281855000011
J	Dobson, A; Borner, M; Sinclair, T				Dobson, Andrew; Borner, Markus; Sinclair, Tony			Road will ruin Serengeti	NATURE			English	Editorial Material							TERRESTRIAL; TANZANIA; MAMMALS		[Dobson, Andrew] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Borner, Markus] Frankfurt Zool Soc, Africa Programme, Arusha, Tanzania; [Sinclair, Tony] Univ British Columbia, Ctr Biodivers Res, Vancouver, BC V6T 1Z4, Canada	Princeton University; University of British Columbia	Dobson, A (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA.	dobson@Princeton.edu	Durant, Sarah M/AAB-9659-2019	Durant, Sarah M/0000-0003-0724-0878; Haydon, Daniel/0000-0002-1240-1886; Hudson, Peter/0000-0003-0468-3403; Ogutu, Joseph O/0000-0002-7379-0387				Boone Randall B., 2004, African Journal of Range & Forage Science, V21, P147, DOI 10.2989/10220110409485847; Chruszcz B, 2003, CAN J ZOOL, V81, P1378, DOI 10.1139/Z03-123; Dobson A, 2008, TRENDS ECOL EVOL, V23, P177, DOI 10.1016/j.tree.2007.08.019; Gereta E., 2009, Ecohydrology and Hydrobiology, V9, P115, DOI 10.2478/v10104-009-0035-7; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Holdo RM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000210; Homewood K, 2009, STUD HUM ECOL ADAPT, V5, P1, DOI 10.1007/978-0-387-87492-0; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; Newmark WD, 1996, AFR J ECOL, V34, P15, DOI 10.1111/j.1365-2028.1996.tb00590.x; Sinclair A.R.E., 1979, SERENGETI DYNAMICS E; Sinclair ARE., 2008, SERENGETI; SINCLAIR ARE, 1995, SERENGETI, V2; SPINAGE C A, 1992, Oryx, V26, P147; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x	15	72	72	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2010	467	7313					272	273		10.1038/467272a	http://dx.doi.org/10.1038/467272a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	650CF	20844519				2022-12-24	WOS:000281824900018
J	Mackay, D; Haw, S; Ayres, JG; Fischbacher, C; Pell, JP				Mackay, Daniel; Haw, Sally; Ayres, Jon G.; Fischbacher, Colin; Pell, Jill P.			Smoke-free Legislation and Hospitalizations for Childhood Asthma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; CROSS-SECTIONAL SURVEY; SECONDHAND SMOKE; 2ND-HAND SMOKE; EXPOSURE; SCOTLAND; IMPLEMENTATION; CHILDREN; HEALTH	Background: Previous studies have shown that after the adoption of comprehensive smoke-free legislation, there is a reduction in respiratory symptoms among workers in bars. However, it is not known whether respiratory disease is also reduced among people who do not have occupational exposure to environmental tobacco smoke. The aim of our study was to determine whether the ban on smoking in public places in Scotland, which was initiated in March 2006, influenced the rate of hospital admissions for childhood asthma. Methods: Routine hospital administrative data were used to identify all hospital admissions for asthma in Scotland from January 2000 through October 2009 among children younger than 15 years of age. A negative binomial regression model was fitted, with adjustment for age group, sex, quintile of socioeconomic status, urban or rural residence, month, and year. Tests for interactions were also performed. Results: Before the legislation was implemented, admissions for asthma were increasing at a mean rate of 5.2% per year (95% confidence interval [CI], 3.9 to 6.6). After implementation of the legislation, there was a mean reduction in the rate of admissions of 18.2% per year relative to the rate on March 26, 2006 (95% CI, 14.7 to 21.8; P<0.001). The reduction was apparent among both preschool and school-age children. There were no significant interactions between hospital admissions for asthma and age group, sex, urban or rural residence, region, or quintile of socioeconomic status. Conclusions: In Scotland, passage of smoke-free legislation in 2006 was associated with a subsequent reduction in the rate of respiratory disease in populations other than those with occupational exposure to environmental tobacco smoke. (Funded by NHS Health Scotland.) N Engl J Med 2010;363:1139-45.	[Mackay, Daniel; Pell, Jill P.] Univ Glasgow, Sect Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland; [Haw, Sally] Scottish Collaborat Publ Hlth Res Policy, Edinburgh, Midlothian, Scotland; [Ayres, Jon G.] Univ Birmingham, Inst Occupat & Environm Med, Birmingham, W Midlands, England; [Fischbacher, Colin] NHS Natl Serv, Informat Serv Div, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Birmingham; NHS National Services Scotland	Pell, JP (corresponding author), Univ Glasgow, Sect Publ Hlth, Rm 305,1 Lilybank Gardens, Glasgow G12 8RZ, Lanark, Scotland.	j.pell@clinmed.gla.ac.uk		Pell, Jill/0000-0002-8898-7035; Fischbacher, Colin/0000-0003-3090-1857	NHS Health Scotland	NHS Health Scotland	Supported by a project grant from NHS Health Scotland.	Akhtar PC, 2009, TOB CONTROL, V18, P409, DOI 10.1136/tc.2009.030627; Akhtar PC, 2007, BMJ-BRIT MED J, V335, P545, DOI 10.1136/bmj.39311.550197.AE; Akhtar PC, 2010, J EPIDEMIOL COMMUN H, V64, P341, DOI 10.1136/jech.2008.084178; Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; Ashley MJ, 1998, TOB CONTROL, V7, P61, DOI 10.1136/tc.7.1.61; Ayres JG, 2009, OCCUP ENVIRON MED, V66, P339, DOI 10.1136/oem.2008.040311; Baena-Cagnani CE, 2009, CURR OPIN ALLERGY CL, V9, P136, DOI 10.1097/ACI.0b013e3283294038; Black C, 2009, SCOTTISH SCH ADOLESC; Gergen PJ, 1998, PEDIATRICS, V101, part. no., DOI 10.1542/peds.101.2.e8; Haw SJ, 2007, BRIT MED J, V335, P549, DOI 10.1136/bmj.39315.670208.47; HERMAN PM, 2010, AM J PUBLIC HLT 0513; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1902, DOI 10.1016/j.jacc.2009.10.004; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Naiman A, 2010, CAN MED ASSOC J, V182, P761, DOI 10.1503/cmaj.091130; *OFF ENV HLTH HAZ, 2005, HLTH EFF EXP ENV TOB; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; Scottish Government, 2009, SCOTL PEOPL ANN REP; Semple S, 2007, ANN OCCUP HYG, V51, P571, DOI 10.1093/annhyg/mem044; Semple S, 2007, TOB CONTROL, V16, P127, DOI 10.1136/tc.2006.018119; Vork KL, 2007, ENVIRON HEALTH PERSP, V115, P1394, DOI 10.1289/ehp.10155	20	207	215	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2010	363	12					1139	1145		10.1056/NEJMoa1002861	http://dx.doi.org/10.1056/NEJMoa1002861			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649TD	20843248	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000281795800008
J	Tehranchi, R; Woll, PS; Anderson, K; Buza-Vidas, N; Mizukami, T; Mead, AJ; Astrand-Grundstrom, I; Strombeck, B; Horvat, A; Ferry, H; Dhanda, RS; Hast, R; Ryden, T; Vyas, P; Gohring, G; Schlegelberger, B; Johansson, B; Hellstrom-Lindberg, E; List, A; Nilsson, L; Jacobsen, SEW				Tehranchi, Ramin; Woll, Petter S.; Anderson, Kristina; Buza-Vidas, Natalija; Mizukami, Takuo; Mead, Adam J.; Astrand-Grundstrom, Ingbritt; Strombeck, Bodil; Horvat, Andrea; Ferry, Helen; Dhanda, Rakesh Singh; Hast, Robert; Ryden, Tobias; Vyas, Paresh; Gohring, Gudrun; Schlegelberger, Brigitte; Johansson, Bertil; Hellstrom-Lindberg, Eva; List, Alan; Nilsson, Lars; Jacobsen, Sten Eirik W.			Persistent Malignant Stem Cells in del(5q) Myelodysplasia in Remission	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN HEMATOPOIETIC-CELLS; RECEPTOR-ALPHA CHAIN; SELF-RENEWAL; MARROW-CELLS; LENALIDOMIDE; LEUKEMIA; 5Q; DELETION; MDS; PROLIFERATION	BACKGROUND The in vivo clinical significance of malignant stem cells remains unclear. METHODS Patients who have the 5q deletion (del[5q]) myelodysplastic syndrome (interstitial deletions involving the long arm of chromosome 5) have complete clinical and cytogenetic remissions in response to lenalidomide treatment, but they often have relapse. To determine whether the persistence of rare but distinct malignant stem cells accounts for such relapses, we examined bone marrow specimens obtained from seven patients with the del(5q) myelodysplastic syndrome who became transfusion-independent while receiving lenalidomide treatment and entered cytogenetic remission. RESULTS Virtually all CD34+, CD38+ progenitor cells and stem cells that were positive for CD34 and CD90, with undetectable or low CD38 (CD38-/low), had the 5q deletion before treatment. Although lenalidomide efficiently reduced these progenitors in patients in complete remission, a larger fraction of the minor, quiescent, CD34+, CD38-/low, CD90+ del(5q) stem cells as well as functionally defined del(5q) stem cells remained distinctly resistant to lenalidomide. Over time, lenalidomide resistance developed in most of the patients in partial and complete remission, with recurrence or expansion of the del(5q) clone and clinical and cytogenetic progression. CONCLUSIONS In these patients with the del(5q) myelodysplastic syndrome, we identified rare and phenotypically distinct del(5q) myelodysplastic syndrome stem cells that were also selectively resistant to therapeutic targeting at the time of complete clinical and cytogenetic remission. (Funded by the EuroCancerStemCell Consortium and others.)	[Woll, Petter S.; Buza-Vidas, Natalija; Mizukami, Takuo; Mead, Adam J.; Ferry, Helen; Jacobsen, Sten Eirik W.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Haematopoiet Stem Cell Lab, Oxford OX3 9DS, England; [Vyas, Paresh; Jacobsen, Sten Eirik W.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Mol Haematol Unit, Oxford OX3 9DS, England; [Tehranchi, Ramin; Anderson, Kristina; Astrand-Grundstrom, Ingbritt; Dhanda, Rakesh Singh; Nilsson, Lars; Jacobsen, Sten Eirik W.] Lund Univ, Lund Stem Cell Ctr, Hematopoiet Stem Cell Lab, Lund, Sweden; [Strombeck, Bodil; Horvat, Andrea; Johansson, Bertil] Lund Univ, Skane Univ Hosp, Univ & Reg Labs, Dept Clin Genet, Lund, Sweden; [Ryden, Tobias] Lund Univ, Dept Math Stat, Lund, Sweden; [Hast, Robert] Karolinska Univ Hosp, Hematol Ctr, Stockholm, Sweden; [Hellstrom-Lindberg, Eva] Karolinska Univ Hosp Huddinge, Div Hematol, Dept Med, Stockholm, Sweden; [Gohring, Gudrun; Schlegelberger, Brigitte] Hannover Med Sch, Inst Cell & Mol Pathol, D-3000 Hannover, Germany; [List, Alan] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA	University of Oxford; University of Oxford; Lund University; Lund University; Skane University Hospital; Lund University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Hannover Medical School; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Jacobsen, SEW (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Haematopoiet Stem Cell Lab, Oxford OX3 9DS, England.	sten.jacobsen@imm.ox.ac.uk	Jacobsen, Sten Eirik W/D-3974-2018; Mead, Adam/A-8796-2012; Mizukami, Takuo/F-9248-2016; Vyas, Paresh/B-5708-2009	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Mead, Adam/0000-0001-8522-1002; Mizukami, Takuo/0000-0001-6105-6049; Vyas, Paresh/0000-0003-3931-0914; Woll, Petter S./0000-0002-2340-2526; LIST, ALAN/0000-0002-1647-2972	EuroCancerStemCell Consortium; Swedish Cancer Society; Swedish Research Council; Avtal om Lakerutbildning och Forskning; Region Skane; Goran Gustafsson Foundation; Hemato-Linne (Swedish Research Council); Torsten and Ragnar Soderbergs Foundation; Cluster of Excellence in the Area of Regenerative Biology and Reconstructive Therapies; Medical Research Council (MRC) United Kingdom; Swedish Research Council (Vetenskapsradet); MRC; MRC Molecular Haematology Unit; Oxford Partnership Comprehensive Biomedical Research Centre; Leukemia and Lymphoma Society; Leukaemia and Lymphoma Research Senior Bennett Fellowship; Astellas Foundation; Celgene; Medical Research Council [G84/6443, G1000801c, G1000729] Funding Source: researchfish; MRC [G84/6443, G1000729] Funding Source: UKRI	EuroCancerStemCell Consortium; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Avtal om Lakerutbildning och Forskning; Region Skane; Goran Gustafsson Foundation; Hemato-Linne (Swedish Research Council)(Swedish Research Council); Torsten and Ragnar Soderbergs Foundation; Cluster of Excellence in the Area of Regenerative Biology and Reconstructive Therapies; Medical Research Council (MRC) United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Molecular Haematology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Partnership Comprehensive Biomedical Research Centre; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Leukaemia and Lymphoma Research Senior Bennett Fellowship; Astellas Foundation(Astellas Pharmaceuticals); Celgene(Bristol-Myers SquibbCelgene Corporation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the EuroCancerStemCell Consortium (a sixth framework European Union integrated project), the Swedish Cancer Society, the Swedish Research Council, Avtal om Lakerutbildning och Forskning (a government public health grant), Region Skane, the Goran Gustafsson Foundation, Hemato-Linne (Swedish Research Council), the Torsten and Ragnar Soderbergs Foundation, and the Cluster of Excellence in the Area of Regenerative Biology and Reconstructive Therapies; a grant from the Medical Research Council (MRC) United Kingdom (to Dr. Jacobsen); a postdoctoral fellowship from the Swedish Research Council (Vetenskapsradet) (to Dr. Tehranchi); an MRC Disease Team Award and grants from the MRC Molecular Haematology Unit and the Oxford Partnership Comprehensive Biomedical Research Centre (to Dr. Vyas); a Career Development Program fellowship from the Leukemia and Lymphoma Society (to Dr. Woll); a Leukaemia and Lymphoma Research Senior Bennett Fellowship (to Dr. Mead); and an Astellas Foundation for Research on Metabolic Disorders fellowship (to Dr. Mizukami).; Dr. Gohring reports receiving consulting fees from Celgene; and Dr. Nilsson, honoraria and fees for the development of educational presentations from Celgene. No other potential conflict of interest relevant to this article was reported.	Abramovich C, 2005, ANN NY ACAD SCI, V1044, P109, DOI 10.1196/annals.1349.014; Ades L, 2009, BLOOD, V113, P3947, DOI 10.1182/blood-2008-08-175778; Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Akala OO, 2006, CURR OPIN GENET DEV, V16, P496, DOI 10.1016/j.gde.2006.08.011; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Eclache V, 2008, HAEMATOLOGICA, V93, P315, DOI [10.3324/haematol.11917, 10.3324/haematol.12059]; Gandhi AK, 2006, LEUKEMIA RES, V30, P849, DOI 10.1016/j.leukres.2006.01.010; Glimm H, 1999, BLOOD, V94, P2161, DOI 10.1182/blood.V94.7.2161.419k32_2161_2168; Gohring G, 2010, ANN HEMATOL, V89, P365, DOI 10.1007/s00277-009-0846-z; Hogge DE, 1996, BLOOD, V88, P3765, DOI 10.1182/blood.V88.10.3765.bloodjournal88103765; Jadersten M, 2009, HAEMATOL-HEMATOL J, V94, P1762, DOI 10.3324/haematol.2009.011528; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; List A, 2005, NEW ENGL J MED, V352, P549, DOI 10.1056/NEJMoa041668; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; Misaghian N, 2009, LEUKEMIA, V23, P25, DOI 10.1038/leu.2008.246; Nilsson L, 2000, BLOOD, V96, P2012, DOI 10.1182/blood.V96.6.2012.h8002012a_2012_2021; Nilsson L, 2002, BLOOD, V100, P259, DOI 10.1182/blood-2001-12-0188; Nilsson L, 2007, BLOOD, V110, P3005, DOI 10.1182/blood-2007-03-079368; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Parseval LAM, 2008, J CLIN INVEST, V118, P248, DOI 10.1172/JCI32322; Petzer AL, 1996, P NATL ACAD SCI USA, V93, P1470, DOI 10.1073/pnas.93.4.1470; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Sato T, 2009, NAT MED, V15, P696, DOI 10.1038/nm.1973; SUTHERLAND HJ, 1990, P NATL ACAD SCI USA, V87, P3584, DOI 10.1073/pnas.87.9.3584; SUTHERLAND HJ, 1989, BLOOD, V74, P1563; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; TERSTAPPEN LWMM, 1991, BLOOD, V77, P1218; VANDENBERGHE H, 1974, NATURE, V251, P437, DOI 10.1038/251437a0; Verhelle D, 2007, CANCER RES, V67, P746, DOI 10.1158/0008-5472.CAN-06-2317; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Wei S, 2009, P NATL ACAD SCI USA, V106, P12974, DOI 10.1073/pnas.0811267106	40	187	200	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					1025	1037		10.1056/NEJMoa0912228	http://dx.doi.org/10.1056/NEJMoa0912228			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647HS	20825315				2022-12-24	WOS:000281609700006
J	Green, BM; Finn, KJ; Li, JJ				Green, Brian M.; Finn, Kenneth J.; Li, Joachim J.			Loss of DNA Replication Control Is a Potent Inducer of Gene Amplification	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; MULTIPLE MECHANISMS; TANDEM DUPLICATION; COPY NUMBER; REREPLICATION; RECOMBINATION; CONSEQUENCES; EVOLUTION; CANCER; DAMAGE	Eukaryotic cells use numerous mechanisms to ensure that no segment of their DNA is inappropriately re-replicated, but the importance of this stringent control on genome stability has not been tested. Here we show that re-replication in Saccharomyces cerevisiae can strongly induce the initial step of gene amplification, increasing gene copy number from one to two or more. The resulting amplicons consist of large internal chromosomal segments that are bounded by Ty repetitive elements and are intrachromosomally arrayed at their endogenous locus in direct head-to-tail orientation. These re-replication-induced gene amplifications are mediated by nonallelic homologous recombination between the repetitive elements. We suggest that re-replication may be a contributor to gene copy number changes, which are important in fields such as cancer biology, evolution, and human genetics.	[Li, Joachim J.] UCSF, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Green, Brian M.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Finn, Kenneth J.] UCSF, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Johns Hopkins University; University of California System; University of California San Francisco	Li, JJ (corresponding author), UCSF, Dept Microbiol & Immunol, San Francisco, CA 94158 USA.	joachim.li@ucsf.edu			Sandler Program in Basic Sciences; Stewart Trust; UCSF Research Evaluation and Allocation Committee; UCSF Academic Senate; UC Cancer Research Coordinating Committee; NIH [R01 GM59704]; NSF; Department of Defense [W81XWH-04-1-0409]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059704] Funding Source: NIH RePORTER	Sandler Program in Basic Sciences; Stewart Trust; UCSF Research Evaluation and Allocation Committee; UCSF Academic Senate; UC Cancer Research Coordinating Committee; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Bainton for the use of his microscope; A. Johnson for the use of his pulsed-field gel electrophoresis system and microscope; and A. Sil, D. Morgan, A. Johnson, D. Toczyski, E. Blackburn, P. O'Farrell, T. Tlsty, J. Haber, S. Elledge, and F. Winston for helpful discussions. This work was supported by grants to J. J. L. from the Sandler Program in Basic Sciences, the Stewart Trust Fund, UCSF Research Evaluation and Allocation Committee, UCSF Academic Senate, UC Cancer Research Coordinating Committee, and NIH (grant R01 GM59704). B.M.G. was supported by an NSF Predoctoral Fellowship and a Department of Defense Breast Cancer Predoctoral Fellowship (W81XWH-04-1-0409). K. J. F. was supported by an NSF Predoctoral Fellowship. Microarray data are deposited with the Gene Expression Omnibus (accession number GSE22018).	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Archambault V, 2005, MOL CELL BIOL, V25, P6707, DOI 10.1128/MCB.25.15.6707-6721.2005; Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; DORSEY MJ, 1993, CURR GENET, V23, P392, DOI 10.1007/BF00312624; Gonzalez MA, 2005, NAT REV CANCER, V5, P135, DOI 10.1038/nrc1548; Green BM, 2006, MOL BIOL CELL, V17, P2401, DOI 10.1091/mbc.E05-11-1043; Green BM, 2005, MOL BIOL CELL, V16, P421, DOI 10.1091/mbc.e04-09-0833; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; KOSHLAND D, 1985, CELL, V40, P393, DOI 10.1016/0092-8674(85)90153-9; Koszul R, 2009, CR BIOL, V332, P254, DOI 10.1016/j.crvi.2008.07.005; Liontos M, 2007, CANCER RES, V67, P10899, DOI 10.1158/0008-5472.CAN-07-2837; Lockwood WW, 2008, ONCOGENE, V27, P4615, DOI 10.1038/onc.2008.98; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; O'Neil J, 2007, J EXP MED, V204, P3059, DOI 10.1084/jem.20071637; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; SCHIMKE RT, 1986, P NATL ACAD SCI USA, V83, P2157, DOI 10.1073/pnas.83.7.2157; Seo J, 2005, ONCOGENE, V24, P8176, DOI 10.1038/sj.onc.1208881; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; Strout MP, 1998, P NATL ACAD SCI USA, V95, P2390, DOI 10.1073/pnas.95.5.2390; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	26	95	95	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					943	946		10.1126/science.1190966	http://dx.doi.org/10.1126/science.1190966			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724634	Green Accepted			2022-12-24	WOS:000281084800034
J	Vinck, P; Pham, PN				Vinck, Patrick; Pham, Phuong N.			Association of Exposure to Violence and Potential Traumatic Events With Self-reported Physical and Mental Health Status in the Central African Republic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOPKINS SYMPTOM CHECKLIST-25; MORTALITY; DEPRESSION; RATES; WAR; QUESTIONNAIRE; PREVALENCE; ATTITUDES; VALIDITY; DARFUR	Context For decades, the Central African Republic (CAR) has experienced violence, economic stagnation, and institutional failure. The latest wave of violence erupted in 2001 and continues to this day in some areas. Yet there has been little attention to the conflict and even less research to document and quantify the conflict's human cost. Objective To study levels of violence in CAR, including mortality levels, and the association between exposure to violence and traumatic events with self-reported physical and mental health status. Design, Setting, and Participants Multistage stratified cluster random survey of 1879 adults 18 years or older in selected households conducted in 5 administrative units of CAR (3 in the south, which has been free from recent violence, and 2 in the north, in which violence continues) between October and December 2009. Main Outcome Measures Mortality, morbidity, exposure to potential traumatic events, sense of insecurity, and meeting of symptom criteria for depression and anxiety using the Hopkins Symptom Checklist-25 with a cut-off score of 1.75. Results The crude mortality rate (CMR) was 4.9 deaths (95% confidence interval [CI], 4.6-5.1) per 1000 population per month and self-reported CMR due to violence was 0.8 deaths(95% CI, 0.6-1.0) per 1000 population per month. Thirty-five percent reported their physical health status as being good or very good while 29% described it as bad or very bad. Respondents in northern prefectures reported higher rates of mortality, exposure to trauma, and insecurity and lower levels of physical health and access to health services compared with those in the south. The estimated prevalences of symptoms of depression and anxiety were 55.3% (95% CI, 51.6%-59.0%) and 52.5% (95% CI, 48.1%-56.8%), respectively. Exposure to violence and self-reported physical health were statistically associated with mental health outcomes (P<.001). Anxiety symptom scores were higher for respondents in the northern prefectures than those in the south (t=2.54, P=.01). Conclusion A high proportion of adult respondents in CAR reported witnessing or having personally experienced traumatic events over the course of the conflicts, and more than half met symptom criteria for depression and anxiety. JAMA. 2010;304(5):544-552 www.jama.com	[Vinck, Patrick; Pham, Phuong N.] Univ Calif Berkeley, Human Rights Ctr, Berkeley, CA 94720 USA; [Pham, Phuong N.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Vinck, Patrick; Pham, Phuong N.] Tulane Univ, Payson Ctr Int Dev, New Orleans, LA 70118 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Tulane University	Vinck, P (corresponding author), Univ Calif Berkeley, Human Rights Ctr, 460 Stephens Hall 2300, Berkeley, CA 94720 USA.	pvinck@berkeley.edu		Pham, Phuong/0000-0002-5696-2933	John D. and Catherine T. MacArthur Foundation, Chicago, Illinois; Humanity United, Redwood City, California; Vulnerable Populations Initiative at University of California, Berkeley	John D. and Catherine T. MacArthur Foundation, Chicago, Illinois; Humanity United, Redwood City, California; Vulnerable Populations Initiative at University of California, Berkeley	The work was supported by grants from the John D. and Catherine T. MacArthur Foundation, Chicago, Illinois, and Humanity United, Redwood City, California.; The study was part of the Vulnerable Populations Initiative at University of California, Berkeley. We thank the respondents, interviewers, and partners in the field for their support. Neil Hendrick, BA, contributed to field supervision. Roger Sherwin, MD, Tulane University; Jennie Sherwin, BA; and Alexander Truong, MD, MPH, Johns Hopkins University, provided invaluable comments on the manuscript. Mr Hendrick was paid to assist with field work. Dr Sherwin, Ms Sherwin, and Dr Truong did not receive compensation for their contributions.	ADLER RJ, 1994, STOCH PROC APPL, V49, P1, DOI 10.1016/0304-4149(94)90109-0; ANTONOVSKY A, 1967, MILBANK FUND Q, V45, P31, DOI 10.2307/3348839; BERMAN EG, 2006, CENTRAL AFRICAN REPU; BOGUE DJ, 1950, J AM STAT ASSOC, V45, P149, DOI 10.2307/2280675; Bolton P, 2004, SOC PSYCH PSYCH EPID, V39, P442, DOI 10.1007/s00127-004-0763-3; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Debos M, 2008, AFR AFFAIRS, V107, P225, DOI 10.1093/afraf/adn004; Degomme O, 2010, LANCET, V375, P294, DOI 10.1016/S0140-6736(09)61967-X; DEJONG J, 2004, TRAUMA WAR VIOLENCE; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Fergusson DM, 2002, PSYCHOL MED, V32, P991, DOI 10.1017/S0033291702005986; Iacopino V, 2001, AM J PUBLIC HEALTH, V91, P2013, DOI 10.2105/AJPH.91.12.2013; International Crisis Group, 2007, 136 INT CRIS GROUP; International Federation for Human Rights, 2003, WAR CRIM CENTR AFR R; Kaaya SF, 2002, ACTA PSYCHIAT SCAND, V106, P9, DOI 10.1034/j.1600-0447.2002.01205.x; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Lhewa D, 2007, ASSESSMENT, V14, P223, DOI 10.1177/1073191106298876; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Mollica RF, 1998, ADVERSITY, STRESS AND PSYCHOPATHOLOGY, P34; Oruc L., 2008, INT J CULTURE MENTAL, V1, P105, DOI [DOI 10.1080/17542860802456620, 10.1080/17542860802456620]; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; ROSENFIELD S, 1980, J HEALTH SOC BEHAV, V21, P33, DOI 10.2307/2136692; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; SCHAEFER C, 1981, Journal of Behavioral Medicine, V4, P381, DOI 10.1007/BF00846149; Silove D, 2007, J NERV MENT DIS, V195, P152, DOI 10.1097/01.nmd.0000254747.03333.70; SPITTAELS S, MAPPING CONFLICT MOT; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283; Vinck P, 2007, JAMA-J AM MED ASSOC, V298, P543, DOI 10.1001/jama.298.5.543; Vinck P, 2008, INT J TRANSIT JUST, V2, P398, DOI 10.1093/ijtj/ijn033; Wakabi W, 2008, LANCET, V371, P15, DOI 10.1016/S0140-6736(08)60051-3	35	26	26	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					544	552		10.1001/jama.2010.1065	http://dx.doi.org/10.1001/jama.2010.1065			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682934				2022-12-24	WOS:000280525700022
J	Hall, W; Chikritzhs, T				Hall, Wayne; Chikritzhs, Tanya			The Australian alcopops tax revisited	LANCET			English	Editorial Material							ALCOHOL PROGRAM; HEALTH; DRINKING; TAXATION; MODEL		[Hall, Wayne] Univ Queensland, UQ Ctr Clin Res, Herston, Qld 4029, Australia; [Chikritzhs, Tanya] Curtin Univ Technol, Natl Drug Res Inst, Perth, WA, Australia	University of Queensland; Curtin University	Hall, W (corresponding author), Univ Queensland, UQ Ctr Clin Res, Herston, Qld 4029, Australia.	w.hall@sph.uq.edu.au	Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096; Chikritzhs, Tanya/0000-0001-8871-3205				Australian Bureau of Statistics, 2010, APP CONS ALC AUSTR 2; Australian Bureau of Statistics, 2010, AUSTR WIN GRAP IND 2; Babor T.F., 2010, ALCHOL NO ORDINARY C, V2nd, DOI DOI 10.1093/ACPROF:OSO/9780199551149.003.002; Chikritzhs T, 2005, ADDICTION, V100, P1625, DOI 10.1111/j.1360-0443.2005.01234.x; Chikritzhs TN, 2009, MED J AUSTRALIA, V190, P294, DOI 10.5694/j.1326-5377.2009.tb02415.x; Doran CM, 2008, LANCET, V372, P701, DOI 10.1016/S0140-6736(08)61287-8; Gray D, 1999, AUST NZ J PUBL HEAL, V23, P651, DOI 10.1111/j.1467-842X.1999.tb01554.x; Gruenewald PJ, 2010, J STUD ALCOHOL DRUGS, V71, P237, DOI 10.15288/jsad.2010.71.237; Hawks D V, 1990, Drug Alcohol Rev, V9, P91, DOI 10.1080/09595239000185121; Laslett A.-M., 2010, RANGE MAGNITUDE ALCO; Purshouse RC, 2010, LANCET, V375, P1355, DOI 10.1016/S0140-6736(10)60058-X; Stockwell T, 2001, Int J Drug Policy, V12, P139, DOI 10.1016/S0955-3959(01)00079-2; Stockwell T, 2001, DRUG ALCOHOL REV, V20, P167, DOI 10.1080/09595230124886; Vandenberg B, 2008, DRUG ALCOHOL REV, V27, P579, DOI 10.1080/09595230802491600; Victorian Alcohol and Drug Association, 2010, ALC TAX; Wagenaar AC, 2009, AM J PUBLIC HEALTH, V99, P1464, DOI 10.2105/AJPH.2007.131326	16	15	15	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1136	1137		10.1016/S0140-6736(10)61420-1	http://dx.doi.org/10.1016/S0140-6736(10)61420-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	750IH	20833425				2022-12-24	WOS:000289539300010
J	Forrest, CB; Bartek, RJ; Rubinstein, Y; Groft, SC				Forrest, Christopher B.; Bartek, Ronald J.; Rubinstein, Yaffa; Groft, Stephen C.			The case for a global rare-diseases registry	LANCET			English	Editorial Material									[Forrest, Christopher B.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Forrest, Christopher B.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Bartek, Ronald J.] Friedreichs Ataxia Res Alliance, Springfield, VA USA; [Rubinstein, Yaffa; Groft, Stephen C.] NIH, Off Rare Dis Res, Bethesda, MD 20892 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Forrest, CB (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	forrestc@email.chop.edu	Forrest, Christopher/CAF-1379-2022	Forrest, Christopher/0000-0003-1252-068X				Butcher J, 2007, LANCET NEUROL, V6, P298, DOI 10.1016/S1474-4422(07)70067-4; Dator DP, 2010, J UROLOGY, V183, P1280, DOI 10.1016/j.juro.2010.01.049; European Commission, RAR DIS; GLIKLICH RE, 2007, REG EV PAT OUTC US G; Haffner ME, 2006, NEW ENGL J MED, V354, P445, DOI 10.1056/NEJMp058317; McCormick J, 2010, LANCET, V375, P1007, DOI 10.1016/S0140-6736(09)62161-9; National Institutes of Health Office of Rare Diseases Research, RAR DIS REL TERMS; *NIH OFF RAR DIS R, ADV RAR DIS RES INT; Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7; Watson MS, 2008, GENET MED, V10, P325, DOI 10.1097/GIM.0b013e31817b80fd; Wrobel P, 2009, WORKSH PAT REG RAR D	11	65	66	2	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2011	377	9771					1057	1059		10.1016/S0140-6736(10)60680-0	http://dx.doi.org/10.1016/S0140-6736(10)60680-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	743QY	20674966				2022-12-24	WOS:000289035000009
J	Delamothe, T; Knapton, M; Richardson, E				Delamothe, Tony; Knapton, Mike; Richardson, Eve			We're all going to die. Deal with it	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Delamothe, Tony] BMJ, London WC1H 9JR, England; [Knapton, Mike] British Heart Fdn, London NW1 7AW, England; [Richardson, Eve] Natl Council Palliat Care, London N7 9AS, England	University of London; University College London	Delamothe, T (corresponding author), BMJ, London WC1H 9JR, England.	tdelamothe@bmj.com			British Heart Foundation	British Heart Foundation(British Heart Foundation)	We are pleased to acknowledge the financial support of the British Heart Foundation in producing this Spotlight. The articles were commissioned and peer reviewed according to the BMJ's usual process. We benefited from discussions with Jane Maher, Scott Murray, Ruth Sack, and Teresa Tate.	Barclay S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4862; Bell D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3231; Boyd K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4863; Ellershaw J, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4861; General Medical Council, 2010, TREATM CAR END LIF G; Grant L, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4859; Seymour JE, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4860	7	6	6	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 16	2010	341								c5028	10.1136/bmj.c5028	http://dx.doi.org/10.1136/bmj.c5028			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653MO	20847024				2022-12-24	WOS:000282095800015
J	Ortega, F; Escaso, F; Sanz, JL				Ortega, Francisco; Escaso, Fernando; Sanz, Jose L.			A bizarre, humped Carcharodontosauria (Theropoda) from the Lower Cretaceous of Spain	NATURE			English	Article							DINOSAUR; FEATHER; PHYLOGENY; EVOLUTION	Carcharodontosaurs were the largest predatory dinosaurs, and their early evolutionary history seems to be more intricate than was previously thought. Until recently, carcharodontosaurs were restricted to a group of large theropods inhabiting the Late Cretaceous Gondwanan land masses(1,2), but in the last few years Laurasian evidence(3-5) has been causing a reevaluation of their initial diversification(6). Here we describe an almost complete and exquisitely preserved skeleton of a medium-sized (roughly six metres long) theropod from the Lower Cretaceous series (Barremian stage) Konservat-Lagerstatte of Las Hoyas(7) in Cuenca, Spain. Cladistic analysis supports the idea that the new taxon Concavenator corcovatus is a primitive member of Carcharodontosauria(6), exhibiting two unusual features: elongation of the neurapophyses of two presacral vertebrae forming a pointed, hump-like structure and a series of small bumps on the ulna. We think that these bumps are homologous to quill knobs present on some modern birds; the knobs are related to the insertion area of follicular ligaments that anchor the roots of the flight feathers (remiges) to the arm. We propose that Concavenator has integumentary follicular structures inserted on the ulna, as in modern birds. Because scales do not have follicles, we consider the structures anchored to the Concavenator arms to be non-scale skin appendages homologous to the feathers of modern birds. If this is true, then the phylogenetic bracket for the presence of non-scale skin structures homologous to feathers in theropod dinosaurs would be extended to the Neotetanurae, enlarging the scope for explaining the origin of feathers in theropods.	[Ortega, Francisco; Escaso, Fernando] Univ Nacl Educ Distancia, Fac Ciencias, Dept Fis Matemat & Fluidos, Grp Biol, E-28040 Madrid, Spain; [Escaso, Fernando; Sanz, Jose L.] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, Unidad Paleontol, E-28049 Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED); Autonomous University of Madrid	Ortega, F (corresponding author), Univ Nacl Educ Distancia, Fac Ciencias, Dept Fis Matemat & Fluidos, Grp Biol, Paseo Senda del Rey 9, E-28040 Madrid, Spain.	fortega@ccia.uned.es	Ortega, Francisco/K-3255-2015; Ortega, Francisco/B-5760-2009; Sanz, Jose Luis/O-1421-2019; Escaso, Fernando/H-9782-2015	Ortega, Francisco/0000-0002-7431-354X; Ortega, Francisco/0000-0002-7431-354X; Escaso, Fernando/0000-0001-7642-1555; Sanz, Jose Luis/0000-0002-5214-5725	Museo de las Ciencias de Castilla-La Mancha; Spanish Ministerio de Ciencia e Innovacion [CGL2005-05614]	Museo de las Ciencias de Castilla-La Mancha; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	We thank S. Prieto for information about the location of the specimen; C. Diaz-Romeral, R. de la Fuente, M. Garcia Oliva and N. Santamaria for participating in the field; P. Garcia, M. Llandres, P. Moyano and J. Saiz for specimen preparation; L. Chiappe (Natural History Museum of LA County) for comments on the manuscript; E. Feeman and Plan de Promocion de la Investigacion en la Universidad Nacional de Educacion a Distancia for manuscript revision; R. Martin for the flesh reconstruction of Concavenator in Fig. 2; and S. Torralba for photography. We acknowledge the Museo de las Ciencias de Castilla-La Mancha for support and funding. Part of this research was financed by project CGL2005-05614 of the Spanish Ministerio de Ciencia e Innovacion.	Alibardi L, 2008, PROG HISTOCHEM CYTO, V43, P1, DOI 10.1016/j.proghi.2008.01.001; Bailey JB, 1997, J PALEONTOL, V71, P1124, DOI 10.1017/S0022336000036076; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Brown B, 1913, B AM MUS NAT HIST, V32, P395; Brusatte SL, 2008, J SYST PALAEONTOL, V6, P155, DOI 10.1017/S1477201907002404; Brusatte SL, 2009, NATURWISSENSCHAFTEN, V96, P1051, DOI 10.1007/s00114-009-0565-2; Brusatte Stephen L., 2008, Monograph of the Palaeontographical Society, P1; Carrano MT, 2008, J SYST PALAEONTOL, V6, P183, DOI 10.1017/S1477201907002246; Chuong CM, 2003, J EXP ZOOL PART B, V298B, P42, DOI 10.1002/jez.b.00025; Chuong CM, 2000, CURR OPIN GENET DEV, V10, P449, DOI 10.1016/S0959-437X(00)00111-8; Coria RA, 2006, GEODIVERSITAS, V28, P71; CORIA RA, 1995, NATURE, V377, P224, DOI 10.1038/377224a0; Currie Philip J., 2000, Geodiversitas, V22, P207; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P71; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Mayr G, 2002, NATURWISSENSCHAFTEN, V89, P361, DOI 10.1007/s00114-002-0339-6; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Novas FE, 2005, NATURWISSENSCHAFTEN, V92, P226, DOI 10.1007/s00114-005-0623-3; Olshevsky G., 1991, SAN DIEGO CALIFORNIA, P1; Paul Gregory S., 2007, P69; Sanz JL, 2001, PALAEOBIOLOGY, VII, P356; Sawyer RH, 2003, J EXP ZOOL PART B, V298B, P57, DOI 10.1002/jez.b.26; Sereno PC, 2008, ACTA PALAEONTOL POL, V53, P15, DOI 10.4202/app.2008.0102; Sereno PC, 1998, SCIENCE, V282, P1298, DOI 10.1126/science.282.5392.1298; STOVALL JW, 1950, AM MIDL NAT, V43, P696, DOI 10.2307/2421859; Stromer E, 1915, ABHANDLUNGEN KONIGLI, V28, P1; Taquet P., 1976, GEOLOGIE PALEONTOLOG; Turner AH, 2007, SCIENCE, V317, P1721, DOI 10.1126/science.1145076; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856	30	83	89	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2010	467	7312					203	206		10.1038/nature09181	http://dx.doi.org/10.1038/nature09181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829793				2022-12-24	WOS:000281616300033
J	van Gils, EJM; Veenhoven, RH; Hak, E; Rodenburg, GD; Keijzers, WCM; Bogaert, D; Trzcinski, K; Bruin, JP; van Alphen, L; van der Ende, A; Sanders, EAM				van Gils, Elske J. M.; Veenhoven, Reinier H.; Hak, Eelko; Rodenburg, Gerwin D.; Keijzers, Wendy C. M.; Bogaert, Debby; Trzcinski, Krzysztof; Bruin, Jacob P.; van Alphen, Loek; van der Ende, Arie; Sanders, Elisabeth A. M.			Pneumococcal Conjugate Vaccination and Nasopharyngeal Acquisition of Pneumococcal Serotype 19A Strains	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE OTITIS-MEDIA; STREPTOCOCCUS-PNEUMONIAE SEROTYPES; INVASIVE DISEASE; ANTIMICROBIAL RESISTANCE; POPULATION SNAPSHOT; TEMPORAL TRENDS; UNITED-STATES; CHILDREN; CARRIAGE; EMERGENCE	Context The rapid increase in multiresistant serotype 19A as a cause of invasive and respiratory pneumococcal disease has been associated in time with the widespread implementation of 7-valent pneumococcal conjugate vaccination (PCV-7) in several countries. Because spontaneous fluctuations in time and antibiotic selective pressure may have induced this serotype 19A increase, controlled studies are needed to assess the role of PCV-7. Objective To examine the association of PCV-7 vaccination and nasopharyngeal acquisition of serotype 19A pneumococci, their clonal distribution, and antibiotic susceptibility. Design, Setting, and Patients Post hoc per-protocol completer's analysis as part of a randomized controlled trial of nasopharyngeal Streptococcus pneumoniae carriage enrolling 1003 healthy newborns with follow-up to the age of 24 months in the Netherlands, which has low antibiotic resistance rates. The study was conducted before widespread PCV-7 implementation in infants, between July 7, 2005, and February 14, 2008. Nasopharyngeal swabs were obtained at the age of 6 weeks and at 6, 12, 18, and 24 months. Intervention Infants were randomly assigned to receive 2 doses of PCV-7 at 2 and 4 months; 2 + 1 doses of PCV-7 at 2, 4, and 11 months; or no dosage (unvaccinated control group). Main Outcome Measure Cumulative proportion of children with nasopharyngeal acquisition of a new serotype 19A strain from 6 through 24 months of age. Results Nine hundred forty-eight children completed the study. Fifty-four nasopharyngeal serotype 19A carriage isolates from 318 in the 2-dose group, 66 isolates from 327 in the 2 + 1-dose group, and 33 isolates from 303 in the unvaccinated were collected from 6 weeks through 24 months. The cumulative proportion who tested positive for new nasopharyngeal serotype 19A acquisition from 6 through 24 months of age was significantly higher in those having received the 2 + 1-dose PCV-7 schedule (16.2%; 95% confidence interval [CI], 12.6%-20.6%) vs those who were unvaccinated (9.2%; 95% CI, 6.5%-13.0%; relative risk [RR], 1.75; 95% CI, 1.14-2.70) but not after a 2-dose schedule (13.2%; 95% CI, 9.9%-17.4%; RR, 1.43; 95% CI, 0.91-2.25). There were 28 different sequence types identified, including 6 new types. The proportion of children with new 19A acquisition who had used antibiotics in the last 6 months (18.7%) did not differ among groups. Five isolates were penicillin-intermediate susceptible and another 3 were nonsusceptible to erythromycin and azithromycin, all in the vaccine groups. Conclusion A 2 + 1-dose PCV-7 schedule was associated with an increase in serotype 19A nasopharyngeal acquisition compared with unvaccinated controls.	[van Gils, Elske J. M.; Hak, Eelko; Rodenburg, Gerwin D.; Bogaert, Debby; Trzcinski, Krzysztof; Sanders, Elisabeth A. M.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, NL-3508 AB Utrecht, Netherlands; [van Gils, Elske J. M.; Veenhoven, Reinier H.; Rodenburg, Gerwin D.] Univ Groningen, Univ Med Ctr Groningen, Spaarne Hosp Hoofddorp, Dept Pediat, Groningen, Netherlands; [Hak, Eelko] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Pharm Pharmacoepidemiol & PharmacoEcon, Groningen, Netherlands; [Hak, Eelko] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Bruin, Jacob P.] Reg Lab Publ Hlth, Haarlem, Netherlands; [van Alphen, Loek] Netherlands Vaccine Inst, Bilthoven, Netherlands; [Keijzers, Wendy C. M.; van der Ende, Arie] Netherlands Reference Lab Bacterial Meningitis, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Spaarne Hospital; University of Groningen; University of Groningen; University of Groningen	Sanders, EAM (corresponding author), Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, KB 03-023-3,POB 85090, NL-3508 AB Utrecht, Netherlands.	l.sanders@umcutrecht.nl	Trzcinski, Krzysztof/I-8840-2019; van der Ende, Arie/A-4346-2012	Trzcinski, Krzysztof/0000-0002-5433-8846; van der Ende, Arie/0000-0003-1298-3086; Bogaert, Debby/0000-0003-2651-7000	GlaxoSmithKline; Wyeth/Pfizer; Baxter; Novartis; Dutch Ministry of Health; Wellcome Trust	GlaxoSmithKline(GlaxoSmithKline); Wyeth/Pfizer(WyethPfizer); Baxter; Novartis(Novartis); Dutch Ministry of Health; Wellcome Trust(Wellcome TrustEuropean Commission)	Dr Veenhoven reported receiving grant support from GlaxoSmithKline and Wyeth/Pfizer for vaccine studies and consulting fees for GlaxoSmithKline. Dr Sanders reported receiving unrestricted grants from Wyeth/Pfizer and Baxter for research, consulting fees for Wyeth/Pfizer and GlaxoSmithKline, lecturing fees from Wyeth/Pfizer, and grant support from Wyeth/Pfizer and GlaxoSmithKline for vaccine studies. Dr Van der Ende reports receiving unrestricted grants from Wyeth/Pfizer and Novartis. For all other authors no potential conflicts were reported.; This work was supported by the Dutch Ministry of Health.; We thank the participating children and their families for their time and effort. We also thank the members of the research team for their invaluable dedicated work and support. We thank all cooperating organizations for their support. We acknowledge the use of the pneumococcal MLST database, which is located at Imperial College London and is funded by Wellcome Trust.	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; Aguiar SI, 2010, J CLIN MICROBIOL, V48, P101, DOI 10.1128/JCM.00665-09; [Anonymous], 2008, M100S18 CLIN LAB STA; Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; Beall B, 2006, J CLIN MICROBIOL, V44, P999, DOI 10.1128/JCM.44.3.999-1017.2006; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Choi EH, 2008, EMERG INFECT DIS, V14, P275, DOI 10.3201/eid1402.070807; Dagan R, 2009, J INFECT DIS, V199, P776, DOI 10.1086/597044; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fenoll A, 2009, J CLIN MICROBIOL, V47, P1012, DOI 10.1128/JCM.01454-08; FILIUS PMG, 2008, NETHMAP 2008 CONSUMP; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Harboe ZB, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000081; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; JACOBS MR, 1992, DIAGN MICR INFEC DIS, V15, P473, DOI 10.1016/0732-8893(92)90093-9; Kaplan SL, 2010, PEDIATRICS, V125, P429, DOI 10.1542/peds.2008-1702; Linares J, 2010, CLIN MICROBIOL INFEC, V16, P402, DOI 10.1111/j.1469-0691.2010.03182.x; Lipsitch M, 2007, J INFECT DIS, V196, P1221, DOI 10.1086/521831; Mahjoub-Messai F, 2008, ARCH PEDIATRIE, V15, P1713, DOI 10.1016/j.arcped.2008.09.003; Mahjoub-Messai F, 2009, J CLIN MICROBIOL, V47, P837, DOI 10.1128/JCM.01547-08; McNeil JC, 2009, PEDIATR INFECT DIS J, V28, P766, DOI 10.1097/INF.0b013e3181a24557; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; Pichichero ME, 2007, JAMA-J AM MED ASSOC, V298, P1772, DOI 10.1001/jama.298.15.1772; Reingold A., 2008, Morbidity and Mortality Weekly Report, V57, P144; Robinson DA, 2001, J INFECT DIS, V183, P1501, DOI 10.1086/320194; Shouval DS, 2006, PEDIATR INFECT DIS J, V25, P602, DOI 10.1097/01.inf.0000220231.79968.f6; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Techasaensiri C, 2010, PEDIATR INFECT DIS J, V29, P294, DOI 10.1097/INF.0b013e3181c2a229; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; VANOOSTEN M, 2006, EUROSURVEILLANCE, V11; Veenhoven RH, 2004, CLIN INFECT DIS, V39, P911, DOI 10.1086/422651; Weinberger DM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000476	38	53	53	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2010	304	10					1099	1106		10.1001/jama.2010.1290	http://dx.doi.org/10.1001/jama.2010.1290			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646RM	20823436	Green Published			2022-12-24	WOS:000281559800020
J	Rabe, KF; Decramer, M; Siafakas, N				Rabe, Klaus F.; Decramer, Marc; Siafakas, Nikolaos			The Year of the Lung	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE		[Rabe, Klaus F.] Leiden Univ, Med Ctr, Dept Pulmonol, NL-2333 ZA Leiden, Netherlands; [Decramer, Marc] Univ Hosp Gasthuisberg, Dept Pulmonol, Ghent, Belgium; [Siafakas, Nikolaos] Univ Gen Hosp, Dept Pulmonol, Iraklion, Greece	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; KU Leuven; University Hospital Leuven; University Hospital of Heraklion	Rabe, KF (corresponding author), Leiden Univ, Med Ctr, Dept Pulmonol, NL-2333 ZA Leiden, Netherlands.	k.f.rabe@lumc.nl	Rabe, Klaus F./AAW-6296-2021; Siafakas, Nikolas/AAI-3324-2020	Rabe, Klaus F./0000-0002-7020-1401; 				Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; *CDCP, 2004, MMWR-MORBID MORTAL W, V58, P29; *GLOB ALL CHRON RE, STOP GLOB EP CHRON D; MacNee W, 2007, EUR RESPIR J, V29, P223, DOI 10.1183/09031936.00159006; *NAT HEART LUNG BL, PARTN GLOB HLTH; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pawankar R, 2009, ASIAN PAC J ALLERGY, V27, P237; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; World Health Organization, CHRON RESP DIS; World Health Organization, 2007, GLOB SURV PREV CONTR; 2010, YEAR LUNG	11	5	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2010	376	9743					753	754		10.1016/S0140-6736(10)61347-5	http://dx.doi.org/10.1016/S0140-6736(10)61347-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	650EC	20816531				2022-12-24	WOS:000281831000009
J	Cui, JX; Yao, Q; Li, S; Ding, XJ; Lu, QH; Mao, HB; Liu, LP; Zheng, N; Chen, S; Shao, F				Cui, Jixin; Yao, Qing; Li, Shan; Ding, Xiaojun; Lu, Qiuhe; Mao, Haibin; Liu, Liping; Zheng, Ning; Chen, She; Shao, Feng			Glutamine Deamidation and Dysfunction of Ubiquitin/NEDD8 Induced by a Bacterial Effector Family	SCIENCE			English	Article							HOST-CELL CYCLE; ESCHERICHIA-COLI; CYCLOMODULIN CIF; PROTEIN; LIGASE; DEGRADATION; CONJUGATION; ACTIVATION; INSIGHTS; BLOCKS	A family of bacterial effectors including Cif homolog from Burkholderia pseudomallei (CHBP) and Cif from Enteropathogenic Escherichia coli (EPEC) adopt a functionally important papain-like hydrolytic fold. We show here that CHBP was a potent inhibitor of the eukaryotic ubiquitination pathway. CHBP acted as a deamidase that specifically and efficiently deamidated Gln(40) in ubiquitin and ubiquitin-like protein NEDD8 both in vitro and during Burkholderia infection. Deamidated ubiquitin was impaired in supporting ubiquitin-chain synthesis. Cif selectively deamidated NEDD8, which abolished the activity of neddylated Cullin-RING ubiquitin ligases (CRLs). Ubiquitination and ubiquitin-dependent degradation of multiple CRL substrates were impaired by Cif in EPEC-infected cells. Mutations of substrate-contacting residues in Cif abolished or attenuated EPEC-induced cytopathic phenotypes of cell cycle arrest and actin stress fiber formation.	[Cui, Jixin; Yao, Qing; Li, Shan; Ding, Xiaojun; Lu, Qiuhe; Liu, Liping; Chen, She; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Cui, Jixin] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Cui, Jixin] Beijing Union Med Coll, Beijing 100730, Peoples R China; [Mao, Haibin; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	Mao, Haibin/B-7609-2011; liu, li/HGC-0900-2022; Yao, Qing/AAE-1680-2020	Lu, Qiuhe/0000-0002-0202-7448; Li, Shan/0000-0001-8646-3193	Chinese Ministry of Science and Technology [2008AA022309]; National Basic Research Plan of China 973; National Institutes of Health [R01 CA107134]; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022309] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Basic Research Plan of China 973(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Y. Ye, C. Fathman, Z. Pan, D. Haas, V. Yu, E. Boedeker, and Z. Chen for providing reagents. We are grateful to F. Du and X. Wang for their assistance in obtaining reagents. We also thank members of the Shao laboratory for helpful discussions and technical assistance. This work was supported by Chinese Ministry of Science and Technology grant 2008AA022309 and National Basic Research Plan of China 973 grants to F. S. and National Institutes of Health grant R01 CA107134 to N.Z. and H. M. N.Z. is a Howard Hughes Medical Institute investigator.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Fu NY, 2007, P NATL ACAD SCI USA, V104, P10051, DOI 10.1073/pnas.0700007104; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Hsu Y, 2008, J MOL BIOL, V384, P465, DOI 10.1016/j.jmb.2008.09.051; Huang J, 2008, NATURE, V456, P112, DOI 10.1038/nature07355; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Yao Q, 2009, P NATL ACAD SCI USA, V106, P3716, DOI 10.1073/pnas.0900212106; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	21	152	162	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1215	1218		10.1126/science.1193844	http://dx.doi.org/10.1126/science.1193844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20688984	Green Accepted			2022-12-24	WOS:000281485600038
J	Allmann, S; Baldwin, IT				Allmann, Silke; Baldwin, Ian T.			Insects Betray Themselves in Nature to Predators by Rapid Isomerization of Green Leaf Volatiles	SCIENCE			English	Article							OLFACTORY RECEPTOR NEURONS; PLANT VOLATILES; EMISSIONS; MAIZE; PARASITOIDS; ATTRACTION; SUFFICIENT; HERBIVORES; PATHOGENS; ACID	Plants emit green leaf volatiles (GLVs) in response to herbivore damage, thereby attracting predators of the herbivores as part of an indirect defense. The GLV component of this indirect defense was thought to be a general wound signal lacking herbivore-specific information. We found that Manduca sexta-infested Nicotiana attenuata attract the generalist hemipteran predator Geocoris spp. as the result of an herbivore-induced decrease in the (Z)/(E) ratio of released GLVs, and that these changes in the volatile bouquet triple the foraging efficiency of predators in nature. These (E)-isomers are produced from plant-derived (Z)-isomers but are converted by a heat-labile constituent of herbivore oral secretions. Hence, attacking herbivores initiate the release of an indirect defense a full day before the attacked plants manufacture their own defensive compounds.	[Allmann, Silke; Baldwin, Ian T.] Max Planck Inst Chem Ecol, Dept Mol Ecol, DE-07745 Jena, Germany; [Allmann, Silke] Swammerdam Inst Life Sci, Dept Plant Physiol, NL-1098 XH Amsterdam, Netherlands	Max Planck Society; University of Amsterdam	Baldwin, IT (corresponding author), Max Planck Inst Chem Ecol, Dept Mol Ecol, Hans Knoll Str 8, DE-07745 Jena, Germany.	baldwin@ice.mpg.de	Allmann, Silke/Q-6522-2017; Baldwin, Ian T/K-1809-2013	Allmann, Silke/0000-0001-6300-3741; Baldwin, Ian/0000-0001-5371-2974	Max Planck Society	Max Planck Society(Max Planck Society)	Supported by the Max Planck Society. We thank M. Kant, R. Schuurink, E. Gaquerel, G. Bonaventure, and three anonymous reviewers for comments on the manuscript; S. Meldau for providing ir-sipk x ir-wipk seeds; D. Kessler and C. Diezel for help with the field experiments and enzyme assays; M. Kallenbach and A. Weinhold for analytical help; and Brigham Young University for the use of their Lytle Ranch Preserve field station.	Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Allison JD, 2009, NEW PHYTOL, V184, P768, DOI 10.1111/j.1469-8137.2009.03046.x; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; D'Auria JC, 2007, PLANT J, V49, P194, DOI 10.1111/j.1365-313X.2006.02946.x; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Gouinguene SP, 2002, PLANT PHYSIOL, V129, P1296, DOI 10.1104/pp.001941; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; Hansson BS, 1999, PHYSIOL ENTOMOL, V24, P121, DOI 10.1046/j.1365-3032.1999.00121.x; Hoballah ME, 2005, J CHEM ECOL, V31, P2003, DOI 10.1007/s10886-005-6074-7; Kant MR, 2004, PLANT PHYSIOL, V135, P483, DOI 10.1104/pp.103.038315; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; KLUN JA, 1973, SCIENCE, V181, P661, DOI 10.1126/science.181.4100.661; Mithofer A, 2005, PLANT PHYSIOL, V137, P1160, DOI 10.1104/pp.104.054460; MUELLER MJ, 1994, ANAL BIOCHEM, V218, P425, DOI 10.1006/abio.1994.1202; Noordermeer MA, 1999, FEBS LETT, V443, P201, DOI 10.1016/S0014-5793(98)01706-2; Prost I, 2005, PLANT PHYSIOL, V139, P1902, DOI 10.1104/pp.105.066274; Rostas M, 2006, J CHEM ECOL, V32, P1897, DOI 10.1007/s10886-006-9147-3; Shiojiri K, 2006, P NATL ACAD SCI USA, V103, P16672, DOI 10.1073/pnas.0607780103; Shiojiri K, 2006, J CHEM ECOL, V32, P969, DOI 10.1007/s10886-006-9047-6; Stensmyr MC, 2001, J COMP PHYSIOL A, V187, P509; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Takamura H, 1996, BBA-LIPID LIPID MET, V1303, P83, DOI 10.1016/0005-2760(96)00076-8; Turlings TCJ, 1998, PLANTA, V207, P146, DOI 10.1007/s004250050466; von Dahl CC, 2006, PLANT J, V46, P948, DOI 10.1111/j.1365-313X.2006.02760.x; Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x	28	171	183	4	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2010	329	5995					1075	1078		10.1126/science.1191634	http://dx.doi.org/10.1126/science.1191634			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798319				2022-12-24	WOS:000281253500040
J	Williams, R				Williams, Ruth			Slowing the decline	NATURE			English	Editorial Material							EARLY PARKINSON-DISEASE; COENZYME Q(10); DOUBLE-BLIND; CLINICAL-TRIAL; DELAYED-START; RASAGILINE											Beal MF, 1998, BRAIN RES, V783, P109, DOI 10.1016/S0006-8993(97)01192-X; Fahn S, 2006, J NEURAL TRANSM-SUPP, P419; Kieburtz K, 2007, NEUROLOGY, V68, P20; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Marks WJ, 2008, LANCET NEUROL, V7, P400, DOI 10.1016/S1474-4422(08)70065-6; Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; Ravina B, 2006, NEUROLOGY, V66, P664; SCHAPIRA A, 2009, PARKINSONISM RELA S2, V15; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Siderowf A, 2004, ARCH NEUROL-CHICAGO, V61, P561; WARD CD, 1994, J NEUROL NEUROSUR PS, V57, P217, DOI 10.1136/jnnp.57.2.217	13	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					S13	S14		10.1038/466S13a	http://dx.doi.org/10.1038/466S13a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20739931	Bronze			2022-12-24	WOS:000281203600062
J	Pryke, SR; Rollins, LA; Griffith, SC				Pryke, Sarah R.; Rollins, Lee A.; Griffith, Simon C.			Females Use Multiple Mating and Genetically Loaded Sperm Competition to Target Compatible Genes	SCIENCE			English	Article							EXTRA-PAIR PATERNITY; SOCIALLY MONOGAMOUS PASSERINES; MATE CHOICE; SELECTION; BIRDS; INFIDELITY; EVOLUTION; INCOMPATIBILITY; FERTILIZATIONS; ALLOCATION	Individuals in socially monogamous species may participate in copulations outside of the pair bond, resulting in extra-pair offspring. Although males benefit from such extra-pair behavior if they produce more offspring, the adaptive function of infidelity to females remains elusive. Here we show that female participation in extra-pair copulations, combined with a genetically loaded process of sperm competition, enables female finches to target genes that are optimally compatible with their own to ensure fertility and optimize offspring viability. Such female behavior, along with the postcopulatory processes demonstrated here, may provide an adaptive function of female infidelity in socially monogamous animals.	[Pryke, Sarah R.; Rollins, Lee A.; Griffith, Simon C.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Macquarie University	Griffith, SC (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	simon.griffith@mq.edu.au	Griffith, Simon/AAH-3706-2021; Griffith, Simon/A-1996-2010; Pryke, Sarah/G-7484-2011; Rollins, Lee/G-3688-2011	Griffith, Simon/0000-0001-7612-4999; Griffith, Simon/0000-0001-7612-4999; Rollins, Lee/0000-0002-3279-7005	Australian Research Council [DP0770889, DP0881019]; L'Oreal; Save the Gouldian Fund	Australian Research Council(Australian Research Council); L'Oreal(L'Oreal Group); Save the Gouldian Fund	We thank T. Birkhead, R. Brooks, R. Calsbeek, S. Immler, S. Ulfstrand, D. Westneat, and M. Whiting for comments on the manuscript. This work was supported by Discovery Grants DP0770889 (S.R.P.) and DP0881019 (S.C.G.) from the Australian Research Council, a L'Oreal for Women in Science Fellowship (S.R.P.), and the Save the Gouldian Fund. The Animal Care and Ethics Committee of Macquarie University approved this research.	Akcay E, 2007, EVOL ECOL RES, V9, P855; Albrecht T, 2006, AM NAT, V167, P739, DOI 10.1086/502633; Arnqvist G, 2005, AM NAT, V165, pS26, DOI 10.1086/429350; Ball MA, 2003, J THEOR BIOL, V224, P27, DOI 10.1016/S0022-5193(03)00118-8; Birkhead T.R., 1988, Advances in the Study of Behavior, V18, P35; BIRKHEAD TR, 1988, NATURE, V334, P60, DOI 10.1038/334060a0; Cockburn A, 2009, BEHAV ECOL, V20, P501, DOI 10.1093/beheco/arp024; COLEGRAVE N, 1995, P ROY SOC B-BIOL SCI, V259, P223, DOI 10.1098/rspb.1995.0033; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith SC, 2007, AM NAT, V169, P274, DOI 10.1086/510601; Griffith SC, 2009, J AVIAN BIOL, V40, P97, DOI 10.1111/j.1600-048X.2009.04562.x; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Merila J, 2001, NATURE, V412, P76, DOI 10.1038/35083580; Merila J, 2003, ANN ZOOL FENN, V40, P269; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Pizzari T, 2003, NATURE, V426, P70, DOI 10.1038/nature02004; Pryke SR, 2007, J EVOLUTION BIOL, V20, P1512, DOI 10.1111/j.1420-9101.2007.01332.x; Pryke SR, 2010, EVOLUTION, V64, P1301, DOI 10.1111/j.1558-5646.2009.00897.x; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Pryke SR, 2009, EVOLUTION, V63, P793, DOI 10.1111/j.1558-5646.2008.00584.x; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Sheldon BC, 1998, P ROY SOC B-BIOL SCI, V265, P1737, DOI 10.1098/rspb.1998.0496; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Westneat DF, 2003, ANNU REV ECOL EVOL S, V34, P365, DOI 10.1146/annurev.ecolsys.34.011802.132439	27	61	62	0	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2010	329	5994					964	967		10.1126/science.1192407	http://dx.doi.org/10.1126/science.1192407			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724639				2022-12-24	WOS:000281084800040
J	Cornwallis, CK; West, SA; Davis, KE; Griffin, AS				Cornwallis, Charlie K.; West, Stuart A.; Davis, Katie E.; Griffin, Ashleigh S.			Promiscuity and the evolutionary transition to complex societies	NATURE			English	Article							KIN SELECTION; BIRDS; PATERNITY; CONSTRAINTS; MONOGAMY; BEHAVIOR; HELPERS; MODELS; SPITE	Theory predicts that the evolution of cooperative behaviour is favoured by low levels of promiscuity leading to high within-group relatedness(1-5). However, in vertebrates, cooperation often occurs between non-relatives and promiscuity rates are among the highest recorded. Here we resolve this apparent inconsistency with a phylogenetic analysis of 267 bird species, demonstrating that cooperative breeding is associated with low promiscuity; that in cooperative species, helping is more common when promiscuity is low; and that intermediate levels of promiscuity favour kin discrimination. Overall, these results suggest that promiscuity is a unifying feature across taxa in explaining transitions to and from cooperative societies.	[Cornwallis, Charlie K.; Griffin, Ashleigh S.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [West, Stuart A.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Davis, Katie E.] Nat Hist Museum, Dept Entomol, London SW7 5BD, England	University of Oxford; University of Oxford; Natural History Museum London	Griffin, AS (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	ashleigh.griffin@zoo.ox.ac.uk	West, Stuart A/M-3608-2014; Griffin, Ashleigh/C-6244-2014; Cornwallis, Charlie/A-6276-2012	West, Stuart A/0000-0003-2152-3153; Griffin, Ashleigh/0000-0001-7674-9825; 	ERC; Royal Society	ERC(European Research Council (ERC)European Commission); Royal Society(Royal Society of London)	We thank J. Hadfield for statistical advice, K. Boomsma, S. Nakagawa and B. Sheldon for comments and discussion, M. Nelson-Flower and P. Brennan for access to unpublished data, and the ERC and Royal Society for funding. The compilation of our data set was made possible by access to the collections of the Alexander Library.	Arnold KE, 1999, BEHAV ECOL, V10, P465, DOI 10.1093/beheco/10.5.465; Arnold KE, 1998, P ROY SOC B-BIOL SCI, V265, P739, DOI 10.1098/rspb.1998.0355; Bennett P. M., 2002, OX ECOL EV; Boomsma JJ, 2007, CURR BIOL, V17, pR673, DOI 10.1016/j.cub.2007.06.033; Boomsma JJ, 2009, PHILOS T R SOC B, V364, P3191, DOI 10.1098/rstb.2009.0101; Boomsma JJ, 1996, PHILOS T R SOC B, V351, P947, DOI 10.1098/rstb.1996.0087; CHARNOV EL, 1978, J THEOR BIOL, V75, P451, DOI 10.1016/0022-5193(78)90356-9; CHARNOV EL, 1981, ANIM BEHAV, V29, P631, DOI 10.1016/S0003-3472(81)80130-3; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Cockburn A, 1998, ANNU REV ECOL SYST, V29, P141, DOI 10.1146/annurev.ecolsys.29.1.141; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cornwallis CK, 2009, J EVOLUTION BIOL, V22, P2445, DOI 10.1111/j.1420-9101.2009.01853.x; DAVIES NB, 1992, DUNNOCK BEHAV SOCIAL, P117; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Gardner A, 2004, P ROY SOC B-BIOL SCI, V271, P1529, DOI 10.1098/rspb.2004.2756; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Goloboff P, 2008, CLADISTICS, V24, P91; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hadfield JD, 2010, J EVOLUTION BIOL, V23, P494, DOI 10.1111/j.1420-9101.2009.01915.x; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hamilton W.D., 1972, Annual Rev Ecol Syst, V3, P193, DOI 10.1146/annurev.es.03.110172.001205; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hatchwell BJ, 2009, PHILOS T R SOC B, V364, P3217, DOI 10.1098/rstb.2009.0109; Hatchwell BJ, 2000, ANIM BEHAV, V59, P1079, DOI 10.1006/anbe.2000.1394; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; KOMDEUR J, 1992, NATURE, V358, P493, DOI 10.1038/358493a0; KREBS JR, 1993, BEHAV ECOLOGY EVOLUT, P291; MULDER RA, 1994, P ROY SOC B-BIOL SCI, V255, P223, DOI 10.1098/rspb.1994.0032; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; Raudenbush S. W., 1994, HDB RES SYNTHESIS, P301, DOI DOI 10.1111/ACPS.12078; SMITH JM, 1995, MAJOR TRANSITIONS EV, P6; Spottiswoode C, 2004, BEHAV ECOL, V15, P41, DOI 10.1093/beheco/arg100; West SA, 2010, SCIENCE, V327, P1341, DOI 10.1126/science.1178332; Wilson E.O., 1975, P1; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	42	244	247	2	347	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					969	U91		10.1038/nature09335	http://dx.doi.org/10.1038/nature09335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725039				2022-12-24	WOS:000281030300033
J	Shargorodsky, J; Curhan, SG; Curhan, GC; Eavey, R				Shargorodsky, Josef; Curhan, Sharon G.; Curhan, Gary C.; Eavey, Roland			Change in Prevalence of Hearing Loss in US Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; NOISE EXPOSURE; UNITED-STATES; CHILDREN 6; PERFORMANCE; IMPAIRMENT; AGE; EPIDEMIOLOGY	Context Hearing loss is common and, in young persons, can compromise social development, communication skills, and educational achievement. Objective To examine the current prevalence of hearing loss in US adolescents and determine whether it has changed over time. Design Cross-sectional analyses of US representative demographic and audiometric data from the 1988 through 1994 and 2005 through 2006 time periods. Setting The Third National Health and Nutrition Examination Survey (NHANES Ill), 1988-1994, and NHANES 2005-2006. Participants NHANES III examined 2928 participants and NHANES 2005-2006 examined 1771 participants, aged 12 to 19 years. Main Outcome Measures We calculated the prevalence of hearing loss in participants aged 12 to 19 years after accounting for the complex survey design. Audiometrically determined hearing loss was categorized as either unilateral or bilateral for low frequency (0.5, 1, and 2 kHz) or high frequency (3, 4, 6, and 8 kHz), and as slight loss (>15 to <25 dB) or mild or greater loss (25 dB) according to hearing sensitivity in the worse ear. The prevalence of hearing loss from NHANES 2005-2006 was compared with the prevalence from NHANES III (1988-1994). We also examined the cross-sectional relations between several potential risk factors and hearing loss. Logistic regression was used to calculate multivariate adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Results The prevalence of any hearing loss increased significantly from 14.9% (95% CI, 13.0%-16.9%) in 1988-1994 to 19.5% (95% CI, 15.2%-23.8%) in 2005-2006 (P=.02). In 2005-2006, hearing loss was more commonly unilateral (prevalence, 14.0%; 95% CI, 10.4%-17.6%, vs 11.1%; 95% CI, 9.5%-12.8% in 1988-1994; P=.005) and involved the high frequencies (prevalence, 16.4%; 95% CI, 13.2%-19.7%, vs 12.8%; 95% CI, 11.1%-14.5% in 1988-1994; P=.02). Individuals from families below the federal poverty threshold (prevalence, 23.6%; 95% CI, 18.5%-28.7%) had significantly higher odds of hearing loss (multivariate adjusted OR, 1.60; 95% CI, 1.10-2.32) than those above the threshold (prevalence, 18.4%; 95% CI, 13.6%-23.2%). Conclusion The prevalence of hearing loss among a sample of US adolescents aged 12 to 19 years was greater in 2005-2006 compared with 1988-1994. JAMA. 2010;304(7):772-778 www.jama.com	[Shargorodsky, Josef; Curhan, Sharon G.; Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Shargorodsky, Josef] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Eavey, Roland] Vanderbilt Univ, Sch Med, Vanderbilt Bill Wilkerson Ctr Otolaryngol & Commu, Nashville, TN 37212 USA; [Curhan, Gary C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Vanderbilt University; Harvard University; Harvard T.H. Chan School of Public Health	Shargorodsky, J (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	josef_shargorodsky@meei.harvard.edu			Massachusetts Eye and Ear Infirmary Foundation; Vanderbilt University School of Medicine	Massachusetts Eye and Ear Infirmary Foundation; Vanderbilt University School of Medicine	This work was supported by the Massachusetts Eye and Ear Infirmary Foundation and Vanderbilt University School of Medicine Development Funds.	Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; ANDERSON KL, 1992, P ASHA AUD SUP, V21, P38; BAILEY BJ, HEAD NECK SURG OTOLA, P2006; Bainbridge KE, 2008, ANN INTERN MED, V149, P1, DOI 10.7326/0003-4819-149-1-200807010-00231; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; BLAIR JC, 1985, VOLTA REV, V87, P87; Chung JH, 2005, PEDIATRICS, V115, P861, DOI 10.1542/peds.2004-0173; Cone BK, 2010, EAR HEARING, V31, P202, DOI 10.1097/AUD.0b013e3181c62263; Czechowicz JA, 2010, OTOLARYNG HEAD NECK, V142, P272, DOI 10.1016/j.otohns.2009.10.040; Knight KRG, 2005, J CLIN ONCOL, V23, P8588, DOI 10.1200/JCO.2004.00.5355; Mehra S, 2009, OTOLARYNG HEAD NECK, V140, P461, DOI 10.1016/j.otohns.2008.12.022; National Center for Health Statistics, 1988, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 1994, PLAN OP 3 NAT HLTH N; Niskar AS, 1998, JAMA-J AM MED ASSOC, V279, P1071, DOI 10.1001/jama.279.14.1071; Niskar AS, 2001, PEDIATRICS, V108, P40, DOI 10.1542/peds.108.1.40; Nondahl DA, 2009, EAR HEARING, V30, P696, DOI 10.1097/AUD.0b013e3181b1d418; Northern JL, 2002, HEARING CHILDREN; PLEIS JR, 2006, VITAL HLTH STAT, V10, P1; Quintanilla-Dieck MD, 2009, J PEDIATR-US, V155, P550, DOI 10.1016/j.jpeds.2009.04.053; Sadhra S, 2002, ANN OCCUP HYG, V46, P455, DOI 10.1093/annhyg/mef051; SCHMIDT JM, 1994, AUDIOLOGY, V33, P185; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Stone SI, 2008, AM J PUBLIC HEALTH, V98, P2223, DOI 10.2105/AJPH.2007.110239; Tharpe AM, 1999, PEDIATR CLIN N AM, V46, P65, DOI 10.1016/S0031-3955(05)70081-X; *US BUR CESNS, CURR POP SURV CPS DE; [No title captured]	26	328	339	2	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2010	304	7					772	778		10.1001/jama.2010.1124	http://dx.doi.org/10.1001/jama.2010.1124			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639SB	20716740				2022-12-24	WOS:000280993700024
J	Lee, ER; Baker, JL; Weinberg, Z; Sudarsan, N; Breaker, RR				Lee, Elaine R.; Baker, Jenny L.; Weinberg, Zasha; Sudarsan, Narasimhan; Breaker, Ronald R.			An Allosteric Self-Splicing Ribozyme Triggered by a Bacterial Second Messenger	SCIENCE			English	Article							GROUP-I INTRONS; METABOLITE-BINDING RIBOSWITCHES; CYCLIC DI-GMP; LIGAND-BINDING; RNA; BACTERIOPHAGE-T4	Group I self-splicing ribozymes commonly function as components of selfish mobile genetic elements. We identified an allosteric group I ribozyme, wherein self-splicing is regulated by a distinct riboswitch class that senses the bacterial second messenger c-di-GMP. The tandem RNA sensory system resides in the 5' untranslated region of the messenger RNA for a putative virulence gene in the pathogenic bacterium Clostridium difficile. c-di-GMP binding by the riboswitch induces folding changes at atypical splice site junctions to modulate alternative RNA processing. Our findings indicate that some self-splicing ribozymes are not selfish elements but are harnessed by cells as metabolite sensors and genetic regulators.	[Lee, Elaine R.; Weinberg, Zasha; Sudarsan, Narasimhan; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Baker, Jenny L.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Weinberg, Zasha; Sudarsan, Narasimhan; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, Box 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010	Weinberg, Zasha/0000-0002-6681-3624; Breaker, Ronald/0000-0002-2165-536X	NIH [PO1 GM022778]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Davis for assistance with genetic experiments and members of the Breaker laboratory for helpful discussions. We also thank L. Sonenshein for supplying C. difficile 630 spores and for training N.S. in C. difficile techniques. This work was supported by NIH grant PO1 GM022778 and by the Howard Hughes Medical Institute. Z.W. advises BioRelix. R.R.B. is a cofounder and Scientific Advisory Board member of BioRelix. Yale University has filed a provisional patent application on this riboswitch technology.	Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Kulshina N, 2009, NAT STRUCT MOL BIOL, V16, P1212, DOI 10.1038/nsmb.1701; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Nielsen H, 2009, RNA BIOL, V6, P375, DOI 10.4161/rna.6.4.9334; Poiata E, 2009, RNA, V15, P2046, DOI 10.1261/rna.1824209; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Sandegren L, 2007, J BACTERIOL, V189, P980, DOI 10.1128/JB.01287-06; SHUB DA, 1987, COLD SPRING HARB SYM, V52, P193, DOI 10.1101/SQB.1987.052.01.024; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Thompson Kristin M, 2002, BMC Biotechnol, V2, P21, DOI 10.1186/1472-6750-2-21; Tseng Huei-Hun, 2009, Journal of Bioinformatics and Computational Biology, V7, P373, DOI 10.1142/S0219720009004126; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Welz R, 2007, RNA, V13, P573, DOI 10.1261/rna.407707	21	261	288	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					845	848		10.1126/science.1190713	http://dx.doi.org/10.1126/science.1190713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705859	Green Accepted			2022-12-24	WOS:000280809900052
J	Young, J; Murthy, L; Westby, M; Akunne, A; O'Mahony, R				Young, John; Murthy, Lakshmi; Westby, Maggie; Akunne, Anayo; O'Mahony, Rachel		Guideline Dev Grp	Guidelines Diagnosis, prevention, and management of delirium: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONFUSION ASSESSMENT METHOD		[Young, John] Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford BD9 6RJ, W Yorkshire, England; [Murthy, Lakshmi; Westby, Maggie; Akunne, Anayo; O'Mahony, Rachel] Royal Coll Physicians, Natl Clin Guideline Ctr, London, England	Bradford Royal Infirmary; Royal College of Physicians	Young, J (corresponding author), Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford BD9 6RJ, W Yorkshire, England.	john.young@bradfordhospitals.nhs.uk	Westby, Maggie/GWZ-2119-2022; Westby, Maggie/O-8794-2014	Westby, Maggie/0000-0003-4273-3942; young, john/0000-0003-4085-9306				American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; *JOINT FORM COMM, 2009, BRIT NAT FORM; National Clinical Guideline Centre, 2010, PAT DEL EXP VID; National Clinical Guideline Centre, 2010, DEL DIAGN PREV MAN; National Collaborating Centre for Acute Care, 2006, NUTR SUPP AD OR NUTR; National Institute for Clinical Excellence, 2003, INF CONTR PREV HEALT; National Institute for Health and Clinical Excellence, 2006, PARK DIS NAT CLIN GU, V35; National Institute for Health and Clinical Excellence, 2005, VIOL SHORT TERM MAN; National Institute for Health and Clinical Excellence, 2007, AC ILL PAT HOSP REC; National Institute for Health and Clinical Excellence, 2007, DEM SUPP PEOPL DEM T, V42	12	151	155	2	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2010	341								c3704	10.1136/bmj.c3704	http://dx.doi.org/10.1136/bmj.c3704			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	634GZ	20667955	Green Accepted			2022-12-24	WOS:000280570100002
J	Somani, BK; Watson, G; Townell, N				Somani, Bhaskar K.; Watson, Graham; Townell, Nick			Easily Missed? Testicular torsion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE SCROTUM; PEDIATRIC-PATIENTS; SPERMATIC CORD; ISCHEMIA; SALVAGE		[Somani, Bhaskar K.; Townell, Nick] Ninewells Hosp, Dundee DD1 9SY, Scotland	University of Dundee	Townell, N (corresponding author), Ninewells Hosp, Dundee DD1 9SY, Scotland.	nicktownell@nhs.net	Somani, B. K./I-8429-2019	Somani, B. K./0000-0002-6248-6478				ANDERSON JB, 1988, BRIT J SURG, V75, P988, DOI 10.1002/bjs.1800751015; BARADA JH, 1989, J UROLOGY, V142, P746, DOI 10.1016/S0022-5347(17)38875-4; BENNETT S, 1987, BMJ-BRIT MED J, V294, P824, DOI 10.1136/bmj.294.6575.824; BRASSO K, 1993, SCAND J UROL NEPHROL, V27, P1; BURKS DD, 1990, RADIOLOGY, V175, P815, DOI 10.1148/radiology.175.3.2188301; CATTOLICA EV, 1982, J UROLOGY, V128, P66, DOI 10.1016/S0022-5347(17)52758-5; Ciftci AO, 2004, EUR J PEDIATR SURG, V14, P333, DOI 10.1055/s-2004-821210; Eaton SH, 2005, J UROLOGY, V174, P1532, DOI 10.1097/01.ju.0000177726.84913.cc; Jefferson RH, 1997, J UROLOGY, V158, P1198, DOI 10.1016/S0022-5347(01)64426-4; LEWIS AG, 1995, J PEDIATR SURG, V30, P277, DOI 10.1016/0022-3468(95)90574-X; Makela E, 2007, SCAND J SURG, V96, P62; MOLOKWU CN, 2010, BJU INT IN PRESS; Mushtaq I, 2003, ANZ J SURG, V73, P55, DOI 10.1046/j.1445-2197.2003.02612.x; Sessions AE, 2003, J UROLOGY, V169, P663, DOI 10.1016/S0022-5347(05)63987-0; SMITH GI, 1955, J UROLOGY, V73, P355, DOI 10.1016/S0022-5347(17)67408-1; Visser AJ, 2003, BJU INT, V92, P200, DOI 10.1046/j.1464-410X.2003.04307.x	16	8	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2010	341								c3213	10.1136/bmj.c3213	http://dx.doi.org/10.1136/bmj.c3213			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634GX	20663836				2022-12-24	WOS:000280569900001
J	Vikstrom, I; Carotta, S; Luthje, K; Peperzak, V; Jost, PJ; Glaser, S; Busslinger, M; Bouillet, P; Strasser, A; Nutt, SL; Tarlinton, DM				Vikstrom, Ingela; Carotta, Sebastian; Luethje, Katja; Peperzak, Victor; Jost, Philipp J.; Glaser, Stefan; Busslinger, Meinrad; Bouillet, Philippe; Strasser, Andreas; Nutt, Stephen L.; Tarlinton, David M.			Mcl-1 Is Essential for Germinal Center Formation and B Cell Memory	SCIENCE			English	Article							PROSURVIVAL BCL-2 PROTEINS; ANTIBODY-FORMING-CELLS; AFFINITY MATURATION; SOMATIC HYPERMUTATION; CLONAL SELECTION; IMMUNE-RESPONSE; EXPRESSION; RECRUITMENT; MICE; FAS	Lymphocyte survival during immune responses is controlled by the relative expression of pro- and anti-apoptotic molecules, regulating the magnitude, quality, and duration of the response. We investigated the consequences of deleting genes encoding the anti-apoptotic molecules Mcl1 and Bcl2l1 (Bcl-xL) from B cells using an inducible system synchronized with expression of activation-induced cytidine deaminase (Aicda) after immunization. This revealed Mcl1 and not Bcl2l1 to be indispensable for the formation and persistence of germinal centers (GCs). Limiting Mcl1 expression reduced the magnitude of the GC response with an equivalent, but not greater, effect on memory B cell formation and no effect on persistence. Our results identify Mcl1 as the main anti-apoptotic regulator of activated B cell survival and suggest distinct mechanisms controlling survival of GC and memory B cells.	[Vikstrom, Ingela; Carotta, Sebastian; Luethje, Katja; Peperzak, Victor; Jost, Philipp J.; Glaser, Stefan; Bouillet, Philippe; Strasser, Andreas; Nutt, Stephen L.; Tarlinton, David M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Busslinger, Meinrad] Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; [Bouillet, Philippe; Strasser, Andreas; Nutt, Stephen L.; Tarlinton, David M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia	Walter & Eliza Hall Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Melbourne	Tarlinton, DM (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	tarlinto@wehi.edu.au	Nutt, Stephen L/C-9256-2013; Strasser, Andreas/C-7581-2013; Busslinger, Meinrad J./J-1249-2016; Bouillet, Philippe/E-1241-2013; Jost, Philipp J./S-4962-2016	Nutt, Stephen L/0000-0002-0020-6637; Strasser, Andreas/0000-0002-5020-4891; Busslinger, Meinrad J./0000-0002-9111-9351; Bouillet, Philippe/0000-0002-9012-6058; Jost, Philipp J./0000-0003-2454-0362; Tarlinton, David/0000-0001-9928-686X	National Health and Medical Research Council (NHMRC) Australia [356202, 461221]; Leukemia and Lymphoma Society [7413]; NIH [CA43540, CA80188]; NHMRC; Pfizer Australia; Olle Engkvist Byggmastare Foundation; Wenner-Gren Foundation; German Academic Exchange Service; Charles and Sylvia Viertel Charitable Foundation; Boehringer Ingelheim; NATIONAL CANCER INSTITUTE [R01CA080188, R01CA043540] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Pfizer Australia(PfizerPfizer Australia); Olle Engkvist Byggmastare Foundation; Wenner-Gren Foundation; German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Charles and Sylvia Viertel Charitable Foundation; Boehringer Ingelheim(Boehringer Ingelheim); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Health and Medical Research Council (NHMRC) Australia (356202 to D. M. T. and S.L.N. and 461221 to P. B. and A. S.), the Leukemia and Lymphoma Society (SCOR grant 7413), and the NIH (CA43540 and CA80188). D. M. T. and A. S. are supported by fellowships from the NHMRC; S.L.N. by a Pfizer Australia Research Fellowship; I. V. by the Olle Engkvist Byggmastare and Wenner-Gren Foundations; K. L. by a fellowship from the German Academic Exchange Service; P. B. by the Charles and Sylvia Viertel Charitable Foundation; and M. B. by Boehringer Ingelheim. DNA sequence data are available in GenBank (accession number HM804028-HM804084). We are indebted to the facilities of our respective institutes, particularly those responsible for animal husbandry and flow cytometry. We also acknowledge the assistance of L. O'Reilly for Western blot antibodies and the many helpful discussions with members of the Walter and Eliza Hall Institute B Cell Program. Author contributions are as follows: I. V. and D. M. T. designed the research; I. V., K. L., S. G., V. P., S. C., and P.J. performed experiments and contributed to interpretation and discussion; M. B., P. B., A. S., and S.L.N. contributed to the design of experiments, interpretation of results, and drafting the manuscript; I. V., K. L., and V. P. analyzed data and prepared figures; and I. V. and D. M. T. wrote the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; Carrington EM, 2010, P NATL ACAD SCI USA, V107, P10967, DOI 10.1073/pnas.1005256107; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cho-Vega JH, 2004, HUM PATHOL, V35, P1095, DOI 10.1016/j.humpath.2004.04.018; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; Fischer SF, 2007, BLOOD, V110, P3978, DOI 10.1182/blood-2007-05-091306; Haberman AM, 2003, NAT REV IMMUNOL, V3, P757, DOI 10.1038/nri1178; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ridderstad A, 1998, J IMMUNOL, V160, P4688; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; SMITH KGC, 1994, IMMUNITY, V1, P803, DOI 10.1016/S1074-7613(94)80022-7; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Takahashi Y, 1999, J EXP MED, V190, P399, DOI 10.1084/jem.190.3.399; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Wagner KU, 2000, DEVELOPMENT, V127, P4949; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Yokoyama T, 2002, IMMUNOL LETT, V81, P107, DOI 10.1016/S0165-2478(02)00003-2	34	157	158	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1095	1099		10.1126/science.1191793	http://dx.doi.org/10.1126/science.1191793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20929728	Green Accepted			2022-12-24	WOS:000284374700041
J	Hutchison, WD; Burkness, EC; Mitchell, PD; Moon, RD; Leslie, TW; Fleischer, SJ; Abrahamson, M; Hamilton, KL; Steffey, KL; Gray, ME; Hellmich, RL; Kaster, LV; Hunt, TE; Wright, RJ; Pecinovsky, K; Rabaey, TL; Flood, BR; Raun, ES				Hutchison, W. D.; Burkness, E. C.; Mitchell, P. D.; Moon, R. D.; Leslie, T. W.; Fleischer, S. J.; Abrahamson, M.; Hamilton, K. L.; Steffey, K. L.; Gray, M. E.; Hellmich, R. L.; Kaster, L. V.; Hunt, T. E.; Wright, R. J.; Pecinovsky, K.; Rabaey, T. L.; Flood, B. R.; Raun, E. S.			Areawide Suppression of European Corn Borer with Bt Maize Reaps Savings to Non-Bt Maize Growers	SCIENCE			English	Article							PEST-MANAGEMENT; INSECT RESISTANCE; TRANSGENIC CROPS; LEPIDOPTERA; PYRALIDAE; TOXIN; POPULATIONS; CRAMBIDAE; EVOLUTION; BOLLWORM	Transgenic maize engineered to express insecticidal proteins from the bacterium Bacillus thuringiensis (Bt) has become widely adopted in U. S. agriculture. In 2009, Bt maize was planted on more than 22.2 million hectares, constituting 63% of the U. S. crop. Using statistical analysis of per capita growth rate estimates, we found that areawide suppression of the primary pest Ostrinia nubilalis (European corn borer) is associated with Bt maize use. Cumulative benefits over 14 years are an estimated $3.2 billion for maize growers in Illinois, Minnesota, and Wisconsin, with more than $2.4 billion of this total accruing to non-Bt maize growers. Comparable estimates for Iowa and Nebraska are $3.6 billion in total, with $1.9 billion for non-Bt maize growers. These results affirm theoretical predictions of pest population suppression and highlight economic incentives for growers to maintain non-Bt maize refugia for sustainable insect resistance management.	[Hutchison, W. D.; Burkness, E. C.; Moon, R. D.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA; [Mitchell, P. D.] Univ Wisconsin, Dept Agr & Appl Econ, Madison, WI 53706 USA; [Leslie, T. W.] Long Isl Univ, Dept Biol, Brooklyn, NY 11201 USA; [Fleischer, S. J.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Abrahamson, M.] Minnesota Dept Agr, St Paul, MN 55107 USA; [Hamilton, K. L.] Wisconsin Dept Agr Trade & Consumer Protect, Madison, WI 53718 USA; [Steffey, K. L.; Gray, M. E.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Hellmich, R. L.] ARS, USDA, Corn Insects & Crop Genet Res Unit, Genet Lab, Ames, IA 50011 USA; [Kaster, L. V.] Syngenta Seeds Inc, Slater, IA 50244 USA; [Hunt, T. E.] Univ Nebraska, Dept Entomol, NEREC, Haskell Agr Lab, Concord, NE 68728 USA; [Wright, R. J.] Univ Nebraska, Dept Entomol, Lincoln, NE 68583 USA; [Pecinovsky, K.] Iowa State Univ, Nashua, IA 50658 USA; [Rabaey, T. L.] Gen Mills Inc, Le Sueur, MN 56058 USA; [Flood, B. R.] Del Monte Foods, Rochelle, IL 61068 USA; [Raun, E. S.] Pest Management Co, Lincoln, NE 68506 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; Long Island University-Brooklyn Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Agriculture (USDA); Syngenta; University of Nebraska System; University of Nebraska System; University of Nebraska Lincoln; Iowa State University	Hutchison, WD (corresponding author), Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.	hutch002@umn.edu	Moon, Roger/ABA-7225-2020; Fleischer, Shelby/AAD-6663-2020; Fleischer, Shelby/AAN-1392-2020	Hutchison, William D./0000-0001-9605-2996	University of Minnesota	University of Minnesota(University of Minnesota System)	This study is part of a large-scale monitoring program for O. nubilalis via cooperating members of USDA Multistate Project NC-205, "Ecology and Management of European Corn Borer and Other Lepidopteran Pests of Corn." Support was also provided by personnel with state departments of agriculture, agricultural experiment stations, and cooperative extension, and a grant from the Rapid Agricultural Response Fund, University of Minnesota. We acknowledge numerous growers who permitted data collection from commercial maize fields over the past 50 years. We thank J. Dyer, L. Lewis, B. Gunnarson, and R. Ritland for technical support, and Y. Carriere, J. Chapman, J.-Z. Zhou, and J. P. Chavas for reviews of earlier versions of the manuscript. P. D. M. also provides limited private economic consulting services to agencies, universities, and private companies, which in the past 3 years has included small projects for Monsanto, Pioneer Hi-Bred International, and Syngenta on topics unrelated to this paper. Mention of a proprietary product does not constitute an endorsement or a recommendation for its use by the universities associated with this research or the USDA.	ALSTAD DN, 1995, SCIENCE, V268, P1894, DOI 10.1126/science.268.5219.1894; Bartels DW, 1997, J ECON ENTOMOL, V90, P449, DOI 10.1093/jee/90.2.449; Brookes G., 2008, AgBioForum, V11, P21; Burkness EC, 2002, CROP PROT, V21, P157, DOI 10.1016/S0261-2194(01)00080-1; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; Goldberger J., 2005, AgBioForum, V8, P151; Hellmich RL, 1999, J ECON ENTOMOL, V92, P1014, DOI 10.1093/jee/92.5.1014; HILL RE, 1979, ENVIRON ENTOMOL, V8, P91, DOI 10.1093/ee/8.1.91; Hurley TM, 2004, AM J AGR ECON, V86, P345, DOI 10.1111/j.0092-5853.2004.00583.x; HUTCHISON W, 2008, MINNESOTA FRUIT 0606; Lewis LC, 2009, BIOL CONTROL, V48, P223, DOI 10.1016/j.biocontrol.2008.10.009; LEWIS P, 2001, 200007A SAP US EPA, P5; MASON CE, 1996, NCR327 IOW STAT U; Mitchell PD, 2002, J AGR RESOUR ECON, V27, P390; O'Rourke ME, 2010, ECOL APPL, V20, P1228, DOI 10.1890/09-0067.1; Onstad DW, 1999, J ECON ENTOMOL, V92, P1256, DOI 10.1093/jee/92.6.1256; OSTLIE KR, 1997, NCR602 U MINN; Pereira EJG, 2008, B ENTOMOL RES, V98, P621, DOI 10.1017/S0007485308005920; Pilcher CD, 2002, J ECON ENTOMOL, V95, P878, DOI 10.1603/0022-0493-95.5.878; Reardon BJ, 2006, J ECON ENTOMOL, V99, P1641, DOI 10.1603/0022-0493-99.5.1641; Royama T., 1992, ANAL POPULATION ECOL; Shelton AM, 2006, ANNU REV ENTOMOL, V51, P285, DOI 10.1146/annurev.ento.51.110104.150959; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Sisterson MS, 2004, J ECON ENTOMOL, V97, P1413, DOI 10.1603/0022-0493-97.4.1413; Storer Nicholas P., 2008, V5, P273, DOI 10.1007/978-1-4020-8373-0_10; Tabashnik BE, 2008, P NATL ACAD SCI USA, V105, P19029, DOI 10.1073/pnas.0810763106; USDA-ARS, AD GEN ENG CROPS US; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550	29	460	490	3	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					222	225		10.1126/science.1190242	http://dx.doi.org/10.1126/science.1190242			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929774	Green Published			2022-12-24	WOS:000282644600042
J	Bisgaard, H; Hermansen, MN; Bonnelykke, K; Stokholm, J; Baty, F; Skytt, NL; Aniscenko, J; Kebadze, T; Johnston, SL				Bisgaard, Hans; Hermansen, Mette Northman; Bonnelykke, Klaus; Stokholm, Jakob; Baty, Florent; Skytt, Nanna Lassen; Aniscenko, Julia; Kebadze, Tatiana; Johnston, Sebastian L.			Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study	BRITISH MEDICAL JOURNAL			English	Article							PLACEBO-CONTROLLED TRIAL; ORAL PREDNISOLONE; VIRAL-INFECTIONS; DOUBLE-BLIND; 1ST YEAR; ASTHMA; EXACERBATIONS; INFANCY; LIFE; CLARITHROMYCIN	Objective To study the association between wheezy symptoms in young children and the presence of bacteria in the airways. Design Birth cohort study. Setting Clinical research unit in Copenhagen. Participants Children of asthmatic mothers, from age 4 weeks to 3 years, with planned visits and acute admissions to the research clinic. Main outcome measure Frequency of bacteria and virus carriage in airway aspirates during wheezy episodes and at planned visits without respiratory symptoms. Results 984 samples (361 children) were analysed for bacteria, 844 (299 children) for viruses, and 696 (277 children) for both viruses and bacteria. Wheezy episodes were associated with both bacterial infection (odds ratio 2.9, 95% confidence interval 1.9 to 4.3; P<0.001) and virus infection (2.8, 1.7 to 4.4; P<0.001). The associations of bacteria and viruses were independent of each other. Conclusion Acute wheezy episodes in young children were significantly associated with bacterial infections similar to but independent of the association with virus infections.	[Bisgaard, Hans; Hermansen, Mette Northman; Bonnelykke, Klaus; Stokholm, Jakob; Baty, Florent; Skytt, Nanna Lassen] Copenhagen Prospect Studies Asthma Childhood, DK-2820 Gentofte, Copenhagen, Denmark; [Bisgaard, Hans; Hermansen, Mette Northman; Bonnelykke, Klaus; Stokholm, Jakob; Baty, Florent; Skytt, Nanna Lassen] Univ Copenhagen, DK-2820 Gentofte, Copenhagen, Denmark; [Bisgaard, Hans; Hermansen, Mette Northman; Bonnelykke, Klaus; Stokholm, Jakob; Baty, Florent; Skytt, Nanna Lassen] Danish Pediat Asthma Ctr, DK-2820 Gentofte, Copenhagen, Denmark; [Bisgaard, Hans; Hermansen, Mette Northman; Bonnelykke, Klaus; Stokholm, Jakob; Baty, Florent; Skytt, Nanna Lassen] Copenhagen Univ Hosp, DK-2820 Gentofte, Copenhagen, Denmark; [Aniscenko, Julia; Kebadze, Tatiana; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, MRC & Asthma UK Ctr Allerg Mech Asthma, Dept Resp Med, London SW7 2AZ, England; [Aniscenko, Julia; Kebadze, Tatiana; Johnston, Sebastian L.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect, London SW7 2AZ, England	University of Copenhagen; University of Copenhagen; Imperial College London; University of London; King's College London; Imperial College London	Bisgaard, H (corresponding author), Copenhagen Prospect Studies Asthma Childhood, Ledreborg Alle 34, DK-2820 Gentofte, Copenhagen, Denmark.	Bisgaard@copsac.com	Johnston, Sebastian Lennox/I-2423-2012; Kronow, Joern/B-1054-2011; Bisgaard, Hans/N-4761-2016	Johnston, Sebastian Lennox/0000-0003-3009-9200; Bisgaard, Hans/0000-0003-4131-7592; Bonnelykke, Klaus/0000-0003-2003-1018; Stokholm, Jakob/0000-0003-4989-9769	Copenhagen Prospective Study on Asthma in Childhood; Lundbeck Foundation; Pharmacy Foundation; Augustinus Foundation; Danish Medical Research Council; Danish Pediatric Asthma Centre; Lundbeck Foundation [R16-2007-1694] Funding Source: researchfish	Copenhagen Prospective Study on Asthma in Childhood; Lundbeck Foundation(Lundbeckfonden); Pharmacy Foundation; Augustinus Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Pediatric Asthma Centre; Lundbeck Foundation(Lundbeckfonden)	The Copenhagen Prospective Study on Asthma in Childhood is funded by private and public research funds (seewww.copsac.com). The study is supported by the Lundbeck Foundation, the Pharmacy Foundation of 1991, Augustinus Foundation, the Danish Medical Research Council, and the Danish Pediatric Asthma Centre. The funding agencies had no role in the study design; the conduct of the study; data collection and management; data analysis; or the preparation, review, or approval of the manuscript.	Andersen ZJ, 2008, THORAX, V63, P710, DOI 10.1136/thx.2007.085480; ANIANSSON G, 1992, J INFECT DIS, V165, pS38, DOI 10.1093/infdis/165-Supplement_1-S38; [Anonymous], 2005, NIH PUBL, V05-4772; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2007, PEDIATR PULM, V42, P723, DOI 10.1002/ppul.20644; Bush A, 2009, NEW ENGL J MED, V360, P409, DOI 10.1056/NEJMe0808951; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Ducharme FM, 2009, NEW ENGL J MED, V360, P339, DOI 10.1056/NEJMoa0808907; Fonseca-Aten M, 2006, ANN ALLERG ASTHMA IM, V97, P457, DOI 10.1016/S1081-1206(10)60935-0; Hahn DL, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010011; Harrison LM, 1999, FEMS IMMUNOL MED MIC, V25, P19, DOI 10.1111/j.1574-695X.1999.tb01323.x; Johnston SL, 2006, NEW ENGL J MED, V354, P1589, DOI 10.1056/NEJMoa044080; Johnston SL, 2006, J ALLERGY CLIN IMMUN, V117, P1233, DOI 10.1016/j.jaci.2006.03.035; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kocevar VS, 2004, CHEST, V125, P1680, DOI 10.1378/chest.125.5.1680; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Kusel MMH, 2006, PEDIATR INFECT DIS J, V25, P680, DOI 10.1097/01.inf.0000226912.88900.a3; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Lund B, 2001, CLIN MICROBIOL INFEC, V7, P230, DOI 10.1046/j.1469-0691.2001.00242.x; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; Oommen A, 2003, LANCET, V362, P1433, DOI 10.1016/S0140-6736(03)14685-5; Panickar J, 2009, NEW ENGL J MED, V360, P329, DOI 10.1056/NEJMoa0804897; Peacock SJ, 2003, J CLIN MICROBIOL, V41, P5718, DOI 10.1128/JCM.41.12.5718-5725.2003; Tahan F, 2007, EUR RESPIR J, V29, P91, DOI 10.1183/09031936.00029206; Talbot TR, 2005, NEW ENGL J MED, V352, P2082, DOI 10.1056/NEJMoa044113; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68	29	220	229	1	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2010	341								c4978	10.1136/bmj.c4978	http://dx.doi.org/10.1136/bmj.c4978			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663IZ	20921080	Green Published, hybrid			2022-12-24	WOS:000282878600001
J	Rosen, CJ; Khosla, S				Rosen, Clifford J.; Khosla, Sundeep			Placebo-Controlled Fracture Trials in Osteoporosis - Proceeding with Caution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISK; PREVENTION; DENSITY; WOMEN		[Rosen, Clifford J.] Maine Med Ctr, Res Inst, Scarborough, ON, Canada; [Khosla, Sundeep] Mayo Clin, Coll Med, Rochester, MN USA	Mayo Clinic	Rosen, CJ (corresponding author), Maine Med Ctr, Res Inst, Scarborough, ON, Canada.		Khosla, Sundeep/AAE-6170-2020	Khosla, Sundeep/0000-0002-2936-4372	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027065] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR027065] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; European Medicines Agency, 2005, GUID EV NEW MED PROD; Food and Drug Administration Division of Metabolic and Endocrine Drug Products, 1994, GUID PRECL CLIN EV A; Fost N, 2003, J BONE MINER RES, V18, P1110, DOI 10.1359/jbmr.2003.18.6.1110; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Silverman SL, 2008, J BONE MINER RES, V23, P159, DOI 10.1359/JBMR.070905	8	16	16	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2010	363	14					1365	1367		10.1056/NEJMsb1002227	http://dx.doi.org/10.1056/NEJMsb1002227			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655TD	20879887	Green Accepted			2022-12-24	WOS:000282271500014
J	McKenna, NJ; O'Malley, BW				McKenna, Neil J.; O'Malley, Bert W.			SnapShot: Nuclear Receptors II	CELL			English	Editorial Material							SYSTEM		[McKenna, Neil J.; O'Malley, Bert W.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	McKenna, NJ (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.			McKenna, Neil/0000-0001-6689-0104	NIDDK NIH HHS [U19-DK62434] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Auwerx J, 1999, CELL, V97, P161; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Kim KW, 2009, MOL CELL ENDOCRINOL, V300, P132, DOI 10.1016/j.mce.2008.09.026; PEAREN MA, MOL ENDOCRINOL, DOI DOI 10.10.1210/ME.2010-0015; TREMBLAY AM, 2007, NUCL RECEPT SIGNAL, V3, pE9; Yin Lei, 2010, Nucl Recept Signal, V8, pe001, DOI 10.1621/nrs.08001	9	5	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 17	2010	142	6					986	U155		10.1016/j.cell.2010.08.041	http://dx.doi.org/10.1016/j.cell.2010.08.041			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850017	Bronze			2022-12-24	WOS:000281855000021
J	Soria, C; Estermann, FE; Espantman, KC; O'Shea, CC				Soria, Conrado; Estermann, Fanny E.; Espantman, Kristen C.; O'Shea, Clodagh C.			Heterochromatin silencing of p53 target genes by a small viral protein	NATURE			English	Article							EARLY REGION 4; ADENOVIRUS MUTANT; TUMOR-SUPPRESSOR; CELLS; REPLICATION; METHYLATION; EXPRESSION; E1A; TRANSCRIPTION; ONYX-015	The transcription factor p53 (also known as TP53) guards against tumour and virus replication and is inactivated in almost all cancers. p53-activated transcription of target genes is thought to be synonymous with the stabilization of p53 in response to oncogenes and DNA damage. During adenovirus replication, the degradation of p53 by E1B-55k is considered essential for p53 inactivation, and is the basis for p53-selective viral cancer therapies. Here we reveal a dominant epigenetic mechanism that silences p53-activated transcription, irrespective of p53 phosphorylation and stabilization. We show that another adenoviral protein, E4-ORF3, inactivates p53 independently of E1B-55k by forming a nuclear structure that induces de novo H3K9me3 heterochromatin formation at p53 target promoters, preventing p53-DNA binding. This suppressive nuclear web is highly selective in silencing p53 promoters and operates in the backdrop of global transcriptional changes that drive oncogenic replication. These findings are important for understanding how high levels of wild-type p53 might also be inactivated in cancer as well as the mechanisms that induce aberrant epigenetic silencing of tumour-suppressor loci. Our study changes the longstanding definition of how p53 is inactivated in adenovirus infection and provides key insights that could enable the development of true p53-selective oncolytic viral therapies.	[Soria, Conrado; Estermann, Fanny E.; Espantman, Kristen C.; O'Shea, Clodagh C.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	O'Shea, CC (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	oshea@salk.edu			Alliance of Cancer Gene Therapy; American Cancer Society; Sontag Foundation; Beckman Foundation; National Cancer Institute [R01CA137094]; NATIONAL CANCER INSTITUTE [R01CA137094] Funding Source: NIH RePORTER	Alliance of Cancer Gene Therapy; American Cancer Society(American Cancer Society); Sontag Foundation; Beckman Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Fitzpatrick and the Waitt Advanced Biophotonics Center for assistance with imaging and analysis, J. Karlseder, I. Verma, T. Hunter, R. Shaw and the O'Shea laboratory for critical reading of this manuscript, L. Haro, S. Panda, R. O'Sullivan and A. Rodriguez for advice and protocols, and P. Branton and D. Ornelles for viruses. C.C.O. acknowledges funding from the Alliance of Cancer Gene Therapy, the American Cancer Society, the Sontag Foundation and the Beckman Foundation. This work was supported by R01CA137094 from the National Cancer Institute.	Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; BARKER DD, 1987, VIROLOGY, V156, P107, DOI 10.1016/0042-6822(87)90441-7; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; CUTT JR, 1987, J VIROL, V61, P543, DOI 10.1128/JVI.61.2.543-552.1987; DEBBAS M, 1993, GENE DEV, V7, P546, DOI 10.1101/gad.7.4.546; Doucas V, 1996, GENE DEV, V10, P196, DOI 10.1101/gad.10.2.196; Downey T, 2006, METHOD ENZYMOL, V411, P256, DOI 10.1016/S0076-6879(06)11013-7; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; HALBERT DN, 1985, J VIROL, V56, P250, DOI 10.1128/JVI.56.1.250-257.1985; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Hoh J, 2002, P NATL ACAD SCI USA, V99, P8467, DOI 10.1073/pnas.132268899; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; HUANG MM, 1989, J VIROL, V63, P2605, DOI 10.1128/JVI.63.6.2605-2615.1989; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson L, 2002, CANCER CELL, V1, P325, DOI 10.1016/S1535-6108(02)00060-0; JONES N, 1979, P NATL ACAD SCI USA, V76, P3665, DOI 10.1073/pnas.76.8.3665; Khuri FR, 2000, NAT MED, V6, P879, DOI 10.1038/78638; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lane DP, 2005, COLD SH Q B, V70, P489, DOI 10.1101/sqb.2005.70.049; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Levine AJ, 2009, VIROLOGY, V384, P285, DOI 10.1016/j.virol.2008.09.034; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Maehara K, 2005, J CELL BIOL, V168, P553, DOI 10.1083/jcb.200411093; Marcellus RC, 1996, J VIROL, V70, P6207, DOI 10.1128/JVI.70.9.6207-6215.1996; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McCormick F, 2003, CANCER BIOL THER, V2, pS157; O'Shea CC, 2005, ONCOGENE, V24, P7640, DOI 10.1038/sj.onc.1209047; O'Shea CC, 2005, CANCER CELL, V8, P61, DOI 10.1016/j.ccr.2005.06.009; O'Shea CC, 2004, CANCER CELL, V6, P611, DOI 10.1016/j.ccr.2004.11.012; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Ries SJ, 2000, NAT MED, V6, P1128, DOI 10.1038/80466; Shepard RN, 2003, J VIROL, V77, P8593, DOI 10.1128/JVI.77.15.8593-8595.2003; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Stracker TH, 2002, NATURE, V418, P348, DOI 10.1038/nature00863; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang N, 2003, NANO LETT, V3, P475, DOI 10.1021/nl034019m; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; Yan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r78; Yondola MA, 2007, J VIROL, V81, P4264, DOI 10.1128/JVI.02629-06	58	105	111	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1076	U85		10.1038/nature09307	http://dx.doi.org/10.1038/nature09307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20740008	Green Accepted			2022-12-24	WOS:000281203600033
J	Huang, CS; Sadre-Bazzaz, K; Shen, Y; Deng, BB; Zhou, ZH; Tong, LA				Huang, Christine S.; Sadre-Bazzaz, Kianoush; Shen, Yang; Deng, Binbin; Zhou, Z. Hong; Tong, Liang			Crystal structure of the alpha(6)beta(6) holoenzyme of propionyl-coenzyme A carboxylase	NATURE			English	Article							ACETYL-COA CARBOXYLASE; BIOTIN CARBOXYLASE; CARBOXYLTRANSFERASE DOMAIN; PYRUVATE-CARBOXYLASE; FUNCTIONAL-ANALYSIS; CATALYTIC-ACTIVITY; MCCB MUTATIONS; A CARBOXYLASE; ACIDEMIA; SUBUNIT	Propionyl-coenzyme A carboxylase (PCC), a mitochondrial biotin-dependent enzyme, is essential for the catabolism of the amino acids Thr, Val, Ile and Met, cholesterol and fatty acids with an odd number of carbon atoms. Deficiencies in PCC activity in humans are linked to the disease propionic acidaemia, an autosomal recessive disorder that can be fatal in infants(1-4). The holoenzyme of PCC is an alpha(6)beta(6) dodecamer, with a molecular mass of 750 kDa. The alpha-subunit contains the biotin carboxylase (BC) and biotin carboxyl carrier protein (BCCP) domains, whereas the beta-subunit supplies the carboxyltransferase (CT) activity. Here we report the crystal structure at 3.2-angstrom resolution of a bacterial PCC alpha(6)beta(6) holoenzyme as well as cryo-electron microscopy (cryo-EM) reconstruction at 15-angstrom resolution demonstrating a similar structure for human PCC. The structure defines the overall architecture of PCC and reveals unexpectedly that the alpha-subunits are arranged as monomers in the holoenzyme, decorating a central beta(6) hexamer. A hitherto unrecognized domain in the alpha-subunit, formed by residues between the BC and BCCP domains, is crucial for interactions with the beta-subunit. We have named it the BT domain. The structure reveals for the first time the relative positions of the BC and CT active sites in the holoenzyme. They are separated by approximately 55 angstrom, indicating that the entire BCCP domain must translocate during catalysis. The BCCP domain is located in the active site of the beta-subunit in the current structure, providing insight for its involvement in the CT reaction. The structural information establishes a molecular basis for understanding the large collection of disease-causing mutations in PCC and is relevant for the holoenzymes of other biotin-dependent carboxylases, including 3-methylcrotonyl-CoA carboxylase (MCC)(5-7) and eukaryotic acetyl-CoA carboxylase (ACC)(8,9).	[Huang, Christine S.; Sadre-Bazzaz, Kianoush; Shen, Yang; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Deng, Binbin; Zhou, Z. Hong] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	Columbia University; University of Texas System; University of Texas Health Science Center Houston; University of California System; University of California Los Angeles	Tong, LA (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	Zhou, Z Hong/HDN-0747-2022	Huang, Christine/0000-0003-4082-3880; Tong, Liang/0000-0002-0563-6468	National Institutes of Health [DK067238, GM071940, AI069015, GM08281]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008281, R01GM071940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Whalen and H. Robinson for access to the X29A beamline at the National Synchrotron Light Source; J. Schwanof and R. Abramowitz for access to the X4A beamline; M. Sampat for help during the initial stages of the project; and W. W. Cleland for discussions. This research was supported in part by National Institutes of Health grants DK067238 (to L. T.), GM071940 and AI069015 (to Z.H.Z.). C. S. H. was also supported by a National Institutes of Health training program in molecular biophysics (GM08281).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bilder P, 2006, BIOCHEMISTRY-US, V45, P1712, DOI 10.1021/bi0520479; Blanchard CZ, 1999, BIOCHEMISTRY-US, V38, P3393, DOI 10.1021/bi982660a; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chou CY, 2009, J BIOL CHEM, V284, P11690, DOI 10.1074/jbc.M805783200; Cronan JE, 2002, PROG LIPID RES, V41, P407, DOI 10.1016/S0163-7827(02)00007-3; Deodato F, 2006, AM J MED GENET C, V142C, P104, DOI 10.1002/ajmg.c.30090; Desviat LR, 2006, J HUM GENET, V51, P992, DOI 10.1007/s10038-006-0068-3; Desviat LR, 2003, MOL GENET METAB, V80, P315, DOI 10.1016/S1096-7192(03)00130-6; Desviat LR, 2004, MOL GENET METAB, V83, P28, DOI 10.1016/j.ymgme.2004.08.001; Diacovich L, 2004, BIOCHEMISTRY-US, V43, P14027, DOI 10.1021/bi049065v; Hall PR, 2003, EMBO J, V22, P2334, DOI 10.1093/emboj/cdg244; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Janiyani K, 2001, J BIOL CHEM, V276, P29864, DOI 10.1074/jbc.M104102200; Jiang H, 2005, J BIOL CHEM, V280, P27719, DOI 10.1074/jbc.M413281200; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lin TW, 2006, P NATL ACAD SCI USA, V103, P3072, DOI 10.1073/pnas.0510580103; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muro S, 2001, MOL GENET METAB, V74, P476, DOI 10.1006/mgme.2001.3254; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Cerda C, 2003, BBA-MOL BASIS DIS, V1638, P43, DOI 10.1016/S0925-4439(03)00039-5; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodriguez-Pombo P, 2005, BBA-MOL BASIS DIS, V1740, P489, DOI 10.1016/j.bbadis.2004.10.009; Shen Y, 2004, MOL CELL, V16, P881, DOI 10.1016/j.molcel.2004.11.034; Shen Y, 2006, MOL CELL, V22, P807, DOI 10.1016/j.molcel.2006.04.026; Sloane V, 2004, J BIOL CHEM, V279, P15772, DOI 10.1074/jbc.M311982200; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Stadler SC, 2006, HUM MUTAT, V27, P748, DOI 10.1002/humu.20349; Stucki M, 2009, J BIOL CHEM, V284, P28953, DOI 10.1074/jbc.M109.050674; Thoden JB, 2000, J BIOL CHEM, V275, P16183, DOI 10.1074/jbc.275.21.16183; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; WAKIL SJ, 1983, ANNU REV BIOCHEM, V52, P537, DOI 10.1146/annurev.bi.52.070183.002541; WALDROP GL, 1994, BIOCHEMISTRY-US, V33, P10249, DOI 10.1021/bi00200a004; Weatherly SC, 2004, BIOCHEM J, V380, P105, DOI 10.1042/BJ20031960; Wendt KS, 2003, EMBO J, V22, P3493, DOI 10.1093/emboj/cdg358; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	39	64	70	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					1001	U135		10.1038/nature09302	http://dx.doi.org/10.1038/nature09302			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725044	Green Accepted			2022-12-24	WOS:000281030300040
J	Matloff, ET; Brierley, KL				Matloff, Ellen T.; Brierley, Karina L.			The double-helix derailed: the story of the BRCA patent	LANCET			English	Editorial Material							CANCER; GENETICS; PHYSICIANS; KNOWLEDGE; HEALTH; BREAST; RISKS		[Matloff, Ellen T.; Brierley, Karina L.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA	Yale University	Matloff, ET (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, 333 Cedar St, New Haven, CT 06510 USA.							*AM CIV LIB UN, 2010, BRCA SUPPL DECL E MA; BRIERLEY KL, CONNECTICUT IN PRESS; Doksum T, 2003, GENET MED, V5, P99, DOI 10.1097/01.GIM.0000055198.63593.32; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Gold ER, 2010, GENET MED, V12, pS39, DOI 10.1097/GIM.0b013e3181d72661; Gollust SE, 2002, JAMA-J AM MED ASSOC, V288, P1762, DOI 10.1001/jama.288.14.1762; Greendale K, 2001, AM J MED GENET, V106, P223, DOI 10.1002/ajmg.10010; Kepler TB, 2010, GENOMICS, V95, P312, DOI 10.1016/j.ygeno.2010.03.003; Kesselheim AS, 2010, NEW ENGL J MED, V362, P1855, DOI 10.1056/NEJMp1004026; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; KORITZ S, 2009, CARLSON CRUVE   0909; Lecrubier A, 2002, EMBO REP, V3, P1120, DOI 10.1093/embo-reports/kvf251; *MYR GEN, ACC EX DALL E; *MYR GEN LAB INC, 2010, MYR FIN ASS PROGR FI; *MYR GEN LAB INC, 2009, MYR GEN ANN REP; RAY T, 2010, PHARMACOGENOMIC 0210; Westphal SP, 2002, NEW SCI, V175, P29; Wideroff L, 2005, J MED GENET, V42, P749, DOI 10.1136/jmg.2004.030296; Williams-Jones B, 2006, NEW GENET SOC, V25, P89, DOI 10.1080/14636770600603527; 2009, PHARMACOGENOMIC 0107	20	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2010	376	9738					314	315		10.1016/S0140-6736(10)61150-6	http://dx.doi.org/10.1016/S0140-6736(10)61150-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636FW	20674708				2022-12-24	WOS:000280717900009
J	Schramek, D; Leibbrandt, A; Sigl, V; Kenner, L; Pospisilik, JA; Lee, HJ; Hanada, R; Joshi, PA; Aliprantis, A; Glimcher, L; Pasparakis, M; Khokha, R; Ormandy, CJ; Widschwendter, M; Schett, G; Penninger, JM				Schramek, Daniel; Leibbrandt, Andreas; Sigl, Verena; Kenner, Lukas; Pospisilik, John A.; Lee, Heather J.; Hanada, Reiko; Joshi, Purna A.; Aliprantis, Antonios; Glimcher, Laurie; Pasparakis, Manolis; Khokha, Rama; Ormandy, Christopher J.; Widschwendter, Martin; Schett, Georg; Penninger, Josef M.			Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer	NATURE			English	Article							HORMONE-REPLACEMENT THERAPY; ESTROGEN-PLUS-PROGESTIN; STEM-CELL; POSTMENOPAUSAL WOMEN; EPITHELIAL-CELLS; MEDROXYPROGESTERONE ACETATE; OSTEOPROTEGERIN-LIGAND; RECEPTOR ACTIVATOR; GLAND DEVELOPMENT; BONE METASTASIS	Breast cancer is one of the most common cancers in humans and will on average affect up to one in eight women in their lifetime in the United States and Europe(1). The Women's Health Initiative and the Million Women Study have shown that hormone replacement therapy is associated with an increased risk of incident and fatal breast cancer(2,3). In particular, synthetic progesterone derivatives (progestins) such as medroxyprogesterone acetate (MPA), used in millions of women for hormone replacement therapy and contraceptives, markedly increase the risk of developing breast cancer. Here we show that the in vivo administration of MPA triggers massive induction of the key osteoclast differentiation factor RANKL (receptor activator of NF-kappa B ligand) in mammary-gland epithelial cells. Genetic inactivation of the RANKL receptor RANK in mammary-gland epithelial cells prevents MPA-induced epithelial proliferation, impairs expansion of the CD49f(hi) stem-cell-enriched population, and sensitizes these cells to DNA-damage-induced cell death. Deletion of RANK from the mammary epithelium results in a markedly decreased incidence and delayed onset of MPA-driven mammary cancer. These data show that the RANKL/RANK system controls the incidence and onset of progestin-driven breast cancer.	[Schramek, Daniel; Leibbrandt, Andreas; Sigl, Verena; Pospisilik, John A.; Hanada, Reiko; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Kenner, Lukas] Med Univ Vienna, A-1090 Vienna, Austria; [Lee, Heather J.; Ormandy, Christopher J.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Joshi, Purna A.; Khokha, Rama] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Aliprantis, Antonios; Glimcher, Laurie] Harvard Univ, Sch Med, Dept Med, Sch Publ Hlth,Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Aliprantis, Antonios; Glimcher, Laurie] MGH MIT, Ragon Inst, Boston, MA 02115 USA; [Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50674 Cologne, Germany; [Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster CECAD, D-50674 Cologne, Germany; [Widschwendter, Martin] UCL, Dept Gynaecol Oncol, London WC1E 6AU, England; [Schett, Georg] Univ Erlangen Nurnberg, Dept Internal Med 3, D-91054 Erlangen, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Medical University of Vienna; Garvan Institute of Medical Research; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Cologne; University of Cologne; University of London; University College London; University of Erlangen Nuremberg	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	Pasparakis, Manolis/N-4350-2019; Lee, Heather/M-2670-2019; Ormandy, Chris/G-4165-2014; Schramek, Daniel/J-5792-2014; Lee, Heather/B-5302-2012; Penninger, Josef M/I-6860-2013; Schramek, Daniel/AAL-1470-2020; Pasparakis, Manolis/H-9292-2017	Pasparakis, Manolis/0000-0002-9870-0966; Lee, Heather/0000-0002-6482-0337; Penninger, Josef M/0000-0002-8194-3777; Schramek, Daniel/0000-0001-9977-2104; Pasparakis, Manolis/0000-0002-9870-0966; Widschwendter, Martin/0000-0002-7778-8380; Ormandy, Christopher/0000-0002-2504-7919; Kenner, Lukas/0000-0003-2184-1338; Joshi, Purna/0000-0002-1628-9940	Burroughs Wellcome Fund; National Institutes of Health (NIH) [HD055601]; German Research Council (Deutsche Forschungsgemeinschaft (DFG)) [FOR643, SFB641, SPP1468]; Interdisciplinary Center for Clinical Sciences Erlangen; European Union (EU); National Health and Medical Research Council of Australia; Australian Cancer Research Fund; Cancer Institute New South Wales; EU InflaCare network; University College London (UCL) Hospital/UCL Comprehensive Biomedical Research Centre [152]; Department of Health National Institute for Health Research Biomedical Research Centres; Institute of Molecular Biotechnology; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); European Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055601] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Council (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Sciences Erlangen; European Union (EU)(CGIAREuropean Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Fund; Cancer Institute New South Wales; EU InflaCare network; University College London (UCL) Hospital/UCL Comprehensive Biomedical Research Centre; Department of Health National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); Institute of Molecular Biotechnology; Austrian Ministry of Sciences; Austrian Academy of Sciences; GEN-AU (AustroMouse); European Research Council(European Research Council (ERC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank all members of our laboratories for helpful discussions; G. Forni for providing NeuT transgenic mice. A.O.A. is a recipient of a Career Award for Medical Scientists from the Burroughs Wellcome Fund. L.G. is supported by National Institutes of Health (NIH) grant HD055601. G.S's work is supported by the German Research Council (Deutsche Forschungsgemeinschaft (DFG): FOR643, SFB641 and SPP1468), by the Interdisciplinary Center for Clinical Sciences Erlangen and by the focus programme SPP1468 (Immunobone) of the DFG and the Masterswitch project of the European Union (EU). C.J.O. is supported by the National Health and Medical Research Council of Australia, the Australian Cancer Research Fund and the Cancer Institute New South Wales. D.S. is supported by the EU InflaCare network. M.W. is supported by a grant from the University College London (UCL) Hospital/UCL Comprehensive Biomedical Research Centre project no. 152, and part of this work was undertaken at UCL Hospital/UCL, which received a proportion of its funding from the Department of Health National Institute for Health Research Biomedical Research Centres funding scheme. J.M.P. is supported by grants from Institute of Molecular Biotechnology, the Austrian Ministry of Sciences, the Austrian Academy of Sciences, GEN-AU (AustroMouse), an EU Marie Curie Excellence Grant, and a European Research Council Advanced Grant. Special thanks go to Limin Zhang, who provided a first idea for this manuscript and died much too early of breast cancer.	Aldaz CM, 1996, CARCINOGENESIS, V17, P2069, DOI 10.1093/carcin/17.9.2069; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Boggio K, 1998, J EXP MED, V188, P589, DOI 10.1084/jem.188.3.589; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; ELMAHGOUB S, 1972, ACTA OBSTET GYN SCAN, V51, P251, DOI 10.3109/00016347209156855; Ewan KB, 2002, CANCER RES, V62, P5627; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hofseth LJ, 1999, J CLIN ENDOCR METAB, V84, P4559, DOI 10.1210/jc.84.12.4559; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; McTiernan A, 2005, JNCI-J NATL CANCER I, V97, P1366, DOI 10.1093/jnci/dji279; Morony S, 2001, CANCER RES, V61, P4432; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pike MC, 1997, J NATL CANCER I, V89, P1110, DOI 10.1093/jnci/89.15.1110; Robinson GW, 1997, DEVELOPMENT, V124, P2701; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Srivastava S, 2003, J BIOL CHEM, V278, P46171, DOI 10.1074/jbc.M308545200; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007	41	413	437	0	55	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					98	+		10.1038/nature09387	http://dx.doi.org/10.1038/nature09387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20881962	Green Accepted			2022-12-24	WOS:000283786900043
J	Nogi, T; Yasui, N; Mihara, E; Matsunaga, Y; Noda, M; Yamashita, N; Toyofuku, T; Uchiyama, S; Goshima, Y; Kumanogoh, A; Takagi, J				Nogi, Terukazu; Yasui, Norihisa; Mihara, Emiko; Matsunaga, Yukiko; Noda, Masanori; Yamashita, Naoya; Toyofuku, Toshihiko; Uchiyama, Susumu; Goshima, Yoshio; Kumanogoh, Atsushi; Takagi, Junichi			Structural basis for semaphorin signalling through the plexin receptor	NATURE			English	Article							CRYSTAL-STRUCTURE; PROTEIN; BINDING; LIGAND; RESOLUTION; COMPLEX; DOMAIN; MET	Semaphorins and their receptor plexins constitute a pleiotropic cell-signalling system that is used in a wide variety of biological processes, and both protein families have been implicated in numerous human diseases(1-4). The binding of soluble or membrane-anchored semaphorins to the membrane-distal region of the plexin ecto-domain activates plexin's intrinsic GTPase-activating protein (GAP) at the cytoplasmic region, ultimately modulating cellular adhesion behaviour(5). However, the structural mechanism underlying the receptor activation remains largely unknown. Here we report the crystal structures of the semaphorin 6A (Sema6A) receptor-binding fragment and the plexin A2 (PlxnA2) ligand-binding fragment in both their pre-signalling (that is, before binding) and signalling (after complex formation) states. Before binding, the Sema6A ectodomain was in the expected 'face-to-face' homodimer arrangement, similar to that adopted by Sema3A and Sema4D, whereas PlxnA2 was in an unexpected 'head-on' homodimer arrangement. In contrast, the structure of the Sema6A-PlxnA2 signalling complex revealed a 2:2 heterotetramer in which the two PlxnA2 monomers dissociated from one another and docked onto the top face of the Sema6A homodimer using the same interface as the head-on homodimer, indicating that plexins undergo 'partner exchange'. Cell-based activity measurements using mutant ligands/receptors confirmed that the Sema6A face-to-face dimer arrangement is physiologically relevant and is maintained throughout signalling events. Thus, homodimer-to-heterodimer transitions of cell-surface plexin that result in a specific orientation of its molecular axis relative to the membrane may constitute the structural mechanism by which the ligand-binding 'signal' is transmitted to the cytoplasmic region, inducing GAP domain rearrangements and activation.	[Nogi, Terukazu; Yasui, Norihisa; Mihara, Emiko; Matsunaga, Yukiko; Takagi, Junichi] Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, Suita, Osaka 5650871, Japan; [Noda, Masanori; Uchiyama, Susumu] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan; [Yamashita, Naoya; Goshima, Yoshio] Yokohama City Univ, Grad Sch Med, Dept Mol Pharmacol & Neurobiol, Yokohama, Kanagawa 2360004, Japan; [Toyofuku, Toshihiko; Kumanogoh, Atsushi] Osaka Univ, Microbial Dis Res Inst, Immunol Frontier Res Ctr, Dept Immunopathol, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Yokohama City University; Osaka University	Takagi, J (corresponding author), Osaka Univ, Inst Prot Res, Lab Prot Synth & Express, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takagi@protein.osaka-u.ac.jp	Yasui, Norihisa/V-8252-2019; UCHIYAMA, Susumu/F-9590-2017; Nogi, Terukazu/GPF-7203-2022	Yasui, Norihisa/0000-0001-7117-3070; UCHIYAMA, Susumu/0000-0002-5181-179X; Nogi, Terukazu/0000-0001-8663-3519; Matsunaga, Yukiko/0000-0002-1392-5681	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We would like to thank Y. Yamada, N. Matsugaki and N. Igarashi of Photon Factory and Y. Kawano and N. Shimizu of SPring-8 BL-41XU for their help with the X-ray data collection; A. Rowe for discussions on the sedimentation equilibrium data analysis; C. Wu for performing the Sema6A-AP binding assay; K. Tamura-Kawakami and M. Nampo for their technical support; and M. Nakano for preparation of the manuscript. This work was supported in part by a 'Target Proteins Research Program (TPRP)' grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chaudhry C, 2009, EMBO J, V28, P1518, DOI 10.1038/emboj.2009.86; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goshima Y, 1997, J NEUROBIOL, V33, P316, DOI 10.1002/(SICI)1097-4695(199709)33:3<316::AID-NEU9>3.0.CO;2-4; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Leahy DJ, 2000, PROTEIN EXPRES PURIF, V20, P500, DOI 10.1006/prep.2000.1331; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Liu HL, 2010, CELL, V142, P749, DOI 10.1016/j.cell.2010.07.040; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Luo BH, 2006, CURR OPIN CELL BIOL, V18, P579, DOI 10.1016/j.ceb.2006.08.005; Merte J, 2010, J NEUROSCI, V30, P5767, DOI 10.1523/JNEUROSCI.5061-09.2010; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasterkamp RJ, 2005, TRENDS CELL BIOL, V15, P61, DOI 10.1016/j.tcb.2004.12.005; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Tabata S, 2010, J PROTEOMICS, V73, P1777, DOI 10.1016/j.jprot.2010.05.012; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Tamagnone L, 2004, EMBO REP, V5, P356, DOI 10.1038/sj.embor.7400114; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Toyofuku T, 2008, DEV BIOL, V321, P251, DOI 10.1016/j.ydbio.2008.06.028; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Xu XM, 2000, J NEUROSCI, V20, P2638; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	42	116	129	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2010	467	7319					1123	U138		10.1038/nature09473	http://dx.doi.org/10.1038/nature09473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20881961				2022-12-24	WOS:000283548600051
J	Broberg, CA; Zhang, LL; Gonzalez, H; Laskowski-Arce, MA; Orth, K				Broberg, Christopher A.; Zhang, Lingling; Gonzalez, Herman; Laskowski-Arce, Michelle A.; Orth, Kim			A Vibrio Effector Protein Is an Inositol Phosphatase and Disrupts Host Cell Membrane Integrity	SCIENCE			English	Article							PARAHAEMOLYTICUS; AUTOPHAGY; BINDING; DOMAINS; GENOME	The marine bacterium Vibrio parahaemolyticus causes gastroenteritis in humans and encodes the type III effector protein VPA0450, which contributes to host cell death caused by autophagy, cell rounding, and cell lysis. We found that VPA0450 is an inositol polyphosphate 5-phosphatase that hydrolyzed the D5 phosphate from the plasma membrane phospholipid phosphatidylinositol 4,5-bisphosphate. VPA0450 disrupted cytoskeletal binding sites on the inner surface of membranes of human cells and caused plasma membrane blebbing, which compromised membrane integrity and probably contributed to cell death by facilitating lysis. Thus, bacterial pathogens can disrupt adaptor protein-binding sites required for proper membrane and cytoskeleton dynamics by altering the homeostasis of membrane-bound inositol-signaling molecules.	[Broberg, Christopher A.; Zhang, Lingling; Gonzalez, Herman; Laskowski-Arce, Michelle A.; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Zhang, Lingling/A-1100-2015; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Broberg, Christopher/0000-0002-9497-5866	NIH [R01-AI056404, R01-AI087808]; Welch Foundation [I-1561]; National Institute of General Medical Sciences [5T32GM008203]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087808, R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008203] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Alto, H. Yin, J. Hurley, F. Robinson, J. Albanesi, B. Barylko, K. Luby-Phelps, Chris Smith, T. Iida, T. Honda, L. McCarter, and the Orth lab for insightful discussions, critical reading, and generous supply of reagents. K.O., L.Z., H. G., M. L.-A., and C. A. B. are supported by grants from NIH-Allergy and Infectious Disease (R01-AI056404 and R01-AI087808) and the Welch Foundation (I-1561). C. A. B is supported by National Institute of General Medical Sciences training grant 5T32GM008203 in cellular and molecular biology. K.O. is a Burroughs Wellcome Investigator in Pathogenesis of Infectious Disease and a W. W. Caruth Jr. Biomedical Scholar.	Broberg CA, 2010, CURR OPIN MICROBIOL, V13, P34, DOI 10.1016/j.mib.2009.12.004; Burdette DL, 2008, P NATL ACAD SCI USA, V105, P12497, DOI 10.1073/pnas.0802773105; Burdette DL, 2009, MOL MICROBIOL, V73, P639, DOI 10.1111/j.1365-2958.2009.06798.x; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Daniels NA, 2000, J INFECT DIS, V181, P1661, DOI 10.1086/315459; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Hurley JH, 2000, ANNU REV BIOPH BIOM, V29, P49, DOI 10.1146/annurev.biophys.29.1.49; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Ono T, 2006, INFECT IMMUN, V74, P1032, DOI 10.1128/IAI.74.2.1032-1042.2006; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Taylor Gregory S, 2004, Methods Mol Biol, V284, P217; Tsujishita Y, 2001, CELL, V105, P379, DOI 10.1016/S0092-8674(01)00326-9; Whisstock JC, 2002, IUBMB LIFE, V53, P15, DOI 10.1080/15216540210814; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	20	78	86	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1660	1662		10.1126/science.1192850	http://dx.doi.org/10.1126/science.1192850			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20724587				2022-12-24	WOS:000282098100046
J	Lopez-Mosqueda, J; Maas, NL; Jonsson, ZO; DeFazio-Eli, LG; Wohlschlegel, J; Toczyski, DP				Lopez-Mosqueda, Jaime; Maas, Nancy L.; Jonsson, Zophonias O.; DeFazio-Eli, Lisa G.; Wohlschlegel, James; Toczyski, David P.			Damage-induced phosphorylation of Sld3 is important to block late origin firing	NATURE			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; S-PHASE CHECKPOINT; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; SHOTGUN PROTEOMICS; BUDDING YEAST; MEC1 KINASE; COMPLEX; INITIATION; CDC7-DBF4	Origins of replication are activated throughout the S phase of the cell cycle such that some origins fire early and others fire late to ensure that each chromosome is completely replicated in a timely fashion. However, in response to DNA damage or replication fork stalling, eukaryotic cells block activation of unfired origins. Human cells derived from patients with ataxia telangiectasia are deficient in this process due to the lack of a functional ataxia telangiectasia mutated (ATM) kinase and elicit radioresistant DNA synthesis(1-3) after gamma-irradiation(2). This effect is conserved in budding yeast, as yeast cells lacking the related kinase Mec1 (ATM and Rad3-related (ATR in humans)) also fail to inhibit DNA synthesis in the presence of DNA damage(4). This intra-S-phase checkpoint actively regulates DNA synthesis by inhibiting the firing of late replicating origins, and this inhibition requires both Mec1 and the downstream checkpoint kinase Rad53 (Chk2 in humans)(5,6). However, the Rad53 substrate(s) whose phosphorylation is required to mediate this function has remained unknown. Here we show that the replication initiation protein Sld3 is phosphorylated by Rad53, and that this phosphorylation, along with phosphorylation of the Cdc7 kinase regulatory subunit Dbf4, blocks late origin firing in Saccharomyces cerevisiae. Upon exposure to DNA-damaging agents, cells expressing non-phosphorylatable alleles of SLD3 and DBF4 (SLD3-m25 and dbf4-m25, respectively) proceed through the S phase faster than wild-type cells by inappropriately firing late origins of replication. SLD3-m25 dbf4-m25 cells grow poorly in the presence of the replication inhibitor hydroxyurea and accumulate multiple Rad52 foci. Moreover, SLD3-m25 dbf4-m25 cells are delayed in recovering from transient blocks to replication and subsequently arrest at the DNA damage checkpoint. These data indicate that the intra-S-phase checkpoint functions to block late origin firing in adverse conditions to prevent genomic instability and maximize cell survival.	[Lopez-Mosqueda, Jaime; Maas, Nancy L.; DeFazio-Eli, Lisa G.; Toczyski, David P.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Jonsson, Zophonias O.; Wohlschlegel, James] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles	Toczyski, DP (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	toczyski@cc.ucsf.edu	Jónsson, Zophonías Oddur/AAO-1354-2020; Jónsson, Zophonías/E-1960-2015	Jónsson, Zophonías Oddur/0000-0001-5798-9647; Eli, Lisa/0000-0003-3896-0966	Ford Foundation; National Institutes of Health [GM059691]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059691, R01GM089778] Funding Source: NIH RePORTER	Ford Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank members of the Toczyski, Morgan, Li and O'Farrell laboratories for discussions. We also thank D. Morgan, G. Narlikar and J. Li for intellectual contributions, J. Benanti and M. Downey for critical reading of this manuscript, and S. Makovets and M. Hoang for assistance with two-dimensional DNA gels. We thank H. Araki for strains, R. Sclafani for plasmids and J. Diffley for communicating results before publication. We are especially grateful to N. Lopez for help with GFP foci and colony quantification. Funding was provided by a Ford Foundation Pre-Doctoral Diversity Fellowship and a National Institutes of Health grant GM059691.	Alabert C, 2009, EMBO J, V28, P1131, DOI 10.1038/emboj.2009.75; Barlow JH, 2009, EMBO J, V28, P1121, DOI 10.1038/emboj.2009.43; Bousset K, 1998, GENE DEV, V12, P480, DOI 10.1101/gad.12.4.480; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Dohrmann PR, 1999, GENETICS, V151, P965; Donaldson AD, 1998, GENE DEV, V12, P491, DOI 10.1101/gad.12.4.491; Duncker BP, 2002, P NATL ACAD SCI USA, V99, P16087, DOI 10.1073/pnas.252093999; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; Gabrielse C, 2006, GENETICS, V173, P541, DOI 10.1534/genetics.106.057521; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; LARNER JM, 1994, MOL CELL BIOL, V14, P1901, DOI 10.1128/MCB.14.3.1901; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Paciotti V, 2001, MOL CELL BIOL, V21, P3913, DOI 10.1128/MCB.21.12.3913-3925.2001; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pike BL, 2004, J BIOL CHEM, V279, P39636, DOI 10.1074/jbc.M405080200; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tam ATY, 2008, BIOCHEMISTRY-US, V47, P3912, DOI 10.1021/bi800027t; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; YOUNG BR, 1989, HUM GENET, V82, P113, DOI 10.1007/BF00284040; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhao XL, 2002, P NATL ACAD SCI USA, V99, P3746, DOI 10.1073/pnas.062502299	39	140	142	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					479	U133		10.1038/nature09377	http://dx.doi.org/10.1038/nature09377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20865002	Green Accepted, Green Submitted			2022-12-24	WOS:000282090200047
J	Lencucha, R				Lencucha, Raphael			Philip Morris versus Uruguay: health governance challenged	LANCET			English	Editorial Material									Univ Lethbridge, Fac Hlth Sci, Lethbridge, AB T1K 3M4, Canada	University of Lethbridge	Lencucha, R (corresponding author), Univ Lethbridge, Fac Hlth Sci, Lethbridge, AB T1K 3M4, Canada.	raphael.lencucha@uleth.ca						[Anonymous], 2010, LANCET, V375, P1580; [Anonymous], 1988, SWITZERLAND URUGUAY; Chapman S, 2003, TOB CONTROL, V12, P13; Koivusalo M, 2009, GLOBALIZATION HLTH P, P105, DOI DOI 10.1001/JAMA.2009.1694; LALIVE, 2009, WHY PLAIN PACK IS VI; Lee K, 2009, LANCET, V373, P416, DOI 10.1016/S0140-6736(08)61776-6; PETERSON LE, 2010, INVESTMENT ARBI 0302; Roemer R, 2005, AM J PUBLIC HEALTH, V95, P936, DOI 10.2105/AJPH.2003.025908; United Nations Conference on Trade and Development, 2007, INT PROP PROV INT IN; Wakefield MA, 2008, TOB CONTROL, V17, P416, DOI 10.1136/tc.2008.026732; Woo Alyssa, 2002, VANDERBILT J TRANSNA, V35, P1731; *WORLD TRAD ORG, 1986, WTO LEG TEXTS GEN AG	12	21	21	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 11	2010	376	9744					852	853		10.1016/S0140-6736(10)61256-1	http://dx.doi.org/10.1016/S0140-6736(10)61256-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653DW	20833287				2022-12-24	WOS:000282069100007
J	Fung, TT; van Dam, RM; Hankinson, SE; Stampfer, M; Willett, WC; Hu, FB				Fung, Teresa T.; van Dam, Rob M.; Hankinson, Susan E.; Stampfer, Meir; Willett, Walter C.; Hu, Frank B.			Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality Two Cohort Studies	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; HIGH-PROTEIN-DIET; RISK-FACTORS; WEIGHT-LOSS; MEAT CONSUMPTION; LUNG-CANCER; COLORECTAL-CANCER; FAT; METAANALYSIS; SCORE	Background: Data on the long-term association between low-carbohydrate diets and mortality are sparse. Objective: To examine the association of low-carbohydrate diets with mortality during 26 years of follow-up in women and 20 years in men. Design: Prospective cohort study of women and men who were followed from 1980 (women) or 1986 (men) until 2006. Low-carbohydrate diets, either animal-based (emphasizing animal sources of fat and protein) or vegetable-based (emphasizing vegetable sources of fat and protein), were computed from several validated food-frequency questionnaires assessed during follow-up. Setting: Nurses' Health Study and Health Professionals' Follow-up Study. Participants: 85 168 women (aged 34 to 59 years at baseline) and 44 548 men (aged 40 to 75 years at baseline) without heart disease, cancer, or diabetes. Measurements: Investigators documented 12 555 deaths (2458 cardiovascular-related and 5780 cancer-related) in women and 8678 deaths (2746 cardiovascular-related and 2960 cancer-related) in men. Results: The overall low-carbohydrate score was associated with a modest increase in overall mortality in a pooled analysis (hazard ratio [HR] comparing extreme deciles, 1.12 [95% CI, 1.01 to 1.24]; P for trend = 0.136). The animal low-carbohydrate score was associated with higher all-cause mortality (pooled HR comparing extreme deciles, 1.23 [CI, 1.11 to 1.37]; P for trend = 0.051), cardiovascular mortality (corresponding HR, 1.14 [CI, 1.01 to 1.29]; P for trend = 0.029), and cancer mortality (corresponding HR, 1.28 [CI, 1.02 to 1.60]; P for trend = 0.089). In contrast, a higher vegetable low-carbohydrate score was associated with lower all-cause mortality (HR, 0.80 [CI, 0.75 to 0.85]; P for trend <= 0.001) and cardiovascular mortality (HR, 0.77 [CI, 0.68 to 0.87]; P for trend < 0.001). Limitations: Diet and lifestyle characteristics were assessed with some degree of error. Sensitivity analyses indicated that results were probably not substantively affected by residual confounding or an unmeasured confounder. Participants were not a representative sample of the U. S. population. Conclusion: A low-carbohydrate diet based on animal sources was associated with higher all-cause mortality in both men and women, whereas a vegetable-based low-carbohydrate diet was associated with lower all-cause and cardiovascular disease mortality rates.	[Fung, Teresa T.] Harvard Univ, Sch Publ Hlth, Simmons Coll, Dept Nutr, Boston, MA 02115 USA; Natl Univ Singapore, Singapore 117548, Singapore	Harvard University; Harvard T.H. Chan School of Public Health; Simmons University; National University of Singapore	Fung, TT (corresponding author), Harvard Univ, Sch Publ Hlth, Simmons Coll, Dept Nutr, 300 Fenway, Boston, MA 02115 USA.	teresa.fung@simmons.edu	van Dam, Rob M/F-9674-2010	van Dam, Rob M/0000-0002-7354-8734	National Institutes of Health [CA87969, HL60712, CA95589]; NATIONAL CANCER INSTITUTE [R01CA095589, P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant Support: By the National Institutes of Health (grants CA87969, HL60712, and CA95589).	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Benetou V, 2008, CANCER EPIDEM BIOMAR, V17, P387, DOI 10.1158/1055-9965.EPI-07-2665; Chao A, 2005, JAMA-J AM MED ASSOC, V293, P172, DOI 10.1001/jama.293.2.172; CHAUNCEY KB, 2003, LOW CARB DIETING DUM; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Cross AJ, 2007, PLOS MED, V4, P1973, DOI 10.1371/journal.pmed.0040325; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; De Stefani E, 2008, LUNG CANCER, V61, P283, DOI 10.1016/j.lungcan.2008.01.004; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Halton TL, 2008, AM J CLIN NUTR, V87, P339, DOI 10.1093/ajcn/87.2.339; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Jenkins DJA, 2009, ARCH INTERN MED, V169, P1046, DOI 10.1001/archinternmed.2009.115; Kelemen LE, 2005, AM J EPIDEMIOL, V161, P239, DOI 10.1093/aje/kwi038; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Lagiou P, 2007, J INTERN MED, V261, P366, DOI 10.1111/j.1365-2796.2007.01774.x; Lam TK, 2009, CANCER RES, V69, P932, DOI 10.1158/0008-5472.CAN-08-3162; Larsson SC, 2006, INT J CANCER, V119, P2657, DOI 10.1002/ijc.22170; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; McMillan-Price J, 2006, ARCH INTERN MED, V166, P1466, DOI 10.1001/archinte.166.14.1466; Muzio F, 2007, AM J CLIN NUTR, V86, P946, DOI 10.1093/ajcn/86.4.946; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Rubin DB, 2004, MULTIPLE IMPUTATION; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Sandhu MS, 2001, CANCER EPIDEM BIOMAR, V10, P439; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Spiegelman D, 1997, AM J CLIN NUTR, V65, P1179; Trichopoulou A, 2007, EUR J CLIN NUTR, V61, P575, DOI 10.1038/sj.ejcn.1602557; Willett W., 2012, NUTR EPIDEMIOLOGY	35	222	225	1	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 7	2010	153	5					289	+		10.7326/0003-4819-153-5-201009070-00003	http://dx.doi.org/10.7326/0003-4819-153-5-201009070-00003			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647GF	20820038	Green Accepted			2022-12-24	WOS:000281605500002
J	Reddy, VS; Natchiar, SK; Stewart, PL; Nemerow, GR				Reddy, Vijay S.; Natchiar, S. Kundhavai; Stewart, Phoebe L.; Nemerow, Glen R.			Crystal Structure of Human Adenovirus at 3.5 angstrom Resolution	SCIENCE			English	Article							CRYOELECTRON MICROSCOPY STRUCTURE; PROTEIN; VECTOR; INFECTIVITY; REVEALS; PENTON; TRIALS	Rational development of adenovirus vectors for therapeutic gene transfer is hampered by the lack of accurate structural information. Here, we report the x-ray structure at 3.5 angstrom resolution of the 150-megadalton adenovirus capsid containing nearly 1 million amino acids. We describe interactions between the major capsid protein (hexon) and several accessory molecules that stabilize the capsid. The virus structure also reveals an altered association between the penton base and the trimeric fiber protein, perhaps reflecting an early event in cell entry. The high-resolution structure provides a substantial advance toward understanding the assembly and cell entry mechanisms of a large double-stranded DNA virus and provides new opportunities for improving adenovirus-mediated gene transfer.	[Reddy, Vijay S.; Natchiar, S. Kundhavai; Nemerow, Glen R.] Scripps Res Inst, La Jolla, CA 92037 USA; [Stewart, Phoebe L.] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA	Scripps Research Institute; Vanderbilt University	Reddy, VS (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gnemerow@scripps.edu; reddyv@scripps.edu			National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NIH [R01 AI070771, HL054352, EY011431, AI042929]; NATIONAL EYE INSTITUTE [R01EY011431] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070771, R01AI042929, R29AI042929] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors express their deep gratitude to J. E. Johnson for advice and guidance during all phases of the structure determination and for reading the manuscript; T.-M. Mullen and L. Gritton for the outstanding technical support for vector production; S. Venkataraman for help with the early crystallization setups of HAdV; I. Mathews of the Stanford Synchrotron Radiation Lightsource for initial help with the data collection; W. Minor and I. Minor for generously providing the larger version of the SCALEPACK program; E. Ollmann-Saphire and J. G. Smith for comments on the manuscript; T. McCarthy for preparation of this paper; and R. Fischetti, N. Sanishvili, and other members at General Medicine and Cancer Institutes Collaborative Access Team (GM/CA CAT) for discussions and technical support. GM/CA CAT has been funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). The use of the Advance Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science (contract no. DE-AC02-06CH11357). The coordinates of Ad35F crystal structure have been deposited in the Protein Data Bank (PDB) with the identification code 1VSZ. This work was supported by NIH grants R01 AI070771 to V. S. R., HL054352 and EY011431 to G.R.N., and AI042929 to P.L.S. This is manuscript no. 20538 from the Scripps Research Institute. G.R.N. holds a patent titled "Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use" (patent no. 7,232,899).	Butt AL, 2006, CORNEA, V25, P199, DOI 10.1097/01.ico.0000170693.13326.fb; Campos SK, 2007, CURR GENE THER, V7, P189, DOI 10.2174/156652307780859062; Edelstein ML, 2004, J GENE MED, V6, P597, DOI 10.1002/jgm.619; Fabry CMS, 2005, EMBO J, V24, P1645, DOI 10.1038/sj.emboj.7600653; Fuschiotti P, 2006, J MOL BIOL, V356, P510, DOI 10.1016/j.jmb.2005.11.048; Gordon YJ, 1996, INVEST OPHTH VIS SCI, V37, P2774; Henry TD, 2007, J AM COLL CARDIOL, V50, P1038, DOI 10.1016/j.jacc.2007.06.010; HILLEMAN MR, 1954, P SOC EXP BIOL MED, V85, P183, DOI 10.3181/00379727-85-20825; Hoffman R, 2006, NETW COMPUT, V17, P18; Lenaerts L, 2008, REV MED VIROL, V18, P357, DOI 10.1002/rmv.589; Metzgar D, 2007, J INFECT DIS, V196, P1465, DOI 10.1086/522970; Reddy VS, 2010, VIROLOGY, V402, P209, DOI 10.1016/j.virol.2010.03.028; Saban SD, 2005, J MOL BIOL, V349, P526, DOI 10.1016/j.jmb.2005.04.034; Saban SD, 2006, J VIROL, V80, P12049, DOI 10.1128/JVI.01652-06; Shayakhmetov DM, 2000, J VIROL, V74, P10274, DOI 10.1128/JVI.74.22.10274-10286.2000; Silvestry M, 2009, J VIROL, V83, P7375, DOI 10.1128/JVI.00331-09; STEWART PL, 1993, EMBO J, V12, P2589, DOI 10.1002/j.1460-2075.1993.tb05919.x; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; VANOOSTRUM J, 1985, J VIROL, V56, P439, DOI 10.1128/JVI.56.2.439-448.1985; von Seggern DJ, 1999, J VIROL, V73, P1601, DOI 10.1128/JVI.73.2.1601-1608.1999; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Zubieta C, 2005, MOL CELL, V17, P121, DOI 10.1016/j.molcel.2004.11.041	22	173	176	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2010	329	5995					1071	1075		10.1126/science.1187292	http://dx.doi.org/10.1126/science.1187292			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798318	Green Accepted			2022-12-24	WOS:000281253500039
J	Lee, LK; Ginsburg, MA; Crovace, C; Donohoe, M; Stock, D				Lee, Lawrence K.; Ginsburg, Michael A.; Crovace, Claudia; Donohoe, Mhairi; Stock, Daniela			Structure of the torque ring of the flagellar motor and the molecular basis for rotational switching	NATURE			English	Article							SALMONELLA-TYPHIMURIUM; PROTEIN FLIG; 3-DIMENSIONAL STRUCTURE; CONFORMATIONAL SPREAD; MUTATIONAL ANALYSIS; CHARGED RESIDUES; ROTOR; REGION; LOCALIZATION; GENERATION	The flagellar motor drives the rotation of flagellar filaments at hundreds of revolutions per second(1,2), efficiently propelling bacteria through viscous media(3). The motor uses the potential energy from an electrochemical gradient of cations(4,5) across the cytoplasmic membrane to generate torque. A rapid switch from anticlockwise to clockwise rotation determines whether a bacterium runs smoothly forward or tumbles to change its trajectory(6,7). A protein called FliG forms a ring in the rotor of the flagellar motor that is involved in the generation of torque(8-13) through an interaction with the cation-channel-forming stator subunit MotA(12). FliG has been suggested to adopt distinct conformations that induce switching but these structural changes and the molecular mechanism of switching are unknown. Here we report the molecular structure of the full-length FliG protein, identify conformational changes that are involved in rotational switching and uncover the structural basis for the formation of the FliG torque ring. This allows us to propose a model of the complete ring and switching mechanism in which conformational changes in FliG reverse the electrostatic charges involved in torque generation.	[Lee, Lawrence K.; Ginsburg, Michael A.; Donohoe, Mhairi; Stock, Daniela] Victor Chang Cardiac Res Inst, Struct & Computat Biol Div, Darlinghurst, NSW 2010, Australia; [Crovace, Claudia] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Stock, Daniela] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia	Victor Chang Cardiac Research Institute; MRC Laboratory Molecular Biology; University of New South Wales Sydney	Stock, D (corresponding author), Victor Chang Cardiac Res Inst, Struct & Computat Biol Div, Lowy Packer Bldg,405 Liverpool St, Darlinghurst, NSW 2010, Australia.	d.stock@victorchang.edu.au		Lee, Lawrence/0000-0002-4453-4886	US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Institutes of Health, National Center for Research Resources [RR007707]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; Australian Nuclear Science Technology Organization; MRC; MRC [MC_U105170645] Funding Source: UKRI; Medical Research Council [MC_U105170645] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER	US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Australian Nuclear Science Technology Organization; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank the staff at beamline ID14-1 at the ESRF, and at beamlines 14-ID (BioCARS) and 23-ID (General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT)) at the APS for their support. Use of the APS was supported by the US Department of Energy, Basic Energy Sciences, Office of Science (contract DE-AC02-06CH11357), and use of the BioCARS Sector 14 was supported by the National Institutes of Health, National Center for Research Resources (grant RR007707). GM/CA-CAT was funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). This work was supported by the Australian Synchrotron Research Program of the Australian Nuclear Science Technology Organization. D. Thomas is acknowledged for providing us with the electron microscopy density map of the clockwise-locked S. typhimurium mutant and O. Perisic and H. Huber are acknowledged for cloning vectors (pOPT-GST) and A. aeolicus genomic DNA, respectively. D. S. was initially funded by an MRC Career development award (UK) and C. C. by an MRC predoctoral fellowship (UK).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANCIS NR, 1992, P NATL ACAD SCI USA, V89, P6304, DOI 10.1073/pnas.89.14.6304; HIROTA N, 1983, J BIOL CHEM, V258, P577; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; Kihara M, 2000, J BACTERIOL, V182, P3022, DOI 10.1128/JB.182.11.3022-3028.2000; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Liu J, 2009, J BACTERIOL, V191, P5026, DOI 10.1128/JB.00340-09; Lloyd SA, 1997, J MOL BIOL, V266, P733, DOI 10.1006/jmbi.1996.0836; Lloyd SA, 1999, NATURE, V400, P472, DOI 10.1038/22794; Lloyd SA, 1996, J BACTERIOL, V178, P223, DOI 10.1128/jb.178.1.223-231.1996; LOWE G, 1987, NATURE, V325, P637, DOI 10.1038/325637a0; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; MANSON MD, 1977, P NATL ACAD SCI USA, V74, P3060, DOI 10.1073/pnas.74.7.3060; Marykwas DL, 1996, J BACTERIOL, V178, P1289, DOI 10.1128/jb.178.5.1289-1294.1996; Murphy GE, 2006, NATURE, V442, P1062, DOI 10.1038/nature05015; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Togashi F, 1997, J BACTERIOL, V179, P2994, DOI 10.1128/jb.179.9.2994-3003.1997; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; UENO T, 1992, J MOL BIOL, V227, P672, DOI 10.1016/0022-2836(92)90216-7; Van Way SM, 2004, J BACTERIOL, V186, P3173, DOI 10.1128/JB.186.10.3173-3181.2004; Yorimitsu T, 2003, J MOL BIOL, V334, P567, DOI 10.1016/j.jmb.2003.09.052; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436	40	129	130	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					996	U129		10.1038/nature09300	http://dx.doi.org/10.1038/nature09300			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20676082	Green Accepted			2022-12-24	WOS:000281030300039
J	Nakada, S; Tai, I; Panier, S; Al-Hakim, A; Iemura, S; Juang, YC; O'Donnell, L; Kumakubo, A; Munro, M; Sicheri, F; Gingras, AC; Natsume, T; Suda, T; Durocher, D				Nakada, Shinichiro; Tai, Ikue; Panier, Stephanie; Al-Hakim, Abdallah; Iemura, Shun-ichiro; Juang, Yu-Chi; O'Donnell, Lara; Kumakubo, Ayako; Munro, Meagan; Sicheri, Frank; Gingras, Anne-Claude; Natsume, Tohru; Suda, Toshio; Durocher, Daniel			Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1	NATURE			English	Article							DOUBLE-STRAND BREAKS; STATISTICAL-MODEL; STRUCTURAL BASIS; MAMMALIAN-CELLS; REPAIR PROTEINS; BINDING; COMPLEX; ENZYME; CHAINS; SPECIFICITY	DNA double-strand breaks (DSBs) pose a potent threat to genome integrity. These lesions also contribute to the efficacy of radiotherapy and many cancer chemotherapeutics. DSBs elicit a signalling cascade that modifies the chromatin surrounding the break, first by ATM-dependent phosphorylation and then by RNF8-, RNF168- and BRCA1-dependent regulatory ubiquitination. Here we report that OTUB1, a deubiquitinating enzyme, is an inhibitor of DSB-induced chromatin ubiquitination. Surprisingly, we found that OTUB1 suppresses RNF168-dependent poly-ubiquitination independently of its catalytic activity. OTUB1 does so by binding to and inhibiting UBC13 (also known as UBE2N), the cognate E2 enzyme for RNF168. This unusual mode of regulation is unlikely to be limited to UBC13 because analysis of OTUB1-associated proteins revealed that OTUB1 binds to E2s of the UBE2D and UBE2E subfamilies. Finally, OTUB1 depletion mitigates the DSB repair defect associated with defective ATM signalling, indicating that pharmacological targeting of the OTUB1-UBC13 interaction might enhance the DNA damage response.	[Panier, Stephanie; Al-Hakim, Abdallah; Juang, Yu-Chi; O'Donnell, Lara; Munro, Meagan; Sicheri, Frank; Gingras, Anne-Claude; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Nakada, Shinichiro; Tai, Ikue] Keio Univ, Sch Med, Ctr Integrated Med Res, Shinjuku Ku, Tokyo 1608582, Japan; [Nakada, Shinichiro; Tai, Ikue; Kumakubo, Ayako; Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol,Shinjuku Ku, Tokyo 1608582, Japan; [Panier, Stephanie; Sicheri, Frank; Gingras, Anne-Claude; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Biol Syst Control Team, Koto Ku, Tokyo 1350064, Japan	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Keio University; Keio University; University of Toronto; National Institute of Advanced Industrial Science & Technology (AIST)	Durocher, D (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	snakada@z3.keio.jp; durocher@lunenfeld.ca	Sicheri, Frank/F-8856-2013; Gingras, Anne-Claude/E-9982-2010; OsakaU/AAY-3661-2020; Gingras, Anne-Claude/ABA-8341-2020; Suda, Toshio/H-6761-2013; 高, 雨莉/HGU-8187-2022; Natsume, Tohru/M-7627-2018; Panier, Stephanie/GVT-6365-2022; Durocher, Daniel/A-7733-2010	Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Suda, Toshio/0000-0001-7540-1771; Natsume, Tohru/0000-0002-1510-2582; Durocher, Daniel/0000-0003-3863-8635; Nakada, Shinichiro/0000-0001-9297-1565	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; MEXT [21870033]; Takeda Science Foundation; Mitsubishi Pharma Research Foundation; Daiwa Anglo-Japanese Foundation; New Energy and Industrial Technology Development Organization (NEDO); Boehringer Ingelheim Fonds; Canadian Institutes of Health Research [MOP10703115, MOP84314]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Daiwa Anglo-Japanese Foundation(Daiwa Anglo-Japanese Foundation); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We are grateful to T. Ikura, S. Olivarius, R. Sakasai, A. Shibata, T. Oikawa, J. Unno, Y. Katuski, I. Imoto, S. Koyasu, R. Greenberg and the Core Instrumentation Facility, Keio University School of Medicine for technical support and reagents. We also thank R. Szilard and S. Angers for reading the manuscript. Work in the Nakada group in the Suda laboratory is supported by the Promotion of Environmental Improvement for Independence of Young Researchers, 'Kanrinmaru Project' from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan, Grant-in-Aid for Young Scientists (Startup 2009, 21870033) from MEXT, Takeda Science Foundation, Mitsubishi Pharma Research Foundation and the Daiwa Anglo-Japanese Foundation. I. T. is supported by MEXT's Distinctive University Education Support Program 'Good Practice'. Work in the Natsume laboratory is supported by the New Energy and Industrial Technology Development Organization (NEDO). S. P. holds a studentship from the Boehringer Ingelheim Fonds. D. D. is the Thomas Kierans Chair in Mechanisms of Cancer Development and a Canada Research Chair (Tier 2) in Proteomics, Bioinformatics and Functional genomics. Work in the Durocher and Gingras laboratories is supported by grants MOP10703115 (DD) and MOP84314 (ACG) from the Canadian Institutes of Health Research.	Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Beucher A, 2009, EMBO J, V28, P3413, DOI 10.1038/emboj.2009.276; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stewart GS, 2007, P NATL ACAD SCI USA, V104, P16910, DOI 10.1073/pnas.0708408104; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Tran H, 2008, GENE DEV, V22, P528, DOI 10.1101/gad.463208; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu JX, 2009, MOL CELL BIOL, V29, P849, DOI 10.1128/MCB.01302-08	38	262	273	4	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					941	U59		10.1038/nature09297	http://dx.doi.org/10.1038/nature09297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	640ED	20725033				2022-12-24	WOS:000281030300027
J	Snow, RW; Okiro, EA; Gething, PW; Atun, R; Hay, SI				Snow, Robert W.; Okiro, Emelda A.; Gething, Peter W.; Atun, Rifat; Hay, Simon I.			Equity and adequacy of international donor assistance for global malaria control:an analysis of populations at risk and external funding commitments	LANCET			English	Article							ELIMINATION		KEMRI Univ Oxford Wellcome Trust Collaborat, Ctr Geog Med, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya; Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, Oxford, England; Imperial Coll, Imperial Coll Business Sch, London, England; Global Fund To Fight AIDS TB & Malaria, Strategy Performance & Evaluat Cluster, Geneva, Switzerland	University of Oxford; Imperial College London	Snow, RW (corresponding author), KEMRI Univ Oxford Wellcome Trust Collaborat, Ctr Geog Med, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya.		Gething, Peter/ABD-2110-2020; Atun, Rifat/AAH-5537-2021; Gething, Peter/GQR-1884-2022; Hay, Simon Iain/F-8967-2015; Snow, Robert William/AFR-1436-2022	Gething, Peter/0000-0001-6759-5449; Hay, Simon Iain/0000-0002-0611-7272; Snow, Robert William/0000-0003-3725-6088; Atun, Rifat/0000-0002-1531-5983; Okiro, Emelda/0000-0001-9543-8360	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	Wellcome Trust	[Anonymous], GLOB MAL ACT PLAN MA; Baird JK, 2007, TRENDS PARASITOL, V23, P533, DOI 10.1016/j.pt.2007.08.011; BALK DL, ADV PARASIT, V62, P119; *BBC, 2010, DAV 2010 W ACC IND C; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; *DON ASS COMM OECD, DAC LIST ODA REC US; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Feachem RGA, 2009, SHRINKING MALARIA MA, P187; GUERRA CA, 2009, PLOS NEGLECT TROP D, V4, pE744; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; International Monetary Fund, DEBT REL HEAV IND PO; Kiszewski A, 2007, B WORLD HEALTH ORGAN, V85, P623, DOI 10.2471/BLT.06.039529; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Organization for Economic Cooperation and Development, CRED REP SYST; Presidents Malaria Initiative, 2009, PMI COUNTR PROF; *ROLL BACK MAL, MON EV REF GROUP; Snow RW, 2008, PLOS MED, V5, P1068, DOI 10.1371/journal.pmed.0050142; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Teklehaimanot HD, 2009, AM J TROP MED HYG, V80, P133, DOI 10.4269/ajtmh.2009.80.133; The Global Fund, 2022, BMJ, DOI DOI 10.1136/BMJ.O2320; The World Bank, WORLDW GOV IND; *UN POP DIV, 2003, HUM DEV REP 2003 MIL; United Nat ions Populat ion Division, 2008, WORLD URB PROSP 2007; *WHO, WORLD MAL REP 2009; World Bank, BOOST PROGR MAL CONT; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	27	43	43	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 23	2010	376	9750					1409	1416		10.1016/S0140-6736(10)61340-2	http://dx.doi.org/10.1016/S0140-6736(10)61340-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20889199	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000283627500039
J	Hawkes, N				Hawkes, Nigel			Climate Change Giving it 10%	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						VIDEO BRIGHTON HOVE	1	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2010	341								c5448	10.1136/bmj.c5448	http://dx.doi.org/10.1136/bmj.c5448			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926481				2022-12-24	WOS:000282879400004
J	Orom, UA; Derrien, T; Beringer, M; Gumireddy, K; Gardini, A; Bussotti, G; Lai, F; Zytnicki, M; Notredame, C; Huang, QH; Guigo, R; Shiekhattar, R				Orom, Ulf Andersson; Derrien, Thomas; Beringer, Malte; Gumireddy, Kiranmai; Gardini, Alessandro; Bussotti, Giovanni; Lai, Fan; Zytnicki, Matthias; Notredame, Cedric; Huang, Qihong; Guigo, Roderic; Shiekhattar, Ramin			Long Noncoding RNAs with Enhancer-like Function in Human Cells	CELL			English	Article							TRANSCRIPTION; GENE; REVEALS; IDENTIFICATION; MECHANISMS; EXPRESSION; POSITION; ELEMENT; GENOME; REGION	While the long noncoding RNAs (ncRNAs) constitute a large portion of the mammalian transcriptome, their biological functions has remained elusive. A few long ncRNAs that have been studied in any detail silence gene expression in processes such as X-inactivation and imprinting. We used a GENCODE annotation of the human genome to characterize over a thousand long ncRNAs that are expressed in multiple cell lines. Unexpectedly, we found an enhancer-like function for a set of these long ncRNAs in human cell lines. Depletion of a number of ncRNAs led to decreased expression of their neighboring protein-coding genes, including the master regulator of hematopoiesis, SCL (also called TAL1), Snai1 and Snai2. Using heterologous transcription assays we demonstrated a requirement for the ncRNAs in activation of gene expression. These results reveal an unanticipated role for a class of long ncRNAs in activation of critical regulators of development and differentiation.	[Orom, Ulf Andersson; Beringer, Malte; Gumireddy, Kiranmai; Gardini, Alessandro; Lai, Fan; Huang, Qihong; Shiekhattar, Ramin] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Derrien, Thomas; Bussotti, Giovanni; Zytnicki, Matthias; Notredame, Cedric; Guigo, Roderic; Shiekhattar, Ramin] UPF, Ctr Genom Regulat CRG, Barcelona, Spain; [Shiekhattar, Ramin] ICREA, Barcelona, Spain	The Wistar Institute; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Shiekhattar, R (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	shiekhattar@wistar.org	Guigo, Roderic/D-1303-2010; Lai, Fan/ABD-2862-2021; Jha, Rajneesh/L-5606-2017; Ørom, Ulf A/F-6727-2010; lai, fan/A-9732-2011; Orom, Ulf A/G-1327-2010; Derrien, Thomas/ABD-6197-2020; Beringer, Malte/N-3766-2015; Beringer, Malte/AAC-5734-2020; notredame, cedric/G-3868-2010; Bussotti, Giovanni/C-3082-2019	Guigo, Roderic/0000-0002-5738-4477; Beringer, Malte/0000-0003-1958-9786; Orom, Ulf/0000-0002-0643-0592; notredame, cedric/0000-0003-1461-0988; Lai, Fan/0000-0002-0568-2616; Bussotti, Giovanni/0000-0002-4078-7413; Derrien, Thomas/0000-0002-8211-5789	Danish Research Council; HFSPO; American Italian Cancer Foundation; Spanish ministry, GENCODE [U54 HG004555-01]; NIH [GM 079091]; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079091] Funding Source: NIH RePORTER	Danish Research Council(Det Frie Forskningsrad (DFF)); HFSPO(Human Frontier Science Program); American Italian Cancer Foundation; Spanish ministry, GENCODE(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to the HAVANA team for use of their genome annotation. We also thank the CRG Genomic Facility and the Functional Genomics Core Facility at Wistar and UPenn for expertise in microarray analysis. We thank Dr. Ken Zaret for helpful discussions. U.A.O. is supported by a grant from the Danish Research Council; M.B. is supported by an HFSPO fellowship; A.G. was supported by a fellowship from the American Italian Cancer Foundation; R.G. was supported through Spanish ministry, GENCODE U54 HG004555-01, and NIH; and R.S. was supported by a grant from NIH, GM 079091.	BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blanco Enrique, 2007, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0403s18; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Euskirchen GM, 2007, GENOME RES, V17, P898, DOI 10.1101/gr.5583007; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; IMPERIALE MJ, 1984, MOL CELL BIOL, V4, P875, DOI 10.1128/MCB.4.5.875; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KHALIL AM, 2009, P NATL ACAD SCI US; KHOURY G, 1983, CELL, V33, P313, DOI 10.1016/0092-8674(83)90410-5; KIM TK, 2010, NATURE; Kong SM, 1997, MOL CELL BIOL, V17, P3955, DOI 10.1128/MCB.17.7.3955; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lecuyer E, 2004, EXP HEMATOL, V32, P11, DOI 10.1016/j.exphem.2003.10.010; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lunter G, 2006, PLOS COMPUT BIOL, V2, P2, DOI 10.1371/journal.pcbi.0020005; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yang PK, 2007, CELL, V128, P777, DOI 10.1016/j.cell.2007.01.032	47	1396	1462	3	196	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2010	143	1					46	58		10.1016/j.cell.2010.09.001	http://dx.doi.org/10.1016/j.cell.2010.09.001			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887892	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-24	WOS:000282362000013
J	Torres, EM; Dephoure, N; Panneerselvam, A; Tucker, CM; Whittaker, CA; Gygi, SP; Dunham, MJ; Amon, A				Torres, Eduardo M.; Dephoure, Noah; Panneerselvam, Amudha; Tucker, Cheryl M.; Whittaker, Charles A.; Gygi, Steven P.; Dunham, Maitreya J.; Amon, Angelika			Identification of Aneuploidy-Tolerating Mutations	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL INSTABILITY; YEAST; DEGRADATION; PROTEASOME; CELLS; DEUBIQUITINATION; DEPLETION; CODE	Aneuploidy causes a proliferative disadvantage in all normal cells analyzed to date, yet this condition is associated with a disease characterized by unabated proliferative potential, cancer. The mechanisms that allow cancer cells to tolerate the adverse effects of aneuploidy are not known. To probe this question, we identified aneuploid yeast strains with improved proliferative abilities. Their molecular characterization revealed strain-specific genetic alterations as well as mutations shared between different aneuploid strains. Among the latter, a loss-of-function mutation in the gene encoding the deubiquitinating enzyme Ubp6 improves growth rates in four different aneuploid yeast strains by attenuating the changes in intracellular protein composition caused by aneuploidy. Our results demonstrate the existence of aneuploidy-tolerating mutations that improve the fitness of multiple different aneuploidies and highlight the importance of ubiquitin-proteasomal degradation in suppressing the adverse effects of aneuploidy.	[Torres, Eduardo M.; Panneerselvam, Amudha; Whittaker, Charles A.; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Torres, Eduardo M.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Dephoure, Noah; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Tucker, Cheryl M.] Princeton Univ, Lewis Sigler Inst, Princeton, NJ 08540 USA; [Dunham, Maitreya J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Princeton University; University of Washington; University of Washington Seattle	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Dephoure, Noah/N-7818-2014	Dephoure, Noah/0000-0001-5802-2657; Whittaker, Charles/0000-0002-2400-0094; Amon, Angelika/0000-0001-9837-0314; Dunham, Maitreya/0000-0001-9944-2666	National Institutes of Health [GM56800, P50 GM071508]; Charles King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, R29GM056800, R01GM056800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles King Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Daniel Finley, Philip Hieter, and Juergen Dohmen for reagents and to Daniel Finley, John Hanna, Frank Solomon, and members of the Amon lab for suggestions and their critical reading of this manuscript. This work was supported by National Institutes of Health grant GM56800 and a Charles King Trust postdoctoral Fellowship to ET. M.J.D. and C.M.T. were supported in part by National Institutes of Health grant P50 GM071508. A.A. is also an Investigator of the Howard Hughes Medical Institute.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Anders KR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-36; Ben-Aroya S, 2008, MOL CELL, V30, P248, DOI 10.1016/j.molcel.2008.02.021; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; DAVIES J, 1964, P NATL ACAD SCI USA, V51, P883, DOI 10.1073/pnas.51.5.883; DAVIES J, 1968, J BIOL CHEM, V243, P3312; Dettman JR, 2007, NATURE, V447, P585, DOI 10.1038/nature05856; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gresham D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000303; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; KATZ W, 1990, MOL CELL BIOL, V10, P5286, DOI 10.1128/MCB.10.10.5286; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Williams BR, 2009, CANCER RES, V69, P5289, DOI 10.1158/0008-5472.CAN-09-0944; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zeyl C, 2006, FEMS YEAST RES, V6, P685, DOI 10.1111/j.1567-1364.2006.00061.x	29	267	269	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2010	143	1					71	83		10.1016/j.cell.2010.08.038	http://dx.doi.org/10.1016/j.cell.2010.08.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20850176	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000282362000015
J	Choa, R; Sharp, R; Mahtani, KR				Choa, Robert; Sharp, Robert; Mahtani, Kamal R.			10-Minute Consultation Hallux valgus	BRITISH MEDICAL JOURNAL			English	Editorial Material							ORTHOSES		[Mahtani, Kamal R.] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; [Choa, Robert; Sharp, Robert] Nuffield Orthopaed Ctr, Dept Foot & Ankle Surg, Oxford OX3 7LD, England	University of Oxford; Nuffield Orthopaedic Centre	Mahtani, KR (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	kamal.mahtani@dphpc.ox.ac.uk			National Institute for Health Research [ACF-2008-13-014] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Coughlin MJ, 2007, FOOT ANKLE INT, V28, P759, DOI 10.3113/FAI.2007.0759; Coughlin MJ, 1996, J BONE JOINT SURG AM, V78A, P932, DOI 10.2106/00004623-199606000-00018; COUGHLIN MJ, 2006, SURG FOOT ANKLE, P230; Landsman A, 2009, J AM PODIAT MED ASSN, V99, P206, DOI 10.7547/0980206; Nguyen USDT, 2010, OSTEOARTHR CARTILAGE, V18, P41, DOI 10.1016/j.joca.2009.07.008; SIMFOOK L, 1958, J BONE JOINT SURG AM, V40, P1058, DOI 10.2106/00004623-195840050-00007; Torkki M, 2003, ACTA ORTHOP SCAND, V74, P209, DOI 10.1080/00016470310013987	7	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 27	2010	341								c5130	10.1136/bmj.c5130	http://dx.doi.org/10.1136/bmj.c5130			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	659LV	20876149				2022-12-24	WOS:000282568900002
J	Bilguvar, K; Ozturk, AK; Louvi, A; Kwan, KY; Choi, M; Tatli, B; Yalnizoglu, D; Tuysuz, B; Caglayan, AO; Gokben, S; Kaymakcalan, H; Barak, T; Bakircioglu, M; Yasuno, K; Ho, W; Sanders, S; Zhu, Y; Yilmaz, S; Dincer, A; Johnson, MH; Bronen, RA; Kocer, N; Per, H; Mane, S; Pamir, MN; Yalcinkaya, C; Kumandas, S; Topcu, M; Ozmen, M; Sestan, N; Lifton, RP; State, MW; Gunel, M				Bilguvar, Kaya; Ozturk, Ali Kemal; Louvi, Angeliki; Kwan, Kenneth Y.; Choi, Murim; Tatli, Burak; Yalnizoglu, Dilek; Tuysuz, Beyhan; Caglayan, Ahmet Okay; Gokben, Sarenur; Kaymakcalan, Hande; Barak, Tanyeri; Bakircioglu, Mehmet; Yasuno, Katsuhito; Ho, Winson; Sanders, Stephan; Zhu, Ying; Yilmaz, Sanem; Dincer, Alp; Johnson, Michele H.; Bronen, Richard A.; Kocer, Naci; Per, Hueseyin; Mane, Shrikant; Pamir, Mehmet Necmettin; Yalcinkaya, Cengiz; Kumandas, Sefer; Topcu, Meral; Ozmen, Meral; Sestan, Nenad; Lifton, Richard P.; State, Matthew W.; Gunel, Murat			Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations	NATURE			English	Article							HUMAN CEREBRAL-CORTEX; GENETIC MALFORMATIONS; CLASSIFICATION; SLITRK1; CAPTURE	The development of the human cerebral cortex is an orchestrated process involving the generation of neural progenitors in the periventricular germinal zones, cell proliferation characterized by symmetric and asymmetric mitoses, followed by migration of post-mitotic neurons to their final destinations in six highly ordered, functionally specialized layers(1,2). An understanding of the molecular mechanisms guiding these intricate processes is in its infancy, substantially driven by the discovery of rare mutations that cause malformations of cortical development(3-6). Mapping of disease loci in putative Mendelian forms of malformations of cortical development has been hindered by marked locus heterogeneity, small kindred sizes and diagnostic classifications that may not reflect molecular pathogenesis. Here we demonstrate the use of whole-exome sequencing to overcome these obstacles by identifying recessive mutations in WD repeat domain 62 (WDR62) as the cause of a wide spectrum of severe cerebral cortical malformations including microcephaly, pachygyria with cortical thickening as well as hypoplasia of the corpus callosum. Some patients with mutations in WDR62 had evidence of additional abnormalities including lissencephaly, schizencephaly, polymicrogyria and, in one instance, cerebellar hypoplasia, all traits traditionally regarded as distinct entities. In mice and humans, WDR62 transcripts and protein are enriched in neural progenitors within the ventricular and subventricular zones. Expression of WDR62 in the neocortex is transient, spanning the period of embryonic neurogenesis. Unlike other known microcephaly genes, WDR62 does not apparently associate with centrosomes and is predominantly nuclear in localization. These findings unify previously disparate aspects of cerebral cortical development and highlight the use of whole-exome sequencing to identify disease loci in settings in which traditional methods have proved challenging.	[Bilguvar, Kaya; Ozturk, Ali Kemal; Louvi, Angeliki; Choi, Murim; Barak, Tanyeri; Bakircioglu, Mehmet; Yasuno, Katsuhito; Ho, Winson; Sanders, Stephan; Mane, Shrikant; Lifton, Richard P.; State, Matthew W.; Gunel, Murat] Yale Univ, Sch Med, Dept Genet, Ctr Human Genet & Genom, New Haven, CT 06510 USA; [Bilguvar, Kaya; Ozturk, Ali Kemal; Louvi, Angeliki; Choi, Murim; Barak, Tanyeri; Bakircioglu, Mehmet; Yasuno, Katsuhito; Ho, Winson; Sanders, Stephan; Mane, Shrikant; Lifton, Richard P.; State, Matthew W.; Gunel, Murat] Yale Univ, Sch Med, Program Neurogenet, New Haven, CT 06510 USA; [Bilguvar, Kaya; Ozturk, Ali Kemal; Louvi, Angeliki; Barak, Tanyeri; Bakircioglu, Mehmet; Yasuno, Katsuhito; Ho, Winson; Johnson, Michele H.; Bronen, Richard A.; Gunel, Murat] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06510 USA; [Bilguvar, Kaya; Ozturk, Ali Kemal; Louvi, Angeliki; Kwan, Kenneth Y.; Barak, Tanyeri; Bakircioglu, Mehmet; Yasuno, Katsuhito; Ho, Winson; Zhu, Ying; Sestan, Nenad; Gunel, Murat] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Kwan, Kenneth Y.; Zhu, Ying; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Tatli, Burak; Ozmen, Meral] Istanbul Univ, Istanbul Fac Med, Dept Pediat, Div Neurol, TR-34093 Istanbul, Turkey; [Yalnizoglu, Dilek; Topcu, Meral] Hacettepe Univ, Sch Med, Dept Pediat, Div Neurol, TR-06100 Ankara, Turkey; [Tuysuz, Beyhan] Istanbul Univ, Cerrahpasa Fac Med, Dept Pediat, Div Genet, TR-34098 Istanbul, Turkey; [Caglayan, Ahmet Okay] Kayseri Educ & Res Hosp, Dept Med Genet, TR-38010 Kayseri, Turkey; [Gokben, Sarenur; Yilmaz, Sanem] Ege Univ, Fac Med, Dept Pediat, Div Neurol, TR-35100 Izmir, Turkey; [Kaymakcalan, Hande] Bahcesehir Univ, Fac Arts & Sci, TR-34353 Istanbul, Turkey; [Sanders, Stephan; State, Matthew W.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; [Sanders, Stephan; State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Dincer, Alp] Acibadem Univ, Sch Med, Dept Radiol, TR-34742 Istanbul, Turkey; [Johnson, Michele H.; Bronen, Richard A.] Yale Univ, Sch Med, Dept Radiol, New Haven, CT 06510 USA; [Johnson, Michele H.] Yale Univ, Sch Med, Dept Otolaryngol, New Haven, CT 06510 USA; [Kocer, Naci] Istanbul Univ, Cerrahpasa Fac Med, Dept Radiol, TR-34098 Istanbul, Turkey; [Per, Hueseyin; Kumandas, Sefer] Erciyes Univ, Sch Med, Dept Pediat, Div Neurol, TR-38039 Kayseri, Turkey; [Mane, Shrikant] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT 06510 USA; [Pamir, Mehmet Necmettin] Acibadem Univ, Sch Med, Dept Neurosurg, TR-34742 Istanbul, Turkey; [Yalcinkaya, Cengiz] Istanbul Univ, Cerrahpasa Fac Med, Dept Neurol, Div Child Neurol, TR-34098 Istanbul, Turkey; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Istanbul University; Hacettepe University; Istanbul University; Istanbul University - Cerrahpasa; Kayseri Training & Research Hospital; Ege University; Bahcesehir University; Yale University; Yale University; Acibadem University; Yale University; Yale University; Istanbul University; Istanbul University - Cerrahpasa; Erciyes University; Yale University; Acibadem University; Istanbul University; Istanbul University - Cerrahpasa; Howard Hughes Medical Institute; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Genet, Ctr Human Genet & Genom, New Haven, CT 06510 USA.	richard.lifton@yale.edu; matthew.state@yale.edu; murat.gunel@yale.edu	Kaymakcalan, Hande/AAO-4208-2021; Kaymakcalan, Hande/AFP-2191-2022; Tüysüz, Beyhan/AAN-4858-2020; Kwan, Kenneth Y/F-8489-2011; Kocer, Naci/AAH-7923-2021; State, Matthew/W-2256-2019; Kwan, Kenneth/AAI-2841-2021; Yasuno, Katsuhito/E-1960-2012; Dincer, Alp/D-3658-2015; Choi, Murim/AAP-9120-2021; Yalcinkaya, Cengiz/B-6288-2012; Caglayan, Ahmet O/D-1066-2012; Sanders, Stephan/S-8645-2019; Zhu, Ying/T-2268-2019	Kaymakcalan, Hande/0000-0001-7736-7634; Kwan, Kenneth Y/0000-0003-4711-071X; Kocer, Naci/0000-0003-0884-6492; Kwan, Kenneth/0000-0003-4711-071X; Yasuno, Katsuhito/0000-0002-3606-532X; Dincer, Alp/0000-0001-9158-8353; Yalcinkaya, Cengiz/0000-0002-3443-8524; Caglayan, Ahmet O/0000-0002-2332-322X; State, Matthew/0000-0003-1624-8302; Sanders, Stephan/0000-0001-9112-5148; Barak, Tanyeri/0000-0002-8522-1552; Zhu, Ying/0000-0002-6594-3734; Pamir, M Necmettin/0000-0002-5958-8625; Tuysuz, Beyhan/0000-0002-9620-5021	Yale Program on Neurogenetics; Yale Center for Human Genetics and Genomics; National Institutes of Health [RC2 NS070477, UL1 RR024139NIH, UO1MH081896]; National Institutes of Health Neuroscience Microarray Consortium [U24 NS051869-02S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH081896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS051869, RC2NS070477] Funding Source: NIH RePORTER	Yale Program on Neurogenetics; Yale Center for Human Genetics and Genomics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Neuroscience Microarray Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are indebted to the patients and families who have contributed to this study. We thank J. Noonan for expert advice and C. Camputaro for her help with three-dimensional reconstruction of the magnetic resonance images. This study was supported by the Yale Program on Neurogenetics, the Yale Center for Human Genetics and Genomics, and National Institutes of Health grants RC2 NS070477 (to M.G.), UL1 RR024139NIH (Yale Clinical and Translational Science Award) and UO1MH081896 (to N.S.). SNP genotyping was supported in part by a National Institutes of Health Neuroscience Microarray Consortium award U24 NS051869-02S1 (to S.M.). R.P.L. is an investigator of the Howard Hughes Medical Institute.	Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Barkovich AJ, 2001, NEUROLOGY, V57, P2168, DOI 10.1212/WNL.57.12.2168; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Guerrini R, 2005, EPILEPSIA, V46, P32, DOI 10.1111/j.0013-9580.2005.461010.x; Guerrini R, 2001, AM J MED GENET, V106, P160, DOI 10.1002/ajmg.1569; Guerrini R, 2008, TRENDS NEUROSCI, V31, P154, DOI 10.1016/j.tins.2007.12.004; Hartl D, 2008, PROTEOMICS, V8, P1257, DOI 10.1002/pmic.200700724; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Roberts E, 1999, EUR J HUM GENET, V7, P815, DOI 10.1038/sj.ejhg.5200385; Stillman AA, 2009, J COMP NEUROL, V513, P21, DOI 10.1002/cne.21919; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Wasserman T, 2010, MOL BIOL CELL, V21, P117, DOI 10.1091/mbc.E09-06-0512	25	354	378	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2010	467	7312					207	U93		10.1038/nature09327	http://dx.doi.org/10.1038/nature09327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20729831	Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000281616300034
J	Alvarado, D; Klein, DE; Lemmon, MA				Alvarado, Diego; Klein, Daryl E.; Lemmon, Mark A.			Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor	CELL			English	Article							AFFINITY INSULIN-BINDING; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; LIGAND-BINDING; ALLOSTERIC REGULATION; ACTIVATION; DIMERIZATION; REGION; MODEL; OLIGOMERIZATION	Transmembrane signaling by the epidermal growth factor receptor (EGFR) involves ligand-induced dimerization and allosteric regulation of the intracellular tyrosine kinase domain. Crystallographic studies have shown how ligand binding induces dimerization of the EGFR extracellular region but cannot explain the "high-affinity" and "low-affinity" classes of cell-surface EGF-binding sites inferred from curved Scatchard plots. From a series of crystal structures of the Drosophila EGFR extracellular region, we show here how Scatchard plot curvature arises from negatively cooperative ligand binding. The first ligand-binding event induces formation of an asymmetric dimer with only one bound ligand. The unoccupied site in this dimer is structurally restrained, leading to reduced affinity for binding of the second ligand, and thus negative cooperativity. Our results explain the cell-surface binding characteristics of EGF receptors and suggest how individual EGFR ligands might stabilize distinct dimeric species with different signaling properties.	[Alvarado, Diego; Klein, Daryl E.; Lemmon, Mark A.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu	Garzon-Alvarado, Diego/AAD-6607-2019	Lemmon, Mark/0000-0002-3379-5319; Klein, Daryl/0000-0002-7188-0450	NCRR [RR-01646]; NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; U.S. Department of Energy; NIH [R01-CA125432, R01-CA079992, T32HD007516]; U.S. Army Breast Cancer Research Program; Damon Runyon Cancer Research Foundation [DRG-1884-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA125432, R01CA079992] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Breast Cancer Research Program(United States Department of Defense); Damon Runyon Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Kate Ferguson, Jim Shorter, Jason Davis, Greg Van Duyne, Ben Black, Steve Stayrook, and members of the Lemmon and Ferguson laboratories for valuable comments. Crystallographic data were collected at Cornell High Energy Synchrotron Source (CHESS) beamline F1, supported by the NSF and NIH/NIGMS under NSF award DMR-0225180, using the Macromolecular Diffraction at CHESS (MacCHESS) facility supported by the NCRR (RR-01646). Additional data were collected at the GM/CA Collaborative Access Team at the Advanced Photon Source (APS), funded by the NCI (Y1-CO-1020), NIGMS (Y1-GM-1104), and the U.S. Department of Energy (contract W-31-109-ENG-38). This work was funded by NIH grants R01-CA125432 and R01-CA079992 (M.A.L.) and predoctoral fellowship W81XWH-04-1-0328 from the U.S. Army Breast Cancer Research Program (D.E.K.). D.A. was supported by NIH postdoctoral training grant T32HD007516 and a postdoctoral fellowship from the Damon Runyon Cancer Research Foundation (DRG-1884-05).	Adams TE, 2009, GROWTH FACTORS, V27, P141, DOI 10.1080/08977190902843565; Alvarado D, 2009, NATURE, V461, P287, DOI 10.1038/nature08297; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bass J, 1996, J BIOL CHEM, V271, P19367, DOI 10.1074/jbc.271.32.19367; BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; Hoyne PA, 2000, FEBS LETT, V479, P15, DOI 10.1016/S0014-5793(00)01872-X; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Klein P, 2004, P NATL ACAD SCI USA, V101, P929, DOI 10.1073/pnas.0307285101; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; LAX I, 1991, J BIOL CHEM, V266, P13828; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; LEVITZKI A, 1971, BIOCHEMISTRY-US, V10, P3371, DOI 10.1021/bi00794a009; LIVNEH E, 1986, J BIOL CHEM, V261, P2490; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; MAGUN BE, 1980, J BIOL CHEM, V255, P6373; Odaka M, 1997, J BIOCHEM-TOKYO, V122, P116; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; Schnepp B, 1998, GENE DEV, V12, P908, DOI 10.1101/gad.12.7.908; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WOFSY C, 1992, BIOPHYS J, V63, P98, DOI 10.1016/S0006-3495(92)81572-2; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035	48	132	134	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					568	579		10.1016/j.cell.2010.07.015	http://dx.doi.org/10.1016/j.cell.2010.07.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723758	Green Accepted, Bronze			2022-12-24	WOS:000281115900011
J	Pedchenko, V; Bondar, O; Fogo, AB; Vanacore, R; Voziyan, P; Kitching, AR; Wieslander, J; Kashtan, C; Borza, DB; Neilson, EG; Wilson, CB; Hudson, BG				Pedchenko, Vadim; Bondar, Olga; Fogo, Agnes B.; Vanacore, Roberto; Voziyan, Paul; Kitching, A. Richard; Wieslander, Joergen; Kashtan, Clifford; Borza, Dorin-Bogdan; Neilson, Eric G.; Wilson, Curtis B.; Hudson, Billy G.			Molecular Architecture of the Goodpasture Autoantigen in Anti-GBM Nephritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BASEMENT-MEMBRANE ANTIBODY; IV COLLAGEN; ALPHA-3 CHAIN; GRAVES-DISEASE; RENAL-TRANSPLANTATION; NONCOLLAGENOUS DOMAIN; CRYPTIC EPITOPES; IMMUNE PRIVILEGE; ALPORT-SYNDROME; NC1 DOMAIN	BACKGROUND In Goodpasture's disease, circulating autoantibodies bind to the noncollagenous-1 (NC1) domain of type IV collagen in the glomerular basement membrane (GBM). The specificity and molecular architecture of epitopes of tissue-bound autoantibodies are unknown. Alport's post-transplantation nephritis, which is mediated by allo-antibodies against the GBM, occurs after kidney transplantation in some patients with Alport's syndrome. We compared the conformations of the antibody epitopes in Goodpasture's disease and Alport's post-transplantation nephritis with the intention of finding clues to the pathogenesis of anti-GBM glomerulonephritis. METHODS We used an enzyme-linked immunosorbent assay to determine the specificity of circulating autoantibodies and kidney-bound antibodies to NC1 domains. Circulating antibodies were analyzed in 57 patients with Goodpasture's disease, and kidney-bound antibodies were analyzed in 14 patients with Goodpasture's disease and 2 patients with Alport's post-transplantation nephritis. The molecular architecture of key epitope regions was deduced with the use of chimeric molecules and a three-dimensional model of the alpha 345NC1 hexamer. RESULTS In patients with Goodpasture's disease, both autoantibodies to the alpha 3NC1 monomer and antibodies to the alpha 5NC1 monomer (and fewer to the alpha 4NC1 monomer) were bound in the kidneys and lungs, indicating roles for the alpha 3NC1 and alpha 5NC1 monomers as autoantigens. High antibody titers at diagnosis of anti-GBM disease were associated with ultimate loss of renal function. The antibodies bound to distinct epitopes encompassing region Ea in the alpha 5NC1 monomer and regions E-A and Eb in the alpha 3NC1 monomer, but they did not bind to the native cross-linked alpha 345NC1 hexamer. In contrast, in patients with Alport's post-transplantation nephritis, allo-antibodies bound to the E-A region of the alpha 5NC1 subunit in the intact hexamer, and binding decreased on dissociation. CONCLUSIONS The development of Goodpasture's disease may be considered an autoimmune "conformeropathy" that involves perturbation of the quaternary structure of the alpha 345NC1 hexamer, inducing a pathogenic conformational change in the alpha 3NC1 and alpha 5NC1 subunits, which in turn elicits an autoimmune response.	[Pedchenko, Vadim; Bondar, Olga; Fogo, Agnes B.; Vanacore, Roberto; Voziyan, Paul; Borza, Dorin-Bogdan; Neilson, Eric G.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Div Nephrol, Ctr Matrix Biol,Dept Med, Nashville, TN 37232 USA; [Fogo, Agnes B.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Fogo, Agnes B.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Kitching, A. Richard] Monash Univ, Ctr Inflammatory Dis, Dept Med, Clayton, Vic, Australia; [Wieslander, Joergen] Univ Lund Hosp, Dept Nephrol, S-22185 Lund, Sweden; [Kashtan, Clifford] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Wilson, Curtis B.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Monash University; Lund University; Skane University Hospital; University of Minnesota System; University of Minnesota Twin Cities; Scripps Research Institute	Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Div Nephrol, Ctr Matrix Biol,Dept Med, S 3223 MCN,1161 21st Ave S, Nashville, TN 37232 USA.	billy.hudson@vanderbilt.edu	Vanacore, Roberto/AAD-6399-2020; Kitching, A Richard/B-6947-2013; Borza, Dorin-Bogdan/AAF-2156-2020; Vanacore, Roberto/C-9763-2012	Vanacore, Roberto/0000-0002-2886-0606; Kitching, A Richard/0000-0002-2713-2391; Borza, Dorin-Bogdan/0000-0003-4568-279X; Vanacore, Roberto/0000-0002-2886-0606; Hudson, Billy/0000-0002-5420-4100	National Institute of Diabetes and Digestive and Kidney Diseases [DK18381-37]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080799, R37DK018381, R01DK018381] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a grant (DK18381-37) from the National Institute of Diabetes and Digestive and Kidney Diseases (to Dr. Hudson). Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Abbate M, 1998, KIDNEY INT, V54, P1550, DOI 10.1046/j.1523-1755.1998.00153.x; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Bondar O, 2002, J AM SOC NEPHROL, V13, p173A; Borza DB, 2000, J BIOL CHEM, V275, P6030, DOI 10.1074/jbc.275.8.6030; Borza DB, 2005, J BIOL CHEM, V280, P27147, DOI 10.1074/jbc.M504050200; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; Calvete JJ, 2006, PROTEOMICS, V6, pS237, DOI 10.1002/pmic.200500495; Chazenbalk GD, 2002, J CLIN INVEST, V110, P209, DOI 10.1172/JCI200215745; Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069; Clyne S, 2009, AM J KIDNEY DIS, V54, P1116, DOI 10.1053/j.ajkd.2009.04.026; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; GUNWAR S, 1991, J BIOL CHEM, V266, P14088; HELLMARK T, 1994, KIDNEY INT, V46, P823, DOI 10.1038/ki.1994.338; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; HUDSON BG, 1992, KIDNEY INT, V42, P179, DOI 10.1038/ki.1992.276; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kalluri R, 1996, J BIOL CHEM, V271, P9062, DOI 10.1074/jbc.271.15.9062; Kalluri R, 1996, P ASSOC AM PHYSICIAN, V108, P134; KALLURI R, 1994, P NATL ACAD SCI USA, V91, P6201, DOI 10.1073/pnas.91.13.6201; KALLURI R, 1995, J AM SOC NEPHROL, V6, P1178; Kang JS, 2007, J BIOL CHEM, V282, P10670, DOI 10.1074/jbc.M611892200; Kasahara H, 2005, INT IMMUNOL, V17, P1533, DOI 10.1093/intimm/dxh330; Kashtan CE, 2006, PEDIATR TRANSPLANT, V10, P651, DOI 10.1111/j.1399-3046.2006.00528.x; Khoshnoodi J, 2006, J BIOL CHEM, V281, P6058, DOI 10.1074/jbc.M506555200; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; MARQUARDT H, 1973, KIDNEY INT, V3, P57, DOI 10.1038/ki.1973.12; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; Sado Y, 1998, KIDNEY INT, V54, P311; Sado Y, 1998, KIDNEY INT, V53, P664, DOI 10.1046/j.1523-1755.1998.00795.x; Salama AD, 2001, LANCET, V358, P917, DOI 10.1016/S0140-6736(01)06077-9; SAUS J, 1988, J BIOL CHEM, V263, P13374; SAXENA R, 1989, CLIN EXP IMMUNOL, V78, P31; Schott M, 2005, TRENDS ENDOCRIN MET, V16, P243, DOI 10.1016/j.tem.2005.05.009; Segelmark M, 2003, NEPHRON CLIN PRACT, V94, pC59, DOI 10.1159/000072022; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Vanacore RM, 2008, J BIOL CHEM, V283, P22737, DOI 10.1074/jbc.M803451200; WIESLANDER J, 1985, J BIOL CHEM, V260, P8564; WILSON CB, 1973, KIDNEY INT, V3, P74, DOI 10.1038/ki.1973.14; Zhao J, 2009, KIDNEY INT, V76, P1108, DOI 10.1038/ki.2009.348	40	214	225	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					343	354		10.1056/NEJMoa0910500	http://dx.doi.org/10.1056/NEJMoa0910500			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628RU	20660402	Green Accepted			2022-12-24	WOS:000280139300007
J	Zhou, AW; Carrell, RW; Murphy, MP; Wei, ZQ; Yan, YH; Stanley, PLD; Stein, PE; Pipkin, FB; Read, RJ				Zhou, Aiwu; Carrell, Robin W.; Murphy, Michael P.; Wei, Zhenquan; Yan, Yahui; Stanley, Peter L. D.; Stein, Penelope E.; Pipkin, Fiona Broughton; Read, Randy J.			A redox switch in angiotensinogen modulates angiotensin release	NATURE			English	Article							OXIDATIVE STRESS; NITRIC-OXIDE; RENIN; HYPERTENSION; PREECLAMPSIA; SYSTEM; KIDNEY; MODEL	Blood pressure is critically controlled by angiotensins(1), which are vasopressor peptides specifically released by the enzyme renin from the tail of angiotensinogen-a non-inhibitory member of the serpin family of protease inhibitors(2,3). Although angiotensinogen has long been regarded as a passive substrate, the crystal structures solved here to 2.1 angstrom resolution show that the angiotensin cleavage site is inaccessibly buried in its amino-terminal tail. The conformational rearrangement that makes this site accessible for proteolysis is revealed in our 4.4 angstrom structure of the complex of human angiotensinogen with renin. The co-ordinated changes involved are seen to be critically linked by a conserved but labile disulphide bridge. Here we show that the reduced unbridged form of angiotensinogen is present in the circulation in a near 40:60 ratio with the oxidized sulphydryl-bridged form, which preferentially interacts with receptor-bound renin. We propose that this redox-responsive transition of angiotensinogen to a form that will more effectively release angiotensin at a cellular level contributes to the modulation of blood pressure. Specifically, we demonstrate the oxidative switch of angiotensinogen to its more active sulphydryl-bridged form in the maternal circulation in pre-eclampsia-the hypertensive crisis of pregnancy that threatens the health and survival of both mother and child.	[Carrell, Robin W.; Stein, Penelope E.] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge CB2 0XY, England; [Zhou, Aiwu; Wei, Zhenquan; Yan, Yahui; Stanley, Peter L. D.; Read, Randy J.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Pipkin, Fiona Broughton] Univ Nottingham, City Hosp, Dept Obstet & Gynaecol, Nottingham NG5 1PB, England	University of Cambridge; University of Cambridge; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Carrell, RW (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Med, Hills Rd, Cambridge CB2 0XY, England.	awz20@cam.ac.uk; rwc1000@cam.ac.uk	Murphy, Michael P/C-2120-2009; Read, Randy J/L-1418-2013	Murphy, Michael P/0000-0003-1115-9618; Read, Randy J/0000-0001-8273-0047; ZHOU, Aiwu/0000-0002-2555-5091	British Heart Foundation; Wellcome Trust; Isaac Newton Trust of the University of Cambridge; UK Medical Research Council with Daresbury SRS; UK Medical Research Council; Diamond Light Source; MRC [MC_U105663142] Funding Source: UKRI; British Heart Foundation [PG/09/072/27945] Funding Source: researchfish; Medical Research Council [MC_U105663142] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Isaac Newton Trust of the University of Cambridge; UK Medical Research Council with Daresbury SRS(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diamond Light Source; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the British Heart Foundation, the Wellcome Trust, the Isaac Newton Trust of the University of Cambridge and the UK Medical Research Council, with the support of the Daresbury SRS and Diamond Light Source. We acknowledge the assistance of G. Bunkoczi in data processing, H. Hong for the HPLC measurements of angiotensin, and T. Prime for analysing S-nitrosothiols.	Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; DEALWIS CG, 1994, J MOL BIOL, V236, P342, DOI 10.1006/jmbi.1994.1139; Dickson ME, 2006, HYPERTENSION, V48, P14, DOI 10.1161/01.HYP.0000227932.13687.60; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; Gimenez-Roqueplo AP, 1998, J BIOL CHEM, V273, P34480, DOI 10.1074/jbc.273.51.34480; Harrison DG, 2009, MED CLIN N AM, V93, P621, DOI 10.1016/j.mcna.2009.02.015; Hoffmann DS, 2008, HYPERTENSION, V51, P1058, DOI 10.1161/HYPERTENSIONAHA.107.107219; Hubel CA, 1999, P SOC EXP BIOL MED, V222, P222, DOI 10.1046/j.1525-1373.1999.d01-139.x; HUBER R, 1989, BIOCHEMISTRY-US, V28, P8951, DOI 10.1021/bi00449a001; INOUE I, 1995, J BIOL CHEM, V270, P11430, DOI 10.1074/jbc.270.19.11430; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; Kilicdag EB, 2005, HYPERTENS PREGNANCY, V24, P147, DOI 10.1081/PRG-200059863; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mistry HD, 2008, HYPERTENSION, V52, P881, DOI 10.1161/HYPERTENSIONAHA.108.116103; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Nasir UM, 1998, BIOSCI BIOTECH BIOCH, V62, P338, DOI 10.1271/bbb.62.338; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Powell NA, 2005, BIOORG MED CHEM LETT, V15, P4713, DOI 10.1016/j.bmcl.2005.07.063; Sedeek M, 2008, AM J HYPERTENS, V21, P1152, DOI 10.1038/ajh.2008.239; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STEIN PE, 1989, BIOCHEM J, V262, P103, DOI 10.1042/bj2620103; Streatfeild-James RMA, 1998, FEBS LETT, V436, P267, DOI 10.1016/S0014-5793(98)01145-4; Wilcox CS, 2005, AM J PHYSIOL-REG I, V289, pR913, DOI 10.1152/ajpregu.00250.2005	30	161	170	1	38	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 4	2010	468	7320					108	111		10.1038/nature09505	http://dx.doi.org/10.1038/nature09505			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	674YF	20927107	Green Accepted, Green Submitted			2022-12-24	WOS:000283786900045
J	Janssen, BJC; Robinson, RA; Perez-Branguli, F; Bell, CH; Mitchell, KJ; Siebold, C; Jones, EY				Janssen, Bert J. C.; Robinson, Ross A.; Perez-Branguli, Francesc; Bell, Christian H.; Mitchell, Kevin J.; Siebold, Christian; Jones, E. Yvonne			Structural basis of semaphorin-plexin signalling	NATURE			English	Article							CRYSTAL-STRUCTURE; RECEPTOR; BINDING; MODEL; TRANSMEMBRANE; FAMILY; LIGAND; MET; GLYCOSYLATION; DIMERIZATION	Cell-cell signalling of semaphorin ligands through interaction with plexin receptors is important for the homeostasis and morphogenesis of many tissues and is widely studied for its role in neural connectivity, cancer, cell migration and immune responses(1). SEMA4D and Sema6A exemplify two diverse vertebrate, membrane-spanning semaphorin classes (4 and 6) that are capable of direct signalling through members of the two largest plexin classes, B and A, respectively(2,3). In the absence of any structural information on the plexin ectodomain or its interaction with semaphorins the extracellular specificity and mechanism controlling plexin signalling has remained unresolved. Here we present crystal structures of cognate complexes of the semaphorin-binding regions of plexins B1 and A2 with semaphorin ectodomains (human PLXNB1(1-2)-SEMA4D(ecto) and murine PlxnA2(1-4)-Sema6A(ecto)), plus unliganded structures of PlxnA2(1-4) and Sema6A(ecto). These structures, together with biophysical and cellular assays of wild-type and mutant proteins, reveal that semaphorin dimers independently bind two plexin molecules and that signalling is critically dependent on the avidity of the resulting bivalent 2: 2 complex (monomeric semaphorin binds plexin but fails to trigger signalling). In combination, our data favour a cell-cell signalling mechanism involving semaphorin-stabilized plexin dimerization, possibly followed by clustering, which is consistent with previous functional data. Furthermore, the shared generic architecture of the complexes, formed through conserved contacts of the amino-terminal seven-bladed beta-propeller (sema) domains of both semaphorin and plexin, suggests that a common mode of interaction triggers all semaphorin-plexin based signalling, while distinct insertions within or between blades of the sema domains determine binding specificity.	[Janssen, Bert J. C.; Robinson, Ross A.; Bell, Christian H.; Siebold, Christian; Jones, E. Yvonne] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England; [Perez-Branguli, Francesc; Mitchell, Kevin J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Perez-Branguli, Francesc; Mitchell, Kevin J.] Trinity Coll Dublin, Inst Neurosci, Dublin 2, Ireland	University of Oxford; Wellcome Centre for Human Genetics; Trinity College Dublin; Trinity College Dublin	Jones, EY (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England.	yvonne@strubi.ox.ac.uk	Janssen, Bert/I-3338-2016; Jones, Yvonne/N-8111-2019; Jones, Yvonne/J-2293-2016	Janssen, Bert/0000-0002-8101-8370; Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Robinson, Ross/0000-0002-1482-0910; Mitchell, Kevin/0000-0002-3433-4530; Siebold, Christian/0000-0002-6635-3621	Human Frontier Science Program; Science Foundation Ireland; Wellcome Trust; Cancer Research UK; MRC [G0700232, G9900061, G0900084] Funding Source: UKRI; Cancer Research UK [10976] Funding Source: researchfish; Medical Research Council [G9900061, G0700232, G0900084] Funding Source: researchfish	Human Frontier Science Program(Human Frontier Science Program); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the staff of European Synchrotron Radiation Facility beamline ID 23-1 and Diamond beamline IO3 for assistance with data collection, the Molecular Cytogenetics and Microscopy Core facility of the Wellcome Trust Centre for Human Genetics, T. S. Walter for help with crystallization, G. Sutton for help with MALS experiments, A. F. Sonnen for help with AUC experiments, W. Lu for help with tissue culture, J. M. Grimes for assistance with figures and A. R. Aricescu and D. I. Stuart for critical reading of the manuscript. This work was funded by Cancer Research UK and the UK Medical Research Council. B. J. C. J. is funded by the Human Frontier Science Program, K. J. M. by a Science Foundation Ireland grant, C. H. B. and C. S. by the Wellcome Trust and E.Y.J. by Cancer Research UK.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gherardi E, 2006, P NATL ACAD SCI USA, V103, P4046, DOI 10.1073/pnas.0509040103; Gherardi E, 2004, CURR OPIN STRUC BIOL, V14, P669, DOI 10.1016/j.sbi.2004.10.010; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Klostermann A, 1998, J BIOL CHEM, V273, P7326, DOI 10.1074/jbc.273.13.7326; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Koppel AM, 1998, J BIOL CHEM, V273, P15708, DOI 10.1074/jbc.273.25.15708; Korostylev A, 2008, DEVELOPMENT, V135, P3333, DOI 10.1242/dev.019760; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie A.G.W., 1992, JOINT CCP4 ESF EMACB; Liu HL, 2010, CELL, V142, P749, DOI 10.1016/j.cell.2010.07.040; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Mayo CJ, 2005, STRUCTURE, V13, P175, DOI 10.1016/j.str.2004.12.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merte J, 2010, J NEUROSCI, V30, P5767, DOI 10.1523/JNEUROSCI.5061-09.2010; Muller KM, 1998, ANAL BIOCHEM, V261, P149, DOI 10.1006/abio.1998.2725; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Turner LJ, 2006, METHOD ENZYMOL, V406, P665, DOI 10.1016/S0076-6879(06)06052-6; Walter TS, 2005, ACTA CRYSTALLOGR D, V61, P651, DOI 10.1107/S0907444905007808; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8	54	160	183	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 28	2010	467	7319					1118	U132		10.1038/nature09468	http://dx.doi.org/10.1038/nature09468			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	671XW	20877282	Green Accepted			2022-12-24	WOS:000283548600050
J	Quanstrum, KH; Hayward, RA				Quanstrum, Kerianne H.; Hayward, Rodney A.			Lessons from the Mammography Wars	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BREAST-CANCER; PREVENTION		[Quanstrum, Kerianne H.; Hayward, Rodney A.] Univ Michigan, Robert Wood Johnson Fdn, Clin Scholars Program, Ann Arbor, MI 48109 USA; [Quanstrum, Kerianne H.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] VA Ann Arbor Healthcare Syst, VA Hlth Serv Res & Dev Ctr Excellence, Dept Vet Affairs VA, Ann Arbor, MI USA	Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Quanstrum, KH (corresponding author), Univ Michigan, Robert Wood Johnson Fdn, Clin Scholars Program, Ann Arbor, MI 48109 USA.							Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; BRYNER J, NEW MAMMOGRAM GUIDEL; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Hayward RA, 2005, HEALTH AFFAIR, V24, P1571, DOI 10.1377/hlthaff.24.6.1571; Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004; Lee CH, 2010, J AM COLL RADIOL, V7, P18, DOI 10.1016/j.jacr.2009.09.022; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; SMITH A, 1911, WEALTH NATIONS 1, P207; Vickers AJ, 2010, SEMIN ONCOL, V37, P31, DOI 10.1053/j.seminoncol.2009.12.004; WALKER EP, USPSTF MEMBERS DEFEN; Zulman DM, 2008, MILBANK Q, V86, P557, DOI 10.1111/j.1468-0009.2008.00534.x	11	89	89	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					1076	1079		10.1056/NEJMsb1002538	http://dx.doi.org/10.1056/NEJMsb1002538			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	647HS	20825322				2022-12-24	WOS:000281609700014
J	Zenilman, A				Zenilman, Ariela			The Hands That Guide Me	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												azenilm1@binghamton.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2010	304	10					1049	1049		10.1001/jama.2010.1291	http://dx.doi.org/10.1001/jama.2010.1291			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646RM	20823426				2022-12-24	WOS:000281559800001
J	Liu, HR; Jin, L; Koh, SBS; Atanasov, I; Schein, S; Wu, L; Zhou, ZH				Liu, Hongrong; Jin, Lei; Koh, Sok Boon S.; Atanasov, Ivo; Schein, Stan; Wu, Lily; Zhou, Z. Hong			Atomic Structure of Human Adenovirus by Cryo-EM Reveals Interactions Among Protein Networks	SCIENCE			English	Article							CRYOELECTRON MICROSCOPY STRUCTURE; RESOLUTION; HEXON; VECTORS; TYPE-2; DNA; IX; BACTERIOPHAGE-PRD1; VISUALIZATION; ORGANIZATION	Construction of a complex virus may involve a hierarchy of assembly elements. Here, we report the structure of the whole human adenovirus virion at 3.6 angstroms resolution by cryo-electron microscopy (cryo-EM), revealing in situ atomic models of three minor capsid proteins (IIIa, VIII, and IX), extensions of the (penton base and hexon) major capsid proteins, and interactions within three protein-protein networks. One network is mediated by protein IIIa at the vertices, within group-of-six (GOS) tiles-a penton base and its five surrounding hexons. Another is mediated by ropes (protein IX) that lash hexons together to form group-of-nine (GON) tiles and bind GONs to GONs. The third, mediated by IIIa and VIII, binds each GOS to five surrounding GONs. Optimization of adenovirus for cancer and gene therapy could target these networks.	[Liu, Hongrong; Jin, Lei; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Liu, Hongrong; Jin, Lei; Atanasov, Ivo; Schein, Stan; Wu, Lily; Zhou, Z. Hong] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA; [Liu, Hongrong] Xiangtan Univ, Inst Modern Phys, Xiangtan 411105, Hunan, Peoples R China; [Koh, Sok Boon S.; Wu, Lily] Univ Calif Los Angeles, Sch Med, Inst Mol Med IMED, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Schein, Stan] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Schein, Stan] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Xiangtan University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA.	Hong.Zhou@ucla.edu	Zhou, Z Hong/HDN-0747-2022; Schein, Stan/G-4942-2018		National Institutes of Health [GM071940, AI069015, CA101904, 1S10RR23057]; National Natural Scientific Foundation of China [10874144]; Congressionally Directed Medical Research Programs [W81XWH-06-1-055]; NATIONAL CANCER INSTITUTE [R01CA101904] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Congressionally Directed Medical Research Programs(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Berk for advice; W. H. Hui for imaging, C.-O. Yun and O.-J. Kwon for providing the Ad-Delta E1B19/55 virus sample, and X. Zhang and P. Ge for discussion. This project is supported in part by grants from the National Institutes of Health (GM071940 and AI069015 to Z.H.Z.) and (CA101904 to L.W.). We acknowledge use of facilities at the Electron Imaging Center for NanoMachines supported in part by NIH (1S10RR23057). H.L. thanks the National Natural Scientific Foundation of China for support (10874144). S.B.K. was supported by Congressionally Directed Medical Research Programs W81XWH-06-1-055 predoctoral training program. Our structure and atomic model have been deposited in the EM Data Bank and the Protein Data Bank with accession numbers EMD-5172 and 3IYN, respectively.	Abrescia NGA, 2004, NATURE, V432, P68, DOI 10.1038/nature03056; Berk A.J., 2007, FIELDS VIROLOGY, VII, P2356; BOUDIN ML, 1980, VIROLOGY, V101, P144, DOI 10.1016/0042-6822(80)90491-2; BURNETT RM, 1985, J MOL BIOL, V185, P125, DOI 10.1016/0022-2836(85)90187-1; Cockburn JJB, 2004, NATURE, V432, P122, DOI 10.1038/nature03053; COLBY WW, 1981, J VIROL, V39, P977, DOI 10.1128/JVI.39.3.977-980.1981; CROWTHER R A, 1972, Journal of Molecular Biology, V68, P181, DOI 10.1016/0022-2836(72)90273-2; Deng BB, 2007, J VIROL, V81, P3640, DOI 10.1128/JVI.02254-06; EVERITT E, 1975, VIROLOGY, V67, P197, DOI 10.1016/0042-6822(75)90417-1; Everts M, 2004, CURR GENE THER, V4, P337; Fabry CMS, 2009, J VIROL, V83, P1135, DOI 10.1128/JVI.01808-08; Fabry CMS, 2005, EMBO J, V24, P1645, DOI 10.1038/sj.emboj.7600653; Jiang W, 2006, NATURE, V439, P612, DOI 10.1038/nature04487; LAVER WG, 1968, J MOL BIOL, V37, P379, DOI 10.1016/0022-2836(68)90109-5; Lehmberg E, 1999, J CHROMATOGR B, V732, P411, DOI 10.1016/S0378-4347(99)00316-3; Liang YY, 2002, J STRUCT BIOL, V137, P292, DOI 10.1016/S1047-8477(02)00014-X; Marsh MP, 2006, J VIROL, V80, P11881, DOI 10.1128/JVI.01471-06; Matthews DA, 1998, J GEN VIROL, V79, P1671, DOI 10.1099/0022-1317-79-7-1671; McGrath WJ, 2003, BBA-PROTEINS PROTEOM, V1648, P1, DOI 10.1016/S1570-9639(03)00024-4; Ostapchuk P, 2005, J CELL BIOCHEM, V96, P25, DOI 10.1002/jcb.20523; Perez-Berna AJ, 2009, J MOL BIOL, V392, P547, DOI 10.1016/j.jmb.2009.06.057; PRAGE L, 1972, VIROLOGY, V49, P745, DOI 10.1016/0042-6822(72)90531-4; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; ROBERTS MM, 1986, SCIENCE, V232, P1148, DOI 10.1126/science.3704642; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Rux JJ, 2003, J VIROL, V77, P9553, DOI 10.1128/JVI.77.17.9553-9566.2003; Saban SD, 2006, J VIROL, V80, P12049, DOI 10.1128/JVI.01652-06; Sargent KL, 2004, GENE THER, V11, P504, DOI 10.1038/sj.gt.3302107; Silvestry M, 2009, J VIROL, V83, P7375, DOI 10.1128/JVI.00331-09; Smith AC, 2009, J VIROL, V83, P2025, DOI 10.1128/JVI.01644-08; SMITH KO, 1965, J BACTERIOL, V90, P254, DOI 10.1128/JB.90.1.254-261.1965; STEWART PL, 1991, CELL, V67, P145, DOI 10.1016/0092-8674(91)90578-M; STEWART PL, 1993, EMBO J, V12, P2589, DOI 10.1002/j.1460-2075.1993.tb05919.x; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Yan M, 2010, NAT NANOTECHNOL, V5, P48, DOI [10.1038/NNANO.2009.341, 10.1038/nnano.2009.341]; Zubieta C, 2005, MOL CELL, V17, P121, DOI 10.1016/j.molcel.2004.11.041	40	263	276	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2010	329	5995					1038	1043		10.1126/science.1187433	http://dx.doi.org/10.1126/science.1187433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798312	Green Accepted			2022-12-24	WOS:000281253500030
J	Moore, MJ; Wang, QQ; Kennedy, CJ; Silver, PA				Moore, Michael J.; Wang, Qingqing; Kennedy, Caleb J.; Silver, Pamela A.			An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis	CELL			English	Article							PRE-MESSENGER-RNA; PROTEIN; STRATEGY; KINASES	Alternative splicing is a vast source of biological regulation and diversity that is misregulated in cancer and other diseases. To investigate global control of alternative splicing in human cells, we analyzed splicing of mRNAs encoding Bcl2 family apoptosis factors in a genome-wide siRNA screen. The screen identified many regulators of Bcl-x and Mcl1 splicing, notably an extensive network of cell-cycle factors linked to aurora kinase A. Drugs or siRNAs that induce mitotic arrest promote proapoptotic splicing of Bcl-x, Mcl1, and caspase-9 and alter splicing of other apoptotic transcripts. This response precedes mitotic arrest, indicating coordinated upregulation of prodeath splice variants that promotes apoptosis in arrested cells. These shifts correspond to posttranslational turnover of splicing regulator ASF/SF2, which directly binds and regulates these target mRNAs and globally regulates apoptosis. Broadly, our results reveal an alternative splicing network linking cell-cycle control to apoptosis.	[Moore, Michael J.; Wang, Qingqing; Kennedy, Caleb J.; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Silver, Pamela A.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University	Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu			National Science Foundation; National Institutes of Health [NIHGM057476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057476] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Junying Yuan and Robin Reed for reagents, Jodene Moore for help with flow cytometry, and Jessica Hurt, Natalie Gilks-Farny, Daniel Ducat, William Senapedis, Faisal Aldaye, Deborah Flusberg, and Ian Swinburne for thoughtful critiques and discussions. RNAi screening capability was provided by the ICCB-Longwood screening facility at Harvard Medical School. We are indebted to ICCB-L staff Caroline Shamu, Sean Johnston, Stewart Rudnicki, Zac Cooper, and David Wrobel. M.J.M. was supported by funding from the National Science Foundation. Work was supported by grant NIHGM057476 to P.A.S. from the National Institutes of Health.	Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Chen YIG, 2007, NUCLEIC ACIDS RES, V35, P3928, DOI 10.1093/nar/gkm347; Cloutier P, 2008, J BIOL CHEM, V283, P21315, DOI 10.1074/jbc.M800353200; Dassah M, 2009, GENETICS, V182, P725, DOI 10.1534/genetics.109.103473; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ditchfield Claire, 2005, Methods Mol Biol, V296, P371; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Hardwick JM, 2009, CELL, V138, P404, DOI 10.1016/j.cell.2009.07.003; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Mercatante DR, 2002, J BIOL CHEM, V277, P49374, DOI 10.1074/jbc.M209236200; Moore MJ, 2008, RNA, V14, P197, DOI 10.1261/rna.868008; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Rines DR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r44; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Taylor JK, 1999, NAT BIOTECHNOL, V17, P1097, DOI 10.1038/15079; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08	40	230	255	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					625	636		10.1016/j.cell.2010.07.019	http://dx.doi.org/10.1016/j.cell.2010.07.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20705336	Bronze, Green Accepted			2022-12-24	WOS:000281115900016
J	Richard, TL				Richard, Tom L.			Challenges in Scaling Up Biofuels Infrastructure	SCIENCE			English	Editorial Material							ENVIRONMENTAL-IMPACT; PIPELINE TRANSPORT; BIOMASS FEEDSTOCKS; SOLID BIOFUELS; CORN STOVER; ENERGY; COST; CERTIFICATION; STRATEGIES; EFFICIENCY	Rapid growth in demand for lignocellulosic bioenergy will require major changes in supply chain infrastructure. Even with densification and preprocessing, transport volumes by mid-century are likely to exceed the combined capacity of current agricultural and energy supply chains, including grain, petroleum, and coal. Efficient supply chains can be achieved through decentralized conversion processes that facilitate local sourcing, satellite preprocessing and densification for long-distance transport, and business models that reward biomass growers both nearby and afar. Integrated systems that are cost-effective and energy-efficient will require new ways of thinking about agriculture, energy infrastructure, and rural economic development. Implementing these integrated systems will require innovation and investment in novel technologies, efficient value chains, and socioeconomic and policy frameworks; all are needed to support an expanded biofuels infrastructure that can meet the challenges of scale.	Penn State Univ, Dept Agr & Biol Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Richard, TL (corresponding author), Penn State Univ, Dept Agr & Biol Engn, University Pk, PA 16802 USA.	trichard@psu.edu	Richard, Tom L/H-5058-2012; Langholtz, Matthew/B-9416-2012	Langholtz, Matthew/0000-0002-8153-7154; Richard, Tom/0000-0002-0833-4844				Aden A., 2002, LIGNOCELLULOSIC BIOM, DOI 10.2172/15001119; Alakangas E, 2006, BIOMASS BIOENERG, V30, P908, DOI 10.1016/j.biombioe.2006.06.001; Alfonso D, 2009, BIOMASS BIOENERG, V33, P1070, DOI 10.1016/j.biombioe.2009.04.002; [Anonymous], 2010, DOEEIA0484; Berndes G, 2003, BIOMASS BIOENERG, V25, P1, DOI 10.1016/S0961-9534(02)00185-X; Berndes G, 2010, BIOMASS BIOENERG, V34, P227, DOI 10.1016/j.biombioe.2009.07.007; Brown R.C., 2003, BIORENEWABLE RESOURC; Campbell JE, 2008, ENVIRON SCI TECHNOL, V42, P5791, DOI 10.1021/es800052w; Carolan JE, 2007, J AGR FOOD IND ORG, DOI [10.2202/1542-0485.1203, DOI 10.2202/1542-0485.1203]; Eisentraut A., 2010, IEA ENERGY PAPERS; Eriksson L, 2010, BIOMASS BIOENERG, V34, P82, DOI 10.1016/j.biombioe.2009.10.002; Faaij A., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P343, DOI 10.1007/s11027-005-9004-7; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Gronalt M, 2007, BIOMASS BIOENERG, V31, P393, DOI 10.1016/j.biombioe.2007.01.007; Hess JR, 2007, BIOFUEL BIOPROD BIOR, V1, P181, DOI 10.1002/bbb.26; Huber GW, 2007, ANGEW CHEM INT EDIT, V46, P7184, DOI 10.1002/anie.200604504; Kaltschmitt M, 2006, BIOMASS BIOENERG, V30, P897, DOI 10.1016/j.biombioe.2006.06.009; Kumar A, 2005, BIORESOURCE TECHNOL, V96, P819, DOI 10.1016/j.biortech.2004.07.007; Kumar A, 2004, APPL BIOCHEM BIOTECH, V113, P27, DOI 10.1385/ABAB:113:1-3:027; Kumar A, 2003, BIOMASS BIOENERG, V24, P445, DOI 10.1016/S0961-9534(02)00149-6; Laser M, 2009, BIOFUEL BIOPROD BIOR, V3, P247, DOI 10.1002/bbb.136; Lenox M.J., 2003, BUS STRATEG ENVIRON, V12, P343, DOI [10.1002/bse.380, DOI 10.1002/BSE.380]; Lewandowski I, 2006, BIOMASS BIOENERG, V30, P83, DOI 10.1016/j.biombioe.2005.11.003; Magelli F, 2009, BIOMASS BIOENERG, V33, P434, DOI 10.1016/j.biombioe.2008.08.016; Mahmudi H, 2006, APPL BIOCHEM BIOTECH, V129, P88, DOI 10.1385/ABAB:129:1:88; Mapemba LD, 2008, BIOMASS BIOENERG, V32, P1016, DOI 10.1016/j.biombioe.2008.02.003; National Academy of Sciences National Academy of Engineering National Research Council, 2009, LIQ TRANSP FUELS COA; Phillips S., 2007, TP51041168 NREL; Ravula PP, 2008, BIORESOURCE TECHNOL, V99, P5710, DOI 10.1016/j.biortech.2007.10.044; Ren HY, 2006, BIOTECHNOL PROGR, V22, P78, DOI 10.1021/bp050174q; Searcy E, 2007, APPL BIOCHEM BIOTECH, V137, P639, DOI 10.1007/s12010-007-9085-8; Shinners KJ, 2010, T ASABE, V53, P359; Singh J, 2010, BIOMASS BIOENERG, V34, P483, DOI 10.1016/j.biombioe.2009.12.012; Smeets EMW, 2007, PROG ENERG COMBUST, V33, P56, DOI 10.1016/j.pecs.2006.08.001; Sokhansanj S, 2004, APPL ENG AGRIC, V20, P495; Sokhansanj S, 2010, BIOMASS BIOENERG, V34, P75, DOI 10.1016/j.biombioe.2009.10.001; Uslu A, 2008, ENERGY, V33, P1206, DOI 10.1016/j.energy.2008.03.007; van Dam J, 2008, BIOMASS BIOENERG, V32, P749, DOI 10.1016/j.biombioe.2008.01.018; [No title captured]; [No title captured]; [No title captured]	41	210	218	2	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					793	796		10.1126/science.1189139	http://dx.doi.org/10.1126/science.1189139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705852				2022-12-24	WOS:000280809900038
J	Mozaffarian, D; Ludwig, DS				Mozaffarian, Dariush; Ludwig, David S.			Dietary Guidelines in the 21st Century-a Time for Food	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; WOMEN; RISK; FAT		[Mozaffarian, Dariush; Ludwig, David S.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Mozaffarian, Dariush; Ludwig, David S.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Mozaffarian, Dariush; Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA; [Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mozaffarian, Dariush; Ludwig, David S.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ludwig, David S.] Childrens Hosp, Optimal Weight Life Program, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Mozaffarian, D (corresponding author), 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008	Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24DK082730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2003, DIET NUTR PREV CHRON; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; HARPER AE, 1987, ANNU REV NUTR, V7, P509, DOI 10.1146/annurev.nu.07.070187.002453; Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; National Heart Lung and Blood Institute, WE CAN WAYS ENH CHIL; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Tinker LF, 2008, ARCH INTERN MED, V168, P1500, DOI 10.1001/archinte.168.14.1500; *US DEP HHS, DIET GUID AM; [World Cancer Research Fund American Institute for Cancer Research], 2007, FOOD NUTR PHYS ACT P	10	155	157	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					681	682		10.1001/jama.2010.1116	http://dx.doi.org/10.1001/jama.2010.1116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699461				2022-12-24	WOS:000280829200025
J	Boal, AK; Cotruvo, JA; Stubbe, J; Rosenzweig, AC				Boal, Amie K.; Cotruvo, Joseph A., Jr.; Stubbe, JoAnne; Rosenzweig, Amy C.			Structural Basis for Activation of Class Ib Ribonucleotide Reductase	SCIENCE			English	Article							SOLUBLE METHANE MONOOXYGENASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; RADICAL COFACTOR; ACTIVE FORM; FLAVODOXIN; MANGANESE; SUBUNIT; PROTEIN; IRON	The class Ib ribonucleotide reductase of Escherichia coli can initiate reduction of nucleotides to deoxynucleotides with either a Mn-2(III)-tyrosyl radical (Y center dot) or a Fe-2(III)-Y center dot cofactor in the NrdF subunit. Whereas Fe-2(III)-Y center dot can self-assemble from Fe-2(II)-NrdF and O-2, activation of Mn-2(II)-NrdF requires a reduced flavoprotein, NrdI, proposed to form the oxidant for cofactor assembly by reduction of O-2. The crystal structures reported here of E. coli Mn-2(II)-NrdF and Fe-2(II)-NrdF reveal different coordination environments, suggesting distinct initial binding sites for the oxidants during cofactor activation. In the structures of Mn-2(II)-NrdF in complex with reduced and oxidized NrdI, a continuous channel connects the NrdI flavin cofactor to the NrdF Mn-2(II) active site. Crystallographic detection of a putative peroxide in this channel supports the proposed mechanism of Mn-2(III)-Y center dot cofactor assembly.	[Cotruvo, Joseph A., Jr.; Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Stubbe, JoAnne] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwestern University; Northwestern University; Massachusetts Institute of Technology (MIT)	Stubbe, J (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	stubbe@mit.edu; amyr@northwestern.edu	Johnson, Michael D. L./B-4352-2012; Cotruvo, Joseph A/C-5700-2019; Cotruvo, Joseph/N-5127-2019	Cotruvo, Joseph A/0000-0003-4243-8257; 	NIH [GM58518, GM81393]; American Cancer Society [PF-10-148-01-DMC]; National Defense Science and Engineering Graduate fellowship; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058518, R01GM081393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Defense Science and Engineering Graduate fellowship; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM58518 (A. C. R.) and GM81393 (J.S.), American Cancer Society grant PF-10-148-01-DMC (A. K. B.), and a National Defense Science and Engineering Graduate fellowship to J.A.C. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Use of the Life Sciences Collaborative Access Team (LS-CAT) Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). Some data were collected at General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT), which has been funded in whole or in part with federal funds from the National Cancer Institute (grant Y1-CO-1020) and the National Institute of General Medical Science (grant Y1-GM-1104). We thank Z. Wawrzak for assistance with data processing and S. Lippard for helpful discussions. Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3N37 (Mn<INF>2</INF><SUP>II</SUP>-NrdF), 3N38 (Fe<INF>2</INF><SUP>II</SUP>-NrdF), 3N39 (NrdI<INF>ox</INF>-NrdF), 3N3A (NrdI<INF>hq</INF>-NrdF), and 3N3B (NrdI<INF>hq</INF>-NrdF<INF>perox</INF>).	ATKIN CL, 1973, J BIOL CHEM, V248, P7464; ATTA M, 1992, J BIOL CHEM, V267, P20682; Barynin VV, 2001, STRUCTURE, V9, P725, DOI 10.1016/S0969-2126(01)00628-1; Cotruvo JA, 2008, P NATL ACAD SCI USA, V105, P14383, DOI 10.1073/pnas.0807348105; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; DIXON M, 1971, BIOCHIM BIOPHYS ACTA, V226, P241, DOI 10.1016/0005-2728(71)90092-2; Do LH, 2010, J AM CHEM SOC, V132, P1273, DOI 10.1021/ja909718f; Drennan CL, 1999, J MOL BIOL, V294, P711, DOI 10.1006/jmbi.1999.3151; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Eriksson M, 1998, BIOCHEMISTRY-US, V37, P13359, DOI 10.1021/bi981380s; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Huque Y, 2000, J BIOL CHEM, V275, P25365, DOI 10.1074/jbc.M002751200; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; LUDWIG ML, 1992, CHEM BIOCH FLAVOENZY, V3, P427; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Monje-Casas F, 2001, J BIOL CHEM, V276, P18031, DOI 10.1074/jbc.M011728200; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Roca I, 2008, J BACTERIOL, V190, P4849, DOI 10.1128/JB.00185-08; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Sazinsky MH, 2005, J AM CHEM SOC, V127, P5814, DOI 10.1021/ja044099b; Uppsten M, 2004, FEBS LETT, V569, P117, DOI 10.1016/j.febslet.2004.05.059; Uppsten M, 2006, J MOL BIOL, V359, P365, DOI 10.1016/j.jmb.2006.03.035; Voegtli WC, 2003, J AM CHEM SOC, V125, P15822, DOI 10.1021/ja0370387; WILLING A, 1988, EUR J BIOCHEM, V170, P603, DOI 10.1111/j.1432-1033.1988.tb13740.x; Wu CH, 2007, BIOCHEMISTRY-US, V46, P11577, DOI 10.1021/bi7012454; ZHOU ZM, 1995, BIOCHEMISTRY-US, V34, P3183, DOI 10.1021/bi00010a007	30	105	105	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1526	1530		10.1126/science.1190187	http://dx.doi.org/10.1126/science.1190187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20688982	Green Accepted			2022-12-24	WOS:000281869000043
J	Ellershaw, J; Dewar, S; Murphy, D				Ellershaw, John; Dewar, Steve; Murphy, Deborah			Spotlight: Palliative Care Beyond Cancer Achieving a good death for all	BRITISH MEDICAL JOURNAL			English	Article									[Ellershaw, John; Murphy, Deborah] Univ Liverpool, Marie Curie Palliat Care Inst, Liverpool L69 3BX, England; [Dewar, Steve] Marie Curie Canc Care, London SE1 7TP, England; [Ellershaw, John; Murphy, Deborah] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool L7 8XP, England	University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital	Ellershaw, J (corresponding author), Univ Liverpool, Marie Curie Palliat Care Inst, Liverpool L69 3BX, England.	j.e.ellershaw@liv.ac.uk		Ellershaw, John/0000-0001-9789-3180				Abel J, 2009, PALLIATIVE MED, V23, P616, DOI 10.1177/0269216309106460; Addicott R, 2008, IMPROVING CHOICE END; CANDY B, 2009, NONSTATUTORY PALLIAT; DAVIES E, 2004, WHO EUROPE BETTER PA; *DEP HLTH, 2008, ENGL END LIF CAR STR; Department of Health, 2009, END LIF CAR STRAT QU; Gambles M, 2006, INT J PALLIAT NURS, V12, P414, DOI 10.12968/ijpn.2006.12.9.21869; Gambles MA, 2009, INT J CARE COORD, V13, P51, DOI 10.1258/jicp.2009.009011; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Hockley J, 2005, J RES NURS, V10, P135, DOI 10.1177/174498710501000209; Jack Barbara A, 2003, Int J Palliat Nurs, V9, P375; *M CUR PALL CAR I, 2009, LCP GEN VERS 12 COR; *M CUR PALL CAR I, 2007, NAT CAR DYING AUD HO; Marie Curie Palliative Care Institute Liverpool and Clinical Standards Department of the Royal College of Physicians, 2009, NAT CAR DYING AUD HO; MAYLAND CR, 2009, EUR ASS PALL CAR 11; National Audit Office, 2008, END LIF CAR; National Institute for Health and Clinical Excellence, 2004, IMPR SUPP PALL CAR A; Office for National Statistics, MORT STAT DEATHS REG; ROBERTS A, 2007, PALLIATIVE NURSING I; Saunders C, 1989, TXB PAIN, P624; SMITH R, 2009, DAILY TELEGRAPH 1017; St John of God Health Care, 2019, OUR VIS; Veerbeek L, 2008, PALLIATIVE MED, V22, P145, DOI 10.1177/0269216307087164	23	15	16	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 16	2010	341								c4861	10.1136/bmj.c4861	http://dx.doi.org/10.1136/bmj.c4861			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653MO	20847021				2022-12-24	WOS:000282095800001
J	Grant, L; Murray, SA; Sheikh, A				Grant, Liz; Murray, Scott A.; Sheikh, Aziz			Spotlight: Palliative Care Beyond Cancer Spiritual dimensions of dying in pluralist societies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LUNG-CANCER; ILLNESS; PEOPLE; NEEDS; LIFE		Univ Edinburgh, Ctr Pop Hlth Sci, Primary Palliat Care Res Grp, Edinburgh, Scotland	University of Edinburgh	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Pop Hlth Sci, Primary Palliat Care Res Grp, Edinburgh, Scotland.	aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Grant, Liz/0000-0001-7248-7792	COMPASS Collaborative; National Cancer Research Institute; Office of the Scottish Government	COMPASS Collaborative; National Cancer Research Institute; Office of the Scottish Government	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; AS and SM are grantholders on the COMPASS Collaborative, a programme grant for the development and evaluation of complex interventions in end of life care, which is supported by the National Cancer Research Institute; LG, SM, and AS had support from the Chief Scientist's Office of the Scottish Government, which has informed the submitted work; no other relationships or activities that could appear to have influenced the submitted work.	Breitbart William, 2009, Palliat Support Care, V7, P139, DOI 10.1017/S1478951509000182; Bryson Kenneth A, 2004, Palliat Support Care, V2, P321; CARPENITOMOYET L, 2008, HDB NURSING DIAGNOSI, P639; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; FOWLER M, 1997, J SUPERVISION TRAINI, V18, P46; Frankl VE, 1963, MANS SEARCH MEANING; Gatrad AR, 2003, LANCET, V362, P748, DOI 10.1016/S0140-6736(03)14219-5; Gatrad AR, 2003, BRIT MED J, V327, P176, DOI 10.1136/bmj.327.7408.176; GATRAD AR, 2006, PALLIATIVE CARE S AS; *GEN MED COUNC, 2009, END LIF TREATM CAR G; Grant E, 2003, J PALLIATIVE CARE, V19, P159, DOI 10.1177/082585970301900303; Grant Elizabeth, 2004, Palliat Support Care, V2, P371; *I MED, 1997, APPR DEATH IMPR CAR; Kissane DW, 2001, J PALLIAT CARE, V17, P12, DOI 10.1177/082585970101700103; LLOYDWILLIAMS M, 2003, PSYCHOSOCIAL ISSUES; *M CUR CANC CAR, 1980, SPIR REL CAR COMP SP; McClain CS, 2003, LANCET, V361, P1603, DOI 10.1016/S0140-6736(03)13310-7; Meador Keith G, 2004, N C Med J, V65, P226; Murray SA, 2004, PALLIATIVE MED, V18, P39, DOI 10.1191/0269216304pm837oa; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murray SA, 2003, BRIT J GEN PRACT, V53, P957; Murray SA, 2007, J PAIN SYMPTOM MANAG, V34, P393, DOI 10.1016/j.jpainsymman.2006.12.009; Narayanasamy Aru, 2002, Br J Nurs, V11, P948; National Institute for Health and Clinical Excellence, 2004, IMPR SUPP PALL CAR A; Puchalski C, 2004, CRIT CARE CLIN, V20, P487, DOI 10.1016/j.ccc.2004.03.007; Sheikh A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a273; Sloan RP, 1999, LANCET, V353, P664, DOI 10.1016/S0140-6736(98)07376-0; Sweeney K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2862; World Health Organization, WHO DEF PALL CAR; Worth A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b183	30	17	18	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2010	341								c4859	10.1136/bmj.c4859	http://dx.doi.org/10.1136/bmj.c4859			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653MO	20847019	Green Submitted			2022-12-24	WOS:000282095800012
J	Vickers, AJ; Cronin, AM; Bjork, T; Manjer, J; Nilsson, PM; Dahlin, A; Bjartell, A; Scardino, PT; Ulmert, D; Lilja, H				Vickers, Andrew J.; Cronin, Angel M.; Bjoerk, Thomas; Manjer, Jonas; Nilsson, Peter M.; Dahlin, Anders; Bjartell, Anders; Scardino, Peter T.; Ulmert, David; Lilja, Hans			Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK; DIAGNOSIS; SERUM; REPRODUCIBILITY; PREVALENCE; MORTALITY; REGISTER; BIOPSY; SWEDEN; PLASMA	Objective To determine the relation between concentrations of prostate specific antigen at age 60 and subsequent diagnosis of clinically relevant prostate cancer in an unscreened population to evaluate whether screening for prostate cancer and chemoprevention could be stratified by risk. Design Case-control study with 1: 3 matching nested within a highly representative population based cohort study. Setting General population of Sweden taking part in the Malmo Preventive Project. Cancer registry at the National Board of Health and Welfare. Participants 1167 men aged 60 who provided blood samples in 1981 and were followed up to age 85. Main outcome measures Metastasis or death from prostate cancer. Results The rate of screening during the course of the study was low. There were 43 cases of metastasis and 35 deaths from prostate cancer. Concentration of prostate specific antigen at age 60 was associated with prostate cancer metastasis (area under the curve 0.86, 95% confidence interval 0.79 to 0.92; P<0.001) and death from prostate cancer (0.90, 0.84 to 0.96; P<0.001). The greater the number for the area under the curve (values from 0 to 1) the better the test. Although only a minority of the men with concentrations in the top quarter (>2 ng/ml) develop fatal prostate cancer, 90% (78% to 100%) of deaths from prostate cancer occurred in these men. Conversely, men aged 60 with concentrations at the median or lower (<= 1 ng/ml) were unlikely to have clinically relevant prostate cancer (0.5% risk of metastasis by age 85 and 0.2% risk of death from prostate cancer). Conclusions The concentration of prostate specific antigen at age 60 predicts lifetime risk of metastasis and death from prostate cancer. Though men aged 60 with concentrations below the median (<= 1 ng/ml) might harbour prostate cancer, it is unlikely to become life threatening. Such men could be exempted from further screening, which should instead focus on men with higher concentrations.	[Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Clin Labs Surg & Med, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Lilja, H (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Clin Labs Surg & Med, New York, NY 10065 USA.	liljah@mskcc.org	Lilja, Hans/S-9703-2019	Lilja, Hans/0000-0001-5871-7846; Vickers, Andrew/0000-0003-1525-6503; Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Cancer Institute [R21-CA127768-01A1, P50-CA92629]; Swedish Cancer Society [3455]; Swedish Research Council (Medicine) [20095]; Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; Fundacion Federico SA; Memorial Sloan-Kettering Cancer Center; NATIONAL CANCER INSTITUTE [R33CA127768, R21CA127768, P50CA092629] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council (Medicine)(Swedish Research Council); Sidney Kimmel Center for Prostate and Urologic Cancers; Prostate Cancer Foundation; Fundacion Federico SA; Memorial Sloan-Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (grant numbers R21-CA127768-01A1, P50-CA92629); the Swedish Cancer Society (3455); the Swedish Research Council (Medicine) (20095); the Sidney Kimmel Center for Prostate and Urologic Cancers; David H Koch through the Prostate Cancer Foundation; and Fundacion Federico SA. The manuscript editing was paid for by internal funds at Memorial Sloan-Kettering Cancer Center. The study sponsors had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Adolfsson J, 2007, SCAND J UROL NEPHROL, V41, P456, DOI 10.1080/00365590701673625; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Catalona WJ, 2009, NEW ENGL J MED, V361, P202, DOI 10.1056/NEJMc090849; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cronin AM, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-75; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Goetzl MA, 2006, NAT CLIN PRACT UROL, V3, P422, DOI 10.1038/ncpuro0574; Greene KL, 2009, J UROLOGY, V182, P2232, DOI 10.1016/j.juro.2009.07.093; Haas GP, 2007, JNCI-J NATL CANCER I, V99, P1484, DOI 10.1093/jnci/djm153; Hernandez J, 2004, CANCER-AM CANCER SOC, V101, P894, DOI 10.1002/cncr.20480; Holmstrom B, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3537; Hsieh K, 2003, UROL CLIN N AM, V30, P669, DOI 10.1016/S0094-0143(03)00058-2; Kramer BS, 2009, J CLIN ONCOL, V27, P1502, DOI 10.1200/JCO.2008.16.9599; Lacher David A, 2006, Adv Data, P1; Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; MITRUNEN K, 1995, CLIN CHEM, V41, P1115; Moskowitz CS, 2008, STAT MED, V27, P3191, DOI 10.1002/sim.3151; *NAT COMPR CANC NE, 2004, J NATL COMPR CANC NE, V2, P190; Ross LE, 2008, CANCER EPIDEM BIOMAR, V17, P636, DOI 10.1158/1055-9965.EPI-07-2709; Sandblom G, 2003, SCAND J UROL NEPHROL, V37, P112, DOI 10.1080/00365590310008839; Schroder F, 2008, EUR UROL, V54, P274, DOI 10.1016/j.eururo.2008.05.022; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; STENMAN UH, 1994, LANCET, V344, P1594, DOI 10.1016/S0140-6736(94)90405-7; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Ulmert D, 2006, CLIN CHEM, V52, P235, DOI 10.1373/clinchem.2005.050641; Ulmert D, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-6; Vickers A, 2010, J CLIN ONCOL, V28, P2493, DOI 10.1200/JCO.2009.24.1968; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278	33	142	147	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2010	341								c4521	10.1136/bmj.c4521	http://dx.doi.org/10.1136/bmj.c4521			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653LK	20843935	hybrid, Green Published			2022-12-24	WOS:000282092600011
J	Carneiro, T; Khair, L; Reis, CC; Borges, V; Moser, BA; Nakamura, TM; Ferreira, MG				Carneiro, Tiago; Khair, Lyne; Reis, Clara C.; Borges, Vanessa; Moser, Bettina A.; Nakamura, Toru M.; Ferreira, Miguel Godinho			Telomeres avoid end detection by severing the checkpoint signal transduction pathway	NATURE			English	Article							FISSION YEAST; DNA-DAMAGE; CELL-CYCLE; DYSFUNCTIONAL TELOMERES; PROTEIN CRB2; RAP1; RECRUITMENT; METHYLATION; REPAIR; BREAKS	Telomeres protect the normal ends of chromosomes from being recognized as deleterious DNA double-strand breaks. Recent studies have uncovered an apparent paradox: although DNA repair is prevented, several proteins involved in DNA damage processing and checkpoint responses are recruited to telomeres in every cell cycle and are required for end protection(1). It is currently not understood how telomeres prevent DNA damage responses from causing permanent cell cycle arrest. Here we show that fission yeast (Schizosaccharomyces pombe) cells lacking Taz1, an orthologue of human TRF1 and TRF2 (ref. 2), recruit DNA repair proteins (Rad22(RAD52) and Rhp51(RAD51), where the superscript indicates the human orthologue) and checkpoint sensors (RPA, Rad9, Rad26(ATRIP) and Cut5/Rad4(TOPBP1)) to telomeres. Despite this, telomeres fail to accumulate the checkpoint mediator Crb2(53BP1) and, consequently, do not activate Chk1-dependent cell cycle arrest. Artificially recruiting Crb2(53BP1) to taz1D telomeres results in a full checkpoint response and cell cycle arrest. Stable association of Crb2(53BP1) to DNA double-strand breaks requires two independent histone modifications: H4 dimethylation at lysine 20 (H4K20me2) and H2A carboxy-terminal phosphorylation (gamma H2A)(3-5). Whereas cH2A can be readily detected, telomeres lack H4K20me2, in contrast to internal chromosome locations. Blocking checkpoint signal transduction at telomeres requires Pot1 and Ccq1, and loss of either Pot1 or Ccq1 from telomeres leads to Crb2(53BP1) foci formation, Chk1 activation and cell cycle arrest. Thus, telomeres constitute a chromatin-privileged region of the chromosomes that lack essential epigenetic markers for DNA damage response amplification and cell cycle arrest. Because the protein kinases ATM and ATR must associate with telomeres in each S phase to recruit telomerase(6), exclusion of Crb2(53BP1) has a critical role in preventing telomeres from triggering cell cycle arrest.	[Carneiro, Tiago; Reis, Clara C.; Borges, Vanessa; Ferreira, Miguel Godinho] Inst Gulbenkian Ciencias, P-2781901 Oeiras, Portugal; [Khair, Lyne; Moser, Bettina A.; Nakamura, Toru M.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	Instituto Gulbenkian de Ciencia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ferreira, MG (corresponding author), Inst Gulbenkian Ciencias, P-2781901 Oeiras, Portugal.	mgferreira@igc.gulbenkian.pt	Ferreira, Miguel/HHZ-6251-2022; Nakamura, Toru M/B-2055-2008; Ferreira, Miguel Godinho/F-9290-2012	Nakamura, Toru M/0000-0001-5752-0814; Ferreira, Miguel Godinho/0000-0002-8363-7183; Borges, Vanessa/0000-0003-0223-9085; Carneiro, Tiago/0000-0001-7909-4182	NIH [GM078253]; FCT [PTDC/BIA-BCM/67261/2006]; Association for International Cancer Research [06-396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078253] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Association for International Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Cooper, K. Tomita and the rest of the Telomere Biology Laboratory (Cancer Research UK, London) for support at the start of this project. We thank J. Cooper, T. Wolkow, P. Russell and A. M. Carr for strains and plasmids. We thank W. Kaufman for her initial effort in the establishment of HO strains. We are grateful to S. Grewal for sharing unpublished results and to D. Lydall for insights on the quantitative analysis of checkpoint activation. We thank K. Labib, L. Jansen, K. Xavier, R. Martinho and S. Lopes for critically reading the manuscript. T. C. and C. C. R. are supported by Fundacao para a Ciencia e a Tecnologia (FCT) postdoctoral fellowships. T.M.N. was supported by the Sidney Kimmel Scholar Program and his laboratory is supported by NIH grant GM078253. This work was supported by the FCT (PTDC/BIA-BCM/67261/2006) and the Association for International Cancer Research (06-396).	Abdallah P, 2009, NAT CELL BIOL, V11, P988, DOI 10.1038/ncb1911; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Churikov D, 2008, NAT STRUCT MOL BIOL, V15, P79, DOI 10.1038/nsmb1331; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Ferreira MG, 2004, GENE DEV, V18, P2249, DOI 10.1101/gad.315804; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Goudsouzian LK, 2006, MOL CELL, V24, P603, DOI 10.1016/j.molcel.2006.10.005; Greeson NT, 2008, J BIOL CHEM, V283, P33168, DOI 10.1074/jbc.M806857200; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hirano Y, 2007, MOL BIOL CELL, V18, P2026, DOI 10.1091/mbc.E06-12-1074; Khair L, 2010, J BIOL CHEM, V285, P5327, DOI 10.1074/jbc.M109.078840; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Michelson RJ, 2005, GENE DEV, V19, P2546, DOI 10.1101/gad.1293805; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Miller KM, 2005, EMBO J, V24, P3128, DOI 10.1038/sj.emboj.7600779; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; Mochida S, 2004, EMBO J, V23, P418, DOI 10.1038/sj.emboj.7600018; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moser BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000622; Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Negrini S, 2007, GENE DEV, V21, P292, DOI 10.1101/gad.400907; Rog O, 2009, MOL CELL, V33, P559, DOI 10.1016/j.molcel.2009.01.027; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Tomita K, 2008, GENE DEV, V22, P3461, DOI 10.1101/gad.498608; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Wang Y, 2009, EPIGENETICS-US, V4, P273, DOI 10.4161/epi.4.5.9212	33	44	47	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2010	467	7312					228	U124		10.1038/nature09353	http://dx.doi.org/10.1038/nature09353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829797	Green Accepted			2022-12-24	WOS:000281616300039
J	Calo, E; Quintero-Estades, JA; Danielian, PS; Nedelcu, S; Berman, SD; Lees, JA				Calo, Eliezer; Quintero-Estades, Jose A.; Danielian, Paul S.; Nedelcu, Simona; Berman, Seth D.; Lees, Jacqueline A.			Rb regulates fate choice and lineage commitment in vivo	NATURE			English	Article							ADIPOCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; RETINOBLASTOMA GENE; TUMOR-SUPPRESSOR; OSTEOSARCOMA; TRANSCRIPTION; INACTIVATION; EXPRESSION; WHITE; P53	Mutation of the retinoblastoma gene (RB1) tumour suppressor occurs in one-third of all human tumours and is particularly associated with retinoblastoma and osteosarcoma(1). Numerous functions have been ascribed to the product of the human RB1 gene, the retinoblastoma protein (pRb). The best known is pRb's ability to promote cell-cycle exit through inhibition of the E2F transcription factors and the transcriptional repression of genes encoding cell-cycle regulators(1). In addition, pRb has been shown in vitro to regulate several transcription factors that are master differentiation inducers(2). Depending on the differentiation factor and cellular context, pRb can either suppress or promote their transcriptional activity. For example, pRb binds to Runx2 and potentiates its ability to promote osteogenic differentiation in vitro(3). In contrast, pRb acts with E2F to suppress peroxisome proliferator-activated receptor gamma subunit (PPAR-gamma), the master activator of adipogenesis(4,5). Because osteoblasts and adipocytes can both arise from mesenchymal stem cells, these observations suggest that pRb might play a role in the choice between these two fates. However, so far, there is no evidence for this in vivo. Here we use mouse models to address this hypothesis in mesenchymal tissue development and tumorigenesis. Our data show that Rb status plays a key role in establishing fate choice between bone and brown adipose tissue in vivo.	[Calo, Eliezer; Quintero-Estades, Jose A.; Danielian, Paul S.; Nedelcu, Simona; Berman, Seth D.; Lees, Jacqueline A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lees, JA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jalees@mit.edu		Danielian, Paul/0000-0003-2651-0386	National Cancer Institute/National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA121921, P01CA042063] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Jacks, C. Tabin and A. McMahon for providing key mutant mouse strains, K. Lane for pCW22, M. Hemann for the Rb shRNA, the University of Iowa Gene Transfer Vector Core for the adenoviral Cre and GFP vectors, and G. Karsenty for p6OSE2-Luc and control p4Luc. We also thank members of the Lees laboratory, S. Mukherjee and M. Hemann for input during this study. This work was supported by an National Cancer Institute/National Institutes of Health grant to J.A.L., who is a Ludwig Scholar at MIT.	Barski Artem, 2008, V455, P177, DOI 10.1007/978-1-59745-104-8_14; Berman SD, 2008, MOL CANCER RES, V6, P1440, DOI 10.1158/1541-7786.MCR-08-0176; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Korenjak M, 2005, CURR OPIN GENET DEV, V15, P520, DOI 10.1016/j.gde.2005.07.001; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417	20	232	244	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					1110	U126		10.1038/nature09264	http://dx.doi.org/10.1038/nature09264			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20686481	Green Accepted, Green Submitted			2022-12-24	WOS:000281203600041
J	Laiteerapong, N; Huang, ES				Laiteerapong, Neda; Huang, Elbert S.			Health Care Reform and Chronic Diseases Anticipating the Health Consequences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							10-YEAR FOLLOW-UP; MEDICARE BENEFICIARIES; ACCESS; ADULTS		[Laiteerapong, Neda; Huang, Elbert S.] Univ Chicago, Gen Internal Med Sect, Dept Med, Chicago, IL 60637 USA	University of Chicago	Laiteerapong, N (corresponding author), Univ Chicago, Gen Internal Med Sect, Dept Med, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	nlaiteer@medicine.bsd.uchicago.edu	Laiteerapong, Neda/ABC-5566-2021; Laiteerapong, Neda/AAO-2596-2020	Laiteerapong, Neda/0000-0003-0124-4325; 	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK089973, P60DK020595] Funding Source: NIH RePORTER; AHRQ HHS [T32HS000084] Funding Source: Medline; NIDDK NIH HHS [F32DK089973, F32 DK089973, P60 DK20595] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; HOFFMAN C, 2009, PUBLICATION HJ KAIS; Hoffman C, 2008, HEALTH AFFAIR, V27, pW340, DOI 10.1377/hlthaff.27.5.w340; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Paez KA, 2009, HEALTH AFFAIR, V28, P15, DOI 10.1377/hlthaff.28.1.15; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Thorpe KE, 2006, HEALTH AFFAIR, V25, pW378, DOI 10.1377/hlthaff.25.w378; Weissman JS, 2008, J HEALTH CARE POOR U, V19, P307, DOI 10.1353/hpu.2008.0021	9	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2010	304	8					899	900		10.1001/jama.2010.1209	http://dx.doi.org/10.1001/jama.2010.1209			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	644OY	20736475				2022-12-24	WOS:000281389900029
J	Yoshida, Y; Kuroiwa, H; Misumi, O; Yoshida, M; Ohnuma, M; Fujiwara, T; Yagisawa, F; Hirooka, S; Imoto, Y; Matsushita, K; Kawano, S; Kuroiwa, T				Yoshida, Yamato; Kuroiwa, Haruko; Misumi, Osami; Yoshida, Masaki; Ohnuma, Mio; Fujiwara, Takayuki; Yagisawa, Fumi; Hirooka, Shunsuke; Imoto, Yuuta; Matsushita, Kazunobu; Kawano, Shigeyuki; Kuroiwa, Tsuneyoshi			Chloroplasts Divide by Contraction of a Bundle of Nanofilaments Consisting of Polyglucan	SCIENCE			English	Article							ALGA CYANIDIOSCHYZON-MEROLAE; PLASTID DIVISION; DYNAMIN; MACHINERY; MITOCHONDRIA; GLYCOGENIN; ORGANELLES; APPARATUS; MECHANISM; SEQUENCE	In chloroplast division, the plastid-dividing (PD) ring is a main structure of the PD machinery and is a universal structure in the plant kingdom. However, the components and formation of the PD ring have been enigmatic. By proteomic analysis of PD machineries isolated from Cyanidioschyzon merolae, we identified the glycosyltransferase protein plastid-dividing ring 1 (PDR1), which constructs the PD ring and is widely conserved from red alga to land plants. Electron microscopy showed that the PDR1 protein forms a ring with carbohydrates at the chloroplast-division site. Fluorometric saccharide ingredient analysis of purified PD ring filaments showed that only glucose was included, and down-regulation of PDR1 impaired chloroplast division. Thus, the chloroplasts are divided by the PD ring, which is a bundle of PDR1-mediated polyglucan filaments.	[Yoshida, Yamato; Kuroiwa, Haruko; Misumi, Osami; Yoshida, Masaki; Ohnuma, Mio; Fujiwara, Takayuki; Yagisawa, Fumi; Imoto, Yuuta; Kuroiwa, Tsuneyoshi] Rikkyo Univ, Cell Biol Lab, Dept Life Sci, Coll Sci,Res Informat Ctr Extremophile, Tokyo 1718501, Japan; [Hirooka, Shunsuke] Chiba Univ, Dept Nanobiol, Grad Sch Adv Integrat Sci, Chiba 2718510, Japan; [Matsushita, Kazunobu] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 7538515, Japan; [Kawano, Shigeyuki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan	Rikkyo University; Chiba University; Yamaguchi University; University of Tokyo	Kuroiwa, T (corresponding author), Rikkyo Univ, Cell Biol Lab, Dept Life Sci, Coll Sci,Res Informat Ctr Extremophile, Tokyo 1718501, Japan.	tsune@rikkyo.ne.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan;  [22247007];  [22657061]; Grants-in-Aid for Scientific Research [22370024] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Y. Miyagishima and K. Nishida for thoughtful advice on the research. This work was supported by grants from the Scientific Research (22247007 and 22657061 to T. K.) and by the Frontier Project "Adaptation and Evolution of Extremophiles" from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Gao HB, 2003, P NATL ACAD SCI USA, V100, P4328, DOI 10.1073/pnas.0530206100; GILLHAM NW, 1994, ANNU REV GENET, V28, P71, DOI 10.1146/annurev.ge.28.120194.000443; Glynn JM, 2007, TRAFFIC, V8, P451, DOI 10.1111/j.1600-0854.2007.00545.x; Hirabaru C, 2010, PLANT CELL PHYSIOL, V51, P682, DOI 10.1093/pcp/pcq046; Kuroiwa H, 2002, PLANTA, V215, P185, DOI 10.1007/s00425-002-0734-4; Kuroiwa T, 2008, INT REV CEL MOL BIO, V271, P97, DOI 10.1016/S1937-6448(08)01203-3; Kuroiwa T, 1998, INT REV CYTOL, V181, P1, DOI 10.1016/S0074-7696(08)60415-5; Lomako J, 2004, BBA-GEN SUBJECTS, V1673, P45, DOI 10.1016/j.bbagen.2004.03.017; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Miyagishima S, 2003, PLANT CELL, V15, P655, DOI 10.1105/tpc.009373; Miyagishima SY, 2001, PLANT CELL, V13, P2257, DOI 10.1105/tpc.010185; Miyagishima SY, 2001, PLANT CELL, V13, P707; Nozaki H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-28; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; OSTERYOUNG KW, 1995, NATURE, V376, P473, DOI 10.1038/376473b0; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pyke KA, 1999, PLANT CELL, V11, P549, DOI 10.1105/tpc.11.4.549; SMYTHE C, 1991, EUR J BIOCHEM, V200, P625, DOI 10.1111/j.1432-1033.1991.tb16225.x; Yoo SH, 2002, CARBOHYD RES, V337, P2195, DOI 10.1016/S0008-6215(02)00228-8; Yoshida Y, 2006, SCIENCE, V313, P1435, DOI 10.1126/science.1129689; Yoshida Y, 2009, CURR BIOL, V19, P1491, DOI 10.1016/j.cub.2009.07.035	22	63	66	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					949	953		10.1126/science.1190791	http://dx.doi.org/10.1126/science.1190791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724635				2022-12-24	WOS:000281084800036
J	Sacco, T; Sacchetti, B				Sacco, Tiziana; Sacchetti, Benedetto			Role of Secondary Sensory Cortices in Emotional Memory Storage and Retrieval in Rats	SCIENCE			English	Article							FEAR-POTENTIATED STARTLE; VISUAL CONDITIONED-STIMULUS; ANTERIOR CINGULATE CORTEX; BASOLATERAL AMYGDALA; PERIRHINAL CORTEX; TEMPORAL CORTEX; AUDITORY-CORTEX; INVOLVEMENT; CONSOLIDATION; THALAMUS	Visual, acoustic, and olfactory stimuli associated with a highly charged emotional situation take on the affective qualities of that situation. Where the emotional meaning of a given sensory experience is stored is a matter of debate. We found that excitotoxic lesions of auditory, visual, or olfactory secondary sensory cortices impaired remote, but not recent, fear memories in rats. Amnesia was modality-specific and not due to an interference with sensory or emotional processes. In these sites, memory persistence was dependent on ongoing protein kinase M zeta activity and was associated with an increased activity of layers II-IV, thus suggesting a synaptic strengthening of corticocortical connections. Lesions of the same areas left intact the memory of sensory stimuli not associated with any emotional charge. We propose that secondary sensory cortices support memory storage and retrieval of sensory stimuli that have acquired a behavioral salience with the experience.	[Sacco, Tiziana; Sacchetti, Benedetto] Univ Turin, Dept Neurosci, I-10125 Turin, Italy; [Sacchetti, Benedetto] Natl Inst Neurosci, I-10125 Turin, Italy	University of Turin	Sacchetti, B (corresponding author), Univ Turin, Dept Neurosci, Corso Raffaello 30, I-10125 Turin, Italy.	benedetto.sacchetti@unito.it	Sacchetti, Benedetto/AAG-2916-2022; Sacchetti, Benedetto/AFK-4141-2022	Sacchetti, Benedetto/0000-0002-8695-8310	Italian Ministry of University	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	We thank J. L. McGaugh for critical comments on the manuscript and L. Milano, A. Renna, D. Germano, V. Pastrone, D. Tonello, and G. Benvenuti for technical assistance. Supported by grants from the Italian Ministry of University.	BARTH DS, 1995, BRAIN RES, V678, P177, DOI 10.1016/0006-8993(95)00182-P; Boatman JA, 2006, EUR J NEUROSCI, V24, P894, DOI 10.1111/j.1460-9568.2006.04965.x; Calu DJ, 2007, CEREB CORTEX, V17, P1342, DOI 10.1093/cercor/bhl045; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Chavez CM, 2009, NEUROBIOL LEARN MEM, V91, P382, DOI 10.1016/j.nlm.2008.10.010; COLEMAN J, 1980, BRAIN RES, V194, P205, DOI 10.1016/0006-8993(80)91329-3; DIAMOND DM, 1984, BEHAV NEUROSCI, V98, P189, DOI 10.1037/0735-7044.98.2.189; FALLS WA, 1993, BEHAV NEURAL BIOL, V60, P259, DOI 10.1016/0163-1047(93)90504-B; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; GONZALEZLIMA F, 1989, BRAIN RES, V489, P67, DOI 10.1016/0006-8993(89)90009-7; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; JARRELL TW, 1987, BRAIN RES, V412, P285, DOI 10.1016/0006-8993(87)91135-8; Kolb B.E., 1990, CEREBRAL CORTEX RAT; Ledoux J E, 1989, J Cogn Neurosci, V1, P238, DOI 10.1162/jocn.1989.1.3.238; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee YL, 1996, BEHAV NEUROSCI, V110, P836, DOI 10.1037/0735-7044.110.4.836; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Malin EL, 2006, P NATL ACAD SCI USA, V103, P1959, DOI 10.1073/pnas.0510890103; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Poremba A, 1998, EUR J NEUROSCI, V10, P3035, DOI 10.1046/j.1460-9568.1998.00304.x; ROMANSKI LM, 1992, NEUROSCI LETT, V142, P228, DOI 10.1016/0304-3940(92)90379-L; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; ROSEN JB, 1992, J NEUROSCI, V12, P4624; Sacchetti B, 1999, J NEUROSCI, V19, P9570; Sacchetti B, 2004, NEURON, V42, P973, DOI 10.1016/j.neuron.2004.05.012; Sacchetti B, 2002, P NATL ACAD SCI USA, V99, P8406, DOI 10.1073/pnas.112660399; Sacchetti B, 2007, EUR J NEUROSCI, V25, P2875, DOI 10.1111/j.1460-9568.2007.05508.x; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shi CJ, 2001, J NEUROSCI, V21, P9844, DOI 10.1523/JNEUROSCI.21-24-09844.2001; Villa AEP, 1999, P NATL ACAD SCI USA, V96, P1106, DOI 10.1073/pnas.96.3.1106; Wan H, 2001, EUR J NEUROSCI, V14, P118, DOI 10.1046/j.0953-816x.2001.01625.x; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Wilson DA, 2008, J NEUROPHYSIOL, V100, P2, DOI 10.1152/jn.90479.2008; ZHU XO, 1995, NEUROSCIENCE, V69, P821, DOI 10.1016/0306-4522(95)00320-I; Zilles K, 1985, CORTEX RAT	39	189	189	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					649	656		10.1126/science.1183165	http://dx.doi.org/10.1126/science.1183165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689011	Green Submitted			2022-12-24	WOS:000280602700030
J	Ludermir, AB; Lewis, G; Valongueiro, SA; de Araujo, TVB; Araya, R				Ludermir, Ana Bernarda; Lewis, Glyn; Valongueiro, Sandra Alves; Barreto de Araujo, Thalia Velho; Araya, Ricardo			Violence against women by their intimate partner during pregnancy and postnatal depression: a prospective cohort study	LANCET			English	Article							DOMESTIC VIOLENCE; HEALTH; MISCLASSIFICATION; PREVALENCE; MOTHERS; SCALE; ABUSE; CARE	Background Partner violence against women is common during pregnancy and might have an adverse effect on the mental health of women after delivery. We aimed to investigate the association of postnatal depression with psychological, physical, and sexual violence against women by their intimate partners during pregnancy. Methods In a prospective cohort study undertaken in Recife, northeastern Brazil, between July, 2005, and December, 2006, we enrolled pregnant women (aged 18-49 years) in their third trimester of pregnancy who were attending primary health-care clinics. The women were interviewed during pregnancy and after delivery. The form of partner violence in pregnancy was assessed with a validated questionnaire, and the Edinburgh postnatal depression scale was used to measure postnatal depression. Associations were estimated with odds ratios (ORs), adjusted for confounding factors contributing to the association between postnatal depression and intimate partner violence. Findings 1133 pregnant women were eligible for inclusion in the study, of whom 1045 had complete data for all variables and were included in the analysis. 270 women (25.8%, 95% CI 23.2-28.6) had postnatal depression. The most common form of partner violence was psychological (294 [28.1%, 25.4-31.0]). Frequency of psychological violence during pregnancy was positively associated with occurrence of postnatal depression, and although this association was attenuated after adjustment, women reporting the highest frequency of psychological violence were more likely to have postnatal depression even after adjustment (adjusted OR 2-29, 95% CI 1-15-4.57). Women who reported physical or sexual violence in pregnancy were more likely to develop postnatal depression (OR 3.28, 2.29-4.70), but this association was substantially reduced after adjustment for psychological violence and confounding factors. Interpretation Psychological violence during pregnancy by an intimate partner is strongly associated with postnatal depression, independently of physical or sexual violence. This finding has important policy implications since most social policies focus on prevention and treatment of physical violence.	[Ludermir, Ana Bernarda; Valongueiro, Sandra Alves; Barreto de Araujo, Thalia Velho] Univ Fed Pernambuco, Hosp Clin, Programa Posgrad Integrado Saude Colet, Recife, PE, Brazil; [Lewis, Glyn; Araya, Ricardo] Univ Bristol, Acad Unit Psychiat, Bristol, Avon, England	Universidade Federal de Pernambuco; University of Bristol	Ludermir, AB (corresponding author), Ave Conselheiro Rosa & Silva 377-1601, BR-52020220 Recife, PE, Brazil.	abl@ufpe.br	Lewis, Glyn/E-9944-2012; Ludermir, Ana B/A-9026-2009; Araya, Ricardo/S-3144-2019	Lewis, Glyn/0000-0001-5205-8245; Araya, Ricardo/0000-0002-0420-5148	Departamento de Ciencia e Tecnologia da Secretaria de Ciencia, Tecnologia, e Insumos Estrategicos (DECIT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil [403060/2004-4, 473545/2004-7]	Departamento de Ciencia e Tecnologia da Secretaria de Ciencia, Tecnologia, e Insumos Estrategicos (DECIT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We are greatly indebted to the women of Recife who participated in the study, and without whom this research would not have been possible. This study was funded by the Departamento de Ciencia e Tecnologia da Secretaria de Ciencia, Tecnologia, e Insumos Estrategicos (DECIT), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil (grant numbers 403060/2004-4 and 473545/2004-7).	Alvarado R, 1992, REV PSIQUIATR, V3, P1168; Bacchus L, 2004, EUR J OBSTET GYN R B, V113, P6, DOI 10.1016/S0301-2115(03)00326-9; Beusenberg M., 1994, WHOMNHPSF948; BROWN GW, 1995, PSYCHOL MED, V25, P7, DOI 10.1017/S003329170002804X; CANTILINO A, 2003, NEUROBIOLOGIA, V66, P75; COUTO MT, 2006, CIENC SAUDE COLETIVA, V11, pS1323; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Doubova SV, 2007, REV SAUDE PUBL, V41, P582, DOI 10.1590/S0034-89102007000400012; Ellsberg M, 1999, AM PSYCHOL, V54, P30, DOI 10.1037/0003-066X.54.1.30; Ellsberg M., 1997, CANDIES HELL DOMESTI; Figueira Patrícia, 2009, Rev. Saúde Pública, V43, P79, DOI 10.1590/S0034-89102009000800012; *FUND I BRAS GEOGR, 1991, CENS DEM PERN; Garcia-Moreno C, 2002, LANCET, V359, P1509, DOI 10.1016/S0140-6736(02)08417-9; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Habermas Jurgen, 1990, DISCURSO FILOSOFICO; HARDING TW, 1980, PSYCHOL MED, V10, P231, DOI 10.1017/S0033291700043993; Heise L., 2002, WORLD REPORT VIOLENC; Heise Lori L., 1994, WORLD BANK DISCUSSIO; Leung WC, 2002, INT J GYNECOL OBSTET, V79, P159, DOI 10.1016/S0020-7292(02)00236-9; Ludermir AB, 2010, PSYCHOL MED, V40, P1467, DOI 10.1017/S003329170999184X; Ludermir AB, 2005, SOC PSYCH PSYCH EPID, V40, P36, DOI 10.1007/s00127-005-0840-2; Ludermir AB, 2003, SOC PSYCH PSYCH EPID, V38, P485, DOI 10.1007/s00127-003-0658-8; Ludermir AB, 2008, SOC SCI MED, V66, P1008, DOI 10.1016/j.socscimed.2007.10.021; Lutz KF, 2005, WESTERN J NURS RES, V27, P802, DOI 10.1177/0193945905278078; MARI JD, 1986, J CHRON DIS, V39, P371; Matthey S, 2006, ARCH WOMEN MENT HLTH, V9, P309, DOI 10.1007/s00737-006-0152-x; Moraes CL, 2002, INT J GYNECOL OBSTET, V79, P269, DOI 10.1016/S0020-7292(02)00250-3; Parker B, 1999, RES NURS HEALTH, V22, P59; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; Pinheiro RT, 2006, ACTA PSYCHIAT SCAND, V113, P230, DOI 10.1111/j.1600-0447.2005.00708.x; Pollock JI, 2006, J AFFECT DISORDERS, V92, P267, DOI 10.1016/j.jad.2006.02.020; *PREF CID REC, 2006, REC SAUD INCL SOC QU; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Rojas G, 2007, LANCET, V370, P1629, DOI 10.1016/S0140-6736(07)61685-7; SANTOS MF, 2000, ESCALAS AVALIACAO CL; Schraiber LB, 2009, CAD SAUDE PUBLICA, V25, pS205, DOI 10.1590/S0102-311X2009001400003; Sharma SP, 2007, LANCET ONCOL, V8, P105, DOI 10.1016/S1470-2045(07)70024-4; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Tiwari A, 2005, BJOG-INT J OBSTET GY, V112, P1249, DOI 10.1111/j.1471-0528.2005.00709.x; VENTURI Gustavo, 2004, MULHER BRASILEIRA NO; Watts C, 2002, LANCET, V359, P1232, DOI 10.1016/S0140-6736(02)08221-1; Yost NR, 2005, OBSTET GYNECOL, V106, P61, DOI 10.1097/01.AOG.0000164468.06070.2a	43	202	215	2	48	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2010	376	9744					903	910		10.1016/S0140-6736(10)60887-2	http://dx.doi.org/10.1016/S0140-6736(10)60887-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653DW	20822809				2022-12-24	WOS:000282069100031
J	Belongia, EA; Irving, SA; Waring, SC; Coleman, LA; Meece, JK; Vandermause, M; Lindstrom, S; Kempf, D; Shay, DK				Belongia, Edward A.; Irving, Stephanie A.; Waring, Stephen C.; Coleman, Laura A.; Meece, Jennifer K.; Vandermause, Mary; Lindstrom, Stephen; Kempf, Debra; Shay, David K.			Clinical Characteristics and 30-Day Outcomes for Influenza A 2009 (H1N1), 2008-2009 (H1N1), and 2007-2008 (H3N2) Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL PATIENTS; NASOPHARYNGEAL ASPIRATE; A(H1N1) INFECTION; NASAL SWAB; OSELTAMIVIR; AUSTRALIA; VIRUS	Context The clinical characteristics of pandemic 2009 influenza A(H1N1) infections have not been compared directly with illnesses caused by other influenza A strains. Objective To compare clinical features and outcomes for 2009 H1N1, seasonal H1N1, and H3N2 influenza in a population-based cohort. Design, Setting, and Participants Active surveillance with 30-day follow-up for influenza cases among children and adults living in a 14-zip code area in Wisconsin. Patients with subjective fever, chills, or cough of fewer than 8 days' duration were screened for eligibility during an outpatient or inpatient encounter. Consenting patients were interviewed and tested for influenza A during the 2007-2008 and 2008-2009 influenza seasons and from May to November 2009; 6874 patients (70%-86% of eligible patients) agreed to participate. Medical records were reviewed to assess outcomes. Main Outcome Measures Hospital admission, radiographically confirmed pneumonia, and clinical characteristics of influenza A by strain. Results We identified 545 2009 H1N1, 221 seasonal H1N1, and 632 H3N2 infections. The median ages of infected participants were 10, 11, and 25 years, respectively (P<.001). Hospital admission occurred within 30 days for 6 of 395 children with 2009 H1N1 (1.5%; 95% confidence interval [CI], 0.6%-3.1%), 5 of 135 with seasonal H1N1 (3.7%; 95% CI, 1.4%-8.0%), and 8 of 255 with H3N2 (3.1%; 95% CI, 1.5%-5.9%). Among adults, hospital admission occurred in 6 of 150 with 2009 H1N1 (4.0%; 95% CI, 1.6%-8.1%), 2 of 86 with seasonal H1N1 (2.3%; 95% CI, 0.3%-8.1%), and 17 of 377 with H3N2 (4.5%; 95% CI, 2.7%-7.0%). Pneumonia occurred in 10 children with 2009 H1N1 (2.5%; 95% CI, 1.3%-4.5%), 2 with seasonal H1N1 (1.5%; 95% CI, 0.2%-5.2%), and 5 with H3N2 (2.0%; 95% CI, 0.7%-4.3%). Among adults, pneumonia occurred in 6 with 2009 H1N1 (4.0%; 95% CI, 1.6%-8.1%), 2 with seasonal H1N1 (2.3%; 95% CI, 0.3%-8.1%), and 4 with H3N2 (1.1%; 95% CI, 0.3%-2.7%). Conclusions In this population, individuals with 2009 H1N1 infection were younger than those with H3N2. The risk of most serious complications was not elevated in adults or children with 2009 H1N1 compared with recent seasonal strains. JAMA. 2010; 304(10): 1091-1098	[Belongia, Edward A.] Marshfield Clin Res Fdn, Epidemiol Res Ctr ML2, Marshfield, WI 54449 USA; [Lindstrom, Stephen; Shay, David K.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Belongia, EA (corresponding author), Marshfield Clin Res Fdn, Epidemiol Res Ctr ML2, 1000 N Oak Ave, Marshfield, WI 54449 USA.	belongia.edward@marshfieldclinic.org	Waring, Stephen/AAR-6870-2021	Waring, Stephen/0000-0002-9674-0083; Belongia, Edward/0000-0001-7478-0415; Irving, Stephanie/0000-0001-7437-6797; Shay, David/0000-0001-9619-4820	CDC [1 U01 CI000192-01]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U01CI000192] Funding Source: NIH RePORTER	CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for this research was provided by a cooperative agreement with the CDC (grant 1 U01 CI000192-01).	Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; Baker MG, 2009, EUROSURVEILLANCE, V14, P6; Belongia E., 2008, Morbidity and Mortality Weekly Report, V57, P393; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Denholm JT, 2010, MED J AUSTRALIA, V192, P84, DOI 10.5694/j.1326-5377.2010.tb03424.x; DeStefano F, 1996, J CLIN EPIDEMIOL, V49, P643, DOI 10.1016/0895-4356(96)00008-X; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Greenlee Robert T, 2003, Clin Med Res, V1, P273; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Heikkinen T, 2002, J CLIN MICROBIOL, V40, P4337, DOI 10.1128/JCM.40.11.4337-4339.2002; Heikkinen T, 2001, BMJ-BRIT MED J, V322, P138, DOI 10.1136/bmj.322.7279.138; Irving SA, 2009, VACCINE, V27, P6546, DOI 10.1016/j.vaccine.2009.08.050; Jackson ML, 2008, LANCET, V372, P398, DOI 10.1016/S0140-6736(08)61160-5; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kelly HA, 2009, MED J AUSTRALIA, V191, P146, DOI 10.5694/j.1326-5377.2009.tb02723.x; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Sato M, 2005, PEDIATR INFECT DIS J, V24, P931, DOI 10.1097/01.inf.0000180976.81055.ce; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; World Health Organization, 2009, CDC PROT REALT RTPCR	27	123	132	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2010	304	10					1091	1098		10.1001/jama.2010.1277	http://dx.doi.org/10.1001/jama.2010.1277			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646RM	20823435	Bronze			2022-12-24	WOS:000281559800019
J	Cohen, D				Cohen, Deborah			Drug Regulation Rosiglitazone: what went wrong?	BRITISH MEDICAL JOURNAL			English	Editorial Material												dcohen@bmj.com						*AM DIAB ASS, FDA REV DAT 2 NEW DI; CALABRESI M, 1916, TIME            0816; Department of Health and Human Services, 2010, ADV COMM M NDA 21071; Douglas IJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000154; *EUR MED AG, 2001, EPAR AV; *EUR MED AG, AV PROC STEPS TAK SC; Gale EAM, 2001, LANCET, V357, P1870, DOI 10.1016/S0140-6736(00)04960-6; Harris G., 2010, NY TIMES        0713; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Krentz AJ, 2000, BMJ-BRIT MED J, V321, P252, DOI 10.1136/bmj.321.7256.252; *MHRA DEAR DOCT CE, 2010, CURR ADV INF US ROS; MULLARD A, 2010, SCRIP           0730; MULLARD A, 2010, SCRIP           0106; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, EUR HEART J, V31, P773, DOI 10.1093/eurheartj/ehq016; THEPH, 1999, AV CPMP KNOCKB OV SB; US Senate Committee on Finance, 2010, STAFF REP GLAXOSMITH; 2006, SCIRPP          0922; 2007, SCRIPP          0214; 2010, GLAXOSMITHKLINE 0323; 1999, THEPHARMLETTER  0429; 1998, SCRIPP          0515; 2010, THEPHARMLETTER  0825; 1998, SCRIPP          1202; 2007, SCRIP           0801	25	73	75	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 6	2010	341								c4848	10.1136/bmj.c4848	http://dx.doi.org/10.1136/bmj.c4848			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	649ZH	20819889				2022-12-24	WOS:000281814700012
J	Das, G; Baglioni, P; Okosieme, O				Das, Gautam; Baglioni, Piero; Okosieme, Onyebuchi			Easily Missed? Primary HIV infection	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS		[Das, Gautam; Baglioni, Piero; Okosieme, Onyebuchi] Prince Charles Hosp, Merthyr Tydfil CF47 9DT, M Glam, Wales		Das, G (corresponding author), Prince Charles Hosp, Merthyr Tydfil CF47 9DT, M Glam, Wales.	drgdas@gmail.com						[Anonymous], UK NAT GUID HIV TEST; British Association for Sexual Health and HIV, 2010, BASHH STAT HIV WIND; Daar ES, 2001, ANN INTERN MED, V134, P25, DOI 10.7326/0003-4819-134-1-200101020-00010; Health Protection Agency, 2009, HIV UK 2009 REP 2009; Kassutto S, 2004, CLIN INFECT DIS, V38, P1452, DOI 10.1086/420745; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Macdonald N, 2007, SEX TRANSM INFECT, V84, P8, DOI 10.1136/sti.2007.027946; Newton PJ, 2002, BRIT MED J, V325, P1225, DOI 10.1136/bmj.325.7374.1225; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Sudarshi D, 2007, SEX TRANSM INFECT, V84, P14, DOI 10.1136/sti.2007.026963; Weintrob AC, 2003, ARCH INTERN MED, V163, P2097, DOI 10.1001/archinte.163.17.2097	12	3	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 6	2010	341								c4583	10.1136/bmj.c4583	http://dx.doi.org/10.1136/bmj.c4583			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	649ZH	20819875	Green Accepted			2022-12-24	WOS:000281814700009
J	Freemantle, N				Freemantle, Nick			Commentary: What can we learn from the continuing regulatory focus on the thiazolidinediones?	BRITISH MEDICAL JOURNAL			English	Editorial Material							MYOCARDIAL-INFARCTION; ROSIGLITAZONE		[Freemantle, Nick] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Freemantle, N (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England.	N.Freemantle@bham.ac.uk		Freemantle, Nick/0000-0001-5807-5740				Fisher R. A., 1966, DESIGN EXPT; Freemantle N, 2008, BMJ-BRIT MED J, V336, P627, DOI 10.1136/bmj.39491.493252.80; [Guidance for Industry Center for Drug Evaluation and Research Food and Drug Administration U. S. Department of Health and Human Services], 2008, GUID IND DIAB MELL E; HIGGINS JPT, COCHRANE HDB; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; TEMPLE R, 1980, NEW ENGL J MED, V303; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6	9	7	7	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 6	2010	341								c4812	10.1136/bmj.c4812	http://dx.doi.org/10.1136/bmj.c4812			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	649ZH	20819888				2022-12-24	WOS:000281814700002
J	Cheng, G; Cox, J; Wang, PH; Krishnan, MN; Dai, JF; Qian, F; Anderson, JF; Fikrig, E				Cheng, Gong; Cox, Jonathan; Wang, Penghua; Krishnan, Manoj N.; Dai, Jianfeng; Qian, Feng; Anderson, John F.; Fikrig, Erol			A C-Type Lectin Collaborates with a CD45 Phosphatase Homolog to Facilitate West Nile Virus Infection of Mosquitoes	CELL			English	Article							MANNOSE-BINDING LECTIN; PROTEIN-TYROSINE PHOSPHATASES; DENGUE-VIRUS; DC-SIGN; DENDRITIC CELL; COMPLEMENT; RECEPTOR; IDENTIFICATION; EPIDEMIOLOGY; ACTIVATION	West Nile virus (WNV) is the most common arthropod-borne flavivirus in the United States; however, the vector ligand(s) that participate in infection are not known. We now show that an Aedes aegypti C-type lectin, mosGCTL-1, is induced by WNV, interacts with WNV in a calcium-dependent manner, and facilitates infection in vivo and in vitro. A mosquito homolog of human CD45 in A. aegypti, designated mosPTP-1, recruits mosGCTL-1 to enable viral attachment to cells and to enhance viral entry. In vivo experiments show that mosGCTL-1 and mosPTP-1 function as part of the same pathway and are critical for WNV infection of mosquitoes. A similar phenomenon was also observed in Culex quinquefasciatus, a natural vector of WNV, further demonstrating that these genes participate in WNV infection. During the mosquito blood-feeding process, WNV infection was blocked in vivo with mosGCTL-1 antibodies. A molecular understanding of flaviviral-arthropod interactions may lead to strategies to control viral dissemination in nature.	[Cheng, Gong; Cox, Jonathan; Wang, Penghua; Krishnan, Manoj N.; Dai, Jianfeng; Fikrig, Erol] Yale Univ, Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT 06520 USA; [Qian, Feng] Yale Univ, Sch Med, Rheumatol Sect, Dept Internal Med, New Haven, CT 06520 USA; [Anderson, John F.] Connecticut Agr Expt Stn, Dept Entomol, New Haven, CT 06504 USA; [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Connecticut Agricultural Experiment Station; Howard Hughes Medical Institute	Fikrig, E (corresponding author), Yale Univ, Sch Med, Infect Dis Sect, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.	erol.fikrig@yale.edu	Qian, Feng/F-8186-2010; wang, Penghua/AAL-4011-2020; Dai, Jianfeng/ACP-1114-2022		National Institutes of Health [AI 50031, AI 070343]; Northeast Biodefense Center [U54-AI057158-Lipkin]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032947, R01AI041440, N01AI050031, U54AI057158, U01AI070343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI 50031 and AI 070343. We thank Yue Zhang, Lei Liu, Lili Zhang, and Sukanya Narasimhan for help with the biochemical studies, Debbie Beck for technical assistance, and Michel Ledizet for providing the purified WNV E protein and the flaviviral E protein antibodies. G.C. is a James Hudson Brown-Alexander Brown Coxe Postdoctoral Fellow at the Yale School of Medicine. P.W. is supported by a Career Development Award from Northeast Biodefense Center (U54-AI057158-Lipkin). E.F. is an investigator with the Howard Hughes Medical Institute. G.C. and E.F. designed the experiments and wrote the manuscript; G.C. performed the majority of the experiments and analyzed data; J.C. assisted the mosquito techniques; J.F.A. provided the A. aegypti and C. quinque-fasciatus mosquitoes and helped with the mosquito feeding; J.D. and F.Q. assisted in FACS and confocal microscopy; and P.W., M.N.K. and J.D. provided suggestions for the project. All authors reviewed, critiqued, and provided comments on the text.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; [Anonymous], FLAVIVIRUSES; Arnold JN, 2006, IMMUNOL LETT, V106, P103, DOI 10.1016/j.imlet.2006.05.007; Bai FW, 2007, J VIROL, V81, P2047, DOI 10.1128/JVI.01840-06; Baldwin TA, 2001, J IMMUNOL, V167, P3829, DOI 10.4049/jimmunol.167.7.3829; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Brackney DE, 2008, AM J TROP MED HYG, V79, P267, DOI 10.4269/ajtmh.2008.79.267; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Cheng G, 2009, J INTERF CYTOK RES, V29, P461, DOI 10.1089/jir.2008.0078; Chong WP, 2005, HEPATOLOGY, V42, P1037, DOI 10.1002/hep.20891; Coleman Judy, 2007, J Vis Exp, P228, DOI 10.3791/228; Dauphin G, 2007, VACCINE, V25, P5563, DOI 10.1016/j.vaccine.2006.12.005; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; EZEKOWITZ RAB, 1989, J EXP MED, V169, P185, DOI 10.1084/jem.169.1.185; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Han YS, 1999, DEV COMP IMMUNOL, V23, P553, DOI 10.1016/S0145-305X(99)00047-6; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Leis AA, 2002, NEW ENGL J MED, V347, P1279, DOI 10.1056/NEJM2002c021587; Lin CC, 2007, VIRUS RES, V124, P176, DOI 10.1016/j.virusres.2006.11.002; Lindsey NP, 2009, PEDIATRICS, V123, pE1084, DOI 10.1542/peds.2008-3278; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Neth O, 2002, J IMMUNOL, V169, P4430, DOI 10.4049/jimmunol.169.8.4430; NIR Y, 1968, AM J EPIDEMIOL, V87, P496, DOI 10.1093/oxfordjournals.aje.a120839; Pal U, 2004, CELL, V119, P457, DOI 10.1016/j.cell.2004.10.027; PIZZI M, 1950, Hum Biol, V22, P151; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Reisen W, 2007, PEST MANAG SCI, V63, P641, DOI 10.1002/ps.1325; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Saifuddin M, 2000, J GEN VIROL, V81, P949, DOI 10.1099/0022-1317-81-4-949; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Tanji T, 2006, BIOCHEM J, V396, P127, DOI 10.1042/BJ20051921; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413; van der Meulen KM, 2005, ARCH VIROL, V150, P637, DOI 10.1007/s00705-004-0463-z; Vanlandingham DL, 2007, AM J TROP MED HYG, V77, P925, DOI 10.4269/ajtmh.2007.77.925; Wilson R, 1999, J IMMUNOL, V162, P1590; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	53	125	128	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					714	725		10.1016/j.cell.2010.07.038	http://dx.doi.org/10.1016/j.cell.2010.07.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20797779	Bronze, Green Accepted			2022-12-24	WOS:000281523200015
J	Tuli, K				Tuli, Karunesh			Personal View The Commonwealth games and "Delhi belly": what India can learn from LA	BRITISH MEDICAL JOURNAL			English	Editorial Material												karuneshtuli@hotmail.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 1	2010	341								c4507	10.1136/bmj.c4507	http://dx.doi.org/10.1136/bmj.c4507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	647JT	20810484				2022-12-24	WOS:000281615500001
J	Olivier, N; Luengo-Oroz, MA; Duloquin, L; Faure, E; Savy, T; Veilleux, I; Solinas, X; Debarre, D; Bourgine, P; Santos, A; Peyrieras, N; Beaurepaire, E				Olivier, Nicolas; Luengo-Oroz, Miguel A.; Duloquin, Louise; Faure, Emmanuel; Savy, Thierry; Veilleux, Israel; Solinas, Xavier; Debarre, Delphine; Bourgine, Paul; Santos, Andres; Peyrieras, Nadine; Beaurepaire, Emmanuel			Cell Lineage Reconstruction of Early Zebrafish Embryos Using Label-Free Nonlinear Microscopy	SCIENCE			English	Article							3RD-HARMONIC GENERATION MICROSCOPY; 2ND-HARMONIC GENERATION; DEVELOPMENTAL BIOLOGY; HARMONIC-GENERATION; ZYGOTIC TRANSITION; ORIGIN; EMBRYOGENESIS; FLUORESCENCE	Quantifying cell behaviors in animal early embryogenesis remains a challenging issue requiring in toto imaging and automated image analysis. We designed a framework for imaging and reconstructing unstained whole zebrafish embryos for their first 10 cell division cycles and report measurements along the cell lineage with micrometer spatial resolution and minute temporal accuracy. Point-scanning multiphoton excitation optimized to preferentially probe the innermost regions of the embryo provided intrinsic signals highlighting all mitotic spindles and cell boundaries. Automated image analysis revealed the phenomenology of cell proliferation. Blastomeres continuously drift out of synchrony. After the 32-cell stage, the cell cycle lengthens according to cell radial position, leading to apparent division waves. Progressive amplification of this process is the rule, contrasting with classical descriptions of abrupt changes in the system dynamics.	[Duloquin, Louise; Peyrieras, Nadine] CNRS, Inst Neurobiol Alfred Fessard, Gif Sur Yvette, France; [Olivier, Nicolas; Veilleux, Israel; Solinas, Xavier; Debarre, Delphine; Beaurepaire, Emmanuel] Ecole Polytech, CNRS, INSERM, Lab Opt & Biosci, F-91128 Palaiseau, France; [Luengo-Oroz, Miguel A.; Santos, Andres] Univ Politecn Madrid, Madrid, Spain; [Luengo-Oroz, Miguel A.; Santos, Andres] CIBER, Biomed Res Ctr, BBN, Madrid, Spain; [Faure, Emmanuel; Savy, Thierry; Bourgine, Paul] Ecole Polytech, CNRS, Ctr Rech Epistemol Appl, F-75230 Paris, France; [Bourgine, Paul] Reseau Natl Syst Complexes, Paris, France; [Peyrieras, Nadine] Inst Syst Complexes Paris Ile de France, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris; Universidad Politecnica de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Centre National de la Recherche Scientifique (CNRS)	Peyrieras, N (corresponding author), CNRS, Inst Neurobiol Alfred Fessard, Gif Sur Yvette, France.	nadine.peyrieras@inaf.cnrs-gif.fr; emmanuel.beaurepaire@polytechnique.edu	Olivier, Nicolas/AAM-4414-2021; Luengo-Oroz, Miguel A/C-2245-2011; Beaurepaire, Emmanuel/C-6343-2014; Santos, Andres/C-4012-2009	Luengo-Oroz, Miguel A/0000-0002-8694-2001; Beaurepaire, Emmanuel/0000-0002-2082-8214; Santos, Andres/0000-0001-7423-9135; Olivier, Nicolas/0000-0001-9042-5456; Peyrieras, Nadine/0000-0002-4905-6414; Debarre, Delphine/0000-0002-0513-6172; Faure, Emmanuel/0000-0003-2787-0885; savy, thierry/0000-0001-5970-3817	Direction Generale de l'Armament; Agence Nationale de la Recherche,; FP6 New Emerging Science and Technology program; Association pour le Recherche Contre le Cancer; Egide Picasso France-Spain; Fondation Louis D.; Institut de France	Direction Generale de l'Armament; Agence Nationale de la Recherche,(French National Research Agency (ANR)); FP6 New Emerging Science and Technology program; Association pour le Recherche Contre le Cancer; Egide Picasso France-Spain; Fondation Louis D.; Institut de France	We thank G. Lutfalla for pAct26H2B/mcherry, pAct26mcherry-F DNA constructs, and transgenic fish lines. We thank P. Herbomel, C. Little, J.-L. Martin, H. Myllykallio, and J.-L. Rubio for critical reading of the manuscript. This work was supported by Direction Generale de l'Armament, Agence Nationale de la Recherche, FP6 New Emerging Science and Technology program, Association pour le Recherche Contre le Cancer, Egide Picasso France-Spain, and Fondation Louis D., Institut de France. Patent application PCT/FR2010/050173 describes the combination of conformal acquisition and beam conditioning in scanning microscopy of 3D objects.	Abrams EW, 2009, CURR OPIN GENET DEV, V19, P396, DOI 10.1016/j.gde.2009.06.002; Barad Y, 1997, APPL PHYS LETT, V70, P922, DOI 10.1063/1.118442; Campagnola PJ, 2002, BIOPHYS J, V82, P493, DOI 10.1016/S0006-3495(02)75414-3; Debarre D, 2005, OPT LETT, V30, P2134, DOI 10.1364/OL.30.002134; Debarre D, 2004, OPT LETT, V29, P2881, DOI 10.1364/OL.29.002881; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; KANE DA, 1992, NATURE, V360, P735, DOI 10.1038/360735a0; KANE DA, 1993, DEVELOPMENT, V119, P447; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kwan AC, 2008, P NATL ACAD SCI USA, V105, P11370, DOI 10.1073/pnas.0805199105; Levraud JP, 2007, J IMMUNOL, V178, P4385, DOI 10.4049/jimmunol.178.7.4385; Lu XM, 2009, DEVELOPMENT, V136, P2101, DOI 10.1242/dev.034421; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; McMahon A, 2008, SCIENCE, V322, P1546, DOI 10.1126/science.1167094; Muzzey D, 2009, ANNU REV CELL DEV BI, V25, P301, DOI 10.1146/annurev.cellbio.042308.113408; Oates AC, 2009, NAT REV GENET, V10, P517, DOI 10.1038/nrg2548; Oron D, 2004, J STRUCT BIOL, V147, P3, DOI 10.1016/S1047-8477(03)00125-4; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Sun CK, 2004, J STRUCT BIOL, V147, P19, DOI 10.1016/j.jsb.2003.10.017; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; TRINKAUS JP, 1993, J EXP ZOOL, V265, P258, DOI 10.1002/jez.1402650308; Vachier C, 2005, J MATH IMAGING VIS, V22, P251, DOI 10.1007/s10851-005-4893-3; Yabe T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000518; Zimmer C, 2006, IEEE SIGNAL PROC MAG, V23, P54, DOI 10.1109/MSP.2006.1628878; Zipfel WR, 2003, P NATL ACAD SCI USA, V100, P7075, DOI 10.1073/pnas.0832308100	27	258	264	4	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					967	971		10.1126/science.1189428	http://dx.doi.org/10.1126/science.1189428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724640	Green Submitted			2022-12-24	WOS:000281084800041
J	van Ham, TJ; Holmberg, MA; van der Goot, AT; Teuling, E; Garcia-Arencibia, M; Kim, HE; Du, D; Thijssen, KL; Wiersma, M; Burggraaff, R; van Bergeijk, P; van Rheenen, J; van Veluw, GJ; Hofstra, RMW; Rubinsztein, DC; Nollen, EAA				van Ham, Tjakko J.; Holmberg, Mats A.; van der Goot, Annemieke T.; Teuling, Eva; Garcia-Arencibia, Moises; Kim, Hyun-eui; Du, Deguo; Thijssen, Karen L.; Wiersma, Marit; Burggraaff, Rogier; van Bergeijk, Petra; van Rheenen, Jeroen; van Veluw, G. Jerre; Hofstra, Robert M. W.; Rubinsztein, David C.; Nollen, Ellen A. A.			Identification of MOAG-4/SERF as a Regulator of Age-Related Proteotoxicity	CELL			English	Article							INCLUSION-BODY FORMATION; POLYGLUTAMINE EXPANSIONS; CAENORHABDITIS-ELEGANS; PROTEIN-DEGRADATION; CELLULAR TOXICITY; MUTANT HUNTINGTIN; AGGREGATION; NEURODEGENERATION; TRANSCRIPTION; LONGEVITY	Fibrillar protein aggregates are the major pathological hallmark of several incurable, age-related, neurodegenerative disorders. These aggregates typically contain aggregation-prone pathogenic proteins, such as amyloid-beta in Alzheimer's disease and alpha-synuclein in Parkinson's disease. It is, however, poorly understood how these aggregates are formed during cellular aging. Here we identify an evolutionarily highly conserved modifier of aggregation, MOAG-4, as a positive regulator of aggregate formation in C. elegans models for polyglutamine diseases. Inactivation of MOAG-4 suppresses the formation of compact polyglutamine aggregation intermediates that are required for aggregate formation. The role of MOAG-4 in driving aggregation extends to amyloid-beta and alpha-synuclein and is evolutionarily conserved in its human orthologs SERF1A and SERF2. MOAG-4/SERF appears to act independently from HSF-1-induced molecular chaperones, proteasomal degradation, and autophagy. Our results suggest that MOAG-4/SERF regulates age-related proteotoxicity through a previously unexplored pathway, which will open up new avenues for research on age-related, neurodegenerative diseases.	[van Ham, Tjakko J.; Holmberg, Mats A.; van der Goot, Annemieke T.; Teuling, Eva; Thijssen, Karen L.; Wiersma, Marit; Burggraaff, Rogier; van Bergeijk, Petra; van Rheenen, Jeroen; van Veluw, G. Jerre; Hofstra, Robert M. W.; Nollen, Ellen A. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Garcia-Arencibia, Moises; Rubinsztein, David C.] Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Addenbrookes Hosp, Cambridge CB2 0XY, England; [Kim, Hyun-eui] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Du, Deguo] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Du, Deguo] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Du, Deguo] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University of Groningen; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Salk Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Nollen, EAA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	e.a.a.nollen@medgen.umcg.nl	Garcia-Arencibia, Moises/B-5538-2012; van Ham, Tjakko/W-8614-2019; Kim, Hyun-Eui/GOV-5988-2022; Garcia-Arencibia, Moises/K-9920-2013; van Ham, Tjakko/A-1989-2015; Rubinsztein, David C/C-3472-2011; van Ham, Tjakko/I-2382-2013	van Ham, Tjakko/0000-0002-2175-8713; Kim, Hyun-Eui/0000-0003-1495-1993; Garcia-Arencibia, Moises/0000-0002-1618-4487; van Ham, Tjakko/0000-0002-2175-8713; Hofstra, Robert/0000-0001-7498-3829	GUIDE; Wellcome Trust; MRC Program; NIA [P01 AG031097]; ZonMw Research Institute of the Elderly; Prinses Beatrix Fonds; de Vereniging van Huntington; Nederlandse Hersenstichting; UMCG Rosalind Franklin Fellowship; Medical Research Council [G0600194] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG031097] Funding Source: NIH RePORTER; MRC [G0600194] Funding Source: UKRI	GUIDE; Wellcome Trust(Wellcome TrustEuropean Commission); MRC Program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ZonMw Research Institute of the Elderly; Prinses Beatrix Fonds; de Vereniging van Huntington; Nederlandse Hersenstichting; UMCG Rosalind Franklin Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources, Rick Morimoto, Tali Gidalevitz, Chris Link, and the Mitani lab for C. elegans strains, Ronald Plasterk for advice, Lieke Geerts for assistance, Andy Dillin and Jeff Kelly for reagents and support, and Jackie Senior for editing the manuscript. We thank Klaas Sjollema from the UMCG Microscopy and Imaging Center (UMIC) and Anke Terwisscha van Scheltinga for advice, Ritsert Jansen and Cisca Wijmenga for reading the manuscript, and the anonymous reviewers for suggestions. This project was funded by a GUIDE Top Master's fellowship (to A.T.v.d.G.), a Wellcome Trust Senior Fellowship (to D.C.R.), an MRC Program Grant (to D.C.R.), NIA P01 AG031097 (A.D. and J.W.K.), the ZonMw Research Institute of the Elderly, the Prinses Beatrix Fonds, de Vereniging van Huntington, the Nederlandse Hersenstichting, and a UMCG Rosalind Franklin Fellowship (to E.A.A.N.).	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; BRENNER S, 1974, GENETICS, V77, P71; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; Gidalevitz T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000399; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Nollen EAA, 2001, P NATL ACAD SCI USA, V98, P12038, DOI 10.1073/pnas.201112398; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ofran Y, 2003, FEBS LETT, V544, P236, DOI 10.1016/S0014-5793(03)00456-3; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scharf JM, 1998, NAT GENET, V20, P83, DOI 10.1038/1753; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sittler A, 1998, MOL CELL, V2, P427, DOI 10.1016/S1097-2765(00)80142-2; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tissenbaum HA, 1998, GENETICS, V148, P703; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721	55	77	82	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					601	612		10.1016/j.cell.2010.07.020	http://dx.doi.org/10.1016/j.cell.2010.07.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723760	Bronze			2022-12-24	WOS:000281115900014
J	Lentine, KL; Schnitzler, MA; Xiao, HL; Saab, G; Salvalaggio, PR; Axelrod, D; Davis, CL; Abbott, KC; Brennan, DC				Lentine, Krista L.; Schnitzler, Mark A.; Xiao, Huiling; Saab, Georges; Salvalaggio, Paolo R.; Axelrod, David; Davis, Connie L.; Abbott, Kevin C.; Brennan, Daniel C.			Racial Variation in Medical Outcomes among Living Kidney Donors	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STAGE RENAL-DISEASE; HYPERTENSION PREVALENCE; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; TRANSPLANTATION; RATES; AWARENESS; RISK; DISPARITIES; INSURANCE	BACKGROUND Data regarding health outcomes among living kidney donors are lacking, especially among nonwhite persons. METHODS We linked identifiers from the Organ Procurement and Transplantation Network (OPTN) with administrative data of a private U. S. health insurer and performed a retrospective study of 4650 persons who had been living kidney donors from October 1987 through July 2007 and who had post-donation nephrectomy benefits with this insurer at some point from 2000 through 2007. We ascertained post-nephrectomy medical diagnoses and conditions requiring medical treatment from billing claims. Cox regression analyses with left and right censoring to account for observed periods of insurance benefits were used to estimate absolute prevalence and prevalence ratios for diagnoses after nephrectomy. We then compared prevalence patterns with those in the 2005-2006 National Health and Nutrition Examination Survey (NHANES) for the general population. RESULTS Among the donors, 76.3% were white, 13.1% black, 8.2% Hispanic, and 2.4% another race or ethnic group. The median time from donation to the end of insurance benefits was 7.7 years. After kidney donation, black donors, as compared with white donors, had an increased risk of hypertension (adjusted hazard ratio, 1.52; 95% confidence interval [CI], 1.23 to 1.88), diabetes mellitus requiring drug therapy (adjusted hazard ratio, 2.31; 95% CI, 1.33 to 3.98), and chronic kidney disease (adjusted hazard ratio, 2.32; 95% CI, 1.48 to 3.62); findings were similar for Hispanic donors. The absolute prevalence of diabetes among all donors did not exceed that in the general population, but the prevalence of hypertension exceeded NHANES estimates in some subgroups. End-stage renal disease was identified in less than 1% of donors but was more common among black donors than among white donors. CONCLUSIONS As in the general U. S. population, racial disparities in medical conditions occur among living kidney donors. Increased attention to health outcomes among demographically diverse kidney donors is needed.	[Lentine, Krista L.] St Louis Univ, Ctr Outcomes Res, Salus Ctr, Sch Med, St Louis, MO 63104 USA; [Lentine, Krista L.] St Louis Univ, Sch Med, Div Nephrol, St Louis, MO 63104 USA; [Saab, Georges; Brennan, Daniel C.] Washington Univ, Div Nephrol, Sch Med, St Louis, MO 63130 USA; [Salvalaggio, Paolo R.; Davis, Connie L.] Univ Washington, Kidney & Pancreas Transplant Program, Seattle, WA 98195 USA; [Axelrod, David] Dartmouth Hitchcock Med Ctr, Dept Surg, Hanover, NH USA; [Abbott, Kevin C.] Walter Reed Army Med Ctr, Serv Nephrol, Washington, DC 20307 USA	Saint Louis University; Saint Louis University; Washington University (WUSTL); University of Washington; University of Washington Seattle; Dartmouth College; United States Department of Defense; United States Army; Walter Reed National Military Medical Center	Lentine, KL (corresponding author), St Louis Univ, Ctr Outcomes Res, Salus Ctr, Sch Med, 4th Fl,3545 Lafayette Ave, St Louis, MO 63104 USA.	lentinek@slu.edu	Lentine, Krista/AAQ-6549-2020	Lentine, Krista/0000-0002-9423-4849; Abbott, Kevin/0000-0003-2111-7112; Axelrod, David/0000-0001-5684-0613	National Institute of Diabetes and Digestive and Kidney Diseases [K08DK073036, P30DK079333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK073036, P30DK079333, K24DK002886] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by grants (K08DK073036 and P30DK079333) from the National Institute of Diabetes and Digestive and Kidney Diseases.	Agency for Healthcare Research and Quality, CREAT VAL IND SOC ST; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; BRANCATI FL, 1992, JAMA-J AM MED ASSOC, V268, P3079, DOI 10.1001/jama.268.21.3079; Brown RS, 2009, AM J TRANSPLANT, V9, P31, DOI 10.1111/j.1600-6143.2008.02433.x; Carter JS, 1996, ANN INTERN MED, V125, P221, DOI 10.7326/0003-4819-125-3-199608010-00011; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Cherikh WS, 2008, AM J TRANSPLANT, V8, P335; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Delmonico FL, 2005, TRANSPLANTATION, V79, pS53; Garg AX, 2008, TRANSPLANTATION, V86, P399, DOI 10.1097/TP.0b013e31817ba9e3; Gibney EM, 2007, TRANSPLANTATION, V84, P647, DOI 10.1097/01.tp.0000277288.78771.c2; Gore JL, 2009, AM J TRANSPLANT, V9, P1124, DOI 10.1111/j.1600-6143.2009.02620.x; Graham W, 2008, LIVING DONOR FOLLOW; HAFFNER SM, 1990, HYPERTENSION, V16, P225, DOI 10.1161/01.HYP.16.3.225; Hebert P L, 1999, Am J Med Qual, V14, P270, DOI 10.1177/106286069901400607; Herring AA, 2008, INT J HEALTH SERV, V38, P641, DOI 10.2190/HS.38.4.d; Horvat LD, 2009, KIDNEY INT, V75, P1088, DOI 10.1038/ki.2009.20; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Lentine KL, 2009, CLIN J AM SOC NEPHRO, V4, P1213, DOI 10.2215/CJN.00670109; Mandelbrot DA, 2009, TRANSPLANTATION, V88, P855, DOI 10.1097/TP.0b013e3181b6dfb9; MITCHELL BD, 1990, AM J EPIDEMIOL, V131, P423, DOI 10.1093/oxfordjournals.aje.a115517; National Institute of Diabetes and Digestive and Kidney Diseases, 2008, US REN DAT SYST USRD; Nogueira JM, 2009, TRANSPLANTATION, V88, P1371, DOI 10.1097/TP.0b013e3181c1e156; Ommen ES, 2010, AM J TRANSPLANT, V10, P747, DOI 10.1111/j.1600-6143.2009.02994.x; Ommen ES, 2006, CLIN J AM SOC NEPHRO, V1, P885, DOI 10.2215/CJN.00840306; *ORG PROC TRANSPL, AB OPTN DAT; Organ Procurement and Transplantation Network, ORG PROC TRANSPL NET; PAPPAS G, 1990, AM J PUBLIC HEALTH, V80, P1431, DOI 10.2105/AJPH.80.12.1431; RAMIREZ E A, 1991, Ethnicity and Disease, V1, P188; Reeves-Daniel A, 2009, CLIN TRANSPLANT, V23, P39, DOI 10.1111/j.1399-0012.2008.00898.x; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; Stevens LA, 2005, J AM SOC NEPHROL, V16, P2439, DOI 10.1681/ASN.2005020192; STORSLEY LJ, 2010, TRANSPLANTATION 0618; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601; Textor SC, 2004, TRANSPLANTATION, V78, P276, DOI 10.1097/01.TP.0000128168.97735.B3; Wainright JL, 2009, AM J TRANSPLANT, V9, P310; Young CJ, 2000, NEW ENGL J MED, V343, P1545, DOI 10.1056/NEJM200011233432107	39	203	204	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2010	363	8					724	732		10.1056/NEJMoa1000950	http://dx.doi.org/10.1056/NEJMoa1000950			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639TE	20818874	Green Accepted, Green Published			2022-12-24	WOS:000280996600006
J	Potrykus, I				Potrykus, Ingo			Regulation must be revolutionized	NATURE			English	Editorial Material											Potrykus, I (corresponding author), Stigler 54, CH-4312 Magden, Switzerland.	ingo@potrykus.ch						POTRYKUS I, TRANSGENIC IN PRESS	1	53	54	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 29	2010	466	7306					561	561		10.1038/466561a	http://dx.doi.org/10.1038/466561a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	632HA	20671692	hybrid			2022-12-24	WOS:000280412100018
J	Spence, D				Spence, Des			From the Frontline Bad medicine: medicated minors	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2010	341								c3907	10.1136/bmj.c3907	http://dx.doi.org/10.1136/bmj.c3907			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GW	20659982				2022-12-24	WOS:000280411700022
J	Sheard, LB; Tan, X; Mao, HB; Withers, J; Ben-Nissan, G; Hinds, TR; Kobayashi, Y; Hsu, FF; Sharon, M; Browse, J; He, SY; Rizo, J; Howe, GA; Zheng, N				Sheard, Laura B.; Tan, Xu; Mao, Haibin; Withers, John; Ben-Nissan, Gili; Hinds, Thomas R.; Kobayashi, Yuichi; Hsu, Fong-Fu; Sharon, Michal; Browse, John; He, Sheng Yang; Rizo, Josep; Howe, Gregg A.; Zheng, Ning			Jasmonate perception by inositol-phosphate-potentiated COI1-JAZ co-receptor	NATURE			English	Article							BOX PROTEIN TIR1; REGULATED DEFENSE; ISOLEUCINE; RECEPTOR; CORONATINE; MECHANISM; ACID; RECOGNITION; REPRESSION; SOFTWARE	Jasmonates are a family of plant hormones that regulate plant growth, development and responses to stress. The F-box protein CORONATINE INSENSITIVE 1 (COI1) mediates jasmonate signalling by promoting hormone-dependent ubiquitylation and degradation of transcriptional repressor JAZ proteins. Despite its importance, the mechanism of jasmonate perception remains unclear. Here we present structural and pharmacological data to show that the true Arabidopsis jasmonate receptor is a complex of both COI1 and JAZ. COI1 contains an open pocket that recognizes the bioactive hormone (3R, 7S)-jasmonoyl-L-isoleucine (JA-Ile) with high specificity. High-affinity hormone binding requires a bipartite JAZ degron sequence consisting of a conserved a-helix for COI1 docking and a loop region to trap the hormone in its binding pocket. In addition, we identify a third critical component of the jasmonate co-receptor complex, inositol pentakisphosphate, which interacts with both COI1 and JAZ adjacent to the ligand. Our results unravel the mechanism of jasmonate perception and highlight the ability of F-box proteins to evolve as multi-component signalling hubs.	[Sheard, Laura B.; Tan, Xu; Mao, Haibin; Hinds, Thomas R.; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Withers, John; He, Sheng Yang; Howe, Gregg A.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA; [Withers, John; He, Sheng Yang] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Ben-Nissan, Gili; Sharon, Michal] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Kobayashi, Yuichi] Tokyo Inst Technol, Dept Biol Engn, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Hsu, Fong-Fu] Washington Univ, Sch Med, Dept Internal Med, Div Endocrinol Diabet Metab & Lipid Res, St Louis, MO 63110 USA; [Browse, John] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Howe, Gregg A.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Michigan State University; Michigan State University; Weizmann Institute of Science; Tokyo Institute of Technology; Washington University (WUSTL); Washington State University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Michigan State University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu	Mao, Haibin/B-7609-2011; Tan, Xu/E-7170-2011; Howe, Gregg A/N-1887-2014	Tan, Xu/0000-0003-4861-4573; Howe, Gregg A/0000-0002-9218-979X; Hsu, Fong-Fu/0000-0001-5368-0183; He, Sheng Yang/0000-0003-1308-498X; Sharon, Michal/0000-0003-3933-0595; Browse, John/0000-0002-2554-2821	Howard Hughes Medical Institute; National Institutes of Health [R01 CA107134, T32 GM07270, R01GM57795, R01AI068718]; National Science Foundation [0929100]; US Department of Energy [DE-FG02-99ER20323, DE-FG02-91ER20021]; Michigan State University; Welch Foundation [I-1304]; European Research Council (ERC) under the European Community [239679]; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057795, T32GM007270] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); Michigan State University; Welch Foundation(The Welch Foundation); European Research Council (ERC) under the European Community(European Research Council (ERC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the beamline staff of the Advanced Light Source at the University of California at Berkeley and the Advanced Photon Source at Argonne National Laboratory for help with data collection. We also thank P. Rajagopal and R. Klevit for <SUP>31</SUP>P NMR analysis, M. Sadilek for mass spectrometry analysis, L. Katsir, C. Hague and J. Lyssand for radioligand binding assay assistance, and C. Mecey and M. Melotto for initial cloning of coi1(sdm) mutants. We also thank members of the Zheng laboratory and W. Xu laboratory and R. Gardner for discussion and help. This work is supported by the Howard Hughes Medical Institute and grants from the National Institutes of Health (R01 CA107134 to N.Z., T32 GM07270 to L.B.S., R01GM57795 to G.A.H., R01AI068718 to S.Y.H.), National Science Foundation (0929100 to N.Z.), US Department of Energy (DE-FG02-99ER20323 to J.B. and DE-FG02-91ER20021 to G.A.H. and S.Y.H.), Michigan State University Plant Science Fellowship (J.W.), the Welch Foundation (I-1304 to J.R.) and the European Research Council (ERC) under the European Community's Seventh Framework Program (FP7/2007-2013)/ERC Grant agreement no. 239679 (G.B.-N. and M.S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2010, PLANT J, V63, P613, DOI 10.1111/j.1365-313X.2010.04265.x; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Grunewald W, 2009, EMBO REP, V10, P923, DOI 10.1038/embor.2009.103; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nettleton EJ, 1998, J MOL BIOL, V281, P553, DOI 10.1006/jmbi.1998.1937; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Ogawa N, 2008, TETRAHEDRON LETT, V49, P7124, DOI 10.1016/j.tetlet.2008.09.144; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SADRZADEH SMH, 1993, J PHARMACOL TOXICOL, V30, P103, DOI 10.1016/1056-8719(93)90013-5; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Shimada A, 2008, NATURE, V456, P520, DOI 10.1038/nature07546; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; STEPHENS LR, 1991, BIOCHEM J, V275, P485, DOI 10.1042/bj2750485; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Yan JB, 2009, PLANT CELL, V21, P2220, DOI 10.1105/tpc.109.065730; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730	38	891	961	13	285	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					400	U301		10.1038/nature09430	http://dx.doi.org/10.1038/nature09430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	20927106	Green Accepted, Green Submitted			2022-12-24	WOS:000284313100035
J	Scheinberg, P; Cooper, JN; Sloand, EM; Wu, CO; Calado, RT; Young, NS				Scheinberg, Phillip; Cooper, James N.; Sloand, Elaine M.; Wu, Colin O.; Calado, Rodrigo T.; Young, Neal S.			Association of Telomere Length of Peripheral Blood Leukocytes With Hematopoietic Relapse, Malignant Transformation, and Survival in Severe Aplastic Anemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTI-THYMOCYTE GLOBULIN; ANTITHYMOCYTE GLOBULIN; ULCERATIVE-COLITIS; CYCLOSPORINE; CANCER; DISEASE; INSTABILITY; PROGRESSION; MUTATIONS; CARCINOMA	Context Critically short telomeres produce apoptosis, cell senescence, and chromosomal instability in tissue culture and animal models. Variations in telomere length have been reported in severe aplastic anemia but their clinical significance is unknown. Objective To investigate the relationship between telomere length and clinical outcomes in severe aplastic anemia. Design, Setting, and Patients Single institution analysis of 183 patients with severe aplastic anemia who were treated in sequential prospective protocols at the National Institutes of Health from 2000 to 2008. The pretreatment leukocyte age-adjusted telomere length of patients with severe aplastic anemia consecutively enrolled in immunosuppression protocols with antithymocyte globulin plus cyclosporine for correlation with clinical outcomes were analyzed. Main Outcome Measures Hematologic response, relapse, clonal evolution, and survival. Results There was no relationship between hematologic response and telomere length with response rates of 56.5% of 46 patients in the first, 54.3% of 46 in the second, 60% of 45 in the third, and 56.5% of 46 in the fourth quartiles. Multivariate analysis demonstrated that telomere length was associated with relapse, clonal evolution, and mortality. Evaluated as a continuous variable, telomere length inversely correlated with the probability of hematologic relapse (hazard ratio [HR], 0.16; 95% confidence interval [CI], 0.03-0.69; P=.01). The probability of clonal evolution was higher in patients in the first quartile (24.5%; 95% CI, 8.7%-37.5%) than in quartiles 2 through 4 (8.4%; 95% CI, 3.2%-13.3%; P=.009), and evolution to monosomy 7 or complex cytogenetics was more common in the first quartile (18.8%; 95% CI, 3.5%-31.6%) than in quartiles 2 through 4 (4.5%; 95% CI, 0.5%-8.2%; P=.002). Survival between these 2 groups differed, with 66% (95% CI, 52.9%-82.5%) surviving 6 years in the first quartile compared with 83.8% (95% CI, 77.3%-90.9%) in quartiles 2 through 4 (P=.008). Conclusion In a cohort of patients with severe aplastic anemia receiving immunosuppressive therapy, telomere length was unrelated to response but was associated with risk of relapse, clonal evolution, and overall survival. JAMA. 2010; 304(12): 1358-1364	[Scheinberg, Phillip; Cooper, James N.; Sloand, Elaine M.; Calado, Rodrigo T.; Young, Neal S.] NHLBI, Hematol Branch, Bethesda, MD 20892 USA; [Wu, Colin O.] NHLBI, Off Biostat Res, Bethesda, MD 20892 USA; [Cooper, James N.] NIH, Clin Res Training Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; Pfizer	Scheinberg, P (corresponding author), NHLBI, Hematol Branch, 10 Ctr Dr,Bldg 10 CRC,Room 3-5140,MSC 1202, Bethesda, MD 20892 USA.	scheinbp@mail.nih.gov	Calado, Rodrigo T./G-2619-2011; Scheinberg, Phillip/H-5251-2012	Calado, Rodrigo T./0000-0002-7966-6029; Scheinberg, Phillip/0000-0002-9047-4538	National Institutes of Health; National Heart, Lung, and Blood Institute; Pfizer Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006089, ZIAHL002315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pfizer Inc(Pfizer); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the Intramural Research Program of the National Institutes of Health; the National Heart, Lung, and Blood Institute. Dr Cooper's research year was made possible through the Clinical Research Training Program (CRTP), a public-private partnership supported jointly by the National Institutes of Health and Pfizer Inc (via a grant to the Foundation for National Institutes of Health from Pfizer Inc).	Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Ball SE, 1998, BLOOD, V91, P3582; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Brummendorf TH, 2001, BLOOD, V97, P895, DOI 10.1182/blood.V97.4.895; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Calado RT, 2009, BLOOD, V114, P2236, DOI 10.1182/blood-2008-09-178871; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Engelhardt M, 1997, CLIN CANCER RES, V3, P1931; Feldser DM, 2007, CANCER CELL, V11, P461, DOI 10.1016/j.ccr.2007.02.026; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Maciejewski JP, 2002, BLOOD, V99, P3129, DOI 10.1182/blood.V99.9.3129; Meeker AK, 2002, CANCER RES, V62, P6405; Morrish TA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000357; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Risques RA, 2007, CANCER EPIDEM BIOMAR, V16, P2649, DOI 10.1158/1055-9965.EPI-07-0624; Rosenfeld S, 2003, JAMA-J AM MED ASSOC, V289, P1130, DOI 10.1001/jama.289.9.1130; Rossi D, 2009, LEUKEMIA, V23, P1062, DOI 10.1038/leu.2008.399; Scheinberg P, 2006, BRIT J HAEMATOL, V133, P622, DOI 10.1111/j.1365-2141.2006.06098.x; Scheinberg P, 2006, BRIT J HAEMATOL, V133, P606, DOI 10.1111/j.1365-2141.2006.06085.x; Scheinberg P, 2009, HAEMATOL-HEMATOL J, V94, P348, DOI 10.3324/haematol.13829; Scheinberg P, 2009, BRIT J HAEMATOL, V144, P206, DOI 10.1111/j.1365-2141.2008.07450.x; Svenson U, 2009, CANCER RES, V69, P2896, DOI 10.1158/0008-5472.CAN-08-3513; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777	31	147	170	1	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2010	304	12					1358	1364		10.1001/jama.2010.1376	http://dx.doi.org/10.1001/jama.2010.1376			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652LK	20858879	Green Accepted			2022-12-24	WOS:000282007900019
J	Zagrosek, A; Messroghli, D; Schulz, O; Dietz, R; Schulz-Menger, J				Zagrosek, Anja; Messroghli, Daniel; Schulz, Olaf; Dietz, Rainer; Schulz-Menger, Jeanette			Effect of Binge Drinking on the Heart as Assessed by Cardiac Magnetic Resonance Imaging	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MYOCARDITIS; ALCOHOL		[Zagrosek, Anja; Schulz-Menger, Jeanette] Humboldt Univ, Charite Campus Buch, HELIOS Clin, Clin Cardiol, D-1086 Berlin, Germany; [Messroghli, Daniel] Deutsch Herzzentrum Berlin, Dept Congenital Heart Defects & Pediat Cardiol, Berlin, Germany; [Schulz, Olaf] Intervent Kardiol Spandau, Berlin, Germany; [Dietz, Rainer] Humboldt Univ, Charite Campus Virchow, Dept Cardiol, D-1086 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Zagrosek, A (corresponding author), Humboldt Univ, Charite Campus Buch, HELIOS Clin, Clin Cardiol, D-1086 Berlin, Germany.	anja.zagrosek@charite.de		Schulz-Menger, Jeanette/0000-0003-3100-1092				Goral J, 2008, ALCOHOL, V42, P237, DOI 10.1016/j.alcohol.2008.02.003; Jaffe A S, 2001, Cardiovasc Toxicol, V1, P87, DOI 10.1385/CT:1:2:087; Kim DJ, 2003, ALCOHOL, V31, P167, DOI 10.1016/j.alcohol.2003.09.003; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1340, DOI 10.1016/j.jacc.2005.02.011; Urbano-Marquez A, 2004, MUSCLE NERVE, V30, P689, DOI 10.1002/mus.20168; Zagrosek A, 2009, JACC-CARDIOVASC IMAG, V2, P131, DOI 10.1016/j.jcmg.2008.09.014	6	32	33	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2010	304	12					1328	1330		10.1001/jama.2010.1343	http://dx.doi.org/10.1001/jama.2010.1343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652LK	20858877	Bronze			2022-12-24	WOS:000282007900014
J	Singh, SK; Sabatinos, S; Forsburg, S; Bastia, D				Singh, Samarendra K.; Sabatinos, Sarah; Forsburg, Susan; Bastia, Deepak			Regulation of Replication Termination by Reb1 Protein-Mediated Action at a Distance	CELL			English	Article							SCHIZOSACCHAROMYCES-POMBE; ESCHERICHIA-COLI; DNA-REPLICATION; RIBOSOMAL DNA; POLAR ARREST; FORK ARREST; GENE; ORGANIZATION; CONTRAHELICASE; MECHANISM	DNA transactions driven by long-range protein-mediated inter-and intrachromosomal interactions have been reported to influence gene expression. Here, we report that site-specific replication termination in Schizosaccharomyces pombe is modulated by protein-mediated interactions between pairs of Ter sites located either on the same or on different chromosomes. The dimeric Reb1 protein catalyzes termination and mediates interaction between Ter sites. The Reb1-dependent interactions between two antiparallel Ter sites in cis caused looping out of the intervening DNA in vitro and enhancement of fork arrest in vivo. A Ter site on chromosome 2 interacted pairwise with two Ter sites located on chromosome 1 by chromosome kissing. Mutational inactivation of the major interacting Ter site on chromosome 1 significantly reduced fork arrest at the Ter site on chromosome 2, thereby revealing a cooperative mechanism of control of replication termination.	[Singh, Samarendra K.; Bastia, Deepak] Med Univ S Carolina, Dept Mol Biol & Biochem, Charleston, SC 29425 USA; [Sabatinos, Sarah; Forsburg, Susan] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	Medical University of South Carolina; University of Southern California	Bastia, D (corresponding author), Med Univ S Carolina, Dept Mol Biol & Biochem, Charleston, SC 29425 USA.	bastia@musc.edu		Forsburg, Susan L/0000-0002-4895-8598	 [GM 049264];  [GM 049264-17S1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049264, R01GM059321] Funding Source: NIH RePORTER	; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the grants GM 049264 and GM 049264-17S1 to D.B. We thank Louise Pape (University of Wisconsin) for strains and S. Biswas for technical help with one of the experiments. We also thank Carlos Escalante (VCU, Richmond, VA) for performing bioinformatics analysis of Reb1 and pointing out the presence of SANT-like domains within the myb-associated domain of Reb1, Tony Carr, Robert Schleif, and Fred Winston for useful comments on our manuscript, and Pablo Hernandez for allowing us to cite his work before its publication.	ARCANGIOLI B, 1991, EMBO J, V10, P3025, DOI 10.1002/j.1460-2075.1991.tb07853.x; Bastia D., 1996, DNA REPLICATION EUKA, P177; Bastia D, 2008, P NATL ACAD SCI USA, V105, P12831, DOI 10.1073/pnas.0805898105; Bastia Deepak, 2006, V47, P155; Biswas S, 2008, MOL CELL BIOL, V28, P6844, DOI 10.1128/MCB.01235-08; Blanco MA, 2000, EMBO J, V19, P3945, DOI 10.1093/emboj/19.15.3945; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; CHOY HE, 1992, P NATL ACAD SCI USA, V89, P11264, DOI 10.1073/pnas.89.23.11264; DE LAAT W, 2007, CURR OPIN CELL BIOL, V19, P317; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DUNN TM, 1984, P NATL ACAD SCI-BIOL, V81, P5017, DOI 10.1073/pnas.81.16.5017; Eydmann T, 2008, GENETICS, V180, P27, DOI 10.1534/genetics.108.089243; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; HOCHSCHILD A, 1986, CELL, V44, P681, DOI 10.1016/0092-8674(86)90833-0; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1471, DOI 10.1083/jcb.104.6.1471; Kaplan DL, 2009, MOL MICROBIOL, V72, P279, DOI 10.1111/j.1365-2958.2009.06656.x; KAUL S, 1994, P NATL ACAD SCI USA, V91, P11143, DOI 10.1073/pnas.91.23.11143; KHATRI GS, 1989, CELL, V59, P667, DOI 10.1016/0092-8674(89)90012-3; Kim SM, 2001, EMBO J, V20, P6115, DOI 10.1093/emboj/20.21.6115; Kitamura K, 1998, MOL BIOL CELL, V9, P1065, DOI 10.1091/mbc.9.5.1065; Krings G, 2005, J BIOL CHEM, V280, P39135, DOI 10.1074/jbc.M508996200; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; KRINGS G, 2007, THESIS MUSC CHARLEST; Krings G, 2006, MOL CELL BIOL, V26, P8061, DOI 10.1128/MCB.01102-06; LEE EH, 1989, P NATL ACAD SCI USA, V86, P9104, DOI 10.1073/pnas.86.23.9104; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Mejia-Ramirez E, 2005, MOL CELL BIOL, V25, P8755, DOI 10.1128/MCB.25.19.8755-8761.2005; MIRON A, 1992, EMBO J, V11, P1205, DOI 10.1002/j.1460-2075.1992.tb05161.x; MUKHERJEE S, 1988, CELL, V52, P375, DOI 10.1016/S0092-8674(88)80030-8; Mulugu S, 2001, P NATL ACAD SCI USA, V98, P9569, DOI 10.1073/pnas.171065898; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; Sanchez-Gorostiaga A, 2004, MOL CELL BIOL, V24, P398, DOI 10.1128/MCB.24.1.398-406.2004; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Segurado M, 2003, EMBO REP, V4, P1048, DOI 10.1038/sj.embor.7400008; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tan-Wong SM, 2009, GENE DEV, V23, P2610, DOI 10.1101/gad.1823209; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; WU JR, 1995, NUCLEIC ACIDS RES, V23, P3997, DOI 10.1093/nar/23.19.3997; Zhao A, 1997, NUCLEIC ACIDS RES, V25, P904, DOI 10.1093/nar/25.4.904; Zzaman S, 2005, MOL CELL, V20, P833, DOI 10.1016/j.molcel.2005.10.037	44	23	23	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					868	878		10.1016/j.cell.2010.08.013	http://dx.doi.org/10.1016/j.cell.2010.08.013			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850009	Bronze, Green Accepted			2022-12-24	WOS:000281855000010
J	Sanderson, WC; Scherbov, S				Sanderson, Warren C.; Scherbov, Sergei			Remeasuring Aging	SCIENCE			English	Editorial Material							LIFE EXPECTANCY; POPULATIONS; HEALTH		[Sanderson, Warren C.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Scherbov, Sergei] Vienna Inst Demog, A-1040 Vienna, Austria; [Sanderson, Warren C.; Scherbov, Sergei] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; International Institute for Applied Systems Analysis (IIASA)	Sanderson, WC (corresponding author), SUNY Stony Brook, Stony Brook, NY 11794 USA.	warren.sanderson@stonybrook.edu	Sanderson, Warren/R-3398-2019; Scherbov, Sergey/F-3158-2019	Scherbov, Sergey/0000-0001-5902-3790; Scherbov, Sergei/0000-0002-0881-1073; Sanderson, Warren/0000-0002-2205-948X				Bhattacharya J, 2004, NBER FR HLTH POL RES, P75; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; COTIS JP, 2003, 239 OECD; *EHEMU, 2009, DAT ACT LIM STAT INC; FUCHS VR, 1984, MILBANK FUND Q, V62, P143; *HUM MORT, HUM MORT DAT; JACOB S, 1993, GENERATION CHANGE PR; Lafortune G, 2007, OECD HLTH WORKING PA; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; Manton KG, 2006, POPUL DEV REV, V32, P81, DOI 10.1111/j.1728-4457.2006.00106.x; MANTON KG, 1986, J AM STAT ASSOC, V81, P635, DOI 10.2307/2288991; *OECD, 2005, AG POP HIGH TIM ACT; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; PETERSON P, 1999, GRAY COMING AGE WAVE; RYDER NB, 1975, POPUL INDEX, V41, P3, DOI 10.2307/2734140; Sanderson W, 2008, CONVENTIONAL PROSPEC; SANDERSON W, 2008, POP B, V63, P4; Sanderson WC, 2007, DEMOGR RES, V16, P27, DOI 10.4054/DemRes.2007.16.2; Sanderson WC, 2005, NATURE, V435, P811, DOI 10.1038/nature03593; SCHULTZ G, 2008, PUTTING OUR HOUSE OR; *SOC SEC ADM, 2010, RETR BEN; *SOC SEC ADM, 2008, SOC SEC WORLD EUR; *UK, CAL YOUR STAT PENS A; *UN, 2001, WORL POP AG 1950 205; United Nations, 2009, WORLD POP AG 2009; United Nations, 2007, WORLD POP AG 2007; United Nations, 2009, WORLD POP PROSP 2008	28	166	170	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2010	329	5997					1287	1288		10.1126/science.1193647	http://dx.doi.org/10.1126/science.1193647			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	647YR	20829469				2022-12-24	WOS:000281657300018
J	Swartzendruber, A; Zenilman, JM				Swartzendruber, Andrea; Zenilman, Jonathan M.			A National Strategy to Improve Sexual Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Zenilman, Jonathan M.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21224 USA; [Swartzendruber, Andrea] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zenilman, JM (corresponding author), Johns Hopkins Univ, Sch Med, 4940 Eastern Ave, Baltimore, MD 21224 USA.	jzenilma@jhmi.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BERENSON A, 2005, NY TIMES        1204; Buller JL, 2007, MIL MED, V172, P511, DOI 10.7205/MILMED.172.5.511; Centers for Disease Control and Prevention, FREQ ASK QUEST HPV V; Centers for Disease Control and Prevention, HIV INC; DOUGLAS J, 2009, CHALL OPP STD PREV U; Lottes IL, 2002, J SEX RES, V39, P79, DOI 10.1080/00224490209552125; Medical Foundation for AIDS and Sexual Health, 2008, PROGR PRIOR WORK TOG; Satcher D., 2001, SURG GEN CALL ACTION; *WHIT HOUS, 2009, JOINT SESS C FEBR 24; WHO, GEND HUM RIGHTS	10	43	43	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2010	304	9					1005	1006		10.1001/jama.2010.1252	http://dx.doi.org/10.1001/jama.2010.1252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645AD	20810379				2022-12-24	WOS:000281422400028
J	Juliano, C; Wessel, G				Juliano, Celina; Wessel, Gary			Versatile Germline Genes	SCIENCE			English	Editorial Material							SOMATIC STEM-CELLS; SMALL MICROMERE LINEAGE; SEA-URCHIN; EXPRESSION; NANOS; POSTERIOR; EMBRYO; ORIGIN; HYDRA		[Juliano, Celina] Yale Univ, Dept Cell Biol, Stem Cell Ctr, New Haven, CT 06520 USA; [Wessel, Gary] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Yale University; Brown University	Juliano, C (corresponding author), Yale Univ, Dept Cell Biol, Stem Cell Ctr, New Haven, CT 06520 USA.	gary_wessel@brown.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD028152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD028152, R01 HD028152-17] Funding Source: Medline; NIGMS NIH HHS [T32 GM007601] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ewen-Campen B, 2010, MOL REPROD DEV, V77, P3, DOI 10.1002/mrd.21091; Funayama N, 2010, DEV GROWTH DIFFER, V52, P1, DOI 10.1111/j.1440-169X.2009.01162.x; Juliano CE, 2006, DEV BIOL, V300, P406, DOI 10.1016/j.ydbio.2006.07.035; Juliano CE, 2010, DEV BIOL, V337, P220, DOI 10.1016/j.ydbio.2009.10.030; Mochizuki K, 2000, DEV GENES EVOL, V210, P591, DOI 10.1007/s004270000105; Mochizuki K, 2001, DEV GENES EVOL, V211, P299, DOI 10.1007/s004270100156; Rabinowitz JS, 2008, CURR BIOL, V18, P331, DOI 10.1016/j.cub.2008.01.055; Rebscher N, 2007, DEV BIOL, V306, P599, DOI 10.1016/j.ydbio.2007.03.521; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Shibata N, 2010, DEV GROWTH DIFFER, V52, P27, DOI 10.1111/j.1440-169X.2009.01155.x; Swartz SZ, 2008, DEV GENES EVOL, V218, P107, DOI 10.1007/s00427-008-0203-6; TANAKA S, 1990, DEV GROWTH DIFFER, V32, P145; Voronina E, 2008, DEV BIOL, V314, P276, DOI 10.1016/j.ydbio.2007.11.039	13	71	71	2	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					640	641		10.1126/science.1194037	http://dx.doi.org/10.1126/science.1194037			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689009	Green Accepted			2022-12-24	WOS:000280602700027
J	Lieber, MR; Wilson, TE				Lieber, Michael R.; Wilson, Thomas E.			SnapShot: Nonhomologous DNA End Joining (NHEJ)	CELL			English	Editorial Material							REPAIR		[Lieber, Michael R.] Univ So Calif, Los Angeles, CA 90089 USA; [Wilson, Thomas E.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Southern California; University of Michigan System; University of Michigan	Lieber, MR (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.			Lieber, Michael/0000-0003-3700-6345; Lieber, Michael/0000-0001-8809-0909	NCI NIH HHS [R01 CA102563, R37 CA051105, R01 CA100504] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA100504, R37CA051105, R01CA102563] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009	5	41	43	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 6	2010	142	3					496	U174	496.e1	10.1016/j.cell.2010.07.035	http://dx.doi.org/10.1016/j.cell.2010.07.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691907	Bronze			2022-12-24	WOS:000280609100026
J	Ramnarayan, P; Thiru, K; Parslow, RC; Harrison, DA; Draper, ES; Rowan, KM				Ramnarayan, Padmanabhan; Thiru, Krish; Parslow, Roger C.; Harrison, David A.; Draper, Elizabeth S.; Rowan, Kathy M.			Effect of specialist retrieval teams on outcomes in children admitted to paediatric intensive care units in England and Wales: a retrospective cohort study	LANCET			English	Article							CRITICALLY-ILL; HOSPITAL VOLUME; HEALTH-CARE; MORTALITY; REDUCTION; TRANSPORT; IMPLEMENTATION; ADMISSION; DELIVERY; SURGERY	Background Intensive care services for children have undergone substantial centralisation in the UK. Along with the establishment of regional paediatric intensive care units (PICUs), specialist retrieval teams were set up to transport critically ill children from other hospitals. We studied the outcome of children transferred from local hospitals to PICUs. Methods We analysed data that were gathered for a cohort of children (<= 16 years) admitted consecutively to 29 PICUs in England and Wales during 4 years (Jan 1, 2005, to Dec 31, 2008). We compared unplanned admissions from wards within the same hospital as the PICU and from other hospitals; interhospital transfers by non-specialist and specialist retrieval teams; and patients transferred to their nearest PICU and those who were not. Primary outcome measures were mortality rate in PICU and length of stay in P ICU. We analysed data by use of logistic regression analysis. Findings There were 57997 admissions to PICUs during the study. Nearly half of unplanned admissions (17 649 [53%] of 33 492) were from other hospitals. Although children admitted from other hospitals were younger (median 10 months [IQR 1-55] vs 18 months [3-85]), sicker at admission (median predicted risk of mortality 6% [4-10] vs 4% [2-7]), stayed longer in PICUs (75 h [33-153] vs 43 h [18-116]), and had higher crude mortality rates (1384 [8%] of 17 649 vs 996 [6%] of 15843; odds ratio 1.27, 95% CI 1.16-1.38), the risk-adjusted mortality rate in PICUs was lower than among children admitted from within the same hospital (0.65, 0.53-0.80). In a multivariable analysis, use of a specialist retrieval team for transfer was associated with improved survival (0 58, 0.39-0.87). Interpretation These findings support the policy of combining centralisation of intensive care services for children with transfer by specialist retrieval teams.	[Ramnarayan, Padmanabhan] Great Ormond St Hosp Sick Children, Childrens Acute Transport Serv, London, England; [Thiru, Krish] City Univ London, Sch Informat, Ctr Hlth Informat, London EC1V 0HB, England; [Parslow, Roger C.] Leeds Inst Genet Hlth & Therapeut, Ctr Biostat & Epidemiol, Paediat Epidemiol Grp, Leeds, W Yorkshire, England; [Harrison, David A.; Draper, Elizabeth S.] Intens Care Natl Audit & Res Ctr, London, England; [Draper, Elizabeth S.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; City University London; University of Leeds; Intensive Care National Audit & Research Centre; University of Leicester	Ramnarayan, P (corresponding author), Great Ormond St Hosp NHS Trust, Childrens Acute Transport Serv, 44-B Bedford Row, London WC1R 4LL, England.		Harrison, David A/O-4355-2018; Draper, Elizabeth/S-6874-2019; Draper, Elizabeth S/I-6304-2018; Parslow, Roger/AAV-1477-2020; Ramnarayan, Padmanabhan/AAI-6783-2020	Harrison, David A/0000-0002-9002-9098; Draper, Elizabeth/0000-0001-9340-8176; Draper, Elizabeth S/0000-0001-9340-8176; Ramnarayan, Padmanabhan/0000-0003-0784-8154; Rowan, Kathryn/0000-0001-8217-5602; Parslow, Roger/0000-0002-3945-5294	National Clinical Audit and Patient Outcomes Programme through Healthcare Quality Improvement Partnership; Health Commission Wales Specialised Services	National Clinical Audit and Patient Outcomes Programme through Healthcare Quality Improvement Partnership; Health Commission Wales Specialised Services	PICANet is funded by the National Clinical Audit and Patient Outcomes Programme through Healthcare Quality Improvement Partnership, Health Commission Wales Specialised Services. National Health Service (NHS) Lothian and National Service Division NHS Scotland. the Royal Belfast Hospital for Sick Children, and the Pan Thames PICU Commissioning Consortium We thank all the staff in participating hospitals who gathered data for PICANet A full list of participating PICUs and steering group and clinical advisory group membership is available on the latest PICANet Annual Report We thank Steve Harris for commenting on an early draft of this report and contributing to discussions about the sensitivity analyses, and Philip McShane for extracting the study data from the PICANet database	Bazzani LG, 2007, CIRCULATION, V115, P2652, DOI 10.1161/CIRCULATIONAHA.106.678904; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Bellingan G, 2000, INTENS CARE MED, V26, P740; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; BRITTO J, 1995, BRIT MED J, V311, P836, DOI 10.1136/bmj.311.7009.836; Chan PS, 2008, JAMA-J AM MED ASSOC, V300, P2506, DOI 10.1001/jama.2008.715; CHAN PS, ARCH INTERN MED, V170, P18; Combes A, 2005, CRIT CARE MED, V33, P705, DOI 10.1097/01.CCM.0000158518.32730.C5; Department of Health, 1997, PAED INT CAR FRAM FU; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; ESCARCE JJ, 1990, JAMA-J AM MED ASSOC, V264, P2389, DOI 10.1001/jama.264.18.2389; FIELD D, 1991, ARCH DIS CHILD-FETAL, V66, P408, DOI 10.1136/adc.66.4_Spec_No.408; Gregory CJ, 2008, PEDIATRICS, V121, pE906, DOI 10.1542/peds.2007-2089; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hanson CC, 2009, QUAL SAF HEALTH CARE, V18, P500, DOI 10.1136/qshc.2007.026054; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Maybloom B, 1997, LANCET, V350, P65, DOI 10.1016/S0140-6736(97)26027-7; McDonnell A, 2007, J CRIT CARE, V22, P212, DOI 10.1016/j.jcrc.2007.02.002; Odetola FO, 2008, PEDIATR CRIT CARE ME, V9, P20, DOI 10.1097/01.PCC.0000298642.11872.29; Orr RA, 2009, PEDIATRICS, V124, P40, DOI 10.1542/peds.2008-0515; Pearson G, 1997, LANCET, V349, P1213, DOI 10.1016/S0140-6736(96)12396-5; *PICA NET, 2006, NAT REP PAED INT CAR; Rosenberg AL, 2003, ANN INTERN MED, V138, P882, DOI 10.7326/0003-4819-138-11-200306030-00009; Shann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317; Stevenson A, 2005, EMERG MED J, V22, P795, DOI 10.1136/emj.2004.017822; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401; *U YORK, 1996, EFF HLTH CAR HOSP VO; Vos GD, 2004, INTENS CARE MED, V30, P302, DOI 10.1007/s00134-003-2066-7	29	96	99	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2010	376	9742					698	704		10.1016/S0140-6736(10)61113-0	http://dx.doi.org/10.1016/S0140-6736(10)61113-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646YW	20708255				2022-12-24	WOS:000281582900029
J	Clarke, JA; Ksepka, DT; Salas-Gismondi, R; Altamirano, AJ; Shawkey, MD; D'Alba, L; Vinther, J; DeVries, TJ; Baby, P				Clarke, Julia A.; Ksepka, Daniel T.; Salas-Gismondi, Rodolfo; Altamirano, Ali J.; Shawkey, Matthew D.; D'Alba, Liliana; Vinther, Jakob; DeVries, Thomas J.; Baby, Patrice			Fossil Evidence for Evolution of the Shape and Color of Penguin Feathers	SCIENCE			English	Article							DIVING BIRDS	Penguin feathers are highly modified in form and function, but there have been no fossils to inform their evolution. A giant penguin with feathers was recovered from the late Eocene (similar to 36 million years ago) of Peru. The fossil reveals that key feathering features, including undifferentiated primary wing feathers and broad body contour feather shafts, evolved early in the penguin lineage. Analyses of fossilized color-imparting melanosomes reveal that their dimensions were similar to those of non-penguin avian taxa and that the feathering may have been predominantly gray and reddish-brown. In contrast, the dark black-brown color of extant penguin feathers is generated by large, ellipsoidal melanosomes previously unknown for birds. The nanostructure of penguin feathers was thus modified after earlier macrostructural modifications of feather shape linked to aquatic flight.	[Clarke, Julia A.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Ksepka, Daniel T.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; [Ksepka, Daniel T.] N Carolina Museum Nat Sci, Dept Paleontol, Raleigh, NC 27601 USA; [Salas-Gismondi, Rodolfo; Altamirano, Ali J.] Univ Nacl Mayor San Marcos, Museo Hist Nat, Dept Paleontol Vertebrados, Lima 14, Peru; [Shawkey, Matthew D.; D'Alba, Liliana] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Vinther, Jakob] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [DeVries, Thomas J.] Univ Washington, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; [Baby, Patrice] Inst Rech Dev, Lab Mecanismes & Transferts Geol, F-31400 Toulouse, France; [Baby, Patrice] Univ Toulouse, F-31400 Toulouse, France	University of Texas System; University of Texas Austin; University of North Carolina; North Carolina State University; Universidad Nacional Mayor de San Marcos; University System of Ohio; University of Akron; Yale University; University of Washington; University of Washington Seattle; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse	Clarke, JA (corresponding author), Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA.	julia_clarke@jsg.utexas.edu	Baby, Patrice/D-2936-2009; D'Alba, Liliana/AAC-4969-2022; Ksepka, Daniel/A-2007-2009; /B-4978-2011; Vinther, Jakob/GZG-4679-2022; Baby, Patrice/AAL-6640-2021	Baby, Patrice/0000-0001-6142-5174; D'Alba, Liliana/0000-0002-2478-3455; /0000-0003-2218-2637; Baby, Patrice/0000-0001-6142-5174; Shawkey, Matthew/0000-0002-5131-8209; Vinther, Jakob/0000-0002-3584-9616; Salas-Gismondi, Rodolfo/0000-0001-9990-8841	National Science Foundation [DEB-0949897, DEB-0949899]; National Geographic Society Expeditions Council; Air Force Office of Scientific Research [FA9550-09-1-0159]	National Science Foundation(National Science Foundation (NSF)); National Geographic Society Expeditions Council(National Geographic Society); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	K. Browne helped produce the figures; W. Aguirre, P. Brinkman, and V. Schneider prepared the fossil. K. Middleton and M. Stucchi provided discussion. P. Unitt, K. Zyskowski, B. Wang, J. Tejada, J. Reyes, E. Diaz, and Z. Jiang provided professional assistance. The research was funded by the National Science Foundation (DEB-0949897 and DEB-0949899), the National Geographic Society Expeditions Council, the Air Force Office of Scientific Research (FA9550-09-1-0159), and University of Akron startup funds. MUSM 1444 is permanently deposited at the Museo de Historia Natural-UNMSM, Lima, Peru.	Arnason U, 2006, MOL PHYLOGENET EVOL, V41, P345, DOI 10.1016/j.ympev.2006.05.022; Berta A, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P861; BONSER RHC, 1995, J EXP BIOL, V198, P1029; Burtt E.H., 1986, ORNITHOL MONOGR, V38, P1; Clarke JA, 2007, P NATL ACAD SCI USA, V104, P11545, DOI 10.1073/pnas.0611099104; Dawson C, 1999, J THEOR BIOL, V199, P291, DOI 10.1006/jtbi.1999.0959; Denny M., 1993, AIR WATER; Fordyce R.E., 1990, P419; Jadwiszczak P, 2009, POL POLAR RES, V30, P3; Ksepka DT, 2010, B AM MUS NAT HIST, P1; Lovvorn JR, 2001, J EXP BIOL, V204, P1547; McGraw KJ, 2007, PIGM CELL RES, V20, P301, DOI 10.1111/j.1600-0749.2007.00386.x; McGraw KJ., 2006, BIRD COLORATION, P243; Rowland HM, 2009, PHILOS T R SOC B, V364, P519, DOI 10.1098/rstb.2008.0261; Slack KE, 2006, MOL BIOL EVOL, V23, P1144, DOI 10.1093/molbev/msj124; Stone-house Bernard, 1975, BIOL PENGUINS; STONEHOUSE B., 1967, ADVAN ECOL RESADVANCES IN ECOLOGICAL RESEARCH, V4, P131, DOI 10.1016/S0065-2504(08)60321-9; Tickell WLN, 2003, WATERBIRDS, V26, P1, DOI 10.1675/1524-4695(2003)026[0001:WP]2.0.CO;2; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Voitkevich A.A.E., 1966, FEATHERS PLUMAGE BIR; WILSON RP, 1992, AM NAT, V140, P179, DOI 10.1086/285409	21	129	133	10	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 12	2010	330	6006					954	957		10.1126/science.1193604	http://dx.doi.org/10.1126/science.1193604			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678XY	20929737				2022-12-24	WOS:000284118000040
J	West, XZ; Malinin, NL; Merkulova, AA; Tischenko, M; Kerr, BA; Borden, EC; Podrez, EA; Salomon, RG; Byzova, TV				West, Xiaoxia Z.; Malinin, Nikolay L.; Merkulova, Alona A.; Tischenko, Mira; Kerr, Bethany A.; Borden, Ernest C.; Podrez, Eugene A.; Salomon, Robert G.; Byzova, Tatiana V.			Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands	NATURE			English	Article							TOLL-LIKE RECEPTOR-2; MACULAR DEGENERATION; CHRONIC INFLAMMATION; PATTERN-RECOGNITION; INNATE IMMUNITY; SYSTEM; CANCER; CELLS; CD36	Reciprocity of inflammation, oxidative stress and neovascularization is emerging as an important mechanism underlying numerous processes from tissue healing and remodelling to cancer progression(1,2). Whereas the mechanism of hypoxia-driven angiogenesis is well understood(3,4), the link between inflammation-induced oxidation and de novo blood vessel growth remains obscure. Here we show that the end products of lipid oxidation, omega-(2-carboxyethyl) pyrrole (CEP) and other related pyrroles(5), are generated during inflammation and wound healing and accumulate at high levels in ageing tissues in mice and in highly vascularized tumours in both murine and human melanoma. The molecular patterns of carboxyalkylpyrroles are recognized by Toll-like receptor 2 (TLR2), but not TLR4 or scavenger receptors on endothelial cells, leading to an angiogenic response that is independent of vascular endothelial growth factor. CEP promoted angiogenesis in hindlimb ischaemia and wound healing models through MyD88-dependent TLR2 signalling. Neutralization of endogenous carboxyalkylpyrroles impaired wound healing and tissue revascularization and diminished tumour angiogenesis. Both TLR2 and MyD88 are required for CEP-induced stimulation of Rac1 and endothelial migration. Taken together, these findings establish a new function of TLR2 as a sensor of oxidation-associated molecular patterns, providing a key link connecting inflammation, oxidative stress, innate immunity and angiogenesis.	[West, Xiaoxia Z.; Malinin, Nikolay L.; Merkulova, Alona A.; Tischenko, Mira; Kerr, Bethany A.; Podrez, Eugene A.; Byzova, Tatiana V.] Cleveland Clin Fdn, Dept Mol Cardiol, JJ Jacobs Ctr Thrombosis & Vasc Biol, Cleveland, OH 44195 USA; [West, Xiaoxia Z.; Salomon, Robert G.] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Borden, Ernest C.; Byzova, Tatiana V.] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Byzova, TV (corresponding author), Cleveland Clin Fdn, Dept Mol Cardiol, JJ Jacobs Ctr Thrombosis & Vasc Biol, NB50,9500 Euclid Ave, Cleveland, OH 44195 USA.	byzovat@ccf.org	Salomon, Robert G/C-3463-2008; Malinin, Nikolay/J-4271-2012; Malinin, Nikolay/Z-5308-2019; Kerr, Bethany/D-1644-2012	Malinin, Nikolay/0000-0002-2654-1783; Kerr, Bethany/0000-0002-2995-7549; Byzova, Tatiana/0000-0002-2615-875X; Salomon, Robert/0000-0001-9456-3557	NIH [HL073311, HL071625, CA126847, HL077213, GM021249]; American Heart Association [10SDG4300062]; NATIONAL CANCER INSTITUTE [R01CA126847] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311, R01HL071625, R01HL077213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021249] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Hong for the help with synthesis of CEP and CPP adducts, Y. Cui for expressing and purifying anti-CEP monoclonal antibodies, and J. Crabb for providing anti-CEP monoclonal antibody hybridoma cells. This work was supported by NIH grants HL073311, HL071625, CA126847 to T.V.B., HL077213 to E.A.P. and GM021249 to R.G.S. and an American Heart Association grant (10SDG4300062) to N.L.M.	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Chen JH, 2005, NAT MED, V11, P1188, DOI 10.1038/nm1307; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Feng WY, 2008, J CELL BIOL, V183, P1145, DOI 10.1083/jcb.200802179; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Grote K, 2010, BLOOD, V115, P2543, DOI 10.1182/blood-2009-05-224402; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Jackson JR, 1997, FASEB J, V11, P457, DOI 10.1096/fasebj.11.6.9194526; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kawai T, 2005, CURR OPIN IMMUNOL, V17, P338, DOI 10.1016/j.coi.2005.02.007; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Mahabeleshwar Ganapati H., 2006, V129, P197; Manley PW, 2002, J MED CHEM, V45, P5687, DOI 10.1021/jm020899q; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Mullick AE, 2005, J CLIN INVEST, V115, P3149, DOI 10.1172/JCI25482; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Schaefer L, 2005, J CLIN INVEST, V115, P2223, DOI 10.1172/JCI23755; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	32	330	339	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					972	U150		10.1038/nature09421	http://dx.doi.org/10.1038/nature09421			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20927103	Green Accepted			2022-12-24	WOS:000283254700040
J	Bodenheimer, T; West, D				Bodenheimer, Thomas; West, David			Low-Cost Lessons from Grand Junction, Colorado	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bodenheimer, Thomas] Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA; [West, David] St Marys Hosp, Grand Junction, CO USA	University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA.							Berenson RA, 2010, NEW ENGL J MED, V363, P101, DOI 10.1056/NEJMp1005588; Gawande A., 2009, NEW YORKER; Medicare Payment Advisory Committee, 2009, REP C MEAS REG VAR S; Nichols L., 2009, GRAND JUNCTION COLOR; WEST D, 2009, MESA COUNTY COLORADO	5	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1391	1393		10.1056/NEJMp1008450	http://dx.doi.org/10.1056/NEJMp1008450			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	659NV	20925540				2022-12-24	WOS:000282575100002
J	Galazka, JM; Tian, CG; Beeson, WT; Martinez, B; Glass, NL; Cate, JHD				Galazka, Jonathan M.; Tian, Chaoguang; Beeson, William T.; Martinez, Bruno; Glass, N. Louise; Cate, Jamie H. D.			Cellodextrin Transport in Yeast for Improved Biofuel Production	SCIENCE			English	Article							FUEL ETHANOL-PRODUCTION; SIMULTANEOUS SACCHARIFICATION; FERMENTATION; DEGRADATION; HYDROLYSIS; MECHANISMS; BIOMASS	Fungal degradation of plant biomass may provide insights for improving cellulosic biofuel production. We show that the model cellulolytic fungus Neurospora crassa relies on a high-affinity cellodextrin transport system for rapid growth on cellulose. Reconstitution of the N. crassa cellodextrin transport system in Saccharomyces cerevisiae promotes efficient growth of this yeast on cellodextrins. In simultaneous saccharification and fermentation experiments, the engineered yeast strains more rapidly convert cellulose to ethanol when compared with yeast lacking this system.	[Galazka, Jonathan M.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Tian, Chaoguang; Glass, N. Louise] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Tian, Chaoguang] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin Airport Econ Area, Tianjin 300308, Peoples R China; [Beeson, William T.; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Martinez, Bruno; Cate, Jamie H. D.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jcate@lbl.gov	Glass, N. Louise/ABA-7303-2021; Galazka, Jonathan Galazka/K-4847-2012	Galazka, Jonathan Galazka/0000-0002-4153-0249	Energy Biosciences Institute	Energy Biosciences Institute	We thank J. Doudna, M. Marletta, J. Taylor, T. Bruns, and C. Phillips for helpful discussions and comments on the manuscript; M. Toews for help with growth assays; S. Bauer and A. Ibanez for help with analytical methods; and C. Anderson for help with confocal microscopy. This work was supported by funding from the Energy Biosciences Institute to J. H. D. C. and N.L.G. The Regents of the University of California, the authors, and British Petroleum Technology Ventures (through the Energy Biosciences Institute) have submitted a patent for the use of cellodextrin transporters in fermenting organisms for the use of plant biomass.	Bai FW, 2008, BIOTECHNOL ADV, V26, P89, DOI 10.1016/j.biotechadv.2007.09.002; Basso LC, 2008, FEMS YEAST RES, V8, P1155, DOI 10.1111/j.1567-1364.2008.00428.x; BHAT KM, 1987, APPL ENVIRON MICROB, V53, P2175, DOI 10.1128/AEM.53.9.2175-2182.1987; Chauve M, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-3; Doran-Peterson J, 2009, METHODS MOL BIOL, V581, P263, DOI 10.1007/978-1-60761-214-8_17; Drissen RET, 2009, BIOCATAL BIOTRANSFOR, V27, P27, DOI 10.1080/10242420802564358; FREER SN, 1991, APPL ENVIRON MICROB, V57, P655, DOI 10.1128/AEM.57.3.655-659.1991; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Martin F, 2010, NATURE, V464, P1033, DOI 10.1038/nature08867; Noguchi Y, 2009, APPL MICROBIOL BIOT, V85, P141, DOI 10.1007/s00253-009-2236-9; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Skinner KA, 2004, J IND MICROBIOL BIOT, V31, P401, DOI 10.1007/s10295-004-0159-0; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; USDA, 2006, EC FEASIBILITY ETHAN; Voutilainen SP, 2008, BIOTECHNOL BIOENG, V101, P515, DOI 10.1002/bit.21940; Wymelenberg AV, 2010, APPL ENVIRON MICROB, V76, P3599, DOI 10.1128/AEM.00058-10; XIN Z, 1993, ENZYME MICROB TECH, V15, P62, DOI 10.1016/0141-0229(93)90117-K	21	233	248	3	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					84	86		10.1126/science.1192838	http://dx.doi.org/10.1126/science.1192838			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20829451				2022-12-24	WOS:000282334500039
J	Litvak, E; Pronovost, PJ				Litvak, Eugene; Pronovost, Peter J.			Rethinking Rapid Response Teams	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Litvak, Eugene] Inst Healthcare Optimizat, Newton, MA 02459 USA; [Litvak, Eugene] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Litvak, E (corresponding author), Inst Healthcare Optimizat, 7 Wells Ave, Newton, MA 02459 USA.	elitvak@ihoptimize.org						Baker DR, 2009, CRIT CARE MED, V37, P2882, DOI 10.1097/CCM.0b013e3181b01caf; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; BUTTERFIELD S, 2007, ACP HOSP         DEC; DeVita MA, 2006, CRIT CARE MED, V34, P2463, DOI 10.1097/01.CCM.0000235743.38172.6E; Gross D., 2008, FUNDAMENTALS QUEUING; Litvak E., 2009, MANAGING PATIENT FLO; Litvak E, 2005, JT COMM J QUAL PATIE, V31, P330, DOI 10.1016/S1553-7250(05)31044-0; Organisation for Economic Co-operation and Development, OECD HLTH DAT 2010 S; Ranji SR, 2007, J HOSP MED, V2, P422, DOI 10.1002/jhm.238; Sakai T, 2009, J ANESTH, V23, P403, DOI 10.1007/s00540-009-0778-8	10	58	73	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2010	304	12					1375	1376		10.1001/jama.2010.1385	http://dx.doi.org/10.1001/jama.2010.1385			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652LK	20858881				2022-12-24	WOS:000282007900021
J	Liao, L; Lin, YC; Bao, MQ; Cheng, R; Bai, JW; Liu, YA; Qu, YQ; Wang, KL; Huang, Y; Duan, XF				Liao, Lei; Lin, Yung-Chen; Bao, Mingqiang; Cheng, Rui; Bai, Jingwei; Liu, Yuan; Qu, Yongquan; Wang, Kang L.; Huang, Yu; Duan, Xiangfeng			High-speed graphene transistors with a self-aligned nanowire gate	NATURE			English	Article							EPITAXIAL GRAPHENE; DIELECTRICS; MOBILITY; PHASE	Graphene has attracted considerable interest as a potential new electronic material(1-11). With its high carrier mobility, graphene is of particular interest for ultrahigh-speed radio-frequency electronics(12-18). However, conventional device fabrication processes cannot readily be applied to produce high-speed graphene transistors because they often introduce significant defects into the monolayer of carbon lattices and severely degrade the device performance(19-21). Here we report an approach to the fabrication of high-speed graphene transistors with a self-aligned nanowire gate to prevent such degradation. A Co(2)Si-Al(2)O(3) core-shell nanowire is used as the gate, with the source and drain electrodes defined through a self-alignment process and the channel length defined by the nanowire diameter. The physical assembly of the nanowire gate preserves the high carrier mobility in graphene, and the self-alignment process ensures that the edges of the source, drain and gate electrodes are automatically and precisely positioned so that no overlapping or significant gaps exist between these electrodes, thus minimizing access resistance. It therefore allows for transistor performance not previously possible. Graphene transistors with a channel length as low as 140 nm have been fabricated with the highest scaled on-current (3.32 mA mu m(-1)) and transconductance (1.27 mS mu m(-1)) reported so far. Significantly, on-chip microwave measurements demonstrate that the self-aligned devices have a high intrinsic cut-off (transit) frequency of f(T) = 100-300 GHz, with the extrinsic f(T) (in the range of a few gigahertz) largely limited by parasitic pad capacitance. The reported intrinsic f(T) of the graphene transistors is comparable to that of the very best high-electron-mobility transistors with similar gate lengths(10).	[Liao, Lei; Qu, Yongquan; Duan, Xiangfeng] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Lin, Yung-Chen; Cheng, Rui; Bai, Jingwei; Liu, Yuan; Huang, Yu] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Bao, Mingqiang; Wang, Kang L.] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA; [Wang, Kang L.; Huang, Yu] Univ Calif Los Angeles, Calif Nanosyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Duan, XF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	xduan@chem.ucla.edu	Bai, Jingwei/G-4245-2012; Huang, Yu/AAZ-9747-2020; liao, lei/O-4052-2014; Duan, Xiangfeng/AAQ-9674-2020; Liu, Yuan/G-4834-2016; Qu, Yongquan/A-7203-2011; Lin, Yung-Chen/G-7333-2012; Duan, Xiangfeng/E-7522-2011	Huang, Yu/0000-0003-1793-0741; Duan, Xiangfeng/0000-0002-4321-6288; Liu, Yuan/0000-0002-0024-9290; Duan, Xiangfeng/0000-0002-4321-6288; Qu, Yongquan/0000-0002-6202-1929	NSF [0956171]; NIH [1DP2OD004342-01]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004342] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Jooyaie and S. Martin for discussions. We also acknowledge the Electron Imaging Center for Nanomachines at UCLA for TEM technical support and the Nanoelectronics Research Facility at UCLA for device fabrication technical support. X.D. acknowledges financial support by the NSF CAREER award 0956171 and the NIH Director's New Innovator Award Program, part of the NIH Roadmap for Medical Research, through grant number 1DP2OD004342-01.	[Anonymous], 2007, PHYS SEMICONDUCTOR D; Avouris P, 2007, NAT NANOTECHNOL, V2, P605, DOI 10.1038/nnano.2007.300; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Bunch JS, 2005, NANO LETT, V5, P287, DOI 10.1021/nl048111+; Farmer DB, 2009, NANO LETT, V9, P4474, DOI 10.1021/nl902788u; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Jeon DY, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.091601; Kim DH, 2008, IEEE ELECTR DEVICE L, V29, P830, DOI 10.1109/LED.2008.2000794; Lee BK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2928228; Lemme MC, 2007, IEEE ELECTR DEVICE L, V28, P282, DOI 10.1109/LED.2007.891668; Liao L, 2010, ADV MATER, V22, P1941, DOI 10.1002/adma.200904415; Liao L, 2010, NANO LETT, V10, P1917, DOI 10.1021/nl100840z; Liao L, 2010, P NATL ACAD SCI USA, V107, P6711, DOI 10.1073/pnas.0914117107; Lin YM, 2010, SCIENCE, V327, P662, DOI 10.1126/science.1184289; Lin YM, 2010, IEEE ELECTR DEVICE L, V31, P68, DOI 10.1109/LED.2009.2034876; Lin YM, 2009, NANO LETT, V9, P422, DOI 10.1021/nl803316h; MERIC I, 2008, P EL DEV M 2008, DOI DOI 10.1109/IEDM.2008.4796738; Meric I, 2008, NAT NANOTECHNOL, V3, P654, DOI 10.1038/nnano.2008.268; Miao F, 2007, SCIENCE, V317, P1530, DOI 10.1126/science.1144359; Moon JS, 2009, IEEE ELECTR DEVICE L, V30, P650, DOI 10.1109/LED.2009.2020699; Murali R, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3147183; Ni ZH, 2008, ACS NANO, V2, P1033, DOI 10.1021/nn800031m; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/NNANO.2010.89, 10.1038/nnano.2010.89]; Seo K, 2009, ACS NANO, V3, P1145, DOI 10.1021/nn900191g; Wang XR, 2008, J AM CHEM SOC, V130, P8152, DOI 10.1021/ja8023059; Xuan Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2828338; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	30	1034	1082	20	783	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2010	467	7313					305	308		10.1038/nature09405	http://dx.doi.org/10.1038/nature09405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20811365	Green Accepted			2022-12-24	WOS:000281824900034
J	Baratz, KH; Tosakulwong, N; Ryu, E; Brown, WL; Branham, K; Chen, W; Tran, KD; Schmid-Kubista, KE; Heckenlively, JR; Swaroop, A; Abecasis, G; Bailey, KR; Edwards, AO				Baratz, Keith H.; Tosakulwong, Nirubol; Ryu, Euijung; Brown, William L.; Branham, Kari; Chen, Wei; Tran, Khoa D.; Schmid-Kubista, Katharina E.; Heckenlively, John R.; Swaroop, Anand; Abecasis, Goncalo; Bailey, Kent R.; Edwards, Albert O.			E2-2 Protein and Fuchs's Corneal Dystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SNOWFLAKE VITREORETINAL DEGENERATION; TYROSINE-PHOSPHATASE-GAMMA; ENDOTHELIAL DYSTROPHY; MACULAR DEGENERATION; TRANSCRIPTION FACTOR; MISSENSE MUTATIONS; IN-SITU; LINKAGE; FAMILY; EXPRESSION	BACKGROUND Fuchs's corneal dystrophy (FCD) is a leading cause of corneal transplantation and affects 5% of persons in the United States who are over the age of 40 years. Clinically visible deposits called guttae develop under the corneal endothelium in patients with FCD. A loss of endothelial cells and deposition of an abnormal extracellular matrix are observed microscopically. In advanced disease, the cornea swells and becomes cloudy because the remaining endothelial cells are not sufficient to keep the cornea dehydrated and clear. Although rare genetic variation that contributes to both early-onset and typical late-onset forms of FCD has been identified, to our knowledge, no common variants have been reported. METHODS We performed a genomewide association study and replicated the most significant observations in a second, independent group of subjects. RESULTS Alleles in the transcription factor 4 gene (TCF4), encoding a member of the E-protein family (E2-2), were associated with typical FCD (P = 2.3x10(-26)). The association increased the odds of having FCD by a factor of 30 for persons with two copies of the disease variants (homozygotes) and discriminated between case subjects and control subjects with about 76% accuracy. At least two regions of the TCF4 locus were associated independently with FCD. Alleles in the gene encoding protein tyrosine phosphatase receptor type G (PTPRG) were associated with FCD (P = 4.0x10(-7)), but the association did not reach genomewide significance. CONCLUSIONS Genetic variation in TCF4 contributes to the development of FCD. (Funded by the National Eye Institute and others.)	[Tran, Khoa D.; Edwards, Albert O.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Baratz, Keith H.; Brown, William L.; Schmid-Kubista, Katharina E.] Mayo Clin, Dept Ophthalmol, Rochester, MN USA; [Tosakulwong, Nirubol; Ryu, Euijung; Bailey, Kent R.] Mayo Clin, Dept Biomed Stat & Informat, Rochester, MN USA; [Branham, Kari; Heckenlively, John R.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Chen, Wei; Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Swaroop, Anand] NEI, Bethesda, MD 20892 USA	University of Oregon; Mayo Clinic; Mayo Clinic; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Edwards, AO (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	edwardsa@uoregon.edu	Brown, William/GXN-2777-2022; Branham, Kari/AAA-8336-2022; Abecasis, Goncalo R/B-7840-2010; Chen, Wei/AAX-5994-2020	Chen, Wei/0000-0001-7196-8703; Swaroop, Anand/0000-0002-1975-1141; Abecasis, Goncalo/0000-0003-1509-1825; Branham, Kari/0000-0002-2492-254X	National Institutes of Health [EY014467, EY016862, HHSN268200782096C]; Foundation Fighting Blindness; American Health Assistance Foundation; Research to Prevent Blindness; Max Kade Foundation; NATIONAL EYE INSTITUTE [R01EY014467, ZIAEY000475, R01EY016862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); American Health Assistance Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Max Kade Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by grants from the National Institutes of Health (EY014467, EY016862, and HHSN268200782096C), the Foundation Fighting Blindness, the American Health Assistance Foundation, Research to Prevent Blindness, and the Max Kade Foundation.	Afshari NA, 2009, INVEST OPHTH VIS SCI, V50, P1093, DOI 10.1167/iovs.08-1839; Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beltran PJ, 2003, FRONT BIOSCI, V8, pD87, DOI 10.2741/941; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Bouyain S, 2010, P NATL ACAD SCI USA, V107, P2443, DOI 10.1073/pnas.0911235107; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Engler C, 2010, AM J OPHTHALMOL, V149, P194, DOI 10.1016/j.ajo.2009.09.009; EPHRUSSI A, 1985, SCIENCE, V227, P134, DOI 10.1126/science.3917574; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Hecker LA, 2010, HUM MOL GENET, V19, P209, DOI 10.1093/hmg/ddp472; Hejtmancik JF, 2008, AM J HUM GENET, V82, P174, DOI 10.1016/j.ajhg.2007.08.002; HOGAN MJ, 1974, AM J OPHTHALMOL, V78, P363, DOI 10.1016/0002-9394(74)90224-4; Joyce NC, 1996, INVEST OPHTH VIS SCI, V37, P1566; Jurkunas UV, 2008, INVEST OPHTH VIS SCI, V49, P2956, DOI 10.1167/iovs.07-1529; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; LAING RA, 1984, OPHTHALMOLOGY, V91, P1129; Lee MM, 2003, OPHTHALMOLOGY, V110, P2418, DOI 10.1016/S0161-6420(03)00828-5; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liu SL, 2004, ONCOGENE, V23, P1256, DOI 10.1038/sj.onc.1207235; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; LORENZETTI DW, 1967, AM J OPHTHALMOL, V64, P1155, DOI 10.1016/0002-9394(67)93073-5; McGowan SL, 2007, MOL VIS, V13, P1984; Moshirfar M, 2005, J CATARACT REFR SURG, V31, P2281, DOI 10.1016/j.jcrs.2004.05.061; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; Riazuddin SA, 2009, INVEST OPHTH VIS SCI, V50, P5667, DOI 10.1167/iovs.09-3764; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Skerjanc IS, 1996, J BIOL CHEM, V271, P3555, DOI 10.1074/jbc.271.7.3555; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P140, DOI 10.1167/iovs.05-0578; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P3919, DOI 10.1167/iovs.05-1619; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; van Niekerk CC, 1999, CANCER LETT, V137, P61, DOI 10.1016/S0304-3835(98)00344-9; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Wang Z, 2007, OPHTHALMOLOGY, V114, P1453, DOI 10.1016/j.ophtha.2006.10.049; Zhang Cheng, 2006, Trans Am Ophthalmol Soc, V104, P85	42	193	202	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					1016	1024		10.1056/NEJMoa1007064	http://dx.doi.org/10.1056/NEJMoa1007064			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647HS	20825314				2022-12-24	WOS:000281609700005
J	Suganuma, T; Mushegian, A; Swanson, SK; Abmayr, SM; Florens, L; Washburn, MP; Workman, JL				Suganuma, Tamaki; Mushegian, Arcady; Swanson, Selene K.; Abmayr, Susan M.; Florens, Laurence; Washburn, Michael P.; Workman, Jerry L.			The ATAC Acetyltransferase Complex Coordinates MAP Kinases to Regulate JNK Target Genes	CELL			English	Article							ACTIVATED PROTEIN-KINASE; C-JUN PROMOTER; MOLYBDOPTERIN SYNTHASE; DNA INTERACTIONS; STRESS; TRANSCRIPTION; OSMOSTRESS; HOG1; EXPRESSION; MISSHAPEN	In response to extracellular cues, signal transduction activates downstream transcription factors like c-Jun to induce expression of target genes. We demonstrate that the ATAC (Ada two A containing) histone acetyltransferase (HAT) complex serves as a transcriptional cofactor for c-Jun at the Jun N-terminal kinase (JNK) target genes Jra and chick-adee. ATAC subunits are required for c-Jun occupancy of these genes and for H4K16 acetylation at the Jra enhancer, promoter, and transcribed sequences. Under conditions of osmotic stress, ATAC colocalizes with c-Jun, recruits the upstream kinases Misshapen, MKK4, and JNK, and suppresses further activation of JNK. Relocalization of these MAPKs and suppression of JNK activation by ATAC are dependent on the CG10238 subunit of ATAC. Thus, ATAC governs the transcriptional response to MAP kinase signaling by serving as both a coactivator of transcription and as a suppressor of upstream signaling.	[Suganuma, Tamaki; Mushegian, Arcady; Swanson, Selene K.; Abmayr, Susan M.; Florens, Laurence; Washburn, Michael P.; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Mushegian, Arcady] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66160 USA; [Swanson, Selene K.; Abmayr, Susan M.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Workman, JL (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlw@stowers.org	Mushegian, Arcady/ABF-5387-2021	Mushegian, Arcady/0000-0002-6809-9225; Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585	Stowers Institute for Medical Research; Workman Lab; Zeitlinger Lab; Conaway Lab; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047867] Funding Source: NIH RePORTER	Stowers Institute for Medical Research; Workman Lab; Zeitlinger Lab; Conaway Lab; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Workman Lab members, Bjoern Gaertner in the Zeitlinger Lab, and Hidehisa Takahashi in the Conaway Lab for advice and support during this project. This research was supported by the Stowers Institute for Medical Research.	Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Alexaki VI, 2008, PIGM CELL MELANOMA R, V21, P429, DOI 10.1111/j.1755-148X.2008.00466.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Butterfield L, 1997, J BIOL CHEM, V272, P10110; Ciurciu A, 2006, MOL CELL BIOL, V26, P9413, DOI 10.1128/MCB.01401-06; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; Dioum EM, 2009, CELL, V139, P462, DOI 10.1016/j.cell.2009.10.007; Edmunds JW, 2004, J CELL SCI, V117, P3715, DOI 10.1242/jcs.01346; Fan Y, 2010, CELL DEATH DIFFER, V17, P912, DOI 10.1038/cdd.2009.182; Fukuyama K, 2000, J BIOL CHEM, V275, P21247, DOI 10.1074/jbc.M001488200; Guelman S, 2006, MOL CELL BIOL, V26, P871, DOI 10.1128/MCB.26.3.871-882.2006; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; Kayali AG, 2000, DIABETES, V49, P1783, DOI 10.2337/diabetes.49.11.1783; Kimura A, 2005, J BIOCHEM, V138, P647, DOI 10.1093/jb/mvi184; Kusch T, 2003, MOL CELL BIOL, V23, P3305, DOI 10.1128/MCB.23.9.3305-3319.2003; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lawrence MC, 2009, P NATL ACAD SCI USA, V106, P22181, DOI 10.1073/pnas.0912596106; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Leimkuhler S, 2003, J BIOL CHEM, V278, P26127, DOI 10.1074/jbc.M303092200; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Morrison DK, 2000, J CELL BIOL, V150, pF57, DOI 10.1083/jcb.150.2.F57; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; ROZEK D, 1993, MOL CELL BIOL, V13, P5490, DOI 10.1128/MCB.13.9.5490; ROZEK D, 1995, J CELL BIOCHEM, V57, P479, DOI 10.1002/jcb.240570313; Rudolph MJ, 2001, NAT STRUCT BIOL, V8, P42; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Su YC, 1998, GENE DEV, V12, P2371, DOI 10.1101/gad.12.15.2371; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Treisman JE, 1997, GENE, V186, P119, DOI 10.1016/S0378-1119(96)00694-4; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Zapater M, 2007, MOL CELL BIOL, V27, P3900, DOI 10.1128/MCB.00089-07; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	48	48	49	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					726	736		10.1016/j.cell.2010.07.045	http://dx.doi.org/10.1016/j.cell.2010.07.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813260	Bronze			2022-12-24	WOS:000281523200016
J	Moster, D; Wilcox, AJ; Vollset, SE; Markestad, T; Lie, RT				Moster, Dag; Wilcox, Allen J.; Vollset, Stein Emil; Markestad, Trond; Lie, Rolv Terje			Cerebral Palsy Among Term and Postterm Births	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GESTATIONAL-AGE; EPIDEMIOLOGIC RESEARCH; PERINATAL FACTORS; PRETERM BIRTH; ANTECEDENTS; OUTCOMES; CHILDREN; COMPLICATIONS; PREVALENCE; INFANTS	Context Although preterm delivery is a well-established risk factor for cerebral palsy (CP), preterm deliveries contribute only a minority of affected infants. There is little information on the relation of CP risk to gestational age in the term range, where most CP occurs. Objective To determine whether timing of birth in the term and postterm period is associated with risk of CP. Design, Setting, and Participants Population-based follow-up study using the Medical Birth Registry of Norway to identify 1 682 441 singleton children born in the years 1967-2001 with a gestational age of 37 through 44 weeks and no congenital anomalies. The cohort was followed up through 2005 by linkage to other national registries. Main Outcome Measures Absolute and relative risk of CP for children surviving to at least 4 years of age. Results Of the cohort of term and postterm children, 1938 were registered with CP in the National Insurance Scheme. Infants born at 40 weeks had the lowest risk of CP, with a prevalence of 0.99/1000 (95% confidence interval [CI], 0.90-1.08). Risk for CP was higher with earlier or later delivery, with a prevalence at 37 weeks of 1.91/1000 (95% CI, 1.58-2.25) and a relative risk (RR) of 1.9 (95% CI, 1.6-2.4), a prevalence at 38 weeks of 1.25/1000 (95% CI, 1.07-1.42) and an RR of 1.3 (95% CI, 1.1-1.6), a prevalence at 42 weeks of 1.36/1000 (95% CI, 1.19-1.53) and an RR of 1.4 (95% CI, 1.2-1.6), and a prevalence after 42 weeks of 1.44 (95% CI, 1.15-1.72) and an RR of 1.4 (95% CI, 1.1-1.8). These associations were even stronger in a subset with gestational age based on ultrasound measurements: at 37 weeks the prevalence was 1.17/1000 (95% CI, 0.30-2.04) and the relative risk was 3.7 (95% CI, 1.5-9.1). At 42 weeks the prevalence was 0.85/1000 (95% CI, 0.33-1.38) and the relative risk was 2.4 (95% CI, 1.1-5.3). Adjustment for infant sex, maternal age, and various socioeconomic measures had little effect. Conclusion Compared with delivery at 40 weeks' gestation, delivery at 37 or 38 weeks or at 42 weeks or later was associated with an increased risk of CP. JAMA. 2010; 304(9): 976-982 www.jama.com	[Moster, Dag; Vollset, Stein Emil; Lie, Rolv Terje] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, N-5020 Bergen, Norway; [Markestad, Trond] Univ Bergen, Dept Clin Med, Sect Pediat, N-5020 Bergen, Norway; [Moster, Dag; Markestad, Trond] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Wilcox, Allen J.] NIEHS, Epidemiol Branch, NIH, Durham, NC USA; [Vollset, Stein Emil; Lie, Rolv Terje] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Norwegian Institute of Public Health (NIPH)	Moster, D (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth Care, POB 7804, N-5020 Bergen, Norway.	Dag.Moster@smis.uib.no	Wilcox, Allen J/C-7723-2019	Wilcox, Allen J/0000-0002-3376-1311	National Institutes of Health, National Institute of Environmental Health Sciences; Unger-Vetlesen Charitable Fund; US-Norway Fulbright Foundation; Norwegian Society of Pediatricians; University of Bergen; Research Council of Norway; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044003] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Unger-Vetlesen Charitable Fund; US-Norway Fulbright Foundation; Norwegian Society of Pediatricians; University of Bergen; Research Council of Norway(Research Council of Norway); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences; the Unger-Vetlesen Charitable Fund; The US-Norway Fulbright Foundation; the Norwegian Society of Pediatricians; the University of Bergen; and the Research Council of Norway.	Allen MC, 2008, CURR OPIN NEUROL, V21, P123, DOI 10.1097/WCO.0b013e3282f88bb4; Backe Bjorn, 1997, Tidsskrift for den Norske Laegeforening, V117, P2314; Blair E, 2009, FETAL NEONATAL NEURO, V4th, P867; Chaudhari BP, 2008, CLIN GENET, V74, P493, DOI 10.1111/j.1399-0004.2008.01124.x; Gulmezoglu AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945; Hack M, 2008, CLIN OBSTET GYNECOL, V51, P763, DOI 10.1097/GRF.0b013e3181870922; Himpens E, 2008, DEV MED CHILD NEUROL, V50, P334, DOI 10.1111/j.1469-8749.2008.02047.x; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jones K.L, 2006, SMITHS RECOGNIZABLE, V6th, P13; Kamel RM, 2010, ARCH GYNECOL OBSTET, V281, P975, DOI 10.1007/s00404-010-1365-9; Krageloh-Mann I, 2009, BRAIN DEV-JPN, V31, P537, DOI 10.1016/j.braindev.2009.03.009; Lynch CD, 2007, PAEDIATR PERINAT EP, V21, P86, DOI 10.1111/j.1365-3016.2007.00865.x; MANNINO F, 1988, J REPROD MED, V33, P271; Mesterman R, 2010, J CHILD NEUROL, V25, P36, DOI 10.1177/0883073809336677; Montenegro MA, 2005, J CHILD NEUROL, V20, P675, DOI 10.1177/08830738050200080801; Moster D, 2001, J PEDIATR-US, V138, P798, DOI 10.1067/mpd.2001.114694; Moster D, 2008, NEW ENGL J MED, V359, P262, DOI 10.1056/NEJMoa0706475; Msall ME, 2006, CLIN PERINATOL, V33, P269, DOI 10.1016/j.clp.2006.03.012; Nelson KB, 2008, CLIN OBSTET GYNECOL, V51, P749, DOI 10.1097/GRF.0b013e318187087c; Nelson KB, 2009, DEV MED CHILD NEUROL, V51, P765, DOI 10.1111/j.1469-8749.2009.03489.x; NELSON KB, 1985, AM J DIS CHILD, V139, P1031, DOI 10.1001/archpedi.1985.02140120077032; NELSON KB, 1986, NEW ENGL J MED, V315, P81, DOI 10.1056/NEJM198607103150202; *NORW MIN LAB, 2010, SURV NORW SOC INS SC; Pakula AT, 2009, PHYS MED REH CLIN N, V20, P427, DOI 10.1016/j.pmr.2009.06.001; Paneth N, 2008, CLIN OBSTET GYNECOL, V51, P742, DOI 10.1097/GRF.0b013e318187081a; Perlman JM, 2006, CLIN PERINATOL, V33, P335, DOI 10.1016/j.clp.2006.03.004; Rankin J, 2010, DEV MED CHILD NEUROL, V52, P345, DOI 10.1111/j.1469-8749.2009.03415.x; Robertson CMT, 2009, PEDIATR NEUROL, V40, P189, DOI 10.1016/j.pediatrneurol.2008.09.017; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Shea KM, 1998, EPIDEMIOLOGY, V9, P199, DOI 10.1097/00001648-199803000-00017; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; *STAT NORW, THIS IS STAT NORW I; The Norwegian Labour and Welfare Administration, MEMB NAT INS SCHEM; Thorngren-Jerneck K, 2006, OBSTET GYNECOL, V108, P1499, DOI 10.1097/01.AOG.0000247174.27979.6b; TORFS CP, 1990, J PEDIATR-US, V116, P615, DOI 10.1016/S0022-3476(05)81615-4; Walstab J, 2002, AUST NZ J OBSTET GYN, V42, P138, DOI 10.1111/j.0004-8666.2002.00138.x; Weijerman ME, 2008, J PEDIATR-US, V152, P15, DOI 10.1016/j.jpeds.2007.09.045; World Health Organization, INT CLASS DIS ICD; Yang S, 2010, AM J EPIDEMIOL, V171, P399, DOI 10.1093/aje/kwp413	39	78	79	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2010	304	9					976	982		10.1001/jama.2010.1271	http://dx.doi.org/10.1001/jama.2010.1271			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645AD	20810375	Green Accepted			2022-12-24	WOS:000281422400023
J	Larkin, J; Gore, M				Larkin, James; Gore, Martin			Is advanced renal cell carcinoma becoming a chronic disease?	LANCET			English	Editorial Material							INTERFERON-ALPHA; DOUBLE-BLIND; SUNITINIB; RESISTANCE		[Larkin, James; Gore, Martin] Royal Marsden Hosp, Dept Med, Renal Canc Unit, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust	Larkin, J (corresponding author), Royal Marsden Hosp, Dept Med, Renal Canc Unit, London SW3 6JJ, England.	james.larkin@rmh.nhs.uk		Larkin, James/0000-0001-5569-9523				Ainsworth NL, 2009, EXPERT REV ANTICANC, V9, P1793, DOI 10.1586/ERA.09.144; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Feldman DR, 2009, J CLIN ONCOL, V27, P1432, DOI 10.1200/JCO.2008.19.0108; Furge KA, 2010, LANCET ONCOL, V11, P571, DOI 10.1016/S1470-2045(09)70380-8; Huang D, 2010, CANCER RES, V70, P1053, DOI 10.1158/0008-5472.CAN-09-3722; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Ravaud A, 2010, ANN ONCOL, V21, DOI 10.1093/annonc/mdp548; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764	13	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 21	2010	376	9741					574	575		10.1016/S0140-6736(10)60816-1	http://dx.doi.org/10.1016/S0140-6736(10)60816-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643PB	20728740				2022-12-24	WOS:000281309100008
J	Colgrove, J; Abiola, S; Mello, MM				Colgrove, James; Abiola, Sara; Mello, Michelle M.			HPV Vaccination Mandates - Lawmaking amid Political and Scientific Controversy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PUBLIC-HEALTH; ADOLESCENTS; COVERAGE		[Abiola, Sara; Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Colgrove, James] Columbia Univ, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY USA	Harvard University; Harvard T.H. Chan School of Public Health; Columbia University	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mmello@hsph.harvard.edu		Mello, Michelle/0000-0003-2877-4270	Robert Wood Johnson Foundation; Greenwall Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Greenwall Foundation	Supported by the Robert Wood Johnson Foundation and the Greenwall Foundation's Faculty Scholars in Bioethics Program.	*ASS IMM MAN, POS STAT SCH CHILD C; Briss PA, 2000, AM J PREV MED, V18, P97, DOI 10.1016/S0749-3797(99)00118-X; *CDCP, 2007, SCH ENTR IMM ASS REP; Charo RA, 2007, NEW ENGL J MED, V356, P1905, DOI 10.1056/NEJMp078054; Childress JF, 2002, J LAW MED ETHICS, V30, P170, DOI 10.1111/j.1748-720X.2002.tb00384.x; COLGROVE J, 2008, PENN CTR GUIDE BIOET, P647; Colgrove James Keith, 2006, STATE IMMUNITY POLIT; Freed GL, 2008, AM J PREV MED, V35, P145, DOI 10.1016/j.amepre.2008.03.033; Gibbs N., 2006, TIME            0621; Giffin R, 2004, HEALTH AFFAIR, V23, P98, DOI 10.1377/hlthaff.23.5.98; Hinman AR, 2000, AM J PREV MED, V18, P92; Lo B, 2006, BMJ-BRIT MED J, V332, P1106, DOI 10.1136/bmj.332.7550.1106; National Conference of State Legislatures, HPV VACC; Olshen E, 2007, J ADOLESCENT HEALTH, V40, P405, DOI 10.1016/j.jadohealth.2006.12.013; OROURKE M, 2007, CANC SLUTS DOES HPV; Salmon DA, 2005, AM J PUBLIC HEALTH, V95, P778, DOI 10.2105/AJPH.2004.046193; Wynia MK, 2007, AM J BIOETHICS, V7, P2, DOI 10.1080/15265160701795809	17	72	72	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2010	363	8					785	791		10.1056/NEJMsr1003547	http://dx.doi.org/10.1056/NEJMsr1003547			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	639TE	20818883				2022-12-24	WOS:000280996600016
J	Manuel, DG; Rosella, LC; Stukel, TA				Manuel, Douglas G.; Rosella, Laura C.; Stukel, Therese A.			Importance of accurately identifying disease in studies using electronic health records	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE; QUALITY; CARE; MISCLASSIFICATION; VALIDITY; ONTARIO		[Manuel, Douglas G.] Ottawa Hosp Res Inst, Ottawa, ON K1Y 4E9, Canada; [Manuel, Douglas G.] Stats Canada, Ottawa, ON, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Epidemiol, Ottawa, ON, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Community Med, Ottawa, ON, Canada; [Manuel, Douglas G.; Rosella, Laura C.; Stukel, Therese A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Manuel, Douglas G.; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rosella, Laura C.; Stukel, Therese A.] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; Statistics Canada; University of Ottawa; University of Ottawa; University of Ottawa; University of Toronto; University of Toronto	Manuel, DG (corresponding author), Ottawa Hosp Res Inst, 1053 Carling Ave, Ottawa, ON K1Y 4E9, Canada.	dmanuel@ohri.ca		armstrong, benedict/0000-0003-4407-0409; Stukel, Therese/0000-0002-2951-1360				Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Couris CM, 2009, J CLIN EPIDEMIOL, V62, P660, DOI 10.1016/j.jclinepi.2008.07.013; Habbema J.D., 2002, EVIDENCE BASE CLIN D, P117; Health Council of Canada, 2007, WHY HLTH CAR REN MAT; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hurtado M.P., 2001, ENVISIONING NATL HLT; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Joshy G, 2006, DIABETES TECHNOL THE, V8, P587, DOI 10.1089/dia.2006.8.587; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kelsey JL., 1996, METHODS OBSERVATIONA; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Lix L, 2006, DEFINING VALIDATING; Lix LM, 2008, J CLIN EPIDEMIOL, V61, P1250, DOI 10.1016/j.jclinepi.2008.02.002; Mower WR, 1999, ANN EMERG MED, V33, P85, DOI 10.1016/S0196-0644(99)70422-1; Mullooly JP, 1996, AM J EPIDEMIOL, V144, P782; Newton J., 2002, DIS REGISTERS ENGLAN; *ONT MIN HLTH LONG, 2008, DIAB STRAT BACKGR; Powell AE, 2003, QUAL SAF HEALTH CARE, V12, P122, DOI 10.1136/qhc.12.2.122; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Schulz EB, 1998, J AM MED INFORM ASSN, V5, P337, DOI 10.1136/jamia.1998.0050337; Sturmer T, 2002, EPIDEMIOLOGY, V13, P507, DOI 10.1097/01.EDE.0000023361.94572.7C; Tu JV, 2008, CAN MED ASSOC J, V179, P909, DOI 10.1503/cmaj.080749; van Walraven C, 2010, J CLIN EPIDEMIOL, V63, P1000, DOI 10.1016/j.jclinepi.2010.01.023; WHITE E, 1986, AM J EPIDEMIOL, V124, P816, DOI 10.1093/oxfordjournals.aje.a114458; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Woodward G, 2006, CAN MED ASSOC J, V174, P327, DOI 10.1503/cmaj.1031433; World Health Organization, 1992, INT STAT CLASS DIS R	27	72	72	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2010	341								c4226	10.1136/bmj.c4226	http://dx.doi.org/10.1136/bmj.c4226			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642KW	20724404				2022-12-24	WOS:000281213400009
J	Lee, CH; Cook, JL; Mendelson, A; Moioli, EK; Yao, H; Mao, JJ				Lee, Chang H.; Cook, James L.; Mendelson, Avital; Moioli, Eduardo K.; Yao, Hai; Mao, Jeremy J.			Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study	LANCET			English	Article							MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; UNITED-STATES; TISSUE; CARTILAGE; OSTEOARTHRITIS; CHONDROCYTES; GROWTH; REPAIR	Background A common approach for tissue regeneration is cell delivery, for example by direct transplantation of stem or progenitor cells. An alternative, by recruitment of endogenous cells, needs experimental evidence. We tested the hypothesis that the articular surface of the synovial joint can regenerate with a biological cue spatially embedded in an anatomically correct bioscaffold. Methods In this proof of concept study, the surface morphology of a rabbit proximal humeral joint was captured with laser scanning and reconstructed by computer-aided design. We fabricated an anatomically correct bioscaffold using a composite of poly-e-caprolactone and hydroxyapatite. The entire articular surface of unilateral proximal humeral condyles of skeletally mature rabbits was surgically excised and replaced with bioscaffolds spatially infused with transforming growth factor beta 3 (TGF beta 3)-adsorbed or TGF beta 3-free collagen hydrogel. Locomotion and weightbearing were assessed 1-2, 3-4, and 5-8 weeks after surgery. At 4 months, regenerated cartilage samples were retrieved from in vivo and assessed for surface fissure, thickness, density, chondrocyte numbers, collagen type II and aggrecan, and mechanical properties. Findings Ten rabbits received TGF beta 3-infused bioscaffolds, ten received TGF beta 3-free bioscaffolds, and three rabbits underwent humeral-head excision without bioscaffold replacement. All animals in the TGF beta 3-delivery group fully resumed weightbearing and locomotion 3-4 weeks after surgery, more consistently than those in the TGF beta 3-free group. Defect-only rabbits limped at all times. 4 months after surgery, TGF beta 3-infused bioscaffolds were fully covered with hyaline cartilage in the articular surface. TGF beta 3-free bioscaffolds had only isolated cartilage formation, and no cartilage formation occurred in defect-only rabbits. TGF beta 3 delivery yielded uniformly distributed chondrocytes in a matrix with collagen type II and aggrecan and had significantly greater thickness (p=0.044) and density (p<0.0001) than did cartilage formed without TGF beta 3. Compressive and shear properties of TGF beta 3-mediated articular cartilage did not differ from those of native articular cartilage, and were significantly greater than those of cartilage formed without TGF beta 3. Regenerated cartilage was avascular and integrated with regenerated subchondral bone that had well defined blood vessels. TGF beta 3 delivery recruited roughly 130% more cells in the regenerated articular cartilage than did spontaneous cell migration without TGF beta 3. Interpretation Our findings suggest that the entire articular surface of the synovial joint can regenerate without cell transplantation. Regeneration of complex tissues is probable by homing of endogenous cells, as exemplified by stratified avascular cartilage and vascularised bone. Whether cell homing acts as an adjunctive or alternative approach of cell delivery for regeneration of tissues with different organisational complexity warrants further investigation.	[Lee, Chang H.; Mendelson, Avital; Moioli, Eduardo K.; Mao, Jeremy J.] Columbia Univ, Med Ctr, Tissue Engn & Regenerat Med Lab, New York, NY 10032 USA; [Cook, James L.] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Cook, James L.] Univ Missouri, Sch Med, Comparat Orthopaed Lab, Columbia, MO USA; [Yao, Hai] Clemson Univ, Clemson, SC 29631 USA; [Yao, Hai] Med Univ S Carolina, Dept Bioengn, Charleston, SC 29425 USA	Columbia University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Clemson University; Medical University of South Carolina	Mao, JJ (corresponding author), Columbia Univ, Med Ctr, Tissue Engn & Regenerat Med Lab, 630 W 168 St,PH7E, New York, NY 10032 USA.	jmao@columbia.edu		Mendelson, Avital/0000-0002-1120-9593; Cook, James/0000-0002-0862-995X	New York State Stem Cell Science; US National Institutes of Health [R01EB002332]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020767] Funding Source: NIH RePORTER	New York State Stem Cell Science; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a research grant from the New York State Stem Cell Science and US National Institutes of Health grant R01EB002332. We thank ICM staff at Columbia University Medical Center for veterinary assistance, and members of J J M laboratory for administrative and additional technical support. Synovium cells were a generous gift from Elena Jones of University of Leeds, UK.	Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106; Alhadlaq A, 2005, J BONE JOINT SURG AM, V87A, P936, DOI 10.2106/JBJS.D.02104; Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Boschetti F, 2008, BIORHEOLOGY, V45, P337, DOI 10.3233/BIR-2008-0479; Buckwalter JA, 2006, ADV DRUG DELIVER REV, V58, P150, DOI 10.1016/j.addr.2006.01.006; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]; Djouad F, 2005, ARTHRITIS RES THER, V7, pR1304, DOI 10.1186/ar1827; Erggelet C, 2009, J ORTHOP RES, V27, P1353, DOI 10.1002/jor.20879; Fodor William L, 2003, Reprod Biol Endocrinol, V1, P102, DOI 10.1186/1477-7827-1-102; Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187; GOLDBERG VM, 2004, ORTHOPEDIC TISSUE EN; Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442; Jones EA, 2008, ARTHRITIS RHEUM-US, V58, P1731, DOI 10.1002/art.23485; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281; Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lee CH, 2009, TISSUE ENG PT A, V15, P3923, DOI 10.1089/ten.TEA.2008.0653; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Mao JJ, 2005, BIOL CELL, V97, P289, DOI 10.1042/BC20040100; Marion NW, 2006, METHOD ENZYMOL, V420, P339, DOI 10.1016/S0079-6879(06)20016-8; Moioli EK, 2007, WOUND REPAIR REGEN, V15, P413, DOI 10.1111/j.1524-475X.2007.00244.x; Moioli EK, 2006, TISSUE ENG, V12, P537, DOI 10.1089/ten.2006.12.537; Muschler GF, 2010, TISSUE ENG PART B-RE, V16, P123, DOI [10.1089/ten.teb.2009.0658, 10.1089/ten.TEB.2009.0658]; Noh MJ, 2010, CYTOTHERAPY, V12, P384, DOI 10.3109/14653240903470639; Park DK, 2009, J BONE JOINT SURG AM, V91A, P350, DOI 10.2106/JBJS.H.00302; PERRIN DE, 1997, HDB BIODEGRADABLE PO, P63; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Si Y, 2010, J CLIN INVEST, V120, P1192, DOI 10.1172/JCI40310; Wood JJ, 2006, J BONE JOINT SURG AM, V88A, P503, DOI 10.2106/JBJS.E.00103; Woodfield TBF, 2009, CELL PROLIFERAT, V42, P485, DOI 10.1111/j.1365-2184.2009.00608.x; YANG R, PLOS ONE IN PRESS; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	38	447	481	3	185	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2010	376	9739					440	448		10.1016/S0140-6736(10)60668-X	http://dx.doi.org/10.1016/S0140-6736(10)60668-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639YK	20692530	Green Accepted			2022-12-24	WOS:000281012900029
J	Birkmeyer, NJO; Dimick, JB; Share, D; Hawasli, A; English, WJ; Genaw, J; Finks, JF; Carlin, AM; Birkmeyer, JD				Birkmeyer, Nancy J. O.; Dimick, Justin B.; Share, David; Hawasli, Abdelkader; English, Wayne J.; Genaw, Jeffrey; Finks, Jonathan F.; Carlin, Arthur M.; Birkmeyer, John D.		Michigan Bariatric Surg Collaborat	Hospital Complication Rates With Bariatric Surgery in Michigan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LAPAROSCOPIC GASTRIC BYPASS; MORBID-OBESITY; SURGICAL QUALITY; PROVIDER VOLUME; OUTCOMES; EXCELLENCE; CENTERS; PROGRAMS; PAYERS; IMPACT	Context Despite the growing popularity of bariatric surgery, there remain concerns about perioperative safety and variation in outcomes across hospitals. Objective To assess complication rates of different bariatric procedures and variability in rates of serious complications across hospitals and according to procedure volume and center of excellence (COE) status. Design, Setting, and Patients Involving 25 hospitals and 62 surgeons statewide, the Michigan Bariatric Surgery Collaborative (MBSC) administers an externally audited, prospective clinical registry. We evaluated short-term morbidity in 15 275 Michigan patients undergoing 1 of 3 common bariatric procedures between 2006 and 2009. We used multilevel regression models to assess variation in risk-adjusted complication rates across hospitals and the effects of procedure volume and COE designation (by the American College of Surgeons or American Society for Metabolic and Bariatric Surgery) status. Main Outcome Measure Complications occurring within 30 days of surgery. Results Overall, 7.3% of patients experienced perioperative complications, most of which were wound problems and other minor complications. Serious complications were most common after gastric bypass (3.6%; 95% confidence interval [CI], 3.2%-4.0%), followed by sleeve gastrectomy (2.2%; 95% CI, 1.2%-3.2%), and laparoscopic adjustable gastric band (0.9%; 95% CI, 0.6%-1.1%) procedures (P<.001). Mortality occurred in 0.04% (95% CI, 0.001%-0.13%) of laparoscopic adjustable gastric band, 0 sleeve gastrectomy, and 0.14% (95% CI, 0.08%-0.25%) of the gastric bypass patients. After adjustment for patient characteristics and procedure mix, rates of serious complications varied from 1.6% (95% CI, 1.3-2.0) to 3.5% (95% CI, 2.4-5.0) (risk difference, 1.9; 95% CI, 0.08-3.7) across hospitals. Average annual procedure volume was inversely associated with rates of serious complications at both the hospital level (<150 cases, 4.1%; 95% CI, 3.0%-5.1%; 150-299 cases, 2.7%; 95% CI, 2.2-3.2; and >= 300 cases, 2.3%; 95% CI, 2.0%-2.6%; P=.003) and surgeon level (<100 cases, 3.8%; 95% CI, 3.2%-4.5%; 100-249 cases, 2.4%; 95% CI, 2.1%-2.8%; >= 250 cases, 1.9%; 95% CI, 1.4%-2.3%; P=.001). Adjusted rates of serious complications were similar in COE and non-COE hospitals (COE, 2.7%; 95% CI, 2.5%-3.1%; non-COE, 2.0%; 95% CI, 1.5%-2.4%; P=.41). Conclusions The frequency of serious complications among patients undergoing bariatric surgery in Michigan was relatively low. Rates of serious complications are inversely associated with hospital and surgeon procedure volume, but unrelated to COE accreditation by professional organizations. JAMA. 2010; 304(4): 435-442	[Birkmeyer, Nancy J. O.] Univ Michigan, Dept Surg, Michigan Surg Collaborat Outcomes Res & Evaluat, Ann Arbor, MI 48104 USA; [Birkmeyer, Nancy J. O.; Dimick, Justin B.; Finks, Jonathan F.; Birkmeyer, John D.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48104 USA; [Share, David] Univ Michigan, Dept Family Med, Ann Arbor, MI 48104 USA; [Hawasli, Abdelkader] St John Hosp & Med Ctr, Dept Surg, Detroit, MI USA; [English, Wayne J.] Marquette Gen Hosp, Dept Surg, Marquette, MI USA; [Genaw, Jeffrey; Carlin, Arthur M.] Henry Ford Hosp, Dept Surg, Detroit, MI 48202 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; St. John Hospital & Medical Center; Henry Ford Health System; Henry Ford Hospital	Birkmeyer, NJO (corresponding author), Univ Michigan, Dept Surg, Michigan Surg Collaborat Outcomes Res & Evaluat, 211 N 4th Ave,Ste 2A & 2B, Ann Arbor, MI 48104 USA.	nbirkmey@umich.edu			Blue Cross and Blue Shield of Michigan; Blue Care Network; Agency for Healthcare Research and Quality [1R01HS018050, 1R01HS018728]; National Institute of Diabetes and Digestive and Kidney Diseases [1R21DK084397]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018050, R01HS018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK084397] Funding Source: NIH RePORTER	Blue Cross and Blue Shield of Michigan; Blue Care Network; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Michigan Bariatric Surgery Collaborative is funded by an unrestricted longitudinal research contract from Blue Cross and Blue Shield of Michigan and Blue Care Network. Drs N. Birkmeyer and Dimick also receive support for research related to the Michigan Bariatric Surgery Collaborative from the Agency for Healthcare Research and Quality (1R01HS018050 and 1R01HS018728) and the National Institute of Diabetes and Digestive and Kidney Diseases (1R21DK084397).	Biertho L, 2003, J AM COLL SURGEONS, V197, P536, DOI 10.1016/S1072-7515(03)00730-0; Birkmeyer NJO, 2006, NEW ENGL J MED, V354, P864, DOI 10.1056/NEJMsb053364; Birkmeyer NJO, 2005, SURGERY, V138, P815, DOI 10.1016/j.surg.2005.06.037; Cottam DR, 2006, OBES SURG, V16, P534, DOI 10.1381/096089206776944913; Courcoulas A, 2003, SURGERY, V134, P613, DOI 10.1016/S0039-6060(03)00306-4; Encinosa WE, 2009, MED CARE, V47, P531, DOI 10.1097/MLR.0b013e31819434c6; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Jan JC, 2005, J GASTROINTEST SURG, V9, P30, DOI 10.1016/j.gassur.2004.09.043; Kim TH, 2006, SURG ENDOSC, V20, P202, DOI 10.1007/s00464-005-0243-1; Latts L, 2010, ARCH SURG-CHICAGO, V145, P106, DOI 10.1001/archsurg.2009.256; Liu JH, 2003, AM SURGEON, V69, P823; Livingston EH, 2009, ARCH SURG-CHICAGO, V144, P319, DOI 10.1001/archsurg.2009.23; Murr MM, 2007, ANN SURG, V245, P699, DOI 10.1097/01.sla.0000256392.04141.04; Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24; Pratt GM, 2010, ARCH SURG-CHICAGO, V145, P105, DOI 10.1001/archsurg.2009.254; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Shikora SA, 2010, ARCH SURG-CHICAGO, V145, P105, DOI 10.1001/archsurg.2009.255; te Riele WW, 2008, OBES SURG, V18, P11, DOI 10.1007/s11695-007-9254-4; Tice JA, 2008, AM J MED, V121, P885, DOI 10.1016/j.amjmed.2008.05.036; Weber M, 2004, ANN SURG, V240, P975, DOI 10.1097/01.sla.0000145924.64932.8f; Weller WE, 2006, J AM COLL SURGEONS, V202, P753, DOI 10.1016/j.jamcollsurg.2006.02.002; Zingmond DS, 2005, JAMA-J AM MED ASSOC, V294, P1918, DOI 10.1001/jama.294.15.1918	24	291	295	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					435	442		10.1001/jama.2010.1034	http://dx.doi.org/10.1001/jama.2010.1034			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664044	Bronze			2022-12-24	WOS:000280350100027
J	Baudry, A; Mouillet-Richard, S; Schneider, B; Launay, JM; Kellermann, O				Baudry, Anne; Mouillet-Richard, Sophie; Schneider, Benoit; Launay, Jean-Marie; Kellermann, Odile			MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants	SCIENCE			English	Article							LOCUS-COERULEUS; RECOGNITION; RECEPTOR; CELLS; RAT	The serotonin transporter (SERT) ensures the recapture of serotonin and is the pharmacological target of selective serotonin reuptake inhibitor (SSRI) antidepressants. We show that SERT is a target of microRNA-16 (miR-16). miR-16 is expressed at higher levels in noradrenergic than in serotonergic cells; its reduction in noradrenergic neurons causes de novo SERT expression. In mice, chronic treatment with the SSRI fluoxetine (Prozac) increases miR-16 levels in serotonergic raphe nuclei, which reduces SERT expression. Further, raphe exposed to fluoxetine release the neurotrophic factor S100 beta, which acts on noradrenergic cells of the locus coeruleus. By decreasing miR-16, S100 beta turns on the expression of serotonergic functions in noradrenergic neurons. Based on pharmacological and behavioral data, we propose that miR-16 contributes to the therapeutic action of SSRI antidepressants in monoaminergic neurons.	[Launay, Jean-Marie] F Hoffmann La Roche, Pharma Res Dept, CH-4070 Basel, Switzerland; [Baudry, Anne; Mouillet-Richard, Sophie; Schneider, Benoit; Kellermann, Odile] Univ Paris 05, INSERM, U747, F-75006 Paris, France; [Launay, Jean-Marie] Hop Lariboisiere, INSERM, AP HP, U942,Serv Biochim,RTRS Sante Mentale, F-75475 Paris, France	Roche Holding; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Launay, JM (corresponding author), F Hoffmann La Roche, Pharma Res Dept, CH-4070 Basel, Switzerland.	jean-marie.launay@lrb.aphp.fr; odile.kellermann@parisdescartes.fr	Baudry, Anne/O-2624-2017; Mouillet, Sophie/E-4960-2017; Schneider, Benoit/AAF-3850-2019	Mouillet, Sophie/0000-0002-8950-1949; Schneider, Benoit/0000-0002-1377-2670; Baudry, Anne/0000-0002-7729-1753	CNRS; ANR; INSERM	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank P. Weil-Malherbe, V. Mutel, F. d'Agostini, G. Zurcher, E. Borroni, J. L. Moreau, F. Jenck, M. Buhler, and N. Pieron for skillful methodological assistance, and S. Blanquet, M. Briley, and L. Aggerbeck for critical reading of the manuscript. O.K. is a professor at Paris XI University. This work was funded by CNRS, ANR, and INSERM.	Azmitia EC, 2007, INT REV NEUROBIOL, V77, P31, DOI 10.1016/S0074-7742(06)77002-7; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benmansour S, 2002, J NEUROSCI, V22, P6766; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; FRAZER A, 1997, J CLIN PSYCHOPHARM S, V17, P25; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Kim MA, 2004, BRAIN RES, V1026, P56, DOI 10.1016/j.brainres.2004.08.022; Launay JM, 2006, FASEB J, V20, P1843, DOI 10.1096/fj.06-5724com; Manev R, 2001, EUR J PHARMACOL, V420, pR1, DOI 10.1016/S0014-2999(01)00989-X; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Mouillet-Richard S, 2000, J BIOL CHEM, V275, P9186, DOI 10.1074/jbc.275.13.9186; Murphy DL, 2008, NEUROPHARMACOLOGY, V55, P932, DOI 10.1016/j.neuropharm.2008.08.034; Nestler EJ, 1999, BIOL PSYCHIAT, V46, P1131, DOI 10.1016/S0006-3223(99)00158-4; QIAN Y, 1995, J NEUROSCI, V15, P1261; Shanmugam N, 2008, J BIOL CHEM, V283, P36221, DOI 10.1074/jbc.M806322200; Surget A, 2009, NEUROPSYCHOPHARMACOL, V34, P1363, DOI 10.1038/npp.2008.76; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456	19	347	368	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1537	1541		10.1126/science.1193692	http://dx.doi.org/10.1126/science.1193692			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847275				2022-12-24	WOS:000281869000046
J	Seymour, JE; French, J; Richardson, E				Seymour, Jane E.; French, Jeff; Richardson, Eve			Spotlight: Palliative Care Beyond Cancer Dying matters: let's talk about it	BRITISH MEDICAL JOURNAL			English	Article							PHYSICIAN-ASSISTED SUICIDE; HOSPICE CARE; ATTITUDES; DEATH; LIFE; END		[Seymour, Jane E.] Univ Nottingham, Sch Nursing Midwif & Physiother, Nottingham NG7 2HA, England; [French, Jeff] Strateg Soc Marketing, Liphook, Guildford GU30 7QW, England; [Richardson, Eve] Natl Council Palliat Care, London N7 9AS, England	University of Nottingham	Seymour, JE (corresponding author), Univ Nottingham, Sch Nursing Midwif & Physiother, Nottingham NG7 2HA, England.	jane.seymour@nottingham.ac.uk	Seymour, Jane E/C-1610-2009	Seymour, Jane E/0000-0002-9384-2551	National Council for Palliative Care	National Council for Palliative Care	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: JS had support from the National Council for Palliative Care and the National End of Life Care Programme for the submitted work; JF is a consultant to the Dying Matters coalition; no other relationships or activities that could appear to have influenced the submitted work.	Arber S, 2008, J AGING STUD, V22, P366, DOI 10.1016/j.jaging.2008.05.009; Bauman Zygmunt, 1992, MORTALITY IMMORTALIT; Berger Peter Ludwig, 1973, SOCIAL REALITY RELIG; Born Wendi, 2004, J Palliat Med, V7, P247, DOI 10.1089/109662104773709369; Burdette AM, 2005, J SCI STUD RELIG, V44, P79, DOI 10.1111/j.1468-5906.2005.00266.x; Catt S, 2005, PALLIATIVE MED, V19, P402, DOI 10.1191/0269216305pm1037oa; CLARK DA, 2007, EUR J PALLIAT CARE S; Clery E, 2007, BRIT SOCIAL ATTITUDE; Department of Health, 2008, END LIF CAR STRAT PR; *DYING MATT COAL, 2009, NATCEN SURV ATT DYIN; Emanuel EJ, 2002, ARCH INTERN MED, V162, P142, DOI 10.1001/archinte.162.2.142; French J., 2017, SOCIAL MARKETING PUB, VSecond, DOI 10.1093/med/9780198717690.001.0001; *HLTH CAR COMM, 2009, SPOTL COMPL REP 2 ST, V9; *ICM RES END UK, 2006, HAV GOOD HLTH GEN PU; Johnson KS, 2008, J AM GERIATR SOC, V56, P1953, DOI 10.1111/j.1532-5415.2008.01919.x; Kellehear A., 2008, Critical Public Health, V18, P111, DOI 10.1080/09581590701848960; Lloyd-Williams M, 2007, J PAIN SYMPTOM MANAG, V34, P60, DOI 10.1016/j.jpainsymman.2006.09.028; *M CUR CANC CAR, 2004, VIEWS DYING HOM SURV; *NAT COUNC PALL CA, 2010, DYING MATT LETS TALK; O'Neill C, 2003, SOC SCI MED, V57, P721, DOI 10.1016/S0277-9536(02)00421-5; Rietjens JAC, 2006, PALLIATIVE MED, V20, P685, DOI 10.1177/0269216306070241; Scottish Government, 2008, LIV DYING WELL NAT A; Seymour J., 2009, PUBLIC ATTITUDES DEA; WILLIAMS R, 1990, PROTESTANT LEGACY AT	24	22	23	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 16	2010	341								c4860	10.1136/bmj.c4860	http://dx.doi.org/10.1136/bmj.c4860			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653MO	20847020				2022-12-24	WOS:000282095800003
J	Liberman, J; O'Brien, M; Hall, W; Hill, D				Liberman, Jonathan; O'Brien, Megan; Hall, Wayne; Hill, David			Ending inequities in access to effective pain relief?	LANCET			English	Editorial Material									[Liberman, Jonathan; O'Brien, Megan; Hill, David] Int Union Canc, Geneva, Switzerland; [Liberman, Jonathan] Canc Council Victoria, Canton S, Vic 3053, Australia; [O'Brien, Megan] Amer Canc Soc, Washington, DC USA; [Hall, Wayne] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia	Cancer Council Victoria; American Cancer Society; University of Queensland	Liberman, J (corresponding author), Int Union Canc, Geneva, Switzerland.	jonathan.liberman@cancervic.org.au	Hall, Wayne D/A-3283-2008	Hall, Wayne D/0000-0003-1984-0096				Amon J, 2009, LANCET, V374, P1676, DOI 10.1016/S0140-6736(09)61990-5; [Anonymous], 1961, SINGL CONV NARC DRUG; [Anonymous], 2008, REP INT NARC CONTR B; Barrett D, 2009, UN DRUG POLICY HUMAN; Cherny NI, 2010, ANN ONCOL, V21, P615, DOI 10.1093/annonc/mdp581; Taylor AL, 2007, J LAW MED ETHICS, V35, P556, DOI 10.1111/j.1748-720X.2007.00180.x; *UN EC SOC COUNC C, 2010, UN EC SOC COUNC COMM; United Nations, 2010, REP INT NARC CONTR B; United Nations, 1971, CONV PSYCH SUBST; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; World Health Organization, 2009, ACC CONTR MED PROGR	11	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 11	2010	376	9744					856	857		10.1016/S0140-6736(10)60880-X	http://dx.doi.org/10.1016/S0140-6736(10)60880-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653DW	20833289				2022-12-24	WOS:000282069100010
J	Goel, H; Lusher, A; Boneh, A				Goel, Himanshu; Lusher, Allison; Boneh, Avihu			Pediatric Mortality Due to Inborn Errors of Metabolism in Victoria, Australia: A Population-Based Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Goel, Himanshu; Boneh, Avihu] Murdoch Childrens Res Inst, Metab Serv, Melbourne, Vic, Australia; [Lusher, Allison] Royal Childrens Hosp, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Goel, H (corresponding author), Murdoch Childrens Res Inst, Metab Serv, Melbourne, Vic, Australia.	avihu.boneh@ghsv.org.au						Applegarth DA, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.1.e10; Bernier FP, 2002, NEUROLOGY, V59, P1406, DOI 10.1212/01.WNL.0000033795.17156.00; Dionisi-Vici C, 2002, J PEDIATR-US, V140, P321, DOI 10.1067/mpd.2002.122394; Hutchesson ACJ, 1998, J MED GENET, V35, P366, DOI 10.1136/jmg.35.5.366; INTERACTIVE STAT CAL	5	5	6	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2010	304	10					1070	1072		10.1001/jama.2010.1259	http://dx.doi.org/10.1001/jama.2010.1259			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646RM	20823432				2022-12-24	WOS:000281559800016
J	Kirby, T				Kirby, Tony			Heather Zar-improving lung health for children in Africa	LANCET			English	Editorial Material												tony.kirby@lancet.com							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 4	2010	376	9743					763	763		10.1016/S0140-6736(10)61366-9	http://dx.doi.org/10.1016/S0140-6736(10)61366-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	650EC	20816534				2022-12-24	WOS:000281831000014
J	Alroy, J				Alroy, J.			The Shifting Balance of Diversity Among Major Marine Animal Groups	SCIENCE			English	Article							PHANEROZOIC TAXONOMIC DIVERSITY; FOSSIL RECORD; MASS EXTINCTIONS; KINETIC-MODEL; DIVERSIFICATION; PATTERNS; FAMILIES; HISTORY; TRENDS	The fossil record demonstrates that each major taxonomic group has a consistent net rate of diversification and a limit to its species richness. It has been thought that long-term changes in the dominance of major taxonomic groups can be predicted from these characteristics. However, new analyses show that diversity limits may rise or fall in response to adaptive radiations or extinctions. These changes are idiosyncratic and occur at different times in each taxa. For example, the end-Permian mass extinction permanently reduced the diversity of important, previously dominant groups such as brachiopods and crinoids. The current global crisis may therefore permanently alter the biosphere's taxonomic composition by changing the rules of evolution.	[Alroy, J.] Univ Calif Santa Barbara, Santa Barbara, CA 93101 USA	University of California System; University of California Santa Barbara	Alroy, J (corresponding author), Macquarie Univ, Fac Sci, Dept Biol Sci, Sydney, NSW 2109, Australia.		Alroy, John/B-4585-2009	Alroy, John/0000-0002-9882-2111				Alroy J, 2004, EVOL ECOL RES, V6, P1; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Bambach RK, 1999, GEOBIOS-LYON, V32, P131, DOI 10.1016/S0016-6995(99)80025-4; Bambach RK, 2002, P NATL ACAD SCI USA, V99, P6854, DOI 10.1073/pnas.092150999; BENTON MJ, 1995, SCIENCE, V268, P52, DOI 10.1126/science.7701342; GILINSKY NL, 1994, PALEOBIOLOGY, V20, P445, DOI 10.1017/S0094837300012926; HOFFMAN A, 1986, PALAEONTOLOGY, V29, P655; Kiessling W, 2008, NAT GEOSCI, V1, P527, DOI 10.1038/ngeo251; McKinney FK, 1998, SCIENCE, V281, P807, DOI 10.1126/science.281.5378.807; MILLER AI, 1988, PALEOBIOLOGY, V14, P364, DOI 10.1017/S0094837300012100; NEWELL NORMAN D., 1952, JOUR PALEONTOL, V26, P371; Peters SE, 2008, NATURE, V454, P626, DOI 10.1038/nature07032; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; Sepkoski JJ, 1997, J PALEONTOL, V71, P533, DOI 10.1017/S0022336000040026; Sepkoski JJ, 2000, PALEOBIOLOGY, V26, P7, DOI 10.1666/0094-8373(2000)026<0007:CDAPPC>2.0.CO;2; SEPKOSKI JJ, 1984, PALEOBIOLOGY, V10, P246, DOI 10.1017/S0094837300008186; SEPKOSKI JJ, 1979, PALEOBIOLOGY, V5, P222, DOI 10.1017/S0094837300006539; SEPKOSKI JJ, 1981, PALEOBIOLOGY, V7, P36, DOI 10.1017/S0094837300003778; Stanley SM, 2007, PALEOBIOLOGY, V33, P1, DOI 10.1666/06020.1; VERMEIJ G J, 1977, Paleobiology, V3, P245; Wagner PJ, 2006, SCIENCE, V314, P1289, DOI 10.1126/science.1133795; Wagner PJ, 1995, PALEOBIOLOGY, V21, P410, DOI 10.1017/S0094837300013464	24	304	312	4	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1191	1194		10.1126/science.1189910	http://dx.doi.org/10.1126/science.1189910			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20813951				2022-12-24	WOS:000281485600032
J	He, G; Luo, WJ; Li, P; Remmers, C; Netzer, WJ; Hendrick, J; Bettayeb, K; Flajolet, M; Gorelick, F; Wennogle, LP; Greengard, P				He, Gen; Luo, Wenjie; Li, Peng; Remmers, Christine; Netzer, William J.; Hendrick, Joseph; Bettayeb, Karima; Flajolet, Marc; Gorelick, Fred; Wennogle, Lawrence P.; Greengard, Paul			Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; TERMINAL FRAGMENT; EPSILON; NOTCH; DIFFERENTIATION; PROTEOLYSIS; GENERATION; MUTATIONS; CLEAVAGE; GENES	Accumulation of neurotoxic amyloid-beta is a major hallmark of Alzheimer's disease(1). Formation of amyloid-beta is catalysed by gamma-secretase, a protease with numerous substrates(2,3). Little is known about the molecular mechanisms that confer substrate specificity on this potentially promiscuous enzyme. Knowledge of the mechanisms underlying its selectivity is critical for the development of clinically effective gamma-secretase inhibitors that can reduce amyloid-beta formation without impairing cleavage of other gamma-secretase substrates, especially Notch, which is essential for normal biological functions(3,4). Here we report the discovery of a novel gamma-secretase activating protein (GSAP) that drastically and selectively increases amyloid-beta production through a mechanism involving its interactions with both gamma-secretase and its substrate, the amyloid precursor protein carboxy-terminal fragment (APP-CTF). GSAP does not interact with Notch, nor does it affect its cleavage. Recombinant GSAP stimulates amyloid-beta production in vitro. Reducing GSAP concentrations in cell lines decreases amyloid-beta concentrations. Knockdown of GSAP in a mouse model of Alzheimer's disease reduces levels of amyloid-beta and plaque development. GSAP represents a type of gamma-secretase regulator that directs enzyme specificity by interacting with a specific substrate. We demonstrate that imatinib, an anticancer drug previously found to inhibit amyloid-beta formation without affecting Notch cleavage 5, achieves its amyloid-beta-lowering effect by preventing GSAP interaction with the gamma-secretase substrate, APP-CTF. Thus, GSAP can serve as an amyloid-beta-lowering therapeutic target without affecting other key functions of gamma-secretase.	[He, Gen; Luo, Wenjie; Remmers, Christine; Netzer, William J.; Bettayeb, Karima; Flajolet, Marc; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Li, Peng; Hendrick, Joseph; Wennogle, Lawrence P.] Intra Cellular Therapies Inc, New York, NY 10032 USA; [Gorelick, Fred] Yale Univ, Sch Med, Dept Internal Med & Cell Biol, New Haven, CT 06520 USA; [Gorelick, Fred] VA Connecticut Healthcare, New Haven, CT 06520 USA	Rockefeller University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Greengard, P (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, 1230 York Ave, New York, NY 10065 USA.	greengard@rockefeller.edu	Luo, Wenjie/ABF-8451-2020	Wennogle, Lawrence/0000-0002-3795-409X; Gorelick, Fred/0000-0001-8293-6803	NIH [AG09464]; DOD [W81XWH-09-1-0402]; Fisher Center for Alzheimer's Research Foundation; F. M. Kirby Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Fisher Center for Alzheimer's Research Foundation; F. M. Kirby Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. Woo and B. Chait for their help with protein identification. We thank Y. M. Li for providing us with the biotinylated transition-state analogue. We thank B. Turner and S. Ku for their technical support. This work was supported by NIH grant AG09464 to P. G., DOD grant W81XWH-09-1-0402 to P. G., the Fisher Center for Alzheimer's Research Foundation and the F. M. Kirby Foundation.	Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Dai HQ, 2003, J PHARMACOL EXP THER, V304, P1085, DOI 10.1124/jpet.102.045260; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Green RC, 2009, JAMA-J AM MED ASSOC, V302, P2557, DOI 10.1001/jama.2009.1866; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kume H, 2006, BIOCHEM BIOPH RES CO, V349, P1356, DOI 10.1016/j.bbrc.2006.08.181; Lathia JD, 2008, J NEUROCHEM, V107, P1471, DOI 10.1111/j.1471-4159.2008.05715.x; Lefranc-Jullien S, 2006, J NEUROCHEM, V97, P807, DOI 10.1111/j.1471-4159.2006.03748.x; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Placanica L, 2009, J BIOL CHEM, V284, P2967, DOI 10.1074/jbc.M807269200; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Thathiah A, 2009, SCIENCE, V323, P946, DOI 10.1126/science.1160649; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wang H, 2004, J BIOL CHEM, V279, P40560, DOI 10.1074/jbc.M404345200; Wiley JC, 2005, J NEUROCHEM, V94, P1189, DOI 10.1111/j.1471-4159.2005.03266.x; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447	26	249	281	4	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					95	U129		10.1038/nature09325	http://dx.doi.org/10.1038/nature09325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811458	Green Accepted			2022-12-24	WOS:000281461200042
J	Mazon, G; Mimitou, EP; Symington, LS				Mazon, Gerard; Mimitou, Eleni P.; Symington, Lorraine S.			SnapShot: Homologous Recombination in DNA Double-Strand Break Repair	CELL			English	Editorial Material							MAINTAINS GENOMIC STABILITY		[Mazon, Gerard; Mimitou, Eleni P.; Symington, Lorraine S.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA	Columbia University	Mazon, G (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.			Mazon Busquets, Gerard/0000-0002-9791-5666	NIH [GM041784]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041784] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W.K. Holloman and H.L. Klein for helpful comments. We are supported by NIH grant GM041784.	Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Svendsen JM, 2010, GENE DEV, V24, P521, DOI 10.1101/gad.1903510; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	10	39	40	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4							648.e2	10.1016/j.cell.2010.08.006	http://dx.doi.org/10.1016/j.cell.2010.08.006			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723763	Bronze			2022-12-24	WOS:000281115900018
J	Ephgrave, KS				Ephgrave, Kimberly S.			Maintenance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												kimberly-ephgrave@uiowa.edu							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					615	616		10.1001/jama.2010.1118	http://dx.doi.org/10.1001/jama.2010.1118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699446				2022-12-24	WOS:000280829200001
J	Shannon, K; Csete, J				Shannon, Kate; Csete, Joanne			Violence, Condom Negotiation, and HIV/STI Risk Among Sex Workers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIV; INTERVENTIONS; PREVENTION; POLICY		[Shannon, Kate] Univ British Columbia, BC Ctr Excellence HIV AIDS, Dept Med, Div Aids, Vancouver, BC V6Z 1Y6, Canada; [Shannon, Kate] Univ British Columbia, Fac Med, Vancouver, BC V6Z 1Y6, Canada; [Csete, Joanne] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia; Columbia University	Shannon, K (corresponding author), Univ British Columbia, BC Ctr Excellence HIV AIDS, Dept Med, Div Aids, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	kshannon@cfenet.ubc.ca						Blankenship KM, 2002, J LAW MED ETHICS, V30, P548, DOI 10.1111/j.1748-720X.2002.tb00425.x; Cohen J, 2004, SCIENCE, V304, P506, DOI 10.1126/science.304.5670.506; Decker MR, 2010, SEX TRANSM INFECT, V86, P236, DOI 10.1136/sti.2009.037846; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; *OP SOC I, SEX WORK ACT NETW AR; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Rhodes T., 2008, BMJ-BRIT MED J, V337/7669, P560; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Shannon Kate, 2009, BRIT MED J, V339, P442	10	171	173	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					573	574		10.1001/jama.2010.1090	http://dx.doi.org/10.1001/jama.2010.1090			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682941				2022-12-24	WOS:000280525700029
J	Taylor, DR				Taylor, Daniel R.			The Haircut	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												daniel.taylor@drexelmed.edu	taylor, daniel/GYU-3348-2022					Canada G., 1995, FIST STICK KNIFE GUN; FERRICK TA, 2007, PHILADELPHIA INQ 072; Hurt H, 2001, ARCH PEDIAT ADOL MED, V155, P1351, DOI 10.1001/archpedi.155.12.1351; PRESTON SH, 2006, WASHINGTON POST 0826	4	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					504	505		10.1001/jama.2010.1085	http://dx.doi.org/10.1001/jama.2010.1085			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633SQ	20682924				2022-12-24	WOS:000280525700001
J	Ou, GS; Stuurman, N; D'Ambrosio, M; Vale, RD				Ou, Guangshuo; Stuurman, Nico; D'Ambrosio, Michael; Vale, Ronald D.			Polarized Myosin Produces Unequal-Size Daughters During Asymmetric Cell Division	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; STEM-CELLS; CYTOKINESIS; NEUROBLAST; MECHANISMS; MIGRATION; DYNAMICS	Asymmetric positioning of the mitotic spindle before cytokinesis can produce different-sized daughter cells that have distinct fates. Here, we found an asymmetric division in the Caenorhabditis elegans Q neuroblast lineage that began with a centered spindle but generated different-sized daughters, the smaller (anterior) of which underwent apoptosis. During this division, more myosin II accumulated anteriorly, suggesting that asymmetric contractile forces might produce different-sized daughters. Indeed, partial inactivation of anterior myosin by chromophore-assisted laser inactivation created a more symmetric division and allowed the survival and differentiation of the anterior daughter. Thus, the balance of myosin activity on the two sides of a dividing cell can govern the size and fate of the daughters.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ou, GS (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	gou@ibp.ac.cn; vale@cmp.ucsf.edu	Stuurman, Nico/AAV-4894-2021	Stuurman, Nico/0000-0002-6179-8613	Damon Runyon Cancer Research Foundation; NIH; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038499] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Cai, D. Sherwood, J. Ziel, P. Zhang, I. Cheeseman, C. Kenyon, G. Garriga, and Caenorhabditis Genetics Center for reagents, equipments and strains, and thank C. Locke and W. Li for myosin quantifications. This work was supported by the Damon Runyon Cancer Research Foundation (G.O.) and the NIH and Howard Hughes Medical Institute (R.D.V.).	Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; Diefenbach TJ, 2002, J CELL BIOL, V158, P1207, DOI 10.1083/jcb.200202028; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Hickson GRX, 2006, CURR BIOL, V16, P359, DOI 10.1016/j.cub.2005.12.043; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Jacobson K, 2008, TRENDS CELL BIOL, V18, P443, DOI 10.1016/j.tcb.2008.07.001; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Monier B, 2010, NAT CELL BIOL, V12, P60, DOI 10.1038/ncb2005; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Ou GS, 2009, J CELL BIOL, V185, P77, DOI 10.1083/jcb.200812077; Schneider SQ, 2003, ANNU REV GENET, V37, P221, DOI 10.1146/annurev.genet.37.110801.142443; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Vale RD, 2009, J CELL BIOL, V186, P727, DOI 10.1083/jcb.200902083; Wang FS, 1996, SCIENCE, V273, P660, DOI 10.1126/science.273.5275.660; Zipkin ID, 1997, CELL, V90, P883, DOI 10.1016/S0092-8674(00)80353-0	20	119	122	2	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					677	680		10.1126/science.1196112	http://dx.doi.org/10.1126/science.1196112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	20929735	Green Accepted			2022-12-24	WOS:000283580600050
J	Smets, T; Bilsen, J; Cohen, J; Rurup, ML; Mortier, F; Deliens, L				Smets, Tinne; Bilsen, Johan; Cohen, Joachim; Rurup, Mette L.; Mortier, Freddy; Deliens, Luc			Reporting of euthanasia in medical practice in Flanders, Belgium: cross sectional analysis of reported and unreported cases	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OF-LIFE DECISIONS; PHYSICIAN-ASSISTED SUICIDE; NETHERLANDS; DEATH; LAW; NOTIFICATION	Objectives To estimate the rate of reporting of euthanasia cases to the Federal Control and Evaluation Committee and to compare the characteristics of reported and unreported cases of euthanasia. Design Cross sectional analysis. Setting Flanders, Belgium. Participants A stratified at random sample was drawn of people who died between 1 June 2007 and 30 November 2007. The certifying physician of each death was sent a questionnaire on end of life decision making in the death concerned. Main outcome measures The rate of euthanasia cases reported to the Federal Control and Evaluation Committee; physicians' reasons for not reporting cases of euthanasia; the relation between reporting and non-reporting and the characteristics of the physician and patient; the time by which life was shortened according to the physician; the labelling of the end of life decision by the physician involved; and differences in characteristics of due care between reported and unreported euthanasia cases. Results The survey response rate was 58.4% (3623/6202 eligible cases). The estimated total number of cases of euthanasia in Flanders in 2007 was 1040 (95% CI 970 to 1109), thus the incidence of euthanasia was estimated as 1.9% of all deaths (95% CI 1.6% to 2.3%). Approximately half (549/1040 (52.8%, 95% CI 43.9% to 60.5%)) of all estimated cases of euthanasia were reported to the Federal Control and Evaluation Committee. Physicians who perceived their case as euthanasia reported it in 93.1% (67/72) of cases. Cases of euthanasia were reported less often when the time by which life was shortened was less than one week compared with when the perceived life shortening was greater (37.3% v 74.1%; P<0.001). Unreported cases were generally dealt with less carefully than reported cases: a written request for euthanasia was more often absent (87.7% v 17.6% verbal request only; P<0.001), other physicians and caregivers specialised in palliative care were consulted less often (54.6% v 97.5%; 33.0% v 63.9%; P<0.001 for both), the life ending act was more often performed with opioids or sedatives (92.1% v 4.4%; P<0.001), and the drugs were more often administered by a nurse (41.3% v 0.0%; P<0.001). Conclusions One out of two euthanasia cases is reported to the Federal Control and Evaluation Committee. Most non-reporting physicians do not perceive their act as euthanasia. Countries debating legalisation of euthanasia should simultaneously consider developing a policy facilitating the due care and reporting obligations of physicians.	[Smets, Tinne; Bilsen, Johan; Cohen, Joachim; Deliens, Luc] Vrije Univ Brussel, Fac Med & Pharm, End Life Care Res Grp, B-1090 Brussels, Belgium; [Rurup, Mette L.; Deliens, Luc] Vrije Univ Amsterdam Med Ctr, Expertise Ctr Palliat Care, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Mortier, Freddy] Univ Ghent, Bioeth Inst Ghent, B-9000 Ghent, Belgium	Vrije Universiteit Brussel; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Ghent University	Smets, T (corresponding author), Vrije Univ Brussel, Fac Med & Pharm, End Life Care Res Grp, Laarbeeklaan 103, B-1090 Brussels, Belgium.	tinne.smets@vub.ac.be	Smets, Tinne/G-3988-2012; Cohen, Joachim/B-6803-2008	Cohen, Joachim/0000-0002-7224-9476; Mortier, Freddy/0000-0002-5390-3508; Smets, Tinne/0000-0003-1439-316X; Deliens, Luc/0000-0002-8158-2422	Institute for the Promotion of Innovation by Science and Technology in Flanders (Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen) [050158]	Institute for the Promotion of Innovation by Science and Technology in Flanders (Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This study is part of the Monitoring Quality of End of Life Care (MELC) study, a collaboration between the Vrije Universiteit Brussel, Ghent University, Antwerp University, the Scientific Institute of Public Health, all in Belgium, and VU University Medical Center Amsterdam, The Netherlands. This study is supported by a grant from the Institute for the Promotion of Innovation by Science and Technology in Flanders (Instituut voor de aanmoediging van Innovatie door Wetenschap en Technologie in Vlaanderen; SBO IWT nr. 050158). The funders had no role in study design; in the collection, analysis and interpretation of the data; in the writing of the manuscript; or in the decision to submit for publication.	ADAMS M, 2001, REGULATING PHYS NEGO, P29; Bilsen J, 2009, NEW ENGL J MED, V361, P1119, DOI 10.1056/NEJMc0904292; Chambaere Kenneth, 2010, J Pain Symptom Manage, V39, pe5, DOI 10.1016/j.jpainsymman.2009.10.001; Chambaere K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-299; Deliens L, 2003, LANCET, V362, P1239, DOI 10.1016/S0140-6736(03)14520-5; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; DILLMAN T, 1978, MAIL TELEPHONE SURVE; Distelmans W, 2006, PSYCHO-ONCOLOGY, V15, pS226; Distelmans W, 2008, PSYCHO-ONCOL, V17, pS222; Douglas C, 2008, BIOETHICS, V22, P388, DOI 10.1111/j.1467-8519.2008.00661.x; George RJD, 2005, BMJ-BRIT MED J, V331, P684, DOI 10.1136/bmj.331.7518.684; Keown J, 2006, J MED ETHICS, V32, P29, DOI 10.1136/jme.2004.011148; Magnusson RS, 2004, J MED ETHICS, V30, P441, DOI 10.1136/jme.2003.005090; Materstvedt LJ, 2003, PALLIATIVE MED, V17, P97, DOI 10.1191/0269216303pm673oa; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; Mortier F, 2000, BIOETHICS, V14, P254, DOI 10.1111/1467-8519.00195; New York State Task Force on Life and the Law, 1994, DEATH IS SOUGHT ASS; Onwuteaka-Philipsen BD, 2000, SOC SCI MED, V51, P429, DOI 10.1016/S0277-9536(99)00476-1; Pollard BJ, 2001, PALLIATIVE MED, V15, P61, DOI 10.1191/026921601668201749; Rurup ML, 2008, MED CARE, V46, P1198, DOI 10.1097/MLR.0b013e31817d69e8; Smets T, 2010, MED CARE, V48, P187, DOI 10.1097/MLR.0b013e3181bd4dde; Smets T, 2009, HEALTH POLICY, V90, P181, DOI 10.1016/j.healthpol.2008.10.003; Sprung CL, 2008, CRIT CARE MED, V36, P8, DOI 10.1097/01.CCM.0000295304.99946.58; Teno Joan M, 2005, J Palliat Med, V8 Suppl 1, pS42; Van den Block L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-79; van der Heide A, 2004, LANCET, V364, P24, DOI 10.1016/S0140-6736(04)17628-9; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; van der Heide A, 2007, NEW ENGL J MED, V356, P1957, DOI 10.1056/NEJMsa071143; Van Wesemael Y, 2009, HEALTH SERV RES, V44, P2180, DOI 10.1111/j.1475-6773.2009.01042.x; vanderWal G, 1996, NEW ENGL J MED, V335, P1706; Weide MCJV, 2005, ARCH INTERN MED, V165, P1698, DOI 10.1001/archinte.165.15.1698; Weide MCJVD, 2004, HEALTH POLICY, V69, P365, DOI 10.1016/j.healthpol.2004.04.010; Weyers H, 2006, SOCIOL HEALTH ILL, V28, P802, DOI 10.1111/j.1467-9566.2006.00543.x	33	46	46	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2010	341								c5174	10.1136/bmj.c5174	http://dx.doi.org/10.1136/bmj.c5174			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JB	20923842	Green Published, hybrid			2022-12-24	WOS:000282879000004
J	Spies, S; Schipper, K; Nollet, F; Abma, TA				Spies, Stefan; Schipper, Karen; Nollet, Frans; Abma, Tineke A.			A Patient's Journey Duchenne muscular dystrophy	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Spies, Stefan; Schipper, Karen] Reinaerde, NL-3502 GJ Utrecht, Netherlands; [Schipper, Karen; Abma, Tineke A.] Vrije Univ Amsterdam Med Ctr, EMGO Inst, Dept Med Humanities, NL-1007 MB Amsterdam, Netherlands; [Nollet, Frans] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, NL-1100 DD Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam	Schipper, K (corresponding author), Reinaerde, Post Box 3364, NL-3502 GJ Utrecht, Netherlands.	k.schipper@vumc.nl; f.nollet@amc.nl	Abma, Tineke/AER-4580-2022	Abma, Tineke/0000-0002-8902-322X					0	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 7	2010	341								c4364	10.1136/bmj.c4364	http://dx.doi.org/10.1136/bmj.c4364			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	649ZI	20823012				2022-12-24	WOS:000281814900008
J	Malzahn, E; Ciprianidis, S; Kaldi, K; Schafmeier, T; Brunner, M				Malzahn, Erik; Ciprianidis, Stilianos; Kaldi, Krisztina; Schafmeier, Tobias; Brunner, Michael			Photoadaptation in Neurospora by Competitive Interaction of Activating and Inhibitory LOV Domains	CELL			English	Article							BLUE-LIGHT PHOTORECEPTOR; CIRCADIAN GENE-EXPRESSION; CLOCK GENE; TRANSCRIPTION FACTOR; BINDING DOMAINS; WHITE COLLAR-1; PROTEIN; TRANSFORMATION; ORGANIZATION; ARABIDOPSIS	Light responses and photoadaptation of Neurospora depend on the photosensory light-oxygen-voltage (LOV) domains of the circadian transcription factor White Collar Complex (WCC) and its negative regulator VIVID (VVD). We found that light triggers LOV-mediated dimerization of the WCC. The activated WCC induces expression of VVD, which then disrupts and inactivates the WCC homodimers by the competitive formation of WCC-VVD heterodimers, leading to photoadaptation. During the day, expression levels of VVD correlate with light intensity, allowing photoadaptation over several orders of magnitude. At night, previously synthesized VVD serves as a molecular memory of the brightness of the preceding day and suppresses responses to light cues of lower intensity. We show that VVD is essential to discriminate between day and night, even in naturally ambiguous photoperiods with moonlight.	[Malzahn, Erik; Ciprianidis, Stilianos; Schafmeier, Tobias; Brunner, Michael] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany; [Kaldi, Krisztina] Semmelweis Univ, Dept Physiol, H-1444 Budapest, Hungary	Ruprecht Karls University Heidelberg; Semmelweis University	Brunner, M (corresponding author), Heidelberg Univ, Biochem Ctr, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	michael.brunner@bzh.uni-heidelberg.de	Káldi, Krisztina/X-4080-2019	Brunner, Michael/0000-0001-9798-3047; Kaldi, Krisztina/0000-0002-5724-0182	DFG [BR 1375-3-1, SFB 638]; FCI [GP1188]; Hungarian OTKA [K 68960]; ETT [477-05]	DFG(German Research Foundation (DFG)); FCI(Fonds der Chemischen Industrie); Hungarian OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ETT	We thank Johanna Scholz and Krisztina Makara for excellent technical assistance. We are grateful to Cornelia Ulbrich for her experienced help with setting up the yeast two-hybrid system. This work was supported by the DFG grant BR 1375-3-1 to M.B. and T.S., SFB 638 and the FCI to M.B., GP1188 to E.M. and by an EMBO-HHMI startup grant by the Hungarian OTKA (K 68960) and ETT (477-05) to K.K., M.B. is a member of CellNetworks and S.C. is a member of HBIGS.	Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Brunner M, 2006, GENE DEV, V20, P1061, DOI 10.1101/gad.1410406; Cho HY, 2007, PLANT PHYSIOL, V143, P517, DOI 10.1104/pp.106.089839; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Corchnoy SB, 2003, J BIOL CHEM, V278, P724, DOI 10.1074/jbc.M209119200; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Doyle S, 2007, COLD SPRING HARB SYM, V72, P499, DOI 10.1101/sqb.2007.72.003; Elvin M, 2005, GENE DEV, V19, P2593, DOI 10.1101/gad.349305; Foster Russell G, 2007, Methods Mol Biol, V362, P3; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Helfrich-Forster C, 2002, ZOOLOGY, V105, P297, DOI 10.1078/0944-2006-00074; Herzberg C, 2007, PROTEOMICS, V7, P4032, DOI 10.1002/pmic.200700491; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; James P, 1996, GENETICS, V144, P1425; Kaiserli E, 2009, PLANT CELL, V21, P3226, DOI 10.1105/tpc.109.067876; Kaldi K, 2006, EMBO REP, V7, P199, DOI 10.1038/sj.embor.7400595; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Krauss U, 2009, J BACTERIOL, V191, P7234, DOI 10.1128/JB.00923-09; Liu Y, 2003, J BIOL RHYTHM, V18, P195, DOI 10.1177/0748730403018003002; Loros JJ, 2007, COLD SPRING HARB SYM, V72, P201, DOI 10.1101/sqb.2007.72.067; McClung CR, 2008, CURR OPIN PLANT BIOL, V11, P514, DOI 10.1016/j.pbi.2008.06.010; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Merrow M, 2007, COLD SPRING HARB SYM, V72, P279, DOI 10.1101/sqb.2007.72.032; Merrow M, 1999, NATURE, V399, P584, DOI 10.1038/21190; Nayak SK, 2007, CELL MOL LIFE SCI, V64, P144, DOI 10.1007/s00018-006-5581-1; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Schafmeier T, 2006, GENE DEV, V20, P297, DOI 10.1101/gad.360906; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schafmeier T, 2008, GENE DEV, V22, P3397, DOI 10.1101/gad.507408; Schwerdtfeger C, 2003, EMBO J, V22, P4846, DOI 10.1093/emboj/cdg451; Schwerdtfeger C, 2001, MOL MICROBIOL, V39, P1080, DOI 10.1046/j.1365-2958.2001.02306.x; Siepka SM, 2007, COLD SPRING HARB SYM, V72, P251, DOI 10.1101/sqb.2007.72.052; SMITH KM, 2010, CELL IN PRESS, DOI DOI 10.1128/EC.00154-10; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Tan Y, 2004, J BIOL RHYTHM, V19, P135, DOI 10.1177/0748730404263015; Vitalini MW, 2006, J BIOL RHYTHM, V21, P432, DOI 10.1177/0748730406294396; Woelfle MA, 2006, J BIOL RHYTHM, V21, P419, DOI 10.1177/0748730406294418; Zoltowski BD, 2008, BIOCHEMISTRY-US, V47, P7012, DOI 10.1021/bi8007017; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128; Zoltowski BD, 2009, NAT CHEM BIOL, V5, P827, DOI 10.1038/nchembio.210	47	115	120	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					762	772		10.1016/j.cell.2010.08.010	http://dx.doi.org/10.1016/j.cell.2010.08.010			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813262	Bronze			2022-12-24	WOS:000281523200019
J	McKenna, NJ; O'Malley, BW				McKenna, Neil J.; O'Malley, Bert W.			SnapShot: Nuclear Receptors I	CELL			English	Editorial Material							UNION-OF-PHARMACOLOGY; SUPERFAMILY		[McKenna, Neil J.; O'Malley, Bert W.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	McKenna, NJ (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.			McKenna, Neil/0000-0001-6689-0104	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER; NIDDK NIH HHS [U19-DK62434] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Auwerx J, 1999, CELL, V97, P161; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Moore DD, 2006, PHARMACOL REV, V58, P742, DOI 10.1124/pr.58.4.6; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Scarpin Katherine M, 2009, Nucl Recept Signal, V7, pe009, DOI 10.1621/nrs.07009; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Zhou Changcheng, 2009, Nucl Recept Signal, V7, pe001, DOI 10.1621/nrs.07001	10	12	12	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 3	2010	142	5							882.e1	10.1016/j.cell.2010.08.026	http://dx.doi.org/10.1016/j.cell.2010.08.026			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813267	Bronze			2022-12-24	WOS:000281523200024
J	Fisher, DE; James, WD				Fisher, David E.; James, William D.			Indoor Tanning - Science, Behavior, and Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MELANOMA		[Fisher, David E.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Fisher, David E.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Fisher, David E.] Harvard Univ, Sch Med, Boston, MA USA; [James, William D.] Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Pennsylvania	Fisher, DE (corresponding author), Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA.		Fisher, David/AAH-2878-2019		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR043369] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; Eller MS, 1996, P NATL ACAD SCI USA, V93, P1087, DOI 10.1073/pnas.93.3.1087; Lazovich D, 2010, CANCER EPIDEM BIOMAR, V19, P1557, DOI 10.1158/1055-9965.EPI-09-1249; Mosher CE, 2010, ARCH DERMATOL, V146, P412, DOI 10.1001/archdermatol.2009.385; Purdue MP, 2008, J INVEST DERMATOL, V128, P2905, DOI 10.1038/jid.2008.159	5	71	72	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 2	2010	363	10					901	903		10.1056/NEJMp1005999	http://dx.doi.org/10.1056/NEJMp1005999			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645GW	20818900	Green Accepted			2022-12-24	WOS:000281441500003
J	Korzhnev, DM; Religa, TL; Banachewicz, W; Fersht, AR; Kay, LE				Korzhnev, Dmitry M.; Religa, Tomasz L.; Banachewicz, Wiktor; Fersht, Alan R.; Kay, Lewis E.			A Transient and Low-Populated Protein-Folding Intermediate at Atomic Resolution	SCIENCE			English	Article							DISPERSION NMR-SPECTROSCOPY; ON-PATHWAY INTERMEDIATE; TIME-SCALE DYNAMICS; RELAXATION DISPERSION; CHEMICAL-SHIFTS; FF DOMAIN; ACCURATE MEASUREMENT; STRUCTURE GENERATION; TRANSITION-STATE; EXCHANGE	Proteins can sample conformational states that are critical for function but are seldom detected directly because of their low occupancies and short lifetimes. In this work, we used chemical shifts and bond-vector orientation constraints obtained from nuclear magnetic resonance relaxation dispersion spectroscopy, in concert with a chemical shift-based method for structure elucidation, to determine an atomic-resolution structure of an "invisible" folding intermediate of a small protein module: the FF domain. The structure reveals non-native elements preventing formation of the native conformation in the carboxyl-terminal part of the protein. This is consistent with the kinetics of folding in which a well-structured intermediate forms rapidly and then rearranges slowly to the native state. The approach introduces a general strategy for structure determination of low-populated and transiently formed protein states.	[Korzhnev, Dmitry M.; Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Korzhnev, Dmitry M.; Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Korzhnev, Dmitry M.; Religa, Tomasz L.; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada; [Banachewicz, Wiktor; Fersht, Alan R.] MRC, Ctr Prot Engn, Cambridge CB2 2QH, England	University of Toronto; University of Toronto; University of Toronto; University of Cambridge	Kay, LE (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca	Fersht, Alan R/B-2189-2008		European Molecular Biology Organization [ALTF 827-2006]; Canadian Institutes of Health Research (CIHR); Medical Research Council [MC_U105484373] Funding Source: researchfish; MRC [MC_U105484373] Funding Source: UKRI	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Forman-Kay (Hospital for Sick Children, Toronto) for providing laboratory space and useful discussions, P. Jemth (Uppsala Univ.) for providing plasmids for protein expression, R. Vernon (Univ. of Washington, Seattle) for valuable discussions, and R. Muhandiram (Univ. of Toronto) for NMR support. T.L.R. acknowledges the European Molecular Biology Organization (ALTF 827-2006) and the Canadian Institutes of Health Research (CIHR) for postdoctoral fellowships. L.E.K. holds a Canada Research Chair in Biochemistry. This work was supported by a grant from the CIHR to L.E.K. The structural ensembles of the WT FF domain-folding intermediate have been deposited in the Protein Data Bank (PDB; www.rcsb.org) with accession code 2KZG.	Allen M, 2002, J MOL BIOL, V323, P411, DOI 10.1016/S0022-2836(02)00968-3; Auer S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.178104; Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757; Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Feng HQ, 2005, P NATL ACAD SCI USA, V102, P5026, DOI 10.1073/pnas.0501372102; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Hansen DF, 2008, J PHYS CHEM B, V112, P5898, DOI 10.1021/jp074793o; Hansen DF, 2008, J AM CHEM SOC, V130, P2667, DOI 10.1021/ja078337p; Igumenova TI, 2007, J AM CHEM SOC, V129, P13396, DOI 10.1021/ja0761636; Ishima R, 2004, J BIOMOL NMR, V29, P187, DOI 10.1023/B:JNMR.0000019249.50306.5d; Ishima R, 2003, J BIOMOL NMR, V25, P243, DOI 10.1023/A:1022851228405; Jemth P, 2005, J MOL BIOL, V350, P363, DOI 10.1016/j.jmb.2005.04.067; Jemth P, 2004, P NATL ACAD SCI USA, V101, P6450, DOI 10.1073/pnas.0401732101; Jemth P, 2008, PROTEIN ENG DES SEL, V21, P207, DOI 10.1093/protein/gzm091; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y; Korzhnev DM, 2007, J MOL BIOL, V372, P497, DOI 10.1016/j.jmb.2007.06.012; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Lundstrom P, 2008, J BIOMOL NMR, V42, P35, DOI 10.1007/s10858-008-9260-4; Lundstrom P, 2009, J AM CHEM SOC, V131, P1915, DOI 10.1021/ja807796a; Lundstrom P, 2007, J BIOMOL NMR, V38, P199, DOI 10.1007/s10858-007-9158-6; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; McCully ME, 2010, BIOPHYS J, V99, P1628, DOI 10.1016/j.bpj.2010.06.040; Neudecker P, 2007, P NATL ACAD SCI USA, V104, P15717, DOI 10.1073/pnas.0705097104; Orekhov VY, 2004, J AM CHEM SOC, V126, P1886, DOI 10.1021/ja038620y; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Religa TL, 2007, P NATL ACAD SCI USA, V104, P9272, DOI 10.1073/pnas.0703434104; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Skrynnikov NR, 2002, J AM CHEM SOC, V124, P12352, DOI 10.1021/ja0207089; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105; Vallurupalli P, 2007, P NATL ACAD SCI USA, V104, P18473, DOI 10.1073/pnas.0708296104; Wensley BG, 2010, NATURE, V463, P685, DOI 10.1038/nature08743; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pW496, DOI 10.1093/nar/gkn305; Wishart DS, 2001, METHOD ENZYMOL, V338, P3	49	237	238	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2010	329	5997					1312	1316		10.1126/science.1191723	http://dx.doi.org/10.1126/science.1191723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829478				2022-12-24	WOS:000281657300029
J	Gale, DP; de Jorge, EG; Cook, HT; Martinez-Barricarte, R; Hadjisavvas, A; McLean, AG; Pusey, CD; Pierides, A; Kyriacou, K; Athanasiou, Y; Voskarides, K; Deltas, C; Palmer, A; Fremeaux-Bacchi, V; de Cordoba, SR; Maxwell, PH; Pickering, MC				Gale, Daniel P.; de Jorge, Elena Goicoechea; Cook, H. Terence; Martinez-Barricarte, Ruben; Hadjisavvas, Andreas; McLean, Adam G.; Pusey, Charles D.; Pierides, Alkis; Kyriacou, Kyriacos; Athanasiou, Yiannis; Voskarides, Konstantinos; Deltas, Constantinos; Palmer, Andrew; Fremeaux-Bacchi, Veronique; Rodriguez de Cordoba, Santiago; Maxwell, Patrick H.; Pickering, Matthew C.			Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis	LANCET			English	Article							HEMOLYTIC-UREMIC SYNDROME; TRANSLATIONAL MINIREVIEW SERIES; MACULAR DEGENERATION; LINKAGE ANALYSIS; DISEASE; AGE; DEPOSITS; RISK	Background Complement is a key component of the innate immune system, and variation in genes that regulate its activation is associated with renal and other disease. We aimed to establish the genetic basis for a familial disorder of complement regulation associated with persistent microscopic haematuria, recurrent macroscopic haematuria, glomerulonephritis, and progressive renal failure. Methods We sought patients from the West London Renal and Transplant Centre (London, UK) with unusual renal disease and affected family members as a method of identification of new genetic causes of kidney disease. Two families of Cypriot origin were identified in which renal disease was consistent with autosomal dominant transmission and renal biopsy of at least one individual showed C3 glomerulonephritis. A mutation was identified via a genomewide linkage study and candidate gene analysis. A PCR-based diagnostic test was then developed and used to screen for the mutation in population-based samples and in individuals and families with renal disease. Findings Occurrence of familial renal disease cosegregated with the same mutation in the complement factor H-related protein 5 gene (CFHR5). In a cohort of 84 Cypriots with unexplained renal disease, four had mutation in CFHR5. Overall, we identified 26 individuals with the mutation and evidence of renal disease from 11 ostensibly unrelated kindreds, including the original two families. A mutant CFHR5 protein present in patient serum had reduced affinity for surface-bound complement. We term this renal disease CFHR5 nephropathy. Interpretation CFHR5 nephropathy accounts for a substantial burden of renal disease in patients of Cypriot origin and can be diagnosed with a specific molecular test. The high risk of progressive renal disease in carriers of the CFHR5 mutation implies that isolated microscopic haematuria or recurrent macroscopic haematuria should not be regarded as a benign finding in individuals of Cypriot descent.	[Maxwell, Patrick H.] UCL, Rayne Inst, Div Med, London WC1E 6JF, England; [de Jorge, Elena Goicoechea; Cook, H. Terence; Pickering, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Ctr Complement & Inflammat Res, London, England; [Gale, Daniel P.; McLean, Adam G.; Pusey, Charles D.; Palmer, Andrew] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Kidney & Transplant Inst, London, England; [Martinez-Barricarte, Ruben; Rodriguez de Cordoba, Santiago] CSIC, Ctr Invest Biol, Ctr Invest Biomed Enfermedades Raras, Madrid, Spain; [Martinez-Barricarte, Ruben; Rodriguez de Cordoba, Santiago] Inst Reina Sofia Invest Nefrol, Madrid, Spain; [Hadjisavvas, Andreas; Kyriacou, Kyriacos] Cyprus Inst Neurol & Genet, Dept Electron Microscopy & Pathol, Nicosia, Cyprus; [Pierides, Alkis] Hippocrateon Hosp, Dept Nephrol, Nicosia, Cyprus; [Athanasiou, Yiannis] Nicosia Gen Hosp, Dept Nephrol, Nicosia, Cyprus; [Voskarides, Konstantinos; Deltas, Constantinos] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Fremeaux-Bacchi, Veronique] Hop Europeen Georges Pompidou, AP HP, Serv Immunol Biol, Paris, France; [Fremeaux-Bacchi, Veronique] Cordeliers Res Ctr, INSERM, UMRS 872, Paris, France	University of London; King's College London; University College London; Imperial College London; Imperial College London; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hippocrateon Private Hospital; University of Cyprus; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Maxwell, PH (corresponding author), UCL, Rayne Inst, Div Med, 5 Univ St, London WC1E 6JF, England.	p.maxwell@ucl.ac.uk	Deltas, Constantinos/J-9345-2013; de Cordoba, Santiago Rodriguez/K-6727-2014; Voskarides, Konstantinos/A-4669-2013; Maxwell, Patrick H/C-5557-2008; Barricarte, Ruben Martinez/W-8695-2019; Gale, Daniel/D-5594-2013; Deltas, Constantinos/A-4936-2013; de Jorge, Elena Goicoechea/L-4580-2016	Deltas, Constantinos/0000-0001-5549-9169; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Voskarides, Konstantinos/0000-0002-3705-3451; Maxwell, Patrick H/0000-0002-0338-2679; Barricarte, Ruben Martinez/0000-0001-7925-449X; Gale, Daniel/0000-0002-9170-1579; Deltas, Constantinos/0000-0001-5549-9169; de Jorge, Elena Goicoechea/0000-0002-4978-2483; Pickering, Matthew/0000-0002-1153-0192	UK Medical Research Council; Wellcome Trust [WT082291MA]; UK National Institute for Health Research Biomedical Research Centre; Cyprus Research Promotion Foundation; Cyprus Research Promotion Foundation [ENISigmaX/0505/02, ENISigmaX/0308/08]; EU; St Peter's Trust; UK National Institute for Health Research; Medical Research Council [G0600420] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish; MRC [G0600420] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); Cyprus Research Promotion Foundation; Cyprus Research Promotion Foundation; EU(European Commission); St Peter's Trust; UK National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DPG is supported by the UK Medical Research Council and EGdJ and MCP are supported by the Wellcome Trust. Additional support was provided by the UK National Institute for Health Research Biomedical Research Centre Funding Scheme and the Cyprus Research Promotion Foundation. No payment was received for the writing of this article. We thank the patients and their families. DPG is supported by a UK Medical Research Council Clinical Research Training Fellowship. MCP is a Wellcome Trust Senior Fellow in Clinical Science (WT082291MA) and EGdJ is funded by this fellowship. CD is supported by the Cyprus Research Promotion Foundation through grants ENI Sigma X/0505/02 and ENI Sigma X/0308/08. Additional support was obtained from the UK National Institute for Health Research Biomedical Research Centre Funding Scheme. PHM is supported by the EU large scale collaborative project Metoxia, the St Peter's Trust, and a Senior Investigator Award from the UK National Institute for Health Research.	BERGER J, 1968, J UROL NEPHROL, V74, P694; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cohen RA, 2003, NEW ENGL J MED, V348, P2330, DOI 10.1056/NEJMcp012694; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Dragon-Durey MA, 2009, J MED GENET, V46, P447, DOI 10.1136/jmg.2008.064766; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Loizidou MA, 2008, BREAST CANCER RES TR, V112, P575, DOI 10.1007/s10549-007-9881-4; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; McRae JL, 2001, J BIOL CHEM, V276, P6747, DOI 10.1074/jbc.M007495200; Murphy B, 2002, AM J KIDNEY DIS, V39, P24, DOI 10.1053/ajkd.2002.29873; Narendra U, 2009, MOL VIS, V15, P731; *NAT COLL CTR CHRO, 2008, CHRON KIDN DIS NAT C, P147; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pickering MC, 2008, CLIN EXP IMMUNOL, V151, P210, DOI 10.1111/j.1365-2249.2007.03574.x; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Servais A, 2007, J MED GENET, V44, P193, DOI 10.1136/jmg.2006.045328; Smith RJH, 2007, J AM SOC NEPHROL, V18, P2447, DOI 10.1681/ASN.2007030356; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Voskarides K, 2007, J AM SOC NEPHROL, V18, P3004, DOI 10.1681/ASN.2007040444; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147	26	228	244	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2010	376	9743					794	801		10.1016/S0140-6736(10)60670-8	http://dx.doi.org/10.1016/S0140-6736(10)60670-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650EC	20800271	Green Published, Green Submitted			2022-12-24	WOS:000281831000030
J	Nikoletopoulou, V; Lickert, H; Frade, JM; Rencurel, C; Giallonardo, P; Zhang, LX; Bibel, M; Barde, YA				Nikoletopoulou, Vassiliki; Lickert, Heiko; Frade, Jose Maria; Rencurel, Chantal; Giallonardo, Patrizia; Zhang, Lixin; Bibel, Miriam; Barde, Yves-Alain			Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not	NATURE			English	Article							NERVE GROWTH-FACTOR; EMBRYONIC STEM-CELLS; SYMPATHETIC NEURONS; GENETIC-EVIDENCE; MESSENGER-RNA; P75; EXPRESSION; DEPENDENCE; GANGLIA; MICE	Neurons of the peripheral nervous system have long been known to require survival factors to prevent their death during development. But why they selectively become dependent on secretory molecules has remained a mystery, as is the observation that in the central nervous system, most neurons do not show this dependency. Using engineered embryonic stem cells, we show here that the neurotrophin receptors TrkA and TrkC (tropomyosin receptor kinase A and C, also known as Ntrk1 and Ntrk3, respectively) instruct developing neurons to die, both in vitro and in vivo. By contrast, TrkB (also known as Ntrk2), a closely related receptor primarily expressed in the central nervous system, does not. These results indicate that TrkA and TrkC behave as dependence receptors, explaining why developing sympathetic and sensory neurons become trophic-factor-dependent for survival. We suggest that the expansion of the Trk gene family that accompanied the segregation of the peripheral from the central nervous system generated a novel mechanism of cell number control.	[Nikoletopoulou, Vassiliki; Rencurel, Chantal; Zhang, Lixin; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Lickert, Heiko; Giallonardo, Patrizia] Helmholtz Zentrum Munchen, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Frade, Jose Maria] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Bibel, Miriam] Novartis Inst BioMed Res, Neurodegenerat Dept, CH-4002 Basel, Switzerland	University of Basel; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Novartis	Nikoletopoulou, V (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.	n.vassiliki@unibas.ch; yves.barde@unibas.ch	Zhang, Li/GWM-7501-2022; Lickert, Heiko/K-9045-2013; Frade, Jose M/E-7913-2013; Barde, Yves/F-6019-2011	Frade, Jose M/0000-0001-7067-2505; Nikoletopoulou, Vassiliki/0000-0003-3646-992X; Barde, Yves/0000-0002-7627-461X	DFG; consortium EuTRACC; Swiss National Foundation	DFG(German Research Foundation (DFG)); consortium EuTRACC; Swiss National Foundation(Swiss National Science Foundation (SNSF))	H.L. is supported by an Emmy-Nother fellowship of the DFG. V.N. and Y.-A.B. thank S. Arber, G. Dechant as well as members of our laboratory for discussions and suggestions.; Tetraploid embryos were generated by P. G. and H. L.; J.M.F. initiated the comparison of the Ngf and TrkA mutant embryos; C. R performed the cloning of the HA-tagged Trk cDNAs; ES lines expressing non-tagged Trk cDNAs from the Mapt locus were generated by M. B.; L.Z. made the first observations with the neuronal differentiation of Trk-expressing ES cells. V.N. and Y.-A.B designed and carried out all other experiments. This work was supported by the consortium EuTRACC and the Swiss National Foundation.	Barbacid M, 1995, ANN NY ACAD SCI, V766, P442, DOI 10.1111/j.1749-6632.1995.tb26693.x; Benito-Gutierrez E, 2005, DEVELOPMENT, V132, P2191, DOI 10.1242/dev.01803; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bredesen DE, 2005, CELL DEATH DIFFER, V12, P1031, DOI 10.1038/sj.cdd.4401680; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; Chao MV, 2010, DEV NEUROBIOL, V70, P269, DOI 10.1002/dneu.20779; COUGHLIN MD, 1981, DEV BIOL, V82, P56, DOI 10.1016/0012-1606(81)90428-0; Davies AM, 2003, EMBO J, V22, P2537, DOI 10.1093/emboj/cdg254; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Frade JM, 1999, DEVELOPMENT, V126, P683; GAESE F, 1994, DEVELOPMENT, V120, P1613; Gschwendtner A, 2003, MOL CELL NEUROSCI, V24, P307, DOI 10.1016/S1044-7431(03)00167-2; HAMBURGER V, 1981, J NEUROSCI, V1, P60, DOI 10.1523/JNEUROSCI.01-01-00060.1981; Holland LZ, 2009, NAT REV NEUROSCI, V10, P736, DOI 10.1038/nrn2703; KAHANE N, 1994, J NEUROBIOL, V25, P571, DOI 10.1002/neu.480250509; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; LIU X, 1995, NATURE, V375, P238, DOI 10.1038/375238a0; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Moqrich A, 2004, NAT NEUROSCI, V7, P812, DOI 10.1038/nn1283; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakagawara A, 2001, CANCER LETT, V169, P107, DOI 10.1016/S0304-3835(01)00530-4; Nikoletopoulou V, 2007, CELL STEM CELL, V1, P529, DOI 10.1016/j.stem.2007.08.011; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897; Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767; Sendtner M, 1996, NEUROCHEM RES, V21, P831, DOI 10.1007/BF02532307; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Stenqvist A, 2005, EMBO REP, V6, P973, DOI 10.1038/sj.embor.7400512; Tauszig-Delamasure S, 2007, P NATL ACAD SCI USA, V104, P13361, DOI 10.1073/pnas.0701243104; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; von Bartheld CS, 1998, HISTOL HISTOPATHOL, V13, P437, DOI 10.14670/HH-13.437; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Wernig M, 2002, J NEUROSCI RES, V69, P918, DOI 10.1002/jnr.10395; White FA, 1996, J NEUROSCI, V16, P4662; WYATT S, 1993, DEVELOPMENT, V119, P635; WYATT S, 1995, J CELL BIOL, V130, P1435, DOI 10.1083/jcb.130.6.1435; Yano H, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0003.2001	48	153	158	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2010	467	7311					59	U87		10.1038/nature09336	http://dx.doi.org/10.1038/nature09336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811452	Green Submitted			2022-12-24	WOS:000281461200034
J	Bhaskaran, K; Hajat, S; Haines, A; Herrett, E; Wilkinson, P; Smeeth, L				Bhaskaran, Krishnan; Hajat, Shakoor; Haines, Andy; Herrett, Emily; Wilkinson, Paul; Smeeth, Liam			Short term effects of temperature on risk of myocardial infarction in England and Wales: time series regression analysis of the Myocardial Ischaemia National Audit Project (MINAP) registry	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AIR-POLLUTION; COLD WEATHER; SAO-PAULO; MORTALITY; HEAT; INCREASES; DEATHS; FIBRINOGEN; PLATELET; PRESSURE	Objective To examine the short term relation between ambient temperature and risk of myocardial infarction. Design Daily time series regression analysis. Setting 15 conurbations in England and Wales. Participants 84 010 hospital admissions for myocardial infarction recorded in the Myocardial Ischaemia National Audit Project during 2003-6 (median 57 events a day). Main outcome measures Change in risk of myocardial infarction associated with a 1 degrees C difference in temperature, including effects delayed by up to 28 days. Results Smoothed graphs revealed a broadly linear relation between temperature and myocardial infarction, which was well characterised by log-linear models without a temperature threshold: each 1 degrees C reduction in daily mean temperature was associated with a 2.0% (95% confidence interval 1.1% to 2.9%) cumulative increase in risk of myocardial infarction over the current and following 28 days, the strongest effects being estimated at intermediate lags of 2-7 and 8-14 days: increase per 1 degrees C reduction 0.6% (95% confidence interval 0.2% to 1.1%) and 0.7% (0.3% to 1.1%), respectively. Heat had no detrimental effect. Adults aged 75-84 and those with previous coronary heart disease seemed more vulnerable to the effects of cold than other age groups (P for interaction 0.001 or less in each case), whereas those taking aspirin were less vulnerable (P for interaction 0.007). Conclusions Increases in risk of myocardial infarction at colder ambient temperatures may be one driver of cold related increases in overall mortality, but an increased risk of myocardial infarction at higher temperatures was not detected. The risk of myocardial infarction in vulnerable people might be reduced by the provision of targeted advice or other interventions, triggered by forecasts of lower temperature.	[Bhaskaran, Krishnan; Herrett, Emily; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1F 7HT, England; [Hajat, Shakoor; Wilkinson, Paul] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Bhaskaran, K (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1F 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Bhaskaran, Krishnan/0000-0001-5364-8757; Haines, Andy/0000-0002-8053-4605; Wilkinson, Paul/0000-0001-7456-259X; Smeeth, Liam/0000-0002-9168-6022	British Heart Foundation [FS/04/045]; Garfield Weston Trust; Wellcome Trust [076583/Z/05/Z]	British Heart Foundation(British Heart Foundation); Garfield Weston Trust; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded through grants from the British Heart Foundation (FS/04/045) and the Garfield Weston Trust. LS is supported by a Wellcome Trust senior research fellowship in clinical science. SH is funded by a Wellcome Trust research career development fellowship (076583/Z/05/Z). The funders had no role in the design or conduct of this review, or in the preparation, review, or approval of the manuscript. All authors carried out this research independently of the funding bodies.	Allender S., 2008, CORONARY HEART DIS S; Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; Brumback BA, 2000, J AM STAT ASSOC, V95, P16; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Danet S, 1999, CIRCULATION, V100, pE11, DOI 10.1161/01.CIR.100.1.e1; Doherty RM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S8; DOMINICI F, 2004, RES REP HLTH EFF I, V3, P27; Donaldson GC, 1997, J EPIDEMIOL COMMUN H, V51, P643, DOI 10.1136/jech.51.6.643; ENQUSELASSIE F, 1993, INT J EPIDEMIOL, V22, P632, DOI 10.1093/ije/22.4.632; Fenn B, 2008, EPIDEMIOLOGY, V19, pS172; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Hajat S, 2007, J EPIDEMIOL COMMUN H, V61, P719, DOI 10.1136/jech.2006.053942; HEPPELL R, 1991, BRIT MED J, V302, P469, DOI 10.1136/bmj.302.6774.469-c; KEATINGE WR, 1984, BMJ-BRIT MED J, V289, P1405, DOI 10.1136/bmj.289.6456.1405; McCullagh P, 1989, GEN LINEAR MODELS; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Mercer JB, 1999, THROMB RES, V95, P93, DOI 10.1016/S0049-3848(99)00028-6; Messner Torbjorn, 2002, Int J Circumpolar Health, V61, P201; Morabito M, 2006, ENVIRON RES, V102, P52, DOI 10.1016/j.envres.2005.12.007; NEILD PJ, 1994, CLIN SCI, V86, P43, DOI 10.1042/cs0860043; OPPER C, 1995, PHARMACOL BIOCHEM BE, V51, P217, DOI 10.1016/0091-3057(94)00432-I; Pattenden S, 2003, J EPIDEMIOL COMMUN H, V57, P628, DOI 10.1136/jech.57.8.628; RAVEN PB, 1970, J APPL PHYSIOL, V29, P417, DOI 10.1152/jappl.1970.29.4.417; Rossi G, 1999, ARCH ENVIRON HEALTH, V54, P158, DOI 10.1080/00039899909602254; Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021; Sharovsky R, 2004, BRAZ J MED BIOL RES, V37, P1651, DOI 10.1590/S0100-879X2004001100009; *UK MET OFF, COPD HLTH FOR WINT 2; Wang Hongli, 2006, Hiroshima Journal of Medical Sciences, V55, P45	34	130	135	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2010	341								c3823	10.1136/bmj.c3823	http://dx.doi.org/10.1136/bmj.c3823			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640DQ	20699305	hybrid, Green Published, Green Accepted			2022-12-24	WOS:000281028800002
J	Inoue, K; Kohda, T; Sugimoto, M; Sado, T; Ogonuki, N; Matoba, S; Shiura, H; Ikeda, R; Mochida, K; Fujii, T; Sawai, K; Otte, AP; Tian, XC; Yang, XZ; Ishino, F; Abe, K; Ogura, A				Inoue, Kimiko; Kohda, Takashi; Sugimoto, Michihiko; Sado, Takashi; Ogonuki, Narumi; Matoba, Shogo; Shiura, Hirosuke; Ikeda, Rieko; Mochida, Keiji; Fujii, Takashi; Sawai, Ken; Otte, Arie P.; Tian, X. Cindy; Yang, Xiangzhong; Ishino, Fumitoshi; Abe, Kuniya; Ogura, Atsuo			Impeding Xist Expression from the Active X Chromosome Improves Mouse Somatic Cell Nuclear Transfer	SCIENCE			English	Article							INACTIVATION; CLONING; MICE	Cloning mammals by means of somatic cell nuclear transfer (SCNT) is highly inefficient because of erroneous reprogramming of the donor genome. Reprogramming errors appear to arise randomly, but the nature of nonrandom, SCNT-specific errors remains elusive. We found that Xist, a noncoding RNA that inactivates one of the two X chromosomes in females, was ectopically expressed from the active X (Xa) chromosome in cloned mouse embryos of both sexes. Deletion of Xist on Xa showed normal global gene expression and resulted in about an eight-to ninefold increase in cloning efficiency. We also identified an Xist-independent mechanism that specifically down-regulated a subset of X-linked genes through somatic-type repressive histone blocks. Thus, we have identified nonrandom reprogramming errors in mouse cloning that can be altered to improve the efficiency of SCNT methods.	[Inoue, Kimiko; Sugimoto, Michihiko; Ogonuki, Narumi; Matoba, Shogo; Shiura, Hirosuke; Ikeda, Rieko; Mochida, Keiji; Abe, Kuniya; Ogura, Atsuo] RIKEN, BioResource Ctr, Tsukuba, Ibaraki 3050024, Japan; [Inoue, Kimiko; Abe, Kuniya; Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Kohda, Takashi; Ishino, Fumitoshi] Tokyo Med & Dent Univ, Med Res Inst, Tokyo 1138510, Japan; [Sado, Takashi] Kyushu Univ, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Fujii, Takashi; Sawai, Ken] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Otte, Arie P.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1018 TV Amsterdam, Netherlands; [Tian, X. Cindy; Yang, Xiangzhong] Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; [Tian, X. Cindy; Yang, Xiangzhong] Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; [Ogura, Atsuo] Univ Tokyo, Fac ofMedicine, Ctr Dis Biol & Integrat Med, Tokyo 1130033, Japan	RIKEN; University of Tsukuba; Tokyo Medical & Dental University (TMDU); Kyushu University; Iwate University; University of Amsterdam; University of Connecticut; University of Connecticut; University of Tokyo	Ogura, A (corresponding author), RIKEN, BioResource Ctr, Tsukuba, Ibaraki 3050024, Japan.	ogura@rtc.riken.go.jp	Sado, Takashi/AAI-1689-2019; MATOBA, Shogo/D-9995-2016; Ogura, Atsuo/J-3916-2014; Kohda, Takashi/C-2879-2014	MATOBA, Shogo/0000-0003-0474-232X; Ogura, Atsuo/0000-0003-0447-1988; Sado, Takashi/0000-0002-1232-0250; Shiura, Hirosuke/0000-0003-2553-6971; Kohda, Takashi/0000-0002-6856-5601	Ministry of Education, Culture, Sports, Science and Technology; NOVARTIS Foundation (Japan) for the Promotion of Science; Grants-in-Aid for Scientific Research [19061001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The mice in which Xist had been knocked out (RBRC 01260) were provided by the RIKEN BioResource Center. This research was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology and NOVARTIS Foundation (Japan) for the Promotion of Science. The H3K9me2 antibody used for chromatin immunoprecipitation on chip was a kind gift from H. Kimura. We thank M. Tachibana, Y. Shinkai, H. Koseki, T. H. Endo, and S. L. Marjani for their invaluable suggestions. The microarray data have been deposited in the Gene Expression Omnibus and given the series accession number GSE23181.	Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; Fulka J, 2004, NAT BIOTECHNOL, V22, P25, DOI 10.1038/nbt0104-25; Huynh KD, 2005, NAT REV GENET, V6, P410, DOI 10.1038/nrg1604; Inoue K, 2002, SCIENCE, V295, P297, DOI 10.1126/science.295.5553.297; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; McDonald LE, 1998, GENOMICS, V54, P379, DOI 10.1006/geno.1998.5570; Meissner A, 2006, DEV DYNAM, V235, P2460, DOI 10.1002/dvdy.20915; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nolen LD, 2005, DEV BIOL, V279, P525, DOI 10.1016/j.ydbio.2005.01.016; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; SALIDO EC, 1992, NAT GENET, V2, P196, DOI 10.1038/ng1192-196; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	18	180	198	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	2010	330	6003					496	499		10.1126/science.1194174	http://dx.doi.org/10.1126/science.1194174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20847234				2022-12-24	WOS:000283329100037
J	Gibiansky, ML; Conrad, JC; Jin, F; Gordon, VD; Motto, DA; Mathewson, MA; Stopka, WG; Zelasko, DC; Shrout, JD; Wong, GCL				Gibiansky, Maxsim L.; Conrad, Jacinta C.; Jin, Fan; Gordon, Vernita D.; Motto, Dominick A.; Mathewson, Margie A.; Stopka, Wiktor G.; Zelasko, Daria C.; Shrout, Joshua D.; Wong, Gerard C. L.			Bacteria Use Type IV Pili to Walk Upright and Detach from Surfaces	SCIENCE			English	Article							BIOFILM FORMATION; MOTILITY	Bacterial biofilms are structured multicellular communities involved in a broad range of infections. Knowing how free-swimming bacteria adapt their motility mechanisms near surfaces is crucial for understanding the transition between planktonic and biofilm phenotypes. By translating microscopy movies into searchable databases of bacterial behavior, we identified fundamental type IV pili-driven mechanisms for Pseudomonas aeruginosa surface motility involved in distinct foraging strategies. Bacteria stood upright and "walked" with trajectories optimized for two-dimensional surface exploration. Vertical orientation facilitated surface detachment and could influence biofilm morphology.	[Gibiansky, Maxsim L.; Jin, Fan; Gordon, Vernita D.; Wong, Gerard C. L.] Univ Calif Los Angeles, Dept Bioengn, Calif Nano Syst Inst, Los Angeles, CA 90024 USA; [Conrad, Jacinta C.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA; [Mathewson, Margie A.; Stopka, Wiktor G.; Zelasko, Daria C.; Wong, Gerard C. L.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Motto, Dominick A.; Shrout, Joshua D.] Univ Notre Dame, Dept Civil Engn & Geol Sci, Notre Dame, IN 46556 USA	University of California System; University of California Los Angeles; University of Houston System; University of Houston; University of Illinois System; University of Illinois Urbana-Champaign; University of Notre Dame	Wong, GCL (corresponding author), Univ Calif Los Angeles, Dept Bioengn, Calif Nano Syst Inst, Los Angeles, CA 90024 USA.	gclwong@seas.ucla.edu	Shrout, Joshua D/C-4743-2012; Conrad, Jacinta/D-6432-2013	Shrout, Joshua D/0000-0001-9509-2187; Conrad, Jacinta/0000-0001-6084-4772; Gordon, Vernita/0000-0002-5989-9378; fan, jin/0000-0003-2313-0388				Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; Sun H, 2000, CURR BIOL, V10, P1143, DOI 10.1016/S0960-9822(00)00705-3; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000	7	139	144	9	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					197	U50		10.1126/science.1194238	http://dx.doi.org/10.1126/science.1194238			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929769	Green Published			2022-12-24	WOS:000282644600033
J	Park, JS; Karnas, E; Ohkubo, K; Chen, P; Kadish, KM; Fukuzumi, S; Bielawski, CW; Hudnall, TW; Lynch, VM; Sessler, JL				Park, Jung Su; Karnas, Elizabeth; Ohkubo, Kei; Chen, Ping; Kadish, Karl M.; Fukuzumi, Shunichi; Bielawski, Christopher W.; Hudnall, Todd W.; Lynch, Vincent M.; Sessler, Jonathan L.			Ion-Mediated Electron Transfer in a Supramolecular Donor-Acceptor Ensemble	SCIENCE			English	Article							PHOTOSYSTEM-II; ANION-BINDING; RECEPTOR	Ion binding often mediates electron transfer in biological systems as a cofactor strategy, either as a promoter or as an inhibitor. However, it has rarely, if ever, been exploited for that purpose in synthetic host-guest assemblies. We report here that strong binding of specific anions (chloride, bromide, and methylsulfate but not tetrafluoroborate or hexafluorophosphate) to a tetrathiafulvalene calix[4]pyrrole (TTF-C4P) donor enforces a host conformation that favors electron transfer to a bisimidazolium quinone (BIQ(2+)) guest acceptor. In contrast, the addition of a tetraethylammonium cation, which binds more effectively than the BIQ(2+) guest in the TTF-C4P cavity, leads to back electron transfer, restoring the initial oxidation states of the donor and acceptor pair. The products of these processes were characterized via spectroscopy and x-ray crystallography.	[Chen, Ping; Kadish, Karl M.] Univ Houston, Dept Chem, Houston, TX 77204 USA; [Park, Jung Su; Karnas, Elizabeth; Bielawski, Christopher W.; Hudnall, Todd W.; Lynch, Vincent M.; Sessler, Jonathan L.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Ohkubo, Kei; Fukuzumi, Shunichi] Osaka Univ, Grad Sch Engn, Dept Mat & Life Sci, Suita, Osaka 5650871, Japan; [Fukuzumi, Shunichi] Ewha Womans Univ, Dept Bioinspired Sci, Seoul 120750, South Korea; [Sessler, Jonathan L.] Yonsei Univ, Dept Chem, Seoul 120749, South Korea	University of Houston System; University of Houston; University of Texas System; University of Texas Austin; Osaka University; Ewha Womans University; Yonsei University	Kadish, KM (corresponding author), Univ Houston, Dept Chem, Univ Pk, Houston, TX 77204 USA.		Sessler, Jonathan/AAY-7091-2021; Fukuzumi, Shunichi/E-4728-2010; Ohkubo, Kei/E-5127-2012; Ohkubo, Kei/L-5002-2019; Hudnall, Todd W/K-8354-2014	Ohkubo, Kei/0000-0001-8328-9249; Ohkubo, Kei/0000-0001-8328-9249; Hudnall, Todd/0000-0002-9260-2986	Ministry of Education, Culture, Sports, Science and Technology, Japan; NSF [CHE 0749571, 0741973]; R.A. Welch Foundation [F-1018, E-680, F-1621]; Korean World Class University [R32-20080-000-10217-0, R31-2008-000-10010-0];  [20108010]; Direct For Mathematical & Physical Scien [0741973] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [20108001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NSF(National Science Foundation (NSF)); R.A. Welch Foundation(The Welch Foundation); Korean World Class University; ; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid (no. 20108010 to S.F.) and a Global Centers of Excellence program from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to S.F.); NSF (grants CHE 0749571 to J.L.S. and 0741973 for the x-ray diffractometer); and the R.A. Welch Foundation (grants F-1018, E-680, and F-1621 to J.LS., K.M.K., and C.W.B., respectively). Support to J.L.S. and S.F. under the Korean World Class University program is also acknowledged (grants R32-20080-000-10217-0 and R31-2008-000-10010-0, respectively). Crystallographic data have been deposited with the Cambridge Crystallographic Data Centre under reference numbers CCDC-775796 to 775804.	Battistuzzi G, 1996, EUR J BIOCHEM, V241, P208, DOI 10.1111/j.1432-1033.1996.0208t.x; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fukuzumi S, 2009, PROG INORG CHEM, V56, P49, DOI 10.1002/9780470440124.ch2; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Nielsen K. A., 2006, ANGEW CHEM, V118, P7002; Nielsen KA, 2006, J AM CHEM SOC, V128, P2444, DOI 10.1021/ja057367u; Nielsen KA, 2004, J AM CHEM SOC, V126, P16296, DOI 10.1021/ja044664a; Rosokha SV, 2007, J AM CHEM SOC, V129, P828, DOI 10.1021/ja064166x; Sessler JL, 2006, J AM CHEM SOC, V128, P12281, DOI 10.1021/ja064012h; Tennyson AG, 2010, CHEM-EUR J, V16, P304, DOI 10.1002/chem.200901883; Utschig LM, 2004, ACCOUNTS CHEM RES, V37, P439, DOI 10.1021/ar020197v; Yocum CF, 2008, COORDIN CHEM REV, V252, P296, DOI 10.1016/j.ccr.2007.08.010; Zhao X, 2005, BIOCHEMISTRY-US, V44, P6559, DOI 10.1021/bi047465c	14	151	151	5	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1324	1327		10.1126/science.1192044	http://dx.doi.org/10.1126/science.1192044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829481				2022-12-24	WOS:000281657300033
J	Bonham, VL; Dover, GJ; Brody, LC				Bonham, Vence L.; Dover, George J.; Brody, Lawrence C.			Screening Student Athletes for Sickle Cell Trait - A Social and Clinical Experiment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bonham, Vence L.] NHGRI, Social & Behav Res Branch, Bethesda, MD 20892 USA; [Brody, Lawrence C.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Dover, George J.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Johns Hopkins University	Bonham, VL (corresponding author), NHGRI, Social & Behav Res Branch, Bethesda, MD 20892 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200324] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		*NAT COLL ATHL ASS, 2010, M NAT COLL ATHL ASS; RUTKOW IM, 1974, AM J PUBLIC HEALTH, V64, P217, DOI 10.2105/AJPH.64.3.217; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; WHITTEN CF, 1973, NEW ENGL J MED, V288, P318, DOI 10.1056/NEJM197302082880612; WILSON B, 2009, NCAA MAY FORCE SCH T	5	62	63	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					997	999		10.1056/NEJMp1007639	http://dx.doi.org/10.1056/NEJMp1007639			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	647HS	20825310				2022-12-24	WOS:000281609700001
J	Jain, D; Hebden, AK; Nakamura, TM; Miller, KM; Cooper, JP				Jain, Devanshi; Hebden, Anna K.; Nakamura, Toru M.; Miller, Kyle M.; Cooper, Julia Promisel			HAATI survivors replace canonical telomeres with blocks of generic heterochromatin	NATURE			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; DROSOPHILA TELOMERES; EPIGENETIC CONTROL; BINDING-PROTEIN; DOMAIN PROTEIN; 2 MODES; RECOMBINATION; MAINTENANCE; CENTROMERE	The notion that telomeres are essential for chromosome linearity stems from the existence of two chief dangers: inappropriate DNA damage response (DDR) reactions that mistake natural chromosome ends for double-strand DNA breaks (DSBs), and the progressive loss of DNA from chromosomal termini due to the end replication problem. Telomeres avert the former peril by binding sequence-specific end-protection factors that control the access of DDR activities(1,2). The latter threat is tackled by recruiting telomerase, a reverse transcriptase that uses an integral RNA subunit to template the addition of telomere repeats to chromosome ends(3). Here we describe an alternative mode of linear chromosome maintenance in which canonical telomeres are superseded by blocks of heterochromatin. We show that in the absence of telomerase, Schizosaccharomyces pombe cells can survive telomere sequence loss by continually amplifying and rearranging heterochromatic sequences. Because the heterochromatin assembly machinery is required for this survival mode, we have termed it 'HAATI' (heterochromatin amplification-mediated and telomerase-independent). HAATI uses the canonical end-protection protein Pot1 (ref. 4) and its interacting partner Ccq1 (ref. 5) to preserve chromosome linearity. The data suggest a model in which Ccq1 is recruited by the amplified heterochromatin and provides an anchor for Pot1, which accomplishes its end-protection function in the absence of its cognate DNA-binding sequence. HAATI resembles the chromosome end-maintenance strategy found in Drosophila melanogaster, which lacks specific telomere sequences but nonetheless assembles terminal heterochromatin structures that recruit end-protection factors. These findings reveal a previously unrecognized mode by which cancer cells might escape the requirement for telomerase activation, and offer a tool for studying genomes that sustain unusually high levels of heterochromatinization.	[Jain, Devanshi; Cooper, Julia Promisel] Canc Res UK, London Res Inst, London WC2A 3PX, England; [Hebden, Anna K.] Univ London Imperial Coll Sci Technol & Med, Ovarian Canc Act Grp, London W12 0NN, England; [Nakamura, Toru M.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Miller, Kyle M.] Gurdon Inst, Cambridge CB2 1QN, England	Cancer Research UK; Imperial College London; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cooper, JP (corresponding author), Canc Res UK, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3PX, England.	julie.cooper@cancer.org.uk	Nakamura, Toru M/B-2055-2008	Nakamura, Toru M/0000-0001-5752-0814; cooper, julia promisel/0000-0003-2171-2587; Miller, Kyle/0000-0002-4544-0013	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We thank T. Cech for discussions and gratefully acknowledge that initial work by T.M.N. on reintroducing Trt1 to circular strains was performed in the Cech laboratory. We thank our current and former laboratory members for discussions and advice. This work was supported by Cancer Research UK.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cenci G, 2005, CHROMOSOMA, V114, P135, DOI 10.1007/s00412-005-0005-9; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ekwall K, 1996, J CELL SCI, V109, P2637; Ferreira MG, 2004, GENE DEV, V18, P2249, DOI 10.1101/gad.315804; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Gao GJ, 2010, EMBO J, V29, P819, DOI 10.1038/emboj.2009.394; Haering CH, 2000, P NATL ACAD SCI USA, V97, P6367, DOI 10.1073/pnas.130187397; Ishii K, 2008, SCIENCE, V321, P1088, DOI 10.1126/science.1158699; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; Mason JM, 2008, BIOESSAYS, V30, P25, DOI 10.1002/bies.20688; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Miyoshi T, 2008, SCIENCE, V320, P1341, DOI 10.1126/science.1154819; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakamura KI, 2008, EMBO J, V27, P3036, DOI 10.1038/emboj.2008.215; Nakamura TM, 1998, SCIENCE, V282, P493, DOI 10.1126/science.282.5388.493; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pardue ML, 2003, ANNU REV GENET, V37, P485, DOI 10.1146/annurev.genet.38.072902.093115; Pitt CW, 2010, NUCLEIC ACIDS RES, V38, P6968, DOI 10.1093/nar/gkq580; Rog O, 2008, CURR OPIN GENET DEV, V18, P212, DOI 10.1016/j.gde.2008.01.011; Sugawara N. F., 1988, THESIS HARVARD U; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Teng SC, 1999, MOL CELL BIOL, V19, P8083; TODA T, 1984, CURR GENET, V8, P93, DOI 10.1007/BF00420224; Tomita K, 2003, MOL CELL BIOL, V23, P5186, DOI 10.1128/MCB.23.15.5186-5197.2003; Tomita K, 2007, CELL, V130, P113, DOI 10.1016/j.cell.2007.05.024; Tomita K, 2008, GENE DEV, V22, P3461, DOI 10.1101/gad.498608; Wang X, 2008, MOL CELL, V31, P463, DOI 10.1016/j.molcel.2008.05.028	37	65	65	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2010	467	7312					223	U118		10.1038/nature09374	http://dx.doi.org/10.1038/nature09374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829796				2022-12-24	WOS:000281616300038
J	Beasley, R; Perrin, K; Weatherall, M; Wijesinghe, M				Beasley, Richard; Perrin, Kyle; Weatherall, Mark; Wijesinghe, Meme			Call for withdrawal of LABA single-therapy inhaler in asthma	LANCET			English	Editorial Material							ACTING BETA-AGONISTS; CORTICOSTEROIDS; SALMETEROL; MORTALITY; RISK; METAANALYSIS; FORMOTEROL		[Beasley, Richard; Perrin, Kyle; Wijesinghe, Meme] Med Res Inst New Zealand, Wellington 6242, New Zealand; [Beasley, Richard; Perrin, Kyle; Weatherall, Mark] Capital & Coast Dist Hlth Board, Wellington, New Zealand; [Weatherall, Mark] Univ Otago Wellington, Wellington, New Zealand	Medical Research Institute Of New Zealand; University of Otago	Beasley, R (corresponding author), Med Res Inst New Zealand, Wellington 6242, New Zealand.	richard.beasley@mrinz.ac.nz	Weatherall, Mark/Y-6824-2019; Beasley, Richard/AAH-3908-2019	Weatherall, Mark/0000-0002-0051-9107; Beasley, Richard/0000-0003-0337-406X				Bateman E, 2008, ANN INTERN MED, V149, P33, DOI 10.7326/0003-4819-149-1-200807010-00229; Chowdhury BA, 2010, NEW ENGL J MED, V362, P1169, DOI 10.1056/NEJMp1002074; Kramer JM, 2009, NEW ENGL J MED, V360, P1592, DOI 10.1056/NEJMp0810561; Nelson H, 2010, J ALLERGY CLIN IMMUN, V125, P390, DOI 10.1016/j.jaci.2009.11.036; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Stempel DA, 2005, RESP MED, V99, P1263, DOI 10.1016/j.rmed.2005.03.002; Stoloff SW, 2004, J ALLERGY CLIN IMMUN, V113, P245, DOI 10.1016/j.jaci.2003.10.011; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Taylor DR, 2008, NEW ZEAL MED J, V121, P106; Weatherall M, 2010, THORAX, V65, P39, DOI 10.1136/thx.2009.116608; Wijesinghe M, 2008, POSTGRAD MED J, V84, P467, DOI 10.1136/pgmj.2007.067165; Wijesinghe M, 2009, EUR RESPIR J, V34, P803, DOI 10.1183/09031936.00159708	12	34	34	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2010	376	9743					750	751		10.1016/S0140-6736(10)61158-0	http://dx.doi.org/10.1016/S0140-6736(10)61158-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650EC	20816529				2022-12-24	WOS:000281831000007
J	Tomer, R; Denes, AS; Tessmar-Raible, K; Arendt, D				Tomer, Raju; Denes, Alexandru S.; Tessmar-Raible, Kristin; Arendt, Detlev			Profiling by Image Registration Reveals Common Origin of Annelid Mushroom Bodies and Vertebrate Pallium	CELL			English	Article							IN-SITU HYBRIDIZATION; PLATYNEREIS-DUMERILII; CELL-TYPES; EVOLUTION; BRAIN; TELENCEPHALON; EXPRESSION; FATE; WNT; FOREBRAIN	The evolution of the highest-order human brain center, the "pallium'' or "cortex,'' remains enigmatic. To elucidate its origins, we set out to identify related brain parts in phylogenetically distant animals, to then unravel common aspects in cellular composition and molecular architecture. Here, we compare vertebrate pallium development to that of the mushroom bodies, sensory-associative brain centers, in an annelid. Using a newly developed protocol for cellular profiling by image registration (PrImR), we obtain a high-resolution gene expression map for the developing annelid brain. Comparison to the vertebrate pallium reveals that the annelid mushroom bodies develop from similar molecular coordinates within a conserved overall molecular brain topology and that their development involves conserved patterning mechanisms and produces conserved neuron types that existed already in the protostome- deuterostome ancestors. These data indicate deep homology of pallium and mushroom bodies and date back the origin of higher brain centers to prebilaterian times.	[Tomer, Raju; Denes, Alexandru S.; Tessmar-Raible, Kristin; Arendt, Detlev] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Tomer, R (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.	tomer@embl.de; arendt@embl.de	Tessmar-Raible, Kristin/F-9642-2011; Tomer, Raju/F-2335-2010	Tessmar-Raible, Kristin/0000-0002-8038-1741; 	Marie Curie RTN ZOONET [MRTN-CT-2004-005624]; DFG Collaborative Research Network [SFB-488]; Louis Jeantet Foundation	Marie Curie RTN ZOONET(European Commission); DFG Collaborative Research Network(German Research Foundation (DFG)); Louis Jeantet Foundation	We thank F. Christodoulou for providing larvae stained with mir-9, 9*, H. Snyman for expert technical assistance, and the Arendt lab for support. The electron micrograph in Figure 5 was taken with C. Nielsen during a practical course. R.T. and K.T.-R. were supported by fellowships of the Marie Curie RTN ZOONET (MRTN-CT-2004-005624), R.T. by DFG Collaborative Research Network SFB-488, and A.D. by a Louis Jeantet Foundation fellowship. R.T. conceived and developed PrImR, designed and performed the experiments, analyzed and interpreted the data, and wrote the paper. A.S.D. contributed clones of vglut and gad. K.T.-R. contributed clones of brn124 and emx. D.A. proposed to study annelid mushroom bodies, provided ideas, interpreted the data, and wrote the paper.	Arendt D, 2005, THEOR BIOSCI, V124, P185, DOI 10.1016/j.thbio.2005.08.002; Arendt D, 2002, DEVELOPMENT, V129, P1143; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010; Bani-Yaghoub M, 2006, DEV BIOL, V295, P52, DOI 10.1016/j.ydbio.2006.03.007; Caubit X, 1999, DEV DYNAM, V214, P66, DOI 10.1002/(SICI)1097-0177(199901)214:1<66::AID-DVDY7>3.0.CO;2-7; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Danesin C, 2009, DEV CELL, V16, P576, DOI 10.1016/j.devcel.2009.03.007; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Ekonomou A, 2005, PLOS BIOL, V3, P1111, DOI 10.1371/journal.pbio.0030186; EVANS SM, 1966, NATURE, V211, P945, DOI 10.1038/211945a0; Farris SA, 2005, ARTHROPOD STRUCT DEV, V34, P211, DOI 10.1016/j.asd.2005.01.008; Farris SM, 2008, BRAIN BEHAV EVOLUT, V72, P106, DOI 10.1159/000151471; Fischer A, 2004, BIOESSAYS, V26, P314, DOI 10.1002/bies.10409; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; Garel S, 1999, DEVELOPMENT, V126, P5285; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Houart C, 2002, NEURON, V35, P255, DOI 10.1016/S0896-6273(02)00751-1; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Jekely G, 2007, BIOTECHNIQUES, V42, P751, DOI 10.2144/000112462; Kandel E., 2000, PRINCIPLES NEURAL SC; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kimura J, 2005, J NEUROSCI, V25, P5097, DOI 10.1523/JNEUROSCI.0239-05.2005; Liu X, 2009, CELL, V139, P623, DOI 10.1016/j.cell.2009.08.044; Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Miura H, 1997, MECH DEVELOP, V65, P99, DOI 10.1016/S0925-4773(97)00062-2; MULLER WA, 1973, Z ZELLFORSCH MIK ANA, V139, P487, DOI 10.1007/BF02028390; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Nieuwenhuys R, 2002, BRAIN RES BULL, V57, P257, DOI 10.1016/S0361-9230(01)00668-2; Noveen A, 2000, DEVELOPMENT, V127, P3475; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Schneider SQ, 2007, DEV CELL, V13, P73, DOI 10.1016/j.devcel.2007.05.002; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Stigloher C, 2006, DEVELOPMENT, V133, P2925, DOI 10.1242/dev.02450; Strausfeld NJ, 2006, P ROY SOC B-BIOL SCI, V273, P1857, DOI 10.1098/rspb.2006.3536; Strausfeld NJ, 2009, J COMP NEUROL, V513, P265, DOI 10.1002/cne.21948; STRAUSFELD NJ, 1993, J COMP NEUROL, V328, P43, DOI 10.1002/cne.903280104; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Taglialatela P, 2004, DEVELOPMENT, V131, P4239, DOI 10.1242/dev.01299; Tessmar-Raible K, 2005, BIOTECHNIQUES, V39, P460, DOI 10.2144/000112023; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Tole S, 2000, DEV BIOL, V217, P254, DOI 10.1006/dbio.1999.9509; Tuoc TC, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-23; Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533; Viola P, 1997, INT J COMPUT VISION, V24, P137, DOI 10.1023/A:1007958904918; Wang B, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-5; Woodger J. H., 1945, ESSAYS GROWTH FORM P, P95; Yun K, 2001, DEVELOPMENT, V128, P193	53	204	205	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					800	809		10.1016/j.cell.2010.07.043	http://dx.doi.org/10.1016/j.cell.2010.07.043			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813265	Bronze			2022-12-24	WOS:000281523200022
J	Mouquet, H; Scheid, JF; Zoller, MJ; Krogsgaard, M; Ott, RG; Shukair, S; Artyomov, MN; Pietzsch, J; Connors, M; Pereyra, F; Walker, BD; Ho, DD; Wilson, PC; Seaman, MS; Eisen, HN; Chakraborty, AK; Hope, TJ; Ravetch, JV; Wardemann, H; Nussenzweig, MC				Mouquet, Hugo; Scheid, Johannes F.; Zoller, Markus J.; Krogsgaard, Michelle; Ott, Rene G.; Shukair, Shetha; Artyomov, Maxim N.; Pietzsch, John; Connors, Mark; Pereyra, Florencia; Walker, Bruce D.; Ho, David D.; Wilson, Patrick C.; Seaman, Michael S.; Eisen, Herman N.; Chakraborty, Arup K.; Hope, Thomas J.; Ravetch, Jeffrey V.; Wardemann, Hedda; Nussenzweig, Michel C.			Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; TYPE-1; AUTOREACTIVITY; INDIVIDUALS; MODULATION; GENERATION	During immune responses, antibodies are selected for their ability to bind to foreign antigens with high affinity, in part by their ability to undergo homotypic bivalent binding. However, this type of binding is not always possible. For example, the small number of gp140 glycoprotein spikes displayed on the surface of the human immunodeficiency virus (HIV) disfavours homotypic bivalent antibody binding(1-3). Here we show that during the human antibody response to HIV, somatic mutations that increase antibody affinity also increase breadth and neutralizing potency. Surprisingly, the responding naive and memory B cells produce polyreactive antibodies, which are capable of bivalent heteroligation between one high-affinity anti-HIV-gp140 combining site and a second low-affinity site on another molecular structure on HIV. Although cross-reactivity to self-antigens or polyreactivity is strongly selected against during B-cell development(4), it is a common serologic feature of certain infections in humans, including HIV, Epstein-Barr virus and hepatitis C virus. Seventy-five per cent of the 134 monoclonal anti-HIV-gp140 antibodies cloned from six patients(5) with high titres of neutralizing antibodies are polyreactive. Despite the low affinity of the polyreactive combining site, heteroligation demonstrably increases the apparent affinity of polyreactive antibodies to HIV.	[Mouquet, Hugo; Scheid, Johannes F.; Pietzsch, John; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Zoller, Markus J.; Wardemann, Hedda] Max Planck Inst Infect Biol, D-10117 Berlin, Germany; [Krogsgaard, Michelle] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Krogsgaard, Michelle] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Ott, Rene G.; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Shukair, Shetha; Hope, Thomas J.] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Artyomov, Maxim N.; Eisen, Herman N.; Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Artyomov, Maxim N.; Eisen, Herman N.; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Artyomov, Maxim N.; Eisen, Herman N.; Chakraborty, Arup K.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Artyomov, Maxim N.; Eisen, Herman N.; Chakraborty, Arup K.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Artyomov, Maxim N.; Eisen, Herman N.; Chakraborty, Arup K.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Pietzsch, John] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Connors, Mark] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Pereyra, Florencia; Walker, Bruce D.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02114 USA; [Pereyra, Florencia; Walker, Bruce D.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ho, David D.] Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Wilson, Patrick C.] Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; New York University; New York University; Rockefeller University; Northwestern University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Free University of Berlin; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School; University of Chicago; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; Rockefeller University	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussenzweig@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Ravetch, Jeffrey/Z-1596-2019; Wilson, Patrick/HGC-3157-2022; Mouquet, Hugo/M-2750-2014	Ravetch, Jeffrey/0000-0003-2024-9041; Mouquet, Hugo/0000-0002-4230-610X; Wardemann, Hedda/0000-0003-3921-5933	Rockefeller University; National Institutes of Health [NIH 1 PO1 AI081677, R01 AI047770]; International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation; German Research Foundation [GRK1121]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090, P01AI081677, ZIAAI000855, R01AI047770] Funding Source: NIH RePORTER	Rockefeller University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. R. Mascola and R. T. Wyatt for discussion and supplying gp140 and gp120 proteins. This research was supported by the Rockefeller University, the National Institutes of Health (NIH 1 PO1 AI081677), the International AIDS Vaccine Initiative and the Bill and Melinda Gates Foundation. T.J.H. was supported by the National Institutes of Health (R01 AI047770). M.J.Z. and H.W. were supported by the German Research Foundation (GRK1121). B.D.W. and M.C.N. are Howard Hughes Medical Institute investigators.	Aguilera I, 2001, IMMUNOLOGY, V102, P273, DOI 10.1046/j.1365-2567.2001.01159.x; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Cheskis B, 1996, BIOCHEMISTRY-US, V35, P3309, DOI 10.1021/bi952283r; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; ICHIYOSHI Y, 1994, J EXP MED, V180, P885, DOI 10.1084/jem.180.3.885; Jay JI, 2009, ADV FUNCT MATER, V19, P2969, DOI 10.1002/adfm.200900757; Karlsson GB, 1996, J VIROL, V70, P6136, DOI 10.1128/JVI.70.9.6136-6142.1996; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Mascola JR, 2007, NATURE, V449, P29, DOI 10.1038/449029a; Meffre E, 2004, J EXP MED, V199, P145, DOI 10.1084/jem.20031550; MICHAELIDES MC, 1974, J EXP MED, V140, P687, DOI 10.1084/jem.140.3.687; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shen XY, 2010, P NATL ACAD SCI USA, V107, P5972, DOI 10.1073/pnas.0912381107; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Tsuiji M, 2006, J EXP MED, V203, P393, DOI 10.1084/jem.20052033; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; ZINKERNAGEL RM, 1990, NATURE, V345, P68, DOI 10.1038/345068a0; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	31	318	333	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					591	U117		10.1038/nature09385	http://dx.doi.org/10.1038/nature09385			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20882016	Green Accepted			2022-12-24	WOS:000282273100039
J	Rosen, CJ				Rosen, Clifford J.			Revisiting the Rosiglitazone Story - Lessons Learned	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Maine Med Ctr, Res Inst, Scarborough, ME USA	Maine Medical Center	Rosen, CJ (corresponding author), Maine Med Ctr, Res Inst, Scarborough, ME USA.							GRAHAM DJ, 2010, JAMA            0628; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2010, ARCH INTERN MED 0628; Rosen CJ, 2007, NEW ENGL J MED, V357, P844, DOI 10.1056/NEJMp078167	4	99	101	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2010	363	9					803	806		10.1056/NEJMp1008233	http://dx.doi.org/10.1056/NEJMp1008233			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642HG	20660395	Bronze			2022-12-24	WOS:000281196600002
J	Baum, M				Baum, Michael			Homoeopathy waives the rules	LANCET			English	Editorial Material									Royal Free & Univ Coll Med Sch, Ctr Clin Sci & Technol, Clin Trials Grp, London N19 5LW, England	University of London; University College London	Baum, M (corresponding author), Royal Free & Univ Coll Med Sch, Ctr Clin Sci & Technol, Clin Trials Grp, London N19 5LW, England.	michael@mbaum.freeserve.co.uk						Department of Health, 2010, GOV RESP SCI TECHN C; Kmietowicz Z, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1091; Vaidya JS, 2010, LANCET, V376, P91, DOI 10.1016/S0140-6736(10)60837-9; DISCUSSIONS DEP HLTH	4	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 21	2010	376	9741					577	577		10.1016/S0140-6736(10)61227-5	http://dx.doi.org/10.1016/S0140-6736(10)61227-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643PB	20728742				2022-12-24	WOS:000281309100010
J	Manicassamy, S; Reizis, B; Ravindran, R; Nakaya, H; Salazar-Gonzalez, RM; Wang, YC; Pulendran, B				Manicassamy, Santhakumar; Reizis, Boris; Ravindran, Rajesh; Nakaya, Helder; Salazar-Gonzalez, Rosa Maria; Wang, Yi-chong; Pulendran, Bali			Activation of beta-Catenin in Dendritic Cells Regulates Immunity Versus Tolerance in the Intestine	SCIENCE			English	Article							TOLL-LIKE RECEPTORS; T-HELPER-CELLS; RETINOIC-ACID; INNATE IMMUNITY; RESPONSES; DIFFERENTIATION; MACROPHAGES; DISEASE; EXPRESSION; INDUCTION	Dendritic cells (DCs) play a vital role in initiating robust immunity against pathogens as well as maintaining immunological tolerance to self antigens. However, the intracellular signaling networks that program DCs to become tolerogenic remain unknown. We report here that the Wnt-beta-catenin signaling in intestinal dendritic cells regulates the balance between inflammatory versus regulatory responses in the gut. beta-catenin in intestinal dendritic cells was required for the expression of anti-inflammatory mediators such as retinoic acid-metabolizing enzymes, interleukin-10, and transforming growth factor-beta, and the stimulation of regulatory T cell induction while suppressing inflammatory effector T cells. Furthermore, ablation of beta-catenin expression in DCs enhanced inflammatory responses and disease in a mouse model of inflammatory bowel disease. Thus, beta-catenin signaling programs DCs to a tolerogenic state, limiting the inflammatory response.	[Manicassamy, Santhakumar; Ravindran, Rajesh; Nakaya, Helder; Salazar-Gonzalez, Rosa Maria; Wang, Yi-chong; Pulendran, Bali] Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Manicassamy, Santhakumar; Ravindran, Rajesh; Nakaya, Helder; Salazar-Gonzalez, Rosa Maria; Wang, Yi-chong; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; [Salazar-Gonzalez, Rosa Maria] Cincinnati Childrens Hosp, Med Ctr, Mol Immunol Div, Cincinnati, OH 45229 USA; [Pulendran, Bali] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Emory University; Columbia University; Cincinnati Children's Hospital Medical Center; Emory University	Pulendran, B (corresponding author), Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.	bpulend@emory.edu	Nakaya, Helder/AAF-1738-2020; Pulendran, Bali/AAW-9550-2021; Nakaya, Helder I/A-1397-2010	Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108; Pulendran, Bali/0000-0001-6517-4333; Reizis, Boris/0000-0003-1140-7853	National Institutes of Health [U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266 200700006C, NO1 AI50019, NO1 AI50025]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI050025, R01AI048638, R37AI048638, U54AI057157, R01AI056499, U19AI057266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665, R01DK057665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. A. Mertens and L. Bronner for assistance with cell sorting and D. Levesque (Emory Vaccine Center) and D. Bonenberger for assistance with maintenance of mice strains at the Emory Vaccine Center vivarium. The work in the laboratory of BP was supported by grants U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266 200700006C, NO1 AI50019, and NO1 AI50025 from the National Institutes of Health and a grant from the Bill & Melinda Gates Foundation. Microarray accession number is GSE2213 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22136).	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Brault V, 2001, DEVELOPMENT, V128, P1253; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Manicassamya S, 2009, SEMIN IMMUNOL, V21, P22, DOI 10.1016/j.smim.2008.07.007; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Rescigno M, 2008, CURR OPIN IMMUNOL, V20, P669, DOI 10.1016/j.coi.2008.09.007; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zhou J, 2009, IMMUNITY, V30, P845, DOI 10.1016/j.immuni.2009.03.021	34	385	397	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					849	853		10.1126/science.1188510	http://dx.doi.org/10.1126/science.1188510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705860	Green Accepted			2022-12-24	WOS:000280809900053
J	Campbell, NRC; Legowski, B; Legetic, B				Campbell, Norm R. C.; Legowski, Barbara; Legetic, Branka			Mobilising the Americas for dietary salt reduction	LANCET			English	Editorial Material							HYPERTENSION; HEALTH		[Campbell, Norm R. C.] Univ Calgary, Libin Cardiovasc Inst, Dept Med, Calgary, AB T2N 4Z6, Canada; [Campbell, Norm R. C.] Univ Calgary, Libin Cardiovasc Inst, Dept Community Hlth Sci, Calgary, AB T2N 4Z6, Canada; [Campbell, Norm R. C.] Univ Calgary, Libin Cardiovasc Inst, Dept Pharmacol & Therapeut, Calgary, AB T2N 4Z6, Canada; [Legowski, Barbara; Legetic, Branka] PAHO Secretariat, Reg Expert Grp Cardiovasc Dis Prevent Dietary Sal, Washington, DC USA; [Legetic, Branka] PAHO, Unit Noncommunicable Dis, Washington, DC USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; Pan American Health Organization	Campbell, NRC (corresponding author), Univ Calgary, Libin Cardiovasc Inst, Dept Med, Calgary, AB T2N 4Z6, Canada.	ncampbel@ucalgary.ca						Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; *GOV BARB, 2009, SALT RED HIGH CNCD C; *HLTH CAN, ISS SOD; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; MATTES RD, 1991, J AM COLL NUTR, V10, P383; *MIN HLTH ARG, 2009, MIN HLTH LAUNCH CAMP; *MIN HLTH CHIL, GLOB STRAT OB EGO CH; Mohan S, 2009, CAN MED ASSOC J, V181, P605, DOI 10.1503/cmaj.090361; *PAN AM HLTH ORG, 2009, CARD DIS PREV DIET S; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Sanchez RA, 2009, J HYPERTENS, V27, P905, DOI 10.1097/HJH.0b013e32832aa6d2; *SECR HLTH MEX, 2010, NAT NUTR HLTH STRAT; 2010, LANCET, V375, P254	13	19	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 5	2011	377	9768					793	795		10.1016/S0140-6736(10)60489-8	http://dx.doi.org/10.1016/S0140-6736(10)60489-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GO	20663548				2022-12-24	WOS:000288628500009
J	Rubinson, EH; Gowda, ASP; Spratt, TE; Gold, B; Eichman, BF				Rubinson, Emily H.; Gowda, A. S. Prakasha; Spratt, Thomas E.; Gold, Barry; Eichman, Brandt F.			An unprecedented nucleic acid capture mechanism for excision of DNA damage	NATURE			English	Article							HUMAN AP ENDONUCLEASE-1; CRYSTAL-STRUCTURE; BASE EXCISION; HEAT REPEATS; SUBSTRATE-SPECIFICITY; GLYCOSYLASE-I; ALKYLATED DNA; REPAIR; RECOGNITION; 3-METHYLADENINE	DNA glycosylases that remove alkylated and deaminated purine nucleobases are essential DNA repair enzymes that protect the genome, and at the same time confound cancer alkylation therapy, by excising cytotoxic N3-methyladenine bases formed by DNA-targeting anticancer compounds. The basis for glycosylase specificity towards N3- and N7-alkylpurines is believed to result from intrinsic instability of the modified bases and not from direct enzyme functional group chemistry. Here we present crystal structures of the recently discovered Bacillus cereus AlkD glycosylase in complex with DNAs containing alkylated, mismatched and abasic nucleotides. Unlike other glycosylases, AlkD captures the extrahelical lesion in a solvent-exposed orientation, providing an illustration for how hydrolysis of N3- and N7-alkylated bases may be facilitated by increased lifetime out of the DNA helix. The structures and supporting biochemical analysis of base flipping and catalysis reveal how the HEAT repeats of AlkD distort the DNA backbone to detect non-Watson-Crick base pairs without duplex intercalation.	[Rubinson, Emily H.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Rubinson, Emily H.; Eichman, Brandt F.] Vanderbilt Univ, Struct Biol Ctr, Nashville, TN 37232 USA; [Gowda, A. S. Prakasha; Spratt, Thomas E.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Gold, Barry] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA	Vanderbilt University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Eichman, BF (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37232 USA.	brandt.eichman@vanderbilt.edu		Eichman, Brandt/0000-0002-0965-2297; ALADAHALLI SANNE GOWDA, PRAKASHA GOWDA/0000-0002-0055-7103; Spratt, Thomas/0000-0002-6805-3729	US Department of Energy Office of Basic Energy Sciences; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; American Cancer Society; NIH [RO1 CA29088]; Vanderbilt Training Program in Molecular Toxicology; NATIONAL CANCER INSTITUTE [R01CA029088, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, P30ES000267] Funding Source: NIH RePORTER	US Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Training Program in Molecular Toxicology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank J. Stivers for providing the pyrene phosphoramidite, Z. Warzak and LS-CAT beamline staff at the Advanced Photon Source (APS) for assistance with X-ray data collection, and T. Ellenberger, J. Stivers and P. O'Brien for comments on the manuscript. Use of the APS was supported by the US Department of Energy Office of Basic Energy Sciences. Use of LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor. This research was supported by a grant from the American Cancer Society (to B.F.E.) and the NIH (RO1 CA29088 to B.G.). E.H.R. was supported in part by the Vanderbilt Training Program in Molecular Toxicology. Additional support for local crystallography facilities was provided by the Vanderbilt Center in Molecular Toxicology and the Vanderbilt-Ingram Cancer Center.	ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811; Adams PD, 2007, NATO SCI SER II-MATH, V245, P101, DOI 10.1007/978-1-4020-6316-9_9; Alseth I, 2006, MOL MICROBIOL, V59, P1602, DOI 10.1111/j.1365-2958.2006.05044.x; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Asaeda A, 2000, BIOCHEMISTRY-US, V39, P1959, DOI 10.1021/bi9917075; Baldwin MR, 2009, BIOCHEMISTRY-US, V48, P6022, DOI 10.1021/bi900517y; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Brown PJ, 2008, CANCER LETT, V260, P48, DOI 10.1016/j.canlet.2007.10.015; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Dalhus B, 2007, NUCLEIC ACIDS RES, V35, P2451, DOI 10.1093/nar/gkm039; Dinner AR, 2001, NATURE, V413, P752, DOI 10.1038/35099587; Drohat AC, 2002, NAT STRUCT BIOL, V9, P659, DOI 10.1038/nsb829; Eichman BF, 2003, EMBO J, V22, P4898, DOI 10.1093/emboj/cdg505; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezaz-Nikpay K, 1994, Chem Biol, V1, P235, DOI 10.1016/1074-5521(94)90016-7; EZAZNIKPAY K, 1992, J AM CHEM SOC, V114, P6562, DOI 10.1021/ja00042a048; Friedberg EC, 2006, DNA REPAIR, V5, P986, DOI 10.1016/j.dnarep.2006.05.005; Ganguly M, 2010, J PHYS CHEM B, V114, P7656, DOI 10.1021/jp101004k; Gates KS, 2004, CHEM RES TOXICOL, V17, P839, DOI 10.1021/tx049965c; Hecht SS, 1999, MUTAT RES-FUND MOL M, V424, P127, DOI 10.1016/S0027-5107(99)00014-7; Holt S, 1998, CARCINOGENESIS, V19, P1763, DOI 10.1093/carcin/19.10.1763; HUNTER WN, 1987, J BIOL CHEM, V262, P9962; Irani RJ, 2002, NUCLEOS NUCLEOT NUCL, V21, P737, DOI 10.1081/NCN-120016477; Jiang YL, 2003, BIOCHEMISTRY-US, V42, P1922, DOI 10.1021/bi027014x; Jiang YL, 2001, J BIOL CHEM, V276, P42347, DOI 10.1074/jbc.M106594200; Jones BN, 2008, METHOD ENZYMOL, V448, P23, DOI 10.1016/S0076-6879(08)02602-5; LARSON K, 1985, MUTAT RES, V150, P77, DOI 10.1016/0027-5107(85)90103-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lau AY, 1998, CELL, V95, P249, DOI 10.1016/S0092-8674(00)81755-9; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; Lee S, 2008, J AM CHEM SOC, V130, P11570, DOI 10.1021/ja8025328; Li L, 2009, CHEM RES TOXICOL, V22, P1464, DOI 10.1021/tx9001572; Lyons DM, 2009, J AM CHEM SOC, V131, P17742, DOI 10.1021/ja908378y; Maher RL, 2007, J BIOL CHEM, V282, P30577, DOI 10.1074/jbc.M704341200; Maher RL, 2007, DNA REPAIR, V6, P71, DOI 10.1016/j.dnarep.2006.09.001; Maiti A, 2009, J BIOL CHEM, V284, P36680, DOI 10.1074/jbc.M109.062356; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Metz AH, 2007, EMBO J, V26, P2411, DOI 10.1038/sj.emboj.7601649; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Mol CD, 2002, J MOL BIOL, V315, P373, DOI 10.1006/jmbi.2001.5264; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; O'Brien PJ, 2004, J BIOL CHEM, V279, P26876, DOI 10.1074/jbc.M403860200; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Plosky BS, 2008, NUCLEIC ACIDS RES, V36, P2152, DOI 10.1093/nar/gkn058; Rubinson EH, 2008, J MOL BIOL, V381, P13, DOI 10.1016/j.jmb.2008.05.078; SHUKER DEG, 1987, CARCINOGENESIS, V8, P959, DOI 10.1093/carcin/8.7.959; SHUKER DEG, 1992, CHEM RES TOXICOL, V5, P450, DOI 10.1021/tx00028a001; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Singer B., 1983, MOL BIOL MUTAGENS CA; Stivers JT, 2008, CHEM-EUR J, V14, P786, DOI 10.1002/chem.200701501; Stivers JT, 2004, PROG NUCLEIC ACID RE, V77, P37, DOI 10.1016/S0079-6603(04)77002-6; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Tubbs JL, 2009, NATURE, V459, P808, DOI 10.1038/nature08076; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yang CG, 2009, CHEMBIOCHEM, V10, P417, DOI 10.1002/cbic.200800580	65	62	64	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2010	468	7322					406	U309		10.1038/nature09428	http://dx.doi.org/10.1038/nature09428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681KP	20927102	Green Accepted			2022-12-24	WOS:000284313100036
J	Camilli, R; Reddy, CM; Yoerger, DR; Van Mooy, BAS; Jakuba, MV; Kinsey, JC; McIntyre, CP; Sylva, SP; Maloney, JV				Camilli, Richard; Reddy, Christopher M.; Yoerger, Dana R.; Van Mooy, Benjamin A. S.; Jakuba, Michael V.; Kinsey, James C.; McIntyre, Cameron P.; Sylva, Sean P.; Maloney, James V.			Tracking Hydrocarbon Plume Transport and Biodegradation at Deepwater Horizon	SCIENCE			English	Article							OIL	The Deepwater Horizon blowout is the largest offshore oil spill in history. We present results from a subsurface hydrocarbon survey using an autonomous underwater vehicle and a ship-cabled sampler. Our findings indicate the presence of a continuous plume of oil, more than 35 kilometers in length, at approximately 1100 meters depth that persisted for months without substantial biodegradation. Samples collected from within the plume reveal monoaromatic petroleum hydrocarbon concentrations in excess of 50 micrograms per liter. These data indicate that monoaromatic input to this plume was at least 5500 kilograms per day, which is more than double the total source rate of all natural seeps of the monoaromatic petroleum hydrocarbons in the northern Gulf of Mexico. Dissolved oxygen concentrations suggest that microbial respiration rates within the plume were not appreciably more than 1 micromolar oxygen per day.	[Camilli, Richard; Yoerger, Dana R.; Kinsey, James C.] Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA; [Reddy, Christopher M.; Van Mooy, Benjamin A. S.; McIntyre, Cameron P.; Sylva, Sean P.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Jakuba, Michael V.] Univ Sydney, Australian Ctr Field Robot, Sydney, NSW 2006, Australia; [Maloney, James V.] Monitor Instruments Co, Cheswick, PA 15024 USA	Woods Hole Oceanographic Institution; Woods Hole Oceanographic Institution; University of Sydney	Camilli, R (corresponding author), Woods Hole Oceanog Inst, Dept Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA.	rcamilli@whoi.edu	Sylva, Sean/D-4400-2014; McIntyre, Cameron P/D-1222-2016	Sylva, Sean/0000-0002-4727-440X; McIntyre, Cameron P/0000-0001-8517-9836; Reddy, Christopher/0000-0002-7814-2071	NSF [OCE-1045025, OCE-0537173, OCE-1043976, OCE-1045670, OCE-0644290]; U.S. Coast Guard [HSCG3210CR0020]; NASA [NNX09AB76G]	NSF(National Science Foundation (NSF)); U.S. Coast Guard; NASA(National Aeronautics & Space Administration (NASA))	This research was supported by NSF grants OCE-1045025 (RAPID Response Research) and OCE-0537173 (National Oceanographic Partnership Program for TETHYS development) to R. C., OCE-1043976 (RAPID) to C. M. R., OCE-1045670 (RAPID) to B. A. S. V. M., and OCE-0644290 [NSF Ocean Sciences (OCE)-Submersible] for Sentry development and integration to D.R.Y.; by U.S. Coast Guard HSCG3210CR0020 to R. C.; and by NASA Astrobiology Science and Technology for Exploring Planets (ASTEP) NNX09AB76G for integrating technology with Sentry to D.R.Y. We thank the officers and crew of the R/V Endeavor and J. Parker and J. Kusek of the U. S. Coast Guard for assistance during marine operations at the Deepwater Horizon well site. We thank K. Keteles (U. S. Environmental Protection Agency); D. Hollander and E. Goddard (Univ. of South Florida); and A. Billings, A. Duester, S. McCue, D. Torres, M. Swartz, C. Murphy, R. Catanach, and J. Fenwick (Woods Hole Oceanographic Institution) for logistics, operations, experimental, and administrative support. We acknowledge J. Ledwell, C. German, R. Munier, and especially J. Farrington for valuable discussions and guidance.	Camilli R., 2007, Oceans 2007, P1; Camilli R, 2009, MAR POLLUT BULL, V58, P1505, DOI 10.1016/j.marpolbul.2009.05.016; Camilli R, 2009, ENVIRON SCI TECHNOL, V43, P5014, DOI 10.1021/es803717d; Chen FH, 2004, J MARINE SYST, V45, P189, DOI 10.1016/j.jmarsys.2003.11.005; Dasanayaka LK, 2009, J HYDRO-ENVIRON RES, V2, P243, DOI 10.1016/j.jher.2009.01.004; GARCIA HE, 2006, WORLD OCEAN ATLAS 20, V3, P342; German CR, 2008, DEEP-SEA RES PT I, V55, P203, DOI 10.1016/j.dsr.2007.11.004; German CR, 1998, EARTH PLANET SC LETT, V156, P267, DOI 10.1016/S0012-821X(98)00020-X; Gillis J., 2010, NY TIMES, pA1; GOLDENBERG S, 2010, GUARDIAN        0701, P26; *INT JOINT AN GROU, REV PREL DAT EX SUBS; Johansen O, 2003, MAR POLLUT BULL, V47, P360, DOI 10.1016/S0025-326X(03)00202-9; Johansen O, 2000, SPILL SCI TECHNOL B, V6, P103, DOI 10.1016/S1353-2561(00)00042-6; Kvenvolden KA, 2003, GEO-MAR LETT, V23, P140, DOI 10.1007/s00367-003-0135-0; Mau S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031344; *MONT BAY AQ RES I, DAT REP NOAA SHIP GO; OUDOT C, 1988, LIMNOL OCEANOGR, V33, P146, DOI 10.4319/lo.1988.33.1.0146; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; *SEA BIRD EL, 2010, 64 SEA BIRD EL; Simecek-Beatty D, 2007, OIL SPILL ENVIRONMENTAL FORENSICS: FINGERPRINTING AND SOURCE IDENTIFICATION, P405, DOI 10.1016/B978-012369523-9.50017-3; STEVENSON LH, 1991, DICT ENV SCI, P294; *UN COMM DEEPW HOR, 2010, US SCI TEAMS REF EST; Valentine DL, 2010, NAT GEOSCI, V3, P345, DOI 10.1038/NGEO848; WANG ZD, 1995, ANAL CHEM, V67, P3491, DOI 10.1021/ac00115a018; Winkler, 1888, BER DTSCH CHEM GES, V21, P2843, DOI [10.1002/cber.188802102122, DOI 10.1002/CBER.188802102122]	25	576	598	9	410	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2010	330	6001					201	204		10.1126/science.1195223	http://dx.doi.org/10.1126/science.1195223			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20724584				2022-12-24	WOS:000282644600036
J	McKenna, NJ; O'Malley, BW				McKenna, Neil J.; O'Malley, Bert W.			SnapShot: NR Coregulators	CELL			English	Editorial Material							REPRESSION; DISEASE		[McKenna, Neil J.; O'Malley, Bert W.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine	McKenna, NJ (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.			McKenna, Neil/0000-0001-6689-0104	NIDDK NIH HHS [U19-DK62434] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; O'Malley BW, 2007, MOL ENDOCRINOL, V21, P1009, DOI 10.1210/me.2007-0012; ONATE SA, 1995, SCIENCE, V270, P1354; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017	11	12	13	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					172	U176		10.1016/j.cell.2010.09.032	http://dx.doi.org/10.1016/j.cell.2010.09.032			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887900	Bronze			2022-12-24	WOS:000282362000024
J	Moresi, V; Williams, AH; Meadows, E; Flynn, JM; Potthoff, MJ; McAnally, J; Shelton, JM; Backs, J; Klein, WH; Richardson, JA; Bassel-Duby, R; Olson, EN				Moresi, Viviana; Williams, Andrew H.; Meadows, Eric; Flynn, Jesse M.; Potthoff, Matthew J.; McAnally, John; Shelton, John M.; Backs, Johannes; Klein, William H.; Richardson, James A.; Bassel-Duby, Rhonda; Olson, Eric N.			Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin Ligases	CELL			English	Article							DEPENDENT CARDIAC-HYPERTROPHY; RING FINGER 1; SKELETAL-MUSCLE; SATELLITE CELLS; SOLEUS MUSCLE; GENE; DENERVATION; EXPRESSION; RAT; PROTEIN	Maintenance of skeletal muscle structure and function requires innervation by motor neurons, such that denervation causes muscle atrophy. We show that myogenin, an essential regulator of muscle development, controls neurogenic atrophy. Myogenin is upregulated in skeletal muscle following denervation and regulates expression of the E3 ubiquitin ligases MuRF1 and atrogin-1, which promote muscle proteolysis and atrophy. Deletion of myogenin from adult mice diminishes expression of MuRF1 and atrogin-1 in denervated muscle and confers resistance to atrophy. Mice lacking histone deacetylases (HDACs) 4 and 5 in skeletal muscle fail to upregulate myogenin and also preserve muscle mass following denervation. Conversely, forced expression of myogenin in skeletal muscle of HDAC mutant mice restores muscle atrophy following denervation. Thus, myogenin plays a dual role as both a regulator of muscle development and an inducer of neurogenic atrophy. These findings reveal a specific pathway for muscle wasting and potential therapeutic targets for this disorder.	[Moresi, Viviana; Williams, Andrew H.; Potthoff, Matthew J.; McAnally, John; Backs, Johannes; Richardson, James A.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Shelton, John M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Richardson, James A.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Meadows, Eric; Flynn, Jesse M.; Klein, William H.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Moresi, Viviana/N-7977-2013	Potthoff, Matthew/0000-0001-9158-5128; Moresi, viviana/0000-0003-1912-0339	National Institutes of Health; Robert A. Welch Foundation [I-0025]; Muscular Dystrophy Association; Deutsche Forschungsgemeinschaft [BA 2258/1-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077439, R01HL093039, R37HL053351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Muscular Dystrophy Association(Muscular Dystrophy Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Marco Sandri for scientific input, Cheryl Nolen and Svetlana Bezprozvannaya for technical assistance, Jose Cabrera for graphics, and Jennifer Brown for editorial assistance. Work in the laboratory of E.N.O. was supported by grants from the National Institutes of Health and the Robert A. Welch Foundation (grant number I-0025). W.H.K. was supported by a grant from the Muscular Dystrophy Association and the Robert A. Welch Foundation. J.B. was supported by the Deutsche Forschungsgemeinschaft (BA 2258/1-1).	Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; Attaix Didier, 2008, Curr Opin Support Palliat Care, V2, P262, DOI 10.1097/SPC.0b013e3283196ac2; Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Beehler BC, 2006, EXP BIOL MED, V231, P335; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Charrel RN, 2008, LANCET INFECT DIS, V8, P5, DOI 10.1016/S1473-3099(07)70296-7; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Eley HL, 2007, J BIOL CHEM, V282, P7087, DOI 10.1074/jbc.M610378200; Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Grifone R, 2004, MOL CELL BIOL, V24, P6253, DOI 10.1128/MCB.24.14.6253-6267.2004; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; HERBISON GJ, 1979, ARCH PHYS MED REHAB, V60, P401; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; Hyatt JPK, 2003, AM J PHYSIOL-CELL PH, V285, pC1161, DOI 10.1152/ajpcell.00128.2003; Ishido M, 2004, AM J PHYSIOL-CELL PH, V287, pC484, DOI 10.1152/ajpcell.00080.2004; Kardon G, 2002, DEV DYNAM, V224, P350, DOI 10.1002/dvdy.10107; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Knapp JR, 2006, DEVELOPMENT, V133, P601, DOI 10.1242/dev.02249; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Laclef C, 2003, DEVELOPMENT, V130, P2239, DOI 10.1242/dev.00440; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Li HH, 2007, J CLIN INVEST, V117, P3211, DOI 10.1172/JCI31757; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lu JR, 1999, P NATL ACAD SCI USA, V96, P552, DOI 10.1073/pnas.96.2.552; Mammucari C, 2008, AUTOPHAGY, V4, P524, DOI 10.4161/auto.5905; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; MEDINA R, 1995, BIOCHEM J, V307, P631, DOI 10.1042/bj3070631; Mercer SE, 2005, J BIOL CHEM, V280, P25788, DOI 10.1074/jbc.M413594200; MERLIE JP, 1994, J BIOL CHEM, V269, P2461; MIDRIO M, 1992, PFLUG ARCH EUR J PHY, V420, P446, DOI 10.1007/BF00374618; Moriscot AS, 2010, J STRUCT BIOL, V170, P344, DOI 10.1016/j.jsb.2010.02.001; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; NWOYE L, 1982, AM J PHYSIOL, V242, pR401, DOI 10.1152/ajpregu.1982.242.3.R401; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Patterson MF, 2006, AM J PHYSIOL-CELL PH, V291, pC518, DOI 10.1152/ajpcell.00013.2006; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Rana ZA, 2004, ACTA PHYSIOL SCAND, V181, P233, DOI 10.1111/j.1365-201X.2004.01282.x; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sato Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1748, DOI 10.1271/bbb.90085; Spencer JA, 2000, J CELL BIOL, V150, P771, DOI 10.1083/jcb.150.4.771; Tang HB, 2006, P NATL ACAD SCI USA, V103, P16977, DOI 10.1073/pnas.0601565103; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Willis MS, 2009, AM J PHYSIOL-HEART C, V296, pH997, DOI 10.1152/ajpheart.00660.2008	63	306	325	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2010	143	1					35	45		10.1016/j.cell.2010.09.004	http://dx.doi.org/10.1016/j.cell.2010.09.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887891	Green Accepted, Bronze			2022-12-24	WOS:000282362000012
J	FitzGerald, JM; Quon, BS				FitzGerald, J. Mark; Quon, Bradley S.			The impact of asthma guidelines	LANCET			English	Editorial Material							MAINTENANCE TREATMENT; MANAGEMENT		[FitzGerald, J. Mark; Quon, Bradley S.] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Ctr Lung Res, Vancouver, BC V7V 2J3, Canada	University of British Columbia; Vancouver Coastal Health Research Institute	FitzGerald, JM (corresponding author), Univ British Columbia, Vancouver Coastal Hlth Res Inst, Ctr Lung Res, Vancouver, BC V7V 2J3, Canada.	markf@interchange.ubc.ca						Bahadori K, 2010, J ASTHMA ALLERGY, V3, P33; Bahadori Katayoun, 2009, BMC Pulm Med, V9, P24, DOI 10.1186/1471-2466-9-24; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Ernst P, 2006, ANN INTERN MED, V145, P692, DOI 10.7326/0003-4819-145-9-200611070-00012; FitzGerald JM, 2004, THORAX, V59, P550, DOI 10.1136/thx.2003.014936; HARGREAVE FE, 1990, J ALLERGY CLIN IMMUN, V85, P1098, DOI 10.1016/0091-6749(90)90056-A; *INT UN TUB LUNG D, 2010, ASTHM DRUG FAC; Lemiere C, 2002, CAN MED ASSOC J, V167, P1008; Lougheed MD, 2010, CAN RESPIR J, V17, P15, DOI 10.1155/2010/827281; *LUNG ASS ONT, 2009, ASTHM CME ONL EV BAS; Poureslami Iraj M, 2007, MedGenMed, V9, P40; Public Health Agency of Canada, 2007, LIF BREATH RESP DIS; QUON B, 2009, COCHRANE DB SYST REV, V1; Thier Sara L, 2008, Manag Care, V17, P48	14	10	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2010	376	9743					751	753		10.1016/S0140-6736(10)61159-2	http://dx.doi.org/10.1016/S0140-6736(10)61159-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	650EC	20816530				2022-12-24	WOS:000281831000008
J	Arana, A; Wentworth, CE; Ayuso-Mateos, JL; Arellano, FM				Arana, Alejandro; Wentworth, Charles E.; Ayuso-Mateos, Jose L.; Arellano, Felix M.			Suicide-Related Events in Patients Treated with Antiepileptic Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMORBIDITY SURVEY REPLICATION; RISK-FACTORS; BIPOLAR DISORDER; EPILEPSY; ANTIDEPRESSANTS; UK; PREVENTION; VALIDATION; ALGORITHM; DEATH	BACKGROUND A previous meta-analysis of data from clinical trials showed an association between antiepileptic drugs and suicidality (suicidal ideation, behavior, or both). We used observational data to examine the association between the use or nonuse of antiepileptic drugs and suicide-related events (attempted suicides and completed suicides) in patients with epilepsy, depression, or bipolar disorder. METHODS We used data collected as part of the clinical care of patients who were representative of the general population in the United Kingdom to identify patients with epilepsy, depression, or bipolar disorder and to determine whether they received antiepileptic drugs. We estimated the incidence rate of suicide-related events and used logistic regression to compute odds ratios, controlling for confounding factors. RESULTS In a cohort of 5,130,795 patients, the incidence of suicide-related events per 100,000 person-years was 15.0 (95% confidence interval [CI], 14.6 to 15.5) among patients without epilepsy, depression, bipolar disorder, or antiepileptic-drug treatment, 38.2 (95% CI, 26.3 to 53.7) among patients with epilepsy who did not receive antiepileptic drugs, and 48.2 (95% CI, 39.4 to 58.5) among patients with epilepsy who received antiepileptic drugs. In adjusted analyses, the use of antiepileptic drugs was not associated with an increased risk of suicide-related events among patients with epilepsy (odds ratio, 0.59; 95% CI, 0.35 to 0.98) or bipolar disorder (1.13; 95% CI, 0.35 to 3.61) but was significantly associated with an increased risk among patients with depression (1.65; 95% CI, 1.24 to 2.19) and those who did not have epilepsy, depression, or bipolar disorder (2.57; 95% CI, 1.78 to 3.71). CONCLUSIONS The current use of antiepileptic drugs was not associated with an increased risk of suicide-related events among patients with epilepsy, but it was associated with an increased risk of such events among patients with depression and among those who did not have epilepsy, depression, or bipolar disorder.	[Arana, Alejandro; Arellano, Felix M.] Risk MR Pharmacovigilance Serv, Zaragoza 50001, Spain; [Ayuso-Mateos, Jose L.] Univ Autonoma Madrid, Hosp Univ Princesa, Dept Psychiat, Madrid, Spain; [Ayuso-Mateos, Jose L.] Inst Salud Carlos III, Ctr Invest Biomed Red Salud Mental, Madrid, Spain; [Wentworth, Charles E.; Arellano, Felix M.] RiskMR, Bridgewater, NJ USA	Autonomous University of Madrid; Hospital de La Princesa; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III	Arana, A (corresponding author), Risk MR Pharmacovigilance Serv, Jeronimo Zurita 14,1-D, Zaragoza 50001, Spain.	arana.riskmr@gmail.com		ARANA, Alejandro/0000-0002-1593-3124; Ayuso-Mateos, Jose Luis/0000-0002-7544-826X				American Foundation for Suicide Prevention, RISK FACT SUIC; ARCLLANO FM, 2009, J ALLERGY CLIN IMMUN, V123, P1111; Arellano FM, 2006, PHARMACOEPIDEM DR S, V15, P861, DOI 10.1002/pds.1343; Bell GS, 2009, CNS DRUGS, V23, P281, DOI 10.2165/00023210-200923040-00002; Blumer D, 2002, EPILEPSY BEHAV, V3, P232, DOI 10.1016/S1525-5050(02)00006-9; Braden JB, 2008, J PAIN, V9, P1106, DOI 10.1016/j.jpain.2008.06.004; Christensen J, 2007, LANCET NEUROL, V6, P693, DOI 10.1016/S1474-4422(07)70175-8; DeLeo D., 2002, WORLD REPORT VIOLENC, P183; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1044, DOI 10.1176/appi.ajp.164.7.1044; Gibbons RD, 2009, ARCH GEN PSYCHIAT, V66, P1354, DOI 10.1001/archgenpsychiatry.2009.159; Goodwin FK, 2003, JAMA-J AM MED ASSOC, V290, P1467, DOI 10.1001/jama.290.11.1467; Hall GC, 2009, PHARMACOEPIDEM DR S, V18, P120, DOI 10.1002/pds.1686; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Hesdorffer DC, 2006, ANN NEUROL, V59, P35, DOI 10.1002/ana.20685; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Jick H, 2004, JAMA-J AM MED ASSOC, V292, P338, DOI 10.1001/jama.292.3.338; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Mortensen PB, 2000, LANCET, V355, P9, DOI 10.1016/S0140-6736(99)06376-X; Moscicki EK, 2001, CLIN NEUROSCI RES, V1, P310, DOI 10.1016/S1566-2772(01)00032-9; MOSCICKI EK, 1985, SUICIDE PREVENTION Y, P22; NHS Centre for Coding and Classification, 1996, READ COD VERS 3; Nilsson L, 2002, EPILEPSIA, V43, P644, DOI 10.1046/j.1528-1157.2002.40001.x; *OFF NAT STAT, 2009, SUIC UK SUIC RAT CON; Patorno E, 2010, JAMA-J AM MED ASSOC, V303, P1401, DOI 10.1001/jama.2010.410; Posner K, 2007, AM J PSYCHIAT, V164, P1035, DOI 10.1176/appi.ajp.164.7.1035; Qin P, 2005, BMJ-BRIT MED J, V331, P23, DOI 10.1136/bmj.38488.462037.8F; Vigo DV, 2009, HARVARD REV PSYCHIAT, V17, P231, DOI 10.1080/10673220903129814; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G	28	120	127	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2010	363	6					542	551		10.1056/NEJMoa0909801	http://dx.doi.org/10.1056/NEJMoa0909801			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634BB	20818889	Bronze			2022-12-24	WOS:000280552700008
J	Sawa, S; Cherrier, M; Lochner, M; Satoh-Takayama, N; Fehling, HJ; Langa, F; Di Santo, JP; Eberl, G				Sawa, Shinichiro; Cherrier, Marie; Lochner, Matthias; Satoh-Takayama, Naoko; Fehling, Hans Joerg; Langa, Francina; Di Santo, James P.; Eberl, Gerard			Lineage Relationship Analysis of ROR gamma t(+) Innate Lymphoid Cells	SCIENCE			English	Article							ROR-GAMMA-T; TISSUE-INDUCER CELLS; NATURAL-KILLER-CELLS; PROINFLAMMATORY IL-17(+); NKP46(+) CELLS; HELPER-CELLS; IN-VIVO; DIFFERENTIATION; IMMUNITY; ORGANOGENESIS	Lymphoid tissue-inducer (LTi) cells initiate the development of lymphoid tissues through the activation of local stromal cells in a process similar to inflammation. LTi cells express the nuclear hormone receptor ROR gamma t, which also directs the expression of the proinflammatory cytokine interleukin-17 in T cells. We show here that LTi cells are part of a larger family of proinflammatory ROR gamma t(+) innate lymphoid cells (ILCs) that differentiate from distinct fetal liver ROR gamma t(+) precursors. The fate of ROR gamma t(+) ILCs is determined by mouse age, and after birth, favors the generation of cells involved in intestinal homeostasis and defense. Contrary to ROR gamma t(+) T cells, however, ROR gamma t(+) ILCs develop in the absence of microbiota. Our study indicates that ROR gamma t(+) ILCs evolve to preempt intestinal colonization by microbial symbionts.	[Sawa, Shinichiro; Cherrier, Marie; Lochner, Matthias; Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France; [Sawa, Shinichiro; Cherrier, Marie; Lochner, Matthias; Eberl, Gerard] CNRS, URA1961, F-75724 Paris, France; [Lochner, Matthias] Hannover Med Sch, Ctr Expt & Clin Infect Res, TWINCORE, Inst Infect Immunol, D-3000 Hannover, Germany; [Lochner, Matthias] Helmholtz Ctr Infect Res, Hannover, Germany; [Satoh-Takayama, Naoko; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75724 Paris, France; [Satoh-Takayama, Naoko; Di Santo, James P.] INSERM, U668, F-75724 Paris, France; [Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, Ulm, Germany; Inst Pasteur, Ctr Ingenieurie Genet Murine, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Ulm University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Eberl, G (corresponding author), Inst Pasteur, Lymphoid Tissue Dev Unit, F-75724 Paris, France.	gerard.eberl@pasteur.fr	Eberl, Gerard/A-1160-2013; Di Santo, James P/M-4298-2014; Lochner, Matthias/L-6963-2015	Di Santo, James P/0000-0002-7146-1862; Lochner, Matthias/0000-0002-7979-5613; Cherrier, Marie/0000-0001-5323-4239; Eberl, Gerard/0000-0002-1119-5638	Institut Pasteur; Mairie de Paris; Agence Nationale de la Recherche; European Commission; Deutsche Forschungsgemeinschaft [FE-578/3-1]; Schlumberger Foundation	Institut Pasteur(European Commission); Mairie de Paris(Region Ile-de-France); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Schlumberger Foundation(Schlumberger)	We thank the members of the Lymphoid Tissue Development lab for discussions and critical reading of the manuscript and L. Polomack, S. Dulauroy, G. Chauveau-Le Friec, and the team of the Centre d'Ingenierie Genetique Murine for technical assistance. We also thank R. Varona for CCR6-deficient mice, I. Gomperts-Boneca for Nod1- and Nod2-deficient mice, and H. Bujard for LC-1-Cre mice. This work was supported by the Institut Pasteur, grants from the Mairie de Paris, the Agence Nationale de la Recherche, and an Excellence Grant from the European Commission. M. L. was supported by the Deutsche Forschungsgemeinschaft and the Schlumberger Foundation. H.J.F. is funded by the Deutsche Forschungsgemeinschaft (FE-578/3-1). The authors have no competing financial interests.	Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Lugering A, 2010, CLIN EXP IMMUNOL, V160, P440, DOI 10.1111/j.1365-2249.2010.04103.x; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 2001, J IMMUNOL, V166, P6593, DOI 10.4049/jimmunol.166.11.6593; Michel ML, 2008, P NATL ACAD SCI USA, V105, P19845, DOI 10.1073/pnas.0806472105; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nishikawa S, 2000, CURR OPIN IMMUNOL, V12, P342, DOI 10.1016/S0952-7915(00)00097-2; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	30	379	390	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 29	2010	330	6004					665	669		10.1126/science.1194597	http://dx.doi.org/10.1126/science.1194597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	20929731				2022-12-24	WOS:000283580600047
J	Xiang, KH; Nagaike, T; Xiang, S; Kilic, T; Beh, MM; Manley, JL; Tong, LA				Xiang, Kehui; Nagaike, Takashi; Xiang, Song; Kilic, Turgay; Beh, Maia M.; Manley, James L.; Tong, Liang			Crystal structure of the human symplekin-Ssu72-CTD phosphopeptide complex	NATURE			English	Article							RNA-POLYMERASE-II; C-TERMINAL DOMAIN; ESS1 PROLYL ISOMERASE; MESSENGER-RNA; TRANSCRIPTION TERMINATION; MACROMOLECULAR STRUCTURES; POLYADENYLATION FACTOR; ANOMALOUS DIFFRACTION; SSU72; PHOSPHATASE	Symplekin (Pta1 in yeast) is a scaffold in the large protein complex that is required for 3'-end cleavage and polyadenylation of eukaryotic messenger RNA precursors (pre-mRNAs)(1-4); it also participates in transcription initiation and termination by RNA polymerase II (Pol II)(5,6). Symplekin mediates interactions between many different proteins in this machinery(1,2,7-9), although the molecular basis for its function is not known. Here we report the crystal structure at 2.4 angstrom resolution of the amino-terminal domain (residues 30-340) of human symplekin in a ternary complex with the Pol II carboxyterminal domain (CTD) Ser 5 phosphatase Ssu72 (refs 7, 10-17) and a CTD Ser 5 phosphopeptide. The N-terminal domain of symplekin has the ARM or HEAT fold, with seven pairs of antiparallel a-helices arranged in the shape of an arc. The structure of Ssu72 has some similarity to that of low-molecular-mass phosphotyrosine protein phosphatase(18,19), although Ssu72 has a unique active-site landscape as well as extra structural features at the C terminus that are important for interaction with symplekin. Ssu72 is bound to the concave face of symplekin, and engineered mutations in this interface can abolish interactions between the two proteins. The CTD peptide is bound in the active site of Ssu72, with the pSer 5-Pro 6 peptide bond in the cis configuration, which contrasts with all other known CTD peptide conformations(20,21). Although the active site of Ssu72 is about 25 angstrom from the interface with symplekin, we found that the symplekin N-terminal domain stimulates Ssu72 CTD phosphatase activity in vitro. Furthermore, the N-terminal domain of symplekin inhibits polyadenylation in vitro, but only when coupled to transcription. Because catalytically active Ssu72 overcomes this inhibition, our results show a role for mammalian Ssu72 in transcription-coupled pre-mRNA 3'-end processing.	[Xiang, Kehui; Nagaike, Takashi; Xiang, Song; Kilic, Turgay; Beh, Maia M.; Manley, James L.; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tong, LA (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu	Xiang, Song/AAF-6422-2019; KILIC, TURGAY/O-4493-2014	Xiang, Song/0000-0001-9314-4684; KILIC, TURGAY/0000-0003-2233-950X; Xiang, Kehui/0000-0002-3770-1367; Manley, James/0000-0002-8341-1459; Tong, Liang/0000-0002-0563-6468	National Institutes of Health [GM077175, GM028983]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028983, R01GM077175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Forouhar and J. Seetharaman for help with data collection; T. Auperin for initial experiments with symplekin; R. Abramowitz and J. Schwanof for setting up the X4C beamline; S. Myers for setting up the X29A beamline at the National Synchrotron Light Source; M. Heidemann and D. Eick for providing the 3E10 antibody; N. Rao and C. Logan for HeLa nuclear extract and help with in vitro assays; and J. Decatur for characterizing the phosphopeptide by NMR. This research is supported in part by grants from the National Institutes of Health to L.T. (GM077175) and J.L.M. (GM028983).	Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Ghazy MA, 2009, MOL CELL BIOL, V29, P2296, DOI 10.1128/MCB.01514-08; Hausmann S, 2005, J BIOL CHEM, V280, P37681, DOI 10.1074/jbc.M505292200; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hirose Y, 1998, NATURE, V395, P93, DOI 10.1038/25786; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kennedy SA, 2009, J MOL BIOL, V392, P115, DOI 10.1016/j.jmb.2009.06.062; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Krishnamurthy S, 2009, MOL CELL BIOL, V29, P2925, DOI 10.1128/MCB.01655-08; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Meinhart A, 2003, J BIOL CHEM, V278, P15917, DOI 10.1074/jbc.M301643200; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reyes-Reyes M, 2007, MOL CELL BIOL, V27, P926, DOI 10.1128/MCB.01361-06; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; St-Pierre B, 2005, NUCLEIC ACIDS RES, V33, P464, DOI 10.1093/nar/gki171; SU XD, 1994, NATURE, V370, P575, DOI 10.1038/370575a0; TAKAGAKI Y, 1988, CELL, V52, P731, DOI 10.1016/0092-8674(88)90411-4; Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; ZHANG M, 1994, BIOCHEMISTRY-US, V33, P11097, DOI 10.1021/bi00203a006; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhao J, 1999, MOL CELL BIOL, V19, P7733	41	114	117	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					729	U124		10.1038/nature09391	http://dx.doi.org/10.1038/nature09391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20861839	Green Accepted			2022-12-24	WOS:000282572500043
J	Balskus, EP; Walsh, CT				Balskus, Emily P.; Walsh, Christopher T.			The Genetic and Molecular Basis for Sunscreen Biosynthesis in Cyanobacteria	SCIENCE			English	Article							AMINO-ACIDS; MYCOSPORINES; SUPERFAMILY; ORGANISMS; PATHWAY; ENZYMES; GENOME	Ultraviolet UV-A and UV-B radiation is harmful to living systems, causing damage to biological macromolecules. An important strategy for dealing with UV exposure is the biosynthesis of small-molecule sunscreens. Among such metabolites, the mycosporine and mycosporine-like amino acids (MAAs) are remarkable for their wide phylogenetic distribution and their unique chemical structures. Here, we report the identification of a MAA biosynthetic gene cluster in a cyanobacterium and the discovery of analogous pathways in other sequenced organisms. We have expressed the cluster in a heterologous bacterial host and characterized all four biosynthetic enzymes in vitro. In addition to clarifying the origin of the MAAs, these efforts have revealed two unprecedented enzymatic strategies for imine formation.	[Balskus, Emily P.; Walsh, Christopher T.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Walsh, CT (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	christopher_walsh@hms.harvard.edu			NIH [GM-20011]; NIH NRSA [GM-084625]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020011, F32GM084625, R37GM020011] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the NIH (GM-20011). E. P. B. is the recipient of an NIH NRSA postdoctoral fellowship (GM-084625). We acknowledge Tri-K Industries (Northvale, NJ) for providing a sample of Helioguard 365 containing authentic standards of shinorine and porphyra-334.	Adams NL, 2001, MAR BIOL, V138, P267, DOI 10.1007/s002270000463; Bandaranayake WM, 1998, NAT PROD REP, V15, P159; BENDER SL, 1989, BIOCHEMISTRY-US, V28, P7555, DOI 10.1021/bi00445a009; Cockell CS, 1999, BIOL REV, V74, P311, DOI 10.1017/S0006323199005356; de la Coba F, 2009, J DERMATOL SCI, V55, P161, DOI 10.1016/j.jdermsci.2009.06.004; DEHORTER B, 1980, PHYTOCHEMISTRY, V19, P2311, DOI 10.1016/S0031-9422(00)91017-3; Dunlap WC, 1998, J PHYCOL, V34, P418, DOI 10.1046/j.1529-8817.1998.340418.x; FAVREBONVIN J, 1987, PHYTOCHEMISTRY, V26, P2509, DOI 10.1016/S0031-9422(00)83866-2; FAVREBONVIN J, 1976, CAN J CHEM, V54, P1105, DOI 10.1139/v76-158; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Galperin MY, 1997, PROTEIN SCI, V6, P2639; LEMOYNE F, 1985, Zeitschrift fuer Naturforschung Section C Journal of Biosciences, V40, P612; Mahmud T, 2007, J NAT PROD, V70, P1384, DOI 10.1021/np070210q; Neale PJ, 1998, J PHYCOL, V34, P928, DOI 10.1046/j.1529-8817.1998.340928.x; Oren A, 1997, GEOMICROBIOL J, V14, P231, DOI 10.1080/01490459709378046; Oren A, 2007, FEMS MICROBIOL LETT, V269, P1, DOI 10.1111/j.1574-6968.2007.00650.x; Portwich A, 2003, PHYCOLOGIA, V42, P384, DOI 10.2216/i0031-8884-42-4-384.1; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Singh SP, 2010, GENOMICS, V95, P120, DOI 10.1016/j.ygeno.2009.10.002; Singh SP, 2008, PHOTOCHEM PHOTOBIOL, V84, P1500, DOI 10.1111/j.1751-1097.2008.00376.x; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Starcevic A, 2008, P NATL ACAD SCI USA, V105, P2533, DOI 10.1073/pnas.0707388105; TRIONE EJ, 1966, NATURE, V212, P163, DOI 10.1038/212163a0; WHITE JD, 1989, J AM CHEM SOC, V111, P8970, DOI 10.1021/ja00206a059; Wu X, 2007, CHEMBIOCHEM, V8, P239, DOI 10.1002/cbic.200600446; Yakovleva I, 2004, COMP BIOCHEM PHYS B, V139, P721, DOI 10.1016/j.cbpc.2004.08.016	26	224	236	1	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1653	1656		10.1126/science.1193637	http://dx.doi.org/10.1126/science.1193637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20813918	Green Accepted, Green Submitted			2022-12-24	WOS:000282098100044
J	Narayan, KMV; Ali, MK; Koplan, JP				Narayan, K. M. Venkat; Ali, Mohammed K.; Koplan, Jeffrey P.			GLOBAL HEALTH Global Noncommunicable Diseases - Where Worlds Meet	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Narayan, K. M. Venkat] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; Emory Univ, Emory Global Hlth Inst, Atlanta, GA USA	Emory University; Rollins School Public Health; Emory University	Narayan, KMV (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.		Narayan, K.M. Venkat/J-9819-2012; Ali, Mohammed K/N-9833-2013	Narayan, K.M. Venkat/0000-0001-8621-5405; Ali, Mohammed/0000-0001-7266-2503				Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Schiffman M, 2009, NEW ENGL J MED, V360, P1453, DOI 10.1056/NEJMe0901167; World Health Organization, 2009, GLOB HLTH RISKS MORT; Yach D, 2004, JAMA-J AM MED ASSOC, V291, P2616, DOI 10.1001/jama.291.21.2616; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5	5	193	203	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2010	363	13					1196	1198		10.1056/NEJMp1002024	http://dx.doi.org/10.1056/NEJMp1002024			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	652ZA	20860499				2022-12-24	WOS:000282050000002
J	Manel, N; Hogstad, B; Wang, YM; Levy, DE; Unutmaz, D; Littman, DR				Manel, Nicolas; Hogstad, Brandon; Wang, Yaming; Levy, David E.; Unutmaz, Derya; Littman, Dan R.			A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELLS; TRANS-ENHANCEMENT; DC-SIGN; INFECTION; REPLICATION; VECTORS; RNA; DIFFERENTIATION; TRANSDUCTION	Dendritic cells serve a key function in host defence, linking innate detection of microbes to activation of pathogen-specific adaptive immune responses(1,2). Whether there is cell-intrinsic recognition of human immunodeficiency virus (HIV) by host innate pattern-recognition receptors and subsequent coupling to antiviral T-cell responses is not yet known(3). Dendritic cells are largely resistant to infection with HIV-1(4), but facilitate infection of co-cultured T-helper cells through a process of trans-enhancement(5,6). Here we show that, when dendritic cell resistance to infection is circumvented(7,8), HIV-1 induces dendritic cell maturation, an antiviral type I interferon response and activation of T cells. This innate response is dependent on the interaction of newly synthesized HIV-1 capsid with cellular cyclophilin A (CYPA) and the subsequent activation of the transcription factor IRF3. Because the peptidylprolyl isomerase CYPA also interacts with HIV-1 capsid to promote infectivity, our results indicate that capsid conformation has evolved under opposing selective pressures for infectivity versus furtiveness. Thus, a cell-intrinsic sensor for HIV-1 exists in dendritic cells and mediates an antiviral immune response, but it is not typically engaged owing to the absence of dendritic cell infection. The virulence of HIV-1 may be related to evasion of this response, the manipulation of which may be necessary to generate an effective HIV-1 vaccine.	[Manel, Nicolas; Hogstad, Brandon; Littman, Dan R.] NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med,Mol Pathogenesis Program, New York, NY 10016 USA; [Manel, Nicolas] Univ Montpellier 1 & 2, Inst Genet Mol Montpellier, CNRS, UMR5535, F-34070 Montpellier, France; [Hogstad, Brandon; Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Wang, Yaming; Levy, David E.; Unutmaz, Derya; Littman, Dan R.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Wang, Yaming; Levy, David E.] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Unutmaz, Derya; Littman, Dan R.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Howard Hughes Medical Institute; New York University; New York University; New York University; New York University	Littman, DR (corresponding author), NYU, Sch Med, Skirball Inst, Kimmel Ctr Biol & Med,Mol Pathogenesis Program, New York, NY 10016 USA.	dan.littman@med.nyu.edu	Levy, David/AAG-6202-2019; Manel, Nicolas/E-2128-2011; Levy, David/GPS-4945-2022	Levy, David/0000-0002-7320-7788; Manel, Nicolas/0000-0002-1481-4430; Unutmaz, Derya/0000-0001-8898-6633	EMBO; Cancer Research Institute; Institut National de la Sante et de la Recherche Medicale; Howard Hughes Medical Institute; Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health (NIH) [AI33856, AI28900, U54AI57168, R01AI065303]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI084633, R01AI033856, U54AI057158, U54AI057168, R01AI028900, R01AI065303] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); Cancer Research Institute; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen and Martin Kimmel Center for Biology and Medicine; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Littman laboratory for valuable discussions and critical reading of the manuscript, and T. Egawa, E. Kurz, X. Gong and L. Kozyhaya for assistance with experiments. We thank S. Hopkins at Scynexis for the gift of the SCY compound, J. Zavadil and the genomic core facility of New York University Medical Center for performing the array studies, M. Emerman, M. Yamashita and W. Sundquist for HIV constructs and critical reading of the manuscript, B. Walker, A. Piechocka-Trocha, D. Kwon, S. M. Vine, N. Bardhwaj and E. Miller for T-cell clones and reagents, and S. Schwab and R. Medzhitov for critical reading of the manuscript. N. M. thanks M. Sitbon, N. Taylor and J.-M. Blanchard for continuous support. The work was supported sequentially by EMBO and Cancer Research Institute fellowships (N.M.), by the Institut National de la Sante et de la Recherche Medicale (N.M.), by the Howard Hughes Medical Institute (D.R.L.), the Helen and Martin Kimmel Center for Biology and Medicine (D.R.L.), and National Institutes of Health (NIH) grants AI33856 (D.R.L.), AI28900 (D.E.L.), U54AI57168 (D.E.L.) and R01AI065303 (D.U.).	Antons AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002952; Boggiano C, 2007, J VIROL, V81, P2519, DOI 10.1128/JVI.01661-06; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Chatterji U, 2009, J BIOL CHEM, V284, P16998, DOI 10.1074/jbc.M109.007625; de Silva TI, 2008, TRENDS MICROBIOL, V16, P588, DOI 10.1016/j.tim.2008.09.003; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Elkon R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-110; Fonteneau JF, 2001, J IMMUNOL METHODS, V258, P111, DOI 10.1016/S0022-1759(01)00477-X; Gett AV, 2003, NAT IMMUNOL, V4, P355, DOI 10.1038/ni908; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Griffin SDC, 2001, J VIROL, V75, P12058, DOI 10.1128/JVI.75.24.12058-12069.2001; Honda K, 2003, P NATL ACAD SCI USA, V100, P10872, DOI 10.1073/pnas.1934678100; Hopkins S, 2010, ANTIMICROB AGENTS CH, V54, P660, DOI 10.1128/AAC.00660-09; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Langenkamp A, 2002, EUR J IMMUNOL, V32, P2046, DOI 10.1002/1521-4141(200207)32:7<2046::AID-IMMU2046>3.0.CO;2-M; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangeot PE, 2002, MOL THER, V5, P283, DOI 10.1006/mthe.2002.0541; Mangeot PE, 2000, J VIROL, V74, P8307, DOI 10.1128/JVI.74.18.8307-8315.2000; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moris A, 2006, BLOOD, V108, P1643, DOI 10.1182/blood-2006-02-006361; Morner A, 1999, J VIROL, V73, P2343; Neagu MR, 2009, J CLIN INVEST, V119, P3035, DOI 10.1172/JCI39354; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004	39	326	339	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2010	467	7312					214	U104		10.1038/nature09337	http://dx.doi.org/10.1038/nature09337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829794	Green Accepted			2022-12-24	WOS:000281616300036
J	Muenzner, P; Bachmann, V; Zimmermann, W; Hentschel, J; Hauck, CR				Muenzner, Petra; Bachmann, Verena; Zimmermann, Wolfgang; Hentschel, Jochen; Hauck, Christof R.			Human-Restricted Bacterial Pathogens Block Shedding of Epithelial Cells by Stimulating Integrin Activation	SCIENCE			English	Article							UROPATHOGENIC ESCHERICHIA-COLI; NEISSERIA-GONORRHOEAE; HOST DEFENSES; CARCINOEMBRYONIC ANTIGENS; FOCAL ADHESIONS; ORGAN-CULTURE; OPA PROTEINS; EXPRESSION; INFECTION; RECEPTORS	Colonization of mucosal surfaces is the key initial step in most bacterial infections. One mechanism protecting the mucosa is the rapid shedding of epithelial cells, also termed exfoliation, but it is unclear how pathogens counteract this process. We found that carcinoembryonic antigen (CEA)-binding bacteria colonized the urogenital tract of CEA transgenic mice, but not of wild-type mice, by suppressing exfoliation of mucosal cells. CEA binding triggered de novo expression of the transforming growth factor receptor CD105, changing focal adhesion composition and activating beta(1) integrins. This manipulation of integrin inside-out signaling promotes efficient mucosal colonization and represents a potential target to prevent or cure bacterial infections.	[Muenzner, Petra; Bachmann, Verena; Hentschel, Jochen; Hauck, Christof R.] Univ Konstanz, Fachbereich Biol, Lehrstuhl Zellbiol, D-78457 Constance, Germany; [Zimmermann, Wolfgang] Univ Munich, LIFE Ctr, Tumor Immunol Lab, D-81377 Munich, Germany; [Hentschel, Jochen] Univ Konstanz, Fachbereich Biol, EM Serv, D-78457 Constance, Germany; [Hauck, Christof R.] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany	University of Konstanz; University of Munich; University of Konstanz; University of Konstanz	Hauck, CR (corresponding author), Univ Konstanz, Fachbereich Biol, Lehrstuhl Zellbiol, D-78457 Constance, Germany.	christof.hauck@uni-konstanz.de	Zimmermann, Wolfgang/L-9277-2013		Deutsche Forschungsgemeinschaft [Ha2856/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank M. C. Beckerle for zyxin-deficient fibroblasts and antibodies; M. Chudakov for the mKate cDNA; J. W. Greiner for sending the CEAtg mice; T. F. Meyer for bacterial strains; D. W. Piston for cDNA of mCerulean; A. J. Schaeffer for hVEC cells; D. Vestweber for providing antibody; C. Hentschel, J. Scharrer, and R. Mak'anyengo for assistance with SEM; and B. Planitz for expert animal care. Supported by Deutsche Forschungsgemeinschaft grant Ha2856/6-1 (C.R.H.).	Berger CN, 2004, MOL MICROBIOL, V52, P963, DOI 10.1111/j.1365-2958.2004.04033.x; CHEN T, 1995, J EXP MED, V182, P511, DOI 10.1084/jem.182.2.511; Conley BA, 2004, J BIOL CHEM, V279, P27440, DOI 10.1074/jbc.M312561200; EADESPERNER AM, 1994, CANCER RES, V54, P4169; Guerrero-Esteo M, 1999, EUR J CELL BIOL, V78, P614, DOI 10.1016/S0171-9335(99)80046-6; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hauck CR, 2003, CURR OPIN MICROBIOL, V6, P43, DOI 10.1016/S1369-5274(03)00004-3; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; JERSE AE, 1994, J EXP MED, V179, P911, DOI 10.1084/jem.179.3.911; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; MCGEE ZA, 1981, J INFECT DIS, V143, P413, DOI 10.1093/infdis/143.3.413; MELLY MA, 1981, J INFECT DIS, V143, P423, DOI 10.1093/infdis/143.3.423; Merz AJ, 2000, ANNU REV CELL DEV BI, V16, P423, DOI 10.1146/annurev.cellbio.16.1.423; Mosleh IM, 1997, INFECT IMMUN, V65, P3391, DOI 10.1128/IAI.65.8.3391-3398.1997; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494; Mulvey MA, 2000, P NATL ACAD SCI USA, V97, P8829, DOI 10.1073/pnas.97.16.8829; Mysorekar IU, 2002, J BIOL CHEM, V277, P7412, DOI 10.1074/jbc.M110560200; Pearson JP, 2005, COLONIZATION OF MUCOSAL SURFACES, P3; SWANSON J, 1988, J EXP MED, V168, P2121, DOI 10.1084/jem.168.6.2121; TJIA KF, 1988, GRAEF ARCH CLIN EXP, V226, P341, DOI 10.1007/BF02172964; Toleman M, 2001, CELL MICROBIOL, V3, P33, DOI 10.1046/j.1462-5822.2001.00089.x; VANPUTTEN JPM, 1995, EMBO J, V14, P2144, DOI 10.1002/j.1460-2075.1995.tb07208.x; Virji M, 2000, MOL MICROBIOL, V36, P784, DOI 10.1046/j.1365-2958.2000.01885.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; World Health Organization, 2001, GLOB PREV INC SEL CU; ZAMBRUNO G, 1995, J CELL BIOL, V129, P853, DOI 10.1083/jcb.129.3.853	30	69	71	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1197	1201		10.1126/science.1190892	http://dx.doi.org/10.1126/science.1190892			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20813953	Green Submitted			2022-12-24	WOS:000281485600034
J	Pasternak, B; Hviid, A				Pasternak, Bjorn; Hviid, Anders			Use of Acyclovir, Valacyclovir, and Famciclovir in the First Trimester of Pregnancy and the Risk of Birth Defects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HERPES-SIMPLEX-VIRUS; GENITAL HERPES; REGISTRATION; INFECTION; ZOSTER; OUTCOMES; SAFETY; TYPE-1; RATES	Context Herpes simplex and herpes zoster infections are common and often treated with antiviral drugs including acyclovir, valacyclovir, and famciclovir. Safety of these antivirals when used in the first trimester of pregnancy is insufficiently documented. Objective To investigate associations between exposure to acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and risk of major birth defects. Design, Setting, and Participants Population-based historical cohort study of 837 795 live-born infants in Denmark from January 1, 1996, to September 30, 2008. Participants had no diagnoses of chromosomal aberrations, genetic syndromes, birth defect syndromes with known causes, or congenital viral infections. Nationwide registries were used to ascertain individual-level information on dispensed antiviral drugs, birth defect diagnoses (categorized according to a standardized classification scheme), and potential confounders. Main Outcome Measure Prevalence odds ratios (PORs) of any major birth defect diagnosed within the first year of life by exposure to antiviral drugs. Results Among 1804 pregnancies exposed to acyclovir, valacyclovir, or famciclovir in the first trimester, 40 infants (2.2%) were diagnosed with a major birth defect compared with 19 920 (2.4%) among the unexposed (adjusted POR, 0.89; 95% confidence interval [CI], 0.65-1.22). For individual antivirals, a major birth defect was diagnosed in 32 of 1561 infants (2.0%) with first-trimester exposure to acyclovir (adjusted POR, 0.82; 95% Cl, 0.57-1.17) and in 7 of 229 infants (3.1%) with first-trimester exposure to valacyclovir (adjusted POR, 1.21; 95% CI, 0.56-2.62). Famciclovir exposure was uncommon (n=26), with 1 infant (3.8%) diagnosed with a birth defect. Exploratory analyses revealed no associations between antiviral drug exposure and 13 different subgroups of birth defects, but the number of exposed cases in each subgroup was small. Conclusion In this large nationwide cohort, exposure to acyclovir or valacyclovir in the first trimester of pregnancy was not associated with an increased risk of major birth defects. JAMA. 2010;304(8):859-866	[Pasternak, Bjorn; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Pasternak, B (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	bjp@ssi.dk	Hviid, Anders/AAH-4319-2020; Pasternak, Bjorn/H-5739-2012	Hviid, Anders/0000-0002-7509-9127; Pasternak, Bjorn/0000-0002-2097-8466	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Danish Medical Research Council and the Lundbeck Foundation.	Andersen TF, 1999, DAN MED BULL, V46, P263; BENEDETTI J, 1994, ANN INTERN MED, V121, P847, DOI 10.7326/0003-4819-121-11-199412010-00004; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Buhimschi CS, 2009, OBSTET GYNECOL, V113, P166, DOI 10.1097/AOG.0b013e31818d6788; Cernik C, 2008, ARCH INTERN MED, V168, P1137, DOI 10.1001/archinte.168.11.1137; CHAHOUD I, 1988, ARCH TOXICOL, V62, P8, DOI 10.1007/BF00316250; *DANM STAT, RES DAT DAT SOURC AV; *EUR NETW, COD EUR SUBGR CONG A; *EUR NETW, MIN AN EXCL; Jepsen P, 2006, INT J RISK SAF MED, V18, P77; Jorgensen Finn Stener, 2003, Ugeskr Laeger, V165, P4409; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; MOORE HL, 1983, FUND APPL TOXICOL, V3, P560, DOI 10.1016/S0272-0590(83)80105-5; Pedersen CB, 2006, DAN MED BULL, V53, P441; Ratanajamit C, 2003, SCAND J INFECT DIS, V35, P255, DOI 10.1080/00365540310000229; SALTZMAN R, 1994, ANTIMICROB AGENTS CH, V38, P2454, DOI 10.1128/AAC.38.10.2454; Sen P, 2007, BMJ-BRIT MED J, V334, P1048, DOI 10.1136/bmj.39189.504306.55; Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739; Stone KM, 2004, BIRTH DEFECTS RES A, V70, P201, DOI 10.1002/bdra.20013; Tyring SK, 2002, J INFECT DIS, V186, pS40, DOI 10.1086/342966; *US FDA, 2005, ZOV AC PROD INF; *US FDA, 2008, VALTR VAL PROD INF; *US FDA, 2009, FAMV FAMC PROD INF; Wareham DW, 2007, BMJ-BRIT MED J, V334, P1211, DOI 10.1136/bmj.39206.571042.AE; Wilton LV, 1998, BRIT J OBSTET GYNAEC, V105, P882, DOI 10.1111/j.1471-0528.1998.tb10234.x; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964; Yawn BP, 2007, MAYO CLIN PROC, V82, P1341, DOI 10.4065/82.11.1341	29	114	118	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2010	304	8					859	866		10.1001/jama.2010.1206	http://dx.doi.org/10.1001/jama.2010.1206			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644OY	20736469	Bronze			2022-12-24	WOS:000281389900023
J	Corbett, KD; Yip, CK; Ee, LS; Walz, T; Amon, A; Harrison, SC				Corbett, Kevin D.; Yip, Calvin K.; Ee, Ly-Sha; Walz, Thomas; Amon, Angelika; Harrison, Stephen C.			The Monopolin Complex Crosslinks Kinetochore Components to Regulate Chromosome-Microtubule Attachments	CELL			English	Article							PROTEIN-INTERACTION MAP; MEIOSIS-I; SACCHAROMYCES-CEREVISIAE; MOLECULAR ARCHITECTURE; DNA-REPLICATION; SISTER KINETOCHORES; YEAST KINETOCHORE; NDC80 COMPLEX; RIBOSOMAL DNA; CELL-CYCLE	The monopolin complex regulates different types of kinetochore-microtubule attachments in fungi, ensuring sister chromatid co-orientation in Saccharomyces cerevisiae meiosis I and inhibiting merotelic attachment in Schizosaccharomyces pombe mitosis. In addition, the monopolin complex maintains the integrity and silencing of ribosomal DNA ( rDNA) repeats in the nucleolus. We show here that the S. cerevisiae Csm1/Lrs4 monopolin subcomplex has a distinctive V-shaped structure, with two pairs of protein-protein interaction domains positioned similar to 10 nm apart. Csm1 presents a conserved hydrophobic surface patch that binds two kinetochore proteins: Dsn1, a subunit of the outer-kinetochore MIND/Mis12 complex, and Mif2/CENP-C. Csm1 point-mutations that disrupt kinetochore-subunit binding also disrupt sister chromatid co-orientation in S. cerevisiae meiosis I. We further show that the same Csm1 point-mutations affect rDNA silencing, probably by disrupting binding to the rDNA-associated protein Tof2. We propose that Csm1/Lrs4 functions as a molecular clamp, crosslinking kinetochore components to enforce sister chromatid co-orientation in S. cerevisiae meiosis I and to suppress merotelic attachment in S. pombe mitosis, and crosslinking rDNA repeats to aid rDNA silencing.	[Corbett, Kevin D.; Harrison, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Yip, Calvin K.; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Ee, Ly-Sha; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Walz, Thomas; Amon, Angelika; Harrison, Stephen C.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Harrison, SC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 250 Longwood Ave, Boston, MA 02115 USA.	harrison@crystal.harvard.edu		Amon, Angelika/0000-0001-9837-0314; Walz, Thomas/0000-0003-2606-2835; Corbett, Kevin/0000-0001-5854-2388; Yip, Calvin/0000-0003-1779-9501	Helen Hay Whitney Foundation; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062207] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source NE-CAT beamlines for advice and assistance with data collection and interpretation; D. Moazed for the gift of S. cerevisiae strains and valuable advice; M. Sawaya for providing advice and script files for anisotropic scaling; J. Al-Bassam for assistance with electron microscopy; members of the Amon laboratory, especially I. Brito and E. Unal, for advice, assistance with yeast strain construction, and light microscopy; and members of the Harrison laboratory and I. Cheeseman for helpful discussions. K.D.C. acknowledges a postdoctoral fellowship from the Helen Hay Whitney Foundation; C.K.Y. acknowledges a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research; T.W., A.A, and S.C.H. are Investigators in the Howard Hughes Medical Institute.	Brito IL, 2010, GENETICS, V185, P55, DOI 10.1534/genetics.110.115139; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Choi SH, 2009, CURR BIOL, V19, P985, DOI 10.1016/j.cub.2009.05.042; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gregan J, 2007, CURR BIOL, V17, P1190, DOI 10.1016/j.cub.2007.06.044; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Johzuka K, 2009, MOL CELL, V34, P26, DOI 10.1016/j.molcel.2009.02.021; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Lee B, 2001, CURR OPIN CELL BIOL, V13, P770, DOI 10.1016/S0955-0674(00)00282-9; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Li XX, 2009, NAT CELL BIOL, V11, P1103, DOI 10.1038/ncb1923; LO HC, 1980, MOL BIOL CELL, V19, P4956; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; Mekhail K, 2008, NATURE, V456, P667, DOI 10.1038/nature07460; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Tanaka K, 2009, DEV CELL, V17, P334, DOI 10.1016/j.devcel.2009.08.004; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2006, STRUCTURE, V14, P1003, DOI 10.1016/j.str.2006.04.007; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765; Wong J, 2007, MOL BIOL CELL, V18, P3800, DOI 10.1091/mbc.E07-06-0536; Wysocka M, 2004, EXP CELL RES, V294, P592, DOI 10.1016/j.yexcr.2003.12.008; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	44	90	91	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					556	567		10.1016/j.cell.2010.07.017	http://dx.doi.org/10.1016/j.cell.2010.07.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723757	Green Submitted, Green Accepted, Bronze			2022-12-24	WOS:000281115900010
J	Zhou, XL; Wang, JL; Lu, J; Song, YP; Kwak, KS; Jiao, QS; Rosenfeld, R; Chen, Q; Boone, T; Simonet, WS; Lacey, DL; Goldberg, AL; Han, HQ				Zhou, Xiaolan; Wang, Jin Lin; Lu, John; Song, Yanping; Kwak, Keith S.; Jiao, Qingsheng; Rosenfeld, Robert; Chen, Qing; Boone, Thomas; Simonet, W. Scott; Lacey, David L.; Goldberg, Alfred L.; Han, H. Q.			Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival	CELL			English	Article							ACTIVIN-A; SATELLITE CELL; TUMOR PROGRESSION; HEART-FAILURE; MYOSTATIN; ATROPHY; INHIBIN; ACTIVATION; MECHANISMS; EXPRESSION	Muscle wasting and cachexia have long been postulated to be key determinants of cancer-related death, but there has been no direct experimental evidence to substantiate this hypothesis. Here, we show that in several cancer cachexia models, pharmacological blockade of ActRIIB pathway not only prevents further muscle wasting but also completely reverses prior loss of skeletal muscle and cancer-induced cardiac atrophy. This treatment dramatically prolongs survival, even of animals in which tumor growth is not inhibited and fat loss and production of proinflammatory cytokines are not reduced. ActRIIB pathway blockade abolished the activation of the ubiquitin-proteasome system and the induction of atrophy-specific ubiquitin ligases in muscles and also markedly stimulated muscle stem cell growth. These findings establish a crucial link between activation of the ActRIIB pathway and the development of cancer cachexia. Thus ActRIIB antagonism is a promising new approach for treating cancer cachexia, whose inhibition per se prolongs survival.	[Zhou, Xiaolan; Wang, Jin Lin; Lu, John; Song, Yanping; Kwak, Keith S.; Jiao, Qingsheng; Rosenfeld, Robert; Chen, Qing; Boone, Thomas; Simonet, W. Scott; Lacey, David L.; Han, H. Q.] Amgen Res, Dept Metab Disorders, Thousand Oaks, CA 91360 USA; [Zhou, Xiaolan; Wang, Jin Lin; Lu, John; Song, Yanping; Kwak, Keith S.; Jiao, Qingsheng; Rosenfeld, Robert; Chen, Qing; Boone, Thomas; Simonet, W. Scott; Lacey, David L.; Han, H. Q.] Amgen Res, Dept Prot Sci, Thousand Oaks, CA 91360 USA; [Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Han, HQ (corresponding author), Amgen Res, Dept Metab Disorders, Thousand Oaks, CA 91360 USA.	hqhan@amgen.com			National Institutes of Health (NIA); Muscular Dystrophy Association	National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Muscular Dystrophy Association(Muscular Dystrophy Association)	We thank Dr. Martin Matzuk for breeding pairs of inhibin-alpha KO mice. We also thank Amgen Protein Science for reagent support, George Doellgast for PK assay, Keith Kelley for confocal microscopy and Keith Langley for helpful comment.; X.Z., J.L.W., J.L., Y.S., K.S.K., R.R., Q.J., Q.C., T.B., W.S.S., D.L.L. and H.Q.H. are all current or former employees of Amgen Inc. A.L.G. is professor of Harvard Medical School and has a consulting agreement with Amgen. His research is supported by grants from the National Institutes of Health (NIA) and the Muscular Dystrophy Association.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cipriano SC, 2000, ENDOCRINOLOGY, V141, P2319, DOI 10.1210/en.141.7.2319; Coerver KA, 1996, MOL ENDOCRINOL, V10, P534, DOI 10.1210/me.10.5.534; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Fearon KCH, 2008, EUR J CANCER, V44, P1124, DOI 10.1016/j.ejca.2008.02.033; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Harada K, 1996, J CLIN ENDOCR METAB, V81, P2125, DOI 10.1210/jc.81.6.2125; Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068; HELLERSTEIN HK, 1950, CIRCULATION, V1, P93, DOI 10.1161/01.CIR.1.1.93; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kwak KS, 2004, CANCER RES, V64, P8193, DOI 10.1158/0008-5472.CAN-04-2102; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Li QL, 2007, MOL HUM REPROD, V13, P675, DOI 10.1093/molehr/gam055; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; MATZUK MM, 1994, P NATL ACAD SCI USA, V91, P8817, DOI 10.1073/pnas.91.19.8817; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MOORE R, 1993, DEVELOPMENT, V117, P1409; MORI M, 1991, CANCER RES, V51, P6656; Otani T, 2001, GYNECOL ONCOL, V83, P31, DOI 10.1006/gyno.2001.6350; Petraglia F, 1998, J CLIN ENDOCR METAB, V83, P1194, DOI 10.1210/jc.83.4.1194; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; RODGERS BD, 2009, J PHYSL, V15, P4873; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Seder CW, 2009, NEOPLASIA, V11, P388, DOI 10.1593/neo.81582; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Solomon V, 1998, P NATL ACAD SCI USA, V95, P12602, DOI 10.1073/pnas.95.21.12602; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; Springer J, 2010, CIRCULATION, V121, P354, DOI 10.1161/CIR.0b013e3181d0ba8b; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; TANAKA M, 1993, CANCER LETT, V72, P65, DOI 10.1016/0304-3835(93)90012-X; Thomas TZ, 1997, J CLIN ENDOCR METAB, V82, P3851, DOI 10.1210/jc.82.11.3851; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Wildi S, 2001, GUT, V49, P409, DOI 10.1136/gut.49.3.409; Yndestad A, 2004, CIRCULATION, V109, P1379, DOI 10.1161/01.CIR.0000120704.97934.41; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	48	638	684	4	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					531	543		10.1016/j.cell.2010.07.011	http://dx.doi.org/10.1016/j.cell.2010.07.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723755	Bronze			2022-12-24	WOS:000281115900008
J	Kanwal, F; Schnitzler, MS; Bacon, BR; Hoang, TY; Buchanan, PM; Asch, SM				Kanwal, Fasiha; Schnitzler, Mark S.; Bacon, Bruce R.; Hoang, Tuyen; Buchanan, Paula M.; Asch, Steven M.			Quality of Care in Patients With Chronic Hepatitis C Virus Infection A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; B VACCINATION; MISSED OPPORTUNITIES; ANTIVIRAL THERAPY; LIVER-DISEASE; VETERANS; PREDICTORS; RIBAVIRIN; IMPACT; MANAGEMENT	Background: Medicare has proposed quality-of-care indicators for chronic hepatitis C virus (HCV) infection. The extent to which these standards are met in practice is largely unknown. Objective: To evaluate the quality of health care that patients with HCV receive and the factors associated with receipt of quality care. Design: Retrospective cohort study. Setting: Nationwide U. S. health insurance company research database. Participants: 10 385 patients with HCV enrolled in the database between 2003 and 2006. Patients were included if they were eligible for at least 1 quality indicator. Measurements: Quality of HCV care received by patients, as measured by 7 explicit quality indicators included in Medicare's 2009 Physician Quality Reporting Initiative. Results: Proportions of patients meeting quality indicators varied, ranging from 21.5% for vaccination to 79% for the HCV genotype testing indicator. Overall, 18.5% of patients (95% CI, 18% to 19%) received all recommended care. Older age and presence of comorbid conditions were associated with lower quality, whereas elevated liver enzyme levels, cirrhosis, and HIV infection were associated with higher quality. Patients who saw both generalists and specialists received the best care (odds ratio of receiving care for which a patient is eligible: specialists alone, 0.79 [CI, 0.66 to 0.95]; primary care physician alone, 0.44 [CI, 0.40 to 0.48]). Limitations: The study had an observational retrospective design, used a convenience sample, and had no information on patient ethnicity. It may be that the indicators or the reporting of the indicators of HCV care-and not the care itself-is suboptimum. Conclusion: Health care quality, based on Medicare criteria, is suboptimum for HCV. Care that included both specialists and generalists is associated with the best quality. Our results support the development of specialist and primary care collaboration to improve the quality of HCV care.	[Kanwal, Fasiha] John Cochran Vet Affairs Med Ctr, St Louis, MO 63106 USA; St Louis Univ, Sch Med, St Louis, MO 63110 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; RAND Corp, Santa Monica, CA USA	Saint Louis University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; RAND Corporation	Kanwal, F (corresponding author), John Cochran Vet Affairs Med Ctr, 915 N Grand Blvd,111 JC GI, St Louis, MO 63106 USA.	fasiha.kanwal@va.gov; schnitm@slu.edu; pbuchan1@slu.edu			Saint Louis University Liver Center; Veterans Affairs Health Services Research and Development Service [IIR-07-111]	Saint Louis University Liver Center; Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs)	Primary Funding Source: Saint Louis University Liver Center.; Grant Support: Dr. Kanwal is supported by Veterans Affairs Health Services Research and Development Service Investigator Initiated Research Award IIR-07-111. This study was supported by an intramural grant from the Saint Louis University Liver Center.	*AM HEART ASS, 2007, HEART DIS STROK STAT; ARMSTRONG GL, 2006, ANN INTERN MED, V705, P1999; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Backus LI, 2007, HEPATOLOGY, V46, P37, DOI 10.1002/hep.21662; Butt AA, 2007, GUT, V56, P385, DOI 10.1136/gut.2006.099150; Centers for Disease Control and Prevention, 1980, NUMB MILL CIV NON PE; Centers for Medicare and Medicaid Services, OV PHYS QUAL REP IN; *COPD INT, COPD STAT; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dominitz JA, 2005, HEPATOLOGY, V41, P88, DOI 10.1002/hep.20502; El-Serag HB, 2002, GASTROENTEROLOGY, V123, P476, DOI 10.1053/gast.2002.34750; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hachem CY, 2008, ALIMENT PHARM THER, V28, P1078, DOI 10.1111/j.1365-2036.2008.03827.x; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hernandez B, 2009, AM J GASTROENTEROL, V104, P1961, DOI 10.1038/ajg.2009.252; Kanwal F, 2007, HEPATOLOGY, V46, P1741, DOI 10.1002/hep.21927; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; LANZA LL, 1995, ARCH INTERN MED, V155, P1371, DOI 10.1001/archinte.155.13.1371; Ong JP, 2005, J CLIN GASTROENTEROL, V39, P826, DOI 10.1097/01.mcg.0000177258.95562.43; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Puoti C, 1997, HEPATOLOGY, V26, P1393; Puoti C, 1997, ITAL J GASTROENTEROL, V29, P383; RAFIQ N, 2009, 44 ANN M EUR ASS STU; Rongey CA, 2009, AM J PREV MED, V36, P235, DOI 10.1016/j.amepre.2008.10.013; Rousseau CM, 2008, AM J PUBLIC HEALTH, V98, P846, DOI 10.2105/AJPH.2007.113225; Shim M, 2005, HEPATOLOGY, V42, P688, DOI 10.1002/hep.20830; Shiratori Y, 2005, ANN INTERN MED, V142, P105, DOI 10.7326/0003-4819-142-2-200501180-00009; Vento S, 1998, NEW ENGL J MED, V338, P286, DOI 10.1056/NEJM199801293380503; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; Weinbaum C., 2006, Morbidity and Mortality Weekly Report, V55, P509; Wong VS, 1996, BRIT MED J, V312, P1336, DOI 10.1136/bmj.312.7042.1336; Yoshida H, 2002, GASTROENTEROLOGY, V123, P483, DOI 10.1053/gast.2002.34785	34	53	53	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2010	153	4					231	239		10.7326/0003-4819-153-4-201008170-00005	http://dx.doi.org/10.7326/0003-4819-153-4-201008170-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639KF	20713791				2022-12-24	WOS:000280973000003
J	Saugstad, OD				Saugstad, Ola Didrik			Resuscitation of newborn infants: from oxygen to room air	LANCET			English	Editorial Material							100-PERCENT OXYGEN; NEONATAL RESUSCITATION; HYPOXANTHINE; METAANALYSIS; 21-PERCENT; INCREASES; HYPOXIA; PIGLETS; INJURY; TRIAL		Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Paediat Res, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway	Saugstad, OD (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Paediat Res, N-0027 Oslo, Norway.	odsaugstad@rr-research.no	Saugstad, Ola/AAS-9041-2021	Saugstad, Ola/0000-0002-3166-5254				[Anonymous], 2006, PEDIATRICS, V117, pe978; Davis PG, 2004, LANCET, V364, P1329, DOI 10.1016/S0140-6736(04)17189-4; Escrig R, 2008, PEDIATRICS, V121, P875, DOI 10.1542/peds.2007-1984; Hansmann G, 2004, LANCET, V364, P1293, DOI 10.1016/S0140-6736(04)17203-6; Koch JD, 2008, J CEREBR BLOOD F MET, V28, P1294, DOI 10.1038/jcbfm.2008.15; Lakshminrusimha S, 2006, PEDIATR RES, V59, P137, DOI 10.1203/01.pdr.0000191136.69142.8c; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; Munkeby BH, 2004, PEDIATR RES, V56, P783, DOI 10.1203/01.PDR.0000141988.89820.E3; Naumburg E, 2002, ACTA PAEDIATR, V91, P1328, DOI 10.1080/08035250216105; Paneth N, 2005, J PEDIATR-US, V147, P4, DOI 10.1016/j.jpeds.2005.04.058; RAMJI S, 1993, PEDIATR RES, V34, P809, DOI 10.1203/00006450-199312000-00023; ROOTWELT T, 1992, PEDIATR RES, V32, P107, DOI 10.1203/00006450-199207000-00021; Saugstad OD, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e1; SAUGSTAD OD, 1980, EUR SURG RES, V12, P123, DOI 10.1159/000128117; SAUGSTAD OD, 1975, PEDIATR RES, V9, P158, DOI 10.1203/00006450-197504000-00002; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Sejersted Y, 2009, PEDIATR RES, V66, P533, DOI 10.1203/PDR.0b013e3181ba1a42; Solberg R, 2007, PEDIATR RES, V62, P559, DOI 10.1203/PDR.0b013e318156e8aa; Spector LG, 2005, J PEDIATR-US, V147, P27, DOI 10.1016/j.jpeds.2005.03.008; Tarnow-Mordi WO, 1998, LANCET, V352, P341, DOI 10.1016/S0140-6736(05)60464-3; Vento M, 2005, AM J RESP CRIT CARE, V172, P1393, DOI 10.1164/rccm.200412-1740OC; Wang CL, 2008, PEDIATRICS, V121, P1083, DOI 10.1542/peds.2007-1460; *WHO, 1997, BAS NEWB RES PRACT G	23	60	61	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 11	2010	376	9757					1970	1971		10.1016/S0140-6736(10)60543-0	http://dx.doi.org/10.1016/S0140-6736(10)60543-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	20663546				2022-12-24	WOS:000285807700008
J	Grandjean, P				Grandjean, Philippe			Even low-dose lead exposure is hazardous	LANCET			English	Editorial Material									[Grandjean, Philippe] Univ So Denmark, Odense, Denmark; [Grandjean, Philippe] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA	University of Southern Denmark; Harvard University; Harvard T.H. Chan School of Public Health	Grandjean, P (corresponding author), Univ So Denmark, Odense, Denmark.	pgrandjean@health.sdu.dk	Grandjean, Philippe/I-2962-2014	Grandjean, Philippe/0000-0003-4046-9658	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Centers for Disease Control and Prevention, 2005, PREV LEAD POIS YOUNG; European Food Safety Authority, 2010, EFSA J, V8, P1570, DOI [10.2903/j.efsa.2010.1570, DOI 10.2903/J.EFSA.2010.1570]; *JOINT FAO WHO EXP, 2000, EV CERT FOOD ADD CON; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; MARKOWITZ GE, 2002, DECEIT DENIAL DEADLY, P35; *SER FRAUD OFF, 2010, INN LTD PROS CORR SF	6	68	68	1	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2010	376	9744					855	856		10.1016/S0140-6736(10)60745-3	http://dx.doi.org/10.1016/S0140-6736(10)60745-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653DW	20833288				2022-12-24	WOS:000282069100009
J	Rothberg, MB; Sivalingam, SK; Ashraf, J; Visintainer, P; Joelson, J; Kleppel, R; Vallurupalli, N; Schweiger, MJ				Rothberg, Michael B.; Sivalingam, Senthil K.; Ashraf, Javed; Visintainer, Paul; Joelson, John; Kleppel, Reva; Vallurupalli, Neelima; Schweiger, Marc J.			Patients' and Cardiologists' Perceptions of the Benefits of Percutaneous Coronary Intervention for Stable Coronary Disease	ANNALS OF INTERNAL MEDICINE			English	Article							OPTIMAL MEDICAL THERAPY; ARTERY-DISEASE; AD-HOC; INFORMED-CONSENT; ANGIOPLASTY; SURGERY; RISKS; TRIAL; REVASCULARIZATION; PCI	Background: It is unclear whether patients understand that percutaneous coronary intervention (PCI) reduces only chronic stable angina and not myocardial infarction (MI) or associated mortality. Objective: To compare cardiologists' and patients' beliefs about PCI. Design: Survey. Setting: Academic center. Participants: 153 patients who consented to elective coronary catheterization and possible PCI, 10 interventional cardiologists, and 17 referring cardiologists. Measurements: Patients' and cardiologists' beliefs about benefits of PCI. All cardiologists reported beliefs about PCI for patients in hypothetical scenarios. Interventional cardiologists also reported beliefs for study patients who underwent PCI. Results: Of 153 patients, 68% had any angina, 42% had activity-limiting angina, 77% had a positive stress test result, and 29% had had previous MI. The 53 patients who underwent PCI were more likely than those who did not to have a positive stress test result, but angina was similar in both groups. Almost three quarters of patients thought that without PCI, they would probably have MI within 5 years, and 88% believed that PCI would reduce risk for MI. Patients were more likely than physicians to believe that PCI would prevent MI (prevalence ratio, 4.25 [95% CI, 2.31 to 7.79]) or fatal MI (prevalence ratio, 4.83 [CI, 2.23 to 10.46]). Patients were less likely than their physicians to report pre-PCI angina (prevalence ratio, 0.79 [CI, 0.67 to 0.92]). For the scenarios, 63% of cardiologists believed that the benefits of PCI were limited to symptom relief. Of cardiologists who identified no benefit of PCI in 2 scenarios, 43% indicated that they would still proceed with PCI in these cases. Limitation: The study was small and conducted at 1 center, and information about precatheterization counseling was limited. Conclusion: Cardiologists' beliefs about PCI reflect trial results, but patients' beliefs do not. Discussions with patients before PCI should better explain anticipated benefits.	[Rothberg, Michael B.] Baystate Med Ctr, Dept Med, Div Gen Med & Geriatr, Springfield, MA 01199 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Baystate Medical Center; Tufts University	Rothberg, MB (corresponding author), Baystate Med Ctr, Dept Med, Div Gen Med & Geriatr, 759 Chestnut St, Springfield, MA 01199 USA.	Michael.Rothberg@bhs.org		Visintainer, Paul/0000-0002-2491-1242				APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Arnold SV, 2008, CIRC-CARDIOVASC QUAL, V1, P21, DOI 10.1161/CIRCOUTCOMES.108.791863; Blankenship JC, 2000, CATHETER CARDIO INTE, V49, P130, DOI 10.1002/(SICI)1522-726X(200002)49:2<130::AID-CCD3>3.3.CO;2-K; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Feldman DN, 2007, AM J CARDIOL, V99, P446, DOI 10.1016/j.amjcard.2006.09.093; Fleiss JL, 2013, STAT METHODS RATES P; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Habib SB, 2008, J VASC INTERV RADIOL, V19, P177, DOI 10.1016/j.jvir.2007.10.016; Holmboe ES, 2000, J GEN INTERN MED, V15, P632, DOI 10.1046/j.1525-1497.2000.90823.x; Hueb W, 2007, CIRCULATION, V115, P1082, DOI 10.1161/CIRCULATIONAHA.106.625475; Katritsis DG, 2005, CIRCULATION, V111, P2906, DOI 10.1161/CIRCULATIONAHA.104.521864; Kee F, 1997, QUAL HEALTH CARE, V6, P131, DOI 10.1136/qshc.6.3.131; Krone RJ, 2006, CATHETER CARDIO INTE, V68, P696, DOI 10.1002/ccd.20910; Larobina ME, 2007, ANZ J SURG, V77, P530, DOI 10.1111/j.1445-2197.2007.04143.x; Le Feuvre Claude, 2003, J Interv Cardiol, V16, P195, DOI 10.1034/j.1600-0854.2003.8045.x; Lin GA, 2008, J GEN INTERN MED, V23, P1458, DOI 10.1007/s11606-008-0706-x; Lin GA, 2007, ARCH INTERN MED, V167, P1604, DOI 10.1001/archinte.167.15.1604; Lucas FL, 2008, CIRCULATION, V118, P2797, DOI 10.1161/CIRCULATIONAHA.108.789446; Morgan MW, 2000, J GEN INTERN MED, V15, P685, DOI 10.1046/j.1525-1497.2000.91139.x; Pfisterer M, 2003, JAMA-J AM MED ASSOC, V289, P1117, DOI 10.1001/jama.289.9.1117; Rahilly-Tierney CR, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-28; Ravdin PM, 1998, J CLIN ONCOL, V16, P515, DOI 10.1200/JCO.1998.16.2.515; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Siegel C, 2008, INFLAMM BOWEL DIS, V14, P1, DOI 10.1002/ibd.20283; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771; Whittle J, 2007, AM HEART J, V154, P662, DOI 10.1016/j.ahj.2007.04.065	27	134	137	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 7	2010	153	5					307	U55		10.7326/0003-4819-153-5-201009070-00005	http://dx.doi.org/10.7326/0003-4819-153-5-201009070-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647GF	20820040				2022-12-24	WOS:000281605500004
J	Kerr, DJ; Midgley, R				Kerr, David J.; Midgley, Rachel			Can We Treat Cancer for a Dollar a Day? Guidelines for Low-Income Countries	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kerr, David J.] Sidra Med & Res Ctr, Doha, Qatar; [Midgley, Rachel] Univ Oxford, Dept Clin Pharmacol, Oxford, England	Sidra Medical & Research Center; University of Oxford	Kerr, DJ (corresponding author), Sidra Med & Res Ctr, Doha, Qatar.			Kerr, Rachel/0000-0002-7240-3269				CanTreat Int, 2010, ANN ONCOL, V21, P680, DOI 10.1093/annonc/mdq055; Groot MT, 2006, BREAST J, V12, pS81, DOI 10.1111/j.1075-122X.2006.00206.x; Kerr F, 2006, ANN ONCOL, V17, P1730, DOI 10.1093/annonc/mdl442; Lingwood RJ, 2008, NAT REV CANCER, V8, P398, DOI 10.1038/nrc2372; Tan-Torres ET, 2003, MAKING CHOICES HLTH	5	43	44	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2010	363	9					801	803		10.1056/NEJMp1002812	http://dx.doi.org/10.1056/NEJMp1002812			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	642HG	20818843				2022-12-24	WOS:000281196600001
J	Lee, WL; Slutsky, AS				Lee, Warren L.; Slutsky, Arthur S.			Sepsis and Endothelial Permeability	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Warren L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; Univ Toronto, Div Respirol, Toronto, ON, Canada; Univ Toronto, Div Crit Care Med, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Lee, WL (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, 30 Bond St, Toronto, ON M5B 1W8, Canada.		Slutsky, Arthur/M-3325-2019	Lee, Warren/0000-0002-1788-6587				Groger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005391; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Russell JA, 2006, NEW ENGL J MED, V355, P2267; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393	5	336	367	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					689	691		10.1056/NEJMcibr1007320	http://dx.doi.org/10.1056/NEJMcibr1007320			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636TN	20818861				2022-12-24	WOS:000280764600016
J	Schirmer, A; Rude, MA; Li, XZ; Popova, E; del Cardayre, SB				Schirmer, Andreas; Rude, Mathew A.; Li, Xuezhi; Popova, Emanuela; del Cardayre, Stephen B.			Microbial Biosynthesis of Alkanes	SCIENCE			English	Article							RIBONUCLEOTIDE REDUCTASE; HYDROCARBONS; ALGAE; ACID; GENE	Alkanes, the major constituents of gasoline, diesel, and jet fuel, are naturally produced by diverse species; however, the genetics and biochemistry behind this biology have remained elusive. Here we describe the discovery of an alkane biosynthesis pathway from cyanobacteria. The pathway consists of an acyl-acyl carrier protein reductase and an aldehyde decarbonylase, which together convert intermediates of fatty acid metabolism to alkanes and alkenes. The aldehyde decarbonylase is related to the broadly functional nonheme diiron enzymes. Heterologous expression of the alkane operon in Escherichia coli leads to the production and secretion of C13 to C17 mixtures of alkanes and alkenes. These genes and enzymes can now be leveraged for the simple and direct conversion of renewable raw materials to fungible hydrocarbon fuels.	[Schirmer, Andreas; Rude, Mathew A.; Li, Xuezhi; Popova, Emanuela; del Cardayre, Stephen B.] LS9 Inc, San Francisco, CA 94080 USA		Schirmer, A (corresponding author), LS9 Inc, 600 Gateway Blvd, San Francisco, CA 94080 USA.	aschirmer@ls9.com			LS9, Inc.	LS9, Inc.	We thank M. Alibhai for homology modeling, S. Brubaker for bioinformatics work, T. Baron for technical assistance, and C. Chang for help with preparing Fig. 3. The patent applications WO 2009/140695 and WO 2009/140696 are relevant to this paper. All authors have a financial interest in LS9, Inc. We would like to dedicate this paper to the memory of C. Richard Hutchinson, who died on 5 January 2010. "Hutch" was an important mentor for A.S. and S.B.d.C. He will be missed.	Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Dembitsky VM, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1276, DOI 10.1023/A:1021309623541; DENNIS M, 1992, P NATL ACAD SCI USA, V89, P5306, DOI 10.1073/pnas.89.12.5306; Doan TTP, 2009, J PLANT PHYSIOL, V166, P787, DOI 10.1016/j.jplph.2008.10.003; FEHLER SWG, 1970, BIOCHEMISTRY-US, V9, P418, DOI 10.1021/bi00804a032; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Ladygina N, 2006, PROCESS BIOCHEM, V41, P1001, DOI 10.1016/j.procbio.2005.12.007; MCINNES AG, 1980, LIPIDS, V15, P609, DOI 10.1007/BF02534009; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; Muller J, 2002, BIOCHEMISTRY-US, V41, P42, DOI 10.1021/bi015668k; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Regalbuto JR, 2009, SCIENCE, V325, P822, DOI 10.1126/science.1174581; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; SHIEA J, 1990, ORG GEOCHEM, V15, P223, DOI 10.1016/0146-6380(90)90001-G; Strobel GA, 2008, MICROBIOL-SGM, V154, P3319, DOI 10.1099/mic.0.2008/022186-0; Stubbe J, 1998, TRENDS BIOCHEM SCI, V23, P438, DOI 10.1016/S0968-0004(98)01296-1; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; TORNABENE TG, 1982, EXPERIENTIA, V38, P43, DOI 10.1007/BF01944525; Wackett LP, 2007, APPL ENVIRON MICROB, V73, P7192, DOI 10.1128/AEM.01785-07; WINTERS K, 1969, SCIENCE, V163, P467, DOI 10.1126/science.163.3866.467; Wu CH, 2007, BIOCHEMISTRY-US, V46, P11577, DOI 10.1021/bi7012454	25	719	804	11	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					559	562		10.1126/science.1187936	http://dx.doi.org/10.1126/science.1187936			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671186				2022-12-24	WOS:000280483500035
J	He, XA; Szewczyk, P; Karyakin, A; Evin, M; Hong, WX; Zhang, QH; Chang, G				He, Xiao; Szewczyk, Paul; Karyakin, Andrey; Evin, Mariah; Hong, Wen-Xu; Zhang, Qinghai; Chang, Geoffrey			Structure of a cation-bound multidrug and toxic compound extrusion transporter	NATURE			English	Article							ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; DIFFRACTION DATA; NMR SYSTEM; PROTEIN; DATABASE; FAMILY; MODEL; CRYSTALLOGRAPHY; SUPERFAMILY	Transporter proteins from the MATE (multidrug and toxic compound extrusion)(1) family are vital in metabolite transport in plants(2,3), directly affecting crop yields worldwide(4). MATE transporters also mediate multiple-drug resistance (MDR) in bacteria and mammals(5), modulating the efficacy of many pharmaceutical drugs used in the treatment of a variety of diseases(6-9). MATE transporters couple substrate transport to electrochemical gradients and are the only remaining class of MDR transporters whose structure has not been determined(10). Here we report the X-ray structure of the MATE transporter NorM from Vibrio cholerae determined to 3.65 angstrom, revealing an outward-facing conformation with two portals open to the outer leaflet of the membrane and a unique topology of the predicted 12 transmembrane helices distinct from any other known MDR transporter. We also report a cation-binding site in close proximity to residues previously deemed critical for transport(11). This conformation probably represents a stage of the transport cycle with high affinity for monovalent cations and low affinity for substrates.	[He, Xiao; Szewczyk, Paul; Karyakin, Andrey; Evin, Mariah; Hong, Wen-Xu; Zhang, Qinghai; Chang, Geoffrey] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Chang, G (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,CB105, La Jolla, CA 92037 USA.	gchang@scripps.edu	Hong, Wen-Xu/H-5021-2014	Hong, Wen-Xu/0000-0003-0260-1099	National Institutes of Health [GM70480, GM73197]; Beckman Foundation; Skaggs Chemical Biology Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070480, P50GM073197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; Skaggs Chemical Biology Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Yin for his contribution to initial clones of NorM. We also thank the Canadian Light Source (CLS), the Stanford Synchrotron Radiation Laboratory (SSRL), the Advanced Light Source (ALS) and the Advanced Photon Source (APS). This work was supported by grants from the National Institutes of Health (GM70480 to G.C., and GM73197 to Q.Z.), the Beckman Foundation and the Skaggs Chemical Biology Foundation.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Becker MSL, 2009, DIABETES, V58, P745, DOI 10.2337/db08-1028; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaatz GW, 2005, ANTIMICROB AGENTS CH, V49, P1857, DOI 10.1128/AAC.49.5.1857-1864.2005; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Leslie A, 1992, NEWSLETTER PROTEIN C; Li XZ, 2003, ANTIMICROB AGENTS CH, V47, P27, DOI 10.1128/AAC.47.1.27-33.2003; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; Morita M, 2009, P NATL ACAD SCI USA, V106, P2447, DOI 10.1073/pnas.0812512106; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Otsuka M, 2005, J BACTERIOL, V187, P1552, DOI 10.1128/JB.187.5.1552-1558.2005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SACK JS, 1988, J MOL GRAPHICS, V6, P224, DOI 10.1016/S0263-7855(98)80040-4; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tsuda M, 2009, MOL PHARMACOL, V75, P1280, DOI 10.1124/mol.109.056242; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Wood S., 2000, PILOT ANAL GLOBAL EC, V12; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhang QH, 2007, ANGEW CHEM INT EDIT, V46, P7023, DOI 10.1002/anie.200701556; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	37	205	213	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 21	2010	467	7318					991	U139		10.1038/nature09408	http://dx.doi.org/10.1038/nature09408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668FT	20861838	Green Accepted			2022-12-24	WOS:000283254700044
J	Kranendijk, M; Struys, EA; van Schaftingen, E; Gibson, KM; Kanhai, WA; van der Knaap, MS; Amiel, J; Buist, NR; Das, AM; de Klerk, JB; Feigenbaum, AS; Grange, DK; Hofstede, FC; Holme, E; Kirk, EP; Korman, SH; Morava, E; Morris, A; Smeitink, J; Sukhai, RN; Vallance, H; Jakobs, C; Salomons, GS				Kranendijk, Martijn; Struys, Eduard A.; van Schaftingen, Emile; Gibson, K. Michael; Kanhai, Warsha A.; van der Knaap, Marjo S.; Amiel, Jeanne; Buist, Neil R.; Das, Anibh M.; de Klerk, Johannis B.; Feigenbaum, Annette S.; Grange, Dorothy K.; Hofstede, Floris C.; Holme, Elisabeth; Kirk, Edwin P.; Korman, Stanley H.; Morava, Eva; Morris, Andrew; Smeitink, Jan; Sukhai, Ram N.; Vallance, Hilary; Jakobs, Cornelis; Salomons, Gajja S.			IDH2 Mutations in Patients with D-2-Hydroxyglutaric Aciduria	SCIENCE			English	Article									[Kranendijk, Martijn; Struys, Eduard A.; Kanhai, Warsha A.; Jakobs, Cornelis; Salomons, Gajja S.] Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Metab Unit, NL-1081 HV Amsterdam, Netherlands; [van Schaftingen, Emile] Catholic Univ Louvain, de Duve Inst, Lab Phys Chem, Louvain, Belgium; [Gibson, K. Michael] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Med Ctr Amsterdam, Dept Child Neurol, Amsterdam, Netherlands; [Amiel, Jeanne] Univ Paris 05, Hop Necker, Dept Genet, Paris, France; [Amiel, Jeanne] Univ Paris 05, Hop Necker, INSERM, U781, Paris, France; [Buist, Neil R.] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR USA; [Buist, Neil R.] Oregon Hlth & Sci Univ, Dept Med Genet, Portland, OR USA; [Das, Anibh M.] Hannover Med Sch, Hannover, Germany; [de Klerk, Johannis B.] ErasmusMC Sophia Childrens Hosp, Dept Metab Dis, Rotterdam, Netherlands; [Feigenbaum, Annette S.] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON, Canada; [Feigenbaum, Annette S.] Univ Toronto, Toronto, ON, Canada; [Grange, Dorothy K.] Washington Univ, Sch Med, St Louis Childrens Hosp, Dept Pediat,Div Genet & Genom Med, St Louis, MO USA; [Hofstede, Floris C.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Metab Dis, Utrecht, Netherlands; [Holme, Elisabeth] Univ Gothenburg, Sahlgrenska Univer Hosp, Dept Clin Chem & Transfus Med, Gothenburg, Sweden; [Kirk, Edwin P.] Sydney Childrens Hosp, Dept Med Genet, Sydney, NSW, Australia; [Korman, Stanley H.] Hadassah Hebrew Univ, Med Ctr, Dept Human Genet & Metab Dis, Jerusalem, Israel; [Morava, Eva] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Morris, Andrew] Children Natl Hlth Serv Trust, Great Ormond St Hosp, London, England; [Smeitink, Jan] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, NL-6500 HB Nijmegen, Netherlands; [Sukhai, Ram N.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Vallance, Hilary] Univ British Columbia, BC Childrens Hosp, Dept Pathol & Lab Med, Vancouver, BC, Canada	Vrije Universiteit Amsterdam; Universite Catholique Louvain; Michigan Technological University; Vrije Universiteit Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Oregon Health & Science University; Oregon Health & Science University; Hannover Medical School; Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; St. Louis Children's Hospital; Washington University (WUSTL); Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of Gothenburg; University of Sydney; Hebrew University of Jerusalem; Hadassah University Medical Center; Radboud University Nijmegen; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; BC Childrens Hospital; University of British Columbia	Jakobs, C (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Metab Unit, NL-1081 HV Amsterdam, Netherlands.	c.jakobs@vumc.nl	amiel, jeanne/H-3501-2017; amiel, jeanne/AGX-1124-2022; Morava, E./L-4529-2015; Smeitink, Jan/C-1351-2013; Van+Schaftingen, Emile/AAF-5532-2020	amiel, jeanne/0000-0001-5973-4728; Vallance, Hilary/0000-0003-1734-1445; Kirk, Edwin/0000-0002-4662-0024; Van Schaftingen, Emile/0000-0002-6199-7647				Aghili M, 2009, J NEURO-ONCOL, V91, P233, DOI 10.1007/s11060-008-9706-2; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Kranendijk M, 2010, HUM MUTAT, V31, P279, DOI 10.1002/humu.21186; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Steenweg ME, 2010, HUM MUTAT, V31, P380, DOI 10.1002/humu.21197; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Struys EA, 2004, FEBS LETT, V557, P115, DOI 10.1016/S0014-5793(03)01459-5; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	9	145	183	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 15	2010	330	6002					336	336		10.1126/science.1192632	http://dx.doi.org/10.1126/science.1192632			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664TY	20847235				2022-12-24	WOS:000282986700031
J	DeKosky, ST; Ikonomovic, MD; Gandy, S				DeKosky, Steven T.; Ikonomovic, Milos D.; Gandy, Sam			Traumatic Brain Injury -- Football, Warfare, and Long-Term Effects.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[DeKosky, Steven T.] Univ Virginia, Sch Med, Dept Neurol, Charlottesville, VA 22908 USA; [Ikonomovic, Milos D.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Ikonomovic, Milos D.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15261 USA; [Ikonomovic, Milos D.] VA Pittsburgh Healthcare Syst, Geriatr Res Edu & Clin Ctr, Pittsburgh, PA USA; [Gandy, Sam] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Gandy, Sam] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Gandy, Sam] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, New York, NY USA; [Gandy, Sam] James J Peters VA Med Ctr, New York, NY USA	University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	DeKosky, ST (corresponding author), Univ Virginia, Sch Med, Dept Neurol, Charlottesville, VA 22908 USA.			DeKosky, Steven/0000-0003-3743-2758	NATIONAL INSTITUTE ON AGING [P01AG010491] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG010491, P01 AG010491-14] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abrahamson EE, 2009, ANN NEUROL, V66, P407, DOI 10.1002/ana.21731; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED	5	233	236	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2010	363	14					1293	1296		10.1056/NEJMp1007051	http://dx.doi.org/10.1056/NEJMp1007051			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	655TD	20879875				2022-12-24	WOS:000282271500001
J	Charlot, M; Ahlehoff, O; Norgaard, ML; Jorgensen, CH; Sorensen, R; Abildstrom, SZ; Hansen, PR; Madsen, JK; Kober, L; Torp-Pedersen, C; Gislason, G				Charlot, Mette; Ahlehoff, Ole; Norgaard, Mette Lykke; Jorgensen, Casper H.; Sorensen, Rikke; Abildstrom, Steen Z.; Hansen, Peter Riis; Madsen, Jan Kyst; Kober, Lars; Torp-Pedersen, Christian; Gislason, Gunnar			Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use A Nationwide Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; MORTALITY; VALIDITY; ASPIRIN	Background: Controversy remains on whether the dual use of clopidogrel and proton-pump inhibitors (PPIs) affects clinical efficacy of clopidogrel. Objective: To examine the risk for adverse cardiovascular outcomes related to concomitant use of PPIs and clopidogrel compared with that of PPIs alone in adults hospitalized for myocardial infarction. Design: A nationwide cohort study based on linked administrative registry data. Setting: All hospitals in Denmark. Patients: All patients discharged after first-time myocardial infarction from 2000 to 2006. Measurements: The primary outcome was a composite of re-hospitalization for myocardial infarction or stroke or cardiovascular death. Patients were examined at several assembly time points, including 7, 14, 21, and 30 days after myocardial infarction. Follow-up was 1 year. Results: Of 56 406 included patients, 9137 (16.2%) were re-hospitalized for myocardial infarction or stroke or experienced cardiovascular death. Of the 24 702 patients (43.8%) who received clopidogrel, 6753 (27.3%) received concomitant PPIs. The hazard ratio for cardiovascular death or rehospitalization for myocardial infarction or stroke for concomitant use of a PPI and clopidogrel among the cohort assembled at day 30 after discharge was 1.29 (95% CI, 1.17 to 1.42). The corresponding ratio for use of a PPI in patients who did not receive clopidogrel was 1.29 (CI, 1.21 to 1.37). No statistically significant interaction occurred between a PPI and clopidogrel (P = 0.72). Limitations: Unmeasured and residual confounding, time-varying measurement errors of exposure, and biases from survival effects were possible. Conclusion: Proton-pump inhibitors seem to be associated with increased risk for adverse cardiovascular outcomes after discharge, regardless of clopidogrel use for myocardial infarction. Dual PPI and clopidogrel use was not associated with any additional risk for adverse cardiovascular events over that observed for patients prescribed a PPI alone.	[Charlot, Mette] Univ So Denmark, Copenhagen, Denmark; [Charlot, Mette] Copenhagen Univ Hosp Rigshosp, Copenhagen, Denmark	University of Southern Denmark; Rigshospitalet; University of Copenhagen	Charlot, M (corresponding author), Copenhagen Univ Hosp Gentofte, Dept Cardiol, Natl Inst Publ Hlth, Post 67,Niels Andersens Vej 65, DK-2900 Hellerup, Denmark.	mc@heart.dk	Hansen, Peter Riis/AAR-7659-2020; Torp-Pedersen, Christian/E-5931-2013; Gislason, Gunnar/B-7561-2009	Gislason, Gunnar/0000-0002-0548-402X; Hansen, Peter Riis/0000-0002-9056-535X; Sorensen, Rikke/0000-0001-9238-6681; Kober, Lars/0000-0002-6635-1466	Danish Medical Research Council [271-06-0572]; Danish Heart Foundation [10-04-R78-A2865-22586]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Heart Foundation	By the Danish Medical Research Council (grant 271-06-0572) and the Danish Heart Foundation (grant 10-04-R78-A2865-22586).	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; BHATT DL, 2010, PROSPECTIVE RANDOMIZ; Dunn SP, 2008, CIRCULATION, V118, pS815; *EUR MED AG, 2010, PUBL STAT POSS INT; Gaist D, 1997, DAN MED BULL, V44, P445; Gilard M, 2006, J THROMB HAEMOST, V4, P2508, DOI 10.1111/j.1538-7836.2006.02162.x; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Gislason GH, 2006, CIRCULATION, V113, P2906, DOI 10.1161/CIRCULATIONAHA.106.616219; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Ishizaki T, 1999, ALIMENT PHARM THERAP, V13, P27; JUURLINK DN, 2009, JAMA PMID, V301, P937; Krarup LH, 2007, NEUROEPIDEMIOLOGY, V28, P150, DOI 10.1159/000102143; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Rasmussen S, 2005, MED CARE, V43, P970, DOI 10.1097/01.mlr.0000178195.07110.d3; Rassen JA, 2009, CIRCULATION, V120, P2322, DOI 10.1161/CIRCULATIONAHA.109.873497; Ray WA, 2010, ANN INTERN MED, V152, P337, DOI 10.7326/0003-4819-152-6-201003160-00003; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Sorensen R, 2008, BRIT J CLIN PHARMACO, V66, P875, DOI 10.1111/j.1365-2125.2008.03284.x; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; *US FDA, 2010, EARL COMM ONG SAF RE; Varenhorst C, 2009, EUR HEART J, V30, P1744, DOI 10.1093/eurheartj/ehp157; Yasuda H, 2009, INTERNAL MED, V48, P1725, DOI 10.2169/internalmedicine.48.2031; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zuern CS, 2010, THROMB RES, V125, pE51, DOI 10.1016/j.thromres.2009.08.016	27	207	214	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2010	153	6					378	386		10.7326/0003-4819-153-6-201009210-00005	http://dx.doi.org/10.7326/0003-4819-153-6-201009210-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652WY	20855802				2022-12-24	WOS:000282043100004
J	Pelliccia, A; Corrado, D				Pelliccia, Antonio; Corrado, Domenico			Can electrocardiographic screening prevent sudden death in athletes? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSENSUS STATEMENT; OF-CARDIOLOGY; CARDIAC DEATH; PROGRAM		[Pelliccia, Antonio] Italian Natl Olymp Comm, Inst Sports Med & Sci, I-00197 Rome, Italy; [Corrado, Domenico] Univ Padua, Sch Med, Dept Cardiac Thorac & Vasc Sci, I-35128 Padua, Italy	University of Padua	Pelliccia, A (corresponding author), Italian Natl Olymp Comm, Inst Sports Med & Sci, Largo Piero Gabrielli, 1, I-00197 Rome, Italy.	ant.pelliccia@libero.it		CORRADO, DOMENICO/0000-0003-1487-0392				Baggish AL, 2010, ANN INTERN MED, V152, P269, DOI 10.7326/0003-4819-152-5-201003020-00004; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Corrado D, 2008, J AM COLL CARDIOL, V52, P1981, DOI 10.1016/j.jacc.2008.06.053; Lawless CE, 2008, MED SCI SPORT EXER, V40, P787, DOI 10.1249/MSS.0b013e318164dd18; Ljungqvist A, 2009, BRIT J SPORT MED, V43, P631, DOI 10.1136/bjsm.2009.064394; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Pelliccia A, 2007, EUR HEART J, V28, P2703, DOI 10.1093/eurheartj/ehm455; Pelliccia A, 2006, EUR HEART J, V27, P2196, DOI 10.1093/eurheartj/ehl137; Wheeler MT, 2010, ANN INTERN MED, V152, P276, DOI 10.7326/0003-4819-152-5-201003020-00005	10	17	18	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 14	2010	341								c4923	10.1136/bmj.c4923	http://dx.doi.org/10.1136/bmj.c4923			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	653LK	20841394				2022-12-24	WOS:000282092600003
J	Moynihan, R				Moynihan, Ray			Prediseases Who benefits from treating prehypertension?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Moynihan, Ray] Univ Newcastle, Newcastle, NSW 2300, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Newcastle, NSW 2300, Australia.	ray.moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					*AM SOC HYP, 1986, 2010 ANN SCI M EXP 2; ARMSTRONG D, 1995, SOCIOL HEALTH ILL, V17, P393, DOI 10.1111/1467-9566.ep10933329; BARKIS G, J CLIN HYPE IN PRESS; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Meltzer JI, 2006, AM J HYPERTENS, V19, P1098, DOI 10.1016/j.amjhyper.2006.09.014; *NAT HEART LUNG BL, 7 JOINT NAT COMM PRE; *PREH CARD SYNDR I, 2010, SPONS EXH PROSP	8	12	12	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2010	341								c4442	10.1136/bmj.c4442	http://dx.doi.org/10.1136/bmj.c4442			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645IG	20736255				2022-12-24	WOS:000281445900025
J	Johannes, L; Mayor, S				Johannes, Ludger; Mayor, Satyajit			Induced Domain Formation in Endocytic Invagination, Lipid Sorting, and Scission	CELL			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; MEDIATED ENDOCYTOSIS; CURVATURE; ACTIN; VESICLES; DRIVEN; REORGANIZATION; CELL	Lipid segregation occurs in biological membranes, but how this plays into cellular processes like endocytosis has been unclear. Here, we discuss how the active or passive induction of lipid-protein domain formation in membranes can alter membrane mechanics and thus affect processes such as the generation of curvature, the scission of buds and tubules, and lipid sorting.	[Johannes, Ludger] Inst Curie, Ctr Rech, Traff Signaling & Delivery Lab, F-75248 Paris 05, France; [Johannes, Ludger] CNRS, UMR144, F-75700 Paris, France; [Mayor, Satyajit] Natl Ctr Biol Sci, Cellular Org & Signaling Grp, Bangalore 560065, Karnataka, India	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Johannes, L (corresponding author), Inst Curie, Ctr Rech, Traff Signaling & Delivery Lab, F-75248 Paris 05, France.	johannes@curie.fr; mayor@ncbs.res.in	Johannes, Ludger/M-9778-2017; Johannes, Ludger/W-8593-2019	Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004	Human Frontier Science Program; Indo-French Centre for the Promotion of Advanced Research (CEFIPRA) [3803]	Human Frontier Science Program(Human Frontier Science Program); Indo-French Centre for the Promotion of Advanced Research (CEFIPRA)(French National Research Agency (ANR))	We thank Patricia Bassereau, Madan Rao, Robert Parton, Pierre Sens, Winfried Romer, and Christophe Lamaze for stimulating discussions. The authors are supported by the Human Frontier Science Program and a grant from the Indo-French Centre for the Promotion of Advanced Research (CEFIPRA Project No. 3803).	Allain JM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158104; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chiantia S, 2007, LANGMUIR, V23, P7659, DOI 10.1021/la7010919; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Idrissi FZ, 2008, J CELL BIOL, V180, P1219, DOI 10.1083/jcb.200708060; Johannes L, 2002, TRAFFIC, V3, P443, DOI 10.1034/j.1600-0854.2002.30701.x; JULICHER F, 1993, PHYS REV LETT, V70, P2964, DOI 10.1103/PhysRevLett.70.2964; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kirchhausen T, 2002, CELL, V109, P413, DOI 10.1016/S0092-8674(02)00751-1; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Roux A, 2008, CELL, V135, P1163, DOI 10.1016/j.cell.2008.12.003; Sarasij RC, 2007, BIOPHYS J, V92, P3140, DOI 10.1529/biophysj.106.085662; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Souza CM, 2007, BBA-MOL CELL BIOL L, V1771, P442, DOI 10.1016/j.bbalip.2006.08.006; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238	42	57	57	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 20	2010	142	4					507	510		10.1016/j.cell.2010.08.007	http://dx.doi.org/10.1016/j.cell.2010.08.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723749	Bronze			2022-12-24	WOS:000281115900002
J	Zhang, APP; Pigli, YZ; Rice, PA				Zhang, Adrianna P. P.; Pigli, Ying Z.; Rice, Phoebe A.			Structure of the LexA-DNA complex and implications for SOS box measurement	NATURE			English	Article							NONCONTACTED BASES; CRYSTAL-STRUCTURE; OPERATOR COMPLEX; BINDING DOMAIN; REPRESSOR; PROTEIN; AFFINITY; IDENTIFICATION; ROTATION; CONTACTS	The eubacterial SOS system is a paradigm of cellular DNA damage and repair, and its activation can contribute to antibiotic resistance(1-3). Under normal conditions, LexA represses the transcription of many DNA repair proteins by binding to SOS 'boxes' in their operators. Under genotoxic stress, accumulating complexes of RecA, ATP and single-stranded DNA (ssDNA) activate LexA for autocleavage. To address how LexA recognizes its binding sites, we determined three crystal structures of Escherichia coli LexA in complex with SOS boxes. Here we report the structure of these LexA-DNA complexes. The DNA-binding domains of the LexA dimer interact with the DNA in the classical fashion of a winged helix-turn-helix motif. However, the wings of these two DNA-binding domains bind to the same minor groove of the DNA. These wing-wing contacts may explain why the spacing between the two half-sites of E. coli SOS boxes is invariant.	[Pigli, Ying Z.; Rice, Phoebe A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Zhang, Adrianna P. P.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Rice, PA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	price@uchicago.edu			National Institutes of Health [GM058827]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Harris and O. Adekeye for help with crystal growth and optimization; Y.-L.C. Leung for advice on DNA-binding assays; S. Montano and other members of the Rice laboratory for help and discussions; the staffs at beamlines BioCARS 14, SBC 19-ID and 19-BM, and LS-CAT 21-ID-F at the Advanced Photon Source, Argonne National Laboratory, for helping with the synchrotron X-ray data collection. The research is supported in part by National Institutes of Health grant GM058827.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Butala M, 2007, FEBS LETT, V581, P4816, DOI 10.1016/j.febslet.2007.09.006; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DUMOULIN P, 1993, P NATL ACAD SCI USA, V90, P2030, DOI 10.1073/pnas.90.5.2030; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Garnett JA, 2008, J MOL BIOL, V379, P284, DOI 10.1016/j.jmb.2008.03.007; Giese KC, 2008, J MOL BIOL, V377, P148, DOI 10.1016/j.jmb.2007.12.025; Groban ES, 2005, NUCLEIC ACIDS RES, V33, P6287, DOI 10.1093/nar/gki939; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; HURSTEL S, 1988, EMBO J, V7, P269, DOI 10.1002/j.1460-2075.1988.tb02809.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KNEGTEL RMA, 1995, PROTEINS, V21, P226, DOI 10.1002/prot.340210305; KOUDELKA GB, 1992, NATURE, V355, P89, DOI 10.1038/355089a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; OERTELBUCHHEIT P, 1990, MOL GEN GENET, V223, P40, DOI 10.1007/BF00315795; OERTELBUCHHEIT P, 1992, J MOL BIOL, V225, P609, DOI 10.1016/0022-2836(92)90389-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Shinagawa H, 1996, EXS, V77, P221; THLIVERIS AT, 1992, P NATL ACAD SCI USA, V89, P4500, DOI 10.1073/pnas.89.10.4500; THLIVERIS AT, 1991, BIOCHIMIE, V73, P449, DOI 10.1016/0300-9084(91)90112-E; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; WALKER GC, 1985, ANNU REV BIOCHEM, V54, P425, DOI 10.1146/annurev.bi.54.070185.002233; WU L, 1992, J BIOL CHEM, V267, P9134	39	70	76	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					883	U119		10.1038/nature09200	http://dx.doi.org/10.1038/nature09200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703307	Green Accepted			2022-12-24	WOS:000280766100040
J	Autier, P; Boniol, M; LaVecchia, C; Vatten, L; Gavin, A; Hery, C; Heanue, M				Autier, Philippe; Boniol, Mathieu; LaVecchia, Carlo; Vatten, Lars; Gavin, Anna; Hery, Clarisse; Heanue, Mary			Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CALMAN-HINE REPORT; RISK-FACTORS; TUMOR CHARACTERISTICS; SCREENING-PROGRAMS; TIME TRENDS; SURVIVAL; IMPACT; WOMEN; RATES; STAGE	Objective To examine changes in temporal trends in breast cancer mortality in women living in 30 European countries. Design Retrospective trend analysis. Data source WHO mortality database on causes of deaths Subjects reviewed Female deaths from breast cancer from 1989 to 2006 Main outcome measures Changes in breast cancer mortality for all women and by age group (<50, 50-69, and >= 70 years) calculated from linear regressions of log transformed, age adjusted death rates. Joinpoint analysis was used to identify the year when trends in all age mortality began to change. Results From 1989 to 2006, there was a median reduction in breast cancer mortality of 19%, ranging from a 45% reduction in Iceland to a 17% increase in Romania. Breast cancer mortality decreased by >= 20% in 15 countries, and the reduction tended to be greater in countries with higher mortality in 1987-9. England and Wales, Northern Ireland, and Scotland had the second, third, and fourth largest decreases of 35%, 29%, and 30%, respectively. In France, Finland, and Sweden, mortality decreased by 11%, 12%, and 16%, respectively. In central European countries mortality did not decline or even increased during the period. Downward mortality trends usually started between 1988 and 1996, and the persistent reduction from 1999 to 2006 indicates that these trends may continue. The median changes in the age groups were -37% (range -76% to -14%) in women aged <50, -21% (-40% to 14%) in 50-69 year olds, and -2% (-42% to 80%) in >= 70 year olds. Conclusions Changes in breast cancer mortality after 1988 varied widely between European countries, and the UK is among the countries with the largest reductions. Women aged <50 years showed the greatest reductions in mortality, also in countries where screening at that age is uncommon. The increasing mortality in some central European countries reflects avoidable mortality.	[Autier, Philippe; Boniol, Mathieu] Int Prevent Res Inst, F-69006 Lyon, France; [Autier, Philippe; Boniol, Mathieu; Hery, Clarisse; Heanue, Mary] Int Agcy Res Canc, F-69372 Lyon, France; [LaVecchia, Carlo] Univ Milan, Mario Negri Inst, Milan, Italy; [LaVecchia, Carlo] Univ Milan, Sch Med, Milan, Italy; [Vatten, Lars] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Gavin, Anna] Queens Univ, No Ireland Canc Registry, Belfast, Antrim, North Ireland	World Health Organization; International Agency for Research on Cancer (IARC); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; University of Milan; Norwegian University of Science & Technology (NTNU); Queens University Belfast	Autier, P (corresponding author), Int Prevent Res Inst, 95 Cours Lafayette, F-69006 Lyon, France.	philippe.autier@i-pri.org	Vatten, Lars/AAF-9380-2022; Autier, Philippe/A-4402-2014; Vatten, Lars/AFK-2073-2022; Boniol, Mathieu/F-9623-2011	Autier, Philippe/0000-0003-1538-5321; Boniol, Mathieu/0000-0003-1052-5604; La Vecchia, Carlo/0000-0003-1441-897X	Public Health Agency for Northern Ireland	Public Health Agency for Northern Ireland	Institutions in which authors work had no influence in the conduct of the research or in the writing of the paper. The work of the Northern Ireland Cancer Registry is funded by the Public Health Agency for Northern Ireland	ABADIE C, 2002, REV MED ASS MALADIE, V33, P267; [Anonymous], 2007, LANCET, V369, P1665, DOI 10.1093/annonc/mdm096; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; AUGUST DA, 1994, ANN SURG ONCOL, V1, P45, DOI 10.1007/BF02303540; Autier P, 2008, BRIT J CANCER, V99, P1185, DOI 10.1038/sj.bjc.6604657; Autier P, 2007, LANCET ONCOL, V8, P1050, DOI 10.1016/S1470-2045(07)70354-6; Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Barnett GC, 2008, J CLIN ONCOL, V26, P3310, DOI 10.1200/JCO.2006.10.3168; Bernardi D, 2008, ACTA ONCOL, V47, P187, DOI 10.1080/02841860701630234; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Bradburn MJ, 1998, BRIT J CANCER, V77, P1944, DOI 10.1038/bjc.1998.322; Burke JP, 2008, EJSO-EUR J SURG ONC, V34, P149, DOI 10.1016/j.ejso.2007.03.025; Chiu C, 2006, CANCER CAUSE CONTROL, V17, P153, DOI 10.1007/s10552-005-2368-x; Coebergh JW, 2008, EUR J CANCER, V44, P1341, DOI 10.1016/j.ejca.2008.04.010; DAY NE, 1989, BRIT J CANCER, V59, P954, DOI 10.1038/bjc.1989.203; Doll R, 1981, CAUSES CANC; Duffy SW, 2006, CANCER EPIDEM BIOMAR, V15, P45, DOI 10.1158/1055-9965.EPI-05-0349; Duffy SW, 2006, CANCER EPIDEM BIOMAR, V15, P52, DOI 10.1158/1055-9965.EPI-05-0953; Eaker S, 2006, PLOS MED, V3, P321, DOI 10.1371/journal.pmed.0030025; *EUR COMM, 2008, CANC SCREEN EUR UN E; Fracheboud J, 2004, BRIT J CANCER, V91, P861, DOI 10.1038/sj.bjc.6602075; Fritsch B, 2007, PRESSE MED, V36, P1712, DOI 10.1016/j.lpm.2007.03.046; Hermon C, 1996, BRIT J CANCER, V73, P955, DOI 10.1038/bjc.1996.171; Hery C, 2008, ANN ONCOL, V19, P1009, DOI 10.1093/annonc/mdm593; Hery C, 2008, ANN ONCOL, V19, P1187, DOI 10.1093/annonc/mdn025; Hofvind S, 2008, ACTA ONCOL, V47, P225, DOI 10.1080/02841860701518041; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Jonsson B, 2007, ANN ONCOL, V18, P1, DOI 10.1093/annonc/mdm095; Jonsson B, 2009, EUR J CANCER, V45, P1100, DOI 10.1016/j.ejca.2009.01.035; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Klug SJ, 2005, EUR J PUBLIC HEALTH, V15, P70, DOI 10.1093/eurpub/cki118; Kumle M, 2008, LANCET, V372, P608, DOI 10.1016/S0140-6736(08)61255-6; Levi F, 2005, EUR J CANCER PREV, V14, P497, DOI 10.1097/00008469-200512000-00002; Lutz JM, 2004, EUR J CANCER PREV, V13, P77, DOI 10.1097/00008469-200402000-00012; Madhavan KS, 2002, BREAST, V11, P265, DOI 10.1054/brst.2001.0410; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; McCann J, 1998, J MED SCREEN, V5, P42, DOI 10.1136/jms.5.1.42; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Micheli A, 2003, ANN ONCOL, V14, pV41, DOI 10.1093/annonc/mdg753; Monaghan P, 2005, J PUBLIC HEALTH, V27, P171, DOI 10.1093/pubmed/fdi003; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Morris E, 2008, ANN ONCOL, V19, P284, DOI 10.1093/annonc/mdm432; Morris E, 2007, EUR J CANCER CARE, V16, P150, DOI 10.1111/j.1365-2354.2006.00723.x; *NAT CANC I, 2009, JOIPOINT REGR PROGR; *NAT EV TEAM BREAS, 2005, NAT EV BREAST CANC S; NYSTROM L, 1995, ACTA ONCOL, V34, P145, DOI 10.3109/02841869509093948; Pisani P, 2004, BRIT J CANCER, V90, P652, DOI 10.1038/sj.bjc.6601614; Ray-Coquard I, 2005, J CLIN ONCOL, V23, P4414, DOI 10.1200/JCO.2005.01.040; Siebel Marisa F, 2005, Curr Oncol Rep, V7, P23, DOI 10.1007/s11912-005-0022-0; Sobotka T, 2003, POPULATION, V58, P511, DOI 10.2307/3271307; Spyckerelle Y, 2002, B CANCER, V89, P957; Sukel MPP, 2008, EUR J CANCER, V44, P1846, DOI 10.1016/j.ejca.2008.06.001; Valentini M, 1999, ANN ONCOL, V10, P789, DOI 10.1023/A:1008355014886; Veronesi U, 2005, LANCET, V365, P1727, DOI 10.1016/S0140-6736(05)66546-4; Vervoort MM, 2004, BRIT J CANCER, V91, P242, DOI 10.1038/sj.bjc.6601969; Waterhouse J., 1976, IARC SCI PUBLICATION, V15; *WOM HLTH COUNC, 2008, BREAT CANC TREATM RE; World Health Organization, 2009, MORT DAT; World Health Organization, 2009, WHO STAT INF SYST; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311; 2007, LANCET ONCOL, V8, P747	62	245	251	2	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2010	341								c3620	10.1136/bmj.c3620	http://dx.doi.org/10.1136/bmj.c3620			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640DR	20702548	Green Published, hybrid			2022-12-24	WOS:000281028900002
J	Conacci-Sorrell, M; Ngouenet, C; Eisenman, RN				Conacci-Sorrell, Maralice; Ngouenet, Celine; Eisenman, Robert N.			Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes alpha-Tubulin Acetylation and Cell Differentiation	CELL			English	Article							C-MYC; IN-VIVO; CYTOSKELETAL ORGANIZATION; ESSENTIAL COFACTOR; SELF-RENEWAL; STEM-CELLS; PROTEIN; CALPAIN; TRANSCRIPTION; INVOLVEMENT	The Myc oncoprotein family comprises transcription factors that control multiple cellular functions and are widely involved in oncogenesis. Here we report the identification of Myc-nick, a cytoplasmic form of Myc generated by calpain-dependent proteolysis at lysine 298 of full-length Myc. Myc-nick retains conserved Myc box regions but lacks nuclear localization signals and the bHLHZ domain essential for heterodimerization with Max and DNA binding. Myc-nick induces alpha-tubulin acetylation and altered cell morphology by recruiting histone acetyltransferase GCN5 to microtubules. During muscle differentiation, while the levels of full-length Myc diminish, Myc-nick and acetylated alpha-tubulin levels are increased. Ectopic expression of Myc-nick accelerates myoblast fusion, triggers the expression of myogenic markers, and permits Myc-deficient fibroblasts to transdifferentiate in response to MyoD. We propose that the cleavage of Myc by calpain abrogates the transcriptional inhibition of differentiation by fulllength Myc and generates Myc-nick, a driver of cytoplasmic reorganization and differentiation.	[Conacci-Sorrell, Maralice; Ngouenet, Celine; Eisenman, Robert N.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Eisenman, RN (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	eisenman@fhcrc.org	Sorrell, Maralice/ABD-6764-2021		EMBO; NIH/NCI [CA20525]; NATIONAL CANCER INSTITUTE [R37CA020525, R01CA020525] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Nao Ikegaki, William Tansey, John Sedivy, and Peter Hurlin for reagents essential for this work. We also thank Stephen Tapscott, Maura Parker, Hector Rincon, Bill Carter, Linda Wordeman, and members of the Eisenman lab for advice and discussion. M.C.-S. was a recipient of an EMBO Long-Term Fellowship. This work was supported by NIH/NCI grant CA20525 (R.N.E.).	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; ALEXANDROVA N, 1995, MOL CELL BIOL, V15, P5188; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; BAI MK, 1994, ONCOLOGY, V51, P314; Calcagno DQ, 2009, ANTICANCER RES, V29, P2479; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Clement CA, 2009, J CELL SCI, V122, P3070, DOI 10.1242/jcs.049676; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Dedieu S, 2004, EXP CELL RES, V292, P187, DOI 10.1016/j.yexcr.2003.08.014; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Gonen H, 1997, FEBS LETT, V406, P17, DOI 10.1016/S0014-5793(97)00225-1; GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Ivanov AI, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-12; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Koch HB, 2007, CELL CYCLE, V6, P205, DOI 10.4161/cc.6.2.3742; KUMAR A, 1992, CELL MOL BIOL, V38, P477; Mailhes John B, 2002, Cell Chromosome, V1, P2, DOI 10.1186/1475-9268-1-2; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Moyen C, 2004, INT J BIOCHEM CELL B, V36, P728, DOI 10.1016/S1357-2725(03)00265-6; Niklinski J, 2000, MOL CELL BIOL, V20, P5276, DOI 10.1128/MCB.20.14.5276-5284.2000; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Okano HJ, 1999, GENE DEV, V13, P2087, DOI 10.1101/gad.13.16.2087; PIETILAINEN T, 1995, ANTICANCER RES, V15, P959; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Small GW, 2002, ARCH BIOCHEM BIOPHYS, V400, P151, DOI 10.1016/S0003-9861(02)00005-X; Spotts GD, 1997, MOL CELL BIOL, V17, P1459, DOI 10.1128/MCB.17.3.1459; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Taira T, 1998, GENES CELLS, V3, P549, DOI 10.1046/j.1365-2443.1998.00206.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Tonami K, 2007, MOL CELL BIOL, V27, P2548, DOI 10.1128/MCB.00992-06; Tworkowski KA, 2002, ONCOGENE, V21, P8515, DOI 10.1038/sj.onc.1205976; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; WAKAMATSU Y, 1993, NEURON, V10, P1, DOI 10.1016/0896-6273(93)90236-K; Wakamatsu Y, 1997, DEVELOPMENT, V124, P1953; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Xiao QR, 1998, GENE DEV, V12, P3803, DOI 10.1101/gad.12.24.3803; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	51	159	163	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					480	493		10.1016/j.cell.2010.06.037	http://dx.doi.org/10.1016/j.cell.2010.06.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691906	Bronze, Green Accepted			2022-12-24	WOS:000280609100024
J	Deahl, M				Deahl, Martin			Service personnel move to NHS mental health inpatient care	LANCET			English	Editorial Material									S Staffordshire & Shropshire NHS Fdn Trust, Stafford ST16 3AG, England		Deahl, M (corresponding author), S Staffordshire & Shropshire NHS Fdn Trust, Stafford ST16 3AG, England.	martindeahl@doctors.org.uk						*CAR QUAL COMM, 2009, MENT HLTH SERV AC IN; Crisp AH, 2000, BRIT J PSYCHIAT, V177, P4, DOI 10.1192/bjp.177.1.4; Iversen A, 2005, BRIT J PSYCHIAT, V186, P480, DOI 10.1192/bjp.186.6.480; *MENT HLTH FDN, 2010, MIL MENT HLTH; *NAT ARCH, DEF NEWS INP ME 1118; *NHS CONF, 2009, DEAL DOWNT GREAT EV; PALMER C, 2010, 2010 MOD PATIENT SAT	7	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 20	2010	376	9754					1717	1719		10.1016/S0140-6736(10)61190-7	http://dx.doi.org/10.1016/S0140-6736(10)61190-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	690EI	20850177				2022-12-24	WOS:000284984900007
J	Rottmann, M; McNamara, C; Yeung, BKS; Lee, MCS; Zou, B; Russell, B; Seitz, P; Plouffe, DM; Dharia, NV; Tan, J; Cohen, SB; Spencer, KR; Gonzalez-Paez, GE; Lakshminarayana, SB; Goh, A; Suwanarusk, R; Jegla, T; Schmitt, EK; Beck, HP; Brun, R; Nosten, F; Renia, L; Dartois, V; Keller, TH; Fidock, DA; Winzeler, EA; Diagana, TT				Rottmann, Matthias; McNamara, Case; Yeung, Bryan K. S.; Lee, Marcus C. S.; Zou, Bin; Russell, Bruce; Seitz, Patrick; Plouffe, David M.; Dharia, Neekesh V.; Tan, Jocelyn; Cohen, Steven B.; Spencer, Kathryn R.; Gonzalez-Paez, Gonzalo E.; Lakshminarayana, Suresh B.; Goh, Anne; Suwanarusk, Rossarin; Jegla, Timothy; Schmitt, Esther K.; Beck, Hans-Peter; Brun, Reto; Nosten, Francois; Renia, Laurent; Dartois, Veronique; Keller, Thomas H.; Fidock, David A.; Winzeler, Elizabeth A.; Diagana, Thierry T.			Spiroindolones, a Potent Compound Class for the Treatment of Malaria	SCIENCE			English	Article							PARASITE PLASMODIUM-FALCIPARUM; CALCIUM-PUMP; DRUG-RESISTANCE; SARCOPLASMIC-RETICULUM; ARTEMISININ; VIVAX; IDENTIFICATION; ANTIMALARIALS; ERADICATION; CHLOROQUINE	Recent reports of increased tolerance to artemisinin derivatives-the most recently adopted class of antimalarials-have prompted a need for new treatments. The spirotetrahydro-beta-carbolines, or spiroindolones, are potent drugs that kill the blood stages of Plasmodium falciparum and Plasmodium vivax clinical isolates at low nanomolar concentration. Spiroindolones rapidly inhibit protein synthesis in P. falciparum, an effect that is ablated in parasites bearing nonsynonymous mutations in the gene encoding the P-type cation-transporter ATPase4 (PfATP4). The optimized spiroindolone NITD609 shows pharmacokinetic properties compatible with once-daily oral dosing and has single-dose efficacy in a rodent malaria model.	[McNamara, Case; Plouffe, David M.; Cohen, Steven B.; Winzeler, Elizabeth A.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Rottmann, Matthias; Seitz, Patrick; Beck, Hans-Peter; Brun, Reto] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Rottmann, Matthias; Seitz, Patrick; Beck, Hans-Peter; Brun, Reto] Univ Basel, CH-4003 Basel, Switzerland; [Yeung, Bryan K. S.; Zou, Bin; Tan, Jocelyn; Lakshminarayana, Suresh B.; Goh, Anne; Dartois, Veronique; Keller, Thomas H.; Diagana, Thierry T.] Novartis Inst Trop Dis, Singapore 138670, Singapore; [Lee, Marcus C. S.; Fidock, David A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Russell, Bruce; Suwanarusk, Rossarin; Renia, Laurent] ASTAR, Singapore Immunol Network, Lab Malaria Immunobiol, Biopolis 138648, Singapore; [Russell, Bruce] Natl Univ Singapore, Dept Microbiol, Singapore 117597, Singapore; [Dharia, Neekesh V.; Spencer, Kathryn R.; Gonzalez-Paez, Gonzalo E.; Winzeler, Elizabeth A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Jegla, Timothy] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Jegla, Timothy] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Schmitt, Esther K.] Novartis Pharma AG, Nat Prod Unit, CH-4002 Basel, Switzerland; [Nosten, Francois] Shoklo Malaria Res Unit, Mae Sot 63110, Tak, Thailand; [Nosten, Francois] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Nosten, Francois] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA	Novartis; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Novartis; Columbia University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Novartis; Mahidol University; Mahidol University; University of Oxford; Columbia University	Winzeler, EA (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	winzeler@scripps.edu; thierry.diagana@novartis.com	Winzeler, Elizabeth/AAP-6752-2020; Renia, Laurent/E-2117-2011; Nosten, Francois/AAC-5509-2019; Suwanarusk, Rossarin/E-2115-2013; Dharia, Neekesh/AAC-1245-2020; Russell, Bruce/A-9240-2011	Winzeler, Elizabeth/0000-0002-4049-2113; Renia, Laurent/0000-0003-0349-1557; Nosten, Francois/0000-0002-7951-0745; Suwanarusk, Rossarin/0000-0002-7310-245X; Dharia, Neekesh/0000-0001-5048-067X; Russell, Bruce/0000-0003-2333-4348; Yeung, Bryan KS/0000-0002-8866-1764; Rottmann, Matthias/0000-0002-2207-7899; Lee, Marcus/0000-0002-4973-0915; Beck, Hans-Peter/0000-0001-8326-4834; Fidock, David/0000-0001-6753-8938; Keller, Thomas/0000-0002-7553-6235; Gonzalez-Paez, Gonzalo/0000-0003-4708-5753; Jegla, Timothy/0000-0001-8616-2390	Fidock laboratory, Medicines for Malaria Venture [MMV08/0015]; Wellcome Trust of Great Britain, Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University; Singapore Immunology Network, A*STAR; Wellcome Trust [WT078285]; Genomics Institute of the Novartis Research Foundation; Swiss Tropical Institute; W. M. Keck Foundation; NIH [R01AI059472]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059472] Funding Source: NIH RePORTER	Fidock laboratory, Medicines for Malaria Venture; Wellcome Trust of Great Britain, Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University(Wellcome Trust); Singapore Immunology Network, A*STAR(Agency for Science Technology & Research (A*STAR)); Wellcome Trust(Wellcome Trust); Genomics Institute of the Novartis Research Foundation; Swiss Tropical Institute; W. M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Matter, M. Tanner, and P. Herrling for their foresight and support in establishing a malaria drug discovery program in the context of a public-private partnership. We thank T. A. Smith (SwissTPH) for the statistical analysis of the stage and rate of action studies. We thank S. Rao (Novartis Institute for Tropical Diseases) and M. Traebert (Novartis-preclinical safety), respectively, for the cytotoxicity and hERG inhibition data. We also thank M. Weaver (Novartis-preclinical safety) for the interpretation of the preclinical toxicology data. The team acknowledges P. Schultz, who had the vision to see the potential of the drug resistance experiments in the exploratory phase. In addition, we are grateful to T. Eastman for providing guidance to establish the in vitro drug-selection protocol and for providing the cloned Dd2 parasites. Finally, the scientific expertise provided by S. E. R. Bopp and S. K. Sharma and their helpful discussions throughout this project are greatly appreciated. Funding for the PfATP4 transfectants was provided to the Fidock laboratory in part by the Medicines for Malaria Venture (MMV08/0015; PI D. Fidock). The Shoklo Malaria Research Unit is sponsored by the Wellcome Trust of Great Britain, as part of the Oxford Tropical Medicine Research Programme of Wellcome Trust-Mahidol University. Laurent Renia's laboratory is supported by a core grant from the Singapore Immunology Network, A*STAR. This work was supported by a grant from the Medicines for Malaria Venture and a translational research grant (WT078285) from the Wellcome Trust to the Novartis Institute for Tropical Diseases, the Genomics Institute of the Novartis Research Foundation and the Swiss Tropical Institute, and by grants to E. A. W. from the W. M. Keck Foundation and the NIH (R01AI059472). NITD609 is described in the Novartis patent application WO2009/132921. All requests for spiroindolones or related compounds are subject to a Material Transfer Agreement. T. H. K. and E. A. W. own shares in Novartis (Switzerland).	AMES BN, 1973, P NATL ACAD SCI USA, V70, P782, DOI 10.1073/pnas.70.3.782; CLARKE DM, 1989, NATURE, V339, P476, DOI 10.1038/339476a0; Dharia NV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r21; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dyer M, 1996, MOL BIOCHEM PARASIT, V78, P1, DOI 10.1016/S0166-6851(96)02593-5; Eastman RT, 2009, NAT REV MICROBIOL, V7, P864, DOI 10.1038/nrmicro2239; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Guthmann JP, 2008, TROP MED INT HEALTH, V13, P91, DOI 10.1111/j.1365-3156.2007.01978.x; Hayton K, 2008, CURR GENET, V54, P223, DOI 10.1007/s00294-008-0214-x; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Krishna S, 2001, J BIOL CHEM, V276, P10782, DOI 10.1074/jbc.M010554200; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lee MCS, 2008, MOL MICROBIOL, V68, P1535, DOI 10.1111/j.1365-2958.2008.06250.x; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nzila A, 2010, J ANTIMICROB CHEMOTH, V65, P390, DOI 10.1093/jac/dkp449; Olliaro P, 2009, CLIN PHARMACOL THER, V85, P584, DOI 10.1038/clpt.2009.51; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Russell BM, 2003, ANTIMICROB AGENTS CH, V47, P170, DOI 10.1128/AAC.47.1.170-173.2003; Sharrock WW, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-94; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Traebert Martin, 2005, Expert Opin Drug Saf, V4, P421, DOI 10.1517/14740338.4.3.421; TROTTEIN F, 1995, GENE, V158, P133, DOI 10.1016/0378-1119(95)00158-3; Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 2007, LANCET INFECT DIS, V7, P549, DOI 10.1016/S1473-3099(07)70187-1; WHITE NJ, 1992, J ANTIMICROB CHEMOTH, V30, P571, DOI 10.1093/jac/30.5.571; *WHO, WORLD MAL REP 2009; Winzeler EA, 2008, NATURE, V455, P751, DOI 10.1038/nature07361; Yatime L, 2009, BBA-BIOENERGETICS, V1787, P207, DOI 10.1016/j.bbabio.2008.12.019	41	892	898	6	434	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2010	329	5996					1175	1180		10.1126/science.1193225	http://dx.doi.org/10.1126/science.1193225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20813948	Green Accepted			2022-12-24	WOS:000281485600027
J	Schnabel, J				Schnabel, Jim			Secrets of the shaking palsy	NATURE			English	Editorial Material							NEURONAL CELL-DEATH; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; LEWY BODIES; TRANSMISSION; PROPAGATION; PATHOLOGY; BRAIN											Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Sulzer D, 2010, MOVEMENT DISORD, V25, pS27, DOI 10.1002/mds.22639; Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009	14	12	13	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					S2	S5		10.1038/466S2b	http://dx.doi.org/10.1038/466S2b			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20739933				2022-12-24	WOS:000281203600058
J	Al-Mohammad, A; Mant, J; Laramee, P; Swain, S				Al-Mohammad, Abdallah; Mant, Jonathan; Laramee, Philippe; Swain, Sharon		Chronic Heart Failure Guideline De	Guidelines Diagnosis and management of adults with chronic heart failure: summary of updated NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Al-Mohammad, Abdallah] Sheffield Teaching Hosp NHS Fdn Trust, S Yorkshire Cardiothorac Ctr, Sheffield S5 7AU, S Yorkshire, England; [Mant, Jonathan] Univ Cambridge, Gen Practice & Primary Care Res Unit, Cambridge CB2 0SR, England; [Laramee, Philippe; Swain, Sharon] Royal Coll Physicians, Natl Clin Guideline Ctr, London NW1 4LE, England	University of Sheffield; University of Cambridge; Royal College of Physicians	Al-Mohammad, A (corresponding author), Sheffield Teaching Hosp NHS Fdn Trust, S Yorkshire Cardiothorac Ctr, Sheffield S5 7AU, S Yorkshire, England.	a.al.mohammad.87@googlemail.com	Al-Mohammad, Abdallah/I-5663-2019; Dawda, Paresh/I-6947-2015	Al-Mohammad, Abdallah/0000-0001-6517-8692; Dawda, Paresh/0000-0003-2727-8320; Foley, Paul/0000-0002-4856-832X; Mant, Jonathan/0000-0002-9531-0268				Cowie MR, 1999, EUR HEART J, V20, P421, DOI 10.1053/euhj.1998.1280; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Mehta PA, 2009, HEART, V95, P1851, DOI 10.1136/hrt.2008.156034; *NAT I CLIN EXC, 2003, CHRON HEART FAIL MAN; *NAT I HLTH CLIN E, 2007, HEART FAIL CARD RES; National Institute for Health and Clinical Excellence, 2006, ARRH IMPL CARD DEF I; National Institute Health and Clinical Excellence, 2010, CHRON HEART FAIL MAN; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Petersen S, 2002, CORONARY HEART DIS S	9	30	30	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 25	2010	341								c4130	10.1136/bmj.c4130	http://dx.doi.org/10.1136/bmj.c4130			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645IH	20739363				2022-12-24	WOS:000281446000003
J	Goldstein, AS; Huang, JT; Guo, CY; Garraway, IP; Witte, ON				Goldstein, Andrew S.; Huang, Jiaoti; Guo, Changyong; Garraway, Isla P.; Witte, Owen N.			Identification of a Cell of Origin for Human Prostate Cancer	SCIENCE			English	Article							STEM-CELLS; EPITHELIAL-CELLS; INTRAEPITHELIAL NEOPLASIA; BASAL; PTEN; EXPRESSION; CARCINOMA; LEADS; SUBPOPULATION; PROGENITORS	Luminal cells are believed to be the cells of origin for human prostate cancer, because the disease is characterized by luminal cell expansion and the absence of basal cells. Yet functional studies addressing the origin of human prostate cancer have not previously been reported because of a lack of relevant in vivo human models. Here we show that basal cells from primary benign human prostate tissue can initiate prostate cancer in immunodeficient mice. The cooperative effects of AKT, ERG, and androgen receptor in basal cells recapitulated the histological and molecular features of human prostate cancer, with loss of basal cells and expansion of luminal cells expressing prostate-specific antigen and alpha-methylacyl-CoA racemase. Our results demonstrate that histological characterization of cancers does not necessarily correlate with the cellular origins of the disease.	[Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med,Dept Mol & Med Pharmacol, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Goldstein, Andrew S.; Witte, Owen N.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Huang, Jiaoti; Guo, Changyong; Garraway, Isla P.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Guo, Changyong; Garraway, Isla P.] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA; [Huang, Jiaoti; Witte, Owen N.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Witte, ON (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med,Dept Mol & Med Pharmacol, Dept Microbiol Mol Genet & Immunol, 675 Charles E Young Dr S,5-748 MRL, Los Angeles, CA 90095 USA.	owenwitte@mednet.ucla.edu		Huang, Jiaoti/0000-0003-1195-1998; Goldstein, Andrew/0000-0003-0434-9149	Ruth L. Kirschstein National Research Service [GM07185]; American Cancer Society; Department of Defense (DOD); UCLA SPORE in Prostate Cancer; Jean Perkins Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA092131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Department of Defense (DOD)(United States Department of Defense); UCLA SPORE in Prostate Cancer; Jean Perkins Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Anderson for manuscript preparation; D. Cheng for cell sorting; Y. Zong for vectors; H. Zhang for tissue preparation; and A. Chhabra, B. Van Handel, D. Mulholland, C. Soroudi, and T. Stoyanova for discussion and technical help. A.S.G. is supported by an institutional Ruth L. Kirschstein National Research Service Award (GM07185). J.H. is supported by the American Cancer Society, the Department of Defense (DOD) Prostate Cancer Research Program, and the UCLA SPORE in Prostate Cancer (principal investigator, R. Reiter). I.P.G is supported by the DOD and the Jean Perkins Foundation. O.N.W. is an Investigator of the Howard Hughes Medical Institute. J.H., I.P.G., and O.N.W. are supported by a Challenge Award from the Prostate Cancer Foundation.	Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Iwata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009427; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; MCNEAL JE, 1986, HUM PATHOL, V17, P64, DOI 10.1016/S0046-8177(86)80156-3; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; OKADA H, 1992, VIRCHOWS ARCH A, V421, P157, DOI 10.1007/BF01607049; Parsons JK, 2001, UROLOGY, V58, P619, DOI 10.1016/S0090-4295(01)01311-5; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Pienta KJ, 2008, PROSTATE, V68, P629, DOI 10.1002/pros.20726; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ruijter ET, 1996, J PATHOL, V180, P295; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; VERHAGEN APM, 1992, CANCER RES, V52, P6182; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; WOJNO KJ, 1995, AM J SURG PATHOL, V19, P251, DOI 10.1097/00000478-199503000-00002; Wu CL, 2004, HUM PATHOL, V35, P1008, DOI 10.1016/j.humpath.2004.03.019; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Yoshimoto M, 2006, CANCER GENET CYTOGEN, V169, P128, DOI 10.1016/j.cancergencyto.2006.04.003; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	31	395	409	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					568	571		10.1126/science.1189992	http://dx.doi.org/10.1126/science.1189992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671189	Green Accepted			2022-12-24	WOS:000280483500038
J	Harries, MJ; Sun, J; Paus, R; King, LE				Harries, M. J.; Sun, J.; Paus, R.; King, L. E., Jr.			Management of alopecia areata	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CLOBETASOL PROPIONATE 0.05-PERCENT; TRIAMCINOLONE ACETONIDE; DOUBLE-BLIND; TOPICAL MINOXIDIL; PULSE THERAPY; EFFICACY; GUIDELINES; ANTHRALIN; TRIAL; FOAM		[Harries, M. J.] Univ Manchester, Salford Royal NHS Fdn Trust, Sch Translat Med, Manchester M6 8HD, Lancs, England; [Sun, J.] Jackson Lab, Bar Harbor, ME 04609 USA; [Sun, J.] Jilin Univ, China Japan Union Hosp, Dept Dermatol, Changchun, Peoples R China; [Paus, R.] Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [King, L. E., Jr.] Vanderbilt Univ Sch Med, Div Dermatol, Skin Dis Res Ctr, Nashville, TN USA	Salford Royal NHS Foundation Trust; University of Manchester; Jackson Laboratory; Jilin University; University of Lubeck; Vanderbilt University	Harries, MJ (corresponding author), Univ Manchester, Salford Royal NHS Fdn Trust, Sch Translat Med, Manchester M6 8HD, Lancs, England.	mjharries@doctors.org.uk	Harries, Matthew J/I-4687-2015; Paus, Ralf/B-5279-2015	Harries, Matthew J/0000-0002-0563-8690; Paus, Ralf/0000-0002-3492-9358	University of Manchester, UK; British Association of Dermatologists; University of Lubeck; National Alopecia Areata Foundation; National Institute of Health [5P30AR041943]; British Skin Foundation; Cicatricial Alopecia Research Foundation; MSD, Germany; NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR041943] Funding Source: NIH RePORTER	University of Manchester, UK; British Association of Dermatologists; University of Lubeck; National Alopecia Areata Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Skin Foundation; Cicatricial Alopecia Research Foundation; MSD, Germany; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Professor C Griffiths (University of Manchester, UK) for support and advice and Professor R Happle (University of Marburg, Germany) for generously supplying clinical images.; Writing of this review was made possible in part by the Geoffrey-Dowling Fellowship from the British Association of Dermatologists (MJH), a grant from the University of Lubeck Research Focus Programme on Autoimmunity (RP), a grant from the National Alopecia Areata Foundation and National Institute of Health 5P30AR041943 (LEK), and a research grant from the British Skin Foundation (MJH, RP).; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: MH and RP have received research grants from the British Skin Foundation and Cicatricial Alopecia Research Foundation; RP has received research grants from the University of Lubeck, has been paid for developing and delivering educational presentations for MSD, Germany, and does consultancy for Hankel (Duesseldorf, Germany) and Dr Wolff (Bielefeld, Germany); LK has received research grants from the NIH and National Alopecia Areata Foundation; no other relationships or activities that could appear to have influenced the submitted work.	ABELL E, 1973, BRIT J DERMATOL, V88, P55; Agarwal A, 2006, J EUR ACAD DERMATOL, V20, P1375, DOI 10.1111/j.1468-3083.2006.01727.x; Chang KH, 2009, J DRUGS DERMATOL, V8, P909; Charuwichitratana S, 2000, ARCH DERMATOL, V136, P1276, DOI 10.1001/archderm.136.10.1276; Delamere FM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004413.pub2; FENTON DA, 1983, BRIT MED J, V287, P1015, DOI 10.1136/bmj.287.6398.1015; FIEDLER VC, 1990, ARCH DERMATOL, V126, P756, DOI 10.1001/archderm.126.6.756; FIEDLERWEISS VC, 1987, ARCH DERMATOL, V123, P1491, DOI 10.1001/archderm.123.11.1491; Georgala S, 2006, ACTA DERM-VENEREOL, V86, P422, DOI 10.2340/00015555-0138; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; GIP L, 1969, ACTA DERM-VENEREOL, V49, P180; Hay IC, 1998, ARCH DERMATOL, V134, P1349, DOI 10.1001/archderm.134.11.1349; Hull SPM, 2003, BRIT J DERMATOL, V149, P692, DOI 10.1046/j.1365-2133.2003.05535.x; Kar BR, 2005, J AM ACAD DERMATOL, V52, P287, DOI 10.1016/j.jaad.2004.10.873; KUBEYINJE EP, 1994, E AFR MED J, V71, P674; Luggen P, 2008, J DTSCH DERMATOL GES, V6, P375, DOI 10.1111/j.1610-0387.2007.06608.x; Mancuso G, 2003, INT J DERMATOL, V42, P572, DOI 10.1046/j.1365-4362.2003.01862.x; Olsen EA, 2004, J AM ACAD DERMATOL, V51, P440, DOI 10.1016/j.jaad.2003.09.032; PASCHER F, 1970, DERMATOLOGICA, V141, P193, DOI 10.1159/000252466; PORTER D, 1971, BRIT J DERMATOL, V85, P272, DOI 10.1111/j.1365-2133.1971.tb07230.x; PRICE VH, 1987, J AM ACAD DERMATOL, V16, P730, DOI 10.1016/S0190-9622(87)70095-4; Rokhsar CK, 1998, J AM ACAD DERMATOL, V39, P751, DOI 10.1016/S0190-9622(98)70048-9; SAFAVI KH, 1995, MAYO CLIN PROC, V70, P628, DOI 10.4065/70.7.628; SCHMOECKEL C, 1979, ARCH DERMATOL, V115, P1254, DOI 10.1001/archderm.115.10.1254; Sharma Vinod Kumar, 1999, Journal of Dermatology (Tokyo), V26, P562; Talpur R, 2009, J AM ACAD DERMATOL, V61, P592, DOI 10.1016/j.jaad.2009.02.037; Tosti A, 2003, J AM ACAD DERMATOL, V49, P96, DOI 10.1067/mjd.2003.423; Tosti A, 2006, J EUR ACAD DERMATOL, V20, P1243, DOI 10.1111/j.1468-3083.2006.01781.x; WALKER SA, 1950, J INVEST DERMATOL, V14, P403, DOI 10.1038/jid.1950.52; Wiseman MC, 2001, ARCH DERMATOL, V137, P1063	30	63	64	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2010	341								c3671	10.1136/bmj.c3671	http://dx.doi.org/10.1136/bmj.c3671			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632GY	20656774	Green Published			2022-12-24	WOS:000280411900001
J	Arie, S				Arie, Sophie			International Health Hungry for profit	BRITISH MEDICAL JOURNAL			English	Editorial Material												ariesophie@yahoo.co.uk						Defourny I., 2007, MANAGEMENT MODERATE; Diop EHI, 2003, AM J CLIN NUTR, V78, P302, DOI 10.1093/ajcn/78.2.302; PRUDHON C, 21 SCN; World Health Organization, 2007, JOINT STAT COMM BAS	4	4	4	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2010	341								c5221	10.1136/bmj.c5221	http://dx.doi.org/10.1136/bmj.c5221			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926480				2022-12-24	WOS:000282879400005
J	Rosenthal, MS				Rosenthal, Marjorie S.			Anticipatory Guidance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												marjorie.rosenthal@yale.edu							0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1421	1422		10.1001/jama.2010.1388	http://dx.doi.org/10.1001/jama.2010.1388			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658SO	20924000				2022-12-24	WOS:000282509900001
J	Stein, CM; Ray, WA				Stein, C. Michael; Ray, Wayne A.			The Ethics of Placebo in Studies with Fracture End Points in Osteoporosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LOW BONE-DENSITY; POSTMENOPAUSAL WOMEN; CLINICAL-TRIALS; PREVENT FRACTURES; DEVELOPING-COUNTRIES; ZOLEDRONIC ACID; UNETHICAL USE; ISSUES; RECOMMENDATIONS; DESIGN		[Stein, C. Michael] Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol & Rheumatol, Nashville, TN 37212 USA; [Ray, Wayne A.] Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University	Stein, CM (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Div Clin Pharmacol & Rheumatol, Nashville, TN 37212 USA.							Al-Khatib SM, 2001, SCIENCE, V292, P2013, DOI 10.1126/science.1057783; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Boers M, 2002, NETH J MED, V60, P310; Brody BA, 2003, J BONE MINER RES, V18, P1105, DOI 10.1359/jbmr.2003.18.6.1105; Cranney A, 2002, ENDOCR REV, V23, P570, DOI 10.1210/er.2001-9002; Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9; Cummings SR, 2008, NEW ENGL J MED, V359, P697, DOI 10.1056/NEJMoa0800743; Cummings SR, 2010, NEW ENGL J MED, V362, P686, DOI 10.1056/NEJMoa0808692; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Delmas PD, 2002, OSTEOPOROSIS INT, V13, P1, DOI 10.1007/s198-002-8331-3; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; European Medicines Agency Committee for Medicinal Products for Human Use, GUID EV MED PROD TRE; Fink HA, 2003, OSTEOPOROSIS INT, V14, P69, DOI 10.1007/s00198-002-1314-y; *FOOD DRUG ADM, 2002, CTR DRUG EV RES ART; Greenspan SL, 2007, ANN INTERN MED, V146, P326, DOI 10.7326/0003-4819-146-5-200703060-00005; Khosla S, 2009, NEW ENGL J MED, V361, P818, DOI 10.1056/NEJMe0905480; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Michels KB, 2003, BIOETHICS, V17, P188, DOI 10.1111/1467-8519.00332; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, BELM REP ETH PRINC G; Pace C, 2003, CRIT CARE MED, V31, pS121, DOI 10.1097/01.CCM.0000054907.33928.48; Qaseem A, 2008, ANN INTERN MED, V149, P404, DOI 10.7326/0003-4819-149-6-200809160-00007; Reginster JY, 2008, ARTHRITIS RHEUM-US, V58, P1687, DOI 10.1002/art.23461; Reginster JY, 2006, OSTEOPOROSIS INT, V17, P1, DOI 10.1007/s00198-005-1984-3; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; Shapiro HT, 2001, NEW ENGL J MED, V345, P139, DOI 10.1056/NEJM200107123450212; Shea B, 2004, COCHRANE DB SYST REV, V1; Silverman SL, 2008, J BONE MINER RES, V23, P159, DOI 10.1359/JBMR.070905; Stein CM, 1999, LANCET, V353, P400, DOI 10.1016/S0140-6736(98)01373-7; Stevenson M, 2005, HEALTH TECHNOL ASSES, V9, P1; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Tanne JH, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1618; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; World Medical Association (WMA), WMA DECL HELS ETH PR	35	16	16	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2010	363	14					1367	1370		10.1056/NEJMsb1006120	http://dx.doi.org/10.1056/NEJMsb1006120			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	655TD	20879888				2022-12-24	WOS:000282271500015
J	Rutz, C; Bluff, LA; Reed, N; Troscianko, J; Newton, J; Inger, R; Kacelnik, A; Bearhop, S				Rutz, Christian; Bluff, Lucas A.; Reed, Nicola; Troscianko, Jolyon; Newton, Jason; Inger, Richard; Kacelnik, Alex; Bearhop, Stuart			The Ecological Significance of Tool Use in New Caledonian Crows	SCIENCE			English	Article							STABLE-ISOTOPES; CORVUS-MONEDULOIDES; WILD CHIMPANZEES; NITROGEN; WOOD	Tool use is so rare in the animal kingdom that its evolutionary origins cannot be traced with comparative analyses. Valuable insights can be gained from investigating the ecological context and adaptive significance of tool use under contemporary conditions, but obtaining robust observational data is challenging. We assayed individual-level tool-use dependence in wild New Caledonian crows by analyzing stable isotope profiles of the birds' feathers, blood, and putative food sources. Bayesian diet-mixing models revealed that a substantial amount of the crows' protein and lipid intake comes from prey obtained with stick tools-wood-boring beetle larvae. Our calculations provide estimates of larva-intake rates and show that just a few larvae can satisfy a crow's daily energy requirements, highlighting the substantial rewards available to competent tool users.	[Rutz, Christian; Bluff, Lucas A.; Kacelnik, Alex] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Reed, Nicola; Inger, Richard; Bearhop, Stuart] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Penryn TR10 9EZ, Cornwall, England; [Troscianko, Jolyon] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Newton, Jason] Scottish Univ Environm Res Ctr, NERC, Life Sci Mass Spectrometry Facil, E Kilbride G75 0QF, Lanark, Scotland	University of Oxford; University of Exeter; University of Birmingham; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Rutz, C (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	christian.rutz@zoo.ox.ac.uk	Bearhop, Stuart/G-3105-2012; Newton, Jason/A-9536-2009; Inger, Richard/D-3445-2009	Bearhop, Stuart/0000-0002-5864-0129; Newton, Jason/0000-0001-7594-3693; Inger, Richard/0000-0003-1660-3706; Troscianko, Jolyon/0000-0001-9071-2594; Rutz, Christian/0000-0001-5187-7417	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C517392/1, BB/G023913/1]; Cogito Foundation [R-120/07]; NERC [NE/F021690/1]; Province Sud (New Caledonia); Rhodes Scholarship; University of Oxford; Linacre College, Oxford; Evolution and Ecology Research Centre, University of New South Wales, Sydney; BBSRC [BB/G023913/1] Funding Source: UKRI; NERC [lsmsf010002] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G023913/1, BB/C517392/1] Funding Source: researchfish; Natural Environment Research Council [NE/F021690/1, lsmsf010002] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cogito Foundation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Province Sud (New Caledonia); Rhodes Scholarship; University of Oxford; Linacre College, Oxford; Evolution and Ecology Research Centre, University of New South Wales, Sydney; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank N. Barre, S. Blancher, and J. Paimbou-Ayouma for logistical support in New Caledonia. Fieldwork was carried out with permissions from the Centre de Recherches sur la Biologie des Populations d'Oiseaux (France) and the Province Sud (New Caledonia), and was in accordance with the University of Oxford's procedures for local ethical review. We are grateful to M. Collett, I. Owens, B. Sheldon, and three referees for comments on the manuscript. The Edward Grey Institute of Field Ornithology (Oxford) kindly allowed us to dry blood samples in one of their ovens. Supported by the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/C517392/1 to A. K.; BB/G023913/1 to C. R.), the Cogito Foundation (R-120/07 to A. K.), NERC (NE/F021690/1 to S. B.), the Province Sud (New Caledonia; to C. R.), a Rhodes Scholarship (to L. A. B.), the University of Oxford (grant to C. R.), and a Junior Research Fellowship at Linacre College, Oxford (to C. R.). C. R. is a BBSRC David Phillips Fellow and currently holds a Visiting Fellowship at the Evolution and Ecology Research Centre, University of New South Wales, Sydney.	Bearhop S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P451, DOI 10.1086/342800; Bluff LA, 2007, COMP COGN BEHAV REV, V2, P1; Bluff LA, 2010, P ROY SOC B-BIOL SCI, V277, P1377, DOI 10.1098/rspb.2009.1953; Boesch C, 2000, CHIMPANZEES TAI FORE; GOODALL J, 1964, NATURE, V201, P1264, DOI 10.1038/2011264a0; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hunt G.R., 2006, ACTA ZOOL SINICA, V52, P622; Hunt GR, 2002, EMU, V102, P283, DOI 10.1071/MU01037; Hunt GR, 2000, EMU, V100, P109, DOI 10.1071/MU9852; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Kenward B, 2005, NATURE, V433, P121, DOI 10.1038/433121a; Mann J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003868; NISHIDA T, 1982, J HUM EVOL, V11, P73, DOI 10.1016/S0047-2484(82)80033-X; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pearson SF, 2003, OECOLOGIA, V135, P516, DOI 10.1007/s00442-003-1221-8; Rutz C, 2007, SCIENCE, V318, P765, DOI 10.1126/science.1146788; SMITH AC, 1981, EUPHORBIACEAE FLORA, V2; Tebbich S, 2002, ECOL LETT, V5, P656, DOI 10.1046/j.1461-0248.2002.00370.x; Yamakoshi G, 1998, AM J PHYS ANTHROPOL, V106, P283, DOI 10.1002/(SICI)1096-8644(199807)106:3<283::AID-AJPA2>3.0.CO;2-O	19	60	63	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 17	2010	329	5998					1523	1526		10.1126/science.1192053	http://dx.doi.org/10.1126/science.1192053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847272				2022-12-24	WOS:000281869000042
J	Michele, TM; Pinheiro, S; Iyasu, S				Michele, Theresa M.; Pinheiro, Simone; Iyasu, Solomon			The Safety of Tiotropium -- The FDA's Conclusions.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Michele, Theresa M.] US FDA, Ctr Drug Evaluat & Res, Off New Drugs, Div Pulm Allergy & Rheumatol Prod, Silver Spring, MD USA; [Pinheiro, Simone; Iyasu, Solomon] US FDA, Ctr Drug Evaluat & Res, Off Surveillance & Epidemiol, Div Epidemiol, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Michele, TM (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off New Drugs, Div Pulm Allergy & Rheumatol Prod, Silver Spring, MD USA.							Food and Drug Administration, 2009, EARL COMM ONG SAF RE; Singh S, 2009, JAMA-J AM MED ASSOC, V301, P1227; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; World Health Organization, WORLD HLTH REP 2008	4	80	84	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2010	363	12					1097	1099		10.1056/NEJMp1008502	http://dx.doi.org/10.1056/NEJMp1008502			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649TD	20843240				2022-12-24	WOS:000281795800001
J	Ramin, B; MacPherson, P				Ramin, Brodie; MacPherson, Paul			Easily Missed? Human brucellosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ramin, Brodie] Univ Ottawa, Ottawa Hosp, Ottawa, ON K1H 8L6, Canada; [MacPherson, Paul] Univ Ottawa, Ottawa Hlth Res Inst, Ottawa Hosp, Div Infect Dis, Ottawa, ON K1H 8L6, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Ramin, B (corresponding author), Univ Ottawa, Ottawa Hosp, Ottawa, ON K1H 8L6, Canada.	bramin@ottawahospital.on.ca						Andriopoulos P, 2007, INT J INFECT DIS, V11, P52, DOI 10.1016/j.ijid.2005.10.011; Ariza J, 2007, PLOS MED, V4, P1872, DOI 10.1371/journal.pmed.0040317; BUZGAN T, INT J INFEC IN PRESS; Centers for Disease Control and Prevention, 2007, BRUC; Franco MP, 2007, LANCET INFECT DIS, V7, P775, DOI 10.1016/S1473-3099(07)70286-4; Memish ZA, 2004, J TRAVEL MED, V11, P49, DOI 10.2310/7060.2004.13551; Nicoletti P, 2002, VET MICROBIOL, V90, P5, DOI 10.1016/S0378-1135(02)00209-2; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Vassalos CM, 2009, REV MED MICROBIOL, V20, P63, DOI 10.1097/MRM.0b013e3283344b5a	10	11	16	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 10	2010	341								c4545	10.1136/bmj.c4545	http://dx.doi.org/10.1136/bmj.c4545			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649ZL	20833741				2022-12-24	WOS:000281815200007
J	Howard, A; Wilson, M				Howard, Andrew; Wilson, Mary			Easily Missed? Septic arthritis in children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSIENT SYNOVITIS; HIP; DIFFERENTIATION; CHILDHOOD		[Howard, Andrew] Hosp Sick Children, Div Orthopaed Surg, Toronto, ON M5G 1X8, Canada; [Wilson, Mary] Marathon Family Hlth Team, Marathon, ON P0T 2E0, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Howard, A (corresponding author), Hosp Sick Children, Div Orthopaed Surg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	andrew.howard@sickkids.ca		Howard, Andrew/0000-0001-7226-6471				Baskett A, 2009, PEDIATR EMERG CARE, V25, P78, DOI 10.1097/PEC.0b013e318196ea43; Caird MS, 2006, J BONE JOINT SURG AM, V88A, P1251, DOI 10.2106/JBJS.E.00216; Choi IH, 2005, CLIN ORTHOP RELAT R, P102, DOI 10.1097/01.blo.0000162412.93473.68; Forlin E, 2008, J PEDIATR ORTHOPED, V28, P524, DOI 10.1097/BPO.0b013e31817bb079; Givon U, 2004, J PEDIATR ORTHOPED, V24, P266, DOI 10.1097/01241398-200405000-00006; Goergens ED, 2005, J PAEDIATR CHILD H, V41, P59, DOI 10.1111/j.1440-1754.2005.00538.x; Gordon JE, 2002, J PEDIATR ORTHOPED, V22, P312, DOI 10.1097/00004694-200205000-00008; Kocher MS, 2004, J BONE JOINT SURG AM, V86A, P1629, DOI 10.2106/00004623-200408000-00005; Kocher MS, 1999, J BONE JOINT SURG AM, V81A, P1662, DOI 10.2106/00004623-199912000-00002; Luhmann SJ, 2004, J BONE JOINT SURG AM, V86A, P956, DOI 10.2106/00004623-200405000-00011; Nunn TR, 2007, J BONE JOINT SURG BR, V89B, P100, DOI 10.1302/0301-620X.89B1.17940; Peltola H, 2009, CLIN INFECT DIS, V48, P1201, DOI 10.1086/597582; Riise OR, 2008, PEDIATRICS, V121, pE299, DOI 10.1542/peds.2007-0291	13	3	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2010	341								c4407	10.1136/bmj.c4407Easily	http://dx.doi.org/10.1136/bmj.c4407Easily			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645IJ	20801999				2022-12-24	WOS:000281446300016
J	Al-Jabri, S; Malus, M; Tulandi, T				Al-Jabri, Sheikha; Malus, Michael; Tulandi, Togas			Easily Missed? Ectopic pregnancy	BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICAL-EXAMINATION; DIAGNOSIS; EMERGENCY; HISTORY; RISK		[Al-Jabri, Sheikha; Malus, Michael] McGill Univ, Dept Family Med, Montreal, PQ H3A 1A1, Canada	McGill University	Al-Jabri, S (corresponding author), McGill Univ, Dept Family Med, Montreal, PQ H3A 1A1, Canada.	s_umreem@hotmail.com						Buckley RG, 1999, ANN EMERG MED, V34, P589, DOI 10.1016/S0196-0644(99)70160-5; Dart RG, 1999, ANN EMERG MED, V33, P283, DOI 10.1016/S0196-0644(99)70364-1; Job-Spira N, 1999, AM J OBSTET GYNECOL, V180, P938, DOI 10.1016/S0002-9378(99)70665-4; Lewis G, 2007, 7 CEMACH, P92; Lipscomb GH, 1999, NEW ENGL J MED, V341, P1974, DOI 10.1056/NEJM199912233412604; Mol BWJ, 1998, HUM REPROD, V13, P3220, DOI 10.1093/humrep/13.11.3220; Robson SJ, 1996, AUST NZ J OBSTET GYN, V36, P182, DOI 10.1111/j.1479-828X.1996.tb03282.x; STOVALL TG, 1990, ANN EMERG MED, V19, P1098, DOI 10.1016/S0196-0644(05)81511-2; Wong TW, 1998, J ACCID EMERG MED, V15, P155	9	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 30	2010	341								c3770	10.1136/bmj.c3770	http://dx.doi.org/10.1136/bmj.c3770			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634HB	20675392				2022-12-24	WOS:000280570300001
J	Nathanson, E; Nunn, P; Uplekar, M; Floyd, K; Jaramillo, E; Lonnroth, K; Weil, D; Raviglione, M				Nathanson, Eva; Nunn, Paul; Uplekar, Mukund; Floyd, Katherine; Jaramillo, Ernesto; Loennroth, Knut; Weil, Diana; Raviglione, Mario			MDR Tuberculosis - Critical Steps for Prevention and Control	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MULTIDRUG-RESISTANT TUBERCULOSIS; COMMUNITY-BASED TREATMENT; XDR-TB; RUSSIAN-FEDERATION; TREATMENT OUTCOMES; HEALTH; CARE; SYSTEMS; PRACTITIONERS; EXPERIENCE		[Nathanson, Eva; Nunn, Paul; Uplekar, Mukund; Floyd, Katherine; Jaramillo, Ernesto; Loennroth, Knut; Weil, Diana; Raviglione, Mario] WHO, Stop TB Dept, CH-1211 Geneva, Switzerland	World Health Organization	Jaramillo, E (corresponding author), WHO, Stop TB Dept, CH-1211 Geneva, Switzerland.	jaramilloe@who.int	alzahrani, saud hamed/C-2014-2012; Lönnroth, Knut/L-2339-2014; Lonnroth, Knut/H-5470-2017	Lönnroth, Knut/0000-0001-5054-8240; Lonnroth, Knut/0000-0001-6944-0256; RAVIGLIONE, Mario/0000-0002-9331-2067	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Supported by a grant from the Bill and Melinda Gates Foundation.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Birx D, 2009, AM J CLIN PATHOL, V131, P849, DOI 10.1309/AJCPGH89QDSWFONS; Blomberg B, 2003, DRUGS, V63, P535, DOI 10.2165/00003495-200363060-00002; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cars O, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1438; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Cheng MH, 2009, LANCET, V373, P1328, DOI 10.1016/S0140-6736(09)60757-1; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Dye C, 2009, NAT REV MICROBIOL, V7, P81, DOI 10.1038/nrmicro2048; FAUCI AS, 2009, OPINION FIGHTING TB; Floyd K, 2006, B WORLD HEALTH ORGAN, V84, P43, DOI 10.2471/BLT.04.018705; Gandhi NR, 2010, AM J RESP CRIT CARE, V181, P80, DOI 10.1164/rccm.200907-0989OC; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; HANSON C, 2006, TB COMPREHENSIVE INT, P1097; Heller T, 2010, INT J TUBERC LUNG D, V14, P420; Hopewell PC, 2006, LANCET INFECT DIS, V6, P710, DOI 10.1016/S1473-3099(06)70628-4; International Labour Organization, 2008, SOC HLTH PROT ILO ST; Irawati SR, 2007, INT J TUBERC LUNG D, V11, P33; KOBAIDZE K, 2009, INTERDISCIP PERSPECT, P513; Lonnroth K, 2006, B WORLD HEALTH ORGAN, V84, P876; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2007, HEALTH POLICY PLANN, V22, P156, DOI 10.1093/heapol/czm007; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Malla P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008313; Marais BJ, 2006, J CLIN MICROBIOL, V44, P3539, DOI 10.1128/JCM.01291-06; Naidoo S, 2006, INT J TUBERC LUNG D, V10, P676; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Nodieva A, 2010, INT J TUBERC LUNG D, V14, P427; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P698; Paramasivan CN, 2010, INT J TUBERC LUNG D, V14, P59; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Reichman LB, 2009, LANCET, V373, P28, DOI 10.1016/S0140-6736(08)61952-2; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Singh JA, 2007, PLOS MED, V4, P19, DOI 10.1371/journal.pmed.0040050; Skodric-Trifunovic V, 2009, INT J TUBERC LUNG D, V13, P640; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; *STOP TB, PARTN GLOB PLAN STOP; *TB ALL, 2007, PATHW PAT CHART DYN; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; Uplekar M, 2008, INT J TUBERC LUNG D, V12, P986; VANDEUN A, 2010, AM J RESP CRIT  0504; WHO, 2015, PREQ PROGR; WHO, 2009, WHOHTMTB2009411; *WHO, GLOB TUB CONTR PAT C; WHO, 2006, WORLD HLTH REPORT 20; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2005, SOC HLTH INS SUST HL; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2006, ENG ALL HLTH CAR PRO; World Health Organization, 2001, MACR HLTH INV HLTH E; World Health Organization (WHO), 2010, GUIDELINES TREATMENT, V2nd; World Health Organization (WHO), 2010, GUID PROGR MAN DRUG; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	59	137	139	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2010	363	11					1050	1058		10.1056/NEJMra0908076	http://dx.doi.org/10.1056/NEJMra0908076			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	647HS	20825317	Bronze			2022-12-24	WOS:000281609700008
J	Park, SY; Cromie, MJ; Lee, EJ; Groisman, EA				Park, Sun-Yang; Cromie, Michael J.; Lee, Eun-Jin; Groisman, Eduardo A.			A Bacterial mRNA Leader that Employs Different Mechanisms to Sense Disparate Intracellular Signals	CELL			English	Article							ESCHERICHIA-COLI K-12; SALMONELLA-ENTERICA; GENE-EXPRESSION; TRANSCRIPTION ATTENUATION; OSMOTIC-STRESS; MG2+; RIBOSWITCH; TRANSPORT; VIRULENCE; MGTA	Bacterial mRNAs often contain leader sequences that respond to specific metabolites or ions by altering expression of the associated downstream protein-coding sequences. Here we report that the leader RNA of the Mg2+ transporter gene mgtA of Salmonella enterica, which was previously known to function as a Mg2+-sensing riboswitch, harbors an 18 codon proline-rich open reading frame-termed mgtL-that permits intracellular proline to regulate mgtA expression. Interfering with mgtL translation by genetic, pharmacological, or environmental means was observed to increase the mRNA levels from the mgtA coding region. Substitution of the mgtL proline codons by other codons abolished the response to proline and to hyperosmotic stress but not to Mg2+. Our findings show that mRNA leader sequences can consist of complex regulatory elements that utilize different mechanisms to sense separate signals and mediate an appropriate cellular response.	[Cromie, Michael J.; Lee, Eun-Jin; Groisman, Eduardo A.] Washington Univ, Howard Hughes Med Inst, Sch Med, St Louis, MO 63110 USA; [Park, Sun-Yang; Cromie, Michael J.; Lee, Eun-Jin; Groisman, Eduardo A.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Groisman, EA (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, Howard Hughes Med Inst,Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.	eduardo.groisman@yale.edu			NIH [AI49561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049561] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Laszlo Csonka, Kerry Hollands, Robert Landick, and Charles Yanofsky for comments on the manuscript; Henry Huang for the plasmid harboring supF; and John Roth for strains. This work was supported, in part, by grant AI49561 from the NIH to E.A.G., who is an Investigator of the Howard Hughes Medical Institute.	Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Barchiesi J, 2008, J BACTERIOL, V190, P4951, DOI 10.1128/JB.00195-08; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; CAYLEY S, 1992, J BACTERIOL, V174, P1586, DOI 10.1128/jb.174.5.1586-1595.1992; CHEN JW, 1991, J BACTERIOL, V173, P2328, DOI 10.1128/JB.173.7.2328-2340.1991; Choi E, 2009, J BACTERIOL, V191, P7174, DOI 10.1128/JB.00958-09; Cromie MJ, 2010, J BACTERIOL, V192, P604, DOI 10.1128/JB.01239-09; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Csonka L.N., 2007, ECOSALESCHERICHIA CO; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eguchi Y, 2004, J BACTERIOL, V186, P3006, DOI 10.1128/JB.186.10.3006-3014.2004; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Grundy FJ, 2006, CRIT REV BIOCHEM MOL, V41, P329, DOI 10.1080/10409230600914294; Hammarlof DL, 2008, MOL MICROBIOL, V70, P1194, DOI 10.1111/j.1365-2958.2008.06472.x; Henkin TM, 2008, GENE DEV, V22, P3383, DOI 10.1101/gad.1747308; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; LANDICK R, 1996, ESCHERICHIA COLI SAL; LANDICK R, 1987, ESCHERICHIA COLI SAL; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; MAGUIRE ME, 1992, J BIOENERG BIOMEMBR, V24, P319; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; O'Connor K, 2009, P NATL ACAD SCI USA, V106, P17522, DOI 10.1073/pnas.0906160106; Perez-Arellano I, 2005, FEBS LETT, V579, P6903, DOI 10.1016/j.febslet.2005.11.037; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Schiller D, 2000, J BACTERIOL, V182, P6247, DOI 10.1128/JB.182.21.6247-6249.2000; Shin D, 2006, SCIENCE, V314, P1607, DOI 10.1126/science.1134930; SNAVELY MD, 1991, J BIOL CHEM, V266, P815; Soncini FC, 1996, J BACTERIOL, V178, P5092, DOI 10.1128/jb.178.17.5092-5099.1996; Spinelli SV, 2008, FEMS MICROBIOL LETT, V280, P226, DOI 10.1111/j.1574-6968.2008.01065.x; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Turnbough CL, 2008, MICROBIOL MOL BIOL R, V72, P266, DOI 10.1128/MMBR.00001-08; Vescovi EG, 1996, CELL, V84, P165, DOI 10.1016/S0092-8674(00)81003-X; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106; YANOFSKY C, 1994, J BACTERIOL, V176, P6245, DOI 10.1128/jb.176.20.6245-6254.1994	40	66	68	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					737	748		10.1016/j.cell.2010.07.046	http://dx.doi.org/10.1016/j.cell.2010.07.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813261	Green Accepted, Bronze			2022-12-24	WOS:000281523200017
J	Shackleton, M				Shackleton, Mark			Moving Targets That Drive Cancer Progression	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELLS		[Shackleton, Mark] Peter MacCallum Canc Ctr, Melanoma Res Lab, Melbourne, Australia; [Shackleton, Mark] Peter MacCallum Canc Ctr, Dept Hematol & Med Oncol, Melbourne, Australia; [Shackleton, Mark] Univ Melbourne, Dept Pathol, Fac Med Dent & Hlth Sci, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne	Shackleton, M (corresponding author), Peter MacCallum Canc Ctr, Melanoma Res Lab, Melbourne, Australia.							Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027	5	13	13	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2010	363	9					885	886		10.1056/NEJMcibr1006328	http://dx.doi.org/10.1056/NEJMcibr1006328			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642HG	20818851				2022-12-24	WOS:000281196600015
J	McGuire, AL; Evans, BJ; Caulfield, T; Burke, W				McGuire, Amy L.; Evans, Barbara J.; Caulfield, Timothy; Burke, Wylie			Regulating Direct-to-Consumer Personal Genome Testing	SCIENCE			English	Editorial Material							DISEASE; RISK		[McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Evans, Barbara J.] Univ Houston, Ctr Law, Hlth Law & Policy Inst, Houston, TX 77204 USA; [Caulfield, Timothy] Univ Alberta, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada; [Burke, Wylie] Univ Washington, Sch Med, Dept Bioeth & Humanities, Seattle, WA 98195 USA	Baylor College of Medicine; University of Houston System; University of Houston; University of Alberta; University of Washington; University of Washington Seattle	McGuire, AL (corresponding author), Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA.	amcguire@bcm.edu			NHGRI NIH HHS [R01HG004333, P50HG3374-06] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004333, P50HG003374] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		American College of Medical Genetics, STAT DIR TO CONS GEN; American Medical Association, DIR TO CONS GEN TEST; Chao S, 2008, ALZ DIS ASSOC DIS, V22, P94, DOI 10.1097/WAD.0b013e31815a9dcc; Collins FS, 2001, JAMA-J AM MED ASSOC, V286, P2322, DOI 10.1001/jama.286.18.2322; *DEP HLTH HUM GEN, 2009, COMM FRAM PRINC DIR; European Commission, 2010, EUR EC, V39, P1, DOI DOI 10.2791/49877; Evans BJ, 2010, NOTRE DAME LAW REV, V85, P419; *FDA, FDA CDRH PUBL M OV L; *FDA, 2010, OV DEV REG; Fed. Trade Comm, 2006, AT HOM GEN TESTS HLT; *FTC, COMM ACT; *GAO, 2006, NUTR TEST TESTS PURC; *GAPP, GAPP KNOWL BAS; Green RC, 2009, NEW ENGL J MED, V361, P245, DOI 10.1056/NEJMoa0809578; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Javitt GH, 2007, FOOD DRUG LAW J, V62, P617; McGuire AL, 2008, JAMA-J AM MED ASSOC, V300, P2669, DOI 10.1001/jama.2008.803; National Center for Biotechnology Information, GENETESTS; National Institutes of Health, GEN TEST REG; Secretary's Advisory Committee On Genetics Health And Society (SACGHS), 2008, US SYST OV GEN TEST; United States Government Accountability Office (GAO), 2010, DIR TO CONS GEN TEST; Wright C., 2009, BAN DIRECT TO CONSUM	23	34	35	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					181	182		10.1126/science.1194006	http://dx.doi.org/10.1126/science.1194006			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	660LP	20929761				2022-12-24	WOS:000282644600025
J	Hoerauf, A				Hoerauf, Achim			Microflora, Helminths, and the Immune System -- Who Controls Whom?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Clin, Bonn, Germany	University of Bonn	Hoerauf, A (corresponding author), Univ Clin, Bonn, Germany.							Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Kefalakes H, 2009, EUR J CLIN PHARMACOL, V65, P963, DOI 10.1007/s00228-009-0719-3; Zapater P, 2009, GASTROENTEROLOGY, V137, P1669, DOI 10.1053/j.gastro.2009.07.058	4	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1476	1478		10.1056/NEJMcibr1007689	http://dx.doi.org/10.1056/NEJMcibr1007689			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	659NV	20925552				2022-12-24	WOS:000282575100016
J	Barclay, S; Maher, J				Barclay, Stephen; Maher, Jane			Spotlight: Palliative Care Beyond Cancer Having the difficult conversations about the end of life	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL-CARE; GOOD DOCTOR; DEATH; COMMUNICATION; ONCOLOGISTS; PREFERENCES; FAMILIES; ILLNESS; DIE		[Barclay, Stephen] Inst Publ Hlth, Gen Pract & Primary Care Res Unit,, Cambridge CB2 2SR, England; [Maher, Jane] Mt Vernon Canc Ctr, London, England	University of Cambridge; Mount Vernon Cancer Centre	Barclay, S (corresponding author), Inst Publ Hlth, Gen Pract & Primary Care Res Unit,, Cambridge CB2 2SR, England.	sigb2@medschl.cam.ac.uk		Barclay, Stephen/0000-0002-4505-7743				[Anonymous], 2005, MORT STAT; Barclay S, 2009, BRIT J GEN PRACT, V59, P642, DOI 10.3399/bjgp09X454052; Berry SR, 2008, J CLIN ONCOL, V26, P157, DOI 10.1200/JCO.2007.12.3224; BUCKMAN R, 1992, BREAK BAD NEWS; Christakis N A, 1998, Hosp J, V13, P71; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Cleland John G F, 2002, Heart Fail Rev, V7, P229, DOI 10.1023/A:1020024122726; Coulter A, 2002, BRIT MED J, V325, P668, DOI 10.1136/bmj.325.7366.668; Dale J, 2009, QUAL SAF HEALTH CARE, V18, P174, DOI 10.1136/qshc.2007.024836; Ellershaw JE, 2003, CARE DYING PATHWAY E; FORD S, 1994, BRIT J CANCER, V70, P767, DOI 10.1038/bjc.1994.393; Gattellari M, 2002, J CLIN ONCOL, V20, P503, DOI 10.1200/JCO.20.2.503; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Heffner JE, 2000, CHEST, V117, P1474, DOI 10.1378/chest.117.5.1474; Hurwitz B, 2002, BMJ-BRIT MED J, V325, P667, DOI 10.1136/bmj.325.7366.667; Kirk P, 2004, BMJ-BRIT MED J, V328, P1343, DOI 10.1136/bmj.38103.423576.55; Koedoot CG, 2004, EUR J CANCER, V40, P225, DOI 10.1016/j.ejca.2003.10.008; Lynn J, 2001, JAMA-J AM MED ASSOC, V285, P925, DOI 10.1001/jama.285.7.925; MACKILLOP WJ, 1988, BRIT J CANCER, V58, P355, DOI 10.1038/bjc.1988.218; *MACM CANC SUPP, 2004, UNCL MILL; Maltoni M, 2002, HEMATOL ONCOL CLIN N, V16, P715, DOI 10.1016/S0889-8588(02)00024-2; Murray SA, 2005, BRIT MED J, V330, P611, DOI 10.1136/bmj.330.7492.611; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murtagh FEM, 2004, CLIN MED, V4, P39, DOI 10.7861/clinmedicine.4-1-39; Quirt CF, 1997, LUNG CANCER-J IASLC, V18, P1, DOI 10.1016/S0169-5002(97)00048-2; TODD CJ, 1984, SOC SCI MED, V18, P667, DOI 10.1016/0277-9536(84)90295-8; Wenrich MD, 2001, ARCH INTERN MED, V161, P868, DOI 10.1001/archinte.161.6.868; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	29	28	29	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2010	341								c4862	10.1136/bmj.c4862	http://dx.doi.org/10.1136/bmj.c4862			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653MO	20847022				2022-12-24	WOS:000282095800006
J	Lazzeri, M; Guazzoni, G				Lazzeri, Massimo; Guazzoni, Giorgio			Focal therapy meets prostate cancer	LANCET			English	Editorial Material							MORTALITY		[Lazzeri, Massimo; Guazzoni, Giorgio] Univ Vita Salute San Raffaele, Hosp San Raffaele, Dept Urol, I-20127 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Lazzeri, M (corresponding author), Univ Vita Salute San Raffaele, Hosp San Raffaele, Dept Urol, I-20127 Milan, Italy.	lazzeri.m@tiscali.it	Lazzeri, Massimo/K-5004-2016; Lazzeri, Massimo/AAB-6955-2021	Lazzeri, Massimo/0000-0002-4411-3715; Lazzeri, Massimo/0000-0002-4411-3715; Guazzoni, Giorgio Ferruccio/0000-0002-5713-8313				Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Carter HB, 2007, J UROLOGY, V178, P2359, DOI 10.1016/j.juro.2007.08.039; Ellis DS, 2007, UROLOGY, V70, P9, DOI 10.1016/j.urology.2007.07.036; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Klotz L, 2008, NAT CLIN PRACT UROL, V5, P2, DOI 10.1038/ncpuro0993; Lindner U, 2009, J UROLOGY, V182, P1371, DOI 10.1016/j.juro.2009.06.035; Loughlin KR, 2010, J UROLOGY, V183, P871, DOI 10.1016/j.juro.2009.11.011; Mulhall JP, 2009, J UROLOGY, V181, P462, DOI 10.1016/j.juro.2008.10.047; Onik G, 2008, UROL ONCOL-SEMIN ORI, V26, P500, DOI 10.1016/j.urolonc.2008.03.004; Quinn M, 2002, BJU INT, V90, P162, DOI 10.1046/j.1464-410X.2002.2822.x; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084	12	19	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2010	376	9746					1036	1037		10.1016/S0140-6736(10)60594-6	http://dx.doi.org/10.1016/S0140-6736(10)60594-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	657KM	20870082				2022-12-24	WOS:000282411600009
J	Sharp, ZD; Shearer, CK; McKeegan, KD; Barnes, JD; Wang, YQ				Sharp, Z. D.; Shearer, C. K.; McKeegan, K. D.; Barnes, J. D.; Wang, Y. Q.			The Chlorine Isotope Composition of the Moon and Implications for an Anhydrous Mantle	SCIENCE			English	Article							EARTHS; IMPACT; ORIGIN; WATER	Arguably, the most striking geochemical distinction between Earth and the Moon has been the virtual lack of water (hydrogen) in the latter. This conclusion was recently challenged on the basis of geochemical data from lunar materials that suggest that the Moon's water content might be far higher than previously believed. We measured the chlorine isotope composition of Apollo basalts and glasses and found that the range of isotopic values [from -1 to +24 per mil (parts per thousand) versus standard mean ocean chloride] is 25 times the range for Earth. The huge isotopic spread is explained by volatilization of metal halides during basalt eruption-a process that could only occur if the Moon had hydrogen concentrations lower than those of Earth by a factor of similar to 10(4) to 10(5), implying that the lunar interior is essentially anhydrous.	[Sharp, Z. D.; Shearer, C. K.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87122 USA; [Shearer, C. K.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87122 USA; [McKeegan, K. D.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Barnes, J. D.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Wang, Y. Q.] Los Alamos Natl Lab, Div Mat Sci & Technol, Los Alamos, NM 87545 USA	University of New Mexico; University of New Mexico; University of California System; University of California Los Angeles; University of Texas System; University of Texas Austin; United States Department of Energy (DOE); Los Alamos National Laboratory	Sharp, ZD (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87122 USA.	zsharp@unm.edu	Barnes, Jaime D/B-5454-2011; McKeegan, Kevin D/A-4107-2008	McKeegan, Kevin D/0000-0002-1827-729X	NASA [07-SSO07-0077, NNX08AY786]; NSF; DOE Office of Basic Energy Sciences	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); DOE Office of Basic Energy Sciences(United States Department of Energy (DOE))	Supported by NASA Origins grant 07-SSO07-0077 (Z.D.S.), NASA LASER grant NNX08AY786 (C.K.S.), and a NASA Cosmochemistry grant (K.D.M.). The UCLA ion microprobe facility is partially supported by a grant from the NSF Instrumentation and Facilities Program. We thank lunar curator G. Lofgren and staff of the Johnson Space Center, Houston. P. Burger provided imaging and quantitative elemental analyses of apatite. The Ion Beam Materials Laboratory at Los Alamos is partially supported by DOE Office of Basic Energy Sciences programs.	Abe Y., 2000, ORIGIN EARTH MOON, P413; Albarede F, 2009, NATURE, V461, P1227, DOI 10.1038/nature08477; Barnes JD, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002587; Barnes JD, 2008, GEOLOGY, V36, P883, DOI 10.1130/G25182A.1; Bonifacie M, 2008, SCIENCE, V319, P1518, DOI 10.1126/science.1150988; Cameron AGW, 1997, ICARUS, V126, P126, DOI 10.1006/icar.1996.5642; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; CARLSON RW, 2000, ORIGIN EARTH MOON, P25; CHOU CL, 1975, P LUNAR PLANET SCI C, V2, P1701; COLSON RO, 1992, P LUNAR PLANET SCI, V22, P427; ESAT TM, 1988, GEOCHIM COSMOCHIM AC, V52, P1409, DOI 10.1016/0016-7037(88)90211-6; FEGLEY B, 1991, GEOPHYS RES LETT, V18, P2073, DOI 10.1029/91GL02624; Fegley B.J., 1993, RES NEAR EARTH SPACE, P367; GREENWOOD JP, 2010, LUNAR PLANET SCI C, V41; HUMAYUN M, 1995, GEOCHIM COSMOCHIM AC, V59, P2131, DOI 10.1016/0016-7037(95)00132-8; LIU Y, 2010, LUNAR PLANET SCI C, V41; McCubbin FM, 2010, P NATL ACAD SCI USA, V107, P11223, DOI 10.1073/pnas.1006677107; McDonough W, 2003, TREATISE GEOCHEMISTR, V2, P547, DOI DOI 10.1016/B0-08-043751-6/02015-6; McKay D. S., 1993, LUNAR PLANET SCI, V24, P961; Morris R.V., 1978, LUNAR PLANETARY SCI, V2, P2287; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Raymond SN, 2004, ICARUS, V168, P1, DOI 10.1016/j.icarus.2003.11.019; Richter FM, 2007, GEOCHIM COSMOCHIM AC, V71, P5544, DOI 10.1016/j.gca.2007.09.005; RINGWOOD AE, 1979, ORIGIN EARTH MOON; Saal AE, 2008, NATURE, V454, P192, DOI 10.1038/nature07047; Schauble EA, 2003, GEOCHIM COSMOCHIM AC, V67, P3267, DOI 10.1016/S0016-7037(02)01375-3; Sharp ZD, 2007, NATURE, V446, P1062, DOI 10.1038/nature05748; Sharp ZD, 2010, GEOCHIM COSMOCHIM AC, V74, P264, DOI 10.1016/j.gca.2009.09.032; Shearer CK, 2006, REV MINERAL GEOCHEM, V60, P365, DOI 10.2138/rmg.2006.60.4; Shearer CK, 1999, AM MINERAL, V84, P1469; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037	32	163	169	5	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2010	329	5995					1050	1053		10.1126/science.1192606	http://dx.doi.org/10.1126/science.1192606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20688980				2022-12-24	WOS:000281253500033
J	Wassersug, RJ; Lieberman, T				Wassersug, Richard J.; Lieberman, Tucker			Personal View Contemporary castration: why the modern day eunuch remains invisible	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANDROGEN-DEPRIVATION THERAPY; CHARACTERIZING MEN		[Wassersug, Richard J.] Dalhousie Univ, Halifax, NS, Canada	Dalhousie University	Wassersug, RJ (corresponding author), La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia.	Richard.Wassersug@dal.ca						Alibhai SMH, 2010, CRIT REV ONCOL HEMAT, V73, P167, DOI 10.1016/j.critrevonc.2009.03.005; Cherner MM, 2009, PSYCHO-ONCOLOGY, V18, P237, DOI 10.1002/pon.1401; Cushman M. A., 2010, INT J MENS HLTH, V9, P3, DOI [10.3149/jmh.0901.3, DOI 10.3149/JMH.0901.3]; DiBlasio CJ, 2008, BJU INT, V102, P39, DOI 10.1111/j.1464-410X.2008.07505.x; Engstrom CA, 2008, AM J MENS HEALTH, V2, P122, DOI 10.1177/1557988306298802; Higano C, 2006, HEMATOL ONCOL CLIN N, V20, P909, DOI 10.1016/j.hoc.2006.03.013; Jim HSL, 2010, SUPPORT CARE CANCER, V18, P21, DOI 10.1007/s00520-009-0625-3; Johnson TW, 2007, J SEX MED, V4, P930, DOI 10.1111/j.1743-6109.2007.00521.x; Mohile SG, 2010, J GERIATR ONCOL, V1, P13, DOI [10.1016/j.jgo.2010.03.001, 10.1016/j.critrevonc.2010.06.009]; Murthy V, 2007, BJU INT, V99, P1380, DOI 10.1111/j.1464-410X.2007.06843.x; Navon L, 2004, SOC SCI MED, V58, P2337, DOI 10.1016/j.socscimed.2003.08.029; Nelson CJ, 2008, CANCER, V113, P1097, DOI 10.1002/cncr.23658; Roberts LF, 2008, J SEX MED, V5, P1669, DOI 10.1111/j.1743-6109.2007.00636.x; Smith Matthew R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P247, DOI 10.1097/MED.0b013e32814db88c; Smith MR, 2004, UROLOGY, V63, P742, DOI 10.1016/j.urology.2003.10.063; Wassersug R, 2010, ANTHROPOL TODAY, V26, P1, DOI 10.1111/j.1467-8322.2010.00707.x; Wassersug RJ, 2007, PERSPECT BIOL MED, V50, P544, DOI 10.1353/pbm.2007.0058; Wassersug RJ, 2009, J RELIG HEALTH, V48, P381, DOI 10.1007/s10943-008-9231-9	18	7	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2010	341								c4509	10.1136/bmj.c4509	http://dx.doi.org/10.1136/bmj.c4509			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	642KT	20719851				2022-12-24	WOS:000281213100009
J	Hotez, PJ; Engels, D; Fenwick, A; Savioli, L				Hotez, Peter J.; Engels, Dirk; Fenwick, Alan; Savioli, Lorenzo			Africa is desperate for praziquantel	LANCET			English	Editorial Material							SCHISTOSOMIASIS; MORBIDITY; INFECTION; IMPACT		[Hotez, Peter J.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Hotez, Peter J.] Sabin Vaccine Inst, Washington, DC 20037 USA; [Engels, Dirk; Savioli, Lorenzo] WHO, Dept Control Neglected Trop Dis, CH-1211 Geneva, Switzerland; [Fenwick, Alan] Univ London Imperial Coll Sci Technol & Med, Schistosomiasis Control Initiat, London, England	George Washington University; World Health Organization; Imperial College London	Hotez, PJ (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA.	photez@gwu.edu		Hotez, Peter/0000-0001-8770-1042				Chen MG, 2005, ACTA TROP, V96, P168, DOI 10.1016/j.actatropica.2005.07.011; Fenwick A, 2006, ADV PARASIT, V61, P567, DOI 10.1016/S0065-308X(05)61013-5; Hotez PJ, 2009, CLIN PHARMACOL THER, V85, P659, DOI 10.1038/clpt.2009.16; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Koukounari A, 2007, J INFECT DIS, V196, P659, DOI 10.1086/520515; Koukounari A, 2006, AM J TROP MED HYG, V75, P278, DOI 10.4269/ajtmh.2006.75.278; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Zhang Y, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-27; 2006, HIST PRAZIQUANTEL	12	49	50	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2010	376	9740					496	498		10.1016/S0140-6736(10)60879-3	http://dx.doi.org/10.1016/S0140-6736(10)60879-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643BE	20709217				2022-12-24	WOS:000281266800009
J	Sachs, J; Remans, R; Smukler, S; Winowiecki, L; Andelman, SJ; Cassman, KG; Castle, D; DeFries, R; Denning, G; Fanzo, J; Jackson, LE; Leemans, R; Lehmann, J; Milder, JC; Naeem, S; Nziguheba, G; Palm, CA; Pingali, PL; Reganold, JP; Richter, DD; Scherr, SJ; Sircely, J; Sullivan, C; Tomich, TP; Sanchez, PA				Sachs, Jeffrey; Remans, Roseline; Smukler, Sean; Winowiecki, Leigh; Andelman, Sandy J.; Cassman, Kenneth G.; Castle, David; DeFries, Ruth; Denning, Glenn; Fanzo, Jessica; Jackson, Louise E.; Leemans, Rik; Lehmann, Johannes; Milder, Jeffrey C.; Naeem, Shahid; Nziguheba, Generose; Palm, Cheryl A.; Pingali, Prabhu L.; Reganold, John P.; Richter, Daniel D.; Scherr, Sara J.; Sircely, Jason; Sullivan, Clare; Tomich, Thomas P.; Sanchez, Pedro A.			Monitoring the world's agriculture	NATURE			English	Editorial Material							GENETICALLY-ENGINEERED PLANTS; SCIENTISTS ANALYSIS; FOODS		[Sachs, Jeffrey; Remans, Roseline; Smukler, Sean; Winowiecki, Leigh; Nziguheba, Generose; Palm, Cheryl A.; Sullivan, Clare; Sanchez, Pedro A.] Columbia Univ, Earth Inst, New York, NY 10027 USA; [Remans, Roseline] Katholieke Univ Leuven, Louvain, Belgium; [Cassman, Kenneth G.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Castle, David] Univ Ottawa, Fac Arts, Ottawa, ON K1N 6N5, Canada; [Castle, David] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada; [DeFries, Ruth; Naeem, Shahid; Sircely, Jason] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Denning, Glenn] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Fanzo, Jessica] Biovers Int, Rome, Italy; [Jackson, Louise E.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Leemans, Rik] Wageningen Univ, Environm Syst Anal Grp, Wageningen, Netherlands; [Lehmann, Johannes] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA; [Milder, Jeffrey C.; Scherr, Sara J.] EcoAgr Partners, Washington, DC USA; [Pingali, Prabhu L.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Reganold, John P.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Richter, Daniel D.] Duke Univ, Nicholas Sch Environm, Environm Sci & Policy Div, Durham, NC 27706 USA; [Tomich, Thomas P.] Univ Calif Davis, Agr Sustainabil Inst, Davis, CA 95616 USA	Columbia University; KU Leuven; University of Nebraska System; University of Nebraska Lincoln; University of Ottawa; University of Ottawa; Columbia University; Columbia University; Alliance; Bioversity International; University of California System; University of California Davis; Wageningen University & Research; Cornell University; Bill & Melinda Gates Foundation; Washington State University; Duke University; University of California System; University of California Davis	Sachs, J (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.		Leemans, Rik/A-1548-2009; Richter, D.D./AAN-4583-2021; Jackson, Louise E/A-3562-2010; Cassman, Kenneth G/C-3646-2019; Fanzo, Jessica/HCH-3533-2022; Lehmann, Johannes/H-2682-2014	Leemans, Rik/0000-0002-4001-6301; Lehmann, Johannes/0000-0002-4701-2936; Castle, David/0000-0002-6884-0001; Fanzo, Jessica/0000-0002-6760-1359; Nziguheba, Generose/0000-0003-4227-2242				[Anonymous], 2005, EC HUM WELL BEING SY; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007; Jackson L.E., 2005, AGROBIODIVERSITY NEW; Lemaux PG, 2008, ANNU REV PLANT BIOL, V59, P771, DOI 10.1146/annurev.arplant.58.032806.103840; Lemaux PG, 2009, ANNU REV PLANT BIOL, V60, P511, DOI 10.1146/annurev.arplant.043008.092013; McIntyre BD, 2009, AGR CROSSR GLOB REP; Sachs JD, 2009, SCIENCE, V325, P1502, DOI 10.1126/science.1175035; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970	10	111	118	2	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 29	2010	466	7306					558	560		10.1038/466558a	http://dx.doi.org/10.1038/466558a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	632HA	20671691				2022-12-24	WOS:000280412100017
J	Heazell, AE				Heazell, Alexander E.			Personal View Towards an end to stillbirths	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Manchester, Manchester M13 9PL, Lancs, England	University of Manchester	Heazell, AE (corresponding author), Univ Manchester, Manchester M13 9PL, Lancs, England.	alexander.heazell@manchester.ac.uk		Heazell, Alexander/0000-0002-4303-7845	National Institute for Health Research [CL-2009-06-002] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Ahman E, 2007, NEONATAL PERINATAL M; [Anonymous], 2009, STUD STILLB CLAIMS; *CONF ENQ STILLB D, 1998, 5 ANN REP CONF ENQ S; *CONF ENQ STILLB D, 2001, 8 ANN REP CONF ENQ S; Confidential Enquiry into Maternal and Child Health, 2009, PER MORT 2007 ENGL W; Guildea ZES, 2001, ARCH DIS CHILD, V84, P307, DOI 10.1136/adc.84.4.307; Haws RA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S5; Henley A, 2008, SEMIN FETAL NEONAT M, V13, P325, DOI 10.1016/j.siny.2008.03.003; *NAT I HLTH RES, 2008, TRANSF HLTH RES 1 2; Scott J, 2009, SAVING BABIES LIVES	10	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2010	341								c5070	10.1136/bmj.c5070	http://dx.doi.org/10.1136/bmj.c5070			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926491				2022-12-24	WOS:000282879400015
J	Kosik, KS				Kosik, Kenneth S.			MicroRNAs and Cellular Phenotypy	CELL			English	Article							NEURAL DEVELOPMENT; STEM-CELLS; MESSENGER-RNAS; EVOLUTION; GENE; BIOLOGY; GENOME; PLURIPOTENCY; CANALIZATION; DEGRADATION		Univ Calif Santa Barbara, Neurosci Res Inst, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	kenneth.kosik@lifesci.ucsb.edu						Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; [Anonymous], 2005, PLAUSIBILITY LIFE; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chi AS, 2009, SCIENCE, V323, P220, DOI 10.1126/science.1166261; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kosik KS, 2009, NAT REV NEUROSCI, V10, P754, DOI 10.1038/nrn2713; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Papagiannakopoulos T, 2008, CANCER RES, V68, P8164, DOI 10.1158/0008-5472.CAN-08-1305; Parter M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000206; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Puzio-Kuter AM, 2009, NAT BIOTECHNOL, V27, P914, DOI 10.1038/nbt1009-914; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rouhana L, 2010, DEV BIOL, V341, P429, DOI 10.1016/j.ydbio.2010.02.037; Sakarya O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000506; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Tsang JS, 2010, MOL CELL, V38, P140, DOI 10.1016/j.molcel.2010.03.007; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	48	95	104	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					21	26		10.1016/j.cell.2010.09.008	http://dx.doi.org/10.1016/j.cell.2010.09.008			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887887	Bronze			2022-12-24	WOS:000282362000008
J	Lu, LF; Boldin, MP; Chaudhry, A; Lin, LL; Taganov, KD; Hanada, T; Yoshimura, A; Baltimore, D; Rudensky, AY				Lu, Li-Fan; Boldin, Mark P.; Chaudhry, Ashutosh; Lin, Ling-Li; Taganov, Konstantin D.; Hanada, Toshikatsu; Yoshimura, Akihiko; Baltimore, David; Rudensky, Alexander Y.			Function of miR-146a in Controlling Treg Cell-Mediated Regulation of Th1 Responses	CELL			English	Article							TRANSCRIPTION FACTOR FOXP3; T-REG-CELLS; IFN-GAMMA; SIGNALING PATHWAYS; IMMUNE-RESPONSES; TARGET GENES; CD4(+); DIFFERENTIATION; CYTOKINE; SOCS1	Foxp3(+) regulatory T (Treg) cells maintain immune homeostasis by limiting different types of inflammatory responses. Here, we report that miR-146a, one of the miRNAs prevalently expressed in Treg cells, is critical for their suppressor function. The deficiency of miR-146a in Treg cells resulted in a breakdown of immunological tolerance manifested in fatal IFN gamma-dependent immune-mediated lesions in a variety of organs. This was likely due to augmented expression and activation of signal transducer and activator transcription 1 (Stat1), a direct target of miR-146a. Likewise, heightened Stat1 activation in Treg cells subjected to a selective ablation of SOCS1, a key negative regulator of Stat1 phosphorylation downstream of the IFN gamma receptor, was associated with analogous Th1-mediated pathology. Our results suggest that specific aspects of Treg suppressor function are controlled by a single miRNA and that an optimal range of Stat1 activation is important for Treg-mediated control of Th1 responses and associated autoimmunity.	[Lu, Li-Fan; Chaudhry, Ashutosh; Lin, Ling-Li; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Lu, Li-Fan; Chaudhry, Ashutosh; Lin, Ling-Li; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Boldin, Mark P.; Taganov, Konstantin D.; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Hanada, Toshikatsu; Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjyuku Ku, Tokyo 1608582, Japan; [Hanada, Toshikatsu; Yoshimura, Akihiko] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Baltimore, David] Regulus Therapeut, San Diego, CA 92121 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; California Institute of Technology; Keio University; Japan Science & Technology Agency (JST); Isis Pharmaceuticals Inc	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Yoshimura, Akihiko/K-5515-2013	Boldin, Mark/0000-0003-4593-0669; Lu, Li-Fan/0000-0002-9727-0036; Chaudhry, Ashutosh/0000-0003-3379-5236	NIH; Ministry of Education, Culture, Sports, Science; Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Ramos for the help in key experiments, Y. Liang, P. Zarin, A. Bravo, and J. Herlihy for superb technical assistance, and all members of our laboratory for discussions. This work was supported by grants from the NIH (A. Y. R. and D. B.) and from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (A. Y.). L.-F. L. is a Leukemia and Lymphoma Society Fellow. A. C. is a Cancer Research Institute Fellow. A. Y. R. is a Howard Hughes Medical Institute investigator. D. B. is the director and M. P. B. and K. D. T. are employees of Regulus Therapeutics Inc., a company devoted to commercializing therapies directed at microRNAs.	Alexander WS, 1999, CELL, V98, P597, DOI 10.1016/S0092-8674(00)80047-1; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Barbi J, 2007, BLOOD, V110, P2215, DOI 10.1182/blood-2007-03-081307; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Curtale G, 2010, BLOOD, V115, P265, DOI 10.1182/blood-2009-06-225987; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Horino J, 2008, INT IMMUNOL, V20, P753, DOI 10.1093/intimm/dxn033; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Huang B, 2009, EMBO REP, V10, P180, DOI 10.1038/embor.2008.224; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Kubo M, 2003, NAT IMMUNOL, V4, P1169, DOI 10.1038/ni1012; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Lu LF, 2009, GENE DEV, V23, P1270, DOI 10.1101/gad.1791009; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Maitra U, 2009, J IMMUNOL, V182, P5763, DOI 10.4049/jimmunol.0900124; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Nakajima C, 2002, EUR J IMMUNOL, V32, P1792, DOI 10.1002/1521-4141(200206)32:6<1792::AID-IMMU1792>3.0.CO;2-0; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Siebler J, 2003, HEPATOLOGY, V38, P1573, DOI 10.1016/j.hep.2003.09.020; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tanaka K, 2008, J IMMUNOL, V180, P3746, DOI 10.4049/jimmunol.180.6.3746; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zhan YF, 2009, IMMUNOL CELL BIOL, V87, P473, DOI 10.1038/icb.2009.23; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	56	697	762	5	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					914	929		10.1016/j.cell.2010.08.012	http://dx.doi.org/10.1016/j.cell.2010.08.012			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850013	Green Accepted, Bronze			2022-12-24	WOS:000281855000014
J	Lowe, AR; Siegel, JJ; Kalab, P; Siu, M; Weis, K; Liphardt, JT				Lowe, Alan R.; Siegel, Jake J.; Kalab, Petr; Siu, Merek; Weis, Karsten; Liphardt, Jan T.			Selectivity mechanism of the nuclear pore complex characterized by single cargo tracking	NATURE			English	Article							PHENYLALANINE-GLYCINE NUCLEOPORINS; PROTEIN IMPORT; TRANSLOCATION; TRANSPORT; MOLECULE; DIFFUSION; HYDROGEL; BETA	The nuclear pore complex (NPC) mediates all exchange between the cytoplasm and the nucleus. Small molecules can passively diffuse through the NPC, whereas larger cargos require transport receptors to translocate(1). How the NPC facilitates the translocation of transport receptor/cargo complexes remains unclear. To investigate this process, we tracked single protein-functionalized quantum dot cargos as they moved through human NPCs. Here we show that import proceeds by successive substeps comprising cargo capture, filtering and translocation, and release into the nucleus. Most quantum dots are rejected at one of these steps and return to the cytoplasm, including very large cargos that abort at a size-selective barrier. Cargo movement in the central channel is subdiffusive and cargos that can bind more transport receptors diffuse more freely. Without Ran GTPase, a critical regulator of transport directionality(1), cargos still explore the entire NPC, but have a markedly reduced probability of exit into the nucleus, suggesting that NPC entry and exit steps are not equivalent and that the pore is functionally asymmetric to importing cargos. The overall selectivity of the NPC seems to arise from the cumulative action of multiple reversible substeps and a final irreversible exit step.	[Lowe, Alan R.; Siegel, Jake J.; Weis, Karsten; Liphardt, Jan T.] Univ Calif Berkeley, QB3, Berkeley, CA 94720 USA; [Lowe, Alan R.; Liphardt, Jan T.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Lowe, Alan R.; Liphardt, Jan T.] Univ Calif Berkeley, Bay Area Phys Sci Oncol Ctr, Berkeley, CA 94720 USA; [Siegel, Jake J.; Siu, Merek; Liphardt, Jan T.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Kalab, Petr; Weis, Karsten] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Lowe, Alan R.; Liphardt, Jan T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Weis, K (corresponding author), Univ Calif Berkeley, QB3, Berkeley, CA 94720 USA.	kweis@berkeley.edu	Weis, Karsten/F-5719-2011; Liphardt, Jan/A-5906-2012; Kalab, Petr/B-2478-2009	Weis, Karsten/0000-0001-7224-925X; Liphardt, Jan/0000-0003-2835-5025; Lowe, Alan/0000-0002-0558-3597	NIH [GM058065, GM77856]; NCI [U54CA143836]; NATIONAL CANCER INSTITUTE [ZIABC011084, U54CA143836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084716, R01GM058065, R01GM077856] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Agarwal for help with initial experiments; H. Aaron, A. Fischer and B. Cohen for use of facilities and discussions; the Bustamante, Chu and Krantz laboratories for use of equipment; and C. Bustamante, M. Welch and D. Grunwald for discussions and comments on the manuscript. This work was partially funded by the NIH (GM058065 to K.W. and GM77856 to J.T.L.) and the NCI (U54CA143836 to J.T.L.).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170; Bickel T, 2002, BIOPHYS J, V83, P3079, DOI 10.1016/S0006-3495(02)75312-5; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Huber J, 2002, J CELL BIOL, V156, P467, DOI 10.1083/jcb.200108114; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Lacoste TD, 2000, P NATL ACAD SCI USA, V97, P9461, DOI 10.1073/pnas.170286097; Lim RYH, 2007, J STRUCT BIOL, V159, P277, DOI 10.1016/j.jsb.2007.01.018; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103; Mitrousis G, 2008, J BIOL CHEM, V283, P7877, DOI 10.1074/jbc.M709093200; MOORE MS, 1993, NATURE, V365, P661, DOI 10.1038/365661a0; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Peters R, 2009, BIOESSAYS, V31, P466, DOI 10.1002/bies.200800159; Pyhtila B, 2003, J BIOL CHEM, V278, P42699, DOI 10.1074/jbc.M307135200; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Weis K, 2007, CELL, V130, P405, DOI 10.1016/j.cell.2007.07.029; Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101	28	123	125	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					600	U126		10.1038/nature09285	http://dx.doi.org/10.1038/nature09285			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20811366	Green Accepted			2022-12-24	WOS:000282273100041
J	Rabone, J; Yue, YF; Chong, SY; Stylianou, KC; Bacsa, J; Bradshaw, D; Darling, GR; Berry, NG; Khimyak, YZ; Ganin, AY; Wiper, P; Claridge, JB; Rosseinsky, MJ				Rabone, J.; Yue, Y. -F.; Chong, S. Y.; Stylianou, K. C.; Bacsa, J.; Bradshaw, D.; Darling, G. R.; Berry, N. G.; Khimyak, Y. Z.; Ganin, A. Y.; Wiper, P.; Claridge, J. B.; Rosseinsky, M. J.			An Adaptable Peptide-Based Porous Material	SCIENCE			English	Article							METAL-ORGANIC FRAMEWORKS; ADSORPTION; COMPLEXES	Porous materials find widespread application in storage, separation, and catalytic technologies. We report a crystalline porous solid with adaptable porosity, in which a simple dipeptide linker is arranged in a regular array by coordination to metal centers. Experiments reinforced by molecular dynamics simulations showed that low-energy torsions and displacements of the peptides enabled the available pore volume to evolve smoothly from zero as the guest loading increased. The observed cooperative feedback in sorption isotherms resembled the response of proteins undergoing conformational selection, suggesting an energy landscape similar to that required for protein folding. The flexible peptide linker was shown to play the pivotal role in changing the pore conformation.	[Rabone, J.; Yue, Y. -F.; Chong, S. Y.; Stylianou, K. C.; Bacsa, J.; Bradshaw, D.; Darling, G. R.; Berry, N. G.; Khimyak, Y. Z.; Ganin, A. Y.; Wiper, P.; Claridge, J. B.; Rosseinsky, M. J.] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England	University of Liverpool	Rosseinsky, MJ (corresponding author), Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England.	m.j.rosseinsky@liverpool.ac.uk	Yue, Yanfeng/F-9332-2011; Claridge, John B/I-7395-2012; Stylianou, Kyriakos/G-7117-2012; BACSA, JOHN/L-8501-2016; Bradshaw, Darren/D-6174-2013; Berry, Neil G/B-7960-2009; Khimyak, Yaroslav/A-4624-2012; Chong, Samantha Y/B-4031-2009	Claridge, John B/0000-0003-4849-6714; Berry, Neil G/0000-0003-1928-0738; Khimyak, Yaroslav/0000-0003-0424-4128; Chong, Samantha Y/0000-0002-3095-875X; Stylianou, Kyriakos/0000-0003-1670-0020; Wiper, Paul/0000-0003-1350-2299; Darling, George/0000-0001-9329-9993; Ganin, Alexey/0000-0002-3754-5819	UK Engineering and Physical Sciences Research Council [EP/F027443]; Engineering and Physical Sciences Research Council [EP/F027443/1] Funding Source: researchfish; EPSRC [EP/F027443/1] Funding Source: UKRI	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the UK Engineering and Physical Sciences Research Council for funding under grant EP/F027443.	ALLISON SA, 1969, J CHEM SOC A, P1717, DOI 10.1039/j19690001717; Anedda R, 2008, CHEM MATER, V20, P2908, DOI 10.1021/cm8001805; Asakura T, 2005, PROTEIN SCI, V14, P2654, DOI 10.1110/ps.051525505; Atwood JL, 2002, SCIENCE, V296, P2367, DOI 10.1126/science.1072252; Bell JA, 1999, PROTEIN SCI, V8, P2033, DOI 10.1110/ps.8.10.2033; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Choi HJ, 2008, J AM CHEM SOC, V130, P7848, DOI 10.1021/ja8024092; Comotti A, 2009, CHEM COMMUN, P284, DOI 10.1039/b820200a; DAVIS ME, 1991, IND ENG CHEM RES, V30, P1675, DOI 10.1021/ie00056a001; Dubbeldam D, 2007, MOL SIMULAT, V33, P305, DOI 10.1080/08927020601156418; Duren T, 2009, CHEM SOC REV, V38, P1237, DOI 10.1039/b803498m; Gorbitz CH, 2008, J PEPT SCI, V14, P210, DOI 10.1002/psc.985; Gorbitz CH, 2007, CHEM-EUR J, V13, P1022, DOI 10.1002/chem.200601427; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; Horike S, 2009, NAT CHEM, V1, P695, DOI [10.1038/NCHEM.444, 10.1038/nchem.444]; Kitaura R, 2003, ANGEW CHEM INT EDIT, V42, P428, DOI 10.1002/anie.200390130; Lee HY, 2008, CRYST GROWTH DES, V8, P296, DOI 10.1021/cg700724h; Mantion A, 2008, J AM CHEM SOC, V130, P2517, DOI 10.1021/ja0762588; MIZUKAMI H, 1977, P SOC EXP BIOL MED, V154, P304, DOI 10.3181/00379727-154-39659; Ohgo K, 2006, BIOMACROMOLECULES, V7, P1210, DOI 10.1021/bm0600522; Okay O, 2000, PROG POLYM SCI, V25, P711, DOI 10.1016/S0079-6700(00)00015-0; OLSON DH, 1981, J PHYS CHEM-US, V85, P2238, DOI 10.1021/j150615a020; Peterca M, 2006, J AM CHEM SOC, V128, P6713, DOI 10.1021/ja0611902; Salles F, 2008, ANGEW CHEM INT EDIT, V47, P8487, DOI 10.1002/anie.200803067; Serre C, 2007, SCIENCE, V315, P1828, DOI 10.1126/science.1137975; Sing K. S. W., 1995, POROSITY CARBONS, P49; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Soldatov DV, 2006, J CHEM CRYSTALLOGR, V36, P747, DOI 10.1007/s10870-006-9133-1; Soldatov DV, 2004, ANGEW CHEM INT EDIT, V43, P6308, DOI 10.1002/anie.200460952; Takayama T, 1996, B CHEM SOC JPN, V69, P1579, DOI 10.1246/bcsj.69.1579; Tiliakos M, 2005, INORG CHEM COMMUN, V8, P1085, DOI 10.1016/j.inoche.2005.09.008; Tranchemontagne DJ, 2009, CHEM SOC REV, V38, P1257, DOI 10.1039/b817735j; Ueda E, 2004, B CHEM SOC JPN, V77, P981, DOI 10.1246/bcsj.77.981; Winston EB, 2008, PHYS CHEM CHEM PHYS, V10, P5188, DOI 10.1039/b808104b	34	287	293	19	392	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2010	329	5995					1053	1057		10.1126/science.1190672	http://dx.doi.org/10.1126/science.1190672			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798314				2022-12-24	WOS:000281253500034
J	Hamilton, W; Watson, J; Round, A				Hamilton, William; Watson, Jessica; Round, Alison			Rational Testing Investigating fatigue in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GENERAL-PRACTICE; FAMILY-PHYSICIANS; COMMON SYMPTOMS; CONSULTATION; PREVALENCE; TIREDNESS; DIAGNOSES; PROGNOSIS; PATIENT		[Hamilton, William] Mt Pleasant Hlth Ctr, Exeter EX4 7BW, Devon, England; [Hamilton, William] Peninsula Coll Med & Dent, Exeter EX2 4SG, Devon, England; [Watson, Jessica] Univ Bristol, Dept Community Based Med, Acad Unit Primary Hlth Care, Bristol BS8 2AA, Avon, England; [Round, Alison] Castle Pl Practice, Tiverton, ON EX16 6NP, Canada	University of Exeter; University of Plymouth; University of Bristol	Hamilton, W (corresponding author), Mt Pleasant Hlth Ctr, Exeter EX4 7BW, Devon, England.	w.t.hamilton@btopenworld.com	Hamilton, Willie/G-8612-2014	Watson, Jessica/0000-0002-8177-6438; Hamilton, William/0000-0003-1611-1373	National Institute for Health Research [ACF-2008-25-003] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		CATHEBRAS PJ, 1992, J GEN INTERN MED, V7, P276, DOI 10.1007/BF02598083; Coeliac Disease, 2009, COEL DIS REC ASS COE; Cullen W, 2002, IRISH J MED SCI, V171, P10, DOI 10.1007/BF03168931; DAVID A, 1990, BMJ-BRIT MED J, V301, P1199, DOI 10.1136/bmj.301.6762.1199; Gallagher AM, 2004, J ROY SOC MED, V97, P571, DOI 10.1258/jrsm.97.12.571; Gialamas Angela, 2003, Aust Fam Physician, V32, P663; Godwin M, 1999, CAN FAM PHYSICIAN, V45, P373; Hamilton WT, 2005, FAM PRACT, V22, P383, DOI 10.1093/fampra/cmi021; Harrison M, 2008, AUST FAM PHYSICIAN, V37, P908; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; Kenter EGH, 2003, FAM PRACT, V20, P434, DOI 10.1093/fampra/cmg418; Koch H, 2009, BRIT J GEN PRACT, V59, P243, DOI 10.3399/bjgp09X420310; Kroenke K, 1998, FAM PRACT, V15, P398, DOI 10.1093/fampra/15.5.398; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Melbye H, 2004, BRIT J GEN PRACT, V54, P653; *NAT I HLTH CLIN E, 2007, CHRON FAT SYNDR MY E; *NHS CLIN KNOWL SU, TIR FAT AD MAN; Okkes IM, 2002, J FAM PRACTICE, V51, P31; RIDSDALE L, 1993, BMJ-BRIT MED J, V307, P103, DOI 10.1136/bmj.307.6896.103; RIDSDALE L, 1994, BRIT J GEN PRACT, V44, P413; Stolper E, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-17; Summerton N, 2003, BRIT J GEN PRACT, V53, P50; Verdon F, 2003, BRIT MED J, V326, P1124, DOI 10.1136/bmj.326.7399.1124; WESSELY S, 1995, LANCET, V345, P1333, DOI 10.1016/S0140-6736(95)92537-6; White PD, 1998, BRIT J PSYCHIAT, V173, P475, DOI 10.1192/bjp.173.6.475	25	15	15	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2010	341								c4259	10.1136/bmj.c4259	http://dx.doi.org/10.1136/bmj.c4259			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645IG	20736254				2022-12-24	WOS:000281445900012
J	Krumholz, HM; Hayward, RA				Krumholz, Harlan M.; Hayward, Rodney A.			Shifting views on lipid lowering therapy	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; STATIN THERAPY; HEART-FAILURE; CANCER-RISK; METAANALYSIS; DISEASE; CHOLESTEROL; PREVENTION; EZETIMIBE; HYPERCHOLESTEROLEMIA		[Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Hayward, Rodney A.] VA Med Ctr, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; [Hayward, Rodney A.] Univ Michigan, Dept Internal Med, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] Univ Michigan, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA	Yale University; Yale University; Yale University; Yale University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020					Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Bonovas S, 2006, J CLIN ONCOL, V24, P4808, DOI 10.1200/JCO.2006.06.3560; *BRIDG EXC, COR ART DIS CAR LINK; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Cannon CP, 2010, LANCET, V375, P700, DOI 10.1016/S0140-6736(10)60234-6; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; Hayward RA, 2006, ANN INTERN MED, V145, P520, DOI 10.7326/0003-4819-145-7-200610030-00010; Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004; Jackevicius CA, 2008, NEW ENGL J MED, V358, P1819, DOI 10.1056/NEJMsa0801461; Josan K, 2008, CAN MED ASSOC J, V178, P576, DOI 10.1503/cmaj.070675; Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lee TH, 2000, JAMA-J AM MED ASSOC, V283, P94, DOI 10.1001/jama.283.1.94; *NAT HEART LUNG BL, 2001, DET EV TREATM HIGH B; PETTYPIECE S, 2008, BLOOMBERG       0116; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Steinberg D, 2008, CIRCULATION, V118, P672, DOI 10.1161/CIRCULATIONAHA.107.753152; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Zulman DM, 2008, MILBANK Q, V86, P557, DOI 10.1111/j.1468-0009.2008.00534.x; 1988, ARCH INTERN MED, V148, P36	25	12	12	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2010	341								c3531	10.1136/bmj.c3531	http://dx.doi.org/10.1136/bmj.c3531			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	634GZ	20667950				2022-12-24	WOS:000280570100001
J	Summers, DM; Johnson, RJ; Allen, J; Fuggle, SV; Collett, D; Watson, CJ; Bradley, JA				Summers, Dominic M.; Johnson, Rachel J.; Allen, Joanne; Fuggle, Susan V.; Collett, David; Watson, Christopher J.; Bradley, J. Andrew			Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study	LANCET			English	Article							DELAYED GRAFT FUNCTION; BEATING DONOR KIDNEYS; RENAL-TRANSPLANTATION; UNITED-KINGDOM; BRAIN-DEATH; HEART; REJECTION; SURVIVAL; ALLOCATION; EXPERIENCE	Background A third of all kidneys from deceased donors in the UK are donated after cardiac death, but concerns have been raised about the long-term outcome of such transplants. We aimed to establish these outcomes for kidneys donated after controlled cardiac death versus brain death, and to identify the factors that affect graft survival and function. Methods We used data from the UK transplant registry to select a cohort of deceased kidney donors and the corresponding transplant recipients (aged years) for transplantations done between Jan 1, 2000, and Dec 31, 2007. Kaplan-Meier estimates were used to assess graft survival, and multivariate analyses were used to identify factors associated with graft survival and with long-term renal function, which was measured from estimated glomerular filtration rate (eGFR). Findings 9134 kidney transplants were done in 23 centres; 8289 kidneys were donated after brain death and 845 after controlled cardiac death. First-time recipients of kidneys from cardiac-death donors (n=739) or brain-death donors (n=6759) showed no difference in graft survival up to 5 years (hazard ratio 1.01, 95% CI 0.83 to 1.19, p=0.97), or in eGFR at 1-5 years after transplantation (at 12 months -0.36 mL/min per 1.73 m(2), 95% CI -2.00 to 1.27, p=0.66). For recipients of kidneys from cardiac-death donors, increasing age of donor and recipient, repeat transplantation, and cold ischaemic time of more than 12 h were associated with worse graft survival; grafts from cardiac-death donors that were poorly matched for HLA had an association with inferior outcome that was not significant, and delayed graft function and warm ischaemic time had no effect on outcome. Interpretation Kidneys from controlled cardiac-death donors provide good graft survival and function up to 5 years in first-time recipients, and are equivalent to kidneys from brain-death donors. Allocation policy for kidneys from cardiac-death donors should reduce cold ischaemic time, avoid large age mismatches between donors and recipients, and restrict use of kidneys poorly matched for HLA in young recipients.	[Summers, Dominic M.; Watson, Christopher J.; Bradley, J. Andrew] Univ Cambridge, Sch Clin Med, Dept Surg, Cambridge, England; [Summers, Dominic M.; Watson, Christopher J.; Bradley, J. Andrew] Biomed Res Ctr, Cambridge Natl Inst Hlth Res, Cambridge, England; [Summers, Dominic M.; Johnson, Rachel J.; Allen, Joanne; Fuggle, Susan V.; Collett, David] Natl Hlth Serv Blood & Transplant, Bristol, Avon, England; [Fuggle, Susan V.] Univ Oxford, Nuffield Dept Surg, Oxford, England	University of Cambridge; University of Cambridge; NHS Blood & Transplant (NHSBT); University of Oxford	Bradley, JA (corresponding author), Addenbrookes Hosp, Univ Dept Surg, Box 202, Cambridge CB2 0QQ, England.	jab52@cam.ac.uk	Summers, D. M./H-8678-2019	Summers, D. M./0000-0003-3360-0726; Collett, David/0000-0003-4861-7627; Johnson, Rachel/0000-0001-9199-3455	Astellas; Novartis; Roche; Wyeth; Organ Recovery Systems; NHS Blood and Transplant; Cambridge NIHR Biomedical Research Centre	Astellas(Astellas Pharmaceuticals); Novartis(Novartis); Roche(Roche Holding); Wyeth(Wyeth); Organ Recovery Systems; NHS Blood and Transplant; Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR))	JAB is a trustee of Roche Organ Transplant Foundation; his department has received grants from pharmaceutical companies which market immunosuppressive therapy, notably Astellas, Novartis, Roche, and Wyeth, and from machine preservation manufacturers Organ Recovery Systems; and he has received travel and accommodation costs from Astellas to attend a training course. CJW has received research grants and honoraria for travel, accommodation, and registration to transplant conferences from Astellas, Novartis, Roche, and Wyeth; and research grants from Organ Recovery Systems. All other authors declare that they have no conflicts of interest.; This study was supported by NHS Blood and Transplant, and Cambridge NIHR Biomedical Research Centre. DMS was supported by a grant from NHS Blood and Transplant.	Barlow AD, 2009, BRIT J SURG, V96, P685, DOI 10.1002/bjs.6607; Bederson JB, 2009, STROKE, V40, P994, DOI 10.1161/STROKEAHA.108.191395; *BRIT TRANSPL SOC, 2004, GUID REL SOL ORG TRA; Brook NR, 2003, AM J TRANSPLANT, V3, P614, DOI 10.1034/j.1600-6143.2003.00113.x; Cecka J Michael, 2008, Clin Transpl, P1; Chapman J, 2006, TRANSPL INT, V19, P715, DOI 10.1111/j.1432-2277.2006.00337.x; Cooper JT, 2004, AM J TRANSPLANT, V4, P1490, DOI 10.1111/j.1600-6143.2004.00531.x; De Fijter JW, 2001, J AM SOC NEPHROL, V12, P1538, DOI 10.1681/ASN.V1271538; Devey LR, 2007, TRANSPLANTATION, V84, P70, DOI 10.1097/01.tp.0000268072.04260.69; Doshi MD, 2007, AM J TRANSPLANT, V7, P122, DOI 10.1111/j.1600-6143.2006.01587.x; Johnson Rachel, 2008, Clin Transpl, P75; Johnson RJ, 2010, TRANSPLANTATION, V89, P387, DOI 10.1097/TP.0b013e3181c9029d; Johnson RJ, 2010, TRANSPLANTATION, V89, P379, DOI 10.1097/TP.0b013e3181c90287; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kokkinos C, 2007, TRANSPLANTATION, V83, P1193, DOI 10.1097/01.tp.0000261710.53848.51; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; Lachmann N, 2009, TRANSPLANTATION, V87, P1505, DOI 10.1097/TP.0b013e3181a44206; LEVEY AS, 2000, J AM SOC NEPHROL, V11, P828; Locke JE, 2007, AM J TRANSPLANT, V7, P1797, DOI 10.1111/j.1600-6143.2007.01852.x; Moreso F, 1999, NEPHROL DIAL TRANSPL, V14, P930, DOI 10.1093/ndt/14.4.930; Morris PJ, 1999, LANCET, V354, P1147, DOI 10.1016/S0140-6736(99)01104-6; *NAT HLTH SERV BLO, TRANSPL ACT UK 2008; Novitzky D, 1997, TRANSPLANT P, V29, P3770, DOI 10.1016/S0041-1345(97)01149-4; OPELZ G, 1992, TRANSPLANT INT, V5, pS601; Pessione F, 2003, TRANSPLANTATION, V75, P361, DOI 10.1097/01.TP.0000044171.97375.61; Pratschke J, 1999, TRANSPLANTATION, V67, P343, DOI 10.1097/00007890-199902150-00001; Pratschke J, 2000, ANN SURG, V232, P263, DOI 10.1097/00000658-200008000-00017; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Rudich SM, 2002, TRANSPLANTATION, V74, P1715, DOI 10.1097/01.TP.0000039165.58547.87; Shoskes DA, 1998, TRANSPLANTATION, V66, P1697, DOI 10.1097/00007890-199812270-00022; Taylor CJ, 2010, TRANSPLANTATION, V89, P185, DOI 10.1097/TP.0b013e3181c926f2; Wells AC, 2009, BRIT J SURG, V96, P299, DOI 10.1002/bjs.6485; Wolfe RA, 2009, AM J TRANSPLANT, V9, P869, DOI 10.1111/j.1600-6143.2009.02564.x	33	236	245	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2010	376	9749					1303	1311		10.1016/S0140-6736(10)60827-6	http://dx.doi.org/10.1016/S0140-6736(10)60827-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671RX	20727576				2022-12-24	WOS:000283528600032
J	Fujii, T; Iwane, AH; Yanagida, T; Namba, K				Fujii, Takashi; Iwane, Atsuko H.; Yanagida, Toshio; Namba, Keiichi			Direct visualization of secondary structures of F-actin by electron cryomicroscopy	NATURE			English	Article							TOBACCO-MOSAIC-VIRUS; CRYO-EM STRUCTURE; ATOMIC MODEL; MICROSCOPY; RESOLUTION; FILAMENT; COMPLEX; RECONSTRUCTION; ARRANGEMENT; CHAPERONIN	F-actin is a helical assembly of actin, which is a component of muscle fibres essential for contraction and has a crucial role in numerous cellular processes, such as the formation of lamellipodia and filopodia(1,2), as the most abundant component and regulator of cytoskeletons by dynamic assembly and disassembly (from G-actin to F-actin and vice versa). Actin is a ubiquitous protein and is involved in important biological functions, but the definitive high-resolution structure of F-actin remains unknown. Although a recent atomic model well reproduced X-ray fibre diffraction intensity data from a highly oriented liquid-crystalline sol specimen(3), its refinement without experimental phase information has certain limitations. Direct visualization of the structure by electron cryomicroscopy, however, has been difficult because it is relatively thin and flexible. Here we report the F-actin structure at 6.6 angstrom resolution, made obtainable by recent advances in electron cryomicroscopy. The density map clearly resolves all the secondary structures of G-actin, such as alpha-helices, beta-structures and loops, and makes unambiguous modelling and refinement possible. Complex domain motions that open the nucleotide-binding pocket on F-actin formation, specific D-loop and terminal conformations, and relatively tight axial but markedly loose interprotofilament interactions hydrophilic in nature are revealed in the F-actin model, and all seem to be important for dynamic functions of actin.	[Fujii, Takashi; Iwane, Atsuko H.; Yanagida, Toshio; Namba, Keiichi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Osaka University	Namba, K (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	keiichi@fbs.osaka-u.ac.jp	Namba, Keiichi/A-9406-2016	Iwane, Atsuko/0000-0003-2641-2268	Ministry of Education, Culture, Sports, Science and Technology of Japan [16087207, 21227006]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T. Kato for setting up and managing our cryoEM and computing facilities for high-throughput, high-resolution image analysis, and I. Tokita, M. Urabe and JEOL for maintaining the electron cryomicroscope in the best conditions. We also thank E. Egelman for his help in the use of the iterative helical real-space refinement method in the early stages of this study, and F. Oosawa, S. Asakura, H. Hotani and D. L. D. Caspar for their discussions, continuous support and encouragement. T. F. was a research fellow of the Japan Society for the Promotion of Science. This work was supported in part by Grants-in-Aid for Scientific Research to K. N. (16087207 and 21227006) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	BELA N, 1965, J AM CHEM SOC, V87, P2480; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Cong Y, 2010, P NATL ACAD SCI USA, V107, P4967, DOI 10.1073/pnas.0913774107; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fujii T, 2009, STRUCTURE, V17, P1485, DOI 10.1016/j.str.2009.08.017; Fujiwara I, 2007, P NATL ACAD SCI USA, V104, P8827, DOI 10.1073/pnas.0702510104; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; NAMBA K, 1986, SCIENCE, V231, P1401, DOI 10.1126/science.3952490; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Sander B, 2005, J STRUCT BIOL, V151, P92, DOI 10.1016/j.jsb,2005.04.004; Schmid MF, 2004, NATURE, V431, P104, DOI 10.1038/nature02881; SUTOH K, 1982, BIOCHEMISTRY-US, V21, P3654, DOI 10.1021/bi00258a020; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Yonekura K, 2006, J STRUCT BIOL, V156, P524, DOI 10.1016/j.jsb.2006.07.016; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Zhang JJ, 2010, NATURE, V463, P379, DOI 10.1038/nature08701; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041	35	269	273	0	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					724	U117		10.1038/nature09372	http://dx.doi.org/10.1038/nature09372			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20844487				2022-12-24	WOS:000282572500042
J	Montessuit, S; Somasekharan, SP; Terrones, O; Lucken-Ardjomande, S; Herzig, S; Schwarzenbacher, R; Manstein, DJ; Bossy-Wetzel, E; Basanez, G; Meda, P; Martinou, JC				Montessuit, Sylvie; Somasekharan, Syam Prakash; Terrones, Oihana; Lucken-Ardjomande, Safa; Herzig, Sebastien; Schwarzenbacher, Robert; Manstein, Dietmar J.; Bossy-Wetzel, Ella; Basanez, Gorka; Meda, Paolo; Martinou, Jean-Claude			Membrane Remodeling Induced by the Dynamin-Related Protein Drp1 Stimulates Bax Oligomerization	CELL			English	Article							CYTOCHROME-C RELEASE; BCL-2 FAMILY-MEMBERS; MITOCHONDRIAL OUTER-MEMBRANE; CELL-DEATH; APOPTOTIC PROTEINS; FISSION; FUSION; PERMEABILIZATION; ACTIVATION; ASSOCIATION	In response to many apoptotic stimuli, oligomerization of Bax is essential for mitochondrial outer membrane permeabilization and the ensuing release of cytochrome c. These events are accompanied by mitochondrial fission that appears to require Drp1, a large GTPase of the dynamin superfamily. Loss of Drp1 leads to decreased cytochrome c release by a mechanism that is poorly understood. Here we show that Drp1 stimulates tBid-induced Bax oligomerization and cytochrome c release by promoting tethering and hemifusion of membranes in vitro. This function of Drp1 is independent of its GTPase activity and relies on arginine 247 and the presence of cardiolipin in membranes. In cells, overexpression of Drp1 R247A/E delays Bax oligomerization and cell death. Our findings uncover a function of Drp1 and provide insight into the mechanism of Bax oligomerization.	[Montessuit, Sylvie; Somasekharan, Syam Prakash; Terrones, Oihana; Lucken-Ardjomande, Safa; Herzig, Sebastien; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Schwarzenbacher, Robert] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Bossy-Wetzel, Ella] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Basanez, Gorka] Univ Pais Vasco Euskal Herriko Unibertsitatea, CSIC, Ctr Mixto, Unidad Biofis, Bilbao 48080, Spain; [Meda, Paolo] Ctr Med Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva; Salzburg University; Hannover Medical School; State University System of Florida; University of Central Florida; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Geneva	Martinou, JC (corresponding author), Univ Geneva, Dept Cell Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jean-claude.martinou@unige.ch	Herzig, Sebastien/AAA-8853-2019; Basanez, Gorka/L-9509-2014; Terrones, Oihana/AAA-8903-2019; Manstein, Dietmar J./AAG-2640-2019; Manstein, Dietmar J. J/M-1034-2013; Terrones, Oihana/I-4023-2015	Herzig, Sebastien/0000-0002-9329-2860; Basanez, Gorka/0000-0002-7475-7861; Manstein, Dietmar J./0000-0003-0763-0147; Manstein, Dietmar J. J/0000-0003-0763-0147; Terrones, Oihana/0000-0001-7421-6486; Somasekharan, Syam/0000-0002-9006-8206; martinou, Jean-claude/0000-0002-9847-2051; Lucken Ardjomande Hasler, Safa/0000-0003-0845-3584	Swiss National Science Foundation [310000-109402]; Juvenile Diabetes Foundation International [1-2007-158]; European Union [222980]; DFG [MA 1081/7-2]; NATIONAL EYE INSTITUTE [R01EY016164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047456, R01NS055193] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Foundation International; European Union(European Commission); DFG(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank P. Chiesa and D. Caille for excellent technical assistance, Dr R. Cartoni for help with electron microscopy, Dr D. Tondera for some exploratory work on Bax oligomerization, Dr L. Chernomordik and Dr M. Schick for helpful discussions on the process of membrane hemifusion and fusion pore formation, Dr T. Halazonetis for help with the 3D structure of Drp1, and Dr. M. Koppen and Alexis Jourdain for careful reading of the manuscript. P. M. is supported by grants from the Swiss National Science Foundation (310000-109402), the Juvenile Diabetes Foundation International (1-2007-158), and the European Union (FP7 BETAIMAGE 222980). D.J.M. is supported by DFG grant MA 1081/7-2. E. B.-W. is supported by NIH grants RO1 EY016164, RO1 NS0474556, and RO1 NS055193 (E. B. W.) and EU grants MCEXT-033534 and MCIRG-046536 (R. S.). This work was funded by the Swiss National Science Foundation (subsidy 31003A-124968/1 to J.-C. M.), the European union (UE6-ONCODEATH-037278), OncoSuisse, and the Geneva	ARDAIL D, 1990, J BIOL CHEM, V265, P18797; Basanez G, 1996, BIOCHEMISTRY-US, V35, P7506, DOI 10.1021/bi953084a; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; CHERNOMORDIK LV, 1993, FEBS LETT, V318, P71, DOI 10.1016/0014-5793(93)81330-3; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; ELLENS H, 1985, BIOCHEMISTRY-US, V24, P3099, DOI 10.1021/bi00334a005; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Heymann JAW, 2009, J CELL SCI, V122, P3427, DOI 10.1242/jcs.051714; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kawai C, 2005, J BIOL CHEM, V280, P34709, DOI 10.1074/jbc.M412532200; Kluck RM, 1999, J CELL BIOL, V147, P809, DOI 10.1083/jcb.147.4.809; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P484, DOI 10.1038/sj.cdd.4402280; Lucken-Ardjomande S, 2005, J CELL SCI, V118, P473, DOI 10.1242/jcs.01654; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Ortiz A, 1999, BIOPHYS J, V77, P2003, DOI 10.1016/S0006-3495(99)77041-4; Ott M, 2007, J BIOL CHEM, V282, P27633, DOI 10.1074/jbc.M703155200; Parone PA, 2006, MOL CELL BIOL, V26, P7397, DOI 10.1128/MCB.02282-05; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Schinzel A, 2004, BBA-MOL CELL RES, V1644, P95, DOI 10.1016/j.bbamcr.2003.09.006; Sheridan C, 2008, MOL CELL, V31, P570, DOI 10.1016/j.molcel.2008.08.002; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Tan KO, 2005, P NATL ACAD SCI USA, V102, P14623, DOI 10.1073/pnas.0503524102; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wasiak S, 2007, J CELL BIOL, V177, P439, DOI 10.1083/jcb.200610042; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	51	310	320	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					889	901		10.1016/j.cell.2010.08.017	http://dx.doi.org/10.1016/j.cell.2010.08.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850011	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000281855000012
J	Tong, C; Li, P; Wu, NL; Yan, YZ; Ying, QL				Tong, Chang; Li, Ping; Wu, Nancy L.; Yan, Youzhen; Ying, Qi-Long			Production of p53 gene knockout rats by homologous recombination in embryonic stem cells	NATURE			English	Article							MUTAGENESIS; MICE; GENERATION; SELECTION	The use of homologous recombination to modify genes in embryonic stem (ES) cells provides a powerful means to elucidate gene function and create disease models(1). Application of this technology to engineer genes in rats has not previously been possible because of the absence of germline-competent ES cells in this species. We have recently established authentic rat ES cells(2,3). Here we report the generation of gene knockout rats using the ES-cell-based gene targeting technology. We designed a targeting vector to disrupt the tumour suppressor gene p53 (also known as Tp53) in rat ES cells by means of homologous recombination. p53 gene-targeted rat ES cells can be routinely generated. Furthermore, the p53 gene-targeted mutation in the rat ES-cell genome can transmit through the germ line via ES-cell rat chimaeras to create p53 gene knockout rats. The rat is the most widely used animal model in biological research(4-7). The establishment of gene targeting technology in rat ES cells, in combination with advances in genomics and the vast amount of research data on physiology and pharmacology in this species, now provide a powerful new platform for the study of human disease.	[Tong, Chang; Li, Ping; Ying, Qi-Long] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Wu, Nancy L.; Yan, Youzhen] Univ So Calif, Keck Sch Med, Norris Canc Ctr Transgen, Knockout Core Facil, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Ying, QL (corresponding author), Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	qying@usc.edu			NIH/NCRR [1R01 RR025881]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025881] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010926] Funding Source: NIH RePORTER	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a NIH/NCRR grant to Q.-L.Y. (1R01 RR025881). We thank members of the Ying laboratory and the USC Stem Cell Core for technical assistance; G. Chester for ordering rats; R. Montano and colleagues for rat husbandry; T. Saunders, E. Bryda and M. Pera for critical reading of the manuscript; E. Kho for financial support. We are also grateful to M. Pera and R. Maxson for their support and encouragement.	Adams DJ, 2008, PHYSIOL GENOMICS, V34, P225, DOI 10.1152/physiolgenomics.90242.2008; Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Cozzi Jean, 2009, Methods Mol Biol, V561, P73, DOI 10.1007/978-1-60327-019-9_5; Feil R, 2007, Handb Exp Pharmacol, P3; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; GILL TJ, 1989, SCIENCE, V245, P269, DOI 10.1126/science.2665079; Hughes ED, 2007, MAMM GENOME, V18, P549, DOI 10.1007/s00335-007-9054-0; Izsvak Z, 2010, NAT METHODS, V7, P443, DOI [10.1038/NMETH.1461, 10.1038/nmeth.1461]; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Kitada K, 2007, NAT METHODS, V4, P131, DOI 10.1038/nmeth1002; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liu X, 1997, DEV DYNAM, V209, P85; Lu BS, 2007, MAMM GENOME, V18, P338, DOI 10.1007/s00335-007-9025-5; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; MCCARRICK JW, 1993, TRANSGENIC RES, V2, P183, DOI 10.1007/BF01977348; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2003, MANIPULATING MOUSE E; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Sambrook J, 2001, MOL CLONING LAB MANU; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830	29	208	284	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2010	467	7312					211	U98		10.1038/nature09368	http://dx.doi.org/10.1038/nature09368			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20703227	Green Accepted			2022-12-24	WOS:000281616300035
J	Niu, HY; Chung, WH; Zhu, Z; Kwon, Y; Zhao, WX; Chi, P; Prakash, R; Seong, CH; Liu, DQ; Lu, L; Ira, G; Sung, P				Niu, Hengyao; Chung, Woo-Hyun; Zhu, Zhu; Kwon, Youngho; Zhao, Weixing; Chi, Peter; Prakash, Rohit; Seong, Changhyun; Liu, Dongqing; Lu, Lucy; Ira, Grzegorz; Sung, Patrick			Mechanism of the ATP-dependent DNA end-resection machinery from Saccharomyces cerevisiae	NATURE			English	Article							REPLICATION-PROTEIN-A; HOMOLOGOUS RECOMBINATION; BREAK REPAIR; IN-VITRO; YEAST; HELICASE; MRE11; SGS1; RECOGNITION; MAINTENANCE	If not properly processed and repaired, DNA double-strand breaks (DSBs) can give rise to deleterious chromosome rearrangements, which could ultimately lead to the tumour phenotype(1,2). DSB ends are resected in a 5' to 3' fashion in cells, to yield single-stranded DNA (ssDNA) for the recruitment of factors critical for DNA damage checkpoint activation and repair by homologous recombination 2. The resection process involves redundant pathways consisting of nucleases, DNA helicases and associated proteins(3). Being guided by recent genetic studies(4-6), we have reconstituted the first eukaryotic ATP-dependent DNA end-resection machinery comprising the Saccharomyces cerevisiae Mre11-Rad50-Xrs2 (MRX) complex, the Sgs1-Top3-Rmi1 complex, Dna2 protein and the heterotrimeric ssDNA-binding protein RPA. Here we show that DNA strand separation during end resection is mediated by the Sgs1 helicase function, in a manner that is enhanced by Top3-Rmi1 and MRX. In congruence with genetic observations(6), although the Dna2 nuclease activity is critical for resection, the Mre11 nuclease activity is dispensable. By examining the top3 Y356F allele and its encoded protein, we provide evidence that the topoisomerase activity of Top3, although critical for the suppression of crossover recombination(2,7), is not needed for resection either in cells or in the reconstituted system. Our results also unveil a multifaceted role of RPA, in the sequestration of ssDNA generated by DNA unwinding, enhancement of 5' strand incision, and protection of the 3' strand. Our reconstituted system should serve as a useful model for delineating the mechanistic intricacy of the DNA break resection process in eukaryotes.	[Chung, Woo-Hyun; Zhu, Zhu; Ira, Grzegorz] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Niu, Hengyao; Kwon, Youngho; Zhao, Weixing; Chi, Peter; Prakash, Rohit; Seong, Changhyun; Liu, Dongqing; Lu, Lucy; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Baylor College of Medicine; Yale University	Ira, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	gira@bcm.edu; patrick.sung@yale.edu	Niu, Hengyao/AAE-9269-2020; zhao, weixing/H-3154-2013; Niu, Hengyao/J-4593-2013; Niu, Hengyao/B-5026-2014; Chi, Peter/AAI-1580-2019; Classen, Scott/AAY-8176-2020; Huang, Wenchi/F-3981-2010	Chi, Peter/0000-0001-9229-8729; Huang, Wenchi/0000-0001-5556-1460; zhao, weixing/0000-0001-5746-3696	US National Institutes of Health; Susan G. Komen for the Cure Foundation; NATIONAL CANCER INSTITUTE [R01CA146940, P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015252, R01ES007061, R01ES015632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057814, R01GM080600] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Campbell, S. Brill and L. Symington for providing materials, X. Xue for the double Holliday junction substrate and S. Kowalczykowski for communicating results. This work was supported by grants from the US National Institutes of Health and by a postdoctoral fellowship from the Susan G. Komen for the Cure Foundation.	Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bressan DA, 1998, GENETICS, V150, P591; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lu JA, 1996, NATURE, V383, P678, DOI 10.1038/383678a0; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Moreau S, 1999, MOL CELL BIOL, V19, P556; Niu HY, 2009, GENE DEV, V23, P1481, DOI 10.1101/gad.1824209; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Trujillo KM, 2003, J BIOL CHEM, V278, P48957, DOI 10.1074/jbc.M309877200; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	29	279	282	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					108	U143		10.1038/nature09318	http://dx.doi.org/10.1038/nature09318			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811460	Green Accepted			2022-12-24	WOS:000281461200045
J	Machlis, GE; McNutt, MK				Machlis, Gary E.; McNutt, Marcia K.			Scenario-Building for the Deepwater Horizon Oil Spill	SCIENCE			English	Editorial Material							CONSERVATION		[Machlis, Gary E.] US Dept Interior, Strateg Sci Working Grp, Washington, DC 20024 USA; [Machlis, Gary E.] Natl Pk Serv, Washington, DC 20024 USA; [McNutt, Marcia K.] US Geol Survey, Washington, DC 20024 USA	United States Department of the Interior; United States Department of the Interior; United States Department of the Interior; United States Geological Survey	Machlis, GE (corresponding author), US Dept Interior, Strateg Sci Working Grp, Washington, DC 20024 USA.	gary_machlis@nps.gov		McNutt, Marcia/0000-0003-0117-7716; Machlis, Gary/0000-0002-8915-5695				Burley D, 2007, ORGAN ENVIRON, V20, P347, DOI 10.1177/1086026607305739; Castillo S. A., 1996, J COAST CONSERV, V2, P13, DOI DOI 10.1007/BF02743033; Chermack T.J., 2001, FUTURES RES Q, V17, P7, DOI DOI 10.1016/j.futures.2005.12.010; Colten C.E., 2008, COMMUNITY RESILIENCE; *DEP INT, 2010, STRAT SCI WORK GROUP; Felder D. L., 2009, GULF MEXICO ORIGIN W, V1, P1; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Kates RW, 2006, P NATL ACAD SCI USA, V103, P14653, DOI 10.1073/pnas.0605726103; Kates RW., 1977, RECONSTRUCTION FOLLO, P261; KHAN H, 1965, THINKING UNTHINKABLE; Machlis GE, 1997, SOC NATUR RESOUR, V10, P347, DOI 10.1080/08941929709381034; MAGUIRE JJ, 2005, FISHERIES TOPICS ECO; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Rabalais NN, 2001, J ENVIRON QUAL, V30, P320, DOI 10.2134/jeq2001.302320x; Robison BH, 2009, CONSERV BIOL, V23, P847, DOI 10.1111/j.1523-1739.2009.01219.x; Sheppard ES., 2004, SCALE GEOGRAPHIC INQ, DOI [10.1002/9780470999141, DOI 10.1002/9780470999141]; Tibbetts J, 2004, ENVIRON HEALTH PERSP, V112, pA282, DOI 10.1289/ehp.112-a282; *US DOI, DEEPW HOR RESP; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; [No title captured], DOI DOI 10.1093/LPR/2.1.25	20	32	32	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2010	329	5995					1018	1019		10.1126/science.1195382	http://dx.doi.org/10.1126/science.1195382			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798302				2022-12-24	WOS:000281253500020
J	Livingston, G; Leavey, G; Manela, M; Livingston, D; Rait, G; Sampson, E; Bavishi, S; Shahriyarmolki, K; Cooper, C				Livingston, Gill; Leavey, Gerard; Manela, Monica; Livingston, Deborah; Rait, Greta; Sampson, Elizabeth; Bavishi, Shilpa; Shahriyarmolki, Khodayar; Cooper, Claudia			Making decisions for people with dementia who lack capacity: qualitative study of family carers in UK	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CAREGIVERS; MEMBER	Objective To identify common difficult decisions made by family carers on behalf of people with dementia, and facilitators of and barriers to such decisions, in order to produce information for family carers about overcoming barriers. Design Qualitative study to delineate decision areas through focus groups and complexity of decision making in individual interviews. Setting Community settings in London. Participants 43 family carers of people with dementia in focus groups and 46 carers who had already made such decisions in individual interviews. Results Family carers identified five core problematic areas of decision making: accessing dementia related health and social services; care homes; legal-financial matters; non-dementia related health care; and making plans for the person with dementia if the carer became too ill to care for them. They highlighted the difficulties in making proxy decisions, especially against active resistance, and their altered role of patient manager while still a family member. Families devised strategies to gain agreement in order to ensure that the person with dementia retained dignity. Conclusions The following strategies helped with implementation of decisions: introducing change slowly; organising legal changes for the carer as well as the patient; involving a professional to persuade the patient to accept services; and emphasising that services optimised, not impeded, independence. To access services, carers made patients' general practice appointments, accompanied them to the surgery, pointed out symptoms, gained permission to receive confidential information, asked for referral to specialist services, and used professionals' authority to gain patients' agreement. End of life decisions were particularly difficult. They were helped by knowledge of the person with dementia's previous views, clear prognostic information, and family support. Information sheets to help carers to overcome barriers to proxy decision making have been developed; their impact in practice has yet to be evaluated.	[Livingston, Gill; Manela, Monica; Livingston, Deborah; Sampson, Elizabeth; Bavishi, Shilpa; Shahriyarmolki, Khodayar; Cooper, Claudia] UCL, Dept Mental Hlth Sci, London W1W 7FJ, England; [Leavey, Gerard] NIAMH, Belfast BT7 1HE, Antrim, North Ireland; [Leavey, Gerard] Univ Ulster, Belfast BT7 1HE, Antrim, North Ireland; [Rait, Greta] MRC Gen Practice Res Framework, London NW1 2ND, England	University of London; University College London; Ulster University	Livingston, G (corresponding author), UCL, Dept Mental Hlth Sci, London W1W 7FJ, England.	g.livingston@ucl.ac.uk	Cooper, Claudia A/C-1556-2008; Sampson, Elizabeth L/B-8647-2009; Livingston, G/C-7081-2008; Leavey, Gerard/AAU-2912-2020	Cooper, Claudia A/0000-0002-2777-7616; Sampson, Elizabeth L/0000-0001-8929-7362; Leavey, Gerard/0000-0001-8411-8919; Livingston, Gill/0000-0001-6741-5516; Rait, Greta/0000-0002-7216-7294	BUPA Foundation; MRC [MC_U122797163] Funding Source: UKRI; Medical Research Council [MC_U122797163] Funding Source: researchfish	BUPA Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by BUPA Foundation, which had no role in the study design; the collection, analysis, and interpretation of data; or the writing of the article and the decision to submit it for publication. All the researchers are independent of the funders.	*ALZH RES FOR, 2008, AD RES PART INF CONS; [Anonymous], 2009, DEM ETH ISS; Butcher HK, 2001, RES NURS HEALTH, V24, P470, DOI 10.1002/nur.10005; Coffey A, 1996, MAKING SENSE QUALITA; Davies S, 2003, AGEING SOC, V23, P429, DOI 10.1017/S0144686X03001259; Department of Health, 2005, MENT CAP ACT 2005; Department of Health, 2009, LIVING WELL DEMENTIA; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Hansen L, 2004, J NURS SCHOLARSHIP, V36, P233, DOI 10.1111/j.1547-5069.2004.04043.x; Hirschman KB, 2006, AM J GERIAT PSYCHIAT, V14, P659, DOI 10.1097/01.JGP.0000203179.94036.69; Mezey M, 1996, J AM GERIATR SOC, V44, P144, DOI 10.1111/j.1532-5415.1996.tb02430.x; Miles M. B., 2019, QUALITATIVE DATA ANA, V4th; Potkins D, 2000, INT J GERIATR PSYCH, V15, P1005, DOI 10.1002/1099-1166(200011)15:11<1005::AID-GPS223>3.0.CO;2-0; Selwood A, 2007, J AFFECT DISORDERS, V101, P75, DOI 10.1016/j.jad.2006.10.025; Shah A, 2009, INT PSYCHOGERIATR, V21, P922, DOI 10.1017/S1041610209990391; Smith JA, 1996, PSYCHOL HEALTH, V11, P261, DOI 10.1080/08870449608400256; Wackerbarth S, 2002, GERONTOLOGIST, V42, P340; Wald C, 2003, INT J GERIATR PSYCH, V18, P313, DOI 10.1002/gps.828	18	146	147	0	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2010	341								c4184	10.1136/bmj.c4184	http://dx.doi.org/10.1136/bmj.c4184			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	642KT	20719843	Green Submitted, hybrid, Green Published			2022-12-24	WOS:000281213100007
J	Javitt, G				Javitt, Gail			Assign regulation appropriate to the level of risk	NATURE			English	Editorial Material							GENOMIC PROFILES		[Javitt, Gail] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21218 USA	Johns Hopkins University	Javitt, G (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21218 USA.	gjavitt1@jhu.edu						Janssens ACJW, 2008, AM J HUM GENET, V82, P593, DOI 10.1016/j.ajhg.2007.12.020; Javitt Gail H, 2004, Oklahoma Law Rev, V57, P251; Lachance CR, 2010, GENET MED, V12, P304, DOI 10.1097/GIM.0b013e3181dbd8b2; Mihaescu R, 2009, GENET MED, V11, P588, DOI 10.1097/GIM.0b013e3181b13a4f; Offit K, 2008, JAMA-J AM MED ASSOC, V299, P1353, DOI 10.1001/jama.299.11.1353	5	22	22	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					817	818		10.1038/466817a	http://dx.doi.org/10.1038/466817a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	636TT	20703288				2022-12-24	WOS:000280766100017
J	Ritchie, K; Carriere, I; Ritchie, CW; Berr, C; Artero, S; Ancelin, ML				Ritchie, K.; Carriere, I.; Ritchie, C. W.; Berr, C.; Artero, S.; Ancelin, M-L			Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors	BRITISH MEDICAL JOURNAL			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; BLOOD-PRESSURE; ELDERLY-PEOPLE; HEAD-INJURY; OLDEST-OLD; METAANALYSIS; POPULATION; CONSUMPTION; ALCOHOL	Objective To estimate the percentage reduction in incidence of dementia that would be obtained if specific risk factors were eliminated. Design Prospective seven year cohort study. Setting General population, Montpellier, France. Participants 1433 people aged over 65 with a mean baseline age of 72.5 (SD 5.1) years. Main outcome measures Diagnosis of mild cognitive impairment or dementia established by a standardised neurological examination. Results Cox models were constructed to derive hazard ratios and determine confounding and interaction effects for potentially modifiable risk factors for dementia. Mean percentage population attributable fractions were calculated with 95% confidence intervals derived from bootstrapping for seven year incidence of mild cognitive impairment or dementia. The final model retained crystallised intelligence (population attributable fraction 18.11%, 95% confidence interval 10.91% to 25.42%), depression (10.31%, 3.66% to 17.17%), fruit and vegetable consumption (6.46%, 0.15% to 13.06%), diabetes (4.88%, 1.87% to 7.98%), and apolipoprotein E epsilon 4 allele (7.11%, 2.44% to 11.98%). Conclusions Increasing crystallised intelligence and fruit and vegetable consumption and eliminating depression and diabetes are likely to have the biggest impact on reducing the incidence of dementia, outweighing even the effect of removing the principal known genetic risk factor. Although causal relations cannot be concluded with certainty, the study suggests priorities that may inform public health programmes.	[Ritchie, K.; Carriere, I.; Berr, C.; Artero, S.; Ancelin, M-L] Colombiere Hosp, INSERM, Nervous Syst Pathol Epidemiol & Clin Res U888, F-34093 Montpellier 5, France; [Ritchie, K.; Carriere, I.; Berr, C.; Artero, S.; Ancelin, M-L] Univ Montpellier 1, F-34000 Montpellier, France; [Ritchie, K.; Ritchie, C. W.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Fac Med, London SW7 2AZ, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Imperial College London	Ritchie, K (corresponding author), Colombiere Hosp, INSERM, Nervous Syst Pathol Epidemiol & Clin Res U888, F-34093 Montpellier 5, France.	karen.ritchie@inserm.fr	Artero, Sylvaine/AAE-6059-2020; Carrière, Isabelle/W-8728-2019; Ritchie, Karen/G-3571-2013; Ancelin, Marie-Laure/F-3079-2013; Ancelin, Marie-Laure/L-1198-2019; berr, Claudine/D-5238-2014	Ritchie, Karen/0000-0002-0688-8982; Ancelin, Marie-Laure/0000-0002-1149-4320; Ancelin, Marie-Laure/0000-0002-1149-4320; berr, Claudine/0000-0001-5254-7655; Carriere, Isabelle/0000-0002-3617-0752; Artero, Sylvaine/0000-0002-1671-226X	Novartis; National Research Agency [07 LVIE004]	Novartis(Novartis); National Research Agency(French National Research Agency (ANR))	The Esprit Study was funded by an unconditional grant from Novartis and from the National Research Agency (ANR Project 07 LVIE004). Funding from Novartis was used to purchase equipment and pay for secretarial assistance. ANR funding provided salaries for the interviewers and the costs of clinical and biological examinations. Neither body was involved in the statistical analyses or preparation of the manuscript.	Akbaraly TN, 2009, NEUROLOGY, V73, P854, DOI 10.1212/WNL.0b013e3181b7849b; Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Ancelin ML, 2005, CURR PHARM DESIGN, V11, P4229, DOI 10.2174/138161205774913228; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Artero S, 2006, DEMENT GERIATR COGN, V22, P465, DOI 10.1159/000096287; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; Blair J. R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI DOI 10.1080/13854048908403285; Carriere I, 2009, ARCH INTERN MED, V169, P1317, DOI 10.1001/archinternmed.2009.229; Duron E, 2008, VASC HEALTH RISK MAN, V4, P363; Eriksson UK, 2008, DEMENT GERIATR COGN, V25, P148, DOI 10.1159/000112729; Etminan M, 2003, BMJ-BRIT MED J, V327, P128, DOI 10.1136/bmj.327.7407.128; Farooki A, 2009, NEUROLOGY, V72, P1030; FERRI C, 2005, LANCET, V17, P2112; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; GAMMANPILA UP, 2007, BMC GERIATR, V6, P7; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; Gharibzadeh S, 2007, MED HYPOTHESES, V68, P718, DOI 10.1016/j.mehy.2006.08.019; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3; Harwood DG, 2010, INT J GERIATR PSYCH, V25, P511, DOI 10.1002/gps.2372; Helzner EP, 2009, ARCH NEUROL-CHICAGO, V66, P343, DOI 10.1001/archneur.66.3.343; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Itzhaki RE, 2004, NEUROBIOL AGING, V25, P619, DOI 10.1016/j.neurobiolaging.2003.12.021; Jorm AF, 2001, AUST NZ J PSYCHIAT, V35, P776, DOI 10.1046/j.1440-1614.2001.00967.x; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; LECRUBIER Y, 1997, EUROPEAN PSYCHIAT, V12, P232; LEE Y, 2009, INT PSYCHOGERIATR, V9, P1; LIN C, 2010, BRIT MED J, V340, pB5465; Luchsinger JA, 2004, J AM GERIATR SOC, V52, P540, DOI 10.1111/j.1532-5415.2004.52159.x; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Peila R, 2001, STROKE, V32, P2882, DOI 10.1161/hs1201.100392; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Razay G, 2009, DEMENT GERIATR COGN, V28, P70, DOI 10.1159/000230877; RITCHIE K, 1995, LANCET, V346, P931, DOI 10.1016/S0140-6736(95)91556-7; Ritchie K, 1999, AGE AGEING, V28, P385, DOI 10.1093/ageing/28.4.385; Ritchie K, 2010, J ALZHEIMERS DIS, V20, pS161, DOI 10.3233/JAD-2010-1387; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Ryan J, 2009, NEUROLOGY, V73, P1729, DOI 10.1212/WNL.0b013e3181c34b0c; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Seripa D, 2009, AGEING RES REV, V8, P214, DOI 10.1016/j.arr.2008.12.003; Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43; STERN Y, 1992, ANN NEUROL, V32, P371, DOI 10.1002/ana.410320311; Stewart R, 2002, J AM GERIATR SOC, V50, P1227, DOI 10.1046/j.1532-5415.2002.50309.x; Stewart R, 2007, ARCH NEUROL-CHICAGO, V64, P103, DOI 10.1001/archneur.64.1.103; VANDUIJN CM, 1991, BRIT MED J, V302, P1491, DOI 10.1136/bmj.302.6791.1491; WHITE L, 2006, ALZ DIS ASSOC DIS, V20, P79	52	142	148	2	32	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 5	2010	341								c3885	10.1136/bmj.c3885	http://dx.doi.org/10.1136/bmj.c3885			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636WK	20688841	hybrid, Green Submitted, Green Published			2022-12-24	WOS:000280774200004
J	Rodriguez-Trigo, G; Zock, JP; Pozo-Rodriguez, F; Gomez, FP; Monyarch, G; Bouso, L; Coll, MD; Verea, H; Anto, JM; Fuster, C; Barbera, JA				Rodriguez-Trigo, Gema; Zock, Jan-Paul; Pozo-Rodriguez, Francisco; Gomez, Federico P.; Monyarch, Gemma; Bouso, Laura; Dolors Coll, M.; Verea, Hector; Anto, Josep M.; Fuster, Carme; Albert Barbera, Joan		SEPAR Soc Espanola Neumologia Ciru	Health Changes in Fishermen 2 Years After Clean-up of the Prestige Oil Spill	ANNALS OF INTERNAL MEDICINE			English	Article							EXHALED BREATH CONDENSATE; CHROMOSOMAL-ABERRATIONS; OXIDATIVE STRESS; TANKER BRAER; INCREASED 8-ISOPROSTANE; ASTHMATIC-CHILDREN; REFERENCE VALUES; CANCER-RISK; EXPOSURE; BIOMARKERS	Background: In 2002, the oil tanker Prestige spilled more than 67 000 tons of bunker oil, heavily contaminating the coast of northwestern Spain. Objective: To assess respiratory effects and chromosomal damage in clean-up workers of the oil spill 2 years after the exposure. Design: Cross-sectional study. Setting: Fishermen cooperatives in coastal villages. Participants: Local fishermen who were highly exposed (n = 501) or not exposed (n = 177) to oil 2 years after the spill. Measurements: Respiratory symptoms; forced spirometry; methacholine challenge; markers of oxidative stress (8-isoprostane), airway inflammation (interleukins, tumor necrosis factor-alpha, and interferon-gamma), and growth factor activity in exhaled breath condensate; and chromosomal lesions and structural alterations in circulating lymphocytes. Results: Compared with nonexposed participants, persons exposed to oil were at increased risk for lower respiratory tract symptoms (risk difference, 8.0 [95% CI, 1.1 to 14.8]). Lung function did not significantly differ between the groups. Among nonsmoking participants, exposed individuals had higher exhaled 8-isoprostane levels than nonexposed individuals (geometric mean ratio, 2.5 [CI, 1.7 to 3.7]), and exposed individuals with lower respiratory tract symptoms had higher 8-isoprostane levels than those of exposed individuals without symptoms. Exposed nonsmoking participants also had higher levels of exhaled vascular endothelial growth factor (risk difference, 44.8 [CI, 27.9 to 61.6]) and basic fibroblast growth factor (risk difference, 16.0 [CI, 3.5 to 28.6]). A higher proportion of exposed participants had structural chromosomal alterations (risk difference, 27.4 [CI, 10.0 to 44.8]), predominantly unbalanced alterations. The risk for elevated levels of exhaled 8-isoprostane, vascular endothelial growth factor, and basic fibroblast growth factor and structural chromosomal alterations seemed to increase with intensity of exposure to clean-up work. Limitations: The clinical significance of exhaled biomarkers and chromosomal findings are uncertain. The association between oil exposure and the observed changes may not be causal. The findings may not apply to spills involving other types of oil or to different populations of oil spill workers. Conclusion: Participation in clean-up of a major oil spill was associated with persistent respiratory symptoms, elevated markers of airway injury in breath condensate, and chromosomal damage.	Complexo Hosp Univ A Coruna, La Coruna, Spain; Hosp Clin San Carlos, Madrid, Spain; Univ Hosp 12 Octubre, Madrid, Spain; Autonomous Univ Barcelona, Ctr Res Environm Epidemiol CREAL, Hosp Clin Inst Invest Biomed August Pi & Sunyer I, IMIM Hosp Mar,CIBERESP,Municipal Inst Med Res, Barcelona, Spain; Pompeu Fabra Univ, Barcelona, Spain; Ctr Invest Biomed Red Enfermedades Resp CIBERES, Bunyola, Mallorca, Spain	Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Hospital Clinico San Carlos; Hospital Universitario 12 de Octubre; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Barbera, JA (corresponding author), Hosp Clin Barcelona, Serv Pneumol, Villarroel 170, E-08036 Barcelona, Spain.	jbarbera@clinic.ub.es	Zock, Jan-Paul/P-5034-2018; Burgos, Felip/J-3055-2014; Burgos, Felip/E-5734-2015; Anto, J M/H-2676-2014	Zock, Jan-Paul/0000-0002-2941-6259; Burgos, Felip/0000-0002-4938-4581; Burgos, Felip/0000-0002-4938-4581; Anto, J M/0000-0002-4736-8529; Barbera, Joan Albert/0000-0003-1469-4990; Serrano-Mollar, Anna/0000-0002-4990-8162	Complexo Hospitalario Universitario A Coruna; Instituto de Salud Carlos III/European Regional Development Fund [PI03/1685, PI05/0548, BAE 06/90018, 01-3058]; SEPAR; Centro de Investigacion en Red de Enfermedades Respiratorias	Complexo Hospitalario Universitario A Coruna; Instituto de Salud Carlos III/European Regional Development Fund(Instituto de Salud Carlos IIIEuropean Commission); SEPAR; Centro de Investigacion en Red de Enfermedades Respiratorias	The authors thank the participating fishermen, the staff of their cooperatives, and the efforts made by A. Devesa; the SEPAR-Prestige data collection team (Y. Torralba, A. Souto, M. Rodriguez-Valcarcel, and L. Vazquez-Rey) for their outstanding work; the staff of Complexo Hospitalario Universitario A Coruna (S. Lamela, E. Rodriguez, M. Garea, and M. Saleta) for their support; D. Macfarlane for assistance with data management and reviewing the manuscript; A. Espinosa for her contribution to the statistical analyses; A. Serrano-Mollar and G. Gay for analysis of EBC; A. Lopez-Rodriguez and C. Rodriguez-Escudero, formerly of Servizo Galego de Saude, for their valuable collaboration; and J.L. Alvarez-Sala and J. Ancochea, past presidents of SEPAR, for their initiative and continuous support.; By Instituto de Salud Carlos III/European Regional Development Fund (grants PI03/1685 and PI05/0548), SEPAR, and Centro de Investigacion en Red de Enfermedades Respiratorias. The Instituto de Salud Carlos III/European Regional Development Fund also provided grants to Dr. Rodriguez-Trigo (grant BAE 06/90018) and Dr. Zock (grant Miguel Servet 01-3058).	*AG TOX SUBST DIS, 1995, TOX PROF FUEL OILS A; [Anonymous], 2009, OIL TANK SPILL STAT; Antczak Adam, 2002, Int J Occup Med Environ Health, V15, P317; Au WW, 2007, INT J HYG ENVIR HEAL, V210, P239, DOI 10.1016/j.ijheh.2006.11.001; Barreto M, 2009, CHEST, V135, P66, DOI 10.1378/chest.08-0722; Beinert T, 1999, Eur J Med Res, V4, P328; Biernacki WA, 2003, THORAX, V58, P294, DOI 10.1136/thorax.58.4.294; Bonassi S, 2008, CARCINOGENESIS, V29, P1178, DOI 10.1093/carcin/bgn075; CAMPBELL D, 1993, BRIT MED J, V307, P1251, DOI 10.1136/bmj.307.6914.1251; CAMPBELL D, 1994, BRIT MED J, V309, P773, DOI 10.1136/bmj.309.6957.773; Celik M, 2007, MUTAT RES-GEN TOX EN, V627, P158, DOI 10.1016/j.mrgentox.2006.11.003; Cole J, 1997, ENVIRON MOL MUTAGEN, V30, P97; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; Forni A, 1996, ENVIRON HEALTH PERSP, V104, P1309, DOI 10.2307/3433181; Frohling S, 2008, NEW ENGL J MED, V359, P722, DOI 10.1056/NEJMra0803109; Hagmar L, 2004, CANCER RES, V64, P2258, DOI 10.1158/0008-5472.CAN-03-3360; Holeckova B, 2004, ANN AGR ENV MED, V11, P175; Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705; Idali F, 2006, EUR RESPIR J, V27, P451, DOI 10.1183/09031936.06.00067105; *INT AG RES CANC, 1998, IARC MON OV EV CA S7, V1; Jang An-Soo, 2007, Korean Journal of Internal Medicine, V22, P8; Koutsokera A, 2008, CURR MED CHEM, V15, P620; Laffon B, 2006, FOOD CHEM TOXICOL, V44, P1714, DOI 10.1016/j.fct.2006.05.010; Leung TF, 2005, INT ARCH ALLERGY IMM, V137, P66, DOI 10.1159/000085106; LGSM Shaffer, 2009, ISCN 2009 INT SYSTEM, DOI DOI 10.1007/S00439-009-0726-6; LITTLEFIELD LG, 1986, MUTAT RES, V170, P145, DOI 10.1016/0165-1218(86)90028-5; Lyons RA, 1999, J EPIDEMIOL COMMUN H, V53, P306, DOI 10.1136/jech.53.5.306; McHale Cliona M, 2008, J Natl Cancer Inst Monogr, P74, DOI 10.1093/jncimonographs/lgn010; Meo SA, 2008, MAR POLLUT BULL, V56, P88, DOI 10.1016/j.marpolbul.2007.09.039; Montuschi P, 1999, AM J RESP CRIT CARE, V160, P216, DOI 10.1164/ajrccm.160.1.9809140; Montuschi P, 2000, AM J RESP CRIT CARE, V162, P1175, DOI 10.1164/ajrccm.162.3.2001063; Norppa H, 2006, MUTAT RES-FUND MOL M, V600, P37, DOI 10.1016/j.mrfmmm.2006.05.030; Norppa H, 2004, TOXICOL LETT, V149, P309, DOI 10.1016/j.toxlet.2003.12.042; Pelclova D, 2008, IND HEALTH, V46, P484, DOI 10.2486/indhealth.46.484; Perez-Cadahia B, 2008, MUTAT RES-GEN TOX EN, V653, P117, DOI 10.1016/j.mrgentox.2008.04.002; Perez-Cadahia B, 2007, ENVIRON INT, V33, P176, DOI 10.1016/j.envint.2006.09.006; Podechard N, 2008, TOXICOL LETT, V177, P130, DOI 10.1016/j.toxlet.2008.01.006; ROCA J, 1986, B EUR PHYSIOPATH RES, V22, P217; Rodriguez-Trigo G, 2007, ARCH BRONCONEUMOL, V43, P628; Roma-Torres J, 2006, MUTAT RES-GEN TOX EN, V604, P19, DOI 10.1016/j.mrgentox.2005.12.005; Rossner P, 2005, ENVIRON HEALTH PERSP, V113, P517, DOI 10.1289/ehp.6925; SPRENT J, 1994, SCIENCE, V265, P1395, DOI 10.1126/science.8073282; Tompa A, 2005, INT J HYG ENVIR HEAL, V208, P509, DOI 10.1016/j.ijheh.2005.01.029; Zhang LP, 2002, CRIT REV TOXICOL, V32, P1, DOI 10.1080/20024091064165; Zock JP, 2007, AM J RESP CRIT CARE, V176, P610, DOI 10.1164/rccm.200701-016OC	45	54	55	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 19	2010	153	8					489	498		10.7326/0003-4819-153-8-201010190-00279	http://dx.doi.org/10.7326/0003-4819-153-8-201010190-00279			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	665SA	20733177				2022-12-24	WOS:000283054600001
J	Garattini, S; Bertele, V				Garattini, Silvio; Bertele, Vittorio			Personal View Rosiglitazone and the need for a new drug safety agency	BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK		[Garattini, Silvio] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy; [Bertele, Vittorio] Mario Negri Inst Pharmacol Res, Drug Regulatory Policies Lab, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Garattini, S (corresponding author), Mario Negri Inst Pharmacol Res, Via Eritrea 62, I-20157 Milan, Italy.	silvio.garattini@marionegri.it	Garattini, Silvio/AAA-6390-2020; Bertele, Vittorio/AAA-6461-2020	Garattini, Silvio/0000-0003-0647-9297; Bertele, Vittorio/0000-0002-0032-7033				Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5291; Green J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4444; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761	6	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2010	341								c5506	10.1136/bmj.c5506	http://dx.doi.org/10.1136/bmj.c5506			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663JE	20926483				2022-12-24	WOS:000282879400010
J	Korley, FK; Pham, JC; Kirsch, TD				Korley, Frederick Kofi; Pham, Julius Cuong; Kirsch, Thomas Dean			Use of Advanced Radiology During Visits to US Emergency Departments for Injury-Related Conditions, 1998-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CERVICAL-SPINE INJURY; COMPUTED-TOMOGRAPHY; TRAUMA PATIENTS; RADIATION-EXPOSURE; BLUNT TRAUMA; HEAD TRAUMA; CT; RADIOGRAPHY; CRITERIA; RULE	Context Excessive use of medical imaging increases health care costs and exposure to ionizing radiation (a potential carcinogen) without yielding significant benefits to all patients. Objective To determine whether there has been a change in the prevalence of emergency department visits for injury-related conditions for which computed tomography (CT) or magnetic resonance imaging (MRI) was obtained and whether there has been a change in the diagnosis of life-threatening conditions and patient disposition. Design, Setting, and Participants Retrospective cross-sectional analysis of emergency department visits using data from the National Hospital Ambulatory Medical Care Survey (1998-2007). Sampled visits were weighted to produce estimates for the United States. Main Outcomes Measures Proportion of visits for injury-related conditions during which a CT or MRI was obtained, a life-threatening condition was diagnosed (eg, cervical spine fracture, skull fracture, intracranial bleeding, liver and spleen laceration), and which resulted in hospital and intensive care unit admission. Results The prevalence of CT or MRI use during emergency department visits for injury-related conditions increased from 6% (95% confidence interval [CI], 5%-7%) (257 of 5237 visits) in 1998 to 15% (95% CI, 14%-17%) (981 of 6567 visits) in 2007 (P<.001 for trend). There was a small increase in the prevalence of life-threatening conditions (1.7% [95% CI, 1.2%-2.2%; 59 of 5237 visits] in 1998 and 2.0% [95% CI, 1.6%-2.5%; 142 of 6567 visits] in 2007; P=.04 for trend). There was no change in prevalence of visits during which patients were either admitted to the hospital (5.9% [95% CI, 4.9%-6.9%] in 1998 and 5.5% [95% CI, 4.7%-6.5%] in 2007; P=.50 for trend) or to an intensive care unit (0.62% [95% CI, 0.40%-1.00%] in 1998 and 0.80% [95% CI, 0.53%-1.21%] in 2007; P=.14 for trend). Visits during which CT or MRI was obtained lasted 126 minutes (95% CI, 123-131 minutes) longer than those for which CT or MRI was not obtained. Conclusion From 1998 to 2007, the prevalence of CT or MRI use during emergency department visits for injury-related conditions increased significantly, without an equal increase in the prevalence of life-threatening conditions. JAMA. 2010; 304(13): 1465-1471	[Korley, Frederick Kofi; Pham, Julius Cuong; Kirsch, Thomas Dean] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Pham, Julius Cuong] Johns Hopkins Univ, Sch Med, Dept Anesthesia & Crit Care Med, Baltimore, MD USA; [Kirsch, Thomas Dean] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Korley, FK (corresponding author), 5801 Smith Ave,Davis Bldg,Ste 3220, Baltimore, MD 21209 USA.	fkorley1@jhmi.edu			National Center Research Resources, National Institutes of Health (NIH) [5KL2RR025006]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025006] Funding Source: NIH RePORTER	National Center Research Resources, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr Korley is supported by the Robert E. Meyerhoff Professorship at the Johns Hopkins University School of Medicine, and by grant 5KL2RR025006 from the National Center Research Resources, a component of the National Institutes of Health (NIH), and the NIH Roadmap for Medical Research.	[Anonymous], 2014, INT CLASS DIS 9 REV; Atzema C, 2004, ANN EMERG MED, V44, P47, DOI 10.1016/j.annemergmed.2004.02.032; Baker LC, 2008, HEALTH AFFAIR, V27, P1467, DOI 10.1377/hlthaff.27.6.1467; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Boland GWL, 2009, EUR RADIOL, V19, P9, DOI 10.1007/s00330-008-1159-7; Boone John M, 2008, J Am Coll Radiol, V5, P132, DOI 10.1016/j.jacr.2007.07.008; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Broder J, 2007, EMERG RADIOL, V14, P227, DOI 10.1007/s10140-007-0618-9; Broder J, 2006, EMERG RADIOL, V13, P25, DOI 10.1007/s10140-006-0493-9; Charlson ME, 2005, J GEN INTERN MED, V20, P497, DOI 10.1111/j.1525-1497.2005.0085.x; Deunk J, 2009, J TRAUMA, V66, P1108, DOI 10.1097/TA.0b013e31817e55c3; Doria AS, 2006, RADIOLOGY, V241, P83, DOI 10.1148/radiol.2411050913; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Griffen MM, 2003, J TRAUMA, V55, P222, DOI 10.1097/01.TA.0000083332.93868.E2; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Holmes JF, 2005, J TRAUMA, V58, P902, DOI 10.1097/01.TA.0000162138.36519.2A; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; MADDEN C, 1995, ACAD EMERG MED, V2, P248, DOI 10.1111/j.1553-2712.1995.tb03217.x; Markel TA, 2009, J TRAUMA, V67, P23, DOI 10.1097/TA.0b013e318184ba9a; McCaig L F, 1994, Vital Health Stat 1, P1; Mitchell AM, 2007, J THROMB HAEMOST, V5, P50, DOI 10.1111/j.1538-7836.2006.02251.x; Nagy KK, 1999, J TRAUMA, V46, P268, DOI 10.1097/00005373-199902000-00012; Pham JC, 2009, ACAD EMERG MED, V16, P949, DOI 10.1111/j.1553-2712.2009.00515.x; Pines JM, 2009, MED CARE, V47, P782, DOI 10.1097/MLR.0b013e31819748e9; PITTS SR, 2008, NATL HLTH STAT REPOR, V7, P1; Prologo JD, 2004, AM J ROENTGENOL, V183, P1093, DOI 10.2214/ajr.183.4.1831093; Salim A, 2006, ARCH SURG-CHICAGO, V141, P468, DOI 10.1001/archsurg.141.5.468; Schneider D, 1979, VITAL HLTH STAT, V2, pi; Self ML, 2003, AM J SURG, V186, P609, DOI 10.1016/j.amjsurg.2003.08.003; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Tien HC, 2007, J TRAUMA, V62, P151, DOI 10.1097/TA.0b013e31802d9700; U.S. Government Accountability Office, MEDICARE B	36	253	257	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1465	1471		10.1001/jama.2010.1408	http://dx.doi.org/10.1001/jama.2010.1408			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658SO	20924012	Bronze			2022-12-24	WOS:000282509900022
J	Keevil, SF; Krestin, GP				Keevil, Stephen F.; Krestin, Gabriel P.			EMF directive still poses a risk to MRI research in Europe	LANCET			English	Editorial Material							EXPOSURE; WORKERS; FUTURE		[Keevil, Stephen F.] Guys & St Thomas NHS Fdn Trust, Dept Med Phys, London SE1 7EH, England; [Keevil, Stephen F.] Kings Coll London, Div Imaging Sci, London WC2R 2LS, England; [Krestin, Gabriel P.] Erasmus MC, Univ Med Ctr, Dept Radiol, Rotterdam, Netherlands	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Erasmus University Rotterdam; Erasmus MC	Keevil, SF (corresponding author), Guys & St Thomas NHS Fdn Trust, Dept Med Phys, London SE1 7EH, England.	stephen.keevil@kcl.ac.uk						Ahlbom A, 1998, HEALTH PHYS, V74, P494; Capstick M, 2008, INVESTIGATION OCCUPA; Crozier S, 2007, J MAGN RESON IMAGING, V26, P1261, DOI 10.1002/jmri.21160; Crozier S, 2007, J MAGN RESON IMAGING, V26, P1236, DOI 10.1002/jmri.21162; *EUR PARL, 2008, OFFICIAL J EUR UNI L, V114; *EUR PARL, 2004, OFFICIAL J EUR UNI L, V159; Hill DLG, 2005, ACAD RADIOL, V12, P1135, DOI 10.1016/j.acra.2005.05.023; International Electrotechnical Commission, 2010, MEDICAL ELECT EQUIPM, V3rd; Keevil SF, 2005, BRIT J RADIOL, V78, P973, DOI 10.1259/bjr/21943393	9	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 2	2010	376	9747					1124	+		10.1016/S0140-6736(10)61387-6	http://dx.doi.org/10.1016/S0140-6736(10)61387-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663UN	20822810				2022-12-24	WOS:000282915700007
J	Hurst, JR; Vestbo, J; Anzueto, A; Locantore, N; Mullerova, H; Tal-Singer, R; Miller, B; Lomas, DA; Agusti, A; MacNee, W; Calverley, P; Rennard, S; Wouters, EFM; Wedzicha, JA				Hurst, John R.; Vestbo, Jorgen; Anzueto, Antonio; Locantore, Nicholas; Muellerova, Hana; Tal-Singer, Ruth; Miller, Bruce; Lomas, David A.; Agusti, Alvar; MacNee, William; Calverley, Peter; Rennard, Stephen; Wouters, Emiel F. M.; Wedzicha, Jadwiga A.		Evaluation COPD Longitudinally	Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COPD EXACERBATIONS; INFLAMMATORY MARKERS; SYMPTOMS; POPULATION; DIAGNOSIS; COHORT	Background: Although we know that exacerbations are key events in chronic obstructive pulmonary disease (COPD), our understanding of their frequency, determinants, and effects is incomplete. In a large observational cohort, we tested the hypothesis that there is a frequent-exacerbation phenotype of COPD that is independent of disease severity. Methods: We analyzed the frequency and associations of exacerbation in 2138 patients enrolled in the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study. Exacerbations were defined as events that led a care provider to prescribe antibiotics or corticosteroids (or both) or that led to hospitalization (severe exacerbations). Exacerbation frequency was observed over a period of 3 years. Results: Exacerbations became more frequent (and more severe) as the severity of COPD increased; exacerbation rates in the first year of follow-up were 0.85 per person for patients with stage 2 COPD (with stage defined in accordance with Global Initiative for Chronic Obstructive Lung Disease [GOLD] stages), 1.34 for patients with stage 3, and 2.00 for patients with stage 4. Overall, 22% of patients with stage 2 disease, 33% with stage 3, and 47% with stage 4 had frequent exacerbations (two or more in the first year of follow-up). The single best predictor of exacerbations, across all GOLD stages, was a history of exacerbations. The frequent-exacerbation phenotype appeared to be relatively stable over a period of 3 years and could be predicted on the basis of the patient's recall of previous treated events. In addition to its association with more severe disease and prior exacerbations, the phenotype was independently associated with a history of gastroesophageal reflux or heartburn, poorer quality of life, and elevated white-cell count. Conclusions: Although exacerbations become more frequent and more severe as COPD progresses, the rate at which they occur appears to reflect an independent susceptibility phenotype. This has implications for the targeting of exacerbation-prevention strategies across the spectrum of disease severity. (Funded by GlaxoSmithKline; ClinicalTrials.gov number, NCT00292552.) N Engl J Med 2010;363:1128-38.	[Hurst, John R.; Wedzicha, Jadwiga A.] UCL Med Sch, Acad Unit Resp Med, London, England; [Vestbo, Jorgen] Hvidovre Univ Hosp, Copenhagen, Denmark; [Vestbo, Jorgen] Univ Copenhagen, Copenhagen, Denmark; [Vestbo, Jorgen] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Translat Med, Resp Res Grp, Manchester, Lancs, England; [Lomas, David A.] Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB2 2QQ, England; [Calverley, Peter] Univ Liverpool, Sch Clin Sci, Dept Resp Med, Liverpool L69 3BX, Merseyside, England; [Anzueto, Antonio] Univ Texas Hlth Sci Ctr San Antonio, Pulm Sect, San Antonio, TX 78229 USA; [Locantore, Nicholas] GlaxoSmithKline Inc, Res Triangle Pk, NC USA; [Muellerova, Hana] GlaxoSmithKline Inc, London, England; [Tal-Singer, Ruth; Miller, Bruce] GlaxoSmithKline Inc, King Of Prussia, PA USA; [Agusti, Alvar] Hosp Clin Barcelona, Inst Torax, CIBER Enfermedades Resp, Barcelona, Spain; [Agusti, Alvar] Fdn Caubet Cimera, Barcelona, Spain; [MacNee, William] Univ Edinburgh, ELEGI Colt Res Labs, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Rennard, Stephen] Nebraska Med Ctr, Dept Pulm & Crit Care Med, Omaha, NE USA; [Wouters, Emiel F. M.] Maastricht Univ Med Ctr, Dept Resp Med, Maastricht, Netherlands	University of London; University College London; University of Copenhagen; University of Copenhagen; University of Manchester; University of Cambridge; University of Liverpool; University of Texas System; University of Texas Health San Antonio; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; Atencio Primaria de Menorca; University of Edinburgh; University of Nebraska System; University of Nebraska Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC)	Vestbo, J (corresponding author), Univ Copenhagen, Hvidovre Hosp, Dept Cardiol & Resp Med 253, Kettegaard Alle 30, DK-2650 Hvidovre, Denmark.	jorgen.vestbo@manchester.ac.uk	Coxson, Harvey O/A-9861-2017; Garcia-Navarro, Alvar Agusti/F-4474-2015; Vestbo, Jorgen/Y-2912-2019; Tal-Singer, Ruth/AAQ-2925-2021; Wouters, Emiel/ABD-6200-2021	Coxson, Harvey O/0000-0001-5750-9711; Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Tal-Singer, Ruth/0000-0002-5275-8062; Mullerova, Hana/0000-0002-0949-0101; MacNee, William/0000-0002-3692-1448; Vestbo, Jorgen/0000-0001-6355-6362; Hurst, John/0000-0002-7246-6040	GlaxoSmithKline; Boehringer Ingelheim; Nycomed; Novartis; AstraZeneca; Chiesi; Talecris; Pfizer; Dey Pharma; Bayer Schering Pharma; Schering-Plough; Almirall; Roche; Esteve; SMB; Biomarck; Centocor; Mpex; Nabi; Otsuka; Able Associates; Adelphi Research; APT Pharma; Britnall; Aradign; CommonHealth; Consult Complete; COPD Forum; Data Monitor; Decision Resource; Defined Health; Dey; Dunn Group; Easton Associates; Equinox; Gerson; Infomed; KOL Connection; M. Pankove; MedaCorp; MDRx Financial; Oriel Therapeutics; Pennside; PharmaVentures; Pharmaxis; PriceWaterhouse; Propagate; Pulmatrix; Reckner Associates; Recruiting Resources; Schlesinger Medical; Scimed; Sudler and Hennessey; TargeGen; Theravance; UBC; Uptake Medical; VantagePoint Management; Respifor; MRC [G0800570, G0500306] Funding Source: UKRI; Medical Research Council [G9900991B, G0800570, G0500306] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Boehringer Ingelheim(Boehringer Ingelheim); Nycomed; Novartis(Novartis); AstraZeneca(AstraZeneca); Chiesi(Chiesi Pharmaceuticals Inc); Talecris; Pfizer(Pfizer); Dey Pharma; Bayer Schering Pharma(Bayer AG); Schering-Plough(Merck & CompanySchering Plough Corporation); Almirall(Almirall); Roche(Roche Holding); Esteve; SMB; Biomarck; Centocor; Mpex; Nabi; Otsuka(Otsuka Pharmaceutical); Able Associates; Adelphi Research; APT Pharma; Britnall; Aradign; CommonHealth; Consult Complete; COPD Forum; Data Monitor; Decision Resource; Defined Health; Dey; Dunn Group; Easton Associates; Equinox; Gerson; Infomed; KOL Connection; M. Pankove; MedaCorp; MDRx Financial; Oriel Therapeutics; Pennside; PharmaVentures; Pharmaxis; PriceWaterhouse; Propagate; Pulmatrix; Reckner Associates; Recruiting Resources; Schlesinger Medical; Scimed; Sudler and Hennessey; TargeGen; Theravance; UBC; Uptake Medical; VantagePoint Management; Respifor; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from GlaxoSmithKline (to Drs. Vestbo, Hurst, Anzueto, Lomas, Agusti, MacNee, Calverley, Rennard, Wouters, and Wedzicha).; Dr. Vestbo reports receiving consulting fees from GlaxoSmithKline, Boehringer Ingelheim, Nycomed, Novartis, and AstraZeneca, receiving speaking fees from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Nycomed, and Talecris, and serving as chairman of the GOLD Scientific Committee; Dr. Hurst, receiving consulting fees from AstraZeneca, speaking fees from AstraZeneca, Chiesi, and Pfizer, and travel support from GlaxoSmithKline and AstraZeneca; Dr. Anzueto, consulting fees, speaking fees, and grants from GlaxoSmithKline and consulting fees and speaking fees from Dey Pharma, Pfizer, Boehringer Ingelheim, Bayer Schering Pharma, and Schering-Plough; Dr. Agusti, consulting fees from Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis, Nycomed, and Roche, speaking fees from Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, Esteve, GlaxoSmithKline, Novartis, and Nycomed, grants from Almirall, GlaxoSmithKline, and Nycomed, and travel support from Almirall, AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis, and Nycomed; Dr. MacNee, consulting fees from Boehringer Ingelheim, SMB, GlaxoSmithKline, Pfizer, and AstraZeneca and speaking fees from GlaxoSmithKline and AstraZeneca; Dr. Calverley, receiving consulting fees from GlaxoSmithKline, AstraZeneca, Nycomed, and Boehringer Ingelheim, speaking fees from GlaxoSmithKline and Nycomed, and travel support from Boehringer Ingelheim and providing expert testimony for Forest and Nycomed; Dr. Rennard, receiving grants from AstraZeneca, Biomarck, Centocor, Mpex, Nabi, Novartis, and Otsuka, consulting or speaking fees from Able Associates, Adelphi Research, APT Pharma and Britnall, Aradign, AstraZeneca, Boehringer Ingelheim, Chiesi, CommonHealth, Consult Complete, COPD Forum, Data Monitor, Decision Resource, Defined Health, Dey, Dunn Group, Easton Associates, Equinox, Gerson, GlaxoSmithKline, Infomed, KOL Connection, M. Pankove, MedaCorp, MDRx Financial, Mpex, Oriel Therapeutics, Otsuka, Pennside, PharmaVentures, Pharmaxis, PriceWaterhouse, Propagate, Pulmatrix, Reckner Associates, Recruiting Resources, Roche, Schlesinger Medical, Scimed, Sudler and Hennessey, TargeGen, Theravance, UBC, Uptake Medical, and VantagePoint Management; Dr. Wouters, consulting fees from GlaxoSmithKline and Nycomed, speaking fees from GlaxoSmithKline, Nycomed, and AstraZeneca, and grants from GlaxoSmithKline and AstraZeneca; and Dr. Wedzicha, speaking fees from GlaxoSmithKline, AstraZeneca, Novartis, Bayer, Boehringer Ingelheim, Chiesi, and Respifor, grants from GlaxoSmithKline, AstraZeneca, Chiesi, and Novartis, and travel reimbursements from Boehringer Ingelheim. Drs. Mullerova, Locantore, Miller, and Tal-Singer are employees of GlaxoSmithKline and report owning stocks and shares of GlaxoSmithKline.	Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Bhowmik A, 2000, THORAX, V55, P114, DOI 10.1136/thorax.55.2.114; Burgel PR, 2009, CHEST, V135, P975, DOI 10.1378/chest.08-2062; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; COMSTOCK GW, 1979, AM REV RESPIR DIS, V119, P45; Donaldson GC, 2008, THORAX, V63, P753; Donaldson GC, 2006, THORAX, V61, P164, DOI 10.1136/thx.2005.041806; Donaldson GC, 2005, AM J RESP CRIT CARE, V171, P446, DOI 10.1164/rccm.200408-1054OC; Foreman MG, 2007, EUR RESPIR J, V30, P1124, DOI 10.1183/09031936.00009307; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; HAN MK, 2010, AM J RESP CRIT  0602; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; Langsetmo L, 2008, AM J RESP CRIT CARE, V177, P396, DOI 10.1164/rccm.200708-1290OC; Meguro M, 2007, CHEST, V132, P456, DOI 10.1378/chest.06-0702; Miravitlles M, 2000, RESPIRATION, V67, P495, DOI 10.1159/000067462; RADLOFF LS, 1977, J APPL PSYCHOL MEASU, V1, P385, DOI DOI 10.1177/014662167700100306; Rascon-Aguilar IE, 2006, CHEST, V130, P1096, DOI 10.1378/chest.130.4.1096; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Shahab L, 2006, THORAX, V61, P1043, DOI 10.1136/thx.2006.064410; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Sullivan SD, 2000, CHEST, V117, P5; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8	27	1848	1940	4	149	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2010	363	12					1128	1138		10.1056/NEJMoa0909883	http://dx.doi.org/10.1056/NEJMoa0909883			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	649TD	20843247	Green Published, Green Submitted			2022-12-24	WOS:000281795800007
J	Roffi, M				Roffi, Marco			Is there a role for revascularisation in asymptomatic carotid stenosis? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							ARTERY STENOSIS; ENDARTERECTOMY; STROKE; TRIAL; RISK; ANGIOPLASTY; GUIDELINES; MANAGEMENT		[Roffi, Marco] Univ Hosp Geneva, Div Cardiol, Intervent Cardiol Unit, CH-1211 Geneva, Switzerland	University of Geneva	Roffi, M (corresponding author), Univ Hosp Geneva, Div Cardiol, Intervent Cardiol Unit, Rue Micheli-du-Crest 24, CH-1211 Geneva, Switzerland.	Marco.Roffi@hcuge.ch	Spence, J. David/K-6396-2013	Spence, J. David/0000-0001-7478-1098				Aichner FT, 2009, EUR J NEUROL, V16, P902, DOI 10.1111/j.1468-1331.2009.02614.x; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Chaturvedi S, 2005, NEUROLOGY, V65, P794, DOI 10.1212/01.wnl.0000176036.07558.82; Eckstein HH, 2008, LANCET NEUROL, V7, P893, DOI 10.1016/S1474-4422(08)70196-0; Halliday A, 2004, LANCET, V363, P1491; Hobson RW, 2008, J VASC SURG, V48, P480, DOI 10.1016/j.jvs.2008.05.036; Inzitari D, 2000, NEW ENGL J MED, V342, P1693, DOI 10.1056/NEJM200006083422302; Kakkos SK, 2009, J VASC SURG, V49, P902, DOI 10.1016/j.jvs.2008.10.059; Liapis CD, 2009, EUR J VASC ENDOVASC, V37, pS1, DOI 10.1016/j.ejvs.2008.11.006; Markus HS, 2010, LANCET NEUROL, V9, P663, DOI 10.1016/S1474-4422(10)70120-4; Mas JL, 2008, LANCET NEUROL, V7, P885, DOI 10.1016/S1474-4422(08)70195-9; Nicolaides AN, 2005, EUR J VASC ENDOVASC, V30, P275, DOI 10.1016/j.ejvs.2005.04.031; Sabeti S, 2007, STROKE, V38, P2887, DOI 10.1161/STROKEAHA.107.488387; 2008, CEREBROVASC DIS, V25, P457	14	6	7	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	SEP 15	2010	341								c4898	10.1136/bmj.c4898	http://dx.doi.org/10.1136/bmj.c4898			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653LV	20843932				2022-12-24	WOS:000282093800008
J	Witherden, DA; Verdino, P; Rieder, SE; Garijo, O; Mills, RE; Teyton, L; Fischer, WH; Wilson, IA; Havran, WL				Witherden, Deborah A.; Verdino, Petra; Rieder, Stephanie E.; Garijo, Olivia; Mills, Robyn E.; Teyton, Luc; Fischer, Wolfgang H.; Wilson, Ian A.; Havran, Wendy L.			The Junctional Adhesion Molecule JAML Is a Costimulatory Receptor for Epithelial gamma delta T Cell Activation	SCIENCE			English	Article							ADENOVIRUS RECEPTOR; SKIN; CAR; COXSACKIE; RECOGNITION; HOMEOSTASIS; PROTEIN	gamma delta T cells present in epithelial tissues provide a crucial first line of defense against environmental insults, including infection, trauma, and malignancy, yet the molecular events surrounding their activation remain poorly defined. Here we identify an epithelial gamma delta T cell-specific costimulatory molecule, junctional adhesion molecule-like protein (JAML). Binding of JAML to its ligand Coxsackie and adenovirus receptor (CAR) provides costimulation leading to cellular proliferation and cytokine and growth factor production. Inhibition of JAML costimulation leads to diminished gamma delta T cell activation and delayed wound closure akin to that seen in the absence of gamma delta T cells. Our results identify JAML as a crucial component of epithelial gamma delta T cell biology and have broader implications for CAR and JAML in tissue homeostasis and repair.	[Witherden, Deborah A.; Rieder, Stephanie E.; Garijo, Olivia; Mills, Robyn E.; Teyton, Luc; Havran, Wendy L.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Verdino, Petra; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Fischer, Wolfgang H.] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Salk Institute	Havran, WL (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	havran@scripps.edu			NIH [AI52257, AI064811, AI42266, CA58896, NS057096]; Austrian Science Fund; Leukemia and Lymphoma Society; Vincent J. Coates Foundation; NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052257, R01AI064811, R01AI042266, R37AI042266, R01AI036964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund(Austrian Science Fund (FWF)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Vincent J. Coates Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Park and W. Low for MS analysis; G. Nemerow for Fiber 5 and Fiber 11 reagents; J. Kaye for the DPK cell line; and M. Haynes, M. Svoboda, J. Barcas, K. Sendaydiego, D. Yeh, and B. Atteberry for technical assistance. J. Lewis provided advice on culture of short-term DETC lines. M. Kronenberg, R. Boismenu, J. Jameson, K. Mowen, T. Meehan, and K. Komori provided advice and critical reading of the manuscript. This work was supported by NIH grants to W. L. H. (AI52257, AI064811) and I. A. W. (AI42266, CA58896), as well as an Erwin-Schroedinger Fellowship of the Austrian Science Fund (P. V.) and the Leukemia and Lymphoma Society (S. E. R.). MS instrumentation was acquired with an NSF shared equipment grant. The MS Laboratory at the Salk Institute is supported by the Vincent J. Coates Foundation and NIH Blueprint NS057096. This is manuscript number 17711-IMM from The Scripps Research Institute.	Bazzoni G, 2003, CURR OPIN CELL BIOL, V15, P525, DOI 10.1016/S0955-0674(03)00104-2; Bergelson JM, 1998, J VIROL, V72, P415, DOI 10.1128/JVI.72.1.415-419.1998; Coyne CB, 2005, ADV DRUG DELIVER REV, V57, P869, DOI 10.1016/j.addr.2005.01.007; Croft M, 1997, CRIT REV IMMUNOL, V17, P89, DOI 10.1615/CritRevImmunol.v17.i1.40; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Havran WL, 2010, J IMMUNOL, V184, P5423, DOI 10.4049/jimmunol.0902733; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Howitt J, 2003, CURR TOP MICROBIOL, V272, P331; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Kirby I, 2001, J VIROL, V75, P7210, DOI 10.1128/JVI.75.15.7210-7214.2001; Luissint AC, 2008, J CELL BIOL, V183, P1159, DOI 10.1083/jcb.200805061; Moog-Lutz C, 2003, BLOOD, V102, P3371, DOI 10.1182/blood-2002-11-3462; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Strid J, 2009, SEMIN IMMUNOL, V21, P110, DOI 10.1016/j.smim.2009.03.002; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; Whang MI, 2009, J IMMUNOL, V182, P4557, DOI 10.4049/jimmunol.0802439; Zen K, 2005, MOL BIOL CELL, V16, P2694, DOI 10.1091/mbc.E05-01-0036	25	149	161	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1205	1210		10.1126/science.1192698	http://dx.doi.org/10.1126/science.1192698			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20813954	Green Accepted			2022-12-24	WOS:000281485600036
J	Ma, RCW; Tam, CHT; Wang, Y; Luk, AO; Hu, C; Yang, XL; Lam, V; Chan, AWH; Ho, JSK; Chow, CC; Tong, PCY; Jia, WP; Ng, MCY; So, WY; Chan, JCN				Ma, Ronald C. W.; Tam, Claudia H. T.; Wang, Ying; Luk, Andrea O.; Hu, Cheng; Yang, Xilin; Lam, Vincent; Chan, Alfred W. H.; Ho, Janice S. K.; Chow, Chun-Chung; Tong, Peter C. Y.; Jia, Weiping; Ng, Maggie C. Y.; So, Wing-Yee; Chan, Juliana C. N.			Genetic Variants of the Protein Kinase C-beta 1 Gene and Development of End-Stage Renal Disease in Patients With Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							KONG CHINESE PATIENTS; GROWTH-FACTOR-BETA; C-BETA; OXIDATIVE STRESS; KIDNEY-DISEASE; RISK SCORE; NEPHROPATHY; EXPRESSION; LOCI; ASSOCIATION	Context Protein kinase C-beta (PKC-beta) is a cell-signaling intermediate implicated in development of diabetic complications. Objective To examine the risk association of PKC-beta 1 gene (PRKCB1) polymorphisms and end-stage renal disease (ESRD) in an 8-year prospective cohort of Chinese patients with type 2 diabetes. Design, Setting, and Participants We genotyped 18 common tag single-nucleotide polymorphisms (SNPs) that span the PRKCB1 gene (r(2)=0.80) in 1172 Chinese patients (recruited 1995-1998) without renal disease at baseline. A validation cohort included an additional 1049 patients with early-onset diabetes who were free of renal disease at baseline and were recruited after 1998. Main Outcome Measures Associations of PRKCB1 polymorphisms under additive, dominant, and recessive genetic models with new onset of ESRD (defined as estimated glomerular filtration rate <15 mL/min/1.73 m(2) or dialysis or renal-related death) were assessed by Cox proportional hazard regression, adjusted for all conventional risk factors including use of medications. Results After a mean (SD) of 7.9 (1.9) years, 90 patients (7.7%) progressed to ESRD. Four common SNPs were associated with ESRD (P<.05). The closely linked T allele at rs3760106 and G allele rs2575390 (r(2)=0.98) showed the strongest association with ESRD (hazard ratio [HR], 2.25; 95% confidence interval [Cl], 1.31-3.87; P=.003, and HR, 2.26; 95% Cl, 1.31-3.88; P=.003, respectively). Four common variants predicted ESRD in separate models. The HR for ESRD increased with increasing number of risk alleles (P<.001) in the joint effect analysis. The adjusted risk for ESRD was 6.04 (95% Cl, 2.00-18.31) for patients with 4 risk alleles compared with patients with 0 or 1 risk allele. Incidence was 4.4 per 1000 person-years (95% Cl, 0.5-8.2) among individuals with 0 or 1 risk allele compared with 20.0 per 1000 person-years (95% Cl, 8.8-31.1) in those carrying 4 risk alleles (6.9% of the cohort). These results were validated in a separate prospective cohort of young-onset diabetic patients. Of 1049 patients in the validation cohort, 151 (14.3%) developed chronic kidney disease (CKD) during follow-up, and there were significant associations between both the T allele of rs3760106 and the G allele of rs2575390 and development of CKD (HR, 1.68; 95% Cl, 1.10-2.57; P=.02, and HR, 1.62; 95% Cl, 1.07-2.47; P=.02, respectively). Conclusion Genetic variants in the PRKCB1 gene were independently associated with development of ESRD in Chinese patients with type 2 diabetes. JAMA. 2010;304(8):881-889	[Ma, Ronald C. W.; Tam, Claudia H. T.; Wang, Ying; Luk, Andrea O.; Yang, Xilin; Lam, Vincent; Chan, Alfred W. H.; Ho, Janice S. K.; Chow, Chun-Chung; Tong, Peter C. Y.; Ng, Maggie C. Y.; So, Wing-Yee; Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Ma, Ronald C. W.; Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong Inst Diabet & Obes, Shatin, Hong Kong, Peoples R China; [Chan, Juliana C. N.] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Hu, Cheng; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6,Shanghai Diabet Inst, Shanghai Key Lab Diabet Mellitus, Dept Endocrinol & Metab,Shanghai Clin Ctr Diabet, Shanghai 200030, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Shanghai Jiao Tong University	Ma, RCW (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	rcwma@cuhk.edu.hk	Hu, Cheng/C-3346-2008; Ma, Ronald/C-2788-2009; Jia, Weiping/B-7483-2012; Chan, Juliana/B-7918-2016; Luk, Andrea/B-5766-2016; Chan, Anthony/N-6719-2016	Hu, Cheng/0000-0003-4314-2386; Ma, Ronald/0000-0002-1227-803X; Chan, Juliana/0000-0003-1325-1194; Chan, Anthony/0000-0002-1771-163X	AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi-Sankyo; GlaxoSmithKline; Lilly; Merck Serono; Merck Sharp Dohme; Novo Nordisk; Pfizer; Roche; Sanofi-Aventis; Chinese University of Hong Kong; Hong Kong Government Research Grant Committee; Innovation and Technology Fund [ITS/088/08]; Department of Medicine and Therapeutics, Chinese University of Hong Kong	AstraZeneca(AstraZeneca); Bayer(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi-Sankyo(Daiichi Sankyo Company Limited); GlaxoSmithKline(GlaxoSmithKline); Lilly(Eli Lilly); Merck Serono(Merck & Company); Merck Sharp Dohme(Merck & Company); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); Chinese University of Hong Kong(Chinese University of Hong Kong); Hong Kong Government Research Grant Committee; Innovation and Technology Fund; Department of Medicine and Therapeutics, Chinese University of Hong Kong(Chinese University of Hong Kong)	Dr Ma reported receiving speakers' honoraria from Sanofi-Aventis and serving as a member of an advisory board for Pfizer, the proceeds of which go to the Chinese University of Hong Kong to support ongoing research. Dr J. Chan reported receiving research funding or speakers' honoraria from AstraZeneca, Bayer, Bristol-Myers Squibb, Daiichi-Sankyo, GlaxoSmithKline, Lilly, Merck Serono, Merck Sharp & Dohme, Novo Nordisk, Pfizer, Roche, and Sanofi-Aventis; serving as a member of advisory boards, and/or speaker forums, and/or steering committees of international projects sponsored by AstraZeneca, Bayer, Lilly, and Merck Sharp & Dohme; with her group and on behalf of the Chinese University of Hong Kong, holding patents to use genetic markers to predict risk of diabetes and diabetic kidney disease in Chinese populations; and in a technology transfer project, establishing a university-affiliated diabetes center (Qualigenics) to deliver a multidisciplinary chronic care program in the community (all related revenues and proceeds go to the Chinese University of Hong Kong to support ongoing research and development in diabetes). None of the coauthors reported currently holding or having filed patents relating to the information contained in the article, namely, the use of the genetic variants of the protein kinase C-beta 1 gene (rs3760106, rs7404928, and rs4787733) for the prediction of diabetic kidney disease. The authors reported that they will not be pursuing any patent application relating to this information, in China or in the United States, until this information has appeared in JAMA.; The study was supported by the Hong Kong Foundation for Research and Development in Diabetes established under the auspices of the Chinese University of Hong Kong, the Hong Kong Government Research Grant Committee, the Innovation and Technology Fund (ITS/088/08), and the Research Fund of the Department of Medicine and Therapeutics, Chinese University of Hong Kong.	Araki SI, 2006, DIABETES CARE, V29, P864, DOI 10.2337/diacare.29.04.06.dc05-1723; Araki SI, 2003, J AM SOC NEPHROL, V14, P2015, DOI 10.1097/01.ASN.0000077347.27669.5C; Asaba K, 2005, KIDNEY INT, V67, P1890, DOI 10.1111/j.1523-1755.2005.00287.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Chan JC, 2009, DIABETES CARE, V32, P977, DOI 10.2337/dc08-1908; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Etoh T, 2003, DIABETOLOGIA, V46, P1428, DOI 10.1007/s00125-003-1205-6; Ferretti V, 2007, NUCLEIC ACIDS RES, V35, pD122, DOI 10.1093/nar/gkl879; Fioretto P, 2008, DIABETOLOGIA, V51, P1347, DOI 10.1007/s00125-008-1051-7; Fioretto P, 1996, DIABETOLOGIA, V39, P1569, DOI 10.1007/s001250050616; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Freedman BI, 2007, CLIN J AM SOC NEPHRO, V2, P1306, DOI 10.2215/CJN.02560607; Gao L, 2009, CARDIOVASC RES, V82, P9, DOI 10.1093/cvr/cvp031; Gilbert RE, 2007, DIABETES CARE, V30, P995, DOI 10.2337/dc06-2079; Gorin Y, 2005, J BIOL CHEM, V280, P39616, DOI 10.1074/jbc.M502412200; HE Z, 2004, DIABETES CARDIOVASCU, P37; Hu C, 2010, DIABETOLOGIA, V53, P290, DOI 10.1007/s00125-009-1594-2; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Kelly DJ, 2009, NEPHROL DIAL TRANSPL, V24, P1782, DOI 10.1093/ndt/gfn729; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Koya D, 2000, FASEB J, V14, P439, DOI 10.1096/fasebj.14.3.439; Koya D, 1997, J CLIN INVEST, V100, P115, DOI 10.1172/JCI119503; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; Langham RG, 2008, DIABETOLOGIA, V51, P668, DOI 10.1007/s00125-008-0927-x; Luk AOY, 2008, DIABETES CARE, V31, P2357, DOI 10.2337/dc08-0971; MA RC, 2004, KIDNEY HYPERTENSION; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; MACLSAAC RJ, 2004, DIABETES CARE, V27, P195; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Noh H, 2007, KIDNEY INT, V72, pS49, DOI 10.1038/sj.ki.5002386; Ohshiro Y, 2006, DIABETES, V55, P3112, DOI 10.2337/db06-0895; Parving HH, 2008, J AM SOC NEPHROL, V19, P771, DOI 10.1681/ASN.2007050582; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Ritz E, 1999, AM J KIDNEY DIS, V34, P795, DOI 10.1016/S0272-6386(99)70035-1; Robertson G, 2006, NUCLEIC ACIDS RES, V34, pD68, DOI 10.1093/nar/gkj075; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Sarafidis PA, 2006, AM J NEPHROL, V26, P232, DOI 10.1159/000093632; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soldatos G, 2008, DIABETES RES CLIN PR, V82, pS75, DOI 10.1016/j.diabres.2008.09.042; Song XY, 2009, DIABETOLOGIA, V52, P1543, DOI 10.1007/s00125-009-1400-1; Toyoda M, 2004, KIDNEY INT, V66, P1107, DOI 10.1111/j.1523-1755.2004.00798.x; Tuttle KR, 2008, DIABETES RES CLIN PR, V82, pS70, DOI 10.1016/j.diabres.2008.09.041; Tuttle KR, 2005, DIABETES CARE, V28, P2686, DOI 10.2337/diacare.28.11.2686; TUTTLE KR, 2007, J AM SOC NEPHROL, V18, pA48; Wu AYT, 2005, DIABETOLOGIA, V48, P17, DOI 10.1007/s00125-004-1599-9; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang XL, 2007, DIABETOLOGIA, V50, P1348, DOI 10.1007/s00125-007-0639-7; Yang XL, 2006, DIABETOLOGIA, V49, P2299, DOI 10.1007/s00125-006-0376-3; Yang XL, 2008, ARCH INTERN MED, V168, P451, DOI 10.1001/archinte.168.5.451; Yang X, 2007, DIABETES CARE, V30, P65, DOI 10.2337/dc06-1273; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1	60	49	58	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2010	304	8					881	889		10.1001/jama.2010.1191	http://dx.doi.org/10.1001/jama.2010.1191			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	644OY	20736472	Bronze			2022-12-24	WOS:000281389900026
J	Visintin, C; Mugglestone, MA; Almerie, MQ; Nherera, LM; James, D; Walkinshaw, S				Visintin, Cristina; Mugglestone, Moira A.; Almerie, Muhammad Q.; Nherera, Leo M.; James, David; Walkinshaw, Stephen		Guideline Dev Grp	Guidelines Management of hypertensive disorders during pregnancy: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Visintin, Cristina; Mugglestone, Moira A.; Nherera, Leo M.; James, David] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Almerie, Muhammad Q.] Diana Princess Wales Hosp, N Yorkshire & E Coast Fdn Sch, Grimsby DN33 2BA, Lincs, England; [Walkinshaw, Stephen] Liverpool Womens Hosp, Liverpool L8 7SS, Merseyside, England	University of Liverpool	Mugglestone, MA (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	mmugglestone@ncc-wch.org.uk	Nherera, Leo/L-1978-2019; Nherera, Leo/P-1567-2018	Nherera, Leo/0000-0003-1758-9504; Nherera, Leo/0000-0003-1758-9504				[Anonymous], 2008, ANT CAR ROUT CAR HLT; Lyons G, 2008, INT J OBSTET ANESTH, V17, P103, DOI 10.1016/j.ijoa.2008.01.006; National Institute for Health and Clinical Excellence, 2007, INTR CAR MAN DEL CAR; National Institute for Health and Clinical Excellence, 2006, POSTN CAR ROUT POSTN; National Institute for Health and Clinical Excellence, 2006, HYP MAN HYP AD PRIM; National Institute for Health and Clinical Excellence: Guidance, 2010, HYP PREGN MAN HYP DI; Royal College of Obstetricians and Gynaecologists, 2006, MAN SEV PREECL ECL; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089	8	119	133	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 25	2010	341								c2207	10.1136/bmj.c2207	http://dx.doi.org/10.1136/bmj.c2207			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645IH	20739360				2022-12-24	WOS:000281446000009
J	Cardwell, CR; Abnet, CC; Cantwell, MM; Murray, LJ				Cardwell, Chris R.; Abnet, Christian C.; Cantwell, Marie M.; Murray, Liam J.			Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GASTROESOPHAGEAL-REFLUX; VALIDATION; APOPTOSIS; THERAPY	Context Use of oral bisphosphonates has increased dramatically in the United States and elsewhere. Esophagitis is a known adverse effect of bisphosphonate use; and recent reports suggest a link between bisphosphonate use and esophageal cancer, but this has not been robustly investigated. Objective To investigate the association between bisphosphonate use and esophageal cancer. Design, Setting, and Participants Data were extracted from the UK General Practice Research Database to compare the incidence of esophageal and gastric cancer in a cohort of patients treated with oral bisphosphonates between January 1996 and December 2006 with incidence in a control cohort. Cancers were identified from relevant Read/Oxford Medical Information System codes in the patient's clinical files. Cox proportional hazards modeling was used to calculate hazard ratios and 95% confidence intervals for risk of esophageal and gastric cancer in bisphosphonate users compared with nonusers, with adjustment for potential confounders. Main Outcome Measure Hazard ratio for the risk of esophageal and gastric cancer in the bisphosphonate users compared with the bisphosphonate nonusers. Results Mean follow-up time was 4.5 and 4.4 years in the bisphosphonate and control cohorts, respectively. Excluding patients with less than 6 months' follow-up, there were 41 826 members in each cohort (81% women; mean age, 70.0 (SD, 11.4) years). One hundred sixteen esophageal or gastric cancers (79 esophageal) occurred in the bisphosphonate cohort and 115 (72 esophageal) in the control cohort. The incidence of esophageal and gastric cancer combined was 0.7 per 1000 person-years of risk in both the bisphosphonate and control cohorts; the incidence of esophageal cancer alone in the bisphosphonate and control cohorts was 0.48 and 0.44 per 1000 person-years of risk, respectively. There was no difference in risk of esophageal and gastric cancer combined between the cohorts for any bisphosphonate use (adjusted hazard ratio, 0.96 [95% confidence interval, 0.74-1.25]) or risk of esophageal cancer only (adjusted hazard ratio, 1.07 [95% confidence interval, 0.77-1.49]). There also was no difference in risk of esophageal or gastric cancer by duration of bisphosphonate intake. Conclusion Among patients in the UK General Practice Research Database, the use of oral bisphosphonates was not significantly associated with incident esophageal or gastric cancer. JAMA. 2010;304(6):657-663	[Cardwell, Chris R.; Cantwell, Marie M.; Murray, Liam J.] Queens Univ Belfast, Ctr Publ Hlth, Belfast BT12 6BJ, Antrim, North Ireland; [Abnet, Christian C.] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA	Queens University Belfast; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cardwell, CR (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Grosvenor Rd, Belfast BT12 6BJ, Antrim, North Ireland.	c.cardwell@qub.ac.uk	Abnet, Christian C/C-4111-2015	Abnet, Christian C/0000-0002-3008-7843; Cardwell, Chris/0000-0002-2689-4335	Medical Research Council; UK Medicines and Healthcare Products Regulatory Agency; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIACP000185] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medicines and Healthcare Products Regulatory Agency; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Access to the GPRD database was funded through the Medical Research Council's license agreement with the UK Medicines and Healthcare Products Regulatory Agency. However, the interpretation and conclusions contained in this study are those of the authors alone.	Abrahamsen B, 2009, NEW ENGL J MED, V360, P1789, DOI 10.1056/NEJMc096026; Breslow NE., 1987, STAT METHODS CANC RE, P81; CHOW WH, 1995, JAMA-J AM MED ASSOC, V274, P474, DOI 10.1001/jama.274.6.474; Coxon JP, 2004, BJU INT, V94, P164, DOI 10.1111/j.1464-4096.2004.04831.x; Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Guise TA, 2008, CANCER TREAT REV, V34, pS19, DOI 10.1016/j.ctrv.2008.03.006; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hollowell J, 1997, Popul Trends, P36; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1997, LANCET, V349, P525, DOI 10.1016/S0140-6736(97)80084-0; KINN S, 1995, BRIT MED J, V311, P739, DOI 10.1136/bmj.311.7007.739; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lassen A, 2006, AM J GASTROENTEROL, V101, P1193, DOI 10.1111/j.1572-0241.2006.00550.x; Ribeiro A, 1998, GASTROINTEST ENDOSC, V47, P525, DOI 10.1016/S0016-5107(98)70256-1; Ryan JM, 1998, RADIOLOGY, V206, P389, DOI 10.1148/radiology.206.2.9457190; Shipman CM, 1997, BRIT J HAEMATOL, V98, P665, DOI 10.1046/j.1365-2141.1997.2713086.x; Solomon DH, 2009, NEW ENGL J MED, V360, P1789; Udell JA, 2006, J BONE MINER RES, V21, P765, DOI 10.1359/JBMR.060119; Usher C, 2006, EUR J CLIN PHARMACOL, V62, P307, DOI 10.1007/s00228-005-0083-x; Watson J, 2007, EUR J CLIN PHARMACOL, V63, P843, DOI 10.1007/s00228-007-0320-6; WHO, AN THER CHEM CLASS S; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738	24	146	152	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					657	663		10.1001/jama.2010.1098	http://dx.doi.org/10.1001/jama.2010.1098			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699457	Green Accepted, Bronze			2022-12-24	WOS:000280829200021
J	Profumo, D; Dinneen, M				Profumo, David; Dinneen, Michael			A Patient's Journey At sixes and sevens: prostate cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dinneen, Michael] Chelsea & Westminster Hosp, London SW10 9NH, England	Imperial College London		david.profumo@virgin.net							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2010	341								c3834	10.1136/bmj.c3834	http://dx.doi.org/10.1136/bmj.c3834			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	640DO	20696746				2022-12-24	WOS:000281028500001
J	Garcia-Perez, JL; Morell, M; Scheys, JO; Kulpa, DA; Morell, S; Carter, CC; Hammer, GD; Collins, KL; O'Shea, KS; Menendez, P; Moran, JV				Garcia-Perez, Jose L.; Morell, Maria; Scheys, Joshua O.; Kulpa, Deanna A.; Morell, Santiago; Carter, Christoph C.; Hammer, Gary D.; Collins, Kathleen L.; O'Shea, K. Sue; Menendez, Pablo; Moran, John V.			Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells	NATURE			English	Article							STEM-CELLS; LINE-1 RETROTRANSPOSITION; SOMATIC MOSAICISM; PROTEIN; MOUSE; EXPRESSION; PATTERNS; VIRUS	Long interspersed element-1 (LINE-1 or L1) retrotransposition continues to affect human genome evolution(1,2). L1s can retrotranspose in the germline, during early development and in select somatic cells(3-8); however, the host response to L1 retrotransposition remains largely unexplored. Here we show that reporter genes introduced into the genome of various human embryonic carcinoma-derived cell lines (ECs) by L1 retrotransposition are rapidly and efficiently silenced either during or immediately after their integration. Treating ECs with histone deacetylase inhibitors rapidly reverses this silencing, and chromatin immunoprecipitation experiments revealed that reactivation of the reporter gene was correlated with changes in chromatin status at the L1 integration site. Under our assay conditions, rapid silencing was also observed when reporter genes were delivered into ECs by mouse L1s and a zebrafish LINE-2 element, but not when similar reporter genes were delivered into ECs by Moloney murine leukaemia virus or human immunodeficiency virus, suggesting that these integration events are silenced by distinct mechanisms. Finally, we demonstrate that subjecting ECs to culture conditions that promote differentiation attenuates the silencing of reporter genes delivered by L1 retrotransposition, but that differentiation, in itself, is not sufficient to reactivate previously silenced reporter genes. Thus, our data indicate that ECs differ from many differentiated cells in their ability to silence reporter genes delivered by L1 retrotransposition.	[Garcia-Perez, Jose L.; Moran, John V.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Garcia-Perez, Jose L.; Morell, Maria; Morell, Santiago; Menendez, Pablo] Univ Granada, Ctr Biomed Res, Consejeria Salud Junta Andalucia, Andalusian Stem Cell Bank, Granada 18100, Spain; [Morell, Maria; Hammer, Gary D.; O'Shea, K. Sue] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Scheys, Joshua O.; Carter, Christoph C.; Hammer, Gary D.; Collins, Kathleen L.; Moran, John V.] Univ Michigan, Sch Med, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Kulpa, Deanna A.; Hammer, Gary D.; Collins, Kathleen L.; Moran, John V.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hammer, Gary D.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Collins, Kathleen L.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Moran, John V.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Michigan System; University of Michigan; University of Granada; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute	Moran, JV (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, 1241 E Catherine St, Ann Arbor, MI 48109 USA.	josel.garcia.perez@juntadeandalucia.es; moranj@umich.edu	Bujan, Pablo Menendez/W-3736-2017; Kulpa, Deanna/ABE-2035-2020; Morell, Maria/ABF-8213-2020; Kulpa, Deanna A/O-5016-2019; Morell, Maria/C-4606-2017	Bujan, Pablo Menendez/0000-0001-9372-1007; Morell, Maria/0000-0001-9613-9741; Kulpa, Deanna A/0000-0002-0411-7295; Morell, Maria/0000-0002-3692-1333; Garcia-Perez, Jose Luis/0000-0002-8132-9849	National Institutes of Health (NIH) [GM060518, GM082970, NS-048187, GM-069985, AI051198]; Howard Hughes Medical Institute; Instituto de Salud Carlos III - Consejeria de Salud Junta de Andalucia (ISCIII-CSJA) [EMER07/056]; Marie Curie International Reintegration Grant action [FP7-PEOPLE-2007-4-3-IRG]; Junta de Andalucia (Spain) [P09-CTS-4980, PI0002/2009, P08-CTS-3678]; Spanish Ministry of Health [FIS PI08171, CP07/00065, FIS PI070026]; Spanish Ministry of Science and Innovation MICINN-PLANE [PLE-2009-0111]; Burroughs Wellcome Foundation; National Institute of Diabetes and Digestive and Kidney Diseases NIH [R01 (DK62027)]; Cellular and Molecular Approaches to Systems and Integrative Biology Training Grant [T32-GM08322]; Cancer Research Institute; University of Michigan; University of Michigan's Cancer Center [NIH 5 P30 CA46592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM069985, R01GM082970, T32GM007315, T32GM008322, R01GM060518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048187] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Instituto de Salud Carlos III - Consejeria de Salud Junta de Andalucia (ISCIII-CSJA); Marie Curie International Reintegration Grant action; Junta de Andalucia (Spain)(Junta de Andalucia); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Science and Innovation MICINN-PLANE(Ministry of Science and Innovation, Spain (MICINN)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); National Institute of Diabetes and Digestive and Kidney Diseases NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cellular and Molecular Approaches to Systems and Integrative Biology Training Grant; Cancer Research Institute; University of Michigan(University of Michigan System); University of Michigan's Cancer Center(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. W. Andrews for providing human EC lines, discussing unpublished data from his laboratory and giving advice during the course of this study. We thank A. Macia and M. Munoz-Lopez (Andalusian Stem Cell Bank) for sharing unpublished data; A. V. Furano, H. Kazazian, J. K. Kim, H. Kopera, A. Muotri, and members of the Moran and Garcia-Perez laboratories for critical reading of the manuscript; and G. Smith and L. Villa for help in creating the time-lapsed movie. We thank M. Velkey for providing plasmid pBSSK-pgk; H. Kazazian for providing plasmid pJCC5/LRE3; J. Boeke for providing synthetic mouse LINE-1 constructs; M. Kajikawa and N. Okada for providing the zebrafish LINE-2 expression plasmids; T. Fanning for providing the polyclonal ORF1 antibody; I. Damjanov for comments on the teratoma characterization; T. Lanigan for preparing Moloney murine leukaemia virus retroviral supernatants; C. Pigott for EC culture advice; and T. de la Cueva, P. Catalina and A. Nieto (Andalusian Stem Cell Bank) for their help with mouse experimentation, SKY-FISH and pathology analyses, respectively. J. V. M. is supported by the National Institutes of Health (NIH) (GM060518 and GM082970) and the Howard Hughes Medical Institute. J. L. G.-P. is supported by the Instituto de Salud Carlos III - Consejeria de Salud Junta de Andalucia (ISCIII-CSJA) (EMER07/056), by a Marie Curie International Reintegration Grant action (FP7-PEOPLE-2007-4-3-IRG), by CICE (P09-CTS-4980) and Proyectos en Salud (PI0002/2009) from Junta de Andalucia (Spain) and through the Spanish Ministry of Health (FIS PI08171 and Miguel Servet CP07/00065). M. M. is supported by the ISCIII-CSJA (EMER07/056). P. M. is supported by the Spanish Ministry of Science and Innovation MICINN-PLANE (PLE-2009-0111), by CICE (P08-CTS-3678) from Junta de Andalucia (Spain) and by the Spanish Ministry of Health (FIS PI070026). K.S.O'S. is supported by the NIH (NS-048187 and GM-069985). K. L. C. is supported by the Burroughs Wellcome Foundation and by an NIH Research Project Grant (R01) (AI051198). G. D. H is supported by a National Institute of Diabetes and Digestive and Kidney Diseases NIH R01 (DK62027). J.O.S. is supported by a Cellular and Molecular Approaches to Systems and Integrative Biology Training Grant (T32-GM08322). D. A. K. is supported by The Irvington Institute Fellowship Program of the Cancer Research Institute. S. M. is supported by a CICE (P08-CTS-3678) scholarship from Junta de Andalucia, Spain. C. C. C. is supported by a Rackham Predoctoral Fellowship from the University of Michigan. We defrayed the costs of DNA sequencing in part with the University of Michigan's Cancer Center Support Grant (NIH 5 P30 CA46592).	Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brouha B, 2002, AM J HUM GENET, V71, P327, DOI 10.1086/341722; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Gummow BM, 2006, MOL ENDOCRINOL, V20, P2711, DOI 10.1210/me.2005-0461; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; LOH TP, 1987, MOL CELL BIOL, V7, P3775, DOI 10.1128/MCB.7.10.3775; MATTHAEI KI, 1983, EXP CELL RES, V143, P471, DOI 10.1016/0014-4827(83)90076-9; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Schumann GG, 2007, BIOCHEM SOC T, V35, P637, DOI 10.1042/BST0350637; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sugano T, 2006, GENE, V365, P74, DOI 10.1016/j.gene.2005.09.037; Suzuki J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000461; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844	30	113	114	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2010	466	7307					769	773		10.1038/nature09209	http://dx.doi.org/10.1038/nature09209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686575	Green Accepted			2022-12-24	WOS:000280562500042
J	Neugut, AI; Lebwohl, B				Neugut, Alfred I.; Lebwohl, Benjamin			Colonoscopy vs Sigmoidoscopy Screening Getting It Right	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLORECTAL-CANCER		[Neugut, Alfred I.] Columbia Univ, Coll Phys & Surg, Med Ctr, Dept Med, New York, NY 10032 USA; [Neugut, Alfred I.] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Neugut, Alfred I.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Neugut, AI (corresponding author), Columbia Univ, Coll Phys & Surg, Med Ctr, Dept Med, 722 W 168th St,Room 725, New York, NY 10032 USA.	ain1@columbia.edu			NATIONAL CANCER INSTITUTE [R43CA095929, T32CA009529] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA095929] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Lieberman DA, 2009, NEW ENGL J MED, V361, P1179, DOI 10.1056/NEJMcp0902176; NEUGUT AI, 1988, AM J GASTROENTEROL, V83, P295; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Singh H, 2010, AM J GASTROENTEROL, V105, P663, DOI 10.1038/ajg.2009.650	10	56	57	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					461	462		10.1001/jama.2010.1001	http://dx.doi.org/10.1001/jama.2010.1001			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664047				2022-12-24	WOS:000280350100030
J	Bobrow, BJ; Spaite, DW; Berg, RA; Stolz, U; Sanders, AB; Kern, KB; Vadeboncoeur, TF; Clark, LL; Gallagher, JV; Stapczynski, JS; LoVecchio, F; Mullins, TJ; Humble, WO; Ewy, GA				Bobrow, Bentley J.; Spaite, Daniel W.; Berg, Robert A.; Stolz, Uwe; Sanders, Arthur B.; Kern, Karl B.; Vadeboncoeur, Tyler F.; Clark, Lani L.; Gallagher, John V.; Stapczynski, J. Stephan; LoVecchio, Frank; Mullins, Terry J.; Humble, Will O.; Ewy, Gordon A.			Chest Compression-Only CPR by Lay Rescuers and Survival From Out-of-Hospital Cardiac Arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BYSTANDER CARDIOPULMONARY-RESUSCITATION; AMERICAN-HEART-ASSOCIATION; HEALTH-CARE PROFESSIONALS; BASIC LIFE-SUPPORT; VENTRICULAR-FIBRILLATION; STROKE-FOUNDATION; TASK-FORCE; STATEMENT; VENTILATION; COMMITTEE	Context Chest compression-only bystander cardiopulmonary resuscitation (CPR) may be as effective as conventional CPR with rescue breathing for out-of-hospital cardiac arrest. Objective To investigate the survival of patients with out-of-hospital cardiac arrest using compression-only CPR (COCPR) compared with conventional CPR. Design, Setting, and Patients A 5-year prospective observational cohort study of survival in patients at least 18 years old with out-of-hospital cardiac arrest between January 1, 2005, and December 31, 2009, in Arizona. The relationship between layperson bystander CPR and survival to hospital discharge was evaluated using multivariable logistic regression. Main Outcome Measure Survival to hospital discharge. Results Among 5272 adults with out-of-hospital cardiac arrest of cardiac etiology not observed by responding emergency medical personnel, 779 were excluded because bystander CPR was provided by a health care professional or the arrest occurred in a medical facility. A total of 4415 met all inclusion criteria for analysis, including 2900 who received no bystander CPR, 666 who received conventional CPR, and 849 who received COCPR. Rates of survival to hospital discharge were 5.2% (95% confidence interval [CI], 4.4%-6.0%) for the no bystander CPR group, 7.8% (95% CI, 5.8%-9.8%) for conventional CPR, and 13.3% (95% CI, 11.0%-15.6%) for COCPR. The adjusted odds ratio (AOR) for survival for conventional CPR vs no CPR was 0.99 (95% CI, 0.69-1.43), for COCPR vs no CPR, 1.59 (95% CI, 1.18-2.13), and for COCPR vs conventional CPR, 1.60 (95% CI, 1.08-2.35). From 2005 to 2009, lay rescuer CPR increased from 28.2% (95% CI, 24.6%-31.8%) to 39.9% (95% CI, 36.8%-42.9%; P<.001); the proportion of CPR that was COCPR increased from 19.6% (95% CI, 13.6%-25.7%) to 75.9% (95% CI, 71.7%-80.1%; P<.001). Overall survival increased from 3.7% (95% CI, 2.2%-5.2%) to 9.8% (95% CI, 8.0%-11.6%; P<.001). Conclusion Among patients with out-of-hospital cardiac arrest, layperson compression-only CPR was associated with increased survival compared with conventional CPR and no bystander CPR in this setting with public endorsement of chest compression-only CPR. JAMA. 2010; 304(13): 1447-1454	[Bobrow, Bentley J.; Mullins, Terry J.; Humble, Will O.] Arizona Dept Hlth Serv, 150 N 18th Ave,Ste 540, Phoenix, AZ 85007 USA; [Bobrow, Bentley J.; Spaite, Daniel W.; Stolz, Uwe] Univ Arizona, Dept Emergency Med, Arizona Emergency Med Res Ctr, Tucson, AZ USA; [Bobrow, Bentley J.; Sanders, Arthur B.; Kern, Karl B.; Clark, Lani L.; Ewy, Gordon A.] Univ Arizona, Sarver Heart Ctr, Tucson, AZ USA; [Berg, Robert A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Vadeboncoeur, Tyler F.] Mayo Clin, Jacksonville, FL 32224 USA; [Gallagher, John V.] Phoenix Fire Dept, Phoenix, AZ USA; [Bobrow, Bentley J.; Stapczynski, J. Stephan; LoVecchio, Frank] Maricopa Cty Gen Hosp, Dept Emergency Med, Phoenix, AZ USA	Arizona Department of Health Services; University of Arizona; University of Arizona; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Mayo Clinic; Maricopa County General Hospital	Bobrow, BJ (corresponding author), Arizona Dept Hlth Serv, 150 N 18th Ave,Ste 540, Phoenix, AZ 85007 USA.	bobrowb@azdhs.gov		Spaite, Daniel/0000-0003-2601-6476	Medtronic Foundation; American Heart Association	Medtronic Foundation; American Heart Association(American Heart Association)	Drs Bobrow, Ewy, and Spaite reported that the University of Arizona has received support from the Medtronic Foundation involving community-based translation of resuscitation science. Dr Bobrow reported being a member of the American Heart Association Basic Life Support Committee and in the past having received a grant from the American Heart Association to study ultrabrief CPR video training. No other disclosures were reported.	[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Assar D, 2000, RESUSCITATION, V45, P7, DOI 10.1016/S0300-9572(00)00152-0; Aufderheide TP, 2004, CIRCULATION, V109, P1960, DOI 10.1161/01.CIR.0000126594.79136.61; Becker LB, 1997, CIRCULATION, V96, P2102, DOI 10.1161/01.CIR.96.6.2102; BERG RA, 1993, CIRCULATION, V88, P1907, DOI 10.1161/01.CIR.88.4.1907; Berg RA, 1997, CIRCULATION, V96, P4364; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; Bobrow BJ, 2008, PREHOSP EMERG CARE, V12, P381, DOI 10.1080/10903120802100670; Bobrow BJ, 2008, JAMA-J AM MED ASSOC, V299, P1158, DOI 10.1001/jama.299.10.1158; Bobrow BJ, 2009, ANN EMERG MED, V54, P656, DOI 10.1016/j.annemergmed.2009.06.011; Bobrow BJ, 2009, ANN EMERG MED, V54, pe1; Coons SJ, 2009, RESUSCITATION, V80, P334, DOI 10.1016/j.resuscitation.2008.11.024; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; GALLAGHER EJ, 1995, JAMA-J AM MED ASSOC, V274, P1922, DOI 10.1001/jama.274.24.1922; Hallstrom A, 2000, NEW ENGL J MED, V342, P1546, DOI 10.1056/NEJM200005253422101; Heidenreich JW, 2004, RESUSCITATION, V62, P283, DOI 10.1016/j.resuscitation.2004.05.013; Iwami T, 2007, CIRCULATION, V116, P2900, DOI 10.1161/CIRCULATIONAHA.107.723411; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kellum MJ, 2008, ANN EMERG MED, V52, P244, DOI 10.1016/j.annemergmed.2008.02.006; Kern KB, 1998, RESUSCITATION, V39, P179, DOI 10.1016/S0300-9572(98)00141-5; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; LOCKE CJ, 1995, ARCH INTERN MED, V155, P938, DOI 10.1001/archinte.155.9.938; Nagao K, 2007, LANCET, V369, P920; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Rea TD, 2010, NEW ENGL J MED, V363, P423, DOI 10.1056/NEJMoa0908993; SANDERS AB, 1985, J AM COLL CARDIOL, V6, P113, DOI 10.1016/S0735-1097(85)80261-8; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Sayre MR, 2008, CIRCULATION, V117, P2162, DOI 10.1161/CIRCULATIONAHA.107.189380; Stiell IG, 1999, ANN EMERG MED, V33, P44, DOI 10.1016/S0196-0644(99)70415-4; Svensson L, 2010, NEW ENGL J MED, V363, P434, DOI 10.1056/NEJMoa0908991; *US BUR CENS, AR QUICKFACTS; Vadeboncoeur T, 2007, RESUSCITATION, V75, P68, DOI 10.1016/j.resuscitation.2007.02.015; Vaillancourt C, 2008, CAN J EMERG MED, V10, P51, DOI 10.1017/S1481803500010010; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Wik L, 2003, JAMA-J AM MED ASSOC, V289, P1389, DOI 10.1001/jama.289.11.1389; Willerson JT, 2000, CIRCULATION, V102, P1	37	327	349	1	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 6	2010	304	13					1447	1454		10.1001/jama.2010.1392	http://dx.doi.org/10.1001/jama.2010.1392			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658SO	20924010				2022-12-24	WOS:000282509900020
J	Snelgrove, RJ; Jackson, PL; Hardison, MT; Noerager, BD; Kinloch, A; Gaggar, A; Shastry, S; Rowe, SM; Shim, YM; Hussell, T; Blalock, JE				Snelgrove, Robert J.; Jackson, Patricia L.; Hardison, Matthew T.; Noerager, Brett D.; Kinloch, Andrew; Gaggar, Amit; Shastry, Suresh; Rowe, Steven M.; Shim, Yun M.; Hussell, Tracy; Blalock, J. Edwin			A Critical Role for LTA(4)H in Limiting Chronic Pulmonary Neutrophilic Inflammation	SCIENCE			English	Article							LEUKOTRIENE-A4 HYDROLASE; ENZYME; CHEMOATTRACTANT	Leukotriene A(4) hydrolase (LTA(4)H) is a proinflammatory enzyme that generates the inflammatory mediator leukotriene B-4 (LTB4). LTA(4)H also possesses aminopeptidase activity with unknown substrate and physiological importance; we identified the neutrophil chemoattractant proline-glycine-proline (PGP) as this physiological substrate. PGP is a biomarker for chronic obstructive pulmonary disease (COPD) and is implicated in neutrophil persistence in the lung. In acute neutrophil-driven inflammation, PGP was degraded by LTA(4)H, which facilitated the resolution of inflammation. In contrast, cigarette smoke, a major risk factor for the development of COPD, selectively inhibited LTA(4)H aminopeptidase activity, which led to the accumulation of PGP and neutrophils. These studies imply that therapeutic strategies inhibiting LTA(4)H to prevent LTB4 generation may not reduce neutrophil recruitment because of elevated levels of PGP.	[Snelgrove, Robert J.; Jackson, Patricia L.; Hardison, Matthew T.; Gaggar, Amit; Shastry, Suresh; Rowe, Steven M.; Blalock, J. Edwin] Univ Alabama Birmingham, Dept Med, Lung Hlth Ctr, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Snelgrove, Robert J.; Hussell, Tracy] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Leukocyte Biol Sect, London SW7 2AZ, England; [Noerager, Brett D.] Univ Montevallo, Dept Biol Chem & Math, Montevallo, AL 35115 USA; [Kinloch, Andrew] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol, London W6 8LH, England; [Gaggar, Amit; Rowe, Steven M.; Blalock, J. Edwin] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Ctr, Birmingham, AL 35294 USA; [Gaggar, Amit] Birmingham VA Med Ctr, Birmingham, AL 35294 USA; [Rowe, Steven M.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Shim, Yun M.] Univ Virginia, Dept Med, Div Pulm & Crit Care Med, Charlottesville, VA 22908 USA	University of Alabama System; University of Alabama Birmingham; Imperial College London; Imperial College London; University of Oxford; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Virginia	Snelgrove, RJ (corresponding author), Univ Alabama Birmingham, Dept Med, Lung Hlth Ctr, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.	rjs198@imperial.ac.uk	Kinloch, Anthony J/F-6042-2011; Hussell, Tracy/O-4630-2014; Shim, Yun Michael/N-2049-2017	Kinloch, Anthony J/0000-0002-8752-7184; Hussell, Tracy/0000-0001-7186-6141; Shim, Yun Michael/0000-0002-3780-3371; Blalock, J. Edwin/0000-0001-5303-8123	Wellcome Trust [082727/Z/07/Z]; National Heart, Lung, and Blood Institute [HL07783, HL090999, HL087824, HL102371-A1, K08HL091127]; Cystic Fibrosis Foundation [GAGGAR07]; National Institute of Diabetes and Digestive and Kidney Diseases [1K23DK075788, 1R03DK084110-01]; Flight Attendant Medical Research Institute; Medical Research Council [P171/03/C1/048]; NIH [RR19231, P30CA13148, P50 AT00477, U54CA100949, P30AR050948, P30 DK079337]; MRC [G0802752, G0400795] Funding Source: UKRI; Medical Research Council [G0802752, G0400795] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA013148, U54CA100949] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P50AT000477] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019231] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102371, F33HL007783, R01HL087824, K08HL091127, R01HL077783, R01HL090999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK075788, R03DK084110, P30DK079337] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Flight Attendant Medical Research Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by grants from the Wellcome Trust (082727/Z/07/Z to R.J.S.), the National Heart, Lung, and Blood Institute (HL07783, HL090999, and HL087824 to J.E.B. and HL102371-A1 to A. G.), the Cystic Fibrosis Foundation (GAGGAR07 to A. G.), the National Institute of Diabetes and Digestive and Kidney Diseases (1K23DK075788 and 1R03DK084110-01 to S. M. R.), the Flight Attendant Medical Research Institute (Young Clinical Scientist Award to Y.M.S.) and the National Heart, Lung, and Blood Institute (K08HL091127 to Y.M.S.), and the Medical Research Council (P171/03/C1/048 to T. H.). The Univ. of Alabama Birmingham (UAB) Lung Health Center Pulmonary Proteomics Laboratory is funded through the NIH (by grants RR19231, P30CA13148, P50 AT00477, U54CA100949, P30AR050948, and P30 DK079337). We thank R. Moore and L. Wilson of the UAB Targeted Metabolomics and Proteomics Laboratory for their technical assistance with mass spectrometry, D. Muccio of the UAB Chemistry Department for the use of his fast protein liquid chromatography system, G. Xia for technical assistance, and D. Saliba of the Kennedy Institute of Rheumatology, Imperial College London, for his technical assistance in the generation of murine LTA<INF>4</INF>H. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the NIH.	Bailie MB, 1996, J IMMUNOL, V157, P5221; BLOMSTER M, 1995, EUR J BIOCHEM, V231, P528, DOI 10.1111/j.1432-1033.1995.tb20728.x; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Crooks SW, 2000, EUR RESPIR J, V15, P274, DOI 10.1034/j.1399-3003.2000.15b09.x; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; FITZPATRICK F, 1983, P NATL ACAD SCI-BIOL, V80, P5425, DOI 10.1073/pnas.80.17.5425; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; GRIFFITHS RJ, 1995, P NATL ACAD SCI USA, V92, P517, DOI 10.1073/pnas.92.2.517; Haddox JL, 1999, INVEST OPHTH VIS SCI, V40, P2427; HAEGGSTROM JZ, 1990, BIOCHEM BIOPH RES CO, V172, P965, DOI 10.1016/0006-291X(90)91540-9; Haeggstrom JZ, 2000, AM J RESP CRIT CARE, V161, pS25, DOI 10.1164/ajrccm.161.supplement_1.ltta-6; Hardison MT, 2009, J IMMUNOL, V182, P4423, DOI 10.4049/jimmunol.0802457; MUNAFO DA, 1994, J CLIN INVEST, V93, P1042, DOI 10.1172/JCI117053; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; O'Reilly P, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-38; ORNING L, 1994, J BIOL CHEM, V269, P11269; Orning L, 1999, ARCH BIOCHEM BIOPHYS, V368, P131, DOI 10.1006/abbi.1999.1289; ORNING L, 1992, BIOCHEMISTRY-US, V31, P4218, DOI 10.1021/bi00132a010; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; van Houwelingen AH, 2008, FASEB J, V22, P3403, DOI 10.1096/fj.07-096230; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; WETTERHOLM A, 1992, BIOCHIM BIOPHYS ACTA, V1123, P275, DOI 10.1016/0005-2760(92)90007-I; WETTERHOLM A, 1992, P NATL ACAD SCI USA, V89, P9141, DOI 10.1073/pnas.89.19.9141; Whittle BJR, 2008, BRIT J PHARMACOL, V153, P983, DOI 10.1038/sj.bjp.0707645	30	182	186	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					90	94		10.1126/science.1190594	http://dx.doi.org/10.1126/science.1190594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20813919	Green Accepted			2022-12-24	WOS:000282334500042
J	Spence, D				Spence, Des			From the Frontline Vascular disease: an amateur observation	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 22	2010	341								c5196	10.1136/bmj.c5196	http://dx.doi.org/10.1136/bmj.c5196			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	655TK	20861115				2022-12-24	WOS:000282272200026
J	Solomon, GM; Janssen, S				Solomon, Gina M.; Janssen, Sarah			Health Effects of the Gulf Oil Spill	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Solomon, Gina M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94104 USA; [Solomon, Gina M.] Nat Resources Def Council, San Francisco, CA 94104 USA	University of California System; University of California San Francisco	Solomon, GM (corresponding author), Univ Calif San Francisco, Dept Med, 111 Sutter St,20th Floor, San Francisco, CA 94104 USA.	gsolomon@nrdc.org		Solomon, Gina/0000-0001-6004-0387				ATSDR (Agency for Toxic Substances and Disease Registry), 1999, TOX PROF TOT PETR HY; GORMA RW, 1991, HETA 89 200 89 273 2; Law R.J., 1999, ENV GEOSCI, V6, P90, DOI [10.1046/j.1526-0984.1999.08039.x, DOI 10.1046/J.1526-0984.1999.08039.X]; *NAT TOX PROGR, 2005, REP CARC; ONEILL AK, 2003, SELF REPORTED EXPOSU; PALINKAS LA, 1993, AM J PSYCHIAT, V150, P1517; Rodriguez-Trigo G, 2007, ARCH BRONCONEUMOL, V43, P628; Sabucedo JM, 2010, DISASTERS, V34, P809, DOI 10.1111/j.1467-7717.2010.01170.x; *US EPA, OD BP OIL SPILL; Zock JP, 2007, AM J RESP CRIT CARE, V176, P610, DOI 10.1164/rccm.200701-016OC	10	68	67	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2010	304	10					1118	1119		10.1001/jama.2010.1254	http://dx.doi.org/10.1001/jama.2010.1254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646RM	20713544				2022-12-24	WOS:000281559800024
J	Abbott, A				Abbott, Alison			Levodopa: the story so far	NATURE			English	Editorial Material																			0	52	57	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					S6	S7		10.1038/466S6a	http://dx.doi.org/10.1038/466S6a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20739934	Bronze			2022-12-24	WOS:000281203600059
J	Rose, KA; Sikes, EL; Guilderson, TP; Shane, P; Hill, TM; Zahn, R; Spero, HJ				Rose, Kathryn A.; Sikes, Elisabeth L.; Guilderson, Thomas P.; Shane, Phil; Hill, Tessa M.; Zahn, Rainer; Spero, Howard J.			Upper-ocean-to-atmosphere radiocarbon offsets imply fast deglacial carbon dioxide release	NATURE			English	Article							PACIFIC-OCEAN; NORTH-ATLANTIC; NEW-ZEALAND; CO2; VENTILATION; CALIBRATION; WESTERLIES; RECORD; AGES; BEDS	Radiocarbon in the atmosphere is regulated largely by ocean circulation, which controls the sequestration of carbon dioxide (CO2) in the deep sea through atmosphere-ocean carbon exchange. During the last glaciation, lower atmospheric CO2 levels were accompanied by increased atmospheric radiocarbon concentrations that have been attributed to greater storage of CO2 in a poorly ventilated abyssal ocean(1,2). The end of the ice age was marked by a rapid increase in atmospheric CO2 concentrations(2) that coincided with reduced C-14/C-12 ratios (Delta C-14) in the atmosphere(3), suggesting the release of very 'old' (C-14-depleted) CO2 from the deep ocean to the atmosphere(3). Here we present radiocarbon records of surface and intermediate-depth waters from two sediment cores in the southwest Pacific and Southern oceans. We find a steady 170 per mil decrease in Delta C-14 that precedes and roughly equals in magnitude the decrease in the atmospheric radiocarbon signal during the early stages of the glacial-interglacial climatic transition. The atmospheric decrease in the radiocarbon signal coincides with regionally intensified upwelling and marine biological productivity(4), suggesting that CO2 released by means of deep water upwelling in the Southern Ocean lost most of its original depleted-C-14 imprint as a result of exchange and isotopic equilibration with the atmosphere. Our data imply that the deglacial C-14 depletion previously identified in the eastern tropical North Pacific(5) must have involved contributions from sources other than the previously suggested carbon release by way of a deep Southern Ocean pathway(5), and may reflect the expanded influence of the C-14-depleted North Pacific carbon reservoir across this interval. Accordingly, shallow water masses advecting north across the South Pacific in the early deglaciation had little or no residual C-14-depleted signals owing to degassing of CO2 and biological uptake in the Southern Ocean.	[Sikes, Elisabeth L.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Rose, Kathryn A.; Hill, Tessa M.; Spero, Howard J.] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Guilderson, Thomas P.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Guilderson, Thomas P.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Shane, Phil] Univ Auckland, Sch Environm, Auckland 1142, New Zealand; [Zahn, Rainer] Univ Autonoma Barcelona, Inst Ciencia & Tecnol Ambientals, Dept Geol, Inst Catalana Recerca & Estudis Avancats,ICREA, Bellaterra 08193, Spain	Rutgers State University New Brunswick; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Santa Cruz; University of Auckland; Autonomous University of Barcelona; ICREA	Sikes, EL (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, 71 Dudley Rd, New Brunswick, NJ 08901 USA.	sikes@marine.rutgers.edu	Hill, Tessa Michelle/P-3401-2019	Hill, Tessa Michelle/0000-0003-4159-9104; Shane, Philip/0000-0002-7824-1184; Sikes, Elisabeth/0000-0003-2900-3283; Spero, Howard/0000-0001-5465-8607	National Science Foundation (NSF) [RR0503]; Evolving Earth Foundation; Geological Society of America; MICINN, Spain; US Department of Energy; Directorate For Geosciences [0823549, 0962077] Funding Source: National Science Foundation; ICREA Funding Source: Custom	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Evolving Earth Foundation; Geological Society of America; MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); US Department of Energy(United States Department of Energy (DOE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); ICREA(ICREA)	We thank the captain and crew of the RV Revelle, and our shipboard colleagues during the Zheng leg 3 (RR0503) cruise funded by the National Science Foundation (NSF), which collected the RR core. Core MD97-2120 was collected through the International Marine Past Global Change Study (IMAGES) program and with the technical support of the Institut Polaire Francais Paul Emile Victor (IPEV) who made the research vessel Marion Dufresne available for core retrieval. H.J.S., E.L.S. and T.P.G., and the shore analyses, were supported by NSF awards and the Evolving Earth Foundation, and the Geological Society of America provided support for K.A.R. during her MSc. R.Z. acknowledges support from the MICINN, Spain. A portion of this work was performed under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory. We especially thank M. Cook for discussions, continuing input and suggestions throughout this study.	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; Bostock HC, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001047; Broecker W, 2007, EARTH PLANET SC LETT, V256, P90, DOI 10.1016/j.epsl.2007.01.015; Broecker W, 2008, EARTH PLANET SC LETT, V274, P322, DOI 10.1016/j.epsl.2008.07.035; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; Galbraith ED, 2007, NATURE, V449, P890, DOI 10.1038/nature06227; Gnanadesikan A, 2007, OCEAN SCI, V3, P43, DOI 10.5194/os-3-43-2007; Gnanadesikan A, 1999, SCIENCE, V283, P2077, DOI 10.1126/science.283.5410.2077; Hanawa K., 2001, INT GEOPHYS, Vpp, P373, DOI [DOI 10.1016/S0074-6142(01)80129-7, 10.1016/S0074-6142(01)80129-7]; Hughen K, 2006, QUATERNARY SCI REV, V25, P3216, DOI 10.1016/j.quascirev.2006.03.014; Keigwin LD, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001029; Key RM, 1996, RADIOCARBON, V38, P425, DOI 10.1017/S0033822200030071; Lowe DJ, 2008, QUATERNARY SCI REV, V27, P95, DOI 10.1016/j.quascirev.2007.01.013; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Muscheler R, 2004, EARTH PLANET SC LETT, V219, P325, DOI 10.1016/S0012-821X(03)00722-2; Pahnke K, 2005, SCIENCE, V307, P1741, DOI 10.1126/science.1102163; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; POLHOLZ RD, 2010, NATURE GEOSCI, V3, P192; Reimer PJ, 2004, RADIOCARBON, V46, P1029, DOI 10.1017/S0033822200032999; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; Russell JL, 2006, J CLIMATE, V19, P6382, DOI 10.1175/JCLI3984.1; Sachs JP, 2005, NATURE, V434, P1118, DOI 10.1038/nature03544; SARNTHEIN M, 2007, GEOPHYS MONOGR SER, V173, P175, DOI DOI 10.1029/173GM13; Shane P, 2006, J VOLCANOL GEOTH RES, V154, P276, DOI 10.1016/j.jvolgeores.2006.03.021; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; Spero HJ, 2002, SCIENCE, V296, P522, DOI 10.1126/science.1069401; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033	32	58	61	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1093	1097		10.1038/nature09288	http://dx.doi.org/10.1038/nature09288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20740012	Green Published			2022-12-24	WOS:000281203600037
J	Jong, P; McKelvie, R; Yusuf, S				Jong, Philip; McKelvie, Robert; Yusuf, Salim			Uncertainties Page Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction?	BRITISH MEDICAL JOURNAL			English	Editorial Material							SYSTOLIC FUNCTION; EUROPEAN-SOCIETY; MORTALITY; MORBIDITY; TRIAL; CANDESARTAN; CARDIOLOGY; REGISTRY; DIGOXIN		[Jong, Philip; McKelvie, Robert; Yusuf, Salim] McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada	McMaster University; Population Health Research Institute	Yusuf, S (corresponding author), McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca		Yusuf, Salim/0000-0003-4776-5601				Ahmed A, 2006, CIRCULATION, V114, P397, DOI 10.1161/CIRCULATIONAHA.106.628347; Bangalore S, 2008, J AM COLL CARDIOL, V52, P1062, DOI 10.1016/j.jacc.2008.05.057; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; Cleland JGF, 2009, EUR J HEART FAIL, V11, P1214, DOI 10.1093/eurjhf/hfp162; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Fonarow GC, 2007, J AM COLL CARDIOL, V50, P768, DOI 10.1016/j.jacc.2007.04.064; Hogg K, 2004, J AM COLL CARDIOL, V43, P317, DOI 10.1016/j.jacc.2003.07.046; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; National Institute Health and Clinical Excellence, 2010, CHRON HEART FAIL MAN; O'Meara E, 2004, EUR HEART J, V25, P1920, DOI 10.1016/j.ehj.2004.07.025; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Perry G, 1997, NEW ENGL J MED, V336, P525; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	16	7	7	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 25	2010	341								c4202	10.1136/bmj.c4202	http://dx.doi.org/10.1136/bmj.c4202			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645IH	20739364				2022-12-24	WOS:000281446000015
J	Farrell, AM; Brazier, M				Farrell, Anne-Maree; Brazier, Margaret			Consent for blood transfusion	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Farrell, Anne-Maree; Brazier, Margaret] Univ Manchester, Sch Law, Inst Sci Eth & Innovat, Ctr Social Eth & Policy, Manchester M13 9PL, Lancs, England	University of Manchester	Farrell, AM (corresponding author), Univ Manchester, Sch Law, Inst Sci Eth & Innovat, Ctr Social Eth & Policy, Manchester M13 9PL, Lancs, England.	a.m.farrell@manchester.ac.uk		Farrell, Anne-Maree/0000-0001-9522-6528	Wellcome Trust [087439] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		*ADV COMM SAF BLOO, 2010, PAT CONS BLOOD TRANS; *CMO NAT BLOOD TRA, 2008, BETT BLOOD TRANSF HS; CONNON W, 2007, COMMUNICATION   0316; General Medical Council, 2008, CONS PAT DOCT MAK DE; HEWITT B, 1997, BRIT MED J, V316, P397; Killion DF, 2007, TRANSFUSION, V47, P557, DOI 10.1111/j.1537-2995.2007.01185.x; MCCLELLAND D, 2007, HDB BLOOD TRANSFUSIO; Murphy MF, 1997, TRANSFUSION MED, V7, P287, DOI 10.1046/j.1365-3148.1997.d01-41.x; Re T, 1992, ALL ER, V4, P649; *SER HAZ TRANSF, ANN REP 2008 SUMM; Williams FG, 1997, BRIT MED J, V315, P380, DOI 10.1136/bmj.315.7105.380	11	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 24	2010	341								c4336	10.1136/bmj.c4336	http://dx.doi.org/10.1136/bmj.c4336			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	645IG	20736271	Green Submitted			2022-12-24	WOS:000281445900006
J	Viles, J; Monte, D; Gawkrodger, DJ				Viles, Jennifer; Monte, Darryl; Gawkrodger, David J.			A Patient's Journey Vitiligo	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Viles, Jennifer; Monte, Darryl] Vitiligo Soc, London SE11 6SF, England; [Gawkrodger, David J.] Univ Sheffield, Royal Hallamshire Hosp, Sheffield S10 2JF, England	University of Sheffield	Viles, J (corresponding author), Vitiligo Soc, London SE11 6SF, England.	jennifer_viles@vitiligosociety.org.uk; david.gawkrodger@sth.nhs.uk	GAWKRODGER, DAVID J./AFO-6373-2022	GAWKRODGER, DAVID J./0000-0002-6863-7011					0	3	4	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	AUG 20	2010	341								c3780	10.1136/bmj.c3780	http://dx.doi.org/10.1136/bmj.c3780			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642KY	20729269				2022-12-24	WOS:000281213600014
J	Volavka, J; Swanson, J				Volavka, Jan; Swanson, Jeffrey			Violent Behavior in Mental Illness: The Role of Substance Abuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SCHIZOPHRENIA; DISORDER; CRIME		[Volavka, Jan] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Swanson, Jeffrey] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA	New York University; Duke University	Volavka, J (corresponding author), POB 160663, Big Sky, MT 59716 USA.	janvolavka@gmail.com	Volavka, Jan/E-9529-2019	Volavka, Jan/0000-0002-4178-8207	NIMH NIH HHS [KO2-MH67864, K02 MH067864] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH067864] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brennan PA, 2000, ARCH GEN PSYCHIAT, V57, P494, DOI 10.1001/archpsyc.57.5.494; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675; Krakowski MI, 2006, ARCH GEN PSYCHIAT, V63, P622, DOI 10.1001/archpsyc.63.6.622; Nolan KA, 2003, PSYCHIAT SERV, V54, P1012, DOI 10.1176/appi.ps.54.7.1012; Swanson JW, 2008, LAW HUMAN BEHAV, V32, P228, DOI 10.1007/s10979-007-9095-7; SWANSON JW, 1990, HOSP COMMUNITY PSYCH, V41, P761; Volavka J, 2008, INT J CLIN PRACT, V62, P1237, DOI 10.1111/j.1742-1241.2008.01797.x; Yates KF, 2010, J FORENSIC PSYCHI PS, V21, P167, DOI 10.1080/14789940903174238	10	41	41	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					563	564		10.1001/jama.2010.1097	http://dx.doi.org/10.1001/jama.2010.1097			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682936	Green Accepted			2022-12-24	WOS:000280525700024
J	Mega, JL; Close, SL; Wiviott, SD; Shen, L; Walker, JR; Simon, T; Antman, EM; Braunwald, E; Sabatine, MS				Mega, Jessica L.; Close, Sandra L.; Wiviott, Stephen D.; Shen, Lei; Walker, Joseph R.; Simon, Tabassome; Antman, Elliott M.; Braunwald, Eugene; Sabatine, Marc S.			Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON-TIMI 38 trial: a pharmacogenetic analysis	LANCET			English	Article							PERCUTANEOUS CORONARY INTERVENTION; OF-FUNCTION POLYMORPHISM; DUODENAL ENTEROCYTES; PLATELET INHIBITION; STENT THROMBOSIS; P-GLYCOPROTEIN; MDR1 GENE; EXPRESSION; RESPONSIVENESS; THROMBOLYSIS	Background Clopidogrel and prasugrel are subject to efflux via P-glycoprotein (encoded by ABCB1, also known as MDR1). ABCB1 polymorphisms, particularly 3435C -> T, may affect drug transport and efficacy. We aimed to assess the effect of this polymorphism by itself and alongside variants in CYP2C/9 on cardiovascular outcomes in patients treated with clopidogrel or prasugrel in TRITON-TIMI 38. We also assessed the effect of genotype on the pharmacodynamic and pharmacoldnetic properties of these drugs in healthy individuals. Methods We genotyped ABCB1 in 2932 patients with acute coronary syndromes undergoing percutaneous intervention who were treated with clopidogrel (n=1471) or prasugrel (n=1461) in the TRITON -> TIMI 38 trial. We evaluated the association between ABCB1 3435C -> T and rates of the primary efficacy endpoint (cardiovascular death, myocardial infarction, or stroke) until 15 months. We then assessed the combined effect of ABCB13435C -> T genotype and reduced-function alleles of CYP2C19. 321 healthy individuals were also genotyped, and we tested the association of genetic variants with reduction in maximum platelet aggregation and plasma concentrations of active drug metabolites. Findings In patients treated with clopidogrel, ABCB1 3435C -> T genotype was significantly associated with the risk of cardiovascular death, myocardial infarction, or stroke (p=0.0064). TT homozygotes had a 72% increased risk of the primary endpoint compared with CT/CC individuals (Kaplan-Meier event rates 12.9% [52 of 414] vs 7.8% [80 of 1057 participants]; HR 1.72, 95% CI 1.22-2.44, p=0.002). ABCB1 3435C -> T and CYP2C19 genotypes were significant, independent predictors of the primary endpoint, and 681 (47%) of the 1454 genotyped patients taking clopidogrel who were either CYP2C19 reduced-function allele carriers, ABCB1 3435 TT homozygotes, or both were at increased risk of the primary endpoint (HR 1.97, 95% CI 1.38-2.82, p=0.0002). In healthy participants, 3435 TT homozygotes had an absolute reduction in maximum platelet aggregation with clopidogrel that was 7.3 percentage points less than for CT/CC individuals (p=0.0127). ABCB1 genotypes were not significantly associated with clinical or pharmacological outcomes in patients with an acute coronary syndrome or healthy individuals treated with prasugrel, respectively. Interpretation Individuals with the ABCB1 3435 TT genotype have reduced platelet inhibition and are at increased risk of recurrent ischaemic events during clopidogrel treatment. In patients with acute coronary syndromes who have undergone percutaneous intervention, when both ABCB1 and CYP2C19 are taken into account, nearly half of the population carries a genotype associated with increased risk of major adverse cardiovascular events while on standard doses of clopidogrel.	[Mega, Jessica L.; Wiviott, Stephen D.; Antman, Elliott M.; Braunwald, Eugene] Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, Boston, MA 02115 USA; [Mega, Jessica L.; Wiviott, Stephen D.; Antman, Elliott M.; Braunwald, Eugene; Sabatine, Marc S.] Harvard Univ, Sch Med, Boston, MA USA; [Close, Sandra L.] Indiana Univ, Indianapolis, IN 46204 USA; [Close, Sandra L.; Shen, Lei] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Walker, Joseph R.] Daiichi Sankyo Inc, Edison, NJ USA; [Simon, Tabassome] Univ Paris 06, AP HP, F-75252 Paris 05, France	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Indiana University System; Indiana University-Purdue University Indianapolis; Eli Lilly; Daiichi Sankyo Company Limited; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite	Mega, JL (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc, 350 Longwood Ave, Boston, MA 02115 USA.	jmega@partners.org; msabatine@partners.org	Sabatine, Marc/AAJ-6751-2020; Wiviott, Stephen/HIK-2534-2022	Sabatine, Marc/0000-0002-0691-3359; SIMON, Tabassome/0000-0002-4550-0450	Daiichi Sankyo; Eli Lilly; Sanofi-Aventis; Bristol-Myers Squibb; AstraZeneca; Schering-Plough/Merck; Johnson Johnson; Bayer Healthcare; National Institutes of Health [K99/R00 HL098461-01]; ARENA; Medco; Portola; Schering-Plough; Servier; Pfizer; Caisse d'Assurance Maladie; Merck; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL098461, K99HL098461] Funding Source: NIH RePORTER	Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Schering-Plough/Merck(Merck & CompanySchering Plough Corporation); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARENA(Australian Renewable Energy Agency (ARENA)); Medco; Portola; Schering-Plough(Merck & CompanySchering Plough Corporation); Servier(Servier); Pfizer(Pfizer); Caisse d'Assurance Maladie; Merck(Merck & Company); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The TIMI Study Group receives research grant support from Daiichi Sankyo, Eli Lilly, Sanofi-Aventis, Bristol-Myers Squibb, AstraZeneca, Schering-Plough/Merck, Johnson & Johnson, and Bayer Healthcare. Additionally, JLM is supported in part by grant K99/R00 HL098461-01 from the National Institutes of Health and reports consulting fees from Sanofi-Aventis, Bristol-Myers Squibb, and AstraZeneca. SDW reports consulting fees from Sanofi-Aventis, Bristol-Myers Squibb, AstraZeneca, ARENA, Medco, and Portola, and lecture fees for CME from Schering-Plough, Daiichi Sanity, Eli Lilly, Novartis, and AstraZeneca. TS reports research grant support from Servier, Pfizer, Daiichi Sankyo, Eli Lilly, Sanofi-Aventis, AstraZeneca, and Caisse d'Assurance Maladie and consulting fees from Eli Lilly, Daiichi Sankyo, Sanofi-Aventis, Bristol-Myers Squibb, and AstraZeneca. EMA has no additional relationships to disclose. EB reports consulting fees from Daiichi Sankyo and lecture fees from Schering-Plough and Merck. MSS reports consulting fees from AstraZeneca, Bristol-Myers Squibb, Sanofi-Aventis, Daiichi Sanity, and Eli Lilly and lecture fees from Bristol-Myers Squibb, Sanofi-Aventis, and Eli Lilly. JRW is an employee of Daiichi Sanity and holds equity ownership or stock options therein. SLC is a former employee of Eli Lilly and holds equity ownership or stock options therein. LS is an employee of Eli Lilly and holds equity ownership or stock options therein.	Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Anderson JL, 2009, J AM COLL CARDIOL, V53, pA27; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Dumaual C, 2007, PHARMACOGENOMICS, V8, P293, DOI 10.2217/14622416.8.3.293; Farid NA, 2007, RAPID COMMUN MASS SP, V21, P169, DOI 10.1002/rcm.2813; Fontana P, 2007, J THROMB HAEMOST, V5, P2153, DOI 10.1111/j.1538-7836.2007.02722.x; Giusti B, 2009, AM J CARDIOL, V103, P806, DOI 10.1016/j.amjcard.2008.11.048; Gladding P, 2008, JACC-CARDIOVASC INTE, V1, P620, DOI 10.1016/j.jcin.2008.09.008; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Mega JL, 2009, CIRCULATION, V119, P2553, DOI 10.1161/CIRCULATIONAHA.109.851949; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Moriya Y, 2002, BIOL PHARM BULL, V25, P1356, DOI 10.1248/bpb.25.1356; Nakamura T, 2002, CLIN PHARMACOL THER, V71, P297, DOI 10.1067/mcp.2002.122055; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Taubert D, 2006, CLIN PHARMACOL THER, V80, P486, DOI 10.1016/j.clpt.2006.07.007; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2006, AM HEART J, V152, P627, DOI 10.1016/j.ahj.2006.04.012; Zhou SF, 2008, CURR DRUG METAB, V9, P738, DOI 10.2174/138920008786049302	29	468	505	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 16	2010	376	9749					1312	1319		10.1016/S0140-6736(10)61273-1	http://dx.doi.org/10.1016/S0140-6736(10)61273-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	671RX	20801494	Green Accepted			2022-12-24	WOS:000283528600033
J	Lee, K; Gallop, JL; Rambani, K; Kirschner, MW				Lee, Kwonmoo; Gallop, Jennifer L.; Rambani, Komal; Kirschner, Marc W.			Self-Assembly of Filopodia-Like Structures on Supported Lipid Bilayers	SCIENCE			English	Article							N-WASP; ARP2/3 COMPLEX; DENDRITIC NETWORK; BARBED END; ACTIN; PROTEINS; FORMIN; CELLS; MOTILITY; FAMILY	Filopodia are finger-like protrusive structures, containing actin bundles. By incubating frog egg extracts with supported lipid bilayers containing phosphatidylinositol 4,5 bisphosphate, we have reconstituted the assembly of filopodia-like structures (FLSs). The actin assembles into parallel bundles, and known filopodial components localize to the tip and shaft. The filopodia tip complexes self-organize-they are not templated by preexisting membrane microdomains. The F-BAR domain protein toca-1 recruits N-WASP, followed by the Arp2/3 complex and actin. Elongation proteins, Diaphanous-related formin, VASP, and fascin are recruited subsequently. Although the Arp2/3 complex is required for FLS initiation, it is not essential for elongation, which involves formins. We propose that filopodia form via clustering of Arp2/3 complex activators, self-assembly of filopodial tip complexes on the membrane, and outgrowth of actin bundles.	[Lee, Kwonmoo; Gallop, Jennifer L.; Rambani, Komal; Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Lee, Kwonmoo] MIT, Dept Phys, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Kirschner, MW (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	marc@hms.harvard.edu		Gallop, Jennifer Louise/0000-0002-9978-1382; Lee, Kwonmoo/0000-0001-6838-7094	Korea Science and Engineering Foundation (KOSEF); Harvard-MIT; European Molecular Biology Organization; NIH [GM26875]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026875, R37GM026875] Funding Source: NIH RePORTER	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Harvard-MIT; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K. L. was the recipient of a Korea Science and Engineering Foundation (KOSEF) Scholarship and Harvard-MIT Health Sciences and Technology Fellowship. J.L.G was the recipient of an European Molecular Biology Organization Long-Term Fellowship. This work was funded by NIH grant GM26875. We thank G. Bokoch for the gift of the GST-RhoA-N19 plasmid, S. Field for the gift of the pEGFP GFP-PLC delta PH domain plasmid, Weiner for the RhoGDI plasmid, R. Tsien for the mCherry plasmid, A. Alberts for the mDia2 plasmid, and D. Vignjevic for the fascin plasmid. We thank A. Lebensohn for helping extract preparation and valuable discussions and M. Coughlin, T. Walz, and D. Kelly for help with EM. We thank J. Waters, W. Salmon, and Nikon Imaging Center at Harvard Medical School.	Arasada R, 2007, BBA-MOL CELL RES, V1773, P631, DOI 10.1016/j.bbamcr.2007.03.009; Brieher WM, 2004, J CELL BIOL, V165, P233, DOI 10.1083/jcb.200311040; Chan YHM, 2007, CURR OPIN CHEM BIOL, V11, P581, DOI 10.1016/j.cbpa.2007.09.020; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Crane JM, 2004, BIOPHYS J, V86, P2965, DOI 10.1016/S0006-3495(04)74347-7; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; Faix J, 2009, INT J BIOCHEM CELL B, V41, P1656, DOI 10.1016/j.biocel.2009.02.012; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Ho HYH, 2001, P NATL ACAD SCI USA, V98, P11306, DOI 10.1073/pnas.211420498; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Johnston SA, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-65; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Liu AP, 2008, NAT PHYS, V4, P789, DOI 10.1038/nphys1071; Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197; Mallavarapu A, 1999, J CELL BIOL, V146, P1097, DOI 10.1083/jcb.146.5.1097; Medalia O, 2007, CURR BIOL, V17, P79, DOI 10.1016/j.cub.2006.11.022; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; MOOSEKER MS, 1982, J CELL BIOL, V95, P223, DOI 10.1083/jcb.95.1.223; Nicholson-Dykstra SM, 2008, CELL MOTIL CYTOSKEL, V65, P904, DOI 10.1002/cm.20312; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Pellegrin S, 2005, CURR BIOL, V15, P129, DOI 10.1016/j.cub.2005.01.011; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Schwille P, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P337; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Vignjevic D, 2003, J CELL BIOL, V160, P951, DOI 10.1083/jcb.200208059; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317	39	115	115	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1341	1345		10.1126/science.1191710	http://dx.doi.org/10.1126/science.1191710			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829485	Green Published, Green Accepted			2022-12-24	WOS:000281657300038
J	Tittensor, DP; Mora, C; Jetz, W; Lotze, HK; Ricard, D; Vanden Berghe, E; Worm, B				Tittensor, Derek P.; Mora, Camilo; Jetz, Walter; Lotze, Heike K.; Ricard, Daniel; Vanden Berghe, Edward; Worm, Boris			Global patterns and predictors of marine biodiversity across taxa	NATURE			English	Article							DIVERSITY; CLIMATE; ENERGY; HOTSPOTS; SCALE; SIZE	Global patterns of species richness and their structuring forces have fascinated biologists since Darwin(1,2) and provide critical context for contemporary studies in ecology, evolution and conservation. Anthropogenic impacts and the need for systematic conservation planning have further motivated the analysis of diversity patterns and processes at regional to global scales(3). Whereas land diversity patterns and their predictors are known for numerous taxa(4,5), our understanding of global marine diversity has been more limited, with recent findings revealing some striking contrasts to widely held terrestrial paradigms(6-8). Here we examine global patterns and predictors of species richness across 13 major species groups ranging from zooplankton to marine mammals. Two major patterns emerged: coastal species showed maximum diversity in the Western Pacific, whereas oceanic groups consistently peaked across broad mid-latitudinal bands in all oceans. Spatial regression analyses revealed sea surface temperature as the only environmental predictor highly related to diversity across all 13 taxa. Habitat availability and historical factors were also important for coastal species, whereas other predictors had less significance. Areas of high species richness were disproportionately concentrated in regions with medium or higher human impacts. Our findings indicate a fundamental role of temperature or kinetic energy in structuring cross-taxon marine biodiversity, and indicate that changes in ocean temperature, in conjunction with other human impacts, may ultimately rearrange the global distribution of life in the ocean.	[Tittensor, Derek P.; Mora, Camilo; Lotze, Heike K.; Ricard, Daniel; Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Jetz, Walter] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Vanden Berghe, Edward] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA	Dalhousie University; Yale University; Rutgers State University New Brunswick	Tittensor, DP (corresponding author), Dalhousie Univ, Dept Biol, 1355 Oxford St, Halifax, NS B3H 4J1, Canada.	derekt@mathstat.dal.ca	Jetz, Walter/ABF-1517-2020; Ricard, Daniel/G-1814-2014; Tittensor, Derek P./AAV-1117-2021	Tittensor, Derek P./0000-0002-9550-3123; Jetz, Walter/0000-0002-1971-7277; Worm, Boris/0000-0002-5742-8716; Lotze, Heike/0000-0001-6258-1304	Sloan Foundation; NSF [DBI-0960550, BCS-0648733]	Sloan Foundation(Alfred P. Sloan Foundation); NSF(National Science Foundation (NSF))	We acknowledge contributions and sharing of data from L. Lucifora, V. Garcia, M. Kulbicki and P. Hull. We thank all the sources in Supplementary Tables 1 and 2 for making their data available. We are grateful to all OBIS data providers for making this study possible; see www.iobis.org for a full list. A. Rollo, G. Britten and D. Boyce provided technical help; W. Blanchard offered statistical advice. This paper builds on the efforts of all Census of Marine Life contributors, and long-term support from the Sloan Foundation. W.J. acknowledges support from NSF grants DBI-0960550 and BCS-0648733.	ALLEN AP, 2007, SCALING BIODIVERSITY; [Anonymous], 2001, BEHAV RES METH INS C; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; BIVAND R, 1956, SPDEP SPATIAL DEPEND; Briggs J, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Brinton E., 2000, EUPHAUSIIDS WORLD OC; Cairns DK, 2008, MAR ECOL PROG SER, V356, P239, DOI 10.3354/meps07286; CASEY KS, 2010, OCEANOGRAPHY SPACE R, pCH16; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Darwin C., 1877, DIFFERENT FORMS FLOW; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Etnoyer Peter, 2004, Oceanography, V17, P90; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Fornwall Mark, 2000, Oceanography, V13, P31; Fraser RH, 1996, AM NAT, V148, P138, DOI 10.1086/285915; Froese R., 2014, FISHBASE; Garcia H. E., 2006, NOAA ATLAS NESDIS, V63; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Green E. E. P., 2003, WORLD ATLAS SEAGRASS; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; KULBICKI M, 2007, MACROCOSME MICROCOSM; KULBICKI M, 2004, CHALLENGING COASTS T; Kulbicki M, 2007, CYBIUM, V31, P275; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; LUCIFORA L, PLOS ONE IN PRESS; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mora C, 2005, J BIOGEOGR, V32, P277, DOI 10.1111/j.1365-2699.2004.01155.x; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Prell W., 1999, IGBP PAGES WORLD DAT; R Core Development Team, 2009, R LANG ENV STAT COMP; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robertson D.R., 2002, SHORE FISHES TROPICA; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Roper CFE, 1984, FAO SPECIES CATALOGU, V3; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Spalding MD, 1997, WORLD MANGROVE ATLAS, DOI DOI 10.1017/S0266467498300528; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Veron J., 2000, CORALS WORLD, V1-3; Wagner H, 2009, VEGAN COMMUNITY ECOL; Webb TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010223; Whitehead H, 2008, ECOL LETT, V11, P1198, DOI 10.1111/j.1461-0248.2008.01234.x; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Worm B, 2009, CLIMATE CHANGE: OBSERVED IMPACTS ON PLANET EARTH, P263, DOI 10.1016/B978-0-444-53301-2.00014-2	62	856	896	31	777	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1098	U107		10.1038/nature09329	http://dx.doi.org/10.1038/nature09329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20668450				2022-12-24	WOS:000281203600038
J	Coste, B; Mathur, J; Schmidt, M; Earley, TJ; Ranade, S; Petrus, MJ; Dubin, AE; Patapoutian, A				Coste, Bertrand; Mathur, Jayanti; Schmidt, Manuela; Earley, Taryn J.; Ranade, Sanjeev; Petrus, Matt J.; Dubin, Adrienne E.; Patapoutian, Ardem			Piezo1 and Piezo2 Are Essential Components of Distinct Mechanically Activated Cation Channels	SCIENCE			English	Article							CURRENTS; NEURONS; PROTEIN; TRANSDUCTION	Mechanical stimuli drive many physiological processes, including touch and pain sensation, hearing, and blood pressure regulation. Mechanically activated (MA) cation channel activities have been recorded in many cells, but the responsible molecules have not been identified. We characterized a rapidly adapting MA current in a mouse neuroblastoma cell line. Expression profiling and RNA interference knockdown of candidate genes identified Piezo1 (Fam38A) to be required for MA currents in these cells. Piezo1 and related Piezo2 (Fam38B) are vertebrate multipass transmembrane proteins with homologs in invertebrates, plants, and protozoa. Overexpression of mouse Piezo1 or Piezo2 induced two kinetically distinct MA currents. Piezos are expressed in several tissues, and knockdown of Piezo2 in dorsal root ganglia neurons specifically reduced rapidly adapting MA currents. We propose that Piezos are components of MA cation channels.	[Coste, Bertrand; Schmidt, Manuela; Earley, Taryn J.; Ranade, Sanjeev; Dubin, Adrienne E.; Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Mathur, Jayanti; Petrus, Matt J.; Patapoutian, Ardem] Novartis Res Fdn GNF, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	ardem@scripps.edu		Schmidt, Manuela/0000-0003-1972-3519; Coste, Bertrand/0000-0002-0163-2494; Ranade, Sanjeev/0000-0001-8601-3563	NIH [DE016927, NS046303]; Novartis Research Foundation; American Heart Association; German Academic Exchange Service (DAAD) [D/07/41089]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046303] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Novartis Research Foundation; American Heart Association(American Heart Association); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors gratefully acknowledge H. Hu for help in cloning Piezo2, J. Walker for contributing to microarray experiments, S. Batalov for help in bioinformatics analysis, K. Spencer for help with imaging, and N. Hong and U. Muller for comments on the manuscript and helpful discussions. This work was supported by grants from NIH (DE016927 and NS046303) and the Novartis Research Foundation. B. C. is the recipient of an American Heart Association postdoctoral fellowship; M. S. is the recipient of a German Academic Exchange Service (DAAD, D/07/41089) fellowship. A provisional patent has been filed by TSRI and GNF that claims methods of screening for molecules that modulate Piezo-dependent ion channel activities. The Piezo1 and Piezo2 sequences used in the paper have been deposited in GenBank under accession numbers HQ215520 and HQ215521, respectively.	Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Besch SR, 2002, PFLUG ARCH EUR J PHY, V445, P161, DOI 10.1007/s00424-002-0903-0; Burnstock G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-69; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Cho H, 2006, EUR J NEUROSCI, V23, P2543, DOI 10.1111/j.1460-9568.2006.04802.x; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; Coste B, 2007, J GEN PHYSIOL, V129, P57, DOI 10.1085/jgp.200609665; Drew LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000515; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Hanlon MR, 2002, BIOCHEMISTRY-US, V41, P2886, DOI 10.1021/bi0119565; Hao Jizhe, 2009, V2, P51, DOI 10.1007/978-1-4020-8716-5_3; Hu J, 2006, J PHYSIOL-LONDON, V577, P815, DOI 10.1113/jphysiol.2006.117648; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IWATSUKI K, 1995, COMP BIOCHEM PHYS A, V110, P167, DOI 10.1016/0300-9629(94)00125-D; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; LAWSON SN, 1984, J COMP NEUROL, V228, P263, DOI 10.1002/cne.902280211; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Monshausen GB, 2009, TRENDS CELL BIOL, V19, P228, DOI 10.1016/j.tcb.2009.02.005; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Rodat-Despoix L, 2009, PFLUG ARCH EUR J PHY, V458, P179, DOI 10.1007/s00424-008-0632-0; SANN H, 1995, CELL TISSUE RES, V282, P155, DOI 10.1007/BF00319142; Satoh K, 2006, BRAIN RES, V1108, P19, DOI 10.1016/j.brainres.2006.06.050; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Tucker SJ, 1998, CURR OPIN NEUROBIOL, V8, P316, DOI 10.1016/S0959-4388(98)80055-X; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394	35	1330	1394	72	470	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2010	330	6000					55	60		10.1126/science.1193270	http://dx.doi.org/10.1126/science.1193270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20813920	Green Accepted			2022-12-24	WOS:000282334500031
J	Rossman, JS; Jing, XH; Leser, GP; Lamb, RA				Rossman, Jeremy S.; Jing, Xianghong; Leser, George P.; Lamb, Robert A.			Influenza Virus M2 Protein Mediates ESCRT-Independent Membrane Scission	CELL			English	Article							ION-CHANNEL PROTEIN; A-VIRUS; CYTOPLASMIC TAIL; PROTON CHANNEL; MATRIX PROTEIN; M1 PROTEIN; PLASMA-MEMBRANES; LIPID-BILAYERS; HEMAGGLUTININ; NEURAMINIDASE	Many viruses utilize host ESCRT proteins for budding; however, influenza virus budding is thought to be ESCRT-independent. In this study we have found a role for the influenza virus M2 proton-selective ion channel protein in mediating virus budding. We observed that a highly conserved amphipathic helix located within the M2 cytoplasmic tail mediates a cholesterol-dependent alteration in membrane curvature. The 17 amino acid amphipathic helix is sufficient for budding into giant unilamellar vesicles, and mutation of this sequence inhibited budding of transfected M2 protein in vivo. We show that M2 localizes to the neck of budding virions and that mutation of the M2 amphipathic helix results in failure of the virus to undergo membrane scission and virion release. These data suggest that M2 mediates the final steps of budding for influenza viruses, bypassing the need for host ESCRT proteins.	[Rossman, Jeremy S.; Jing, Xianghong; Leser, George P.; Lamb, Robert A.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Rossman, Jeremy S.; Lamb, Robert A.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA	Northwestern University; Howard Hughes Medical Institute; Northwestern University	Lamb, RA (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	ralamb@northwestern.edu		Rossman, Jeremy/0000-0001-6124-4103	National Institute of Allergy and Infectious Diseases [R01 AI-20201]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020201] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Lamb laboratory for helpful discussions and critical reading of the manuscript. The electron microscopy was performed in the Northwestern University Biological Imaging Facility. This research was supported in part by a grant R01 AI-20201 from the National Institute of Allergy and Infectious Diseases. J.S.R. is an Associate and R. A. L. is an Investigator of the Howard Hughes Medical Institute.	Allain JM, 2006, EUR PHYS J E, V20, P409, DOI 10.1140/epje/i2006-10030-4; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Barman S, 2004, J VIROL, V78, P5258, DOI 10.1128/JVI.78.10.5258-5269.2004; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Bruce EA, 2009, VIROLOGY, V390, P268, DOI 10.1016/j.virol.2009.05.016; Bui M, 1996, J VIROL, V70, P8391, DOI 10.1128/JVI.70.12.8391-8401.1996; Carlton JG, 2009, BIOCHEM SOC T, V37, P195, DOI 10.1042/BST0370195; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chen BJ, 2008, J VIROL, V82, P10059, DOI 10.1128/JVI.01184-08; Chen BJ, 2008, VIROLOGY, V372, P221, DOI 10.1016/j.virol.2007.11.008; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Chen BJ, 2005, J VIROL, V79, P13673, DOI 10.1128/JVI.79.21.13673-13684.2005; CHERNOMORDIK L, 1995, J MEMBRANE BIOL, V146, P1; Cheung TKW, 2005, J GEN VIROL, V86, P1447, DOI 10.1099/vir.0.80727-0; DE MEYER F, 2009, P NATL ACAD SCI USA, V106, P3654; DEMPSEY CE, 1990, BIOCHIM BIOPHYS ACTA, V1031, P143, DOI 10.1016/0304-4157(90)90006-X; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Egashira M, 2002, BIOCHEMISTRY-US, V41, P4165, DOI 10.1021/bi011885+; Girard P, 2004, BIOPHYS J, V87, P419, DOI 10.1529/biophysj.104.040360; Iwatsuki-Horimoto K, 2006, J VIROL, V80, P5233, DOI 10.1128/JVI.00049-06; Jackson D, 2008, J GEN VIROL, V89, P3097, DOI 10.1099/vir.0.2008/004739-0; Jin H, 1997, EMBO J, V16, P1236, DOI 10.1093/emboj/16.6.1236; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Keller H, 2009, CHEMPHYSCHEM, V10, P2805, DOI 10.1002/cphc.200900598; Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201; Lamb R.F., 2005, CONT TOPICS INFLUENZ, P65; Lee MT, 2008, P NATL ACAD SCI USA, V105, P5087, DOI 10.1073/pnas.0710625105; Leser GP, 1996, MOL BIOL CELL, V7, P155, DOI 10.1091/mbc.7.1.155; Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Ma CL, 2009, P NATL ACAD SCI USA, V106, P12283, DOI 10.1073/pnas.0905726106; McCown MF, 2006, J VIROL, V80, P8178, DOI 10.1128/JVI.00627-06; McCown MF, 2005, J VIROL, V79, P3595, DOI 10.1128/JVI.79.6.3595-3605.2005; Nguyen PA, 2008, BIOCHEMISTRY-US, V47, P9934, DOI 10.1021/bi801315m; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; PATTNAIK AK, 1986, J VIROL, V60, P994, DOI 10.1128/JVI.60.3.994-1001.1986; Pinto LH, 2007, MOL BIOSYST, V3, P18, DOI 10.1039/b611613m; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Rossman JS, 2010, J VIROL, V84, P5078, DOI 10.1128/JVI.00119-10; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schroeder C, 2005, EUR BIOPHYS J BIOPHY, V34, P52, DOI 10.1007/s00249-004-0424-1; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Streicher P, 2009, BBA-BIOMEMBRANES, V1788, P2291, DOI 10.1016/j.bbamem.2009.07.025; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Tian CL, 2003, PROTEIN SCI, V12, P2597, DOI 10.1110/ps.03168503; TOSTESON MT, 1994, J MEMBRANE BIOL, V142, P117; VENKATACHALAPATHI, 1993, PROTEINS, V15, P349; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yuan B, 2000, J VIROL, V74, P7250, DOI 10.1128/JVI.74.16.7250-7260.2000; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zhang J, 1996, VIROLOGY, V225, P255, DOI 10.1006/viro.1996.0599	56	360	366	2	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 17	2010	142	6					902	913		10.1016/j.cell.2010.08.029	http://dx.doi.org/10.1016/j.cell.2010.08.029			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850012	Green Accepted, Bronze			2022-12-24	WOS:000281855000013
J	Haurwitz, RE; Jinek, M; Wiedenheft, B; Zhou, KH; Doudna, JA				Haurwitz, Rachel E.; Jinek, Martin; Wiedenheft, Blake; Zhou, Kaihong; Doudna, Jennifer A.			Sequence- and Structure-Specific RNA Processing by a CRISPR Endonuclease	SCIENCE			English	Article							IDENTIFICATION; DEFENSE; TRANSCRIPTION; RECOGNITION; SULFOLOBUS; COMPLEX	Many bacteria and archaea contain clustered regularly interspaced short palindromic repeats (CRISPRs) that confer resistance to invasive genetic elements. Central to this immune system is the production of CRISPR-derived RNAs (crRNAs) after transcription of the CRISPR locus. Here, we identify the endoribonuclease (Csy4) responsible for CRISPR transcript (pre-crRNA) processing in Pseudomonas aeruginosa. A 1.8 angstrom crystal structure of Csy4 bound to its cognate RNA reveals that Csy4 makes sequence-specific interactions in the major groove of the crRNA repeat stem-loop. Together with electrostatic contacts to the phosphate backbone, these enable Csy4 to bind selectively and cleave pre-crRNAs using phylogenetically conserved serine and histidine residues in the active site. The RNA recognition mechanism identified here explains sequence-and structure-specific processing by a large family of CRISPR-specific endoribonucleases.	[Haurwitz, Rachel E.; Jinek, Martin; Wiedenheft, Blake; Zhou, Kaihong; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Wiedenheft, Blake; Zhou, Kaihong; Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	doudna@berkeley.edu	Jinek, Martin/E-6621-2011	Jinek, Martin/0000-0002-7601-210X	U.S. NIH [5 T32 GM08295]; Human Frontier Science Program; NSF; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008295] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NSF(National Science Foundation (NSF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Westphal for help with purification of Csy4 constructs; J. van der Oost for discussion; J. Doudna Cate and members of the Doudna laboratory for critical reading of the manuscript; and C. Ralston and J. Holton (Beamlines 8.2.2 and 8.3.1, Advanced Light Source, Lawrence Berkeley National Laboratory) and S. Coyle for assistance with X-ray data collection. R.E.H. is supported by the U.S. NIH training grant 5 T32 GM08295. M.J. is supported by a Human Frontier Science Program Long-Term Fellowship. B. W. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. This work was supported in part by grants from NSF and the Bill and Melinda Gates Foundation. J.A.D. is a Howard Hughes Medical Institute Investigator. Coordinates and structure factors for the Csy4-crRNA complex have been deposited in the Protein Data Bank under accession codes 2xli, 2xlj, and 2xlk. The authors have filed a related patent.	Anand K, 2008, NAT STRUCT MOL BIOL, V15, P1287, DOI 10.1038/nsmb.1513; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cai ZP, 1998, NAT STRUCT BIOL, V5, P203, DOI 10.1038/nsb0398-203; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; HAIT DH, 2005, PLOS COMPUT BIOL, V1, pE60; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huppler A, 2002, NAT STRUCT BIOL, V9, P431, DOI 10.1038/nsb800; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Legault P, 1998, CELL, V93, P289, DOI 10.1016/S0092-8674(00)81579-2; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Ye XM, 1996, NAT STRUCT BIOL, V3, P1026, DOI 10.1038/nsb1296-1026	23	459	559	10	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2010	329	5997					1355	1358		10.1126/science.1192272	http://dx.doi.org/10.1126/science.1192272			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829488	Green Accepted			2022-12-24	WOS:000281657300042
J	Jacquet, J; Pauly, D; Ainley, D; Holt, S; Dayton, P; Jackson, J				Jacquet, Jennifer; Pauly, Daniel; Ainley, David; Holt, Sidney; Dayton, Paul; Jackson, Jeremy			Seafood stewardship in crisis	NATURE			English	Editorial Material									[Jacquet, Jennifer; Pauly, Daniel] Univ British Columbia, Fisheries Ctr, Sea Around Us Project, Vancouver, BC V6T 1Z4, Canada; [Ainley, David] HT Harvey & Associates, Los Gatos, CA 95032 USA; [Dayton, Paul; Jackson, Jeremy] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92037 USA	University of British Columbia; University of California System; University of California San Diego; Scripps Institution of Oceanography	Jacquet, J (corresponding author), Univ British Columbia, Fisheries Ctr, Sea Around Us Project, Vancouver, BC V6T 1Z4, Canada.	j.jacquet@fisheries.ubc.ca	Pauly, Daniel Marc/AAY-2316-2021	Pauly, Daniel/0000-0003-3756-4793				Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Chuenpagdee R, 2003, FRONT ECOL ENVIRON, V1, P517; *FISH OC CAN, 2009, CAN ASS PAC HAK US C; lanelli J. N., 2009, ASSESSMENT WALLEYE P; *MAR STEW COUNC, 2010, PRINC CRIT SUST FISH	5	168	169	0	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					28	29		10.1038/467028a	http://dx.doi.org/10.1038/467028a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	645MB	20811437				2022-12-24	WOS:000281461200018
J	Makde, RD; England, JR; Yennawar, HP; Tan, S				Makde, Ravindra D.; England, Joseph R.; Yennawar, Hemant P.; Tan, Song			Structure of RCC1 chromatin factor bound to the nucleosome core particle	NATURE			English	Article							CHROMOSOME CONDENSATION RCC1; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; NUCLEAR TRANSPORT; MITOTIC SPINDLE; BETA-GAMMA; RAN; DNA; COMPLEX; BINDING	The small GTPase Ran enzyme regulates critical eukaryotic cellular functions including nuclear transport and mitosis through the creation of a RanGTP gradient around the chromosomes. This concentration gradient is created by the chromatin-bound RCC1 (regulator of chromosome condensation) protein, which recruits Ran to nucleosomes and activates Ran's nucleotide exchange activity. Although RCC1 has been shown to bind directly with the nucleosome, the molecular details of this interaction were not known. Here we determine the crystal structure of a complex of Drosophila RCC1 and the nucleosome core particle at 2.9 angstrom resolution, providing an atomic view of how a chromatin protein interacts with the histone and DNA components of the nucleosome. Our structure also suggests that the Widom 601 DNA positioning sequence present in the nucleosomes forms a 145-base-pair nucleosome core particle, not the expected canonical 147-base-pair particle.	[Makde, Ravindra D.; England, Joseph R.; Yennawar, Hemant P.; Tan, Song] Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Tan, S (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr Eukaryot Gene Regulat, University Pk, PA 16802 USA.	sxt30@psu.edu		Yennawar, Hemant P./0000-0003-2869-1109; Makde, Ravindra D./0000-0001-7020-0065	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088236] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM088236-02, R01 GM088236, R01 GM088236-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bao YH, 2006, J MOL BIOL, V361, P617, DOI 10.1016/j.jmb.2006.06.051; Barbera AJ, 2006, SCIENCE, V311, P856, DOI 10.1126/science.1120541; Bilbao-Cortes D, 2002, CURR BIOL, V12, P1151, DOI 10.1016/S0960-9822(02)00927-2; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carazo-Salas RE, 1999, NATURE, V400, P178, DOI 10.1038/22133; Chakravarthy S, 2006, J BIOL CHEM, V281, P25522, DOI 10.1074/jbc.M602258200; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Clapier CR, 2008, PROTEINS, V71, P1, DOI 10.1002/prot.21720; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; DeLano W.L., PYMOL MOL GRAPHICS S; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Edayathumangalam RS, 2005, J MOL BIOL, V345, P103, DOI 10.1016/j.jmb.2004.10.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; England JR, 2010, J MOL BIOL, V398, P518, DOI 10.1016/j.jmb.2010.03.037; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Hao Y, 2008, J CELL BIOL, V182, P827, DOI 10.1083/jcb.200803110; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luger K, 1999, METH MOL B, V119, P1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540; Ong MS, 2007, J MOL BIOL, V368, P1067, DOI 10.1016/j.jmb.2007.02.062; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Partridge JR, 2009, J MOL BIOL, V391, P375, DOI 10.1016/j.jmb.2009.06.011; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Seewald MJ, 2002, NATURE, V415, P662, DOI 10.1038/415662a; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Suto RK, 2003, J MOL BIOL, V326, P371, DOI 10.1016/S0022-2836(02)01407-9; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Tsunaka Y, 2005, NUCLEIC ACIDS RES, V33, P3424, DOI 10.1093/nar/gki663; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Zhang CM, 2002, EUR J CELL BIOL, V81, P623, DOI 10.1078/0171-9335-00288	50	271	273	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					562	U81		10.1038/nature09321	http://dx.doi.org/10.1038/nature09321			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20739938	Green Accepted			2022-12-24	WOS:000282273100032
J	Young, BP; Shin, JJH; Orij, R; Chao, JT; Li, SC; Guan, XL; Khong, A; Jan, E; Wenk, MR; Prinz, WA; Smits, GJ; Loewen, CJR				Young, Barry P.; Shin, John J. H.; Orij, Rick; Chao, Jesse T.; Li, Shu Chen; Guan, Xue Li; Khong, Anthony; Jan, Eric; Wenk, Markus R.; Prinz, William A.; Smits, Gertien J.; Loewen, Christopher J. R.			Phosphatidic Acid Is a pH Biosensor That Links Membrane Biogenesis to Metabolism	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; H+-ATPASE; YEAST; PROTEIN; LOCALIZATION; HOMEOSTASIS; VACUOLAR	Recognition of lipids by proteins is important for their targeting and activation in many signaling pathways, but the mechanisms that regulate such interactions are largely unknown. Here, we found that binding of proteins to the ubiquitous signaling lipid phosphatidic acid (PA) depended on intracellular pH and the protonation state of its phosphate headgroup. In yeast, a rapid decrease in intracellular pH in response to glucose starvation regulated binding of PA to a transcription factor, Opi1, that coordinately repressed phospholipid metabolic genes. This enabled coupling of membrane biogenesis to nutrient availability.	[Young, Barry P.; Shin, John J. H.; Chao, Jesse T.; Li, Shu Chen; Loewen, Christopher J. R.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Orij, Rick; Smits, Gertien J.] Univ Amsterdam, Dept Mol Biol & Microbial Food Safety, NL-1018 WV Amsterdam, Netherlands; [Guan, Xue Li] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 119077, Singapore; [Guan, Xue Li; Wenk, Markus R.] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland; [Khong, Anthony; Jan, Eric] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 119077, Singapore; [Wenk, Markus R.] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Prinz, William A.] NIDDKD, Lab Cell Biochem & Biol, NIH, Bethesda, MD 20892 USA; [Loewen, Christopher J. R.] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of Amsterdam; National University of Singapore; University of Geneva; University of British Columbia; National University of Singapore; University of Basel; Swiss Tropical & Public Health Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of British Columbia	Loewen, CJR (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada.	christopher.loewen@ubc.ca	Wenk, Markus Rene/D-1441-2014; Smits, Gertien J./I-4327-2014; Jan, Eric/O-1923-2019; Khong, Anthony/AHD-6446-2022; Guan, Xue Li/D-2935-2014	Smits, Gertien J./0000-0002-8439-7791; Guan, Xue Li/0000-0002-5189-8178; Chao, Jesse/0000-0002-6995-9581; , John/0000-0002-8905-8350	National Sciences and Engineering Council of Canada (NSERC); Canadian Institute of Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); Canada Foundation for Innovation; British Columbia Knowledge Development Fund; National Institute of Diabetes and Digestive and Kidney Diseases; Singapore National Research Foundation [2007-04]; Biomedical Research Council of Singapore [R-183-000-211-305]; National Medical Research Council [R-183-000-224-213]; SystemsX.ch RTD project LipidX; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060004] Funding Source: NIH RePORTER	National Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Singapore National Research Foundation(National Research Foundation, Singapore); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SystemsX.ch RTD project LipidX; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to T. Levine for insight and critical reading of the manuscript; C. Boone for access to SGA technologies; M. Davies and L. Conibear for a preliminary inositol screen; and J. Church for discussions. This research was supported by grants from the National Sciences and Engineering Council of Canada (NSERC), the Canadian Institute of Health Research (CIHR), the Michael Smith Foundation for Health Research (MSFHR), the Canada Foundation for Innovation, and the British Columbia Knowledge Development Fund (C.J.R.L. and E.J.); the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases (W.A.P.); and the Singapore National Research Foundation under CRP Award 2007-04, the Biomedical Research Council of Singapore (R-183-000-211-305), the National Medical Research Council (R-183-000-224-213), and the SystemsX.ch RTD project LipidX (M.R.W.). J.J.H.S. is the recipient of a NSERC Alexander Graham Bell Canada Graduate Scholarship. C.J.R.L. is a CIHR New Investigator, a MSFHR Scholar, and a Tula Foundation Investigator.	BHUSHAN A, 1993, BIOPHYS J, V64, P716, DOI 10.1016/S0006-3495(93)81431-0; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Chan G, 2007, J BIOCHEM MOL TOXIC, V21, P252, DOI 10.1002/jbt.20189; Ferreira T, 2001, J BIOL CHEM, V276, P29613, DOI 10.1074/jbc.R100022200; Giaever G, 1999, NAT GENET, V21, P278, DOI 10.1038/6791; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hancock LC, 2006, GENETICS, V173, P621, DOI 10.1534/genetics.106.057489; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kooijman EE, 2008, BIOPHYS J, V94, P4320, DOI 10.1529/biophysj.107.121046; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kooijman EE, 2009, BIOCHEMISTRY-US, V48, P9360, DOI 10.1021/bi9008616; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Orij R, 2009, MICROBIOL-SGM, V155, P268, DOI 10.1099/mic.0.022038-0; Porat Z, 2005, CELL MOL LIFE SCI, V62, P3106, DOI 10.1007/s00018-005-5341-7; Williams-Hart T, 2002, GENETICS, V160, P1423; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	20	178	180	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2010	329	5995					1085	1088		10.1126/science.1191026	http://dx.doi.org/10.1126/science.1191026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798321				2022-12-24	WOS:000281253500043
J	de Jonge, R; van Esse, HP; Kombrink, A; Shinya, T; Desaki, Y; Bours, R; van der Krol, S; Shibuya, N; Joosten, MHAJ; Thomma, BPHJ				de Jonge, Ronnie; van Esse, H. Peter; Kombrink, Anja; Shinya, Tomonori; Desaki, Yoshitake; Bours, Ralph; van der Krol, Sander; Shibuya, Naoto; Joosten, Matthieu H. A. J.; Thomma, Bart P. H. J.			Conserved Fungal LysM Effector Ecp6 Prevents Chitin-Triggered Immunity in Plants	SCIENCE			English	Article							RECEPTOR-LIKE KINASE; CLADOSPORIUM-FULVUM; VIRULENCE FACTOR; BINDING; DEFENSE; TOMATO; CELLS; AVR4; RECOGNITION; ARABIDOPSIS	Multicellular organisms activate immunity upon recognition of pathogen-associated molecular patterns (PAMPs). Chitin is the major component of fungal cell walls, and chitin oligosaccharides act as PAMPs in plant and mammalian cells. Microbial pathogens deliver effector proteins to suppress PAMP-triggered host immunity and to establish infection. Here, we show that the LysM domain-containing effector protein Ecp6 of the fungal plant pathogen Cladosporium fulvum mediates virulence through perturbation of chitin-triggered host immunity. During infection, Ecp6 sequesters chitin oligosaccharides that are released from the cell walls of invading hyphae to prevent elicitation of host immunity. This may represent a common strategy of host immune suppression by fungal pathogens, because LysM effectors are widely conserved in the fungal kingdom.	[de Jonge, Ronnie; van Esse, H. Peter; Kombrink, Anja; Joosten, Matthieu H. A. J.; Thomma, Bart P. H. J.] Wageningen Univ, Phytopathol Lab, NL-6708 PB Wageningen, Netherlands; [Thomma, Bart P. H. J.] Ctr Biosyst Genom, NL-6700 AB Wageningen, Netherlands; [Shinya, Tomonori; Desaki, Yoshitake; Shibuya, Naoto] Meiji Univ, Fac Agr, Dept Life Sci, Kanagawa 2148571, Japan; [Bours, Ralph; van der Krol, Sander] Wageningen Univ, Lab Plant Physiol, NL-6708 PB Wageningen, Netherlands	Wageningen University & Research; Centre for BioSystems Genomics; Meiji University; Wageningen University & Research	Thomma, BPHJ (corresponding author), Wageningen Univ, Phytopathol Lab, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.	bart.thomma@wur.nl	Joosten, Matthieu/AAB-5150-2022; de Jonge, Ronnie/I-3260-2016; Thomma, Bart/E-5959-2011; van Esse, Peter/U-5304-2018; van der Krol, Alexander/C-5720-2015; Desaki, Yoshitake/M-7264-2015; Joosten, Matthieu/AAB-5131-2022; Thomma, Bart/ABH-6344-2020	de Jonge, Ronnie/0000-0001-5065-8538; Thomma, Bart/0000-0003-4125-4181; van Esse, Peter/0000-0002-3667-060X; van der Krol, Alexander/0000-0001-6585-7572; Desaki, Yoshitake/0000-0002-0916-9051; Joosten, Matthieu/0000-0002-6243-4547; Thomma, Bart/0000-0003-4125-4181	Research Council for Earth and Life Sciences (ALW) of the Netherlands Organization for Scientific Research (NWO); European Research Area-Network (ERA-NET) Plant Genomics; Centre for BioSystems Genomics (CBSG), Netherlands Genomics Initiative; NWO; Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Education, Culture, Sports, Science and Technology, Japan	Research Council for Earth and Life Sciences (ALW) of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Area-Network (ERA-NET) Plant Genomics; Centre for BioSystems Genomics (CBSG), Netherlands Genomics Initiative; NWO(Netherlands Organization for Scientific Research (NWO)); Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are indebted to Yaizu Suisankagaku Industrial Co. Ltd. for the supply of chitosan oligosaccharides and to the Consortium for Functional Glycomics (CFG) for performing the glycan array analysis. This research was supported by a Vidi grant of the Research Council for Earth and Life Sciences (ALW) of the Netherlands Organization for Scientific Research (NWO), by the European Research Area-Network (ERA-NET) Plant Genomics and by the Centre for BioSystems Genomics (CBSG), which is part of the Netherlands Genomics Initiative and NWO. Part of this research was supported by the Program for Promotion of Basic Research Activities for Innovative Bioscience (PROBRAIN) and a grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors thank P. de Wit, F. Govers, T. Bisseling, N. Talbot, and anonymous reviewers for critical evaluation of the manuscript and L. Verhage and L. Kaaij for technical assistance.	Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BOLLER T, 1995, ANNU REV PLANT PHYS, V46, P189, DOI 10.1146/annurev.arplant.46.1.189; Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; de Jonge R, 2009, TRENDS MICROBIOL, V17, P151, DOI 10.1016/j.tim.2009.01.002; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Rooney HCE, 2005, SCIENCE, V308, P1783, DOI 10.1126/science.1111404; SCHLUMBAUM A, 1986, NATURE, V324, P365, DOI 10.1038/324365a0; Shabab M, 2008, PLANT CELL, V20, P1169, DOI 10.1105/tpc.107.056325; Shinya T, 2010, PLANT CELL PHYSIOL, V51, P262, DOI 10.1093/pcp/pcp185; Thomma BPHJ, 2005, MOL PLANT PATHOL, V6, P379, DOI 10.1111/J.1364-3703.2005.00292.X; van den Burg HA, 2004, J BIOL CHEM, V279, P16786, DOI 10.1074/jbc.M312594200; van den Burg HA, 2006, MOL PLANT MICROBE IN, V19, P1420, DOI 10.1094/MPMI-19-1420; van Esse HP, 2008, PLANT CELL, V20, P1948, DOI 10.1105/tpc.108.059394; van Esse HP, 2007, MOL PLANT MICROBE IN, V20, P1092, DOI 10.1094/MPMI-20-9-1092; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754	25	462	468	13	209	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					953	955		10.1126/science.1190859	http://dx.doi.org/10.1126/science.1190859			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724636				2022-12-24	WOS:000281084800037
J	Moyle, LC; Nakazato, T				Moyle, Leonie C.; Nakazato, Takuya			Hybrid Incompatibility "Snowballs" Between Solanum Species	SCIENCE			English	Article							MALE-STERILITY; GENETICS; EPISTASIS; EVOLUTION; DOMINANCE; LOCI	Among the reproductive barriers that can isolate species, hybrid sterility is frequently due to dysfunctional interactions between loci that accumulate between differentiating lineages. Theory describing the evolution of these incompatibilities has generated the prediction, still empirically untested, that loci underlying hybrid incompatibility should accumulate faster than linearly with time-the "snowball effect." We evaluated the accumulation of quantitative trait loci (QTL) between species in the plant group Solanum and found evidence for a faster-than-linear accumulation of hybrid seed sterility QTL, thus empirically evaluating and confirming this theoretical prediction. In comparison, loci underlying traits unrelated to hybrid sterility show no evidence for an accelerating rate of accumulation between species.	[Moyle, Leonie C.; Nakazato, Takuya] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Nakazato, Takuya] Univ Memphis, Memphis, TN 38152 USA	Indiana University System; Indiana University Bloomington; University of Memphis	Moyle, LC (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	lmoyle@indiana.edu			National Science Foundation [DEB-0532097, DEB-0849157]	National Science Foundation(National Science Foundation (NSF))	M. Fryska, E. Graham, E. Lines, and K. Wolt contributed to collection of the data. C. Muir drew Figure 1. M. Hahn, C. Muir, and M. Turelli provided comments on the manuscript. Supported by National Science Foundation grants DEB-0532097 and DEB-0849157 (LCM).	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; CABOT EL, 1994, GENETICS, V137, P175; Chang AS, 2010, EVOLUTION, V64, P253, DOI 10.1111/j.1558-5646.2009.00823.x; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Coyne JA, 2004, SPECIATION, V37; Dobzhansky T, 1936, GENETICS, V21, P113; Gourbiere S, 2010, EVOLUTION, V64, P1, DOI 10.1111/j.1558-5646.2009.00844.x; Johnson Norman A., 2006, P374; Kondrashov AS, 2003, EVOLUTION, V57, P151; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Mendelson TC, 2004, EVOLUTION, V58, P1424; Moyle LC, 2006, MOL BIOL EVOL, V23, P973, DOI 10.1093/molbev/msj112; Moyle LC, 2005, GENETICS, V169, P355, DOI 10.1534/genetics.104.029546; Moyle LC, 2008, GENETICS, V179, P1437, DOI 10.1534/genetics.107.083618; Muller HJ, 1942, BIOL S, V6, P71; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 2001, EVOLUTION, V55, P1085; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Tao Y, 2003, GENETICS, V164, P1399; Turelli M, 2000, GENETICS, V154, P1663; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; UNCKLESS R, COMMUNICATION; Zar JH, 1999, BIOSTATISTICAL ANAL	23	147	148	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1521	1523		10.1126/science.1193063	http://dx.doi.org/10.1126/science.1193063			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847271				2022-12-24	WOS:000281869000041
J	Vermeulen, M; Eberl, HC; Matarese, F; Marks, H; Denissov, S; Butter, F; Lee, KK; Olsen, JV; Hyman, AA; Stunnenberg, HG; Mann, M				Vermeulen, Michiel; Eberl, H. Christian; Matarese, Filomena; Marks, Hendrik; Denissov, Sergei; Butter, Falk; Lee, Kenneth K.; Olsen, Jesper V.; Hyman, Anthony A.; Stunnenberg, Henk G.; Mann, Matthias			Quantitative Interaction Proteomics and Genome-wide Profiling of Epigenetic Histone Marks and Their Readers	CELL			English	Article							CHROMATIN MODIFICATIONS; BAC TRANSGENEOMICS; MOLECULAR-BASIS; TUDOR DOMAIN; PWWP DOMAIN; METHYLATION; H3; COMPLEXES; BINDING; LYSINE-4	Trimethyl-lysine (me3) modifications on histones are the most stable epigenetic marks and they control chromatin-mediated regulation of gene expression. Here, we determine proteins that bind these marks by high-accuracy, quantitative mass spectrometry. These chromatin "readers'' are assigned to complexes by interaction proteomics of full-length BAC-GFP-tagged proteins. ChIP-Seq profiling identifies their genomic binding sites, revealing functional properties. Among the main findings, the human SAGA complex binds to H3K4me3 via a double Tudor-domain in the C terminus of Sgf29, and the PWWP domain is identified as a putative H3K36me3 binding motif. The ORC complex, including LRWD1, binds to the three most prominent transcriptional repressive lysine methylation sites. Our data reveal a highly adapted interplay between chromatin marks and their associated protein complexes. Reading specific trimethyl-lysine sites by specialized complexes appears to be a widespread mechanism to mediate gene expression.	[Vermeulen, Michiel; Eberl, H. Christian; Butter, Falk; Olsen, Jesper V.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Matarese, Filomena; Marks, Hendrik; Denissov, Sergei; Stunnenberg, Henk G.] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Fac Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Lee, Kenneth K.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Olsen, Jesper V.] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark	Max Planck Society; Radboud University Nijmegen; Stowers Institute for Medical Research; Max Planck Society; University of Copenhagen	Vermeulen, M (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, Utrecht, Netherlands.	m.vermeulen-3@umcutrecht.nl; h.stunnenberg@ncmls.ru.nl; mmann@biochem.mpg.de	Vermeulen, Michiel/C-8883-2013; Olsen, Jesper/ABH-4638-2020; Hyman, Anthony A/B-3917-2017; Marks, Hendrik/E-2801-2012; Mann, Matthias/A-3454-2013; Hyman, Tony/F-1923-2011; Stunnenberg, Hendrik G./D-6875-2012	Vermeulen, Michiel/0000-0003-0836-6894; Olsen, Jesper/0000-0002-4747-4938; Hyman, Anthony A/0000-0003-3664-154X; Marks, Hendrik/0000-0002-4198-3731; Mann, Matthias/0000-0003-1292-4799; Stunnenberg, Hendrik G./0000-0002-0066-1576; Butter, Falk/0000-0002-7197-7279; Eberl, H. Christian/0000-0002-4159-5958	Max-Planck Society for the Advancement of Science, HEROIC; European Union [LSHG-CT-2005-018883]	Max-Planck Society for the Advancement of Science, HEROIC(Max Planck Society); European Union(European Commission)	Eva Janssen-Megens, Kees-Jan Francois, and Yan Tan helped with the sequencing, the MPI core facility expressed and purified recombinant proteins, and Dr. F. Tashiro kindly provided Sgf29 antibody. This work was supported by the Max-Planck Society for the Advancement of Science, HEROIC, an Integrated Project funded by the European Union under the 6th Framework Program (LSHG-CT-2005-018883) and by Interaction Proteome (LSHG-CT-2003-505520). M. V. received a fellowship of the Dutch Cancer Society (KWF/NKB) and a grant from the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research.	Butter F, 2010, EMBO REP, V11, P305, DOI 10.1038/embor.2010.6; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Franz H, 2009, J BIOL CHEM, V284, P35049, DOI 10.1074/jbc.M109.052332; Garcia BA, 2007, CURR OPIN CHEM BIOL, V11, P66, DOI 10.1016/j.cbpa.2006.11.022; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee N, 2009, MOL CELL BIOL, V29, P1401, DOI 10.1128/MCB.01643-08; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Mandel S, 2007, DEV BIOL, V303, P814, DOI 10.1016/j.ydbio.2006.11.039; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mateescu B, 2004, EMBO REP, V5, P490, DOI 10.1038/sj.embor.7400139; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Nagy Z, 2010, CELL MOL LIFE SCI, V67, P611, DOI 10.1007/s00018-009-0199-8; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; VAN OEVELEN C, 2008, MOL CELL, V32, P359; Vermeulen M, 2008, CURR OPIN BIOTECH, V19, P331, DOI 10.1016/j.copbio.2008.06.001; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Vermeulen M, 2009, CURR OPIN CELL BIOL, V21, P761, DOI 10.1016/j.ceb.2009.09.003; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Winter S, 2008, CELL CYCLE, V7, P1336, DOI 10.4161/cc.7.10.5946; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	56	553	578	2	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					967	980		10.1016/j.cell.2010.08.020	http://dx.doi.org/10.1016/j.cell.2010.08.020			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850016	Bronze			2022-12-24	WOS:000281855000018
J	Dosenbach, NUF; Nardos, B; Cohen, AL; Fair, DA; Power, JD; Church, JA; Nelson, SM; Wig, GS; Vogel, AC; Lessov-Schlaggar, CN; Barnes, KA; Dubis, JW; Feczko, E; Coalson, RS; Pruett, JR; Barch, DM; Petersen, SE; Schlaggar, BL				Dosenbach, Nico U. F.; Nardos, Binyam; Cohen, Alexander L.; Fair, Damien A.; Power, Jonathan D.; Church, Jessica A.; Nelson, Steven M.; Wig, Gagan S.; Vogel, Alecia C.; Lessov-Schlaggar, Christina N.; Barnes, Kelly Anne; Dubis, Joseph W.; Feczko, Eric; Coalson, Rebecca S.; Pruett, John R., Jr.; Barch, Deanna M.; Petersen, Steven E.; Schlaggar, Bradley L.			Prediction of Individual Brain Maturity Using fMRI	SCIENCE			English	Article							RESTING HUMAN BRAIN; FUNCTIONAL CONNECTIVITY; COGNITIVE CONTROL; PATTERN-ANALYSIS; CHILDREN; CORTEX; REPRESENTATIONS; NETWORKS; ABILITY; HUMANS	Group functional connectivity magnetic resonance imaging (fcMRI) studies have documented reliable changes in human functional brain maturity over development. Here we show that support vector machine-based multivariate pattern analysis extracts sufficient information from fcMRI data to make accurate predictions about individuals' brain maturity across development. The use of only 5 minutes of resting-state fcMRI data from 238 scans of typically developing volunteers (ages 7 to 30 years) allowed prediction of individual brain maturity as a functional connectivity maturation index. The resultant functional maturation curve accounted for 55% of the sample variance and followed a nonlinear asymptotic growth curve shape. The greatest relative contribution to predicting individual brain maturity was made by the weakening of short-range functional connections between the adult brain's major functional networks.	[Dosenbach, Nico U. F.; Nardos, Binyam; Cohen, Alexander L.; Power, Jonathan D.; Church, Jessica A.; Nelson, Steven M.; Wig, Gagan S.; Vogel, Alecia C.; Barnes, Kelly Anne; Dubis, Joseph W.; Coalson, Rebecca S.; Petersen, Steven E.; Schlaggar, Bradley L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Fair, Damien A.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97239 USA; [Nelson, Steven M.; Barch, Deanna M.; Petersen, Steven E.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Wig, Gagan S.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Wig, Gagan S.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Lessov-Schlaggar, Christina N.; Feczko, Eric; Pruett, John R., Jr.; Barch, Deanna M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Coalson, Rebecca S.; Barch, Deanna M.; Petersen, Steven E.; Schlaggar, Bradley L.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Petersen, Steven E.; Schlaggar, Bradley L.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Schlaggar, Bradley L.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Oregon Health & Science University; Washington University (WUSTL); Harvard University; Harvard University; Massachusetts General Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Dosenbach, NUF (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	ndosenbach@wustl.edu; schlaggarb@neuro.wustl.edu	Nelson, Steven/C-1003-2009; Kennedy, Kristen M/B-4699-2008; Schlaggar, Bradley/AAZ-4153-2020; Barch, Deanna M/G-8638-2013; Cohen, Alexander/A-6865-2009; Church, Jessica/E-2836-2010; Cohen, Alexander Li/H-6594-2019; Church, Jessica/L-2659-2016; Petersen, Steve/ABF-1368-2020	Kennedy, Kristen M/0000-0001-5373-9026; Cohen, Alexander/0000-0001-6557-5866; Cohen, Alexander Li/0000-0001-6557-5866; Church, Jessica/0000-0003-1369-9116; Power, Jonathan/0000-0002-6922-100X	NIH [NS55582, NS053425, HD057076, NS00169011, NS51281, NS32979, NS41255, NS46424, DA027046]; John Merck Scholars Fund; Burroughs-Wellcome Fund; Dana Foundation; Ogle Family Fund; McDonnell Center; Simons Foundation; American Hearing Research Foundation; Diabetes Research Center at Washington University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057076] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K12EY016336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH062130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032979, K02NS053425, R21NS041255, R01NS046424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA027046] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Merck Scholars Fund; Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Dana Foundation; Ogle Family Fund; McDonnell Center; Simons Foundation; American Hearing Research Foundation; Diabetes Research Center at Washington University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH grants NS55582, NS053425, HD057076, and NS00169011 (B.L.S.); NS51281, NS32979, NS41255, and NS46424 (S.E.P.); DA027046 (C.N.L.-S.); EY16336 (J.R.P.); and MH62130 (D.M.B.) and by the John Merck Scholars Fund (B.L.S.), Burroughs-Wellcome Fund (B.L.S.), Dana Foundation (B.L.S.), Ogle Family Fund (B.L.S.), McDonnell Center (S.E.P. and B.L.S.), Simons Foundation (S.E.P.), American Hearing Research Foundation (J. E. C. Lieu), and Diabetes Research Center at Washington University (T. G. Hershey). We thank J. E. C. Lieu, C. E. Pizoli, and T. G. Hershey for providing data and F. M. Miezin, J. Harwell, A. Z. Snyder, and H. M. Lugar for help with data analysis.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 2009, PSYCHOL SCI, V20, P1364, DOI 10.1111/j.1467-9280.2009.02460.x; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Craik FIM, 2006, TRENDS COGN SCI, V10, P131, DOI 10.1016/j.tics.2006.01.007; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Johnson JD, 2009, NEURON, V63, P697, DOI 10.1016/j.neuron.2009.08.011; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; POLYN SM, 1963, SCIENCE, V310, P2005; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Somerville LH, 2010, CURR OPIN NEUROBIOL, V20, P236, DOI 10.1016/j.conb.2010.01.006; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2; Velanova K, 2009, J NEUROSCI, V29, P12558, DOI 10.1523/JNEUROSCI.1579-09.2009; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198	37	1353	1381	13	265	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2010	329	5997					1358	1361		10.1126/science.1194144	http://dx.doi.org/10.1126/science.1194144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829489	Green Accepted			2022-12-24	WOS:000281657300043
J	Ito, T; Yokoyama, S				Ito, Takuhiro; Yokoyama, Shigeyuki			Two enzymes bound to one transfer RNA assume alternative conformations for consecutive reactions	NATURE			English	Article							STRUCTURAL BASIS; SYNTHETASE; AMIDOTRANSFERASE; CRYSTALLOGRAPHY; RECRUITMENT; GLUTAMINE	In most bacteria and all archaea, glutamyl-tRNA synthetase (GluRS) glutamylates both tRNA(Glu) and tRNA(Gln), and then Glu-tRNA(Gln) is selectively converted to Gln-tRNA(Gln) by a tRNAdependent amidotransferase(1,2). The mechanisms by which the two enzymes recognize their substrate tRNA(s), and how they cooperate with each other in Gln-tRNA(Gln) synthesis, remain to be determined. Here we report the formation of the 'glutamine transamidosome' from the bacterium Thermotoga maritima, consisting of tRNA(Gln), GluRS and the heterotrimeric amidotransferase GatCAB, and its crystal structure at 3.35 angstrom resolution. The anticodon-binding body of GluRS recognizes the common features of tRNA(Gln) and tRNA(Glu), whereas the tail body of GatCAB recognizes the outer corner of the L-shaped tRNA(Gln) in a tRNA(Gln)-specific manner. GluRS is in the productive form, as its catalytic body binds to the amino-acid-acceptor arm of tRNA(Gln). In contrast, GatCAB is in the non-productive form: the catalytic body of GatCAB contacts that of GluRS and is located near the acceptor stem of tRNA(Gln), in an appropriate site to wait for the completion of Glu-tRNA(Gln) formation by GluRS. We identified the hinges between the catalytic and anticodon-binding bodies of GluRS and between the catalytic and tail bodies of GatCAB, which allow both GluRS and GatCAB to adopt the productive and non-productive forms. The catalytic bodies of the two enzymes compete for the acceptor arm of tRNA(Gln) and therefore cannot assume their productive forms simultaneously. The transition from the present glutamylation state, with the productive GluRS and the non-productive GatCAB, to the putative amidation state, with the nonproductive GluRS and the productive GatCAB, requires an intermediate state with the two enzymes in their non-productive forms, for steric reasons. The proposed mechanism explains how the transamidosome efficiently performs the two consecutive steps of Gln-tRNA(Gln) formation, with a low risk of releasing the unstable intermediate Glu-tRNA(Gln).	[Ito, Takuhiro; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo 1130033, Japan; [Ito, Takuhiro; Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Ito, Takuhiro; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	University of Tokyo; University of Tokyo; RIKEN	Yokoyama, S (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Ito, Takuhiro/N-6893-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Ito, Takuhiro/0000-0003-3704-5205	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank S. Sekine for discussions and help with data collection, S. Goto-Ito for reading the manuscript, and S. Takahashi, N. Kiyasu and R. Matsunaga for help with sample preparation. We are grateful to the staff of the beamline BL41XU in the SPring-8 and the beamline AR-NE3A in the Photon Factory for their support during data collection. This work was supported by the Targeted Proteins Research Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and MEXT, and the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailly M, 2007, MOL CELL, V28, P228, DOI 10.1016/j.molcel.2007.08.017; Bailly M, 2006, NUCLEIC ACIDS RES, V34, P6083, DOI 10.1093/nar/gkl622; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ito T, 2010, ACTA CRYSTALLOGR D, V66, P813, DOI 10.1107/S0907444910019086; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakamura A, 2010, NUCLEIC ACIDS RES, V38, P672, DOI 10.1093/nar/gkp955; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Oshikane H, 2006, SCIENCE, V312, P1950, DOI 10.1126/science.1128470; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAMPIAS T, NUCL ACIDS IN PRESS; RUFF M, 1991, SCIENCE, V252, P1682, DOI 10.1126/science.2047877; Sekine S, 2003, EMBO J, V22, P676, DOI 10.1093/emboj/cdg053; Sekine S, 2001, NAT STRUCT BIOL, V8, P203, DOI 10.1038/84927; Tumbula DL, 2000, NATURE, V407, P106, DOI 10.1038/35024120; WILCOX M, 1968, P NATL ACAD SCI USA, V61, P229, DOI 10.1073/pnas.61.1.229; Wu J, 2009, J MOL BIOL, V391, P703, DOI 10.1016/j.jmb.2009.06.014	24	44	46	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					612	U143		10.1038/nature09411	http://dx.doi.org/10.1038/nature09411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20882017				2022-12-24	WOS:000282273100044
J	Matsuzaki, Y; Ogawa-Ohnishi, M; Mori, A; Matsubayashi, Y				Matsuzaki, Yo; Ogawa-Ohnishi, Mari; Mori, Ayaka; Matsubayashi, Yoshikatsu			Secreted Peptide Signals Required for Maintenance of Root Stem Cell Niche in Arabidopsis	SCIENCE			English	Article							PHYTOSULFOKINE; PROLIFERATION; PROTEINS; GENES	Stem cells are maintained in the niche by intercellular interactions and signaling networks. In this work, we study extracellular signals required for maintenance of the root stem cell niche in higher plants. We identify a family of functionally redundant homologous peptides that are secreted, tyrosine-sulfated, and expressed mainly in the stem cell area and the innermost layer of central columella cells. We name these peptides root meristem growth factors (RGFs). RGFs are required for maintenance of the root stem cell niche and transit amplifying cell proliferation in Arabidopsis. RGF1 defines expression levels and patterns of the stem cell transcription factor PLETHORA, mainly at the posttranscriptional level. The RGFs function independently of the auxin pathway. These peptide signals play a crucial role in postembryonic root development.	[Matsuzaki, Yo; Ogawa-Ohnishi, Mari; Mori, Ayaka; Matsubayashi, Yoshikatsu] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Matsubayashi, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	matsu@agr.nagoya-u.ac.jp	MATSUBAYASHI, Yoshikatsu/AAA-9705-2019	Matsubayashi, Yoshikatsu/0000-0002-2669-2119; Ogawa-Ohnishi, Mari/0000-0002-7581-2607	Ministry of Education, Culture, Sports, Science, and Technology [19060010]; Japan Society for the Promotion of Science [19GS0315]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank P. Doerner for providing the CYCB1; 1: GUS seeds, T. Guilfoyle for the DR5:GUS seeds, and B. Scheres for the plt1-4 plt2-2 seeds. This research was supported by a Grant-in-Aid for Scientific Research for Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology (no. 19060010) and a Grant-in-Aid for Creative Scientific Research from the Japan Society for the Promotion of Science (no. 19GS0315).	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Amano Y, 2007, P NATL ACAD SCI USA, V104, P18333, DOI 10.1073/pnas.0706403104; Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Komori R, 2009, P NATL ACAD SCI USA, V106, P15067, DOI 10.1073/pnas.0902801106; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Matsubayashi Y, 2006, PLANT PHYSIOL, V142, P45, DOI 10.1104/pp.106.081109; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Sarkar AK, 2007, NATURE, V446, P811, DOI 10.1038/nature05703; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963	11	278	313	6	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2010	329	5995					1065	1067		10.1126/science.1191132	http://dx.doi.org/10.1126/science.1191132			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20798316				2022-12-24	WOS:000281253500037
J	Panakova, D; Werdich, AA; MacRae, CA				Panakova, Daniela; Werdich, Andreas A.; MacRae, Calum A.			Wnt11 patterns a myocardial electrical gradient through regulation of the L-type Ca2+ channel	NATURE			English	Article							VOLTAGE-SENSITIVE DYES; CARDIAC TISSUE; CELL-CULTURES; CONDUCTION; GASTRULATION; ACTIVATION; MOVEMENTS; DIFFERENTIATION; MORPHOGENESIS; MECHANISMS	Electrical gradients are critical for many biological processes, including the normal function of excitable tissues, left-right patterning, organogenesis and wound healing(1-4). The fundamental mechanisms that regulate the establishment and maintenance of such electrical polarities are poorly understood. Here we identify a gradient of electrical coupling across the developing ventricular myocardium using high-speed optical mapping of transmembrane potentials and calcium concentrations in the zebrafish heart. We excluded a role for differences in cellular excitability, connexin localization, tissue geometry and mechanical inputs, but in contrast we were able to demonstrate that non-canonical Wnt11 signals are required for the genesis of this myocardial electrical gradient. Although the traditional planar cell polarity pathway is not involved, we obtained evidence that Wnt11 acts to set up this gradient of electrical coupling through effects on transmembrane Ca2+ conductance mediated by the L-type calcium channel. These data reveal a previously unrecognized role for Wnt/Ca2+ signalling in establishing an electrical gradient in the plane of the developing cardiac epithelium through modulation of ion-channel function. The regulation of cellular coupling through such mechanisms may be a general property of non-canonical Wnt signals.	[Panakova, Daniela; Werdich, Andreas A.; MacRae, Calum A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	MacRae, CA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, 75 Francis St,Thorn 11, Boston, MA 02115 USA.	camacrae@bics.bwh.harvard.edu		Werdich, Andreas/0000-0002-1222-1180; Panakova, Daniela/0000-0002-8739-6225	HFSP; NIH; March of Dimes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098938, K08HL068711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM075946] Funding Source: NIH RePORTER	HFSP(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. P. Heisenberg, L. Solnica-Krezel and J. Mably for the gift of reagents. We thank R. Peterson and I. Drummond for comments on the manuscript. D. P. is supported by a fellowship from the HFSP. A. A. W. was supported by an NIH training award to the CVRC at MGH. C. A. M. is supported by the March of Dimes and the NIH.	Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Bayly PV, 1998, IEEE T BIO-MED ENG, V45, P563, DOI 10.1109/10.668746; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Chung CY, 2007, J CARDIOVASC ELECTR, V18, P1323, DOI 10.1111/j.1540-8167.2007.00959.x; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Eisenberg CA, 1999, DEV DYNAM, V216, P45, DOI 10.1002/(SICI)1097-0177(199909)216:1<45::AID-DVDY7>3.0.CO;2-L; Eloff BC, 2001, CARDIOVASC RES, V51, P681, DOI 10.1016/S0008-6363(01)00341-8; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; FAST VG, 1993, CIRC RES, V73, P914, DOI 10.1161/01.RES.73.5.914; FAST VG, 1995, CARDIOVASC RES, V29, P697, DOI 10.1016/S0008-6363(96)88643-3; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Girouard SD, 1996, J CARDIOVASC ELECTR, V7, P1024, DOI 10.1111/j.1540-8167.1996.tb00478.x; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; HOYT RH, 1989, CIRC RES, V64, P563, DOI 10.1161/01.RES.64.3.563; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; LOEW LM, 1992, J MEMBRANE BIOL, V130, P1, DOI 10.1007/bf00233734; Milan DJ, 2006, AM J PHYSIOL-HEART C, V291, pH269, DOI 10.1152/ajpheart.00960.2005; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Mills RW, 2008, AM J PHYSIOL-HEART C, V295, pH1270, DOI 10.1152/ajpheart.00350.2008; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; ROHR S, 1994, BIOPHYS J, V67, P1301, DOI 10.1016/S0006-3495(94)80602-2; Rohr S, 1998, BIOPHYS J, V75, P1062, DOI 10.1016/S0006-3495(98)77596-4; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Thisse C., 2005, ZDBPUB0510251; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; WATANABE T, 1983, CIRC RES, V52, P280, DOI 10.1161/01.RES.52.3.280; Windisch H, 2001, OPTICAL MAPPING OF CARDIAC EXCITATION AND ARRHYTHMIAS, P97; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017; Yao L, 2009, HIPPOCAMPUS, V19, P855, DOI 10.1002/hipo.20569; Yao SH, 2008, FEBS LETT, V582, P2325, DOI 10.1016/j.febslet.2008.05.036; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhou WL, 2007, NAT GENET, V39, P1225, DOI 10.1038/ng2112	42	101	102	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					874	U109		10.1038/nature09249	http://dx.doi.org/10.1038/nature09249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20657579	Green Accepted			2022-12-24	WOS:000280766100038
J	Streicker, DG; Turmelle, AS; Vonhof, MJ; Kuzmin, IV; McCracken, GF; Rupprecht, CE				Streicker, Daniel G.; Turmelle, Amy S.; Vonhof, Maarten J.; Kuzmin, Ivan V.; McCracken, Gary F.; Rupprecht, Charles E.			Host Phylogeny Constrains Cross-Species Emergence and Establishment of Rabies Virus in Bats	SCIENCE			English	Article							UNITED-STATES; EPIDEMIOLOGY; TRANSMISSION; DYNAMICS	For RNA viruses, rapid viral evolution and the biological similarity of closely related host species have been proposed as key determinants of the occurrence and long-term outcome of cross-species transmission. Using a data set of hundreds of rabies viruses sampled from 23 North American bat species, we present a general framework to quantify per capita rates of cross-species transmission and reconstruct historical patterns of viral establishment in new host species using molecular sequence data. These estimates demonstrate diminishing frequencies of both cross-species transmission and host shifts with increasing phylogenetic distance between bat species. Evolutionary constraints on viral host range indicate that host species barriers may trump the intrinsic mutability of RNA viruses in determining the fate of emerging host-virus interactions.	[Streicker, Daniel G.; Turmelle, Amy S.; Kuzmin, Ivan V.; Rupprecht, Charles E.] Ctr Dis Control & Prevent, Rabies Team, Atlanta, GA 30333 USA; [Streicker, Daniel G.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Turmelle, Amy S.; McCracken, Gary F.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Vonhof, Maarten J.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Vonhof, Maarten J.] Western Michigan Univ, Environm Studies Program, Kalamazoo, MI 49008 USA	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia; University of Tennessee System; University of Tennessee Knoxville; Western Michigan University; Western Michigan University	Streicker, DG (corresponding author), Ctr Dis Control & Prevent, Rabies Team, Atlanta, GA 30333 USA.	dstrike@uga.edu	Rupprecht, Charles/AAI-1544-2020	McCracken, Gary/0000-0002-2493-8103; Streicker, Daniel/0000-0001-7475-2705; Gilbert, Amy T./0000-0002-8256-0081	Association of Public Health Laboratories/Centers for Disease Control Emerging Infectious Diseases; NSF; NSF-NIH [0430418]; U.S. Army Engineer Research Development Center-Construction Engineering Research Laboratory; Western Michigan University	Association of Public Health Laboratories/Centers for Disease Control Emerging Infectious Diseases; NSF(National Science Foundation (NSF)); NSF-NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Engineer Research Development Center-Construction Engineering Research Laboratory; Western Michigan University	For helpful discussion and comments, we thank P. Beerli, J. Davies, S. Altizer, A. Park, P. Rohani, J. Allgeier, B. Han, P. Stephens, and three anonymous reviewers. For contributing rabid bats, we thank the Arizona State Public Health Laboratory, the California Department of Public Health, the Georgia Department of Community Health, the Florida Department of Health, the Idaho Department of Health and Welfare, the Indiana State Department of Health, the University of Iowa's University Hygienic Laboratory, the Mississippi State Department of Health, the New Jersey Department of Health and Senior Services, the Tennessee Department of Health, the Texas Department of State Health Services, the Virginia Consolidated Laboratory, and the Washington State Department of Health. For providing museum-vouchered bat tissues, we thank the Angelo State Natural History Collection, the Carnegie Museum of Natural History, the Centro de Investigaciones Biologicas del Noroeste, the Louisiana State University Museum of Natural Science, the Museum of Vertebrate Zoology, the U. S. National Museum of Natural History, the Royal Ontario Museum, and the University of Alaska Museum. The sequences generated in this study can be found at GenBank under accession numbers GU644641 to GU645012 and GU722925 to GU723257 (table S1). This work was supported by Association of Public Health Laboratories/Centers for Disease Control Emerging Infectious Diseases and NSF Graduate Research Fellowships to D. G. S., NSF-NIH Ecology of Infectious Disease grant 0430418 to G. F. M., and funding from the U.S. Army Engineer Research Development Center-Construction Engineering Research Laboratory and Western Michigan University to M.J.V.	Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103; BAER GM, 1990, LANCET, V335, P664, DOI 10.1016/0140-6736(90)90454-D; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blanton JD, 2009, JAVMA-J AM VET MED A, V235, P676, DOI 10.2460/javma.235.6.676; BRASS DA, 1994, RABIES BATS NATURAL, P151; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; de Vienne DM, 2009, J EVOLUTION BIOL, V22, P2532, DOI 10.1111/j.1420-9101.2009.01878.x; Finke S, 2005, VIRUS RES, V111, P120, DOI 10.1016/j.virusres.2005.04.004; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Hughes GJ, 2005, J GEN VIROL, V86, P1467, DOI 10.1099/vir.0.80710-0; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Smith JS, 1995, SEMIN VIROL, V6, P387, DOI 10.1016/S1044-5773(05)80016-2; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102	19	304	309	1	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					676	679		10.1126/science.1188836	http://dx.doi.org/10.1126/science.1188836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689015				2022-12-24	WOS:000280602700037
J	Matson, PA; Parton, WJ; Power, AG; Swift, MJ				Matson, PA; Parton, WJ; Power, AG; Swift, MJ			Agricultural intensification and ecosystem properties	SCIENCE			English	Article							SOIL ORGANIC-MATTER; VEGETATIONAL DIVERSITY; NITROGEN; CULTIVATION; MANAGEMENT; DYNAMICS; INSECTS; GROWTH	Expansion and intensification of cultivation are among the predominant global changes of this century. Intensification of agriculture by use of high-yielding crop varieties, fertilization, irrigation, and pesticides has contributed substantially to the tremendous increases in food production over the past 50 years. Land conversion and intensification, however, also alter the biotic interactions and patterns of resource availability in ecosystems and can have serious local, regional, and global environmental consequences. The use of ecologically based management strategies can increase the sustainability of agricultural production while reducing off-site consequences.	COLORADO STATE UNIV, NAT RESOURCE ECOL LAB, FT COLLINS, CO 80523 USA; CORNELL UNIV, ECOL & SYSTEMAT SECT, ITHACA, NY 14853 USA; UNESCO, ROSTA, TROP SOIL BIOL & FERTIL PROGRAMME, NAIROBI, KENYA	Colorado State University; Cornell University	Matson, PA (corresponding author), UNIV CALIF BERKELEY, DEPT ENVIRONM SCI POLICY & MANAGEMENT, ECOSYST SCI DIV, BERKELEY, CA 94720 USA.							ALTIERI MA, 1986, AGR ECOSYST ENVIRON, V16, P29, DOI 10.1016/0167-8809(86)90073-3; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; Beare MH, 1997, APPL SOIL ECOL, V6, P87, DOI 10.1016/S0929-1393(96)00150-3; BEARE MH, 1992, ECOL MONOGR, V62, P569, DOI 10.2307/2937317; BECKER B, 1997, ISSUES AGR, V10, P63; BOATMAN N, 1994, FIELD MARGINS INTEGR; BOUDREAU MA, 1993, PLANT PATHOL, V42, P16, DOI 10.1111/j.1365-3059.1993.tb01467.x; BOUDREAU MA, 1992, PHYTOPATHOLOGY, V82, P1051, DOI 10.1094/Phyto-82-1051; BOUDREAU MA, 1994, ECOL APPL, V4, P729, DOI 10.2307/1942003; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Cassman K. G., 1995, Agricultural sustainability: economic, environmental and statistical considerations., P231; CASSMAN KG, 1995, ADV SOIL SCI, P181; CHAMEIDES WL, 1994, SCIENCE, V264, P74, DOI 10.1126/science.264.5155.74; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; CRITCHLEY BR, 1979, PEDOBIOLOGIA, V19, P425; CRITCHLEY BR, 1989, RES METHODS CEREAL L, P200; CROSSON P, 1995, SCIENCE, V269, P461, DOI 10.1126/science.269.5223.461; DELMAS R, NUTR CYCLING AGROECO; Donigian Jr. A.S., 1994, EPA600R94067; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; Giller PS, 1996, BIODIVERS CONSERV, V5, P135, DOI 10.1007/BF00055827; GREENBERG R, 1994, AUK, V111, P672; Greenberg Russell, 1996, P59; GRIGG D, 1993, WORLD FOOD PROBLEM 1; Hall SJ, 1996, ANNU REV ENERG ENV, V21, P311, DOI 10.1146/annurev.energy.21.1.311; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Huber D., 1981, CRC HDB PEST MANAGEM, P357; HUBER DM, 1974, ANNU REV PHYTOPATHOL, V12, P139, DOI 10.1146/annurev.py.12.090174.001035; IZAC AMN, 1994, ECOL ECON, V11, P105, DOI 10.1016/0921-8009(94)90022-1; JENKINSON DS, 1990, PHILOS T R SOC B, V329, P361, DOI DOI 10.1098/rstb.1990.0177; LAVELLE P, 1989, PEDOBIOLOGIA, V33, P283; LAVELLE P, 1994, SOIL RESILIENCE AND SUSTAINABLE LAND USE, P291; LAVELLE P, COMMUNICATION; Lynam J. K., 1989, Agricultural Economics, V3, P381, DOI 10.1016/0169-5150(89)90010-8; Matson PA, 1996, J GEOPHYS RES-ATMOS, V101, P18533, DOI 10.1029/96JD01536; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Metherell AK, 1995, SOIL MANAGEMENT GREE, V6, P259; MEYER WB, 1992, ANNU REV ECOL SYST, V23, P39, DOI 10.1146/annurev.es.23.110192.000351; Nambiar K.K., 1994, SOIL FERTILITY CROP, P234; *NAT RES COUNC, 1993, MAN WAST COAST URB A; Naylor R, 1997, POPUL DEV REV, V23, P41, DOI 10.2307/2137460; Naylor R. L., 1997, Nature's services: societal dependence on natural ecosystems., P151; Naylor RL, 1996, ANNU REV ENERG ENV, V21, P99, DOI 10.1146/annurev.energy.21.1.99; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; PANKHURST CE, 1994, SOIL BIOTA MANAGEMEN; PARTON WJ, 1994, SOIL SCI SOC AM J, V58, P530, DOI 10.2136/sssaj1994.03615995005800020040x; Paul E.A., 1997, SOIL ORGANIC MATTER; PAUSTIAN K, 1992, SOIL SCI SOC AM J, V56, P476, DOI 10.2136/sssaj1992.03615995005600020023x; Paustian K, 1995, SOIL MANAGEMENT GREE, P69; PIMENTEL D, 1982, BIOSCIENCE, V32, P595, DOI 10.2307/1308603; Pimentel D, 1993, WORLD SOIL EROSION C; Postel S., 1997, Nature's services: societal dependence on natural ecosystems., P195; Postel Sandra, 1996, V1996, P40; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Power A.G., 1990, AGROECOL RES ECOL BA, V78, P47; POWER AG, 1991, ECOLOGY, V72, P232, DOI 10.2307/1938917; Power AG, 1996, ECOL STU AN, V122, P173; Power Alison G., 1996, P91; REISSIG WH, 1986, ILLUSTRATED GUIDE IN; RISCH SJ, 1986, ECOLOGY, V67, P505, DOI 10.2307/1938593; ROBBINS CS, 1992, COMP NEOTROPICAL MIG; Robertson G. Philip, 1993, V55, P95; ROBERTSON GP, AGR ECOLOGY; RUSSELL EP, 1989, ENVIRON ENTOMOL, V18, P590, DOI 10.1093/ee/18.4.590; Scriber J.M., 1984, NITROGEN CROP PRODUC; SWIFT MJ, 1997, APPL SOIL ECOL, V6; SWIFT MJ, 1996, 13 GCTE; SWIFT MJ, 1993, BIODIVERSITY ECOSYST, P29; SWIFT MJ, 1997, ADV AGROECOLOGY; Tian G., 1997, P125; TONHASCA A, 1994, ECOL ENTOMOL, V19, P239, DOI 10.1111/j.1365-2311.1994.tb00415.x; *TROP SOIL BIOL FE, 1997, TSBF REP 1997; *UN FAO, 1993, AGR TOW 2010; VITOUSEK PM, 1993, BIOGEOCHEMISTRY OF GLOBAL CHANGE, P193; VITOUSEK PM, IN PRESS ECOL APPL; Williams EJ, 1992, GLOBAL BIOGEOCHEM CY, V6, P351, DOI 10.1029/92GB02124; Woomer P.L., 1994, BIOL MANAG TROP SOIL; WUNDERLE JM, 1993, CONDOR, V95, P904, DOI 10.2307/1369428	78	1866	2035	43	1228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	1997	277	5325					504	509		10.1126/science.277.5325.504	http://dx.doi.org/10.1126/science.277.5325.504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM867	20662149	Green Submitted			2022-12-24	WOS:A1997XM86700032
J	Daniels, JP; Khan, KS				Daniels, Jane P.; Khan, Khalid S.			Chronic pelvic pain in women	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PREVALENCE		[Daniels, Jane P.] Univ Birmingham, Reprod Genes & Develop & Clin Trials Unit, Birmingham B15 2TT, England; [Khan, Khalid S.] Barts & London Queen Marys Sch Med & Dent, London E1 2DD, England	University of Birmingham; University of London; Queen Mary University London	Daniels, JP (corresponding author), Univ Birmingham, Reprod Genes & Develop & Clin Trials Unit, Birmingham B15 2TT, England.	j.p.daniels@bham.ac.uk	Khan, Khalid S/AAT-8824-2020	Khan, Khalid S/0000-0001-5084-7312				ALSOM N, 2009, BJOG, V116, P1551; *AM COLL OBST GYN, 2004, ACOG PRACT B, V51; Ballard K, 2010, FERTIL STERIL, V94, P20, DOI 10.1016/j.fertnstert.2009.01.164; Cody RF, 2000, BEST PRACT RES CL OB, V14, P433, DOI 10.1053/beog.1999.0085; Daniels J, 2009, JAMA-J AM MED ASSOC, V302, P955, DOI 10.1001/jama.2009.1268; DANIELS JP, 2010, HUM REPROD UPDATE; Fall M, 2010, EUR UROL, V57, P35, DOI 10.1016/j.eururo.2009.08.020; Grace Victoria, 2006, Health Care Women Int, V27, P585, DOI 10.1080/07399330600803725; Grace VM, 2007, WOMEN HEALTH, V46, P81, DOI 10.1300/J013v46n04_05; Howard F M, 1993, Obstet Gynecol Surv, V48, P357, DOI 10.1097/00006254-199306000-00001; Howard FM, 2000, BEST PRACT RES CL OB, V14, P467, DOI 10.1053/beog.1999.0086; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Latthe P, 2006, BMJ-BRIT MED J, V332, P749, DOI 10.1136/bmj.38748.697465.55; Latthe P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-177; PETERS AAW, 1991, OBSTET GYNECOL, V77, P740; *RCOG GUID AUD COM, 2006, 24 RCOG GUID AUD COM; *RCOG GUID AUT COM, 2005, 41 RCOG GUID AUD COM; Stones RW, 2002, J ROY SOC MED, V95, P531, DOI 10.1258/jrsm.95.11.531; STONES W, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000387; Wesselmann U, 2001, WORLD J UROL, V19, P180, DOI 10.1007/s003450100201; Williams RE, 2004, OBSTET GYNECOL, V103, P686, DOI 10.1097/01.AOG.0000115513.92318.b7; WONG CL, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD002120.PUB3; Zondervan KT, 2001, BRIT J GEN PRACT, V51, P541; Zondervan KT, 1999, BRIT J OBSTET GYNAEC, V106, P1149, DOI 10.1111/j.1471-0528.1999.tb08140.x	24	59	63	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2010	341								c4834	10.1136/bmj.c4834	http://dx.doi.org/10.1136/bmj.c4834			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	663JB	20923840				2022-12-24	WOS:000282879000005
J	Parrinello, S; Napoli, I; Ribeiro, S; Digby, PW; Fedorova, M; Parkinson, DB; Doddrell, RDS; Nakayama, M; Adams, RH; Lloyd, AC				Parrinello, Simona; Napoli, Ilaria; Ribeiro, Sara; Digby, Patrick Wingfield; Fedorova, Marina; Parkinson, David B.; Doddrell, Robin D. S.; Nakayama, Masanori; Adams, Ralf H.; Lloyd, Alison C.			EphB Signaling Directs Peripheral Nerve Regeneration through Sox2-Dependent Schwann Cell Sorting	CELL			English	Article							NEURAL CREST MIGRATION; N-CADHERIN; AXON; SYSTEM; FIBROBLASTS; PRECURSORS; EXPRESSION; PATTERNS; ADHESION; GUIDANCE	The peripheral nervous system has astonishing regenerative capabilities in that cut nerves are able to reconnect and re-establish their function. Schwann cells are important players in this process, during which they dedifferentiate to a progenitor/stem cell and promote axonal regrowth. Here, we report that fibroblasts also play a key role. Upon nerve cut, ephrin-B/EphB2 signaling between fibroblasts and Schwann cells results in cell sorting, followed by directional collective cell migration of Schwann cells out of the nerve stumps to guide regrowing axons across the wound. Mechanistically, we find that cell-sorting downstream of EphB2 is mediated by the stemness factor Sox2 through N-cadherin relocalization to Schwann cell-cell contacts. In vivo, loss of EphB2 signaling impaired organized migration of Schwann cells, resulting in misdirected axonal regrowth. Our results identify a link between Ephs and Sox proteins, providing a mechanism by which progenitor cells can translate environmental cues to orchestrate the formation of new tissue.	[Parrinello, Simona; Napoli, Ilaria; Ribeiro, Sara; Digby, Patrick Wingfield; Fedorova, Marina; Lloyd, Alison C.] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England; [Parrinello, Simona; Napoli, Ilaria; Ribeiro, Sara; Digby, Patrick Wingfield; Fedorova, Marina; Lloyd, Alison C.] UCL, UCL Canc Inst, London WC1E 6BT, England; [Parkinson, David B.; Doddrell, Robin D. S.] Univ Plymouth, Peninsula Coll Med & Dent, Plymouth PL6 8BU, Devon, England; [Nakayama, Masanori; Adams, Ralf H.] Univ Munster, Dept Tissue Morphogenesis, Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Nakayama, Masanori; Adams, Ralf H.] Univ Munster, Fac Med, D-48149 Munster, Germany	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London; University of Plymouth; Max Planck Society; University of Munster; University of Munster	Lloyd, AC (corresponding author), UCL, MRC Lab Mol Cell Biol, Gower St, London WC1E 6BT, England.	alison.lloyd@ucl.ac.uk	Adams, Ralf H/AAE-9274-2019; Ribeiro, Sara/I-1615-2013	Ribeiro, Sara/0000-0002-6500-8412; Napoli, Ilaria/0000-0002-0649-1950	Cancer Research UK program; Association for International Cancer Research; Cancer Research UK [11244] Funding Source: researchfish	Cancer Research UK program(Cancer Research UK); Association for International Cancer Research; Cancer Research UK(Cancer Research UK)	S.P. is a Royal Society D.H. Research Fellow. This work was supported by a Cancer Research UK program and an Association for International Cancer Research project grant. We thank C.D. Nobes for advice and M. Raff and B. Baum for critical reading of the manuscript, M. Herlyn, J. Milbrandt, E. Battle, and D. Wilkinson for constructs and G. Parrinello, A. Mira, and J. Kriston-Vizi for statistics.	Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Crawford AT, 2008, GLIA, V56, P1637, DOI 10.1002/glia.20716; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Lai KO, 2004, J BIOL CHEM, V279, P13383, DOI 10.1074/jbc.M313356200; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; LETOURNEAU PC, 1991, J NEUROBIOL, V22, P707, DOI 10.1002/neu.480220706; Luria V, 2008, NEURON, V60, P1039, DOI 10.1016/j.neuron.2008.11.011; Mathon NF, 2001, SCIENCE, V291, P872, DOI 10.1126/science.1056782; Mcdonald D, 2006, NEURON GLIA BIOL, V2, P139, DOI 10.1017/S1740925X05000347; McDonald DS, 2003, J NEUROSCI METH, V122, P171, DOI 10.1016/S0165-0270(02)00319-9; MORRIS JH, 1972, Z ZELLFORSCH MIK ANA, V124, P165, DOI 10.1007/BF00335678; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Navarro X, 2009, INT REV NEUROBIOL, V87, P483, DOI 10.1016/S0074-7742(09)87027-X; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Parrinello S, 2008, GENE DEV, V22, P3335, DOI 10.1101/gad.490608; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Scherer SS, 2001, AXON SCHWANN CELL IN; SCHRODER JM, 1993, CLIN NEUROL NEUROSUR, V95, P78; Sorrell JM, 2009, INT REV CEL MOL BIO, V276, P161, DOI 10.1016/S1937-6448(09)76004-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Von Philipsborn AC, 2006, NAT PROTOC, V1, P1322, DOI 10.1038/nprot.2006.251; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; Wanner IB, 2006, GLIA, V54, P439, DOI 10.1002/glia.20390; Wanner IB, 2006, GLIA, V54, P424, DOI 10.1002/glia.20389; Zochodne DW, 2008, NEUROBIOLOGY OF PERIPHERAL NERVE REGENERATION, P1, DOI 10.1017/CBO9780511541759	38	332	343	4	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					145	155		10.1016/j.cell.2010.08.039	http://dx.doi.org/10.1016/j.cell.2010.08.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20869108	Bronze, Green Accepted			2022-12-24	WOS:000282362000021
J	Kim, YJ; Lee, HS; Kim, ES; Bae, SS; Lim, JK; Matsumi, R; Lebedinsky, AV; Sokolova, TG; Kozhevnikova, DA; Cha, SS; Kim, SJ; Kwon, KK; Imanaka, T; Atomi, H; Bonch-Osmolovskaya, EA; Lee, JH; Kang, SG				Kim, Yun Jae; Lee, Hyun Sook; Kim, Eun Sook; Bae, Seung Seob; Lim, Jae Kyu; Matsumi, Rie; Lebedinsky, Alexander V.; Sokolova, Tatyana G.; Kozhevnikova, Darya A.; Cha, Sun-Shin; Kim, Sang-Jin; Kwon, Kae Kyoung; Imanaka, Tadayuki; Atomi, Haruyuki; Bonch-Osmolovskaya, Elizaveta A.; Lee, Jung-Hyun; Kang, Sung Gyun			Formate-driven growth coupled with H-2 production	NATURE			English	Article							SEA HYDROTHERMAL VENT; HYPERTHERMOPHILIC ARCHAEON; ESCHERICHIA-COLI; METHANOBACTERIUM-FORMICICUM; METHANOCOCCUS-MARIPALUDIS; HYDROGENLYASE SYSTEM; OPERON; HYDROGENASE-3; METABOLISM; PREDICTION	Although a common reaction in anaerobic environments, the conversion of formate and water to bicarbonate and H-2 (with a change in Gibbs free energy of Delta G degrees = + 1.3 kJ mol(-1)) has not been considered energetic enough to support growth of microorganisms. Recently, experimental evidence for growth on formate was reported for syntrophic communities of Moorella sp. strain AMP and a hydrogen-consuming Methanothermobacter species and of Desulfovibrio sp. strain G11 and Methanobrevibacter arboriphilus strain AZ(1). The basis of the sustainable growth of the formate-users is explained by H-2 consumption by the methanogens, which lowers the H-2 partial pressure, thus making the pathway exergonic(2). However, it has not been shown that a single strain can grow on formate by catalysing its conversion to bicarbonate and H-2. Here we report that several hyperthermophilic archaea belonging to the Thermococcus genus are capable of formate-oxidizing, H-2-producing growth. The actual Delta G values for the formate metabolism are calculated to range between -8 and -20 kJ mol(-1) under the physiological conditions where Thermococcus onnurineus strain NA1 are grown. Furthermore, we detected ATP synthesis in the presence of formate as a sole energy source. Gene expression profiling and disruption identified the gene cluster encoding formate hydrogen lyase, cation/proton antiporter and formate transporter, which were responsible for the growth of T. onnurineus NA1 on formate. This work shows formate-driven growth by a single microorganism with protons as the electron acceptor, and reports the biochemical basis of this ability.	[Kim, Yun Jae; Lee, Hyun Sook; Kim, Eun Sook; Bae, Seung Seob; Lim, Jae Kyu; Cha, Sun-Shin; Kim, Sang-Jin; Kwon, Kae Kyoung; Lee, Jung-Hyun; Kang, Sung Gyun] Korea Ocean Res & Dev Inst, Ansan 425600, South Korea; [Lee, Hyun Sook; Bae, Seung Seob; Lim, Jae Kyu; Cha, Sun-Shin; Kim, Sang-Jin; Kwon, Kae Kyoung; Lee, Jung-Hyun; Kang, Sung Gyun] Univ Sci & Technol, Dept Marine Biotechnol, Taejon 305333, South Korea; [Matsumi, Rie; Imanaka, Tadayuki; Atomi, Haruyuki] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Lebedinsky, Alexander V.; Sokolova, Tatyana G.; Kozhevnikova, Darya A.; Bonch-Osmolovskaya, Elizaveta A.] Russian Acad Sci, Winogradsky Inst Microbiol, Moscow 117312, Russia	Korea Institute of Ocean Science & Technology (KIOST); Kyoto University; Research Center of Biotechnology RAS; Russian Academy of Sciences	Lee, JH (corresponding author), Korea Ocean Res & Dev Inst, POB 29, Ansan 425600, South Korea.	jlee@kordi.re.kr; sgkang@kordi.re.kr	Sokolova, Tatyana/AAU-3465-2021; Sokolova, Tatyana/E-9492-2014; Lebedinsky, Alexander V/E-9075-2014; Kozhevnikova, Daria/E-2536-2014	Sokolova, Tatyana/0000-0002-3879-2993; Sokolova, Tatyana/0000-0002-3879-2993; Lebedinsky, Alexander V/0000-0002-3686-7437; LIM, JAE KYU/0000-0002-9696-9830; Atomi, Haruyuki/0000-0001-9687-6426; Kozhevnikova, Daria/0000-0002-7263-3611; Cha, Sun-Shin/0000-0002-0913-8706	KORDI [PE98513]; Marine and Extreme Genome Research Center; Ministry of Land, Transport, and Maritime Affairs, Korea; RAS; Russian Foundation of Basic Research [10-04-01180]	KORDI; Marine and Extreme Genome Research Center; Ministry of Land, Transport, and Maritime Affairs, Korea(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); RAS(Russian Academy of SciencesRegione Sardegna); Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the KORDI in-house programme (PE98513), the Marine and Extreme Genome Research Center programme and the Development of Biohydrogen Production Technology using Hyperthermophilic Archaea programme of the Ministry of Land, Transport, and Maritime Affairs, Korea, as well as by the Molecular and Cell Biology programme of RAS and the Russian Foundation of Basic Research (grant no. 10-04-01180). We thank J. Querellou and the crew of the French scientific vessel Pourquoi pas?, and A.-L. Reysenbach and the crew of the American scientific vessel Thomas G. Thompson for opportunities to obtain deep-sea samples. We thank W. B. Whitman and R. K. Thauer for comments on the manuscript, and S. G. Jeon, K.-B. Yi and J.-G. Na for discussions.	Amaratunga D, 2001, J AM STAT ASSOC, V96, P1161, DOI 10.1198/016214501753381814; Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1111/j.1574-6976.2001.tb00576.x; Andrews SC, 1997, MICROBIOL-SGM, V143, P3633, DOI 10.1099/00221287-143-11-3633; Bae SS, 2006, J MICROBIOL BIOTECHN, V16, P1826; Bagramyan K, 2002, FEBS LETT, V516, P172, DOI 10.1016/S0014-5793(02)02555-3; BARON SF, 1989, J BACTERIOL, V171, P3854, DOI 10.1128/jb.171.7.3854-3859.1989; BOHM R, 1990, MOL MICROBIOL, V4, P231, DOI 10.1111/j.1365-2958.1990.tb00590.x; Dolfing J, 2008, APPL ENVIRON MICROB, V74, P6126, DOI 10.1128/AEM.01428-08; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; Holden JF, 2001, FEMS MICROBIOL ECOL, V36, P51, DOI 10.1016/S0168-6496(01)00118-0; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jenney FE, 2008, ANN NY ACAD SCI, V1125, P252, DOI 10.1196/annals.1419.013; Lee HS, 2008, J BACTERIOL, V190, P7491, DOI 10.1128/JB.00746-08; Lupa B, 2008, APPL ENVIRON MICROB, V74, P6584, DOI 10.1128/AEM.01455-08; Matsumi R, 2007, J BACTERIOL, V189, P2683, DOI 10.1128/JB.01692-06; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Sapra R, 2000, J BACTERIOL, V182, P3423, DOI 10.1128/JB.182.12.3423-3428.2000; SAUTER M, 1992, MOL MICROBIOL, V6, P1523, DOI 10.1111/j.1365-2958.1992.tb00873.x; SCHAUER NL, 1980, J BACTERIOL, V142, P800, DOI 10.1128/JB.142.3.800-807.1980; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Sokolova TG, 2004, EXTREMOPHILES, V8, P317, DOI 10.1007/s00792-004-0389-0; Stams AJM, 2009, NAT REV MICROBIOL, V7, P568, DOI 10.1038/nrmicro2166; Takacs M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-88; THAUER RK, 1984, MICROBE 1984 2, P123; Wood GE, 2003, J BACTERIOL, V185, P2548, DOI 10.1128/JB.185.8.2548-2554.2003; Zivanovic Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r70	27	167	176	3	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2010	467	7313					352	U137		10.1038/nature09375	http://dx.doi.org/10.1038/nature09375			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20844539				2022-12-24	WOS:000281824900044
J	Kobayashi, T; Yamaguchi, T; Hamanaka, S; Kato-Itoh, M; Yamazaki, Y; Ibata, M; Sato, H; Lee, YS; Usui, J; Knisely, AS; Hirabayashi, M; Nakauchi, H				Kobayashi, Toshihiro; Yamaguchi, Tomoyuki; Hamanaka, Sanae; Kato-Itoh, Megumi; Yamazaki, Yuji; Ibata, Makoto; Sato, Hideyuki; Lee, Youn-Su; Usui, Jo-ichi; Knisely, A. S.; Hirabayashi, Masumi; Nakauchi, Hiromitsu			Generation of Rat Pancreas in Mouse by Interspecific Blastocyst Injection of Pluripotent Stem Cells	CELL			English	Article							DIFFERENTIATION; MICE; TRANSPLANTATION; CULTURE; PIGS	The complexity of organogenesis hinders in vitro generation of organs derived from a patient's pluripotent stem cells (PSCs), an ultimate goal of regenerative medicine. Mouse wild-type PSCs injected into Pdx1(-/-) (pancreatogenesis-disabled) mouse blastocysts developmentally compensated vacancy of the pancreatic "developmental niche,'' generating almost entirely PSC-derived pancreas. To examine the potential for xenogenic approaches in blastocyst complementation, we injected mouse or rat PSCs into rat or mouse blastocysts, respectively, generating interspecific chimeras and thus confirming that PSCs can contribute to xenogenic development between mouse and rat. The development of these mouse/rat chimeras was primarily influenced by host blastocyst and/or foster mother, evident by body size and species-specific organogenesis. We further injected rat wild-type PSCs into Pdx1(-/-) mouse blastocysts, generating normally functioning rat pancreas in Pdx1(-/-) mice. These data constitute proof of principle for interspecific blastocyst complementation and for generation in vivo of organs derived from donor PSCs using a xenogenic environment.	[Kobayashi, Toshihiro; Yamaguchi, Tomoyuki; Hamanaka, Sanae; Yamazaki, Yuji; Sato, Hideyuki; Lee, Youn-Su; Usui, Jo-ichi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, Tokyo 1088639, Japan; [Kobayashi, Toshihiro; Yamaguchi, Tomoyuki; Hamanaka, Sanae; Kato-Itoh, Megumi; Yamazaki, Yuji; Ibata, Makoto; Sato, Hideyuki; Lee, Youn-Su; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Minato Ku, Tokyo 1088639, Japan; [Kato-Itoh, Megumi; Hirabayashi, Masumi] Natl Inst Nat Sci, Natl Inst Physiol Sci, Ctr Genet Anal Behav, Okazaki, Aichi 4448585, Japan; [Hirabayashi, Masumi] Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan; [Knisely, A. S.] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England	University of Tokyo; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Nakauchi, H (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	nakauchi@ims.u-tokyo.ac.jp	Hirabayashi, Masumi/C-8935-2019	Hirabayashi, Masumi/0000-0002-1059-5883; Kobayashi, Toshihiro/0000-0001-8019-0008	JST, the Ministry of Education, Culture, Sport, Science, and Technology, Japan	JST, the Ministry of Education, Culture, Sport, Science, and Technology, Japan	We thank Ryo Sumazaki for critical advice on this work, Kazuya Ise and Hirofumi Noguchi for technical advice on islet isolation and islet transplantation, and Naoki Iwamori for technical advice on embryo manipulation. This work was supported by grants from JST, the Ministry of Education, Culture, Sport, Science, and Technology, Japan. H.N. is a founder and shareholder of ReproCELL Inc.	Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; DELTOUR L, 1991, DEVELOPMENT, V112, P1115; FEHILLY CB, 1984, NATURE, V307, P634, DOI 10.1038/307634a0; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Goldstein RS, 2002, DEV DYNAM, V225, P80, DOI 10.1002/dvdy.10108; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Hirabayashi M, 2010, MOL REPROD DEV, V77, P94, DOI 10.1002/mrd.21123; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; KAMELREID S, 1988, SCIENCE, V242, P1706, DOI 10.1126/science.2904703; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Muller SM, 2005, P NATL ACAD SCI USA, V102, P10587, DOI 10.1073/pnas.0502752102; Nagashima H, 2004, BIOL REPROD, V70, P702, DOI 10.1095/biolreprod.103.022681; Nagy A., 2003, MANIPULATING MOUSE E; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Offield MF, 1996, DEVELOPMENT, V122, P983; OGAWA S, 1971, NATURE, V233, P422, DOI 10.1038/233422a0; Oh SH, 1998, BIOL REPROD, V59, P884, DOI 10.1095/biolreprod59.4.884; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okabe M, 2009, BLOOD, V114, P1764, DOI 10.1182/blood-2009-02-203695; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; ROSSANT J, 1980, SCIENCE, V208, P419, DOI 10.1126/science.7367871; ROSSANT J, 1982, J EMBRYOL EXP MORPH, V69, P141; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Satoh M, 2007, TRANSPLANTATION, V83, P1085, DOI 10.1097/01.tp.0000260161.81775.58; Shinohara T, 2006, P NATL ACAD SCI USA, V103, P13624, DOI 10.1073/pnas.0604205103; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Stanger BZ, 2007, NATURE, V445, P886, DOI 10.1038/nature05537; STERN MS, 1973, NATURE, V244, P472; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TARKOWSKI AK, 1962, J EMBRYOL EXP MORPH, V10, P476; Ueno H, 2009, P NATL ACAD SCI USA, V106, P175, DOI 10.1073/pnas.0810325105; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; ZEILMAKER GH, 1973, NATURE, V242, P115, DOI 10.1038/242115a0	43	366	400	3	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					787	799		10.1016/j.cell.2010.07.039	http://dx.doi.org/10.1016/j.cell.2010.07.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813264	Bronze			2022-12-24	WOS:000281523200021
J	McDaniel, LD; Young, E; Delaney, J; Ruhnau, F; Ritchie, KB; Paul, JH				McDaniel, Lauren D.; Young, Elizabeth; Delaney, Jennifer; Ruhnau, Fabian; Ritchie, Kim B.; Paul, John H.			High Frequency of Horizontal Gene Transfer in the Oceans	SCIENCE			English	Article							TRANSFER AGENT GENES; MARINE		[McDaniel, Lauren D.; Young, Elizabeth; Delaney, Jennifer; Paul, John H.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Ruhnau, Fabian] Univ Duisburg Essen, Biofilm Ctr, D-47057 Duisburg, Germany; [Ritchie, Kim B.] Ctr Coral Reef Res, Mote Marine Lab, Sarasota, FL 34236 USA	State University System of Florida; University of South Florida; University of Duisburg Essen; Mote Marine Laboratory & Aquarium	McDaniel, LD (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	mcdaniel@marine.usf.edu						Biers EJ, 2008, APPL ENVIRON MICROB, V74, P2933, DOI 10.1128/AEM.02129-07; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P2780; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Sanchez Federico, 2008, Plant Biology (Rockville), V2008, P65; Williams HG, 1997, MOL MAR BIOL BIOTECH, V6, P238; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zhao YL, 2010, APPL ENVIRON MICROB, V76, P589, DOI 10.1128/AEM.01450-09	7	212	218	6	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					50	50		10.1126/science.1192243	http://dx.doi.org/10.1126/science.1192243			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	656KW	20929803				2022-12-24	WOS:000282334500029
J	Lemmers, RJLF; van der Vliet, PJ; Klooster, R; Sacconi, S; Camano, P; Dauwerse, JG; Snider, L; Straasheijm, KR; van Ommen, GJ; Padberg, GW; Miller, DG; Tapscott, SJ; Tawil, R; Frants, RR; van der Maarel, SM				Lemmers, Richard J. L. F.; van der Vliet, Patrick J.; Klooster, Rinse; Sacconi, Sabrina; Camano, Pilar; Dauwerse, Johannes G.; Snider, Lauren; Straasheijm, Kirsten R.; van Ommen, Gert Jan; Padberg, George W.; Miller, Daniel G.; Tapscott, Stephen J.; Tawil, Rabi; Frants, Rune R.; van der Maarel, Silvere M.			A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy	SCIENCE			English	Article							DNA REARRANGEMENTS; FSHD; RNA; 4Q; D4Z4	Facioscapulohumeral muscular dystrophy (FSHD) is a common form of muscular dystrophy in adults that is foremost characterized by progressive wasting of muscles in the upper body. FSHD is associated with contraction of D4Z4 macrosatellite repeats on chromosome 4q35, but this contraction is pathogenic only in certain "permissive" chromosomal backgrounds. Here, we show that FSHD patients carry specific single-nucleotide polymorphisms in the chromosomal region distal to the last D4Z4 repeat. This FSHD-predisposing configuration creates a canonical polyadenylation signal for transcripts derived from DUX4, a double homeobox gene of unknown function that straddles the last repeat unit and the adjacent sequence. Transfection studies revealed that DUX4 transcripts are efficiently polyadenylated and are more stable when expressed from permissive chromosomes. These findings suggest that FSHD arises through a toxic gain of function attributable to the stabilized distal DUX4 transcript.	[Lemmers, Richard J. L. F.; van der Vliet, Patrick J.; Klooster, Rinse; Straasheijm, Kirsten R.; van Ommen, Gert Jan; Frants, Rune R.; van der Maarel, Silvere M.] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands; [Sacconi, Sabrina] Univ Nice, Ctr Reference Malad Neuromusculaires, F-06202 Nice, France; [Sacconi, Sabrina] Univ Nice, CNRS, UMR6543, F-06202 Nice, France; [Camano, Pilar] Hosp Donostia, BioDonostia Hlth Res Inst, Dept Neurosci, San Sebastian 20014, Spain; [Camano, Pilar] Inst Salud Carlos III, CIBERNED, Madrid 28029, Spain; [Dauwerse, Johannes G.] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands; [Snider, Lauren; Tapscott, Stephen J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Padberg, George W.] Radboud Univ Nijmegen, Med Ctr Nijmegen, Dept Neurol, NL-6500 HC Nijmegen, Netherlands; [Miller, Daniel G.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Tawil, Rabi] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; CIBERNED; Instituto de Salud Carlos III; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Fred Hutchinson Cancer Center; Radboud University Nijmegen; University of Washington; University of Washington Seattle; University of Rochester	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZA Leiden, Netherlands.	maarel@lumc.nl	SACCONI, Sabrina/AFT-1096-2022; Padberg, G.W.A.M./H-8079-2014; van der Maarel, Silvere/X-3631-2018; Camaño, Pilar/B-7733-2018	SACCONI, Sabrina/0000-0002-0246-1455; van der Maarel, Silvere/0000-0001-8103-711X; Camaño, Pilar/0000-0002-4116-5579; Miller, Daniel/0000-0002-5700-3048; Tapscott, Stephen/0000-0002-0319-0968	Fields Center for FSHD and Neuromuscular Research; Netherlands Organization for Scientific Research [NWO 917.56.338]; Netherlands Genomics Initiative [NWO 93.51.8001]; National Institutes of Health [P01NS069539]; Muscular Dystrophy Association; Shaw Family Foundation; FSH Society; Dutch FSHD Foundation; Pacific Northwest Friends of FSH Research; Centro Investigacion Biomedica en Red para Enfermedades Neurodegenerativas (CIBERNED); Basque Government [2008111011]; Instituto Carlos III, ILUNDAIN Fundazioa; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS069539] Funding Source: NIH RePORTER	Fields Center for FSHD and Neuromuscular Research; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Shaw Family Foundation; FSH Society; Dutch FSHD Foundation; Pacific Northwest Friends of FSH Research; Centro Investigacion Biomedica en Red para Enfermedades Neurodegenerativas (CIBERNED); Basque Government(Basque Government); Instituto Carlos III, ILUNDAIN Fundazioa(Instituto de Salud Carlos III); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all patients and family members for their participation. This study was supported by the Fields Center for FSHD and Neuromuscular Research, the Netherlands Organization for Scientific Research NWO 917.56.338, a Breakthrough Project Grant by the Netherlands Genomics Initiative NWO 93.51.8001, the National Institutes of Health P01NS069539, the Muscular Dystrophy Association, the Shaw Family Foundation, a Marjorie Bronfman Fellowship grant from the FSH Society, the Dutch FSHD Foundation, the Pacific Northwest Friends of FSH Research, Centro Investigacion Biomedica en Red para Enfermedades Neurodegenerativas (CIBERNED), the Basque Government (Fellowship grant, 2008111011), and Instituto Carlos III, ILUNDAIN Fundazioa.	AHMED F, 2009, SILICO BIOL, V9, P13; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; de Greef JC, 2008, MUTAT RES-FUND MOL M, V647, P94, DOI 10.1016/j.mrfmmm.2008.07.011; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Klooster R, 2009, EUR J HUM GENET, V17, P1615, DOI 10.1038/ejhg.2009.62; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2010, AM J HUM GENET, V86, P364, DOI 10.1016/j.ajhg.2010.01.035; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Liu HQ, 2005, BIOINFORMATICS, V21, P671, DOI 10.1093/bioinformatics/bth437; Masny PS, 2010, EUR J HUM GENET, V18, P448, DOI 10.1038/ejhg.2009.183; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Tupler R, 1996, J MED GENET, V33, P366, DOI 10.1136/jmg.33.5.366; van der Maarel SM, 2000, AM J HUM GENET, V66, P26, DOI 10.1086/302730; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559	22	457	476	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1650	1653		10.1126/science.1189044	http://dx.doi.org/10.1126/science.1189044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20724583	Green Accepted, Green Published			2022-12-24	WOS:000282098100043
J	MacLeod, N; Benfield, M; Culverhouse, P				MacLeod, Norman; Benfield, Mark; Culverhouse, Phil			Time to automate identification	NATURE			English	Editorial Material							EXPERTS		[MacLeod, Norman] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Benfield, Mark] Louisiana State Univ, Sch Coast & Environm, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Culverhouse, Phil] Univ Plymouth, Ctr Robot Neural Syst, Plymouth PL4 8AA, Devon, England	Natural History Museum London; Louisiana State University System; Louisiana State University; University of Plymouth	MacLeod, N (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	n.macleod@nhm.ac.uk; mbenfie@lsu.edu; pculverhouse@plymouth.ac.uk		Culverhouse, Phil/0000-0002-7586-6496				Colquhoun W. P., 1959, ERGONOMICS, V2, P367, DOI 10.1080/00140135908930451; Culverhouse PF, 2003, MAR ECOL PROG SER, V247, P17, DOI 10.3354/meps247017; Culverhouse PF, 2007, SYST ASSOC SPEC VOL, V74, P25; Gauld I.D., 2000, P303; Ginsburg RN, 1997, MAR MICROPALEONTOL, V29, P67, DOI 10.1016/S0377-8398(96)00038-2; Gobalet KW, 2001, J ARCHAEOL SCI, V28, P377, DOI 10.1006/jasc.2000.0564; Kelly MG, 2001, WATER RES, V35, P2784, DOI 10.1016/S0043-1354(00)00554-6; SIMPSON R, 1991, IEEE CONFERENCE ON NEURAL NETWORKS FOR OCEAN ENGINEERING, P223, DOI 10.1109/ICNN.1991.163354; Zachariasse W. J., 1978, UTRECHT MICROPALEONT, V17, P1	9	158	166	2	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2010	467	7312					154	155		10.1038/467154a	http://dx.doi.org/10.1038/467154a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829777				2022-12-24	WOS:000281616300017
J	Tooley, CES; Petkowski, JJ; Muratore-Schroeder, TL; Balsbaugh, JL; Shabanowitz, J; Sabat, M; Minor, W; Hunt, DF; Macara, IG				Tooley, Christine E. Schaner; Petkowski, Janusz J.; Muratore-Schroeder, Tara L.; Balsbaugh, Jeremy L.; Shabanowitz, Jeffrey; Sabat, Michal; Minor, Wladek; Hunt, Donald F.; Macara, Ian G.			NRMT is an alpha-N-methyltransferase that methylates RCC1 and retinoblastoma protein	NATURE			English	Article							AMINO-ACID; RIBOSOME; DIMETHYLPROLINE; SUBUNIT; H2B	The post-translational methylation of alpha-amino groups was first discovered over 30 years ago on the bacterial ribosomal proteins L16 and L33 (refs 1, 2), but almost nothing is known about the function or enzymology of this modification. Several other bacterial and eukaryotic proteins have since been shown to be alpha-N-methylated(3-10). However, the Ran guanine nucleotide-exchange factor, RCC1, is the only protein for which any biological function of alpha-N-methylation has been identified(3,11). Methylation-defective mutants of RCC1 have reduced affinity for DNA and cause mitotic defects(3,11), but further characterization of this modification has been hindered by ignorance of the responsible methyltransferase. All fungal and animal N-terminally methylated proteins contain a unique N-terminal motif, Met-(Ala/Pro/Ser)Pro-Lys, indicating that they may be targets of the same, unknown enzyme(3,12). The initiating Met is cleaved, and the exposed alpha-amino group is mono-, di- or trimethylated. Here we report the discovery of the first alpha-N-methyltransferase, which we named N-terminal RCC1 methyltransferase (NRMT). Substrate docking and mutational analysis of RCC1 defined the NRMT recognition sequence and enabled the identification of numerous new methylation targets, including SET (also known as TAF-I or PHAPII) and the retinoblastoma protein, RB. Knockdown of NRMT recapitulates the multi-spindle phenotype seen with methylation-defective RCC1 mutants(3), demonstrating the importance of alpha-N-methylation for normal bipolar spindle formation and chromosome segregation.	[Tooley, Christine E. Schaner; Petkowski, Janusz J.; Macara, Ian G.] Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Petkowski, Janusz J.; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Muratore-Schroeder, Tara L.; Balsbaugh, Jeremy L.; Shabanowitz, Jeffrey; Sabat, Michal; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Tooley, CES (corresponding author), Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA.	ces5g@virginia.edu	Hunt, Donald F/I-6936-2012; Minor, Wladek/F-3096-2014; Petkowski, Janusz Jurand/GPT-0474-2022; Petkowski, Janusz Jurand/T-4792-2019	Hunt, Donald F/0000-0003-2815-6368; Minor, Wladek/0000-0001-7075-7090; Petkowski, Janusz Jurand/0000-0002-1921-4848; Petkowski, Janusz Jurand/0000-0002-1921-4848; BALSBAUGH, JEREMY/0000-0002-1852-8749	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537, R01GM050526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research grants from the National Institutes of Health to I.G.M., D.F.H., and W.M.; C.E.S.T. was the recipient of a post-doctoral fellowship from the National Institutes of Health.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BLOOM KS, 1978, J BIOL CHEM, V253, P4446; Boyer SN, 1996, CANCER RES, V56, P4620; BROSIUS J, 1976, FEBS LETT, V68, P105, DOI 10.1016/0014-5793(76)80415-2; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Grimm R, 1997, FEBS LETT, V408, P350, DOI 10.1016/S0014-5793(97)00462-6; Hao Y, 2008, J CELL BIOL, V182, P827, DOI 10.1083/jcb.200803110; HENRY GD, 1982, FEBS LETT, V144, P11, DOI 10.1016/0014-5793(82)80558-9; Hu RM, 2000, P NATL ACAD SCI USA, V97, P9543, DOI 10.1073/pnas.160270997; MARTINAGE A, 1985, EUR J BIOCHEM, V147, P351, DOI 10.1111/j.1432-1033.1985.tb08757.x; Meng FY, 2004, ANAL CHEM, V76, P2852, DOI 10.1021/ac0354903; NOMOTO M, 1982, J BIOCHEM-TOKYO, V91, P897, DOI 10.1093/oxfordjournals.jbchem.a133778; PETTIGREW GW, 1977, NATURE, V265, P661, DOI 10.1038/265661a0; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; WITTMANNLIEBOLD B, 1976, FEBS LETT, V68, P115, DOI 10.1016/0014-5793(76)80417-6; Yamamoto H, 1999, CLIN CANCER RES, V5, P1805; Yu WS, 2008, MOL CELLS, V26, P443	23	81	94	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1125	1128		10.1038/nature09343	http://dx.doi.org/10.1038/nature09343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20668449	Green Accepted			2022-12-24	WOS:000281203600044
J	Radoshevich, L; Murrow, L; Chen, N; Fernandez, E; Roy, S; Fung, C; Debnath, J				Radoshevich, Lilliana; Murrow, Lyndsay; Chen, Nan; Fernandez, Estefania; Roy, Srirupa; Fung, Christopher; Debnath, Jayanta			ATG12 Conjugation to ATG3 Regulates Mitochondrial Homeostasis and Cell Death	CELL			English	Article							PROTEIN-ACTIVATING ENZYME; UBIQUITIN-LIKE PROTEINS; CRYSTAL-STRUCTURE; MAMMALIAN HOMOLOG; E2 ENZYME; AUTOPHAGY; LIPIDATION; APOPTOSIS; FISSION; SYSTEM	ATG12, an ubiquitin-like modifier required for macroautophagy, has a single known conjugation target, another autophagy regulator called ATG5. Here, we identify ATG3 as a substrate for ATG12 conjugation. ATG3 is the E2-like enzyme necessary for ATG8/LC3 lipidation during autophagy. ATG12-ATG3 complex formation requires ATG7 as the E1 enzyme and ATG3 autocatalytic activity as the E2, resulting in the covalent linkage of ATG12 onto a single lysine on ATG3. Surprisingly, disrupting ATG12 conjugation to ATG3 does not affect starvation-induced autophagy. Rather, the lack of ATG12-ATG3 complex formation produces an expansion in mitochondrial mass and inhibits cell death mediated by mitochondrial pathways. Overall, these results unveil a role for ATG12-ATG3 in mitochondrial homeostasis and implicate the ATG12 conjugation system in cellular functions distinct from the early steps of autophagosome formation.	[Radoshevich, Lilliana; Murrow, Lyndsay; Chen, Nan; Fernandez, Estefania; Roy, Srirupa; Fung, Christopher; Debnath, Jayanta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Radoshevich, Lilliana; Murrow, Lyndsay; Chen, Nan; Fernandez, Estefania; Roy, Srirupa; Fung, Christopher; Debnath, Jayanta] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Radoshevich, Lilliana; Murrow, Lyndsay; Debnath, Jayanta] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Debnath, J (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	jayanta.debnath@ucsf.edu	Fung, Christopher/AFM-0101-2022	Fung, Christopher/0000-0003-3585-1385; Radoshevich, Lilliana/0000-0003-0294-9300; Debnath, Jayanta/0000-0002-8745-4069; Murrow, Lyndsay/0000-0002-5935-8977	NIH [RO1CA126792, KO8CA098419]; Culpeper Medical Scholar Award; AACR-Genentech BioOncology Award; HHMI Physician-Scientist Early Career Award; Stewart Family Trust Award; NATIONAL CANCER INSTITUTE [K08CA098419, R01CA126792] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Culpeper Medical Scholar Award; AACR-Genentech BioOncology Award; HHMI Physician-Scientist Early Career Award(Howard Hughes Medical Institute); Stewart Family Trust Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Noboru Mizushima, Masaaki Komatsu, and Patrick Dennis for generously providing reagents and Drs. Gerard Evan, Don Ganem, Abul Abbas, and Feroz Papa for critically reading the manuscript. Confocal microscopy was performed in the Biological Imaging Development Center at UCSF. Grant support to J.D. includes the NIH (RO1CA126792, KO8CA098419), a Culpeper Medical Scholar Award (Partnership For Cures), an AACR-Genentech BioOncology Award, a HHMI Physician-Scientist Early Career Award, and a Stewart Family Trust Award. L R. was a Genentech/Sandler Graduate Student Fellow, and E.F. was an HHMI Summer Undergraduate Research Fellow.	Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; de Graaf AO, 2004, EXP CELL RES, V299, P533, DOI 10.1016/j.yexcr.2004.06.024; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Dennis PB, 2009, METHOD ENZYMOL, V452, P97, DOI 10.1016/S0076-6879(08)03607-0; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; GWOZD CS, 1995, BIOCHEMISTRY-US, V34, P6296, DOI 10.1021/bi00019a006; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hanada T, 2005, AUTOPHAGY, V1, P110, DOI 10.4161/auto.1.2.1858; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nemoto T, 2003, J BIOL CHEM, V278, P39517, DOI 10.1074/jbc.M300550200; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki NN, 2005, AUTOPHAGY, V1, P119, DOI 10.4161/auto.1.2.1859; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tanida I, 2002, BIOCHEM BIOPH RES CO, V296, P1164, DOI 10.1016/S0006-291X(02)02057-0; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	46	205	219	1	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 20	2010	142	4					590	600		10.1016/j.cell.2010.07.018	http://dx.doi.org/10.1016/j.cell.2010.07.018			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723759	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000281115900013
J	Kim, J; Zhang, CZ; Zhang, XH; Springer, TA				Kim, Jongseong; Zhang, Cheng-Zhong; Zhang, Xiaohui; Springer, Timothy A.			A mechanically stabilized receptor-ligand flex-bond important in the vasculature	NATURE			English	Article							VON-WILLEBRAND-FACTOR; IB-IX-V; LEUCINE-RICH REPEATS; FACTOR A1 DOMAIN; PLATELET-ADHESION; SINGLE-MOLECULE; CATCH BONDS; SHEAR; COMPLEX; FORCE	Haemostasis in the arteriolar circulation mediated by von Willebrand factor (VWF) binding to platelets is an example of an adhesive interaction that must withstand strong hydrodynamic forces acting on cells. VWF is a concatenated, multifunctional protein that has binding sites for platelets as well as subendothelial collagen(1,2). Binding of the A1 domain in VWF to the glycoprotein Ib alpha subunit (GPIb alpha) on the surface of platelets mediates crosslinking of platelets to one another and the formation of a platelet plug for arterioles(3,4). The importance of VWF is illustrated by its mutation in von Willebrand disease, a bleeding diathesis(1). Here, we describe a novel mechanochemical specialization of the A1-GPIb alpha bond for force-resistance. We have developed a method that enables, for the first time, repeated measurements of the binding and unbinding of a receptor and ligand in a single molecule (ReaLiSM). We demonstrate two states of the receptor-ligand bond, that is, a flex-bond. One state is seen at low force; a second state begins to engage at 10 pN with a similar to 20-fold longer lifetime and greater force resistance. The lifetimes of the two states, how force exponentiates lifetime, and the kinetics of switching between the two states are all measured. For the first time, single-molecule measurements on this system are in agreement with bulk phase measurements. The results have important implications not only for how platelets bound to VWF are able to resist force to plug arterioles, but also how increased flow activates platelet plug formation.	[Kim, Jongseong; Zhang, Cheng-Zhong; Zhang, Xiaohui; Springer, Timothy A.] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Kim, Jongseong; Zhang, Cheng-Zhong; Zhang, Xiaohui; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Springer, TA (corresponding author), Childrens Hosp, Immune Dis Inst, 3 Blackfan Circle, Boston, MA 02115 USA.	springer@idi.harvard.edu	Kim, Jongseong/I-7307-2019; Kim, Jongseong/M-9940-2014; Kim, Jongseong/I-6358-2013	Kim, Jongseong/0000-0001-9595-2765; Kim, Jongseong/0000-0001-9595-2765; Zhang, Xiaohui (Frank)/0000-0002-8778-595X; Kim, Jongseong/0000-0002-9553-2258	NIH [HL-48675]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by NIH HL-48675 (TAS). The authors are indebted to S. B. Smith and C. Bustamante for help with laser tweezers construction and insightful discussion. We thank B. Coller, O. K. Dudko and C. Lu for reagents and insightful discussions, and J. Dill for software for data analysis.	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; BUSTAMANTE C, 2004, Patent No. 7133132; Celikel R, 2000, NAT STRUCT BIOL, V7, P881; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; De Luca M, 2000, BLOOD, V95, P164; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Dong JF, 2001, BLOOD, V97, P162, DOI 10.1182/blood.V97.1.162; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; KIELISZEWSKI M J, 1989, Peptide Research, V2, P246; Miura S, 2000, J BIOL CHEM, V275, P7539, DOI 10.1074/jbc.275.11.7539; Nesbitt WS, 2009, NAT MED, V15, P665, DOI 10.1038/nm.1955; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Ruggeri ZM, 2007, CIRC RES, V100, P1673, DOI 10.1161/01.RES.0000267878.97021.ab; Ruggeri ZM, 2006, BLOOD, V108, P1903, DOI 10.1182/blood-2006-04-011551; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Shen Y, 2000, BLOOD, V95, P903, DOI 10.1182/blood.V95.3.903.003k37_903_910; Shen Y, 2006, J BIOL CHEM, V281, P26419, DOI 10.1074/jbc.M604296200; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Springer TA, 2009, P NATL ACAD SCI USA, V106, P91, DOI 10.1073/pnas.0810784105; Thomas W, 2006, BIOPHYS J, V90, P753, DOI 10.1529/biophysj.105.066548; Thomas WE, 2008, ANNU REV BIOPHYS, V37, P399, DOI 10.1146/annurev.biophys.37.032807.125804; Ulrichts H, 2006, J BIOL CHEM, V281, P4699, DOI 10.1074/jbc.M513314200; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905	31	196	203	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2010	466	7309					992	U123		10.1038/nature09295	http://dx.doi.org/10.1038/nature09295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725043	Green Accepted			2022-12-24	WOS:000281030300038
J	Tarutani, Y; Shiba, H; Iwano, M; Kakizaki, T; Suzuki, G; Watanabe, M; Isogai, A; Takayama, S				Tarutani, Yoshiaki; Shiba, Hiroshi; Iwano, Megumi; Kakizaki, Tomohiro; Suzuki, Go; Watanabe, Masao; Isogai, Akira; Takayama, Seiji			Trans-acting small RNA determines dominance relationships in Brassica self-incompatibility	NATURE			English	Article							II S-HAPLOTYPES; GENOMIC ORGANIZATION; GENE-EXPRESSION; DNA METHYLATION; POLLEN; LOCUS; CAMPESTRIS; PARAMUTATION; ALLELES; REGION	A diploid organism has two copies of each gene, one inherited from each parent. The expression of two inherited alleles is sometimes biased by the effects known as dominant/recessive relationships, which determine the final phenotype of the organism. To explore the mechanisms underlying these relationships, we have examined the monoallelic expression of S-locus protein 11 genes (SP11), which encode the male determinants of self-incompatibility in Brassica. We previously reported that SP11 expression was monoallelic in some S heterozygotes, and that the promoter regions of recessive SP11 alleles were specifically methylated in the anther tapetum(1-3). Here we show that this methylation is controlled by trans-acting small non-coding RNA(sRNA). We identified inverted genomic sequences that were similar to the recessive SP11 promoters in the flanking regions of dominant SP11 alleles. These sequences were specifically expressed in the anther tapetum and processed into 24-nucleotide sRNA, named SP11 methylation inducer (Smi). Introduction of the Smi genomic region into the recessive S homozygotes triggered the methylation of the promoter of recessive SP11 alleles and repressed their transcription. This is an example showing sRNA encoded in the flanking region of a dominant allele acts in trans to induce transcriptional silencing of the recessive allele. Our finding may provide new insights into the widespread monoallelic gene expression systems.	[Tarutani, Yoshiaki; Shiba, Hiroshi; Iwano, Megumi; Isogai, Akira; Takayama, Seiji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300192, Japan; [Kakizaki, Tomohiro] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Suzuki, Go] Osaka Kyoiku Univ, Div Nat Sci, Osaka 5828582, Japan; [Watanabe, Masao] Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan	Nara Institute of Science & Technology; Iwate University; Osaka University of Education; Tohoku University	Takayama, S (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Ikoma 6300192, Japan.	takayama@bs.naist.jp	KAKIZAKI, Tomohiro/E-6304-2011; Watanabe, Masao/N-1465-2019; Isogai, Akira/O-8897-2017; Watanabe, Masao/E-6300-2011	KAKIZAKI, Tomohiro/0000-0002-3636-6616; Watanabe, Masao/0000-0002-9419-5149; Isogai, Akira/0000-0001-8095-0441; Watanabe, Masao/0000-0002-9419-5149	Bio-oriented Technology Research Advancement Institution (BRAIN); Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Bio-oriented Technology Research Advancement Institution (BRAIN); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Q. A. Ngo and P. Kaothien-Nakayama for critical comments and discussion; K. Nakashima for helpful comments; and H. Ichikawa, T. Ohnishi, F. Yamamoto, M. Kawashima and R. Nagai for technical assistance. This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences (to S. T.) from the Bio-oriented Technology Research Advancement Institution (BRAIN), by Grants-in-Aid for Creative Scientific Research (to A. I., M. W. and S. T.) from the Japan Society for the Promotion of Science (JSPS), and by Grants-in-Aid for Scientific Research on Priority Area (to H. S., M. W. and S. T.) and Grants-in-Aid for the Global Center of Excellence Program to NAIST from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Alleman M, 2006, NATURE, V442, P295, DOI 10.1038/nature04884; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Casselman AL, 2000, PLANT CELL, V12, P23, DOI 10.1105/tpc.12.1.23; Darwin CR, 1876, EFFECTS CROSS SELF F; Erhard KF, 2009, SCIENCE, V323, P1201, DOI 10.1126/science.1164508; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Guo M, 2004, PLANT CELL, V16, P1707, DOI 10.1105/tpc.022087; Hale CJ, 2007, PLOS BIOL, V5, P2156, DOI 10.1371/journal.pbio.0050275; Hatakeyama K, 1998, HEREDITY, V80, P241, DOI 10.1046/j.1365-2540.1998.00295.x; Kachroo A, 2001, SCIENCE, V293, P1824, DOI 10.1126/science.1062509; Kakizaki T, 2003, PLANT CELL PHYSIOL, V44, P70, DOI 10.1093/pcp/pcg009; Kakizaki T, 2006, GENES GENET SYST, V81, P63, DOI 10.1266/ggs.81.63; Khraiwesh B, 2010, CELL, V140, P111, DOI 10.1016/j.cell.2009.12.023; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; NASRALLAH JB, 1993, PLANT CELL, V5, P1325, DOI 10.2307/3869785; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2006, NAT GENET, V38, P297, DOI 10.1038/ng1734; Shiba H, 2000, BIOSCI BIOTECH BIOCH, V64, P1016, DOI 10.1271/bbb.64.1016; Shiba H, 2003, BIOSCI BIOTECH BIOCH, V67, P622, DOI 10.1271/bbb.67.622; Shiba H, 2002, PLANT CELL, V14, P491, DOI 10.1105/tpc.010378; Shiba H, 2001, PLANT PHYSIOL, V125, P2095, DOI 10.1104/pp.125.4.2095; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; STEIN JC, 1991, P NATL ACAD SCI USA, V88, P8816, DOI 10.1073/pnas.88.19.8816; Suzuki G, 1999, GENETICS, V153, P391; Takasaki T, 2000, NATURE, V403, P913, DOI 10.1038/35002628; Takayama S, 2000, P NATL ACAD SCI USA, V97, P1920, DOI 10.1073/pnas.040556397; Takayama S, 2001, NATURE, V413, P534, DOI 10.1038/35097104; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001293	31	102	106	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2010	466	7309					983	U110		10.1038/nature09308	http://dx.doi.org/10.1038/nature09308			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725042				2022-12-24	WOS:000281030300036
J	Long, F; Su, CC; Zimmermann, MT; Boyken, SE; Rajashankar, KR; Jernigan, RL; Yu, EW				Long, Feng; Su, Chih-Chia; Zimmermann, Michael T.; Boyken, Scott E.; Rajashankar, Kanagalaghatta R.; Jernigan, Robert L.; Yu, Edward W.			Crystal structures of the CusA efflux pump suggest methionine-mediated metal transport	NATURE			English	Article							MEMBRANE-FUSION PROTEIN; MULTIDRUG EFFLUX; RECOGNITION; SYSTEM; CU(I); CRYSTALLOGRAPHY; RESISTANCE; SOFTWARE; DYNAMICS; COMPLEX	Gram-negative bacteria, such as Escherichia coli, frequently use tripartite efflux complexes in the resistance-nodulation-cell division (RND) family to expel various toxic compounds from the cell(1,2). The efflux system CusCBA is responsible for extruding biocidal Cu(I) and Ag(I) ions(3,4). No previous structural information was available for the heavy-metal efflux (HME) subfamily of the RND efflux pumps. Here we describe the crystal structures of the inner-membrane transporter CusA in the absence and presence of bound Cu(I) or Ag(I). These CusA structures provide new structural information about the HME subfamily of RND efflux pumps. The structures suggest that the metal-binding sites, formed by a three-methionine cluster, are located within the cleft region of the periplasmic domain. This cleft is closed in the apo-CusA form but open in the CusA-Cu(I) and CusA-Ag(I) structures, which directly suggests a plausible pathway for ion export. Binding of Cu(I) and Ag(I) triggers significant conformational changes in both the periplasmic and transmembrane domains. The crystal structure indicates that CusA has, in addition to the three-methionine metal-binding site, four methionine pairs-three located in the transmembrane region and one in the periplasmic domain. Genetic analysis and transport assays suggest that CusA is capable of actively picking up metal ions from the cytosol, using these methionine pairs or clusters to bind and export metal ions. These structures suggest a stepwise shuttle mechanism for transport between these sites.	[Long, Feng; Yu, Edward W.] Iowa State Univ, Mol Cellular & Dev Biol Interdept Grad Program, Ames, IA 50011 USA; [Su, Chih-Chia; Yu, Edward W.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Zimmermann, Michael T.; Boyken, Scott E.; Jernigan, Robert L.; Yu, Edward W.] Iowa State Univ, Bioinformat & Computat Biol Interdept Grad Progra, Ames, IA 50011 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, Argonne Natl Lab, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, NE CAT, Argonne Natl Lab, Argonne, IL 60439 USA; [Jernigan, Robert L.; Yu, Edward W.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Yu, Edward W.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA	Iowa State University; Iowa State University; Iowa State University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Iowa State University; Iowa State University	Yu, EW (corresponding author), Iowa State Univ, Mol Cellular & Dev Biol Interdept Grad Program, Ames, IA 50011 USA.	ewyu@iastate.edu	Jernigan, Robert L/A-5421-2012; Long, Feng/F-5475-2011	Jernigan, Robert L/0000-0003-0996-8360; Long, Feng/0000-0001-6313-8558; Zimmermann, Michael/0000-0001-7073-0525; Boyken, Scott/0000-0002-5378-0632	National Institutes of Health (NIH), National Center for Research Resources [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NIH [GM074027, GM086431, GM081680, GM072014]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086431, R01GM072014, R01GM074027, R01GM081680] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. D. Routh for critical reading of the manuscript. This work is based on research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, supported by National Institutes of Health (NIH) award RR-15301 from the National Center for Research Resources. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. This work was supported by NIH grants GM074027 (to E.W.Y.), GM086431 (to E.W.Y.), GM081680 (to R.L.J.) and GM072014 (to R.L.J.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aires JR, 2005, J BACTERIOL, V187, P1923, DOI 10.1128/JB.187.6.1923-1929.2005; Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200; Arnesano F, 2001, BIOCHEMISTRY-US, V40, P1528, DOI 10.1021/bi0014711; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Franke S, 2003, J BACTERIOL, V185, P3804, DOI 10.1128/JB.185.13.3804-3812.2003; Franke S, 2001, MICROBIOL-SGM, V147, P965, DOI 10.1099/00221287-147-4-965; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Goldberg M, 1999, J BIOL CHEM, V274, P26065, DOI 10.1074/jbc.274.37.26065; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Jiang JF, 2005, INORG CHEM, V44, P9787, DOI 10.1021/ic051180m; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Loftin IR, 2007, PROTEIN SCI, V16, P2287, DOI 10.1110/ps.073021307; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OTWINOWSKI Z, 1991, CCP4 P, V80; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Su CC, 2006, J BACTERIOL, V188, P7290, DOI 10.1128/JB.00684-06; Su CC, 2009, J MOL BIOL, V393, P342, DOI 10.1016/j.jmb.2009.08.029; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Xue Y, 2008, NAT CHEM BIOL, V4, P107, DOI 10.1038/nchembio.2007.57; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	44	174	177	1	70	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					484	U140		10.1038/nature09395	http://dx.doi.org/10.1038/nature09395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20865003	Green Accepted			2022-12-24	WOS:000282090200048
J	Boitano, AE; Wang, JA; Romeo, R; Bouchez, LC; Parker, AE; Sutton, SE; Walker, JR; Flaveny, CA; Perdew, GH; Denison, MS; Schultz, PG; Cooke, MP				Boitano, Anthony E.; Wang, Jian; Romeo, Russell; Bouchez, Laure C.; Parker, Albert E.; Sutton, Sue E.; Walker, John R.; Flaveny, Colin A.; Perdew, Gary H.; Denison, Michael S.; Schultz, Peter G.; Cooke, Michael P.			Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells	SCIENCE			English	Article							UMBILICAL-CORD BLOOD; EX-VIVO EXPANSION; BONE-MARROW; TRANSPLANTATION; ENGRAFTMENT; MICE; BIOLOGY; BINDING	Although practiced clinically for more than 40 years, the use of hematopoietic stem cell (HSC) transplants remains limited by the ability to expand these cells ex vivo. An unbiased screen with primary human HSCs identified a purine derivative, StemRegenin 1 (SR1), that promotes the ex vivo expansion of CD34(+) cells. Culture of HSCs with SR1 led to a 50-fold increase in cells expressing CD34 and a 17-fold increase in cells that retain the ability to engraft immunodeficient mice. Mechanistic studies show that SR1 acts by antagonizing the aryl hydrocarbon receptor (AHR). The identification of SR1 and AHR modulation as a means to induce ex vivo HSC expansion should facilitate the clinical use of HSC therapy.	[Boitano, Anthony E.; Wang, Jian; Bouchez, Laure C.; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Boitano, Anthony E.; Romeo, Russell; Parker, Albert E.; Sutton, Sue E.; Walker, John R.; Cooke, Michael P.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Flaveny, Colin A.; Perdew, Gary H.] Penn State Univ, University Pk, PA 16803 USA; [Denison, Michael S.] Univ Calif Davis, Davis, CA 95616 USA	Scripps Research Institute; Novartis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Davis	Schultz, PG (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schultz@scripps.edu; mcooke@gnf.org	wang, jian/GVS-0711-2022	bouchez, laure/0000-0003-4583-6760	California Institute for Regenerative Medicine; Skaggs Institute for Chemical Biology; National Institutes of Environmental Health Sciences [ES007685, ES04699]; NIH [ES004869]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004869, R01ES007685, R29ES004869, P42ES004699] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Skaggs Institute for Chemical Biology; National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank C. Trussell, D. Rines, and M. Hull for assistance with flow cytometry and screen development; J. E. Tellew, S. Pan, Y. Wan, and X. Wang for synthesis of LGC006; and J. Hogenesch for helpful discussions. A. E. B was funded by grants from the California Institute for Regenerative Medicine and the Skaggs Institute for Chemical Biology. M.S.D. was funded by grants from the National Institutes of Environmental Health Sciences (ES007685 and ES04699). G.H.P. was funded by a grant from the NIH (ES004869). A patent application has been filed on SR1 for applications related to HSC expansion.	Brunstein CG, 2007, BRIT J HAEMATOL, V137, P20, DOI 10.1111/j.1365-2141.2007.06521.x; Campbell TB, 2007, STEM CELLS DEV, V16, P347, DOI 10.1089/scd.2007.9995; Ding S, 2002, J AM CHEM SOC, V124, P1594, DOI 10.1021/ja0170302; Flaveny CA, 2009, MOL PHARMACOL, V75, P1412, DOI 10.1124/mol.109.054825; Frericks M, 2007, TOXICOL APPL PHARM, V220, P320, DOI 10.1016/j.taap.2007.01.014; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jang JY, 2007, REPROD TOXICOL, V24, P303, DOI 10.1016/j.reprotox.2007.08.002; Kelly SS, 2009, BONE MARROW TRANSPL, V44, P673, DOI 10.1038/bmt.2009.284; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301; Mogul MJ, 2000, BONE MARROW TRANSPL, V25, pS58, DOI 10.1038/sj.bmt.1702372; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Sakai R, 2003, TOXICOL SCI, V72, P84, DOI 10.1093/toxsci/kfg002; Singh KP, 2009, BIOCHEM PHARMACOL, V77, P577, DOI 10.1016/j.bcp.2008.10.001; Singh KP, 2009, CARCINOGENESIS, V30, P11, DOI 10.1093/carcin/bgn224; Smith BG, 1908, BIOL BULL-US, V15, P9, DOI 10.2307/1535560; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; Xia LJ, 2004, BLOOD, V104, P3091, DOI 10.1182/blood-2004-02-0650	22	714	787	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1345	1348		10.1126/science.1191536	http://dx.doi.org/10.1126/science.1191536			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20688981	Green Accepted			2022-12-24	WOS:000281657300039
J	Moreno-Risueno, MA; Van Norman, JM; Moreno, A; Zhang, JY; Ahnert, SE; Benfey, PN				Moreno-Risueno, Miguel A.; Van Norman, Jaimie M.; Moreno, Antonio; Zhang, Jingyuan; Ahnert, Sebastian E.; Benfey, Philip N.			Oscillating Gene Expression Determines Competence for Periodic Arabidopsis Root Branching	SCIENCE			English	Article							PATTERN DETECTION; AUXIN TRANSPORT; INITIATION; MODEL	Plants and animals produce modular developmental units in a periodic fashion. In plants, lateral roots form as repeating units along the root primary axis; however, the developmental mechanism regulating this process is unknown. We found that cyclic expression pulses of a reporter gene mark the position of future lateral roots by establishing prebranch sites and that prebranch site production and root bending are periodic. Microarray and promoter-luciferase studies revealed two sets of genes oscillating in opposite phases at the root tip. Genetic studies show that some oscillating transcriptional regulators are required for periodicity in one or both developmental processes. This molecular mechanism has characteristics that resemble molecular clock-driven activities in animal species.	[Moreno-Risueno, Miguel A.; Van Norman, Jaimie M.; Zhang, Jingyuan; Benfey, Philip N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Moreno-Risueno, Miguel A.; Van Norman, Jaimie M.; Zhang, Jingyuan; Benfey, Philip N.] Duke Univ, Inst Genome Sci, Durham, NC 27708 USA; [Moreno-Risueno, Miguel A.; Van Norman, Jaimie M.; Zhang, Jingyuan; Benfey, Philip N.] Duke Univ, Policy Ctr Syst Biol, Durham, NC 27708 USA; [Moreno, Antonio] CSIC, Inst Acust, Dept Acust Ambiental, E-28006 Madrid, Spain; [Ahnert, Sebastian E.] Univ Cambridge, Cavendish Lab, Condensed Matter Theory Grp, Cambridge CB3 0HE, England	Duke University; Duke University; Duke University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acustica (IA); University of Cambridge	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	MORENO-RISUENO, MIGUEL ANGEL/J-8832-2016	MORENO-RISUENO, MIGUEL ANGEL/0000-0002-9794-1450	Defense Advanced Research Projects Agency (DARPA) [HR0011-05-1-0057, HR0011-09-1-0055]; NIH [R01-GM043778]; Ministry of Science and Innovation (MICINN), government of Spain; Leverhulme Trust, UK; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Innovation (MICINN), government of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Leverhulme Trust, UK(Leverhulme Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Tsukagoshi for cloning the promoter regions of ARF7, SHP1, and ATAF1. This work was supported by grants to P.N.B. from Defense Advanced Research Projects Agency (DARPA, grants HR0011-05-1-0057 and HR0011-09-1-0055) and the NIH (R01-GM043778); a fellowship from the Ministry of Science and Innovation (MICINN), government of Spain, to M.A.M.-R.; a National Research Service Award fellowship from the NIH to J.M.V.N.; and support from the Leverhulme Trust, UK, to S.E.A. We thank W. Busch, J. Petricka, I. Rubio-Somoza, and R. Sozzani for critical reading of the manuscript. The authors would like to thank O. Pourquie for many useful discussions. The authors have declared that no competing interests exist. The National Center for Biotechnology Information Gene Expression Omnibus accession numbers for new microarrays data discussed in this manuscript are GSE21611.	Ahnert SE, 2006, BIOINFORMATICS, V22, P1471, DOI 10.1093/bioinformatics/btl121; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; De Smet I, 2007, DEVELOPMENT, V134, P681, DOI 10.1242/dev.02753; De Smet I, 2010, P NATL ACAD SCI USA, V107, P2705, DOI 10.1073/pnas.0915001107; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Dequeant ML, 2006, SCIENCE, V314, P1595, DOI 10.1126/science.1133141; Dequeant ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002856; Dinneny JR, 2005, BIOESSAYS, V27, P42, DOI 10.1002/bies.20165; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; Dubrovsky JG, 2006, ANN BOT-LONDON, V97, P903, DOI 10.1093/aob/mcj604; Dubrovsky JG, 2008, P NATL ACAD SCI USA, V105, P8790, DOI 10.1073/pnas.0712307105; Dunlap JC, 2007, COLD SPRING HARB SYM, V72, P57, DOI 10.1101/sqb.2007.72.072; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Fukaki H, 2007, INT REV CYTOL, V256, P111, DOI 10.1016/S0074-7696(07)56004-3; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Himanen K, 2004, P NATL ACAD SCI USA, V101, P5146, DOI 10.1073/pnas.0308702101; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kubo M, 2005, GENE DEV, V19, P1855, DOI 10.1101/gad.1331305; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Lu PL, 2007, PLANT MOL BIOL, V63, P289, DOI 10.1007/s11103-006-9089-8; Lucas M, 2008, J EXP BOT, V59, P55, DOI 10.1093/jxb/erm171; Lucas M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003673; Malamy JE, 1997, DEVELOPMENT, V124, P33; Malamy JE, 2001, PLANT PHYSIOL, V127, P899, DOI 10.1104/pp.010406; McGregor Alistair P., 2009, Communicative & Integrative Biology, V2, P174; McSteen P, 2005, ANNU REV PLANT BIOL, V56, P353, DOI 10.1146/annurev.arplant.56.032604.144122; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanneste S, 2005, PLANT CELL, V17, P3035, DOI 10.1105/tpc.105.035493; Yant L, 2009, CURR OPIN PLANT BIOL, V12, P580, DOI 10.1016/j.pbi.2009.07.006	34	402	409	2	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2010	329	5997					1306	1311		10.1126/science.1191937	http://dx.doi.org/10.1126/science.1191937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829477	Green Accepted			2022-12-24	WOS:000281657300028
J	Bax, BD; Chan, PF; Eggleston, DS; Fosberry, A; Gentry, DR; Gorrec, F; Giordano, I; Hann, MM; Hennessy, A; Hibbs, M; Huang, JZ; Jones, E; Jones, J; Brown, KK; Lewis, CJ; May, EW; Saunders, MR; Singh, O; Spitzfaden, CE; Shen, C; Shillings, A; Theobald, AJ; Wohlkonig, A; Pearson, ND; Gwynn, MN				Bax, Benjamin D.; Chan, Pan F.; Eggleston, Drake S.; Fosberry, Andrew; Gentry, Daniel R.; Gorrec, Fabrice; Giordano, Ilaria; Hann, Michael M.; Hennessy, Alan; Hibbs, Martin; Huang, Jianzhong; Jones, Emma; Jones, Jo; Brown, Kristin Koretke; Lewis, Ceri J.; May, Earl W.; Saunders, Martin R.; Singh, Onkar; Spitzfaden, Claus E.; Shen, Carol; Shillings, Anthony; Theobald, Andrew J.; Wohlkonig, Alexandre; Pearson, Neil D.; Gwynn, Michael N.			Type IIA topoisomerase inhibition by a new class of antibacterial agents	NATURE			English	Article							INFECTIOUS-DISEASES-SOCIETY; BREAKAGE-REUNION DOMAIN; DNA GYRASE; CRYSTAL-STRUCTURE; BAD BUGS; FUSION PROTEIN; MECHANISM; CLEAVAGE; IA; DRUGS	Despite the success of genomics in identifying new essential bacterial genes, there is a lack of sustainable leads in antibacterial drug discovery to address increasing multidrug resistance. Type IIA topoisomerases cleave and religate DNA to regulate DNA topology and are a major class of antibacterial and anticancer drug targets, yet there is no well developed structural basis for understanding drug action. Here we report the 2.1 angstrom crystal structure of a potent, new class, broad-spectrum antibacterial agent in complex with Staphylococcus aureus DNA gyrase and DNA, showing a new mode of inhibition that circumvents fluoroquinolone resistance in this clinically important drug target. The inhibitor 'bridges' the DNA and a transient non-catalytic pocket on the two-fold axis at the GyrA dimer interface, and is close to the active sites and fluoroquinolone binding sites. In the inhibitor complex the active site seems poised to cleave the DNA, with a single metal ion observed between the TOPRIM (topoisomerase/primase) domain and the scissile phosphate. This work provides new insights into the mechanism of topoisomerase action and a platform for structure-based drug design of a new class of antibacterial agents against a clinically proven, but conformationally flexible, enzyme class.	[Bax, Benjamin D.; Hann, Michael M.; Saunders, Martin R.; Singh, Onkar; Spitzfaden, Claus E.] GlaxoSmithKline, Med Res Ctr, Mol Discovery Res, Stevenage SG1 2NY, Herts, England; [Chan, Pan F.; Gentry, Daniel R.; Huang, Jianzhong; May, Earl W.; Shen, Carol; Pearson, Neil D.; Gwynn, Michael N.] GlaxoSmithKline, Infect Dis Ctr Excellence Drug Discovery, Antibacterial Discovery Performance Unit, Collegeville, PA 19426 USA; [Eggleston, Drake S.; Fosberry, Andrew; Gorrec, Fabrice; Hibbs, Martin; Jones, Emma; Jones, Jo; Lewis, Ceri J.; Shillings, Anthony; Theobald, Andrew J.] GlaxoSmithKline, Mol Discovery Res, Harlow CM19 5AW, Essex, England; [Giordano, Ilaria; Hennessy, Alan; Wohlkonig, Alexandre] GlaxoSmithKline, Med Res Ctr, Antibacterial Discovery Performance Unit, Stevenage SG1 2NY, Herts, England; [Brown, Kristin Koretke] GlaxoSmithKline, Mol Discovery Res, Collegeville, PA 19426 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Bax, BD (corresponding author), GlaxoSmithKline, Med Res Ctr, Mol Discovery Res, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England.	benjamin.d.bax@gsk.com; mick.gwynn@gsk.com		Gorrec, Fabrice/0000-0002-9998-3611; Wohlkonig, Alexandre/0000-0003-3103-5022; Bax, Ben/0000-0003-1940-3785	Wellcome Trust Seeding Drug Discovery Initiative; US Department of Defense (DoD) [HDTRA1-07-9-0002]; Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD) [HDTRA1-07-9-0002]; Defense Threat Reduction Agency (DTRA); Transformational Medical Technologies (TMT)	Wellcome Trust Seeding Drug Discovery Initiative(Wellcome Trust); US Department of Defense (DoD)(United States Department of Defense); Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD)(United States Department of DefenseDefense Threat Reduction Agency); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Transformational Medical Technologies (TMT)	We thank H. Hiasa, A. Maxwell, J. C. Wang and D. B. Wigley for discussions. We thank S. Erskine, A. West and S. Brooks for experimental work that helped initiate this project. We thank P. Rowland for help with data collection and processing, the antimicrobial profiling group at GlaxoSmithKline (GSK) for antibacterial data, and K. Smith and D. Payne and members of the project team for discussions. A. W. was supported by the Wellcome Trust Seeding Drug Discovery Initiative and contract HDTRA1-07-9-0002 with the US Department of Defense (DoD) Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD), and the Defense Threat Reduction Agency (DTRA) Transformational Medical Technologies (TMT). The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the DoD or the US Government.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Berger JM, 1998, P NATL ACAD SCI USA, V95, P7876, DOI 10.1073/pnas.95.14.7876; Black MT, 2008, ANTIMICROB AGENTS CH, V52, P3339, DOI 10.1128/AAC.00496-08; Bock CW, 1999, J AM CHEM SOC, V121, P7360, DOI 10.1021/ja9906960; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Changela A, 2007, J MOL BIOL, V368, P105, DOI 10.1016/j.jmb.2007.01.065; Clinical and Laboratory Standards Institute, 2008, METH DIL ANT SUSC TE; COATES WJ, 1999, Patent No. 1051413; Critchlow SE, 1996, BIOCHEMISTRY-US, V35, P7387, DOI 10.1021/bi9603175; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Deweese JE, 2008, NUCLEIC ACIDS RES, V36, P4883, DOI 10.1093/nar/gkn466; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Edwards MJ, 2009, SCIENCE, V326, P1415, DOI 10.1126/science.1179123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu GS, 2009, NUCLEIC ACIDS RES, V37, P5908, DOI 10.1093/nar/gkp586; GELLERT M, 1979, P NATL ACAD SCI USA, V76, P6289, DOI 10.1073/pnas.76.12.6289; Gmunder H, 1997, NUCLEIC ACIDS RES, V25, P604, DOI 10.1093/nar/25.3.604; Gomez L, 2007, BIOORG MED CHEM LETT, V17, P2723, DOI 10.1016/j.bmcl.2007.03.003; Hansen CL, 2002, P NATL ACAD SCI USA, V99, P16531, DOI 10.1073/pnas.262485199; HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339; Jeffrey G.A., 2012, HYDROGEN BONDING BIO; KLEYWEGT GJ, 1995, STRUCTURE, V3, P535, DOI 10.1016/S0969-2126(01)00187-3; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; Lavasani LS, 2001, BIOCHEMISTRY-US, V40, P8438, DOI 10.1021/bi0155201; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liu QY, 1998, J BIOL CHEM, V273, P20252, DOI 10.1074/jbc.273.32.20252; Liu QY, 1999, P NATL ACAD SCI USA, V96, P881, DOI 10.1073/pnas.96.3.881; MILLER WH, 2010, Patent No. 7691850; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; Mueller-Planitz F, 2008, J BIOL CHEM, V283, P17463, DOI 10.1074/jbc.M710014200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Noble CG, 2002, J MOL BIOL, V318, P361, DOI 10.1016/S0022-2836(02)00049-9; Nollmann M, 2007, NAT STRUCT MOL BIOL, V14, P264, DOI 10.1038/nsmb1213; Oezguen N, 2007, PROTEINS, V68, P313, DOI 10.1002/prot.21397; Pan XS, 2009, ANTIMICROB AGENTS CH, V53, P3822, DOI 10.1128/AAC.00113-09; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; REECE RJ, 1991, J BIOL CHEM, V266, P3540; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sissi C, 2009, NUCLEIC ACIDS RES, V37, P702, DOI 10.1093/nar/gkp024; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Tanaka M, 2000, J Infect Chemother, V6, P131, DOI 10.1007/s101560070010; Tretter EM, 2010, PROTEINS, V78, P492, DOI 10.1002/prot.22600; Trigueros S, 2002, GENES CELLS, V7, P249, DOI 10.1046/j.1365-2443.2002.00516.x; Wiener JJM, 2007, BIOORG MED CHEM LETT, V17, P2718, DOI 10.1016/j.bmcl.2007.03.004; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0	53	506	519	2	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					935	U51		10.1038/nature09197	http://dx.doi.org/10.1038/nature09197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20686482				2022-12-24	WOS:000281030300026
J	Bonfanti, P; Claudinot, S; Amici, AW; Farley, A; Blackburn, CC; Barrandon, Y				Bonfanti, Paola; Claudinot, Stephanie; Amici, Alessandro W.; Farley, Alison; Blackburn, C. Clare; Barrandon, Yann			Microenvironmental reprogramming of thymic epithelial cells to skin multipotent stem cells	NATURE			English	Article							HAIR-FOLLICLES; PROGENITOR CELLS; CLONAL ANALYSIS; TOLERANCE; IDENTIFICATION; ORGANOGENESIS; REGENERATION; KERATINOCYTE; GENERATION; AIRE	The thymus develops from the third pharyngeal pouch of the anterior gut and provides the necessary environment for thymopoiesis (the process by which thymocytes differentiate into mature T lymphocytes) and the establishment and maintenance of self-tolerance(1-3). It contains thymic epithelial cells (TECs) that form a complex three-dimensional network organized in cortical and medullary compartments, the organization of which is notably different from simple or stratified epithelia(4). TECs have an essential role in the generation of self-tolerant thymocytes through expression of the autoimmune regulator Aire(5,6), but the mechanisms involved in the specification and maintenance of TECs remain unclear(7-9). Despite the different embryological origins of thymus and skin (endodermal and ectodermal, respectively), some cells of the thymic medulla express stratified-epithelium markers(10-12), interpreted as promiscuous gene expression. Here we show that the thymus of the rat contains a population of clonogenic TECs that can be extensively cultured while conserving the capacity to integrate in a thymic epithelial network and to express major histocompatibility complex class II (MHC II) molecules and Aire. These cells can irreversibly adopt the fate of hair follicle multipotent stem cells when exposed to an inductive skin microenvironment; this change in fate is correlated with robust changes in gene expression. Hence, microenvironmental cues are sufficient here to re-direct epithelial cell fate, allowing crossing of primitive germ layer boundaries and an increase in potency(13).	[Bonfanti, Paola; Claudinot, Stephanie; Amici, Alessandro W.; Barrandon, Yann] Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland; [Bonfanti, Paola; Claudinot, Stephanie; Amici, Alessandro W.; Barrandon, Yann] CHU Vaudois, Univ Lausanne Hosp, Dept Expt Surg, CH-1011 Lausanne, Switzerland; [Farley, Alison; Blackburn, C. Clare] Univ Edinburgh, Sch Biol Sci, MRC, Ctr Regenerat Med,Inst Stem Cell Res, Edinburgh EH16 4SB, Midlothian, Scotland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Edinburgh	Barrandon, Y (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland.	Yann.Barrandon@epfl.ch	Amici, Alessandro W/AGL-7640-2022; Blackburn, Clare/B-2847-2009; Blackburn, Clare/AAM-7954-2020	Blackburn, Clare/0000-0002-6326-640X; Blackburn, Clare/0000-0002-6326-640X; FARLEY, ALISON/0000-0002-9609-8983; Bonfanti, Paola/0000-0001-9655-3766	Swiss National Science Foundation [3100A0-104160]; Juvenile Diabetes Research Foundation; EPFL; CHUV; Leukaemia Research Fund; European Union (EU); Heiwa Nakajima Foundation; Medical Research Council [G0700711B] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); EPFL; CHUV; Leukaemia Research Fund; European Union (EU)(CGIAREuropean Commission); Heiwa Nakajima Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to M. Nicolas and A. Smith for discussions and support, M. Okabe for supplying EGFP rats, J. Roberts, M. Garcia and R. Teisanu for help with cell sorting, J. C. Sarria and T. Laroche for confocal imaging, and K. Harsman, O. Hagenbuchle and S. Pradervand from the DAFL for microarray analyses. Y.B was supported in this work by the Swiss National Science Foundation (grant 3100A0-104160), the Juvenile Diabetes Research Foundation, the EPFL and the CHUV. C. B. was supported by a Leukaemia Research Fund grant. The European Union (EU) supported Y.B. and C. B. through the sixth (EuroStemCell) and seventh (EuroSyStem, OptiStem) framework programmes. A. W. A. was supported by a fellowship from the Heiwa Nakajima Foundation.	Abramson J, 2010, CELL, V140, P123, DOI 10.1016/j.cell.2009.12.030; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BARRANDON Y, 1985, P NATL ACAD SCI USA, V82, P5390, DOI 10.1073/pnas.82.16.5390; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 2002, TRENDS IMMUNOL, V23, P391, DOI 10.1016/S1471-4906(02)02265-2; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Hale LP, 2004, J IMMUNOL, V172, P617, DOI 10.4049/jimmunol.172.1.617; Hamazaki Y, 2007, NAT IMMUNOL, V8, P304, DOI 10.1038/ni1438; HEID HW, 1988, DIFFERENTIATION, V37, P137, DOI 10.1111/j.1432-0436.1988.tb00805.x; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hollander G, 2006, IMMUNOL REV, V209, P28, DOI 10.1111/j.0105-2896.2006.00357.x; Ito T, 2001, J AM SOC NEPHROL, V12, P2625, DOI 10.1681/ASN.V12122625; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; LASTER AJ, 1986, DIFFERENTIATION, V31, P67, DOI 10.1111/j.1432-0436.1986.tb00385.x; Manley NR, 2003, CURR OPIN IMMUNOL, V15, P225, DOI 10.1016/S0952-7915(03)00006-2; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; MOSCONA A, 1961, EXP CELL RES, V22, P455, DOI 10.1016/0014-4827(61)90122-7; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sheridan JM, 2009, GENESIS, V47, P346, DOI 10.1002/dvg.20505; Smith A, 2006, NATURE, V441, P1060, DOI 10.1038/nature04954; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; SUN TT, 1984, CELL IMMUNOL, V83, P1, DOI 10.1016/0008-8749(84)90219-3; van Ewijk W, 1999, SEMIN IMMUNOL, V11, P57, DOI 10.1006/smim.1998.0158	33	105	106	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2010	466	7309					978	U105		10.1038/nature09269	http://dx.doi.org/10.1038/nature09269			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725041				2022-12-24	WOS:000281030300035
J	Zhang, XZ; Saaddine, JB; Chou, CF; Cotch, MF; Cheng, YJ; Geiss, LS; Gregg, EW; Albright, AL; Klein, BEK; Klein, R				Zhang, Xinzhi; Saaddine, Jinan B.; Chou, Chin-Fang; Cotch, Mary Frances; Cheng, Yiling J.; Geiss, Linda S.; Gregg, Edward W.; Albright, Ann L.; Klein, Barbara E. K.; Klein, Ronald			Prevalence of Diabetic Retinopathy in the United States, 2005-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; EYE CARE; POPULATION; DISEASE; PEOPLE; ADULTS; AGE; HEALTH	Context The prevalence of diabetes in the United States has increased. People with diabetes are at risk for diabetic retinopathy. No recent national population-based estimate of the prevalence and severity of diabetic retinopathy exists. Objectives To describe the prevalence and risk factors of diabetic retinopathy among US adults with diabetes aged 40 years and older. Design, Setting, and Participants Analysis of a cross-sectional, nationally representative sample of the National Health and Nutrition Examination Survey 2005-2008 (N=1006). Diabetes was defined as a self-report of a previous diagnosis of the disease (excluding gestational diabetes mellitus) or glycated hemoglobin A(1c) of 6.5% or greater. Two fundus photographs were taken of each eye with a digital nonmydriatic camera and were graded using the Airlie House classification scheme and the Early Treatment Diabetic Retinopathy Study severity scale. Prevalence estimates were weighted to represent the civilian, noninstitutionalized US population aged 40 years and older. Main Outcome Measurements Diabetic retinopathy and vision-threatening diabetic retinopathy. Results The estimated prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy was 28.5% (95% confidence interval [Cl], 24.9%-32.5%) and 4.4% (95% Cl, 3.5%-5.7%) among US adults with diabetes, respectively. Diabetic retinopathy was slightly more prevalent among men than women with diabetes (31.6%; 95% Cl, 26.8%-36.8%; vs 25.7%; 95% Cl, 21.7%-30.1%; P=.04). Non-Hispanic black individuals had a higher crude prevalence than non-Hispanic white individuals of diabetic retinopathy (38.8%; 95% Cl, 31.9%-46.1%; vs 26.4%; 95% Cl, 21.4%-32.2%; P=.01) and vision-threatening diabetic retinopathy (9.3%; 95% Cl, 5.9%-14.4%; vs 3.2%; 95% Cl, 2.0%-5.1%; P=.01). Male sex was independently associated with the presence of diabetic retinopathy (odds ratio [OR], 2.07; 95% Cl, 1.39-3.10), as well as higher hemoglobin A(1c) level (OR, 1.45; 95% Cl, 1.20-1.75), longer duration of diabetes (OR, 1.06 per year duration; 95% Cl, 1.03-1.10), insulin use (OR, 3.23; 95% Cl, 1.99-5.26), and higher systolic blood pressure (OR, 1.03 per mm Hg; 95% Cl, 1.02-1.03). Conclusion In a nationally representative sample of US adults with diabetes aged 40 years and older, the prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy was high, especially among Non-Hispanic black individuals. JAMA. 2010;304(6):649-656	[Zhang, Xinzhi; Saaddine, Jinan B.; Chou, Chin-Fang; Cheng, Yiling J.; Geiss, Linda S.; Gregg, Edward W.; Albright, Ann L.] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; [Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA; [Klein, Barbara E. K.; Klein, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Wisconsin System; University of Wisconsin Madison	Zhang, XZ (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy,NE K-10, Atlanta, GA 30341 USA.	XZhang4@cdc.gov	Cheng, Yiling J/A-6547-2009	Cheng, Yiling J/0000-0002-5053-0814; Cotch, Mary Frances/0000-0002-2046-4350; Gregg, Edward/0000-0003-2381-6822; Klein, Ronald/0000-0002-4428-6237	National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC); Division of Diabetes Translation, CDC [05FED47304]; National Eye Institute, National Institutes of Health [Z01EY000402]; Division of Diabetes Translation; NATIONAL EYE INSTITUTE [Z01EY000402, ZIAEY000402] Funding Source: NIH RePORTER	National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Division of Diabetes Translation, CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Division of Diabetes Translation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). Funding for the National Health and Nutrition Examination Survey (NHANES) retinal component was provided by the Intra Agency Agreement 05FED47304 from the Division of Diabetes Translation, CDC. Funding for the vision component was provided by the National Eye Institute, National Institutes of Health, Intramural Research Program grant Z01EY000402.; The NCHS was involved in the design and conduct of the NHANES study and in data collection, but was not involved in the analysis or interpretation of the study results or in the preparation of the manuscript. The Division of Diabetes Translation provided funding support for the retinal component and was involved in the design and conduct of the study; in the collection, analysis, and interpretation of the data; and in the preparation, review, and approval of this article before submission.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 1991, Ophthalmology, V98, P786; Burrows NR, 2010, DIABETES CARE, V33, P73, DOI 10.2337/dc09-0343; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2004, ANTIBIOTIC RESISTANC; Cheng YJ, 2009, DIABETES CARE, V32, P2027, DOI 10.2337/dc09-0440; Cheung N, 2008, PROG RETIN EYE RES, V27, P161, DOI 10.1016/j.preteyeres.2007.12.001; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Geiss Linda, 2005, Diabetes Technol Ther, V7, P198, DOI 10.1089/dia.2005.7.198; Harris MI, 1998, DIABETES CARE, V21, P1230, DOI 10.2337/diacare.21.8.1230; Hirsch IB, 2010, JAMA-J AM MED ASSOC, V303, P2291, DOI 10.1001/jama.2010.785; HOLT D, 1991, STATISTICIAN, V40, P333, DOI 10.2307/2348286; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; JAVITT JC, 1994, DIABETES CARE, V17, P909, DOI 10.2337/diacare.17.8.909; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; Klein R, 2004, ARCH OPHTHALMOL-CHIC, V122, P1642, DOI 10.1001/archopht.122.11.1642; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; KLEIN R, 1986, OPHTHALMOLOGY, V93, P1183; KLEIN R, 1992, OPHTHALMOLOGY, V99, P58; KLEIN R, 1995, DIABETES AM, P293; Klein R, 2009, OPHTHALMOLOGY, V116, P1937, DOI 10.1016/j.ophtha.2009.03.012; Korn E. L., 1999, ANAL HLTH SURVEYS; LEUREDUPREE AE, 1981, INVEST OPHTH VIS SCI, V21, P1; Liew G, 2009, HEART, V95, P391, DOI 10.1136/hrt.2008.146670; Mitchell P, 1998, OPHTHALMOLOGY, V105, P406, DOI 10.1016/S0161-6420(98)93019-6; *NAT DIAB DAT GROU, 1995, DIAB AM; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nkondi Mbadi ANsunguJ, 2009, MALI MED, V24, P17; Nordwall M, 2004, DIABETOLOGIA, V47, P1266, DOI 10.1007/s00125-004-1431-6; Nsiah-Kumi P, 2009, J NATL MED ASSOC, V101, P430, DOI 10.1016/S0027-9684(15)30929-9; Saaddine JB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1740, DOI 10.1001/archopht.126.12.1740; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sloan FA, 2009, OPHTHALMOLOGY, V116, P1515, DOI 10.1016/j.ophtha.2009.03.010; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889; Wang CY, 2010, AM J EPIDEMIOL, V171, P426, DOI 10.1093/aje/kwp412; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Zhang XZ, 2007, ARCH OPHTHALMOL-CHIC, V125, P411, DOI 10.1001/archopht.125.3.411	42	689	725	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					649	656		10.1001/jama.2010.1111	http://dx.doi.org/10.1001/jama.2010.1111			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699456	Bronze, Green Accepted			2022-12-24	WOS:000280829200020
J	Robert, S; Kleine-Vehn, J; Barbez, E; Sauer, M; Paciorek, T; Baster, P; Vanneste, S; Zhang, J; Simon, S; Covanova, M; Hayashi, K; Dhonukshe, P; Yang, Z; Bednarek, SY; Jones, AM; Luschnig, C; Aniento, F; Zazimalova, E; Friml, J				Robert, Stephanie; Kleine-Vehn, Juergen; Barbez, Elke; Sauer, Michael; Paciorek, Tomasz; Baster, Pawel; Vanneste, Steffen; Zhang, Jing; Simon, Sibu; Covanova, Milada; Hayashi, Kenichiro; Dhonukshe, Pankaj; Yang, Zhenbiao; Bednarek, Sebastian Y.; Jones, Alan M.; Luschnig, Christian; Aniento, Fernando; Zazimalova, Eva; Friml, Jiri			ABP1 Mediates Auxin Inhibition of Clathrin-Dependent Endocytosis in Arabidopsis	CELL			English	Article							OF-FUNCTION MUTATION; BOX PROTEIN TIR1; BINDING PROTEIN-1; CELL EXPANSION; ENDOPLASMIC-RETICULUM; TRANSFERRIN RECEPTOR; PLASMA-MEMBRANE; EFFLUX CARRIER; TYRPHOSTIN A23; TRANSPORT	Spatial distribution of the plant hormone auxin regulates multiple aspects of plant development. These self-regulating auxin gradients are established by the action of PIN auxin transporters, whose activity is regulated by their constitutive cycling between the plasma membrane and endosomes. Here, we show that auxin signaling by the auxin receptor AUXIN-BINDING PROTEIN 1 (ABP1) inhibits the clathrin-mediated internalization of PIN proteins. ABP1 acts as a positive factor in clathrin recruitment to the plasma membrane, thereby promoting endocytosis. Auxin binding to ABP1 interferes with this action and leads to the inhibition of clathrin-mediated endocytosis. Our study demonstrates that ABP1 mediates a nontranscriptional auxin signaling that regulates the evolutionarily conserved process of clathrin-mediated endocytosis and suggests that this signaling may be essential for the developmentally important feedback of auxin on its own transport.	[Robert, Stephanie; Kleine-Vehn, Juergen; Barbez, Elke; Sauer, Michael; Paciorek, Tomasz; Baster, Pawel; Vanneste, Steffen; Zhang, Jing; Friml, Jiri] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Robert, Stephanie; Kleine-Vehn, Juergen; Barbez, Elke; Sauer, Michael; Paciorek, Tomasz; Baster, Pawel; Vanneste, Steffen; Zhang, Jing; Friml, Jiri] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Simon, Sibu; Covanova, Milada; Zazimalova, Eva] ASCR, Inst Expt Bot, Prague 16502 6, Czech Republic; [Hayashi, Kenichiro] Okayama Univ Sci, Dept Biochem, Okayama 7000005, Japan; [Dhonukshe, Pankaj] Univ Utrecht, Dept Biol, NL-3584 CH Utrecht, Netherlands; [Yang, Zhenbiao] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Yang, Zhenbiao] Univ Calif Riverside, Ctr Plant Cell Biol, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Bednarek, Sebastian Y.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Luschnig, Christian] Univ Nat Resources & Appl Life Sci, BOKU, Inst Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Aniento, Fernando] Univ Valencia, Dept Bioquim & Biol Mol, Burjassot 46100, Spain	Flanders Institute for Biotechnology (VIB); Ghent University; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Okayama University of Science; Utrecht University; University of California System; University of California Riverside; University of California System; University of California Riverside; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Natural Resources & Life Sciences, Vienna; University of Valencia	Friml, J (corresponding author), VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	jiri.friml@psb.vib-ugent.be	Covanova, Milada/F-7473-2014; Simon, Sibu/A-2614-2012; Sauer, Michael/F-6519-2014; Sauer, Michael/G-3424-2011; Robert, Stéphanie/K-7604-2012; Vanneste, Steffen/K-8353-2013; Company, Fernando Aniento/G-9781-2015; Barbez, Elke/AAP-2131-2021; Kleine-Vehn, Jürgen/C-8984-2014; Friml, Jiri/D-9511-2012; Hayashi, Ken-ichiro/AAP-3513-2021; Eva, Zazimalova/G-7432-2014	Sauer, Michael/0000-0002-4014-9825; Robert, Stéphanie/0000-0002-0013-3239; Vanneste, Steffen/0000-0002-9948-9672; Company, Fernando Aniento/0000-0003-3553-585X; Kleine-Vehn, Jürgen/0000-0002-4354-3756; Friml, Jiri/0000-0002-8302-7596; Hayashi, Ken-ichiro/0000-0002-9812-2801; Eva, Zazimalova/0000-0002-8325-7092; Barbez, Elke/0000-0002-5531-7916; Luschnig, Christian/0000-0003-2099-9280	Research Foundation Flanders; Ministry of Education of the Czech Republic [LC06034]; Ministerio de Educacion y Ciencia [BFU2005-00071]; Agency for Innovation by Science and Technology; HFSP long-term; Marie Curie IEF; National Institute of General Medical Sciences [GM65989]; Department of Energy [DE-FG02-05er15671]; National Science Foundation [MCB0718202, 0723515]; NWO-VENI;  [ATLF 142-2007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081451, R01GM065989, R01GM100130] Funding Source: NIH RePORTER	Research Foundation Flanders(FWO); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministerio de Educacion y Ciencia(Spanish Government); Agency for Innovation by Science and Technology; HFSP long-term; Marie Curie IEF(European Commission); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); NWO-VENI(Netherlands Organization for Scientific Research (NWO)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the anonymous reviewer for helpful comments and Martine De Cock for help in preparing the manuscript. We are very grateful to X.Y. Chen, M. Estelle, T. Gaude, N. Geldner, O. Leyser, C. Perrot-Rechen-mann, and J.W. Reed for sharing published materials and Drs. Jin-Gui Chen and Ming-Jing Wu for generating abp1 mutants. This work was supported by the Odysseus program of the Research Foundation Flanders, the Ministry of Education of the Czech Republic (project LC06034), and the Ministerio de Educacion y Ciencia (grant BFU2005-00071). E.B. is indebted to the Agency for Innovation by Science and Technology for a predoctoral fellowship and S.V. to EMBO for a long-term fellowship (ATLF 142-2007). M.S. was supported by HFSP long-term and Marie Curie IEF fellowships. A.M.J is supported by grants from The National Institute of General Medical Sciences (GM65989), The Department of Energy (DE-FG02-05er15671), and The National Science Foundation (MCB0718202, 0723515). P.D. is supported by NWO-VENI grant.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Badescu GO, 2006, TRENDS PLANT SCI, V11, P217, DOI 10.1016/j.tplants.2006.03.001; Banbury AN, 2003, J BIOL CHEM, V278, P12022, DOI 10.1074/jbc.M211966200; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Braun N, 2008, PLANT CELL, V20, P2746, DOI 10.1105/tpc.108.059048; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Collings DA, 2008, J EXP BOT, V59, P361, DOI 10.1093/jxb/erm324; Dharmasiri N, 2004, TRENDS PLANT SCI, V9, P302, DOI 10.1016/j.tplants.2004.04.003; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Henderson J, 1997, PLANTA, V202, P313, DOI 10.1007/s004250050133; HERTEL R, 1972, PLANTA, V107, P325, DOI 10.1007/BF00386394; JONES AM, 1993, PLANT PHYSIOL, V101, P595, DOI 10.1104/pp.101.2.595; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; JONES AM, 1994, ANNU REV PLANT PHYS, V45, P393, DOI 10.1146/annurev.pp.45.060194.002141; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Kepinski S, 2002, PLANT CELL, V14, pS81, DOI 10.1105/tpc.010447; Kim YW, 2001, PLANT PHYSIOL, V127, P1243, DOI 10.1104/pp.010450; Kleine-Vehn J, 2008, P NATL ACAD SCI USA, V105, P17812, DOI 10.1073/pnas.0808073105; Knox K, 2003, DEVELOPMENT, V130, P5769, DOI 10.1242/dev.00659; Konopka CA, 2008, PLANT CELL, V20, P1363, DOI 10.1105/tpc.108.059428; Lau S, 2009, TRENDS PLANT SCI, V14, P182, DOI 10.1016/j.tplants.2009.01.004; Leblanc N, 1997, PLANT MOL BIOL, V33, P679, DOI 10.1023/A:1005757815212; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; LIU SH, 1995, CELL, V83, P257, DOI 10.1016/0092-8674(95)90167-1; LOBLER M, 1985, J BIOL CHEM, V260, P9848; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Napier RM, 2002, PLANT MOL BIOL, V49, P339, DOI 10.1023/A:1015259130955; Ortiz-Zapater E, 2006, PLANT J, V48, P757, DOI 10.1111/j.1365-313X.2006.02909.x; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Pan JW, 2009, PLANT CELL, V21, P568, DOI 10.1105/tpc.108.061465; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Robinson DG, 2008, PLANT PHYSIOL, V147, P1482, DOI 10.1104/pp.108.120105; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Schenck D, 2010, PLANT PHYSIOL, V152, P1183, DOI 10.1104/pp.109.149591; Shimomura S, 1999, PLANTA, V209, P118, DOI 10.1007/s004250050613; Sieberer T, 2000, CURR BIOL, V10, P1595, DOI 10.1016/S0960-9822(00)00861-7; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; TIAN HC, 1995, J BIOL CHEM, V270, P26962, DOI 10.1074/jbc.270.45.26962; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; TIMPTE C, 1994, GENETICS, V138, P1239; Tromas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006648; Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Vieten A, 2007, TRENDS PLANT SCI, V12, P160, DOI 10.1016/j.tplants.2007.03.006; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woo EJ, 2002, EMBO J, V21, P2877, DOI 10.1093/emboj/cdf291; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; Yang HB, 2009, PLANT J, V59, P179, DOI 10.1111/j.1365-313X.2009.03856.x; ZAZIMALOVA E, 1985, PLANT GROWTH REGUL, V3, P15, DOI 10.1007/BF00123542	61	300	317	0	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2010	143	1					111	121		10.1016/j.cell.2010.09.027	http://dx.doi.org/10.1016/j.cell.2010.09.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887896	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000282362000018
J	Fleming, SM; Weil, RS; Nagy, Z; Dolan, RJ; Rees, G				Fleming, Stephen M.; Weil, Rimona S.; Nagy, Zoltan; Dolan, Raymond J.; Rees, Geraint			Relating Introspective Accuracy to Individual Differences in Brain Structure	SCIENCE			English	Article							PREFRONTAL CORTEX; CONFIDENCE; MEMORY; DISCRIMINATION; INSIGHTS; DECISION; ANATOMY; CHOICE	The ability to introspect about self-performance is key to human subjective experience, but the neuroanatomical basis of this ability is unknown. Such accurate introspection requires discriminating correct decisions from incorrect ones, a capacity that varies substantially across individuals. We dissociated variation in introspective ability from objective performance in a simple perceptual-decision task, allowing us to determine whether this interindividual variability was associated with a distinct neural basis. We show that introspective ability is correlated with gray matter volume in the anterior prefrontal cortex, a region that shows marked evolutionary development in humans. Moreover, interindividual variation in introspective ability is also correlated with white-matter microstructure connected with this area of the prefrontal cortex. Our findings point to a focal neuroanatomical substrate for introspective ability, a substrate distinct from that supporting primary perception.	[Fleming, Stephen M.; Weil, Rimona S.; Nagy, Zoltan; Dolan, Raymond J.; Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Weil, Rimona S.; Rees, Geraint] UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Fleming, SM (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, 12 Queen Sq, London WC1N 3BG, England.	s.fleming@fil.ion.ucl.ac.uk	Rees, Geraint/C-1493-2008; Fleming, Steve/A-9584-2010; Weil, Rimona S/B-6151-2009; Nagy, Zoltan/AAI-2485-2019	Rees, Geraint/0000-0002-9623-7007; Nagy, Zoltan/0000-0001-6611-6362; Dolan, Ray/0000-0001-9356-761X; Fleming, Stephen/0000-0003-0233-4891; Weil, Rimona/0000-0002-5092-6325	Wellcome Trust; University College London; Medical Research Council; MRC [G0500743] Funding Source: UKRI; Medical Research Council [G0500743] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); University College London(General Electric); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded by the Wellcome Trust (G. R., R.J.D., Z.N.), the University College London four-year Ph.D. program in neuroscience (S.M.F.), and the Medical Research Council (R. S. W.). We thank T. Sharot, G. Ridgway, and C. Frith for comments on earlier drafts of this manuscript.	Burgin GH, 2007, IEEE T EVOLUT COMPUT, V11, P290, DOI 10.1109/TEVC.2007.899730; Carreiras M, 2009, NATURE, V461, P983, DOI 10.1038/nature08461; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Cleeremans A, 2007, NEURAL NETWORKS, V20, P1032, DOI 10.1016/j.neunet.2007.09.011; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; DEL CUL A, 2009, BRAIN 9, V132, P2531; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Fleming SM, 2010, CONSCIOUS COGN, V19, P352, DOI 10.1016/j.concog.2009.11.002; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fuentemilla L, 2009, J NEUROSCI, V29, P8698, DOI 10.1523/JNEUROSCI.5270-08.2009; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; Graziano M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004909; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kornbrot DE, 2006, PERCEPT PSYCHOPHYS, V68, P393, DOI 10.3758/BF03193685; Kunimoto C, 2001, CONSCIOUS COGN, V10, P294, DOI 10.1006/ccog.2000.0494; Lau HC, 2008, PROG BRAIN RES, V168, P35, DOI 10.1016/S0079-6123(07)68004-2; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; METCALFE J, 2008, HDB METAMEMORY MEMOR, P27; Metcalfe J, 1996, METACOGNITION KNOWIN; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rounis E, 2010, COGN NEUROSCI-UK, V1, P165, DOI 10.1080/17588921003632529; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Shimamura AP, 2000, CONSCIOUS COGN, V9, P313, DOI 10.1006/ccog.2000.0450; Simons JS, 2010, CEREB CORTEX, V20, P479, DOI 10.1093/cercor/bhp116; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Szczepanowski R, 2007, J VISION, V7, DOI 10.1167/7.4.10; Titchener E. B., 1909, LECT EXPT PSYCHOL TH; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Washburn DA, 2005, J GEN PSYCHOL, V132, P446, DOI 10.3200/GENP.132.4.446-461	31	483	486	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1541	1543		10.1126/science.1191883	http://dx.doi.org/10.1126/science.1191883			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847276	Green Accepted, Green Published			2022-12-24	WOS:000281869000047
J	Aigouy, B; Farhadifar, R; Staple, DB; Sagner, A; Roper, JC; Julicher, F; Eaton, S				Aigouy, Benoit; Farhadifar, Reza; Staple, Douglas B.; Sagner, Andreas; Roeper, Jens-Christian; Juelicher, Frank; Eaton, Suzanne			Cell Flow Reorients the Axis of Planar Polarity in the Wing Epithelium of Drosophila	CELL			English	Article							TISSUE MORPHOGENESIS; PROLIFERATION CONTROL; CADHERIN SUPERFAMILY; FAT; SHAPE; GENE; MUTATIONS; EXTENSION; MECHANISM; PACKING	Planar cell polarity (PCP) proteins form polarized cortical domains that govern polarity of external structures such as hairs and cilia in both vertebrate and invertebrate epithelia. The mechanisms that globally orient planar polarity are not understood, and are investigated here in the Drosophila wing using a combination of experiment and theory. Planar polarity arises during growth and PCP domains are initially oriented toward the well-characterized organizer regions that control growth and patterning. At pupal stages, the wing hinge contracts, subjecting wing-blade epithelial cells to anisotropic tension in the proximal-distal axis. This results in precise patterns of oriented cell elongation, cell rearrangement and cell division that elongate the blade proximo-distally and realign planar polarity with the proximal-distal axis. Mutation of the atypical Cadherin Dachsous perturbs the global polarity pattern by altering epithelial dynamics. This mechanism utilizes the cellular movements that sculpt tissues to align planar polarity with tissue shape.	[Farhadifar, Reza; Staple, Douglas B.; Juelicher, Frank] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Aigouy, Benoit; Sagner, Andreas; Roeper, Jens-Christian; Eaton, Suzanne] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society; Max Planck Society	Julicher, F (corresponding author), Max Planck Inst Phys Komplexer Syst, Noethnitzer Str 38, D-01187 Dresden, Germany.	julicher@pks.mpg.de; eaton@mpi-cbg.de	/AAG-7913-2021; Sagner, Andreas/AAF-6235-2020; Eaton, Suzanne/D-7698-2017; Julicher, Frank/B-1828-2009	Sagner, Andreas/0000-0001-5698-8191; Eaton, Suzanne/0000-0002-8319-284X; Julicher, Frank/0000-0003-4731-9185	Max Planck Gesellschaft; Fondation pour la Recherche Medicale; Boehringer Ingelheim Fonds	Max Planck Gesellschaft(Max Planck Society); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work represents a truly collaborative effort. Each author has contributed significantly to the findings and regular group discussions guided the development of the ideas presented here. The manuscript was written jointly by all authors. S.E., A.S., J.R., R.F., and F.J. were supported by the Max Planck Gesellschaft. B.A. was funded by the Fondation pour la Recherche Medicale. D.S. acknowledges the Natural Sciences and Engineering Research Council of Canada and the German Academic Exchange Service. J.R. was supported by a predoctoral fellowship from the Boehringer Ingelheim Fonds. We thank Tony Hyman and Stephan Grill for use of the laser cutting microscope. We are grateful to Stephan Grill, Ewa Paluch, Elisabeth Knust, and Carl-Philipp Heisenberg for critical comments on the manuscript. We thank David Strutt, Seth S.Blair, VDRC and the Bloomington Stock Center for providing fly stocks, Barry Dickson for DNA constructs, Julia Gabel for help with cloning, Sven Ssykor for transgenic injections.	Adler PN, 1998, DEVELOPMENT, V125, P959; Amonlirdviman K, 2005, SCIENCE, V307, P423, DOI 10.1126/science.1105471; Axelrod JD, 2009, SEMIN CELL DEV BIOL, V20, P964, DOI 10.1016/j.semcdb.2009.08.001; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000628; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Cho E, 2004, DEVELOPMENT, V131, P4489, DOI 10.1242/dev.01315; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Classen Anne-Kathrin, 2008, V420, P265, DOI 10.1007/978-1-59745-583-1_16; Cortes S, 2006, BIOPHYS CHEM, V120, P168, DOI 10.1016/j.bpc.2005.11.002; Daga RR, 2008, J CELL SCI, V121, P1973, DOI 10.1242/jcs.011825; de Gennes P. G., 1993, PHYS LIQUID CRYSTALS; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Garoia F, 2005, MECH DEVELOP, V122, P175, DOI 10.1016/j.mod.2004.10.007; Garoia F, 2000, MECH DEVELOP, V94, P95, DOI 10.1016/S0925-4773(00)00306-3; Haase SB, 2007, CURR BIOL, V17, pR249, DOI 10.1016/j.cub.2007.02.003; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Joanny JF, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/422; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Le Garrec JF, 2006, DEV DYNAM, V235, P235, DOI 10.1002/dvdy.20617; Lopez-Schier H, 2004, DEV CELL, V7, P401, DOI 10.1016/j.devcel.2004.07.018; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Ma D, 2008, P NATL ACAD SCI USA, V105, P18800, DOI 10.1073/pnas.0808868105; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Strutt H, 2005, BIOESSAYS, V27, P1218, DOI 10.1002/bies.20318; Strutt H, 2002, DEV CELL, V3, P851, DOI 10.1016/S1534-5807(02)00363-5; Strutt H, 2008, CURR BIOL, V18, P1555, DOI 10.1016/j.cub.2008.08.063; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Uemura T, 2003, J BIOCHEM, V134, P625, DOI 10.1093/jb/mvg186; VILLANO JL, 1995, DEVELOPMENT, V121, P2767; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wu J, 2008, DEV CELL, V15, P462, DOI 10.1016/j.devcel.2008.08.004; Wu J, 2009, TRENDS CELL BIOL, V19, P295, DOI 10.1016/j.tcb.2009.04.003; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940	53	468	471	2	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 3	2010	142	5					773	786		10.1016/j.cell.2010.07.042	http://dx.doi.org/10.1016/j.cell.2010.07.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813263	Bronze			2022-12-24	WOS:000281523200020
J	Nowak, MA; Tarnita, CE; Wilson, EO				Nowak, Martin A.; Tarnita, Corina E.; Wilson, Edward O.			The evolution of eusociality	NATURE			English	Article							DIVISION-OF-LABOR; GROUP-SELECTION; KIN SELECTION; SOCIAL INTERACTIONS; INCLUSIVE FITNESS; COOPERATION; ALTRUISM; POLYMORPHISM; HYMENOPTERA; MULTILEVEL	Eusociality, in which some individuals reduce their own lifetime reproductive potential to raise the offspring of others, underlies the most advanced forms of social organization and the ecologically dominant role of social insects and humans. For the past four decades kin selection theory, based on the concept of inclusive fitness, has been the major theoretical attempt to explain the evolution of eusociality. Here we show the limitations of this approach. We argue that standard natural selection theory in the context of precise models of population structure represents a simpler and superior approach, allows the evaluation of multiple competing hypotheses, and provides an exact framework for interpreting empirical observations.	[Nowak, Martin A.; Tarnita, Corina E.] Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Wilson, Edward O.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	Harvard University; Harvard University	Nowak, MA (corresponding author), Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu	Chapuisat, Michel/T-8686-2017; Nowak, Martin A/A-6977-2008	Chapuisat, Michel/0000-0001-7207-199X; Alizon, Samuel/0000-0002-0779-9543	John Templeton Foundation; NSF/NIH [R01GM078986]; Bill and Melinda Gates Foundation [37874]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	John Templeton Foundation; NSF/NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. M. Horton for advice and help in preparing the manuscript. M.A.N. and C.E.T. gratefully acknowledge support from the John Templeton Foundation, the NSF/NIH joint program in mathematical biology (NIH grant R01GM078986), the Bill and Melinda Gates Foundation (Grand Challenges grant 37874), and J. Epstein.	Abouheif E, 2002, SCIENCE, V297, P249, DOI 10.1126/science.1071468; Antal T, 2009, P NATL ACAD SCI USA, V106, P8597, DOI 10.1073/pnas.0902528106; Bonabeau E, 1996, P ROY SOC B-BIOL SCI, V263, P1565, DOI 10.1098/rspb.1996.0229; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Cole BJ, 1999, SCIENCE, V285, P891, DOI 10.1126/science.285.5429.891; Costa J., 2006, OTHER INSECT SOC; Cowan D.P., 1991, P33; Doebeli M, 2006, J EVOLUTION BIOL, V19, P1386, DOI 10.1111/j.1420-9101.2006.01157.x; Duffy J. Emmett, 2007, P387; Fletcher JA, 2004, J THEOR BIOL, V228, P303, DOI 10.1016/j.jtbi.2004.01.004; Fletcher JA, 2006, TRENDS ECOL EVOL, V21, P597, DOI 10.1016/j.tree.2006.08.008; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Foster KR, 2005, TRENDS ECOL EVOL, V20, P363, DOI 10.1016/j.tree.2005.05.005; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; Gadagkar R, 2001, SOCIAL BIOL ROPALIDI; Grafen A, 2007, J EVOLUTION BIOL, V20, P2278, DOI 10.1111/j.1420-9101.2007.01413.x; Grafen A, 1984, BEHAV ECOLOGY EVOLUT, V2, P62; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Holldobler B., 1990, pi; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Hunt JH, 2007, P NATL ACAD SCI USA, V104, P14020, DOI 10.1073/pnas.0705660104; Hunt JH, 2005, SCIENCE, V308, P264, DOI 10.1126/science.1109724; Hunt JH, 2007, EVOLUTION SOCIAL WAS; Jeanson R, 2005, ANIM BEHAV, V70, P1183, DOI 10.1016/j.anbehav.2005.03.004; Johns PM, 2009, P NATL ACAD SCI USA, V106, P17452, DOI 10.1073/pnas.0907961106; Jones JC, 2004, SCIENCE, V305, P402, DOI 10.1126/science.1096340; Khila A, 2010, PHILOS T R SOC B, V365, P617, DOI 10.1098/rstb.2009.0257; Linksvayer TA, 2005, Q REV BIOL, V80, P317, DOI 10.1086/432266; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, P ROY SOC B-BIOL SCI, V273, P2249, DOI 10.1098/rspb.2006.3576; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pepper JW, 2002, AM NAT, V160, P205, DOI 10.1086/341018; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Rheindt FE, 2005, INSECT SOC, V52, P163, DOI 10.1007/s00040-004-0787-4; ROBINSON GE, 1989, WESTV STUD, P61; Ross KG, 1998, P NATL ACAD SCI USA, V95, P14232, DOI 10.1073/pnas.95.24.14232; ROUSSET F, 2004, GENETIC STRUCTURE SE; SAKAGAMI S. F., 1960, INSECTES SOCIAUX, V7, P57, DOI 10.1007/BF02225757; Sakagami S. F., 1987, Animal societies: theories and facts., P1; Schwander T, 2005, BEHAV ECOL SOCIOBIOL, V59, P215, DOI 10.1007/s00265-005-0027-6; Swenson W, 2000, P NATL ACAD SCI USA, V97, P9110, DOI 10.1073/pnas.150237597; Tarnita CE, 2009, J THEOR BIOL, V259, P570, DOI 10.1016/j.jtbi.2009.03.035; Tarnita CE, 2009, P NATL ACAD SCI USA, V106, P8601, DOI 10.1073/pnas.0903019106; Thorne BL, 2003, P NATL ACAD SCI USA, V100, P12808, DOI 10.1073/pnas.2133530100; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Traulsen A, 2006, P NATL ACAD SCI USA, V103, P10952, DOI 10.1073/pnas.0602530103; Traulsen A, 2010, EVOLUTION, V64, P316, DOI 10.1111/j.1558-5646.2009.00899.x; van Veelen M, 2009, J THEOR BIOL, V259, P589, DOI 10.1016/j.jtbi.2009.04.019; Wade MJ, 2010, NATURE, V463, pE8, DOI 10.1038/nature08809; WADE MJ, 1976, P NATL ACAD SCI USA, V73, P4604, DOI 10.1073/pnas.73.12.4604; Wcislo WT, 1997, INSECT SOC, V44, P199, DOI 10.1007/s000400050041; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; West-Eberhard Mary Jane, 2003, pi; Wilson DS, 2008, AM SCI, V96, P380, DOI 10.1511/2008.74.1; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wilson E.O., 1975, P1; Wilson E.O., 1971, INSECT SOC; Wilson EO, 2008, BIOSCIENCE, V58, P17, DOI 10.1641/B580106; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; Wolf JB, 2001, J EVOLUTION BIOL, V14, P347, DOI 10.1046/j.1420-9101.2001.00277.x	61	666	694	7	1043	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1057	1062		10.1038/nature09205	http://dx.doi.org/10.1038/nature09205			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20740005	Green Accepted			2022-12-24	WOS:000281203600030
J	Terkelsen, CJ; Sorensen, JT; Maeng, M; Jensen, LO; Tilsted, HH; Trautner, S; Vach, W; Johnsen, SP; Thuesen, L; Lassen, JF				Terkelsen, Christian Juhl; Sorensen, Jacob Thorsted; Maeng, Michael; Jensen, Lisette Okkels; Tilsted, Hans-Henrik; Trautner, Sven; Vach, Werner; Johnsen, Soren Paaske; Thuesen, Leif; Lassen, Jens Flensted			System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; TO-BALLOON TIME; REPERFUSION THERAPY; PRIMARY ANGIOPLASTY; PRIMARY PCI; ASSOCIATION; SURVIVAL; IMPACT; MATTER; SIZE	Context Timely reperfusion therapy is recommended for patients with ST-segment elevation myocardial infarction (STEMI), and door-to-balloon delay has been proposed as a performance measure in triaging patients for primary percutaneous coronary intervention (PCI). However, focusing on the time from first contact with the health care system to the initiation of reperfusion therapy (system delay) may be more relevant, because it constitutes the total time to reperfusion modifiable by the health care system. No previous studies have focused on the association between system delay and outcome in patients with STEMI treated with primary PCI. Objective To evaluate the associations between system, treatment, patient, and door-to-balloon delays and mortality in patients with STEMI. Design, Setting, and Patients Historical follow-up study based on population-based Danish medical registries of patients with STEMI transported by the emergency medical service and treated with primary PCI from January 1, 2002, to December 31, 2008, at 3 high-volume PCI centers in Western Denmark. Patients (N=6209) underwent primary PCI within 12 hours of symptom onset. The median follow-up time was 3.4 (interquartile range, 1.8-5.2) years. Main Outcome Measures Crude and adjusted hazard ratios of mortality obtained by Cox proportional regression analysis. Results A system delay of 0 through 60 minutes (n=347) corresponded to a long-term mortality rate of 15.4% (n=43); a delay of 61 through 120 minutes (n=2643) to a rate of 23.3% (n=380); a delay of 121 through 180 minutes (n=2092) to a rate of 28.1% (n=378); and a delay of 181 through 360 minutes (n=1127) to a rate of 30.8% (n=275) (P<.001). In multivariable analysis adjusted for other predictors of mortality, system delay was independently associated with mortality (adjusted hazard ratio, 1.10 [95% confidence interval, 1.04-1.16] per 1-hour delay), as was its components, prehospital system delay and door-to-balloon delay. Conclusion System delay was associated with mortality in patients with STEMI treated with primary PCI. JAMA. 2010;304(7):763-771 www.jama.com	[Terkelsen, Christian Juhl; Sorensen, Jacob Thorsted; Maeng, Michael; Thuesen, Leif; Lassen, Jens Flensted] Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark; [Johnsen, Soren Paaske] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark; [Jensen, Lisette Okkels] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark; [Tilsted, Hans-Henrik] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Trautner, Sven] Falck Emergency Med Serv, Copenhagen, Denmark; [Vach, Werner] Univ Med Ctr, Dept Clin Epidemiol, Freiburg, Germany	Aarhus University; Aarhus University; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital; University of Freiburg	Terkelsen, CJ (corresponding author), Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark.	christian_juhl_terkelsen@hotmail.com	Lassen, Jens Flensted/AAY-2127-2021; terkelsen, christian/ABD-6294-2021; Vach, Werner/F-2512-2011; Maeng, Michael/AAY-2135-2021	Lassen, Jens Flensted/0000-0001-7972-9192; Vach, Werner/0000-0003-1865-8399; Maeng, Michael/0000-0002-4310-6433; terkelsen, christian juhl/0000-0003-0205-9551; Jensen, Lisette Okkels/0000-0002-4838-2429	Helga and Peter Kornings Foundation, Aarhus, Denmark [40-134918]; Central Denmark Region, Aarhus, Denmark [1-45-72-1-08]	Helga and Peter Kornings Foundation, Aarhus, Denmark; Central Denmark Region, Aarhus, Denmark	This study was supported by grants from the Helga and Peter Kornings Foundation, Aarhus, Denmark (J.No. 40-134918) and the Health Research Fund of Central Denmark Region, Aarhus, Denmark (J.No. 1-45-72-1-08).	Allison PD, 2002, MISSING DATA; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Aquaro GD, 2007, AM J CARDIOL, V100, P28, DOI 10.1016/j.amjcard.2007.02.050; Arntz HR, 1998, EUR HEART J, V19, P1140; Blohm MB, 1996, HEART, V76, P430, DOI 10.1136/hrt.76.5.430; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Bradley EH, 2009, J AM COLL CARDIOL, V54, P2423, DOI 10.1016/j.jacc.2009.11.003; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Brodie BR, 2001, AM J CARDIOL, V88, P1085, DOI 10.1016/S0002-9149(01)02039-2; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hedges JR, 2000, ACAD EMERG MED, V7, P862, DOI 10.1111/j.1553-2712.2000.tb02063.x; Le May MR, 2008, NEW ENGL J MED, V358, P231, DOI 10.1056/NEJMoa073102; LEIZOROVICZ A, 1993, NEW ENGL J MED, V329, P383; LOWEL H, 1991, DEUT MED WOCHENSCHR, V116, P729, DOI 10.1055/s-2008-1063671; McNamara RL, 2006, J AM COLL CARDIOL, V47, P45, DOI 10.1016/j.jacc.2005.04.071; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Nallamothu BK, 2007, NEW ENGL J MED, V357, P1631, DOI 10.1056/NEJMra065985; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; Schemper M, 1997, STAT MED, V16, P73; SCHEMPER M, 1990, STAT MED, V9, P777, DOI 10.1002/sim.4780090707; Sorensen H T, 1997, Int J Risk Saf Med, V10, P1, DOI 10.3233/JRS-1997-10101; Terkelsen CJ, 2009, HEART, V95, P362, DOI 10.1136/hrt.2007.139493; Terkelsen CJ, 2008, J AM COLL CARDIOL, V52, P1211, DOI 10.1016/j.jacc.2008.05.061; Terkelsen CJ, 2009, J ELECTROCARDIOL, V42, P64, DOI 10.1016/j.jelectrocard.2008.08.038; Terkelsen CJ, 2005, EUR HEART J, V26, P770, DOI 10.1093/eurheartj/ehi100; VACH W, 1993, BIOMETRIKA, V80, P353, DOI 10.2307/2337205; Zijistra F, 2002, EUR HEART J, V23, P550, DOI 10.1053/euhj.2001.2901	34	444	464	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2010	304	7					763	771		10.1001/jama.2010.1139	http://dx.doi.org/10.1001/jama.2010.1139			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639SB	20716739				2022-12-24	WOS:000280993700023
J	Jensen, RB; Carreira, A; Kowalczykowski, SC				Jensen, Ryan B.; Carreira, Aura; Kowalczykowski, Stephen C.			Purified human BRCA2 stimulates RAD51-mediated recombination	NATURE			English	Article							REPLICATION PROTEIN-A; DNA STRAND EXCHANGE; HUMAN RAD51 PROTEIN; SUSCEPTIBILITY GENE BRCA2; HOMOLOGY-DIRECTED REPAIR; RADIATION HYPERSENSITIVITY; NUCLEOPROTEIN FILAMENTS; BINDING SELECTIVITY; COMPLEX-FORMATION; RECA PROTEIN	Mutation of the breast cancer susceptibility gene, BRCA2, leads to breast and ovarian cancers. Mechanistic insight into the functions of human BRCA2 has been limited by the difficulty of isolating this large protein (3,418 amino acids). Here we report the purification of full-length BRCA2 and show that it both binds RAD51 and potentiates recombinational DNA repair by promoting assembly of RAD51 onto single-stranded DNA (ssDNA). BRCA2 acts by targeting RAD51 to ssDNA over double-stranded DNA, enabling RAD51 to displace replication protein-A (RPA) from ssDNA and stabilizing RAD51-ssDNA filaments by blocking ATP hydrolysis. BRCA2 does not anneal ssDNA complexed with RPA, implying it does not directly function in repair processes that involve ssDNA annealing. Our findings show that BRCA2 is a key mediator of homologous recombination, and they provide a molecular basis for understanding how this DNA repair process is disrupted by BRCA2 mutations, which lead to chromosomal instability and cancer.	[Jensen, Ryan B.; Carreira, Aura; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Jensen, Ryan B.; Carreira, Aura; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu		Carreira, Aura/0000-0001-5489-4343	NIH [NIH GM 62653]; DOD [BC085223]; American Cancer Society [PF-05-225-01-GMC]; Ministerio de Educacion y Ciencia (Spain); American Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062653, R37GM062653] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); American Cancer Society(American Cancer Society); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Shin for BRCA2 cDNA clones; M. Zdzienicka for VC8 cells; A. Mazin for RAD52; A. Nimonkar for DMC1; W. Heyer and Kowalczykowski laboratory for comments. Supported by grants from NIH (NIH GM 62653) and DOD-Breast Cancer Research Program (BC085223) to S.C.K., American Cancer Society Postdoctoral Fellowship to R.B.J. (PF-05-225-01-GMC), and Postdoctoral Fellowship from Ministerio de Educacion y Ciencia (Spain) to A.C.; R.B.J. acknowledges financial support from C. Hornung, who funded this work through the American Cancer Society and who passed away last year.	Baumann P, 1999, J MOL BIOL, V291, P363, DOI 10.1006/jmbi.1999.2954; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Bianco P. R., 1998, FRONT BIOSCI, V3, pD570; Bignell G, 1997, HUM MOL GENET, V6, P53, DOI 10.1093/hmg/6.1.53; Carreira A, 2009, CELL CYCLE, V8, P3445, DOI 10.4161/cc.8.21.9748; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Chen CF, 1999, J BIOL CHEM, V274, P32931, DOI 10.1074/jbc.274.46.32931; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Godthelp BC, 2002, ONCOGENE, V21, P5002, DOI 10.1038/sj.onc.1205656; Hartley CL, 2008, MOL MICROBIOL, V68, P1237, DOI 10.1111/j.1365-2958.2008.06230.x; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; LEBOWITZ JH, 1985, THESIS J HOPKINS U; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; LIU J, NATURE STRU IN PRESS; Lomonosov M, 2003, GENE DEV, V17, P3017, DOI 10.1101/gad.279003; Marmorstein LY, 1998, P NATL ACAD SCI USA, V95, P13869, DOI 10.1073/pnas.95.23.13869; Mazloum N, 2007, BIOCHEMISTRY-US, V46, P7163, DOI 10.1021/bi700399m; McIlwraith MJ, 2000, J MOL BIOL, V304, P151, DOI 10.1006/jmbi.2000.4180; Mine J, 2007, NUCLEIC ACIDS RES, V35, P7171, DOI 10.1093/nar/gkm752; Mirshad JK, 2003, BIOCHEMISTRY-US, V42, P5945, DOI 10.1021/bi027233i; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Petalcorin MIR, 2006, J MOL BIOL, V361, P231, DOI 10.1016/j.jmb.2006.06.020; Phelan CM, 1996, NAT GENET, V13, P120, DOI 10.1038/ng0596-120; Saeki H, 2006, P NATL ACAD SCI USA, V103, P8768, DOI 10.1073/pnas.0600298103; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Thorslund T, 2007, EMBO J, V26, P2915, DOI 10.1038/sj.emboj.7601739; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; van der Heijden T, 2007, NUCLEIC ACIDS RES, V35, P5646, DOI 10.1093/nar/gkm629; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; Wong JMS, 2003, ONCOGENE, V22, P28, DOI 10.1038/sj.onc.1206071; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; YOSHIMURA Y, 1993, NUCLEIC ACIDS RES, V21, P1665, DOI 10.1093/nar/21.7.1665; Yu VPCC, 2000, GENE DEV, V14, P1400; Yuan SSF, 1999, CANCER RES, V59, P3547; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907	53	447	458	0	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					678	U62		10.1038/nature09399	http://dx.doi.org/10.1038/nature09399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20729832	Green Accepted, Green Submitted			2022-12-24	WOS:000282572500031
J	Choate, KA; Lu, Y; Zhou, J; Choi, M; Elias, PM; Farhi, A; Nelson-Williams, C; Crumrine, D; Williams, ML; Nopper, AJ; Bree, A; Milstone, LM; Lifton, RP				Choate, Keith A.; Lu, Yin; Zhou, Jing; Choi, Murim; Elias, Peter M.; Farhi, Anita; Nelson-Williams, Carol; Crumrine, Debra; Williams, Mary L.; Nopper, Amy J.; Bree, Alanna; Milstone, Leonard M.; Lifton, Richard P.			Mitotic Recombination in Patients with Ichthyosis Causes Reversion of Dominant Mutations in KRT10	SCIENCE			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; REVERTANT MOSAICISM; STEM-CELLS; INTERMEDIATE FILAMENTS; HUMAN EPIDERMIS; KERATIN-10; RNA; RETINOBLASTOMA; ERYTHRODERMA; MECHANISM	Somatic loss of wild-type alleles can produce disease traits such as neoplasia. Conversely, somatic loss of disease-causing mutations can revert phenotypes; however, these events are infrequently observed. Here we show that ichthyosis with confetti, a severe, sporadic skin disease in humans, is associated with thousands of revertant clones of normal skin that arise from loss of heterozygosity on chromosome 17q via mitotic recombination. This allowed us to map and identify disease-causing mutations in the gene encoding keratin 10 (KRT10); all result in frameshifts into the same alternative reading frame, producing an arginine-rich C-terminal peptide that redirects keratin 10 from the cytokeratin filament network to the nucleolus. The high frequency of somatic reversion in ichthyosis with confetti suggests that revertant stem cell clones are under strong positive selection and/or that the rate of mitotic recombination is elevated in individuals with this disorder.	[Choate, Keith A.; Lu, Yin; Choi, Murim; Farhi, Anita; Nelson-Williams, Carol; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Choate, Keith A.; Zhou, Jing; Milstone, Leonard M.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Elias, Peter M.; Crumrine, Debra; Williams, Mary L.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94122 USA; [Nopper, Amy J.] Childrens Mercy Hosp & Clin, Kansas City, MO 64108 USA; [Bree, Alanna] Texas Childrens Hosp, Houston, TX 77030 USA	Howard Hughes Medical Institute; Yale University; Yale University; University of California System; University of California San Francisco; Children's Mercy Hospital; Baylor College of Medicine	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA.	richard.lifton@yale.edu	Choi, Murim/AAP-9120-2021		NIAMS; Foundation for Ichthyosis and Related Skin Types; National Center for Research Resources; Yale Clinical and Translational Science Award; Yale Center for Human Genetics and Genomics; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR056305, T32AR007016] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Foundation for Ichthyosis and Related Skin Types; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Yale Clinical and Translational Science Award; Yale Center for Human Genetics and Genomics; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the patients studied and their families for their invaluable contributions to this study. We thank L. Boyden and S. Baserga for helpful discussions; N. DeSilva, S. Mane, and the Yale Center for Genome Analysis for assistance in development of critical methodologies; and M. Ceneri for the identification of a previously unreported IWC kindred. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH, and the Yale Skin Diseases Research Center provided cell culture support for this work. K. A. C. is supported by a K08 award from NIAMS and a fellowship from the Foundation for Ichthyosis and Related Skin Types. Supported in part by a National Center for Research Resources High-End Instrumentation Grant, the Yale Clinical and Translational Science Award, and the Yale Center for Human Genetics and Genomics. R. P. L. is an investigator of the Howard Hughes Medical Institute.	Almaani N, 2010, J INVEST DERMATOL, V130, P1937, DOI 10.1038/jid.2010.64; BRUSASCO A, 1994, DERMATOLOGY, V188, P40, DOI 10.1159/000247084; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; CAMENZIND M, 1984, ANN DERMATOL VENER, V111, P675; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Chen JL, 2006, J CELL SCI, V119, P5067, DOI 10.1242/jcs.03298; Darling TN, 1999, J CLIN INVEST, V103, P1371, DOI 10.1172/JCI4338; Davis BR, 2009, IMMUNOL RES, V44, P127, DOI 10.1007/s12026-008-8091-4; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; ELLIS NA, 1995, AM J HUM GENET, V57, P1019; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; Hirschhorn R, 2003, J MED GENET, V40, P721, DOI 10.1136/jmg.40.10.721; Jensen UB, 1999, DEVELOPMENT, V126, P2409; Jonkman MF, 1997, CELL, V88, P543, DOI 10.1016/S0092-8674(00)81894-2; Kalb R, 2006, GENOME DYN, V1, P218, DOI 10.1159/000092510; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kocer SS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-359; MARGHESCU S, 1984, HAUTARZT, V35, P522; O'Keefe C, 2010, BLOOD, V115, P2731, DOI 10.1182/blood-2009-10-201848; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Pasmooij AMG, 2005, AM J HUM GENET, V77, P727, DOI 10.1086/497344; Pasmooij AMG, 2007, J CLIN INVEST, V117, P1240, DOI 10.1172/JCI30465; ROTHNAGEL JA, 1992, SCIENCE, V257, P1128, DOI 10.1126/science.257.5073.1128; Schuilenga-Hut PHL, 2002, J INVEST DERMATOL, V118, P626, DOI 10.1046/j.1523-1747.2002.01715.x; Shen J, 2006, GENE THER, V13, P225, DOI 10.1038/sj.gt.3302641; Smith FJD, 2004, J INVEST DERMATOL, V122, P73, DOI 10.1046/j.0022-202X.2003.22129.x; STEINERT PM, 1991, J STRUCT BIOL, V107, P175, DOI 10.1016/1047-8477(91)90020-W; STEINERT PM, 1990, J BIOL CHEM, V265, P8766; Sugaya M, 2008, J PEPT SCI, V14, P924, DOI 10.1002/psc.1027; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; ZHOU XM, 1988, J BIOL CHEM, V263, P15584	32	126	129	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					94	97		10.1126/science.1192280	http://dx.doi.org/10.1126/science.1192280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20798280	Green Accepted			2022-12-24	WOS:000282334500043
J	Elliott, MR; Zheng, SQ; Park, D; Woodson, RI; Reardon, MA; Juncadella, IJ; Kinchen, JM; Zhang, J; Lysiak, JJ; Ravichandran, KS				Elliott, Michael R.; Zheng, Shuqiu; Park, Daeho; Woodson, Robin I.; Reardon, Michael A.; Juncadella, Ignacio J.; Kinchen, Jason M.; Zhang, Jun; Lysiak, Jeffrey J.; Ravichandran, Kodi S.			Unexpected requirement for ELMO1 in clearance of apoptotic germ cells in vivo	NATURE			English	Article							CRKII/DOCK180/RAC PATHWAY; SCAVENGER RECEPTOR; SERTOLI-CELLS; PH DOMAIN; PHAGOCYTOSIS; ELEGANS; CORPSE; ISCHEMIA/REPERFUSION; ACTIVATION; ENGULFMENT	Apoptosis and the subsequent clearance of dying cells occurs throughout development and adult life in many tissues. Failure to promptly clear apoptotic cells has been linked to many diseases(1-3). ELMO1 is an evolutionarily conserved cytoplasmic engulfment protein that functions downstream of the phosphatidylserine receptor BAI1, and, along with DOCK1 and the GTPase RAC1, promotes internalization of the dying cells(4-7). Here we report the generation of ELMO1-deficient mice, which we found to be unexpectedly viable and grossly normal. However, they had a striking testicular pathology, with disrupted seminiferous epithelium, multinucleated giant cells, uncleared apoptotic germ cells and decreased sperm output. Subsequent in vitro and in vivo analyses revealed a crucial role for ELMO1 in the phagocytic clearance of apoptotic germ cells by Sertoli cells lining the seminiferous epithelium. The engulfment receptor BAI1 and RAC1 (upstream and downstream of ELMO1, respectively) were also important for Sertoli-cell-mediated engulfment. Collectively, these findings uncover a selective requirement for ELMO1 in Sertoli-cell-mediated removal of apoptotic germ cells and make a compelling case for a relationship between engulfment and tissue homeostasis in vivo.	[Elliott, Michael R.; Park, Daeho; Juncadella, Ignacio J.; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Elliott, Michael R.; Park, Daeho; Juncadella, Ignacio J.; Kinchen, Jason M.; Lysiak, Jeffrey J.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Zheng, Shuqiu; Woodson, Robin I.; Reardon, Michael A.; Zhang, Jun; Lysiak, Jeffrey J.] Univ Virginia, Dept Urol, Charlottesville, VA 22908 USA; [Kinchen, Jason M.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	jl6n@virginia.edu; ravi@virginia.edu	Kinchen, Jason/ABC-5663-2021; Reardon, Michael/ABF-8880-2021	Kinchen, Jason/0000-0001-8430-2265; Elliott, Michael/0000-0002-0642-482X; Ravichandran, Kodi/0000-0001-9049-1410; Zhang, Jun/0000-0002-3339-0346	National Institutes of Health; American Cancer Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD057242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Turner, K. Tung and members of the Ravichandran and Lysiak groups for suggestions. We also thank L. Haney, A. C. Tosello-Trampont, J. Kim and S. Clugston for technical assistance. This work was supported by funding from the National Institutes of Health (to K.S.R. and J.J.L.) and the American Cancer Society (to M.R.E.). K.S.R. is a Bill Benter fellow of the American Asthma Foundation.	A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Akakura S, 2004, EXP CELL RES, V292, P403, DOI 10.1016/j.yexcr.2003.09.011; Bailey RW, 2002, BIOL REPROD, V66, P1042, DOI 10.1095/biolreprod66.4.1042; Braun RE, 1998, NAT GENET, V18, P202, DOI 10.1038/ng0398-202; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Chen YM, 2009, REPRODUCTION, V138, P655, DOI 10.1530/REP-09-0101; Cool J, 2009, SEMIN REPROD MED, V27, P5, DOI 10.1055/s-0028-1108005; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Gillot I, 2005, J CELL SCI, V118, P3027, DOI 10.1242/jcs.02430; Gregory Christopher D., 2009, P271, DOI 10.1007/978-1-4020-9293-0_9; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Henson PM, 2005, NAT IMMUNOL, V6, P1179, DOI 10.1038/ni1205-1179; Holdcraft RW, 2004, DEVELOPMENT, V131, P459, DOI 10.1242/dev.00957; HOLSTEIN AF, 1986, ANDROLOGIA, V18, P5; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Loveland KL, 2005, ANN NY ACAD SCI, V1061, P173, DOI 10.1196/annals.1336.018; Lu MJ, 2004, NAT STRUCT MOL BIOL, V11, P756, DOI 10.1038/nsmb800; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lysiak JJ, 2007, CELL TISSUE RES, V328, P411, DOI 10.1007/s00441-006-0341-y; Lysiak JJ, 2000, BIOL REPROD, V63, P1465, DOI 10.1095/biolreprod63.5.1465; Lysiak JJ, 2001, BIOL REPROD, V65, P718, DOI 10.1095/biolreprod65.3.718; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Park SY, 2008, CELL DEATH DIFFER, V15, P192, DOI 10.1038/sj.cdd.4402242; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Shiratsuchi A, 1999, J BIOL CHEM, V274, P5901, DOI 10.1074/jbc.274.9.5901; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Wu YC, 2001, DEV CELL, V1, P491, DOI 10.1016/S1534-5807(01)00056-9; Xiong W, 2008, REPRODUCTION, V135, P77, DOI 10.1530/REP-07-0287; Zhou Z, 2004, CURR TOP DEV BIOL, V63, P91, DOI 10.1016/S0070-2153(04)63004-3; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	37	113	113	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2010	467	7313					333	U114		10.1038/nature09356	http://dx.doi.org/10.1038/nature09356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20844538	Green Accepted			2022-12-24	WOS:000281824900040
J	Chen, M; Schliep, M; Willows, RD; Cai, ZL; Neilan, BA; Scheer, H				Chen, Min; Schliep, Martin; Willows, Robert D.; Cai, Zheng-Li; Neilan, Brett A.; Scheer, Hugo			A Red-Shifted Chlorophyll	SCIENCE			English	Article								Chlorophylls are essential for light-harvesting and energy transduction in photosynthesis. Four chemically distinct varieties have been known for the past 60 years. Here we report isolation of a fifth, which we designate chlorophyll f. Its in vitro absorption (706 nanometers) and fluorescence (722 nanometers) maxima are red-shifted compared to all other chlorophylls from oxygenic phototrophs. On the basis of the optical, mass, and nuclear magnetic resonance spectra, we propose that chlorophyll f is [2-formyl]-chlorophyll a (C55H70O6N4Mg). This finding suggests that oxygenic photosynthesis can be extended further into the infrared region and may open associated bioenergy applications.	[Chen, Min; Schliep, Martin; Scheer, Hugo] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Willows, Robert D.] Macquarie Univ, Dept Chem & Biomol Sci, N Ryde, NSW 2109, Australia; [Cai, Zheng-Li] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Neilan, Brett A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Scheer, Hugo] Univ Munich, Dept Biol 1, D-80638 Munich, Germany	University of Sydney; Macquarie University; University of Sydney; University of New South Wales Sydney; University of Munich	Chen, M (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	min.chen@sydney.edu.au	Neilan, Brett A/I-5767-2012; Willows, Robert/C-1537-2010	Neilan, Brett A/0000-0001-6113-772X; Willows, Robert/0000-0002-0731-2950; Chen, Min/0000-0001-8070-3248	Macquarie University; ARC; National Health and Medical Research Council (NHMRC)	Macquarie University; ARC(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	M.C. and B.A.N. hold Australian Research Council (ARC) fellowships and associated financial support. M.C. thanks K. Donohoe (University of Sydney) for assistance with polymerase chain reactions. M. C. and M. S. thank B. Crossett (University of Sydney) for mass spectral analysis. M.C. and H.S. thank A. Kwan and J. Mackay (University of Sydney) for NMR spectral analysis and A. W. D. Larkum (University of Sydney) for valuable discussions and continued support. R.D.W. acknowledges support from Macquarie University Strategic Infrastructure Scheme and Research and Development Scheme grants and the ARC and National Health and Medical Research Council (NHMRC) fluorescent applications for biotechnology in life sciences network for use of the Leica confocal imaging system. R.D.W. and M.C. thank D. Birch (Macquarie University) for help with the Olympus confocal imaging. Z.-L.C. thanks J. Reimers (University of Sydney) for supercomputer access. The 16S rRNA sequence has been deposited in GenBank under accession number 1370306.	Allen M.B., 1966, CHLOROPHYLLS, P511; Bjorn L, 2009, PHOTOSYNTH RES, V99, P85, DOI 10.1007/s11120-008-9395-x; Falk J. E., 1975, PORPHYRNS MET, P399; Holt A.S., 1966, CHLOROPHYLLS, P111; Kuhl Michael, 2007, V11, P101; Manning WM, 1943, J BIOL CHEM, V151, P1; MEEKS JC, 1974, ALGAL PHYSL BIOCH, V10, P161; Miyashita H, 1996, NATURE, V383, P402, DOI 10.1038/383402a0; Nieuwenburg P, 2003, PHOTOCHEM PHOTOBIOL, V77, P628, DOI 10.1562/0031-8655(2003)077<0628:EOTPPO>2.0.CO;2; Reid RP, 2000, NATURE, V406, P989, DOI 10.1038/35023158; Scheer Hugo, 2006, V25, P1; Strain H.H., 1951, MANUAL PHYCOLOGY, P243; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719	13	333	345	8	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2010	329	5997					1318	1319		10.1126/science.1191127	http://dx.doi.org/10.1126/science.1191127			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20724585				2022-12-24	WOS:000281657300031
J	Chao, MP; Alizadeh, AA; Tang, C; Myklebust, JH; Varghese, B; Gill, S; Jan, M; Cha, AC; Chan, CK; Tan, BT; Park, CY; Zhao, FF; Kohrt, HE; Malumbres, R; Briones, J; Gascoyne, RD; Lossos, IS; Levy, R; Weissman, IL; Majeti, R				Chao, Mark P.; Alizadeh, Ash A.; Tang, Chad; Myklebust, June H.; Varghese, Bindu; Gill, Saar; Jan, Max; Cha, Adriel C.; Chan, Charles K.; Tan, Brent T.; Park, Christopher Y.; Zhao, Feifei; Kohrt, Holbrook E.; Malumbres, Raquel; Briones, Javier; Gascoyne, Randy D.; Lossos, Izidore S.; Levy, Ronald; Weissman, Irving L.; Majeti, Ravindra			Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma	CELL			English	Article							B-CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; DRUG-COMBINATION; CD20 EXPRESSION; CD47; THERAPY; MECHANISMS	Monoclonal antibodies are standard therapeutics for several cancers including the anti-CD20 antibody rituximab for B cell non-Hodgkin lymphoma (NHL). Rituximab and other antibodies are not curative and must be combined with cytotoxic chemotherapy for clinical benefit. Here we report the eradication of human NHL solely with a monoclonal antibody therapy combining rituximab with a blocking anti-CD47 antibody. We identified increased expression of CD47 on human NHL cells and determined that higher CD47 expression independently predicted adverse clinical outcomes in multiple NHL subtypes. Blocking anti-CD47 antibodies preferentially enabled phagocytosis of NHL cells and synergized with rituximab. Treatment of human NHL-engrafted mice with anti-CD47 antibody reduced lymphoma burden and improved survival, while combination treatment with rituximab led to elimination of lymphoma and cure. These antibodies synergized through a mechanism combining Fc receptor (FcR)-dependent and FcR-independent stimulation of phagocytosis that might be applicable to many other cancers.	[Chao, Mark P.; Alizadeh, Ash A.; Tang, Chad; Jan, Max; Cha, Adriel C.; Chan, Charles K.; Park, Christopher Y.; Zhao, Feifei; Weissman, Irving L.; Majeti, Ravindra] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford Canc Ctr, Palo Alto, CA 94304 USA; [Chao, Mark P.; Alizadeh, Ash A.; Tang, Chad; Jan, Max; Cha, Adriel C.; Chan, Charles K.; Park, Christopher Y.; Zhao, Feifei; Weissman, Irving L.; Majeti, Ravindra] Stanford Univ, Ludwig Ctr Stanford, Palo Alto, CA 94304 USA; [Alizadeh, Ash A.; Kohrt, Holbrook E.; Majeti, Ravindra] Stanford Univ, Dept Internal Med, Div Hematol, Palo Alto, CA 94304 USA; [Alizadeh, Ash A.; Myklebust, June H.; Varghese, Bindu; Kohrt, Holbrook E.; Levy, Ronald] Stanford Univ, Div Oncol, Palo Alto, CA 94304 USA; [Tan, Brent T.; Park, Christopher Y.; Weissman, Irving L.] Stanford Univ, Dept Pathol, Palo Alto, CA 94304 USA; [Gill, Saar] Stanford Univ, Div Blood & Bone Marrow Transplantat, Palo Alto, CA 94304 USA; [Malumbres, Raquel; Lossos, Izidore S.] Univ Miami, Miller Sch Med, Div Hematol Oncol, Dept Med, Miami, FL 33136 USA; [Briones, Javier] Autonomous Univ Barcelona, Hosp Santa Creu & St Pau, Dept Hematol, E-08193 Barcelona, Spain; [Gascoyne, Randy D.] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC V5Z 1L3, Canada; [Myklebust, June H.] Univ Oslo, Inst Canc Res, Dept Immunol, Oslo Univ Hosp,Ctr Canc Biomed, N-0310 Oslo, Norway	Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Miami; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; British Columbia Cancer Agency; University of Oslo	Chao, MP (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford Canc Ctr, Palo Alto, CA 94304 USA.	mpchao@stanford.edu	Myklebust, June Helen/ABH-6494-2020; Alizadeh, Ash A/C-5594-2009; Malumbres, Raquel/N-3745-2014	Myklebust, June Helen/0000-0003-0394-9986; Alizadeh, Ash A/0000-0002-5153-5625; Malumbres, Raquel/0000-0003-0767-9442; Majeti, Ravindra/0000-0002-5814-0984; Briones Meijide, Javier/0000-0003-2750-3735; Tan, Brent/0000-0001-7375-6878; Levy, Ronald/0000-0003-2061-0650	HHMI; Stanford Cancer Biology Program; NIH [HL007970, CA122105, P01CA139490]; Fundacion Caja Madrid; AACR; Burroughs Wellcome Fund; Smith Family Fund; NATIONAL CANCER INSTITUTE [P01CA139490, R01CA122105, T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007970, R01HL058770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961, T32AI007290] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Stanford Cancer Biology Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion Caja Madrid; AACR; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Smith Family Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge Dr. Christopher Contag for providing luciferase constructs, Dr. Robert Negrin for assistance, Dr. Yaso Natkunam for immunohistochemistry, Libuse Jerabek and Theresa Storm for lab management, and Adriane Mosely for animal husbandry. We also acknowledge the patients and surgeons including Drs. Wapnir, Chang, Cheng, Janisiewicz, Koltai, Liebowitz, and Messner for providing research specimens. M.P.C. is supported by the HHMI and the Stanford Cancer Biology Program, A.A.A. by an NIH T32 Ruth L. Kirschstein National Research Service Award (HL007970), R. Malumbres by a fellowship from Fundacion Caja Madrid, I.S.L. by NIH grant CA122105, and R. Majeti by a grant from the AACR. R. Majeti holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. I.L.W., M.P.C., A.A.A., and R. Majeti have filed U.S. Patent Application Serial No. 12/321,215 entitled "Methods For Manipulating Phagocytosis Mediated by CD47.'' This research is supported by NIH grant P01CA139490 to I.L.W. and funding from the Smith Family Fund.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Cheson BD, 2008, NEW ENGL J MED, V359, P613, DOI 10.1056/NEJMra0708875; Chou TC, 2008, LEUKEMIA LYMPHOMA, V49, P2059, DOI 10.1080/10428190802353591; Daniel D, 2007, BLOOD, V110, P4037, DOI 10.1182/blood-2007-02-076075; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Foran JM, 2001, BRIT J HAEMATOL, V114, P881, DOI 10.1046/j.1365-2141.2001.03019.x; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Hiraga J, 2009, BLOOD, V113, P4885, DOI 10.1182/blood-2008-08-175208; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kennedy AD, 2004, J IMMUNOL, V172, P3280, DOI 10.4049/jimmunol.172.5.3280; Kikuchi Y, 2005, LEUKEMIA RES, V29, P445, DOI 10.1016/j.leukres.2004.09.005; Kikuchi Y, 2004, BIOCHEM BIOPH RES CO, V315, P912, DOI 10.1016/j.bbrc.2004.01.128; Kim MJ, 2008, TUMOR BIOL, V29, P28, DOI 10.1159/000132568; Leonard JP, 2007, ANN ONCOL, V18, P1216, DOI 10.1093/annonc/mdm114; Leonard JP, 2008, CANCER-AM CANCER SOC, V113, P2714, DOI 10.1002/cncr.23890; Leonard JP, 2005, J CLIN ONCOL, V23, P5044, DOI 10.1200/JCO.2005.13.821; Maddipatla S, 2007, CLIN CANCER RES, V13, P4556, DOI 10.1158/1078-0432.CCR-07-0680; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mateo V, 1999, NAT MED, V5, P1277, DOI 10.1038/15233; Milush JM, 2009, BLOOD, V114, P4823, DOI 10.1182/blood-2009-04-216374; Nimmerjahn F, 2007, CURR OPIN IMMUNOL, V19, P239, DOI 10.1016/j.coi.2007.01.005; Oscier DG, 2002, BLOOD, V100, P1177, DOI 10.1182/blood.V100.4.1177.h81602001177_1177_1184; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Smith MR, 2003, ONCOGENE, V22, P7359, DOI 10.1038/sj.onc.1206939; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Taylor RP, 2008, CURR OPIN IMMUNOL, V20, P444, DOI 10.1016/j.coi.2008.05.011; Uno S, 2007, ONCOL REP, V17, P1189	37	712	790	2	105	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 3	2010	142	5					699	713		10.1016/j.cell.2010.07.044	http://dx.doi.org/10.1016/j.cell.2010.07.044			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813259	Green Accepted, Bronze			2022-12-24	WOS:000281523200014
J	Grunwald, D; Singer, RH				Grunwald, David; Singer, Robert H.			In vivo imaging of labelled endogenous beta-actin mRNA during nucleocytoplasmic transport	NATURE			English	Article							NUCLEAR-PORE COMPLEX; CRYOELECTRON TOMOGRAPHY; AMPHIBIAN OOCYTES; SINGLE-MOLECULE; MYOSIN-V; EXPORT; TRANSLOCATION; ARCHITECTURE; ENVELOPE; PROTEIN	Export of messenger RNA occurs via nuclear pores, which are large nanomachines with diameters of roughly 120 nm that are the only link between the nucleus and cytoplasm(1). Hence, mRNA export occurs over distances smaller than the optical resolution of conventional light microscopes. There is extensive knowledge on the physical structure and composition of the nuclear pore complex(2-7), but transport selectivity and the dynamics of mRNA export at nuclear pores remain unknown(8). Here we developed a super-registration approach using fluorescence microscopy that can overcome the current limitations of co-localization by means of measuring intermolecular distances of chromatically different fluorescent molecules with nanometre precision. With this method we achieve 20-ms time-precision and at least 26-nm spatial precision, enabling the capture of highly transient interactions in living cells. Using this approach we were able to spatially resolve the kinetics of mRNA transport in mammalian cells and present a three-step model consisting of docking (80 ms), transport (5-20 ms) and release (80 ms), totalling 180 +/- 10 ms. Notably, the translocation through the channel was not the rate-limiting step, mRNAs can move bi-directionally in the pore complex and not all pores are equally active.	[Grunwald, David; Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Grunwald, David; Singer, Robert H.] Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Grunwald, David] Delft Univ Technol, Dept BioNanoSci, Kavli Inst NanoSci, NL-2628 CJ Delft, Netherlands	Yeshiva University; Albert Einstein College of Medicine; Delft University of Technology	Singer, RH (corresponding author), Albert Einstein Coll Med, Dept Anat & Struct Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	Robert.Singer@einstein.yu.edu		Grunwald, David/0000-0001-9067-804X	DFG [3388/1]; NIH [EB2060, GM86217]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084364, R01GM086217] Funding Source: NIH RePORTER	DFG(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Dange, K. Czaplinski, T. Lionnet and X. Meng for help with cell lines and cloning; A. Gennerich, H. Y. Park and D. Entenberg for help on data analysis and programming; S. M. Shenoy for development of alignment software for detector pre-registration and his additional support; D. Larson, I. Lepper and U. Kubitscheck for providing fitting routines; and A. Wells for FISH and TIRF data, proof reading and discussion. Lentiviral vector was a gift from G. Mostoslavsky and R. C. Mulligan. Supported by DFG 3388/1 to D.G. Supported by NIH EB2060 and GM86217 to R.H.S. The authors express their appreciation to E. Gruss Lipper for her gift founding the Gruss Lipper Biophotonics Center that provided the equipment used in this research.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bachi A, 2000, RNA, V6, P136, DOI 10.1017/S1355838200991994; Bastos R, 1995, INT REV CYTOL, V162B, P257; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Chakraborty P, 2006, METHODS, V39, P363, DOI 10.1016/j.ymeth.2006.07.002; Clemen AEM, 2005, BIOPHYS J, V88, P4402, DOI 10.1529/biophysj.104.053504; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; Dange T, 2008, J CELL BIOL, V183, P77, DOI 10.1083/jcb.200806173; FRANKE WW, 1970, J ULTRA MOL STRUCT R, V30, P317, DOI 10.1016/S0022-5320(70)80065-X; FRANKE WW, 1970, J ULTRA MOL STRUCT R, V30, P288, DOI 10.1016/S0022-5320(70)80064-8; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; HALLBERG E, 1993, J CELL BIOL, V122, P513, DOI 10.1083/jcb.122.3.513; Kiseleva E, 1998, J CELL SCI, V111, P223; Kopito RB, 2007, P NATL ACAD SCI USA, V104, P12743, DOI 10.1073/pnas.0702690104; Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x; Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; STOCKLEY PG, 1995, NUCLEIC ACIDS RES, V23, P2512, DOI 10.1093/nar/23.13.2512; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Sun C, 2008, P NATL ACAD SCI USA, V105, P8613, DOI 10.1073/pnas.0710867105; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	31	226	229	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP	2010	467	7315					604	U128		10.1038/nature09438	http://dx.doi.org/10.1038/nature09438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20844488	Green Accepted			2022-12-24	WOS:000282273100042
J	Rao, P; Hayden, MS; Long, MX; Scott, ML; West, AP; Zhang, DK; Oeckinghaus, A; Lynch, C; Hoffmann, A; Baltimore, D; Ghosh, S				Rao, Ping; Hayden, Mathew S.; Long, Meixiao; Scott, Martin L.; West, A. Philip; Zhang, Dekai; Oeckinghaus, Andrea; Lynch, Candace; Hoffmann, Alexander; Baltimore, David; Ghosh, Sankar			I kappa B beta acts to inhibit and activate gene expression during the inflammatory response	NATURE			English	Article							TUMOR NECROSIS FACTOR; C-REL; RHEUMATOID-ARTHRITIS; DEFICIENT MICE; DNA-BINDING; ALPHA; PHOSPHORYLATION; BIOSYNTHESIS; SIMILARITIES; SEQUENCES	The activation of pro-inflammatory gene programs by nuclear factor-kappa B (NF-kappa B) is primarily regulated through cytoplasmic sequestration of NF-kappa B by the inhibitor of kappa B (I kappa B) family of proteins(1). I kappa B beta, a major isoform of I kappa B, can sequester NF-kappa B in the cytoplasm(2), although its biological role remains unclear. Although cells lacking IkBb have been reported(3,4), in vivo studies have been limited and suggested redundancy between I kappa B alpha and I kappa B beta(5). Like I kappa B alpha, I kappa B beta is also inducibly degraded; however, upon stimulation by lipopolysaccharide (LPS), it is degraded slowly and re-synthesized as a hypophosphorylated form that can be detected in the nucleus(6-11). The crystal structure of I kappa B beta bound to p65 suggested this complex might bind DNA(12). In vitro, hypophosphorylated I kappa B beta can bind DNA with p65 and c-Rel, and the DNA-bound NF-kappa B:I kappa B beta complexes are resistant to I kappa B alpha, suggesting hypophosphorylated, nuclear I kappa B beta may prolong the expression of certain genes(9-11). Here we report that in vivo I kappa B beta serves both to inhibit and facilitate the inflammatory response. I kappa B beta degradation releases NF-kappa B dimers which upregulate proinflammatory target genes such as tumour necrosis factor-alpha (TNF-alpha). Surprisingly, absence of I kappa B beta results in a dramatic reduction of TNF-alpha in response to LPS even though activation of NF-kappa B is normal. The inhibition of TNF-alpha messenger RNA (mRNA) expression correlates with the absence of nuclear, hypophosphorylated-I kappa B beta bound to p65:c-Rel heterodimers at a specific kappa B site on the TNF-alpha promoter. Therefore I kappa B beta acts through p65:c-Rel dimers to maintain prolonged expression of TNF-alpha. As a result, I kappa B beta(-/-) mice are resistant to LPS-induced septic shock and collagen-induced arthritis. Blocking I kappa B beta might be a promising new strategy for selectively inhibiting the chronic phase of TNF-alpha production during the inflammatory response.	[Rao, Ping; Hayden, Mathew S.; Long, Meixiao; West, A. Philip; Zhang, Dekai; Oeckinghaus, Andrea; Ghosh, Sankar] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Rao, Ping; Hayden, Mathew S.; Long, Meixiao; West, A. Philip; Zhang, Dekai; Oeckinghaus, Andrea; Ghosh, Sankar] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hayden, Mathew S.; Long, Meixiao; Oeckinghaus, Andrea; Ghosh, Sankar] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Scott, Martin L.; Baltimore, David] CALTECH, Dept Biol, Pasadena, CA 91125 USA; [Lynch, Candace; Hoffmann, Alexander] Univ Calif San Diego, Signaling Syst Lab, Dept Chem & Biochem, La Jolla, CA 92093 USA	Yale University; Yale University; Columbia University; California Institute of Technology; University of California System; University of California San Diego	Ghosh, S (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	sg2715@columbia.edu	West, A. Phillip/W-8171-2019; Oeckinghaus, Andrea/AAW-9933-2020; West, A. Phillip/A-7867-2009; Hayden, Matthew/C-1263-2008	West, A. Phillip/0000-0003-2884-6895; Hayden, Matthew/0000-0003-1670-6430	National Institutes of Health [R37-AI03343]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083453, R37AI033443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Lin at the Yale W. M. Keck Biostatistics Resource for analysis of microarray data. S. G. was supported by grants from the National Institutes of Health (R37-AI03343).	BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Cheng JD, 1998, J EXP MED, V188, P1055, DOI 10.1084/jem.188.6.1055; Chu ZL, 1996, MOL CELL BIOL, V16, P5974; ERNST MK, 1995, MOL CELL BIOL, V15, P872; EVANS GF, 1989, CIRC SHOCK, V29, P279; Feldmann M, 2002, NAT REV IMMUNOL, V2, P364, DOI 10.1038/nri802; Goudeau B, 2003, P NATL ACAD SCI USA, V100, P15800, DOI 10.1073/pnas.2535880100; HAN J, 1990, J EXP MED, V171, P465, DOI 10.1084/jem.171.2.465; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hertlein E, 2005, MOL CELL BIOL, V25, P4956, DOI 10.1128/MCB.25.12.4956-4968.2005; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; KERR LD, 1991, GENE DEV, V5, P1464, DOI 10.1101/gad.5.8.1464; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kuprash DV, 1999, J IMMUNOL, V162, P4045; Malek S, 2003, J BIOL CHEM, V278, P23094, DOI 10.1074/jbc.M301022200; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; Memet S, 1999, J IMMUNOL, V163, P5994; Miagkov AV, 1998, P NATL ACAD SCI USA, V95, P13859, DOI 10.1073/pnas.95.23.13859; Phillips RJ, 1997, MOL CELL BIOL, V17, P4390, DOI 10.1128/MCB.17.8.4390; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; Suyang H, 1996, MOL CELL BIOL, V16, P5444; Tergaonkar V, 2005, NAT CELL BIOL, V7, P921, DOI 10.1038/ncb1296; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; Tran K, 1997, MOL CELL BIOL, V17, P5386, DOI 10.1128/MCB.17.9.5386; Weil R, 1997, J BIOL CHEM, V272, P9942	30	140	144	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					1115	U132		10.1038/nature09283	http://dx.doi.org/10.1038/nature09283			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20740013	Green Accepted			2022-12-24	WOS:000281203600042
J	Zhao, MS; Running, SW				Zhao, Maosheng; Running, Steven W.			Drought-Induced Reduction in Global Terrestrial Net Primary Production from 2000 Through 2009	SCIENCE			English	Article							FORESTS GREEN-UP; CARBON; ECOSYSTEMS; HEAT; RESPIRATION; VARIABILITY; FEEDBACK; SINKS	Terrestrial net primary production (NPP) quantifies the amount of atmospheric carbon fixed by plants and accumulated as biomass. Previous studies have shown that climate constraints were relaxing with increasing temperature and solar radiation, allowing an upward trend in NPP from 1982 through 1999. The past decade (2000 to 2009) has been the warmest since instrumental measurements began, which could imply continued increases in NPP; however, our estimates suggest a reduction in the global NPP of 0.55 petagrams of carbon. Large-scale droughts have reduced regional NPP, and a drying trend in the Southern Hemisphere has decreased NPP in that area, counteracting the increased NPP over the Northern Hemisphere. A continued decline in NPP would not only weaken the terrestrial carbon sink, but it would also intensify future competition between food demand and proposed biofuel production.	[Zhao, Maosheng; Running, Steven W.] Univ Montana, Numer Terradynam Simulat Grp, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	Zhao, MS (corresponding author), Univ Montana, Numer Terradynam Simulat Grp, Dept Ecosyst & Conservat Sci, Missoula, MT 59812 USA.	zhao@ntsg.umt.edu	Zhao, Maosheng/G-5706-2010		NASA [NNX08AG87A]	NASA(National Aeronautics & Space Administration (NASA))	We thank the reviewers and L. Jones, C. Cleveland, and Q. Mu for helpful comments. This work would not have been possible without continuous financial support from the NASA Earth Observing System MODIS project (grant NNX08AG87A). Moreover, we gratefully acknowledge all MODIS land product science team members for their efforts in generating high-quality data sets. NCEP_Reanalysis 2 data were provided by the NOAA/OAR/Earth System Research Laboratory Physical Sciences Division, Boulder, Colorado, USA, from their Web site at www.esrl.noaa.gov/psd/.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Angert A, 2005, P NATL ACAD SCI USA, V102, P10823, DOI 10.1073/pnas.0501647102; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Canadell Josep G., 2007, P1; Chen JM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025919; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Fung IY, 2005, P NATL ACAD SCI USA, V102, P11201, DOI 10.1073/pnas.0504949102; Funk C, 2008, P NATL ACAD SCI USA, V105, P11081, DOI 10.1073/pnas.0708196105; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/NGEO844, 10.1038/ngeo844]; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; KEELING CD, 2001, SIO REFERENCE SERIES, V21; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; Le Quere C, 2009, NAT GEOSCI, V2, P831, DOI 10.1038/ngeo689; MASARIE KA, 1995, J GEOPHYS RES-ATMOS, V100, P11593, DOI 10.1029/95JD00859; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Mildrexler DJ, 2009, REMOTE SENS ENVIRON, V113, P2103, DOI 10.1016/j.rse.2009.05.016; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Palmer W.C., 1965, METEOROLOGICAL DROUG; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Samanta A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042154; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; van der Werf GR, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003122; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011	36	1721	1872	73	1229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2010	329	5994					940	943		10.1126/science.1192666	http://dx.doi.org/10.1126/science.1192666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724633				2022-12-24	WOS:000281084800033
J	Branco, T; Clark, BA; Hausser, M				Branco, Tiago; Clark, Beverley A.; Haeusser, Michael			Dendritic Discrimination of Temporal Input Sequences in Cortical Neurons	SCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; BASAL DENDRITES; SYNAPTIC INTEGRATION; ACTION-POTENTIALS; SPIKES; PLASTICITY; REPRESENTATION; MECHANISM; NETWORK; CELLS	The detection and discrimination of temporal sequences is fundamental to brain function and underlies perception, cognition, and motor output. By applying patterned, two-photon glutamate uncaging, we found that single dendrites of cortical pyramidal neurons exhibit sensitivity to the sequence of synaptic activation. This sensitivity is encoded by both local dendritic calcium signals and somatic depolarization, leading to sequence-selective spike output. The mechanism involves dendritic impedance gradients and nonlinear synaptic N-methyl-D-aspartate receptor activation and is generalizable to dendrites in different neuronal types. This enables discrimination of patterns delivered to a single dendrite, as well as patterns distributed randomly across the dendritic tree. Pyramidal cell dendrites can thus act as processing compartments for the detection of synaptic sequences, thereby implementing a fundamental cortical computation.	[Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Hausser, M (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	m.hausser@ucl.ac.uk	Clark, Beverley/C-1519-2008; Hausser, Michael/AAW-6827-2020; Branco, Tiago/C-1503-2008	Hausser, Michael/0000-0002-2673-8957; 	Wellcome Trust; Gatsby Charitable Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation	We thank M. London, A. Roth, P. Dayan, J. Jack, and S. Smith for discussions; B. Judkewitz for help with image acquisition software; and C. Schmidt-Hieber for help with hippocampal granule cell experiments. This work was supported by grants from the Wellcome Trust and the Gatsby Charitable Foundation.	BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lazar A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.023.2009; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Rall W, 1964, NEURAL THEORY MODELI, P73; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3	34	272	274	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1671	1675		10.1126/science.1189664	http://dx.doi.org/10.1126/science.1189664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20705816	Green Accepted			2022-12-24	WOS:000282098100049
J	Bhatt, DL; Eagle, KA; Ohman, EM; Hirsch, AT; Goto, S; Mahoney, EM; Wilson, PWF; Alberts, MJ; D'Agostino, R; Liau, CS; Mas, JL; Rother, J; Smith, SC; Salette, G; Contant, CF; Massaro, JM; Steg, PG				Bhatt, Deepak L.; Eagle, Kim A.; Ohman, E. Magnus; Hirsch, Alan T.; Goto, Shinya; Mahoney, Elizabeth M.; Wilson, Peter W. F.; Alberts, Mark J.; D'Agostino, Ralph; Liau, Chiau-Suong; Mas, Jean-Louis; Roether, Joachim; Smith, Sidney C., Jr.; Salette, Genevieve; Contant, Charles F.; Massaro, Joseph M.; Steg, Ph. Gabriel		REACH Registry Investigators	Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE CORONARY SYNDROME; DISEASE; ROSIGLITAZONE; CLOPIDOGREL; PREVENTION; REDUCTION; CANGRELOR; MORTALITY; OUTCOMES; ASPIRIN	Context Clinicians and trialists have difficulty with identifying which patients are highest risk for cardiovascular events. Prior ischemic events, polyvascular disease, and diabetes mellitus have all been identified as predictors of ischemic events, but their comparative contributions to future risk remain unclear. Objective To categorize the risk of cardiovascular events in stable outpatients with various initial manifestations of atherothrombosis using simple clinical descriptors. Design, Setting, and Patients Outpatients with coronary artery disease, cerebrovascular disease, or peripheral arterial disease or with multiple risk factors for atherothrombosis were enrolled in the global Reduction of Atherothrombosis for Continued Health (REACH) Registry and were followed up for as long as 4 years. Patients from 3647 centers in 29 countries were enrolled between 2003 and 2004 and followed up until 2008. Final database lock was in April 2009. Main Outcome Measures Rates of cardiovascular death, myocardial infarction, and stroke. Results A total of 45 227 patients with baseline data were included in this 4-year analysis. During the follow-up period, a total of 5481 patients experienced at least 1 event, including 2315 with cardiovascular death, 1228 with myocardial infarction, 1898 with stroke, and 40 with both a myocardial infarction and stroke on the same day. Among patients with atherothrombosis, those with a prior history of ischemic events at baseline (n=21 890) had the highest rate of subsequent ischemic events (18.3%; 95% confidence interval [CI], 17.4%-19.1%); patients with stable coronary, cerebrovascular, or peripheral artery disease (n=15 264) had a lower risk (12.2%; 95% CI, 11.4%-12.9%); and patients without established atherothrombosis but with risk factors only (n=8073) had the lowest risk (9.1%; 95% CI, 8.3%-9.9%) (P<.001 for all comparisons). In addition, in multivariable modeling, the presence of diabetes (hazard ratio [HR], 1.44; 95% CI, 1.36-1.53; P<.001), an ischemic event in the previous year (HR, 1.71; 95% CI, 1.57-1.85; P<.001), and polyvascular disease (HR, 1.99; 95% CI, 1.78-2.24; P<.001) each were associated with a significantly higher risk of the primary end point. Conclusion Clinical descriptors can assist clinicians in identifying high-risk patients within the broad range of risk for outpatients with atherothrombosis. JAMA. 2010; 304(12): 1350-1357	[Bhatt, Deepak L.] VA Boston Healthcare Syst, Boston, MA 02132 USA; [Alberts, Mark J.] Northwestern Univ, Sch Med, Chicago, IL USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Sch Med, Boston, MA USA; [D'Agostino, Ralph] Boston Univ, Boston, MA 02215 USA; [Eagle, Kim A.] Univ Michigan, Ann Arbor, MI 48109 USA; [Goto, Shinya] Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; [Hirsch, Alan T.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Liau, Chiau-Suong] Taiwan Univ Hosp, Taipei, Taiwan; [Liau, Chiau-Suong] Coll Med, Taipei, Taiwan; [Mas, Jean-Louis] Ctr Raymond Garcin, Paris, France; [Ohman, E. Magnus] Duke Univ, Med Ctr, Durham, NC USA; [Roether, Joachim] Asklepios Klin Altona, Dept Neurol, Hamburg, Germany; [Smith, Sidney C., Jr.] Univ N Carolina, Chapel Hill, NC USA; [Steg, Ph. Gabriel] Hop Bichat Claude Bernard, F-75877 Paris 18, France; [Wilson, Peter W. F.] Emory Univ, Sch Med, Atlanta, GA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Northwestern University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; University of Michigan System; University of Michigan; Tokai University; University of Minnesota System; University of Minnesota Twin Cities; National Taiwan University; Duke University; Asklepios Klinik Altona; University of North Carolina; University of North Carolina Chapel Hill; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Emory University	Bhatt, DL (corresponding author), VA Boston Healthcare Syst, 1400 VFW Pkwy, Boston, MA 02132 USA.	dlbhattmd@post.harvard.edu	Goto, Shinya/AAU-6045-2020; Wilson, Peter W.F./J-2455-2016; STEG, Philippe Gabriel/Z-1567-2019; Statsenko, Mikhail E./N-7573-2015	Goto, Shinya/0000-0002-6821-1504; Statsenko, Mikhail E./0000-0002-3306-0312; STEG, Philippe Gabriel/0000-0001-6896-2941; Massaro, Joseph/0000-0002-2682-4812	AstraZeneca; Bristol-Myers Squibb; Eisai; Ethicon; Heartscape; Sanofi-Aventis; Medicines Company; Blue Cross Blue Shield of Michigan; National Institutes of Health (NIH); Mardigian Foundation; GORE; Hewlett Foundation; CV Therapeutics; Daiichi Sankyo; Datascope; Eli Lilly; Marquet; Schering-Plough; Abbott Vascular; Ono; Otsuka; Sankyo; Daiichi; Takeda; Asteras; Kowa; AGA Medical; Boehringer Ingelheim; EKR; Servier; Waksman Foundation (Tokyo, Japan)	AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai(Eisai Co Ltd); Ethicon; Heartscape; Sanofi-Aventis(Sanofi-Aventis); Medicines Company; Blue Cross Blue Shield of Michigan; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mardigian Foundation; GORE; Hewlett Foundation; CV Therapeutics; Daiichi Sankyo(Daiichi Sankyo Company Limited); Datascope; Eli Lilly(Eli Lilly); Marquet; Schering-Plough(Merck & CompanySchering Plough Corporation); Abbott Vascular(Abbott Laboratories); Ono; Otsuka(Otsuka Pharmaceutical); Sankyo; Daiichi(Daiichi Sankyo Company Limited); Takeda(Takeda Pharmaceutical Company Ltd); Asteras; Kowa; AGA Medical; Boehringer Ingelheim(Boehringer Ingelheim); EKR; Servier(Servier); Waksman Foundation (Tokyo, Japan)	Dr Bhatt reported having received institutional research support from AstraZeneca, Bristol-Myers Squibb, Eisai, Ethicon, Heartscape, Sanofi-Aventis, and The Medicines Company. Dr Eagle reported having received grant/research support from Bristol-Myers Squibb, Blue Cross Blue Shield of Michigan, the National Institutes of Health (NIH), Sanofi-Aventis, the Mardigian Foundation Varbedian Fund, GORE, and the Hewlett Foundation and being a consultant for the NIH National Heart, Lung, and Blood Institute, Sanofi-Aventis, and the Robert Wood Johnson Foundation. Dr Ohman reported receiving research grants from Bristol-Myers Squibb, CV Therapeutics, Daiichi Sankyo, Datascope, Eli Lilly, Marquet, Sanofi-Aventis, Schering-Plough, and The Medicines Company and providing consulting or other services for Abiomed, AstraZeneca, CV Therapeutics, Datascope, Gilead Sciences, Liposcience, Marquet, Northpoint Domain, Pozen, Response Biomedical, Sanofi-Aventis, The Medicines Company, and WebMD (theheart.org). Dr Hirsch reported having received research grants from Bristol-Myers Squibb, Sanofi-Aventis, and Abbott Vascular and served as a consultant to Roche, Cytokinetics, ev3, and Talecris. Dr Goto reported having received research grants from Pfizer, Sanofi-Aventis, Ono, Eisai, Otsuka, Sankyo, Daiichi, Takeda, Asteras, Kowa, and AstraZeneca and honoraria from Sanofi-Aventis, Eisai, Otsuka, Daiichi-Sankyo, and Schering-Plough. Dr Mahoney reported having received grant support from Sanofi-Aventis, Bristol-Myers Squibb, Daiichi-Sankyo, and Eli Lilly and honoraria from Sanofi-Aventis and Bristol-Myers Squibb. Dr Wilson reported having received research grants from Sanofi-Aventis. Dr Alberts reported having received research support from AGA Medical, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, EKR, Sanofi-Aventis, and Schering-Plough; having participated in speakers' bureaus for Bristol-Myers Squibb, Boehringer Ingelheim, DiaDexus, Genentech, MedScape, and Sanofi-Aventis; having received honoraria from Bristol-Myers Squibb, Boehringer Ingelheim, DiaDexus, Genentech, MedScape, and Sanofi-Aventis; and having acted as a consultant or advisory board member for Bristol-Myers Squibb, Boehringer Ingelheim, EKR, Genentech, Merck, Pfizer, and Sanofi-Aventis. Dr D'Agostino reported having received honoraria from Sanofi-Aventis. Dr Liau reported no disclosures. Dr Mas reported having received research grants, honoraria, and consulting fees from Sanofi-Aventis, Bristol-Myers Squibb, and Servier and honoraria and consulting fees from Boehringer Ingelheim. Dr Rother reported having participated in speakers' bureaus for Boehringer-Ingelheim, Bristol-Myers Squibb, Sanofi-Aventis, and Lundbeck and having acted as a consultant or advisory board member for Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, Sanofi-Aventis, and Lundbeck. Dr Smith Jr reported no disclosures. Dr Salette reported being an employee of Sanofi-Aventis. Dr Contant reported no disclosures. Dr Massaro reported having received honoraria from Sanofi-Aventis. Dr Steg reported having received research grants (to his institution) from Servier; participating in consultancy or advisory boards for Astellas, AstraZeneca, Bayer, Boehringer-Ingelheim, BMS, Daiichi-Sankyo-Lilly, GlaxoSmithKline, Medtronic, Otsuka, Pfizer, Roche, Sanofi-Aventis, Servier, and The Medicines Company; and being a stockholder in Aterovax.; The REACH Registry is sponsored by Sanofi-Aventis, Bristol-Myers Squibb, and the Waksman Foundation (Tokyo, Japan). The REACH Registry is endorsed by the World Heart Federation.	Alberts MJ, 2009, EUR HEART J, V30, P2318, DOI 10.1093/eurheartj/ehp355; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V303, P2188, DOI 10.1001/jama.2010.743; Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Bhatt DL, 2009, EUR HEART J, V30, P1195, DOI 10.1093/eurheartj/ehp099; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Brilakis ES, 2009, CIRCULATION, V120, P560, DOI 10.1161/CIRCULATIONAHA.109.877092; CHANG IM, 1982, J CHRON DIS, V35, P669, DOI 10.1016/0021-9681(82)90019-4; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Fonarow GC, 2005, JAMA-J AM MED ASSOC, V293, P572, DOI 10.1001/jama.293.5.572; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Harrington RA, 2009, NEW ENGL J MED, V361, P2318, DOI 10.1056/NEJMoa0908628; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Krempf M, 2010, AM J CARDIOL, V105, P667, DOI 10.1016/j.amjcard.2009.10.048; Mahoney EM, 2008, CIRC-CARDIOVASC QUAL, V1, P38, DOI 10.1161/CIRCOUTCOMES.108.775247; Mehta C, 2009, CIRCULATION, V119, P597, DOI 10.1161/CIRCULATIONAHA.108.809707; Muller-Riemenschneider F, 2010, ARCH INTERN MED, V170, P719, DOI 10.1001/archinternmed.2010.66; Ohman EM, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.11.004; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; Topol EJ, 2010, LANCET, V376, P517, DOI 10.1016/S0140-6736(10)60935-X	23	539	591	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2010	304	12					1350	1357		10.1001/jama.2010.1322	http://dx.doi.org/10.1001/jama.2010.1322			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652LK	20805624	Bronze			2022-12-24	WOS:000282007900018
J	Akella, JS; Wloga, D; Kim, J; Starostina, NG; Lyons-Abbott, S; Morrissette, NS; Dougan, ST; Kipreos, ET; Gaertig, J				Akella, Jyothi S.; Wloga, Dorota; Kim, Jihyun; Starostina, Natalia G.; Lyons-Abbott, Sally; Morrissette, Naomi S.; Dougan, Scott T.; Kipreos, Edward T.; Gaertig, Jacek			MEC-17 is an alpha-tubulin acetyltransferase	NATURE			English	Article							TOUCH RECEPTOR NEURONS; TETRAHYMENA-THERMOPHILA; CAENORHABDITIS-ELEGANS; C-ELEGANS; ACETYLATION; MICROTUBULE; CILIA; TRANSPORT; DOMAIN; IDENTIFICATION	In most eukaryotic cells, subsets of microtubules are adapted for specific functions by post-translational modifications (PTMs) of tubulin subunits. Acetylation of the epsilon-amino group of K40 on alpha-tubulin is a conserved PTM on the luminal side of microtubules(1) that was discovered in the flagella of Chlamydomonas reinhardtii(2,3). Studies on the significance of microtubule acetylation have been limited by the undefined status of the alpha-tubulin acetyltransferase. Here we show that MEC-17, a protein related to the Gcn5 histone acetyltransferases(4) and required for the function of touch receptor neurons in Caenorhabditis elegans(5,6), acts as a K40-specific acetyltransferase for alpha-tubulin. In vitro, MEC-17 exclusively acetylates K40 of alpha-tubulin. Disruption of the Tetrahymena MEC-17 gene phenocopies the K40R alpha-tubulin mutation and makes microtubules more labile. Depletion of MEC-17 in zebrafish produces phenotypes consistent with neuromuscular defects. In C. elegans, MEC-17 and its paralogue W06B11.1 are redundantly required for acetylation of MEC-12 alpha-tubulin, and contribute to the function of touch receptor neurons partly via MEC-12 acetylation and partly via another function, possibly by acetylating another protein. In summary, we identify MEC-17 as an enzyme that acetylates the K40 residue of alpha-tubulin, the only PTM known to occur on the luminal surface of microtubules.	[Akella, Jyothi S.; Wloga, Dorota; Kim, Jihyun; Starostina, Natalia G.; Dougan, Scott T.; Kipreos, Edward T.; Gaertig, Jacek] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Lyons-Abbott, Sally; Morrissette, Naomi S.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University System of Georgia; University of Georgia; University of California System; University of California Irvine	Gaertig, J (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	jgaertig@cb.uga.edu	Gaertig, Jacek/F-1553-2010; Włoga, Dorota/R-4078-2016; Dougan, Scott/B-8416-2008	Włoga, Dorota/0000-0003-3314-7773; Dougan, Scott/0000-0003-0214-4772; Akella, Jyothi Shilpa/0000-0003-4839-4910	National Science Foundation [MBC-033965]; American Cancer Society [RSG DDC-112979]; National Institutes of Health [R01GM074212, R01AI067981, R01GM089912]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074212, R01GM089912] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the National Science Foundation (MBC-033965 to J.G.), American Cancer Society (RSG DDC-112979 to S.T.D.), and National Institutes of Health (R01GM074212 to E. T. K., R01AI067981 to N.S.M., R01GM089912 to J.G.). S.T.D. is a Georgia Cancer Coalition Distinguished Investigator. We are grateful to M. Chalfie for the mec-12(e1607) mutant, J. Frankel for 12G10 mAb (available from the Developmental Studies Hybridoma Bank), M. Gorovsky for SG anti-tubulin antibodies, D. Allis for anti-hv1 antibodies, B. Feldman for mismatch morpholinos, and S. T. Dougan laboratory members for advice and assistance with zebrafish experiments.	Barlow SB, 2002, J CELL SCI, V115, P3469; Bounoutas A, 2009, CURR BIOL, V19, P1362, DOI 10.1016/j.cub.2009.06.036; BRENNER S, 1974, GENETICS, V77, P71; CassidyHanley D, 1997, GENETICS, V146, P135; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chen CC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000561; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Fox MA, 2007, J COMP NEUROL, V503, P280, DOI 10.1002/cne.21381; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Fukushige T, 1999, J CELL SCI, V112, P395; GAERTIG J, 1995, J CELL BIOL, V129, P1301, DOI 10.1083/jcb.129.5.1301; Gaertig J, 1999, NAT BIOTECHNOL, V17, P462, DOI 10.1038/8638; Hai B, 1997, P NATL ACAD SCI USA, V94, P1310, DOI 10.1073/pnas.94.4.1310; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Jerka-Dziadosz M, 2001, PROTIST, V152, P53, DOI 10.1078/1434-4610-00043; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; KOZMINSKI KG, 1993, CELL MOTIL CYTOSKEL, V25, P158, DOI 10.1002/cm.970250205; Kuninger D, 2007, J BIOTECHNOL, V131, P253, DOI 10.1016/j.jbiotec.2007.07.498; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LEDIZET M, 1991, METHOD ENZYMOL, V196, P264; LHERNAULT SW, 1983, J CELL BIOL, V97, P258, DOI 10.1083/jcb.97.1.258; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Miller DM, 1995, METHOD CELL BIOL, V48, P365; Mochizuki K, 2008, GENE, V425, P79, DOI 10.1016/j.gene.2008.08.007; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Ohkawa N, 2008, GENES CELLS, V13, P1171, DOI 10.1111/j.1365-2443.2008.01235.x; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; Steczkiewicz K, 2006, CELL CYCLE, V5, P2927, DOI 10.4161/cc.5.24.3572; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; WILSON SW, 1991, DEVELOPMENT, V112, P723; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Wloga D, 2008, EUKARYOT CELL, V7, P1362, DOI 10.1128/EC.00084-08; Wloga D, 2006, MOL BIOL CELL, V17, P2799, DOI 10.1091/mbc.E05-05-0450; Wloga D, 2009, DEV CELL, V16, P867, DOI 10.1016/j.devcel.2009.04.008; Yakovich AJ, 2006, EXP PARASITOL, V114, P289, DOI 10.1016/j.exppara.2006.04.008; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	44	320	336	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2010	467	7312					218	U111		10.1038/nature09324	http://dx.doi.org/10.1038/nature09324			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829795	Green Accepted			2022-12-24	WOS:000281616300037
J	Mendez-Ferrer, S; Michurina, TV; Ferraro, F; Mazloom, AR; MacArthur, BD; Lira, SA; Scadden, DT; Ma'ayan, A; Enikolopov, GN; Frenette, PS				Mendez-Ferrer, Simon; Michurina, Tatyana V.; Ferraro, Francesca; Mazloom, Amin R.; MacArthur, Ben D.; Lira, Sergio A.; Scadden, David T.; Ma'ayan, Avi; Enikolopov, Grigori N.; Frenette, Paul S.			Mesenchymal and haematopoietic stem cells form a unique bone marrow niche	NATURE			English	Article							PROGENITOR CELLS; SELF-RENEWAL; NEURAL STEM; EXPRESSION; DIFFERENTIATION; OSTEOPONTIN; OSTEOBLASTS; COOPERATION; RECEPTORS; COMPONENT	The cellular constituents forming the haematopoietic stem cell (HSC) niche in the bone marrow are unclear, with studies implicating osteoblasts, endothelial and perivascular cells. Here we demonstrate that mesenchymal stem cells (MSCs), identified using nestin expression, constitute an essential HSC niche component. Nestin(+) MSCs contain all the bone-marrow colony-forming-unit fibroblastic activity and can be propagated as non-adherent 'mesenspheres' that can self-renew and expand in serial transplantations. Nestin(+) MSCs are spatially associated with HSCs and adrenergic nerve fibres, and highly express HSC maintenance genes. These genes, and others triggering osteoblastic differentiation, are selectively downregulated during enforced HSC mobilization or beta 3 adrenoreceptor activation. Whereas parathormone administration doubles the number of bone marrow nestin(+) cells and favours their osteoblastic differentiation, in vivo nestin(+) cell depletion rapidly reduces HSC content in the bone marrow. Purified HSCs home near nestin(+) MSCs in the bone marrow of lethally irradiated mice, whereas in vivo nestin(+) cell depletion significantly reduces bone marrow homing of haematopoietic progenitors. These results uncover an unprecedented partnership between two distinct somatic stem-cell types and are indicative of a unique niche in the bone marrow made of heterotypic stem-cell pairs.	[Mendez-Ferrer, Simon; Lira, Sergio A.; Frenette, Paul S.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Mendez-Ferrer, Simon; Frenette, Paul S.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Michurina, Tatyana V.; Enikolopov, Grigori N.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Ferraro, Francesca; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Mazloom, Amin R.; MacArthur, Ben D.; Ma'ayan, Avi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Frenette, Paul S.] Yeshiva Univ Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cold Spring Harbor Laboratory; Harvard University; Harvard Medical School; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	simon.mendez-ferrer@cnic.es; paul.frenette@einstein.yu.edu	Méndez-Ferrer, Simón/L-8088-2014; Ma'ayan, Avi/AAG-3131-2019; Enikolopov, Grigori/P-5731-2019; Frenette, Paul S/J-8272-2012; Méndez-Ferrer, Simón/ABG-8547-2020	Méndez-Ferrer, Simón/0000-0002-9805-9988; Ma'ayan, Avi/0000-0002-6904-1017; Enikolopov, Grigori/0000-0001-8178-8917; Frenette, Paul S/0000-0003-0862-9922; Méndez-Ferrer, Simón/0000-0002-9805-9988; MacArthur, Ben/0000-0002-5396-9750	National Institutes of Health [DK056638, HL69438, HL097819]; Department of Defence [PC060271]; National Institute of Mental Health; Ira Hazan Fund; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097819, R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defence; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ira Hazan Fund; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Garcia-Fernandez, Y. Kunisaki, C. Scheiermann, J. Isern, E. Nistal-Villan and D. Lucas for help with some experiments; M. Kiel and S. Morrison for advice about immunohistological analysis of HSCs; C. Lin for help with intravital microscopy imaging; G. Fishell for the gift of Nes-cre<SUP>ERT2</SUP> and RCE:loxP transgenic mice; J. Ahmed, W. Kao and J. Godbold for help with immunofluorescence and statistical analyses; S. Lymperi for advice about LT-CIC; L. Silberstein, G. Khitrov and W. Zhang for help with microarray experiments; M. Grisotto for help with cell sorting; and L. Shang, A. J. Peired and C. Prophete for help with animals. This work was supported by the National Institutes of Health (R01 grants DK056638, HL69438, HL097819) and the Department of Defence (Idea Development Award PC060271) to P. S. F. and by the National Institute of Mental Health and Ira Hazan Fund to G.N.E. S.M.-F. is the recipient of a Scholar Award by the American Society of Hematology. P. S. F. is an Established Investigator of the American Heart Association.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; CRISAN M, 2008, CURR PROTOC STEM CEL, V2; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lymperi S, 2008, BLOOD, V111, P1173, DOI 10.1182/blood-2007-03-082800; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2007, ANN NY ACAD SCI, V1116, P392, DOI 10.1196/annals.1402.086; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mignone JL, 2007, CELL CYCLE, V6, P2161, DOI 10.4161/cc.6.17.4593; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SOUSA VH, 2009, CEREB CORTEX S1, V19, P1, DOI DOI 10.1093/CERCOR/BHP038; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; YAMAZAKI K, 1990, AM J ANAT, V187, P261, DOI 10.1002/aja.1001870306; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	43	2302	2403	12	376	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					829	U59		10.1038/nature09262	http://dx.doi.org/10.1038/nature09262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703299	Green Accepted			2022-12-24	WOS:000280766100028
J	Chi, P; Chen, Y; Zhang, L; Guo, XY; Wongvipat, J; Shamu, T; Fletcher, JA; Dewell, S; Maki, RG; Zheng, DY; Antonescu, CR; Allis, CD; Sawyers, CL				Chi, Ping; Chen, Yu; Zhang, Lei; Guo, Xingyi; Wongvipat, John; Shamu, Tambudzai; Fletcher, Jonathan A.; Dewell, Scott; Maki, Robert G.; Zheng, Deyou; Antonescu, Cristina R.; Allis, C. David; Sawyers, Charles L.			ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours	NATURE			English	Article							INTERSTITIAL-CELLS; GENE-EXPRESSION; MOUSE MODEL; MUTATIONS; CAJAL; INHIBITION; GIST	Gastrointestinal stromal tumour (GIST) is the most common human sarcoma and is primarily defined by activating mutations in the KIT or PDGFRA receptor tyrosine kinases(1,2). KIT is highly expressed in interstitial cells of Cajal (ICCs)-the presumed cell of origin for GIST-as well as in haematopoietic stem cells, melanocytes, mast cells and germ cells(2,3). Yet, families harbouring germline activating KIT mutations and mice with knock-in Kit mutations almost exclusively develop ICC hyperplasia and GIST(4-7), suggesting that the cellular context is important for KIT to mediate oncogenesis. Here we show that the ETS family member ETV1 is highly expressed in the subtypes of ICCs sensitive to oncogenic KIT mediated transformation(8), and is required for their development. In addition, ETV1 is universally highly expressed in GISTs and is required for growth of imatinib-sensitive and resistant GIST cell lines. Transcriptome profiling and global analyses of ETV1-binding sites suggest that ETV1 is a master regulator of an ICC-GIST-specific transcription network mainly through enhancer binding. The ETV1 transcriptional program is further regulated by activated KIT, which prolongs ETV1 protein stability and cooperates with ETV1 to promote tumorigenesis. We propose that GIST arises from ICCs with high levels of endogenous ETV1 expression that, when coupled with an activating KIT mutation, drives an oncogenic ETS transcriptional program. This differs from other ETS-dependent tumours such as prostate cancer, melanoma and Ewing sarcoma where genomic translocation or amplification drives aberrant ETS expression(9-11). It also represents a novel mechanism of oncogenic transcription factor activation.	[Chi, Ping; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Chi, Ping; Chen, Yu; Maki, Robert G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Chen, Yu; Wongvipat, John; Shamu, Tambudzai; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Zhang, Lei; Antonescu, Cristina R.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Guo, Xingyi; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Fletcher, Jonathan A.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Brigham & Women's Hospital; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Howard Hughes Medical Institute	Sawyers, CL (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA.	alliscd@rockefeller.edu; sawyersc@mskcc.org	Pillay, Nischalan/F-9536-2012; Maki, Robert G./AAI-2793-2020; Maki, Robert G/J-9145-2019; Sawyers, Charles/G-5327-2016; ravegnini, gloria/K-1330-2016	Maki, Robert G/0000-0002-9853-2528; ravegnini, gloria/0000-0002-7774-402X; Shamu, Tambudzai/0000-0001-8944-8079; Zheng, Deyou/0000-0003-4354-5337	National Cancer Institute [K08CA140946, 5F32CA130372, CA47179, CA148260]; US National Institute of Mental Health [R21MH087840]; National Cancer Institute-American Society of Clinical Oncology Cancer Foundation Clinical Investigator Team; American Society of Clinical Oncology; Doris Duke; Charles H Revson; Charles A. Dana foundations; Rockefeller University; American Cancer Society [CCE-106841, P01CA47179]; Life Raft Group; GIST; Shuman Family Fund for GIST Research; Cycle for Survival; Albert Einstein College of Medicine; National Institutes of Health [GM40922]; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [P30CA008748, K08CA140946, P50CA140146, P01CA047179, RC2CA148260, F32CA130372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087840] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute-American Society of Clinical Oncology Cancer Foundation Clinical Investigator Team; American Society of Clinical Oncology; Doris Duke(Doris Duke Charitable Foundation (DDCF)); Charles H Revson; Charles A. Dana foundations; Rockefeller University; American Cancer Society(American Cancer Society); Life Raft Group; GIST; Shuman Family Fund for GIST Research; Cycle for Survival; Albert Einstein College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the National Cancer Institute (K08CA140946, to Y.C.), (5F32CA130372, to P. C.), (CA47179, to C. R. A. and R. G. M.), (CA148260, to R. G. M.), US National Institute of Mental Health (R21MH087840, to D.Z.), National Cancer Institute-American Society of Clinical Oncology Cancer Foundation Clinical Investigator Team Leadership Supplemental Award (to R. G. M.), American Society of Clinical Oncology Young Investigator Award (to P. C.), the Doris Duke (to C. L. S.), Charles H Revson (to Y.C.) and Charles A. Dana (to Y.C.) foundations, The Rockefeller University Fund (to C. D. A.), American Cancer Society Mentored Research Scholar Grant CCE-106841 (to C. R. A.), P01CA47179 (to C. R. A. and R. G. M.), the Life Raft Group (to C. R. A.), the GIST Cancer Research Fund (to C. R. A.), the Shuman Family Fund for GIST Research (to P. C., C. R. A. and R. G. M.), Cycle for Survival (to R. G. M.), Startup Funds from the Albert Einstein College of Medicine (to D.Z.), National Institutes of Health (GM40922, to C. D. A.) and the Starr Cancer Consortium (to P. C., Y.C., C. L. S. and C. D. A.). We thank the International Genomics Consortium for generating ExpO data. We thank G. Wang, P. Iaquinta, and H. Hieronymus for discussions, and especially T. M. Jessell and J. N. Betley for providing and breeding Etv1<SUP>-/-</SUP> mice.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Antonescu CR, 2006, SEMIN DIAGN PATHOL, V23, P63, DOI 10.1053/j.semdp.2006.08.003; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bauer S, 2006, CANCER RES, V66, P9153, DOI 10.1158/0008-5472.CAN-06-0165; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Chen H, 2007, PHYSIOL GENOMICS, V31, P492, DOI 10.1152/physiolgenomics.00113.2007; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Jane-Valbuena J, 2010, CANCER RES, V70, P2075, DOI 10.1158/0008-5472.CAN-09-3092; Kindblom LG, 1998, AM J PATHOL, V152, P1259; Kwon JG, 2009, GASTROENTEROLOGY, V136, P630, DOI 10.1053/j.gastro.2008.10.031; Mertens F, 2009, SEMIN ONCOL, V36, P312, DOI 10.1053/j.seminoncol.2009.06.004; Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nakai N, 2008, J PATHOL, V214, P302, DOI 10.1002/path.2296; Nielsen TO, 2002, LANCET, V359, P1301, DOI 10.1016/S0140-6736(02)08270-3; Ostrowski J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-413; Rubin BP, 2005, CANCER RES, V65, P6631, DOI 10.1158/0008-5472.CAN-05-0891; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Segal NH, 2003, AM J PATHOL, V163, P691, DOI 10.1016/S0002-9440(10)63696-6; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Ward SM, 2001, AM J PHYSIOL-GASTR L, V281, pG602, DOI 10.1152/ajpgi.2001.281.3.G602; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	33	213	226	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					849	U117		10.1038/nature09409	http://dx.doi.org/10.1038/nature09409			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20927104	Green Accepted			2022-12-24	WOS:000282898700068
J	Hazen, TC; Dubinsky, EA; DeSantis, TZ; Andersen, GL; Piceno, YM; Singh, N; Jansson, JK; Probst, A; Borglin, SE; Fortney, JL; Stringfellow, WT; Bill, M; Conrad, ME; Tom, LM; Chavarria, KL; Alusi, TR; Lamendella, R; Joyner, DC; Spier, C; Baelum, J; Auer, M; Zemla, ML; Chakraborty, R; Sonnenthal, EL; D'haeseleer, P; Holman, HYN; Osman, S; Lu, ZM; Van Nostrand, JD; Deng, Y; Zhou, JZ; Mason, OU				Hazen, Terry C.; Dubinsky, Eric A.; DeSantis, Todd Z.; Andersen, Gary L.; Piceno, Yvette M.; Singh, Navjeet; Jansson, Janet K.; Probst, Alexander; Borglin, Sharon E.; Fortney, Julian L.; Stringfellow, William T.; Bill, Markus; Conrad, Mark E.; Tom, Lauren M.; Chavarria, Krystle L.; Alusi, Thana R.; Lamendella, Regina; Joyner, Dominique C.; Spier, Chelsea; Baelum, Jacob; Auer, Manfred; Zemla, Marcin L.; Chakraborty, Romy; Sonnenthal, Eric L.; D'haeseleer, Patrik; Holman, Hoi-Ying N.; Osman, Shariff; Lu, Zhenmei; Van Nostrand, Joy D.; Deng, Ye; Zhou, Jizhong; Mason, Olivia U.			Deep-Sea Oil Plume Enriches Indigenous Oil-Degrading Bacteria	SCIENCE			English	Article							PETROLEUM-HYDROCARBONS; GEN.-NOV.; CRUDE-OIL; COMMUNITIES; TEMPERATURES; ANTARCTICA; GEOCHIP; SPILL	The biological effects and expected fate of the vast amount of oil in the Gulf of Mexico from the Deepwater Horizon blowout are unknown owing to the depth and magnitude of this event. Here, we report that the dispersed hydrocarbon plume stimulated deep-sea indigenous gamma-Proteobacteria that are closely related to known petroleum degraders. Hydrocarbon-degrading genes coincided with the concentration of various oil contaminants. Changes in hydrocarbon composition with distance from the source and incubation experiments with environmental isolates demonstrated faster-than-expected hydrocarbon biodegradation rates at 5 degrees C. Based on these results, the potential exists for intrinsic bioremediation of the oil plume in the deep-water column without substantial oxygen drawdown.	[Hazen, Terry C.; Dubinsky, Eric A.; DeSantis, Todd Z.; Andersen, Gary L.; Piceno, Yvette M.; Singh, Navjeet; Jansson, Janet K.; Probst, Alexander; Borglin, Sharon E.; Fortney, Julian L.; Stringfellow, William T.; Bill, Markus; Conrad, Mark E.; Tom, Lauren M.; Chavarria, Krystle L.; Alusi, Thana R.; Lamendella, Regina; Joyner, Dominique C.; Baelum, Jacob; Auer, Manfred; Zemla, Marcin L.; Chakraborty, Romy; Sonnenthal, Eric L.; Holman, Hoi-Ying N.; Osman, Shariff; Zhou, Jizhong; Mason, Olivia U.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Stringfellow, William T.; Spier, Chelsea] Univ Pacific, Ecol Engn Res Program, Stockton, CA 95211 USA; [Lu, Zhenmei; Van Nostrand, Joy D.; Deng, Ye; Zhou, Jizhong] Univ Oklahoma, Norman, OK 73072 USA; [D'haeseleer, Patrik] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of the Pacific; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Hazen, TC (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, MS 70A-3317,1 Cyclotron Rd, Berkeley, CA 94720 USA.	tchazen@lbl.gov	Holman, Hoi-Ying/N-8451-2014; Chakraborty, Romy/D-9230-2015; Bælum, Jacob/I-2353-2013; Mason, Olivia/AAP-2627-2021; Andersen, Gary/G-2792-2015; 5.4, ALS Beamline/I-2863-2014; Bill, Markus/D-8478-2013; Hazen, Terry C/C-1076-2012; Stringfellow, William T/O-4389-2015; 1.4, ALS Beamline/I-1886-2014; Van Nostrand, Joy D/F-1740-2016; Jansson, Janet/H-5478-2018; Lu, Zhenmei/I-3218-2014; Conrad, Mark E/G-2767-2010; Probst, Alexander J/K-2813-2016; Piceno, Yvette/I-6738-2016; Borglin, Sharon E/I-1013-2016; Sonnenthal, Eric LLoyd/A-4336-2009; 吴, 昊/AAB-1620-2020; Dubinsky, Eric A/D-3787-2015; Deng, Ye/X-4358-2019; Tom, Lauren/E-9739-2015	Holman, Hoi-Ying/0000-0002-7534-2625; Chakraborty, Romy/0000-0001-9326-554X; Bælum, Jacob/0000-0002-1022-6586; Andersen, Gary/0000-0002-1618-9827; Bill, Markus/0000-0001-7002-2174; Hazen, Terry C/0000-0002-2536-9993; Stringfellow, William T/0000-0003-3189-5604; Van Nostrand, Joy D/0000-0001-9548-6450; Jansson, Janet/0000-0002-5487-4315; Conrad, Mark E/0000-0001-9509-7324; Piceno, Yvette/0000-0002-7915-4699; Sonnenthal, Eric LLoyd/0000-0003-2987-3481; Dubinsky, Eric A/0000-0002-9420-6661; Deng, Ye/0000-0002-7584-0632; Probst, Alexander/0000-0002-9392-6544; D'haeseleer, Patrik/0000-0003-0007-8150	University of California at Berkeley, Energy Biosciences Institute under U.S. Department of Energy [DE-AC02-05CH11231]; University of Oklahoma Research Foundation; British Petroleum; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy	University of California at Berkeley, Energy Biosciences Institute under U.S. Department of Energy; University of Oklahoma Research Foundation; British Petroleum; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by a subcontract from the University of California at Berkeley, Energy Biosciences Institute, to Lawrence Berkeley National Laboratory under U.S. Department of Energy contract DE-AC02-05CH11231 and by the University of Oklahoma Research Foundation. The Energy Biosciences Institute is funded by British Petroleum. The SR-FTIR work was conducted at the infrared beamline at the Advanced Light Source, which is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy. We thank T. Pollard, K. Keller, M. Carrera, P. Willems, P. Carragher, P. Collinson, S. Lisiecki, P. Vaishampayan, R. Graham, J. Wong, N. Duncan, D. Long, and N. Tam for logistical and technical support. We also thank the captain, crew, and science teams aboard the R/V Ocean Veritas and the R/V Brooks McCall. The National Center for Biotechnology Information accession numbers of the 16S rRNA genes retrieved from clone library analyses are HM587888, HM587889, and HM587890. Sequences for 16S rRNA are also available at greengenes.lbl.gov.	Aries E, 2001, ORG GEOCHEM, V32, P891, DOI 10.1016/S0146-6380(01)00052-3; Atlas R, 2009, MICROB BIOTECHNOL, V2, P213, DOI 10.1111/j.1751-7915.2008.00079.x; Brakstad OG, 2006, BIODEGRADATION, V17, P71, DOI 10.1007/s10532-005-3342-8; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Gentile G, 2006, ENVIRON MICROBIOL, V8, P2150, DOI 10.1111/j.1462-2920.2006.01097.x; George S., 2001, INFRARED RAMAN CHARA, V3rd; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; Judson RS, 2010, ENVIRON SCI TECHNOL, V44, P5979, DOI 10.1021/es102150z; Kovac N, 2002, MAR CHEM, V78, P205, DOI 10.1016/S0304-4203(02)00033-6; Lasch P., 2015, ENCY ANAL CHEM, P1, DOI DOI 10.1002/9780470027318.A0117.PUB2; Macnaughton SJ, 1999, APPL ENVIRON MICROB, V65, P3566; Pfiffner SM, 2006, GEOMICROBIOL J, V23, P431, DOI 10.1080/01490450600875712; ROBINSON N, 2000, WEARCHECK TECH B; Schlosser A, 2008, INT J SYST EVOL MICR, V58, P2122, DOI 10.1099/ijs.0.65767-0; Venosa AD, 2007, MAR POLLUT BULL, V54, P545, DOI 10.1016/j.marpolbul.2006.12.013; Yakimov MM, 2007, CURR OPIN BIOTECH, V18, P257, DOI 10.1016/j.copbio.2007.04.006; Yakimov MM, 2004, FEMS MICROBIOL ECOL, V49, P419, DOI 10.1016/j.femsec.2004.04.018; Yakimov MM, 2003, INT J SYST EVOL MICR, V53, P779, DOI 10.1099/ijs.0.02366-0	19	820	860	17	902	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					204	208		10.1126/science.1195979	http://dx.doi.org/10.1126/science.1195979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20736401	Green Submitted			2022-12-24	WOS:000282644600037
J	Kuehne, SA; Cartman, ST; Heap, JT; Kelly, ML; Cockayne, A; Minton, NP				Kuehne, Sarah A.; Cartman, Stephen T.; Heap, John T.; Kelly, Michelle L.; Cockayne, Alan; Minton, Nigel P.			The role of toxin A and toxin B in Clostridium difficile infection	NATURE			English	Article							DIARRHEA; STRAIN; RESISTANT; GENOME	Clostridium difficile infection is the leading cause of healthcare-associated diarrhoea in Europe and North America(1,2). During infection, C. difficile produces two key virulence determinants, toxin A and toxin B. Experiments with purified toxins have indicated that toxin A alone is able to evoke the symptoms of C. difficile infection, but toxin B is unable to do so unless it is mixed with toxin A or there is prior damage to the gut mucosa(3). However, a recent study indicated that toxin B is essential for C. difficile virulence and that a strain producing toxin A alone was avirulent(4). This creates a paradox over the individual importance of toxin A and toxin B. Here we show that isogenic mutants of C. difficile producing either toxin A or toxin B alone can cause fulminant disease in the hamster model of infection. By using a gene knockout system(5,6) to inactivate the toxin genes permanently, we found that C. difficile producing either one or both toxins showed cytotoxic activity in vitro that translated directly into virulence in vivo. Furthermore, by constructing the first ever double-mutant strain of C. difficile, in which both toxin genes were inactivated, we were able to completely attenuate virulence. Our findings re-establish the importance of both toxin A and toxin B and highlight the need to continue to consider both toxins in the development of diagnostic tests and effective countermeasures against C. difficile.	[Kuehne, Sarah A.; Cartman, Stephen T.; Heap, John T.; Kelly, Michelle L.; Cockayne, Alan; Minton, Nigel P.] Univ Nottingham, NIHR Biomed Res Unit, Nottingham Digest Dis Ctr, Sch Mol Med Sci,Ctr Biomol Sci,Clostridia Res Grp, Nottingham NG7 2RD, England	University of Nottingham	Minton, NP (corresponding author), Univ Nottingham, NIHR Biomed Res Unit, Nottingham Digest Dis Ctr, Sch Mol Med Sci,Ctr Biomol Sci,Clostridia Res Grp, Nottingham NG7 2RD, England.	nigel.minton@nottingham.ac.uk	Kuehne, Sarah/AAV-3481-2021	Kuehne, Sarah/0000-0001-6790-8433; Minton, Nigel/0000-0002-9277-1261	UK Medical Research Council [G0601176]; European Union [HEALTH-F3-2008-223585]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F003390/1]; BBSRC [BB/F003390/1] Funding Source: UKRI; MRC [G0601176] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F003390/1] Funding Source: researchfish; Medical Research Council [G0601176] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	S.A.K., S.T.C., A.C. and N.P.M. acknowledge the financial support of the UK Medical Research Council (G0601176). Support for M.L.K. was provided by the European Union (HEALTH-F3-2008-223585) and for J.T.H. by the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/F003390/1). We thank C. von-Eichel Streiber for supplying the neutralizing antibody serums and Y. Mahida for the Vero cells. We are also grateful to A. Olling and R. Gerhard for methodological advice on western blots.	Alfa MJ, 2000, J CLIN MICROBIOL, V38, P2706, DOI 10.1128/JCM.38.7.2706-2714.2000; Cartman ST, 2010, APPL ENVIRON MICROB, V76, P1103, DOI 10.1128/AEM.02525-09; Chaves-Olarte E, 2003, J BIOL CHEM, V278, P7956, DOI 10.1074/jbc.M209244200; Drudy D, 2007, INFECT CONT HOSP EP, V28, P932, DOI 10.1086/519181; Drudy D, 2007, INT J INFECT DIS, V11, P5, DOI 10.1016/j.ijid.2006.04.003; Du Tim, 2004, Can J Infect Dis, V15, P83; Elliott B, 2007, INTERN MED J, V37, P561, DOI 10.1111/j.1445-5994.2007.01403.x; HACHLER H, 1987, ANTIMICROB AGENTS CH, V31, P1039, DOI 10.1128/AAC.31.7.1039; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Just I, 2005, REV PHYSIOL BIOCH P, V152, P23, DOI 10.1007/s10254-004-0033-5; KIM PH, 1987, INFECT IMMUN, V55, P2984, DOI 10.1128/IAI.55.12.2984-2992.1987; LYERLY DM, 1985, INFECT IMMUN, V47, P349, DOI 10.1128/IAI.47.2.349-352.1985; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; O'Connor JR, 2006, MOL MICROBIOL, V61, P1335, DOI 10.1111/j.1365-2958.2006.05315.x; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Sambrook J, 2001, MOL CLONING LAB MANU; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Sorg JA, 2008, J BACTERIOL, V190, P2505, DOI 10.1128/JB.01765-07; Stabler RA, 2008, J MED MICROBIOL, V57, P771, DOI 10.1099/jmm.0.47743-0; TORRES J, 1992, TOXICON, V30, P419, DOI 10.1016/0041-0101(92)90538-G; TORRES JF, 1991, J MED MICROBIOL, V35, P40, DOI 10.1099/00222615-35-1-40; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; WILLIAMS DR, 1990, J GEN MICROBIOL, V136, P819, DOI 10.1099/00221287-136-5-819	26	581	604	1	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2010	467	7316					711	U97		10.1038/nature09397	http://dx.doi.org/10.1038/nature09397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20844489	Green Submitted			2022-12-24	WOS:000282572500039
J	Drake, JM; Griffen, BD				Drake, John M.; Griffen, Blaine D.			Early warning signals of extinction in deteriorating environments	NATURE			English	Article							REGIME SHIFTS; POPULATIONS; STOCHASTICITY; ECOSYSTEMS; SYSTEM; TIMES	During the decline to extinction, animal populations may present dynamical phenomena not exhibited by robust populations(1,2). Some of these phenomena, such as the scaling of demographic variance, are related to small size(3-6) whereas others result from density-dependent nonlinearities(7). Although understanding the causes of population extinction has been a central problem in theoretical biology for decades(8), the ability to anticipate extinction has remained elusive(9). Here we argue that the causes of a population's decline are central to the predictability of its extinction. Specifically, environmental degradation may cause a tipping point in population dynamics, corresponding to a bifurcation in the underlying population growth equations, beyond which decline to extinction is almost certain. In such cases, imminent extinction will be signalled by critical slowing down (CSD). We conducted an experiment with replicate laboratory populations of Daphnia magna to test this hypothesis. We show that populations crossing a transcritical bifurcation, experimentally induced by the controlled decline in environmental conditions, show statistical signatures of CSD after the onset of environmental deterioration and before the critical transition. Populations in constant environments did not have these patterns. Four statistical indicators all showed evidence of the approaching bifurcation as early as 110 days (similar to 8 generations) before the transition occurred. Two composite indices improved predictability, and comparative analysis showed that early warning signals based solely on observations in deteriorating environments without reference populations for standardization were hampered by the presence of transient dynamics before the onset of deterioration, pointing to the importance of reliable baseline data before environmental deterioration begins. The universality of bifurcations in models of population dynamics suggests that this phenomenon should be general(10-12).	[Drake, John M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Griffen, Blaine D.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University System of Georgia; University of Georgia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Drake, JM (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	jdrake@uga.edu	Griffen, Blaine/AAC-6384-2021; Drake, John/D-6622-2012	Drake, John/0000-0003-4646-1235	Odum School of Ecology, University of Georgia; University of South Carolina	Odum School of Ecology, University of Georgia; University of South Carolina	G. Fussman, A. Hastings, A. Kramer, R. Hall, A. Park and T. Stratmann provided comments on earlier versions of this paper. A. Silletti assisted with the preparation of the manuscript. This research was supported by funding from the Odum School of Ecology, a University of Georgia Faculty Research Grant and funding from the University of South Carolina.	BAILLIE JEM, 2004, 2004 IUCN RED LIST T, P10; Becks L, 2005, NATURE, V435, P1226, DOI 10.1038/nature03627; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Drake JM, 2005, PLOS BIOL, V3, P1300, DOI 10.1371/journal.pbio.0030222; Drake JM, 2006, ECOLOGY, V87, P2215, DOI 10.1890/0012-9658(2006)87[2215:ETIEP]2.0.CO;2; Fagan WF, 2006, ECOL LETT, V9, P51, DOI 10.1111/j.1461-0248.2005.00845.x; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; HALLAM TG, 1981, J THEOR BIOL, V93, P303, DOI 10.1016/0022-5193(81)90106-5; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Jagers P, 2002, J APPL PROBAB, V39, P395, DOI 10.1017/S0021900200022609; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; Lande R, 1998, OIKOS, V83, P353, DOI 10.2307/3546849; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Ludwig D, 1996, AM NAT, V147, P506, DOI 10.1086/285863; Ludwig D, 1999, ECOLOGY, V80, P298, DOI 10.1890/0012-9658(1999)080[0298:IIMTEA]2.0.CO;2; McSharry PE, 2003, NAT MED, V9, P241, DOI 10.1038/nm0303-241; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; Oborny B, 2005, OIKOS, V109, P291; Saether, 2003, STOCHASTIC POPULATIO, DOI [10.1093/acprof:oso/9780198525257.001.0001, DOI 10.1093/ACPROF:OSO/9780198525257.001.0001]; Scheffer M., 2009, CRITICAL TRANSITIONS; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Takimoto G, 2009, POPUL ECOL, V51, P419, DOI 10.1007/s10144-009-0148-2; VAN NES EH, 2007, AM NAT, V169, P738; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	30	353	368	6	236	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					456	459		10.1038/nature09389	http://dx.doi.org/10.1038/nature09389			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20827269				2022-12-24	WOS:000282090200042
J	Lowe, AJ; Carlin, JB; Bennett, CM; Hosking, CS; Allen, KJ; Robertson, CF; Axelrad, C; Abramson, MJ; Hill, DJ; Dharmage, SC				Lowe, Adrian J.; Carlin, John B.; Bennett, Catherine M.; Hosking, Clifford S.; Allen, Katrina J.; Robertson, Colin F.; Axelrad, Christine; Abramson, Michael J.; Hill, David J.; Dharmage, Shyamali C.			Paracetamol use in early life and asthma: prospective birth cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLUTATHIONE LEVELS; MEDICATION USE; RISK; ACETAMINOPHEN; CHILDREN; ASSOCIATION; INFECTIONS; IBUPROFEN; DISEASE; SENSITIZATION	Objective To determine if use of paracetamol in early life is an independent risk factor for childhood asthma. Design Prospective birth cohort study. Setting Melbourne Atopy Cohort Study. Participants 620 children with a family history of allergic disease, with paracetamol use prospectively documented on 18 occasions from birth to 2 years of age, followed until age 7 years. Main outcome measures The primary outcome was childhood asthma, ascertained by questionnaire at 6 and 7 years. Secondary outcomes were infantile wheeze, allergic rhinitis, eczema, and skin prick test positivity. Results Paracetamol had been used in 51% (295/575) of children by 12 weeks of age and in 97% (556/575) by 2 years. Between 6 and 7 years, 80% (495/620) were followed up; 30% (148) had current asthma. Increasing frequency of paracetamol use was weakly associated with increased risk of childhood asthma (crude odds ratio 1.18, 95% confidence interval 1.00 to 1.39, per doubling of days of use). However, after adjustment for frequency of respiratory infections, this association essentially disappeared (odds ratio 1.08, 0.91 to 1.29). Paracetamol use for non-respiratory causes was not associated with asthma (crude odds ratio 0.95, 0.81 to 1.12). Conclusions In children with a family history of allergic diseases, no association was found between early paracetamol use and risk of subsequent allergic disease after adjustment for respiratory infections or when paracetamol use was restricted to non-respiratory tract infections. These findings suggest that early paracetamol use does not increase the risk of asthma.	[Lowe, Adrian J.; Carlin, John B.; Allen, Katrina J.; Robertson, Colin F.; Axelrad, Christine; Hill, David J.; Dharmage, Shyamali C.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Lowe, Adrian J.; Carlin, John B.; Bennett, Catherine M.; Dharmage, Shyamali C.] Univ Melbourne, Sch Pop Hlth, Ctr Mol Environm Genet & Anal Epidemiol, Carlton, Vic 3053, Australia; [Hosking, Clifford S.] John Hunter Childrens Hosp New Lambton, Dept Paediat, Newcastle, NSW 2305, Australia; [Abramson, Michael J.] Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; Monash University	Lowe, AJ (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	lowe.adrian@gmail.com	Carlin, John/AAG-4332-2020; Allen, Katrina/I-4361-2018; Abramson, Michael/AAQ-2671-2020; Carlin, John B/B-3492-2012	Carlin, John/0000-0002-2694-9463; Allen, Katrina/0000-0002-1921-4493; Abramson, Michael/0000-0002-9954-0538; Carlin, John B/0000-0002-2694-9463; Dharmage, Shyamali/0000-0001-6063-1937; Bennett, Catherine/0000-0001-9581-1612; Lowe, Adrian/0000-0002-4691-8162	Dairy Australia; CRC for Asthma; National Health and Medical Research Council; Nestec, a subsidiary of Nestle Australia; GlaxoSmithKline; Reckitt Benckiser	Dairy Australia(Dairy Australia); CRC for Asthma(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Nestec, a subsidiary of Nestle Australia(Nestle SA); GlaxoSmithKline(GlaxoSmithKline); Reckitt Benckiser	Dairy Australia, CRC for Asthma, and VicHealth supported AJL during his PhD, when the work presented in the manuscript was first developed. AJL, SCD, and KJA are supported by the National Health and Medical Research Council. Nestec, a subsidiary of Nestle Australia, provided staff funding for the first six years of the study. The funding bodies had no role in the design, analysis, conduct, or reporting of the study. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) DJH has received support from Nestec (a subsidiary of Nestle Australia) for the submitted work; (2) within the previous 3 years, SCD has received a grant from GlaxoSmithKline for unrelated work, MJA received funding from Reckitt Benckiser for an unrelated research project, CFR is on the GlaxoSmithKline Pediatric Asthma Scientific Board, and MJA is on the GlaxoSmithKline Scientific Advisory Committee for the Australian Asthma Study, and these companies might have an interest in the submitted work; (3) all authors their spouses, partners, or children have no other financial relationships that may be relevant to the submitted work; and (4) all authors have no non-financial interests that may be relevant to the submitted work.	AAS K, 1973, INT ARCH ALLER A IMM, V45, P57, DOI 10.1159/000231002; Barr RG, 2008, LANCET, V372, P1011, DOI 10.1016/S0140-6736(08)61417-8; Barr RG, 2004, AM J RESP CRIT CARE, V169, P836, DOI 10.1164/rccm.200304-596OC; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Celedon JC, 2004, CLIN EXP ALLERGY, V34, P1011, DOI 10.1111/j.1365-2222.2004.01994.x; Cohet C, 2004, J EPIDEMIOL COMMUN H, V58, P852, DOI 10.1136/jech.2003.019182; Dimova S, 2005, INT J BIOCHEM CELL B, V37, P1727, DOI 10.1016/j.biocel.2005.03.005; Eneli I, 2005, CHEST, V127, P604, DOI 10.1378/chest.127.2.604; Farquhar H, 2009, J ALLERGY CLIN IMMUN, V124, P649, DOI 10.1016/j.jaci.2009.07.037; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; KOGAN MD, 1994, JAMA-J AM MED ASSOC, V272, P1025, DOI 10.1001/jama.272.13.1025; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Lesko SM, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.4.e39; Lesko SM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e20; Lowe AJ, 2007, CLIN EXP ALLERGY, V37, P1624, DOI 10.1111/j.1365-2222.2007.02822.x; Lowe AJ, 2007, CLIN EXP ALLERGY, V37, P536, DOI 10.1111/j.1365-2222.2007.02691.x; Lowe A, 2009, LANCET, V373, P120, DOI 10.1016/S0140-6736(09)60030-1; Lowe AJ, 2006, J ALLERGY CLIN IMMUN, V117, P682, DOI 10.1016/j.jaci.2005.10.027; McKeever TM, 2005, AM J RESP CRIT CARE, V171, P966, DOI 10.1164/rccm.200409-1269OC; Merkus PJFM, 1996, PEDIATR PULM, V21, P383, DOI 10.1002/(SICI)1099-0496(199606)21:6<383::AID-PPUL6>3.0.CO;2-M; MICHELI L, 1994, ENVIRON HEALTH PERSP, V102, P63, DOI 10.1289/ehp.94102s963; Oddy WH, 2002, EUR RESPIR J, V19, P899, DOI 10.1183/09031936.02.00103602; Perzanowski MS, 2010, THORAX, V65, P118, DOI 10.1136/thx.2009.121459; Rebordosa C, 2008, INT J EPIDEMIOL, V37, P583, DOI 10.1093/ije/dyn070; Rockenbauer M, 2001, EPIDEMIOLOGY, V12, P461, DOI 10.1097/00001648-200107000-00017; Shaheen SO, 2002, THORAX, V57, P958, DOI 10.1136/thorax.57.11.958; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5	29	73	74	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2010	341								c4616	10.1136/bmj.c4616	http://dx.doi.org/10.1136/bmj.c4616			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	653LV	20843914	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000282093800015
J	Oh, DY; Talukdar, S; Bae, EJ; Imamura, T; Morinaga, H; Fan, WQ; Li, PP; Lu, WJ; Watkins, SM; Olefsky, JM				Oh, Da Young; Talukdar, Saswata; Bae, Eun Ju; Imamura, Takeshi; Morinaga, Hidetaka; Fan, WuQiang; Li, Pingping; Lu, Wendell J.; Watkins, Steven M.; Olefsky, Jerrold M.			GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects	CELL			English	Article							FREE FATTY-ACIDS; PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; ADIPOSE-TISSUE; OBESITY; INFLAMMATION; RESISTANCE; ACTIVATION; SECRETION; CELLS	Omega-3 fatty acids (omega-3 FAs), DHA and EPA, exert anti-inflammatory effects, but the mechanisms are poorly understood. Here, we show that the G protein-coupled receptor 120 (GPR120) functions as an omega-3 FA receptor/sensor. Stimulation of GPR120 with omega-3 FAs or a chemical agonist causes broad anti-inflammatory effects in monocytic RAW 264.7 cells and in primary intraperitoneal macrophages. All of these effects are abrogated by GPR120 knock-down. Since chronic macrophage-mediated tissue inflammation is a key mechanism for insulin resistance in obesity, we fed obese WT and GPR120 knockout mice a high-fat diet with or without omega-3 FA supplementation. The omega-3 FA treatment inhibited inflammation and enhanced systemic insulin sensitivity in WT mice, but was without effect in GPR120 knockout mice. In conclusion, GPR120 is a functional omega-3 FA receptor/sensor and mediates potent insulin sensitizing and antidiabetic effects in vivo by repressing macrophage-induced tissue inflammation.	[Oh, Da Young; Talukdar, Saswata; Bae, Eun Ju; Morinaga, Hidetaka; Fan, WuQiang; Li, Pingping; Lu, Wendell J.; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Imamura, Takeshi] Shiga Univ Med Sci, Div Pharmacol, Otsu, Shiga 5202192, Japan; [Watkins, Steven M.] Tethys Biosci, W Sacramento, CA 95691 USA	University of California System; University of California San Diego; Shiga University of Medical Science	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Eckhardt, Erik/G-1567-2010; Li, Pingping/F-1109-2019; OH, DA YOUNG/B-2369-2008	Li, Pingping/0000-0003-0679-270X; Talukdar, Saswata/0000-0003-3042-0025	National Institutes of Health [NIDDK DK033651, DK063491, DK 074868]; NICHD/NIH [U54 HD 012303-25]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033651, R37DK033651, P01DK074868, P30DK063491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Jachelle M. Ofrecio and Sarah Nalbandian for their help with animal maintenance and Elizabeth J. Hansen for editorial assistance. We are grateful to Dr. Robert Lefkowitz (Howard Hughes Medical Institute, Duke University) for the gift of FLAG-tagged serial mutant beta-arrestin2 constructs and to Dr. Maziyar Saberi at NGM Bio Inc. (San Francisco, CA) for GLP-1 measurements. We thank the Flow Cytometry Resource and Neal Sekiya for assistance with FACS analysis at the VA San Diego hospital, the UCSD Histology Core lab for technical help with processing liver specimens, and UCSD Microscope Resource for microscopy analysis. This study was funded in part by the National Institutes of Health grants NIDDK DK033651 (J.M.O.), DK063491 (J.M.O.), DK 074868 (J.M.O.), and the Eunice Kennedy Shriver NICHD/NIH through a cooperative agreement U54 HD 012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research.	Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Buettner R, 2006, J MOL ENDOCRINOL, V36, P485, DOI 10.1677/jme.1.01909; Calder PC, 2005, BIOCHEM SOC T, V33, P423, DOI 10.1042/BST0330423; Cen B, 2001, MOL PHARMACOL, V59, P758, DOI 10.1124/mol.59.4.758; Gao H, 2004, MOL CELL, V14, P303, DOI 10.1016/S1097-2765(04)00216-3; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Gotoh C, 2007, BIOCHEM BIOPH RES CO, V354, P591, DOI 10.1016/j.bbrc.2007.01.028; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Imamura T, 1999, MOL CELL BIOL, V19, P6765; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jucker BM, 1999, DIABETES, V48, P134, DOI 10.2337/diabetes.48.1.134; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Luttrell LM, 2002, J CELL SCI, V115, P455; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Oh DY, 2005, MOL ENDOCRINOL, V19, P722, DOI 10.1210/me.2004-0220; Polozova A, 2007, J MOL NEUROSCI, V33, P56, DOI 10.1007/s12031-007-0039-y; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schulte G, 2003, CELL SIGNAL, V15, P813, DOI 10.1016/S0898-6568(03)00058-5; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Tazoe H, 2008, J PHYSIOL PHARMACOL, V59, P251; Ulloa-Aguirre A, 1999, ARCH MED RES, V30, P420, DOI 10.1016/S0188-0128(99)00041-X; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wang YY, 2006, NAT IMMUNOL, V7, P139, DOI 10.1038/ni1294; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	36	1649	1720	16	280	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					687	698		10.1016/j.cell.2010.07.041	http://dx.doi.org/10.1016/j.cell.2010.07.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813258	Bronze, Green Accepted			2022-12-24	WOS:000281523200013
J	Maquat, LE; Tarn, WY; Isken, O				Maquat, Lynne E.; Tarn, Woan-Yuh; Isken, Olaf			The Pioneer Round of Translation: Features and Functions	CELL			English	Article							MESSENGER-RNA DECAY; EXON-JUNCTION COMPLEX; UPF1 PHOSPHORYLATION; ENHANCE TRANSLATION; PROLONGED HYPOXIA; GENE-EXPRESSION; BINDING-PROTEIN; NONSENSE; MECHANISMS; INITIATION	In mammalian cells, newly synthesized mRNAs undergo a pioneer round of translation that is important for mRNA quality control. Following maturation of messenger ribonucleoprotein particles during and after the pioneer round, steady-state cycles of mRNA translation generate most of the cell's proteins. Translation factors, RNA-binding proteins, and targets of signaling pathways that are particular to newly synthesized mRNAs regulate critical functions of the pioneer round.	[Maquat, Lynne E.; Tarn, Woan-Yuh] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Maquat, Lynne E.; Tarn, Woan-Yuh] Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Rochester, NY 14642 USA; [Isken, Olaf] Univ Lubeck, Inst Virol & Cell Biol, D-23562 Lubeck, Germany; [Tarn, Woan-Yuh] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	University of Rochester; University of Rochester; University of Lubeck; Academia Sinica - Taiwan	Maquat, LE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu; isken@molbio.uni-luebeck.de	Tarn, Woan-Yuh/N-8464-2018	Maquat, Lynne/0000-0002-2789-2075	NIGMS NIH HHS [GM59614, R01 GM074593-27, R01 GM074593, R01 GM059614, R37 GM074593, GM074593, R01 GM059614-11, R01 GM059614-11S1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074593, R01GM059614] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Boyne JR, 2010, EMBO J, V29, P1851, DOI 10.1038/emboj.2010.77; Cakmakci NG, 2008, MOL CELL BIOL, V28, P1182, DOI 10.1128/MCB.01500-07; Choe J, 2010, EMBO REP, V11, P380, DOI 10.1038/embor.2010.44; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; di Penta A, 2009, J CELL BIOL, V184, P423, DOI 10.1083/jcb.200807033; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; HATCHET O, 2004, NATURE, V428, P959; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hwang J, 2010, MOL CELL, V39, P396, DOI 10.1016/j.molcel.2010.07.004; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kim KM, 2009, GENE DEV, V23, P2033, DOI 10.1101/gad.1823409; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Lee HC, 2008, BIOCHEM BIOPH RES CO, V369, P1160, DOI 10.1016/j.bbrc.2008.03.017; Lee HC, 2009, BIOCHEM BIOPH RES CO, V384, P334, DOI 10.1016/j.bbrc.2009.04.123; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marin-Vinader L, 2006, BBA-GENE STRUCT EXPR, V1759, P535, DOI 10.1016/J.bbaexp.2006.10.003; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; Oh N, 2007, FEBS LETT, V581, P5158, DOI 10.1016/j.febslet.2007.10.002; Oh N, 2007, BIOCHEM BIOPH RES CO, V362, P145, DOI 10.1016/j.bbrc.2007.07.169; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Sato H, 2008, MOL CELL, V29, P255, DOI 10.1016/j.molcel.2007.12.009; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Wilson KF, 2000, BIOL CHEM, V381, P357, DOI 10.1515/BC.2000.048; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	38	158	160	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					368	374		10.1016/j.cell.2010.07.022	http://dx.doi.org/10.1016/j.cell.2010.07.022			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691898	Green Accepted, Bronze			2022-12-24	WOS:000280609100014
J	Filion, GJ; van Bemmel, JG; Braunschweig, U; Talhout, W; Kind, J; Ward, LD; Brugman, W; de Castro, IJ; Kerkhoven, RM; Bussemaker, HJ; van Steensel, B				Filion, Guillaume J.; van Bemmel, Joke G.; Braunschweig, Ulrich; Talhout, Wendy; Kind, Jop; Ward, Lucas D.; Brugman, Wim; de Castro, Ines J.; Kerkhoven, Ron M.; Bussemaker, Harmen J.; van Steensel, Bas			Systematic Protein Location Mapping Reveals Five Principal Chromatin Types in Drosophila Cells	CELL			English	Article							B-TYPE LAMIN; HISTONE H3; DOSAGE COMPENSATION; MELANOGASTER GENOME; GENE-EXPRESSION; LINKER HISTONE; NUCLEAR LAMINA; TRANSCRIPTION; COMPLEX; HETEROCHROMATIN	Chromatin is important for the regulation of transcription and other functions, yet the diversity of chromatin composition and the distribution along chromosomes are still poorly characterized. By integrative analysis of genome-wide binding maps of 53 broadly selected chromatin components in Drosophila cells, we show that the genome is segmented into five principal chromatin types that are defined by unique yet overlapping combinations of proteins and form domains that can extend over > 100 kb. We identify a repressive chromatin type that covers about half of the genome and lacks classic heterochromatin markers. Furthermore, transcriptionally active euchromatin consists of two types that differ in molecular organization and H3K36 methylation and regulate distinct classes of genes. Finally, we provide evidence that the different chromatin types help to target DNA-binding factors to specific genomic regions. These results provide a global view of chromatin diversity and domain organization in a metazoan cell.	[Filion, Guillaume J.; van Bemmel, Joke G.; Braunschweig, Ulrich; Talhout, Wendy; Kind, Jop; de Castro, Ines J.; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Brugman, Wim; Kerkhoven, Ron M.] Netherlands Canc Inst, Cent Microarray Facil, NL-1066 CX Amsterdam, Netherlands; [Ward, Lucas D.; Bussemaker, Harmen J.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Ward, Lucas D.; Bussemaker, Harmen J.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Columbia University; Columbia University	van Steensel, B (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	b.v.steensel@nki.nl	Filion, Guillaume/G-9619-2015; Braunschweig, Ulrich/I-1070-2019	Filion, Guillaume/0000-0002-3473-1632; Braunschweig, Ulrich/0000-0001-6653-0926; Ward, Lucas/0000-0002-8017-809X; de Castro, Ines/0000-0001-8710-3667	EMBO; National Institutes of Health [T32GM082797, R01HG003008, U54CA121852]; Netherlands Genomics Initiative; NWO-ALW VICI; EURYI; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM082797] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Genomics Initiative; NWO-ALW VICI(Netherlands Organization for Scientific Research (NWO)); EURYI(European Science Foundation (ESF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Francesco Russo for help with vector cloning; Marja Nieuwland and Arno Velds for help with RNA tag sequencing; Dirk Schubeler's laboratory for sharing H3K36 methylation data prior to publication; and Reuven Agami, Fred van Leeuwen, Wouter Meuleman, Ludo Pagie, and Aleksey Pindyurin for helpful suggestions. Supported by an EMBO long-term fellowship to J.K.; National Institutes of Health grants T32GM082797, R01HG003008, and U54CA121852 to L. D. W. and H. J.B.; and grants from the Netherlands Genomics Initiative, NWO-ALW VICI, and an EURYI Award to B. v. S.	Babenko VN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-318; Beato M, 1997, NUCLEIC ACIDS RES, V25, P3559, DOI 10.1093/nar/25.18.3559; Bell O, 2010, NAT STRUCT MOL BIOL, V17, P894, DOI 10.1038/nsmb.1825; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bianchi-Frias D, 2004, PLOS BIOL, V2, P975, DOI 10.1371/journal.pbio.0020178; Braunschweig U, 2009, EMBO J, V28, P3635, DOI 10.1038/emboj.2009.301; Cenci G, 1997, GENE DEV, V11, P863, DOI 10.1101/gad.11.7.863; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Collas P, 2009, METHODS MOL BIOL, V567, P1, DOI 10.1007/978-1-60327-414-2_1; Crevel G, 2001, J CELL SCI, V114, P37; Czermin B, 2001, EMBO REP, V2, P915, DOI 10.1093/embo-reports/kve210; de Wit E, 2007, PLOS GENET, V3, P346, DOI 10.1371/journal.pgen.0030038; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Fauvarque MO, 2001, GENET RES, V78, P137, DOI 10.1017/S0016672301005274; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Foat BC, 2006, BIOINFORMATICS, V22, pE141, DOI 10.1093/bioinformatics/btl223; Gelbart ME, 2005, GENE DEV, V19, P942, DOI 10.1101/gad.1298905; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gilbert DM, 2002, CURR OPIN CELL BIOL, V14, P377, DOI 10.1016/S0955-0674(02)00326-5; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Greil F, 2007, EMBO J, V26, P741, DOI 10.1038/sj.emboj.7601527; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Hediger F, 2006, CURR OPIN GENET DEV, V16, P143, DOI 10.1016/j.gde.2006.02.013; Kelley RL, 2003, GENETICS, V164, P565; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; LAYBOURN PJ, 1991, SCIENCE, V254, P238, DOI 10.1126/science.1718039; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; LenzBohme B, 1997, J CELL BIOL, V137, P1001, DOI 10.1083/jcb.137.5.1001; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Liu ZQ, 2005, MOL CELL BIOL, V25, P2819, DOI 10.1128/MCB.25.7.2819-2831.2005; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; MacAlpine HK, 2010, GENOME RES, V20, P201, DOI 10.1101/gr.097873.109; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pindyurin AV, 2007, J CELL SCI, V120, P2344, DOI 10.1242/jcs.006007; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Schmiedeberg L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004636; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Singh RK, 2009, NAT CELL BIOL, V11, P925, DOI 10.1038/ncb1903; Smith MB, 2010, CHROMOSOMA, V119, P287, DOI 10.1007/s00412-010-0257-x; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tie F, 2003, MOL CELL BIOL, V23, P3352, DOI 10.1128/MCB.23.9.3352-3362.2003; Tie F, 2001, DEVELOPMENT, V128, P275; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989; Zhimulev IF, 2003, CHROMOSOMA, V111, P377, DOI 10.1007/s00412-002-0218-0	63	664	683	0	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 15	2010	143	2					212	224		10.1016/j.cell.2010.09.009	http://dx.doi.org/10.1016/j.cell.2010.09.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	665RC	20888037	Green Accepted, Bronze			2022-12-24	WOS:000283052200011
J	Dang, SY; Sun, LF; Huang, YJ; Lu, FR; Liu, YF; Gong, HP; Wang, JW; Yan, NE				Dang, Shangyu; Sun, Linfeng; Huang, Yongjian; Lu, Feiran; Liu, Yufeng; Gong, Haipeng; Wang, Jiawei; Yan, Nieng			Structure of a fucose transporter in an outward-open conformation	NATURE			English	Article							H+ SYMPORT PROTEIN; LACTOSE PERMEASE; MECHANISM; BINDING; IDENTIFICATION; FUCP; SITE	The major facilitator superfamily (MFS) transporters are an ancient and widespread family of secondary active transporters(1). In Escherichia coli, the uptake of L-fucose, a source of carbon for microorganisms, is mediated by an MFS proton symporter, FucP(2,3). Despite intensive study of the MFS transporters, atomic structure information is only available on three proteins and the outward-open conformation has yet to be captured(4-6). Here we report the crystal structure of FucP at 3.1 angstrom resolution, which shows that it contains an outward-open, amphipathic cavity. The similarly folded amino and carboxyl domains of FucP have contrasting surface features along the transport path, with negative electrostatic potential on the N domain and hydrophobic surface on the C domain. FucP only contains two acidic residues along the transport path, Asp 46 and Glu 135, which can undergo cycles of protonation and deprotonation. Their essential role in active transport is supported by both in vivo and in vitro experiments. Structure-based biochemical analyses provide insights into energy coupling, substrate recognition and the transport mechanism of FucP.	[Wang, Jiawei] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; Tsinghua Univ, Sch Med, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Wang, JW (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	jwwang@tsinghua.edu.cn; nyan@tsinghua.edu.cn	Huang, Yongjian/GPK-5986-2022; Wang, Jiawei/D-1144-2010	Huang, Yongjian/0000-0002-1168-6111; Wang, Jiawei/0000-0001-9893-8539; Lu, Feiran/0000-0002-1757-2895; Liu, Yufeng/0000-0003-0848-5113; Dang, Shangyu/0000-0001-9141-1865	Ministry of Science and Technology [2009CB918802]; Tsinghua University [985]; Yuyuan Foundation; Li Foundation	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University; Yuyuan Foundation; Li Foundation	We thank N. Shimizu and T. Kumasaka at Spring-8 beamline BL41XU in Japan, and J. He and S. Huang at the Shanghai Synchrotron Radiation Facility (SSRF) for on-site assistance. This work was supported by funds from the Ministry of Science and Technology (grant number 2009CB918802) and by Tsinghua University 985 Phase II funds. N.Y. acknowledges support from the Yuyuan Foundation and the Li Foundation.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; BRADLEY SA, 1987, BIOCHEM J, V248, P495, DOI 10.1042/bj2480495; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Christensen M, 2003, J BACTERIOL, V185, P6042, DOI 10.1128/JB.185.20.6042-6050.2003; COWTAN K, 1994, INT CCP4 ESF EACBM N, V31, P34; DeLano W.L., 2002, PYMOL MOL VIEWER; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANCO PJ, 1994, J BIOL CHEM, V269, P7379; Guan L, 2004, P NATL ACAD SCI USA, V101, P12148, DOI 10.1073/pnas.0404936101; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; GUNN FJ, 1995, MOL MICROBIOL, V15, P771, DOI 10.1111/j.1365-2958.1995.tb02384.x; GUNN FJ, 1994, MOL MICROBIOL, V12, P799, DOI 10.1111/j.1365-2958.1994.tb01066.x; Horiba N, 2003, J BIOL CHEM, V278, P14669, DOI 10.1074/jbc.M212240200; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Paulsen IT, 1998, J BACTERIOL, V180, P498, DOI 10.1128/JB.180.3.498-504.1998; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Psakis G, 2009, MOL MICROBIOL, V71, P391, DOI 10.1111/j.1365-2958.2008.06535.x; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Smirnova I, 2009, P NATL ACAD SCI USA, V106, P21561, DOI 10.1073/pnas.0911434106; Veenhoff LM, 1999, J BIOL CHEM, V274, P33244, DOI 10.1074/jbc.274.47.33244; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629	33	213	221	3	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2010	467	7316					734	U130		10.1038/nature09406	http://dx.doi.org/10.1038/nature09406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20877283				2022-12-24	WOS:000282572500044
J	Liu, H; Takeda, S; Kumar, R; Westergard, TD; Brown, EJ; Pandita, TK; Cheng, EHY; Hsieh, JJD				Liu, Han; Takeda, Shugaku; Kumar, Rakesh; Westergard, Todd D.; Brown, Eric J.; Pandita, Tej K.; Cheng, Emily H. -Y.; Hsieh, James J. -D.			Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint	NATURE			English	Article							CELL-CYCLE; DNA-DAMAGE; FUSION GENE; MAINTENANCE; PROTEINS; COMPLEX; ASSOCIATION; ACTIVATION; EXPRESSION; STABILITY	Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors(1,2). Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2- and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity(3,4). Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias(5-9). Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCFSkp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll(-/-) (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or Delta SET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll-CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.	[Liu, Han; Takeda, Shugaku; Westergard, Todd D.; Cheng, Emily H. -Y.; Hsieh, James J. -D.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Kumar, Rakesh; Pandita, Tej K.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Brown, Eric J.] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA	Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Pennsylvania	Hsieh, JJD (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	jhsieh@dom.wustl.edu	Pandita, Tej K/AAM-9188-2020	Liu, Han/0000-0002-0022-1861; kumar, rakesh/0000-0002-0741-3663	American Society of Hematology [CA119008, CA129537/CA123232]; NATIONAL CANCER INSTITUTE [R01CA123232, R01CA129537, R01CA119008] Funding Source: NIH RePORTER	American Society of Hematology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Y. Wang and Z. You for discussions during the inception and the completion of this study, respectively. H.L. is supported by the Scholar award of the American Society of Hematology. The Mll<SUP>+1/ex7(stop)CBP</SUP> mice were provided by S. Armstrong and the late S. Korsmeyer. This study is supported by CA119008, the Scholar award of the American Society of Hematology, the Scholar award of the American Cancer Society, to J.J.-D.H., and CA129537/CA123232, to T.K.P.	Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Eguchi M, 2006, GENE CHROMOSOME CANC, V45, P754, DOI 10.1002/gcc.20338; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Gupta A, 2008, MOL CELL BIOL, V28, P397, DOI 10.1128/MCB.01045-07; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; Liedtke M, 2009, BLOOD, V113, P6061, DOI 10.1182/blood-2008-12-197061; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Liu H, 2007, GENE DEV, V21, P2385, DOI 10.1101/gad.1574507; Liu H, 2009, CANCER BIOL THER, V8, P1204, DOI 10.4161/cbt.8.13.8924; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Rodriguez-Perales S, 2008, INT J HEMATOL, V87, P3, DOI 10.1007/s12185-007-0001-3; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Takeda S, 2006, GENE DEV, V20, P2397, DOI 10.1101/gad.1449406; Theunissen JWF, 2006, METHOD ENZYMOL, V409, P251, DOI 10.1016/S0076-6879(05)09015-4; Tu HC, 2009, P NATL ACAD SCI USA, V106, P1093, DOI 10.1073/pnas.0808173106; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Wang J, 2005, EMBO J, V24, P368, DOI 10.1038/sj.emboj.7600521; Xia ZB, 2005, P NATL ACAD SCI USA, V102, P14028, DOI 10.1073/pnas.0506464102; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022	38	101	105	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2010	467	7313					343	U126		10.1038/nature09350	http://dx.doi.org/10.1038/nature09350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20818375	Green Accepted			2022-12-24	WOS:000281824900042
J	Perocchi, F; Gohil, VM; Girgis, HS; Bao, XR; McCombs, JE; Palmer, AE; Mootha, VK				Perocchi, Fabiana; Gohil, Vishal M.; Girgis, Hany S.; Bao, X. Robert; McCombs, Janet E.; Palmer, Amy E.; Mootha, Vamsi K.			MICU1 encodes a mitochondrial EF hand protein required for Ca2+ uptake	NATURE			English	Article							RAT KIDNEY MITOCHONDRIA; CALCIUM-UPTAKE; YEAST MITOCHONDRIA; INNER MEMBRANE; UNIPORTER; TRANSPORT; CELL; PHOSPHORYLATION; GLYCOPROTEIN; OSCILLATIONS	Mitochondrial calcium uptake has a central role in cell physiology by stimulating ATP production, shaping cytosolic calcium transients and regulating cell death. The biophysical properties of mitochondrial calcium uptake have been studied in detail, but the underlying proteins remain elusive. Here we use an integrative strategy to predict human genes involved in mitochondrial calcium entry based on clues from comparative physiology, evolutionary genomics and organelle proteomics. RNA interference against 13 top candidates highlighted one gene, CBARA1, that we call hereafter mitochondrial calcium uptake 1 (MICU1). Silencing MICU1 does not disrupt mitochondrial respiration or membrane potential but abolishes mitochondrial calcium entry in intact and permeabilized cells, and attenuates the metabolic coupling between cytosolic calcium transients and activation of matrix dehydrogenases. MICU1 is associated with the mitochondrial inner membrane and has two canonical EF hands that are essential for its activity, indicating a role in calcium sensing. MICU1 represents the founding member of a set of proteins required for high-capacity mitochondrial calcium uptake. Its discovery may lead to the complete molecular characterization of mitochondrial calcium uptake pathways, and offers genetic strategies for understanding their contribution to normal physiology and disease.	[Perocchi, Fabiana; Gohil, Vishal M.; Girgis, Hany S.; Bao, X. Robert; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Perocchi, Fabiana; Gohil, Vishal M.; Girgis, Hany S.; Bao, X. Robert; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02142 USA; [Perocchi, Fabiana; Gohil, Vishal M.; Girgis, Hany S.; Bao, X. Robert; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [McCombs, Janet E.; Palmer, Amy E.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Boulder	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	vamsi@hms.harvard.edu		perocchi, fabiana/0000-0002-1102-6500; Bao, Xiaoyan/0000-0001-7931-2944; McCombs, Janet/0000-0002-3514-8019; Gohil, Vishal/0000-0002-9920-2563	National Institutes of Health [GM084027, TR2 GM08759, GM0077465, DK080261]; HHMI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084027, R01GM077465, T32GM008759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Grabarek, S. Silver and D. Root for advice; S. Calvo and A. Wolf for assistance with bioinformatics; P. Federico for technical assistance; and members of the Mootha Laboratory for valuable feedback. This work was supported by grants from the National Institutes of Health (GM084027) to A.E.P, TR2 GM08759 to J.E.M. and GM0077465, DK080261 awarded to V.K.M., and by an HHMI Early Career Physician Scientist Award to V.K.M.	Aichberger KJ, 2005, J IMMUNOL, V175, P1286, DOI 10.4049/jimmunol.175.2.1286; Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; BALCAVAG.WX, 1973, BIOCHIM BIOPHYS ACTA, V305, P41, DOI 10.1016/0005-2728(73)90229-6; Bernardi P., 2007, V45, P481; BRAGADIN M, 1979, BIOCHEMISTRY-US, V18, P5972, DOI 10.1021/bi00593a033; Brini M, 1999, MICROSC RES TECHNIQ, V46, P380, DOI 10.1002/(SICI)1097-0029(19990915)46:6<380::AID-JEMT6>3.0.CO;2-Y; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; DOCAMPO R, 1989, J BIOL CHEM, V264, P108; FAVARON M, 1985, FEBS LETT, V183, P260, DOI 10.1016/0014-5793(85)80789-4; Filippin L, 2003, J BIOL CHEM, V278, P39224, DOI 10.1074/jbc.M302301200; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Gaspers LD, 2008, METHODS, V46, P224, DOI 10.1016/j.ymeth.2008.09.012; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; IGBAVBOA U, 1988, J BIOL CHEM, V263, P1405; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; Kaftan EJ, 2000, J BIOL CHEM, V275, P25465, DOI 10.1074/jbc.M000903200; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lawrie AM, 1996, J BIOL CHEM, V271, P10753, DOI 10.1074/jbc.271.18.10753; McDonald T, 2006, MOL CELL PROTEOMICS, V5, P2392, DOI 10.1074/mcp.T500036-MCP200; MIRONOVA GD, 1982, J BIOENERG BIOMEMBR, V14, P213, DOI 10.1007/BF00751016; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; PANFILI E, 1976, NATURE, V264, P185, DOI 10.1038/264185a0; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; URIBE S, 1992, CELL CALCIUM, V13, P211, DOI 10.1016/0143-4160(92)90009-H; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; VERCESI AE, 1992, BIOCHEM J, V284, P463, DOI 10.1042/bj2840463; Zazueta C, 1998, J BIOENERG BIOMEMBR, V30, P489, DOI 10.1023/A:1020546331217; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	48	616	633	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2010	467	7313					291	U67		10.1038/nature09358	http://dx.doi.org/10.1038/nature09358			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20693986	Green Accepted			2022-12-24	WOS:000281824900031
J	Larson, HJ; Brocard, P; Garnett, G				Larson, Heidi J.; Brocard, Pauline; Garnett, Geoffrey			The India HPV-vaccine suspension	LANCET			English	Editorial Material									[Larson, Heidi J.; Brocard, Pauline; Garnett, Geoffrey] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth, London SW7 1NA, England	Imperial College London	Larson, HJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth, London SW7 1NA, England.	h.larson@imperial.ac.uk	Garnett, Geoffrey P/A-9312-2008; Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583				Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; Cooper LZ, 2008, PEDIATRICS, V122, P149, DOI 10.1542/peds.2008-0987; Ramanathan Mala, 2010, Indian J Med Ethics, V7, P43; *SAH WOM RES CTR S, 2009, WOM ORG OPP HPV VACC; *SAM RES GROUP WOM, 2009, CONC HPV VACC MEM HL; *SAM RES GROUP WOM, 2010, MEM HLTH MIN WORLD H; SINHA K, 2010, TIMES INDIA     0409; THACKER T, 2010, MINISTRY ADMITS LAPS; 2010, UPDATE PATHS HPV VAC; 2010, TIMES INDIA     0422; 2010, GLAXOSMITHKLINE RESP	11	60	61	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 21	2010	376	9741					572	573		10.1016/S0140-6736(10)60881-1	http://dx.doi.org/10.1016/S0140-6736(10)60881-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643PB	20728739				2022-12-24	WOS:000281309100007
J	Berne, O; Marcelino, N; Cernicharo, J				Berne, Olivier; Marcelino, Nuria; Cernicharo, Jose			Waves on the surface of the Orion molecular cloud	NATURE			English	Article							H-2 EMISSION; GAS; PHOTOEVAPORATION; REGION; STARS	Massive stars influence their parental molecular cloud, and it has long been suspected that the development of hydrodynamical instabilities can compress or fragment the cloud(1,2). Identifying such instabilities has proved difficult. It has been suggested that elongated structures (such as the 'pillars of creation'(3)) and other shapes arise because of instabilities(4,5), but alternative explanations are available(6,7). One key signature of an instability is a wave-like structure in the gas, which has hitherto not been seen. Here we report the presence of 'waves' at the surface of the Orion molecular cloud near where massive stars are forming. The waves seem to be a Kelvin-Helmholtz instability that arises during the expansion of the nebula as gas heated and ionized by massive stars is blown over pre-existing molecular gas.	[Berne, Olivier; Marcelino, Nuria; Cernicharo, Jose] CSIC INTA, Ctr Astrobiol, Torrejon De Ardoz 28850, Spain; [Berne, Olivier] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Leiden University; Leiden University - Excl LUMC	Berne, O (corresponding author), CSIC INTA, Ctr Astrobiol, Carretera Torrejon Ajalvir,Km 4, Torrejon De Ardoz 28850, Spain.	berne@strw.leidenuniv.nl	Marcelino, Nuria/H-4400-2017; Cernicharo, Jose/G-3059-2015	Marcelino, Nuria/0000-0001-7236-4047; Cernicharo, Jose/0000-0002-3518-2524	NASA	NASA(National Aeronautics & Space Administration (NASA))	We thank J. Bally and M. Pound for their comments, which contributed to the improvement of the manuscript. We also acknowledge B. Lefloc'h, J. Goicoechea and J. Martin-Pintado for discussions. D. Hochberg is acknowledged for his reading of the manuscript. O.B. acknowledges C. Joblin for support. This work is based in part on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA.	Bachiller R, 1996, ANNU REV ASTRON ASTR, V34, P111, DOI 10.1146/annurev.astro.34.1.111; Bally J, 2006, ASTRON J, V131, P473, DOI 10.1086/498265; Bally J, 2008, MONOGR ASTRON SOC PA, V4, P459; Berne O, 2009, ASTROPHYS J LETT, V706, pL160, DOI 10.1088/0004-637X/706/1/L160; CHANDRASEKHAR S, 1961, HYDRODYNAMIC HYDROMA, pCH11; GENZEL R, 1989, ANNU REV ASTRON ASTR, V27, P41, DOI 10.1146/annurev.aa.27.090189.000353; Gudel M, 2008, SCIENCE, V319, P309, DOI 10.1126/science.1149926; Hester JJ, 1996, ASTRON J, V111, P2349, DOI 10.1086/117968; Johnstone D, 1998, ASTROPHYS J, V499, P758, DOI 10.1086/305658; Kaufman MJ, 2006, ASTROPHYS J, V644, P283, DOI 10.1086/503596; Lefloch B, 2003, ASTROPHYS J, V590, pL41, DOI 10.1086/376673; Menten KM, 2007, ASTRON ASTROPHYS, V474, P515, DOI 10.1051/0004-6361:20078247; Neufeld DA, 2009, ASTROPHYS J, V706, P170, DOI 10.1088/0004-637X/706/1/170; Pound MW, 1998, ASTROPHYS J, V493, pL113, DOI 10.1086/311131; Pound MW, 2003, ASTRON J, V125, P2108, DOI 10.1086/368138; RODRIGUEZFRANCO A, 1992, ASTRON ASTROPHYS, V264, P592; Ryutov DD, 2007, ASTROPHYS SPACE SCI, V307, P173, DOI 10.1007/s10509-006-9233-6; Ryutov DD, 2003, PLASMA PHYS CONTR F, V45, P769, DOI 10.1088/0741-3335/45/5/319; Schuster KF, 2004, ASTRON ASTROPHYS, V423, P1171, DOI 10.1051/0004-6361:20034179; SPITZER L, 1978, PHYSICAL PROCESSES I, P223; Tappe A, 2008, ASTROPHYS J LETT, V680, pL117, DOI 10.1086/589998; TENORIOTAGLE G, 1988, ANNU REV ASTRON ASTR, V26, P145; TIELENS AGGM, 1993, SCIENCE, V262, P86, DOI 10.1126/science.262.5130.86; Weingartner JC, 2001, ASTROPHYS J, V548, P296, DOI 10.1086/318651; Wilms J, 2000, ASTROPHYS J, V542, P914, DOI 10.1086/317016; WOODWARD PR, 1976, ASTROPHYS J, V207, P484, DOI 10.1086/154516	26	32	32	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					947	949		10.1038/nature09289	http://dx.doi.org/10.1038/nature09289			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725034	Green Submitted			2022-12-24	WOS:000281030300028
J	Kallen, AJ; Mu, Y; Bulens, S; Reingold, A; Petit, S; Gershman, K; Ray, SM; Harrison, LH; Lynfield, R; Dumyati, G; Townes, JM; Schaffner, W; Patel, PR; Fridkin, SK				Kallen, Alexander J.; Mu, Yi; Bulens, Sandra; Reingold, Arthur; Petit, Susan; Gershman, Ken; Ray, Susan M.; Harrison, Lee H.; Lynfield, Ruth; Dumyati, Ghinwa; Townes, John M.; Schaffner, William; Patel, Priti R.; Fridkin, Scott K.		ABCs MRSA Investigators Emerging I	Health Care-Associated Invasive MRSA Infections, 2005-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BLOOD-STREAM INFECTIONS; SURVEILLANCE CULTURES; DISEASE; IMPACT; COLONIZATION; EMERGENCE; ADMISSION	Context Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogen of public health importance; MRSA prevention programs that may affect MRSA transmission and infection are increasingly common in health care settings. Whether there have been changes in MRSA infection incidence as these programs become established is unknown; however, recent data have shown that rates of MRSA bloodstream infections (BSIs) in intensive care units are decreasing. Objective To describe changes in rates of invasive health care associated MRSA infections from 2005 through 2008 among residents of 9 US metropolitan areas. Design, Setting, and Participants Active, population-based surveillance for invasive MRSA in 9 metropolitan areas covering a population of approximately 15 million persons. All reports of laboratory-identified episodes of invasive (from a normally sterile body site) MRSA infections from 2005 through 2008 were evaluated and classified based on the setting of the positive culture and the presence or absence of health care exposures. Health care associated infections (ie, hospital-onset and health care associated community-onset), which made up 82% of the total infections, were included in this analysis. Main Outcome Measures Change in incidence of invasive health care associated MRSA infections and health care associated MRSA BSIs using population of the catchment area as the denominator. Results From 2005 through 2008, there were 21 503 episodes of invasive MRSA infection; 17 508 were health care associated. Of these, 15 458 were MRSA BSIs. The incidence rate of hospital-onset invasive MRSA infections was 1.02 per 10 000 population in 2005 and decreased 9.4% per year (95% confidence interval [Cl], 14.7% to 3.8%; P=.005), and the incidence of health care associated community-onset infections was 2.20 per 10 000 population in 2005 and decreased 5.7% per year (95% Cl, 9.7% to 1.6%; P=.01). The decrease was most prominent for the subset of infections with BSIs (hospital-onset: -11.2%; 95% Cl -15.9% to -6.3%; health care associated community-onset: -6.6%; 95% Cl -9.5% to -3.7%). Conclusion Over the 4-year period from 2005 through 2008 in 9 diverse metropolitan areas, rates of invasive health care associated MRSA infections decreased among patients with health care associated infections that began in the community and also decreased among those with hospital-onset invasive disease. JAMA. 2010;304(6):641-648	[Kallen, Alexander J.; Mu, Yi; Bulens, Sandra; Patel, Priti R.; Fridkin, Scott K.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA; [Bulens, Sandra] Atlanta Res & Educ Fdn, Decatur, GA USA; [Reingold, Arthur] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Petit, Susan] Connecticut Dept Publ Hlth & Addict Serv, Hartford, CT 06106 USA; [Gershman, Ken] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Ray, Susan M.] Emory Univ, Sch Med, Atlanta, GA USA; [Harrison, Lee H.] Maryland Emerging Infect Program, Baltimore, MD USA; [Harrison, Lee H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [Dumyati, Ghinwa] Univ Rochester, Rochester, NY USA; [Townes, John M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Schaffner, William] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Centers for Disease Control & Prevention - USA; University of California System; University of California Berkeley; Colorado Department of Public Health & Environment; Emory University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Minnesota Department of Health (MHD); University of Rochester; Oregon Health & Science University; Vanderbilt University	Kallen, AJ (corresponding author), 1600 Clifton Rd NE,MS A-35, Atlanta, GA 30333 USA.	AKallen@cdc.gov		Ray, Susan/0000-0002-6327-088X; Shutt, Kathleen/0000-0003-3376-6152				[Anonymous], 2005, MMWR MORB MORTAL WKL; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; Calfee DP, 2008, INFECT CONT HOSP EP, V29, pS62, DOI 10.1086/591061; Carrillo-Marquez MA, 2009, PEDIATR INFECT DIS J, V28, P1076, DOI 10.1097/INF.0b013e3181adbcfe; Centers for Disease Control and Prevention, ACT BACT COR SURV RE; Chaberny IF, 2008, J ANTIMICROB CHEMOTH, V62, P1422, DOI 10.1093/jac/dkn373; Cohen AL, 2008, INFECT CONT HOSP EP, V29, P901, DOI 10.1086/591741; Collins A., 2007, Morbidity and Mortality Weekly Report, V56, P197; DeFrances Carol J, 2007, Vital Health Stat 13, P1; DeFrances CJ, 2008, 5 NAT CTR HLTH STAT; Enayet I, 2006, CLIN INFECT DIS, V42, pE57, DOI 10.1086/501125; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Kallen AJ, 2009, ANN EMERG MED, V53, P358, DOI 10.1016/j.annemergmed.2008.04.027; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Liebowitz Lynne D, 2009, Int J Antimicrob Agents, V34 Suppl 3, pS11, DOI 10.1016/S0924-8579(09)70551-5; Limbago B, 2009, J CLIN MICROBIOL, V47, P1344, DOI 10.1128/JCM.02264-08; Liu C, 2008, CLIN INFECT DIS, V46, P1637, DOI 10.1086/587893; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Muder RR, 2008, INFECT CONT HOSP EP, V29, P702, DOI 10.1086/589981; Pearson A, 2009, J ANTIMICROB CHEMOTH, V64, P11, DOI 10.1093/jac/dkp260; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Ridenour G, 2007, INFECT CONT HOSP EP, V28, P1155, DOI 10.1086/520102; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Robicsek A, 2009, INFECT CONT HOSP EP, V30, P623, DOI 10.1086/597550; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Siegel JD, 2006, HEALTHCARE INFECT CO; U.S. Department of Health and Human Services Office of the Secretary Office of the Assistant Secretary for Health, HHS ACT PLAN PREV HE	31	325	334	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					641	648		10.1001/jama.2010.1115	http://dx.doi.org/10.1001/jama.2010.1115			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699455	Bronze			2022-12-24	WOS:000280829200019
J	Cooper, S; Khatib, F; Treuille, A; Barbero, J; Lee, J; Beenen, M; Leaver-Fay, A; Baker, D; Popovic, Z; Players, F				Cooper, Seth; Khatib, Firas; Treuille, Adrien; Barbero, Janos; Lee, Jeehyung; Beenen, Michael; Leaver-Fay, Andrew; Baker, David; Popovic, Zoran; Players, Foldit			Predicting protein structures with a multiplayer online game	NATURE			English	Article								People exert large amounts of problem-solving effort playing computer games. Simple image-and text-recognition tasks have been successfully 'crowd-sourced' through games(1-3), but it is not clear if more complex scientific problems can be solved with human-directed computing. Protein structure prediction is one such problem: locating the biologically relevant native conformation of a protein is a formidable computational challenge given the very large size of the search space. Here we describe Foldit, a multiplayer online game that engages non-scientists in solving hard prediction problems. Foldit players interact with protein structures using direct manipulation tools and user-friendly versions of algorithms from the Rosetta structure prediction methodology(4), while they compete and collaborate to optimize the computed energy. We show that top-ranked Foldit players excel at solving challenging structure refinement problems in which substantial backbone rearrangements are necessary to achieve the burial of hydrophobic residues. Players working collaboratively develop a rich assortment of new strategies and algorithms; unlike computational approaches, they explore not only the conformational space but also the space of possible search strategies. The integration of human visual problem-solving and strategy development capabilities with traditional computational algorithms through interactive multiplayer games is a powerful new approach to solving computationally-limited scientific problems.	[Cooper, Seth; Treuille, Adrien; Barbero, Janos; Beenen, Michael; Popovic, Zoran] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Khatib, Firas; Leaver-Fay, Andrew; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Treuille, Adrien; Lee, Jeehyung] Carnegie Mellon Univ, Sch Comp Sci, Pittsburgh, PA 15213 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Carnegie Mellon University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Popovic, Z (corresponding author), Univ Washington, Dept Comp Sci & Engn, Box 352350, Seattle, WA 98195 USA.	dabaker@u.washington.edu; zoran@cs.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Barbero, Janos/0000-0002-8256-7734; Newman, Gregory/0000-0003-0503-5782	NSF [IIS0811902, 0906026]; DARPA [N00173-08-1-G025]; Howard Hughes Medical Institute; Microsoft; NVIDIA Fellowship; Div Of Biological Infrastructure [0906026] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [0953985] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Microsoft(Microsoft); NVIDIA Fellowship; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank D. Salesin, K. Tuite, J. Snyder, D. Suskin, P. Krahenbuhl, A. C. Snyder, H. Lu, L. S. Tan, A. Chia, M. Yao, E. Butler, C. Carrico, P. Bradley, I. Davis, D. Kim, R. Das, W. Sheffler, J. Thompson, O. Lange, R. Vernon, B. Correia, D. Anderson, Y. Zhao, S. Herin and B. Bethurum for their help. We would like to thank N. Koga, R. Koga and A. Deacon and the JCSG for providing us with protein structures before their public release. We would also like to acknowledge all of the Foldit players who have made this work possible. Usernames of players whose solutions were used in figures can be found in Supplementary Table 4. This work was supported by NSF grants IIS0811902 and 0906026, DARPA grant N00173-08-1-G025, the DARPA PDP program, the Howard Hughes Medical Institute (D. B.), Microsoft, and an NVIDIA Fellowship. This material is based upon work supported by the National Science Foundation under a grant awarded in 2009.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rosato A, 2009, NAT METHODS, V6, P625, DOI 10.1038/nmeth0909-625; von Ahn L., 2004, P SIGCHI C HUM FACT, P319, DOI [DOI 10.1145/985692.985733, 10.1145/985692.985733]; von Ahn L., 2006, P SIGCHI C HUMAN FAC, P55, DOI DOI 10.1145/1124772.1124782; Westphal AJ, 2010, AIP CONF PROC, V1221, P131, DOI 10.1063/1.3399239; Yee N, 2006, CYBERPSYCHOL BEHAV, V9, P772, DOI 10.1089/cpb.2006.9.772	11	700	715	5	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					756	760		10.1038/nature09304	http://dx.doi.org/10.1038/nature09304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686574	Green Accepted			2022-12-24	WOS:000280562500039
J	Buckholtz, JW; Treadway, MT; Cowan, RL; Woodward, ND; Li, R; Ansari, MS; Baldwin, RM; Schwartzman, AN; Shelby, ES; Smith, CE; Kessler, RM; Zald, DH				Buckholtz, Joshua W.; Treadway, Michael T.; Cowan, Ronald L.; Woodward, Neil D.; Li, Rui; Ansari, M. Sib; Baldwin, Ronald M.; Schwartzman, Ashley N.; Shelby, Evan S.; Smith, Clarence E.; Kessler, Robert M.; Zald, David H.			Dopaminergic Network Differences in Human Impulsivity	SCIENCE			English	Article							COCAINE		[Buckholtz, Joshua W.; Treadway, Michael T.; Schwartzman, Ashley N.; Shelby, Evan S.; Zald, David H.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Buckholtz, Joshua W.] Vanderbilt Univ, Vanderbilt Brain Inst, Grad Program Neurosci, Nashville, TN 37240 USA; [Cowan, Ronald L.; Woodward, Neil D.; Smith, Clarence E.; Zald, David H.] Vanderbilt Univ, Dept Psychiat, Nashville, TN 37240 USA; [Cowan, Ronald L.; Woodward, Neil D.] Vanderbilt Univ, Psychiat Neuroimaging Program, Nashville, TN 37240 USA; [Li, Rui; Ansari, M. Sib; Baldwin, Ronald M.; Kessler, Robert M.] Vanderbilt Univ, Dept Radiol, Nashville, TN 37240 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Buckholtz, JW (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	joshua.buckholtz@vanderbilt.edu	Buckholtz, Joshua/E-7299-2010; Woodward, Neil D/N-3365-2017; Zald, David H/A-1448-2011; Woodward, Neil/V-3735-2019; Treadway, Michael/O-9056-2017	Buckholtz, Joshua/0000-0002-9418-8686; 	National Institute on Drug Abuse [R01DA019670-04]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019670] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the National Institute on Drug Abuse (R01DA019670-04).	Barratt ES, 1999, PSYCHIAT RES, V86, P163, DOI 10.1016/S0165-1781(99)00024-4; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Lambert NM, 2006, ADDICTION, V101, P713, DOI 10.1111/j.1360-0443.2006.01408.x; Malloy-Diniz L, 2007, J INT NEUROPSYCH SOC, V13, P693, DOI 10.1017/S1355617707070889; SANTIAGO M, 1991, EUR J PHARMACOL, V204, P79, DOI 10.1016/0014-2999(91)90838-H; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Zilberman ML, 2003, BMC PSYCHIATRY, V3, DOI 10.1186/1471-244X-3-1	8	423	431	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					532	532		10.1126/science.1185778	http://dx.doi.org/10.1126/science.1185778			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	633EX	20671181	Green Accepted			2022-12-24	WOS:000280483500026
J	Burre, J; Sharma, M; Tsetsenis, T; Buchman, V; Etherton, MR; Sudhof, TC				Burre, Jacqueline; Sharma, Manu; Tsetsenis, Theodoros; Buchman, Vladimir; Etherton, Mark R.; Suedhof, Thomas C.			alpha-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro	SCIENCE			English	Article							MEMBRANE-FUSION; GAMMA-SYNUCLEIN; CSP-ALPHA; NEURODEGENERATION; DEGENERATION; MICE	Presynaptic nerve terminals release neurotransmitters repeatedly, often at high frequency, and in relative isolation from neuronal cell bodies. Repeated release requires cycles of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE)-complex assembly and disassembly, with continuous generation of reactive SNARE-protein intermediates. Although many forms of neurodegeneration initiate presynaptically, only few pathogenic mechanisms are known, and the functions of presynaptic proteins linked to neurodegeneration, such as a-synuclein, remain unclear. Here, we show that maintenance of continuous presynaptic SNARE-complex assembly required a nonclassical chaperone activity mediated by synucleins. Specifically, a-synuclein directly bound to the SNARE-protein synaptobrevin-2/vesicle-associated membrane protein 2 (VAMP2) and promoted SNARE-complex assembly. Moreover, triple-knockout mice lacking synucleins developed age-dependent neurological impairments, exhibited decreased SNARE-complex assembly, and died prematurely. Thus, synucleins may function to sustain normal SNARE-complex assembly in a presynaptic terminal during aging.	[Burre, Jacqueline; Sharma, Manu; Tsetsenis, Theodoros; Etherton, Mark R.; Suedhof, Thomas C.] Stanford Univ, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Burre, Jacqueline; Sharma, Manu; Tsetsenis, Theodoros; Etherton, Mark R.; Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Palo Alto, CA 94304 USA; [Buchman, Vladimir] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Stanford University; Howard Hughes Medical Institute; Stanford University; Cardiff University	Sudhof, TC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	tcs1@stanford.edu	Buchman, Vladimir L/A-4814-2010	Buchman, Vladimir L/0000-0002-7631-8352; Tsetsenis, Theodoros/0000-0002-4642-6539	Human Frontiers Program [LT00527/2006-L, LT000135/2009-L]; Deutsche Akademie der Naturforscher Leopoldina [BMBF-LPD 9901/8-161]	Human Frontiers Program; Deutsche Akademie der Naturforscher Leopoldina	We thank S. Chandra for advice. This work was supported by postdoctoral fellowships from the Human Frontiers Program (LT00527/2006-L to M. S. and LT000135/2009-L to T. T.) and the Deutsche Akademie der Naturforscher Leopoldina (BMBF-LPD 9901/8-161 to J.B.).	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ahmad M, 2007, FASEB J, V21, P3419, DOI 10.1096/fj.07-8379rev; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Chandra S, 2003, J BIOL CHEM, V278, P15313, DOI 10.1074/jbc.M213128200; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Clayton DF, 1998, TRENDS NEUROSCI, V21, P249, DOI 10.1016/S0166-2236(97)01213-7; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; Gray BC, 2009, NEUROBIOL DIS, V35, P63, DOI 10.1016/j.nbd.2009.04.001; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Liu SM, 2004, EMBO J, V23, P4506, DOI 10.1038/sj.emboj.7600451; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Ninkina N, 2003, MOL CELL BIOL, V23, P8233, DOI 10.1128/MCB.23.22.8233-8245.2003; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Takeda A, 1998, AM J PATHOL, V152, P367; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451	25	1114	1136	3	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2010	329	5999					1663	1667		10.1126/science.1195227	http://dx.doi.org/10.1126/science.1195227			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20798282	Green Accepted			2022-12-24	WOS:000282098100047
J	Winter, SE; Thiennimitr, P; Winter, MG; Butler, BP; Huseby, DL; Crawford, RW; Russell, JM; Bevins, CL; Adams, LG; Tsolis, RM; Roth, JR; Baumler, AJ				Winter, Sebastian E.; Thiennimitr, Parameth; Winter, Maria G.; Butler, Brian P.; Huseby, Douglas L.; Crawford, Robert W.; Russell, Joseph M.; Bevins, Charles L.; Adams, L. Garry; Tsolis, Renee M.; Roth, John R.; Baeumler, Andreas J.			Gut inflammation provides a respiratory electron acceptor for Salmonella	NATURE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INTESTINAL MICROBIOTA; SEROTYPE TYPHIMURIUM; VIRULENCE FACTORS; HYDROGEN-SULFIDE; HOST; METHANETHIOL; DISRUPTS; DISEASE; MUCOSA	Salmonella enterica serotype Typhimurium (S. Typhimurium) causes acute gut inflammation by using its virulence factors to invade the intestinal epithelium and survive in mucosal macrophages. The inflammatory response enhances the transmission success of S. Typhimurium by promoting its outgrowth in the gut lumen through unknown mechanisms. Here we show that reactive oxygen species generated during inflammation react with endogenous, luminal sulphur compounds (thiosulphate) to form a new respiratory electron acceptor, tetrathionate. The genes conferring the ability to use tetrathionate as an electron acceptor produce a growth advantage for S. Typhimurium over the competing microbiota in the lumen of the inflamed gut. We conclude that S. Typhimurium virulence factors induce host-driven production of a new electron acceptor that allows the pathogen to use respiration to compete with fermenting gut microbes. Thus the ability to trigger intestinal inflammation is crucial for the biology of this diarrhoeal pathogen.	[Winter, Sebastian E.; Thiennimitr, Parameth; Winter, Maria G.; Butler, Brian P.; Crawford, Robert W.; Russell, Joseph M.; Bevins, Charles L.; Tsolis, Renee M.; Baeumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Thiennimitr, Parameth] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Huseby, Douglas L.; Roth, John R.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Adams, L. Garry] Texas A&M Univ, Dept Vet Pathobiol, Coll Vet Med, College Stn, TX 77843 USA	University of California System; University of California Davis; Chiang Mai University; University of California System; University of California Davis; Texas A&M University System; Texas A&M University College Station	Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Winter, Sebastian E/A-4118-2009; Bevins, Charles L/P-4438-2015; Thiennimitr, Parameth/AAH-1761-2019; Butler, Brian/AAF-4821-2019; Baumler, Andreas J/H-2301-2011	Winter, Sebastian E/0000-0003-1532-9178; Bevins, Charles L/0000-0003-2725-2622; Butler, Brian/0000-0002-8554-2997; Baumler, Andreas J/0000-0001-9152-7809; Huseby, Douglas/0000-0001-9974-578X; Tsolis, Renee/0000-0001-9131-6657; Thiennimitr, Parameth/0000-0002-6339-8744	Public Health Service [AI040124, AI044170, AI073120, AI076246, AI088122]; Department of Microbiology, Chiang Mai University, Thailand; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738, R29AI040124, R01AI076246, R01AI044170, R01AI040124, R21AI073120, R21AI088122] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Microbiology, Chiang Mai University, Thailand; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank H. Chu for providing real-time PCR primers, V. Tolstikov for performing the liquid chromatography-mass spectrometry analysis, M. Xavier for assistance with histopathology and V. Gerriets for technical assistance. Work in A.J.B.'s laboratory is supported by Public Health Service grants AI040124, AI044170, AI073120, AI076246 and AI088122. P. T. was supported by a stipend from the Department of Microbiology, Chiang Mai University, Thailand.	Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Furne J, 2001, BIOCHEM PHARMACOL, V62, P255, DOI 10.1016/S0006-2952(01)00657-8; HARRIS JC, 1972, ANN INTERN MED, V76, P697, DOI 10.7326/0003-4819-76-5-697; Hensel M, 1999, MOL MICROBIOL, V32, P275, DOI 10.1046/j.1365-2958.1999.01345.x; Hensel M, 1999, MOL MICROBIOL, V31, P489, DOI 10.1046/j.1365-2958.1999.01190.x; Hinsley AP, 2002, MICROBIOL-SGM, V148, P3631, DOI 10.1099/00221287-148-11-3631; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Muller L, 1923, CR SOC BIOL, V89, P434; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Reinders CI, 2007, SCAND J GASTROENTERO, V42, P1151, DOI 10.1080/00365520701320505; Santos RL, 2009, TRENDS MICROBIOL, V17, P498, DOI 10.1016/j.tim.2009.08.008; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Tsolis RM, 1999, INFECT IMMUN, V67, P4879, DOI 10.1128/IAI.67.9.4879-4885.1999; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002	19	795	811	7	142	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					426	429		10.1038/nature09415	http://dx.doi.org/10.1038/nature09415			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20864996	Green Accepted, Green Submitted			2022-12-24	WOS:000282090200035
J	Waage, J; Banerji, R; Campbell, O; Chirwa, E; Collender, G; Dieltiens, V; Dorward, A; Godfrey-Faussett, P; Hanvoravongchai, P; Kingdon, G; Little, A; Mills, A; Mulholland, K; Mwinga, A; North, A; Patcharanarumol, W; Poulton, C; Tangcharoensathien, V; Unterhalter, E				Waage, Jeff; Banerji, Rukmini; Campbell, Oona; Chirwa, Ephraim; Collender, Guy; Dieltiens, Veerle; Dorward, Andrew; Godfrey-Faussett, Peter; Hanvoravongchai, Piya; Kingdon, Geeta; Little, Angela; Mills, Anne; Mulholland, Kim; Mwinga, Alwyn; North, Amy; Patcharanarumol, Walaiporn; Poulton, Colin; Tangcharoensathien, Viroj; Unterhalter, Elaine			The Millennium Development Goals: a cross-sectoral analysis and principles for goal setting after 2015	LANCET			English	Review							HEALTH-CARE; CHILD-MORTALITY; POVERTY; GENDER; EQUITY; INEQUALITIES; PROGRESS; AFRICA; POLICY		[Waage, Jeff; Collender, Guy] London Int Dev Ctr, London WC1H 0PD, England; [Banerji, Rukmini] Pratham ASER Ctr, New Delhi, India; [Campbell, Oona; Godfrey-Faussett, Peter; Hanvoravongchai, Piya; Mills, Anne; Mulholland, Kim] London Sch Hyg & Trop Med, London WC1, England; [Hanvoravongchai, Piya] London Sch Hyg & Trop Med, Bangkok, Thailand; [Chirwa, Ephraim] Univ Malawi, Zomba, Malawi; [Dieltiens, Veerle] Univ Witwatersrand, Johannesburg, South Africa; [Dorward, Andrew; Poulton, Colin] Univ London, Sch Oriental & African Studies, London, England; [Kingdon, Geeta; Little, Angela; North, Amy; Unterhalter, Elaine] Univ London, Inst Educ, London WC1N 1AZ, England; [Mwinga, Alwyn] Ctr Dis Control & Prevent, Global AIDS Program, Lusaka, Zambia; [Patcharanarumol, Walaiporn; Tangcharoensathien, Viroj] Int Hlth Policy Program, Nonthaburi, Thailand	University of London; London School of Hygiene & Tropical Medicine; University of Malawi; University of Witwatersrand; University of London; University of London School Oriental & African Studies (SOAS); University of London; University College London; UCL Institute of Education	Waage, J (corresponding author), London Int Dev Ctr, 36 Gordon Sq, London WC1H 0PD, England.	jeff.waage@lidc.bloomsbury.ac.uk	Hanvoravongchai, Piya/A-1569-2012; North, Amy/AAS-7619-2021; Kingdon, Geeta/AAQ-2321-2021	Hanvoravongchai, Piya/0000-0003-4256-1271; Unterhalter, Elaine/0000-0002-2302-6583; North, Amy/0000-0003-0546-2397; Campbell, Oona/0000-0002-9311-0115; Mills, Anne/0000-0001-9863-9950; Kingdon, Geeta/0000-0002-1583-5540	Economic and Social Research Council [RES-167-25-0260]; ESRC [ES/E021859/1] Funding Source: UKRI; Economic and Social Research Council [ES/E021859/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	EU has received a grant from the Economic and Social Research Council (award number RES-167-25-0260).	ADDISON T, 2008, CHRONIC POVERTY REPO; Anand S, 2000, WORLD DEV, V28, P2029, DOI 10.1016/S0305-750X(00)00071-1; [Anonymous], MILL DEV GOALS REP 2; [Anonymous], 2010, GLOBAL INEQUALITIES; Barton Carol., 2005, GENDER DEV, V13, P25, DOI DOI 10.1080/13552070512331332274; Bhana D, 2009, EDUC REV, V61, P49, DOI 10.1080/00131910802684771; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bose C., 2009, GLOBAL GENDER RES TR; BOURGUIGNON F, 2009, 2015 BRUSS JUN; CABRERA L, 2005, POLITICAL THEORY GLO; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Castello LD, 2010, ENVIRON SCI POLICY, V13, P154, DOI 10.1016/j.envsci.2009.12.001; *CENTR STAT OFF MA, 2009, ZAMB DEM HLTH SURV 2; CHEN S, 2007, ABSOLUTE POVERTY MEA; *COMM MACR HLTH, 2002, INV HLTH EC DEV; *COMM MACR HLTH, 2002, 5 WHO COMM MACR HLTH; CONWAY GR, 1985, AGR ADMIN EXT, V20, P31, DOI 10.1016/0309-586X(85)90064-0; Corbett EL, 2009, INT J TUBERC LUNG D, V13, P1231; *CSO CENTR BOARD H, 2003, ZAMB DEM HLTH SURV 2; *DAW, 2009, EXP GROUP M IMP IMPL; *DFID, 2006, CHIN COUNTR ASS PLAN; DFID, 2009, EL WORLD POV BUILD O; *DHS, 2003, ER 2002 FIN REP; Dieltiens V, 2009, PERSPECT EDUC, V27, P365; Dorward A, 2009, DEV POLICY REV, V27, P131, DOI 10.1111/j.1467-7679.2009.00439.x; Easterly W, 2009, WORLD DEV, V37, P26, DOI 10.1016/j.worlddev.2008.02.009; FISCHER AM, 2009, 2015 PROM PROP POL M; FLEISCH B, 2007, PRIMARY ED CRISIS S; FLEURBAEY M, 2008, GDP IS THERE PROGR M; Fraser Nancy, 1997, JUSTICE INTERRUPTUS; FUKUDAPARR S, 2008, 48 UN DEV PROGR INT; Glewwe P, 2002, J ECON LIT, V40, P436, DOI 10.1257/002205102320161258; GORE C, 2009, 2015 PROM PROP POL M; Gore C, 2010, IDS BULL-I DEV STUD, V41, P70, DOI 10.1111/j.1759-5436.2010.00106.x; *GOV MAL, 2008, MAL MILL DEV GOALS R; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grubb M, 2010, CLIM POLICY, V10, P127, DOI 10.3763/cpol.2010.ED83; *GRZ, 2008, ZAMB MILL DEV GOALS; GWATICIN DR, 2000, CURRENT STATE KNOWLE; Gwatkin D. R., 2005, REACHING POOR HLTH N; Habermas J., 1984, THEORY COMMUNICATIVE, V1; Held D., 2005, POLITICAL PHILOS COS, P10; HILLS J, 2010, ANATOMY EC INEQUALIT; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Hulme D., 2007, MAKING MILLENNIUM DE; HULME D, 2009, 2015 PROM PROP POL M; Jahan R., 1995, ELUSIVE AGENDA MAINS; Jewkes R, 2002, SOC SCI MED, V55, P1603, DOI 10.1016/S0277-9536(01)00294-5; Joint United Nations Programme on HIV/AIDS (UNAIDS) Zambia National HIV/AIDS/STI/TB Council, 2009, ZAMB HIV PREV RESP M; Jones N, 2010, IDS BULL-I DEV STUD, V41, P113, DOI 10.1111/j.1759-5436.2010.00112.x; KABEER N, 2008, POVERTY FOCUS, V13, P3; Kai M., 2006, 11 5 YEAR PLAN TARGE; KAKURU DM, 2008, GENDER EQUALITY HIV; KINGDON G, 2010, WPS201014 CSAE U OXF; Kingdon GG, 2006, J DEV STUD, V42, P1199, DOI 10.1080/00220380600884167; Knights F, 2010, EARLY MUSIC, V38, P1, DOI 10.1093/em/caq003; Langford M, 2010, IDS BULL-I DEV STUD, V41, P83, DOI 10.1111/j.1759-5436.2010.00108.x; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Limwattananon S, 2010, B WORLD HEALTH ORGAN, V88, P420, DOI 10.2471/BLT.09.068791; Macdonald M., 2003, GENDER EQUALITY MAIN; Malawi Government, 2011, MAL GROWTH DEV STRAT; Manning, 2009, USING INDICATORS ENC; McCowan, 2009, RETHINKING CITIZENSH; *MHRD, 2006, ANN REP 2005 2006; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; *MIN HLTH ZAMB, 2005, NAT HLTH STRAT PLAN; *MIN HLTH ZAMB, 2000, NAT HLTH STRAT PLAN; MINUJIN A, 2004, SOCIOECONOMIC INEQUA; MOLETSANE R, 2010, ENG EMP ED EQ E4 C D; MOOROSI P, 2006, THESIS U KWAZULUNATA; Morrell R., 2009, GENDER EQUALITY S AF; Moser C., 2005, GENDER DEV, V13, P11, DOI [10.1080/13552070512331332283, DOI 10.1080/13552070512331332283]; Mulholland EK, 2008, B WORLD HEALTH ORGAN, V86, P399, DOI 10.2471/BLT.07.044545; *NAC, 2008, COMPR HIV AIDS PREV; *OECD, 2008, EFF AID BETT HLTH; OECD, 1996, SHAP 21 CENT CONTR D; Office of the National Economic and Social Development Board, 2004, THAIL MILL DEV GOALS; Phillips Ann, 2007, MULTICULTURALISM CUL; Pogge Thomas, 2008, GLOBAL JUSTICE SEMIN; Prakongsai P, 2009, J INT DEV, V21, P291, DOI 10.1002/jid.1553; PRIDMORE P, 2007, CREATE PATHWAYS ACCE, V2; Prins G, 2010, HARTWELL PAPER NEW D; Reetika Khera, 2006, Economic and Political Weekly, V41, P4742; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; ROLLESTON C, 2009, HUMAN CAPITAL POVERT; Ruger JP, 2008, GEORGETOWN LAW J, V96, P423; Rutherford ME, 2009, B WORLD HEALTH ORGAN, V87, P216, DOI 10.2471/BLT.08.052175; Sachs J., 2005, END POVERTY WE CAN M; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Schaefer I., 2013, WORLD BANK; Schech S, 2010, SOC POLIT, V17, P111, DOI 10.1093/sp/jxp025; Sen A., 2003, READINGS HUMAN DEV, P41; Sen A., 2009, J HUMAN DEV 9, P331, DOI DOI 10.2307/J.CTVJNRV7N; Sen A.K., 1999, DEV FREEDOM; SETS A, 1992, INEQUALITY REEXAMINE; SHETTY S, 2009, 2015 BRUSS JUN; Skard T, 2009, FORUM DEV STUD, V36, P155, DOI 10.1080/08039410.2009.9666429; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Stiglitz J, MEASUREMENT EC PERFO; Sumner A., 2009, BROKER, V14, P8; Sumner A, 2010, IDS BULL-I DEV STUD, V41, P1, DOI 10.1111/j.1759-5436.2010.00097.x; TANGCHAROENSATH.V, 2009, BUILDING DECENT SOC; Tangcharoensathien V, 2005, SOC POLICY DEV CONTE, P257; *TASKF INN INT FIN, 2009, 1 WHO TASKF INN INT; Tiwari M., 2009, 2015 INT DEV POLICY; Tottrup C, 2009, TROP MED INT HEALTH, V14, P653, DOI 10.1111/j.1365-3156.2009.02275.x; *UN MDG GAP TASK F, 2009, STRENGTH GLOB PARTN; *UN STAT DIV, OFF LIST MDG IND 200; *UNDG, 2005, MAK MDGS MATT COUNTR; UNDP, 2003, HUMAN DEV REPORT 200; *UNDP, MDG PLUS CAS STUD TH; UNESCO, 2010, ED ALL GLOB MON REP; *UNESCO, 2008, ED ALL GLOB MON REP; United Nation, 2001, ROAD MAP IMPL UN MIL; United Nations, 2010, MILL DEV GOALS REP 2; United Nations Development Programme (UNDP), 2007, HUMAN DEV REPORT 200; United Nations General Assembly Resolution, 2000, A55L2 UN; UNTERHALTER E, 2000, CHALLENGING DEMOCRAC; UNTERHALTER E, 2009, 1 GEND ED GLOB POV R; Unterhalter E, 2009, STUD PHILOS EDUC, V28, P415, DOI 10.1007/s11217-009-9125-7; *USAID DEL PROJ, 2009, ZAMB NAT LONG TERM F; Vandemoortele J, 2009, DEV POLICY REV, V27, P355, DOI 10.1111/j.1467-7679.2009.00451.x; Vapattanawong P, 2007, LANCET, V369, P850, DOI 10.1016/S0140-6736(07)60413-9; Victora CG, 2006, B WORLD HEALTH ORGAN, V84, P792, DOI 10.2471/BLT.06.030502; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; WHO, 2007, EV BUS STRENGTH HLTH; Wilkinson R., 2009, SPIRIT LEVEL; World Bank, 1993, INV HLTH WORLD DEV R; World Commission on Environment and Development (WCED), 1987, OUR COMMON FUTURE; 2009, ASER ANN STATUS ED R; COUNTDOWN 2015 TRACK	132	196	202	0	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2010	376	9745					991	1023		10.1016/S0140-6736(10)61196-8	http://dx.doi.org/10.1016/S0140-6736(10)61196-8			33	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	655JZ	20833426	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000282247600031
J	Ji, H; Ehrlich, LIR; Seita, J; Murakami, P; Doi, A; Lindau, P; Lee, H; Aryee, MJ; Irizarry, RA; Kim, K; Rossi, DJ; Inlay, MA; Serwold, T; Karsunky, H; Ho, LN; Daley, GQ; Weissman, IL; Feinberg, AP				Ji, Hong; Ehrlich, Lauren I. R.; Seita, Jun; Murakami, Peter; Doi, Akiko; Lindau, Paul; Lee, Hwajin; Aryee, Martin J.; Irizarry, Rafael A.; Kim, Kitai; Rossi, Derrick J.; Inlay, Matthew A.; Serwold, Thomas; Karsunky, Holger; Ho, Lena; Daley, George Q.; Weissman, Irving L.; Feinberg, Andrew P.			Comprehensive methylome map of lineage commitment from haematopoietic progenitors	NATURE			English	Article							DNA METHYLTRANSFERASE; TRANSCRIPTION FACTOR; STEM; METHYLATION; CELLS; MICE; MEIS1	Epigenetic modifications must underlie lineage-specific differentiation as terminally differentiated cells express tissue-specific genes, but their DNA sequence is unchanged. Haematopoiesis provides a well-defined model to study epigenetic modifications during cell-fate decisions, as multipotent progenitors (MPPs) differentiate into progressively restricted myeloid or lymphoid progenitors. Although DNA methylation is critical for myeloid versus lymphoid differentiation, as demonstrated by the myeloerythroid bias in Dnmt1 hypomorphs(1), a comprehensive DNA methylation map of haematopoietic progenitors, or of any multipotent/oligopotent lineage, does not exist. Here we examined 4.6 million CpG sites throughout the genome for MPPs, common lymphoid progenitors (CLPs), common myeloid progenitors (CMPs), granulocyte/macrophage progenitors (GMPs), and thymocyte progenitors (DN1, DN2, DN3). Marked epigenetic plasticity accompanied both lymphoid and myeloid restriction. Myeloid commitment involved less global DNA methylation than lymphoid commitment, supported functionally by myeloid skewing of progenitors following treatment with a DNA methyltransferase inhibitor. Differential DNA methylation correlated with gene expression more strongly at CpG island shores than CpG islands. Many examples of genes and pathways not previously known to be involved in choice between lymphoid/myeloid differentiation have been identified, such as Arl4c and Jdp2. Several transcription factors, including Meis1, were methylated and silenced during differentiation, indicating a role in maintaining an undifferentiated state. Additionally, epigenetic modification of modifiers of the epigenome seems to be important in haematopoietic differentiation. Our results directly demonstrate that modulation of DNA methylation occurs during lineage-specific differentiation and defines a comprehensive map of the methylation and transcriptional changes that accompany myeloid versus lymphoid fate decisions.	[Ji, Hong; Murakami, Peter; Doi, Akiko; Lee, Hwajin; Irizarry, Rafael A.; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA; [Ji, Hong; Murakami, Peter; Doi, Akiko; Lee, Hwajin; Irizarry, Rafael A.; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Ehrlich, Lauren I. R.; Seita, Jun; Lindau, Paul; Rossi, Derrick J.; Inlay, Matthew A.; Serwold, Thomas; Karsunky, Holger; Ho, Lena; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Aryee, Martin J.; Irizarry, Rafael A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Aryee, Martin J.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Kim, Kitai; Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Div Pediat Hematol Oncol,Stem Cell Transplantat P, Boston, MA 02115 USA; [Kim, Kitai; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kim, Kitai; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Kim, Kitai; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kim, Kitai; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; Stanford University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Epigenet, 570 Rangos,725 N Wolfe St, Baltimore, MD 21205 USA.	afeinberg@jhu.edu	Grieshaber-Bouyer, Ricardo/R-7512-2016; Seita, Jun/AAM-1478-2020; Feinberg, Andrew/AAY-7666-2020; Aryee, Martin/AAC-8113-2020	Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Seita, Jun/0000-0002-3008-3615; Ehrlich, Lauren/0000-0002-1697-1755; Ho, Lena/0000-0002-9358-621X; Ji, Hong/0000-0002-9558-0620; Feinberg, Andrew/0000-0002-8364-1991	National Institutes of Health [R37CA053458, P50HG003233, R01AI047457, R01AI047458, R00AGO29760, CA09151, F32AI058521]; Thomas and Stacey Siebel Foundation; Leukemia and Lymphoma Society; California Institute for Regenerative Medicine [T1-00001]; NATIONAL CANCER INSTITUTE [R37CA054358, T32CA009151, R01CA086065] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI058521, T32AI007290, R01AI047458, R01AI047457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG029760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas and Stacey Siebel Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Jerabek for laboratory management, C. Richter and N. Teja for antibody production, A. Mosley, J. Dollaga and D. Escoto for animal care, E. Zuo and the Stanford PAN facility for microarray processing, and E. Briem and A. N. Allen for CHARM array processing. This investigation was supported by National Institutes of Health grants R37CA053458 and P50HG003233 (to A. P. F), R01AI047457 and R01AI047458 (to I.L.W.), and a grant from the Thomas and Stacey Siebel Foundation (to I.L.W). L.I.R.E. was supported by Special Fellow Career Development award from the Leukemia and Lymphoma Society; J. S. was supported by a fellowship from the California Institute for Regenerative Medicine (T1-00001); D.J.R. was supported by National Institutes of Health grant R00AGO29760; M.A.I. was supported by National Institutes of Health grant CA09151 and a fellowship from the California Institute for Regenerative Medicine (T1-00001); T.S. was supported by a fellowship from the National Institutes of Health (F32AI058521).	Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Chadwick K, 2005, BLOOD, V105, P1905, DOI 10.1182/blood-2004-03-0881; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Claus R, 2005, SEMIN ONCOL, V32, P511, DOI 10.1053/j.seminoncol.2005.07.024; Crable SC, 2003, BLOOD, V101, P4757, DOI 10.1182/blood-2002-09-2702; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Engel N, 2009, EPIGENETICS-US, V4, P98, DOI 10.4161/epi.4.2.7858; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gupta SK, 2006, ONCOGENE, V25, P5537, DOI 10.1038/sj.onc.1209555; Hu YL, 2009, MOL CELL BIOL, V29, P5181, DOI 10.1128/MCB.00545-09; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jin CY, 2006, NAT STRUCT MOL BIOL, V13, P331, DOI 10.1038/nsmb1063; Kim K., 2010, NATURE, V467, P285, DOI [10.1038/nature09342, DOI 10.1038/NATURE09342]; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Pillay LM, 2010, DEV BIOL, V340, P306, DOI 10.1016/j.ydbio.2010.01.033; Popov VM, 2010, TRENDS ENDOCRIN MET, V21, P41, DOI 10.1016/j.tem.2009.08.002; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wei SM, 2009, BIOCHEM BIOPH RES CO, V384, P352, DOI 10.1016/j.bbrc.2009.04.125	30	466	475	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2010	467	7313					338	U120		10.1038/nature09367	http://dx.doi.org/10.1038/nature09367			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20720541	Green Accepted, Green Submitted			2022-12-24	WOS:000281824900041
J	Frick, WF; Pollock, JF; Hicks, AC; Langwig, KE; Reynolds, DS; Turner, GG; Butchkoski, CM; Kunz, TH				Frick, Winifred F.; Pollock, Jacob F.; Hicks, Alan C.; Langwig, Kate E.; Reynolds, D. Scott; Turner, Gregory G.; Butchkoski, Calvin M.; Kunz, Thomas H.			An Emerging Disease Causes Regional Population Collapse of a Common North American Bat Species	SCIENCE			English	Article							WHITE-NOSE SYNDROME; ECOLOGY; CHYTRIDIOMYCOSIS; BIODIVERSITY; CONSERVATION; MORTALITY; DECLINES; BEHAVIOR; THREATS	White-nose syndrome (WNS) is an emerging disease affecting hibernating bats in eastern North America that causes mass mortality and precipitous population declines in winter hibernacula. First discovered in 2006 in New York State, WNS is spreading rapidly across eastern North America and currently affects seven species. Mortality associated with WNS is causing a regional population collapse and is predicted to lead to regional extinction of the little brown myotis (Myotis lucifugus), previously one of the most common bat species in North America. Novel diseases can have serious impacts on naive wildlife populations, which in turn can have substantial impacts on ecosystem integrity.	[Frick, Winifred F.; Langwig, Kate E.; Reynolds, D. Scott; Kunz, Thomas H.] Boston Univ, Dept Biol, CECB, Boston, MA 02215 USA; [Frick, Winifred F.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Pollock, Jacob F.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Hicks, Alan C.; Langwig, Kate E.] New York State Dept Environm Conservat, Endangered Species Unit, Albany, NY 12233 USA; [Reynolds, D. Scott] St Pauls Sch, Concord, NH 03301 USA; [Turner, Gregory G.; Butchkoski, Calvin M.] Penn Game Commiss, Wildlife Divers Div, Harrisburg, PA 16669 USA	Boston University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Frick, WF (corresponding author), Boston Univ, Dept Biol, CECB, 5 Cummington St, Boston, MA 02215 USA.	wfrick@batresearch.org	Frick, Winifred F/G-3501-2012; Frick, Winifred/ABA-3519-2020	Frick, Winifred/0000-0002-9469-1839	U.S. Fish and Wildlife Service (USFWS); USFWS Section 6; State Wildlife Grants; Federal Aid in Wildlife Restoration [WE-173-G]	U.S. Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service); USFWS Section 6(US Fish & Wildlife Service); State Wildlife Grants; Federal Aid in Wildlife Restoration	Funding was provided by grants from the U.S. Fish and Wildlife Service (USFWS) to W. F. F., J.F.P., D. S. R., T. H. K., and G. G. T. We thank three anonymous reviewers, J. P. Hayes, and D. F. Doak for helpful reviews and A. M. Kilpatrick for fruitful discussion. Funding for winter counts of bats at hibernacula was provided by USFWS Section 6 and State Wildlife Grants issued to the Pennsylvania Game Commission, and by Federal Aid in Wildlife Restoration Grant WE-173-G issued to the New York State Department of Environmental Conservation. Count data from hibernating colonies were kindly provided by the Connecticut Department of Environmental Protection; the Pennsylvania Game Commission; the New York Department of Environmental Conservation; Vermont Fish and Game; the Massachusetts Division of Fisheries and Wildlife; and K. Berner, State University of New York at Cobleskill. We are grateful to the many individuals who were involved in conducting annual counts of bats at hibernacula over the past 30 years. Data are available upon request from the authors.	Barbour R.W., 1969, BATS AM; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Courchamp F, 1999, P ROY SOC B-BIOL SCI, V266, P557, DOI 10.1098/rspb.1999.0672; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; Fenner F, 2000, FEMS MICROBIOL REV, V24, P123, DOI 10.1111/j.1574-6976.2000.tb00536.x; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; GELUSO KN, 1976, SCIENCE, V194, P184, DOI 10.1126/science.959845; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kunz TH, 2003, BAT ECOLOGY, P3; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; McCallum H, 2008, TRENDS ECOL EVOL, V23, P631, DOI 10.1016/j.tree.2008.07.001; Morris W. F., 2002, QUANTITATIVE CONSERV; OSHEA TJ, 2003, USGSBRDITR2003003; POSLUSZNY ET, 2000, P BAT CONS MIN TECHN, P159; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Tuttle M.D., 1993, Bats (Austin), V11, P3	25	586	611	5	575	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					679	682		10.1126/science.1188594	http://dx.doi.org/10.1126/science.1188594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689016	Green Submitted			2022-12-24	WOS:000280602700038
J	Huarte, M; Guttman, M; Feldser, D; Garber, M; Koziol, MJ; Kenzelmann-Broz, D; Khalil, AM; Zuk, O; Amit, I; Rabani, M; Attardi, LD; Regev, A; Lander, ES; Jacks, T; Rinn, JL				Huarte, Maite; Guttman, Mitchell; Feldser, David; Garber, Manuel; Koziol, Magdalena J.; Kenzelmann-Broz, Daniela; Khalil, Ahmad M.; Zuk, Or; Amit, Ido; Rabani, Michal; Attardi, Laura D.; Regev, Aviv; Lander, Eric S.; Jacks, Tyler; Rinn, John L.			A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response	CELL			English	Article							BINDING-SITE; TRANSCRIPTION; APOPTOSIS; PROTEINS; PATHWAY	Recently, more than 1000 large intergenic noncoding RNAs (lincRNAs) have been reported. These RNAs are evolutionarily conserved in mammalian genomes and thus presumably function in diverse biological processes. Here, we report the identification of lincRNAs that are regulated by p53. One of these lincRNAs (lincRNA-p21) serves as a repressor in p53-dependent transcriptional responses. Inhibition of lincRNA-p21 affects the expression of hundreds of gene targets enriched for genes normally repressed by p53. The observed transcriptional repression by lincRNA-p21 is mediated through the physical association with hnRNP-K. This interaction is required for proper genomic localization of hnRNP-K at repressed genes and regulation of p53 mediates apoptosis. We propose a model whereby transcription factors activate lincRNAs that serve as key repressors by physically associating with repressive complexes and modulate their localization to sets of previously active genes.	[Huarte, Maite; Guttman, Mitchell; Garber, Manuel; Koziol, Magdalena J.; Khalil, Ahmad M.; Zuk, Or; Amit, Ido; Rabani, Michal; Regev, Aviv; Lander, Eric S.; Rinn, John L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Huarte, Maite; Koziol, Magdalena J.; Khalil, Ahmad M.; Rinn, John L.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Guttman, Mitchell; Feldser, David; Regev, Aviv; Lander, Eric S.; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Feldser, David; Jacks, Tyler] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Kenzelmann-Broz, Daniela; Attardi, Laura D.] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Kenzelmann-Broz, Daniela; Attardi, Laura D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; Harvard University; Harvard Medical School	Huarte, M (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	mhuarte@broadinstitute.org; jrinn@broadinstitute.org	Huarte, Maite/J-6903-2014	Huarte, Maite/0000-0003-3753-6493; Rinn, John/0000-0002-7231-7539; Koziol, Magdalena/0000-0002-4123-4343	National Institutes of Health (NIH) [1R01CA119176-01]; Smith Family Foundation; Damon Runyon Cancer Foundation; Searle Scholar Program; NATIONAL CANCER INSTITUTE [R01CA119176] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006670, DP1OD003958] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Foundation; Damon Runyon Cancer Foundation; Searle Scholar Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Loyal A. Goff (Massachusetts Institute of Technology [MIT]) for bioinformatic support, Nadya Dimitrova (MIT) for input on the manuscript, David Garcia (MIT) for experimental assistance, and Sigrid Hart (Broad Institute) for illustration support. J.L.R. is a Damon Runyon-Rachleff, Searle, and Smith Family Foundation Scholar. J.L.R. and A. R. are Richard Merkin Foundation Scholars. This work was supported by the National Institutes of Health (NIH) Director's New Innovator Award, Smith Family Foundation, Damon Runyon Cancer Foundation, Searle Scholar Program, and NIH 1R01CA119176-01.	BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Carninci P, 2008, NAT CELL BIOL, V10, P1023, DOI 10.1038/ncb0908-1023; Denisenko ON, 1997, MOL CELL BIOL, V17, P4707, DOI 10.1128/MCB.17.8.4707; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	32	1587	1722	5	195	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					409	419		10.1016/j.cell.2010.06.040	http://dx.doi.org/10.1016/j.cell.2010.06.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20673990	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000280609100018
J	Xue, G; Dong, Q; Chen, CS; Lu, ZL; Mumford, JA; Poldrack, RA				Xue, Gui; Dong, Qi; Chen, Chuansheng; Lu, Zhonglin; Mumford, Jeanette A.; Poldrack, Russell A.			Greater Neural Pattern Similarity Across Repetitions Is Associated with Better Memory	SCIENCE			English	Article							BRAIN ACTIVITY; ENCODING VARIABILITY; RETRIEVAL-PROCESSES; FREE-RECALL; REACTIVATION; HIPPOCAMPUS; CORTEX; REPLAY; FACES; TASK	Repeated study improves memory, but the underlying neural mechanisms of this improvement are not well understood. Using functional magnetic resonance imaging and representational similarity analysis of brain activity, we found that, compared with forgotten items, subsequently remembered faces and words showed greater similarity in neural activation across multiple study in many brain regions, including (but not limited to) the regions whose mean activities were correlated with subsequent memory. This result addresses a longstanding debate in the study of memory by showing that successful episodic memory encoding occurs when the same neural representations are more precisely reactivated across study episodes, rather than when patterns of activation are more variable across time.	[Xue, Gui; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Xue, Gui; Lu, Zhonglin] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Chen, Chuansheng] Univ Calif Irvine, Dept Psychol, Irvine, CA 92697 USA; [Chen, Chuansheng] Univ Calif Irvine, Dept Social Behav, Irvine, CA 92697 USA; [Mumford, Jeanette A.; Poldrack, Russell A.] Univ Texas Austin, Dept Psychol, Austin, TX 78759 USA; [Poldrack, Russell A.] Univ Texas Austin, Imaging Res Ctr, Austin, TX 78759 USA; [Poldrack, Russell A.] Univ Texas Austin, Dept Neurobiol, Austin, TX 78759 USA	Beijing Normal University; University of Southern California; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Dong, Q (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	dongqi@bnu.edu.cn; poldrack@mail.utexas.edu	Xue, Gui/A-1762-2009	Xue, Gui/0000-0001-7891-8151; Chen, Chuansheng/0000-0002-8224-1005; Poldrack, Russell/0000-0001-6755-0259	Program for New Century Excellent Talents in University; NSF [BCS 0823624, BCS 0823495]; NIH [HD057884-01A2]; 111 Project of China [B07008]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057884] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [0823624] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [0823495] Funding Source: National Science Foundation	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 111 Project of China; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	We wish to thank C. Stark for his suggestions in implementing Experiment 3; R. A. Bjork, D. M. Schnyer, and R. Raizada for their helpful comments on an earlier version of this report; and L. Mei, F. Xue, X. Lei, X. Xiao and M. Zhang for their help in data collection. This study was supported by the Program for New Century Excellent Talents in University, NSF (BCS 0823624 and BCS 0823495), NIH (HD057884-01A2), and the 111 Project of China (B07008).	Appleton-Knapp SL, 2005, J CONSUM RES, V32, P266, DOI 10.1086/432236; Bjork R., 1975, INFORM PROCESSING CO, P396; Bower GH., 1972, CODING PROCESS HUM, V3, P85; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Cepeda NJ, 2009, EXP PSYCHOL, V56, P236, DOI 10.1027/1618-3169.56.4.236; Ebbinghaus H., 1885, MEMORY CONTRIBUTION; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Hintzman D. L., 1974, THEORIES COGNITIVE P, P77; HOERL AE, 1970, TECHNOMETRICS, V12, P69, DOI 10.2307/1267352; Howard MW, 2002, J MATH PSYCHOL, V46, P269, DOI 10.1006/jmps.2001.1388; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kahana MJ, 1996, MEM COGNITION, V24, P103, DOI 10.3758/BF03197276; Kahn I, 2004, J NEUROSCI, V24, P4172, DOI 10.1523/JNEUROSCI.0624-04.2004; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; Kuhl BA, 2010, NAT NEUROSCI, V13, P501, DOI 10.1038/nn.2498; Kuskowski MA, 1999, NEUROIMAGE, V9, P599, DOI 10.1006/nimg.1999.0442; MARTIN E, 1968, PSYCHOL REV, V75, P421, DOI 10.1037/h0026301; Mei LL, 2010, NEUROIMAGE, V52, P371, DOI 10.1016/j.neuroimage.2010.03.067; MELTON AW, 1970, J VERB LEARN VERB BE, V9, P596, DOI 10.1016/S0022-5371(70)80107-4; Nyberg L, 2001, NEUROIMAGE, V14, P521, DOI 10.1006/nimg.2001.0801; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Prince SE, 2009, NEUROPSYCHOLOGIA, V47, P2282, DOI 10.1016/j.neuropsychologia.2009.01.021; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Smith APR, 2004, NEUROIMAGE, V22, P868, DOI 10.1016/j.neuroimage.2004.01.049; THIOS SJ, 1976, J VERB LEARN VERB BE, V15, P529, DOI 10.1016/0022-5371(76)90047-5; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125	31	207	215	7	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2010	330	6000					97	101		10.1126/science.1193125	http://dx.doi.org/10.1126/science.1193125			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656KW	20829453	Green Accepted, Green Submitted			2022-12-24	WOS:000282334500044
J	Duce, JA; Tsatsanis, A; Cater, MA; James, SA; Robb, E; Wikhe, K; Leong, SL; Perez, K; Johanssen, T; Greenough, MA; Cho, HH; Galatis, D; Moir, RD; Masters, CL; McLean, C; Tanzi, RE; Cappai, R; Barnham, KJ; Ciccotosto, GD; Rogers, JT; Bush, AI				Duce, James A.; Tsatsanis, Andrew; Cater, Michael A.; James, Simon A.; Robb, Elysia; Wikhe, Krutika; Leong, Su Ling; Perez, Keyla; Johanssen, Timothy; Greenough, Mark A.; Cho, Hyun-Hee; Galatis, Denise; Moir, Robert D.; Masters, Colin L.; McLean, Catriona; Tanzi, Rudolph E.; Cappai, Roberto; Barnham, Kevin J.; Ciccotosto, Giuseppe D.; Rogers, Jack T.; Bush, Ashley I.			Iron-Export Ferroxidase Activity of beta-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease	CELL			English	Article							ISOFORM MESSENGER-RNAS; TARGETING A-BETA; SENILE PLAQUE; METAL-BINDING; BRAIN; CERULOPLASMIN; EXPRESSION; ACCUMULATION; AGE; OXIDATION	Alzheimer's Disease (AD) is complicated by pro-oxidant intraneuronal Fe2+ elevation as well as extracellular Zn2+ accumulation within amyloid plaque. We found that the AD beta-amyloid protein precursor (APP) possesses ferroxidase activity mediated by a conserved H-ferritin-like active site, which is inhibited specifically by Zn2+. Like ceruloplasmin, APP catalytically oxidizes Fe2+, loads Fe3+ into transferrin, and has a major interaction with ferroportin in HEK293T cells (that lack ceruloplasmin) and in human cortical tissue. Ablation of APP in HEK293T cells and primary neurons induces marked iron retention, whereas increasing APP695 promotes iron export. Unlike normal mice, APP(-/-) mice are vulnerable to dietary iron exposure, which causes Fe2+ accumulation and oxidative stress in cortical neurons. Paralleling iron accumulation, APP ferroxidase activity in AD postmortem neocortex is inhibited by endogenous Zn2+, which we demonstrate can originate from Zn2+-laden amyloid aggregates and correlates with A beta burden. Abnormal exchange of cortical zinc may link amyloid pathology with neuronal iron accumulation in AD.	[Leong, Su Ling; Perez, Keyla; Johanssen, Timothy; Cappai, Roberto; Barnham, Kevin J.; Ciccotosto, Giuseppe D.; Rogers, Jack T.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Greenough, Mark A.] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Leong, Su Ling; Perez, Keyla; Galatis, Denise; Cappai, Roberto; Barnham, Kevin J.; Ciccotosto, Giuseppe D.; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Duce, James A.; Tsatsanis, Andrew; Cater, Michael A.; James, Simon A.; Robb, Elysia; Wikhe, Krutika; Perez, Keyla; Greenough, Mark A.; Masters, Colin L.; Barnham, Kevin J.; Ciccotosto, Giuseppe D.; Bush, Ashley I.] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Cho, Hyun-Hee; Rogers, Jack T.] Harvard Univ, Sch Med, Dept Psychiat, Neurochem Lab, Boston, MA 02129 USA; [Moir, Robert D.; Tanzi, Rudolph E.] Massachusetts Gen Hosp, Genet & Aging Res Unit, Boston, MA 02129 USA; [McLean, Catriona] Alfred Hosp, Dept Anat Pathol, Melbourne, Vic 3004, Australia	University of Melbourne; University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Florey Institute of Neuroscience & Mental Health	Rogers, JT (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia.	jrogers@partners.org; abush@mhri.edu.au	Moir, Robert D./M-7612-2017; Johanssen, Tim/G-6106-2014; Bush, Ashley I/A-1186-2007; James, Simon/ABA-8646-2020; Tanzi, Rudolph/AAE-9622-2019; Bush, Ashley/Y-2457-2019; Greenough, Mark/AAK-1615-2021; James, Simon/J-5320-2012; Cappai, Roberto/B-3347-2010	Moir, Robert D./0000-0001-5431-3553; Johanssen, Tim/0000-0001-6757-586X; Bush, Ashley I/0000-0001-8259-9069; Tanzi, Rudolph/0000-0002-7032-1454; Bush, Ashley/0000-0001-8259-9069; James, Simon/0000-0001-9369-3288; McLean, Catriona/0000-0002-0302-5727; Duce, James/0000-0002-8762-2245; Greenough, Mark/0000-0001-6767-0584; Rogers, Jack/0000-0003-1262-8578; Cappai, Roberto/0000-0002-9505-8496	National Institute on Aging [1RO1AG12686]; Australian Research Council; Australian National Health & Medical Research Council (NHMRC); NATIONAL INSTITUTE ON AGING [R01AG012686] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Australian Research Council(Australian Research Council); Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by funds from the National Institute on Aging (1RO1AG12686), the Australian Research Council, the Australian National Health & Medical Research Council (NHMRC), Operational Infrastructure Support Victorian State Government, and the Alzheimer's Association. The Victorian Brain Bank Network is supported by The University of Melbourne, The Mental Health Research Institute, The Alfred Hospital, and the Victorian Forensic Institute of Medicine and funded by Neurosciences Australia and the NHMRC. We thank Gerd Multhaup for helpful comments and for providing APP reagents for pilot studies, Paul Adlard for human tissue samples, and Wilma Wasco for the APLP2 construct. C. L. M., R. E. T., K.J.B., and A. I. B. are shareholders, paid consultants, and advisory board members of Prana Biotechnology Ltd. A.I.B. is a shareholder of Cogstate Ltd and Eucalyptus Biosciences Pty Ltd. M. A. C. is a shareholder in Prana Biotechnology Ltd.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; BAKKER GR, 1986, J BIOL CHEM, V261, P3182; Bartzokis G, 2000, CELL MOL BIOL, V46, P821; BARTZOKIS G, 1994, AM J NEURORADIOL, V15, P1129; BARTZOKIS G, 1994, BIOL PSYCHIAT, V35, P480, DOI 10.1016/0006-3223(94)90047-7; BODOVITZ S, 1995, J NEUROCHEM, V64, P307; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Chinnery PF, 2007, BRAIN, V130, P110, DOI 10.1093/brain/awl319; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; DE DOMENICO I, 2008, CELL METAB, V8, P146; DE DOMENICO I, 2007, EMBO J, V26, P2823; deSilva HAR, 1997, MOL BRAIN RES, V47, P147; Ding B, 2009, J MAGN RESON IMAGING, V29, P793, DOI 10.1002/jmri.21730; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; EL TAYARA NE, 2006, NEUROBIOL DIS, V22, P199; Falangola MF, 2005, NEUROCHEM RES, V30, P201, DOI 10.1007/s11064-004-2442-x; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gonzalez-Cuyar LF, 2008, NEUROPATHOLOGY, V28, P466, DOI 10.1111/j.1440-1789.2008.00901.x; GRAY CW, 1993, NEUROREPORT, V4, P811, DOI 10.1097/00001756-199306000-00054; GRUNDKEIQBAL I, 1990, ACTA NEUROPATHOL, V81, P105, DOI 10.1007/BF00334497; Gutierrez JA, 1997, J CELL BIOL, V139, P895, DOI 10.1083/jcb.139.4.895; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Hao Q, 2005, J ALZHEIMERS DIS, V8, P161; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; Honda K, 2005, J BIOL CHEM, V280, P20978, DOI 10.1074/jbc.M500526200; Jack CR, 2005, J NEUROSCI, V25, P10041, DOI 10.1523/JNEUROSCI.2588-05.2005; Jeong SY, 2006, J NEUROSCI, V26, P9810, DOI 10.1523/JNEUROSCI.2922-06.2006; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; Klomp LWJ, 1996, J CLIN INVEST, V98, P207, DOI 10.1172/JCI118768; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Mantovan MC, 2006, EUR J NEUROL, V13, P827, DOI 10.1111/j.1468-1331.2006.01363.x; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; MITA S, 1989, AM J PATHOL, V134, P1253; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; OSAKI S, 1966, J BIOL CHEM, V241, P5053; Patel BN, 2002, J NEUROSCI, V22, P6578; Qian ZM, 2007, BBA-MOL BASIS DIS, V1772, P527, DOI 10.1016/j.bbadis.2007.02.006; Religa D, 2006, NEUROLOGY, V67, P69, DOI 10.1212/01.wnl.0000223644.08653.b5; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; ROBINSON SR, 1995, ALZ RES, V1, P191; Rogers JT, 2002, J BIOL CHEM, V277, P45518, DOI 10.1074/jbc.M207435200; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Takahashi M, 2000, NEURON, V28, P461, DOI 10.1016/S0896-6273(00)00125-2; Toussaint L, 2007, J MOL BIOL, V365, P440, DOI 10.1016/j.jmb.2006.10.010; UCHIDA Y, 1991, NEURON, V7, P337, DOI 10.1016/0896-6273(91)90272-2; Visser CC, 2004, PHARM RES-DORDR, V21, P761, DOI 10.1023/B:PHAM.0000026425.69874.8e; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; Yamamoto A, 2002, J NEUROCHEM, V82, P1137; Yang XK, 1998, BIOCHEMISTRY-US, V37, P9743, DOI 10.1021/bi973128a; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	64	477	495	2	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					857	867		10.1016/j.cell.2010.08.014	http://dx.doi.org/10.1016/j.cell.2010.08.014			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20817278	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000281855000009
J	Worobey, M; Telfer, P; Souquiere, S; Hunter, M; Coleman, CA; Metzger, MJ; Reed, P; Makuwa, M; Hearn, G; Honarvar, S; Roques, P; Apetrei, C; Kazanji, M; Marx, PA				Worobey, Michael; Telfer, Paul; Souquiere, Sandrine; Hunter, Meredith; Coleman, Clint A.; Metzger, Michael J.; Reed, Patricia; Makuwa, Maria; Hearn, Gail; Honarvar, Shaya; Roques, Pierre; Apetrei, Cristian; Kazanji, Mirdad; Marx, Preston A.			Island Biogeography Reveals the Deep History of SIV	SCIENCE			English	Article							EVOLUTION		[Telfer, Paul; Hunter, Meredith; Coleman, Clint A.; Metzger, Michael J.; Reed, Patricia; Apetrei, Cristian; Marx, Preston A.] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; [Worobey, Michael] Univ Arizona, Tucson, AZ 85721 USA; [Telfer, Paul; Souquiere, Sandrine; Reed, Patricia; Makuwa, Maria; Roques, Pierre; Kazanji, Mirdad] Ctr Int Med Res, Franceville, Gabon; [Hearn, Gail; Honarvar, Shaya] Drexel Univ, Philadelphia, PA 19104 USA	Tulane University; University of Arizona; Drexel University	Marx, PA (corresponding author), Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.	pmarx@tulane.edu	Roques, Pierre/M-2212-2013; Metzger, Michael/E-2242-2014; Metzger, Michael/AAA-3635-2022; Apetrei, Cristian/AAG-9032-2021	Roques, Pierre/0000-0003-1825-1054; Metzger, Michael/0000-0001-7855-1388; Metzger, Michael/0000-0001-7855-1388; Apetrei, Cristian/0000-0002-0322-7185	NIH [1RO1AI27698, 1RO1AI44596]; Tulane Phase II Enhancement Grant; ExxonMobil Foundation; David and Lucile Packard Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044596, R01AI027698] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane Phase II Enhancement Grant; ExxonMobil Foundation(Exxon Mobil Corporation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T. M. Butynski, J. M. Esara Echube, A. Lackner, and M. Sanderson for assistance and comments and acknowledge support from NIH grants 1RO1AI27698 and 1RO1AI44596, a Tulane Phase II Enhancement Grant, the ExxonMobil Foundation, and the David and Lucile Packard Foundation. Newly reported SIV sequences have been deposited in GenBank under accession numbers HM363406 to HM363427. P. Reed and P. T. are at the Wildlife Conservation Society, Bronx, NY, USA. P. Roques is at Commissariat a l'Energie Atomique-Life Science Division, Fontenay-aux-Roses, France. C. A. is at University of Pittsburgh, PA. M. J. M. is at University of Washington, Seattle, WA. M. K. is at Institut de Bangui, Bangui, Central African Republic.	de Sousa JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009936; Drucker E, 2001, LANCET, V358, P1989, DOI 10.1016/S0140-6736(01)06967-7; Gifford RJ, 2008, P NATL ACAD SCI USA, V105, P20362, DOI 10.1073/pnas.0807873105; JONES PJ, 1994, BIODIVERS CONSERV, V3, P772, DOI 10.1007/BF00129657; Sharp PM, 2000, BIOCHEM SOC T, V28, P275, DOI 10.1042/bst0280275; Wertheim JO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000377	6	144	146	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1487	1487		10.1126/science.1193550	http://dx.doi.org/10.1126/science.1193550			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847261				2022-12-24	WOS:000281869000031
J	Lopez-Garcia, C; Klein, AM; Simons, BD; Winton, DJ				Lopez-Garcia, Carlos; Klein, Allon M.; Simons, Benjamin D.; Winton, Douglas J.			Intestinal Stem Cell Replacement Follows a Pattern of Neutral Drift	SCIENCE			English	Article							MOUSE SMALL-INTESTINE; SOMATIC MUTATION; CRYPT; ORGANIZATION; COLON; CLONALITY; KINETICS; CYCLES	With the capacity for rapid self-renewal and regeneration, the intestinal epithelium is stereotypical of stem cell-supported tissues. Yet the pattern of stem cell turnover remains in question. Applying analytical methods from population dynamics and statistical physics to an inducible genetic labeling system, we showed that clone size distributions conform to a distinctive scaling behavior at short times. This result demonstrates that intestinal stem cells form an equipotent population in which the loss of a stem cell is compensated by the multiplication of a neighbor, leading to neutral drift dynamics in which clones expand and contract at random until they either take over the crypt or they are lost. Combined with long-term clonal fate data, we show that the rate of stem cell replacement is comparable to the cell division rate, implying that neutral drift and symmetrical cell divisions are central to stem cell homeostasis.	[Klein, Allon M.; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Lopez-Garcia, Carlos; Winton, Douglas J.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Klein, Allon M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Harvard University; Harvard Medical School	Simons, BD (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	bds10@cam.ac.uk; doug.winton@cancer.org.uk	Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071; Lopez-Garcia, Carlos/0000-0001-9848-8216	Cancer Research UK; Cambridge Research Institute (CRI); CRI Biological Resource Unit and Histopathology Core; Seneca Foundation; Engineering and Physical Sciences Research Council [EP/F043325/1, EP/F032773/1]; EPSRC [EP/F043325/1, EP/F032773/1] Funding Source: UKRI; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cambridge Research Institute (CRI); CRI Biological Resource Unit and Histopathology Core; Seneca Foundation(Fundacion Seneca); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H. Zecchini and R. Kemp at Cancer Research UK, Cambridge Research Institute (CRI), and the CRI Biological Resource Unit and Histopathology Core. This work was supported by Cancer Research UK (D.J.W.), Seneca Foundation (Region de Murcia, Spain) (C.L.-G.), the Engineering and Physical Sciences Research Council fellowship EP/F043325/1 (A. M. K.), and the Engineering and Physical Sciences Research Council Programme grant EP/F032773/1 (B. D. S.). A patent application on drug and toxicity testing has been submitted.	ALDEWACHI HS, 1979, VIRCHOWS ARCH B, V31, P37, DOI 10.1007/BF02889921; ALDEWACHI HS, 1975, VIRCHOWS ARCH B, V18, P225; Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BJERKNES M, 1985, BIOPHYS J, V48, P85, DOI 10.1016/S0006-3495(85)83762-0; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; Klein AM, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021910; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; LOEFFLER M, 1993, J THEOR BIOL, V160, P471, DOI 10.1006/jtbi.1993.1031; Loeffler M, 1997, J THEOR BIOL, V186, P41, DOI 10.1006/jtbi.1996.0340; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; PARK HS, 1995, AM J PATHOL, V147, P1416; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1986, INT J RADIAT BIOL, V49, P257, DOI 10.1080/09553008514552541; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WILLIAMS ED, 1992, AM J PATHOL, V141, P773; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; WRIGHT NA, 1982, CELL TISSUE KINET, V15, P595, DOI 10.1111/j.1365-2184.1982.tb01066.x	23	443	449	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2010	330	6005					822	825		10.1126/science.1196236	http://dx.doi.org/10.1126/science.1196236			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	20929733				2022-12-24	WOS:000283855700043
J	Snippert, HJ; van der Flier, LG; Sato, T; van Es, JH; van den Born, M; Kroon-Veenboer, C; Barker, N; Klein, AM; van Rheenen, J; Simons, BD; Clevers, H				Snippert, Hugo J.; van der Flier, Laurens G.; Sato, Toshiro; van Es, Johan H.; van den Born, Maaike; Kroon-Veenboer, Carla; Barker, Nick; Klein, Allon M.; van Rheenen, Jacco; Simons, Benjamin D.; Clevers, Hans			Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem Cells	CELL			English	Article							MOUSE SMALL-INTESTINE; SELF-RENEWAL; HAIR FOLLICLE; BETA-CATENIN; IN-VITRO; DIFFERENTIATION; DIVISION; MARKER; GENE; IDENTIFICATION	Intestinal stem cells, characterized by high Lgr5 expression, reside between Paneth cells at the small intestinal crypt base and divide every day. We have carried out fate mapping of individual stem cells by generating a multicolor Cre-reporter. As a population, Lgr5(hi) stem cells persist life-long, yet crypts drift toward clonality within a period of 1-6 months. We have collected short- and long-term clonal tracing data of individual Lgr5(hi) cells. These reveal that most Lgr5(hi) cell divisions occur symmetrically and do not support a model in which two daughter cells resulting from an Lgr5(hi) cell division adopt divergent fates (i.e., one Lgr5(hi) cell and one transit-amplifying [TA] cell per division). The cellular dynamics are consistent with a model in which the resident stem cells double their numbers each day and stochastically adopt stem or TA fates. Quantitative analysis shows that stem cell turnover follows a pattern of neutral drift dynamics.	[Snippert, Hugo J.; van der Flier, Laurens G.; Sato, Toshiro; van Es, Johan H.; van den Born, Maaike; Kroon-Veenboer, Carla; Barker, Nick; van Rheenen, Jacco; Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Snippert, Hugo J.; van der Flier, Laurens G.; Sato, Toshiro; van Es, Johan H.; van den Born, Maaike; Kroon-Veenboer, Carla; Barker, Nick; van Rheenen, Jacco; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Klein, Allon M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Klein, Allon M.; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Harvard University; Harvard Medical School; University of Cambridge	Clevers, H (corresponding author), KNAW, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	clevers@hubrecht.eu	van+Es, Johan/ABD-5411-2021; Simons, Benjamin/AAY-8920-2020; van Rheenen, Jacco/G-3655-2014; Barker, Nick/AAS-2774-2020; Barker, Nick/A-5535-2011; Sato, Toshiro/J-3522-2014; Barker, Nick/AAE-9833-2021	Simons, Benjamin/0000-0002-3875-7071; Sato, Toshiro/0000-0001-8353-8137; Barker, Nick/0000-0003-3566-4475	EPSRC [EP/F043325/1, EP/F032773/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F043325/1, EP/F032773/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; BenNaim E, 1996, PHYS REV E, V53, P3078, DOI 10.1103/PhysRevE.53.3078; BRAMSON M, 1980, Z WAHRSCHEINLICHKEIT, V53, P183, DOI 10.1007/BF01013315; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Cowan CR, 2004, ANNU REV CELL DEV BI, V20, P427, DOI 10.1146/annurev.cellbio.19.111301.113823; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Krapivsky PL, 1997, PHYS REV E, V56, P3788, DOI 10.1103/PhysRevE.56.3788; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; LOPEZGARCIA C, 2010, SCIENCE IN PRESS; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; WU FY, 1982, REV MOD PHYS, V54, P235, DOI 10.1103/RevModPhys.54.235; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	40	1275	1298	7	139	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					134	144		10.1016/j.cell.2010.09.016	http://dx.doi.org/10.1016/j.cell.2010.09.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887898	Bronze			2022-12-24	WOS:000282362000020
J	Yu, HJ; Liao, QH; Yuan, YA; Zhou, L; Xiang, NJ; Huai, Y; Guo, XH; Zheng, YD; van Doorn, HR; Farrar, J; Gao, ZC; Feng, ZJ; Wang, Y; Yang, WZ				Yu, Hongjie; Liao, Qiaohong; Yuan, Yuan; Zhou, Lei; Xiang, Nijuan; Huai, Yang; Guo, Xiuhua; Zheng, Yingdong; van Doorn, H. Rogier; Farrar, Jeremy; Gao, Zhancheng; Feng, Zijian; Wang, Yu; Yang, Weizhong			Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEURAMINIDASE INHIBITOR OSELTAMIVIR; HOSPITALIZED-PATIENTS; RESPIRATORY-FAILURE; INFECTION; THERAPY; A(H1N1); PREVENTION; EFFICACY; SAFETY	Objective To describe the clinical features and effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A(H1N1) virus infection. Design Opportunistic retrospective review of medical charts of patients with confirmed 2009 H1N1 identified through the national surveillance system in China from May to July 2009. Setting Under coordination of the Ministry of Health, local health departments were asked to collect medical records of confirmed patients and send them to the Chinese Centre for Disease Control and Prevention on a voluntary basis as part of the public health response. Population 1291 patients with confirmed 2009 H1N1 infection and available data for chart review. Main outcome measures Demographic characteristics, comorbidities, symptoms and signs, laboratory tests, findings on chest radiography, antiviral treatment, duration of fever, and duration of viral RNA shedding. Results The median age of 1291 patients was 20 years (interquartile range 12-26); 701 (54%) were male. The most common symptoms were fever (820, 64%), cough (864, 67%), sore throat (425, 33%), sputum (239, 19%), and rhinorrhoea (228, 18%). Of 920 patients who underwent chest radiography, 110 (12%) had abnormal findings consistent with pneumonia. Some 983 (76%) patients were treated with oseltamivir from a median of the third day of symptoms (2-4). No patients required admission to the intensive care unit or mechanical ventilation. 2009 H1N1 was shed from one day before onset of symptoms to up to eight days after onset in most (91%) patients, with a median of 5 (3-6) days of shedding after onset. Treatment with oseltamivir significantly protected against subsequent development of radiographically confirmed pneumonia (odds ratio 0.12, 95% confidence interval 0.08 to 0.18), and treatment started within two days of symptom onset reduced the duration of fever and viral RNA shedding. Conclusions Chinese patients with 2009 H1N1 infection predominantly presented with features of uncomplicated, self limiting acute respiratory illness. 2009 H1N1 might be shed longer than seasonal influenza virus. Treatment with oseltamivir was associated with a significantly reduced development of radiographically confirmed pneumonia and a shorter duration of fever and viral RNA shedding. Though these patients benefited from treatment, the findings should be interpreted with caution as the study was retrospective and not all patients underwent chest radiography.	[Yu, Hongjie; Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China	Chinese Center for Disease Control & Prevention	Yang, WZ (corresponding author), Chinese Ctr Dis Control & Prevent, 155 Changbai Rd, Beijing 102206, Peoples R China.	yuhj@chinacdc.cn; yangwz@chinacdc.cn	Yu, Hongjie/GZK-5351-2022; van Doorn, H. Rogier/H-3080-2019; Farrar, Jeremy J./HGA-7610-2022	van Doorn, H. Rogier/0000-0002-9807-1821; Zhou, Lei/0000-0002-6640-0774; Farrar, Jeremy/0000-0002-2700-623X	US National Institutes of Health [U19 AI51915]; China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; South East Asia Infectious Disease Clinical Research Network; Wellcome Trust; Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051915] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases; South East Asia Infectious Disease Clinical Research Network; Wellcome Trust(Wellcome TrustEuropean Commission); Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from US National Institutes of Health (Comprehensive International Program for Research on AIDS grant U19 AI51915), the China-US Collaborative Program on Emerging and Re-emerging Infectious Diseases, South East Asia Infectious Disease Clinical Research Network, and Wellcome Trust Major Overseas Programme, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam. None of the funders had any role in the study design and the collection, analysis, and interpretation of data, or in the writing of the article and the decision to submit it for publication. The researchers confirm their independence from funders and sponsors. All authors had full access to all data included in the study and are jointly responsible for the integrity of the data and accuracy of data analyses.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; [Anonymous], 2009, GAZ BOSNIA HERZEGOVI, V43; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; *CDCP, 2009, UPD INT REC US ANT M; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; De Serres G, 2010, EMERG INFECT DIS, V16, P783, DOI 10.3201/eid1605.091894; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; HALL CB, 1975, PEDIATRICS, V55, P673; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; KLIMOV AI, 1995, J INFECT DIS, V172, P1352, DOI 10.1093/infdis/172.5.1352; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lee N, 2008, CLIN INFECT DIS, V46, P1323, DOI 10.1086/533477; Lee N, 2007, ANTIVIR THER, V12, P501; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; *MIN HLTH CHIN, 2009, DISCH CRIT HUM INF P; *MIN HLTH CHIN, 2009, CLIN MAN HUM INF PAN; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Nicholson K G, 1992, Semin Respir Infect, V7, P26; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Nicoll A, 2010, EUROSURVEILLANCE, V15; Ong AK, 2007, J INFECT DIS, V196, P181, DOI 10.1086/518939; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8044; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Uyeki Tim, 2009, N Engl J Med, V361, pe110, DOI 10.1056/NEJMopv0910738; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; WHO, CLIN MAN HUM INF PAN; Witkop CT, 2010, AM J PREV MED, V38, P121, DOI 10.1016/j.amepre.2009.10.005; World Health Organization, 2010, PAND H1N1 2009 UPD 1; World Health Organization, 2009, CDC PROT REALT RTPCR; 2009, N ENGL J MED, V260, P2605	43	75	80	1	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 28	2010	341								c4779	10.1136/bmj.c4779	http://dx.doi.org/10.1136/bmj.c4779			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659MF	20876641	Green Published, hybrid			2022-12-24	WOS:000282569900004
J	Sasai, M; Linehan, MM; Iwasaki, A				Sasai, Miwa; Linehan, Melissa M.; Iwasaki, Akiko			Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3	SCIENCE			English	Article							INTERFERON-ALPHA PRODUCTION; I INTERFERON; DENDRITIC CELLS; AP-3 ADAPTER; INDUCTION; ACTIVATION; TLR9; TOLL-LIKE-RECEPTOR-9; LOCALIZATION; TRAF3	Endosomal Toll-like receptors (TLRs) 7 and 9 recognize viral pathogens and induce signals leading to the activation of nuclear factor kappa B (NF-kappa B)-dependent proinflammatory cytokines and interferon regulatory factor 7 (IRF7)-dependent type I interferons (IFNs). Recognition of viral nucleic acids by TLR9 requires its cleavage in the endolysosomal compartment. Here, we show that TLR9 signals leading to the activation of type I IFN, but not proinflammatory cytokine genes, require TLR9 trafficking from endosomes to a specialized lysosome-related organelle. Furthermore, we identify adapter protein-3 as the protein complex responsible for the trafficking of TLR9 to this subcellular compartment. Our results reveal an intracellular mechanism for bifurcation of TLR9 signals by selective receptor trafficking within the endosomal system.	[Sasai, Miwa; Linehan, Melissa M.; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856; Sasai, Miwa/0000-0001-6440-3958	NIH [AI054359, AI081884, AI064705]; Uehara Memorial Foundation; Gilead Sciences; Burroughs Wellcome Investigators in Pathogenesis of Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054359, R01AI064705, R01AI081884] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Gilead Sciences(Gilead Sciences); Burroughs Wellcome Investigators in Pathogenesis of Infectious Disease(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Medzhitov for critical reading of the manuscript and W. Mothes for helpful discussion. This work is supported by NIH grants to A. I. (AI054359, AI081884, and AI064705). M. S. is a Japan Society for the Promotion of Science fellow and a recipient of Uehara Memorial Foundation fellowship. A. I. acknowledges support by Gilead Sciences. A. I. is a recipient of the Burroughs Wellcome Investigators in Pathogenesis of Infectious Disease.	Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; DE MATTEIS MA, 2004, NAT CELL BIOL, V6, P487; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Gotoh K, 2010, J EXP MED, V207, P721, DOI 10.1084/jem.20091776; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Watarai H, 2008, P NATL ACAD SCI USA, V105, P2993, DOI 10.1073/pnas.0710351105	29	257	260	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1530	1534		10.1126/science.1187029	http://dx.doi.org/10.1126/science.1187029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847273	Green Accepted			2022-12-24	WOS:000281869000044
J	Aguirre, A; Rubio, ME; Gallo, V				Aguirre, Adan; Rubio, Maria E.; Gallo, Vittorio			Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal	NATURE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; GROWTH-FACTOR RECEPTOR; SUBVENTRICULAR ZONE; PROGENITOR CELLS; IN-VIVO; INTRACELLULAR DOMAIN; MAMMALIAN BRAIN; PROLIFERATION; NICHE; VISUALIZATION	Specialized cellular microenvironments, or 'niches', modulate stem cell properties, including cell number, self-renewal and fate decisions(1,2). In the adult brain, niches that maintain a source of neural stem cells (NSCs) and neural progenitor cells (NPCs) are the subventricular zone (SVZ) of the lateral ventricle and the dentate gyrus of the hippocampus(3-5). The size of the NSC population of the SVZ at any time is the result of several ongoing processes, including self-renewal, cell differentiation, and cell death. Maintaining the balance between NSCs and NPCs in the SVZ niche is critical to supply the brain with specific neural populations, both under normal conditions or after injury. A fundamental question relevant to both normal development and to cell-based repair strategies in the central nervous system is how the balance of different NSC and NPC populations is maintained in the niche. EGFR (epidermal growth factor receptor) and Notch signalling pathways have fundamental roles during development of multicellular organisms(6). In Drosophila and in Caenorhabditis elegans these pathways may have either cooperative or antagonistic functions(7-9). In the SVZ, Notch regulates NSC identity and self-renewal, whereas EGFR specifically affects NPC proliferation and migration(10-13). This suggests that interplay of these two pathways may maintain the balance between NSC and NPC numbers. Here we show that functional cell-cell interaction between NPCs and NSCs through EGFR and Notch signalling has a crucial role in maintaining the balance between these cell populations in the SVZ. Enhanced EGFR signalling in vivo results in the expansion of the NPC pool, and reduces NSC number and self-renewal. This occurs through a non-cell-autonomous mechanism involving EGFR-mediated regulation of Notch signalling. Our findings define a novel interaction between EGFR and Notch pathways in the adult SVZ, and thus provide a mechanism for NSC and NPC pool maintenance.	[Aguirre, Adan; Gallo, Vittorio] Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA; [Rubio, Maria E.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA 15261 USA	Children's National Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gallo, V (corresponding author), Childrens Natl Med Ctr, Neurosci Res Ctr, Washington, DC 20010 USA.	vgallo@cnmcresearch.org			NIH [R01NS045702, R01NS056427, K99NS057944, ROO NS057944-03, R01DC006881]; NIH IDDRC [P30HD40677]; NSF [DBI-0420580]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS057944, R01NS056427, R01NS045702, R00NS057944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006881] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH IDDRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank N. Ratner for the Cnp-hEGFR mice. We are thankful to T. Hawley for technical advice in all FACS sorting experiments. We are grateful to J. Corbin and T. Haydar for critically reading this manuscript, and to all our colleagues at the Center for Neuroscience Research for discussion and support. We are thankful to N. Gaiano for discussion, for providing reagents and for his continuous advice on this project. We thank G. Corfas, A. Israel, C. L. Cepko, R. Kopan, R. Grosschedl, N. Gaiano and R. Kageyama for the gift of CBF-1, Hes1-GFP, Hes1-dsRED, Notch constructs, Dll-GFP, CBFRE-EGFP and Hes5-GFP, respectively. This work was supported by NIH R01NS045702 and R01NS056427 (V. G.), K99NS057944 (A. A.), ROO NS057944-03 (A. A.) and by NIH IDDRC P30HD40677 (V. G.). Electron microscopy was performed at the University of Connecticut, Department of Physiology and Neurobiology, with funding from NIH R01DC006881 to M.E.R., and from NSF DBI-0420580 for funds to purchase the Tecnai 12 Biotwin electron microscope.	Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Aguirre A, 2007, NEURON GLIA BIOL, V3, P209, DOI 10.1017/S1740925X08000082; Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Alexson TO, 2006, DEV NEUROSCI-BASEL, V28, P34, DOI 10.1159/000090751; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Galceran J, 2004, GENE DEV, V18, P2718, DOI 10.1101/gad.1249504; Hasson P, 2005, NAT GENET, V37, P101, DOI 10.1038/ng1486; Hitoshi S, 2002, GENE DEV, V16, P846, DOI 10.1101/gad.975202; Jablonska B, 2007, J CELL BIOL, V179, P1231, DOI 10.1083/jcb.200702031; Kohyama J, 2005, DEV BIOL, V286, P311, DOI 10.1016/j.ydbio.2005.08.003; Kolev V, 2005, FEBS LETT, V579, P5798, DOI 10.1016/j.febslet.2005.09.042; Kumar JP, 2001, DEVELOPMENT, V128, P2689; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lillien L, 2000, DEVELOPMENT, V127, P4993; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Ling BC, 2005, CANCER CELL, V7, P65, DOI 10.1016/j.ccr.2004.10.016; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Morshead CM, 1998, DEVELOPMENT, V125, P2251; Ohtsuka T, 2006, MOL CELL NEUROSCI, V31, P109, DOI 10.1016/j.mcn.2005.09.006; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Sundaram MV, 2005, GENE DEV, V19, P1825, DOI 10.1101/gad.1330605; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Wehner T, 2003, J NEUROSCI, V23, P5004; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639	38	330	350	1	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2010	467	7313					323	U101		10.1038/nature09347	http://dx.doi.org/10.1038/nature09347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20844536	Green Accepted			2022-12-24	WOS:000281824900038
J	Liu, HL; Juo, ZS; Shim, AHR; Focia, PJ; Chen, XY; Garcia, KC; He, XL				Liu, Heli; Juo, Z. Sean; Shim, Ann Hye-Ryong; Focia, Pamela J.; Chen, Xiaoyan; Garcia, K. Christopher; He, Xiaolin			Structural Basis of Semaphorin-Plexin Recognition and Viral Mimicry from Sema7A and A39R Complexes with PlexinC1	CELL			English	Article							HIGH-LEVEL EXPRESSION; CRYSTAL-STRUCTURE; MOLECULAR-BIOLOGY; BIVALENT BINDING; KIT RECEPTOR; DIMERIZATION; INTEGRINS; FAMILY; DOMAIN; 7A	Repulsive signaling by Semaphorins and Plexins is crucial for the development and homeostasis of the nervous, immune, and cardiovascular systems. Sema7A acts as both an immune and a neural Semaphorin through PlexinC1, and A39R is a Sema7A mimic secreted by smallpox virus. We report the structures of Sema7A and A39R complexed with the Semaphorin-binding module of PlexinC1. Both structures show two PlexinC1 molecules symmetrically bridged by Semaphorin dimers, in which the Semaphorin and PlexinC1 beta propellers interact in an edge-on, orthogonal orientation. Both binding interfaces are dominated by the insertion of the Semaphorin's 4c-4d loop into a deep groove in blade 3 of the PlexinC1 propeller. A39R appears to achieve Sema7A mimicry by preserving key Plexin-binding determinants seen in the mammalian Sema7A complex that have evolved to achieve higher affinity binding to the host-derived PlexinC1. The complex structures support a conserved Semaphorin-Plexin recognition mode and suggest that Plexins are activated by dimerization.	[Liu, Heli; Shim, Ann Hye-Ryong; Focia, Pamela J.; Chen, Xiaoyan; He, Xiaolin] Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Chicago, IL 60611 USA; [Juo, Z. Sean; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Juo, Z. Sean; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Juo, Z. Sean; Garcia, K. Christopher] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA	Northwestern University; Feinberg School of Medicine; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	He, XL (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Biol Chem & Mol Pharmacol, Searle 8-417,303 E Chicago Ave, Chicago, IL 60611 USA.	x-he@northwestern.edu			NIH [1R01GM07805, NIH-R01-AI51321]; R.H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098259, R01GM078055] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); R.H. Lurie Comprehensive Cancer Center of Northwestern University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the LS-CAT beamlines at APS and the staffs of ALS and SSRL for the support in X-ray data collection. We also thank L. Colf, and N. Goriatcheva for help with the expression of A39R. X.H. is supported by the NIH grant 1R01GM07805, and K.C.G. is an Investigator of the Howard Hughes Medical Institute and is supported by NIH-R01-AI51321. The Structural Biology Facility is supported by the R.H. Lurie Comprehensive Cancer Center of Northwestern University.	Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Gewurz BE, 2001, CURR OPIN IMMUNOL, V13, P442, DOI 10.1016/S0952-7915(00)00239-9; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; He XL, 2006, J MOL BIOL, V361, P698, DOI 10.1016/j.jmb.2006.06.060; He Zhigang, 2002, Sci STKE, V2002, pre1, DOI 10.1126/stke.2002.119.re1; Holmes S, 2002, SCAND J IMMUNOL, V56, P270, DOI 10.1046/j.1365-3083.2002.01129.x; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; KOLLER KJ, 1992, CIRCULATION, V86, P1081, DOI 10.1161/01.CIR.86.4.1081; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Lemmon MA, 1997, J BIOL CHEM, V272, P6311, DOI 10.1074/jbc.272.10.6311; LEV S, 1992, J BIOL CHEM, V267, P15970; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Scott GA, 2009, J INVEST DERMATOL, V129, P954, DOI 10.1038/jid.2008.329; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Uniewicz KA, 2008, FRONT BIOSCI-LANDMRK, V13, P4339, DOI 10.2741/3008; Waimey KE, 2006, NEUROSCIENTIST, V12, P398, DOI 10.1177/1073858406292631; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xu XM, 1998, J BIOL CHEM, V273, P22428, DOI 10.1074/jbc.273.35.22428; Yamada A, 1999, J IMMUNOL, V162, P4094	46	99	109	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					749	761		10.1016/j.cell.2010.07.040	http://dx.doi.org/10.1016/j.cell.2010.07.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20727575	Green Accepted, Bronze			2022-12-24	WOS:000281523200018
J	Lee, HH; Molla, MN; Cantor, CR; Collins, JJ				Lee, Henry H.; Molla, Michael N.; Cantor, Charles R.; Collins, James J.			Bacterial charity work leads to population-wide resistance	NATURE			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; INDUCED MUTAGENESIS; EVOLUTION; INDOLE; DEATH; ADAPTATION; EXPRESSION; MUTATIONS; STRAINS	Bacteria show remarkable adaptability in the face of antibiotic therapeutics. Resistance alleles in drug target-specific sites and general stress responses have been identified in individual end-point isolates(1-7). Less is known, however, about the population dynamics during the development of antibiotic-resistant strains. Here we follow a continuous culture of Escherichia coli facing increasing levels of antibiotic and show that the vast majority of isolates are less resistant than the population as a whole. We find that the few highly resistant mutants improve the survival of the population's less resistant constituents, in part by producing indole, a signalling molecule generated by actively growing, unstressed cells(8). We show, through transcriptional profiling, that indole serves to turn on drug efflux pumps and oxidative-stress protective mechanisms. The indole production comes at a fitness cost to the highly resistant isolates, and whole-genome sequencing reveals that this bacterial altruism is made possible by drug-resistance mutations unrelated to indole production. This work establishes a population-based resistance mechanism constituting a form of kin selection(9) whereby a small number of resistant mutants can, at some cost to themselves, provide protection to other, more vulnerable, cells, enhancing the survival capacity of the overall population in stressful environments.	[Lee, Henry H.; Molla, Michael N.; Collins, James J.] Howard Hughes Med Inst, Ctr BioDynam, Boston, MA 02115 USA; [Lee, Henry H.; Molla, Michael N.; Cantor, Charles R.; Collins, James J.] Boston Univ, Dept Biomed Engn, Ctr Adv Biotechnol, Boston, MA 02215 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02215 USA	Howard Hughes Medical Institute; Boston University; Harvard University	Collins, JJ (corresponding author), Howard Hughes Med Inst, Ctr BioDynam, Boston, MA 02115 USA.	jcollins@bu.edu	Lee, Henry/GVS-2114-2022	Lee, Henry/0000-0002-0577-2275	National Institutes of Health [DP1OD003644]; National Science Foundation [DMS-0602204]; Howard Hughes Medical Institute; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Chaparian and Q. Beg for help with bioreactor instrumentation. We also thank A. Herbert and C. Ordija for use of the Covaris sonicator for preparing sequencing libraries. This work was supported by the National Institutes of Health through the NIH Director's Pioneer Award Program, grant number DP1OD003644; the National Science Foundation through RTG grant number DMS-0602204; and the Howard Hughes Medical Institute.	Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; GOODER H, 1954, BIOCHEM J, V57, P369, DOI 10.1042/bj0570369; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Hirakawa H, 2005, MOL MICROBIOL, V55, P1113, DOI 10.1111/j.1365-2958.2004.04449.x; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Lee JT, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-42; Livermore DM, 2003, CLIN INFECT DIS, V36, pS11, DOI 10.1086/344654; Long F, 2008, ANTIMICROB AGENTS CH, V52, P3052, DOI 10.1128/AAC.00475-08; Miller JH, 1996, ANNU REV MICROBIOL, V50, P625, DOI 10.1146/annurev.micro.50.1.625; MILLER PF, 1994, ANTIMICROB AGENTS CH, V38, P1773, DOI 10.1128/AAC.38.8.1773; Mouneimne H, 1999, ANTIMICROB AGENTS CH, V43, P62, DOI 10.1128/AAC.43.1.62; Smith BT, 1998, GENETICS, V148, P1599; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Steiling K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005043; Talloen W, 2007, BIOINFORMATICS, V23, P2897, DOI 10.1093/bioinformatics/btm478; Travisano M, 1996, GENETICS, V143, P15; Tucker NP, 2010, TRENDS MICROBIOL, V18, P149, DOI 10.1016/j.tim.2009.12.009; Wang H, 2001, ANTIMICROB AGENTS CH, V45, P1515, DOI 10.1128/AAC.45.5.1515-1521.2001; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Woodford N, 2007, CLIN MICROBIOL INFEC, V13, P5, DOI 10.1111/j.1469-0691.2006.01492.x	30	400	420	7	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					82	U113		10.1038/nature09354	http://dx.doi.org/10.1038/nature09354			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811456	Green Accepted			2022-12-24	WOS:000281461200039
J	Burke, MK; Dunham, JP; Shahrestani, P; Thornton, KR; Rose, MR; Long, AD				Burke, Molly K.; Dunham, Joseph P.; Shahrestani, Parvin; Thornton, Kevin R.; Rose, Michael R.; Long, Anthony D.			Genome-wide analysis of a long-term evolution experiment with Drosophila	NATURE			English	Article							SELECTION; ADAPTATION; GENETICS; LOCUS	Experimental evolution systems allow the genomic study of adaptation, and so far this has been done primarily in asexual systems with small genomes, such as bacteria and yeast(1-3). Here we present whole-genome resequencing data from Drosophila melanogaster populations that have experienced over 600 generations of laboratory selection for accelerated development. Flies in these selected populations develop from egg to adult similar to 20% faster than flies of ancestral control populations, and have evolved a number of other correlated phenotypes. On the basis of 688,520 intermediate-frequency, high-quality single nucleotide polymorphisms, we identify several dozen genomic regions that show strong allele frequency differentiation between a pooled sample of five replicate populations selected for accelerated development and pooled controls. On the basis of resequencing data from a single replicate population with accelerated development, as well as single nucleotide polymorphism data from individual flies from each replicate population, we infer little allele frequency differentiation between replicate populations within a selection treatment. Signatures of selection are qualitatively different than what has been observed in asexual species; in our sexual populations, adaptation is not associated with 'classic' sweeps whereby newly arising, unconditionally advantageous mutations become fixed. More parsimonious explanations include 'incomplete' sweep models, in which mutations have not had enough time to fix, and 'soft' sweep models, in which selection acts on pre-existing, common genetic variants. We conclude that, at least for life history characters such as development time, unconditionally advantageous alleles rarely arise, are associated with small net fitness gains or cannot fix because selection coefficients change over time.	[Burke, Molly K.; Shahrestani, Parvin; Thornton, Kevin R.; Rose, Michael R.; Long, Anthony D.] Univ Calif Irvine, Irvine, CA 92697 USA; [Dunham, Joseph P.] Univ So Calif, Los Angeles, CA 90098 USA	University of California System; University of California Irvine; University of Southern California	Burke, MK (corresponding author), Univ Calif Irvine, 321 Steinhaus Hall, Irvine, CA 92697 USA.	burkem@uci.edu; tdlong@uci.edu		Burke, Molly/0000-0002-4280-0247; Long, Tony/0000-0002-5007-8514; Thornton, Kevin/0000-0003-0743-4445; Rose, Michael/0000-0002-7766-0731	UCI; NSF [DEB-0614429, DGE-0638751]	UCI; NSF(National Science Foundation (NSF))	We thank K. Aeling and D. Heck at the UCI DNA and Protein Microarray Facility for help with preparation and sequencing of the ACO<INF>1</INF> library. The pooled ACO and CO libraries were sequenced at the University of Oregon High-Throughput Sequencing Facility, with advice from D. Turnbull. We are grateful to S. Nuzdhin, T. Turner and J. J. Emerson for providing suggestions during the conception of the project, and to O. Tenaillon and F. Barreto for comments on previous versions of the manuscript. We also thank A. K. Chippindale for discussion of the phenotype data. This work was supported by a UCI Faculty Research and Training Grant to M.R.R. and NSF DEB-0614429 to A.D.L. M.K.B. is supported by an NSF Graduate Fellowship in STEM K-12 Education (DGE-0638751).	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Chevin LM, 2008, GENETICS, V180, P1645, DOI 10.1534/genetics.108.093351; Chippindale Adam K., 2004, P413, DOI 10.1142/9789812567222_0034; Chippindale AK, 1997, EVOLUTION, V51, P1536, DOI [10.2307/2411206, 10.1111/j.1558-5646.1997.tb01477.x]; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; Garland T., 2009, EXPT EVOLUTION CONCE; Hegreness M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-201; Hermisson J, 2005, GENETICS, V169, P2335, DOI 10.1534/genetics.104.036947; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Innan H, 2004, P NATL ACAD SCI USA, V101, P10667, DOI 10.1073/pnas.0401720101; KAPLAN NL, 1989, GENETICS, V123, P887; Papadopoulos D, 1999, P NATL ACAD SCI USA, V96, P3807, DOI 10.1073/pnas.96.7.3807; Pelz HJ, 2005, GENETICS, V170, P1839, DOI 10.1534/genetics.104.040360; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Rose M.R., 2004, METHUSELAH FLIES CAS; Teotonio H, 2000, NATURE, V408, P463, DOI 10.1038/35044070; Teotonio H, 2009, NAT GENET, V41, P251, DOI 10.1038/ng.289	22	298	300	6	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					587	U111		10.1038/nature09352	http://dx.doi.org/10.1038/nature09352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20844486				2022-12-24	WOS:000282273100038
J	de Bono, JS; Ashworth, A				de Bono, J. S.; Ashworth, Alan			Translating cancer research into targeted therapeutics	NATURE			English	Article							CIRCULATING TUMOR-CELLS; RESISTANT PROSTATE-CANCER; PROGRESSION-FREE SURVIVAL; CLINICAL-TRIAL; ABIRATERONE ACETATE; PHASE-I; DRUG; GENE; IMATINIB; INHIBITION	The emphasis in cancer drug development has shifted from cytotoxic, non-specific chemotherapies to molecularly targeted, rationally designed drugs promising greater efficacy and less side effects. Nevertheless, despite some successes drug development remains painfully slow. Here, we highlight the issues involved and suggest ways in which this process can be improved and expedited. We envision an increasing shift to integrated cancer research and biomarker-driven adaptive and hypothesis testing clinical trials. The goal is the development of specific cancer medicines to treat the individual patient, with treatment selection being driven by a detailed understanding of the genetics and biology of the patient and their cancer.	[de Bono, J. S.] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [de Bono, J. S.] Royal Marsden NHS Fdn Trust, Sutton SM2 5PT, Surrey, England; [Ashworth, Alan] Inst Canc Res, Breakthrough Breast Canc Ctr, London SW3 6JB, England	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	de Bono, JS (corresponding author), Inst Canc Res, Cotswold Rd, Sutton SM2 5NG, Surrey, England.	johann.de-bono@icr.ac.uk; alan.ashworth@icr.ac.uk		de Bono, Johann S/0000-0002-2034-595X	Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Breast Cancer Now		Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Attard G, 2008, J CLIN PATHOL, V61, P891, DOI 10.1136/jcp.2008.056341; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Attard G, 2009, CANCER CELL, V16, P458, DOI 10.1016/j.ccr.2009.11.006; Attard G, 2009, NAT REV UROL, V6, P473, DOI 10.1038/nrurol.2009.130; Attard G, 2009, J CLIN ONCOL, V27, P3742, DOI 10.1200/JCO.2008.20.0642; Attard G, 2009, CANCER RES, V69, P2912, DOI 10.1158/0008-5472.CAN-08-3667; Becher OJ, 2006, CANCER RES, V66, P3355, DOI 10.1158/0008-5472.CAN-05-3827; Betensky RA, 2002, J CLIN ONCOL, V20, P2495, DOI 10.1200/JCO.2002.06.140; BOLLAG G, 2010, NATURE          0907, DOI DOI 10.1038/NATURE09454; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; Buyse M, 2000, BIOSTATISTICS, V1, P49, DOI DOI 10.1093/BIOSTATISTICS/1.1.49; Buyse M, 2007, J CLIN ONCOL, V25, P5218, DOI 10.1200/JCO.2007.11.8836; Carden CP, 2009, CLIN PHARMACOL THER, V85, P131, DOI 10.1038/clpt.2008.223; Carden CP, 2010, DRUG DISCOV TODAY, V15, P88, DOI 10.1016/j.drudis.2009.11.006; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; de Bono JS, 2007, CLIN CANCER RES, V13, P3611, DOI 10.1158/1078-0432.CCR-07-0268; de Bono JS, 2003, BREAST CANCER RES, V5, P154, DOI 10.1186/bcr597; De Giorgi U, 2009, J CLIN ONCOL, V27, P3303, DOI 10.1200/JCO.2008.19.4423; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Dowsett M, 2007, JNCI-J NATL CANCER I, V99, P167, DOI 10.1093/jnci/djk020; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Goodsaid F, 2007, AAPS J, V9, pE105, DOI 10.1208/aapsj0901010; Grantab R, 2006, CANCER RES, V66, P1033, DOI 10.1158/0008-5472.CAN-05-3077; Greystoke A, 2008, ANN ONCOL, V19, P990, DOI 10.1093/annonc/mdn014; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hennessy BT, 2009, CLIN CANCER RES, V15, P417, DOI 10.1158/1078-0432.CCR-08-2620; INGLE JN, 1981, NEW ENGL J MED, V304, P16, DOI 10.1056/NEJM198101013040104; Iorns E, 2007, NAT REV DRUG DISCOV, V6, P556, DOI 10.1038/nrd2355; Jordan VC, 2003, J NATL CANCER I, V95, P338, DOI 10.1093/jnci/95.5.338; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kreeger PK, 2010, CARCINOGENESIS, V31, P2, DOI 10.1093/carcin/bgp261; Kwak EL, 2009, J CLIN ONCOL, V27; Lord CJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-38; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mandrekar SJ, 2009, J CLIN ONCOL, V27, P4027, DOI 10.1200/JCO.2009.22.3701; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Olmos D, 2009, ANN ONCOL, V20, P27, DOI 10.1093/annonc/mdn544; Propper DJ, 2003, J CLIN ONCOL, V21, P203, DOI 10.1200/JCO.2003.02.008; Reid AHM, 2010, BRIT J CANCER, V102, P678, DOI 10.1038/sj.bjc.6605554; Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Sausville EA, 2006, CANCER RES, V66, P3351, DOI 10.1158/0008-5472.CAN-05-3627; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Sobrero A, 2009, J CLIN ONCOL, V27, P5868, DOI 10.1200/JCO.2009.22.4162; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Taube SE, 2009, JNCI-J NATL CANCER I, V101, P1453, DOI 10.1093/jnci/djp334; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Workman P, 2008, CURR OPIN PHARMACOL, V8, P359, DOI 10.1016/j.coph.2008.07.007; Workman P, 2006, JNCI-J NATL CANCER I, V98, P580, DOI 10.1093/jnci/djj162; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004	70	242	246	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					543	549		10.1038/nature09339	http://dx.doi.org/10.1038/nature09339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20882008				2022-12-24	WOS:000282273100029
J	Kan, ZY; Jaiswal, BS; Stinson, J; Janakiraman, V; Bhatt, D; Stern, HM; Yue, P; Haverty, PM; Bourgon, R; Zheng, JB; Moorhead, M; Chaudhuri, S; Tomsho, LP; Peters, BA; Pujara, K; Cordes, S; Davis, DP; Carlton, VEH; Yuan, WL; Li, L; Wang, WR; Eigenbrot, C; Kaminker, JS; Eberhard, DA; Waring, P; Schuster, SC; Modrusan, Z; Zhang, ZM; Stokoe, D; de Sauvage, FJ; Faham, M; Seshagiri, S				Kan, Zhengyan; Jaiswal, Bijay S.; Stinson, Jeremy; Janakiraman, Vasantharajan; Bhatt, Deepali; Stern, Howard M.; Yue, Peng; Haverty, Peter M.; Bourgon, Richard; Zheng, Jianbiao; Moorhead, Martin; Chaudhuri, Subhra; Tomsho, Lynn P.; Peters, Brock A.; Pujara, Kanan; Cordes, Shaun; Davis, David P.; Carlton, Victoria E. H.; Yuan, Wenlin; Li, Li; Wang, Weiru; Eigenbrot, Charles; Kaminker, Joshua S.; Eberhard, David A.; Waring, Paul; Schuster, Stephan C.; Modrusan, Zora; Zhang, Zemin; Stokoe, David; de Sauvage, Frederic J.; Faham, Malek; Seshagiri, Somasekar			Diverse somatic mutation patterns and pathway alterations in human cancers	NATURE			English	Article							HUMAN BREAST; IDENTIFICATION; MELANOMA; INSIGHTS; REVEALS	The systematic characterization of somatic mutations in cancer genomes is essential for understanding the disease and for developing targeted therapeutics(1). Here we report the identification of 2,576 somatic mutations across similar to 1,800 megabases of DNA representing 1,507 coding genes from 441 tumours comprising breast, lung, ovarian and prostate cancer types and subtypes. We found that mutation rates and the sets of mutated genes varied substantially across tumour types and subtypes. Statistical analysis identified 77 significantly mutated genes including protein kinases, G-protein-coupled receptors such as GRM8, BAI3, AGTRL1 (also called APLNR) and LPHN3, and other druggable targets. Integrated analysis of somatic mutations and copy number alterations identified another 35 significantly altered genes including GNAS, indicating an expanded role for G alpha subunits in multiple cancer types. Furthermore, our experimental analyses demonstrate the functional roles of mutant GNAO1 (a G alpha subunit) and mutant MAP2K4 (a member of the JNK signalling pathway) in oncogenesis. Our study provides an overview of the mutational spectra across major human cancers and identifies several potential therapeutic targets.	[Kan, Zhengyan; Jaiswal, Bijay S.; Stinson, Jeremy; Janakiraman, Vasantharajan; Bhatt, Deepali; Chaudhuri, Subhra; Peters, Brock A.; Pujara, Kanan; Cordes, Shaun; Davis, David P.; Yuan, Wenlin; Modrusan, Zora; Stokoe, David; de Sauvage, Frederic J.; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Kan, Zhengyan; Yue, Peng; Haverty, Peter M.; Bourgon, Richard; Li, Li; Kaminker, Joshua S.; Zhang, Zemin] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Stern, Howard M.; Eberhard, David A.; Waring, Paul] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Zheng, Jianbiao; Moorhead, Martin; Carlton, Victoria E. H.; Faham, Malek] Affymetrix Inc, Santa Clara, CA 95051 USA; [Tomsho, Lynn P.; Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Wang, Weiru; Eigenbrot, Charles] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Affymetrix; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Roche Holding; Genentech	Seshagiri, S (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	sekar@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584; Bourgon, Richard/0000-0002-5890-4374; Peters, Brock/0000-0002-5137-3902; Wang, Weiru/0000-0001-8845-301X; Seshagiri, Somasekar/0000-0003-4272-6443				Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Bastida Eizaguirre M, 2001, An Esp Pediatr, V54, P598; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Cazillis M, 2004, ONCOGENE, V23, P4735, DOI 10.1038/sj.onc.1207619; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clifford RJ, 2004, BIOINFORMATICS, V20, P1006, DOI 10.1093/bioinformatics/bth029; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fakhrai-Rad H, 2004, GENOME RES, V14, P1404, DOI 10.1101/gr.2373904; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Kaminker JS, 2007, CANCER RES, V67, P465, DOI 10.1158/0008-5472.CAN-06-1736; Kidd KK, 2006, FORENSIC SCI INT, V164, P20, DOI 10.1016/j.forsciint.2005.11.017; Marson VJ, 2004, HISTOPATHOLOGY, V45, P125, DOI 10.1111/j.1365-2559.2004.01893.x; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Parmigiani G, 2009, GENOMICS, V93, P17, DOI 10.1016/j.ygeno.2008.07.005; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Peters BA, 2007, NAT METHODS, V4, P713, DOI 10.1038/NMETH1081; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Ram PT, 2000, SCIENCE, V287, P142, DOI 10.1126/science.287.5450.142; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rubin AF, 2007, SCIENCE, V317, DOI 10.1126/science.1138956; Sanchez JJ, 2006, ELECTROPHORESIS, V27, P1713, DOI 10.1002/elps.200500671; Shiratsuchi T, 1997, CYTOGENET CELL GENET, V79, P103, DOI 10.1159/000134693; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Teng DHF, 1997, CANCER RES, V57, P4177; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; WEINSTEIN LS, 1993, CLIN BIOCHEM, V26, P333, DOI 10.1016/0009-9120(93)90109-J; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yue P, 2010, HUM MUTAT, V31, P264, DOI 10.1002/humu.21194; Zheng JB, 2009, P NATL ACAD SCI USA, V106, P6712, DOI 10.1073/pnas.0901902106	43	769	811	3	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					869	U103		10.1038/nature09208	http://dx.doi.org/10.1038/nature09208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20668451				2022-12-24	WOS:000280766100037
J	Wang, FW; Dai, J; Daum, JR; Niedzialkowska, E; Banerjee, B; Stukenberg, PT; Gorbsky, GJ; Higgins, JMG				Wang, Fangwei; Dai, Jun; Daum, John R.; Niedzialkowska, Ewa; Banerjee, Budhaditya; Stukenberg, P. Todd; Gorbsky, Gary J.; Higgins, Jonathan M. G.			Histone H3 Thr-3 Phosphorylation by Haspin Positions Aurora B at Centromeres in Mitosis	SCIENCE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; HELA-CELLS; SURVIVIN; SPINDLE; KINASE; MCAK; ALIGNMENT; BOREALIN; KINETOCHORES; SMAC/DIABLO	Aurora B is a component of the chromosomal passenger complex (CPC) required for correct spindle-kinetochore attachments during chromosome segregation and for cytokinesis. The chromatin factors that recruit the CPC to centromeres are unknown, however. Here we show that phosphorylation of histone H3 threonine 3 (H3T3ph) by Haspin is necessary for CPC accumulation at centromeres and that the CPC subunit Survivin binds directly to H3T3ph. A nonbinding Survivin-D70A/D71A mutant does not support centromeric CPC concentration, and both Haspin depletion and Survivin-D70A/D71A mutation diminish centromere localization of the kinesin MCAK and the mitotic checkpoint response to taxol. Survivin-D70A/D71A mutation and microinjection of H3T3ph-specific antibody both compromise centromeric Aurora B functions but do not prevent cytokinesis. Therefore, H3T3ph generated by Haspin positions the CPC at centromeres to regulate selected targets of Aurora B during mitosis.	[Wang, Fangwei; Dai, Jun; Higgins, Jonathan M. G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Daum, John R.; Gorbsky, Gary J.] Oklahoma Med Res Fdn, Cell Cycle & Canc Biol Res Program, Oklahoma City, OK 73104 USA; [Niedzialkowska, Ewa; Banerjee, Budhaditya; Stukenberg, P. Todd] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Oklahoma Medical Research Foundation; University of Virginia	Higgins, JMG (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Smith Bldg,1 Jimmy Fund Way, Boston, MA 02115 USA.	jhiggins@rics.bwh.harvard.edu	Dai, Jun/J-9718-2015	Niedzialkowska, Ewa/0000-0002-0348-3154; Higgins, Jonathan/0000-0001-6622-8268; Gorbsky, Gary/0000-0003-3076-4725; Stukenberg, Todd/0000-0002-6788-2111; Wang, Fangwei/0000-0001-5617-282X	American Cancer Society [RSG-05-13401-GMC]; National Institutes of Health [R01-GM074210, R01-GM050412, R01-GM063045]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074210, R01GM050412, R01GM063045] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. C. Earnshaw, H. Funabiki, M. A. Lampson, S. M. A. Lens, J. P. Noel, S. S. Taylor, L. Wordeman, and Y. Zheng for cDNAs and antibodies; C. Crafter of AstraZeneca for ZM447439; and H. Funabiki and A. Kelly for sharing unpublished results. J. D. and J. M. G. H. have patents pending on Haspin inhibitors. This work was funded by grants from the American Cancer Society (RSG-05-13401-GMC to J. M. G. H) and the National Institutes of Health (R01-GM074210 to J. M. G. H., R01-GM050412 to G. J. G., and R01-GM063045 to P.T.S.).	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Cao LH, 2006, BIOCHEM BIOPH RES CO, V346, P400, DOI 10.1016/j.bbrc.2006.05.131; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lens SMA, 2006, MOL BIOL CELL, V17, P1897, DOI 10.1091/mbc.E05-08-0727; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun CH, 2005, BIOCHEMISTRY-US, V44, P11, DOI 10.1021/bi0485171; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Yue ZJ, 2008, J CELL BIOL, V183, P279, DOI 10.1083/jcb.200806118; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125	30	329	340	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					231	235		10.1126/science.1189435	http://dx.doi.org/10.1126/science.1189435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20705812	Green Accepted			2022-12-24	WOS:000282644600045
J	Bengtson, MH; Joazeiro, CAP				Bengtson, Mario H.; Joazeiro, Claudio A. P.			Role of a ribosome-associated E3 ubiquitin ligase in protein quality control	NATURE			English	Article							MESSENGER-RNA SURVEILLANCE; YEAST; TRANSLATION; IDENTIFICATION; PROTEASOME; ANTIBIOTICS; DEGRADATION; EXPRESSION; MECHANISM; REVEALS	Messenger RNA lacking stop codons ('non-stop mRNA') can arise from errors in gene expression, and encode aberrant proteins whose accumulation could be deleterious to cellular function(1,2). In bacteria, these 'non-stop proteins' become co-translationally tagged with a peptide encoded by ssrA/tmRNA (transfer-messenger RNA), which signals their degradation by energy-dependent proteases(1,3). How eukaryotic cells eliminate non-stop proteins has remained unknown. Here we show that the Saccharomyces cerevisiae Ltn1 RING-domain-type E3 ubiquitin ligase acts in the quality control of non-stop proteins, in a process that is mechanistically distinct but conceptually analogous to that performed by ssrA: Ltn1 is predominantly associated with ribosomes, and it marks nascent non-stop proteins with ubiquitin to signal their proteasomal degradation. Ltn1-mediated ubiquitylation of non-stop proteins seems to be triggered by their stalling in ribosomes on translation through the poly(A) tail. The biological relevance of this process is underscored by the finding that loss of Ltn1 function confers sensitivity to stress caused by increased non-stop protein production. We speculate that defective protein quality control may underlie the neurodegenerative phenotype that results from mutation of the mouse Ltn1 homologue Listerin.	[Bengtson, Mario H.; Joazeiro, Claudio A. P.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Joazeiro, CAP (corresponding author), Scripps Res Inst, Dept Cell Biol, CB168,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	joazeiro@scripps.edu			American Cancer Society [08-298-01-TBE]; National Institute of General Medical Sciences [R01GM083060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083060] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. C. Sogayar for continued mentorship; I. Kwan for technical help; A. Bacconi for help with microscopy; T. Inada, A. van Hoof, S. Liebman and J. Frydman for reagents; the Williamson and Saez laboratories for help with sucrose-gradient fractionation and real-time PCR, respectively; E. Peters for mass spectrometry analyses; M. Smolka for help with yeast methods; and R. Deshaies, E. P. Geiduschek and T. Hunter for discussions. Work in the Joazeiro laboratory is supported by Research Scholar Grant 08-298-01-TBE from the American Cancer Society and grant R01GM083060 from the National Institute of General Medical Sciences.	Bradley ME, 2003, YEAST, V20, P625, DOI 10.1002/yea.985; Braun MA, 2007, MOL CELL BIOL, V27, P2800, DOI 10.1128/MCB.01947-06; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dulebohn D, 2007, BIOCHEMISTRY-US, V46, P4681, DOI 10.1021/bi6026055; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Kirillov S, 1997, FEBS LETT, V406, P223, DOI 10.1016/S0014-5793(97)00261-5; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Rospert S, 2004, CURR BIOL, V14, pR386, DOI 10.1016/j.cub.2004.05.013; VAN HOOF A, 2002, SCIENCE, V295, P2262; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wilson MA, 2007, GENETICS, V177, P773, DOI 10.1534/genetics.107.073205; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	23	305	309	2	39	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					470	473		10.1038/nature09371	http://dx.doi.org/10.1038/nature09371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20835226	Green Accepted			2022-12-24	WOS:000282090200045
J	Polli, D; Altoe, P; Weingart, O; Spillane, KM; Manzoni, C; Brida, D; Tomasello, G; Orlandi, G; Kukura, P; Mathies, RA; Garavelli, M; Cerullo, G				Polli, Dario; Altoe, Piero; Weingart, Oliver; Spillane, Katelyn M.; Manzoni, Cristian; Brida, Daniele; Tomasello, Gaia; Orlandi, Giorgio; Kukura, Philipp; Mathies, Richard A.; Garavelli, Marco; Cerullo, Giulio			Conical intersection dynamics of the primary photoisomerization event in vision	NATURE			English	Article							INITIO MOLECULAR-DYNAMICS; EXCITED-STATE DYNAMICS; 1ST STEP; FEMTOSECOND ISOMERIZATION; PERTURBATION-THEORY; CHROMOPHORE MODELS; VISUAL PIGMENTS; ENERGY-STORAGE; RHODOPSIN; SPECTROSCOPY	Ever since the conversion of the 11-cis retinal chromophore to its all-trans form in rhodopsin was identified as the primary photochemical event in vision(1), experimentalists and theoreticians have tried to unravel the molecular details of this process. The high quantum yield of 0.65 (ref. 2), the production of the primary ground-state rhodopsin photoproduct within a mere 200 fs (refs 3-7), and the storage of considerable energy in the first stable bathorhodopsin intermediate(8) all suggest an unusually fast and efficient photoactivated one-way reaction(9). Rhodopsin's unique reactivity is generally attributed to a conical intersection between the potential energy surfaces of the ground and excited electronic states(10,11) enabling the efficient and ultrafast conversion of photon energy into chemical energy(12-16). But obtaining direct experimental evidence for the involvement of a conical intersection is challenging: the energy gap between the electronic states of the reacting molecule changes significantly over an ultrashort time-scale, which calls for observational methods that combine high temporal resolution with a broad spectral observation window. Here we show that ultrafast optical spectroscopy with sub-20-fs time resolution and spectral coverage from the visible to the near-infrared allows us to follow the dynamics leading to the conical intersection in rhodopsin isomerization. We track coherent wave-packet motion from the photoexcited Franck-Condon region to the photoproduct by monitoring the loss of reactant emission and the subsequent appearance of photoproduct absorption, and find excellent agreement between the experimental observations and molecular dynamics calculations that involve a true electronic state crossing. Taken together, these findings constitute the most compelling evidence to date for the existence and importance of conical intersections in visual photochemistry.	[Altoe, Piero; Tomasello, Gaia; Orlandi, Giorgio; Garavelli, Marco] Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy; [Polli, Dario; Manzoni, Cristian; Brida, Daniele; Cerullo, Giulio] Politecn Milan, IFN, CNR, Dipartimento Fis, I-20133 Milan, Italy; [Weingart, Oliver] Univ Duisburg Essen, Lehrstuhl Theoret Chem, D-45117 Essen, Germany; [Weingart, Oliver] Max Planck Inst Kohlenforsch, D-45470 Mulheim, Germany; [Spillane, Katelyn M.; Mathies, Richard A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kukura, Philipp] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England	University of Bologna; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR); Polytechnic University of Milan; University of Duisburg Essen; Max Planck Society; University of California System; University of California Berkeley; University of Oxford	Garavelli, M (corresponding author), Univ Bologna, Dipartimento Chim G Ciamician, Via F Selmi 2, I-40126 Bologna, Italy.	marco.garavelli@unibo.it; giulio.cerullo@fisi.polimi.it	Manzoni, Cristian/ABF-1906-2020; Brida, Daniele/A-9301-2010; Cerullo, Giulio/F-6534-2011; Manzoni, Cristian/GPX-1379-2022; Weingart, Oliver/O-6470-2019; Manzoni, Cristian/F-6669-2011; Weingart, Oliver/P-9920-2017; Polli, Dario/B-4809-2011; GARAVELLI, MARCO/P-5510-2015; Brida, Daniele/AAT-6672-2020	Brida, Daniele/0000-0003-2060-5480; Cerullo, Giulio/0000-0002-9534-2702; Manzoni, Cristian/0000-0002-4169-8869; Weingart, Oliver/0000-0001-6033-3702; Manzoni, Cristian/0000-0002-4169-8869; Weingart, Oliver/0000-0001-6033-3702; Polli, Dario/0000-0002-6960-5708; GARAVELLI, MARCO/0000-0002-0796-289X; Brida, Daniele/0000-0003-2060-5480; Kukura, Philipp/0000-0003-0136-7704	DFG [FOR490]; PRIN programme [2008JKBBK4]; UK Engineering and Physical Sciences Research Council [EP/H003541/1]; Engineering and Physical Sciences Research Council [EP/H003541/1] Funding Source: researchfish; EPSRC [EP/H003541/1] Funding Source: UKRI	DFG(German Research Foundation (DFG)); PRIN programme(Ministry of Education, Universities and Research (MIUR)); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	M.G., O.W., G.O., G. T. and P. A. thank E4-Computer Engineering S. p. A. for computational time and technical assistance. Part of this study was financially supported by the DFG (FOR490) and by the PRIN programme (2008JKBBK4). P. K. is supported by a Career Acceleration Fellowship awarded by the UK Engineering and Physical Sciences Research Council (EP/H003541/1).	Altoe P, 2007, THEOR CHEM ACC, V118, P219, DOI 10.1007/s00214-007-0275-9; ANDERSSON K, 1992, J CHEM PHYS, V96, P1218, DOI 10.1063/1.462209; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cembran A, 2004, J AM CHEM SOC, V126, P16018, DOI 10.1021/ja048782+; Chosrowjan H, 1998, J AM CHEM SOC, V120, P9706, DOI 10.1021/ja981659w; Forsberg N, 1997, CHEM PHYS LETT, V274, P196, DOI 10.1016/S0009-2614(97)00669-6; Frutos LM, 2007, P NATL ACAD SCI USA, V104, P7764, DOI 10.1073/pnas.0701732104; Garavelli M, 1997, J AM CHEM SOC, V119, P6891, DOI 10.1021/ja9610895; Gonzalez-Luque R, 2000, P NATL ACAD SCI USA, V97, P9379, DOI 10.1073/pnas.97.17.9379; Groenhof G, 2004, J AM CHEM SOC, V126, P4228, DOI 10.1021/ja039557f; Groenhof G, 2007, J AM CHEM SOC, V129, P6812, DOI 10.1021/ja069176c; Haran G, 1999, J PHYS CHEM A, V103, P2202, DOI 10.1021/jp9832847; Hayashi S, 2003, BIOPHYS J, V85, P1440, DOI 10.1016/S0006-3495(03)74576-7; Hayashi S, 2009, BIOPHYS J, V96, P403, DOI 10.1016/j.bpj.2008.09.049; Hudock HR, 2007, J PHYS CHEM A, V111, P8500, DOI 10.1021/jp0723665; Hudock HR, 2008, CHEMPHYSCHEM, V9, P2486, DOI 10.1002/cphc.200800649; Kandori H, 2001, CHEM PHYS LETT, V334, P271, DOI 10.1016/S0009-2614(00)01457-3; Karlstrom G, 2003, COMP MATER SCI, V28, P222, DOI 10.1016/S0927-0256(03)00109-5; Kim JE, 2001, BIOCHEMISTRY-US, V40, P13774, DOI 10.1021/bi0116137; KLESSINGER M, 1994, EXCITED STATES PHOTO; Kochendoerfer GG, 1996, J PHYS CHEM-US, V100, P14526, DOI 10.1021/jp960509+; Kukura P, 2005, SCIENCE, V310, P1006, DOI 10.1126/science.1118379; Levine BG, 2007, ANNU REV PHYS CHEM, V58, P613, DOI 10.1146/annurev.physchem.57.032905.104612; Lin H, 2007, THEOR CHEM ACC, V117, P185, DOI 10.1007/s00214-006-0143-z; Manzoni C, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2167128; Mathies R. A., 2000, HDB BIOL PHYSICS, P55, DOI DOI 10.1016/S1383-8121(00)80005-6; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Polli D, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2800778; Roos B.O., 1987, ADV CHEM PHYS, V69, P399, DOI DOI 10.1002/9780470142943.CH7; SCHICK GA, 1987, BIOCHEMISTRY-US, V26, P2556, DOI 10.1021/bi00383a022; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; SINGH UC, 1986, J COMPUT CHEM, V7, P718, DOI 10.1002/jcc.540070604; SLOANE CS, 1977, J CHEM PHYS, V66, P1523, DOI 10.1063/1.434116; Stenta M, 2008, J PHYS CHEM B, V112, P1057, DOI 10.1021/jp7104105; Tao HL, 2009, J PHYS CHEM A, V113, P13656, DOI 10.1021/jp9063565; Tomasello G, 2009, J AM CHEM SOC, V131, P5172, DOI 10.1021/ja808424b; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; WANG Q, 1994, SCIENCE, V266, P422, DOI 10.1126/science.7939680; WARSHEL A, 1982, J AM CHEM SOC, V104, P1469, DOI 10.1021/ja00370a003; WARSHEL A, 1976, NATURE, V260, P679, DOI 10.1038/260679a0; Weingart O, 2007, J AM CHEM SOC, V129, P10618, DOI 10.1021/ja071793t; Weingart O, 2007, J PHYS CHEM B, V111, P3782, DOI 10.1021/jp0683216; Werner HJ, 2008, MOLPRO VERSION 2008; YOSHIZAWA T, 1963, NATURE, V197, P1279, DOI 10.1038/1971279a0	45	637	642	6	433	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					440	U88		10.1038/nature09346	http://dx.doi.org/10.1038/nature09346			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20864998				2022-12-24	WOS:000282090200038
J	Chou, YH; Zheng, XY; Beachy, PA; Luo, LQ				Chou, Ya-Hui; Zheng, Xiaoyan; Beachy, Philip A.; Luo, Liqun			Patterning Axon Targeting of Olfactory Receptor Neurons by Coupled Hedgehog Signaling at Two Distinct Steps	CELL			English	Article							DEPENDENT PROTEIN-KINASE; SONIC HEDGEHOG; PRONEURAL GENE; SENSE-ORGANS; DROSOPHILA; MAP; TRANSCRIPTION; SYSTEM; ORGANIZATION; SPECIFICITY	We present evidence for a coupled two-step action of Hedgehog signaling in patterning axon targeting of Drosophila olfactory receptor neurons (ORNs). In the first step, differential Hedgehog pathway activity in peripheral sensory organ precursors creates ORN populations with different levels of the Patched receptor. Different Patched levels in ORNs then determine axonal responsiveness to target-derived Hedgehog in the brain: only ORN axons that do not express high levels of Patched are responsive to and require a second step of Hedgehog signaling for target selection. Hedgehog signaling in the imaginal sensory organ precursors thus confers differential ORN responsiveness to Hedgehog-mediated axon targeting in the brain. This mechanism contributes to the spatial coordination of ORN cell bodies in the periphery and their glomerular targets in the brain. Such coupled two-step signaling may be more generally used to coordinate other spatially and temporally segregated developmental events.	[Chou, Ya-Hui; Zheng, Xiaoyan; Beachy, Philip A.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Chou, Ya-Hui; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Zheng, Xiaoyan; Beachy, Philip A.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	lluo@stanford.edu	Chou, Ya-Hui/F-3775-2014; Zheng, Xiaoyan/AAG-1251-2020	Chou, Ya-Hui/0000-0001-6552-8728; Zheng, Xiaoyan/0000-0003-4983-5503; Luo, Liqun/0000-0001-5467-9264	NIH [R01-DC005982]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank T. Clandinin, M. Scott, K. Shen, G. Struhl, and members of the Luo lab, in particular L. Sweeney, M. Spletter, D. Berdnik, K. Miyamichi, and T. Mosca for discussion and comments on the manuscript. We are grateful to D. Luginbuhl and S. Wheaton for assistance. We thank T. Tabata, I. Salecker, C. T. Chien, G. Struhl, Y.H. Sun, T. Lee, B. Dickson, R. Holmgren, N.E. Baker, J. Jiang, M. P. Scott, P. Therond, I. Guerrero, E. Sanchez-Herrero, R. Carthew, G. W. Davis, L. A. Raftery, K. Saigo, Bloomington Stock Center, Kyoto Stock Center, GETDB (NIG), and Developmental Studies Hybridoma Bank for reagents. Supported by an NIH grant (R01-DC005982 to L. L.). L. L. and P. A. B. are HHMI investigators.	Bourikas D, 2005, NAT NEUROSCI, V8, P297, DOI 10.1038/nn1396; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Casali A, 2004, NATURE, V431, P76, DOI 10.1038/nature02835; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Chotard C, 2005, NEURON, V48, P237, DOI 10.1016/j.neuron.2005.09.019; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; EATON S, 1990, GENE DEV, V4, P1068, DOI 10.1101/gad.4.6.1068; Endo K, 2007, NAT NEUROSCI, V10, P153, DOI 10.1038/nn1832; Eugster C, 2007, DEV CELL, V13, P57, DOI 10.1016/j.devcel.2007.04.019; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Gupta BP, 1998, DEV BIOL, V203, P400, DOI 10.1006/dbio.1998.9064; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEPAGE T, 1995, NATURE, V373, P711, DOI 10.1038/373711a0; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; PAN DJ, 1995, CELL, V80, P543, DOI 10.1016/0092-8674(95)90508-1; Parra LM, 2010, NAT NEUROSCI, V13, P29, DOI 10.1038/nn.2457; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; Song HJ, 2001, NAT CELL BIOL, V3, pE81, DOI 10.1038/35060164; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Takeuchi H, 2010, CELL, V141, P1056, DOI 10.1016/j.cell.2010.04.041; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Zheng XY, 2010, GENE DEV, V24, P57, DOI 10.1101/gad.1870310; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	51	32	32	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					954	966		10.1016/j.cell.2010.08.015	http://dx.doi.org/10.1016/j.cell.2010.08.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850015	Green Accepted, Bronze			2022-12-24	WOS:000281855000017
J	Mariappan, M; Li, XZ; Stefanovic, S; Sharma, A; Mateja, A; Keenan, RJ; Hegde, RS				Mariappan, Malaiyalam; Li, Xingzhe; Stefanovic, Sandra; Sharma, Ajay; Mateja, Agnieszka; Keenan, Robert J.; Hegde, Ramanujan S.			A ribosome-associating factor chaperones tail-anchored membrane proteins	NATURE			English	Article							ENDOPLASMIC-RETICULUM; ER MEMBRANE; INSERTION; GET3; COMPLEX; RECOGNITION; BINDING; IDENTIFICATION; TRANSLATION; TERMINATION	Hundreds of proteins are inserted post-translationally into the endoplasmic reticulum (ER) membrane by a single carboxyterminal transmembrane domain (TMD)(1). During targeting through the cytosol, the hydrophobic TMD of these tail-anchored (TA) proteins requires constant chaperoning to prevent aggregation or inappropriate interactions. A central component of this targeting system is TRC40, a conserved cytosolic factor that recognizes the TMD of TA proteins and delivers them to the ER for insertion(2-4). The mechanism that permits TRC40 to find and capture its TA protein cargos effectively in a highly crowded cytosol is unknown. Here we identify a conserved three-protein complex composed of Bat3, TRC35 and Ubl4A that facilitates TA protein capture by TRC40. This Bat3 complex is recruited to ribosomes synthesizing membrane proteins, interacts with the TMDs of newly released TA proteins, and transfers them to TRC40 for targeting. Depletion of the Bat3 complex allows non-TRC40 factors to compete for TA proteins, explaining their mislocalization in the analogous yeast deletion strains(5-7). Thus, the Bat3 complex acts as a TMD-selective chaperone that effectively channels TA proteins to the TRC40 insertion pathway.	[Mariappan, Malaiyalam; Li, Xingzhe; Stefanovic, Sandra; Sharma, Ajay; Hegde, Ramanujan S.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Li, Xingzhe] Peking Univ, Sch Basic Med Sci, Beijing 100191, Peoples R China; [Mateja, Agnieszka; Keenan, Robert J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Peking University; University of Chicago	Hegde, RS (corresponding author), NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	hegder@mail.nih.gov	mariappan, malaiyalam/K-9024-2012	Hegde, Ramanujan/0000-0001-8338-852X; Keenan, Robert/0000-0003-1466-0889	National Institutes of Health; Edward Mallinckrodt Jr Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Jr Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank S. Appathurai and M. Downing for technical assistance, Hegde lab members for advice, and J. Weissman and W. Clemons for useful discussions and sharing results before publication. This work was supported by the Intramural Research Program of the National Institutes of Health (R.S.H.) and Edward Mallinckrodt Jr Foundation (R.J.K.).	Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Bozkurt G, 2010, FEBS LETT, V584, P1509, DOI 10.1016/j.febslet.2010.02.070; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Cao JH, 1996, MOL CELL BIOL, V16, P603; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Copic A, 2009, GENETICS, V182, P757, DOI 10.1534/genetics.109.101105; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; HIGH S, 1991, J CELL BIOL, V113, P35, DOI 10.1083/jcb.113.1.35; HOBDEN AN, 1978, BIOCHEM J, V170, P57, DOI 10.1042/bj1700057; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; LODISH HF, 1972, J BIOL CHEM, V247, P3622; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; WANG S, 1995, J CELL BIOL, V130, P519, DOI 10.1083/jcb.130.3.519; WOLIN SL, 1989, J CELL BIOL, V109, P2617, DOI 10.1083/jcb.109.6.2617; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x	30	196	201	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1120	U138		10.1038/nature09296	http://dx.doi.org/10.1038/nature09296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20676083	Green Accepted			2022-12-24	WOS:000281203600043
J	Yang, JY; Reth, M				Yang, Jianying; Reth, Michael			Oligomeric organization of the B-cell antigen receptor on resting cells	NATURE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; IG-ALPHA/IG-BETA; LIVING CELLS; PROTEIN INTERACTIONS; ACTIVATION; VISUALIZATION; INITIATION; ITAM; BCR	B lymphocytes are activated by many different antigens to produce specific antibodies protecting higher organisms from infection. To detect its cognate antigen, each B cell contains up to 120,000 B-cell antigen receptor (BCR) complexes on its cell surface. How these abundant receptors stay silent on resting B cells and how they can be activated by a molecularly diverse set of ligands is poorly understood(1). Here we show, with the use of a quantitative bifluorescence complementation assay (BiFC)(2,3), that the BCR has an intrinsic ability to form oligomers on the surface of living cells. A BCR mutant that fails to form oligomers is more active and cannot be expressed stably on the B-cell surface, whereas BiFC-stabilized BCR oligomers are less active and more strongly expressed on the surface. We propose that oligomers are the autoinhibited form of the BCR and that it is the shift from closed BCR oligomers to clustered monomers that drives B-cell activation in a way that is independent of the structural input from the antigen.	[Yang, Jianying; Reth, Michael] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Dept Mol Immunol, Fac Biol, D-79108 Freiburg, Germany; [Yang, Jianying; Reth, Michael] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany	University of Freiburg; Max Planck Society	Reth, M (corresponding author), Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Dept Mol Immunol, Fac Biol, Stubeweg 51, D-79108 Freiburg, Germany.	michael.reth@bioss.uni-freiburg.de		YANG, JIANYING/0000-0001-8197-5413	Excellence Initiative of the German Federal and State Governments [EXC 294]; Deutsche Forschungsgemeinschaft [SFB746]; FRISYS	Excellence Initiative of the German Federal and State Governments; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FRISYS	We thank L. Leclercq, P. Nielsen, H. Jumaa and W. Schamel for critical reading of this manuscript. This study was supported by the Excellence Initiative of the German Federal and State Governments (EXC 294), by the Deutsche Forschungsgemeinschaft through SFB746 and by the FRISYS programme.	Chiorazzi N, 2003, ANNU REV IMMUNOL, V21, P841, DOI 10.1146/annurev.immunol.21.120601.141018; Engels N, 2008, ADV IMMUNOL, V97, P251, DOI 10.1016/S0065-2776(08)00005-9; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kawauchi K, 2002, INT J HEMATOL, V75, P508, DOI 10.1007/BF02982115; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kim JH, 2005, J IMMUNOL, V175, P147, DOI 10.4049/jimmunol.175.1.147; Kim YM, 2006, P NATL ACAD SCI USA, V103, P3327, DOI 10.1073/pnas.0511315103; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Lankester AC, 1996, LEUKEMIA LYMPHOMA, V24, P27, DOI 10.3109/10428199609045711; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Meixlsperger S, 2007, IMMUNITY, V26, P323, DOI 10.1016/j.immuni.2007.01.012; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Monroe JG, 2006, NAT REV IMMUNOL, V6, P283, DOI 10.1038/nri1808; Payelle-Brogard B, 2002, BRIT J HAEMATOL, V118, P976, DOI 10.1046/j.1365-2141.2002.03759.x; Peng SL, 2009, AUTOIMMUN REV, V8, P179, DOI 10.1016/j.autrev.2008.07.040; Pugh-Bernard AE, 2006, CURR OPIN RHEUMATOL, V18, P451, DOI 10.1097/01.bor.0000240353.99808.5f; Reth M, 2001, TRENDS IMMUNOL, V22, P356, DOI 10.1016/S1471-4906(01)01964-0; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Schrum Adam G, 2007, Sci STKE, V2007, ppl2, DOI 10.1126/stke.3892007pl2; Semichon M, 1997, LEUKEMIA, V11, P1921, DOI 10.1038/sj.leu.2400832; Siegers GM, 2006, INT IMMUNOL, V18, P1385, DOI 10.1093/intimm/dxl072; Storch B, 2007, EUR J IMMUNOL, V37, P252, DOI 10.1002/eji.200636667; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tolar P, 2008, IMMUNOL REV, V221, P64, DOI 10.1111/j.1600-065X.2008.00583.x; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; VENKITARAMAN AR, 1991, NATURE, V352, P777, DOI 10.1038/352777a0	31	126	128	0	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					465	U117		10.1038/nature09357	http://dx.doi.org/10.1038/nature09357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20818374				2022-12-24	WOS:000282090200044
J	Wang, G; Chen, HW; Oktay, Y; Zhang, J; Allen, EL; Smith, GM; Fan, KC; Hong, JS; French, SW; McCaffery, JM; Lightowlers, RN; Morse, HC; Koehler, CM; Teitell, MA				Wang, Geng; Chen, Hsiao-Wen; Oktay, Yavuz; Zhang, Jin; Allen, Eric L.; Smith, Geoffrey M.; Fan, Kelly C.; Hong, Jason S.; French, Samuel W.; McCaffery, J. Michael; Lightowlers, Robert N.; Morse, Herbert C., III; Koehler, Carla M.; Teitell, Michael A.			PNPASE Regulates RNA Import into Mitochondria	CELL			English	Article							HUMAN POLYNUCLEOTIDE PHOSPHORYLASE; HELA-CELL MITOCHONDRIA; POLY(A) POLYMERASE; P-ACTIVITY; PROTEIN; LIVER; CONTAINS; BINDING	RNA import into mammalian mitochondria is considered essential for replication, transcription, and translation of the mitochondrial genome but the pathway(s) and factors that control this import are poorly understood. Previously, we localized polynucleotide phosphorylase (PNPASE), a 3' -> 5' exoribonuclease and poly-A polymerase, in the mitochondrial intermembrane space, a location lacking resident RNAs. Here, we show a new role for PNPASE in regulating the import of nuclear-encoded RNAs into the mitochondrial matrix. PNPASE reduction impaired mitochondrial RNA processing and polycistronic transcripts accumulated. Augmented import of RNase P, 5S rRNA, and MRP RNAs depended on PNPASE expression and PNPASE-imported RNA interactions were identified. PNPASE RNA processing and import activities were separable and a mitochondrial RNA targeting signal was isolated that enabled RNA import in a PNPASE-dependent manner. Combined, these data strongly support an unanticipated role for PNPASE in mediating the translocation of RNAs into mitochondria.	[Wang, Geng; Oktay, Yavuz; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Koehler, Carla M.; Teitell, Michael A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Broad Stem Cell Res Ctr, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Ctr Cell Control, Los Angeles, CA 90095 USA; [Chen, Hsiao-Wen] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA; [Zhang, Jin; Allen, Eric L.; Smith, Geoffrey M.; Fan, Kelly C.; Hong, Jason S.; French, Samuel W.; Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA; [Lightowlers, Robert N.] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Morse, Herbert C., III] NIAID, Immunopathol Lab, NIH, Rockville, MD 20852 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Koehler, CM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	koehler@chem.ucla.edu; mteitell@mednet.ucla.edu	Oktay, Yavuz/G-4794-2015; ZHANG, JIN/D-1435-2013	Oktay, Yavuz/0000-0002-0158-2693; Morse, Herbert/0000-0002-9331-3705	NIH [R01GM061721, R01GM073981, R01CA90571, PN2EY018228, K22CA120147]; NIH, National Institute of Allergy and Infectious Diseases; Muscular Dystrophy Association [022398]; American Heart Association [0640076N]; California Institute of Regenerative Medicine [RS1-00313, RB1-01397]; NATIONAL CANCER INSTITUTE [R01CA156674, K22CA120147, R01CA090571, R01CA107300] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000858, ZIAAI001057, ZIAAI001024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073981, R01GM061721] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Muscular Dystrophy Association(Muscular Dystrophy Association); American Heart Association(American Heart Association); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michelle Husain for expertise in TEM. Supported by NIH grants R01GM061721 and R01GM073981 (C.M.K.), R01CA90571 (M.A.T.) and PN2EY018228 (Roadmap for Medical Research Nanomedicine Initiative) (M.A.T.), and K22CA120147 (S.W.F.), the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (H.C.M. III), the Muscular Dystrophy Association 022398 (C.M.K.), the American Heart Association 0640076N (C.M.K.), and the California Institute of Regenerative Medicine (RS1-00313 and RB1-01397, M.A.T.). C.M.K. is an Established Investigator of the American Heart Association and M.A.T. is a Scholar of the Leukemia and Lymphoma Society.	Alfonzo JD, 2009, BIOL CHEM, V390, P717, DOI 10.1515/BC.2009.101; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Diaz F, 2008, GUT, V57, P232, DOI 10.1136/gut.2006.119180; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; Duchene AM, 2009, CURR GENET, V55, P1, DOI 10.1007/s00294-008-0223-9; Entelis NS, 2001, ADV DRUG DELIVER REV, V49, P199, DOI 10.1016/S0169-409X(01)00135-1; French SW, 2007, CANCER LETT, V248, P198, DOI 10.1016/j.canlet.2006.07.006; HOLLINGSWORTH MJ, 1986, MOL CELL BIOL, V6, P1058, DOI 10.1128/MCB.6.4.1058; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Lisitsky I, 1996, P NATL ACAD SCI USA, V93, P13398, DOI 10.1073/pnas.93.23.13398; Mandel H, 2001, HEPATOLOGY, V34, P776, DOI 10.1053/jhep.2001.27664; Mukherjee S, 2007, EMBO REP, V8, P589, DOI 10.1038/sj.embor.7400979; Portnoy V, 2008, RNA, V14, P297, DOI 10.1261/rna.698108; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; Rainey RN, 2006, MOL CELL BIOL, V26, P8488, DOI 10.1128/MCB.01006-06; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Smirnov AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1418, DOI 10.1134/S000629790813004X; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; Walker SC, 2008, CELL, V135, P412, DOI 10.1016/j.cell.2008.10.010; Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605; Yehudai-Resheff S, 2000, NUCLEIC ACIDS RES, V28, P1139, DOI 10.1093/nar/28.5.1139; Yehudai-Resheff S, 2001, MOL CELL BIOL, V21, P5408, DOI 10.1128/MCB.21.16.5408-5416.2001; [No title captured]	37	240	249	2	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					456	467		10.1016/j.cell.2010.06.035	http://dx.doi.org/10.1016/j.cell.2010.06.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691904	Green Accepted, Bronze			2022-12-24	WOS:000280609100022
J	Taniguchi, Y; Choi, PJ; Li, GW; Chen, HY; Babu, M; Hearn, J; Emili, A; Xie, XS				Taniguchi, Yuichi; Choi, Paul J.; Li, Gene-Wei; Chen, Huiyi; Babu, Mohan; Hearn, Jeremy; Emili, Andrew; Xie, X. Sunney			Quantifying E-coli Proteome and Transcriptome with Single-Molecule Sensitivity in Single Cells	SCIENCE			English	Article							STOCHASTIC GENE-EXPRESSION; REGULATORY NETWORKS; NOISE; REVEALS; LEVEL; YEAST; TIME	Protein and messenger RNA (mRNA) copy numbers vary from cell to cell in isogenic bacterial populations. However, these molecules often exist in low copy numbers and are difficult to detect in single cells. We carried out quantitative system-wide analyses of protein and mRNA expression in individual cells with single-molecule sensitivity using a newly constructed yellow fluorescent protein fusion library for Escherichia coli. We found that almost all protein number distributions can be described by the gamma distribution with two fitting parameters which, at low expression levels, have clear physical interpretations as the transcription rate and protein burst size. At high expression levels, the distributions are dominated by extrinsic noise. We found that a single cell's protein and mRNA copy numbers for any given gene are uncorrelated.	[Taniguchi, Yuichi; Choi, Paul J.; Li, Gene-Wei; Chen, Huiyi; Hearn, Jeremy; Xie, X. Sunney] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Li, Gene-Wei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Chen, Huiyi] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Babu, Mohan; Emili, Andrew] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Emili, Andrew] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Harvard University; Harvard University; Harvard University; University of Toronto; University of Toronto	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Li, Gene-Wei/E-7657-2010; Mohan, Babu P./I-7362-2019; Taniguchi, Yuichi/N-5986-2015	Taniguchi, Yuichi/0000-0001-5677-8901; Li, Gene-Wei/0000-0001-7036-8511	Gates Foundation; NIH; Canadian Institutes of Health Research [MOP-77639]; Japan Society for the Promotion of Science; Uehara Memorial Foundation; Marubun Research Promotion Foundation; John and Fannie Hertz Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Marubun Research Promotion Foundation; John and Fannie Hertz Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Xun, N. K. Lee, D. Court, C. Zong, R. Roy, and J. Agresti for experimental assistance; and E. Rubin, L. Cai, and J. Elf for helpful discussions. This work was supported by the Gates Foundation (X.S.X.), the NIH Pioneer Director's Award (X.S.X.), and the Canadian Institutes of Health Research (MOP-77639) (A.E.). Y.T. acknowledges additional support from the Japan Society for the Promotion of Science, the Uehara Memorial Foundation, and the Marubun Research Promotion Foundation, and P.J.C. from the John and Fannie Hertz Foundation.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	31	1378	1400	9	491	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					533	538		10.1126/science.1188308	http://dx.doi.org/10.1126/science.1188308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671182	Green Accepted			2022-12-24	WOS:000280483500027
J	Telfer, S; Lambin, X; Birtles, R; Beldomenico, P; Burthe, S; Paterson, S; Begon, M				Telfer, Sandra; Lambin, Xavier; Birtles, Richard; Beldomenico, Pablo; Burthe, Sarah; Paterson, Steve; Begon, Mike			Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population	SCIENCE			English	Article							COWPOX; HOST; ASSOCIATIONS; COINFECTION; HELMINTH; RODENTS; IMPACT	Most hosts, including humans, are simultaneously or sequentially infected with several parasites. A key question is whether patterns of coinfection arise because infection by one parasite species affects susceptibility to others or because of inherent differences between hosts. We used time-series data from individual hosts in natural populations to analyze patterns of infection risk for a microparasite community, detecting large positive and negative effects of other infections. Patterns remain once variations in host susceptibility and exposure are accounted for. Indeed, effects are typically of greater magnitude, and explain more variation in infection risk, than the effects associated with host and environmental factors more commonly considered in disease studies. We highlight the danger of mistaken inference when considering parasite species in isolation rather than parasite communities.	[Telfer, Sandra; Paterson, Steve; Begon, Mike] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Telfer, Sandra; Lambin, Xavier] Univ Aberdeen, Sch Biol Sci, Aberdeen AB24 2TZ, Scotland; [Birtles, Richard] Univ Liverpool, Sch Vet Sci, Liverpool CH64 7TE, Merseyside, England; [Beldomenico, Pablo] Univ Nacl Litoral, Fac Ciencias Vet, RA-3080 Esperanza, Santa Fe, Argentina; [Burthe, Sarah] Ctr Ecol & Hydrol Edinburgh, Penicuik EH26 0QB, Midlothian, Scotland	University of Liverpool; University of Aberdeen; University of Liverpool; National University of the Littoral; UK Centre for Ecology & Hydrology (UKCEH)	Telfer, S (corresponding author), Univ Liverpool, Sch Biol Sci, Crown St, Liverpool L69 7ZB, Merseyside, England.	s.telfer@abdn.ac.uk	Lambin, Xavier/E-8284-2011; Paterson, Steve/D-2154-2009; Burthe, Sarah J/Q-9505-2016	Lambin, Xavier/0000-0003-4643-2653; Paterson, Steve/0000-0002-1307-2981; Burthe, Sarah J/0000-0001-8871-3432; Telfer, Sandra/0000-0002-9596-0711; Birtles, Richard/0000-0002-4216-5044; Begon, Mike/0000-0003-1715-5327; BELDOMENICO, Pablo/0000-0001-5039-8975	Natural Environment Research Council [GR3/13051]; Wellcome Trust [075202/Z/04/Z, 070675/Z/03/Z]; Dorothy Hodgkin Studentship; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Dorothy Hodgkin Studentship; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the following for data collection in the field and laboratory and for discussion and comments: R. Anderson, M. Bennett, K. Bown, S. Gebert, C. Glover, A. Goodsall, G. Hutcheson, D. Jones, L. Lukomski, J. Rogers, A. Smith, G. Telford, and D. Tidhar. The work was supported by funding from the Natural Environment Research Council (GR3/13051) and The Wellcome Trust (075202/Z/04/Z; 070675/Z/03/Z). P. B. was supported by a Dorothy Hodgkin Studentship and is currently a career investigator of the Argentine Council for Science and Technology (CONICET). Metadata are available at the Knowledge Network for Biocomplexity (KNB) data repository (http://knb.ecoinformatics.org). After discussion of specific requirements, more detailed data will be made available on request from mbegon@liv.ac.uk or s.telfer@abdn.ac.uk.	Akaike H, 1973, INT S INF THEOR, P267, DOI DOI 10.2307/2334537; Behnke JM, 2008, PARASITOLOGY, V135, P751, DOI 10.1017/S0031182008000334; Belongia EA, 2002, VECTOR-BORNE ZOONOT, V2, P265, DOI 10.1089/153036602321653851; Birtles RJ, 2005, ANN NY ACAD SCI, V1063, P270, DOI 10.1196/annals.1355.044; Booth M, 2006, TRENDS PARASITOL, V22, P359, DOI 10.1016/j.pt.2006.06.007; Burthe S, 2008, J ANIM ECOL, V77, P110, DOI 10.1111/j.1365-2656.2007.01302.x; Chantrey J, 1999, EPIDEMIOL INFECT, V122, P455, DOI 10.1017/S0950268899002423; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Graham AL, 2005, J INFECT DIS, V191, P410, DOI 10.1086/426871; Graham AL, 2008, P NATL ACAD SCI USA, V105, P566, DOI 10.1073/pnas.0707221105; Irwin P, 2005, ARTHROPOD BORNE INFE, P63; Jackson JA, 2006, INT J PARASITOL, V36, P1341, DOI 10.1016/j.ijpara.2006.07.003; Johns JL, 2009, INFECT IMMUN, V77, P4070, DOI 10.1128/IAI.00570-09; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Lello J, 2004, NATURE, V428, P840, DOI 10.1038/nature02490; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; PURNELL RE, 1977, VET REC, V100, P4, DOI 10.1136/vr.100.1.4; Rodriguez M, 1999, PARASITE IMMUNOL, V21, P177, DOI 10.1046/j.1365-3024.1999.00218.x; Seet BT, 2003, ANNU REV IMMUNOL, V21, P377, DOI 10.1146/annurev.immunol.21.120601.141049; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Telfer S, 2008, PARASITOLOGY, V135, P767, DOI 10.1017/S0031182008000395; Telfer S, 2007, PARASITOLOGY, V134, P413, DOI 10.1017/S0031182006001624; Telfer S, 2005, OIKOS, V109, P317, DOI 10.1111/j.0030-1299.2005.13734.x	24	388	398	4	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					243	246		10.1126/science.1190333	http://dx.doi.org/10.1126/science.1190333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929776	Green Accepted			2022-12-24	WOS:000282644600048
J	Yamagishi, Y; Honda, T; Tanno, Y; Watanabe, Y				Yamagishi, Yuya; Honda, Takashi; Tanno, Yuji; Watanabe, Yoshinori			Two Histone Marks Establish the Inner Centromere and Chromosome Bi-Orientation	SCIENCE			English	Article							SISTER-CHROMATID COHESION; AURORA-B; MITOTIC CHROMOSOME; SHUGOSHIN; KINETOCHORE; SPINDLE; LOCALIZATION; ATTACHMENT; MEIOSIS; CHECKPOINT	For proper partitioning of chromosomes in mitosis, the chromosomal passenger complex (CPC) including Aurora B and survivin must be localized at the center of paired kinetochores, at the site called the inner centromere. It is largely unknown what defines the inner centromere and how the CPC is targeted to this site. Here, we show that the phosphorylation of histone H3-threonine 3 (H3-pT3) mediated by Haspin cooperates with Bub1-mediated histone 2A-serine 121 (H2A-S121) phosphorylation in targeting the CPC to the inner centromere in fission yeast and human cells. H3-pT3 promotes nucleosome binding of survivin, whereas phosphorylated H2A-S121 facilitates the binding of shugoshin, the centromeric CPC adaptor. Haspin colocalizes with cohesin by associating with Pds5, whereas Bub1 localizes at kinetochores. Thus, the inner centromere is defined by intersection of two histone kinases.	[Yamagishi, Yuya; Honda, Takashi; Tanno, Yuji; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Yamagishi, Yuya; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 1130033, Japan; [Honda, Takashi; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp		Watanabe, Yoshinori/0000-0002-5488-4812	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critical reading of the manuscript, the Yeast Genetic Resource Centre for yeast strains, and all the members of our laboratory for their valuable support and discussion. This work was supported in part by Japan Society for the Promotion of Science research fellowships (to Y.Y., T.H., and Y.T.); the Global Center of Excellence Program; and a Grant-in-Aid for Specially Promoted Research (to Y.W.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Hamant O, 2005, CURR BIOL, V15, P948, DOI 10.1016/j.cub.2005.04.049; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Morishita J, 2001, GENES CELLS, V6, P743, DOI 10.1046/j.1365-2443.2001.00459.x; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Resnick TD, 2006, DEV CELL, V11, P57, DOI 10.1016/j.devcel.2006.04.021; Rivera T, 2009, CHROMOSOMA, V118, P223, DOI 10.1007/s00412-008-0190-4; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Shintomi K, 2009, GENE DEV, V23, P2224, DOI 10.1101/gad.1844309; Sonoda E, 2001, DEV CELL, V1, P759, DOI 10.1016/S1534-5807(01)00088-0; Tanaka TU, 2008, CHROMOSOMA, V117, P521, DOI 10.1007/s00412-008-0173-5; Tsukahara T, 2010, NATURE, V467, P719, DOI 10.1038/nature09390; Vanoosthuyse V, 2007, MOL BIOL CELL, V18, P1657, DOI 10.1091/mbc.E06-10-0890; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217	27	330	341	4	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					239	243		10.1126/science.1194498	http://dx.doi.org/10.1126/science.1194498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929775				2022-12-24	WOS:000282644600047
J	Dzhindzhev, NS; Yu, QAD; Weiskopf, K; Tzolovsky, G; Cunha-Ferreira, I; Riparbelli, M; Rodrigues-Martins, A; Bettencourt-Dias, M; Callaini, G; Glover, DM				Dzhindzhev, Nikola S.; Yu, Quan D.; Weiskopf, Kipp; Tzolovsky, George; Cunha-Ferreira, Ines; Riparbelli, Maria; Rodrigues-Martins, Ana; Bettencourt-Dias, Monica; Callaini, Giuliano; Glover, David M.			Asterless is a scaffold for the onset of centriole assembly	NATURE			English	Article							POLO-BOX DOMAIN; DROSOPHILA; DUPLICATION; PROTEINS; CYTOKINESIS; BIOGENESIS; SUFFICIENT; SUBSTRATE; EMBRYO; CELLS	Centrioles are found in the centrosome core and, as basal bodies, at the base of cilia and flagella. Centriole assembly and duplication is controlled by Polo-like-kinase 4 (Plk4): these processes fail if Plk4 is downregulated and are promoted by Plk4 overexpression(1-7). Here we show that the centriolar protein Asterless (Asl; human orthologue CEP152) provides a conserved molecular platform, the amino terminus of which interacts with the cryptic Polo box of Plk4 whereas the carboxy terminus interacts with the centriolar protein Sas-4 (CPAP in humans). Drosophila Asl and human CEP152 are required for the centrosomal loading of Plk4 in Drosophila and CPAP in human cells, respectively. Depletion of Asl or CEP152 caused failure of centrosome duplication; their overexpression led to de novo centriole formation in Drosophila eggs, duplication of free centrosomes in Drosophila embryos, and centrosome amplification in cultured Drosophila and human cells. Overexpression of a Plk4-binding-deficient mutant of Asl prevented centriole duplication in cultured cells and embryos. However, this mutant protein was able to promote microtubule organizing centre (MTOC) formation in both embryos and oocytes. Such MTOCs had pericentriolar material and the centriolar protein Sas-4, but no centrioles at their core. Formation of such acentriolar MTOCs could be phenocopied by overexpression of Sas-4 in oocytes or embryos. Our findings identify independent functions for Asl as a scaffold for Plk4 and Sas-4 that facilitates self-assembly and duplication of the centriole and organization of pericentriolar material.	[Dzhindzhev, Nikola S.; Yu, Quan D.; Weiskopf, Kipp; Tzolovsky, George; Cunha-Ferreira, Ines; Rodrigues-Martins, Ana; Glover, David M.] Univ Cambridge, Dept Genet, Canc Res UK Cell Cycle Genet Grp, Cambridge CB2 3EH, England; [Tzolovsky, George; Riparbelli, Maria; Rodrigues-Martins, Ana; Glover, David M.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Riparbelli, Maria; Callaini, Giuliano] Univ Siena, Dipartimento Biol Evolut, I-53100 Siena, Italy	University of Cambridge; Instituto Gulbenkian de Ciencia; University of Siena	Dzhindzhev, NS (corresponding author), Univ Cambridge, Dept Genet, Canc Res UK Cell Cycle Genet Grp, Downing St, Cambridge CB2 3EH, England.	nsd23@cam.ac.uk; dmg25@cam.ac.uk	Bettencourt-Dias, Monica/B-5176-2015; Callaini, Giuliano/T-6353-2018	Bettencourt-Dias, Monica/0000-0003-1987-5598; Callaini, Giuliano/0000-0003-2252-0309; Dzhindzhev, Nikola/0000-0001-9866-3600; Glover, David/0000-0003-0956-0103	Cancer Research UK; Fundacao Calouste Gulbenkian; Fundacao para a Ciencia e Tecnologia (FCT); Royal Society; Cancer Research UK [11431] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Fundacao Calouste Gulbenkian(European Commission); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Royal Society(Royal Society of London); Cancer Research UK(Cancer Research UK)	We thank E. Wegel for technical help. We thank P. Coelho, G. Mao, P. Gonczy, T. Megraw and J. Raff for antibodies. We thank Cancer Research UK for a Programme Grant to D.M.G. and a studentship to Q.D.Y. K.W. was a visiting scholar of the Winston Churchill Foundation of the United States. Fundacao Calouste Gulbenkian, Fundacao para a Ciencia e Tecnologia (FCT) provided support to M.B.-D. and scholarships to I.C.-F. and A.R.-M. The Royal Society provided an International Joint Project Grant for collaboration between M.B.-D. and D.M.G.	Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Chang J, 2010, EMBO J, V29, P2395, DOI 10.1038/emboj.2010.118; Cunha-Ferreira I, 2009, CURR BIOL, V19, P43, DOI 10.1016/j.cub.2008.11.037; D'Avino PP, 2006, J CELL SCI, V119, P4402, DOI 10.1242/jcs.03210; D'Avino PP, 2009, METHODS MOL BIOL, V545, P99, DOI 10.1007/978-1-60327-993-2_6; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fox JD, 2003, FEBS LETT, V537, P53, DOI 10.1016/S0014-5793(03)00070-X; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Leung GC, 2002, NAT STRUCT BIOL, V9, P719, DOI 10.1038/nsb848; Lowery DM, 2005, ONCOGENE, V24, P248, DOI 10.1038/sj.onc.1208280; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Mottier-Pavie V, 2009, MOL BIOL CELL, V20, P2605, DOI 10.1091/mbc.E08-11-1115; Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Rogers GC, 2009, J CELL BIOL, V184, P225, DOI 10.1083/jcb.200808049; Varmark H, 2007, CURR BIOL, V17, P1735, DOI 10.1016/j.cub.2007.09.031; WARN RM, 1986, EXP CELL RES, V163, P201, DOI 10.1016/0014-4827(86)90573-2	24	217	223	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					714	U104		10.1038/nature09445	http://dx.doi.org/10.1038/nature09445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20852615				2022-12-24	WOS:000282572500040
J	Mayer, M; Depken, M; Bois, JS; Julicher, F; Grill, SW				Mayer, Mirjam; Depken, Martin; Bois, Justin S.; Juelicher, Frank; Grill, Stephan W.			Anisotropies in cortical tension reveal the physical basis of polarizing cortical flows	NATURE			English	Article							C-ELEGANS EMBRYOS; CAENORHABDITIS-ELEGANS; EARLY EMBRYOGENESIS; PROTEINS RGA-3; CELL-DIVISION; PAR PROTEINS; GERM-LINE; CYTOKINESIS; MICROFILAMENTS; MORPHOGENESIS	Asymmetric cell divisions are essential for the development of multicellular organisms. To proceed, they require an initially symmetric cell to polarize(1). In Caenorhabditis elegans zygotes, anteroposterior polarization is facilitated by a large-scale flow of the actomyosin cortex(2-4), which directs the asymmetry of the first mitotic division. Cortical flows appear in many contexts of development(5), but their underlying forces and physical principles remain poorly understood. How actomyosin contractility and cortical tension interact to generate large-scale flow is unclear. Here we report on the subcellular distribution of cortical tension in the polarizing C. elegans zygote, which we determined using position- and direction-sensitive laser ablation. We demonstrate that cortical flow is associated with anisotropies in cortical tension and is not driven by gradients in cortical tension, which contradicts previous proposals(5). These experiments, in conjunction with a theoretical description of active cortical mechanics, identify two prerequisites for large-scale cortical flow: a gradient in actomyosin contractility to drive flow and a sufficiently large viscosity of the cortex to allow flow to be long-ranged. We thus reveal the physical requirements of large-scale intracellular cortical flow that ensure the efficient polarization of the C. elegans zygote.	[Mayer, Mirjam; Depken, Martin; Bois, Justin S.; Grill, Stephan W.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Mayer, Mirjam; Depken, Martin; Bois, Justin S.; Juelicher, Frank; Grill, Stephan W.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany	Max Planck Society; Max Planck Society	Grill, SW (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	grill@mpi-cbg.de	Julicher, Frank/B-1828-2009; Grill, Stephan/D-9427-2012	Julicher, Frank/0000-0003-4731-9185; Bois, Justin/0000-0001-7137-8746	Boehringer Ingelheim Fonds; Human Frontier Science Program	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Human Frontier Science Program(Human Frontier Science Program)	We thank C. Cowan, N. Goehring, P. Gonczy, J. Howard, T. Hyman, M. Loose, F. Nedelec and K. Oegema for advice and suggestions on the manuscript. We are grateful to E. Munro for scientific advice, worm strains and discussions. M. M. is supported by a predoctoral fellowship from the Boehringer Ingelheim Fonds, and J.S.B. by a postdoctoral fellowship from the Human Frontier Science Program.	BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; BRENNER S, 1974, GENETICS, V77, P71; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; Dai JW, 1999, BIOPHYS J, V77, P1168, DOI 10.1016/S0006-3495(99)76968-7; Daniels BR, 2006, BIOPHYS J, V90, P4712, DOI 10.1529/biophysj.105.080606; Gardel ML, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.088102; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; HILL DP, 1988, DEV BIOL, V125, P75, DOI 10.1016/0012-1606(88)90060-7; HIRAMOTO Y, 1970, Biorheology, V6, P201; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Kruse K, 2005, EUR PHYS J E, V16, P5, DOI 10.1140/epje/e2005-00002-5; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lieleg O, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.108101; Mandato CA, 2001, J CELL BIOL, V154, P785, DOI 10.1083/jcb.200103105; Motegi F, 2006, DEV CELL, V10, P509, DOI 10.1016/j.devcel.2006.03.001; Motegi F, 2006, NAT CELL BIOL, V8, P978, DOI 10.1038/ncb1459; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Munro E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003400; Nance J, 2003, DEVELOPMENT, V130, P5339, DOI 10.1242/dev.00735; PASTERNAK C, 1989, NATURE, V341, P549, DOI 10.1038/341549a0; Raffel M, 2007, EXP FLUID MECH, P1, DOI 10.1007/978-3-540-72308-0; Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798; Salbreux G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058102; Schmutz C, 2007, DEVELOPMENT, V134, P3495, DOI 10.1242/dev.000802; Schonegg S, 2007, P NATL ACAD SCI USA, V104, P14976, DOI 10.1073/pnas.0706941104; Shelton CA, 1996, DEVELOPMENT, V122, P2043; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; STROME S, 1986, J CELL BIOL, V103, P2241, DOI 10.1083/jcb.103.6.2241; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; STROME S, 1988, BIOESSAYS, V8, P145, DOI 10.1002/bies.950080504; SVEEN J, 2004, ADV COASTAL OCEAN EN, V9, pCH1; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Velarde N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-142; Wottawah F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098103; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Zhang WD, 2005, P NATL ACAD SCI USA, V102, P7186, DOI 10.1073/pnas.0502545102; Zonies S, 2010, DEVELOPMENT, V137, P1669, DOI 10.1242/dev.045823	47	326	334	4	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP	2010	467	7315					617	U150		10.1038/nature09376	http://dx.doi.org/10.1038/nature09376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20852613				2022-12-24	WOS:000282273100045
J	Vorosmarty, CJ; McIntyre, PB; Gessner, MO; Dudgeon, D; Prusevich, A; Green, P; Glidden, S; Bunn, SE; Sullivan, CA; Liermann, CR; Davies, PM				Voeroesmarty, C. J.; McIntyre, P. B.; Gessner, M. O.; Dudgeon, D.; Prusevich, A.; Green, P.; Glidden, S.; Bunn, S. E.; Sullivan, C. A.; Liermann, C. Reidy; Davies, P. M.			Global threats to human water security and river biodiversity	NATURE			English	Article							AMERICAN FRESH-WATER; MARINE; VULNERABILITY; INDICATORS; RESOURCES; MAP	Protecting the world's freshwater resources requires diagnosing threats over a broad range of scales, from global to local. Here we present the first worldwide synthesis to jointly consider human and biodiversity perspectives on water security using a spatial framework that quantifies multiple stressors and accounts for downstream impacts. We find that nearly 80% of the world's population is exposed to high levels of threat to water security. Massive investment in water technology enables rich nations to offset high stressor levels without remedying their underlying causes, whereas less wealthy nations remain vulnerable. A similar lack of precautionary investment jeopardizes biodiversity, with habitats associated with 65% of continental discharge classified as moderately to highly threatened. The cumulative threat framework offers a tool for prioritizing policy and management responses to this crisis, and underscores the necessity of limiting threats at their source instead of through costly remediation of symptoms in order to assure global water security for both humans and freshwater biodiversity.	[Voeroesmarty, C. J.; Green, P.] CUNY City Coll, Environm CrossRd Initiat, New York, NY 10035 USA; [McIntyre, P. B.] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Gessner, M. O.] Swiss Fed Inst Technol, Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, CH-8600 Dubendorf, Switzerland; [Gessner, M. O.] Swiss Fed Inst Technol, Inst Integrat Biol IBZ, CH-8600 Dubendorf, Switzerland; [Gessner, M. O.] Leibniz Inst Freshwater Ecol & Inland Fisheries I, D-16775 Stechlin, Germany; [Dudgeon, D.] Univ Hong Kong, Sch Biol Sci, Div Ecol & Biodivers, Hong Kong, Hong Kong, Peoples R China; [Prusevich, A.; Glidden, S.] Univ New Hampshire, Water Syst Anal Grp, Durham, NH 03824 USA; [Bunn, S. E.] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Sullivan, C. A.] So Cross Univ, Sch Environm Sci & Management, Lismore, NSW 2480, Australia; [Liermann, C. Reidy] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Davies, P. M.] Univ Western Australia, Ctr Excellence Nat Resource Management, Albany 6330, Australia	City University of New York (CUNY) System; City College of New York (CUNY); University of Michigan System; University of Michigan; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University of Hong Kong; University System Of New Hampshire; University of New Hampshire; Griffith University; Southern Cross University; University of Washington; University of Washington Seattle; University of Western Australia	Vorosmarty, CJ (corresponding author), CUNY City Coll, Environm CrossRd Initiat, New York, NY 10035 USA.	contact@riverthreat.net	Sullivan, Caroline/T-8668-2017; Hu, Lile/E-7961-2015; Quinn, Patrick/B-5489-2010; Davies, Peter M/C-3518-2013; Bunn, Stuart E/B-9065-2008	Sullivan, Caroline/0000-0001-8486-0523; Bunn, Stuart E/0000-0002-6540-3586; Gessner, Mark O./0000-0003-2516-7416; Prusevich, Alexander/0000-0002-9529-443X	NASA [NNX07AF28G]; NSF Division of Earth Sciences [0854957]; Global Environment Facility [UPI 00345306]; D.H. Smith Fellowship	NASA(National Aeronautics & Space Administration (NASA)); NSF Division of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Global Environment Facility; D.H. Smith Fellowship	We thank A. DeSherbinin, L. Poff, C. Revenga, J. Melillo and O. Young for comments on the manuscript; D. Allan, R. Abell, J. Bogardi, M. Meybeck, W. Wollheim, R. F. Wright, D. Boswell, R. Lacey, N. Schneider and D. Vorosmarty for advice; and D. Dube and B. Fekete for technical support. Grant support for database and tool development was from NASA Inter-Disciplinary Science Program Grant NNX07AF28G, with additional support from the NSF Division of Earth Sciences (Hydrologic Sciences Program Award #0854957) and Global Environment Facility (UPI 00345306). P.B.M. was supported by a D.H. Smith Fellowship. Financial and logistical support for expert group meetings and communications was from the Global Water System Project (Bonn), DIVERSITAS-freshwaterBIODIVERSITY (Paris), NSF BestNet, and Australian Agency for International Development (AusAID) through the Australian Water Research Facility. Conference facilities were provided by the Swiss Federal Institute of Science & Technology (Eawag) and The City College of New York/CUNY.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Arthington AH, 2006, ECOL APPL, V16, P1311, DOI 10.1890/1051-0761(2006)016[1311:TCOPEF]2.0.CO;2; ASHLEY R, 2006, INFRASTRUCTURE 2030, pCH5; Balian EV, 2008, HYDROBIOLOGIA, V595, P627, DOI 10.1007/s10750-007-9246-3; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brown Oli, 2009, RISING TEMPERATURES; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Clausen R, 2008, SOC SCI RES, V37, P1310, DOI 10.1016/j.ssresearch.2007.10.002; *CONV BIOL DIV, 2004, TEXT CONV BIOL DIV; Dinda S, 2004, ECOL ECON, V49, P431, DOI 10.1016/j.ecolecon.2004.02.011; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Esty D.C., 2006, PILOT ENV PERFORMANC; Esty D. C., 2005, 2005 ENV SUSTAINABIL; FAO (Food and Agriculture Organization), 2006, WAT MON MAPP EX GLOB; Fekete BM, 2001, WATER RESOUR RES, V37, P1955, DOI 10.1029/2001WR900024; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; *GLOB ENV FAC, 2008, FIN STEW GLOB BIOD; *GLOB WAT SYST PRO, 2004, EOS AGU T, V85, P513; Grey D., 2006, WATER GROWTH DEV THE; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2009, CONSERV LETT, V2, P189, DOI 10.1111/j.1755-263X.2009.00060.x; International Organization of Supreme Audit Institutions (INTOSAI), 2009, INT LAB C 98 SESS GE, P1; Jelks HL, 2008, FISHERIES, V33, P372, DOI 10.1577/1548-8446-33.8.372; Karl T. R., 2009, Global climate change impacts in the United States; MEYBECK M, 2003, PHIL T R SOC LOND B; *MIN ENV PROT, 2009, STAT ENV CHIN 2008; Palmer MA, 2009, SCIENCE, V325, P575, DOI 10.1126/science.1172976; Reid W.V, 2005, MILLENNIUM ECOSYSTEM; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Seitzinger SP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002606; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Sullivan C, 2005, WATER SCI TECHNOL, V51, P69, DOI 10.2166/wst.2005.0111; Tockner K, 2009, RIVERS OF EUROPE, 1ST EDITION, P1; *UN DEV PROGR, 2006, HDR 2006 SCARC POW P; UN Environmental Programme, 2010, UNEPIPBES33; *UNEP GEMS WAT PRO, 2008, WAT QUAL EC HUM HLTH; US-Environmental Protection Agency, 2000, EPA841R02001; VOROSMARTY C. J., 2005, MILLENNIUM ECOSYSTEM, V1, P165; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Vorosmarty CJ, 2005, AMBIO, V34, P230, DOI 10.1639/0044-7447(2005)034[0230:GIOEWS]2.0.CO;2; Vorosmarty CJ, 2002, AQUAT SCI, V64, P328, DOI 10.1007/PL00012590; WCD (World Commission on Dams), 2000, DAMS DEV NEW FRAMEWO; WHO UNICEF, 2010, PROGR SAN DRINK WAT; *WORLD BANK, 2010, COUNTR CLASS; *WORLD CONS MON CT, 1998, WCMC BIOD SER, V8; *WORLD WAT ASS PRO, 2009, WAT CHANG WORLD; Zalasiewicz J., 2008, GSA TODAY, V18, P4, DOI DOI 10.1130/GSAT01802A.1	50	4000	4155	147	2497	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					555	561		10.1038/nature09440	http://dx.doi.org/10.1038/nature09440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20882010	Green Submitted, Green Accepted			2022-12-24	WOS:000282273100031
J	Berry, MPR; Graham, CM; McNab, FW; Xu, ZH; Bloch, SAA; Oni, T; Wilkinson, KA; Banchereau, R; Skinner, J; Wilkinson, RJ; Quinn, C; Blankenship, D; Dhawan, R; Cush, JJ; Mejias, A; Ramilo, O; Kon, OM; Pascual, V; Banchereau, J; Chaussabel, D; O'Garra, A				Berry, Matthew P. R.; Graham, Christine M.; McNab, Finlay W.; Xu, Zhaohui; Bloch, Susannah A. A.; Oni, Tolu; Wilkinson, Katalin A.; Banchereau, Romain; Skinner, Jason; Wilkinson, Robert J.; Quinn, Charles; Blankenship, Derek; Dhawan, Ranju; Cush, John J.; Mejias, Asuncion; Ramilo, Octavio; Kon, Onn M.; Pascual, Virginia; Banchereau, Jacques; Chaussabel, Damien; O'Garra, Anne			An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis	NATURE			English	Article							GENE-EXPRESSION PATTERNS; MYCOBACTERIUM-TUBERCULOSIS; INFECTION; RESPONSES; IMMUNITY; CELLS	Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of morbidity and mortality worldwide. Efforts to control it are hampered by difficulties with diagnosis, prevention and treatment(1,2). Most people infected with M. tuberculosis remain asymptomatic, termed latent TB, with a 10% lifetime risk of developing active TB disease. Current tests, however, cannot identify which individuals will develop disease(3). The immune response to M. tuberculosis is complex and incompletely characterized, hindering development of new diagnostics, therapies and vaccines(4,5). Here we identify a whole-blood 393 transcript signature for active TB in intermediate and high-burden settings, correlating with radiological extent of disease and reverting to that of healthy controls after treatment. A subset of patients with latent TB had signatures similar to those in patients with active TB. We also identify a specific 86-transcript signature that discriminates active TB from other inflammatory and infectious diseases. Modular and pathway analysis revealed that the TB signature was dominated by a neutrophil-driven interferon (IFN)-inducible gene profile, consisting of both IFN-gamma and type I IFN-alpha beta signalling. Comparison with transcriptional signatures in purified cells and flow cytometric analysis suggest that this TB signature reflects changes in cellular composition and altered gene expression. Although an IFN-inducible signature was also observed in whole blood of patients with systemic lupus erythematosus (SLE), their complete modular signature differed from TB, with increased abundance of plasma cell transcripts. Our studies demonstrate a hitherto underappreciated role of type I IFN-alpha beta signalling in the pathogenesis of TB, which has implications for vaccine and therapeutic development. Our study also provides a broad range of transcriptional biomarkers with potential as diagnostic and prognostic tools to combat the TB epidemic.	[Berry, Matthew P. R.; Graham, Christine M.; McNab, Finlay W.; O'Garra, Anne] Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England; [Wilkinson, Katalin A.; Wilkinson, Robert J.] Natl Inst Med Res, MRC, Div Mycobacterial Res, London NW7 1AA, England; [Bloch, Susannah A. A.; Kon, Onn M.] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Resp Med, London W2 1NY, England; [Oni, Tolu; Wilkinson, Katalin A.; Wilkinson, Robert J.] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Observatory, South Africa; [Oni, Tolu] Univ London Imperial Coll Sci Technol & Med, Wright Fleming Inst, Div Med, London W2 1PG, England; [Xu, Zhaohui; Skinner, Jason; Quinn, Charles; Cush, John J.; Pascual, Virginia; Banchereau, Jacques; Chaussabel, Damien] ANRS Ctr Human Vaccines, INSERM, U899, Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Blankenship, Derek] Baylor Hlth Care Syst, Inst Hlth Care Res & Improvement, Dallas, TX 75206 USA; [Dhawan, Ranju] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Dept Radiol, London W2 1NY, England; [Banchereau, Romain] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Mejias, Asuncion; Ramilo, Octavio] Nationwide Childrens Hosp, Ctr Vaccines & Immun, Res Inst, Columbus, OH 43205 USA	MRC National Institute for Medical Research; MRC National Institute for Medical Research; Imperial College London; University of Cape Town; Imperial College London; Baylor Scott & White Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Baylor Health Care System; Imperial College London; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	O'Garra, A (corresponding author), Natl Inst Med Res, MRC, Div Immunoregulat, Mill Hill, London NW7 1AA, England.	aogarra@nimr.mrc.ac.uk	Pascual, Virginia/ABD-3099-2020; Wilkinson, Katalin/AAQ-7713-2021; Mejias, Maria Asuncion/E-3659-2011; Chaussabel, Damien/AAX-1909-2020; Wilkinson, Katalin/AAF-6805-2020; Mejias, Asuncion/AAC-5998-2019	Wilkinson, Katalin/0000-0002-9796-2040; Mejias, Asuncion/0000-0002-5983-8006; Oni, Tolu/0000-0003-4499-1910; Xu, Zhaohui/0000-0003-0645-1737; Graham, Christine/0000-0001-9329-6231; Chaussabel, Damien/0000-0002-6131-7242; Wilkinson, Robert/0000-0002-2753-1800; Skinner, Jason/0000-0002-2408-7695; O'Garra, Anne/0000-0001-9845-6134; Kon, Onn Min/0000-0003-2647-4688	MRC; Dana Foundation; Medical Research Council, UK [U117565642]; National Institutes of Health (NIH) [R01 AR050770-01, P50 ARO54083, 1 U19 AI082715-01, U19 AIO57234-02, U01 AI082110, P01 CA084512]; Baylor Health Care System Foundation; Medical Research Council [MC_U117588499, MC_U117565642] Funding Source: researchfish; MRC [MC_U117588499, MC_U117565642] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P01CA084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057234, U19AI082715, U01AI082110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050770, P50AR054083] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dana Foundation; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Health Care System Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the patients and volunteer participants. We thank D. Kioussis (MRC National Institute for Medical Research (NIMR)) and D. Young (NIMR) for discussion and input. We thank N. Baldwin (Baylor Institute for Immunology Research (BIIR)) for advice and support on bioinformatics analysis, Q.-A. Nguyen (BIIR) and colleagues for providing technical assistance with microarray processing, and S. Caidan (NIMR), J. Wills (NIMR) and S. Phillips (BIIR) for help and advice with sample storage and transport. We thank the TB service at Imperial College Healthcare NHS Trust, B. M. Haselden and the TB service at Hillingdon Hospital, Uxbridge, UK. We also thank H. Giedon and R. Seldon for help in laboratory analyses, and Y. Hlombe for recruitment of patients and follow-up in South Africa. A. Rae (NIMR), T. Dipucchio (BIIR) and K. Palucka (BIIR) provided advice on flow cytometry. We thank G. Hayward for help depositing the microarray data. We thank J. Brock (NIMR) for help with graphics. M. P. R. B. was supported by an MRC career development fellowship and a grant from the Dana Foundation Program in Human Immunology. The research was funded by the Medical Research Council, UK, MRC Grant U117565642 and The Dana Foundation Program in Human Immunology. A.O'G., C. M. G. and F.W.McN. are funded by the Medical Research Council, UK. V. P. is supported by National Institutes of Health (NIH) R01 AR050770-01, NIH P50 ARO54083 and NIH 1 U19 AI082715-01. The work of J. B., D. C. and V. P. is supported by the Baylor Health Care System Foundation and the NIH (U19 AIO57234-02, U01 AI082110, P01 CA084512).	Allantaz F, 2007, J EXP MED, V204, P2131, DOI 10.1084/jem.20070070; Ardura MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005446; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; BECK JS, 1985, CLIN EXP IMMUNOL, V60, P49; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Cooper AM, 2000, INFECT IMMUN, V68, P6879, DOI 10.1128/IAI.68.12.6879-6882.2000; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; DYE C, 2008, GLOBAL TUBERCULOSIS, P17; Eruslanov EB, 2005, INFECT IMMUN, V73, P1744, DOI 10.1128/IAI.73.3.1744-1753.2005; EURN SY, 2010, CHEST, V137, P122; Falk A, 1969, DIAGNOSTIC STANDARDS, P68; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Kaufmann SHE, 2005, NAT MED, V11, pS33, DOI 10.1038/nm1221; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; SALISBURY DM, 2006, IMMUNIZATION INFECTI, P391; Telesca Claudia, 2007, J Infect, V54, pe223, DOI 10.1016/j.jinf.2006.12.009; Young DB, 2008, J CLIN INVEST, V118, P1255, DOI 10.1172/JCI34614; [No title captured]	30	1267	1320	5	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					973	U98		10.1038/nature09247	http://dx.doi.org/10.1038/nature09247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725040	Green Accepted			2022-12-24	WOS:000281030300034
J	Allen, HL; Estrada, K; Lettre, G; Berndt, SI; Weedon, MN; Rivadeneira, F; Willer, CJ; Jackson, AU; Vedantam, S; Raychaudhuri, S; Ferreira, T; Wood, AR; Weyant, RJ; Segre, AV; Speliotes, EK; Wheeler, E; Soranzo, N; Park, JH; Yang, J; Gudbjartsson, D; Heard-Costa, NL; Randall, JC; Qi, L; Smith, AV; Magi, R; Pastinen, T; Liang, L; Heid, IM; Luan, J; Thorleifsson, G; Winkler, TW; Goddard, ME; Lo, KS; Palmer, C; Workalemahu, T; Aulchenko, YS; Johansson, A; Zillikens, MC; Feitosa, MF; Esko, T; Johnson, T; Ketkar, S; Kraft, P; Mangino, M; Prokopenko, I; Absher, D; Albrecht, E; Ernst, F; Glazer, NL; Hayward, C; Hottenga, JJ; Jacobs, KB; Knowles, JW; Kutalik, Z; Monda, KL; Polasek, O; Preuss, M; Rayner, NW; Robertson, NR; Steinthorsdottir, V; Tyrer, JP; Voight, BF; Wiklund, F; Xu, JF; Zhao, JH; Nyholt, DR; Pellikka, N; Perola, M; Perry, JRB; Surakka, I; Tammesoo, ML; Altmaier, EL; Amin, N; Aspelund, T; Bhangale, T; Boucher, G; Chasman, DI; Chen, C; Coin, L; Cooper, MN; Dixon, AL; Gibson, Q; Grundberg, E; Hao, K; Junttila, MJ; Kaplan, LM; Kettunen, J; Konig, IR; Kwan, T; Lawrence, RW; Levinson, DF; Lorentzon, M; McKnight, B; Morris, AP; Muller, M; Ngwa, JS; Purcell, S; Rafelt, S; Salem, RM; Salvi, E; Sanna, S; Shi, JX; Sovio, U; Thompson, JR; Turchin, MC; Vandenput, L; Verlaan, DJ; Vitart, V; White, CC; Ziegler, A; Almgren, P; Balmforth, AJ; Campbell, H; Citterio, L; De Grandi, A; Dominiczak, A; Duan, J; Elliott, P; Elosua, R; Eriksson, JG; Freimer, NB; Geus, EJC; Glorioso, N; Haiqing, S; Hartikainen, AL; Havulinna, AS; Hicks, AA; Hui, JN; Igl, W; Illig, T; Jula, A; Kajantie, E; Kilpelaeinen, TO; Koiranen, M; Kolcic, I; Koskinen, S; Kovacs, P; Laitinen, J; Liu, JJ; Lokki, ML; Marusic, A; Maschio, A; Meitinger, T; Mulas, A; Pare, G; Parker, AN; Peden, JF; Petersmann, A; Pichler, I; Pietilainen, KH; Pouta, A; Riddertrale, M; Rotter, JI; Sambrook, JG; Sanders, AR; Schmidt, CO; Sinisalo, J; Smit, JH; Stringham, HM; Walters, GB; Widen, E; Wild, SH; Willemsen, G; Zagato, L; Zgaga, L; Zitting, P; Alavere, H; Farrall, M; McArdle, WL; Nelis, M; Peters, MJ; Ripatti, S; Meurs, JBJ; Aben, KK; Ardlie, KG; Beckmann, JS; Beilby, JP; Bergman, RN; Bergmann, S; Collins, FS; Cusi, D; den Heijer, M; Eiriksdottir, G; Gejman, PV; Hall, AS; Hamsten, A; Huikuri, HV; Iribarren, C; Kahonen, M; Kaprio, J; Kathiresan, S; Kiemeney, L; Kocher, T; Launer, LJ; Lehtimaki, T; Melander, O; Mosley, TH; Musk, AW; Nieminen, MS; O'Donnell, CJ; Ohlsson, C; Oostra, B; Palmer, LJ; Raitakari, O; Ridker, PM; Rioux, JD; Rissanen, A; Rivolta, C; Schunkert, H; Shuldiner, AR; Siscovick, DS; Stumvoll, M; Tonjes, A; Tuomilehto, J; van Ommen, GJ; Viikari, J; Heath, AC; Martin, NG; Montgomery, GW; Province, MA; Kayser, M; Arnold, AM; Atwood, LD; Boerwinkle, E; Chanock, SJ; Deloukas, P; Gieger, C; Gronberg, H; Hall, P; Hattersley, AT; Hengstenberg, C; Hoffman, W; Lathrop, GM; Salomaa, V; Schreiber, S; Uda, M; Waterworth, D; Wright, AF; Assimes, TL; Barroso, I; Hofman, A; Mohlke, KL; Boomsma, DI; Caulfield, MJ; Cupples, LA; Erdmann, J; Fox, CS; Gudnason, V; Gyllensten, U; Harris, TB; Hayes, RB; Jarvelin, MR; Mooser, V; Munroe, PB; Ouwehand, WH; Penninx, BW; Pramstaller, PP; Quertermous, T; Rudan, I; Samani, NJ; Spector, TD; Volzke, H; Watkins, H; Wilson, JF; Groop, LC; Haritunians, T; Hu, FB; Kaplan, RC; Metspalu, A; North, KE; Schlessinger, D; Wareham, NJ; Hunter, DJ; O'Connell, JR; Strachan, DP; Schadt, HE; Thorsteinsdottir, U; Peltonen, L; Uitterlinden, AG; Visscher, PM; Chatterjee, N; Loos, RJF; Boehnke, M; McCarthy, MI; Ingelsson, E; Lindgren, CM; Abecasis, GR; Stefansson, K; Frayling, TM; Hirschhorn, JN				Allen, Hana Lango; Estrada, Karol; Lettre, Guillaume; Berndt, Sonja I.; Weedon, Michael N.; Rivadeneira, Fernando; Willer, Cristen J.; Jackson, Anne U.; Vedantam, Sailaja; Raychaudhuri, Soumya; Ferreira, Teresa; Wood, Andrew R.; Weyant, Robert J.; Segre, Ayellet V.; Speliotes, Elizabeth K.; Wheeler, Eleanor; Soranzo, Nicole; Park, Ju-Hyun; Yang, Jian; Gudbjartsson, Daniel; Heard-Costa, Nancy L.; Randall, Joshua C.; Qi, Lu; Smith, Albert Vernon; Maegi, Reedik; Pastinen, Tomi; Liang, Liming; Heid, Iris M.; Luan, Jian'an; Thorleifsson, Gudmar; Winkler, Thomas W.; Goddard, Michael E.; Lo, Ken Sin; Palmer, Cameron; Workalemahu, Tsegaselassie; Aulchenko, Yurii S.; Johansson, Asa; Zillikens, M. Carola; Feitosa, Mary F.; Esko, Tonu; Johnson, Toby; Ketkar, Shamika; Kraft, Peter; Mangino, Massimo; Prokopenko, Inga; Absher, Devin; Albrecht, Eva; Ernst, Florian; Glazer, Nicole L.; Hayward, Caroline; Hottenga, Jouke-Jan; Jacobs, Kevin B.; Knowles, Joshua W.; Kutalik, Zoltan; Monda, Keri L.; Polasek, Ozren; Preuss, Michael; Rayner, Nigel W.; Robertson, Neil R.; Steinthorsdottir, Valgerdur; Tyrer, Jonathan P.; Voight, Benjamin F.; Wiklund, Fredrik; Xu, Jianfeng; Zhao, Jing Hua; Nyholt, Dale R.; Pellikka, Niina; Perola, Markus; Perry, John R. B.; Surakka, Ida; Tammesoo, Mari-Liis; Altmaier, Elizabeth L.; Amin, Najaf; Aspelund, Thor; Bhangale, Tushar; Boucher, Gabrielle; Chasman, Daniel I.; Chen, Constance; Coin, Lachlan; Cooper, Matthew N.; Dixon, Anna L.; Gibson, Quince; Grundberg, Elin; Hao, Ke; Junttila, M. Juhani; Kaplan, Lee M.; Kettunen, Johannes; Koenig, Inke R.; Kwan, Tony; Lawrence, Robert W.; Levinson, Douglas F.; Lorentzon, Mattias; McKnight, Barbara; Morris, Andrew P.; Mueller, Martina; Ngwa, Julius Suh; Purcell, Shaun; Rafelt, Suzanne; Salem, Rany M.; Salvi, Erika; Sanna, Serena; Shi, Jianxin; Sovio, Ulla; Thompson, John R.; Turchin, Michael C.; Vandenput, Liesbeth; Verlaan, Dominique J.; Vitart, Veronique; White, Charles C.; Ziegler, Andreas; Almgren, Peter; Balmforth, Anthony J.; Campbell, Harry; Citterio, Lorena; De Grandi, Alessandro; Dominiczak, Anna; Duan, Jubao; Elliott, Paul; Elosua, Roberto; Eriksson, Johan G.; Freimer, Nelson B.; Geus, Eco J. C.; Glorioso, Nicola; Haiqing, Shen; Hartikainen, Anna-Liisa; Havulinna, Aki S.; Hicks, Andrew A.; Hui, Jennie; Igl, Wilmar; Illig, Thomas; Jula, Antti; Kajantie, Eero; Kilpelaeinen, Tuomas O.; Koiranen, Markku; Kolcic, Ivana; Koskinen, Seppo; Kovacs, Peter; Laitinen, Jaana; Liu, Jianjun; Lokki, Marja-Liisa; Marusic, Ana; Maschio, Andrea; Meitinger, Thomas; Mulas, Antonella; Pare, Guillaume; Parker, Alex N.; Peden, John F.; Petersmann, Astrid; Pichler, Irene; Pietilainen, Kirsi H.; Pouta, Anneli; Riddertrale, Martin; Rotter, Jerome I.; Sambrook, Jennifer G.; Sanders, Alan R.; Schmidt, Carsten Oliver; Sinisalo, Juha; Smit, Jan H.; Stringham, Heather M.; Walters, G. Bragi; Widen, Elisabeth; Wild, Sarah H.; Willemsen, Gonneke; Zagato, Laura; Zgaga, Lina; Zitting, Paavo; Alavere, Helene; Farrall, Martin; McArdle, Wendy L.; Nelis, Mari; Peters, Marjolein J.; Ripatti, Samuli; vVan Meurs, Joyce B. J.; Aben, Katja K.; Ardlie, Kristin G.; Beckmann, Jacques S.; Beilby, John P.; Bergman, Richard N.; Bergmann, Sven; Collins, Francis S.; Cusi, Daniele; den Heijer, Martin; Eiriksdottir, Gudny; Gejman, Pablo V.; Hall, Alistair S.; Hamsten, Anders; Huikuri, Heikki V.; Iribarren, Carlos; Kahonen, Mika; Kaprio, Jaakko; Kathiresan, Sekar; Kiemeney, Lambertus; Kocher, Thomas; Launer, Lenore J.; Lehtimaki, Terho; Melander, Olle; Mosley, Tom H., Jr.; Musk, Arthur W.; Nieminen, Markku S.; O'Donnell, Christopher J.; Ohlsson, Claes; Oostra, Ben; Palmer, Lyle J.; Raitakari, Olli; Ridker, Paul M.; Rioux, John D.; Rissanen, Aila; Rivolta, Carlo; Schunkert, Heribert; Shuldiner, Alan R.; Siscovick, David S.; Stumvoll, Michael; Toenjes, Anke; Tuomilehto, Jaakko; van Ommen, Gert-Jan; Viikari, Jorma; Heath, Andrew C.; Martin, Nicholas G.; Montgomery, Grant W.; Province, Michael A.; Kayser, Manfred; Arnold, Alice M.; Atwood, Larry D.; Boerwinkle, Eric; Chanock, Stephen J.; Deloukas, Panos; Gieger, Christian; Gronberg, Henrik; Hall, Per; Hattersley, Andrew T.; Hengstenberg, Christian; Hoffman, Wolfgang; Lathrop, G. Mark; Salomaa, Veikko; Schreiber, Stefan; Uda, Manuela; Waterworth, Dawn; Wright, Alan F.; Assimes, Themistocles L.; Barroso, Ines; Hofman, Albert; Mohlke, Karen L.; Boomsma, Dorret I.; Caulfield, Mark J.; Cupples, L. Adrienne; Erdmann, Jeanette; Fox, Caroline S.; Gudnason, Vilmundur; Gyllensten, Ulf; Harris, Tamara B.; Hayes, Richard B.; Jarvelin, Marjo-Ritta; Mooser, Vincent; Munroe, Patricia B.; Ouwehand, Willem H.; Penninx, Brenda W.; Pramstaller, Peter P.; Quertermous, Thomas; Rudan, Igor; Samani, Nilesh J.; Spector, Timothy D.; Voelzke, Henry; Watkins, Hugh; Wilson, James F.; Groop, Leif C.; Haritunians, Talin; Hu, Frank B.; Kaplan, Robert C.; Metspalu, Andres; North, Kari E.; Schlessinger, David; Wareham, Nicholas J.; Hunter, David J.; O'Connell, Jeffrey R.; Strachan, David P.; Schadt, H. -Erich; Thorsteinsdottir, Unnur; Peltonen, Leena; Uitterlinden, Andre G.; Visscher, Peter M.; Chatterjee, Nilanjan; Loos, Ruth J. F.; Boehnke, Michael; McCarthy, Mark I.; Ingelsson, Erik; Lindgren, Cecilia M.; Abecasis, Goncalo R.; Stefansson, Kari; Frayling, Timothy M.; Hirschhorn, Joel N.		Procardis Consortium	Hundreds of variants clustered in genomic loci and biological pathways affect human height	NATURE			English	Article							WIDE ASSOCIATION; COMMON VARIANTS; HERITABILITY; ADULT	Most common human traits and diseases have a polygenic pattern of inheritance: DNA sequence variants at many genetic loci influence the phenotype. Genome-wide association (GWA) studies have identified more than 600 variants associated with human traits(1), but these typically explain small fractions of phenotypic variation, raising questions about the use of further studies. Here, using 183,727 individuals, we show that hundreds of genetic variants, in at least 180 loci, influence adult height, a highly heritable and classic polygenic trait(2,3). The large number of loci reveals patterns with important implications for genetic studies of common human diseases and traits. First, the 180 loci are not random, but instead are enriched for genes that are connected in biological pathways (P = 0.016) and that underlie skeletal growth defects (P<0.001). Second, the likely causal gene is often located near the most strongly associated variant: in 13 of 21 loci containing a known skeletal growth gene, that gene was closest to the associated variant. Third, at least 19 loci have multiple independently associated variants, suggesting that allelic heterogeneity is a frequent feature of polygenic traits, that comprehensive explorations of already-discovered loci should discover additional variants and that an appreciable fraction of associated loci may have been identified. Fourth, associated variants are enriched for likely functional effects on genes, being over-represented among variants that alter amino-acid structure of proteins and expression levels of nearby genes. Our data explain approximately 10% of the phenotypic variation in height, and we estimate that unidentified common variants of similar effect sizes would increase this figure to approximately 16% of phenotypic variation (approximately 20% of heritable variation). Although additional approaches are needed to dissect the genetic architecture of polygenic human traits fully, our findings indicate that GWA studies can identify large numbers of loci that implicate biologically relevant genes and pathways.	[Allen, Hana Lango; Weedon, Michael N.; Wood, Andrew R.; Perry, John R. B.; Hattersley, Andrew T.; Frayling, Timothy M.] Univ Exeter, Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England; [Estrada, Karol; Rivadeneira, Fernando; Aulchenko, Yurii S.; Amin, Najaf; vVan Meurs, Joyce B. J.; Hofman, Albert; Uitterlinden, Andre G.] Erasmus Sch Ctr, Dept Epidemiol, NL-3015 GE Rotterdam, Netherlands; [Estrada, Karol; Rivadeneira, Fernando; Zillikens, M. Carola; Peters, Marjolein J.; vVan Meurs, Joyce B. J.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3015 GE Rotterdam, Netherlands; [Estrada, Karol; Rivadeneira, Fernando; Aulchenko, Yurii S.; Peters, Marjolein J.; vVan Meurs, Joyce B. J.; Hofman, Albert; Uitterlinden, Andre G.] NCHA, NGI, NL-42300 RC Leiden, Netherlands; [Lettre, Guillaume; Lo, Ken Sin; Boucher, Gabrielle; Rioux, John D.] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lettre, Guillaume; Rioux, John D.] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Berndt, Sonja I.; Park, Ju-Hyun; Shi, Jianxin; Chatterjee, Nilanjan] Natl Canc Inst, Natl Inst Hlth, Divis Canc Epidemiol & Genet, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Willer, Cristen J.; Jackson, Anne U.; Weyant, Robert J.; Stringham, Heather M.; Boehnke, Michael; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Vedantam, Sailaja; Palmer, Cameron; Altmaier, Elizabeth L.; Salem, Rany M.; Turchin, Michael C.] Childrens Hosp, Div Genet & Endocrinol, Boston, MA 02115 USA; [Vedantam, Sailaja; Palmer, Cameron; Altmaier, Elizabeth L.; Salem, Rany M.; Turchin, Michael C.] Childrens Hosp, Program Gen, Boston, MA 02115 USA; [Vedantam, Sailaja; Palmer, Cameron; Altmaier, Elizabeth L.; Salem, Rany M.; Turchin, Michael C.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya; Segre, Ayellet V.; Voight, Benjamin F.; Ardlie, Kristin G.; Kathiresan, Sekar] MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya; Segre, Ayellet V.; Voight, Benjamin F.; Ardlie, Kristin G.; Kathiresan, Sekar] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Ferreira, Teresa; Randall, Joshua C.; Maegi, Reedik; Prokopenko, Inga; Rayner, Nigel W.; Robertson, Neil R.; Morris, Andrew P.; Peden, John F.; Farrall, Martin; Watkins, Hugh; McCarthy, Mark I.; Lindgren, Cecilia M.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Segre, Ayellet V.; Voight, Benjamin F.; Purcell, Shaun; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Segre, Ayellet V.; Voight, Benjamin F.] Massachusetts Gen Hosp, Dept Biol Mol, Boston, MA 02114 USA; [Speliotes, Elizabeth K.; Kaplan, Lee M.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Wheeler, Eleanor; Soranzo, Nicole; Grundberg, Elin; Chanock, Stephen J.; Deloukas, Panos; Barroso, Ines; Ouwehand, Willem H.; Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Soranzo, Nicole; Mangino, Massimo; Spector, Timothy D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Yang, Jian; Visscher, Peter M.] Queensland Inst Med Res, Queensland Stat Genet Lab, Queensland 4006, Australia; [Gudbjartsson, Daniel; Thorleifsson, Gudmar; Steinthorsdottir, Valgerdur; Walters, G. Bragi; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Heard-Costa, Nancy L.; Atwood, Larry D.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Qi, Lu; Workalemahu, Tsegaselassie; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Pietilainen, Kirsi H.; Kaprio, Jaakko; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Med, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Hu, Frank B.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Smith, Albert Vernon; Aspelund, Thor; Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert Vernon; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, IS-101 Reykjavik, Iceland; [Pastinen, Tomi; Grundberg, Elin; Kwan, Tony; Verlaan, Dominique J.] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Pastinen, Tomi; Grundberg, Elin; Kwan, Tony; Verlaan, Dominique J.] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Pastinen, Tomi; Grundberg, Elin; Kwan, Tony; Verlaan, Dominique J.] McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Cambridge, MA 02138 USA; [Liang, Liming] Harvard Univ, Sch Publ Hlth, Dept Biostat, Cambridge, MA 02138 USA; [Heid, Iris M.; Winkler, Thomas W.] Univ Regensburg, Med Ctr, Dept Epidemiol & Prevent Med, D-93053 Regensburg, Germany; [Heid, Iris M.; Albrecht, Eva; Mueller, Martina; Illig, Thomas; Gieger, Christian; Schadt, H. -Erich] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; [Luan, Jian'an; Zhao, Jing Hua; Kilpelaeinen, Tuomas O.; Wareham, Nicholas J.; Loos, Ruth J. F.] Addenbrookes Hosp, Inst Met Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Goddard, Michael E.] Univ Melbourne, Fac Land & Environm, Parkville, Vic 3010, Australia; [Goddard, Michael E.] Dept Primary Ind, Bundoora, Vic 3086, Australia; [Johansson, Asa; Igl, Wilmar; Gyllensten, Ulf] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; [Johansson, Asa] Norwegian Univ Sci & Technol NTNU, Dept Canc Res & Mol Med, Fac Med, N-7489 Trondheim, Norway; [Feitosa, Mary F.; Ketkar, Shamika; Province, Michael A.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Esko, Tonu; Tammesoo, Mari-Liis; Alavere, Helene; Nelis, Mari] Univ Tartu, Estonian Genome Ctr, EE-50410 Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Metspalu, Andres] Estonian Bioctr, EE-51010 Tartu, Estonia; [Esko, Tonu; Nelis, Mari; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Johnson, Toby; Kutalik, Zoltan; Beckmann, Jacques S.; Bergmann, Sven; Rivolta, Carlo] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Johnson, Toby; Kutalik, Zoltan; Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Johnson, Toby] Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Johnson, Toby; Caulfield, Mark J.; Munroe, Patricia B.] Univ London, William Harvey Res Inst, Barts & London Genome Ctr, Barts & London Sch Med & Dent, London EC1M6BQ, England; [Kraft, Peter; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Prokopenko, Inga; Rayner, Nigel W.; Robertson, Neil R.; Lindgren, Cecilia M.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Absher, Devin] Hudson Alpha Inst Biotechnol, Huntsville, AL 35806 USA; [Ernst, Florian] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Gen, D-17487 Greifswald, Germany; [Glazer, Nicole L.; Wiklund, Fredrik] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Glazer, Nicole L.; Wiklund, Fredrik] Univ Washington, Dept Med, Seattle, WA 98101 USA; [Hayward, Caroline; Xu, Jianfeng; Vitart, Veronique; Wright, Alan F.; Rudan, Igor] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Hottenga, Jouke-Jan; Geus, Eco J. C.; Willemsen, Gonneke; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, NL-1081 BT Amsterdam, Netherlands; [Jacobs, Kevin B.] NCI Frederick, SAIC Frederick Inc, Frederick, MD 21702 USA; [Knowles, Joshua W.; Assimes, Themistocles L.; Quertermous, Thomas] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Monda, Keri L.; North, Kari E.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Polasek, Ozren; Kolcic, Ivana; Zgaga, Lina] Univ Zagreb, Andrija Stampar Sch Publ Hlth, Sch Med, Zagreb 10000, Croatia; [Polasek, Ozren] Gen Info Ltd, Zagreb 10000, Croatia; [Preuss, Michael; Koenig, Inke R.] Univ Lubeck, Inst Med Biometrie & Stat, D-23562 Lubeck, Germany; [Tyrer, Jonathan P.] Univ Cambridge, Dept Oncol, Cambridge CB1 8RN, England; [Gronberg, Henrik; Hall, Per; Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostatist, S-17177 Stockholm, Sweden; [Shuldiner, Alan R.] Wake Forest Univ, Ctr Human Genome, Winston Salem, NC 27157 USA; [Nyholt, Dale R.] Queensland Inst Med Res, Neurogenet Lab, Queensland 4006, Australia; [Pellikka, Niina; Perola, Markus; Surakka, Ida; Kettunen, Johannes; Widen, Elisabeth; Ripatti, Samuli; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki 00014, Finland; [Pellikka, Niina; Perola, Markus; Surakka, Ida; Kettunen, Johannes; Ripatti, Samuli; Peltonen, Leena] Natl Inst Hlth & Welfare, Dept Chron Dis Prevent, Unit Publ Hlth Gen, FIN-00014 Helsinki, Finland; [Bhangale, Tushar] Univ Washington, Dept Gen Sci, Seattle, WA 98195 USA; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Chasman, Daniel I.; Kaplan, Lee M.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chen, Constance] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Coin, Lachlan; Sovio, Ulla; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Fac Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Cooper, Matthew N.; Lawrence, Robert W.; Hui, Jennie; Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostatist, Crawley, WA 6009, Australia; [Dixon, Anna L.] Univ Bath, Bath BA1 1RL, Avon, England; [Dixon, Anna L.] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England; [Gibson, Quince; Haiqing, Shen; Shuldiner, Alan R.; O'Connell, Jeffrey R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Hao, Ke] Rosetta Inpharmat Wholly Owned Subsidiary Merck&C, Dept Genet, Seattle, WA 98109 USA; [Junttila, M. Juhani; Huikuri, Heikki V.] Univ Oulu, Dept Internal Med, Oulu 90014, Finland; [Kaplan, Lee M.] Massachusetts Gen Hosp, MGH Weight Ctr, Boston, MA 02114 USA; [Levinson, Douglas F.] Stanford Univ, Sch ofMedicine, Stanford, CA 93405 USA; [Lorentzon, Mattias; Vandenput, Liesbeth; Ohlsson, Claes] Univ Gothenburg, Inst Med, Dept Internal Med, Sahlgrenska Acad, S-41345 Gothenburg, Sweden; [McKnight, Barbara; Arnold, Alice M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Mueller, Martina] Univ Munich, Dept Med 1, Univ Hosp Grosshadern, D-81377 Munich, Germany; [Mueller, Martina; Schadt, H. -Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, D-81377 Munich, Germany; [Ngwa, Julius Suh; White, Charles C.; Cupples, L. Adrienne] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Purcell, Shaun; Schreiber, Stefan; Peltonen, Leena] Broad Inst Harvard, Cambridge, MA 02142 USA; [Purcell, Shaun; Peltonen, Leena] MIT, Cambridge, MA 02142 USA; [Purcell, Shaun] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Rafelt, Suzanne; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Salvi, Erika; Cusi, Daniele] Univ Milan, Dept Med Surg & Dent, I-20139 Milan, Italy; [Salvi, Erika] KOS Genet Srl, I-20123 Milan, Italy; [Sanna, Serena; Maschio, Andrea; Mulas, Antonella; Uda, Manuela] Ist Neurogenet & Neurofarmacol CNR, I-09042 Cagliari, Italy; [Thompson, John R.; Samani, Nilesh J.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Thompson, John R.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Ziegler, Andreas] Univ Lubeck, Inst Med Biometrie & Stat, D-23562 Lubeck, Germany; [Almgren, Peter; Groop, Leif C.] Lund Univ, Ctr Diabet, Dept Clin Sci, S-20502 Malmo, Sweden; [Balmforth, Anthony J.; Hall, Alistair S.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England; [Campbell, Harry; Wild, Sarah H.; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Citterio, Lorena; Zagato, Laura] Univ Vita Salute San Raffaele, Div Nephrol & Dialysis, I-20132 Milan, Italy; [De Grandi, Alessandro; Dominiczak, Anna; Hicks, Andrew A.; Pichler, Irene; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, I-39100 Bolzano, Italy; [De Grandi, Alessandro; Dominiczak, Anna; Hicks, Andrew A.; Pichler, Irene; Pramstaller, Peter P.] Univ Lubeck, Affiliated Inst, Lubeck, Germany; [Strachan, David P.] Univ Glasgow, British Heart Fdn Glasgow Cardiovascular Res Ct, Glasgow G12 8TA, Lanark, Scotland; [Duan, Jubao; Sanders, Alan R.; Gejman, Pablo V.] Northshore Univ Healthsyst, Evanston, IL 60201 USA; [Elosua, Roberto; Eriksson, Johan G.] Inst Municipal Invest Medica & CIBER Epidemiol &, Barcelona, Spain; Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki 00014, Finland; [Eriksson, Johan G.; Kajantie, Eero] Natl Inst Hlth & Welf, Helsinki 00271, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki 00280, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki 00250, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa 65130, Finland; [Freimer, Nelson B.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; [Glorioso, Nicola] Univ Sassari, Hypertens & Cardiovasc Prevent Ctr, I-07100 Sassari, Italy; [Hartikainen, Anna-Liisa; Pouta, Anneli] Univ Oulu, Dept Clin Sci Obstet & Gynecol, Oulu 90014, Finland; [Havulinna, Aki S.; Koskinen, Seppo; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Chron Dis Epidemiol & Prevent Unit, Helsinki 00014, Finland; [Hui, Jennie; Beilby, John P.] QEII Med Ctr, PathW Lab Western Australia, Dept Mol Genet, Nedlands, WA 6009, Australia; [Hui, Jennie; Beilby, John P.; Musk, Arthur W.; Palmer, Lyle J.] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn Inc, Nedlands, WA, Australia; [Jula, Antti] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Populat Studies Unit, Turku 20720, Finland; [Koiranen, Markku; Jarvelin, Marjo-Ritta] Univ Oulu, Inst Hlth Sci, Oulu 90014, Finland; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, D-04103 Leipzig, Germany; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu 90220, Finland; [Liu, Jianjun] Genome Inst Singapore, Singapore 138672, Singapore; [Lokki, Marja-Liisa] Univ Helsinki, Haartman Inst, Transplantat Lab, Helsinki 00014, Finland; [Marusic, Ana; Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split 21000, Croatia; [Meitinger, Thomas] Klinikum Rechts Isar Techn Univ Mu nchen, Inst Human Genet, D-81675 Munich, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Human Genet, D-85764 Neuherberg, Germany; [Pare, Guillaume] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Parker, Alex N.] Amgen Inc, Cambridge, MA 02139 USA; [Peden, John F.; Farrall, Martin; Watkins, Hugh; Procardis Consortium] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England; [Petersmann, Astrid] Ernst Moritz Arndt Univ Greifswald, Inst Klin Chem, D-17475 Greifswald, Germany; [Petersmann, Astrid] Ernst Moritz Arndt Univ Greifswald, Lab Med, D-17475 Greifswald, Germany; [Pietilainen, Kirsi H.; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki 00014, Finland; [Pietilainen, Kirsi H.; Rissanen, Aila] Univ Helsinki, Cent Hosp, Dept Psychiat, Obes Res unit, Helsinki, Finland; [Pouta, Anneli; Jarvelin, Marjo-Ritta] Natl Inst Hlth & Welf, Oulu 90101, Finland; [Riddertrale, Martin; Melander, Olle] Lund Univ, Dept Clin Sci, S-20502 Maimo, Sweden; [Sambrook, Jennifer G.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 OPT, England; [Sambrook, Jennifer G.; Ouwehand, Willem H.] Cambridge Ctr, Cambridge CB2 0PT, England; [Schmidt, Carsten Oliver; Hoffman, Wolfgang; Voelzke, Henry] Inst Community Med, D-17489 Greifswald, Germany; [Sinisalo, Juha; Nieminen, Markku S.] Univ Helsinki, Cent Hosp, Cardiovasc Lab, Div Cardiol, Helsinki 00029, Finland; [Smit, Jan H.; Penninx, Brenda W.] Vrije Univ Amsterdam, Med Ctr, Dept Psychiatry EMGO Inst, NL-1081 BT Amsterdam, Netherlands; [Zitting, Paavo] Lapland Cent Hosp, Dept Physiat, Rovaniemi 96101, Finland; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, ALSPAC, Bristol BS8 2BN, Avon, England; [Aben, Katja K.; Kiemeney, Lambertus] Comprehens Canc Ctr E, NL-6501 BG Nijmegen, Netherlands; [Beckmann, Jacques S.] CHU Vaudois, Univ Hosp, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Beilby, John P.] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Bergman, Richard N.] Univ So Calif, Keck Sch Med, Dept Phys & Biophys, Los Angeles, CA 90033 USA; [Collins, Francis S.] Natl Human Genome Res Inst, Natl Inst Hlth, Bethesda, MD 20892 USA; [den Heijer, Martin] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6500 HB Nijmegen, Netherlands; [Hamsten, Anders] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Atherosclerosis Res Unit, S-17176 Solna, Sweden; [Iribarren, Carlos] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; [Iribarren, Carlos] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, Tampere 33520, Finland; [Kahonen, Mika] Tampere Univ Hosp, Tampere 33520, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth & Substance Abuse Serv, Unit Child & Adolescent Mental Hlth, Helsinki 00271, Finland; [Kathiresan, Sekar; McCarthy, Mark I.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Kathiresan, Sekar; McCarthy, Mark I.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Kathiresan, Sekar; O'Donnell, Christopher J.] Boston Univ, Framingham, MA 01702 USA; [Kathiresan, Sekar; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Kathiresan, Sekar] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Kiemeney, Lambertus] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostatist & HTA, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; [Kocher, Thomas] Zentrum Zahn Mund & Kieferheilkunde, D-17489 Greifswald, Germany; [Launer, Lenore J.; Harris, Tamara B.] Natl Inst Hlth, NIA, Lab Epidemiol Demog, Bethesda, MD 20892 USA; [Lehtimaki, Terho] Univ Tampere, Dept Clin Chem, Tampere 33520, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, Tampere 33520, Finland; [Mosley, Tom H., Jr.] Univ Mississippi, Div Geriatr, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Musk, Arthur W.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [O'Donnell, Christopher J.] Natl Inst Hlth, Nat Lung & Blood Inst, Framingham, MA 01702 USA; [Oostra, Ben] Erasmus MC, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; [Raitakari, Olli] Turku Univ, Res Ctr Appl & Prevent Cardiovasc Med, Turku 20520, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol, Turku 20520, Finland; [Schunkert, Heribert; Erdmann, Jeanette] Univ Lubeck, Med Klin 2, D-23562 Lubeck, Germany; [Shuldiner, Alan R.] Baltimore Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Siscovick, David S.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Siscovick, David S.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Siscovick, David S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Stumvoll, Michael; Toenjes, Anke] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany; [Stumvoll, Michael] Univ Leipzig, LIFE Study Ctr, Leipzig, Germany; [Toenjes, Anke] Univ Leipzig, Coordinat Ctr Clin Trials, D-04103 Leipzig, Germany; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki 00271, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki 00014, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki 60220, Finland; [van Ommen, Gert-Jan] Leiden Univ, Med Ctr, Dept Human Genet, NL-2333 ZC Leiden, Netherlands; [van Ommen, Gert-Jan] Leiden Univ, Med Ctr, Ctr Med Syst Biol, NL-2333 ZC Leiden, Netherlands; [Viikari, Jorma] Univ Turku, Dept Med, Turku 20520, Finland; [Viikari, Jorma] Turku Univ Hosp, Turku 20520, Finland; [Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat & Midwest, Res Inst Alcoholism, St Louis, MO 63108 USA; [Martin, Nicholas G.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Province, Michael A.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Kayser, Manfred] Erasmus MC, Dept Forens Mol Biol, NL-3015 GE Rotterdam, Netherlands; [Arnold, Alice M.] Collaborat Hlth Studies Coordinating Ctr, Seattle, WA 98115 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Inst Mol Med, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Div Epidemiol, Houston, TX 77030 USA; [Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, D-93053 Regensburg, Germany; [Hengstenberg, Christian] Univ Regensburg, Med Ctr, Innere Med 2, D-93053 Regensburg, Germany; [Lathrop, G. Mark] Ctr Natl Genotypage, F-91057 Paris, France; [Schreiber, Stefan] Univ Kiel, Univ Hosp Schleswig Holstein, Clin Mol Biol, D-24105 Kiel, Germany; [Schreiber, Stefan] Dept Internal Med 1, D-24105 Kiel, Germany; [Waterworth, Dawn; Mooser, Vincent] GlaxoSmithKline, Div Genet, King Of Prussia, PA 19406 USA; [Barroso, Ines] Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 OQQ, England; [Fox, Caroline S.] NHLBI, Div Intramural Res, Framingham, MA 01702 USA; [Hayes, Richard B.] NYU, Med Ctr, New York, NY 10016 USA; [Jarvelin, Marjo-Ritta] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland; [Penninx, Brenda W.] Leiden Univ, Med Ctr, Dept Psychiat, NL-2300 RC Leiden, Netherlands; [Penninx, Brenda W.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 GZ Groningen, Netherlands; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Kaplan, Robert C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [North, Kari E.] Univ N Carolina, Sch Publ Hlth, Carolina Ctr Genome Sci, Chapel Hill, NC 27514 USA; [Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Strachan, David P.] St Georges Univ London, Div Community Hlth Sci, London SW17 0RE, England; [Schadt, H. -Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Eriksson, Johan G.] Pacific Biosci, Menlo Pk, CA 94025 USA; Sage Bionetworks, Seattle, WA 98109 USA; [Thorsteinsdottir, Unnur] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, Helsinki 00014, Finland; [McCarthy, Mark I.] Churchill Hosp, NIHR Oxford Biomed Res Ctr, Oxford OX3 7LJ, England; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Exeter; University of Plymouth; Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Universite de Montreal; Universite de Montreal; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Wellcome Trust Sanger Institute; University of London; King's College London; QIMR Berghofer Medical Research Institute; Boston University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Icelandic Heart Association; University of Iceland; McGill University; McGill University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Melbourne; Uppsala University; Norwegian University of Science & Technology (NTNU); Washington University (WUSTL); University of Tartu; Estonian Biocentre; University of Tartu; University of Lausanne; Swiss Institute of Bioinformatics; University of London; Queen Mary University London; University of London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Ernst Moritz Arndt Universitat Greifswald; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Edinburgh; Vrije Universiteit Amsterdam; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of Zagreb; University of Lubeck; University of Cambridge; Karolinska Institutet; Wake Forest University; QIMR Berghofer Medical Research Institute; University of Helsinki; Finland National Institute for Health & Welfare; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; University of Western Australia; University of Bath; Royal National Hospital for Rheumatic Diseases (RNHRD); University System of Maryland; University of Maryland Baltimore; Merck & Company; University of Oulu; Harvard University; Massachusetts General Hospital; Stanford University; University of Gothenburg; University of Washington; University of Washington Seattle; University of Munich; University of Munich; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Milan; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Leicester; University of Lubeck; Lund University; University of Leeds; University of Edinburgh; Vita-Salute San Raffaele University; European Academy of Bozen-Bolzano; University of Lubeck; University of Glasgow; NorthShore University Health System; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Vaasa Central Hospital; University of California System; University of California Los Angeles; University of Sassari; University of Oulu; Finland National Institute for Health & Welfare; University of Western Australia; University of Western Australia; Finland National Institute for Health & Welfare; University of Oulu; Leipzig University; Finnish Institute of Occupational Health; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Helsinki; University of Split; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; McMaster University; Amgen; University of Oxford; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; Lund University; University of Cambridge; University of Helsinki; Helsinki University Central Hospital; Vrije Universiteit Amsterdam; University of Oxford; Wellcome Centre for Human Genetics; University of Bristol; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Western Australia; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Radboud University Nijmegen; Karolinska Institutet; Karolinska University Hospital; Kaiser Permanente; University of California System; University of California San Francisco; Tampere University; Tampere University; Tampere University Hospital; Finland National Institute for Health & Welfare; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School; Radboud University Nijmegen; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Tampere University; Tampere University; Tampere University Hospital; University of Mississippi; University of Mississippi Medical Center; University of Western Australia; National Institutes of Health (NIH) - USA; Erasmus University Rotterdam; Erasmus MC; University of Turku; University of Turku; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Leipzig University; Leipzig University; Leipzig University; Finland National Institute for Health & Welfare; University of Helsinki; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Turku; University of Turku; Washington University (WUSTL); QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Washington University (WUSTL); Erasmus University Rotterdam; Erasmus MC; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Regensburg; University of Regensburg; CEA; University of Kiel; Schleswig Holstein University Hospital; GlaxoSmithKline; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); New York University; University of Oulu; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; Krankenhaus Bozen; Yeshiva University; Albert Einstein College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); St Georges University London; University of Munich; University of Iceland; University of Helsinki; University of Oxford; Harvard University; Harvard Medical School	Allen, HL (corresponding author), Univ Exeter, Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England.		Sovio, Ulla/H-8532-2019; Salvi, Erika/AAA-1415-2019; Palmer, Lyle John/K-3196-2014; Ohlsson, Claes/AGP-3544-2022; Johansson, Åsa/G-5270-2011; Deloukas, Panos/B-2922-2013; Coin, Lachlan JM/A-9001-2014; Wilson, James F/A-5704-2009; Wood, Andrew R/AAB-3807-2019; Loos, Ruth J F/Q-2862-2016; Kaprio, Jaakko/A-1820-2008; Visscher, Peter/ABB-6151-2020; Salvi, Erika/C-1033-2015; Rioux, John D/A-9599-2015; Allen, Hana Lango/G-9026-2012; Abecasis, Goncalo R/B-7840-2010; Mangino, Massimo/F-5134-2011; Uda, Manuela/AAC-2645-2019; Hicks, Andrew Anthony/E-9518-2017; sanna, serena/H-3009-2019; Nelis, Mari/ABG-7775-2020; Gudnason, Vilmundur/K-6885-2015; Dominiczak, Anna F/P-9390-2017; Rivadeneira, Fernando/O-5385-2015; Citterio, Lorena/AAC-1589-2019; Kutalik, Zoltan/HHZ-5697-2022; Hayward, Caroline/M-8818-2016; Aulchenko, Yurii/M-8270-2013; Polasek, Ozren/B-6002-2011; Montgomery, Grant W/B-7148-2008; Aspelund, Thor/F-4826-2011; Stefansson, Kari/AAE-7187-2019; Raitakari, Olli/AAQ-7389-2021; Loos, Ruth/GON-5877-2022; Pare, Guillaume/T-9631-2018; Erdmann, Jeanette/P-7513-2014; Zgaga, Lina/Q-9415-2018; de Geus, Eco J.C./M-9318-2015; Aspelund, Thor/C-5983-2008; Spector, Tim D/F-6533-2012; Maschio, Andrea/AAX-8185-2020; Nyholt, Dale Robert/J-3174-2017; König, Inke R/A-4544-2009; Segre, Ayellet V/E-9800-2010; Voight, Benjamin/F-1775-2011; Liu, Jianjun/AAK-4989-2020; Amin, Najaf N/D-1859-2012; Prokopenko, Inga/H-3241-2014; Mulas, Antonella/B-4231-2015; Yang, Jian/A-5852-2010; Walters, G. Bragi/L-4215-2013; Aspelund, Thor/K-7022-2019; Kiemeney, Lambertus A./D-3357-2009; Kolcic, Ivana/E-2713-2017; Stumvoll, Michael/ABE-1121-2021; Campbell, Harry/E-2959-2010; Schmidt, Carsten Oliver/AAH-2778-2019; Marusic, Ana/E-7683-2013; Johansson, Åsa/AAG-6799-2021; Havulinna, Aki/AAM-4769-2021; Cooper, Matthew N/J-4420-2014; Ridderstråle, Martin/F-7678-2012; Vandenput, Liesbeth/AAP-3655-2020; Smith, Albert Vernon/K-5150-2015; Mägi, Reedik/AAJ-9679-2021; Kaplan, Robert/A-2526-2011; Gudnason, Vilmundur/AAE-7126-2019; Rotter, Jerome/AAY-6598-2021; Hall, Alistair/K-1953-2019; Kilpeläinen, Tuomas/F-8569-2012; Prokopenko, Inga/AAU-9895-2020; Assimes, Themistocles Leonard/D-9696-2015; Colaus, PsyColaus/K-6607-2013; Erdmann, Jeanette/A-4417-2009; Beckmann, Jacques S/A-9772-2008; Palmer, Lyle John/N-1948-2019; Pramstaller, Peter P/C-2357-2008; Penninx, Brenda WJH/S-7627-2017; Hengstenberg, Christian/U-5485-2019; Meitinger, Thomas/O-1318-2015; Aben, Katja KH/G-9686-2016; Berndt, Sonja I/J-8423-2016; Feitosa, Mary F/K-8044-2012; Lehtimäki, Terho/AAD-1094-2022; Hui, Jennie/A-9543-2013; Rudan, Igor/I-1467-2012; Boomsma, Dorret I/AAX-4470-2020; Ripatti, Samuli/H-9446-2014; Coin, Lachlan/O-4976-2019; Zagato, Laura/AAC-7739-2022; Müller-Nurasyid, Martina/I-8735-2018; Vandenput, Liesbeth/AAI-4100-2021; Lorentzon, Mattias/W-7878-2019; McCarthy, Mark/M-3763-2015; Ziegler, Andreas/G-4246-2012; den Heijer, Martin/J-8036-2015	Sovio, Ulla/0000-0002-0799-1105; Salvi, Erika/0000-0002-2724-2291; Palmer, Lyle John/0000-0002-1628-3055; Ohlsson, Claes/0000-0002-9633-2805; Johansson, Åsa/0000-0002-2915-4498; Deloukas, Panos/0000-0001-9251-070X; Coin, Lachlan JM/0000-0002-4300-455X; Wilson, James F/0000-0001-5751-9178; Wood, Andrew R/0000-0003-1726-948X; Loos, Ruth J F/0000-0002-8532-5087; Kaprio, Jaakko/0000-0002-3716-2455; Visscher, Peter/0000-0002-2143-8760; Salvi, Erika/0000-0002-2724-2291; Rioux, John D/0000-0001-7560-8326; Allen, Hana Lango/0000-0002-7803-8688; Mangino, Massimo/0000-0002-2167-7470; Uda, Manuela/0000-0002-4890-6456; Hicks, Andrew Anthony/0000-0001-6320-0411; sanna, serena/0000-0002-3768-1749; Nelis, Mari/0000-0001-9748-1020; Gudnason, Vilmundur/0000-0001-5696-0084; Dominiczak, Anna F/0000-0003-4913-3608; Rivadeneira, Fernando/0000-0001-9435-9441; Citterio, Lorena/0000-0001-6455-2291; Kutalik, Zoltan/0000-0001-8285-7523; Hayward, Caroline/0000-0002-9405-9550; Aulchenko, Yurii/0000-0002-7899-1575; Polasek, Ozren/0000-0002-5765-1862; Montgomery, Grant W/0000-0002-4140-8139; Pare, Guillaume/0000-0002-6795-4760; Erdmann, Jeanette/0000-0002-4486-6231; Zgaga, Lina/0000-0003-4089-9703; de Geus, Eco J.C./0000-0001-6022-2666; Aspelund, Thor/0000-0002-7998-5433; Nyholt, Dale Robert/0000-0001-7159-3040; König, Inke R/0000-0003-0504-6465; Liu, Jianjun/0000-0002-3255-3019; Prokopenko, Inga/0000-0003-1624-7457; Yang, Jian/0000-0003-2001-2474; Walters, G. Bragi/0000-0002-5415-6487; Aspelund, Thor/0000-0002-7998-5433; Kiemeney, Lambertus A./0000-0002-2368-1326; Kolcic, Ivana/0000-0001-7918-6052; Stumvoll, Michael/0000-0001-6225-8240; Campbell, Harry/0000-0002-6169-6262; Schmidt, Carsten Oliver/0000-0001-5266-9396; Marusic, Ana/0000-0001-6272-0917; Johansson, Åsa/0000-0002-2915-4498; Cooper, Matthew N/0000-0003-1139-3682; Vandenput, Liesbeth/0000-0002-1712-6131; Smith, Albert Vernon/0000-0003-1942-5845; Gudnason, Vilmundur/0000-0001-5696-0084; Kilpeläinen, Tuomas/0000-0002-8349-3028; Assimes, Themistocles Leonard/0000-0003-2349-0009; Beckmann, Jacques S/0000-0002-9741-1900; Palmer, Lyle John/0000-0002-1628-3055; Penninx, Brenda WJH/0000-0001-7779-9672; Aben, Katja KH/0000-0002-0214-2147; Feitosa, Mary F/0000-0002-0933-2410; Lehtimäki, Terho/0000-0002-2555-4427; Hui, Jennie/0000-0002-1653-2496; Rudan, Igor/0000-0001-6993-6884; Ripatti, Samuli/0000-0002-0504-1202; Coin, Lachlan/0000-0002-4300-455X; Müller-Nurasyid, Martina/0000-0003-3793-5910; Vandenput, Liesbeth/0000-0002-1712-6131; Lorentzon, Mattias/0000-0003-0749-1431; Gudbjartsson, Daniel/0000-0002-5222-9857; Sinisalo, Juha/0000-0002-0169-5137; Randall, Joshua/0000-0003-1540-203X; McCarthy, Mark/0000-0002-4393-0510; Munroe, Patricia/0000-0002-4176-2947; Mulas, Antonella/0000-0002-6856-1483; Eriksson, Johan/0000-0002-2516-2060; Voight, Benjamin/0000-0002-6205-9994; Soranzo, Nicole/0000-0003-1095-3852; Melander, Olle/0000-0002-2581-484X; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Quertermous, Thomas/0000-0002-7645-9067; Magi, Reedik/0000-0002-2964-6011; Gieger, Christian/0000-0001-6986-9554; Kahonen, Mika/0000-0002-4510-7341; Surakka, Ida/0000-0002-6669-5541; Pietilainen, Kirsi/0000-0002-8522-1288; Watkins, Hugh/0000-0002-5287-9016; Hayes, Richard/0000-0002-0918-661X; Cupples, L. Adrienne/0000-0003-0273-7965; Meitinger, Thomas/0000-0002-8838-8403; Pichler, Irene/0000-0001-8251-0757; Bergman, Richard/0000-0003-1539-4471; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Weyant, Robert/0000-0002-5252-9120; Ouwehand, Willem/0000-0002-7744-1790; Workalemahu, Tsegaselassie/0000-0003-4571-9740; Esko, Tonu/0000-0003-1982-6569; Elliott, Paul/0000-0002-7511-5684; Bergmann, Sven/0000-0002-6785-9034; Wheeler, Eleanor/0000-0002-8616-6444; Raychaudhuri, Soumya/0000-0002-1901-8265; Ziegler, Andreas/0000-0002-8386-5397; Shuldiner, Alan/0000-0001-9921-4305; Amin, Najaf/0000-0002-8944-1771; Pramstaller, Peter P/0000-0002-9831-8302; Goddard, Michael/0000-0001-9917-7946; Frayling, Timothy/0000-0001-8362-2603; Weedon, Michael/0000-0002-6174-6135; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Van Duijn, Cornelia/0000-0002-2374-9204; Glazer, Nicole/0000-0002-6397-609X; Peters, Marjolein/0000-0003-3167-9063; Salem, Rany/0000-0001-8816-6862; Caulfield, Mark/0000-0001-9295-3594; Rivolta, Carlo/0000-0002-0733-9950; Martin, Nicholas/0000-0003-4069-8020; Heard-Costa, Nancy/0000-0001-9730-0306; den Heijer, Martin/0000-0003-3620-5617; Barroso, Ines/0000-0001-5800-4520; Turchin, Michael/0000-0003-3569-1529; Hall, Alistair/0000-0003-0306-7887; Abecasis, Goncalo/0000-0003-1509-1825; Willer, Cristen/0000-0001-5645-4966; Kovacs, Peter/0000-0002-0290-5423; Johnson, Toby/0000-0002-5998-3270; Hattersley, Andrew/0000-0001-5620-473X; van Meurs, Joyce/0000-0001-6245-2123; Lindgren, Cecilia/0000-0002-4903-9374; maschio, andrea/0000-0002-4238-9144; Zagato, Laura/0000-0002-0441-2120; Beilby, John/0000-0002-4915-2254; Willemsen, Gonneke/0000-0003-3755-0236; Preuss, Michael/0000-0001-5266-8465	Academy of Finland [104781, 117797, 120315, 121584, 126925, 129269, 129494, 129680, 213506]; Affymetrix for genotyping services [N02-HL-6-4278]; Agency for Science, Technology and Research of Singapore; ALF/LUA Gothenburg; Althingi (the Icelandic Parliament); Amgen; AstraZeneca AB; Australian National Health and Medical Research Council [241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485, 613672]; Australian Research Council [DP0770096]; Biocentrum Helsinki; Boston Obesity Nutrition Research Center [DK46200]; British Diabetes Association; British Heart Foundation [PG/02/128]; British Heart Foundation Centre for Research Excellence, Oxford; CamStrad; Cancer Research UK; Centre for Neurogenomics and Cognitive Research; Chief Scientist Office of the Scottish Government [CZB/4/279]; Council of Health of the Academy of Finland; German Network of Diabetes; Diabetes UK; Donald W. Reynolds Foundation; Emil and Vera Cornell Foundation; Erasmus MC; Estonian Government [SF0180142s08]; European Commission [201413, ECOGENE:205419, BBMRI:212111, OPENGENE:245536, ENGAGE:HEALTH-F4-2007-201413, EURODIA:LSHG-CT-2004-518153, EU/WLRT-2001-01254, HEALTH-F2-2008-ENGAGE, HEALTH-F4-2007-201550, LSH-2006-037593, LSHG-CT-2006-018947, LSHG-CT-2006-01947, Procardis:LSHM-CT-2007-037273, POLYGENE:LSHC-CT-2005, QLG1-CT-2000-01643, QLG2-CT-2002-01254]; Eve Appeal; Finnish Ministry of Education; Finnish Diabetes Research Foundation; Finnish Diabetes Research Society; Finnish Foundation for Cardiovascular Research; Finnish Medical Society; Finska Lakaresallskapet; Folkhalsan Research Foundation; Fondation LeDucq; Foundation for Life and Health in Finland; Foundation for Strategic Research; GEN-AU; Genetic Association Information Network; German Bundesministerium fuer Forschung und Technology [01 AK 803 A-H, 01 IG 07015 G]; German Federal Ministry of Education and Research [01GS0831]; German Ministry for Health, Welfare and Sports; German Ministry of Cultural Affairs; German Ministry of Education, Culture and Science; German National Genome Research Net [01GS0823, 01ZZ0103, 01ZZ0403, 01ZZ9603, 03ZIK012]; German Research Council [KFO-152]; GlaxoSmithKline; Goteborg Medical Society; Gyllenberg Foundation; Helmholtz Center Munich; Juvenile Diabetes Research Foundation International [U01 DK062418]; Karolinska Institute; Knut and Alice Wallenberg Foundation; Lundberg Foundation; March of Dimes [6-FY-09-507]; MC Health; Medical Research Council UK [G0000649, G0000934, G0500539, G0600331, G0601261, G9521010D]; Microarray Core Facility of the Interdisciplinary Centre for Clinical Research [B27]; Mid-Atlantic Nutrition and Obesity Research Center of Maryland [P30 DK072488]; Ministry of Health and Department of Educational Assistance (South Tyrol, Italy); Ministry of Science, Education and Sport of the Republic of Croatia [216-1080315-0302]; Montreal Heart Institute Foundation; Narpes Health Care Foundation; National Cancer Institute; National Institute for Health Research Cambridge Biomedical Research Centre; National Institute for Health Research Oxford Biomedical Research Centre; National Institute for Health Research Comprehensive Biomedical Research Centre; National Institutes of Health [263-MA-410953, AA014041, AA07535, AA10248, AA13320, AA13321, AA13326, CA047988, CA49449, CA50385, CA65725, CA67262, CA87969, DA12854, DK062370, DK063491, DK072193, DK079466, DK080145, DK58845, HG002651, HG005214, HG005581, HL043851, HL084729, HL69757, HL71981, K08-AR055688]; ADA; Netherlands Genomics Initiative/Netherlands Consortium for Healthy Aging [050-060-810]; Netherlands Organisation for Scientific Research [175.010.2005.011, 911-03-012]; Netherlands Organization for the Health Research and Development [10-000-1002]; Netherlands Scientific Organization [904-61-090, 904-61-193, 480-04-004, 400-05-717, SPI 56-464-1419]; NIA; Nordic Center of Excellence in Disease Genetics; Novo Nordisk Foundation; Ollqvist Foundation; Paavo Nurmi Foundation; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Queensland Institute of Medical Research; Radboud University Nijmegen Medical Centre; Research Institute for Diseases in the Elderly [014-93-015]; Royal Swedish Academy of Science; Sahlgrenska Center for Cardiovascular and Metabolic Research [A305:188]; Siemens Healthcare, Erlangen, Germany; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Social Insurance Institution of Finland; Social Ministry of the Federal State of Mecklenburg-West Pomerania; South Tyrolean Sparkasse Foundation; Stockholm County Council; Support for Science Funding programme; Susan G. Komen Breast Cancer Foundation; Swedish Cancer Society; Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research; Swedish Heart-Lung Foundation; Swedish Medical Research Council; Swedish National Cancer Institute; Swedish Research Council; Swedish Society of Medicine; Swiss National Science Foundation; Torsten and Ragnar Soderberg's Foundation; Vandervell Foundation; Vastra Gotaland Foundation; Wellcome Trust [072960, 075491, 079557, 079895, 083270, 068545/Z/02, 076113/B/04/Z, 076113/C/04/Z, 077016/Z/05/Z, 081682/Z/06/Z, 084183/Z/07/Z, 085301/Z/08/Z, 086596/Z/08/Z, 091746/Z/10/Z]; Wellcome Trust; Western Australian Genetic Epidemiology Resource; Western Australian DNA Bank;  [560183];  [K2007-66X-20270-01-3];  [8691];  [33CSCO-122661]; MRC [G0701863, G0000934, MC_U106188470, G0600331, G0601261, MC_U127561128, MC_qA137934, G9521010] Funding Source: UKRI; Medical Research Council [MC_qA137934, MC_U106188470, MC_U106179471, G0000934, MC_U127561128, G0600331, G0701863, G0601261, G9521010] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055020, N01HC085081, N01HC085082, N01HC015103, N01HC055222, N01HC075150, N01HC055021, N01HC055018, N01HC055016, N01HC055019, N01HC055022, N01HC085080, N01HC085086, N01HC035129, N01HC085083, N01HC025195, N01HC045133, N01HC055015, N01HC085084, N01HC085085, N01HC085079] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA049449, U01CA049449, R01CA067262, R01CA065725, P01CA087969, U01CA067262, R01CA104021, R01CA047988, R01CA050385, U01CA098233] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425, UL1RR025005, U54RR020278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL055018, K99HL094535, R01HL117078, ZIAHL006094, R01HL087647, R01HL087641, R01HL087679, R01HL087676, U01HL072515, U01HL084729, R01HL088119, R01HL043851, R01HL064278, R01HL071981, R01HL087700, ZIAHL006002, U01HL080295, R41HL055018, U01HL084756, U19HL069757, U01HL069757, R01HL059367, R01HL087652, R01HL086694] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004399, Z01HG000024, ZIAHG000024, T32HG000040, R01HG002651, RC2HG005581, U01HG005214, U01HG004402, N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062370, K23DK080145, R01DK089256, R01DK058845, P30DK072488, P30DK063491, R01DK075787, R01DK062370, U01DK062370, R01DK072193, P30DK046200, R01DK068336, U01DK062418, R01DK091718, R01DK073490, R01DK075681, F32DK079466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081800, R01MH059586, R01MH059566, U01MH079470, R01MH059565, R01MH084698, U01MH079469, R01MH060870, R01MH063706, R01MH060879, R01MH067257, R01MH059571, R01MH059160, RL1MH083268, R01MH059588, R01MH061675, R01MH059587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012100, ZIAAG006000, Z01AG007380, R01AG031890, Z01AG000675, ZIAAG007380, ZIAAG000675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014041, R01AA013320, R01AA013326, R01AA007535, R01AA013321, K05AA017688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012854, R01DA012854] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); Affymetrix for genotyping services; Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); ALF/LUA Gothenburg; Althingi (the Icelandic Parliament); Amgen(Amgen); AstraZeneca AB(AstraZeneca); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Biocentrum Helsinki; Boston Obesity Nutrition Research Center; British Diabetes Association(Diabetes UK); British Heart Foundation(British Heart Foundation); British Heart Foundation Centre for Research Excellence, Oxford; CamStrad; Cancer Research UK(Cancer Research UK); Centre for Neurogenomics and Cognitive Research; Chief Scientist Office of the Scottish Government; Council of Health of the Academy of Finland(Academy of Finland); German Network of Diabetes; Diabetes UK(Diabetes UK); Donald W. Reynolds Foundation; Emil and Vera Cornell Foundation; Erasmus MC; Estonian Government; European Commission(European CommissionEuropean Commission Joint Research Centre); Eve Appeal; Finnish Ministry of Education; Finnish Diabetes Research Foundation; Finnish Diabetes Research Society; Finnish Foundation for Cardiovascular Research; Finnish Medical Society; Finska Lakaresallskapet; Folkhalsan Research Foundation; Fondation LeDucq(Leducq Foundation); Foundation for Life and Health in Finland; Foundation for Strategic Research; GEN-AU; Genetic Association Information Network; German Bundesministerium fuer Forschung und Technology; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Ministry for Health, Welfare and Sports; German Ministry of Cultural Affairs; German Ministry of Education, Culture and Science; German National Genome Research Net; German Research Council(German Research Foundation (DFG)); GlaxoSmithKline(GlaxoSmithKline); Goteborg Medical Society; Gyllenberg Foundation; Helmholtz Center Munich(Helmholtz Association); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Karolinska Institute(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lundberg Foundation(European Commission); March of Dimes(March of Dimes); MC Health; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Microarray Core Facility of the Interdisciplinary Centre for Clinical Research; Mid-Atlantic Nutrition and Obesity Research Center of Maryland; Ministry of Health and Department of Educational Assistance (South Tyrol, Italy); Ministry of Science, Education and Sport of the Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); Montreal Heart Institute Foundation; Narpes Health Care Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADA(American Diabetes Association); Netherlands Genomics Initiative/Netherlands Consortium for Healthy Aging; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for the Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Scientific Organization; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Nordic Center of Excellence in Disease Genetics; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Ollqvist Foundation; Paavo Nurmi Foundation; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Queensland Institute of Medical Research; Radboud University Nijmegen Medical Centre; Research Institute for Diseases in the Elderly; Royal Swedish Academy of Science; Sahlgrenska Center for Cardiovascular and Metabolic Research; Siemens Healthcare, Erlangen, Germany(Siemens AG); Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Social Insurance Institution of Finland; Social Ministry of the Federal State of Mecklenburg-West Pomerania; South Tyrolean Sparkasse Foundation; Stockholm County Council(Stockholm County Council); Support for Science Funding programme; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Swedish Cancer Society(Swedish Cancer Society); Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish National Cancer Institute; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Torsten and Ragnar Soderberg's Foundation; Vandervell Foundation; Vastra Gotaland Foundation; Wellcome Trust(Wellcome Trust); Wellcome Trust(Wellcome Trust); Western Australian Genetic Epidemiology Resource; Western Australian DNA Bank; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Several participating studies are members of the CHARGE and ENGAGE consortia. We acknowledge funding from the following organizations: the Academy of Finland (104781, 117797, 120315, 121584, 126925, 129269, 129494, 129680, 213506); Affymetrix for genotyping services (N02-HL-6-4278); Agency for Science, Technology and Research of Singapore; ALF/LUA Gothenburg; Althingi (the Icelandic Parliament); Amgen; AstraZeneca AB; Australian National Health and Medical Research Council (241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688, 552485, 613672); Australian Research Council (DP0770096); Biocentrum Helsinki; Boston Obesity Nutrition Research Center (DK46200); British Diabetes Association; British Heart Foundation (PG/02/128); British Heart Foundation Centre for Research Excellence, Oxford; CamStrad; Cancer Research UK; Centre for Neurogenomics and Cognitive Research; Chief Scientist Office of the Scottish Government (CZB/4/279); Council of Health of the Academy of Finland; DIAB Core project of the German Network of Diabetes; Diabetes UK; Donald W.; Reynolds Foundation; Emil and Vera Cornell Foundation; Erasmus MC; Estonian Government (SF0180142s08); European Commission (201413, ECOGENE:205419, BBMRI:212111, OPENGENE:245536, ENGAGE:HEALTH-F4-2007-201413, EURODIA:LSHG-CT-2004-518153, EU/WLRT-2001-01254, HEALTH-F2-2008-ENGAGE, HEALTH-F4-2007-201550, LSH-2006-037593, LSHG-CT-2006-018947, LSHG-CT-2006-01947, Procardis:LSHM-CT-2007-037273, POLYGENE:LSHC-CT-2005, QLG1-CT-2000-01643, QLG2-CT-2002-01254, DG XII, Marie Curie Intra-European Fellowship); Eve Appeal; Finnish Ministry of Education; Finnish Diabetes Research Foundation; Finnish Diabetes Research Society; Finnish Foundation for Cardiovascular Research; Finnish Medical Society; Finska Lakaresallskapet; Folkhalsan Research Foundation; Fondation LeDucq; Foundation for Life and Health in Finland; Foundation for Strategic Research; GEN-AU-Programme 'GOLD'; Genetic Association Information Network; German Bundesministerium fuer Forschung und Technology (01 AK 803 A-H, 01 IG 07015 G); German Federal Ministry of Education and Research (01GS0831); German Ministry for Health, Welfare and Sports; German Ministry of Cultural Affairs; German Ministry of Education, Culture and Science; German National Genome Research Net (01GS0823, 01ZZ0103, 01ZZ0403, 01ZZ9603, 03ZIK012); German Research Council (KFO-152); GlaxoSmithKline; Goteborg Medical Society; Gyllenberg Foundation; Helmholtz Center Munich; Juvenile Diabetes Research Foundation International (U01 DK062418); Karolinska Institute; Knut and Alice Wallenberg Foundation; Lundberg Foundation; March of Dimes (6-FY-09-507); MC Health; Medical Research Council UK (G0000649, G0000934, G0500539, G0600331, G0601261, G9521010D, PrevMetSyn); Microarray Core Facility of the Interdisciplinary Centre for Clinical Research (B27); Mid-Atlantic Nutrition and Obesity Research Center of Maryland (P30 DK072488); Ministry of Health and Department of Educational Assistance (South Tyrol, Italy); Ministry of Science, Education and Sport of the Republic of Croatia (216-1080315-0302); Montreal Heart Institute Foundation; Narpes Health Care Foundation; National Cancer Institute; National Institute for Health Research Cambridge Biomedical Research Centre; National Institute for Health Research Oxford Biomedical Research Centre; National Institute for Health Research Comprehensive Biomedical Research Centre; National Institutes of Health (263-MA-410953, AA014041, AA07535, AA10248, AA13320, AA13321, AA13326, CA047988, CA49449, CA50385, CA65725, CA67262, CA87969, A12854, DK062370, DK063491, DK072193, DK079466, DK080145, DK58845, HG002651, HG005214, HG005581, HL043851, HL084729, HL69757, HL71981, K08-AR055688, K23-DK080145, K99-HL094535, M01-RR00425, MH084698, N01-AG12100, N01-AG12109, N01-HC15103, N01-HC25195, N01-HC35129, N01-HC45133, N01-HC55015, N01-HC55016, N01-HC55018N01-HC55022, N01-HC55222, N01-HC75150, N01-HC85079-N01-HC85086, N01-HG65403, R01-AG031890, R01 CA104021, R01-DK068336, R01-DK073490, R01-DK075681, R01-DK075787, R01-HL086694, R01-HL087641, R01-HL087647, R01-HL087652, R01-HL087676, R01-HL087679, R01-HL087700, R01-HL088119, R01-HL59367, R01-MH059160, R01-MH59565, R01-MH59566, R01-MH59571, R01-MH59586, R01-MH59587, R01-MH59588, R01-MH60870, R01-MH60879, R01-MH61675, R01-MH63706, R01-MH67257, R01-MH79469, R01-MH81800, RL1-MH083268, T32-HG00040, U01-CA098233, U01-GM074518, U01-HG004399, U01-HG004402, U01-HL080295, U01-HL084756, U01-HL72515, U01-MH79469, U01-MH79470, U54-RR020278, UL1-RR025005, Z01-AG00675, Z01-AG007380, Z01-HG000024; contract HHSN268200625226C; ADA Mentor-Based Postdoctoral Fellowship; Pew S; holarship for the Biomedical Sciences); Netherlands Genomics Initiative/Netherlands Consortium for Healthy Aging (050-060-810); Netherlands Organisation for Scientific Research (investment number 175.010.2005.011, 911-03-012); Netherlands Organization for the Health Research and Development (10-000-1002); Netherlands Scientific Organization (904-61-090, 904-61-193, 480-04-004, 400-05-717, Center for Medical Systems Biology (NOW Genomics), SPI 56-464-1419); NIA Intramural Research Program; Nordic Center of Excellence in Disease Genetics; Novo Nordisk Foundation; Ollqvist Foundation; Paavo Nurmi Foundation; Perklen Foundation; Petrus and Augusta Hedlunds Foundation; Queensland Institute of Medical Research; Radboud University Nijmegen Medical Centre; Research Institute for Diseases in the Elderly (014-93-015); Royal Swedish Academy of Science; Sahlgrenska Center for Cardiovascular and Metabolic Research (A305:188); Siemens Healthcare, Erlangen, Germany; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Social Insurance Institution of Finland; Social Ministry of the Federal State of Mecklenburg-West Pomerania; South Tyrolean Sparkasse Foundation; Stockholm County Council (560183); Support for Science Funding programme; Susan G. Komen Breast Cancer Foundation; Swedish Cancer Society; Swedish Cultural Foundation in Finland; Swedish Foundation for Strategic Research; Swedish Heart-Lung Foundation; Swedish Medical Research Council (K2007-66X-20270-01-3, 8691); Swedish National Cancer Institute; Swedish Research Council; Swedish Society of Medicine; Swiss National Science Foundation (33CSCO-122661); Torsten and Ragnar Soderberg's Foundation; Vandervell Foundation; Vastra Gotaland Foundation; Wellcome Trust (072960, 075491, 079557, 079895, 083270, 068545/Z/02, 076113/B/04/Z, 076113/C/04/Z, 076113/C/04/Z, 077016/Z/05/Z, 081682/Z/06/Z, 084183/Z/07/Z, 085301/Z/08/Z, 086596/Z/ 08/Z, 091746/Z/10/Z; Wellcome Trust Research Career Development Fellowship); Western Australian Genetic Epidemiology Resource and the Western Australian DNA Bank (both National Health and Medical Research Council of Australia Enabling Facilities). A detailed list of acknowledgements by study is given in the Supplementary Information.	Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Estrada K, 2009, HUM MOL GENET, V18, P3516, DOI 10.1093/hmg/ddp296; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galton F, 1885, J R ANTHR I, V5, P329; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Johansson A, 2009, HUM MOL GENET, V18, P373, DOI 10.1093/hmg/ddn350; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Weinstein M, 1998, DEVELOPMENT, V125, P3615; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	28	1393	1422	6	278	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2010	467	7317					832	838		10.1038/nature09410	http://dx.doi.org/10.1038/nature09410			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663PB	20881960	Green Submitted, Green Accepted			2022-12-24	WOS:000282898700065
J	Kelly, AE; Ghenoiu, C; Xue, JZ; Zierhut, C; Kimura, H; Funabiki, H				Kelly, Alexander E.; Ghenoiu, Cristina; Xue, John Z.; Zierhut, Christian; Kimura, Hiroshi; Funabiki, Hironori			Survivin Reads Phosphorylated Histone H3 Threonine 3 to Activate the Mitotic Kinase Aurora B	SCIENCE			English	Article							CHROMOSOMAL PASSENGERS; STRUCTURAL BASIS; SMAC/DIABLO; CHROMATIN; SPINDLE; INCENP; INHIBITION; MECHANISM; BINDING; COMPLEX	A hallmark of mitosis is the appearance of high levels of histone phosphorylation, yet the roles of these modifications remain largely unknown. Here, we demonstrate that histone H3 phosphorylated at threonine 3 is directly recognized by an evolutionarily conserved binding pocket in the BIR domain of Survivin, which is a member of the chromosomal passenger complex (CPC). This binding mediates recruitment of the CPC to chromosomes and the resulting activation of its kinase subunit Aurora B. Consistently, modulation of the kinase activity of Haspin, which phosphorylates H3T3, leads to defects in the Aurora B-dependent processes of spindle assembly and inhibition of nuclear reformation. These findings establish a direct cellular role for mitotic histone H3T3 phosphorylation, which is read and translated by the CPC to ensure accurate cell division.	[Kelly, Alexander E.; Ghenoiu, Cristina; Xue, John Z.; Zierhut, Christian; Funabiki, Hironori] Rockefeller Univ, Lab Chromosome & Cell Biol, New York, NY 10065 USA; [Ghenoiu, Cristina] Cornell Med Sch, Dept Mol Biol, Weill Cornell Grad Sch Biomed Sci, New York, NY 10021 USA; [Kimura, Hiroshi] Osaka Univ, Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Rockefeller University; Cornell University; Osaka University	Kelly, AE (corresponding author), Rockefeller Univ, Lab Chromosome & Cell Biol, New York, NY 10065 USA.	akelly@rockefeller.edu; funabih@rockefeller.edu	Kelly, Alexander/AAZ-8425-2021; Kimura, Hiroshi/B-9524-2015	Kimura, Hiroshi/0000-0003-0854-083X; KELLY, ALEXANDER/0000-0002-3395-6012; Funabiki, Hironori/0000-0003-4831-4087; Zierhut, Christian/0000-0003-3501-603X; Xue, John/0000-0002-7334-0589	Charles H. Revson Biomedical Fellowship; Marie-Josee and Henry Kravis postdoctoral fellowship; Erwin Schrodinger postdoctoral fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan; NIH [GM075249]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075249] Funding Source: NIH RePORTER	Charles H. Revson Biomedical Fellowship; Marie-Josee and Henry Kravis postdoctoral fellowship; Erwin Schrodinger postdoctoral fellowship(Austrian Science Fund (FWF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The GenBank accession number for X. laevis Haspin is HM559585. We thank M. Dasso, J. Higgins, and S. Mochida for reagents; T. Maniar and K. Yap for technical assistance; J. Higgins for sharing results; and the Rockefeller University Bio-Imaging Resource Center. This work was supported by a Charles H. Revson Biomedical Fellowship (A. E. K), Marie-Josee and Henry Kravis and Erwin Schrodinger postdoctoral fellowships (C.Z.), grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (H. K.) and NIH (GM075249, H.F.).	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Cao LH, 2006, BIOCHEM BIOPH RES CO, V346, P400, DOI 10.1016/j.bbrc.2006.05.131; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Markaki Y, 2009, J CELL SCI, V122, P2809, DOI 10.1242/jcs.043810; Polioudaki H, 2004, FEBS LETT, V560, P39, DOI 10.1016/S0014-5793(04)00060-2; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Sun CH, 2005, BIOCHEMISTRY-US, V44, P11, DOI 10.1021/bi0485171; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yue ZJ, 2008, J CELL BIOL, V183, P279, DOI 10.1083/jcb.200806118	20	352	364	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					235	239		10.1126/science.1189505	http://dx.doi.org/10.1126/science.1189505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20705815	Green Accepted			2022-12-24	WOS:000282644600046
J	Kotov, NA				Kotov, Nicholas A.			Inorganic Nanoparticles as Protein Mimics	SCIENCE			English	Editorial Material							SEMICONDUCTOR NANOPARTICLES; QUANTUM DOTS; SIZE; DNA		Univ Michigan, Dept Biomed Engn, Dept Chem Engn, Dept Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Kotov, NA (corresponding author), Univ Michigan, Dept Biomed Engn, Dept Chem Engn, Dept Mat Sci, Ann Arbor, MI 48109 USA.	kotov@umich.edu	Kotov, Nicholas/AAZ-4204-2021; Nanozymes, Nanozymes/D-8197-2019	Kotov, Nicholas/0000-0002-6864-5804; 				AGRANOVSKY AA, 1995, P NATL ACAD SCI USA, V92, P2470, DOI 10.1073/pnas.92.7.2470; Aubin-Tam ME, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034001; Bayraktar H, 2006, CHEM COMMUN, P1390, DOI 10.1039/b516096k; Bharali DJ, 2005, P NATL ACAD SCI USA, V102, P11539, DOI 10.1073/pnas.0504926102; Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h; CHEMSEDDINE A, 1993, BER BUNSEN PHYS CHEM, V97, P636, DOI 10.1002/bbpc.19930970417; Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675; Errington J, 2001, NAT REV MOL CELL BIO, V2, P538, DOI 10.1038/35080005; Ishii D, 2003, NATURE, V423, P628, DOI 10.1038/nature01663; Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m; Klein J, 2007, P NATL ACAD SCI USA, V104, P2029, DOI 10.1073/pnas.0611610104; Li XQ, 2008, CATAL LETT, V124, P413, DOI 10.1007/s10562-008-9494-5; Mahtab R, 2000, J AM CHEM SOC, V122, P14, DOI 10.1021/ja9907156; Manea F, 2004, ANGEW CHEM INT EDIT, V43, P6165, DOI 10.1002/anie.200460649; Mohanan JL, 2005, SCIENCE, V307, P397, DOI 10.1126/science.1106525; Seleverstov O, 2006, NANO LETT, V6, P2826, DOI 10.1021/nl0619711; Sinyagin AY, 2006, J PHYS CHEM B, V110, P7500, DOI 10.1021/jp057105e; Sleytr UB, 1999, ANGEW CHEM INT EDIT, V38, P1035, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1034::AID-ANIE1034>3.0.CO;2-#; Srivastava S, 2010, SCIENCE, V327, P1355, DOI 10.1126/science.1177218; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086	21	265	269	6	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2010	330	6001					188	189		10.1126/science.1190094	http://dx.doi.org/10.1126/science.1190094			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929766				2022-12-24	WOS:000282644600030
J	Moellering, ER; Muthan, B; Benning, C				Moellering, Eric R.; Muthan, Bagyalakshmi; Benning, Christoph			Freezing Tolerance in Plants Requires Lipid Remodeling at the Outer Chloroplast Membrane	SCIENCE			English	Article							COLD RESPONSE PATHWAY; ARABIDOPSIS-THALIANA; GALACTOLIPID GALACTOSYLTRANSFERASE; BETA-GLUCOSIDASE; PLASMA-MEMBRANE; ACCLIMATION; MECHANISMS; BIOSYNTHESIS; ENVELOPES; SYSTEMS	Plants show complex adaptations to freezing that prevent cell damage caused by cellular dehydration. Lipid remodeling of cell membranes during dehydration is one critical mechanism countering loss of membrane integrity and cell death. SENSITIVE TO FREEZING 2 (SFR2), a gene essential for freezing tolerance in Arabidopsis, encodes a galactolipid remodeling enzyme of the outer chloroplast envelope membrane. SFR2 processively transfers galactosyl residues from the abundant monogalactolipid to different galactolipid acceptors, forming oligogalactolipids and diacylglycerol, which is further converted to triacylglycerol. The combined activity of SFR2 and triacylglycerol-biosynthetic enzymes leads to the removal of monogalactolipids from the envelope membrane, changing the ratio of bilayer-to non-bilayer-forming membrane lipids. This SFR2-based mechanism compensates for changes in organelle volume and stabilizes membranes during freezing.	[Moellering, Eric R.; Muthan, Bagyalakshmi; Benning, Christoph] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Moellering, Eric R.] Michigan State Univ, Dept Energy, Plant Res Lab, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Benning, C (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	benning@msu.edu	Benning, Christoph/Y-2528-2019	Benning, Christoph/0000-0001-8585-3667	U.S. Department of Energy [DE-FG02-98ER20305]; Michigan Agricultural Experiment Station	U.S. Department of Energy(United States Department of Energy (DOE)); Michigan Agricultural Experiment Station	We thank S. Marshall and T. Durret for help with proton-NMR and mass spectrometry analyses, respectively, and the laboratory of M. Thomashow for use of equipment and advice on the plant freezing experiments conducted in this work. This work was supported in parts by a grant from the U.S. Department of Energy (DE-FG02-98ER20305) and Michigan Agricultural Experiment Station.	Benning C, 2005, J BIOL CHEM, V280, P2397, DOI 10.1074/jbc.R400032200; BROWSE J, 1989, PLANT PHYSIOL, V90, P522, DOI 10.1104/pp.90.2.522; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Dormann P, 1999, SCIENCE, V284, P2181, DOI 10.1126/science.284.5423.2181; DORNE AJ, 1982, FEBS LETT, V145, P30, DOI 10.1016/0014-5793(82)81200-3; Du ZY, 2010, PLANT PHYSIOL, V152, P1585, DOI 10.1104/pp.109.147066; Fourrier N, 2008, PLANT J, V55, P734, DOI 10.1111/j.1365-313X.2008.03549.x; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; HEEMSKERK JW, 1983, BIOCHIM BIOPHYS ACTA, V754, P181, DOI 10.1016/0005-2760(83)90160-1; HEINZ E, 1996, ADV LIPID METHODOLOG, P211; Hill AD, 2008, BIOPOLYMERS, V89, P1021, DOI 10.1002/bip.21052; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Kelly AA, 2003, PLANT CELL, V15, P2694, DOI 10.1105/tpc.016675; Li W, 2008, J BIOL CHEM, V283, P461, DOI 10.1074/jbc.M706692200; Marques AR, 2003, BIOCHEM J, V370, P793, DOI 10.1042/BJ20021249; McKown R, 1996, J EXP BOT, V47, P1919, DOI 10.1093/jxb/47.12.1919; Perugino G, 2004, TRENDS BIOTECHNOL, V22, P31, DOI 10.1016/j.tibtech.2003.10.008; Siegel DP, 1997, BIOPHYS J, V73, P3089, DOI 10.1016/S0006-3495(97)78336-X; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; STEPONKUS PL, 1984, ANNU REV PLANT PHYS, V35, P543, DOI 10.1146/annurev.pp.35.060184.002551; Steponkus PL, 1998, P NATL ACAD SCI USA, V95, P14570, DOI 10.1073/pnas.95.24.14570; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Thorlby G, 2004, PLANT CELL, V16, P2192, DOI 10.1105/tpc.104.024018; Uemura M, 2003, PLANT PHYSIOL, V131, P1800, DOI 10.1104/pp.102.013227; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; VANBESOUW A, 1978, BIOCHIM BIOPHYS ACTA, V529, P44, DOI 10.1016/0005-2760(78)90102-9; WIESLANDER A, 1986, BIOCHEMISTRY-US, V25, P7511, DOI 10.1021/bi00371a038; Wolfe J, 1999, CRYOBIOLOGY, V39, P103, DOI 10.1006/cryo.1999.2195	28	322	335	10	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					226	228		10.1126/science.1191803	http://dx.doi.org/10.1126/science.1191803			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20798281				2022-12-24	WOS:000282644600043
J	Dierolf, M; Menzel, A; Thibault, P; Schneider, P; Kewish, CM; Wepf, R; Bunk, O; Pfeiffer, F				Dierolf, Martin; Menzel, Andreas; Thibault, Pierre; Schneider, Philipp; Kewish, Cameron M.; Wepf, Roger; Bunk, Oliver; Pfeiffer, Franz			Ptychographic X-ray computed tomography at the nanoscale	NATURE			English	Article							DIFFRACTION MICROSCOPY; PHASE RETRIEVAL	X-ray tomography is an invaluable tool in biomedical imaging. It can deliver the three-dimensional internal structure of entire organisms as well as that of single cells, and even gives access to quantitative information, crucially important both for medical applications and for basic research(1-4). Most frequently such information is based on X-ray attenuation. Phase contrast is sometimes used for improved visibility but remains significantly harder to quantify(5,6). Here we describe an X-ray computed tomography technique that generates quantitative high-contrast three-dimensional electron density maps from phase contrast information without reverting to assumptions of a weak phase object or negligible absorption. This method uses a ptychographic coherent imaging approach to record tomographic data sets, exploiting both the high penetration power of hard X-rays and the high sensitivity of lensless imaging(7-9). As an example, we present images of a bone sample in which structures on the 100 nm length scale such as the osteocyte lacunae and the interconnective canalicular network are clearly resolved. The recovered electron density map provides a contrast high enough to estimate nanoscale bone density variations of less than one per cent. We expect this high-resolution tomography technique to provide invaluable information for both the life and materials sciences.	[Dierolf, Martin; Thibault, Pierre; Pfeiffer, Franz] Tech Univ Munich, Dept Phys E17, D-85748 Garching, Germany; [Menzel, Andreas; Kewish, Cameron M.; Bunk, Oliver] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Schneider, Philipp] ETH, Inst Biomech, CH-8093 Zurich, Switzerland; [Wepf, Roger] EMEZ, CH-8093 Zurich, Switzerland	Technical University of Munich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Thibault, P (corresponding author), Tech Univ Munich, Dept Phys E17, D-85748 Garching, Germany.	pierre.thibault@tum.de	Kewish, Cameron/H-5103-2011; Thibault, Pierre/B-2656-2010; Bunk, Oliver/B-7602-2013; Dierolf, Martin J/B-9816-2008; Schneider, Philipp/AAP-6133-2021; Menzel, Andreas/C-4388-2012	Kewish, Cameron/0000-0001-6242-7059; Thibault, Pierre/0000-0003-1278-8846; Bunk, Oliver/0000-0001-6563-4053; Dierolf, Martin J/0000-0001-5150-2949; Schneider, Philipp/0000-0001-7499-3576; Menzel, Andreas/0000-0002-0489-609X; Wepf, Roger/0000-0003-2203-3674	DFG Cluster of Excellence "Munich-Centre for Advanced Photonics"	DFG Cluster of Excellence "Munich-Centre for Advanced Photonics"(German Research Foundation (DFG))	We acknowledge technical support by X. Donath, FIB preparation of the specimen by P. Gasser and M. Meier and the assistance of W. Gutscher during the experiments. P. T., M. D. and F. P. acknowledge support through the DFG Cluster of Excellence "Munich-Centre for Advanced Photonics''.	Chapman HN, 2006, J OPT SOC AM A, V23, P1179, DOI 10.1364/JOSAA.23.001179; Chu YS, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857476; Cloetens P, 1996, J PHYS D APPL PHYS, V29, P133, DOI 10.1088/0022-3727/29/1/023; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Dierolf M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035017; Faulkner HML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.023903; Ghiglia D.C., 1998, 2 DIMENSIONAL PHASE, V1st; Giewekemeyer K, 2010, P NATL ACAD SCI USA, V107, P529, DOI 10.1073/pnas.0905846107; Guizar-Sicairos M, 2008, OPT EXPRESS, V16, P7264, DOI 10.1364/OE.16.007264; HADDAD WS, 1994, SCIENCE, V266, P1213, DOI 10.1126/science.266.5188.1213; Howells MR, 2009, J ELECTRON SPECTROSC, V170, P4, DOI 10.1016/j.elspec.2008.10.008; Hubbell JH., 1995, TABLES XRAY MASS ATT; Kamioka H, 2009, MICROSC MICROANAL, V15, P377, DOI 10.1017/S1431927609990420; Kraft P, 2009, J SYNCHROTRON RADIAT, V16, P368, DOI 10.1107/S0909049509009911; Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473; MORRISON GR, 1983, OPTIK, V64, P1; Nishino Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.018101; Nugent KA, 1996, PHYS REV LETT, V77, P2961, DOI 10.1103/PhysRevLett.77.2961; Nugent KA, 2010, ADV PHYS, V59, P1, DOI 10.1080/00018730903270926; Parkinson DY, 2008, J STRUCT BIOL, V162, P380, DOI 10.1016/j.jsb.2008.02.003; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Rodenburg JM, 2008, ADV IMAG ELECT PHYS, V150, P87, DOI 10.1016/S1076-5670(07)00003-1; Rodenburg JM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.034801; Schneider P, 2010, BONE, V47, P848, DOI 10.1016/j.bone.2010.07.026; Schropp A, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3332591; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Thibault P, 2009, ULTRAMICROSCOPY, V109, P338, DOI 10.1016/j.ultramic.2008.12.011; Vine DJ, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.063823; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Yin GC, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2211300	30	595	624	10	266	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					436	U82		10.1038/nature09419	http://dx.doi.org/10.1038/nature09419			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20864997				2022-12-24	WOS:000282090200037
J	Moffatt, MF; Gut, IG; Demenais, F; Strachan, DP; Bouzigon, E; Heath, S; von Mutius, E; Farrall, M; Lathrop, M; Cookson, WOCM; Kumar, A; Burney, P; Jarvis, D; Wjst, M; Kogevinas, M; Jogi, R; Janson, C; Franklin, KA; Omenaas, E; Leynaert, B; Pin, I; Heinrich, J; Probst-Hensch, NM; Anto, JM; Sunyer, J; Maldonado, JA; Martinez-Moratalla, J; Urrutia, I; Payo, F; Kauffmann, F; Dizier, MH; Siroux, V; Boznanski, A; Braun-Fahrlander, C; Genuneit, J; Glas, J; Horak, E; Kabesch, M; Pillai, SG; Helms, PJ; Carlsen, K; Carlsen, KH; Gerritsen, J; Silverman, M; Sly, P; Tsanakas, J; Von Berg, A; Whyte, M; Blumenthal, M; Imboden, M; Rochat, T; Thun, GA; Gerbase, MW; Curjuric, I; Gaspoz, JM; Liu, LJS; Wouters, IM; Sigsgaard, T; Heederik, D; Basinas, I; Schlunssen, V; Omland, O; Cullinan, P; Vermeulen, R; Henderson, J; Granell, R; McArdle, WL; Smith, GD; James, AL; Hui, J; Palmer, LJ; Beilby, J; Musk, AW; Laprise, C; Hudson, TJ; Lemire, M; Daley, D; Becker, A; Chan-Yeung, M; Sandford, A; Kozyrskyj, AL; Pare, P; Ferguson, A; Dimich-Ward, H; Watson, WT; Freidin, MB; Bragina, EI; Deev, IA; Deeva, EV; Kobyakova, OS; Puzyrev, VP; Ogorodova, LM; Khusnutdinova, EK; Karunas, AS; Fedorova, YY; Hall, IP; Sayers, I; Tobin, MD; Wan, YI; Heaney, LG; Al-Momani, BAH; Mansur, AH; Manney, S; Thomson, NC; Chaudhuri, R; Brightling, CE; Bafadhel, M; Singapuri, A; Niven, R; Simpson, A; Holloway, JW; Howarth, PH; Polonikov, AV; Ivanov, VP; Solodilova, MA; Melen, E; Pershagen, G; Bergstrom, A; Kull, I; Nyberg, F; Wickman, M; Soderhall, C; Kere, J; Postma, DS; Kerkhof, M; Brunekreef, B; Smit, HA; de Jongste, JC; Wijga, A; Aalberse, RC; Hoekstra, MO; Koppelman, GH; Binia, A; Chung, KF; Bhavsar, P; Chow, F; Macedo, P; Menzies-Gow, A; van Stiphout, N; Bush, A; Lee, YA; Esparza-Gordillo, J; Nickel, R; Wahn, U; Lau, S; Marenholz, I; Haahtela, T; von Hertzen, L; Jousilahti, P; Laatikainen, T; Makela, MJ; Vartiainen, E; Laitinen, T; Balding, DJ; Peden, JF; Corda, E; Lechner, D; Besse, C; Zelenika, D; Boland, A; Bacq, D; Demonchy, S; Blanche, H; Kamatani, Y; von Mutius, E; Farrall, M; Lathrop, M; Cookson, WOCM				Moffatt, Miriam F.; Gut, Ivo G.; Demenais, Florence; Strachan, David P.; Bouzigon, Emmanuelle; Heath, Simon; von Mutius, Erika; Farrall, Martin; Lathrop, Mark; Cookson, William O. C. M.; Kumar, Ashish; Burney, Peter; Jarvis, Debbie; Wjst, Matthias; Kogevinas, Manolis; Jogi, Rain; Janson, Christer; Franklin, Karl A.; Omenaas, Ernst; Leynaert, Benedicte; Pin, Isabelle; Heinrich, Joachim; Probst-Hensch, Nicole M.; Anto, Josep M.; Sunyer, Jordi; Maldonado, Jose-Antonio; Martinez-Moratalla, Jesus; Urrutia, Isabel; Payo, Felix; Kauffmann, Francine; Dizier, Marie-Helene; Siroux, Valerie; Boznanski, Andrzej; Braun-Fahrlaender, Charlotte; Genuneit, Jon; Glas, Juergen; Horak, Elisabeth; Kabesch, Michael; Pillai, Sreekumar G.; Helms, Peter J.; Carlsen, Karin; Carlsen, Kai-Hakon; Gerritsen, Jorrit; Silverman, Michael; Sly, Peter; Tsanakas, John; Von Berg, Andrea; Whyte, Moira; Blumenthal, Malcolm; Imboden, Medea; Rochat, Thierry; Thun, Gian Andri; Gerbase, Margaret W.; Curjuric, Ivan; Gaspoz, Jean-Michel; Liu, Lee-Jane S.; Wouters, Inge M.; Sigsgaard, Torben; Heederik, Dick; Basinas, Ioannis; Schlunssen, Vivi; Omland, Oyvind; Cullinan, Paul; Vermeulen, Roel; Henderson, John; Granell, Raquel; McArdle, Wendy L.; Smith, George Davey; James, Alan L.; Hui, Jennie; Palmer, Lyle J.; Beilby, John; Musk, A. William; Laprise, Catherine; Hudson, Thomas J.; Lemire, Mathieu; Daley, Denise; Becker, Allan; Chan-Yeung, Moira; Sandford, Andrew; Kozyrskyj, Anita L.; Pare, Peter; Ferguson, Alexander; Dimich-Ward, Helen; Watson, Wade T.; Freidin, Maxim B.; Bragina, Elena Iu.; Deev, Ivan A.; Deeva, Eugenia V.; Kobyakova, Olga S.; Puzyrev, Valery P.; Ogorodova, Ludmila M.; Khusnutdinova, Elza K.; Karunas, Alexandra S.; Fedorova, Yuliya Y.; Hall, Ian P.; Sayers, Ian; Tobin, Martin D.; Wan, Yize I.; Heaney, Liam G.; Al-Momani, Basima A. H.; Mansur, Adel H.; Manney, Sarah; Thomson, Neil C.; Chaudhuri, Rekha; Brightling, Christopher E.; Bafadhel, Mona; Singapuri, Amisha; Niven, Robert; Simpson, Angela; Holloway, John W.; Howarth, Peter H.; Polonikov, Alexey V.; Ivanov, Vladimir P.; Solodilova, Maria A.; Melen, Erik; Pershagen, Goeran; Bergstroem, Anna; Kull, Inger; Nyberg, Fredrik; Wickman, Magnus; Soderhall, Cilla; Kere, Juha; Postma, Dirkje S.; Kerkhof, Marjan; Brunekreef, Bert; Smit, Henriette A.; de Jongste, Johan C.; Wijga, Alet; Aalberse, R. C.; Hoekstra, Maarten O.; Koppelman, Gerard H.; Binia, Aristea; Chung, Kian Fan; Bhavsar, Pankaj; Chow, Florence; Macedo, Patricia; Menzies-Gow, Andrew; van Stiphout, Nicole; Bush, Andrew; Lee, Young-Ae; Esparza-Gordillo, Jorge; Nickel, Renate; Wahn, Ulrich; Lau, Susanne; Marenholz, Ingo; Haahtela, Tari; von Hertzen, Leena; Jousilahti, Pekka; Laatikainen, Tiina; Makela, Mika J.; Vartiainen, Erkki; Laitinen, Tarja; Balding, David J.; Peden, John F.; Corda, Eve; Lechner, Doris; Besse, Celine; Zelenika, Diana; Boland, Anne; Bacq, Delphine; Demonchy, Stephanie; Blanche, Helene; Kamatani, Yoichiro; von Mutius, Erika; Farrall, Martin; Lathrop, Mark; Cookson, William O. C. M.		GABRIEL Consortium	A Large-Scale, Consortium-Based Genomewide Association Study of Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUSCEPTIBILITY GENE; POSITIONAL CLONING; IN-VIVO; VARIANTS; DISEASE; EXPRESSION; CYTOKINE; RECEPTOR; ALLERGY; TRAITS	BACKGROUND Susceptibility to asthma is influenced by genes and environment; implicated genes may indicate pathways for therapeutic intervention. Genetic risk factors may be useful in identifying subtypes of asthma and determining whether intermediate phenotypes, such as elevation of the total serum IgE level, are causally linked to disease. METHODS We carried out a genomewide association study by genotyping 10,365 persons with physician-diagnosed asthma and 16,110 unaffected persons, all of whom were matched for ancestry. We used random-effects pooled analysis to test for association in the overall study population and in subgroups of subjects with childhood-onset asthma (defined as asthma developing before 16 years of age), later-onset asthma, severe asthma, and occupational asthma. RESULTS We observed associations of genomewide significance between asthma and the following single-nucleotide polymorphisms: rs3771166 on chromosome 2, implicating IL1RL1/IL18R1 (P = 3x10(-9)); rs9273349 on chromosome 6, implicating HLA-DQ (P = 7x10(-14)); rs1342326 on chromosome 9, flanking IL33 (P = 9x10(-10)); rs744910 on chromosome 15 in SMAD3 (P = 4x10(-9)); and rs2284033 on chromosome 22 in IL2RB (P = 1.1x10(-8)). Association with the ORMDL3/GSDMB locus on chromosome 17q21 was specific to childhood-onset disease (rs2305480, P = 6x10(-23)). Only HLA-DR showed a significant genomewide association with the total serum IgE concentration, and loci strongly associated with IgE levels were not associated with asthma. CONCLUSIONS Asthma is genetically heterogeneous. A few common alleles are associated with disease risk at all ages. Implicated genes suggest a role for communication of epithelial damage to the adaptive immune system and activation of airway inflammation. Variants at the ORMDL3/GSDMB locus are associated only with childhood-onset disease. Elevation of total serum IgE levels has a minor role in the development of asthma.	[Moffatt, Miriam F.; Cookson, William O. C. M.; Burney, Peter; Jarvis, Debbie; Cullinan, Paul; Binia, Aristea; Chung, Kian Fan; Bhavsar, Pankaj; Macedo, Patricia; Menzies-Gow, Andrew; Bush, Andrew; Cookson, William O. C. M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Farrall, Martin; Peden, John F.; Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [von Mutius, Erika; von Mutius, Erika] Univ Munich, Asthma & Allergy Dept, Univ Childrens Hosp, Munich, Germany; [Demenais, Florence; Bouzigon, Emmanuelle; Dizier, Marie-Helene] Univ Paris 07, Inst Univ Hematol, Paris, France; [Demenais, Florence; Bouzigon, Emmanuelle; Lathrop, Mark; Dizier, Marie-Helene; Corda, Eve; Blanche, Helene; Kamatani, Yoichiro; Lathrop, Mark] Fdn Jean Dausset CEPH, Paris, France; [Demenais, Florence; Bouzigon, Emmanuelle; Dizier, Marie-Helene; Corda, Eve] Fdn Jean Dausset, CEPH, INSERM, U946, Paris, France; [Gut, Ivo G.; Heath, Simon; Lathrop, Mark; Lechner, Doris; Besse, Celine; Zelenika, Diana; Boland, Anne; Bacq, Delphine; Demonchy, Stephanie; Lathrop, Mark] Commissariat Energie Atom, Inst Genom, Ctr Natl Genotypage, Evry, France; [Cookson, William O. C. M.; van Stiphout, Nicole; Bush, Andrew] Royal Brompton & Harefield NHS Fdn Trust, London, England; [Strachan, David P.] Univ London, Div Community Hlth Sci, London, England; [Burney, Peter; Jarvis, Debbie] Imperial Coll, NHLI, Respiratory Epidemiol & Publ Hlth, London, England; [Wjst, Matthias] Helmholtz Zentrum, Inst Lung Biol & Dis, Munich, Germany; [Wjst, Matthias] German Res Ctr Environm Hlth GmbH, Neuherberg, Germany; [Kogevinas, Manolis; Anto, Josep M.; Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Kogevinas, Manolis; Anto, Josep M.; Sunyer, Jordi] Municipal Inst Med Res IMIM Hosp Mar, Barcelona, Spain; [Kogevinas, Manolis; Anto, Josep M.; Sunyer, Jordi] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Kogevinas, Manolis] Natl Sch Publ Hlth, Athens, Greece; [Jogi, Rain] Tartu Univ Hosp, Lung Clin, Tartu, Estonia; [Janson, Christer] Uppsala Univ, Resp Med & Allergol, Uppsala, Sweden; [Franklin, Karl A.] Umea Univ, Dept Surg, S-90187 Umea, Sweden; [Omenaas, Ernst] Univ Bergen, Inst Med, N-5020 Bergen, Norway; [Omenaas, Ernst] Haukeland Hosp, Ctr Clin Res, Bergen, Norway; [Leynaert, Benedicte] Inserm, Unite 700, Paris, France; [Leynaert, Benedicte] Univ Paris Diderot, Paris, France; [Pin, Isabelle] Ctr Hosp Univ, Grenoble, France; [Pin, Isabelle; Siroux, Valerie] Inserm, Unite 823, Grenoble, France; [Pin, Isabelle; Siroux, Valerie] Univ Joseph Fourier, F-38041 Grenoble, France; [Heinrich, Joachim] Helmholtz Zentrum Munich, Inst Epidemiol, Munich, Germany; [Probst-Hensch, Nicole M.; Braun-Fahrlaender, Charlotte; Imboden, Medea; Thun, Gian Andri; Curjuric, Ivan; Liu, Lee-Jane S.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Probst-Hensch, Nicole M.; Braun-Fahrlaender, Charlotte; Imboden, Medea; Thun, Gian Andri; Curjuric, Ivan; Liu, Lee-Jane S.] Univ Basel, CH-4003 Basel, Switzerland; [Probst-Hensch, Nicole M.; Imboden, Medea; Thun, Gian Andri; Curjuric, Ivan] Univ Zurich, UPF, Dept Ciencies Expt Salut, CH-8006 Zurich, Switzerland; [Maldonado, Jose-Antonio] Hosp Juan Ramon Jimenez, Serv Neumol, Huelva, Spain; [Maldonado, Jose-Antonio; Martinez-Moratalla, Jesus] Hosp Gen Univ Albacete, Serv Neumol, Albacete, Spain; [Urrutia, Isabel] Galdakao Hosp, Pneumol Serv, Galdakao, Bizkaia, Spain; [Payo, Felix] Hosp Gen Asturias, Serv Neumol, Oviedo, Asturias, Spain; [Kauffmann, Francine] Inserm, Unite 780, Villejuif, France; [Kauffmann, Francine] Univ Paris Sud, IFR69, Villejuif, France; [Boznanski, Andrzej] Wroclaw Med Univ, Dep Paediat Allergol & Cardiol 1, Wroclaw, Poland; [Genuneit, Jon] Ulm Univ, Inst Epidemiol, Ulm, Germany; [Glas, Juergen] Univ Munich, Dept Prevent Dentistry & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; [Horak, Elisabeth] Innsbruck Med Univ, Dept Pediat Pediat Pulmonol, Innsbruck, Austria; [Kabesch, Michael] Hannover Med Sch, Clin Paediat Pneumol & Neonatol, Ctr Paediat Adolescent Med, Hannover, Germany; [Pillai, Sreekumar G.] GlaxoSmithKline R&D, Genet, Res Triangle Pk, NC USA; [Helms, Peter J.] Univ Aberdeen, Royal Aberdeen Childrens Hosp, Aberdeen, Scotland; [Carlsen, Karin; Carlsen, Kai-Hakon] Oslo Univ Hosp, Dept Paediat, N-0316 Oslo, Norway; [Carlsen, Karin; Carlsen, Kai-Hakon] Univ Oslo, Fac Med, Oslo, Norway; [Gerritsen, Jorrit] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Groningen, Netherlands; [Silverman, Michael] Univ Leicester, Div Child Hlth, Leicester, Leics, England; [Sly, Peter] Univ Western Australia, Ctr Child Hlth Res, Perth, WA, Australia; [Tsanakas, John] Aristotle Univ Thessaloniki, Pediat Pulmonol, Thessaloniki, Greece; [Whyte, Moira] Univ Sheffield, Acad Unit Resp Med, Sheffield S10 2TN, S Yorkshire, England; [Blumenthal, Malcolm] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Rochat, Thierry; Gerbase, Margaret W.] Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; [Gaspoz, Jean-Michel] Univ Hosp Geneva, Div Commun Med & Primary Care, Geneva, Switzerland; [Wouters, Inge M.; Heederik, Dick; Basinas, Ioannis; Vermeulen, Roel; Brunekreef, Bert] Univ Utrecht, IRAS, NL-3508 TC Utrecht, Netherlands; [Sigsgaard, Torben; Basinas, Ioannis; Schlunssen, Vivi; Omland, Oyvind] Univ Aarhus, Sch Publ Hlth, Dept Environm & Occupat Med, DK-8000 Aarhus, Denmark; [Omland, Oyvind] Aarhus Univ Hosp, Aalborg Hosp, Dept Occupat Hlth, DK-9000 Aalborg, Denmark; [Henderson, John] Univ Bristol, Dept Community Based Med, Bristol BS8 1TH, Avon, England; [Granell, Raquel; McArdle, Wendy L.; Smith, George Davey] Univ Bristol, Dept Med, Bristol BS8 1TH, Avon, England; [Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol CAiTE, Bristol BS8 1TH, Avon, England; [James, Alan L.] Sir Charles Gairdner Hosp, West Australian Sleep Disorders Res Inst, Dept Pulm Physiol, Nedlands, WA, Australia; [James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Hui, Jennie] PathWest Lab Med, Mol Genet, Nedlands, WA, Australia; [Palmer, Lyle J.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Nedlands, WA 6009, Australia; [Beilby, John] PathWest Lab Med, Biochem, Nedlands, WA, Australia; [Musk, A. William] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA, Australia; [Musk, A. William] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [Laprise, Catherine] Univ Montreal, Chicoutimi Univ Hosp, Commun Genom Med Ctr, Chicoutimi, PQ, Canada; [Laprise, Catherine] Univ Quebec Chicoutimi, Chicoutimi, PQ, Canada; [Hudson, Thomas J.; Lemire, Mathieu] Ontario Inst Canc Res, Toronto, ON, Canada; [Daley, Denise; Sandford, Andrew; Pare, Peter] Univ British Columbia, James Hogg iCAPTURE Ctr, Vancouver, BC V5Z 1M9, Canada; [Becker, Allan; Kozyrskyj, Anita L.; Watson, Wade T.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Chan-Yeung, Moira; Dimich-Ward, Helen] Univ British Columbia, Occupat & Environm Lung Dis Unit, Vancouver, BC V5Z 1M9, Canada; [Kozyrskyj, Anita L.] Univ Alberta, Univ Alberta & Sch Publ Hlth, Fac Med & Dent, Dept Pediat, Edmonton, AB T6G 2M7, Canada; [Kozyrskyj, Anita L.] Univ Manitoba, Fac Med, Dept Commun Hlth Sci, Winnipeg, MB R3T 2N2, Canada; [Ferguson, Alexander] Univ British Columbia, Dept Pediat, Div Allergy, Vancouver, BC V5Z 1M9, Canada; [Freidin, Maxim B.; Bragina, Elena Iu.; Puzyrev, Valery P.] Russian Acad Med Sci, Res Inst Med Genet Siberian Branch, Populat Genet Lab, Tomsk 634050, Russia; [Deev, Ivan A.; Deeva, Eugenia V.; Ogorodova, Ludmila M.] Siberian State Med Univ, Dept Fac Paediat, Tomsk 634050, Russia; [Kobyakova, Olga S.] Siberian State Med Univ, Gen Doctor Practice Dept, Tomsk 634050, Russia; [Khusnutdinova, Elza K.; Karunas, Alexandra S.; Fedorova, Yuliya Y.] Russian Acad Sci, UFA Sci Ctr, Inst Biochem & Genet, Ufa 450054, Russia; [Hall, Ian P.; Sayers, Ian; Wan, Yize I.] Queens Med Ctr, Nottingham Resp Biomed Res Unit, Div Therapeut & Mol Med, Nottingham, England; [Tobin, Martin D.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Heaney, Liam G.] Queens Univ Belfast, Ctr Infect & Immun, Belfast BT7 1NN, Antrim, North Ireland; [Al-Momani, Basima A. H.] Queens Univ Belfast, Sch Pharm, Belfast BT7 1NN, Antrim, North Ireland; [Mansur, Adel H.; Manney, Sarah] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Mansur, Adel H.; Manney, Sarah] Birmingham Heartlands Hosp, Resp Med, Birmingham B15 2TT, W Midlands, England; [Thomson, Neil C.; Chaudhuri, Rekha] Univ Glasgow, Div Immunol Infect & Inflammat, Resp Med Sect, Glasgow G12 8QQ, Lanark, Scotland; [Brightling, Christopher E.; Bafadhel, Mona; Singapuri, Amisha] Univ Leicester, Glenfield Hosp, Inst Lung Hlth, Leicester LE1 7RH, Leics, England; [Niven, Robert; Simpson, Angela] Univ Manchester, Manchester Acad Hlth Sci Ctr, NIHR Translat Res Fac Resp Med, Manchester, Lancs, England; [Holloway, John W.; Howarth, Peter H.] Univ Southampton, Sch Med, Div Human Genet, Southampton SO9 5NH, Hants, England; [Holloway, John W.; Howarth, Peter H.] Univ Southampton, Sch Med, Div Infect, Southampton SO9 5NH, Hants, England; [Howarth, Peter H.] Univ Southampton, Sch Med, Southampton NIHR Resp Biomed Res Unit, Southampton SO9 5NH, Hants, England; [Polonikov, Alexey V.; Ivanov, Vladimir P.; Solodilova, Maria A.] Kursk State Med Univ, Dept Biol Med Genet & Ecol, Kursk 305041, Russia; [Melen, Erik; Pershagen, Goeran; Bergstroem, Anna; Kull, Inger; Nyberg, Fredrik; Wickman, Magnus] Karolinska Inst, Inst Environ Med, Stockholm, Sweden; [Melen, Erik] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Nyberg, Fredrik] AstraZeneca R&D, Molndal, Sweden; [Wickman, Magnus] Sachs Childrens Hosp, Stockholm, Sweden; [Soderhall, Cilla; Kere, Juha] Karolinska Inst, Dept Biosci & Nutrit, S-10401 Stockholm, Sweden; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonology, NL-9700 AB Groningen, Netherlands; [Kerkhof, Marjan] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiology, NL-9700 AB Groningen, Netherlands; [Brunekreef, Bert; Smit, Henriette A.] Uni Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Jongste, Johan C.] Sophia Childrens Univ Hosp, Erasmus Univ Med Ctr, Dept Pediat, Rotterdam, Netherlands; [Wijga, Alet] Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, Bilthoven, Netherlands; [Aalberse, R. C.] Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands; [Hoekstra, Maarten O.] Radboud Univ Nijmegen Med Ctr, Dept Gen Paediat, Nijmegen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, NL-9700 AB Groningen, Netherlands; Royal Brompton & Harefield NHS Fdn Trust, Dept Paediat Resp Med, London, England; [Lee, Young-Ae; Esparza-Gordillo, Jorge; Nickel, Renate; Wahn, Ulrich; Lau, Susanne; Marenholz, Ingo] Charite Univ Med Berlin, Pediat Pneumol & Immunol, Berlin, Germany; [Lee, Young-Ae; Esparza-Gordillo, Jorge; Marenholz, Ingo] Max Delbruck Centrum MDC Mol Med, Berlin, Germany; [Haahtela, Tari; von Hertzen, Leena; Makela, Mika J.] Helsinki Univ Cent Hosp, Skin & Allergy Hosp, Helsinki, Finland; [Jousilahti, Pekka; Laatikainen, Tiina; Vartiainen, Erkki] Natl Inst Hlth & Welfare, Helsinki, Finland; [Laitinen, Tarja] Helsinki Univ Cent Hosp, Dept Pulm Med, Helsinki, Finland; [Balding, David J.] Imperial Coll, Dept Epidemiol & Publ Hlth, London, England; Univ Munich, Univ Childrens Hosp, Asthma & Allergy Dept, D-80337 Munich, Germany	Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; UDICE-French Research Universities; Universite Paris Cite; Foundation Jean Dausset-CEPH; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Royal Brompton & Harefield NHS Foundation Trust; University of London; Imperial College London; Helmholtz Association; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; National & Kapodistrian University of Athens; Uppsala University; Umea University; University of Bergen; University of Bergen; Haukeland University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Zurich; Hospital Juan Ramon Jimenez; Galdakao Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Wroclaw Medical University; Ulm University; University of Munich; RWTH Aachen University; Medical University of Innsbruck; Hannover Medical School; GlaxoSmithKline; University of Aberdeen; University of Oslo; University of Oslo; University of Groningen; University of Leicester; University of Western Australia; Aristotle University of Thessaloniki; University of Sheffield; University of Minnesota System; University of Minnesota Twin Cities; University of Geneva; University of Geneva; Utrecht University; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; University of Bristol; University of Bristol; University of Bristol; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Universite de Montreal; University of Quebec; University of Quebec Chicoutimi; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of British Columbia; University of Manitoba; University of British Columbia; University of Alberta; University of Manitoba; University of British Columbia; Russian Academy of Medical Sciences; Russian Academy of Sciences; Tomsk National Research Medical Center; Research Institute of Medical Genetics - Tomsk; Siberian State Medical University; Siberian State Medical University; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; University of Nottingham; University of Leicester; Queens University Belfast; Queens University Belfast; University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham; University of Glasgow; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Manchester; University of Southampton; University of Southampton; University of Southampton; Kursk State Medical University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; AstraZeneca; Karolinska Institutet; University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; University of Groningen; Royal Brompton & Harefield NHS Foundation Trust; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Imperial College London; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich	Cookson, WOCM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Royal Brompton Campus,Guy Scadding Bldg,Dovehouse, London SW3 6LY, England.	w.cookson@imperial.ac.uk	Kere, Juha/AAX-9117-2021; Heinrich, Joachim/N-1720-2013; Davey Smith, George/A-7407-2013; Cookson, William/HHC-1790-2022; Pare, Peter D/C-7425-2011; Vermeulen, Roel/F-8037-2011; Fedorova, Yuliya/P-8808-2017; Sigsgaard, Torben/AAC-1292-2020; Dizier, Marie-Hélène/K-8463-2018; Granell, Raquel/AAB-5256-2022; Puzyrev, Valery P/A-7925-2014; Sunyer, Jordi/G-6909-2014; Kogevinas, Manolis/C-3918-2017; Bragina, Elena/AAF-7983-2019; Balding, David/G-9898-2011; PIN, Isabelle/N-3020-2013; Heath, Simon C/J-4138-2012; Bafadhel, Mona/ABB-1170-2021; Kabesch, Michael/AAB-5701-2020; Palmer, Lyle John/N-1948-2019; Genuneit, Jon/I-9323-2012; Sly, Peter D/F-1486-2010; Karunas, Alexandra S/E-6421-2014; Söderhäll, Cilla/E-3940-2012; Granell, Raquel/AAY-4846-2020; Anto, J M/H-2676-2014; Kere, Juha/A-9179-2008; Demenais, Florence/G-3298-2013; Chung, Kian Fan/B-1872-2012; Puzyrev, Valery P/S-3144-2016; Gut, Ivo/ABF-3188-2020; Freydin, Maxim/A-5603-2011; Koppelman, Gerard/AAG-9187-2020; Kobyakova, Olga/M-5287-2014; Solodilova, Maria/GSJ-2104-2022; Holloway, John W/B-5424-2009; Khusnutdinova, Elza Kamilevna/A-4810-2013; Laatikainen, Tiina/ABD-6622-2021; Leynaert, Benedicte/N-5251-2018; Kabesch, Michael/GZM-1583-2022; Bouzigon, Emmanuelle/L-2766-2017; Palmer, Lyle John/K-3196-2014; Hui, Jennie/A-9543-2013; Freidin, Maxim B/A-8222-2014; Polonikov, Alexey/R-7537-2016; Bragina, Elena/A-8049-2014	Kere, Juha/0000-0003-1974-0271; Heinrich, Joachim/0000-0002-9620-1629; Davey Smith, George/0000-0002-1407-8314; Vermeulen, Roel/0000-0003-4082-8163; Sigsgaard, Torben/0000-0002-2043-7571; Dizier, Marie-Hélène/0000-0001-8460-7667; Granell, Raquel/0000-0002-4890-4012; Sunyer, Jordi/0000-0002-2602-4110; Kogevinas, Manolis/0000-0002-9605-0461; Balding, David/0000-0002-1480-6115; Heath, Simon C/0000-0002-9550-0897; Palmer, Lyle John/0000-0002-1628-3055; Genuneit, Jon/0000-0001-5764-1528; Sly, Peter D/0000-0001-6305-2201; Karunas, Alexandra S/0000-0002-2570-0789; Söderhäll, Cilla/0000-0002-8397-3080; Anto, J M/0000-0002-4736-8529; Kere, Juha/0000-0003-1974-0271; Demenais, Florence/0000-0001-8361-0936; Chung, Kian Fan/0000-0001-7101-1426; Puzyrev, Valery P/0000-0002-2113-4556; Gut, Ivo/0000-0001-7219-632X; Freydin, Maxim/0000-0002-1439-6259; Kobyakova, Olga/0000-0003-0098-1403; Solodilova, Maria/0000-0003-4607-4913; Holloway, John W/0000-0001-9998-0464; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Laatikainen, Tiina/0000-0002-6614-4782; Bouzigon, Emmanuelle/0000-0001-5756-4286; Palmer, Lyle John/0000-0002-1628-3055; Hui, Jennie/0000-0002-1653-2496; Freidin, Maxim B/0000-0002-1439-6259; Polonikov, Alexey/0000-0001-6280-247X; Bragina, Elena/0000-0002-1103-3073; Leynaert, Benedicte/0000-0001-5045-2492; Jarvis, Deborah/0000-0002-1753-3896; Beilby, John/0000-0002-4915-2254; Sayers, Ian/0000-0001-5601-5410; Kumar, Ashish/0000-0002-7075-5930; Wouters, Inge M./0000-0001-7834-9390; Bafadhel, Mona/0000-0002-9993-2478; Kull, Inger/0000-0001-6096-3771; Heederik, Dick/0000-0002-4550-1437; Simpson, Angela/0000-0003-2733-6666; Niven, Robert/0000-0003-2249-960X; von Mutius, Erika/0000-0002-8893-4515; Koppelman, Gerard/0000-0001-8567-3252; Binia, Aristea/0000-0002-8327-049X; Nyberg, Fredrik/0000-0003-0892-5668; Fedorova, Yuliya/0000-0002-9344-828X; Makela, Mika/0000-0002-2933-3111; Burney, Peter/0000-0001-8635-5678; Basinas, Ioannis/0000-0001-7708-3017; Schlunssen, Vivi/0000-0003-4915-1734; Franklin, Karl/0000-0002-5306-1697; Pershagen, Goran/0000-0002-9701-1130	European Commission [018996]; French Ministry of Research; Wellcome Trust [WT084703MA]; Asthma UK; Medical Research Council [G0801056B, G0501942, G0401540, G0902125, G9815508, MC_qA137934, G0000934, G0800649] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; MRC [G0000934, G0902125, G0401540, G0800649, MC_qA137934, G0501942] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Asthma UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by a contract from the European Commission (018996) and grants from the French Ministry of Research, the Wellcome Trust (WT084703MA), and Asthma UK.	Allen M, 2003, NAT GENET, V35, P258, DOI 10.1038/ng1256; Anthoni M, 2007, INT J BIOL SCI, V3, P477; Balaci L, 2007, AM J HUM GENET, V80, P1103, DOI 10.1086/518259; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Fukao T, 2000, J IMMUNOL, V164, P64, DOI 10.4049/jimmunol.164.1.64; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Konstantinidis AK, 2007, EUR RESPIR J, V30, P40, DOI 10.1183/09031936.00025706; Koppelman GH, 2009, AM J RESP CRIT CARE, V180, P929, DOI 10.1164/rccm.200810-1621OC; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Letourneau S, 2009, J ALLERGY CLIN IMMUN, V123, P758, DOI 10.1016/j.jaci.2009.02.011; MARSH DG, 1981, NEW ENGL J MED, V305, P1551, DOI 10.1056/NEJM198112243052603; MARSH DG, 1992, P 11 INT HIST WORKSH, P765; Moffatt MF, 1997, HUM MOL GENET, V6, P551, DOI 10.1093/hmg/6.4.551; Moffatt MF, 2001, EUR J HUM GENET, V9, P341, DOI 10.1038/sj.ejhg.5200636; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; *NAT ASTHM CAMP, 1998, ASTHM AG; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Nouri-Aria Kayhan T., 2008, Inflammation & Allergy Drug Targets, V7, P237, DOI 10.2174/187152808786848405; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Smith DH, 1997, AM J RESP CRIT CARE, V156, P787, DOI 10.1164/ajrccm.156.3.9611072; Taylor JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007651; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Vercelli D, 2008, J ALLERGY CLIN IMMUN, V122, P267, DOI 10.1016/j.jaci.2008.06.008; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Walley AJ, 2001, NAT GENET, V29, P175, DOI 10.1038/ng728; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Weinmayr G, 2007, AM J RESP CRIT CARE, V176, P565, DOI 10.1164/rccm.200607-994OC; White JH, 2008, HUM MOL GENET, V17, P1890, DOI 10.1093/hmg/ddn087; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166	47	1401	1443	1	204	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2010	363	13					1211	1221		10.1056/NEJMoa0906312	http://dx.doi.org/10.1056/NEJMoa0906312			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652ZA	20860503	Green Published, Green Accepted			2022-12-24	WOS:000282050000005
J	Rodondi, N; den Elzen, WPJ; Bauer, DC; Cappola, AR; Razvi, S; Walsh, JP; Asvold, BO; Iervasi, G; Imaizumi, M; Collet, TH; Bremner, A; Maisonneuve, P; Sgarbi, JA; Khaw, KT; Vanderpump, MPJ; Newman, AB; Cornuz, J; Franklyn, JA; Westendorp, RGJ; Vittinghoff, E; Gussekloo, J				Rodondi, Nicolas; den Elzen, Wendy P. J.; Bauer, Douglas C.; Cappola, Anne R.; Razvi, Salman; Walsh, John P.; Asvold, Bjorn O.; Iervasi, Giorgio; Imaizumi, Misa; Collet, Tinh-Hai; Bremner, Alexandra; Maisonneuve, Patrick; Sgarbi, Jose A.; Khaw, Kay-Tee; Vanderpump, Mark P. J.; Newman, Anne B.; Cornuz, Jacques; Franklyn, Jayne A.; Westendorp, Rudi G. J.; Vittinghoff, Eric; Gussekloo, Jacobijn		Thyroid Studies Collaboration	Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INDIVIDUAL PATIENT DATA; 20-YEAR FOLLOW-UP; THYROID-DYSFUNCTION; CARDIOVASCULAR RISK; ALL-CAUSE; METAANALYSIS; ASSOCIATION; THYROXINE; FAILURE; EVENTS	Context Data regarding the association between subclinical hypothyroidism and cardiovascular disease outcomes are conflicting among large prospective cohort studies. This might reflect differences in participants' age, sex, thyroid-stimulating hormone (TSH) levels, or preexisting cardiovascular disease. Objective To assess the risks of coronary heart disease (CHD) and total mortality for adults with subclinical hypothyroidism. Data Sources and Study Selection The databases of MEDLINE and EMBASE (1950 to May 31, 2010) were searched without language restrictions for prospective cohort studies with baseline thyroid function and subsequent CHD events, CHD mortality, and total mortality. The reference lists of retrieved articles also were searched. Data Extraction Individual data on 55 287 participants with 542 494 person-years of follow-up between 1972 and 2007 were supplied from 11 prospective cohorts in the United States, Europe, Australia, Brazil, and Japan. The risk of CHD events was examined in 25 977 participants from 7 cohorts with available data. Euthyroidism was defined as a TSH level of 0.50 to 4.49 mIU/L. Subclinical hypothyroidism was defined as a TSH level of 4.5 to 19.9 mIU/L with normal thyroxine concentrations. Results Among 55 287 adults, 3450 had subclinical hypothyroidism (6.2%) and 51 837 had euthyroidism. During follow-up, 9664 participants died (2168 of CHD), and 4470 participants had CHD events (among 7 studies). The risk of CHD events and CHD mortality increased with higher TSH concentrations. In age-and sex-adjusted analyses, the hazard ratio (HR) for CHD events was 1.00 (95% confidence interval [CI], 0.86-1.18) for a TSH level of 4.5 to 6.9 mIU/L (20.3 vs 20.3/1000 person-years for participants with euthyroidism), 1.17 (95% CI, 0.96-1.43) for a TSH level of 7.0 to 9.9 mIU/L (23.8/1000 person-years), and 1.89 (95% CI, 1.28-2.80) for a TSH level of 10 to 19.9 mIU/L (n=70 events/235; 38.4/1000 person-years; P<.001 for trend). The corresponding HRs for CHD mortality were 1.09 (95% CI, 0.91-1.30; 5.3 vs 4.9/1000 person-years for participants with euthyroidism), 1.42 (95% CI, 1.03-1.95; 6.9/1000 person-years), and 1.58 (95% CI, 1.10-2.27, n=28 deaths/333; 7.7/1000 person-years; P=.005 for trend). Total mortality was not increased among participants with subclinical hypothyroidism. Results were similar after further adjustment for traditional cardiovascular risk factors. Risks did not significantly differ by age, sex, or preexisting cardiovascular disease. Conclusions Subclinical hypothyroidism is associated with an increased risk of CHD events and CHD mortality in those with higher TSH levels, particularly in those with a TSH concentration of 10 mIU/L or greater. JAMA. 2010; 304(12): 1365-1374	[Rodondi, Nicolas; Collet, Tinh-Hai; Cornuz, Jacques] Univ Lausanne, Dept Ambulatory Care & Community Med, CH-1011 Lausanne, Switzerland; [den Elzen, Wendy P. J.; Gussekloo, Jacobijn] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Westendorp, Rudi G. J.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Bauer, Douglas C.; Vittinghoff, Eric] Univ Calif San Francisco, Dept Med Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bauer, Douglas C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Cappola, Anne R.] Univ Penn, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Philadelphia, PA 19104 USA; [Razvi, Salman] Gateshead Hlth Fdn NHS Trust, Dept Endocrinol, Gateshead, England; [Walsh, John P.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Nedlands, WA, Australia; [Walsh, John P.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA, Australia; [Bremner, Alexandra] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; [Asvold, Bjorn O.] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Iervasi, Giorgio] CNR, Inst Clin Physiol, I-56100 Pisa, Italy; [Imaizumi, Misa] Radiat Effects Res Fdn, Dept Clin Studies, Nagasaki, Japan; [Maisonneuve, Patrick] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [Sgarbi, Jose A.] Univ Fed Sao Paulo, Dept Med, Div Endocrinol, Sao Paulo, Brazil; [Sgarbi, Jose A.] Fac Med Marilia, Div Endocrinol, Marilia, Brazil; [Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Vanderpump, Mark P. J.] Royal Free Hosp, Dept Endocrinol, London NW3 2QG, England; [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Franklyn, Jayne A.] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Westendorp, Rudi G. J.] Netherlands Consortium Healthy Ageing, Leiden, Netherlands	University of Lausanne; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Pennsylvania; University of Western Australia; University of Western Australia; University of Western Australia; Norwegian University of Science & Technology (NTNU); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Radiation Effects Research Foundation - Japan; IRCCS European Institute of Oncology (IEO); Universidade Federal de Sao Paulo (UNIFESP); Faculdade de Medicina de Marilia; University of Cambridge; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Birmingham	Rodondi, N (corresponding author), Univ Lausanne, Dept Ambulatory Care & Community Med, Bugnon 44, CH-1011 Lausanne, Switzerland.	Nicolas.Rodondi@hospvd.ch	Maisonneuve, Patrick/U-9789-2018; Newman, Anne B./C-6408-2013; Khaw, Kay-Tee/AAZ-3209-2021; Razvi, Salman/H-6118-2019; Gussekloo, Jacobijn/ABE-3879-2021; Collet, Tinh-Hai/I-4462-2019	Maisonneuve, Patrick/0000-0002-5309-4704; Newman, Anne B./0000-0002-0106-1150; Razvi, Salman/0000-0002-9047-1556; Gussekloo, Jacobijn/0000-0001-7186-8278; Collet, Tinh-Hai/0000-0002-3243-1222; den Elzen, Wendy/0000-0002-6774-4077; Bremner, Alexandra/0000-0002-4068-4860; Rodondi, Nicolas/0000-0001-9083-6896; Walsh, John/0000-0002-1766-2612; Sgarbi, Jose/0000-0001-7187-984X	National Heart, Lung, and Blood Institute [N01-HC-80007, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295, R01 HL-075366]; National Institute of Neurological Disorders and Stroke; National Institute on Aging [R01 AG-15928, R01 AG-20098, AG027058, AG-032317, N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106, AG-023629]; University of Pittsburgh Claude. D. Pepper Older Americans Independence Center [P30-AG-024827]; American Heart Association; Dutch Ministry of Health, Welfare, and Sports; UK Department of Health; Wallac Oy (Turku, Finland); Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan; Japanese Ministry of Health, Labor and Welfare; US Department of Energy; National Academy of Sciences; Radiation Effects Research Foundation [A-10-08]; UK Medical Research Council; UK Cancer Research; Sao Paulo State Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [6/59737-9]; Netherlands Organization for Scientific Research [NGI/NWO911-03-016]; Medical Research Council [G0401527] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055222, N01HC015103, N01HC045133, N01HC085082, N01HC085081, N01HC085083, N01HC035129, N01HC075150, N01HC085086, N01HC085084, N01HC085079, N01HC085080, N01HC085085] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL075366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827, R01AG020098, R01AG015928, R01AG027058, R56AG023629, N01AG062101, R01AG023629, R01AG032317, N01AG062103, N01AG062106] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Pittsburgh Claude. D. Pepper Older Americans Independence Center; American Heart Association(American Heart Association); Dutch Ministry of Health, Welfare, and Sports; UK Department of Health; Wallac Oy (Turku, Finland); Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan; Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); US Department of Energy(United States Department of Energy (DOE)); National Academy of Sciences; Radiation Effects Research Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Cancer Research; Sao Paulo State Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Cardiovascular Health Study and the research reported in this article were supported by contract numbers N01-HC-80007, N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, grant number U01 HL080295 from the National Heart, Lung, and Blood Institute, with additional funding from the National Institute of Neurological Disorders and Stroke. Additional support was provided through grants R01 AG-15928, R01 AG-20098, AG027058, and AG-032317 from the National Institute on Aging, grant R01 HL-075366 from the National Heart, Lung, and Blood Institute, and grant P30-AG-024827 from the University of Pittsburgh Claude. D. Pepper Older Americans Independence Center. A full list of principal investigators and institutions of the Cardiovascular Health Study can be found at http://www.chs-nhlbi.org/pi.htm. The thyroid measurements in the Cardiovascular Health Study were supported by an American Heart Association Grant-in-Aid (to Linda Fried). The Health, Aging, and Body Composition Study is supported by National Institute on Aging contract numbers N01-AG-6-2101, N01-AG-6-2103, and N01-AG-6-2106, and in part by the Intramural Research Program of the National Institutes of Health. The National Institute on Aging funded the Health Aging, and Body Composition study. The Leiden 85-plus Study was partly funded by the Dutch Ministry of Health, Welfare, and Sports. The Whickham Survey was supported by the UK Department of Health. The HUNT Study was a collaborative effort of the Faculty of Medicine, Norwegian University of Science and Technology, the Norwegian Institute of Public Health, and the Nord-Trondelag County Council. The thyroid testing in the HUNT Study was financially supported by Wallac Oy (Turku, Finland). The Nagasaki Adult Health Study was supported by the Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan, a private, nonprofit foundation funded by the Japanese Ministry of Health, Labor and Welfare and the US Department of Energy, the latter in part through the National Academy of Sciences. This publication was supported by research protocol A-10-08 from the Radiation Effects Research Foundation. The EPIC-Norfolk study was supported by research grants from the UK Medical Research Council and the UK Cancer Research. The Brazilian Thyroid Study was supported by an unrestricted grant from the Sao Paulo State Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo grant 6/59737-9 to Rui Maciel). Dr Newman is supported by grant AG-023629 from the the National Institute on Aging. Dr Westendorp is supported by grant NGI/NWO911-03-016 from the Netherlands Organization for Scientific Research. Role of the Sponsor: The majority of the sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. The National Institute on Aging funded the Health, Aging, and Body Composition study and reviewed the manuscript and approved its publication. The Radiation Effects Research Foundation funded the Nagasaki Adult Health Study and reviewed the manuscript and approved its publication.	Asvold BO, 2008, ARCH INTERN MED, V168, P855, DOI 10.1001/archinte.168.8.855; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Boekholdt SM, 2010, CLIN ENDOCRINOL, V72, P404, DOI 10.1111/j.1365-2265.2009.03640.x; Cappola AR, 2007, J CLIN ENDOCR METAB, V92, P3404, DOI 10.1210/jc.2007-1575; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cooper DS, 2004, JAMA-J AM MED ASSOC, V292, P2651, DOI 10.1001/jama.292.21.2651; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2001, SYSTEMATIC REV HLTH; Fatourechi V, 2003, MAYO CLIN PROC, V78, P554, DOI 10.4065/78.5.554; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Gharib H, 2005, J CLIN ENDOCR METAB, V90, P581, DOI 10.1210/jc.2004-1231; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Heinze G, 2001, BIOMETRICS, V57, P114, DOI 10.1111/j.0006-341X.2001.00114.x; Helfand M, 2004, ANN INTERN MED, V140, P128, DOI 10.7326/0003-4819-140-2-200401200-00015; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Iervasi G, 2007, ARCH INTERN MED, V167, P1526, DOI 10.1001/archinte.167.14.1526; Imaizumi M, 2004, J CLIN ENDOCR METAB, V89, P3365, DOI 10.1210/jc.2003-031089; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Ladenson PW, 2008, ANN INTERN MED, V148, P880, DOI 10.7326/0003-4819-148-11-200806030-00011; Monzani F, 2004, J CLIN ENDOCR METAB, V89, P2099, DOI 10.1210/jc.2003-031669; NICOLOFF JT, 1990, J CLIN ENDOCR METAB, V71, P553, DOI 10.1210/jcem-71-3-553; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; Parle JV, 2001, LANCET, V358, P861, DOI 10.1016/S0140-6736(01)06067-6; Razvi S, 2008, J CLIN ENDOCR METAB, V93, P2998, DOI 10.1210/jc.2008-0167; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Razvi S, 2010, J CLIN ENDOCR METAB, V95, P1734, DOI 10.1210/jc.2009-1749; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P431, DOI 10.1016/j.jclinepi.2006.09.009; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; Rodondi N, 2008, J AM COLL CARDIOL, V52, P1152, DOI 10.1016/j.jacc.2008.07.009; SAWIN CT, 1994, NEW ENGL J MED, V331, P1249, DOI 10.1056/NEJM199411103311901; Sgarbi JA, 2010, EUR J ENDOCRINOL, V162, P569, DOI 10.1530/EJE-09-0845; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Vanderpump MPJ, 1996, THYROID, V6, P155; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Volzke H, 2007, J CLIN ENDOCR METAB, V92, P2421, DOI 10.1210/jc.2007-0179; Walsh JP, 2005, ARCH INTERN MED, V165, P2467, DOI 10.1001/archinte.165.21.2467	45	727	777	2	75	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2010	304	12					1365	1374		10.1001/jama.2010.1361	http://dx.doi.org/10.1001/jama.2010.1361			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	652LK	20858880	Green Accepted, Green Published			2022-12-24	WOS:000282007900020
J	Dyrbye, LN; Massie, FS; Eacker, A; Harper, W; Power, D; Durning, SJ; Thomas, MR; Moutier, C; Satele, D; Sloan, J; Shanafelt, TD				Dyrbye, Liselotte N.; Massie, F. Stanford, Jr.; Eacker, Anne; Harper, William; Power, David; Durning, Steven J.; Thomas, Matthew R.; Moutier, Christine; Satele, Daniel; Sloan, Jeff; Shanafelt, Tait D.			Relationship Between Burnout and Professional Conduct and Attitudes Among US Medical Students	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SCHOOL; CARE; PERCEPTIONS; DISTRESS; MULTICENTER; INSTRUMENTS; DEPRESSION; EXPOSURE; EMPATHY	Context The relationship between professionalism and distress among medical students is unknown. Objective To determine the relationship between measures of professionalism and burnout among US medical students. Design, Setting, and Participants Cross-sectional survey of all medical students attending 7 US medical schools (overall response rate, 2682/4400 [61%]) in the spring of 2009. The survey included the Maslach Burnout Inventory (MBI), the PRIME-MD depression screening instrument, and the SF-8 quality of life (QOL) assessment tool, as well as items exploring students' personal engagement in unprofessional conduct, understanding of appropriate relationships with industry, and attitudes regarding physicians' responsibility to society. Main Outcome Measures Frequency of self-reported cheating/dishonest behaviors, understanding of appropriate relationships with industry as defined by American Medical Association policy, attitudes about physicians' responsibility to society, and the relationship of these dimensions of professionalism to burnout, symptoms of depression, and QOL. Results Of the students who responded to all the MBI items, 1354 of 2566 (52.8%) had burnout. Cheating/dishonest academic behaviors were rare (endorsed by < 10%) in comparison to unprofessional conduct related to patient care (endorsed by up to 43%). Only 14% (362/2531) of students had opinions on relationships with industry consistent with guidelines for 6 scenarios. Students with burnout were more likely to report engaging in 1 or more unprofessional behaviors than those without burnout (35.0% vs 21.9%; odds ratio [OR], 1.89; 95% confidence interval [CI], 1.59-2.24). Students with burnout were also less likely to report holding altruistic views regarding physicians' responsibility to society. For example, students with burnout were less likely to want to provide care for the medically underserved than those without burnout (79.3% vs 85.0%; OR, 0.68; 95% CI, 0.55-0.83). After multivariable analysis adjusting for personal and professional characteristics, burnout was the only aspect of distress independently associated with reporting 1 or more unprofessional behaviors (OR, 1.76; 95% CI, 1.45-2.13) or holding at least 1 less altruistic view regarding physicians' responsibility to society (OR, 1.65; 95% CI, 1.35-2.01). Conclusion Burnout was associated with self-reported unprofessional conduct and less altruistic professional values among medical students at 7 US schools. JAMA. 2010;304(11):1173-1180 www.jama.com	[Dyrbye, Liselotte N.; Thomas, Matthew R.; Shanafelt, Tait D.] Mayo Clin, Coll Med, Rochester, MN USA; [Satele, Daniel; Sloan, Jeff] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Massie, F. Stanford, Jr.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Eacker, Anne] Univ Washington, Sch Med, Seattle, WA USA; [Harper, William] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Power, David] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Durning, Steven J.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Moutier, Christine] Univ Calif San Diego, San Diego, CA 92103 USA	Mayo Clinic; Mayo Clinic; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; University of Chicago; University of Minnesota System; University of Minnesota Twin Cities; Uniformed Services University of the Health Sciences - USA; University of California System; University of California San Diego	Dyrbye, LN (corresponding author), 200 1st St SW, Rochester, MN 55905 USA.	dyrbye.liselotte@mayo.edu			Mayo Clinic; Mayo Clinic Department of Medicine; Division of Primary Care; Mayo Medical School Office of Educational Research	Mayo Clinic; Mayo Clinic Department of Medicine; Division of Primary Care; Mayo Medical School Office of Educational Research	This work was supported by a Professionalism Award from the Mayo Clinic; from the Mayo Clinic Department of Medicine, Division of Primary Care intramural funds; the Mayo Clinic Department of Medicine Program on Physician Well-being; and the Mayo Medical School Office of Educational Research.	*AM MED ASS, COD MED ETH OP 8 061; American Medical Association, 2001, DECL PROF RESP MED S; ANDERSON RE, 1994, ACAD MED, V69, P323, DOI 10.1097/00001888-199405000-00002; *ASS AM MED COLL, 1996, GRAD QUEST 1995 1996; *ASS AM MED COLL, 2002, ENR GRAD MD PHD DAT; Cooke M, 2006, NEW ENGL J MED, V355, P1339, DOI 10.1056/NEJMra055445; Crandall SJS, 2007, ADV HEALTH SCI EDUC, V12, P71, DOI 10.1007/s10459-005-2297-1; Crandall Sonia J. S., 1993, JAMA (Journal of the American Medical Association), V269, P2519, DOI 10.1001/jama.269.19.2519; Dans PE, 1996, ACAD MED, V71, pS70, DOI 10.1097/00001888-199601000-00046; Dyrbye LN, 2008, ANN INTERN MED, V149, P334, DOI 10.7326/0003-4819-149-5-200809020-00008; Dyrbye LN, 2010, ACAD MED, V85, P94, DOI 10.1097/ACM.0b013e3181c46aad; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; Dyrbye LN, 2006, ACAD MED, V81, P374, DOI 10.1097/00001888-200604000-00010; FEUDTNER C, 1994, ACAD MED, V69, P670, DOI 10.1097/00001888-199408000-00017; FirthCozens J, 1997, SOC SCI MED, V44, P1017, DOI 10.1016/S0277-9536(96)00227-4; Grande D, 2009, ARCH INTERN MED, V169, P887, DOI 10.1001/archinternmed.2009.64; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Lo B, 2010, NEW ENGL J MED, V362, P669, DOI 10.1056/NEJMp1000213; Maslach C., 1996, MASLACH BURNOUT INVE; MORIN K, 2003, AM MED ASS ETHICAL G; Norman Geoffrey R, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P581, DOI 10.1586/14737167.4.5.581; Papadakis MA, 2005, NEW ENGL J MED, V353, P2673, DOI 10.1056/NEJMsa052596; Schaufeli WB, 2001, PSYCHOL HEALTH, V16, P565, DOI 10.1080/08870440108405527; Shanafelt TD, 2009, ANN SURG, V250, P463, DOI 10.1097/SLA.0b013e3181ac4dfd; Shanafelt TD, 2005, J GEN INTERN MED, V20, P559, DOI 10.1007/s11606-005-0102-8; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; SIERLES F, 1980, J MED EDUC, V55, P124; Sierles FS, 2005, JAMA-J AM MED ASSOC, V294, P1034, DOI 10.1001/jama.294.9.1034; SIMPSON DE, 1989, ACAD MED, V64, P221, DOI 10.1097/00001888-198904000-00013; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Thomas MR, 2007, J GEN INTERN MED, V22, P177, DOI 10.1007/s11606-006-0039-6; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; Turner-Bowker DM, 2003, QUAL LIFE RES, V12, P1003, DOI 10.1023/A:1026179517081; Veloski JJ, 2005, ACAD MED, V80, P366, DOI 10.1097/00001888-200504000-00014; Ware JE Jr, 2001, SCORE INTERPRET SING; West CP, 2009, JAMA-J AM MED ASSOC, V302, P1294, DOI 10.1001/jama.2009.1389; WEST CP, 2007, BMC MED ED, V7; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x	39	500	515	3	109	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2010	304	11					1173	1180		10.1001/jama.2010.1318	http://dx.doi.org/10.1001/jama.2010.1318			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	649LF	20841530				2022-12-24	WOS:000281770600009
J	Lestas, I; Vinnicombe, G; Paulsson, J				Lestas, Ioannis; Vinnicombe, Glenn; Paulsson, Johan			Fundamental limits on the suppression of molecular fluctuations	NATURE			English	Article							PLASMID REPLICATION; FEEDBACK-CONTROL; GENE-EXPRESSION; POISSON-TYPE; SINGLE-CELL; NOISE; PERFORMANCE; INFORMATION; LIMITATIONS; ROBUSTNESS	Negative feedback is common in biological processes and can increase a system's stability to internal and external perturbations. But at the molecular level, control loops always involve signalling steps with finite rates for random births and deaths of individual molecules. Here we show, by developing mathematical tools that merge control and information theory with physical chemistry, that seemingly mild constraints on these rates place severe limits on the ability to suppress molecular fluctuations. Specifically, the minimum standard deviation in abundances decreases with the quartic root of the number of signalling events, making it extremely expensive to increase accuracy. Our results are formulated in terms of experimental observables, and existing data show that cells use brute force when noise suppression is essential; for example, regulatory genes are transcribed tens of thousands of times per cell cycle. The theory challenges conventional beliefs about biochemical accuracy and presents an approach to the rigorous analysis of poorly characterized biological systems.	[Lestas, Ioannis; Vinnicombe, Glenn] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Paulsson, Johan] Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA	University of Cambridge; Harvard University	Vinnicombe, G (corresponding author), Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England.	gv@eng.cam.ac.uk; johan_paulsson@hms.harvard.edu			BBSRC [BB/C008073/1]; National Science Foundation [DMS-074876-0, 0720056]; National Institutes of Health [GM081563-02, GM068763-06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763, R01GM081563] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [0748760] Funding Source: National Science Foundation; Biotechnology and Biological Sciences Research Council [BB/C008073/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the BBSRC under grant BB/C008073/1, by the National Science Foundation grants DMS-074876-0 and CAREER 0720056, and by grants GM081563-02 and GM068763-06 from the National Institutes of Health.	Barkai N, 2007, MOL CELL, V28, P755, DOI 10.1016/j.molcel.2007.11.013; Bialek W, 2005, P NATL ACAD SCI USA, V102, P10040, DOI 10.1073/pnas.0504321102; Bialek W, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.258101; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cover TM, 1991, ELEMENTS INFORM THEO; Das N, 2005, P NATL ACAD SCI USA, V102, P2856, DOI 10.1073/pnas.0409790102; DAVIS MHA, 1980, IEEE T INFORM THEORY, V26, P710, DOI 10.1109/TIT.1980.1056262; Doan T, 2006, SCIENCE, V313, P530, DOI 10.1126/science.1126612; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; El-Samad H, 2005, P NATL ACAD SCI USA, V102, P2736, DOI 10.1073/pnas.0403510102; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Gorbunov A. K., 1973, Problems of Information Transmission, V9, P184; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; KABANOV YM, 1978, THEOR PROBAB APPL+, V23, P143, DOI 10.1137/1123013; Keizer J, 1987, STAT THERMODYNAMICS; Korobkova EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058105; Martins NC, 2008, IEEE T AUTOMAT CONTR, V53, P1604, DOI 10.1109/TAC.2008.929361; Martins NC, 2007, IEEE T AUTOMAT CONTR, V52, P56, DOI 10.1109/TAC.2006.887898; MAXWELL JC, 1867, P ROY SOC, V16, P270; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; SAVAGEAU MA, 1971, NATURE, V229, P542, DOI 10.1038/229542a0; SHANNON E, 1948, BELL SYST TECH J, V379, P623; Singh A, 2009, BIOPHYS J, V96, P4013, DOI 10.1016/j.bpj.2009.02.064; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; TOMIZAWA J, 1986, CELL, V47, P89, DOI 10.1016/0092-8674(86)90369-7; Walczak AM, 2009, P NATL ACAD SCI USA, V106, P6529, DOI 10.1073/pnas.0811999106; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	32	286	288	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2010	467	7312					174	178		10.1038/nature09333	http://dx.doi.org/10.1038/nature09333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829788	Green Accepted			2022-12-24	WOS:000281616300027
J	Gray, DC; Mahrus, S; Wells, JA				Gray, Daniel C.; Mahrus, Sami; Wells, James A.			Activation of Specific Apoptotic Caspases with an Engineered Small-Molecule-Activated Protease	CELL			English	Article							CELL-DEATH; KEY MEDIATORS; GRANZYME-B; CLEAVAGE; INHIBITION; DROSOPHILA; PATHWAYS; PROTEINS; NEURONS; MYELOMA	Apoptosis is a conserved cellular pathway that results in the activation of cysteine-aspartyl proteases, or caspases. To dissect the nonredundant roles of the executioner caspase-3, -6, and -7 in orchestrating apoptosis, we have developed an orthogonal protease to selectively activate each isoform in human cells. Our approach uses a split-tobacco etch virus (TEV) protease under small-molecule control, which we call the SNIPer, with caspase alleles containing genetically encoded TEV cleavage sites. These studies reveal that all three caspases are transiently activated but only activation of caspase-3 or -7 is sufficient to induce apoptosis. Proteomic analysis shown here and from others reveals that 20 of the 33 subunits of the 26S proteasome can be cut by caspases, and we demonstrate synergy between proteasome inhibition and dose-dependent caspase activation. We propose a model of proteolytic reciprocal negative regulation with mechanistic implications for the combined clinical use of proteasome inhibitors and proapoptotic drugs.	[Gray, Daniel C.; Mahrus, Sami; Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wells, James A.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [Gray, Daniel C.] Univ Calif San Francisco, Grad Grp Chem & Chem Biol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wells, JA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	jim.wells@ucsf.edu	Wells, Jim A/O-9854-2016		NIH [R01 GM081051, CA136779]; Hartwell Foundation; University of California [2008-23]; NATIONAL CANCER INSTITUTE [R01CA136779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081051] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the Wells lab for useful discussions and to Emily Crawford for curation of the laboratory caspase substrate database. We also thank the UCSF NIKON Imaging Center and Dr. Kurt Thorn for assistance with live-cell imaging. We also thank Drs. Al Burlingame, David Maltby, and Jon Trinidad for use of the Mass Spectrometry Facility at the Mission Bay Campus of UCSF. This work was supported by NIH R01 GM081051 and CA136779 (J.A.W.), The Hartwell Foundation (J.A.W.), and the University of California Systemwide Biotechnology Research & Education Program GREAT Training Grant 2008-23 (D.C.G.).	Adrain C, 2004, J BIOL CHEM, V279, P36923, DOI 10.1074/jbc.M402638200; Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Casciola-Rosen L, 2007, J BIOL CHEM, V282, P4545, DOI 10.1074/jbc.M606564200; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Ernst JD, 1998, ANAL BIOCHEM, V260, P18, DOI 10.1006/abio.1998.2677; Feeney B, 2006, BIOCHEMISTRY-US, V45, P13249, DOI 10.1021/bi0611964; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hell K, 2003, CELL DEATH DIFFER, V10, P1234, DOI 10.1038/sj.cdd.4401298; Jang M, 2007, BIOCHEM BIOPH RES CO, V363, P388, DOI 10.1016/j.bbrc.2007.08.183; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thiede B, 2005, PROTEOMICS, V5, P2123, DOI 10.1002/pmic.200401110; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Williams DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007474; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012	38	147	160	3	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					637	646		10.1016/j.cell.2010.07.014	http://dx.doi.org/10.1016/j.cell.2010.07.014			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723762	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000281115900017
J	Gehrke, S; Imai, Y; Sokol, N; Lu, BW				Gehrke, Stephan; Imai, Yuzuru; Sokol, Nicholas; Lu, Bingwei			Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression	NATURE			English	Article							LET-7 MICRORNA; DISTINCT ROLES; CELL-DEATH; DROSOPHILA; MUTATIONS; 4E-BP; GENE; IDENTIFICATION; GROWTH	Gain-of-function mutations in leucine-rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson's disease characterized by age-dependent degeneration of dopaminergic neurons(1,2). The molecular mechanism of LRRK2 action is not known. Here we show that LRRK2 interacts with the microRNA (miRNA) pathway to regulate protein synthesis. Drosophila e2f1 and dp messenger RNAs are translationally repressed by let-7 and miR-184*, respectively. Pathogenic LRRK2 antagonizes these miRNAs, leading to the overproduction of E2F1/DP, previously implicated in cell cycle and survival control 3 and shown here to be critical for LRRK2 pathogenesis. Genetic deletion of let-7, antagomir-mediated blockage of let-7 and miR-184* action, transgenic expression of dp target protector, or replacement of endogenous dp with a dp transgene non-responsive to let-7 each had toxic effects similar to those of pathogenic LRRK2. Conversely, increasing the level of let-7 or miR-184* attenuated pathogenic LRRK2 effects. LRRK2 associated with Drosophila Argonaute-1 (dAgo1) or human Argonaute-2 (hAgo2) of the RNA-induced silencing complex (RISC). In aged fly brain, dAgo1 protein level was negatively regulated by LRRK2. Further, pathogenic LRRK2 promoted the association of phospho-4E-BP1 with hAgo2. Our results implicate deregulated synthesis of E2F1/DP caused by the miRNA pathway impairment as a key event in LRRK2 pathogenesis and suggest novel miRNA-based therapeutic strategies.	[Gehrke, Stephan; Lu, Bingwei] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Imai, Yuzuru] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Sokol, Nicholas] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Stanford University; Tohoku University; Indiana University System; Indiana University Bloomington	Gehrke, S (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	sgehrke@stanford.edu; bingwei@stanford.edu	Sokol, Nicholas N/K-2761-2012; Imai, Yuzuru/AAA-6472-2019	Imai, Yuzuru/0000-0003-2924-5231; Lu, Bingwei/0000-0002-5807-7014; Sokol, Nicholas/0000-0002-2768-4102	National Institutes of Health [R01AR054926, R01MH080378, R21NS056878]; McKnight Foundation; Beckman Foundation; Sloan Foundation; MEXT in Japan; Asahi Glass Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; Beckman Foundation; Sloan Foundation(Alfred P. Sloan Foundation); MEXT in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. W. Carthew, B. Dickson, B. Edgar, D. St Johnston, N. Sonenberg, W. Smith, Z. Zhang, H. Siomi, B. Hay, S. Cohen, the Vienna Drosophila RNAi Center and the Bloomington Drosophila Stock Center for fly stocks and cell line, and Bestgene Inc. for help with making gDPwt and gDPmut transgenics; N.J. Dyson, R. P. Wharton, C. Zeng, G. Meister and Y. Liu for antibodies; T. Tuschl, P. A. Sharp and Y. Tomari for plasmids; P. Sarnow and R. Cevallos for advice on polysome preparation; S. Guo and A. Fire for reading the manuscript; W. Lee and G. Silverio for technical support; and members of the Lu laboratory for discussions. This work was supported by the National Institutes of Health (R01AR054926, R01MH080378 and R21NS056878), the McKnight, Beckman and Sloan Foundations (B. L.), and the Program for Young Researchers from Special Coordination Funds for Promoting Science and Technology commissioned by MEXT in Japan and an Asahi Glass Foundation Research Grant (Y.I).	Asano M, 1996, GENE DEV, V10, P1422, DOI 10.1101/gad.10.11.1422; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chan SP, 2008, RNA, V14, P2104, DOI 10.1261/rna.551208; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; GIRLING R, 1993, NATURE, V362, P83, DOI 10.1038/362083a0; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	30	301	312	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					637	U9		10.1038/nature09191	http://dx.doi.org/10.1038/nature09191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20671708	Green Accepted			2022-12-24	WOS:000280412100056
J	Kaida, D; Berg, MG; Younis, I; Kasim, M; Singh, LN; Wan, L; Dreyfuss, G				Kaida, Daisuke; Berg, Michael G.; Younis, Ihab; Kasim, Mumtaz; Singh, Larry N.; Wan, Lili; Dreyfuss, Gideon			U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation	NATURE			English	Article							DISEASE GENE-PRODUCT; MAMMALIAN-CELLS; MINOR CLASS; SPLICEOSOME; COMPLEX; SMN; TRANSCRIPTION; DEFICIENCY; INSIGHTS	In eukaryotes, U1 small nuclear ribonucleoprotein (snRNP) forms spliceosomes in equal stoichiometry with U2, U4, U5 and U6 snRNPs; however, its abundance in human far exceeds that of the other snRNPs. Here we used antisense morpholino oligonucleotide to U1 snRNA to achieve functional U1 snRNP knockdown in HeLa cells, and identified accumulated unspliced pre-mRNAs by genomic tiling microarrays. In addition to inhibiting splicing, U1 snRNP knockdown caused premature cleavage and polyadenylation in numerous pre-mRNAs at cryptic polyadenylation signals, frequently in introns near (<5 kilobases) the start of the transcript. This did not occur when splicing was inhibited with U2 snRNA antisense morpholino oligonucleotide or the U2-snRNP-inactivating drug spliceostatin A unless U1 antisense morpholino oligonucleotide was also included. We further show that U1 snRNA-pre-mRNA base pairing was required to suppress premature cleavage and polyadenylation from nearby cryptic polyadenylation signals located in introns. These findings reveal a critical splicing-independent function for U1 snRNP in protecting the transcriptome, which we propose explains its overabundance.	[Kaida, Daisuke; Berg, Michael G.; Younis, Ihab; Kasim, Mumtaz; Singh, Larry N.; Wan, Lili; Dreyfuss, Gideon] Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Dreyfuss, G (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	gdreyfuss@hhmi.upenn.edu	Singh, Larry N./AAG-6880-2021; Younis, Ihab/M-1849-2019; Dreyfuss, Gideon/D-1218-2013	Singh, Larry N./0000-0002-2478-5864; Younis, Ihab/0000-0003-3329-5979; Dreyfuss, Gideon/0000-0001-8129-8774; Kaida, Daisuke/0000-0003-4014-5231	Association Francaise Contre les Myopathies (AFM)	Association Francaise Contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	We are grateful to the members of our laboratory, especially J. Yong and J. Bachorik, for discussions and comments on this manuscript. We thank M. Yoshida for providing spliceostatin A. We also thank D. A. Baldwin and H. Rodriguez at the Microarray Core Facility at the University of Pennsylvania School of Medicine for help with the tiling array. This work was supported by the Association Francaise Contre les Myopathies (AFM). G.D. is an Investigator of the Howard Hughes Medical Institute.	Baserga S., 1993, RNA WORLD, P359; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Cifuentes-Diaz Carmen, 2002, Semin Pediatr Neurol, V9, P145, DOI 10.1053/spen.2002.33801; Danckwardt S, 2008, EMBO J, V27, P482, DOI 10.1038/sj.emboj.7601932; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fortes P, 2003, P NATL ACAD SCI USA, V100, P8264, DOI 10.1073/pnas.1332669100; Friend K, 2007, MOL CELL, V28, P240, DOI 10.1016/j.molcel.2007.09.026; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gromak N, 2006, MOL CELL BIOL, V26, P3986, DOI 10.1128/MCB.26.10.3986-3996.2006; Gu MG, 2005, CURR OPIN STRUC BIOL, V15, P99, DOI 10.1016/j.sbi.2005.01.009; Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; Iannaccone Susan T, 2004, Curr Neurol Neurosci Rep, V4, P74, DOI 10.1007/s11910-004-0016-6; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kambach C, 1999, CURR OPIN STRUC BIOL, V9, P222, DOI 10.1016/S0959-440X(99)80032-3; Kataoka N, 2004, J BIOL CHEM, V279, P7009, DOI 10.1074/jbc.M307692200; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Kramer A, 2005, BIOCHEM SOC T, V33, P439; Kyburz A, 2006, MOL CELL, V23, P195, DOI 10.1016/j.molcel.2006.05.037; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Matter N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni041; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Millevoi S, 2010, NUCLEIC ACIDS RES, V38, P2757, DOI 10.1093/nar/gkp1176; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Staley JP, 1998, CELL, V92, P315, DOI 10.1016/S0092-8674(00)80925-3; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; Vagner S, 2000, RNA, V6, P178, DOI 10.1017/S1355838200991854; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	42	406	415	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 2	2010	468	7324					664	U81		10.1038/nature09479	http://dx.doi.org/10.1038/nature09479			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688GB	20881964	Green Accepted			2022-12-24	WOS:000284836700034
J	Shiels, MS; Pfeiffer, RM; Engels, EA				Shiels, Meredith S.; Pfeiffer, Ruth M.; Engels, Eric A.			Age at Cancer Diagnosis Among Persons With AIDS in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED INDIVIDUALS; HODGKIN LYMPHOMA; CROHNS-DISEASE; HEPATOCELLULAR-CARCINOMA; GENETIC ANTICIPATION; LUNG-CANCER; RISK; PEOPLE	Background: Studies have reported young ages at cancer diagnosis in HIV-infected persons and have suggested that HIV accelerates carcinogenesis. However, these comparisons did not account for differences in population age structures. Objective: To compare ages at diagnosis for non-AIDS-defining types of cancer that occur in both the AIDS and general populations, after adjustment for differences in age and other demographic characteristics between these populations. Design: Registry linkage study. Setting: 15 HIV/AIDS and cancer registry databases in the United States. Participants: 212 055 persons with AIDS enrolled in the U. S. HIV/AIDS Cancer Match Study from 1996 to 2007. Measurements: Comparison of age-at-diagnosis distributions for various types of cancer in both the AIDS and general populations, after adjustment for age and other demographic characteristics. Results: The proportion of person-time contributed by older persons (age >= 65 years) was far smaller in the AIDS population (1.5%) than in the general population (12.5%). Reflecting this difference, the ages at diagnosis for most types of cancer were approximately 20 years younger among persons with AIDS. However, after adjustment for differences in the populations at risk, the median ages at diagnosis in the AIDS and general populations did not differ for most types of cancer (for example, colon, prostate, or breast cancer; all P > 0.100). In contrast, ages at diagnosis of lung (median, 50 vs. 54 years) and anal cancer (median, 42 vs. 45 years) were significantly younger in persons with AIDS than expected in the general population (P < 0.001), and the age at diagnosis of Hodgkin lymphoma was significantly older (median, 42 vs. 40 years; P < 0.001). Limitations: Information on other cancer risk factors, including cigarette smoking, was not available. Analysis was restricted to non-Hispanic white and black persons who had AIDS, which could limit the generalizability of the findings to other racial and ethnic groups or to persons with HIV but not AIDS. Conclusion: For most types of cancer, the age at diagnosis is similar in the AIDS and general populations, after adjustment for the ages of the populations at risk. Modest age differences remained for a few types of cancer, which may indicate either acceleration of carcinogenesis by HIV or earlier exposure to cancer risk factors.	[Shiels, Meredith S.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shiels, MS (corresponding author), NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, 6120 Execut Blvd,EPS 7059, Rockville, MD 20892 USA.	shielsms@mail.nih.gov	Pfeiffer, Ruth M/F-4748-2011		National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010150, Z01CP010150] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By the intramural research program of the National Cancer Institute.	Alshafie MT, 1997, BRIT J SURG, V84, P1068, DOI 10.1002/bjs.1800840808; Bhavan Kavita P, 2008, Curr HIV/AIDS Rep, V5, P150, DOI 10.1007/s11904-008-0023-3; Biggar RJ, 2006, BLOOD, V108, P3786, DOI 10.1182/blood-2006-05-024109; Brau N, 2007, J HEPATOL, V47, P527, DOI 10.1016/j.jhep.2007.06.010; Brock MV, 2006, JAIDS-J ACQ IMM DEF, V43, P47, DOI 10.1097/01.qai.0000232260.95288.93; BROWN GW, 1950, P 2 BERK S MATH STAT, P159; Carbone A, 2009, CURR OPIN HIV AIDS, V4, P3, DOI 10.1097/COH.0b013e32831a722b; CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; *CDCP, 2009, HIV AIDS SURV REP 20; Chapman C, 2009, CLIN COLORECTAL CANC, V8, P215, DOI 10.3816/CCC.2009.n.036; Clifford GM, 2009, BLOOD, V113, P5737, DOI 10.1182/blood-2009-02-204172; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Crum-Cianflone NF, 2010, AIDS, V24, P535, DOI 10.1097/QAD.0b013e328331f6e2; D'Souza G, 2008, J GEN INTERN MED, V23, P1452, DOI 10.1007/s11606-008-0698-6; Demopoulos BP, 2003, ARCH PATHOL LAB MED, V127, P589; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Frisch M, 1996, LANCET, V347, P1551, DOI 10.1016/S0140-6736(96)90703-5; Goedert JJ, 2006, BRIT J CANCER, V95, P642, DOI 10.1038/sj.bjc.6603282; Grandbastien B, 1998, GUT, V42, P170, DOI 10.1136/gut.42.2.170; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Horner MJ, 2009, SEER CANC STAT REV 1; Long JL, 2008, AIDS, V22, P489, DOI 10.1097/QAD.0b013e3282f47082; Mani H, 2009, CLIN LYMPHOMA MYELOM, V9, P206, DOI 10.3816/CLM.2009.n.042; Mofenson Lynne M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Picco MF, 2001, ANN INTERN MED, V134, P1124, DOI 10.7326/0003-4819-134-12-200106190-00013; Polito JMII, 1996, LANCET, V347, P798, DOI 10.1016/S0140-6736(96)90870-3; Puoti M, 2004, AIDS, V18, P2285, DOI 10.1097/00002030-200411190-00009; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Silverberg MJ, 2006, AIDS, V20, P1531, DOI 10.1097/01.aids.0000237369.41617.0f; Silverberg MJ, 2009, AIDS, V23, P2337, DOI 10.1097/QAD.0b013e3283319184; Tobias C, 2007, AIDS PATIENT CARE ST, V21, pS3, DOI 10.1089/apc.2007.9992; U.S. Census Bureau Population Division, 2009, ANN EST RES POP SEX; World Health Organization, 2000, INT CLASS DIS ONC	39	154	157	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 5	2010	153	7					452	+		10.7326/0003-4819-153-7-201010050-00008	http://dx.doi.org/10.7326/0003-4819-153-7-201010050-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	658VG	20921544	Green Accepted			2022-12-24	WOS:000282517000004
J	Heinig, M; Petretto, E; Wallace, C; Bottolo, L; Rotival, M; Lu, H; Li, YY; Sarwar, R; Langley, SR; Bauerfeind, A; Hummel, O; Lee, YA; Paskas, S; Rintisch, C; Saar, K; Cooper, J; Buchan, R; Gray, EE; Cyster, JG; Erdmann, J; Hengstenberg, C; Maouche, S; Ouwehand, WH; Rice, CM; Samani, NJ; Schunkert, H; Goodall, AH; Schulz, H; Roider, HG; Vingron, M; Blankenberg, S; Munzel, T; Zeller, T; Szymczak, S; Ziegler, A; Tiret, L; Smyth, DJ; Pravenec, M; Aitman, TJ; Cambien, F; Clayton, D; Todd, JA; Hubner, N; Cook, SA				Heinig, Matthias; Petretto, Enrico; Wallace, Chris; Bottolo, Leonardo; Rotival, Maxime; Lu, Han; Li, Yoyo; Sarwar, Rizwan; Langley, Sarah R.; Bauerfeind, Anja; Hummel, Oliver; Lee, Young-Ae; Paskas, Svetlana; Rintisch, Carola; Saar, Kathrin; Cooper, Jason; Buchan, Rachel; Gray, Elizabeth E.; Cyster, Jason G.; Erdmann, Jeanette; Hengstenberg, Christian; Maouche, Seraya; Ouwehand, Willem H.; Rice, Catherine M.; Samani, Nilesh J.; Schunkert, Heribert; Goodall, Alison H.; Schulz, Herbert; Roider, Helge G.; Vingron, Martin; Blankenberg, Stefan; Muenzel, Thomas; Zeller, Tanja; Szymczak, Silke; Ziegler, Andreas; Tiret, Laurence; Smyth, Deborah J.; Pravenec, Michal; Aitman, Timothy J.; Cambien, Francois; Clayton, David; Todd, John A.; Hubner, Norbert; Cook, Stuart A.		Cardiogenics Consortium	A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk	NATURE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTORS; MOLECULAR NETWORKS; GENE-EXPRESSION; DISEASE; INFLAMMATION; RESPONSES; IFIH1; SNPS; RAT	Combined analyses of gene networks and DNA sequence variation can provide new insights into the aetiology of common diseases that may not be apparent from genome-wide association studies alone. Recent advances in rat genomics are facilitating systems-genetics approaches(1,2). Here we report the use of integrated genome-wide approaches across seven rat tissues to identify gene networks and the loci underlying their regulation. We defined an interferon regulatory factor 7 (IRF7(3))-driven inflammatory network (IDIN) enriched for viral response genes, which represents a molecular biomarker for macrophages and which was regulated in multiple tissues by a locus on rat chromosome 15q25. We show that Epstein-Barr virus induced gene 2 (Ebi2, also known as Gpr183), which lies at this locus and controls B lymphocyte migration(4,5), is expressed in macrophages and regulates the IDIN. The human orthologous locus on chromosome 13q32 controlled the human equivalent of the IDIN, which was conserved in monocytes. IDIN genes were more likely to associate with susceptibility to type 1 diabetes (T1D)-amacrophage-associated autoimmune disease-than randomly selected immune response genes (P = 8.85 x 10(-6)). The human locus controlling the IDIN was associated with the risk of T1D at single nucleotide polymorphism rs9585056 (P = 7.0 x 10(-10); odds ratio, 1.15), which was one of five single nucleotide polymorphisms in this region associated with EBI2 (GPR183) expression. These data implicate IRF7 network genes and their regulatory locus in the pathogenesis of T1D.	[Heinig, Matthias; Bauerfeind, Anja; Hummel, Oliver; Lee, Young-Ae; Paskas, Svetlana; Rintisch, Carola; Saar, Kathrin; Schulz, Herbert; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Heinig, Matthias; Roider, Helge G.; Vingron, Martin] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Petretto, Enrico; Bottolo, Leonardo; Lu, Han; Li, Yoyo; Sarwar, Rizwan; Langley, Sarah R.; Buchan, Rachel; Aitman, Timothy J.; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Med Res Council,Clin Sci Ctr, London W12 0NN, England; [Petretto, Enrico; Bottolo, Leonardo] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Biostat, London W2 1PG, England; [Wallace, Chris; Cooper, Jason; Smyth, Deborah J.; Clayton, David; Todd, John A.] Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 0XY, England; [Rotival, Maxime; Maouche, Seraya; Tiret, Laurence; Cambien, Francois] Univ Paris 06, INSERM, UMRS 937, F-75013 Paris, France; [Rotival, Maxime; Maouche, Seraya; Tiret, Laurence; Cambien, Francois] Sch Med, F-75013 Paris, France; [Lee, Young-Ae] Charite, D-13353 Berlin, Germany; [Gray, Elizabeth E.; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Gray, Elizabeth E.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Erdmann, Jeanette; Schunkert, Heribert] Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Hengstenberg, Christian] Univ Regensburg, Klin & Poliklin Innere Med 2, D-93053 Regensburg, Germany; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England; [Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge CB2 0PT, England; [Ouwehand, Willem H.; Rice, Catherine M.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Samani, Nilesh J.; Goodall, Alison H.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Samani, Nilesh J.; Goodall, Alison H.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Blankenberg, Stefan; Muenzel, Thomas; Zeller, Tanja] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin, D-55131 Mainz, Germany; [Szymczak, Silke; Ziegler, Andreas] Univ Lubeck, Inst Med Biometrie & Stat, Univ Klinikum Schleswig Holstein, D-23562 Lubeck, Germany; [Pravenec, Michal] Acad Sci Czech Republic, Inst Physiol, Prague 14220 4, Czech Republic; [Pravenec, Michal] Ctr Appl Genom, Prague 14220 4, Czech Republic; [Hubner, Norbert] Charite, CC4, D-10117 Berlin, Germany; [Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Imperial College London; University of Cambridge; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Franche-Comte; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Regensburg; University of Cambridge; NHS Blood & Transplant (NHSBT); Wellcome Trust Sanger Institute; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Johannes Gutenberg University of Mainz; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London	Hubner, N (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	nhuebner@mdc-berlin.de; stuart.cook@csc.mrc.ac.uk	Erdmann, Jeanette/P-7513-2014; Erdmann, Jeanette/A-4417-2009; Szymczak, Silke/HGT-8202-2022; Hengstenberg, Christian/U-5485-2019; Cambien, Francois/AAP-9751-2020; Langley, Sarah R/E-4481-2019; Pravenec, Michal/B-1666-2012; Cook, Stuart/G-9567-2011; Szymczak, Silke/C-6625-2013; Munzel, Thomas/A-2912-2014; Todd, John/A-3542-2010; Ziegler, Andreas/G-4246-2012	Erdmann, Jeanette/0000-0002-4486-6231; Pravenec, Michal/0000-0001-9197-5871; Munzel, Thomas/0000-0001-5503-4150; Maouche, Seraya/0000-0001-8186-1635; Ouwehand, Willem/0000-0002-7744-1790; Schmitz, Gerd/0000-0002-1325-1007; Paskas, Svetlana/0000-0002-1206-5376; Todd, John/0000-0003-2740-8148; Zeller, Tanja/0000-0003-3379-2641; Bottolo, Leonardo/0000-0002-6381-2327; Saar, Kathrin/0000-0002-4483-1557; smyth, deborah/0000-0002-6330-2669; Szymczak, Silke/0000-0002-8897-9035; Heinig, Matthias/0000-0002-5612-1720; Buchan, Rachel/0000-0003-2490-9289; Goodall, Alison/0000-0002-7883-9645; Matvienko-Sikar, Karen/0000-0003-2777-6581; Aitman, Timothy/0000-0002-7875-4502; Cook, Stuart/0000-0001-6628-194X; Ziegler, Andreas/0000-0002-8386-5397; Rotival, Maxime/0000-0003-2519-8044; Wallace, Chris/0000-0001-9755-1703	German National Genome Research Network; Helmholtz Association Alliance on Systems Biology; EURATools [LSHG-CT-2005-019015]; European Union [LSHM-CT-2006-037593]; PHC ALLIANCE [19419PH]; UK National Institute for Health Research Biomedical Research Unit (Royal Brompton and Harefield NHS Trusts, University Hospitals of Leicester NHS Trusts); Biomedical Research Centre (Imperial College NHS Trust); British Heart Foundation; Grant Agency of the Czech Republic [P301/10/0290]; Ministry of Education of the Czech Republic [1M6837805002]; Fondation Leducq; Medical Research Council UK; Research Councils UK; Juvenile Diabetes Research Foundation International; National Institute for Health Research (UK); National Institute of Diabetes and Digestive and Kidney Diseases (USA); Wellcome Trust; European Community [HEALTH-F4-2010-241504]; Medical Research Council [MC_U120085815, MC_U120061454, MC_U120097112] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish; MRC [MC_U120061454, MC_U120085815, MC_U120097112] Funding Source: UKRI	German National Genome Research Network; Helmholtz Association Alliance on Systems Biology; EURATools; European Union(European Commission); PHC ALLIANCE; UK National Institute for Health Research Biomedical Research Unit (Royal Brompton and Harefield NHS Trusts, University Hospitals of Leicester NHS Trusts); Biomedical Research Centre (Imperial College NHS Trust); British Heart Foundation(British Heart Foundation); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Fondation Leducq(Leducq Foundation); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research Councils UK(UK Research & Innovation (UKRI)); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); National Institute for Health Research (UK)(National Institute for Health Research (NIHR)); National Institute of Diabetes and Digestive and Kidney Diseases (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge funding from the German National Genome Research Network (NGFN-Plus 'Genetics of Heart Failure'), the Helmholtz Association Alliance on Systems Biology (MSBN), EURATools (LSHG-CT-2005-019015), European Union FP6 (LSHM-CT-2006-037593), PHC ALLIANCE 2009 (19419PH), UK National Institute for Health Research Biomedical Research Unit (Royal Brompton and Harefield NHS Trusts, University Hospitals of Leicester NHS Trusts) and Biomedical Research Centre (Imperial College NHS Trust) awards, the British Heart Foundation, grant P301/10/0290 from the Grant Agency of the Czech Republic, grant 1M6837805002 from the Ministry of Education of the Czech Republic, the Fondation Leducq, the Medical Research Council UK, Research Councils UK, the Juvenile Diabetes Research Foundation International, National Institute for Health Research (UK), National Institute of Diabetes and Digestive and Kidney Diseases (USA), and the Wellcome Trust. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. HEALTH-F4-2010-241504 (EURATRANS). O. Burren performed T1DBase analyses.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cooper JD, 2009, GENES IMMUN, V10, pS85, DOI 10.1038/gene.2009.97; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Gatto D, 2009, IMMUNITY, V31, P259, DOI 10.1016/j.immuni.2009.06.016; HOLNESS CL, 1993, BLOOD, V81, P1607; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Li Q, 2008, P NATL ACAD SCI USA, V105, P12439, DOI 10.1073/pnas.0806439105; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pereira JP, 2009, NATURE, V460, P1122, DOI 10.1038/nature08226; Petretto E, 2008, NAT GENET, V40, P546, DOI 10.1038/ng.134; Petretto E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000737; Plagnol V, 2009, BIOSTATISTICS, V10, P327, DOI 10.1093/biostatistics/kxn039; Roider HG, 2009, BIOINFORMATICS, V25, P435, DOI 10.1093/bioinformatics/btn627; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; VON HERRATH M, 2009, NATURE, V459, P518; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	29	213	221	0	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					460	464		10.1038/nature09386	http://dx.doi.org/10.1038/nature09386			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20827270	Green Accepted, Green Published			2022-12-24	WOS:000282090200043
J	Medina, PP; Nolde, M; Slack, FJ				Medina, Pedro P.; Nolde, Mona; Slack, Frank J.			OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma	NATURE			English	Article							ONCOGENE ADDICTION; EXPRESSION; CANCER; MICRORNAS; PROGNOSIS; INVASION; MIR-21; MYC	MicroRNAs (miRNAs) belong to a recently discovered class of small RNA molecules that regulate gene expression at the post-transcriptional level. miRNAs have crucial functions in the development and establishment of cell identity, and aberrant metabolism or expression of miRNAs has been linked to human diseases, including cancer(1). Components of the miRNA machinery and miRNAs themselves are involved in many cellular processes that are altered in cancer, such as differentiation, proliferation and apoptosis. Some miRNAs, referred to as oncomiRs(2), show differential expression levels in cancer and are able to affect cellular transformation, carcinogenesis and metastasis, acting either as oncogenes or tumour suppressors. The phenomenon of 'oncogene addiction' reveals that despite the multistep nature of tumorigenesis, targeting of certain single oncogenes can have therapeutic value(3,4), and the possibility of oncomiR addiction has been proposed but never demonstrated(3). MicroRNA-21 (miR-21) is a unique miRNA in that it is overexpressed in most tumour types analysed so far. Despite great interest in miR-21, most of the data implicating it in cancer have been obtained through miRNA profiling and limited in vitro functional assays. To explore the role of miR-21 in cancer in vivo, we used Cre and Tet-off technologies to generate mice conditionally expressing miR-21. Here we show that overexpression of miR-21 leads to a pre-B malignant lymphoid-like phenotype, demonstrating that mir-21 is a genuine oncogene. When miR-21 was inactivated, the tumours regressed completely in a few days, partly as a result of apoptosis. These results demonstrate that tumours can become addicted to oncomiRs and support efforts to treat human cancers through pharmacological inactivation of miRNAs such as miR-21.	[Medina, Pedro P.; Nolde, Mona; Slack, Frank J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Slack, FJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	frank.slack@yale.edu	Vico, Pedro Pablo Medina/D-1688-2013	Vico, Pedro Pablo Medina/0000-0002-7834-7093; Slack, Frank/0000-0001-8263-0409	Hope Funds for Cancer Research; James McDonnell Foundation; Yale Comprehensive Cancer Center	Hope Funds for Cancer Research; James McDonnell Foundation; Yale Comprehensive Cancer Center	We thank X. Liang for help in mouse colony maintenance and genotyping; D. Scavone and T. Nottoli for assistance with generating the transgenic mice; Yale rodent care staff M. Bonk, K. Mclaughlin, J. Graham, D. Clark; C. Zeiss, L. Johnson and G. Terwilliger for help with the necropsy/pathological analysis; and I. Babar, P. Trang and J. Sklar for critical reading of the manuscript. P. P. M. is the recipient of a Postdoctoral Fellowship from Hope Funds for Cancer Research. This work was funded by a grant from the James McDonnell Foundation to F. J. S. and J. B. Weidhaas, and a pilot grant from the Yale Comprehensive Cancer Center.	Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Imai Y, 2010, STEM CELLS DEV, V19, P461, DOI 10.1089/scd.2009.0251; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Mao JH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni146; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; PENNYCOOK JL, 1993, J EXP MED, V178, P1007, DOI 10.1084/jem.178.3.1007; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; YOKOYAMA K, 1987, P NATL ACAD SCI USA, V84, P7363, DOI 10.1073/pnas.84.21.7363; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	30	731	807	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2010	467	7311					86	U119		10.1038/nature09284	http://dx.doi.org/10.1038/nature09284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20693987				2022-12-24	WOS:000281461200040
J	Somerville, C; Youngs, H; Taylor, C; Davis, SC; Long, SP				Somerville, Chris; Youngs, Heather; Taylor, Caroline; Davis, Sarah C.; Long, Stephen P.			Feedstocks for Lignocellulosic Biofuels	SCIENCE			English	Editorial Material							ENERGY-CONVERSION; MISCANTHUS; BIOENERGY; GROWTH; CROP; LANDS; YIELD	In 2008, the world produced approximately 87 gigaliters of liquid biofuels, which is roughly equal to the volume of liquid fuel consumed by Germany that year. Essentially, all of this biofuel was produced from crops developed for food production, raising concerns about the net energy and greenhouse gas effects and potential competition between use of land for production of fuels, food, animal feed, fiber, and ecosystem services. The pending implementation of improved technologies to more effectively convert the nonedible parts of plants (lignocellulose) to liquid fuels opens diverse options to use biofuel feedstocks that reach beyond current crops and the land currently used for food and feed. However, there has been relatively little discussion of what types of plants may be useful as bioenergy crops.	[Somerville, Chris; Youngs, Heather; Taylor, Caroline] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Davis, Sarah C.; Long, Stephen P.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA	University of California System; University of California Berkeley; University of Illinois System; University of Illinois Urbana-Champaign	Somerville, C (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA.	crs@berkeley.edu	Long, Stephen/AAA-1741-2019; Long, Stephen P/A-2488-2008; Somerville, Christopher R/A-4048-2009	Long, Stephen/0000-0002-8501-7164; Long, Stephen P/0000-0002-8501-7164; Somerville, Christopher R/0000-0003-4647-0094				BEALE CV, 1995, PLANT CELL ENVIRON, V18, P641, DOI 10.1111/j.1365-3040.1995.tb00565.x; Borland AM, 2009, J EXP BOT, V60, P2879, DOI 10.1093/jxb/erp118; Campbell JE, 2008, ENVIRON SCI TECHNOL, V42, P5791, DOI 10.1021/es800052w; Centro de Gestao e Estudos Estrategicos (CGEE), 2008, SUG CAN BAS BIOETH E; Christian DG, 2008, IND CROP PROD, V28, P320, DOI 10.1016/j.indcrop.2008.02.009; Clifton-Brown JC, 2007, GLOBAL CHANGE BIOL, V13, P2296, DOI 10.1111/j.1365-2486.2007.01438.x; Committee on America's Energy Future, 2009, AM EN FUT; Davis SC, 2010, ECOSYSTEMS, V13, P144, DOI 10.1007/s10021-009-9306-9; Dohleman FG, 2009, PLANT CELL ENVIRON, V32, P1525, DOI 10.1111/j.1365-3040.2009.02017.x; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Goldemberg J, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-6; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Lal R, 2005, ENVIRON INT, V31, P575, DOI 10.1016/j.envint.2004.09.005; Long SP, 1992, PRIMARY PRODUCTIVITY; Lynd L, 2006, SCIENCE, V312, P1746; Miguez FE, 2008, AGR FOREST METEOROL, V148, P1280, DOI 10.1016/j.agrformet.2008.03.010; Miguez FE, 2009, GCB BIOENERGY, V1, P282, DOI 10.1111/j.1757-1707.2009.01019.x; Mitchell CP, 1995, BIOMASS BIOENERG, V9, P11, DOI 10.1016/0961-9534(95)00076-3; Nobel PS, 1988, ENV BIOL AGAVES CACT; Purseglove J. W., 1972, TROPICAL CROPS MONOC; Pyter R, 2009, METHODS MOL BIOL, V581, P41, DOI 10.1007/978-1-60761-214-8_3; Sokhansanj S, 2002, BIOMASS BIOENERG, V23, P347, DOI 10.1016/S0961-9534(02)00063-6; UNEP, 2007, GLOB ENV OUTL ENV DE; *UNICA, 2010, SUG PROD BRAZ	25	907	941	13	444	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					790	792		10.1126/science.1189268	http://dx.doi.org/10.1126/science.1189268			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705851				2022-12-24	WOS:000280809900037
J	Ieda, M; Fu, JD; Delgado-Olguin, P; Vedantham, V; Hayashi, Y; Bruneau, BG; Srivastava, D				Ieda, Masaki; Fu, Ji-Dong; Delgado-Olguin, Paul; Vedantham, Vasanth; Hayashi, Yohei; Bruneau, Benoit G.; Srivastava, Deepak			Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors	CELL			English	Article							EMBRYONIC STEM-CELLS; CARDIAC FIBROBLASTS; PROGENITOR CELLS; BETA-CELLS; HEART; TRANSCRIPTION; EXPRESSION; CHROMATIN; TBX5; DIFFERENTIATION	The reprogramming of fibroblasts to induced pluripotent stem cells (iPSCs) raises the possibility that a somatic cell could be reprogrammed to an alternative differentiated fate without first becoming a stem/progenitor cell. A large pool of fibroblasts exists in the postnatal heart, yet no single "master regulator'' of direct cardiac reprogramming has been identified. Here, we report that a combination of three developmental transcription factors (i.e., Gata4, Mef2c, and Tbx5) rapidly and efficiently reprogrammed postnatal cardiac or dermal fibroblasts directly into differentiated cardiomyocyte-like cells. Induced cardiomyocytes expressed cardiac-specific markers, had a global gene expression profile similar to cardiomyocytes, and contracted spontaneously. Fibroblasts transplanted into mouse hearts one day after transduction of the three factors also differentiated into cardiomyocyte-like cells. We believe these findings demonstrate that functional cardiomyocytes can be directly reprogrammed from differentiated somatic cells by defined factors. Reprogramming of endogenous or explanted fibroblasts might provide a source of cardiomyocytes for regenerative approaches.	[Ieda, Masaki; Fu, Ji-Dong; Delgado-Olguin, Paul; Vedantham, Vasanth; Hayashi, Yohei; Bruneau, Benoit G.; Srivastava, Deepak] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ieda, Masaki; Fu, Ji-Dong; Delgado-Olguin, Paul; Bruneau, Benoit G.; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Ieda, Masaki; Fu, Ji-Dong; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Delgado-Olguin, Paul; Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Vedantham, Vasanth] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ieda, M (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	ieda@cpnet.med.keio.ac.jp; dsrivastava@gladstone.ucsf.edu	Wilson, Matthew H/K-3193-2013; Fu, Jidong/E-8173-2012; Hayashi, Yohei/AAF-6059-2020; Hayashi, Yohei/L-8190-2019; Olguin, Paul Delgado/H-9293-2019	Hayashi, Yohei/0000-0001-5490-7052; Olguin, Paul Delgado/0000-0002-5355-247X; Vedantham, Vasanth/0000-0003-1032-700X; Bruneau, Benoit/0000-0002-0804-7597; Fu, Jidong/0000-0003-2797-5193	Uehara Memorial Foundation; GlaxoSmithKline Cardiovascular Research and Education Foundation; NHLBI/NIH; California Institute for Regenerative Medicine; National Center for Research Resources [RR18928-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057181, U01HL100406, P01HL089707, R01HL080592, K08HL101989] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); GlaxoSmithKline Cardiovascular Research and Education Foundation; NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to members of the Srivastava lab, to K. Tomoda for critical discussions and comments on the manuscript, to J. Olgin and C. Ding for electrophysiology assistance, to Z. Yang and K. Worringer for help with lentivirus experiments, to Y. Huang for cell transplantation experiments, to B. Taylor, G. Howard, and S. Ordway for editorial assistance and manuscript preparation, to C. Barker and L. Ta in the Gladstone Genomics core, to C. Miller and J. Fish in the Gladstone Histology core, to A. Holloway in the Gladstone Bioinformatics core, and to S. Elmes in the Laboratory for Cell Analysis in UCSF. We also thank S. Yamanaka for helpful discussions and providing pMXs-DsRed Express plasmid, T. Kitamura for Plat-E cells, J. Robbins for alpha-MHC promoter plasmid, T.M. Jessell for Isl1-Cre mice, and F. Costantini for R26R-EYFP mice. M.I. and Y.H. are supported by a grant from the Uehara Memorial Foundation. V.V. is supported by grants from the GlaxoSmithKline Cardiovascular Research and Education Foundation and the NIH/NHLBI. P.D.-O. was a postdoctoral scholar of the California Institute for Regenerative Medicine. D.S. and B.G.B are supported by grants from NHLBI/NIH and the California Institute for Regenerative Medicine. The J. David Gladstone Institutes received support from a National Center for Research Resources Grant RR18928-01. D.S. is a member of the Scientific Advisory Board of iPierian, Inc., and RegeneRx. B.G.B. is a member of the Scientific Advisory Board of iPierian Inc.	Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Ghosh TK, 2009, MOL CELL BIOL, V29, P2205, DOI 10.1128/MCB.01923-08; GULICK J, 1991, J BIOL CHEM, V266, P9180; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hudon-David F, 2007, J MOL CELL CARDIOL, V42, P991, DOI 10.1016/j.yjmcc.2007.02.009; Ieda M, 2007, NAT MED, V13, P604, DOI 10.1038/nm1570; Ivey KN, 2006, J CLIN INVEST, V116, P2863, DOI 10.1172/JCI30349; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Saga Y, 1999, DEVELOPMENT, V126, P3437; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	38	1719	1879	2	327	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					375	386		10.1016/j.cell.2010.07.002	http://dx.doi.org/10.1016/j.cell.2010.07.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691899	Bronze, Green Accepted			2022-12-24	WOS:000280609100015
J	Kaya, M; Higuchi, H				Kaya, Motoshi; Higuchi, Hideo			Nonlinear Elasticity and an 8-nm Working Stroke of Single Myosin Molecules in Myofilaments	SCIENCE			English	Article							SKELETAL-MUSCLE; FORCE; ACTIN; SIZE; CONTRACTION; DEPENDENCE; STIFFNESS; DYNAMICS; FIBERS; MOTION	Using optical trapping and fluorescence imaging techniques, we measured the step size and stiffness of single skeletal myosins interacting with actin filaments and arranged on myosin-rod cofilaments that approximate myosin mechanics during muscle contraction. Stiffness is dramatically lower for negatively compared to positively strained myosins, consistent with buckling of myosin's subfragment 2 rod domain. Low stiffness minimizes drag of negatively strained myosins during contraction at loaded conditions. Myosin's elastic portion is stretched during active force generation, reducing apparent step size with increasing load, even though the working stroke is approximately constant at about 8 nanometers. Taking account of the nonlinear nature of myosin elasticity is essential to relate myosin's internal structural changes to physiological force generation and filament sliding.	[Kaya, Motoshi; Higuchi, Hideo] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Higuchi, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	higuchi@phys.s.u-tokyo.ac.jp			Japan Ministry of Education, Culture, Sports, Science, and Technology; Japan Science and Technology Agency; Japan Society for the Promotion of Science	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to J. Kerssemakers and M. Dogterom for generously providing their step-finding algorithm, W. Herzog and Y. Goldman for valuable discussion and critical reading of this manuscript, and T. Kambara for comments. This work has been supported by Grants-in-Aid for Scientific Research in Priority Areas from the Japan Ministry of Education, Culture, Sports, Science, and Technology (H. H.), Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency (H. H.), and Young Scientists from the Japan Society for the Promotion of Science (M.K.).	Adamovic I, 2008, BIOPHYS J, V94, P3779, DOI 10.1529/biophysj.107.122028; Barclay CJ, 1996, J PHYSIOL-LONDON, V497, P781, DOI 10.1113/jphysiol.1996.sp021809; Bieling P, 2008, EMBO REP, V9, P1121, DOI 10.1038/embor.2008.169; Capitanio M, 2006, P NATL ACAD SCI USA, V103, P87, DOI 10.1073/pnas.0506830102; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; GOLDMAN YE, 1988, J PHYSL, V398, P72; HIGUCHI H, 1995, BIOPHYS J, V69, P1000, DOI 10.1016/S0006-3495(95)79975-1; Hopkins SC, 2002, J MOL BIOL, V318, P1275, DOI 10.1016/S0022-2836(02)00189-4; Howard J, 1996, Proc Natl Acad Sci U S A, V93, P4462; Howard J, 2001, MECH MOTOR PROTEINS; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1971, J PHYSIOL, V218, P59; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Lewalle A, 2008, BIOPHYS J, V94, P2160, DOI 10.1529/biophysj.107.119396; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Nishizaka T, 2000, BIOPHYS J, V79, P962, DOI 10.1016/S0006-3495(00)76350-8; PATE E, 1993, P NATL ACAD SCI USA, V90, P2451, DOI 10.1073/pnas.90.6.2451; Piazzesi G, 2002, J PHYSIOL-LONDON, V545, P145, DOI 10.1113/jphysiol.2002.028969; Piazzesi G, 2007, CELL, V131, P784, DOI 10.1016/j.cell.2007.09.045; Reconditi M, 2004, NATURE, V428, P578, DOI 10.1038/nature02380; Steffen W, 2003, P NATL ACAD SCI USA, V100, P6434, DOI 10.1073/pnas.1231998100; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; WINKELMANN DA, 1995, BIOPHYS J, V68, P2444, DOI 10.1016/S0006-3495(95)80426-1	26	127	130	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					686	689		10.1126/science.1191484	http://dx.doi.org/10.1126/science.1191484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689017				2022-12-24	WOS:000280602700040
J	Vaaje-Kolstad, G; Westereng, B; Horn, SJ; Liu, ZL; Zhai, H; Sorlie, M; Eijsink, VGH				Vaaje-Kolstad, Gustav; Westereng, Bjorge; Horn, Svein J.; Liu, Zhanliang; Zhai, Hong; Sorlie, Morten; Eijsink, Vincent G. H.			An Oxidative Enzyme Boosting the Enzymatic Conversion of Recalcitrant Polysaccharides	SCIENCE			English	Article							BINDING PROTEIN CBP21; GLYCOSIDE HYDROLASE FAMILY; SERRATIA-MARCESCENS; BIOFUELS	Efficient enzymatic conversion of crystalline polysaccharides is crucial for an economically and environmentally sustainable bioeconomy but remains unfavorably inefficient. We describe an enzyme that acts on the surface of crystalline chitin, where it introduces chain breaks and generates oxidized chain ends, thus promoting further degradation by chitinases. This enzymatic activity was discovered and further characterized by using mass spectrometry and chromatographic separation methods to detect oxidized products generated in the absence or presence of H(2)(18)O or (18)O(2). There are strong indications that similar enzymes exist that work on cellulose. Our findings not only demonstrate the existence of a hitherto unknown enzyme activity but also provide new avenues toward more efficient enzymatic conversion of biomass.	[Vaaje-Kolstad, Gustav; Westereng, Bjorge; Horn, Svein J.; Liu, Zhanliang; Zhai, Hong; Sorlie, Morten; Eijsink, Vincent G. H.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	Norwegian University of Life Sciences	Eijsink, VGH (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, POB 5003, N-1432 As, Norway.	vincent.eijsink@umb.no	Westereng, Bjørge/A-1688-2013; Horn, Svein/F-9723-2010; Horn, Svein Jarle/C-6258-2008	Westereng, Bjørge/0000-0002-5141-7231; Horn, Svein Jarle/0000-0002-1590-9001; Vaaje-Kolstad, Gustav/0000-0002-3077-8003	Norwegian Research Council [171991/V40, 164653, 186946/I30, 190877/S60]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank A. C. Bunaes for technical assistance and G. Vriend for helpful discussions. This work was supported by Norwegian Research Council grants 171991/V40, 164653, 186946/I30, and 190877/S60.	Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; Eijsink VGH, 2008, TRENDS BIOTECHNOL, V26, P228, DOI 10.1016/j.tibtech.2008.02.004; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Karkehabadi S, 2008, J MOL BIOL, V383, P144, DOI 10.1016/j.jmb.2008.08.016; Moser F, 2008, BIOTECHNOL BIOENG, V100, P1066, DOI 10.1002/bit.21856; REESE ET, 1950, J BACTERIOL, V59, P485, DOI 10.1128/JB.59.4.485-497.1950; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010	14	819	855	20	417	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					219	222		10.1126/science.1192231	http://dx.doi.org/10.1126/science.1192231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20929773				2022-12-24	WOS:000282644600041
J	Tsukahara, T; Tanno, Y; Watanabe, Y				Tsukahara, Tatsuya; Tanno, Yuji; Watanabe, Yoshinori			Phosphorylation of the CPC by Cdk1 promotes chromosome bi-orientation	NATURE			English	Article							SISTER-CHROMATID COHESION; FISSION YEAST; CELL-DIVISION; SCHIZOSACCHAROMYCES-POMBE; AURORA-B; MICROTUBULE ATTACHMENT; PASSENGER COMPLEX; INNER CENTROMERE; MITOTIC SPINDLE; MEIOSIS-I	Successful partition of replicated genomes at cell division requires chromosome attachment to opposite poles of mitotic spindle (bi-orientation). Any defects in this regulation bring about chromosomal instability, which may accelerate tumour progression in humans. To achieve chromosome bi-orientation at prometaphase, the chromosomal passenger complex (CPC), composed of catalytic kinase Aurora B and regulatory components (INCENP, Survivin and Borealin), must be localized to centromeres to phosphorylate kinetochore substrates(1-7). Although the CPC dynamically changes the subcellular localization, the regulation of centromere targeting is largely unknown(1). Here we isolated a fission yeast cyclin B mutant defective specifically in chromosome bi-orientation. Accordingly, we identified Cdk1 (also known as Cdc2)-cyclin-B-dependent phosphorylation of Survivin. Preventing Survivin phosphorylation impairs centromere CPC targeting as well as chromosome bi-orientation, whereas phosphomimetic Survivin suppresses the bi-orientation defect in the cyclin B mutant. Survivin phosphorylation promotes direct binding with shugoshin(8,9), which we now define as a conserved centromeric adaptor of the CPC. In human cells, the phosphorylation of Borealin has a comparable role. Thus, our study resolves the conserved mechanisms of CPC targeting to centromeres, highlighting a key role of Cdk1-cyclin B in chromosome bi-orientation.	[Tsukahara, Tatsuya; Watanabe, Yoshinori] Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 1130032, Japan; [Tsukahara, Tatsuya; Tanno, Yuji; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo	Watanabe, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Tokyo 1130032, Japan.	ywatanab@iam.u-tokyo.ac.jp	Tsukahara, Tatsuya/AAO-1707-2021	Tsukahara, Tatsuya/0000-0002-6928-8562; Watanabe, Yoshinori/0000-0002-5488-4812	Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms); JSPS; MEXT, Japan; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Hauf for critically reading the manuscript and the Yeast Genetic Resource Center (YGRC) for yeast strains, and all the members of our laboratory, particularly S. A. Kawashima, for their valuable support and discussion. This work was supported in part by Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), JSPS Research Fellowship (to T.T. and Y.T.) and a Grant-in-Aid for Specially Promoted Research, MEXT, Japan (to Y.W.).	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bohnert KA, 2009, MOL BIOL CELL, V20, P3646, DOI 10.1091/mbc.E09-04-0289; Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chen Q, 2008, CELL RES, V18, P268, DOI 10.1038/cr.2008.11; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Liu ST, 2003, NAT CELL BIOL, V5, P341, DOI 10.1038/ncb953; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Nonaka N, 2002, NAT CELL BIOL, V4, P89, DOI 10.1038/ncb739; Rajagopalan S, 2002, GENETICS, V160, P445; Resnick TD, 2006, DEV CELL, V11, P57, DOI 10.1016/j.devcel.2006.04.021; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Tanaka TU, 2008, CHROMOSOMA, V117, P521, DOI 10.1007/s00412-008-0173-5; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Vanoosthuyse V, 2007, MOL BIOL CELL, V18, P1657, DOI 10.1091/mbc.E06-10-0890; Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003; Xu Z, 2009, MOL CELL, V35, P426, DOI 10.1016/j.molcel.2009.06.031; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yokobayashi S, 2003, MOL CELL BIOL, V23, P3965, DOI 10.1128/MCB.23.11.3965-3973.2003; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013	35	179	183	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					719	U111		10.1038/nature09390	http://dx.doi.org/10.1038/nature09390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20739936				2022-12-24	WOS:000282572500041
J	Cabernard, C; Prehoda, KE; Doe, CQ				Cabernard, Clemens; Prehoda, Kenneth E.; Doe, Chris Q.			A spindle-independent cleavage furrow positioning pathway	NATURE			English	Article							NONMUSCLE MYOSIN-II; DROSOPHILA NEUROBLASTS; ASYMMETRIC DIVISIONS; CELL-DIVISION; CORTICAL POLARITY; CONTRACTILE RING; PROTEIN COMPLEX; ALPHA-I; CYTOKINESIS; ORIENTATION	The mitotic spindle determines the cleavage furrow site during metazoan cell division(1,2), but whether other mechanisms exist remains unknown. Here we identify a spindle-independent mechanism for cleavage furrow positioning in Drosophila neuroblasts. We show that early and late furrow proteins (Pavarotti, Anillin, and Myosin) are localized to the neuroblast basal cortex at anaphase onset by a Pins cortical polarity pathway, and can induce a basally displaced furrow even in the complete absence of a mitotic spindle. Rotation or displacement of the spindle results in two furrows: an early polarity-induced basal furrow and a later spindle-induced furrow. This spindle-independent cleavage furrow mechanism may be relevant to other highly polarized mitotic cells, such as mammalian neural progenitors.	[Cabernard, Clemens; Doe, Chris Q.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA; [Cabernard, Clemens; Prehoda, Kenneth E.; Doe, Chris Q.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Cabernard, Clemens; Doe, Chris Q.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon; University of Oregon; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA.	cdoe@uoregon.edu	Cabernard, Clemens/A-9033-2010	Cabernard, Clemens/0000-0003-3706-6401; Prehoda, Ken/0000-0003-4214-6158	National Institutes of Health [GM068032]; American Heart Association; Swiss National Science Foundation; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068032] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Brand, D. Glover, C.-Y. Lee, M. Peifer, J. Raff, E. Wieschaus, A. Wilde, and the Bloomington and Vienna Drosophila RNAi Center stock centres for fly stocks and/or antibody reagents; R. Andersen, B. Bowerman, M. Goulding and B. Nolan for comments on the manuscript; and T. Gillies and K. Hirono for technical support. This work was supported by the National Institutes of Health (GM068032; to K. P.), the American Heart Association (to C. C. and K. P.), the Swiss National Science Foundation (to C. C.) and HHMI (to C.Q.D.).	Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Basto R, 2000, NAT CELL BIOL, V2, P939, DOI 10.1038/35046592; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bonaccorsi S, 2000, NAT CELL BIOL, V2, P54, DOI 10.1038/71378; Bonaccorsi S, 1998, J CELL BIOL, V142, P751, DOI 10.1083/jcb.142.3.751; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Cabernard C, 2009, DEV CELL, V17, P134, DOI 10.1016/j.devcel.2009.06.009; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; CONRAD GW, 1974, DEV BIOL, V36, P363, DOI 10.1016/0012-1606(74)90058-X; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Foe VE, 2008, J CELL BIOL, V183, P457, DOI 10.1083/jcb.200807128; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Giansanti MG, 2008, CURR BIOL, V18, P303, DOI 10.1016/j.cub.2008.01.058; Giansanti MG, 2001, DEVELOPMENT, V128, P1137; Guan ZH, 2000, P NATL ACAD SCI USA, V97, P8122, DOI 10.1073/pnas.97.14.8122; Hickson GRX, 2006, CURR BIOL, V16, P359, DOI 10.1016/j.cub.2005.12.043; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kosodo Y, 2008, EMBO J, V27, P3151, DOI 10.1038/emboj.2008.227; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Megraw TL, 2001, CURR BIOL, V11, P116, DOI 10.1016/S0960-9822(01)00017-3; Minestrini G, 2003, MOL BIOL CELL, V14, P4028, DOI 10.1091/mbc.E03-04-0214; Oliferenko S, 2009, GENE DEV, V23, P660, DOI 10.1101/gad.1772009; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Silverman-Gavrila RV, 2008, MOL BIOL CELL, V19, P3735, DOI 10.1091/mbc.E08-01-0049; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; von Dassow G, 2009, TRENDS CELL BIOL, V19, P165, DOI 10.1016/j.tcb.2009.01.008; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174	41	123	123	3	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					91	U124		10.1038/nature09334	http://dx.doi.org/10.1038/nature09334			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811457	Green Accepted			2022-12-24	WOS:000281461200041
J	Daniel, JA; Santos, MA; Wang, ZB; Zang, CZ; Schwab, KR; Jankovic, M; Filsuf, D; Chen, HT; Gazumyan, A; Yamane, A; Cho, YW; Sun, HW; Ge, K; Peng, WQ; Nussenzweig, MC; Casellas, R; Dressler, GR; Zhao, KJ; Nussenzweig, A				Daniel, Jeremy A.; Santos, Margarida Almeida; Wang, Zhibin; Zang, Chongzhi; Schwab, Kristopher R.; Jankovic, Mila; Filsuf, Darius; Chen, Hua-Tang; Gazumyan, Anna; Yamane, Arito; Cho, Young-Wook; Sun, Hong-Wei; Ge, Kai; Peng, Weiqun; Nussenzweig, Michel C.; Casellas, Rafael; Dressler, Gregory R.; Zhao, Keji; Nussenzweig, Andre			PTIP Promotes Chromatin Changes Critical for Immunoglobulin Class Switch Recombination	SCIENCE			English	Article							LYSINE-4 METHYLTRANSFERASE COMPLEX; CYTIDINE DEAMINASE AID; RNA-POLYMERASE-II; BRCT-DOMAIN; HISTONE MODIFICATIONS; CHROMOSOME BREAKS; PROTEIN PTIP; DNA-DAMAGE; TRANSCRIPTION; METHYLATION	Programmed genetic rearrangements in lymphocytes require transcription at antigen receptor genes to promote accessibility for initiating double-strand break (DSB) formation critical for DNA recombination and repair. Here, we showed that activated B cells deficient in the PTIP component of the MLL3 (mixed-lineage leukemia 3)-MLL4 complex display impaired trimethylation of histone 3 at lysine 4 (H3K4me3) and transcription initiation of downstream switch regions at the immunoglobulin heavy-chain (Igh) locus, leading to defective immunoglobulin class switching. We also showed that PTIP accumulation at DSBs contributes to class switch recombination (CSR) and genome stability independently of Igh switch transcription. These results demonstrate that PTIP promotes specific chromatin changes that control the accessibility of the Igh locus to CSR and suggest a nonredundant role for the MLL3-MLL4 complex in altering antibody effector function.	[Daniel, Jeremy A.; Santos, Margarida Almeida; Filsuf, Darius; Chen, Hua-Tang; Nussenzweig, Andre] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Wang, Zhibin; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Zang, Chongzhi; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Schwab, Kristopher R.; Dressler, Gregory R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Jankovic, Mila; Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Jankovic, Mila; Gazumyan, Anna; Nussenzweig, Michel C.] Howard Hughes Med Inst, New York, NY 10065 USA; [Yamane, Arito; Casellas, Rafael] NIAMSD NIAMS, Bethesda, MD 20892 USA; [Cho, Young-Wook; Ge, Kai] NIDDKD, Nucl Receptor Biol Sect, CEB, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMS, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University; University of Michigan System; University of Michigan; Rockefeller University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Zang, Chongzhi/D-1445-2011; Yamane, Arito/A-2959-2013; Ge, Kai/H-2810-2019; Daniel, Jeremy/S-4729-2016; Santos, Margarida/GWR-2285-2022; /AAI-2516-2019; Cho, Young-Wook/F-8269-2011; Nussenzweig, Michel/AAE-7292-2019	Zang, Chongzhi/0000-0003-4812-3627; Ge, Kai/0000-0002-7442-5138; Daniel, Jeremy/0000-0002-1981-5571; Peng, Weiqun/0000-0001-5521-9091; Schwab, Kristopher/0000-0001-8056-1817	NIH, National Cancer Institute, and Center for Cancer Research; National Heart, Lung, and Blood Institute; NIH; NATIONAL CANCER INSTITUTE [ZIABC010959, ZICBC009255, ZIABC010283] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZIAHL006030, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041149, ZICAR041181, ZIHAR041173, ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075003, ZIADK047055] Funding Source: NIH RePORTER	NIH, National Cancer Institute, and Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Gutierrez-Cruz, V. Sartorelli, M. Kruhlak, K. Cui, and Q. Tang for technical assistance. This work was supported by funding from the Intramural Research Program of the NIH, National Cancer Institute, and Center for Cancer Research to A.N.; the Division of Intramural Research at the National Heart, Lung, and Blood Institute to K.Z.; and an NIH Director's Challenge Award on "Epigenomic regulation of mammalian development and differentiation" to A.N., K.Z., and R.C. M.C.N. is a Howard Hughes Medical Institute investigator. The authors declare no competing financial interests and apologize for not being able to cite all primary references due to space limitations. All sequence data have been deposited in the Gene Expression Omnibus database (accession number GSE20852) at http://ncbi.nlm.nih.gov/geo/.	Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Cho EA, 2003, MOL CELL BIOL, V23, P1666, DOI 10.1128/MCB.23.5.1666-1673.2003; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Fang M, 2009, DEVELOPMENT, V136, P1929, DOI 10.1242/dev.026559; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Kuang FL, 2009, P NATL ACAD SCI USA, V106, P5288, DOI 10.1073/pnas.0901368106; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Wang LL, 2009, J EXP MED, V206, P1817, DOI 10.1084/jem.20081678; Wang X, 2010, GENES CELLS, V15, P243, DOI 10.1111/j.1365-2443.2009.01379.x; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Wu JX, 2009, J BIOL CHEM, V284, P18078, DOI 10.1074/jbc.M109.002527; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067	39	104	108	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					917	923		10.1126/science.1187942	http://dx.doi.org/10.1126/science.1187942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20671152	Green Accepted			2022-12-24	WOS:000281084800027
J	Xu, TD; Wen, MZ; Nagawa, S; Fu, Y; Chen, JG; Wu, MJ; Perrot-Rechenmann, C; Friml, J; Jones, AM; Yang, ZB				Xu, Tongda; Wen, Mingzhang; Nagawa, Shingo; Fu, Ying; Chen, Jin-Gui; Wu, Ming-Jing; Perrot-Rechenmann, Catherine; Friml, Jiri; Jones, Alan M.; Yang, Zhenbiao			Cell Surface- and Rho GTPase-Based Auxin Signaling Controls Cellular Interdigitation in Arabidopsis	CELL			English	Article							RESPONSIVE GENE-EXPRESSION; BOX PROTEIN TIR1; BINDING PROTEIN-1; PLANT DEVELOPMENT; PLASMA-MEMBRANE; ROP2 GTPASE; LEAF-CELLS; POLARITY; EXPANSION; GROWTH	Auxin is a multifunctional hormone essential for plant development and pattern formation. A nuclear auxin-signaling system controlling auxin-induced gene expression is well established, but cytoplasmic auxin signaling, as in its coordination of cell polarization, is unexplored. We found a cytoplasmic auxin-signaling mechanism that modulates the interdigitated growth of Arabidopsis leaf epidermal pavement cells (PCs), which develop interdigitated lobes and indentations to form a puzzle-piece shape in a two-dimensional plane. PC interdigitation is compromised in leaves deficient in either auxin biosynthesis or its export mediated by PINFORMED 1 localized at the lobe tip. Auxin coordinately activates two Rho GTPases, ROP2 and ROP6, which promote the formation of complementary lobes and indentations, respectively. Activation of these ROPs by auxin occurs within 30 s and depends on AUXIN-BINDING PROTEIN 1. These findings reveal Rho GTPase-based auxin-signaling mechanisms, which modulate the spatial coordination of cell expansion across a field of cells.	[Xu, Tongda; Wen, Mingzhang; Nagawa, Shingo; Fu, Ying; Yang, Zhenbiao] Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Chen, Jin-Gui; Wu, Ming-Jing; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Perrot-Rechenmann, Catherine] CNRS, Inst Sci Vegetal, UPR2355, F-91198 Gif Sur Yvette, France; [Friml, Jiri] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Friml, Jiri] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of California System; University of California Riverside; University of North Carolina; University of North Carolina Chapel Hill; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; University of North Carolina; University of North Carolina Chapel Hill	Yang, ZB (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	yang@ucr.edu	Xu, Tongda/ABD-9589-2020; Chen, Jin-Gui/AFV-6337-2022; Chen, Jin-Gui/A-4773-2011; Friml, Jiri/D-9511-2012	Chen, Jin-Gui/0000-0002-1752-4201; Chen, Jin-Gui/0000-0002-1752-4201; Friml, Jiri/0000-0002-8302-7596; Xu, Tongda/0000-0003-3398-9217	U.S. National Institute of General Medical Sciences [GM081451, GM065989]; National Science Foundation [MCB-0718202]; Department of Energy [DE-FG02-05ER15671, DE-FG02-04ER15555]; Research Foundation-Flanders (Odysseus); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989, R01GM100130, R01GM081451] Funding Source: NIH RePORTER	U.S. National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Research Foundation-Flanders (Odysseus)(FWO); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Veronica Grieneisen, Ben Scheres, Athanasius F. M. Maree, Paulien Hogeweg, Xuemei Chen, and G. Venugopala Reddy for their stimulating discussion and critical comments on this manuscript; and to Xinping Cui for her assistance with the statistical analysis. We are grateful to Tom Guil-foyle and Yunde Zhao for their generous supply of Arabidopsis mutant lines used in this work. This work is supported by grants from the U.S. National Institute of General Medical Sciences to Z.Y. (GM081451) and to A.M.J. (GM065989), by the National Science Foundation to A.M.J. (MCB-0718202) and the Department of Energy to A.M.J. (DE-FG02-05ER15671) and to Z.Y. (DE-FG02-04ER15555) and by the Research Foundation-Flanders (Odysseus) to J.F.	Abel S, 1996, PLANT PHYSIOL, V111, P9, DOI 10.1104/pp.111.1.9; Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Badescu GO, 2006, TRENDS PLANT SCI, V11, P217, DOI 10.1016/j.tplants.2006.03.001; Baxter-Burrell A, 2002, SCIENCE, V296, P2026, DOI 10.1126/science.1071505; Braun N, 2008, PLANT CELL, V20, P2746, DOI 10.1105/tpc.108.059048; Chen JG, 2001, PLANT J, V28, P607, DOI 10.1046/j.1365-313x.2001.01152.x; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; David KM, 2007, PLANT J, V50, P197, DOI 10.1111/j.1365-313X.2007.03038.x; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Dhonukshe P, 2008, NATURE, V456, P962, DOI 10.1038/nature07409; DIEKMANN W, 1995, P NATL ACAD SCI USA, V92, P3425, DOI 10.1073/pnas.92.8.3425; Fischer U, 2006, CURR BIOL, V16, P2143, DOI 10.1016/j.cub.2006.08.091; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Fu Y, 2002, PLANT CELL, V14, P777, DOI 10.1105/tpc.001537; Fu Y, 2009, CURR BIOL, V19, P1827, DOI 10.1016/j.cub.2009.08.052; Green JBA, 2007, NAT CELL BIOL, V9, P1010, DOI 10.1038/ncb438; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hazak O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000282; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Hwang JU, 2005, MOL BIOL CELL, V16, P5385, DOI 10.1091/mbc.E05-05-0409; JONES AM, 1993, PLANT PHYSIOL, V101, P595, DOI 10.1104/pp.101.2.595; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; JONES AM, 1994, ANNU REV PLANT PHYS, V45, P393, DOI 10.1146/annurev.pp.45.060194.002141; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; Mathur J, 1997, BIOTECHNIQUES, V22, P280, DOI 10.2144/97222bm19; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Paciorek T, 2005, NATURE, V435, P1251, DOI 10.1038/nature03633; Parry G, 2006, CURR OPIN CELL BIOL, V18, P152, DOI 10.1016/j.ceb.2006.02.001; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Sauer M, 2006, GENE DEV, V20, P2902, DOI 10.1101/gad.390806; SENN AP, 1988, PLANT PHYSIOL, V88, P131, DOI 10.1104/pp.88.1.131; Settleman J, 2005, CELL, V120, P570, DOI 10.1016/j.cell.2005.02.025; Sheen J, 2001, PLANT PHYSIOL, V127, P1466, DOI 10.1104/pp.010820; Shimomura S, 2006, PLANT MOL BIOL, V60, P663, DOI 10.1007/s11103-005-5471-1; Shishova M, 2004, J PLANT PHYSIOL, V161, P937, DOI 10.1016/j.jplph.2003.12.005; Steffens B, 2001, PLANT J, V27, P591, DOI 10.1046/j.1365-313X.2001.01103.x; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Tao LZ, 2002, PLANT CELL, V14, P2745, DOI 10.1105/tpc.006320; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wasteneys GO, 1997, J MICROSC-OXFORD, V188, P51, DOI 10.1046/j.1365-2818.1977.2390796.x; Wisniewska J, 2006, SCIENCE, V312, P883, DOI 10.1126/science.1121356; Woo EJ, 2002, EMBO J, V21, P2877, DOI 10.1093/emboj/cdf291; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yang ZB, 2008, ANNU REV CELL DEV BI, V24, P551, DOI 10.1146/annurev.cellbio.23.090506.123233; Zhao YD, 2001, SCIENCE, V291, P306, DOI 10.1126/science.291.5502.306	52	332	359	4	103	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					99	110		10.1016/j.cell.2010.09.003	http://dx.doi.org/10.1016/j.cell.2010.09.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887895	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000282362000017
J	Ohta, S; Bukowski-Wills, JC; Sanchez-Pulido, L; Alves, FD; Wood, L; Chen, ZA; Platani, M; Fischer, L; Hudson, DF; Ponting, CP; Fukagawa, T; Earnshaw, WC; Rappsilber, J				Ohta, Shinya; Bukowski-Wills, Jimi-Carlo; Sanchez-Pulido, Luis; Alves, Flavia de Lima; Wood, Laura; Chen, Zhuo A.; Platani, Melpi; Fischer, Lutz; Hudson, Damien F.; Ponting, Chris P.; Fukagawa, Tatsuo; Earnshaw, William C.; Rappsilber, Juri			The Protein Composition of Mitotic Chromosomes Determined Using Multiclassifier Combinatorial Proteomics	CELL			English	Article							QUANTITATIVE PROTEOMICS; CENP-A; REVEALS; COMPLEX; IDENTIFICATION	Despite many decades of study, mitotic chromosome structure and composition remain poorly characterized. Here, we have integrated quantitative proteomics with bioinformatic analysis to generate a series of independent classifiers that describe the similar to 4,000 proteins identified in isolated mitotic chromosomes. Integrating these classifiers by machine learning uncovers functional relationships between protein complexes in the context of intact chromosomes and reveals which of the similar to 560 uncharacterized proteins identified here merits further study. Indeed, of 34 GFP-tagged predicted chromosomal proteins, 30 were chromosomal, including 13 with centromere-association. Of 16 GFP-tagged predicted nonchromosomal proteins, 14 were confirmed to be nonchromosomal. An unbiased analysis of the whole chromosome proteome from genetic knockouts of kinetochore protein Ska3/Rama1 revealed that the APC/C and RanBP2/RanGAP1 complexes depend on the Ska complex for stable association with chromosomes. Our integrated analysis predicts that up to 97 new centromere-associated proteins remain to be discovered in our data set.	[Ohta, Shinya; Bukowski-Wills, Jimi-Carlo; Alves, Flavia de Lima; Wood, Laura; Chen, Zhuo A.; Platani, Melpi; Fischer, Lutz; Hudson, Damien F.; Earnshaw, William C.; Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Bukowski-Wills, Jimi-Carlo] Univ Edinburgh, Ctr Syst Biol Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Fukagawa, Tatsuo] Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan; [Fukagawa, Tatsuo] Grad Univ Adv Studies, Mishima, Shizuoka 4118540, Japan; [Sanchez-Pulido, Luis; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3QX, England	University of Edinburgh; University of Edinburgh; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; University of Oxford	Earnshaw, WC (corresponding author), Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland.	bill.earnshaw@ed.ac.uk; juri.rappsilber@ed.ac.uk	Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015; Earnshaw, William/AAY-7438-2020; Fukagawa, Tatsuo/AAK-3922-2021; Ponting, Chris/AAV-2621-2021	Rappsilber, Juri/0000-0001-5999-1310; Earnshaw, William/0000-0002-7191-0621; CHEN, ZHUO/0000-0003-0811-8348; Sanchez Pulido, Luis/0000-0002-2300-8502; Wills, Jimi/0000-0003-1669-007X; Ponting, Chris/0000-0003-0202-7816; Fischer, Lutz/0000-0003-4978-0864; Platani, Melpomeni/0000-0001-6408-4774; Ohta, Shinya/0000-0003-2424-1741	European Community; MRC; EMBO; Wellcome Trust; BBSRC [BB/D019621/1] Funding Source: UKRI; MRC [MC_U137761446] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1] Funding Source: researchfish; Medical Research Council [MC_U137761446] Funding Source: researchfish	European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EMBO(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We dedicate this paper to Uli Laemmli on the occasion of his 70th birthday. We thank Mayumi Takahashi for assistance with preparation of the Ska3/Rama1 knockout, Frauke Melchior for anti-RanBP2 and David Tollervey, Margarete Heck, Robin Allshire, Iain Cheeseman, Kumiko Samejima, Susana Ribeiro and Jan Bergmann for critical reading of the manuscript. This work was supported by a European Community Marie Curie Excellence Grant (JR), the MRC (CPP), EMBO (LSP) and the Wellcome Trust (WCE, JR). WCE and JR are Principal and Senior Research Fellows of The Wellcome Trust, respectively.	ALTAF M, 2010, J BIOL CHEM IN PRESS; Amano M, 2009, J CELL BIOL, V186, P173, DOI 10.1083/jcb.200903100; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Andrade MA, 2000, J MOL BIOL, V298, P521, DOI 10.1006/jmbi.2000.3684; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daum JR, 2009, CURR BIOL, V19, P1467, DOI 10.1016/j.cub.2009.07.017; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96; Gassmann R, 2005, CHROMOSOMA, V113, P385, DOI 10.1007/s00412-004-0326-0; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; JIANG WD, 1993, MOL CELL BIOL, V13, P4884, DOI 10.1128/MCB.13.8.4884; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kops GJPL, 2010, J CELL SCI, V123, P1623, DOI 10.1242/jcs.061549; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; LEWIS CD, 1982, CELL, V29, P171, DOI 10.1016/0092-8674(82)90101-5; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Maiato H, 2002, J CELL BIOL, V157, P749, DOI 10.1083/jcb.200201101; Marin I, 2003, J MOL EVOL, V56, P527, DOI 10.1007/s00239-002-2422-1; Morrison C, 2002, NUCLEIC ACIDS RES, V30, P5318, DOI 10.1093/nar/gkf665; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Okada M, 2006, NAT CELL BIOL, V8, P446, DOI 10.1038/ncb1396; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Porter IM, 2007, J CELL BIOL, V179, P187, DOI 10.1083/jcb.200704098; Raaijmakers JA, 2009, J CELL SCI, V122, P2436, DOI 10.1242/jcs.051912; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Takata H, 2007, GENES CELLS, V12, P269, DOI 10.1111/j.1365-2443.2007.01051.x; Theis M, 2009, EMBO J, V28, P1453, DOI 10.1038/emboj.2009.114; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Uchiyama S, 2005, J BIOL CHEM, V280, P16994, DOI 10.1074/jbc.M412774200; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Welburn JPI, 2009, DEV CELL, V16, P374, DOI 10.1016/j.devcel.2009.01.011; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Wu WH, 2005, NAT STRUCT MOL BIOL, V12, P1064, DOI 10.1038/nsmb1023	50	212	233	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2010	142	5					810	821		10.1016/j.cell.2010.07.047	http://dx.doi.org/10.1016/j.cell.2010.07.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	646FL	20813266	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000281523200023
J	Altshuler, DM; Gibbs, RA; Peltonen, L; Dermitzakis, E; Schaffner, SF; Yu, FL; Bonnen, PE; de Bakker, PIW; Deloukas, P; Gabriel, SB; Gwilliam, R; Hunt, S; Inouye, M; Jia, XM; Palotie, A; Parkin, M; Whittaker, P; Chang, K; Hawes, A; Lewis, LR; Ren, YR; Wheeler, D; Muzny, DM; Barnes, C; Darvishi, K; Hurles, M; Korn, JM; Kristiansson, K; Lee, C; McCarroll, SA; Nemesh, J; Keinan, A; Montgomery, SB; Pollack, S; Price, AL; Soranzo, N; Gonzaga-Jauregui, C; Anttila, V; Brodeur, W; Daly, MJ; Leslie, S; McVean, G; Moutsianas, L; Nguyen, H; Zhang, QR; Ghori, MJR; McGinnis, R; McLaren, W; Takeuchi, F; Grossman, SR; Shlyakhter, I; Hostetter, EB; Sabeti, PC; Adebamowo, CA; Foster, MW; Gordon, DR; Licinio, J; Manca, MC; Marshall, PA; Matsuda, I; Ngare, D; Wang, VO; Reddy, D; Rotimi, CN; Royal, CD; Sharp, RR; Zeng, CQ; Brooks, LD; McEwen, JE				Altshuler, David M.; Gibbs, Richard A.; Peltonen, Leena; Dermitzakis, Emmanouil; Schaffner, Stephen F.; Yu, Fuli; Bonnen, Penelope E.; de Bakker, Paul I. W.; Deloukas, Panos; Gabriel, Stacey B.; Gwilliam, Rhian; Hunt, Sarah; Inouye, Michael; Jia, Xiaoming; Palotie, Aarno; Parkin, Melissa; Whittaker, Pamela; Chang, Kyle; Hawes, Alicia; Lewis, Lora R.; Ren, Yanru; Wheeler, David; Muzny, Donna Marie; Barnes, Chris; Darvishi, Katayoon; Hurles, Matthew; Korn, Joshua M.; Kristiansson, Kati; Lee, Charles; McCarroll, Steven A.; Nemesh, James; Keinan, Alon; Montgomery, Stephen B.; Pollack, Samuela; Price, Alkes L.; Soranzo, Nicole; Gonzaga-Jauregui, Claudia; Anttila, Verneri; Brodeur, Wendy; Daly, Mark J.; Leslie, Stephen; McVean, Gil; Moutsianas, Loukas; Nguyen, Huy; Zhang, Qingrun; Ghori, Mohammed J. R.; McGinnis, Ralph; McLaren, William; Takeuchi, Fumihiko; Grossman, Sharon R.; Shlyakhter, Ilya; Hostetter, Elizabeth B.; Sabeti, Pardis C.; Adebamowo, Clement A.; Foster, Morris W.; Gordon, Deborah R.; Licinio, Julio; Manca, Maria Cristina; Marshall, Patricia A.; Matsuda, Ichiro; Ngare, Duncan; Wang, Vivian Ota; Reddy, Deepa; Rotimi, Charles N.; Royal, Charmaine D.; Sharp, Richard R.; Zeng, Changqing; Brooks, Lisa D.; McEwen, Jean E.		Int HapMap 3 Consortium	Integrating common and rare genetic variation in diverse human populations	NATURE			English	Article							GENOME-WIDE ASSOCIATION; COPY NUMBER VARIATION; POSITIVE SELECTION; HAPLOTYPE MAP; VARIANTS; DISEASES; SIGNALS; REGIONS; SNPS	Despite great progress in identifying genetic variants that influence human disease, most inherited risk remains unexplained. A more complete understanding requires genome-wide studies that fully examine less common alleles in populations with a wide range of ancestry. To inform the design and interpretation of such studies, we genotyped 1.6 million common single nucleotide polymorphisms (SNPs) in 1,184 reference individuals from 11 global populations, and sequenced ten 100-kilobase regions in 692 of these individuals. This integrated data set of common and rare alleles, called 'HapMap 3', includes both SNPs and copy number polymorphisms (CNPs). We characterized population-specific differences among low-frequency variants, measured the improvement in imputation accuracy afforded by the larger reference panel, especially in imputing SNPs with a minor allele frequency of <= 5%, and demonstrated the feasibility of imputing newly discovered CNPs and SNPs. This expanded public resource of genome variants in global populations supports deeper interrogation of genomic variation and its role in human disease, and serves as a step towards a high-resolution map of the landscape of human genetic variation.	[Altshuler, David M.; Schaffner, Stephen F.; de Bakker, Paul I. W.; Gabriel, Stacey B.; Jia, Xiaoming; Parkin, Melissa; Korn, Joshua M.; McCarroll, Steven A.; Pollack, Samuela; Brodeur, Wendy; Nguyen, Huy; Shlyakhter, Ilya] Broad Inst, Cambridge, MA 02138 USA; [Gibbs, Richard A.; Yu, Fuli; Bonnen, Penelope E.; Chang, Kyle; Hawes, Alicia; Lewis, Lora R.; Ren, Yanru; Wheeler, David; Muzny, Donna Marie; Gonzaga-Jauregui, Claudia] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dermitzakis, Emmanouil; Montgomery, Stephen B.] Univ Geneva, Sch Med, Dept Genet Med & Dev, Fac Med, CH-1211 Geneva, Switzerland; [de Bakker, Paul I. W.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, Boston, MA 02115 USA; [Deloukas, Panos; Gwilliam, Rhian; Hunt, Sarah; Inouye, Michael; Palotie, Aarno; Whittaker, Pamela; Barnes, Chris; Hurles, Matthew; Kristiansson, Kati; Soranzo, Nicole; Anttila, Verneri; Zhang, Qingrun; Ghori, Mohammed J. R.; McGinnis, Ralph; McLaren, William; Takeuchi, Fumihiko] Wellcome Trust Sanger Inst, Dept Human Genet, Cambridge CB10 1HH, England; [Palotie, Aarno; Anttila, Verneri] Univ Helsinki, Inst Mol Med Finland, FIN-00290 Helsinki, Finland; [Palotie, Aarno; Anttila, Verneri] Univ Helsinki, Dept Med Genet, FIN-00290 Helsinki, Finland; [Palotie, Aarno; Anttila, Verneri] Univ Cent Hosp, Helsinki 00290, Finland; [Darvishi, Katayoon; Lee, Charles] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Keinan, Alon] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Simches Res Ctr, Boston, MA 02114 USA; [Leslie, Stephen; McVean, Gil; Moutsianas, Loukas] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Grossman, Sharon R.; Hostetter, Elizabeth B.; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02215 USA; [Adebamowo, Clement A.] Univ Maryland, Sch Med, Dept Epidemiol & Preventat Med, Inst Human Virol N406, Baltimore, MD 21201 USA; [Foster, Morris W.] Univ Oklahoma, Dept Anthropol, Norman, OK 73019 USA; [Gordon, Deborah R.] Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA; [Licinio, Julio] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2603, Australia; [Manca, Maria Cristina] Inst Oncol Study & Prevent, I-50139 Florence, Italy; [Marshall, Patricia A.] Case Western Reserve Univ, Dept Bioeth, Sch Med TA200, Cleveland, OH 44106 USA; [Matsuda, Ichiro] Hlth Sci Univ Hokkaido, Tobetsu, Hokkaido 0610293, Japan; [Ngare, Duncan] Moi Univ, Dept Populat & Family Hlth, Eldoret 30100, Kenya; [Wang, Vivian Ota; Brooks, Lisa D.; McEwen, Jean E.] NHGRI, NIH, Bethesda, MD 20892 USA; [Reddy, Deepa] Univ Houston Clear Lake City, Dept Anthropol, Houston, TX 77058 USA; [Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA; [Royal, Charmaine D.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Sharp, Richard R.] Cleveland Clin, Dept Bioeth, Cleveland, OH 44124 USA; [Zeng, Changqing] Chinese Acad Sci, Beijing Inst Genom, Beijing 101300, Peoples R China	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Baylor College of Medicine; University of Geneva; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Wellcome Trust Sanger Institute; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; University of Oxford; Harvard University; University System of Maryland; University of Maryland Baltimore; University of Oklahoma System; University of Oklahoma - Norman; University of California System; University of California San Francisco; Australian National University; John Curtin School of Medical Research; Case Western Reserve University; Health Sciences University of Hokkaido; Moi University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Houston System; University of Houston; University of Houston Clear Lake; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Duke University; Cleveland Clinic Foundation; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Altshuler, DM (corresponding author), Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02138 USA.	altshuler@molbio.mgh.harvard.edu; agibbs@bcm.edu	Deloukas, Panos/B-2922-2013; Sabeti, Pardis/GQH-8610-2022; Adebamowo, Clement/C-8778-2011; Wheeler, David A/M-9740-2018; Daly, Mark J/B-2453-2017; Dermitzakis, Emmanouil/B-7687-2013; de Bakker, Paul IW/B-8730-2009; Licinio, Julio/L-4244-2013; Altshuler, David M/A-4476-2009; Schaffner, Stephen F/D-1189-2011; Nguyen, Huy/GWQ-6433-2022; Nguyen, Huy/AAF-9560-2019; Gonzaga-Jauregui, Claudia/H-4752-2019	Deloukas, Panos/0000-0001-9251-070X; Adebamowo, Clement/0000-0002-6571-2880; Wheeler, David A/0000-0002-9056-6299; Daly, Mark J/0000-0002-0949-8752; de Bakker, Paul IW/0000-0001-7735-7858; Licinio, Julio/0000-0001-6905-5884; Altshuler, David M/0000-0002-7250-4107; Nguyen, Huy/0000-0002-5896-9661; Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; McGinnis, Ralph/0000-0003-4540-9857; Hunt, Sarah/0000-0002-8350-1235; Anttila, Verneri/0000-0002-0073-4675; Chang, Kyle/0000-0001-5295-9676; McLaren, William/0000-0001-6218-1116; Montgomery, Stephen/0000-0002-5200-3903; Soranzo, Nicole/0000-0003-1095-3852; Barnes, Chris/0000-0002-9459-1395; Inouye, Michael/0000-0001-9413-6520; Jia, Xiaoming/0000-0002-5104-5431; Schaffner, Stephen/0000-0001-6699-3568; Palotie, Aarno/0000-0002-2527-5874; Keinan, Alon/0000-0002-9760-1122; Kristiansson, Kati/0000-0003-4688-107X	USA National Institutes of Health; National Human Genome Research Institute; National Institute on Deafness and Other Communication Disorders; Wellcome Trust [068545/Z/02, 076113]; Louis-Jeantet Foundation; NCCR 'Frontiers in Genetics' (Swiss National Science Foundation); UK Medical Research Council [G0000934]; Medical Research Council [G0000934] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; MRC [G0000934] Funding Source: UKRI	USA National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Wellcome Trust(Wellcome TrustEuropean Commission); Louis-Jeantet Foundation; NCCR 'Frontiers in Genetics' (Swiss National Science Foundation)(Swiss National Science Foundation (SNSF)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We dedicate this work to Leena Peltonen for her vital leadership role in this study, and in memory of a valued friend and colleague. We thank E. Boerwinkle and R. Durbin for critical reading of the manuscript. We thank the USA National Institutes of Health, the National Human Genome Research Institute, the National Institute on Deafness and Other Communication Disorders and the Wellcome Trust for supporting the majority of this work. Funding was also provided by the Louis-Jeantet Foundation and the NCCR 'Frontiers in Genetics' (Swiss National Science Foundation). We thank the people from the following communities who were generous in donating their blood samples to be studied in this project: the Yoruba in Ibadan, Nigeria; the Maasai in Kinyawa, Kenya; the Luhya in Webuye, Kenya; the Han Chinese in Beijing, China; the Japanese in Tokyo, Japan; the Chinese in metropolitan Denver, Colorado; the Gujarati Indians in Houston, Texas; the Toscani in Italia; the community of African ancestry in the southwestern USA; and the community of Mexican ancestry in Los Angeles, California. We also thank the people in the Utah Centre d'Etude du Polymorphisme Humain community who allowed the samples they donated earlier to be used for the project. The authors acknowledge use of DNA from the 1958 British birth cohort collection, funded by the UK Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. The Illumina 550K genotype data for the 1958 British birth cohort samples were made available by the Sanger Institute. For the 1958 British birth cohort Affymetrix 500K genotype data, we thank the Wellcome Trust Case Control Consortium (http://www.wtccc.org.uk), which was funded by Wellcome Trust award 076113.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Gu JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005767; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Pe'er I, 2006, AM J HUM GENET, V78, P588, DOI 10.1086/502803; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053	27	1883	1912	3	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					52	58		10.1038/nature09298	http://dx.doi.org/10.1038/nature09298			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811451	Green Accepted			2022-12-24	WOS:000281461200033
J	Li, NX; Lee, B; Liu, RJ; Banasr, M; Dwyer, JM; Iwata, M; Li, XY; Aghajanian, G; Duman, RS				Li, Nanxin; Lee, Boyoung; Liu, Rong-Jian; Banasr, Mounira; Dwyer, Jason M.; Iwata, Masaaki; Li, Xiao-Yuan; Aghajanian, George; Duman, Ronald S.			mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists	SCIENCE			English	Article							MAJOR DEPRESSIVE DISORDER; D-ASPARTATE ANTAGONIST; KETAMINE; DISEASE	The rapid antidepressant response after ketamine administration in treatment-resistant depressed patients suggests a possible new approach for treating mood disorders compared to the weeks or months required for standard medications. However, the mechanisms underlying this action of ketamine [a glutamate N-methyl-D-aspartic acid (NMDA) receptor antagonist] have not been identified. We observed that ketamine rapidly activated the mammalian target of rapamycin (mTOR) pathway, leading to increased synaptic signaling proteins and increased number and function of new spine synapses in the prefrontal cortex of rats. Moreover, blockade of mTOR signaling completely blocked ketamine induction of synaptogenesis and behavioral responses in models of depression. Our results demonstrate that these effects of ketamine are opposite to the synaptic deficits that result from exposure to stress and could contribute to the fast antidepressant actions of ketamine.	[Duman, Ronald S.] Yale Univ, Sch Med, Dept Psychiat, Lab Mol Psychiat,Ctr Genes & Behav, New Haven, CT 06508 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06508 USA	Yale University; Yale University	Duman, RS (corresponding author), Yale Univ, Sch Med, Dept Psychiat, Lab Mol Psychiat,Ctr Genes & Behav, 34 Pk St, New Haven, CT 06508 USA.	ronald.duman@yale.edu	Li, Nanxin/D-9755-2011; Lee, Boyoung/AAV-8719-2021; Iwata, Masaaki/AAP-3732-2020	Lee, Boyoung/0000-0001-9445-510X; Iwata, Masaaki/0000-0002-6143-0181	U.S. Public Health Service [MH45481, 2P01 MH25642]; Connecticut Mental Health Center; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045481, P01MH025642, R29MH045481, R37MH045481] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Connecticut Mental Health Center; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by U.S. Public Health Service grants MH45481 and 2P01 MH25642 and by the Connecticut Mental Health Center.	Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Drevets WC, 1998, ANNU REV MED, V49, P341, DOI 10.1146/annurev.med.49.1.341; Farber NB, 1998, PROG BRAIN RES, V116, P421, DOI 10.1016/S0079-6123(08)60453-7; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Krystal JH, 2007, SWISS MED WKLY, V137, P215; Lambe EK, 2007, NEUROSCIENCE, V145, P900, DOI 10.1016/j.neuroscience.2006.12.048; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Preskorn SH, 2008, J CLIN PSYCHOPHARM, V28, P631, DOI 10.1097/JCP.0b013e31818a6cea; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	14	1875	1970	11	378	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					959	964		10.1126/science.1190287	http://dx.doi.org/10.1126/science.1190287			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724638	Green Accepted			2022-12-24	WOS:000281084800039
J	Guo, HL; Ingolia, NT; Weissman, JS; Bartel, DP				Guo, Huili; Ingolia, Nicholas T.; Weissman, Jonathan S.; Bartel, David P.			Mammalian microRNAs predominantly act to decrease target mRNA levels	NATURE			English	Article							GENOME-WIDE ANALYSIS; POSTTRANSCRIPTIONAL REGULATION; PROTEIN-SYNTHESIS; IN-VIVO; TRANSLATION; INITIATION; DEADENYLATION; DEGRADATION; ELEGANS; MIRNAS	MicroRNAs (miRNAs) are endogenous similar to 22-nucleotide RNAs that mediate important gene-regulatory events by pairing to the mRNAs of protein-coding genes to direct their repression. Repression of these regulatory targets leads to decreased translational efficiency and/or decreased mRNA levels, but the relative contributions of these two outcomes have been largely unknown, particularly for endogenous targets expressed at low-to-moderate levels. Here, we use ribosome profiling to measure the overall effects on protein production and compare these to simultaneously measured effects on mRNA levels. For both ectopic and endogenous miRNA regulatory interactions, lowered mRNA levels account for most (>= 84%) of the decreased protein production. These results show that changes in mRNA levels closely reflect the impact of miRNAs on gene expression and indicate that destabilization of target mRNAs is the predominant reason for reduced protein output.	[Guo, Huili; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Guo, Huili; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Guo, Huili; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu		Guo, Huili/0000-0002-2294-5684; Weissman, Jonathan/0000-0003-2445-670X	NIH; Agency for Science, Technology and Research, Singapore; Ruth L. Kirschstein National Research Service Award [GM080853]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080853, R01GM067031] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Camargo, C. Jan, J. Kim and C. Petersen for advice and discussions, R. Green and O. Rissland for comments on the manuscript, and the Whitehead Institute's Genome Technology Core for sequencing and microarray profiling. This work was supported by grants from the NIH (D. P. B. and J. S. W.). H. G. was supported by the Agency for Science, Technology and Research, Singapore. N.T.I. was supported by a Ruth L. Kirschstein National Research Service Award (GM080853). D. P. B and J. S. W. are investigators of the Howard Hughes Medical Institute.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103	34	2936	3049	4	337	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					835	U66		10.1038/nature09267	http://dx.doi.org/10.1038/nature09267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703300	Green Submitted, Green Accepted			2022-12-24	WOS:000280766100029
J	Ho, CY; Lopez, B; Coelho-Filho, OR; Lakdawala, NK; Cirino, AL; Jarolim, P; Kwong, R; Gonzalez, A; Colan, SD; Seidman, JG; Diez, J; Seidman, CE				Ho, Carolyn Y.; Lopez, Begona; Coelho-Filho, Otavio R.; Lakdawala, Neal K.; Cirino, Allison L.; Jarolim, Petr; Kwong, Raymond; Gonzalez, Arantxa; Colan, Steven D.; Seidman, J. G.; Diez, Javier; Seidman, Christine E.			Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIAC MAGNETIC-RESONANCE; EXTRACELLULAR-MATRIX TURNOVER; LEFT-VENTRICULAR FUNCTION; HEART-FAILURE; DILATED CARDIOMYOPATHY; DELAYED ENHANCEMENT; BIOCHEMICAL MARKERS; GENE-MUTATIONS; SERUM; ECHOCARDIOGRAPHY	BACKGROUND Myocardial fibrosis is a hallmark of hypertrophic cardiomyopathy and a proposed substrate for arrhythmias and heart failure. In animal models, profibrotic genetic pathways are activated early, before hypertrophic remodeling. Data showing early profibrotic responses to sarcomere-gene mutations in patients with hypertrophic cardiomyopathy are lacking. METHODS We used echocardiography, cardiac magnetic resonance imaging (MRI), and serum biomarkers of collagen metabolism, hemodynamic stress, and myocardial injury to evaluate subjects with hypertrophic cardiomyopathy and a confirmed genotype. RESULTS The study involved 38 subjects with pathogenic sarcomere mutations and overt hypertrophic cardiomyopathy, 39 subjects with mutations but no left ventricular hypertrophy, and 30 controls who did not have mutations. Levels of serum C-terminal propeptide of type I procollagen (PICP) were significantly higher in mutation carriers without left ventricular hypertrophy and in subjects with overt hypertrophic cardiomyopathy than in controls (31% and 69% higher, respectively; P<0.001). The ratio of PICP to C-terminal telopeptide of type I collagen was increased only in subjects with overt hypertrophic cardiomyopathy, suggesting that collagen synthesis exceeds degradation. Cardiac MRI studies showed late gadolinium enhancement, indicating myocardial fibrosis, in 71% of subjects with overt hypertrophic cardiomyopathy but in none of the mutation carriers without left ventricular hypertrophy. CONCLUSIONS Elevated levels of serum PICP indicated increased myocardial collagen synthesis in sarcomere-mutation carriers without overt disease. This profibrotic state preceded the development of left ventricular hypertrophy or fibrosis visible on MRI. (Funded by the National Institutes of Health and others.)	[Ho, Carolyn Y.; Coelho-Filho, Otavio R.; Lakdawala, Neal K.; Cirino, Allison L.; Kwong, Raymond; Seidman, J. G.; Seidman, Christine E.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Jarolim, Petr] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Colan, Steven D.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Seidman, J. G.; Seidman, Christine E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Lopez, Begona; Gonzalez, Arantxa; Diez, Javier] Univ Navarra, Div Cardiovasc Sci, Ctr Appl Med Res, E-31080 Pamplona, Spain; [Lopez, Begona; Gonzalez, Arantxa; Diez, Javier] Univ Navarra, Univ Clin, E-31080 Pamplona, Spain; [Seidman, Christine E.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Navarra; University of Navarra; Howard Hughes Medical Institute	Ho, CY (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	cho@partners.org	Coelho-Filho, Otavio/G-9250-2012; Díez, Javier/D-7014-2017; Coelho-Filho, Otavio/AAV-9557-2021; Colan, Steven/ABB-4580-2020; Kwong, Raymond Y/R-1925-2016; González, Arantxa/D-6860-2017	Coelho-Filho, Otavio/0000-0003-4428-5186; Díez, Javier/0000-0002-3414-6919; Coelho-Filho, Otavio/0000-0003-4428-5186; Kwong, Raymond Y/0000-0001-8212-0759; González, Arantxa/0000-0001-5986-6528; Lopez Salazar, Begona/0000-0001-8508-698X; Ho, Carolyn/0000-0002-7334-7924	National Institutes of Health; Arthur L. Lenahan Sr. Family Foundation; GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease; Howard Hughes Medical Institute; Foundation for Applied Medical Research; Institute of Health Carlos III, Ministry of Science and Innovation; European Union InGenious HyperCare; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL101408, R01HL084553, K23HL078901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthur L. Lenahan Sr. Family Foundation; GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease(GlaxoSmithKline); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Foundation for Applied Medical Research; Institute of Health Carlos III, Ministry of Science and Innovation(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); European Union InGenious HyperCare(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the National Institutes of Health (to Drs. Ho, J.G. Seidman, and C.E. Seidman), the Arthur L. Lenahan Sr. Family Foundation (to Dr. Ho), the GlaxoSmithKline Research and Education Foundation for Cardiovascular Disease (to Dr. Ho), the Howard Hughes Medical Institute (to Dr. C. E. Seidman), and the Foundation for Applied Medical Research and Union Temporal de Empresas project Centro de Investigacion Medica Aplicada, the Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares from the Institute of Health Carlos III, Ministry of Science and Innovation, and the European Union InGenious HyperCare (all to Drs. Lopez, Gonzalez, and Diez).	Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Basso C, 2000, HUM PATHOL, V31, P988, DOI 10.1053/hupa.2000.16659; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Choudhury L, 2002, J AM COLL CARDIOL, V40, P2156, DOI 10.1016/S0735-1097(02)02602-5; Crilley JG, 2003, J AM COLL CARDIOL, V41, P1776, DOI 10.1016/S0735-1097(02)03009-7; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Fassbach M, 2005, Z KARDIOL, V94, P328, DOI 10.1007/s00392-005-0214-5; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Germans T, 2006, J AM COLL CARDIOL, V48, P2518, DOI 10.1016/j.jacc.2006.08.036; Gonzalez A, 2009, CARDIOVASC RES, V81, P509, DOI 10.1093/cvr/cvn235; Grothues F, 2002, AM J CARDIOL, V90, P29, DOI 10.1016/S0002-9149(02)02381-0; Ho CY, 2009, CIRC-CARDIOVASC GENE, V2, P314, DOI 10.1161/CIRCGENETICS.109.862128; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; Kim RJ, 1999, CIRCULATION, V100, P1992, DOI 10.1161/01.CIR.100.19.1992; KLAPPACHER G, 1995, AM J CARDIOL, V75, P913, DOI 10.1016/S0002-9149(99)80686-9; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lombardi R, 2003, CIRCULATION, V108, P1455, DOI 10.1161/01.CIR.0000090687.97972.10; Lombardi R, 2009, CIRCULATION, V119, P1398, DOI 10.1161/CIRCULATIONAHA.108.790501; Lopez B, 2010, CIRCULATION, V121, P1645, DOI 10.1161/CIRCULATIONAHA.109.912774; Marino P, 2002, J AM SOC ECHOCARDIOG, V15, P935, DOI 10.1067/mje.2002.121196; Maron BJ, 2004, J AM COLL CARDIOL, V44, P2125, DOI 10.1016/j.jacc.2004.08.052; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron MS, 2008, CIRC-HEART FAIL, V1, P184, DOI 10.1161/CIRCHEARTFAILURE.108.768119; McKenna WJ, 1997, HEART, V77, P130, DOI 10.1136/hrt.77.2.130; Moon JC, 2005, HEART, V91, P1036, DOI 10.1136/hrt.2004.041384; Moon JCC, 2003, J AM COLL CARDIOL, V41, P1561, DOI 10.1016/S0735-1097(03)00189-X; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nagueh SF, 2001, CIRCULATION, V104, P128, DOI 10.1161/01.CIR.104.2.128; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Noji Y, 2004, CIRC J, V68, P355, DOI 10.1253/circj.68.355; Ommen SR, 2000, CIRCULATION, V102, P1788; Poulsen SH, 2001, CARDIOLOGY, V96, P45, DOI 10.1159/000047385; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Ricciardi MJ, 2001, CIRCULATION, V103, P2780, DOI 10.1161/hc2301.092121; Richard P, 2006, J AM COLL CARDIOL, V48, pA79, DOI 10.1016/j.jacc.2006.09.014; Roldan V, 2008, AM HEART J, V156, P85, DOI 10.1016/j.ahj.2008.01.035; Rudolph A, 2009, J AM COLL CARDIOL, V53, P284, DOI 10.1016/j.jacc.2008.08.064; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shirani J, 2000, J AM COLL CARDIOL, V35, P36, DOI 10.1016/S0735-1097(99)00492-1; Sluysmans T, 2005, J APPL PHYSIOL, V99, P445, DOI 10.1152/japplphysiol.01144.2004; Strauss DG, 2008, CIRC-ARRHYTHMIA ELEC, V1, P327, DOI 10.1161/CIRCEP.108.798660; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; TRIVEDI P, 1991, PEDIATR RES, V30, P276, DOI 10.1203/00006450-199109000-00016; Varnava AM, 2000, HEART, V84, P476, DOI 10.1136/heart.84.5.476; Varnava AM, 2001, AM J CARDIOL, V88, P275, DOI 10.1016/S0002-9149(01)01640-X; Wu E, 2001, LANCET, V357, P21, DOI 10.1016/S0140-6736(00)03567-4; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700	49	442	465	2	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2010	363	6					552	563		10.1056/NEJMoa1002659	http://dx.doi.org/10.1056/NEJMoa1002659			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634BB	20818890	Green Accepted, Green Published			2022-12-24	WOS:000280552700009
J	Kapranov, P; Ozsolak, F; Kim, SW; Foissac, S; Lipson, D; Hart, C; Roels, S; Borel, C; Antonarakis, SE; Monaghan, AP; John, B; Milos, PM				Kapranov, Philipp; Ozsolak, Fatih; Kim, Sang Woo; Foissac, Sylvain; Lipson, Doron; Hart, Chris; Roels, Steve; Borel, Christelle; Antonarakis, Stylianos E.; Monaghan, A. Paula; John, Bino; Milos, Patrice M.			New class of gene-termini-associated human RNAs suggests a novel RNA copying mechanism	NATURE			English	Article							POLYMERASE-II; TRANSCRIPTION	Small (<200 nucleotide) RNA (sRNA) profiling of human cells using various technologies demonstrates unexpected complexity of sRNAs with hundreds of thousands of sRNA species present(1-4). Genetic and in vitro studies show that these RNAs are not merely degradation products of longer transcripts but could indeed have a function(1,2,5). Furthermore, profiling of RNAs, including the sRNAs, can reveal not only novel transcripts, but also make clear predictions about the existence and properties of novel biochemical pathways operating in a cell. For example, sRNA profiling in human cells indicated the existence of an unknown capping mechanism operating on cleaved RNA(2), a biochemical component of which was later identified(6). Here we show that human cells contain a novel type of sRNA that has non-genomically encoded 5' poly(U) tails. The presence of these RNAs at the termini of genes, specifically at the very 3' ends of known mRNAs, strongly argues for the presence of a yet uncharacterized endogenous biochemical pathway in cells that can copy RNA. We show that this pathway can operate on multiple genes, with specific enrichment towards transcript-encoding components of the translational machinery. Finally, we show that genes are also flanked by sense, 3' polyadenylated sRNAs that are likely to be capped.	[Kapranov, Philipp; Ozsolak, Fatih; Lipson, Doron; Hart, Chris; Roels, Steve; Milos, Patrice M.] Helicos BioSci Corp, Cambridge, MA 02139 USA; [Kim, Sang Woo; John, Bino] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Foissac, Sylvain] Integromics SL, Madrid 28760, Spain; [Borel, Christelle; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Monaghan, A. Paula] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Geneva; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kapranov, P (corresponding author), Helicos BioSci Corp, 1 Kendall Sq,Ste B7301, Cambridge, MA 02139 USA.	philippk08@gmail.com; pmilos@helicosbio.com	borel, christelle/AAC-9645-2019; Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823; Kapranov, Philipp/0000-0003-2647-4856; Foissac, Sylvain/0000-0002-2631-5356; Kim, Sang Woo/0000-0002-3144-4822	Swiss National Science Foundation; NIH [GM079756, MH60774]; American Cancer Society [RSG0905401]; Comunidad de Madrid; European Union [Exp. 11/2009]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060774] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Comunidad de Madrid(Comunidad de Madrid); European Union(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to thank A. Willingham, J. Thompson and Z. Li for discussions and help in the preparation of the manuscript. S. E. A. is supported by the Swiss National Science Foundation, B. J. by the NIH (GM079756) and American Cancer Society (RSG0905401), and A. P. M. by the NIH (MH60774). S. F. acknowledges support by a grant from the Comunidad de Madrid and European Union (Exp. 11/2009).	Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Aspegren A, 2004, NUCLEIC ACIDS RES, V32, P4646, DOI 10.1093/nar/gkh804; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Fodor E, 2000, EMBO REP, V1, P513; GILADI E, J COMPUT BI IN PRESS; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Lai MMC, 2005, J VIROL, V79, P7951, DOI 10.1128/JVI.79.13.7951-7958.2005; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Volloch V, 1996, P NATL ACAD SCI USA, V93, P2476, DOI 10.1073/pnas.93.6.2476	19	61	69	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					642	646		10.1038/nature09190	http://dx.doi.org/10.1038/nature09190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20671709	Green Accepted			2022-12-24	WOS:000280412100057
J	Feng, LA; Campbell, EB; Hsiung, YC; MacKinnon, R				Feng, Liang; Campbell, Ernest B.; Hsiung, Yichun; MacKinnon, Roderick			Structure of a Eukaryotic CLC Transporter Defines an Intermediate State in the Transport Cycle	SCIENCE			English	Article							MUSCLE CHLORIDE CHANNEL; DEPENDENT K+ CHANNEL; X-RAY-STRUCTURE; CYTOPLASMIC DOMAIN; MOLECULAR-BASIS; /H+ ANTIPORTER; OSTEOPETROSIS; SELECTIVITY; MUTATIONS; TRANSMEMBRANE	CLC proteins transport chloride (Cl-) ions across cell membranes to control the electrical potential of muscle cells, transfer electrolytes across epithelia, and control the pH and electrolyte composition of intracellular organelles. Some members of this protein family are Cl- ion channels, whereas others are secondary active transporters that exchange Cl- ions and protons (H+) with a 2: 1 stoichiometry. We have determined the structure of a eukaryotic CLC transporter at 3.5 angstrom resolution. Cytoplasmic cystathionine beta-synthase (CBS) domains are strategically positioned to regulate the ion-transport pathway, and many disease-causing mutations in human CLCs reside on the CBS-transmembrane interface. Comparison with prokaryotic CLC shows that a gating glutamate residue changes conformation and suggests a basis for 2: 1 Cl-/H+ exchange and a simple mechanistic connection between CLC channels and transporters.	[Feng, Liang; Campbell, Ernest B.; Hsiung, Yichun; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline; NIGMS NIH HHS [R01 GM043949-21, R01 GM043949-20, R01 GM043949] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; Accardi A, 2010, BBA-BIOMEMBRANES, V1798, P1457, DOI 10.1016/j.bbamem.2010.02.022; Bennetts B, 2005, J BIOL CHEM, V280, P32452, DOI 10.1074/jbc.M502890200; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; Chen TY, 2008, PHYSIOL REV, V88, P351, DOI 10.1152/physrev.00058.2006; DAVE S, CHANNELS AUSTIN, DOI DOI 10.4161/CHAN.4.4.12445; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Engh AM, 2005, J GEN PHYSIOL, V125, P601, DOI 10.1085/jgp.200509258; Frattini A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/jbmr.2003.18.10.1740; Garcia-Olivares J, 2008, J PHYSIOL-LONDON, V586, P5325, DOI 10.1113/jphysiol.2008.158097; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Hebeisen S, 2005, BIOPHYS J, V89, P1710, DOI 10.1529/biophysj.104.056093; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Hryciw DH, 1998, J BIOL CHEM, V273, P4304, DOI 10.1074/jbc.273.8.4304; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lossin C, 2008, ADV GENET, V63, P25, DOI 10.1016/S0065-2660(08)01002-X; Maduke M, 1998, BIOCHEMISTRY-US, V37, P1315, DOI 10.1021/bi972418o; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Matsuda JJ, 2010, J BIOL CHEM, V285, P2569, DOI 10.1074/jbc.M109.018002; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; Miller C, 2009, PHILOS T R SOC B, V364, P175, DOI 10.1098/rstb.2008.0138; Pangrazio A, 2010, HUM MUTAT, V31, pE1071, DOI 10.1002/humu.21167; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Pusch M, 2002, HUM MUTAT, V19, P423, DOI 10.1002/humu.10063; RICHARD EA, 1990, SCIENCE, V247, P1208, DOI 10.1126/science.2156338; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; SchmidtRose T, 1997, J BIOL CHEM, V272, P20515, DOI 10.1074/jbc.272.33.20515; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Waguespack SG, 2003, J BONE MINER RES, V18, P1513, DOI 10.1359/jbmr.2003.18.8.1513; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; ZHANG JM, 1994, J BIOL CHEM, V269, P23518; Zifarelli G, 2007, REV PHYSIOL BIOCH P, V158, P23, DOI 10.1007/112_2006_0605; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	49	195	198	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2010	330	6004					635	641		10.1126/science.1195230	http://dx.doi.org/10.1126/science.1195230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	672KB	20929736	Green Accepted			2022-12-24	WOS:000283580600038
J	Mohrmann, R; de Wit, H; Verhage, M; Neher, E; Sorensen, JB				Mohrmann, Ralf; de Wit, Heidi; Verhage, Matthijs; Neher, Erwin; Sorensen, Jakob B.			Fast Vesicle Fusion in Living Cells Requires at Least Three SNARE Complexes	SCIENCE			English	Article							MEMBRANE-FUSION; SECRETORY VESICLES; EXOCYTOSIS; RELEASE; SYNAPSE; DOMAIN	Exocytosis requires formation of SNARE [soluble N-ethylmaleimide-sensitive factor attachment protein (SNAP) receptor] complexes between vesicle and target membranes. Recent assessments in reduced model systems have produced divergent estimates of the number of SNARE complexes needed for fusion. Here, we used a titration approach to answer this question in intact, cultured chromaffin cells. Simultaneous expression of wild-type SNAP-25 and a mutant unable to support exocytosis progressively altered fusion kinetics and fusion-pore opening, indicating that both proteins assemble into heteromeric fusion complexes. Expressing different wild-type: mutant ratios revealed a third-power relation for fast (synchronous) fusion and a near-linear relation for overall release. Thus, fast fusion typically observed in synapses and neurosecretory cells requires at least three functional SNARE complexes, whereas slower release might occur with fewer complexes. Heterogeneity in SNARE-complex number may explain heterogeneity in vesicular release probability.	[Mohrmann, Ralf; Neher, Erwin; Sorensen, Jakob B.] Max Planck Inst Biophys Chem, Dept Membrane Biophys, Gottingen, Germany; [Mohrmann, Ralf] Univ Saarland, Dept Physiol, D-6650 Homburg, Germany; [de Wit, Heidi; Verhage, Matthijs] Vrije Univ Amsterdam, Dept Funct Genom, Ctr Neurogenom & Cognit Res, Amsterdam, Netherlands; [de Wit, Heidi; Verhage, Matthijs] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Sorensen, Jakob B.] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Sorensen, Jakob B.] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Copenhagen, Denmark	Max Planck Society; Saarland University; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Copenhagen; Lundbeckfonden; University of Copenhagen	Mohrmann, R (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, Gottingen, Germany.	Ralf.Mohrmann@uks.eu; jakobbs@sund.ku.dk	Neher, Erwin/A-2109-2013	verhage, matthijs/0000-0002-6085-7503; Sorensen, Jakob/0000-0001-5465-3769	Lundbeck Foundation; Lundbeck Foundation Center for Biomembranes in Nanomedicine; Danish Medical Research Council; Netherlands Organization for Scientific Research [Pionier/VICI900-01-001, ZonMW 903-42-095, VENI 916-36-043]; NeuroBsik Mouse Phenomics Consortium [BSIK03053]; European Union [HEALTH-F2-2009-242167]; Lundbeck Foundation [R28-2008-1976] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation Center for Biomembranes in Nanomedicine; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NeuroBsik Mouse Phenomics Consortium; European Union(European Commission); Lundbeck Foundation(Lundbeckfonden)	We thank I. Herfort and D. Reuter for expert technical assistance and S. Young for help with viral expression systems. This work was supported by the Lundbeck Foundation (Junior Group Leader Fellowship, J.B.S.), the Lundbeck Foundation Center for Biomembranes in Nanomedicine (J.B.S.), the Danish Medical Research Council (J.B.S.), the Netherlands Organization for Scientific Research (Pionier/VICI900-01-001 and ZonMW 903-42-095 to M.V. and VENI 916-36-043 to H.d.W.), the NeuroBsik Mouse Phenomics Consortium (BSIK03053), and the European Union Seventh Framework Programme under grant agreement no. HEALTH-F2-2009-242167 ("SynSys" project to both J.B.S. and M.V.).	Aikawa Y, 2006, MOL BIOL CELL, V17, P2113, DOI 10.1091/mbc.E06-01-0074; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Karatekin E, 2010, P NATL ACAD SCI USA, V107, P3517, DOI 10.1073/pnas.0914723107; Kweon DH, 2002, BIOCHEMISTRY-US, V41, P5449, DOI 10.1021/bi0256476; Liu W, 2008, BIOPHYS J, V95, P419, DOI 10.1529/biophysj.107.127886; Montecucco C, 2005, TRENDS BIOCHEM SCI, V30, P367, DOI 10.1016/j.tibs.2005.05.002; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sorensen JB, 2009, ANNU REV CELL DEV BI, V25, P513, DOI 10.1146/annurev.cellbio.24.110707.175239; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200; Yersin A, 2003, P NATL ACAD SCI USA, V100, P8736, DOI 10.1073/pnas.1533137100	24	211	213	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 22	2010	330	6003					502	505		10.1126/science.1193134	http://dx.doi.org/10.1126/science.1193134			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	669EL	20847232				2022-12-24	WOS:000283329100039
J	Valentine, DL; Kessler, JD; Redmond, MC; Mendes, SD; Heintz, MB; Farwell, C; Hu, L; Kinnaman, FS; Yvon-Lewis, S; Du, MR; Chan, EW; Tigreros, FG; Villanueva, CJ				Valentine, David L.; Kessler, John D.; Redmond, Molly C.; Mendes, Stephanie D.; Heintz, Monica B.; Farwell, Christopher; Hu, Lei; Kinnaman, Franklin S.; Yvon-Lewis, Shari; Du, Mengran; Chan, Eric W.; Tigreros, Fenix Garcia; Villanueva, Christie J.			Propane Respiration Jump-Starts Microbial Response to a Deep Oil Spill	SCIENCE			English	Article							HYDROCARBON DEGRADATION; METHANE OXIDATION; GEN. NOV.; CARBON; PLUME; BACTERIUM; SEDIMENTS; MARGIN	The Deepwater Horizon event resulted in suspension of oil in the Gulf of Mexico water column because the leakage occurred at great depth. The distribution and fate of other abundant hydrocarbon constituents, such as natural gases, are also important in determining the impact of the leakage but are not yet well understood. From 11 to 21 June 2010, we investigated dissolved hydrocarbon gases at depth using chemical and isotopic surveys and on-site biodegradation studies. Propane and ethane were the primary drivers of microbial respiration, accounting for up to 70% of the observed oxygen depletion in fresh plumes. Propane and ethane trapped in the deep water may therefore promote rapid hydrocarbon respiration by low-diversity bacterial blooms, priming bacterial populations for degradation of other hydrocarbons in the aging plume.	[Valentine, David L.; Redmond, Molly C.; Mendes, Stephanie D.; Heintz, Monica B.; Farwell, Christopher; Kinnaman, Franklin S.; Villanueva, Christie J.] Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA; [Valentine, David L.; Redmond, Molly C.; Mendes, Stephanie D.; Heintz, Monica B.; Farwell, Christopher; Kinnaman, Franklin S.; Villanueva, Christie J.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Kessler, John D.; Hu, Lei; Yvon-Lewis, Shari; Du, Mengran; Chan, Eric W.; Tigreros, Fenix Garcia] Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Texas A&M University System; Texas A&M University College Station	Valentine, DL (corresponding author), Univ Calif Santa Barbara, Dept Earth Sci, Santa Barbara, CA 93106 USA.	valentine@geol.ucsb.edu	Hu, Lei/AAZ-4423-2021; Kessler, John/U-6398-2017; Valentine, David/E-5594-2012; du, mengran/AAO-7295-2021; Yvon-Lewis, Shari/E-4108-2012	Kessler, John/0000-0003-1097-6800; Yvon-Lewis, Shari/0000-0003-1378-8434; Valentine, David/0000-0001-5914-9107; Garcia-Tigreros, Fenix/0000-0001-8694-9046; Redmond, Molly/0000-0003-4227-394X; du, meng ran/0000-0001-8862-5256	National Science Foundation [OCE 1042097, OCE 0961725, OCE 1042650, OCE 0849246]; Department of Energy [DE-NT0005667]; Direct For Education and Human Resources [0929836] Funding Source: National Science Foundation; Division Of Ocean Sciences [0849246] Funding Source: National Science Foundation; Division Of Undergraduate Education [0806926] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Undergraduate Education(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	This research was supported by the National Science Foundation through awards OCE 1042097 and OCE 0961725 to D. L. V. and OCE 1042650 and OCE 0849246 to J.D.K. and by the Department of Energy through award DE-NT0005667 to D. L. V. We thank the captain and crew of the research vessel Cape Hatteras, R. Stephens Smith, R. Amon, K. Goodman S. Bagby, G. Paradis, A. Best, L. Werra, C. Hansen, L. Sanchez, H. Hill, S. Joye, and the staff at Picarro Inc. for valuable technical assistance and discussions. Sequences are available on GenBank, accession numbers HQ222989 to HQ222996.	Brakstad OG, 2008, MICROB ECOL, V55, P540, DOI 10.1007/s00248-007-9299-x; BROOKS JM, 1975, THESIS TEXAS A M U; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Chen FH, 2004, J MARINE SYST, V45, P189, DOI 10.1016/j.jmarsys.2003.11.005; Chung WK, 2001, APPL ENVIRON MICROB, V67, P5585, DOI 10.1128/AEM.67.12.5585-5592.2001; Dasanayaka LK, 2009, J HYDRO-ENVIRON RES, V2, P243, DOI 10.1016/j.jher.2009.01.004; Department of Epidemiology I, 2010, EHES JOINT ACT PROGR, P31; DYKSTERHOUSE SE, 1995, INT J SYST BACTERIOL, V45, P116, DOI 10.1099/00207713-45-1-116; Geiselbrecht AD, 1998, APPL ENVIRON MICROB, V64, P4703; GELWICKS JT, 1994, APPL ENVIRON MICROB, V60, P467, DOI 10.1128/AEM.60.2.467-472.1994; GELWICKS JT, 1989, ORG GEOCHEM, V14, P441, DOI 10.1016/0146-6380(89)90009-0; Grant NJ, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001851; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hedlund BP, 1999, APPL ENVIRON MICROB, V65, P251; Kinnaman FS, 2007, GEOCHIM COSMOCHIM AC, V71, P271, DOI 10.1016/j.gca.2006.09.007; Maruyama A, 2003, MICROBIAL ECOL, V46, P442, DOI 10.1007/s00248-002-3010-z; Mastalerz V, 2009, GEOCHIM COSMOCHIM AC, V73, P3849, DOI 10.1016/j.gca.2008.12.030; Mau S, 2006, MAR GEOL, V225, P129, DOI 10.1016/j.margeo.2005.09.007; Mau S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031344; Redmond MC, 2010, APPL ENVIRON MICROB, V76, P6412, DOI 10.1128/AEM.00271-10; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; Schrope M, 2010, NATURE, V465, P274, DOI 10.1038/465274a; U. S. Geological Survey, 2010, DEEPW HOR MC252 GULF; Valentine DL, 2010, NATURE, V465, P421, DOI 10.1038/465421a; Valentine DL, 2001, GEOCHIM COSMOCHIM AC, V65, P2633, DOI 10.1016/S0016-7037(01)00625-1; YAPA PD, 2008, OCEANS, V1, P109	26	320	330	8	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					208	211		10.1126/science.1196830	http://dx.doi.org/10.1126/science.1196830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20847236				2022-12-24	WOS:000282644600038
J	Kagey, MH; Newman, JJ; Bilodeau, S; Zhan, Y; Orlando, DA; van Berkum, NL; Ebmeier, CC; Goossens, J; Rahl, PB; Levine, SS; Taatjes, DJ; Dekker, J; Young, RA				Kagey, Michael H.; Newman, Jamie J.; Bilodeau, Steve; Zhan, Ye; Orlando, David A.; van Berkum, Nynke L.; Ebmeier, Christopher C.; Goossens, Jesse; Rahl, Peter B.; Levine, Stuart S.; Taatjes, Dylan J.; Dekker, Job; Young, Richard A.			Mediator and cohesin connect gene expression and chromatin architecture	NATURE			English	Article							EMBRYONIC STEM-CELLS; DE-LANGE-SYNDROME; TRANSCRIPTIONAL REGULATORY CIRCUITRY; INTEGRATION HOST FACTOR; NIPPED-B; COACTIVATOR; ACTIVATION; PROTEINS; COMPLEX; MED12	Transcription factors control cell-specific gene expression programs through interactions with diverse coactivators and the transcription apparatus. Gene activation may involve DNA loop formation between enhancer-bound transcription factors and the transcription apparatus at the core promoter, but this process is not well understood. Here we report that mediator and cohesin physically and functionally connect the enhancers and core promoters of active genes in murine embryonic stem cells. Mediator, a transcriptional coactivator, forms a complex with cohesin, which can form rings that connect two DNA segments. The cohesin-loading factor Nipbl is associated with mediator-cohesin complexes, providing a means to load cohesin at promoters. DNA looping is observed between the enhancers and promoters occupied by mediator and cohesin. Mediator and cohesin co-occupy different promoters in different cells, thus generating cell-type-specific DNA loops linked to the gene expression program of each cell.	[Kagey, Michael H.; Newman, Jamie J.; Bilodeau, Steve; Orlando, David A.; Rahl, Peter B.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Newman, Jamie J.; Levine, Stuart S.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Zhan, Ye; van Berkum, Nynke L.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Zhan, Ye; van Berkum, Nynke L.; Dekker, Job] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Ebmeier, Christopher C.; Goossens, Jesse; Taatjes, Dylan J.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Colorado System; University of Colorado Boulder	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	Dylan.Taatjes@Colorado.EDU; young@wi.mit.edu	Young, Richard A/F-6495-2012; Taatjes, Dylan J/G-2027-2011	Young, Richard A/0000-0001-8855-8647; Levine, Stuart/0000-0001-7363-562X; Bilodeau, Steve/0000-0002-9799-3832; Goossens, Jesse/0000-0002-9078-8182	NIH [HG003143, HG002668]; Canadian Institutes of Health Research; American Cancer Society; Keck Distinguished young scholar award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143, R01HG002668] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Cancer Society(American Cancer Society); Keck Distinguished young scholar award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Lee for discussions; D. Root, S. Silver, T. Neiland and H. Le at the RNAi Screening Platform at the Broad Institute for screening advice and technical support; and J.-A. Kwon, J. Love, S. Gupta and T. Volkert for assistance with ChIP-Seq. Immunofluorescence images were collected using the W. M. Keck Foundation Biological Imagining Facility at the Whitehead Institute and Whitehead-MIT Bioimaging Center. This work was supported by Susan Whitehead and Landon and Lavinia Clay, an NIH Fellowship (M. H. K.), a Canadian Institutes of Health Research Fellowship (S. B.), the American Cancer Society (D. J. T.), a Keck Distinguished young scholar award (J. D.) and by NIH grants HG003143 (J. D.) and HG002668 (R.A.Y.).	ADHYA S, 1989, ANNU REV GENET, V23, P227, DOI 10.1146/annurev.genet.23.1.227; Bose T, 2010, J CELL BIOL, V189, P201, DOI 10.1083/jcb.200912129; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; CLAVERIEMARTIN F, 1991, P NATL ACAD SCI USA, V88, P1631, DOI 10.1073/pnas.88.5.1631; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Dorsett D, 2007, CHROMOSOMA, V116, P1, DOI 10.1007/s00412-006-0072-6; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; HOOVER TR, 1990, CELL, V63, P11, DOI 10.1016/0092-8674(90)90284-L; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang HM, 2008, MOL CELL BIOL, V28, P907, DOI 10.1128/MCB.00909-07; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MATTHEWS KS, 1992, MICROBIOL REV, V56, P123, DOI 10.1128/MMBR.56.1.123-136.1992; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Philiber RA, 2007, PHARMACOGENOMICS, V8, P909, DOI 10.2217/14622416.8.8.909; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; PTASHNE M, 2002, GENES SIGNALS; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Saiz L, 2006, CURR OPIN STRUC BIOL, V16, P344, DOI 10.1016/j.sbi.2006.05.008; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Strachan T, 2005, CURR OPIN GENET DEV, V15, P258, DOI 10.1016/j.gde.2005.04.005; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yeom YI, 1996, DEVELOPMENT, V122, P881	50	1317	1349	1	181	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					430	435		10.1038/nature09380	http://dx.doi.org/10.1038/nature09380			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20720539	Green Submitted, Green Accepted			2022-12-24	WOS:000282090200036
J	Kertesz, M; Wan, Y; Mazor, E; Rinn, JL; Nutter, RC; Chang, HY; Segal, E				Kertesz, Michael; Wan, Yue; Mazor, Elad; Rinn, John L.; Nutter, Robert C.; Chang, Howard Y.; Segal, Eran			Genome-wide measurement of RNA secondary structure in yeast	NATURE			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; TRANSLATION; SITE; PREDICTION; TRANSPORT; ELEMENTS	The structures of RNA molecules are often important for their function and regulation(1-6), yet there are no experimental techniques for genome-scale measurement of RNA structure. Here we describe a novel strategy termed parallel analysis of RNA structure (PARS), which is based on deep sequencing fragments of RNAs that were treated with structure-specific enzymes, thus providing simultaneous in vitro profiling of the secondary structure of thousands of RNA species at single nucleotide resolution. We apply PARS to profile the secondary structure of the messenger RNAs (mRNAs) of the budding yeast Saccharomyces cerevisiae and obtain structural profiles for over 3,000 distinct transcripts. Analysis of these profiles reveals several RNA structural properties of yeast transcripts, including the existence of more secondary structure over coding regions compared with untranslated regions, a three-nucleotide periodicity of secondary structure across coding regions and an anti-correlation between the efficiency with which an mRNA is translated and the structure over its translation start site. PARS is readily applicable to other organisms and to profiling RNA structure in diverse conditions, thus enabling studies of the dynamics of secondary structure at a genomic scale.	[Wan, Yue; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Program Epithelial Biol, Stanford, CA 94305 USA; [Kertesz, Michael; Mazor, Elad; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Rinn, John L.] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Rinn, John L.] MIT, Cambridge, MA 02142 USA; [Nutter, Robert C.] Life Technol, Foster City, CA 94404 USA; [Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Howard Hughes Medical Institute; Stanford University; Weizmann Institute of Science; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Thermo Fisher Scientific; Weizmann Institute of Science	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu; eran@weizmann.ac.il	Segal, Eran/AAF-4855-2019	Rinn, John/0000-0002-7231-7539; Segal, Eran/0000-0002-6859-1164	National Institutes of Health [RO1HG004361]; Agency of Science, Technology and Research of Singapore; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency of Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. Herschlag's group, A. Adler, A. Fire, M. Kay, the Life Technologies SOLiD team, M. Rabani, G. Sherlock and A. Weinberger for assistance and critiques. This work was supported by a National Institutes of Health grant (RO1HG004361). Y.W. is funded by the Agency of Science, Technology and Research of Singapore. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute. E. S. is the incumbent of the Soretta and Henry Shapiro career development chair.	Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Palazzo AF, 2007, PLOS BIOL, V5, P2862, DOI 10.1371/journal.pbio.0050322; Reineke LC, 2008, J BIOL CHEM, V283, P19011, DOI 10.1074/jbc.M803109200; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shabalina SA, 2006, NUCLEIC ACIDS RES, V34, P2428, DOI 10.1093/nar/gkl287; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tucker BJ, 2005, CURR OPIN STRUC BIOL, V15, P342, DOI 10.1016/j.sbi.2005.05.003; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Ziehler W A, 2001, Curr Protoc Nucleic Acid Chem, VChapter 6, DOI 10.1002/0471142700.nc0601s00	20	538	564	5	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					103	107		10.1038/nature09322	http://dx.doi.org/10.1038/nature09322			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811459	Green Accepted			2022-12-24	WOS:000281461200044
J	Piao, SL; Ciais, P; Huang, Y; Shen, ZH; Peng, SS; Li, JS; Zhou, LP; Liu, HY; Ma, YC; Ding, YH; Friedlingstein, P; Liu, CZ; Tan, K; Yu, YQ; Zhang, TY; Fang, JY				Piao, Shilong; Ciais, Philippe; Huang, Yao; Shen, Zehao; Peng, Shushi; Li, Junsheng; Zhou, Liping; Liu, Hongyan; Ma, Yuecun; Ding, Yihui; Friedlingstein, Pierre; Liu, Chunzhen; Tan, Kun; Yu, Yongqiang; Zhang, Tianyi; Fang, Jingyun			The impacts of climate change on water resources and agriculture in China	NATURE			English	Review							YANGTZE-RIVER BASIN; YELLOW-RIVER; FUTURE CLIMATE; WINTER-WHEAT; ELEVATED CO2; CARBON-DIOXIDE; SPRING WHEAT; CROP YIELD; TRENDS; PRECIPITATION	China is the world's most populous country and a major emitter of greenhouse gases. Consequently, much research has focused on China's influence on climate change but somewhat less has been written about the impact of climate change on China. China experienced explosive economic growth in recent decades, but with only 7% of the world's arable land available to feed 22% of the world's population, China's economy may be vulnerable to climate change itself. We find, however, that notwithstanding the clear warming that has occurred in China in recent decades, current understanding does not allow a clear assessment of the impact of anthropogenic climate change on China's water resources and agriculture and therefore China's ability to feed its people. To reach a more definitive conclusion, future work must improve regional climate simulations-especially of precipitation-and develop a better understanding of the managed and unmanaged responses of crops to changes in climate, diseases, pests and atmospheric constituents.	[Piao, Shilong; Shen, Zehao; Peng, Shushi; Zhou, Liping; Liu, Hongyan; Ma, Yuecun; Tan, Kun; Fang, Jingyun] Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Coll Urban & Environm Sci,Dept Geog,Dept Ecol, Beijing 100871, Peoples R China; [Piao, Shilong; Shen, Zehao; Peng, Shushi; Zhou, Liping; Liu, Hongyan; Ma, Yuecun; Tan, Kun; Fang, Jingyun] Peking Univ, Ctr Climate Res, Beijing 100871, Peoples R China; [Ciais, Philippe; Friedlingstein, Pierre] UMR CEA CNRS UVSQ, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Huang, Yao; Yu, Yongqiang; Zhang, Tianyi] Chinese Acad Sci, Inst Atmospher Phys, State Key Lab Atmospher Boundary Layer Phys & Atm, Beijing 100029, Peoples R China; [Li, Junsheng] Chinese Res Inst Environm Sci, Beijing 100012, Peoples R China; [Ding, Yihui] China Meteorol Adm, Natl Climate Ctr, Lab Climate Studies, Beijing 100081, Peoples R China; [Friedlingstein, Pierre] Univ Bristol, Dept Earth Sci, QUEST, Bristol BS8 1RJ, Avon, England; [Liu, Chunzhen] China Water Informat Ctr, Hydrol Bur, Beijing 100053, Peoples R China	Peking University; Peking University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Chinese Academy of Sciences; Institute of Atmospheric Physics, CAS; Chinese Research Academy of Environmental Sciences; China Meteorological Administration; University of Bristol	Piao, SL (corresponding author), Peking Univ, Minist Educ, Key Lab Earth Surface Proc, Coll Urban & Environm Sci,Dept Geog,Dept Ecol, Beijing 100871, Peoples R China.	slpiao@pku.edu.cn	Huang, Yao/GQH-3308-2022; Ciais, Philippe/A-6840-2011; Yu, Yongqiang/C-9661-2011; Zhang, Tianyi/AAJ-6909-2020; Peng, Shushi/J-4779-2014; PENG, Shushi/AAS-2603-2020; huang, yao/GWR-5388-2022; Friedlingstein, Pierre/H-2700-2014; LAPC, IAP/AAI-6991-2020; Shen, Zehao/GQI-1121-2022; Huang, Yao/O-6832-2014	Huang, Yao/0000-0002-0192-1421; Ciais, Philippe/0000-0001-8560-4943; Yu, Yongqiang/0000-0002-9345-2211; Zhang, Tianyi/0000-0002-9266-6082; Peng, Shushi/0000-0001-5098-726X; PENG, Shushi/0000-0001-5098-726X; Friedlingstein, Pierre/0000-0003-3309-4739; LAPC, IAP/0000-0002-0025-3484; 	National Natural Science Foundation of China [30970511, 90711002, 30721140306, 40638039]; Chinese Academy of Sciences [KZCX2-YW-305]; National Basic Research Program of China [2004CB720207]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [FANEDD-200737]; NERC [quest010001] Funding Source: UKRI; Natural Environment Research Council [quest010001] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank X. L. Yang and G. N. Liu for detailed and constructive comments. We thank J. H. Gash, M. Minnock and C. Koven for English language editing. We also thank Y. Li and Y. Kuang for providing photos of glacier retreat between 1985 and 2005 at Mt Anyemaqen, Qinghai. This study was supported by the National Natural Science Foundation of China (30970511, 90711002, 30721140306 and 40638039), the Knowledge Innovation Program of the Chinese Academy of Sciences (KZCX2-YW-305), the National Basic Research Program of China (2004CB720207) and the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD-200737).	Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P31, DOI 10.1016/j.gloenvcha.2003.10.006; Baker JT, 2004, AGR FOREST METEOROL, V122, P129, DOI 10.1016/j.agrformet.2003.09.012; Bannayan M, 2005, FIELD CROP RES, V93, P237, DOI 10.1016/j.fcr.2004.10.003; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Becker S, 2008, INT J CLIMATOL, V28, P579, DOI 10.1002/joc.1572; Chavas DR, 2009, AGR FOREST METEOROL, V149, P1118, DOI 10.1016/j.agrformet.2009.02.001; CHEN SD, 2003, 50 YEARS PLANT PROTE; CHEN YY, 2005, CLIMATE ENV CHANGES; [初子莹 CHU ZiYing], 2005, [气候与环境研究, Climatic and environmental research], V10, P826; Ci L.-J., 1997, J DESERT RES, V17, P107; Dai A, 2004, J HYDROMETEOROL, V5, P1117, DOI 10.1175/JHM-386.1; Ding Y., 2005, CHANGES CLIMATE ENV, V1, P398; Ding YH, 2008, INT J CLIMATOL, V28, P1139, DOI 10.1002/joc.1615; Ding YH, 2007, ADV ATMOS SCI, V24, P954, DOI 10.1007/s00376-007-0954-4; Ding YJ, 2006, ANN GLACIOL-SER, V43, P97, DOI 10.3189/172756406781812005; [段建平 DUAN Jianping], 2009, [地理科学进展, Progress in Geography], V28, P231; *ED BOARD, 2007, CHIN NAT ASS REP CLI; Fu GB, 2004, CLIMATIC CHANGE, V65, P149, DOI 10.1023/B:CLIM.0000037491.95395.bb; Fuhrer J, 2003, AGR ECOSYST ENVIRON, V97, P1, DOI 10.1016/S0167-8809(03)00125-7; Gao X, 2008, METEOROL ATMOS PHYS, V100, P73, DOI 10.1007/s00703-008-0296-5; Ge QS, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041281; Gemmer M, 2008, QUATERN INT, V186, P12, DOI 10.1016/j.quaint.2007.10.001; Gong DY, 2004, THEOR APPL CLIMATOL, V77, P25, DOI 10.1007/s00704-003-0019-2; Hao XM, 2008, WATER RESOUR MANAG, V22, P1159, DOI 10.1007/s11269-007-9218-4; Hu ZZ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003651; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Huang Y, 2007, ECOL APPL, V17, P692, DOI 10.1890/05-1792; Jiang T, 2007, GEOMORPHOLOGY, V85, P143, DOI 10.1016/j.geomorph.2006.03.015; Zhang JL, 2007, PROCEEDINGS OF THE FIRST INTERNATIONAL SYMPOSIUM ON DATA, PRIVACY, AND E-COMMERCE, P138, DOI 10.1109/ISDPE.2007.53; Kang E.S., 2000, GLACIERS THEIR ENV S, P190; Li WL, 2007, AGR WATER MANAGE, V87, P106, DOI 10.1016/j.agwat.2006.06.027; Li X, 2008, GLOBAL PLANET CHANGE, V62, P210, DOI 10.1016/j.gloplacha.2008.02.001; [李忠勤 LI Zhongqin], 2007, [冰川冻土, Journal of Glaciology and Geocryology], V29, P333; LI ZX, 2009, QUATERN INT, DOI DOI 10.1016/J.QUAINT.2009.05.010; LI ZX, 2007, HYDROL EARTH SYST SC, V4, P3395; LIN E, 2007, ADV CLIM CHANG RES, V3, P6; Lin ED, 2005, PHILOS T R SOC B, V360, P2149, DOI 10.1098/rstb.2005.1743; [刘时银 Liu Shiyin], 2006, [第四纪研究, Quaternary Sciences], V26, P762; Liu SY, 2009, J GLACIOL, V55, P353, DOI 10.3189/002214309788608778; Liu YA, 2010, GLOBAL CHANGE BIOL, V16, P2287, DOI 10.1111/j.1365-2486.2009.02077.x; Long SP, 2005, PHILOS T R SOC B, V360, P2011, DOI 10.1098/rstb.2005.1749; Longo F, 2006, ANN ONCOL, V17, P74; LU AG, 2005, CHINA J MOUNT SCI, V2, P313; Ma HL, 2007, PLANT SOIL, V294, P137, DOI 10.1007/s11104-007-9241-5; Ma ZG, 2005, CHINESE J GEOPHYS-CH, V48, P1270; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; *MIN WAT RES PEOPL, 2007, B WAT RES CHIN; Nakicenovic N., 2000, SPECIAL REPORT EMISS; *NAT BUR STAT CHIN, 2009, CHIN STAT YB 2009, P38; National Development and Reform Commission P. R. China, 2007, CHIN NAT CLIM CHANG; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Qian WH, 2004, CLIM RES, V27, P119, DOI 10.3354/cr027119; [秦年秀 Qin Nianxiu], 2005, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V14, P589; REN G, 2004, CLIMATE CHANGE YANGT; REN GY, 2007, CLIMATE CHANGE CHINA; *RUR SOC SURV ORG, 2009, NAT BUR STAT CHIN AG; Sakai H, 2006, NEW PHYTOL, V170, P321, DOI 10.1111/j.1469-8137.2006.01688.x; Seneviratne SI, 2006, NATURE, V443, P205, DOI 10.1038/nature05095; [沈永平 Shen Yongping], 2003, [冰川冻土, Journal of Glaciology and Geocryology], V25, P124; Shen YP, 2006, ADV CLIM CHANG RES, V2, P32; Shi Y., 2001, J GLACIOL GEOCRYOL, V23, P333, DOI DOI 10.3969/J.ISSN.1000-0240.2001.04.001; Shi YF, 2007, CLIMATIC CHANGE, V80, P379, DOI 10.1007/s10584-006-9121-7; Shi YF, 2000, CHINESE SCI BULL, V45, P668, DOI 10.1007/BF02886048; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; State Council Information Office, 2008, CHIN POL ACT CLIM CH; Tao F, 2008, AGR FOREST METEOROL, V148, P94, DOI 10.1016/j.agrformet.2007.09.012; Tao FL, 2008, CLIM RES, V38, P83, DOI 10.3354/cr00771; Tao H, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006186; Thomas A, 2000, AGR FOREST METEOROL, V102, P71, DOI 10.1016/S0168-1923(00)00126-X; Thomas A, 2008, GLOBAL PLANET CHANGE, V60, P306, DOI 10.1016/j.gloplacha.2007.03.009; Wang FH, 2009, FIELD CROP RES, V111, P181, DOI 10.1016/j.fcr.2008.12.004; Wang GL, 2005, CLIM DYNAM, V25, P739, DOI 10.1007/s00382-005-0057-9; Wang HL, 2008, AGR FOREST METEOROL, V148, P1242, DOI 10.1016/j.agrformet.2008.03.003; Wang JX, 2009, AGR ECON-BLACKWELL, V40, P323, DOI 10.1111/j.1574-0862.2009.00379.x; Wang XP, 2004, ATMOS ENVIRON, V38, P4383, DOI 10.1016/j.atmosenv.2004.03.067; [王瑗 WANG Yuan], 2008, [水资源与水工程学报, Journal of Water Resources and Water Engineering], V19, P10; Wei K, 2009, ATMOS OCEAN SCI LETT, V2, P153, DOI 10.1080/16742834.2009.11446795; Wentz FJ, 2007, SCIENCE, V317, P233, DOI 10.1126/science.1140746; Xiao JF, 2009, EARTH INTERACT, V13, DOI 10.1175/2009EI275.1; [谢自楚 XIE Zichu], 2006, [冰川冻土, Journal of Glaciology and Geocryology], V28, P457; Xiong W, 2008, IMPACTS CLIMATE CHAN; Xiong W, 2010, AGR ECOSYST ENVIRON, V135, P58, DOI 10.1016/j.agee.2009.08.015; Xu JJ, 2008, QUATERN INT, V186, P32, DOI 10.1016/j.quaint.2007.10.014; Yang W, 2008, CHINESE SCI BULL, V53, P2547, DOI 10.1007/s11434-008-0288-3; Yang XL, 2006, FRONT ECOL ENVIRON, V4, P362, DOI 10.1890/1540-9295(2006)004[0362:ICWA]2.0.CO;2; Yao T, 2007, ARCT ANTARCT ALP RES, V39, P642, DOI 10.1657/1523-0430(07-510)[YAO]2.0.CO;2; You LZ, 2009, AGR FOREST METEOROL, V149, P1009, DOI 10.1016/j.agrformet.2008.12.004; [翟建青 Zhai Jianqing], 2009, [气候变化研究进展, Advances in Climate Change Research], V5, P220; Zhai JQ, 2010, J CLIMATE, V23, P649, DOI 10.1175/2009JCLI2968.1; Zhai P -M, 2005, ADV CLIM CHANG RES, V1, P16, DOI [10.3969/j.issn.1673-1719.2005.01.004, DOI 10.3969/J.ISSN.1673-1719.2005.01.004]; Zhai PM, 2005, J CLIMATE, V18, P1096, DOI 10.1175/JCLI-3318.1; Zhai PM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018004; Zhang GH, 2007, T ASABE, V50, P911, DOI 10.13031/2013.23155; Zhang Q, 2009, WATER RESOUR MANAG, V23, P1157, DOI 10.1007/s11269-008-9320-2; Zhang Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027229; Zhou Y, 2007, CROP SCI, V47, P245, DOI 10.2135/cropsci2006.03.0175; Ziska LH, 2008, FIELD CROP RES, V108, P54, DOI 10.1016/j.fcr.2008.03.006; Zong YQ, 2000, NAT HAZARDS, V22, P165, DOI 10.1023/A:1008119805106	98	2115	2397	243	3151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2010	467	7311					43	51		10.1038/nature09364	http://dx.doi.org/10.1038/nature09364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811450	Green Submitted			2022-12-24	WOS:000281461200032
J	Schaller, V; Weber, C; Semmrich, C; Frey, E; Bausch, AR				Schaller, Volker; Weber, Christoph; Semmrich, Christine; Frey, Erwin; Bausch, Andreas R.			Polar patterns of driven filaments	NATURE			English	Article							SELF-ORGANIZATION; ACTIVE GELS; MOTORS; HYDRODYNAMICS; MICROTUBULES; VORTICES; DYNAMICS	The emergence of collective motion exhibited by systems ranging from flocks of animals to self-propelled microorganisms to the cytoskeleton is a ubiquitous and fascinating self-organization phenomenon(1-12). Similarities between these systems, such as the inherent polarity of the constituents, a density-dependent transition to ordered phases or the existence of very large density fluctuations(13-16), suggest universal principles underlying pattern formation. This idea is followed by theoretical models at all levels of description: micro-or mesoscopic models directly map local forces and interactions using only a few, preferably simple, interaction rules(12,17-21), and more macroscopic approaches in the hydrodynamic limit rely on the systems' generic symmetries(8,22,23). All these models characteristically have a broad parameter space with a manifold of possible patterns, most of which have not yet been experimentally verified. The complexity of interactions and the limited parameter control of existing experimental systems are major obstacles to our understanding of the underlying ordering principles(13). Here we demonstrate the emergence of collective motion in a high-density motility assay that consists of highly concentrated actin filaments propelled by immobilized molecular motors in a planar geometry. Above a critical density, the filaments self-organize to form coherently moving structures with persistent density modulations, such as clusters, swirls and interconnected bands. These polar nematic structures are long lived and can span length scales orders of magnitudes larger than their constituents. Our experimental approach, which offers control of all relevant system parameters, complemented by agent-based simulations, allows backtracking of the assembly and disassembly pathways to the underlying local interactions. We identify weak and local alignment interactions to be essential for the observed formation of patterns and their dynamics. The presented minimal polar-pattern-forming system may thus provide new insight into emerging order in the broad class of active fluids(8,23,24) and self-propelled particles(17,25)	[Schaller, Volker; Semmrich, Christine; Bausch, Andreas R.] Tech Univ Munich, Lehrstuhl Biophy E27, D-85748 Garching, Germany; [Weber, Christoph; Frey, Erwin] Univ Munich, Dept Phys, Arnold Sommerfeld Ctr Theoret Phys, D-80333 Munich, Germany; [Weber, Christoph; Frey, Erwin] Univ Munich, Dept Phys, CENS, D-80333 Munich, Germany	Technical University of Munich; University of Munich; University of Munich	Bausch, AR (corresponding author), Tech Univ Munich, Lehrstuhl Biophy E27, D-85748 Garching, Germany.	abausch@ph.tum.de	Frey, Erwin/M-2613-2017	Frey, Erwin/0000-0001-8792-3358	DFG [SFB 863]; German Excellence Initiatives via the 'Nano-Initiative Munich (NIM)'; Technische Universitat Munchen - Institute for Advanced Study; Elite Network of Bavaria	DFG(German Research Foundation (DFG)); German Excellence Initiatives via the 'Nano-Initiative Munich (NIM)'; Technische Universitat Munchen - Institute for Advanced Study; Elite Network of Bavaria	We thank A. Baskaran and C. Marchetti for discussions. Financial support from the DFG in the framework of the SFB 863 and the German Excellence Initiatives via the 'Nano-Initiative Munich (NIM)' and the Technische Universitat Munchen - Institute for Advanced Study is gratefully acknowledged. V. S. and C. W. acknowledge support from the Elite Network of Bavaria by the graduate programmes CompInt and NanoBioTechnology.	Aranson IS, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.050901; Backouche F, 2006, PHYS BIOL, V3, P264, DOI 10.1088/1478-3975/3/4/004; Baskaran A, 2009, P NATL ACAD SCI USA, V106, P15567, DOI 10.1073/pnas.0906586106; Baskaran A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011920; Baskaran A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.268101; Chate H, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046113; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Czirok A, 1996, PHYS REV E, V54, P1791, DOI 10.1103/PhysRevE.54.1791; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; Fulga F, 2009, INTEGR BIOL-UK, V1, P150, DOI 10.1039/b814985b; Ginelli F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.184502; Grossman D, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/023036; Joanny JF, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/422; Julicher F, 2007, PHYS REP, V449, P3, DOI 10.1016/j.physrep.2007.02.018; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Kraikivski P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.258103; Kruse K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.078101; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Mishra S, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061916; Narayan V, 2007, SCIENCE, V317, P105, DOI 10.1126/science.1140414; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Riedel IH, 2005, SCIENCE, V309, P300, DOI 10.1126/science.1110329; SHEETZ MP, 1984, J CELL BIOL, V99, P1867, DOI 10.1083/jcb.99.5.1867; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226	28	551	553	6	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					73	77		10.1038/nature09312	http://dx.doi.org/10.1038/nature09312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811454				2022-12-24	WOS:000281461200037
J	Park, J; Myong, S; Niedziela-Majka, A; Lee, KS; Yu, J; Lohman, TM; Ha, T				Park, Jeehae; Myong, Sua; Niedziela-Majka, Anita; Lee, Kyung Suk; Yu, Jin; Lohman, Timothy M.; Ha, Taekjip			PcrA Helicase Dismantles RecA Filaments by Reeling in DNA in Uniform Steps	CELL			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI RECBCD; VIRUS NS3 HELICASE; UVRD HELICASE; REP HELICASE; NUCLEOPROTEIN FILAMENTS; UNWINDING MECHANISM; CRYSTAL-STRUCTURES; TRANSLOCATION; RNA	Translocation of helicase-like proteins on nucleic acids underlies key cellular functions. However, it is still unclear how translocation can drive removal of DNA-bound proteins, and basic properties like the elementary step size remain controversial. Using single-molecule fluorescence analysis on a prototypical superfamily 1 helicase, Bacillus stearothermophilus PcrA, we discovered that PcrA preferentially translocates on the DNA lagging strand instead of unwinding the template duplex. PcrA anchors itself to the template duplex using the 2B subdomain and reels in the lagging strand, extruding a single-stranded loop. Static disorder limited previous ensemble studies of a PcrA stepping mechanism. Here, highly repetitive looping revealed that PcrA translocates in uniform steps of 1 nt. This reeling-in activity requires the open conformation of PcrA and can rapidly dismantle a preformed RecA filament even at low PcrA concentrations, suggesting a mode of action for eliminating potentially deleterious recombination intermediates.	[Park, Jeehae; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Myong, Sua; Ha, Taekjip] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Lee, Kyung Suk; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Lee, Kyung Suk; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Niedziela-Majka, Anita; Lohman, Timothy M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA; [Yu, Jin] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California Berkeley	Ha, T (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	tjha@illinois.edu	Ha, Taekjip/B-9506-2009; Yu, Jin/X-6895-2019	Ha, Taekjip/0000-0003-2195-6258; Yu, Jin/0000-0001-8224-1374	National Institutes of Health [GM-065367, GM-045948]; National Science Foundation [0822613, 0646550]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045948, R01GM065367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Joo, R. Roy, M. Schlierf, S. Syed, M.C. McKinney, M.K. Nahas, B. Okumus, S.A. McKinney, E. Bozek, and J.D. Smith for experimental help; S. Arslan, J. Yodh, H. Balci, I. Cisse, B.C. Stevens, G. Lee, M. Brenner, E. Tomko, C. Fischer, and M. Spies for helpful discussion; I. Cann and his lab for providing Staphylococcus aureus PcrA for the initial studies; R. Pugh for help on ExoIII footprint assay; M. Schlierf, J. Yodh, H. Balci, and E. Tomko for careful reading of the manuscript. Funds were provided by the National Institutes of Health (GM-065367 to T.H. and GM-045948 to T.M.L.) and by the National Science Foundation (0822613 and 0646550 to T.H.). T.H. is an investigator with the Howard Hughes Medical Institute.	Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Anand SP, 2004, NUCLEIC ACIDS RES, V32, P3190, DOI 10.1093/nar/gkh641; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; ARAMENDIA PF, 1994, J PHYS CHEM-US, V98, P3165, DOI 10.1021/j100063a020; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bidnenko V, 2006, MOL MICROBIOL, V62, P382, DOI 10.1111/j.1365-2958.2006.05382.x; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lestini R, 2007, EMBO J, V26, P3804, DOI 10.1038/sj.emboj.7601804; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; MOREL P, 1993, NUCLEIC ACIDS RES, V21, P3205, DOI 10.1093/nar/21.14.3205; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; RANEY KD, 1995, J BIOL CHEM, V270, P22236, DOI 10.1074/jbc.270.38.22236; Sanborn ME, 2007, J PHYS CHEM B, V111, P11064, DOI 10.1021/jp072912u; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Slatter AF, 2009, BIOCHEMISTRY-US, V48, P6326, DOI 10.1021/bi900101h; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Tan E, 2003, P NATL ACAD SCI USA, V100, P9308, DOI 10.1073/pnas.1233536100; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wu CG, 2008, J MOL BIOL, V382, P312, DOI 10.1016/j.jmb.2008.07.012; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013; ZIEG J, 1978, J BACTERIOL, V134, P958, DOI 10.1128/JB.134.3.958-966.1978	56	136	136	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					544	555		10.1016/j.cell.2010.07.016	http://dx.doi.org/10.1016/j.cell.2010.07.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723756	Bronze, Green Accepted			2022-12-24	WOS:000281115900009
J	Zegerman, P; Diffley, JFX				Zegerman, Philip; Diffley, John F. X.			Checkpoint-dependent inhibition of DNA replication initiation by Sld3 and Dbf4 phosphorylation	NATURE			English	Article							S-PHASE CHECKPOINT; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; PROGRESSION; FORKS; ORIGINS; ACTIVATION; KINASES; PATHWAY; STRESS	The initiation of eukaryotic DNA replication is regulated by three protein kinase classes: cyclin-dependent kinases (CDK), Dbf4-dependent kinase (DDK) and the DNA damage checkpoint kinases(1). CDK phosphorylation of two key initiation factors, Sld2 and Sld3, promotes essential interactions with Dpb11 (refs 2-4), whereas DDK acts by phosphorylating subunits of the Mcm2-7 helicase(5). CDK has an additional role in replication by preventing the re-loading of Mcm2-7 during the S, G2 and M phases(6), thus preventing origin re-firing and re-replication. During the G1 phase, both CDK and DDK are downregulated, which allows origin licensing and prevents premature replication initiation(3). Origin firing is also inhibited during the S phase when DNA damage or replication fork stalling activates the checkpoint kinases(7-10). Here we show that, analogous to the situation in the G1 phase, the Saccharomyces cerevisiae checkpoint kinase Rad53 inhibits both CDK- and DDK-dependent pathways, which acts redundantly to block further origin firing. Rad53 acts on DDK directly by phosphorylating Dbf4, whereas the CDK pathway is blocked by Rad53-mediated phosphorylation of the downstream CDK substrate, Sld3. This allows CDK to remain active during the S phase in the presence of DNA damage, which is crucial to prevent re-loading of Mcm2-7 onto origins that have already fired(6). Our results explain how checkpoints regulate origin firing and demonstrate that the slowing of S phase by the 'intra-S checkpoint' is primarily due to the inhibition of origin firing.	[Zegerman, Philip; Diffley, John F. X.] Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Diffley, JFX (corresponding author), Canc Res UK London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England.	John.Diffley@cancer.org.uk		Diffley, John/0000-0001-5184-7680; Zegerman, Philip/0000-0002-5707-1083	Cancer Research UK	Cancer Research UK(Cancer Research UK)	We are grateful to K. Bousset, M. Godinho Ferreira, D. Quintana and C. Santocanale for early contributions to this project. We thank J. Gannon and T. Hunt for providing recombinant cyclin A/Cdk2, N. O'Reilly and the Peptide Synthesis Facility at the London Research Institute for the peptide arrays, and D. Toczyski for sharing information before publication. Work was supported by Cancer Research UK.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Heffernan TP, 2007, J BIOL CHEM, V282, P9458, DOI 10.1074/jbc.M611292200; Jares P, 2000, EMBO REP, V1, P319, DOI 10.1093/embo-reports/kvd076; Kamimura Y, 2001, EMBO J, V20, P2097, DOI 10.1093/emboj/20.8.2097; Kanemaki M, 2006, EMBO J, V25, P1753, DOI 10.1038/sj.emboj.7601063; Kim Y, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-18; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Larner JM, 1999, NUCLEIC ACIDS RES, V27, P803, DOI 10.1093/nar/27.3.803; Liu PJ, 2006, J BIOL CHEM, V281, P30631, DOI 10.1074/jbc.M602982200; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Sanchez-Pulido L, 2010, CURR BIOL, V20, pR509, DOI 10.1016/j.cub.2010.05.021; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Santocanale C, 1999, GENE DEV, V13, P2360, DOI 10.1101/gad.13.18.2360; Segurado M, 2008, GENE DEV, V22, P1816, DOI 10.1101/gad.477208; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432	30	203	206	1	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					474	478		10.1038/nature09373	http://dx.doi.org/10.1038/nature09373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20835227	Green Accepted			2022-12-24	WOS:000282090200046
J	Vossel, KA; Zhang, K; Brodbeck, J; Daub, AC; Sharma, P; Finkbeiner, S; Cui, BX; Mucke, L				Vossel, Keith A.; Zhang, Kai; Brodbeck, Jens; Daub, Aaron C.; Sharma, Punita; Finkbeiner, Steven; Cui, Bianxiao; Mucke, Lennart			Tau Reduction Prevents A beta-Induced Defects in Axonal Transport	SCIENCE			English	Article							ALZHEIMERS-DISEASE; AMYLOID-BETA; HIPPOCAMPAL-NEURONS; MOUSE MODEL; OVEREXPRESSION; TRAFFICKING; MECHANISM	Amyloid-beta (A beta) peptides, derived from the amyloid precursor protein, and the microtubule-associated protein tau are key pathogenic factors in Alzheimer's disease (AD). How exactly they impair cognitive functions is unknown. We assessed the effects of A beta and tau on axonal transport of mitochondria and the neurotrophin receptor TrkA, cargoes that are critical for neuronal function and survival and whose distributions are altered in AD. A beta oligomers rapidly inhibited axonal transport of these cargoes in wild-type neurons. Lowering tau levels prevented these defects without affecting baseline axonal transport. Thus, A beta requires tau to impair axonal transport, and tau reduction protects against A beta-induced axonal transport defects.	[Vossel, Keith A.; Brodbeck, Jens; Daub, Aaron C.; Sharma, Punita; Finkbeiner, Steven; Mucke, Lennart] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Vossel, Keith A.; Finkbeiner, Steven; Mucke, Lennart] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Zhang, Kai; Cui, Bianxiao] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Stanford University	Vossel, KA (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	kvossel@gladstone.ucsf.edu; lmucke@gladstone.ucsf.edu	Zhang, Kai/ABD-1498-2021; Zhang, Kai/G-6437-2010; Brodbeck, Jens/AAB-9275-2020	Zhang, Kai/0000-0002-6687-4558; Zhang, Kai/0000-0002-6687-4558; 	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041787, R00NS057906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011385, R37AG011385] Funding Source: NIH RePORTER; NCRR NIH HHS [C06 RR018928] Funding Source: Medline; NIA NIH HHS [AG011385, R01 AG011385, R01 AG011385-07, R37 AG011385] Funding Source: Medline; NINDS NIH HHS [R00 NS057906, NS057906, R01 NS041787-09, R00 NS057906-05, K99 NS057906, NS041787, R01 NS041787] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dawson HN, 2010, NEUROSCIENCE, V169, P516, DOI 10.1016/j.neuroscience.2010.04.037; Decker H, 2010, J NEUROSCI, V30, P9166, DOI 10.1523/JNEUROSCI.1074-10.2010; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hiruma H, 2003, J NEUROSCI, V23, P8967; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Pigino G, 2009, P NATL ACAD SCI USA, V106, P5907, DOI 10.1073/pnas.0901229106; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rui YF, 2006, J NEUROSCI, V26, P10480, DOI 10.1523/JNEUROSCI.3231-06.2006; Schindowski K, 2008, GENES BRAIN BEHAV, V7, P43, DOI 10.1111/j.1601-183X.2007.00378.x; Yuan A, 2008, J NEUROSCI, V28, P1682, DOI 10.1523/JNEUROSCI.5242-07.2008	12	374	387	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					198	U52		10.1126/science.1194653	http://dx.doi.org/10.1126/science.1194653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20829454	Green Accepted			2022-12-24	WOS:000282644600034
J	Matute, DR; Butler, IA; Turissini, DA; Coyne, JA				Matute, Daniel R.; Butler, Ian A.; Turissini, David A.; Coyne, Jerry A.			A Test of the Snowball Theory for the Rate of Evolution of Hybrid Incompatibilities	SCIENCE			English	Article							DROSOPHILA; INVIABILITY; GENETICS; MELANOGASTER; SPECIATION; STERILITY	Hybrids between species are often sterile or inviable because the long-diverged genomes of their parents cause developmental problems when they come together in a single individual. According to the Dobzhansky-Muller (DM) model, the number of genes involved in these "intrinsic postzygotic incompatibilities" should increase faster than linearly with the divergence time between species. This straightforward prediction of the DM model has remained contentious owing to a lack of explicit tests. Examining two pairs of Drosophila species, we show that the number of genes involved in postzygotic isolation increases at least as fast as the square of the number of substitutions (an index of divergence time) between species. This observation verifies a key prediction of the DM model.	[Matute, Daniel R.; Butler, Ian A.; Turissini, David A.; Coyne, Jerry A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Matute, DR (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	dmatute@uchicago.edu		Butler, Ian/0000-0002-1386-2430	NIH [R01GM058260]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058260] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. C. Presgraves, T. D. Price, R. Unckless, D. Kennedy, M. A. Sprigge, and M. Przeworski for discussions and reading of the manuscript; P. Andolfatto, T. Hu, and K. Thornton for sharing data; and A. Harris and J. Gladstone for technical help. Funded by NIH grant R01GM058260 (J.A.C.).	Bolnick DI, 2005, EVOLUTION, V59, P1754, DOI 10.1111/j.0014-3820.2005.tb01824.x; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Coyne JA, 1998, GENETICS, V150, P1091; Coyne JA, 2004, SPECIATION, V37; Dobzhansky T., 1937; Gourbiere S, 2010, EVOLUTION, V64, P1, DOI 10.1111/j.1558-5646.2009.00844.x; Johnson Norman A., 2006, P374; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Matute DR, 2009, CELL, V139, P1180, DOI 10.1016/j.cell.2009.10.033; Moyle LC, 2008, GENETICS, V179, P1437, DOI 10.1534/genetics.107.083618; Moyle LC, 2009, TRENDS ECOL EVOL, V24, P591, DOI 10.1016/j.tree.2009.05.010; Muller HJ, 1942, BIOL S, V6, P71; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 2001, EVOLUTION, V55, P1085; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Presgraves DC, 2007, CURR BIOL, V17, pR125, DOI 10.1016/j.cub.2006.12.030; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Presgraves DC, 2003, GENETICS, V163, P955; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tang SW, 2009, SCIENCE, V323, P779, DOI 10.1126/science.1169123	21	130	132	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 17	2010	329	5998					1518	1521		10.1126/science.1193440	http://dx.doi.org/10.1126/science.1193440			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847270				2022-12-24	WOS:000281869000040
J	Kim, SK; Shindo, A; Park, TJ; Oh, EC; Ghosh, S; Gray, RS; Lewis, RA; Johnson, CA; Attie-Bittach, T; Katsanis, N; Wallingford, JB				Kim, Su Kyoung; Shindo, Asako; Park, Tae Joo; Oh, Edwin C.; Ghosh, Srimoyee; Gray, Ryan S.; Lewis, Richard A.; Johnson, Colin A.; Attie-Bittach, Tania; Katsanis, Nicholas; Wallingford, John B.			Planar Cell Polarity Acts Through Septins to Control Collective Cell Movement and Ciliogenesis	SCIENCE			English	Article							CILIATED EPITHELIAL-CELLS; BARDET-BIEDL-SYNDROME; CONVERGENT EXTENSION; EMBRYONIC-DEVELOPMENT; XENOPUS GASTRULATION; ZEBRAFISH; FORCHLORFENURON; POLARIZATION; ORGANIZATION; DISRUPTION	The planar cell polarity (PCP) signaling pathway governs collective cell movements during vertebrate embryogenesis, and certain PCP proteins are also implicated in the assembly of cilia. The septins are cytoskeletal proteins controlling behaviors such as cell division and migration. Here, we identified control of septin localization by the PCP protein Fritz as a crucial control point for both collective cell movement and ciliogenesis in Xenopus embryos. We also linked mutations in human Fritz to Bardet-Biedl and Meckel-Gruber syndromes, a notable link given that other genes mutated in these syndromes also influence collective cell movement and ciliogenesis. These findings shed light on the mechanisms by which fundamental cellular machinery, such as the cytoskeleton, is regulated during embryonic development and human disease.	[Kim, Su Kyoung; Shindo, Asako; Park, Tae Joo; Ghosh, Srimoyee; Gray, Ryan S.; Wallingford, John B.] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Kim, Su Kyoung; Shindo, Asako; Park, Tae Joo; Ghosh, Srimoyee; Gray, Ryan S.; Wallingford, John B.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Dept Cell Biol, Durham, NC 27710 USA; [Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Dept Pediat, Durham, NC 27710 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol, Leeds LS9 7TF, W Yorkshire, England; [Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Attie-Bittach, Tania] Univ Paris 05, Hop Necker Enfants Malad, INSERM, Dept Genet,U781, Paris, France; [Wallingford, John B.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Duke University; Duke University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin	Wallingford, JB (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	wallingford@mail.utexas.edu	Gray, Ryan/G-2187-2010; Katsanis, Nicholas/E-1837-2012; Park, Tae Joo/G-1460-2011; ATTIE-BITACH, Tania/K-1453-2017; Gray, Ryan/L-3923-2019; Gray, Ryan/W-8366-2019	Gray, Ryan/0000-0001-9668-6497; Park, Tae Joo/0000-0003-3176-177X; ATTIE-BITACH, Tania/0000-0002-1155-3626; Gray, Ryan/0000-0001-9668-6497; Shindo, Asako/0000-0002-3314-7151; Katsanis, Nicholas/0000-0002-2480-0171; Johnson, Colin/0000-0002-2979-8234	Uehara Memorial Foundation; National Institute of General Medcial Science (NIH); March of Dimes; Burroughs Wellcome Fund; Sandler Program for Asthma Research; Texas Advanced Research Program; National Institute of Child Health and Human Development; National Institute of Digestive Diseases and Kidney Disease (NIH); MRC [G0700073] Funding Source: UKRI; Medical Research Council [G0700073] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075972, R01DK072301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094268] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); National Institute of General Medcial Science (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Sandler Program for Asthma Research; Texas Advanced Research Program; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Digestive Diseases and Kidney Disease (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Abitua for technical assistance; E. Spiliotis for the antibodies; and A. Ewald, B. Mitchell, E. Brooks, and K. Smith for critical discussions and reading. This work was supported by grants from the Uehara Memorial Foundation (A.S.); National Institute of General Medcial Science (NIH), March of Dimes, Burroughs Wellcome Fund, the Sandler Program for Asthma Research, and the Texas Advanced Research Program (J.B.W.); National Institute of Child Health and Human Development and National Institute of Digestive Diseases and Kidney Disease (NIH) (N.K.). N.K. is the George W. Brumley Professor. J.B.W. is an Early Career Scientist of the Howard Hughes Medical Institute.	Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Collier S, 2005, GENETICS, V169, P2035, DOI 10.1534/genetics.104.033381; Ewald AJ, 2004, DEVELOPMENT, V131, P6195, DOI 10.1242/dev.01542; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Iwase M, 2004, GENES GENET SYST, V79, P199, DOI 10.1266/ggs.79.199; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; SHIH J, 1992, DEVELOPMENT, V116, P901; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; TRINKAUS JP, 1969, CELL ORGANS FORCES S; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Zeng HQ, 2010, DEV BIOL, V339, P418, DOI 10.1016/j.ydbio.2010.01.003	33	245	259	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1337	1340		10.1126/science.1191184	http://dx.doi.org/10.1126/science.1191184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20671153	Green Accepted			2022-12-24	WOS:000281657300037
J	Elden, AC; Kim, HJ; Hart, MP; Chen-Plotkin, AS; Johnson, BS; Fang, XD; Armakola, M; Geser, F; Greene, R; Lu, MM; Padmanabhan, A; Clay-Falcone, D; McCluskey, L; Elman, L; Juhr, D; Gruber, PJ; Rub, U; Auburger, G; Trojanowski, JQ; Lee, VMY; Van Deerlin, VM; Bonini, NM; Gitler, AD				Elden, Andrew C.; Kim, Hyung-Jun; Hart, Michael P.; Chen-Plotkin, Alice S.; Johnson, Brian S.; Fang, Xiaodong; Armakola, Maria; Geser, Felix; Greene, Robert; Lu, Min Min; Padmanabhan, Arun; Clay-Falcone, Dana; McCluskey, Leo; Elman, Lauren; Juhr, Denise; Gruber, Peter J.; Rueb, Udo; Auburger, Georg; Trojanowski, John Q.; Lee, Virginia M. -Y.; Van Deerlin, Vivianna M.; Bonini, Nancy M.; Gitler, Aaron D.			Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS	NATURE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SPINOCEREBELLAR ATAXIA; ALPHA-SYNUCLEIN; SACCHAROMYCES-CEREVISIAE; TRINUCLEOTIDE REPEAT; STRESS GRANULES; P-BODIES; TDP-43; TOXICITY; AGGREGATION	The causes of amyotrophic lateral sclerosis (ALS), a devastating human neurodegenerative disease, are poorly understood, although the protein TDP-43 has been suggested to have a critical role in disease pathogenesis. Here we show that ataxin 2 (ATXN2), a polyglutamine (polyQ) protein mutated in spinocerebellar ataxia type 2, is a potent modifier of TDP-43 toxicity in animal and cellular models. ATXN2 and TDP-43 associate in a complex that depends on RNA. In spinal cord neurons of ALS patients, ATXN2 is abnormally localized; likewise, TDP-43 shows mislocalization in spinocerebellar ataxia type 2. To assess the involvement of ATXN2 in ALS, we analysed the length of the polyQ repeat in the ATXN2 gene in 915 ALS patients. We found that intermediate-length polyQ expansions (27-33 glutamines) in ATXN2 were significantly associated with ALS. These data establish ATXN2 as a relatively common ALS susceptibility gene. Furthermore, these findings indicate that the TDP-43-ATXN2 interaction may be a promising target for therapeutic intervention in ALS and other TDP-43 proteinopathies.	[Elden, Andrew C.; Hart, Michael P.; Johnson, Brian S.; Fang, Xiaodong; Armakola, Maria; Lu, Min Min; Padmanabhan, Arun; Gitler, Aaron D.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Kim, Hyung-Jun; Bonini, Nancy M.] Univ Penn, Howard Hughes Med Inst, Dept Biol, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice S.; Geser, Felix; Greene, Robert; Clay-Falcone, Dana; Trojanowski, John Q.; Lee, Virginia M. -Y.; Van Deerlin, Vivianna M.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice S.; Geser, Felix; Greene, Robert; Clay-Falcone, Dana; Trojanowski, John Q.; Lee, Virginia M. -Y.; Van Deerlin, Vivianna M.] Univ Penn, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Chen-Plotkin, Alice S.; McCluskey, Leo; Elman, Lauren] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Juhr, Denise; Gruber, Peter J.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Rueb, Udo] Goethe Univ Frankfurt, Inst Clin Neuroanat, D-60590 Frankfurt, Germany; [Auburger, Georg] Goethe Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany	University of Pennsylvania; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Goethe University Frankfurt; Goethe University Frankfurt	Gitler, AD (corresponding author), Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	nbonini@sas.upenn.edu; gitler@mail.med.upenn.edu	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020	Johnson, Brian/0000-0003-3711-5920; Hart, Michael/0000-0001-8865-3062; Gitler, Aaron/0000-0001-8603-1526	University of Pennsylvania Institute on Aging; NIH [1DP2OD004417-01, 1R01NS065317-01, P01 AG-09215, AG-10124, AG-17586, K08 AG-033101-01]; Pew Charitable Trusts; Burroughs Wellcome Fund; Howard Hughes Medical Institute; Deutsche Heredo-Ataxie Gesellschaft (DHAG); Autosomal Dominant Cerebellar Ataxia (ADCA) Vereniging Nederland; Spinocerebellar Ataxias (EuroSCA); Deutsche Forschungsgemeinschaft (DFG) [AU96/11-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017586, P30AG010124, K08AG033101, P01AG009215] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004417] Funding Source: NIH RePORTER	University of Pennsylvania Institute on Aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable Trusts; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Heredo-Ataxie Gesellschaft (DHAG); Autosomal Dominant Cerebellar Ataxia (ADCA) Vereniging Nederland; Spinocerebellar Ataxias (EuroSCA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by a Pilot grant from the University of Pennsylvania Institute on Aging (A.D.G.), an NIH Director's New Innovator Award 1DP2OD004417-01 (A.D.G.), 1R01NS065317-01 (A.D.G.), P01 AG-09215 (N.M.B.), AG-10124 (J.Q.T., V.M.V.D.) and AG-17586, (V.M.-Y.L., V.M.V.D.). A.D.G. is a Pew Scholar in the Biomedical Sciences, supported by The Pew Charitable Trusts. A.S.C.-P. is supported by a Burroughs Wellcome Fund Career Award and NIH K08 AG-033101-01. N.M.B. is an Investigator of the Howard Hughes Medical Institute. U.R. has support from the Deutsche Heredo-Ataxie Gesellschaft (DHAG) and Autosomal Dominant Cerebellar Ataxia (ADCA) Vereniging Nederland, G.A. from the European Integrated Project on Spinocerebellar Ataxias (EuroSCA) and the Deutsche Forschungsgemeinschaft (DFG) (AU96/11-1). We acknowledge W. den Dunnen and E. Brunt for autopsy tissue and M. Babl for technical assistance. We thank J. Epstein, J. Shorter, A. Cashmore and members of the Gitler laboratory for comments on the manuscript and discussions. We are grateful for the dedication of the patients and their families and for their invaluable contributions to this research.	Al-Ramahi I, 2007, PLOS GENET, V3, P2551, DOI 10.1371/journal.pgen.0030234; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Huynh DP, 2003, HUM MOL GENET, V12, P1485, DOI 10.1093/hmg/ddg175; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; Infante J, 2004, MOVEMENT DISORD, V19, P848, DOI 10.1002/mds.20090; Jackson M, 2002, EXPERT OPIN INV DRUG, V11, P1343, DOI 10.1517/13543784.11.10.1343; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lessing D, 2008, PLOS BIOL, V6, P266, DOI 10.1371/journal.pbio.0060029; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Lorenzetti D, 1997, NEUROLOGY, V49, P1009, DOI 10.1212/WNL.49.4.1009; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; Nanetti L, 2009, J NEUROL, V256, P1926, DOI 10.1007/s00415-009-5237-9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200	33	832	854	3	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1069	U77		10.1038/nature09320	http://dx.doi.org/10.1038/nature09320			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20740007	Green Accepted			2022-12-24	WOS:000281203600032
J	Xu, YP; Ramu, Y; Lu, Z				Xu, Yanping; Ramu, Yajamana; Lu, Zhe			A Shaker K+ Channel with a Miniature Engineered Voltage Sensor	CELL			English	Article							POTASSIUM-CHANNEL; GATING-CHARGE; SODIUM-CHANNELS; SENSING RESIDUES; ACTIVATION GATE; MOLECULAR-BASIS; MOVEMENT; S4; PORE; CURRENTS	Voltage-gated ion channels sense transmembrane voltage changes via a paddle-shaped motif that includes the C-terminal part of the third transmembrane segment (S3b) and the N-terminal part of the fourth segment ((NT)S4) that harbors voltage-sensing arginines. Here, we find that residue triplets in S3b and (NT)S4 can be deleted individually, or even in some combinations, without compromising the channels' basic voltage-gating capability. Thus, a high degree of complementarity between these S3b and (NT)S4 regions is not required for basic voltage gating per se. Remarkably, the voltage-gated Shaker K+ channel remains voltage gated after a 43 residue paddle sequence is replaced by a glycine triplet. Therefore, the paddle motif comprises a minimal core that suffices to confer voltage gating in the physiological voltage range, and a larger, modulatory part. Our study also shows that the hydrophobic residues between the voltage-sensing arginines help set the sensor's characteristic chemical equilibrium between activated and deactivated states.	[Xu, Yanping; Ramu, Yajamana; Lu, Zhe] Univ Penn, Howard Hughes Med Inst, Dept Physiol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Lu, Z (corresponding author), Univ Penn, Howard Hughes Med Inst, Dept Physiol, Philadelphia, PA 19104 USA.	zhelu@mail.med.upenn.edu			National Institutes of Health [GM55560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. De Weer for critical review and discussion of our manuscript and K. Baek for help with figure preparation. Molecular models were prepared with PyMOL 1.0 (DeLano Scientific). This study was supported by grant GM55560 from the National Institutes of Health to Z.L. Z. L. is an investigator of the Howard Hughes Medical Institute.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Broomand A, 2008, NEURON, V59, P770, DOI 10.1016/j.neuron.2008.07.008; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gonzalez C, 2001, P NATL ACAD SCI USA, V98, P9617, DOI 10.1073/pnas.171306298; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Kitaguchi T, 2004, J GEN PHYSIOL, V124, P319, DOI 10.1085/jgp.200409098; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Posson DJ, 2008, NEURON, V59, P98, DOI 10.1016/j.neuron.2008.05.006; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Silverman WR, 2003, P NATL ACAD SCI USA, V100, P2935, DOI 10.1073/pnas.0636603100; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Tang CY, 1997, J GEN PHYSIOL, V109, P301, DOI 10.1085/jgp.109.3.301; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	64	37	37	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 20	2010	142	4					580	589		10.1016/j.cell.2010.07.013	http://dx.doi.org/10.1016/j.cell.2010.07.013			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20691466	Green Accepted, Bronze			2022-12-24	WOS:000281115900012
J	Subramanian, R; Wilson-Kubalek, EM; Arthur, CP; Bick, MJ; Campbell, EA; Darst, SA; Milligan, RA; Kapoor, TM				Subramanian, Radhika; Wilson-Kubalek, Elizabeth M.; Arthur, Christopher P.; Bick, Matthew J.; Campbell, Elizabeth A.; Darst, Seth A.; Milligan, Ronald A.; Kapoor, Tarun M.			Insights into Antiparallel Microtubule Crosslinking by PRC1, a Conserved Nonmotor Microtubule Binding Protein	CELL			English	Article							FISSION YEAST; NDC80 COMPLEX; MOTORS; CYTOKINESIS; ATTACHMENT; ASE1P; VISUALIZATION; MOVEMENTS; KINESIN-5; TRACKING	Formation of microtubule architectures, required for cell shape maintenance in yeast, directional cell expansion in plants and cytokinesis in eukaryotes, depends on antiparallel microtubule crosslinking by the conserved MAP65 protein family. Here, we combine structural and single molecule fluorescence methods to examine how PRC1, the human MAP65, crosslinks antiparallel microtubules. We find that PRC1's microtubule binding is mediated by a structured domain with a spectrin-fold and an unstructured Lys/Arg-rich domain. These two domains, at each end of a homodimer, are connected by a linkage that is flexible on single microtubules, but forms well-defined crossbridges between antiparallel filaments. Further, we show that PRC1 crosslinks are compliant and do not substantially resist filament sliding by motor proteins in vitro. Together, our data show how MAP65s, by combining structural flexibility and rigidity, tune microtubule associations to establish crosslinks that selectively "mark'' antiparallel overlap in dynamic cytoskeletal networks.	[Subramanian, Radhika; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA; [Wilson-Kubalek, Elizabeth M.; Arthur, Christopher P.; Milligan, Ronald A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Bick, Matthew J.; Campbell, Elizabeth A.; Darst, Seth A.] Rockefeller Univ, Lab Mol Biophys, New York, NY 10065 USA	Rockefeller University; Scripps Research Institute; Rockefeller University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA.	kapoor@mail.rockefeller.edu		Bick, Matthew/0000-0002-9585-859X; Campbell, Elizabeth/0000-0002-1332-128X	NIH [GM65933, GM65933-S1, GM52468]; Rockefeller Women and Science postdoctoral fellowship; National Resource for Automated Molecular Microscopy (NIH) [RR17573]; SBRC (NIH) [1S10RR022321-01]; Keck Facility at Yale University (NIH) [1S10RR023748-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023748, S10RR022321, P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052468, R01GM065933, R01GM052468] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller Women and Science postdoctoral fellowship; National Resource for Automated Molecular Microscopy (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBRC (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Facility at Yale University (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Rajashankar (Argonne Advanced Photon Source) and Deena Oren (Rockefeller University Structural Biology Resource Center (SBRC)) for technical assistance. T.M.K. is grateful to the NIH (GM65933 and GM65933-S1) for support. R.S. is a recipient of the Rockefeller Women and Science postdoctoral fellowship. R.A.M. acknowledges support from the NIH (GM52468). We also acknowledge the National Resource for Automated Molecular Microscopy (NIH RR17573), the SBRC (NIH 1S10RR022321-01), and the Keck Facility at Yale University (NIH 1S10RR023748-01) for instrument use.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Chan J, 1999, P NATL ACAD SCI USA, V96, P14931, DOI 10.1073/pnas.96.26.14931; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Gaillard J, 2008, MOL BIOL CELL, V19, P4534, DOI 10.1091/mbc.E08-04-0341; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Khmelinskii A, 2009, DEV CELL, V17, P244, DOI 10.1016/j.devcel.2009.06.011; Korneev MJ, 2007, EUR BIOPHYS J BIOPHY, V36, P675, DOI 10.1007/s00249-007-0134-6; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Millman BM, 1998, PHYSIOL REV, V78, P359, DOI 10.1152/physrev.1998.78.2.359; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ribbeck K, 2006, MOL BIOL CELL, V17, P2646, DOI 10.1091/mbc.E05-12-1178; Sasabe M, 2006, CURR OPIN PLANT BIOL, V9, P563, DOI 10.1016/j.pbi.2006.09.010; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Thadani R, 2009, CURR BIOL, V19, P1861, DOI 10.1016/j.cub.2009.09.063; Valentine MT, 2009, BIOPHYS J, V97, P1671, DOI 10.1016/j.bpj.2009.07.013; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; WHITTAKER M, 1995, ULTRAMICROSCOPY, V58, P245, DOI 10.1016/0304-3991(95)00057-8; Wilson-Kubalek EM, 2008, J CELL BIOL, V182, P1055, DOI 10.1083/jcb.200804170; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Zeng CQ, 2000, MICROSC RES TECHNIQ, V49, P467, DOI 10.1002/(SICI)1097-0029(20000601)49:5<467::AID-JEMT9>3.3.CO;2-M; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	40	199	202	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					433	443		10.1016/j.cell.2010.07.012	http://dx.doi.org/10.1016/j.cell.2010.07.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691902	Green Accepted, Bronze			2022-12-24	WOS:000280609100020
J	Musunuru, K; Strong, A; Frank-Kamenetsky, M; Lee, NE; Ahfeldt, T; Sachs, KV; Li, XY; Li, H; Kuperwasser, N; Ruda, VM; Pirruccello, JP; Muchmore, B; Prokunina-Olsson, L; Hall, JL; Schadt, EE; Morales, CR; Lund-Katz, S; Phillips, MC; Wong, J; Cantley, W; Racie, T; Ejebe, KG; Orho-Melander, M; Melander, O; Koteliansky, V; Fitzgerald, K; Krauss, RM; Cowan, CA; Kathiresan, S; Rader, DJ				Musunuru, Kiran; Strong, Alanna; Frank-Kamenetsky, Maria; Lee, Noemi E.; Ahfeldt, Tim; Sachs, Katherine V.; Li, Xiaoyu; Li, Hui; Kuperwasser, Nicolas; Ruda, Vera M.; Pirruccello, James P.; Muchmore, Brian; Prokunina-Olsson, Ludmila; Hall, Jennifer L.; Schadt, Eric E.; Morales, Carlos R.; Lund-Katz, Sissel; Phillips, Michael C.; Wong, Jamie; Cantley, William; Racie, Timothy; Ejebe, Kenechi G.; Orho-Melander, Marju; Melander, Olle; Koteliansky, Victor; Fitzgerald, Kevin; Krauss, Ronald M.; Cowan, Chad A.; Kathiresan, Sekar; Rader, Daniel J.			From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus	NATURE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; GENOME-WIDE ASSOCIATION; PROTEIN; GENE; SORTILIN; TRANSCRIPTION; DISEASE; DESIGN; RISK; MICE	Recent genome-wide association studies (GWASs) have identified a locus on chromosome 1p13 strongly associated with both plasma low-density lipoprotein cholesterol (LDL-C) and myocardial infarction (MI) in humans. Here we show through a series of studies in human cohorts and human-derived hepatocytes that a common noncoding polymorphism at the 1p13 locus, rs12740374, creates a C/EBP (CCAAT/enhancer binding protein) transcription factor binding site and alters the hepatic expression of the SORT1 gene. With small interfering RNA (siRNA) knockdown and viral overexpression in mouse liver, we demonstrate that Sort1 alters plasma LDL-C and very low-density lipoprotein (VLDL) particle levels by modulating hepatic VLDL secretion. Thus, we provide functional evidence for a novel regulatory pathway for lipoprotein metabolism and suggest that modulation of this pathway may alter risk for MI in humans. We also demonstrate that common noncoding DNA variants identified by GWASs can directly contribute to clinical phenotypes.	[Strong, Alanna; Sachs, Katherine V.; Li, Xiaoyu; Li, Hui; Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Strong, Alanna; Sachs, Katherine V.; Li, Xiaoyu; Li, Hui; Rader, Daniel J.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Strong, Alanna; Sachs, Katherine V.; Li, Xiaoyu; Li, Hui; Rader, Daniel J.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Musunuru, Kiran; Lee, Noemi E.; Ahfeldt, Tim; Kuperwasser, Nicolas; Ruda, Vera M.; Pirruccello, James P.; Ejebe, Kenechi G.; Cowan, Chad A.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Musunuru, Kiran; Lee, Noemi E.; Ahfeldt, Tim; Kuperwasser, Nicolas; Ruda, Vera M.; Pirruccello, James P.; Ejebe, Kenechi G.; Cowan, Chad A.; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Musunuru, Kiran; Lee, Noemi E.; Kuperwasser, Nicolas; Ruda, Vera M.; Pirruccello, James P.; Ejebe, Kenechi G.; Cowan, Chad A.; Kathiresan, Sekar] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Musunuru, Kiran; Pirruccello, James P.; Hall, Jennifer L.; Ejebe, Kenechi G.; Cowan, Chad A.; Kathiresan, Sekar] Broad Inst, Cambridge, MA 02142 USA; [Musunuru, Kiran] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD 21287 USA; [Frank-Kamenetsky, Maria; Wong, Jamie; Cantley, William; Racie, Timothy; Koteliansky, Victor; Fitzgerald, Kevin] Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA; [Ahfeldt, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol Mol Cell Biol 2, D-20246 Hamburg, Germany; [Muchmore, Brian; Prokunina-Olsson, Ludmila] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Hall, Jennifer L.] Univ Minnesota, Program Cardiovasc Translat Genom, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Schadt, Eric E.] Sage Bionetworks, Seattle, WA 98109 USA; [Morales, Carlos R.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Lund-Katz, Sissel; Phillips, Michael C.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; [Orho-Melander, Marju; Melander, Olle] Lund Univ, Skania Univ Hosp, Dept Clin Sci, SE-20502 Malmo, Sweden; [Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University; University of Hamburg; University Medical Center Hamburg-Eppendorf; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities; McGill University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Lund University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Rader, DJ (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	skathiresan@partners.org; rader@mail.med.upenn.edu	Morales, Carlos R./H-1055-2011; Prokunina-Olsson, Ludmila/A-8240-2019; Ahfeldt, Tim/E-2935-2017; Prokunina-Olsson, Ludmila/V-7960-2019; Ejebe, Kenechi/I-9238-2016	Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Ejebe, Kenechi/0000-0002-6090-8657; Ahfeldt, Tim/0000-0001-6377-7376; Pirruccello, James/0000-0001-6088-4037; Melander, Olle/0000-0002-2581-484X; Phillips, Michael/0000-0002-7147-8007	United States National Institutes of Health (NIH); NIH [K99-HL098364, U01-HL069757, RC2-HL101864, P01-HL059407]; Harvard Stem Cell Institute; Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH; Swedish Medical Research Council; Heart-Lung Foundation; Pahlsson Foundation; Quest Diagnostics, Inc.; Bristol-Myers Squibb; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL098364, RC2HL101864, P01HL059407, U01HL069757, T32HL007954] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Heart-Lung Foundation(Swedish Heart-Lung Foundation); Pahlsson Foundation; Quest Diagnostics, Inc.; Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Altshuler, E. Fisher and J. Maraganore for advice and guidance, and A. Akinc, J. Billheimer, R. Brown, R. Camahort, D. Cromley, E. Eduoard, I. Fuki, C. Geaney, G. Hinkle, I. Kohaar, S. Kuchimanchi, W. Lagor, F. Lau, D. Lum, M. Maier, D. Marchadier, R. Meyers, J. Millar, S. Milstein, D. Nguyen, D. Perez, D. Peters, V. Redon, A. Rigamonti, R. Schinzel, M.-S. Sun, S.-A. Toh, A. Wilson and K. Wojnoonski for assistance and suggestions. We acknowledge the National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Resource Program for providing support for viral vector production as well as the Vector Core laboratory of the University of Pennsylvania for producing the vectors. We acknowledge the members of the NHLBI Candidate Gene Association Resource (CARe) lipids working group for the contribution of association data in African Americans. This work was supported in part by a T32 grant in Cell and Molecular Training for Cardiovascular Biology from the United States National Institutes of Health (NIH), K99-HL098364 from the NIH, and the Clinician Scientist Program of the Harvard Stem Cell Institute (K. M.); a Medical Scientist Training Program grant from the NIH (A. S.); the intramural research program of the Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH (L.P.-O.); the Swedish Medical Research Council, Heart-Lung Foundation, and Pahlsson Foundation (M.O.-M., O.M.); U01-HL069757 from the NIH and research support from Quest Diagnostics, Inc. (R. M. K.); RC2-HL101864 from the NIH (S. K.); and P01-HL059407 and RC2-HL101864 from the NIH and a "Freedom to Discover'' Unrestricted Cardiovascular Research Grant from Bristol-Myers Squibb (D.J.R.).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Brown MS, 1996, SCIENCE, V272, P629, DOI 10.1126/science.272.5262.629; DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Keebler ME, 2009, CIRC-CARDIOVASC GENE, V2, P238, DOI 10.1161/CIRCGENETICS.108.829473; Kitajima K, 2006, ARTERIOSCL THROM VAS, V26, P1852, DOI 10.1161/01.ATV.0000231520.26490.54; Linsel-Nitschke P, 2010, ATHEROSCLEROSIS, V208, P183, DOI 10.1016/j.atherosclerosis.2009.06.034; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Musunuru K, 2009, ARTERIOSCL THROM VAS, V29, P1975, DOI 10.1161/ATVBAHA.109.190405; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Olive M, 1996, J BIOL CHEM, V271, P2040, DOI 10.1074/jbc.271.4.2040; Osada S, 1996, J BIOL CHEM, V271, P3891; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Siri-Tarino PW, 2009, OBESITY, V17, P1768, DOI 10.1038/oby.2009.146; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Waters DD, 2009, CIRCULATION, V120, P28, DOI 10.1161/CIRCULATIONAHA.108.838466; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zeng JB, 2009, EXP CELL RES, V315, P3112, DOI 10.1016/j.yexcr.2009.08.016	35	772	806	1	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					714	U2		10.1038/nature09266	http://dx.doi.org/10.1038/nature09266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686566	Green Accepted			2022-12-24	WOS:000280562500030
J	Pavri, R; Gazumyan, A; Jankovic, M; Di Virgilio, M; Klein, I; Ansarah-Sobrinho, C; Resch, W; Yamane, A; San-Martin, BR; Barreto, V; Nieland, TJ; Root, DE; Casellas, R; Nussenzweig, MC				Pavri, Rushad; Gazumyan, Anna; Jankovic, Mila; Di Virgilio, Michela; Klein, Isaac; Ansarah-Sobrinho, Camilo; Resch, Wolfgang; Yamane, Arito; San-Martin, Bernardo Reina; Barreto, Vasco; Nieland, Thomas J.; Root, David E.; Casellas, Rafael; Nussenzweig, Michel C.			Activation-Induced Cytidine Deaminase Targets DNA at Sites of RNA Polymerase II Stalling by Interaction with Spt5	CELL			English	Article							CLASS-SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; TRANSCRIPTION ELONGATION-FACTOR; ANTIBODY DIVERSIFICATION ENZYME; PROTEIN-KINASE-A; CENTER B-CELLS; SOMATIC HYPERMUTATION; C-MYC; IMMUNOGLOBULIN GENES; P-TEFB	Activation-induced cytidine deaminase (AID) initiates antibody gene diversification by creating U:G mismatches. However, AID is not specific for antibody genes; Off-target lesions can activate oncogenes or cause chromosome translocations. Despite its importance in these transactions little is known about how AID finds its targets. We performed an shRNA screen to identify factors required for class switch recombination (CSR) of antibody loci. We found that Spt5, a factor associated with stalled RNA polymerase II (Pol II) and single stranded DNA (ssDNA), is required for CSR. Spt5 interacts with AID, it facilitates association between AID and Pol II, and AID recruitment to its Ig and non-Ig targets. ChIP-seq experiments reveal that Spt5 colocalizes with AID and stalled Pol II. Further, Spt5 accumulation at sites of Pol II stalling is predictive of AID-induced mutation. We propose that AID is targeted to sites of Pol II stalling in part via its association with Spt5.	[Pavri, Rushad; Gazumyan, Anna; Jankovic, Mila; Di Virgilio, Michela; Klein, Isaac; San-Martin, Bernardo Reina; Barreto, Vasco; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Ansarah-Sobrinho, Camilo; Resch, Wolfgang; Yamane, Arito; Casellas, Rafael] NCI, Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Ctr Canc Res, Bethesda, MD 20892 USA; [San-Martin, Bernardo Reina] Univ Strasbourg, INSERM U964, CNRS UMR7104, IGBMC, F-67404 Illkirch Graffenstaden, France; [Barreto, Vasco] Inst Gulbenkian Ciencias, Lab Epigenet Soma, P-2780156 Oeiras, Portugal; [Nieland, Thomas J.] MIT, Broad Inst, RNAi Platform, Cambridge, MA 02142 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Instituto Gulbenkian de Ciencia; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	casellar@mail.nih.gov; nussen@mail.rockefeller.edu	Reina-San-Martin, Bernardo/I-9484-2016; Yamane, Arito/A-2959-2013; Barreto, Vasco M./H-2306-2018; Di Virgilio, Michela/AAE-9298-2022; Nussenzweig, Michel/AAE-7292-2019; Barreto, Vasco/D-4275-2012	Reina-San-Martin, Bernardo/0000-0003-2083-6166; Barreto, Vasco M./0000-0002-0010-8607; Barreto, Vasco/0000-0002-0010-8607; Pavri, Rushad/0000-0002-6191-6333; Resch, Wolfgang/0000-0001-7594-5963; Di Virgilio, Michela/0000-0001-5189-0793	Cancer Research Institute; NIH [AI037526]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037526] Funding Source: NIH RePORTER	Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Nussenzweig lab for helpful discussions, Klara Velinzon for FACS sorting, and Tom Eisenreich and David Bosque for animal management. We thank Drs Jayanta Chaudhuri and Urszula Nowak for ChIP protocols and anti-AID antibody, Dr. Sohail Malik for generously providing purified recombinant DSIF and Dr. Alan Derr for assistance with informatics. M.D.V. is a fellow of the American-Italian Cancer Foundation. R.P was a recipient of The Irvington Institute Postdoctoral Fellowship of the Cancer Research Institute. The work was supported by NIH grant (AI037526) to M.C.N.M.C.N. is a Howard Hughes Medical Institute Investigator.	Amir-Zilberstein L, 2008, J BIOL CHEM, V283, P1317, DOI 10.1074/jbc.M706767200; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Ding BJ, 2010, J BIOL CHEM, V285, P5317, DOI 10.1074/jbc.M109.082818; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lefebvre B, 2002, MOL CELL BIOL, V22, P1446, DOI 10.1128/MCB.22.5.1446-1459.2002; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Nakamura Y, 2008, CANCER GENET CYTOGEN, V182, P144, DOI 10.1016/j.cancergencyto.2008.01.013; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816; Pei Y, 2002, J BIOL CHEM, V277, P19639, DOI 10.1074/jbc.M200015200; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Raschke EE, 1999, J IMMUNOL, V163, P4375; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rohwer F, 1996, J IMMUNOL, V157, P643; Ronai D, 2007, J EXP MED, V204, P181, DOI 10.1084/jem.20062032; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Shen HM, 2009, J EXP MED, V206, P1057, DOI 10.1084/jem.20082678; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; Storb U, 2007, ADV EXP MED BIOL, V596, P83; SWANSON MS, 1991, MOL CELL BIOL, V11, P4286, DOI 10.1128/MCB.11.8.4286; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang LL, 2009, J EXP MED, V206, P1817, DOI 10.1084/jem.20081678; Wang M, 2010, J EXP MED, V207, P141, DOI 10.1084/jem.20092238; Wen YX, 1999, GENE DEV, V13, P1774, DOI 10.1101/gad.13.14.1774; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	87	268	274	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 1	2010	143	1					122	133		10.1016/j.cell.2010.09.017	http://dx.doi.org/10.1016/j.cell.2010.09.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887897	Green Accepted, Bronze			2022-12-24	WOS:000282362000019
J	Vannini, A; Ringel, R; Kusser, AG; Berninghausen, O; Kassavetis, GA; Cramer, P				Vannini, Alessandro; Ringel, Rieke; Kusser, Anselm G.; Berninghausen, Otto; Kassavetis, George A.; Cramer, Patrick			Molecular Basis of RNA Polymerase III Transcription Repression by Maf1	CELL			English	Article							ELECTRON-MICROSCOPY; STRUCTURAL BIOLOGY; SUBCOMPLEX; PROTEIN; SUBUNIT; COMPLEX; TFIIF; DEPHOSPHORYLATION; TERMINATION; INITIATION	RNA polymerase III (Pol III) transcribes short RNAs required for cell growth. Under stress conditions, the conserved protein Maf1 rapidly represses Pol III transcription. We report the crystal structure of Maf1 and cryo-electron microscopic structures of Pol III, an active Pol III-DNA-RNA complex, and a repressive Pol III-Maf1 complex. Binding of DNA and RNA causes ordering of the Pol III-specific sub-complex C82/34/31 that is required for transcription initiation. Maf1 binds the Pol III clamp and rearranges C82/34/31 at the rim of the active center cleft. This impairs recruitment of Pol III to a complex of promoter DNA with the initiation factors Brf1 and TBP and thus prevents closed complex formation. Maf1 does however not impair binding of a DNA-RNA scaffold and RNA synthesis. These results explain how Maf1 specifically represses transcription initiation from Pol III promoters and indicate that Maf1 also prevents reinitiation by binding Pol III during transcription elongation.	[Vannini, Alessandro; Ringel, Rieke; Kusser, Anselm G.; Berninghausen, Otto; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Vannini, Alessandro; Ringel, Rieke; Kusser, Anselm G.; Berninghausen, Otto; Cramer, Patrick] Univ Munich, Dept Biochem, CIPSM, D-81377 Munich, Germany; [Kassavetis, George A.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of Munich; University of Munich; University of California System; University of California San Diego	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@genzentrum.lmu.de	Vannini, Alessandro/N-4528-2014; Vannini, Alessandro/E-6988-2011	Vannini, Alessandro/0000-0001-7212-5425	European Molecular Biology Organization; European Union [MEIF-CT-2006-040653]; Deutsche Forschungsgemeinschaft; Nanosystems Initiative Munich; Elitenetzwerk Bayern; Jung-Stiftung;  [SFB646];  [TR5]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Nanosystems Initiative Munich; Elitenetzwerk Bayern; Jung-Stiftung; ; 	We thank R. Beckmann, T. Becker, C. Ungewickel, J. Burger, and T. Mielke for help with E.M. We thank A. Imhof (Zentrallabor fur Proteinanalytik) and T. Frohlich (Laboratory for Functional Genome Analysis) for mass spectrometry. We acknowledge the crystallization facility at the department of E. Conti at the Max Planck Institute of Biochemistry, Martinsried. We thank D. Deak for help with figure preparation. A.V. was supported by a European Molecular Biology Organization long-term fellowship and by the European Union training program Marie Curie (MEIF-CT-2006-040653). P.C. was supported by the Deutsche Forschungsgemeinschaft, the SFB646, the TR5, the Nanosystems Initiative Munich, the Elitenetzwerk Bayern, and the Jung-Stiftung. A.V. prepared Pol III complexes, A.V. and A.G.K. determined EM structures, R.R. prepared and crystallized Maf1, R.R. and A.V. determined the Maf1 X-ray structure, R.R. and A.V. conducted functional assays, G.A.K. advised on Pol III preparation, A.V., R.R., A.G.K., and P.C. wrote the manuscript, and P.C. designed and supervised research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrau JC, 1999, J MOL BIOL, V288, P511, DOI 10.1006/jmbi.1999.2724; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; BARDELEBEN C, 1994, J MOL BIOL, V235, P1193, DOI 10.1006/jmbi.1994.1073; BARTHOLOMEW B, 1993, MOL CELL BIOL, V13, P942, DOI 10.1128/MCB.13.2.942; Boguta M, 1997, GENE, V185, P291, DOI 10.1016/S0378-1119(96)00669-5; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; Cabart P, 2008, J BIOL CHEM, V283, P36108, DOI 10.1074/jbc.M807538200; Carter R, 2009, MOL BIOL EVOL, V26, P2515, DOI 10.1093/molbev/msp164; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Damsma GE, 2009, J BIOL CHEM, V284, P31658, DOI 10.1074/jbc.M109.022764; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P., 2007, SCALA SCALE TOGETHER; Fernandez-Tornero C, 2007, MOL CELL, V25, P813, DOI 10.1016/j.molcel.2007.02.016; Ferri ML, 2000, MOL CELL BIOL, V20, P488, DOI 10.1128/MCB.20.2.488-495.2000; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Geiduschek EP, 2006, CURR BIOL, V16, pR849, DOI 10.1016/j.cub.2006.08.071; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jasiak AJ, 2006, MOL CELL, V23, P71, DOI 10.1016/j.molcel.2006.05.013; Juo ZS, 2003, NATURE, V422, P534, DOI 10.1038/nature01534; Kassavetis GA, 2005, P NATL ACAD SCI USA, V102, P15406, DOI 10.1073/pnas.0507653102; Kassavetis GA, 2003, J BIOL CHEM, V278, P17912, DOI 10.1074/jbc.M300743200; Kassavetis GA, 2010, J BIOL CHEM, V285, P2695, DOI 10.1074/jbc.M109.074013; KHOO B, 1994, GENE DEV, V8, P2879, DOI 10.1101/gad.8.23.2879; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; Lannutti BJ, 1996, BIOCHEMISTRY-US, V35, P9821, DOI 10.1021/bi960525x; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; LESLIE AGW, 1986, CCP4 NEWSLETTER, V18, P33; Lorenzen K, 2007, STRUCTURE, V15, P1237, DOI 10.1016/j.str.2007.07.016; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; SADHALE PP, 1994, MOL CELL BIOL, V14, P6164, DOI 10.1128/MCB.14.9.6164; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THUILLIER V, 1995, EMBO J, V14, P351, DOI 10.1002/j.1460-2075.1995.tb07009.x; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Wang ZX, 1997, GENE DEV, V11, P1315, DOI 10.1101/gad.11.10.1315; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WERNER M, 1993, J BIOL CHEM, V268, P20721; WERNER M, 1992, MOL CELL BIOL, V12, P1087, DOI 10.1128/MCB.12.3.1087; Willis IM, 2004, PROG NUCLEIC ACID RE, V77, P323, DOI 10.1016/S0079-6603(04)77009-9	60	119	122	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2010	143	1					59	70		10.1016/j.cell.2010.09.002	http://dx.doi.org/10.1016/j.cell.2010.09.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	656UC	20887893	Green Accepted, Bronze			2022-12-24	WOS:000282362000014
J	Lee, BH; Lee, MJ; Park, S; Oh, DC; Elsasser, S; Chen, PC; Gartner, C; Dimova, N; Hanna, J; Gygi, SP; Wilson, SM; King, RW; Finley, D				Lee, Byung-Hoon; Lee, Min Jae; Park, Soyeon; Oh, Dong-Chan; Elsasser, Suzanne; Chen, Ping-Chung; Gartner, Carlos; Dimova, Nevena; Hanna, John; Gygi, Steven P.; Wilson, Scott M.; King, Randall W.; Finley, Daniel			Enhancement of proteasome activity by a small-molecule inhibitor of USP14	NATURE			English	Article							DEUBIQUITINATING ENZYME USP14; 26S PROTEASOME; ATAXIA MICE; UBIQUITIN; DEGRADATION; PROTEINS; SUBUNIT; SURVIVAL; SYSTEM; STRESS	Proteasomes, the primary mediators of ubiquitin-protein conjugate degradation, are regulated through complex and poorly understood mechanisms. Here we show that USP14, a proteasome-associated deubiquitinating enzyme, can inhibit the degradation of ubiquitin-protein conjugates both in vitro and in cells. A catalytically inactive variant of USP14 has reduced inhibitory activity, indicating that inhibition is mediated by trimming of the ubiquitin chain on the substrate. A high-throughput screen identified a selective small-molecule inhibitor of the deubiquitinating activity of human USP14. Treatment of cultured cells with this compound enhanced degradation of several proteasome substrates that have been implicated in neurodegenerative disease. USP14 inhibition accelerated the degradation of oxidized proteins and enhanced resistance to oxidative stress. Enhancement of proteasome activity through inhibition of USP14 may offer a strategy to reduce the levels of aberrant proteins in cells under proteotoxic stress.	[Lee, Byung-Hoon; Lee, Min Jae; Park, Soyeon; Elsasser, Suzanne; Gartner, Carlos; Dimova, Nevena; Hanna, John; Gygi, Steven P.; King, Randall W.; Finley, Daniel] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Oh, Dong-Chan] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Oh, Dong-Chan] Seoul Natl Univ, Coll Pharm, Inst Nat Prod Res, Seoul 151742, South Korea; [Chen, Ping-Chung; Wilson, Scott M.] Univ Alabama, Civitan Int Res Ctr, Evelyn F McKnight Brain Inst, Dept Neurobiol, Birmingham, AL 35294 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Seoul National University (SNU); University of Alabama System; University of Alabama Birmingham	King, RW (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	randy_king@hms.harvard.edu; daniel_finley@hms.harvard.edu	Lee, Min Jae/C-9814-2015	Lee, Min Jae/0000-0002-3252-6467; Lee, Byung-Hoon/0000-0002-7101-0471; King, Randall/0000-0001-7882-8180; Wilson, Scott/0000-0001-9376-9430	National Institutes of Health [DK082906, GM65592, GM66492, NS047533]; Harvard Technology Development Accelerator Fund; Merck Co.; Johnson Johnson; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065592, R01GM066492, R01GM067945, R56GM066492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047533, P30NS057098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Technology Development Accelerator Fund; Merck Co.(Merck & Company); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Gordon, J. Y. Suk and N. Bays for advice and assistance, and members of the Finley laboratory for comments on the manuscript. We thank C. Shamu and the staff of the ICCB facility at Harvard Medical School, where the HT screen was carried out. We also thank N. Hathaway for ubiquitinated cyclin B, L. Huang for the tagged proteasome cell line, R. Baker for anti-USP14 antibody, G. DeMartino for anti-UCH37 antibody, K. Wilkinson and K. Walters for DUB enzymes, as well as C. Seong, M. Kim, S. M. Lim and D. Waterman for assistance in some experiments. For plasmids, we thank K. Walters, M. Sowa, W. Harper, V. Lee, F. Baralle, H. Paulson, Y. T. Kwon, M. Masucci, M.-K. Kwak, P. Coffino and C. Kahana. This work was supported by grants from the National Institutes of Health (DK082906 to D. F., GM65592 to D. F., GM66492 to R.W.K. and NS047533 to S.M.W.); the Harvard Technology Development Accelerator Fund (D.F.); Merck & Co. (D.F. and R.W.K.); and Johnson & Johnson (D.F. and R.W.K.).	Ahmed EK, 2007, ANN NY ACAD SCI, V1119, P88, DOI 10.1196/annals.1404.020; Amerik AY, 2000, BIOL CHEM, V381, P981, DOI 10.1515/BC.2000.121; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Chauhan D, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S1; Chen PC, 2009, J NEUROSCI, V29, P10909, DOI 10.1523/JNEUROSCI.2635-09.2009; Chernova TA, 2003, J BIOL CHEM, V278, P52102, DOI 10.1074/jbc.M310283200; Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; Crimmins S, 2009, DEV BIOL, V325, P33, DOI 10.1016/j.ydbio.2008.09.021; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Hoyt MA, 2005, METHOD ENZYMOL, V398, P399, DOI 10.1016/S0076-6879(05)98033-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jacobson AD, 2009, J BIOL CHEM, V284, P35485, DOI 10.1074/jbc.M109.052928; JORDAN MA, 1991, CANCER RES, V51, P2212; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kobayashi H, 2005, J BIOL CHEM, V280, P10468, DOI 10.1074/jbc.M409969200; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Kwong LK, 2008, NEUROSIGNALS, V16, P41, DOI 10.1159/000109758; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; LI X, 1995, CYTOMETRY, V20, P172, DOI 10.1002/cyto.990200210; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shabek N, 2009, P NATL ACAD SCI USA, V106, P11907, DOI 10.1073/pnas.0905746106; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Varshavsky A, 2000, BIOL CHEM, V381, P779, DOI 10.1515/BC.2000.101; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	64	681	712	5	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2010	467	7312					179	U63		10.1038/nature09299	http://dx.doi.org/10.1038/nature09299			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20829789	Green Accepted			2022-12-24	WOS:000281616300028
J	Luxton, GWG; Gomes, ER; Folker, ES; Vintinner, E; Gundersen, GG				Luxton, G. W. Gant; Gomes, Edgar R.; Folker, Eric S.; Vintinner, Erin; Gundersen, Gregg G.			Linear Arrays of Nuclear Envelope Proteins Harness Retrograde Actin Flow for Nuclear Movement	SCIENCE			English	Article							MICROFILAMENT BUNDLES BENEATH; NEURONAL MIGRATION; MYOSIN-II; F-ACTIN; CENTROSOME; GROWTH; DYNEIN; ROLES; NEUROGENESIS; FIBROBLASTS	Nuclei move to specific locations to polarize migrating and differentiating cells. Many nuclear movements are microtubule-dependent. However, nuclear movement to reorient the centrosome in migrating fibroblasts occurs through an unknown actin-dependent mechanism. We found that linear arrays of outer (nesprin2G) and inner (SUN2) nuclear membrane proteins assembled on and moved with retrogradely moving dorsal actin cables during nuclear movement in polarizing fibroblasts. Inhibition of nesprin2G, SUN2, or actin prevented nuclear movement and centrosome reorientation. The coupling of actin cables to the nuclear membrane for nuclear movement via specific membrane proteins indicates that, like plasma membrane integrins, nuclear membrane proteins assemble into actin-dependent arrays for force transduction.	[Luxton, G. W. Gant; Gomes, Edgar R.; Folker, Eric S.; Vintinner, Erin; Gundersen, Gregg G.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Gomes, Edgar R.] Univ Paris 06, INSERM, UMR S 787, F-75634 Paris, France; [Gomes, Edgar R.] Grp Hosp Pitie Salpetriere, Inst Myol, F-75013 Paris, France	Columbia University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Gundersen, GG (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.	ggg1@columbia.edu	Luxton, GW Gant/A-7212-2017; Gomes, Edgar/ABH-7441-2020; Gomes, Edgar r/D-9000-2015	Gomes, Edgar/0000-0002-6941-4872; Gomes, Edgar r/0000-0002-6941-4872; Folker, Eric/0000-0003-1619-7330; Luxton, GW Gant/0000-0002-6180-8906	Dystonia Medical Research Foundation; American Heart Association; Muscular Dystrophy Association; Association pour la Recherche sur le Cancer; Ligue Nacionale contre le Cancer; NIH [GM06929, NS059352]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099481, R01GM062939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS059352, R01NS059352] Funding Source: NIH RePORTER	Dystonia Medical Research Foundation; American Heart Association(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nacionale contre le Cancer; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. Dauer, H. Herrmann, E. Marcantonio, G. Morris, S. Shackleton, R. Wedlich-Soldner, and H. Worman for providing reagents; members of the Dauer, Hirano, and Worman labs for helpful discussions; and Y. Zhao for analysis. This work was supported by a Dystonia Medical Research Foundation Fellowship (G.W.G.L.), an American Heart Association fellowship (E.S.F.), a Muscular Dystrophy Association grant (E.R.G.), an Association pour la Recherche sur le Cancer grant (E.R.G.), a Ligue Nacionale contre le Cancer grant (E.R.G.), a Dystonia Medical Research Foundation grant (G.G.G.), and NIH (GM06929 and NS059352) grants (G.G.G.).	Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Gomes ER, 2005, CELL, V121, P451, DOI 10.1016/j.cell.2005.02.022; Goulding MB, 2007, J CELL BIOL, V178, P1177, DOI 10.1083/jcb.200703159; HEATH JP, 1981, CELL BIOL INT REP, V5, P975, DOI 10.1016/0309-1651(81)90214-9; HEATH JP, 1983, J CELL SCI, V60, P331; Ketelaar T, 2002, PLANT CELL, V14, P2941, DOI 10.1105/tpc.005892; King MC, 2008, CELL, V134, P427, DOI 10.1016/j.cell.2008.06.022; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Luke Y, 2008, J CELL SCI, V121, P1887, DOI 10.1242/jcs.019075; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Ramos-Garcia SL, 2009, EUKARYOT CELL, V8, P1880, DOI 10.1128/EC.00062-09; Reinsch S, 1998, J CELL SCI, V111, P2283; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Schmoranzer J, 2009, CURR BIOL, V19, P1065, DOI 10.1016/j.cub.2009.05.065; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Starr DA, 2009, J CELL SCI, V122, P577, DOI 10.1242/jcs.037622; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Wilhelmsen K, 2006, J CELL SCI, V119, P5021, DOI 10.1242/jcs.03295; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	26	326	333	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					956	959		10.1126/science.1189072	http://dx.doi.org/10.1126/science.1189072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20724637	Green Accepted			2022-12-24	WOS:000281084800038
J	Seifert, U; Bialy, LP; Ebstein, F; Bech-Otschir, D; Voigt, A; Schroter, F; Prozorovski, T; Lange, N; Steffen, J; Rieger, M; Kuckelkorn, U; Aktas, O; Kloetzel, PM; Kruger, E				Seifert, Ulrike; Bialy, Lukasz P.; Ebstein, Frederic; Bech-Otschir, Dawadschargal; Voigt, Antje; Schroeter, Friederike; Prozorovski, Timour; Lange, Nicole; Steffen, Janos; Rieger, Melanie; Kuckelkorn, Ulrike; Aktas, Orhan; Kloetzel, Peter-M.; Krueger, Elke			Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress	CELL			English	Article							NEWLY SYNTHESIZED PROTEINS; CD8(+) T-CELLS; PROTEASOME SYSTEM; GAMMA-INTERFERON; HEAT-SHOCK; INDUCTION; DEGRADATION; UBIQUITIN; IMMUNITY; PATHWAY	Interferon (IFN)-induced immunoproteasomes (i-proteasomes) have been associated with improved processing of major histocompatibility complex (MHC) class I antigens. Here, we show that i-proteasomes function to protect cell viability under conditions of IFN-induced oxidative stress. IFNs trigger the production of reactive oxygen species, which induce protein oxidation and the formation of nascent, oxidant-damaged proteins. We find that the ubiquitylation machinery is concomitantly upregulated in response to IFNs, functioning to target defective ribosomal products (DRiPs) for degradation by i-proteasomes. i-proteasome-deficiency in cells and in murine inflammation models results in the formation of aggresome-like induced structures and increased sensitivity to apoptosis. Efficient clearance of these aggregates by the enhanced proteolytic activity of the i-proteasome is important for the preservation of cell viability upon IFN-induced oxidative stress. Our findings suggest that rather than having a specific role in the production of class I antigens, i-proteasomes increase the peptide supply for antigen presentation as part of a more general role in the maintenance of protein homeostasis.	[Seifert, Ulrike; Bialy, Lukasz P.; Ebstein, Frederic; Bech-Otschir, Dawadschargal; Schroeter, Friederike; Lange, Nicole; Steffen, Janos; Rieger, Melanie; Kuckelkorn, Ulrike; Kloetzel, Peter-M.; Krueger, Elke] Charite, Inst Biochem CC2, D-13347 Berlin, Germany; [Voigt, Antje] Charite, Med Klin Kardiol & Angiol CC13, D-10117 Berlin, Germany; [Prozorovski, Timour; Aktas, Orhan] Univ Dusseldorf, Fac Med, Dept Neurol, D-40225 Dusseldorf, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Heinrich Heine University Dusseldorf	Kloetzel, PM (corresponding author), Charite, Inst Biochem CC2, Oudenarder Str 16, D-13347 Berlin, Germany.	p-m.kloetzel@charite.de; elke.krueger@charite.de	Voigt, Antje/E-4332-2013; Biały, Lukasz/AAW-8500-2021; Beling, Antje/AAW-5380-2020; Aktas, Orhan/B-7623-2009; Bialy, Lukasz P./I-1785-2019; Krueger, Elke/B-1462-2012; Steffen, Janos/AAI-7646-2020	Aktas, Orhan/0000-0002-2020-9210; Bialy, Lukasz P./0000-0001-6931-6431; Krueger, Elke/0000-0002-2551-242X; Beling, Antje/0000-0002-1826-5248; Kuckelkorn, Ulrike/0000-0002-3085-9161	Deutsche Forschungsgemeinschaft [SFB421, SFB740, Transregio 19, Transregio 43, KR1915/4-1, SPP 1365]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	D. Ludwig and E. Burger are acknowledged for their excellent technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (SFB421, SFB740, Transregio 19, Transregio 43, KR1915/4-1, SPP 1365).	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Bose S, 2001, BIOCHEM J, V353, P291, DOI 10.1042/0264-6021:3530291; Callahan MK, 2006, J IMMUNOL, V177, P8393, DOI 10.4049/jimmunol.177.12.8393; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; Chou B, 2008, MICROBES INFECT, V10, P241, DOI 10.1016/j.micinf.2007.11.010; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Deol P, 2007, J IMMUNOL, V178, P7557, DOI 10.4049/jimmunol.178.12.7557; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Ebstein F, 2009, INT J BIOCHEM CELL B, V41, P1205, DOI 10.1016/j.biocel.2008.10.023; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Ishii K, 2006, MICROBES INFECT, V8, P1045, DOI 10.1016/j.micinf.2005.10.023; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kotamraju S, 2006, FREE RADICAL BIO MED, V40, P1034, DOI 10.1016/j.freeradbiomed.2005.10.052; Kruger E, 2004, REV PHYSIOL BIOCH P, V148, P81, DOI 10.1007/s10254-003-0010-4; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; Lelouard H, 2007, J CELL BIOL, V179, P1427, DOI 10.1083/jcb.200707166; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nussbaum AK, 2005, J IMMUNOL, V175, P1153, DOI 10.4049/jimmunol.175.2.1153; Pearl-Yafe M, 2003, BIOCHEM PHARMACOL, V65, P833, DOI 10.1016/S0006-2952(02)01620-9; Puttaparthi K, 2005, EXP NEUROL, V196, P441, DOI 10.1016/j.expneurol.2005.08.027; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; SASAKI M, 2008, FREE RADICAL RES, V4, P1; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sijts AJAM, 2000, J EXP MED, V191, P503, DOI 10.1084/jem.191.3.503; Strehl B, 2008, J BIOL CHEM, V283, P17891, DOI 10.1074/jbc.M710042200; Strehl B, 2006, J IMMUNOL, V177, P6238, DOI 10.4049/jimmunol.177.9.6238; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; VAN KL, 1994, IMMUNITY, V1, P533; Voigt A, 2010, AMINO ACIDS, V39, P243, DOI 10.1007/s00726-009-0434-5; Watanabe Y, 2003, J CELL BIOCHEM, V89, P244, DOI 10.1002/jcb.10501; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 2005, IMMUNOL REV, V207, P8; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102	49	394	402	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					613	624		10.1016/j.cell.2010.07.036	http://dx.doi.org/10.1016/j.cell.2010.07.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723761	Bronze			2022-12-24	WOS:000281115900015
J	Filippakopoulos, P; Qi, J; Picaud, S; Shen, Y; Smith, WB; Fedorov, O; Morse, EM; Keates, T; Hickman, TT; Felletar, I; Philpott, M; Munro, S; McKeown, MR; Wang, YC; Christie, AL; West, N; Cameron, MJ; Schwartz, B; Heightman, TD; La Thangue, N; French, CA; Wiest, O; Kung, AL; Knapp, S; Bradner, JE				Filippakopoulos, Panagis; Qi, Jun; Picaud, Sarah; Shen, Yao; Smith, William B.; Fedorov, Oleg; Morse, Elizabeth M.; Keates, Tracey; Hickman, Tyler T.; Felletar, Ildiko; Philpott, Martin; Munro, Shonagh; McKeown, Michael R.; Wang, Yuchuan; Christie, Amanda L.; West, Nathan; Cameron, Michael J.; Schwartz, Brian; Heightman, Tom D.; La Thangue, Nicholas; French, Christopher A.; Wiest, Olaf; Kung, Andrew L.; Knapp, Stefan; Bradner, James E.			Selective inhibition of BET bromodomains	NATURE			English	Article							ABL TYROSINE KINASE; PROTEIN BRD4; P-TEFB; AGGRESSIVE CARCINOMA; MITOTIC CHROMOSOMES; SIGNAL-TRANSDUCTION; STRUCTURAL BASIS; CHEMICAL PROBES; IN-VIVO; LEUKEMIA	Epigenetic proteins are intently pursued targets in ligand discovery. So far, successful efforts have been limited to chromatin modifying enzymes, or so-called epigenetic 'writers' and 'erasers'. Potent inhibitors of histone binding modules have not yet been described. Here we report a cell-permeable small molecule (JQ1) that binds competitively to acetyl-lysine recognition motifs, or bromodomains. High potency and specificity towards a subset of human bromodomains is explained by co-crystal structures with bromodomain and extra-terminal (BET) family member BRD4, revealing excellent shape complementarity with the acetyl-lysine binding cavity. Recurrent translocation of BRD4 is observed in a genetically-defined, incurable subtype of human squamous carcinoma. Competitive binding by JQ1 displaces the BRD4 fusion oncoprotein from chromatin, prompting squamous differentiation and specific antiproliferative effects in BRD4-dependent cell lines and patient-derived xenograft models. These data establish proof-of-concept for targeting protein-protein interactions of epigenetic 'readers', and provide a versatile chemical scaffold for the development of chemical probes more broadly throughout the bromodomain family.	[Filippakopoulos, Panagis; Picaud, Sarah; Fedorov, Oleg; Keates, Tracey; Felletar, Ildiko; Philpott, Martin; Heightman, Tom D.; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Dept Clin Med, Oxford OX3 7DQ, England; [Qi, Jun; Smith, William B.; Morse, Elizabeth M.; McKeown, Michael R.; West, Nathan; Bradner, James E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Shen, Yao; Wiest, Olaf] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Shen, Yao; Wiest, Olaf] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA; [Hickman, Tyler T.; Cameron, Michael J.; Schwartz, Brian; French, Christopher A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Munro, Shonagh; La Thangue, Nicholas; Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England; [McKeown, Michael R.; Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Wang, Yuchuan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02115 USA; [Christie, Amanda L.; Kung, Andrew L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Lurie Family Imaging Ctr, Boston, MA 02115 USA; [Kung, Andrew L.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kung, Andrew L.] Childrens Hosp, Boston, MA 02115 USA	University of Oxford; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Notre Dame; University of Notre Dame; Walther Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oxford; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Knapp, S (corresponding author), Univ Oxford, Struct Genom Consortium, Dept Clin Med, Old Rd Campus,Roosevelt Dr, Oxford OX3 7DQ, England.	stefan.knapp@sgc.ox.ac.uk; james_bradner@dfci.harvard.edu	Kung, Andrew/AAL-2384-2020; Knapp, Stefan/AAG-2347-2019; Fedorov, Oleg Y./B-6412-2014; Kung, Andrew L/AEU-0826-2022	Knapp, Stefan/0000-0001-5995-6494; Fedorov, Oleg Y./0000-0001-9004-1815; Kung, Andrew L/0000-0002-9091-488X; Wang, Yuchuan/0000-0001-5111-6562; Philpott, Martin/0000-0003-3632-0084; Schwartz, Brian/0000-0002-4659-9800; Filippakopoulos, Panagis/0000-0002-1515-1317; Luoma, Elizabeth/0000-0001-9371-5715; Hickman, Tyler/0000-0003-2623-3251	Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; University of Notre Dame; NIGMS [T32-075762]; DF/HCC; National Institutes of Health; Burroughs Wellcome Fund; Leukemia & Lymphoma Society; MRC [G9400953, G0500905] Funding Source: UKRI; Medical Research Council [G9400953, G0500905] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K08CA128972] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); University of Notre Dame; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DF/HCC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to U. Oppermann, S. Muller, S. Sallan, C. Lathan, P. Rahl, R. Young, K. Lee and K. Shaw for discussions and sharing unpublished information; K. Agu, S. Johnston and L. Li for analytical chemistry support; J. Daley for flow cytometry support; T. Bowman, T. Caron, C. Marvin and S. Rodig for immunohistochemistry; and A. Bass for sharing cell lines. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. This research was supported by a Graduate Fellowship from the Chemistry-Biochemistry-Biology Interface Program at the University of Notre Dame, NIGMS T32-075762 (to Y.S.), the DF/HCC (to C. A. F. and J. E. B.), the National Institutes of Health, the Burroughs Wellcome Fund, and the Leukemia & Lymphoma Society (to J.E.B.).	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Adachi K, 2006, WPO Patent, Patent No. [WO2006129623A1, 2006129623, PCT/JP2006/310709 (WO/2006/129623)]; [Anonymous], 2009, [No title captured], Patent No. [2009084693, WO2009084693]; Buchdunger E, 1996, CANCER RES, V56, P100; BUCHDUNGER E, 1995, P NATL ACAD SCI USA, V92, P2558, DOI 10.1073/pnas.92.7.2558; Bullock AN, 2005, J MED CHEM, V48, P7604, DOI 10.1021/jm0504858; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2009, MOL BIOL CELL, V20, P4899, DOI 10.1091/mbc.E09-05-0380; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; French CA, 2003, CANCER RES, V63, P304; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Haack H, 2009, AM J SURG PATHOL, V33, P984, DOI 10.1097/PAS.0b013e318198d666; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; MARUSHIGE K, 1976, P NATL ACAD SCI USA, V73, P3937, DOI 10.1073/pnas.73.11.3937; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oprea TI, 2009, NAT CHEM BIOL, V5, P441, DOI 10.1038/nchembio0709-441; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Phelps MA, 2009, BLOOD, V113, P2637, DOI 10.1182/blood-2008-07-168583; Ptashne M, 2009, CURR BIOL, V19, pR234, DOI 10.1016/j.cub.2009.02.015; Quinn AM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp899; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; SUEOKA H, 1998, THIENOTRIAZOLODIAZEP, P1; Toretsky JA, 2003, AM J CLIN ONCOL-CANC, V26, P300, DOI 10.1097/00000421-200306000-00019; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; VONVOIGTLANDER PF, 1985, DRUG DEVELOP RES, V6, P1, DOI 10.1002/ddr.430060102; Yang XJ, 2005, ONCOGENE, V24, P1653, DOI 10.1038/sj.onc.1208173; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; You JX, 2006, J VIROL, V80, P8909, DOI 10.1128/JVI.00502-06; You JX, 2009, MOL CELL BIOL, V29, P5094, DOI 10.1128/MCB.00299-09; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	43	2680	2913	20	556	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 23	2010	468	7327					1067	1073		10.1038/nature09504	http://dx.doi.org/10.1038/nature09504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	697XT	20871596	Green Accepted			2022-12-24	WOS:000285553800051
J	Duncan, AW; Taylor, MH; Hickey, RD; Newell, AEH; Lenzi, ML; Olson, SB; Finegold, MJ; Grompe, M				Duncan, Andrew W.; Taylor, Matthew H.; Hickey, Raymond D.; Newell, Amy E. Hanlon; Lenzi, Michelle L.; Olson, Susan B.; Finegold, Milton J.; Grompe, Markus			The ploidy conveyor of mature hepatocytes as a source of genetic variation	NATURE			English	Article							TYROSINEMIA TYPE-I; MURINE MODEL; CELL-FUSION; MOUSE MODEL; STEM-CELLS; LIVER; MICE; VIVO; FUMARYLACETOACETATE; POLYPLOIDIZATION	Mononucleated and binucleated polyploid hepatocytes (4n, 8n, 16n and higher) are found in all mammalian species, but the functional significance of this conserved phenomenon remains unknown(1-4). Polyploidization occurs through failed cytokinesis, begins at weaning in rodents and increases with age(2,5-7). Previously, we demonstrated that the opposite event, ploidy reversal, also occurs in polyploid hepatocytes generated by artificial cell fusion(8-10). This raised the possibility that somatic 'reductive mitoses' can also happen in normal hepatocytes. Here we show that multipolar mitotic spindles form frequently in mouse polyploid hepatocytes and can result in one-step ploidy reversal to generate offspring with halved chromosome content. Proliferating hepatocytes produce a highly diverse population of daughter cells with multiple numerical chromosome imbalances as well as uniparental origins. Our findings support a dynamic model of hepatocyte polyploidization, ploidy reversal and aneuploidy, a phenomenon that we term the 'ploidy conveyor'. We propose that this mechanism evolved to generate genetic diversity and permits adaptation of hepatocytes to xenobiotic or nutritional injury.	[Duncan, Andrew W.; Hickey, Raymond D.; Grompe, Markus] Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Oregon Stem Cell Ctr, Portland, OR 97239 USA; [Taylor, Matthew H.] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97239 USA; [Hickey, Raymond D.; Newell, Amy E. Hanlon; Lenzi, Michelle L.; Olson, Susan B.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Finegold, Milton J.] Texas Childrens Hosp, Dept Pathol, Houston, TX 77030 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Baylor College of Medicine	Duncan, AW (corresponding author), Oregon Hlth & Sci Univ, Pape Family Pediat Res Inst, Oregon Stem Cell Ctr, Portland, OR 97239 USA.	duncanan@ohsu.edu		Grompe, Markus/0000-0002-6616-4345; Duncan, Andrew/0000-0003-4962-4191	Advanced Light Microscopy Core at OHSU [S10-RR023432]; Morphology Core of the Texas Medical Center [DK56338]; National Institute of Health [R01DK067636, F32DK076232]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338, F32DK076232, R01DK067636] Funding Source: NIH RePORTER	Advanced Light Microscopy Core at OHSU; Morphology Core of the Texas Medical Center; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank P. Canaday (Flow Cytometry Resource at OHSU) for cell sorting; A. Snyder and S. Kaech Petrie (Advanced Light Microscopy Core at OHSU, Core grant S10-RR023432) for microscopy assistance; and the Morphology Core of the Texas Medical Center (DK56338) for histology support. We also thank L. Smith and M. Thayer for discussions. This work was supported by grants from the National Institute of Health to M.G. (R01DK067636) and A.W.D. (F32DK076232).	BARBASON H, 1974, CELL TISSUE KINET, V7, P319, DOI 10.1111/j.1365-2184.1974.tb00414.x; BAYANI J, 2004, CURR PROTOC CELL BIO, DOI DOI 10.1002/0471143030.CB2204S2322; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; DARLINGTON GJ, 1987, IN VITRO CELL DEV B, V23, P349; Duncan AW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000385; FAKTOR VM, 1975, TSITOLOGIYA+, V17, P909; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; GROMPE M, 1993, GENE DEV, V7, P2298, DOI 10.1101/gad.7.12a.2298; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Jorquera R, 1997, BIOCHEM BIOPH RES CO, V232, P42, DOI 10.1006/bbrc.1997.6220; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Manning K, 1999, P NATL ACAD SCI USA, V96, P11928, DOI 10.1073/pnas.96.21.11928; Margall-Ducos G, 2007, J CELL SCI, V120, P3633, DOI 10.1242/jcs.016907; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Overturf K, 1997, HUM GENE THER, V8, P513, DOI 10.1089/hum.1997.8.5-513; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Willenbring H, 2004, NAT MED, V10, P744, DOI 10.1038/nm1062; Yannoutsos N, 1996, GENES CELLS, V1, P409, DOI 10.1046/j.1365-2443.1996.d01-244.x; YIM APC, 1982, BRIT J EXP PATHOL, V63, P458	26	334	343	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 7	2010	467	7316					707	U93		10.1038/nature09414	http://dx.doi.org/10.1038/nature09414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659NE	20861837	Green Accepted			2022-12-24	WOS:000282572500038
J	Asher, G; Reinke, H; Altmeyer, M; Gutierrez-Arcelus, M; Hottiger, MO; Schibler, U				Asher, Gad; Reinke, Hans; Altmeyer, Matthias; Gutierrez-Arcelus, Maria; Hottiger, Michael O.; Schibler, Ueli			Poly(ADP-Ribose) Polymerase 1 Participates in the Phase Entrainment of Circadian Clocks to Feeding	CELL			English	Article							GENE-EXPRESSION; DNA-BINDING; TRANSCRIPTION; FEEDBACK; PROTEIN; PARP-1; LIVER	Circadian clocks in peripheral organs are tightly coupled to cellular metabolism and are readily entrained by feeding-fasting cycles. However, the molecular mechanisms involved are largely unknown. Here we show that in liver the activity of PARP-1, an NAD(+)-dependent ADP-ribosyltransferase, oscillates in a daily manner and is regulated by feeding. We provide biochemical evidence that PARP-1 binds and poly(ADP-ribosyl)ates CLOCK at the beginning of the light phase. The loss of PARP-1 enhances the binding of CLOCK-BMAL1 to DNA and leads to a phase-shift of the interaction of CLOCK-BMAL1 with PER and CRY repressor proteins. As a consequence, CLOCK-BMAL1-dependent gene expression is altered in PARP-1-deficient mice, in particular in response to changes in feeding times. Our results show that Parp-1 knockout mice exhibit impaired food entrainment of peripheral circadian clocks and support a role for PARP-1 in connecting feeding with the mammalian timing system.	[Asher, Gad; Gutierrez-Arcelus, Maria; Schibler, Ueli] Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; [Reinke, Hans] Heinrich Heine Univ IUF, Inst Mol Prevent Med, Sch Med, Heinrich Heine Univ,Inst Clin Chem & Lab Diagnost, D-40225 Dusseldorf, Germany; [Altmeyer, Matthias; Hottiger, Michael O.] Univ Zurich, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland; [Altmeyer, Matthias] Univ Zurich, Mol Life Sci Program, Life Sci Zurich Grad Sch, CH-8057 Zurich, Switzerland	University of Geneva; Heinrich Heine University Dusseldorf; University of Zurich; University of Zurich	Asher, G (corresponding author), Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland.	gad.asher@unige.ch; ueli.schibler@unige.ch	Hottiger, Michael O./J-7747-2013; Altmeyer, Matthias/AAE-8186-2019; ASHER, GAD/K-1333-2012	Hottiger, Michael O./0000-0002-7323-2270; Altmeyer, Matthias/0000-0003-3780-1170; Asher, Gad/0000-0001-9403-7856	Swiss National Foundation [SNF 31-113565, SNF 31-128656/1]; European Research Council [ERC2009-AdG 20090506]; State of Geneva; Louis Jeantet Foundation of Medicine	Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); State of Geneva; Louis Jeantet Foundation of Medicine	The work performed in the laboratory of U.S. was supported by the Swiss National Foundation (SNF 31-113565, SNF 31-128656/1, and the NCCR program grant Frontiers in Genetics), the European Research Council (ERC2009-AdG 20090506), the State of Geneva, the Louis Jeantet Foundation of Medicine, and the 6<SUP>th</SUP> European Framework Project EUCLOCK. The work conducted in the laboratory of M.O.H. was supported by the Swiss National Foundation (SNF 31-122421) and the Kanton of Zurich. G. A. received long-term fellowships from EMBO and the Human Frontier Science Program.	Altmeyer M, 2009, AGING-US, V1, P458, DOI 10.18632/aging.100052; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Kauppinen TM, 2006, P NATL ACAD SCI USA, V103, P7136, DOI 10.1073/pnas.0508606103; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871; LE MINH N, 2001, EMBO J, V20, P7128; MAZEN A, 1989, NUCLEIC ACIDS RES, V17, P4689, DOI 10.1093/nar/17.12.4689; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Panda S, 2002, DEV CELL, V3, P51, DOI 10.1016/S1534-5807(02)00200-9; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zaniolo K, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-96	37	252	265	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2010	142	6					943	953		10.1016/j.cell.2010.08.016	http://dx.doi.org/10.1016/j.cell.2010.08.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20832105	Bronze			2022-12-24	WOS:000281855000016
J	Rai, K; Sarkar, S; Broadbent, TJ; Voas, M; Grossmann, KF; Nadauld, LD; Dehghanizadeh, S; Hagos, FT; Li, YM; Toth, RK; Chidester, S; Bahr, TM; Johnson, WE; Sklow, B; Burt, R; Cairns, BR; Jones, DA				Rai, Kunal; Sarkar, Sharmistha; Broadbent, Talmage J.; Voas, Matthew; Grossmann, Kenneth F.; Nadauld, Lincoln D.; Dehghanizadeh, Somaye; Hagos, Fanuel T.; Li, Yumei; Toth, Rachel K.; Chidester, Stephanie; Bahr, Timothy M.; Johnson, W. Evan; Sklow, Brad; Burt, Randall; Cairns, Bradley R.; Jones, David A.			DNA Demethylase Activity Maintains Intestinal Cells in an Undifferentiated State Following Loss of APC	CELL			English	Article							ADENOMATOUS POLYPOSIS-COLI; RETINOIC ACID; COLORECTAL-CANCER; ALDEHYDE DEHYDROGENASE; REGULATES EXPRESSION; GENE-EXPRESSION; BETA-CATENIN; ZEBRAFISH; HYPOMETHYLATION; MICE	Although genome-wide hypomethylation is a hallmark of many cancers, roles for active DNA demethylation during tumorigenesis are unknown. Here, loss of the APC tumor suppressor gene causes upregulation of a DNA demethylase system and the concomitant hypomethylation of key intestinal cell fating genes. Notably, this hypomethylation maintained zebrafish intestinal cells in an undifferentiated state that was released upon knockdown of demethylase components. Mechanistically, the demethylase genes are directly activated by Pou5f1 and Cebp beta and are indirectly repressed by retinoic acid, which antagonizes Pou5f1 and Cebp beta. Apc mutants lack retinoic acid as a result of the transcriptional repression of retinol dehydrogenase l1 via a complex that includes Lef1, Groucho2, Ctbp1, Lsd1, and Corest. Our findings imply a model wherein APC controls intestinal cell fating through a switch in DNA methylation dynamics. Wild-type APC and retinoic acid downregulate demethylase components, thereby promoting DNA methylation of key genes and helping progenitors commit to differentiation.	[Rai, Kunal; Sarkar, Sharmistha; Broadbent, Talmage J.; Voas, Matthew; Grossmann, Kenneth F.; Nadauld, Lincoln D.; Dehghanizadeh, Somaye; Hagos, Fanuel T.; Li, Yumei; Toth, Rachel K.; Chidester, Stephanie; Johnson, W. Evan; Sklow, Brad; Burt, Randall; Cairns, Bradley R.; Jones, David A.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Rai, Kunal; Grossmann, Kenneth F.; Cairns, Bradley R.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Rai, Kunal; Sarkar, Sharmistha; Broadbent, Talmage J.; Voas, Matthew; Grossmann, Kenneth F.; Dehghanizadeh, Somaye; Hagos, Fanuel T.; Toth, Rachel K.; Cairns, Bradley R.; Jones, David A.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Jones, David A.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA; [Burt, Randall] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Li, Yumei; Johnson, W. Evan; Sklow, Brad] Univ Utah, Dept Surg, Salt Lake City, UT 84112 USA; [Bahr, Timothy M.] Brigham Young Univ, Dept Stat, Provo, UT 84602 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Brigham Young University	Cairns, BR (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	brad.cairns@hci.utah.edu; david.jones@hci.utah.edu		Johnson, W. Evan/0000-0002-6247-6595; Chidester, Stephanie/0000-0003-4163-3480; Rai, Kunal/0000-0003-2321-6894	National Cancer Institute [CA073992, CA96934]; National Institute of Child Health and Development [HD058506]; Howard Hughes Medical Institute; Huntsman Cancer Foundation; Cancer Center [CA042014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058506] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA042014, P01CA073992, R01CA116468] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Huntsman Cancer Foundation; Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Smitha James and Adam Karpf for liquid chromatography-mass spectrometry assay, Kornelia Edes, Chad Zavala, Jennifer Swift, Abby Evans, and Erek Winett for technical help, and Richard Dorsky for reagents. This work is supported by grants from the National Cancer Institute (CA073992 and CA96934) awarded to D. A. J., the National Institute of Child Health and Development (HD058506 to B. R. C. and D. A. J), the Howard Hughes Medical Institute (to B. R. C), and the Huntsman Cancer Foundation. The work was also supported by access to technical cores supported by a Cancer Center Support Grant (CA042014).	Begemann G, 2001, DEVELOPMENT, V128, P3081; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Blanc V, 2007, CANCER RES, V67, P8565, DOI 10.1158/0008-5472.CAN-07-1593; Dobbs-McAuliffe B, 2004, MECH DEVELOP, V121, P339, DOI 10.1016/j.mod.2004.02.008; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Eads CA, 2002, CANCER RES, V62, P1296; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Eisinger AL, 2007, J BIOL CHEM, V282, P29394, DOI 10.1074/jbc.M609768200; Eisinger AL, 2006, J BIOL CHEM, V281, P20474, DOI 10.1074/jbc.M602859200; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Guimond J, 2002, BBA-GENE STRUCT EXPR, V1579, P81, DOI 10.1016/S0167-4781(02)00510-9; HOLLIDAY R, 1985, CANCER SURV, V4, P557; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Jette C, 2004, J BIOL CHEM, V279, P34397, DOI 10.1074/jbc.M314021200; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Mudumana SP, 2004, DEV DYNAM, V230, P165, DOI 10.1002/dvdy.20032; Nadauld LD, 2005, J BIOL CHEM, V280, P30490, DOI 10.1074/jbc.M504973200; Nadauld LD, 2004, J BIOL CHEM, V279, P51581, DOI 10.1074/jbc.M408830200; Nadauld LD, 2006, J BIOL CHEM, V281, P37828, DOI 10.1074/jbc.M602119200; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Parvin MS, 2008, DEV DYNAM, V237, P1373, DOI 10.1002/dvdy.21539; Phelps RA, 2009, CELL CYCLE, V8, P2549, DOI 10.4161/cc.8.16.9278; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; RUSSO JE, 1988, BIOCHEM PHARMACOL, V37, P1639, DOI 10.1016/0006-2952(88)90030-5; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Sparks AB, 1998, CANCER RES, V58, P1130; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	37	75	77	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 17	2010	142	6					930	942		10.1016/j.cell.2010.08.030	http://dx.doi.org/10.1016/j.cell.2010.08.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	650NA	20850014	Green Accepted, Bronze			2022-12-24	WOS:000281855000015
J	Garaj, S; Hubbard, W; Reina, A; Kong, J; Branton, D; Golovchenko, JA				Garaj, S.; Hubbard, W.; Reina, A.; Kong, J.; Branton, D.; Golovchenko, J. A.			Graphene as a subnanometre trans-electrode membrane	NATURE			English	Article							CARBON NANOTUBES; LARGE-AREA; DNA; NANOPORES; MOLECULES; WATER	Isolated, atomically thin conducting membranes of graphite, called graphene, have recently been the subject of intense research with the hope that practical applications in fields ranging from electronics to energy science will emerge(1). The atomic thinness, stability and electrical sensitivity of graphene motivated us to investigate the potential use of graphene membranes and graphene nanopores to characterize single molecules of DNA in ionic solution. Here we show that when immersed in an ionic solution, a layer of graphene becomes a new electrochemical structure that we call a transelectrode. The trans-electrode's unique properties are the consequence of the atomic-scale proximity of its two opposing liquid-solid interfaces together with graphene's well known inplane conductivity. We show that several trans-electrode properties are revealed by ionic conductance measurements on a graphene membrane that separates two aqueous ionic solutions. Although our membranes are only one to two atomic layers(2,3) thick, we find they are remarkable ionic insulators with a very small stable conductance that depends on the ion species in solution. Electrical measurements on graphene membranes in which a single nanopore has been drilled show that the membrane's effective insulating thickness is less than one nanometre. This small effective thickness makes graphene an ideal substrate for very high resolution, high throughput nanopore-based single-molecule detectors. The sensitivity of graphene's in-plane electronic conductivity to its immediate surface environment and trans-membrane solution potentials will offer new insights into atomic surface processes and sensor development opportunities.	[Garaj, S.; Golovchenko, J. A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Hubbard, W.; Golovchenko, J. A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Reina, A.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Kong, J.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Branton, D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Golovchenko, JA (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	sgaraj@fas.harvard.edu; golovchenko@physics.harvard.edu	Garaj, Slaven/AAA-9824-2020; Garaj, Slaven/B-9782-2013	Garaj, Slaven/0000-0001-5529-4040; Hubbard, William/0000-0002-2924-0820	National Human Genome Research Institute, National Institutes of Health [R01 HG003703]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003703] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by a grant (number R01 HG003703) to J.A.G. and D.B. from the National Human Genome Research Institute, National Institutes of Health.	Alexiadis A, 2008, CHEM REV, V108, P5014, DOI 10.1021/cr078140f; Bard A.J., 2001, ELECTROCHEMICAL METH, P534; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; HALL JE, 1975, J GEN PHYSIOL, V66, P531, DOI 10.1085/jgp.66.4.531; Hille B., 2001, ION CHANNELS EXCITAB; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Hoogerheide DP, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.256804; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Li JL, 2003, NAT MATER, V2, P611, DOI 10.1038/nmat965; Liu HT, 2010, SCIENCE, V327, P64, DOI 10.1126/science.1181799; MERCHANT CA, 2010, NANO LETT, DOI DOI 10.1021/NL101046T; Reina A, 2009, NANO RES, V2, P509, DOI 10.1007/s12274-009-9059-y; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Schneider GF, 2010, NANO LETT, V10, P3163, DOI [10.1021/nl102069z, 10.1021/nl101046t]; Sint K, 2008, J AM CHEM SOC, V130, P16448, DOI 10.1021/ja804409f; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Werder T, 2003, J PHYS CHEM B, V107, P1345, DOI 10.1021/jp0268112; Zwolak M, 2008, REV MOD PHYS, V80, P141, DOI 10.1103/RevModPhys.80.141; Zwolak M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.128102	21	1088	1184	27	1052	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2010	467	7312					190	U73		10.1038/nature09379	http://dx.doi.org/10.1038/nature09379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20720538	Green Submitted, Green Accepted			2022-12-24	WOS:000281616300030
J	Jiao, XF; Xiang, S; Oh, C; Martin, CE; Tong, LA; Kiledjian, M				Jiao, Xinfu; Xiang, Song; Oh, ChanSeok; Martin, Charles E.; Tong, Liang; Kiledjian, Megerditch			Identification of a quality-control mechanism for mRNA 5 '-end capping	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; DECAPPING ENZYME; CAP METHYLTRANSFERASE; POLYMERASE-II; YEAST-CELLS; PROTEIN; COMPLEX; DEADENYLATION; TRANSLATION; EXPRESSION	The 7-methylguanosine cap structure at the 5' end of eukaryotic messenger RNAs is a critical determinant of their stability and translational efficiency(1-3). It is generally believed that 5'-end capping is a constitutive process that occurs during mRNA maturation and lacks the need for a quality-control mechanism to ensure its fidelity. We recently reported that the yeast Rai1 protein has pyrophosphohydrolase activity towards mRNAs lacking a 5'-end cap(4). Here we show that, in vitro as well as in yeast cells, Rai1 possesses a novel decapping endonuclease activity that can also remove the entire cap structure dinucleotide from an mRNA. This activity is targeted preferentially towards mRNAs with unmethylated caps in contrast to the canonical decapping enzyme, Dcp2, which targets mRNAs with a methylated cap. Capped but unmethylated mRNAs generated in yeast cells with a defect in the methyltransferase gene are more stable in a rai1-gene-disrupted background. Moreover, rai1 Delta yeast cells with wild-type capping enzymes show significant accumulation of mRNAs with 5'-end capping defects under nutritional stress conditions of glucose starvation or amino acid starvation. These findings provide evidence that 5'-end capping is not a constitutive process that necessarily always proceeds to completion and demonstrates that Rai1 has an essential role in clearing mRNAs with aberrant 5'-end caps. We propose that Rai1 is involved in an as yet uncharacterized quality control process that ensures mRNA 5'-end integrity by an aberrant-cap-mediated mRNA decay mechanism.	[Jiao, Xinfu; Oh, ChanSeok; Martin, Charles E.; Kiledjian, Megerditch] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Xiang, Song; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Rutgers State University New Brunswick; Columbia University	Kiledjian, M (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.	kiledjian@biology.rutgers.edu	Xiang, Song/AAF-6422-2019	Xiang, Song/0000-0001-9314-4684; Tong, Liang/0000-0002-0563-6468	National Institutes of Health (NIH) [GM077175, GM67005]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077175, R01GM090059, R01GM067005] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Schwer for the abd1-5 yeast strain and A. Shatkin for discussions. This research was supported by grants from the National Institutes of Health (NIH) to L.T. (GM077175) and M.K. (GM67005).	Cowling VH, 2007, MOL CELL BIOL, V27, P2059, DOI 10.1128/MCB.01828-06; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; Fischer PM, 2009, CELL CYCLE, V8, P2535, DOI 10.4161/cc.8.16.9301; Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Goodfellow IG, 2008, INT J BIOCHEM CELL B, V40, P2675, DOI 10.1016/j.biocel.2007.10.023; He F, 2001, MOL CELL BIOL, V21, P1515, DOI 10.1128/MCB.21.5.1515-1530.2001; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; Hilgers V, 2006, RNA, V12, P1835, DOI 10.1261/rna.241006; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Jiao XF, 2009, J NEUROSCI, V29, P12419, DOI 10.1523/JNEUROSCI.5954-08.2009; Jimeno-Gonzalez S, 2010, MOL CELL, V37, P580, DOI 10.1016/j.molcel.2010.01.019; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Li Y, 2010, WIRES RNA, V1, P253, DOI 10.1002/wrna.15; Liu HD, 2005, MOL CELL BIOL, V25, P9764, DOI 10.1128/MCB.25.22.9764-9772.2005; Liu HD, 2002, EMBO J, V21, P4699, DOI 10.1093/emboj/cdf448; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Mannan MAU, 2009, ANAL BIOCHEM, V389, P77, DOI 10.1016/j.ab.2009.03.014; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Meyer S, 2004, CRIT REV BIOCHEM MOL, V39, P197, DOI 10.1080/10409230490513991; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; Piccirillo C, 2003, RNA, V9, P1138, DOI 10.1261/rna.5690503; Schwer B, 2000, GENETICS, V155, P1561; SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8; Shuman S, 2002, NAT REV MOL CELL BIO, V3, P619, DOI 10.1038/nrm880; SHUMAN S, 1995, PROG NUCLEIC ACID RE, V50, P101, DOI 10.1016/S0079-6603(08)60812-0; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; Wang ZR, 1999, MOL CELL BIOL, V19, P4552; Wang ZR, 2001, CELL, V107, P751, DOI 10.1016/S0092-8674(01)00592-X; Wen YX, 2000, GENE DEV, V14, P2944, DOI 10.1101/gad.848200; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Yue ZY, 1997, P NATL ACAD SCI USA, V94, P12898, DOI 10.1073/pnas.94.24.12898; Zhang S, 1999, METHODS, V17, P46, DOI 10.1006/meth.1998.0706	35	119	120	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP	2010	467	7315					608	U137		10.1038/nature09338	http://dx.doi.org/10.1038/nature09338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655TT	20802481	Green Accepted			2022-12-24	WOS:000282273100043
J	Lee, CC; Hu, YL; Ribbe, MW				Lee, Chi Chung; Hu, Yilin; Ribbe, Markus W.			Vanadium Nitrogenase Reduces CO	SCIENCE			English	Article							CHEMISTRY; MECHANISM		[Lee, Chi Chung; Hu, Yilin; Ribbe, Markus W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hu, YL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	yilinh@uci.edu; mribbe@uci.edu			Herman Frasch Foundation [617-HF07]; NIH [GM-67626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626] Funding Source: NIH RePORTER	Herman Frasch Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. C. Rees of Caltech (Pasadena) for help on the GC-MS analysis. This work was supported by Herman Frasch Foundation grant 617-HF07 (M. W. R.) and NIH grant GM-67626 (M.W.R.).	Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Hill HGM, 2003, ASTROBIOLOGY, V3, P291, DOI 10.1089/153110703769016389; ROBSON RL, 1986, NATURE, V322, P388, DOI 10.1038/322388a0; ROFERDEPOORTER CK, 1981, CHEM REV, V81, P447, DOI 10.1021/cr00045a002; Schlogl R, 2003, ANGEW CHEM INT EDIT, V42, P2004, DOI 10.1002/anie.200301553	6	188	189	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					642	642		10.1126/science.1191455	http://dx.doi.org/10.1126/science.1191455			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689010	Green Accepted			2022-12-24	WOS:000280602700028
J	Power, M; Wigglesworth, N; Donaldson, E; Chadwick, P; Gillibrand, S; Goldmann, D				Power, Maxine; Wigglesworth, Neil; Donaldson, Emma; Chadwick, Paul; Gillibrand, Stephen; Goldmann, Donald			Quality Improvement Report Reducing Clostridium difficile infection in acute care by using an improvement collaborative	BRITISH MEDICAL JOURNAL			English	Article							DIARRHEA	Problem In 2006, despite a focus on infection control, Salford Royal had the fourth highest rate of Clostridium difficile infection in north west England. Design Interrupted time series in five collaborative wards ( intervention group) and 35 non-collaborative wards ( control group). Setting University teaching hospital with 850 acute beds. Key measures for improvement Number of cases of C difficile infection per 1000 occupied bed days. Strategies for change In February 2007, a newly formed antimicrobial team led the implementation of revised guidelines in all wards and departments. From March to December 2007, five wards participated in an improvement collaborative. Since December 2007, the changes from the collaborative have been collated and implemented throughout the organisation. Effects of change At baseline the non-collaborative wards had 1.15 (95% CI 1.03 to 1.29) cases per 1000 occupied bed days. In August 2007 cases reduced 56% from baseline (0.51, 0.44 to 0.60), which has been maintained since that time. In the collaborative wards, there were 2.60 (2.11 to 3.17) cases per 1000 occupied bed days at baseline. A shift occurred in April 2007 representing a reduction of 73% (0.69, 0.50 to 0.91) from baseline, which has been maintained. Lessons learnt Careful use of antimicrobial drugs is important in reducing the number of cases of C difficile infection. A collaborative learning model can enable teams to test and implement changes that can accelerate, amplify, and sustain control of C difficile.	[Power, Maxine] Dept Hlth, London SE1 6LH, England; [Wigglesworth, Neil] NHS E Lancashire, Nelson BB9 8AS, Lancs, England; [Donaldson, Emma; Chadwick, Paul; Gillibrand, Stephen] Salford Royal NHS Fdn Trust, Salford M6 8HD, Lancs, England; [Goldmann, Donald] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Goldmann, Donald] Inst Healthcare Improvement, Cambridge, MA 02138 USA	Salford Royal NHS Foundation Trust; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Healthcare Improvement	Power, M (corresponding author), Dept Hlth, London SE1 6LH, England.	maxine.power@dh.gsi.gov.uk	Donaldson, Emma/AAT-4254-2021	Donaldson, Emma/0000-0002-8052-6744				[Anonymous], 2003, BREAKTHR SER IHIS CO; *DEP HLTH, 1994, CLOSTR DIFF INF PREV; *DEP HLTH HLTH PRO, 2009, CLOSTR DIFF INF DEAL; Health Protection Agency, RES MAND CLOSTR DIFF; *HLTH PROT AG, 2009, C DIFF MAND SURV N W; Hurley BW, 2002, ARCH INTERN MED, V162, P2177, DOI 10.1001/archinte.162.19.2177; Langley GL., 2009, IMPROVEMENT GUIDE PR, V2nd; Mohammed MA, 2008, QUAL SAF HEALTH CARE, V17, P137, DOI 10.1136/qshc.2004.012047; Mylonakis E, 2001, ARCH INTERN MED, V161, P525, DOI 10.1001/archinte.161.4.525	9	14	14	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2010	341								c3359	10.1136/bmj.c3359	http://dx.doi.org/10.1136/bmj.c3359			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632GW	20659985				2022-12-24	WOS:000280411700001
J	Wu, BL; Chien, EYT; Mol, CD; Fenalti, G; Liu, W; Katritch, V; Abagyan, R; Brooun, A; Wells, P; Bi, FC; Hamel, DJ; Kuhn, P; Handel, TM; Cherezov, V; Stevens, RC				Wu, Beili; Chien, Ellen Y. T.; Mol, Clifford D.; Fenalti, Gustavo; Liu, Wei; Katritch, Vsevolod; Abagyan, Ruben; Brooun, Alexei; Wells, Peter; Bi, F. Christopher; Hamel, Damon J.; Kuhn, Peter; Handel, Tracy M.; Cherezov, Vadim; Stevens, Raymond C.			Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists	SCIENCE			English	Article							ANTI-HIV ACTIVITY; CRYSTAL-STRUCTURE; RECEPTOR DIMERIZATION; LIGAND; GP120; REVEALS; IDENTIFICATION; MIGRATION; RESIDUES; CELLS	Chemokine receptors are critical regulators of cell migration in the context of immune surveillance, inflammation, and development. The G protein-coupled chemokine receptor CXCR4 is specifically implicated in cancer metastasis and HIV-1 infection. Here we report five independent crystal structures of CXCR4 bound to an antagonist small molecule IT1t and a cyclic peptide CVX15 at 2.5 to 3.2 angstrom resolution. All structures reveal a consistent homodimer with an interface including helices V and VI that may be involved in regulating signaling. The location and shape of the ligand-binding sites differ from other G protein-coupled receptors and are closer to the extracellular surface. These structures provide new clues about the interactions between CXCR4 and its natural ligand CXCL12, and with the HIV-1 glycoprotein gp120.	[Wu, Beili; Chien, Ellen Y. T.; Mol, Clifford D.; Fenalti, Gustavo; Liu, Wei; Kuhn, Peter; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Katritch, Vsevolod; Abagyan, Ruben; Hamel, Damon J.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Katritch, Vsevolod; Abagyan, Ruben; Hamel, Damon J.; Handel, Tracy M.] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Brooun, Alexei; Wells, Peter; Bi, F. Christopher] Pfizer Worldwide Res & Dev, San Diego, CA 92121 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Pfizer	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Cherezov, Vadim/L-9812-2013; Liu, Wei/F-1820-2011; Stevens, Raymond/K-7272-2015; Katritch, Vsevolod/Q-8357-2016; Katritch, Vsevolod/Y-2721-2019	Cherezov, Vadim/0000-0002-5265-3914; Stevens, Raymond/0000-0002-4522-8725; Katritch, Vsevolod/0000-0003-3883-4505; 	Protein Structure Initiative [U54 GM074961]; NIH Roadmap Initiative [P50 GM073197]; NIH [R21 RR025336, R21 AI087189, R01 AI037113, R01 GM081763, GM075915]; Pfizer; NSF [IIS0308078]; Science Foundation Ireland [02-IN1-B266]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104];  [F32 GM083463];  [R01 GM071872]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025336] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087189, R01AI037113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073197, R01GM075915, R01GM081763, U54GM094618, R01GM071872, R01GM089857, F32GM083463, U54GM074961] Funding Source: NIH RePORTER	Protein Structure Initiative; NIH Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); NSF(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Protein Structure Initiative grant U54 GM074961 for structure production, NIH Roadmap Initiative grant P50 GM073197 for technology development, NIH grants R21 RR025336 and R21 AI087189 to V. C., and Pfizer. T. M. H. acknowledges support from NIH R01 AI037113 and R01 GM081763, D.J.H. from F32 GM083463, and R. A. from R01 GM071872. The authors thank J. Velasquez for help on molecular biology, T. Trinh and K. Allin for help on baculovirus expression, I. Wilson and D. Burton for careful review and scientific feedback on the manuscript, W. Schief for electron microscopy models of gp120-gp41-CD4 complex, G. W. Han for evaluating the structure quality and preparation for PDB submission, and A. Walker for assistance with manuscript preparation. The authors acknowledge E. La Chapelle on chemistry tool compound synthesis; A. Rane on radiolabeling of [<SUP>3</SUP>H]BIMA; M. Cui for help developing [<SUP>3</SUP>H]BIMA binding assay; Y. Zheng, The Ohio State University, and M. Caffrey, Trinity College (Dublin, Ireland), for the generous loan of the in meso robot [built with support from the National Institutes of Health (GM075915), the NSF (IIS0308078), and Science Foundation Ireland (02-IN1-B266)]; and J. Smith, R. Fischetti, and N. Sanishvili at the General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT) beamline at the Advanced Photon Source for assistance in development and use of the minibeam and beamtime. The GM/CA-CAT beamline (23-ID) is supported by the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). R. C. S. is the founder and is a board member of Receptos, a biotech company focused on GPCR structure-based drug discovery. Transfer of IT1t, CVX15, and [3H] BIMA will require a Material Transfer Agreement (MTA) with Pfizer, and transfer of all other constructs and biological materials requires an MTA with the Scripps Research Institute. Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification codes 3ODU (CXCR4-2-IT1t, P21), 3OE0 (CXCR4-3-CVX15, C2), 3OE8 (CXCR4-2-IT1t, P1), 3OE9 (CXCR4-3-IT1t, P1), and 3OE6 (CXCR4-1-IT1t, I222).	Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Appay V, 1999, J BIOL CHEM, V274, P27505, DOI 10.1074/jbc.274.39.27505; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balabanian K, 2005, BLOOD, V105, P2449, DOI 10.1182/blood-2004-06-2289; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; DeMarco SJ, 2006, BIOORGAN MED CHEM, V14, P8396, DOI 10.1016/j.bmc.2006.09.003; Diskin R, 2010, NAT STRUCT MOL BIOL, V17, P608, DOI 10.1038/nsmb.1796; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Fanelli F, 2006, J COMPUT AID MOL DES, V20, P449, DOI 10.1007/s10822-006-9064-0; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Filizola M, 2010, LIFE SCI, V86, P590, DOI 10.1016/j.lfs.2009.05.004; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Gupta SK, 2001, IMMUNOL LETT, V78, P29, DOI 10.1016/S0165-2478(01)00228-0; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kofuku Y, 2009, J BIOL CHEM, V284, P35240, DOI 10.1074/jbc.M109.024851; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298; Moncunill G, 2008, MOL PHARMACOL, V73, P1264, DOI 10.1124/mol.107.042911; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nemoto W, 2006, CURR PROTEIN PEPT SC, V7, P561, DOI 10.2174/138920306779025657; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pello OM, 2008, EUR J IMMUNOL, V38, P537, DOI 10.1002/eji.200737630; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Reggio PH, 2006, AAPS J, V8, pE322; Roth CB, 2008, J MOL BIOL, V376, P1305, DOI 10.1016/j.jmb.2007.12.028; Salanga CL, 2009, CELL MOL LIFE SCI, V66, P1370, DOI 10.1007/s00018-008-8666-1; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thoma G, 2008, J MED CHEM, V51, P7915, DOI 10.1021/jm801065q; Tian SM, 2005, J VIROL, V79, P12667, DOI 10.1128/JVI.79.20.12667-12673.2005; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Vohra S, 2007, BIOCHEM SOC T, V35, P749, DOI 10.1042/BST0350749; Wang JH, 2008, DRUG DISCOV TODAY, V13, P625, DOI 10.1016/j.drudis.2008.04.004; Wang JH, 2006, MOL CANCER THER, V5, P2474, DOI 10.1158/1535-7163.MCT-05-0261; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wells TNC, 1996, J LEUKOCYTE BIOL, V59, P53, DOI 10.1002/jlb.59.1.53; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555; Zlotnik A, 2008, J PATHOL, V215, P211, DOI 10.1002/path.2350; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	65	1388	1440	7	385	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2010	330	6007					1066	1071		10.1126/science.1194396	http://dx.doi.org/10.1126/science.1194396			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682BU	20929726	Green Accepted			2022-12-24	WOS:000284374700033
J	Lee, S; Yoon, BE; Berglund, K; Oh, SJ; Park, H; Shin, HS; Augustine, GJ; Lee, CJ				Lee, Soojung; Yoon, Bo-Eun; Berglund, Ken; Oh, Soo-Jin; Park, Hyungju; Shin, Hee-Sup; Augustine, George J.; Lee, C. Justin			Channel-Mediated Tonic GABA Release from Glia	SCIENCE			English	Article							CEREBELLAR GRANULE CELLS; SYNAPTIC INHIBITION; RAT CEREBELLUM; ACTIVATION; ASTROCYTES; NEURONS; RECEPTORS; CHLORIDE; BRAIN; DEGENERATION	Synaptic inhibition is based on both tonic and phasic release of the inhibitory transmitter gamma-aminobutyric acid (GABA). Although phasic GABA release arises from Ca2+-dependent exocytosis from neurons, the mechanism of tonic GABA release is unclear. Here we report that tonic inhibition in the cerebellum is due to GABA being released from glial cells by permeation through the Bestrophin 1 (Best1) anion channel. We demonstrate that GABA directly permeates through Best1 to yield GABA release and that tonic inhibition is eliminated by silencing of Best1. Glial cells express both GABA and Best1, and selective expression of Best1 in glial cells, after preventing general expression of Best1, fully rescues tonic inhibition. Our results identify a molecular mechanism for tonic inhibition and establish a role for interactions between glia and neurons in mediating tonic inhibition.	[Lee, Soojung; Yoon, Bo-Eun; Oh, Soo-Jin; Park, Hyungju; Shin, Hee-Sup; Lee, C. Justin] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Yoon, Bo-Eun; Oh, Soo-Jin; Shin, Hee-Sup; Augustine, George J.; Lee, C. Justin] Korea Inst Sci & Technol, Ctr Funct Connect, Seoul, South Korea; [Berglund, Ken; Augustine, George J.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Augustine, George J.] Duke NUS Grad Med Sch, Program Neurosci & Behav Disorders, Singapore, Singapore; [Yoon, Bo-Eun; Lee, C. Justin] Univ Sci & Technol, Neurosci Program, Taejon, South Korea	Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); Duke University; National University of Singapore	Lee, CJ (corresponding author), Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea.	cjl@kist.re.kr	Lee, C. Justin/AAC-1663-2019; Augustine, George James/J-9228-2013; Park, Hyungju/C-4608-2016	Park, Hyungju/0000-0002-9010-9434; Lee, C Justin/0000-0002-3555-0980	KIST; International Cooperation Program; Korean national honor scientist grant; NIMH; World Class Institute	KIST(Korea Institute of Science & Technology Information (KISTI)); International Cooperation Program; Korean national honor scientist grant; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); World Class Institute	We thank J. Park for the ANO1 clone, J. Adelman for the human SK1 clone, K. Kunzelmann for mouse Best1 antibody, and J. Lee for image analysis. We specially thank K. McCarthy for his generous gift of hGFAP-CreERT2 transgenic mice. This study was supported by the KIST Core Competency Program and International Cooperation Program, by a Korean national honor scientist grant, an NIMH grant, and a World Class Institute grant to the Center for Functional Connectomics.	AMIN J, 1994, RECEPTOR CHANNEL, V2, P227; BARDAKDJIAN J, 1979, NEUROCHEM RES, V4, P517, DOI 10.1007/BF00964645; Bellamy TC, 2006, CEREBELLUM, V5, P116, DOI 10.1080/14734220600724569; Berglund K, 2008, BRAIN CELL BIOL, V36, P101, DOI 10.1007/s11068-008-9031-x; BLOMQVIST A, 1988, J NEUROCYTOL, V17, P629, DOI 10.1007/BF01260990; Bond CT, 2005, CURR OPIN NEUROBIOL, V15, P305, DOI 10.1016/j.conb.2005.05.001; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Caraiscos VB, 2004, P NATL ACAD SCI USA, V101, P3662, DOI 10.1073/pnas.0307231101; Carland JE, 2004, NEUROPHARMACOLOGY, V46, P770, DOI 10.1016/j.neuropharm.2003.11.027; Cavelier P, 2005, PROG BIOPHYS MOL BIO, V87, P3, DOI 10.1016/j.pbiomolbio.2004.06.001; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; CHANPALAY V, 1972, Z ANAT ENTWICKLUNGS, V138, P1, DOI 10.1007/BF00519921; Chebib M, 2004, CLIN EXP PHARMACOL P, V31, P800, DOI 10.1111/j.1440-1681.2004.04083.x; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cope DW, 2009, NAT MED, V15, P1392, DOI 10.1038/nm.2058; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Gadea A, 2001, J NEUROSCI RES, V63, P461, DOI 10.1002/jnr.1040; Glykys J, 2007, NEURON, V56, P763, DOI 10.1016/j.neuron.2007.11.002; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Jia F, 2005, J NEUROPHYSIOL, V94, P4491, DOI 10.1152/jn.00421.2005; Jones SM, 2009, J NEUROPHYSIOL, V102, P691, DOI 10.1152/jn.00285.2009; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; Kirischuk S, 1995, J NEUROSCI, V15, P7861; Kozlov AS, 2006, P NATL ACAD SCI USA, V103, P10058, DOI 10.1073/pnas.0603741103; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; LANDIS DMD, 1983, DEV BRAIN RES, V8, P231, DOI 10.1016/0165-3806(83)90008-1; MARTINEZRODRIGUEZ R, 1993, CELL MOL BIOL, V39, P115; Muller T, 1995, INT REV NEUROBIOL, V38, P341, DOI 10.1016/S0074-7742(08)60530-9; O'Driscoll KE, 2009, BIOCHEM BIOPH RES CO, V384, P476, DOI 10.1016/j.bbrc.2009.05.008; OCHI S, 1993, GLIA, V9, P188, DOI 10.1002/glia.440090304; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; OTIS TS, 1991, BRAIN RES, V545, P142, DOI 10.1016/0006-8993(91)91280-E; Park H, 2009, J NEUROSCI, V29, P13063, DOI 10.1523/JNEUROSCI.3193-09.2009; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Qu ZQ, 2008, AM J PHYSIOL-CELL PH, V294, pC1371, DOI 10.1152/ajpcell.00398.2007; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Ribak CE, 1996, ANAT EMBRYOL, V194, P379; Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459; Santhakumar V, 2006, J NEUROSCI, V26, P3357, DOI 10.1523/JNEUROSCI.4799-05.2006; Takayama K, 2008, NEUROSCI LETT, V443, P7, DOI 10.1016/j.neulet.2008.07.058; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Yu K, 2007, INVEST OPHTH VIS SCI, V48, P4694, DOI 10.1167/iovs.07-0301	46	363	371	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 5	2010	330	6005					790	796		10.1126/science.1184334	http://dx.doi.org/10.1126/science.1184334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	675SY	20929730				2022-12-24	WOS:000283855700035
J	Rodrigues, J; Brayner, FA; Alves, LC; Dixit, R; Barillas-Mury, C				Rodrigues, Janneth; Brayner, Fabio Andre; Alves, Luiz Carlos; Dixit, Rajnikant; Barillas-Mury, Carolina			Hemocyte Differentiation Mediates Innate Immune Memory in Anopheles gambiae Mosquitoes	SCIENCE			English	Article							RED FLOUR BEETLE; TRIBOLIUM-CASTANEUM; INSECT; DROSOPHILA; PARASITE; INVASION	Mosquito midgut invasion by ookinetes of the malaria parasite Plasmodium disrupts the barriers that normally prevent the gut microbiota from coming in direct contact with epithelial cells. This triggers a long-lived response characterized by increased abundance of granulocytes, a subpopulation of hemocytes that circulates in the insect's hemocoel, and enhanced immunity to bacteria that indirectly reduces survival of Plasmodium parasites upon reinfection. In mosquitoes, differentiation of hemocytes was necessary and sufficient to confer innate immune memory.	[Rodrigues, Janneth; Brayner, Fabio Andre; Alves, Luiz Carlos; Dixit, Rajnikant; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Barillas-Mury, C (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA.	cbarillas@niaid.nih.gov	Dixit, Rajnikant/D-2566-2009; Alves, Luiz/V-5314-2019	Dixit, Rajnikant/0000-0002-3536-8329; Rodrigues, Janneth/0000-0001-9693-1958	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; Conselho Nacionale de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazilian government agencies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Conselho Nacionale de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazilian government agencies; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. We thank A. Laughinghouse and K. Lee for insectary support; C. Ortega for experimental support; L. Koo for confocal assistance; J. Ribeiro and J. Valenzuela for their comments and insight; and B. R. Marshall for editorial assistance. F. A. B. and L. C. A. were funded by the Conselho Nacionale de Desenvolvimento Cientifico e Tecnologico and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazilian government agencies, respectively.	BEIER MS, 1994, J MED ENTOMOL, V31, P561, DOI 10.1093/jmedent/31.4.561; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Brown MJF, 2003, PARASITOLOGY, V126, P253, DOI 10.1017/S0031182002002755; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Eleftherianos I, 2006, INSECT BIOCHEM MOLEC, V36, P517, DOI 10.1016/j.ibmb.2006.04.001; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; HUBER M, 1991, P NATL ACAD SCI USA, V88, P2807, DOI 10.1073/pnas.88.7.2807; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Moret Y, 2003, P ROY SOC B-BIOL SCI, V270, P2475, DOI 10.1098/rspb.2003.2511; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Roth O, 2009, P ROY SOC B-BIOL SCI, V276, P145, DOI 10.1098/rspb.2008.1157; Roth O, 2010, J ANIM ECOL, V79, P403, DOI 10.1111/j.1365-2656.2009.01617.x; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sadd BM, 2005, BIOL LETTERS, V1, P386, DOI 10.1098/rsbl.2005.0369; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044	18	314	321	4	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1353	1355		10.1126/science.1190689	http://dx.doi.org/10.1126/science.1190689			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20829487	Green Accepted			2022-12-24	WOS:000281657300041
J	Cejka, P; Cannavo, E; Polaczek, P; Masuda-Sasa, T; Pokharel, S; Campbell, JL; Kowalczykowski, SC				Cejka, Petr; Cannavo, Elda; Polaczek, Piotr; Masuda-Sasa, Taro; Pokharel, Subhash; Campbell, Judith L.; Kowalczykowski, Stephen C.			DNA end resection by Dna2-Sgs1-RPA and its stimulation by Top3-Rmi1 and Mre11-Rad50-Xrs2	NATURE			English	Article							REPLICATION-PROTEIN-A; DOUBLE-STRAND BREAKS; RECOMBINATIONAL REPAIR; MRE11 NUCLEASE; RECQ HELICASE; RECBCD ENZYME; BLM HELICASE; IN-VIVO; SGS1; YEAST	The repair of DNA double-strand breaks (DSBs) by homologous recombination requires processing of broken ends. For repair to start, the DSB must first be resected to generate a 3'-single-stranded DNA (ssDNA) overhang, which becomes a substrate for the DNA strand exchange protein, Rad51 (ref. 1). Genetic studies have implicated a multitude of proteins in the process, including helicases, nucleases and topoisomerases(2-4). Here we biochemically reconstitute elements of the resection process and reveal that it requires the nuclease Dna2, the RecQ-family helicase Sgs1 and the ssDNA-binding protein replication protein-A (RPA). We establish that Dna2, Sgs1 and RPA constitute a minimal protein complex capable of DNA resection in vitro. Sgs1 helicase unwinds the DNA to produce an intermediate that is digested by Dna2, and RPA stimulates DNA unwinding by Sgs1 in a species-specific manner. Interestingly, RPA is also required both to direct Dna2 nucleolytic activity to the 5'-terminated strand of the DNA break and to inhibit 39 to 59 degradation by Dna2, actions that generate and protect the 3'-ssDNA overhang, respectively. In addition to this core machinery, we establish that both the topoisomerase 3 (Top3) and Rmi1 complex and the Mre11-Rad50-Xrs2 complex (MRX) have important roles as stimulatory components. Stimulation of end resection by the Top3-Rmi1 heterodimer and the MRX proteins is by complex formation with Sgs1 (refs 5, 6), which unexpectedly stimulates DNA unwinding. We suggest that Top3-Rmi1 and MRX are important for recruitment of the Sgs1-Dna2 complex to DSBs. Our experiments provide a mechanistic framework for understanding the initial steps of recombinational DNA repair in eukaryotes.	[Cejka, Petr; Cannavo, Elda; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Cejka, Petr; Cannavo, Elda; Kowalczykowski, Stephen C.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Polaczek, Piotr; Masuda-Sasa, Taro; Pokharel, Subhash; Campbell, Judith L.] CALTECH, Div Biol, Pasadena, CA 91125 USA	University of California System; University of California Davis; University of California System; University of California Davis; California Institute of Technology	Kowalczykowski, SC (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	sckowalczykowski@ucdavis.edu	Cejka, Petr/B-4829-2009	Cejka, Petr/0000-0002-9087-032X	Swiss National Science Foundation; National Institutes of Health [GM-78666, GM-41347, GM-62653]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062653, R37GM062653, R01GM041347, R01GM078666] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J.-B. Boule, A. Nicolas, X. Veaute, B. Rad, J. L. Plank and P. Sung for purified proteins and DNA substrates, L. Symington for discussions, and W. D. Heyer and the members of the Kowalczykowski and Campbell laboratories for their comments on the manuscript. We are particularly grateful to P. Sung and colleagues for communicating their results to us before their publication. This work was supported by a Swiss National Science Foundation Fellowship (to P. C.), and National Institutes of Health grants GM-78666 (to J. L. C.), GM-41347 (to S. C. K.) and GM-62653 (to S.C.K.).	ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Budd ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004267; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; CEJKA P, NAT STRUCT IN PRESS; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Kao HI, 2004, J BIOL CHEM, V279, P15014, DOI 10.1074/jbc.M313216200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; LEBOWITZ JH, 1985, THESIS J HOPKINS U; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Solinger JA, 2001, J MOL BIOL, V307, P1207, DOI 10.1006/jmbi.2001.4555; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; SZANKASI P, 1995, SCIENCE, V267, P1166, DOI 10.1126/science.7855597; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zierhut C, 2008, EMBO J, V27, P1875, DOI 10.1038/emboj.2008.111	35	333	341	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2010	467	7311					112	U149		10.1038/nature09355	http://dx.doi.org/10.1038/nature09355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20811461	Green Accepted, Green Submitted			2022-12-24	WOS:000281461200046
J	Lee, JH; Fang, L; Vlahos, E; Ke, XL; Jung, YW; Kourkoutis, LF; Kim, JW; Ryan, PJ; Heeg, T; Roeckerath, M; Goian, V; Bernhagen, M; Uecker, R; Hammel, PC; Rabe, KM; Kamba, S; Schubert, J; Freeland, JW; Muller, DA; Fennie, CJ; Schiffer, P; Gopalan, V; Johnston-Halperin, E; Schlom, DG				Lee, June Hyuk; Fang, Lei; Vlahos, Eftihia; Ke, Xianglin; Jung, Young Woo; Kourkoutis, Lena Fitting; Kim, Jong-Woo; Ryan, Philip J.; Heeg, Tassilo; Roeckerath, Martin; Goian, Veronica; Bernhagen, Margitta; Uecker, Reinhard; Hammel, P. Chris; Rabe, Karin M.; Kamba, Stanislav; Schubert, Juergen; Freeland, John W.; Muller, David A.; Fennie, Craig J.; Schiffer, Peter; Gopalan, Venkatraman; Johnston-Halperin, Ezekiel; Schlom, Darrell G.			A strong ferroelectric ferromagnet created by means of spin-lattice coupling	NATURE			English	Article							MAGNETIC-PROPERTIES; OXIDE; SYSTEM	Ferroelectric ferromagnets are exceedingly rare, fundamentally interesting multiferroic materials that could give rise to new technologies in which the low power and high speed of field-effect electronics are combined with the permanence and routability of voltage-controlled ferromagnetism(1,2). Furthermore, the properties of the few compounds that simultaneously exhibit these phenomena(1-5) are insignificant in comparison with those of useful ferroelectrics or ferromagnets: their spontaneous polarizations or magnetizations are smaller by a factor of 1,000 or more. The same holds for magnetic-or electric-field-induced multiferroics(6-8). Owing to the weak properties of single-phase multiferroics, composite and multilayer approaches involving strain-coupled piezoelectric and magnetostrictive components are the closest to application today(1,2). Recently, however, a new route to ferroelectric ferromagnets was proposed(9) by which magnetically ordered insulators that are neither ferroelectric nor ferromagnetic are transformed into ferroelectric ferromagnets using a single control parameter, strain. The system targeted, EuTiO3, was predicted to exhibit strong ferromagnetism (spontaneous magnetization, similar to 7 Bohr magnetons per Eu) and strong ferroelectricity (spontaneous polarization, similar to 10 mu C cm(-2)) simultaneously under large biaxial compressive strain(9). These values are orders of magnitude higher than those of any known ferroelectric ferromagnet and rival the best materials that are solely ferroelectric or ferromagnetic. Hindered by the absence of an appropriate substrate to provide the desired compression we turned to tensile strain. Here we show both experimentally and theoretically the emergence of a multiferroic state under biaxial tension with the unexpected benefit that even lower strains are required, thereby allowing thicker high-quality crystalline films. This realization of a strong ferromagnetic ferroelectric points the way to high-temperature manifestations of this spin-lattice coupling mechanism(10). Our work demonstrates that a single experimental parameter, strain, simultaneously controls multiple order parameters and is a viable alternative tuning parameter to composition(11) for creating multiferroics.	[Lee, June Hyuk; Heeg, Tassilo; Schlom, Darrell G.] Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; [Lee, June Hyuk; Vlahos, Eftihia; Gopalan, Venkatraman] Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA; [Fang, Lei; Jung, Young Woo; Hammel, P. Chris; Johnston-Halperin, Ezekiel] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Ke, Xianglin; Schiffer, Peter] Penn State Univ, Dept Phys, University Pk, PA 16802 USA; [Ke, Xianglin; Schiffer, Peter] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA; [Kourkoutis, Lena Fitting; Muller, David A.; Fennie, Craig J.] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Kim, Jong-Woo; Ryan, Philip J.; Freeland, John W.] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Roeckerath, Martin] Forschungszentrum Julich, JARA Fundamentals Future Informat Technol, Inst Bio & Nanosyst, D-52425 Julich, Germany; [Goian, Veronica; Kamba, Stanislav] Acad Sci Czech Republ, Inst Phys, Prague 18221 8, Czech Republic; [Bernhagen, Margitta; Uecker, Reinhard] Leibniz Inst Crystal Growth, D-12489 Berlin, Germany; [Rabe, Karin M.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Muller, David A.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Helmholtz Association; Research Center Julich; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Leibniz Institut fur Kristallzuchtung (IKZ); Rutgers State University New Brunswick	Schlom, DG (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	schlom@cornell.edu	Kamba, Stanislav/G-5332-2014; Schlom, Darrell G/J-2412-2013; Hammel, P Chris/O-4845-2014; Schubert, Jürgen/K-9543-2013; Schiffer, Peter/F-3227-2011; Muller, David/A-7745-2010; Goian, Veronica/G-6154-2014; Johnston-Halperin, Ezekiel/B-5902-2012; Johnston-Halperin, Ezekiel/AAM-2564-2021; Kourkoutis, Lena/B-4229-2010	Kamba, Stanislav/0000-0003-4699-869X; Schlom, Darrell G/0000-0003-2493-6113; Hammel, P Chris/0000-0002-4138-4798; Schubert, Jürgen/0000-0003-0185-6794; Muller, David/0000-0003-4129-0473; Goian, Veronica/0000-0002-7971-2224; Johnston-Halperin, Ezekiel/0000-0002-6240-3505; Schiffer, Peter/0000-0002-6430-6549; Kim, Jong-Woo/0000-0001-9641-2947; Barnes, Eftihia/0000-0002-6075-6278; Kourkoutis, Lena/0000-0002-1303-1362; Hammel, Pascal/0000-0002-4630-4996; Ke, Xianglin/0000-0003-1882-9039	National Science Foundation [DMR-0507146]; National Science Foundation through MRSEC [DMR-0520404, DMR-0820404, DMR-0820414]; Czech Science Foundation [202/09/0682]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	National Science Foundation(National Science Foundation (NSF)); National Science Foundation through MRSEC; Czech Science Foundation(Grant Agency of the Czech Republic); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	The authors acknowledge discussions and interactions with M. D. Biegalski, D. H. A. Blank, C. B. Eom, M. B. Holcomb, M. Lezaic, J. Mannhart, L. W. Martin, D. V. Pelekhov, R. Ramesh, K. Z. Rushchanskii, N. Samarth, A. Schmehl, D. A. Tenne, J.-M. Triscone, D. Viehland and L. Yan. In addition, the financial support of the National Science Foundation through grant DMR-0507146 and the MRSEC program (DMR-0520404, DMR-0820404 and DMR-0820414), and of the Czech Science Foundation (project no. 202/09/0682), is gratefully acknowledged. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357.	Anisimov VI, 1997, J PHYS-CONDENS MAT, V9, P767, DOI 10.1088/0953-8984/9/4/002; Bayrashev A, 2004, SENSOR ACTUAT A-PHYS, V114, P244, DOI 10.1016/j.sna.2004.01.007; BEACH RS, 1993, PHYS REV LETT, V70, P3502, DOI 10.1103/PhysRevLett.70.3502; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Bozovic I, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.107001; BROUS J, 1953, ACTA CRYSTALLOGR, V6, P67, DOI 10.1107/S0365110X53000156; Chae SC, 2009, J ELECTROCERAM, V22, P216, DOI 10.1007/s10832-008-9460-z; Choi KJ, 2004, SCIENCE, V306, P1005, DOI 10.1126/science.1103218; Chu MW, 2004, NAT MATER, V3, P87, DOI 10.1038/nmat1057; Das J, 2009, ADV MATER, V21, P2045, DOI 10.1002/adma.200803376; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Fennie CJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.267602; Fetisov YK, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2191950; Fong DD, 2004, SCIENCE, V304, P1650, DOI 10.1126/science.1098252; Fuchs D, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.014434; Fujita K, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3072598; Gajek M, 2007, NAT MATER, V6, P296, DOI 10.1038/nmat1860; Goto T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.257201; Haeni JH, 2004, NATURE, V430, P758, DOI 10.1038/nature02773; Hatabayashi K, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.100208; Hellwege KH, 1981, LANDOLTBORNSTEIN N A, V16, P59; Ikeda N, 2005, NATURE, V436, P1136, DOI 10.1038/nature04039; Junquera J, 2003, NATURE, V422, P506, DOI 10.1038/nature01501; Katsufuji T, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.054415; Ke X, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3117190; Kimura T, 2008, NAT MATER, V7, P291, DOI 10.1038/nmat2125; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Koster G, 1998, APPL PHYS LETT, V73, P2920, DOI 10.1063/1.122630; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kugimiya K, 2007, J MAGN MAGN MATER, V310, P2268, DOI 10.1016/j.jmmm.2006.10.839; Lee JH, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3133351; Lee JH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.207204; Lottermoser T, 2004, NATURE, V430, P541, DOI 10.1038/nature02728; NGUYEN LD, 1992, IEEE T ELECTRON DEV, V39, P2007, DOI 10.1109/16.155871; Park JY, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2798597; Pertsev NA, 2000, PHYS REV B, V61, pR825, DOI 10.1103/PhysRevB.61.R825; Ramesh R, 2007, NAT MATER, V6, P21, DOI 10.1038/nmat1805; RIVERA JP, 1981, FERROELECTRICS, V36, P447, DOI 10.1080/00150198108218150; Schlom DG, 2007, ANNU REV MATER RES, V37, P589, DOI 10.1146/annurev.matsci.37.061206.113016; Shvartsman VV, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.064426; Steins M, 1997, Z KRIST-NEW CRYST ST, V212, P77, DOI 10.1524/ncrs.1997.212.1.77; Theis CD, 1996, J VAC SCI TECHNOL A, V14, P2677, DOI 10.1116/1.580185; Velickov B, 2007, Z KRISTALLOGR, V222, P466, DOI 10.1524/zkri.2007.222.9.466; Wang HH, 2004, J APPL PHYS, V96, P5324, DOI 10.1063/1.1794362; Zhai JY, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2172706	47	578	585	15	706	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					954	U72		10.1038/nature09331	http://dx.doi.org/10.1038/nature09331			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20725036				2022-12-24	WOS:000281030300030
J	Li, J; Liu, ZY; Tan, C; Guo, XM; Wang, LJ; Sancar, A; Zhong, DP				Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Sancar, Aziz; Zhong, Dongping			Dynamics and mechanism of repair of ultraviolet-induced (6-4) photoproduct by photolyase	NATURE			English	Article							DNA PHOTOLYASE; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; COFACTOR; ENZYME; CRYPTOCHROME; HISTIDINES; BINDING	One of the detrimental effects of ultraviolet radiation on DNA is the formation of the (6-4) photoproduct, 6-4PP, between two adjacent pyrimidine rings(1). This lesion interferes with replication and transcription, and may result in mutation and cell death(2). In many organisms, a flavoenzyme called photolyase uses blue light energy to repair the 6-4PP (ref. 3). The molecular mechanism of the repair reaction is poorly understood. Here, we use ultrafast spectroscopy to show that the key step in the repair photocycle is a cyclic proton transfer between the enzyme and the substrate. By femtosecond synchronization of the enzymatic dynamics with the repair function, we followed the function evolution and observed direct electron transfer from the excited flavin cofactor to the 6-4PP in 225 picoseconds, but surprisingly fast back electron transfer in 50 picoseconds without repair. We found that the catalytic proton transfer between a histidine residue in the active site and the 6-4PP, induced by the initial photoinduced electron transfer from the excited flavin cofactor to 6-4PP, occurs in 425 picoseconds and leads to 6-4PP repair in tens of nanoseconds. These key dynamics define the repair photocycle and explain the underlying molecular mechanism of the enzyme's modest efficiency.	[Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Dept Biochem, Program Biophys, Columbus, OH 43210 USA; [Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Chem Phys Program, Columbus, OH 43210 USA; [Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Program Biochem, Columbus, OH 43210 USA; [Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zhong, DP (corresponding author), Ohio State Univ, Dept Phys, 191 W Woodruff Ave, Columbus, OH 43210 USA.	dongping@mps.ohio-state.edu	Liu, Zheyun/N-4054-2013; Zhong, Dongping/I-2444-2013; Guo, Xunmin/E-7908-2013	Zhong, Dongping/0000-0001-9381-8992; 	National Institutes of Health [GM074813]; Packard fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074813] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard fellowship(The David & Lucile Packard Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank T. Todo and T. Kitagawa for the generous gift of Arabidopsis thaliana (6-4) photolyase plasmid; C. Forsyth for discussions; and Y.-T. Kao and C.-W. Chang for help during the experiments. This work is supported in part by the National Institutes of Health (research grant GM074813) and the Packard fellowship.	Borg OA, 2007, J PHYS CHEM A, V111, P2351, DOI 10.1021/jp0676383; Chang CW, 2010, P NATL ACAD SCI USA, V107, P2914, DOI 10.1073/pnas.1000001107; Domratcheva T, 2009, J AM CHEM SOC, V131, P17793, DOI 10.1021/ja904550d; Glas AF, 2009, CHEM-EUR J, V15, P10387, DOI 10.1002/chem.200901004; Hitomi K, 2001, J BIOL CHEM, V276, P10103, DOI 10.1074/jbc.M008828200; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Joseph A, 2000, J AM CHEM SOC, V122, P11219, DOI 10.1021/ja002541u; Kao YT, 2008, J AM CHEM SOC, V130, P7695, DOI 10.1021/ja801152h; Kao YT, 2007, CELL BIOCHEM BIOPHYS, V48, P32, DOI 10.1007/s12013-007-0034-5; Kao YT, 2005, P NATL ACAD SCI USA, V102, P16128, DOI 10.1073/pnas.0506586102; LECLERC JE, 1991, P NATL ACAD SCI USA, V88, P9685, DOI 10.1073/pnas.88.21.9685; Li J, 2006, J PHYS CHEM B, V110, P16724, DOI 10.1021/jp062998b; Marcus RA, 2006, PHILOS T R SOC B, V361, P1445, DOI 10.1098/rstb.2006.1873; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Saxena C, 2004, J PHYS CHEM B, V108, P18026, DOI 10.1021/jp048376c; Schleicher E, 2007, J BIOL CHEM, V282, P4738, DOI 10.1074/jbc.M604734200; TAYLOR JS, 1994, ACCOUNTS CHEM RES, V27, P76, DOI 10.1021/ar00039a003; TODO T, 1993, NATURE, V361, P371, DOI 10.1038/361371a0; Wang HY, 2007, SCIENCE, V316, P747, DOI 10.1126/science.1140030; Yamamoto J, 2009, ORG BIOMOL CHEM, V7, P161, DOI 10.1039/b815458a; Yamamoto J, 2009, BIOCHEMISTRY-US, V48, P9306, DOI 10.1021/bi900956p; Zhao XD, 1997, J BIOL CHEM, V272, P32580, DOI 10.1074/jbc.272.51.32580; Zhong DP, 2007, CURR OPIN CHEM BIOL, V11, P174, DOI 10.1016/j.cbpa.2007.02.034	26	161	161	1	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					887	U124		10.1038/nature09192	http://dx.doi.org/10.1038/nature09192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20657578	Green Submitted, Green Accepted			2022-12-24	WOS:000280766100041
J	Liu, WM; Li, YY; Learn, GH; Rudicell, RS; Robertson, JD; Keele, BF; Ndjango, JBN; Sanz, CM; Morgan, DB; Locatelli, S; Gonder, MK; Kranzusch, PJ; Walsh, PD; Delaporte, E; Mpoudi-Ngole, E; Georgiev, AV; Muller, MN; Shaw, GM; Peeters, M; Sharp, PM; Rayner, JC; Hahn, BH				Liu, Weimin; Li, Yingying; Learn, Gerald H.; Rudicell, Rebecca S.; Robertson, Joel D.; Keele, Brandon F.; Ndjango, Jean-Bosco N.; Sanz, Crickette M.; Morgan, David B.; Locatelli, Sabrina; Gonder, Mary K.; Kranzusch, Philip J.; Walsh, Peter D.; Delaporte, Eric; Mpoudi-Ngole, Eitel; Georgiev, Alexander V.; Muller, Martin N.; Shaw, George M.; Peeters, Martine; Sharp, Paul M.; Rayner, Julian C.; Hahn, Beatrice H.			Origin of the human malaria parasite Plasmodium falciparum in gorillas	NATURE			English	Article							INFECTION; HIV-1; DIVERSIFICATION; EVOLUTIONARY; PHYLOGENIES; RESERVOIRS; MULTIPLE; ACID; GENE; APES	Plasmodium falciparum is the most prevalent and lethal of the malaria parasites infecting humans, yet the origin and evolutionary history of this important pathogen remain controversial. Here we develop a single-genome amplification strategy to identify and characterize Plasmodium spp. DNA sequences in faecal samples from wild-living apes. Among nearly 3,000 specimens collected from field sites throughout central Africa, we found Plasmodium infection in chimpanzees (Pan troglodytes) and western gorillas (Gorilla gorilla), but not in eastern gorillas (Gorilla beringei) or bonobos (Pan paniscus). Ape plasmodial infections were highly prevalent, widely distributed and almost always made up of mixed parasite species. Analysis of more than 1,100 mitochondrial, apicoplast and nuclear gene sequences from chimpanzees and gorillas revealed that 99% grouped within one of six host-specific lineages representing distinct Plasmodium species within the subgenus Laverania. One of these from western gorillas comprised parasites that were nearly identical to P. falciparum. In phylogenetic analyses of full-length mitochondrial sequences, human P. falciparum formed a monophyletic lineage within the gorilla parasite radiation. These findings indicate that P. falciparum is of gorilla origin and not of chimpanzee, bonobo or ancient human origin.	[Liu, Weimin; Li, Yingying; Learn, Gerald H.; Robertson, Joel D.; Keele, Brandon F.; Shaw, George M.; Rayner, Julian C.; Hahn, Beatrice H.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Rudicell, Rebecca S.; Shaw, George M.; Hahn, Beatrice H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Ndjango, Jean-Bosco N.] Univ Kisangani, Dept Ecol & Management Plant & Anim Resources, Fac Sci, Kisangani, DEM REP CONGO; [Sanz, Crickette M.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Sanz, Crickette M.; Morgan, David B.] Wildlife Conservat Soc, Congo Program, Brazzaville, Rep Congo; [Morgan, David B.] Lester E Fisher Ctr Study & Conservat Apes, Chicago, IL 60614 USA; [Locatelli, Sabrina; Gonder, Mary K.] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Kranzusch, Philip J.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Walsh, Peter D.] VaccinApe, Bethesda, MD USA; [Delaporte, Eric; Peeters, Martine] Univ Montpellier I, F-34394 Montpellier, France; [Delaporte, Eric; Peeters, Martine] Inst Rech Dev, F-34394 Montpellier, France; [Mpoudi-Ngole, Eitel] Ctr Rech Med, Inst Rech Med & Etud Plantes Med Prevent Sida Cam, Yaounde, Cameroon; [Georgiev, Alexander V.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Muller, Martin N.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Sharp, Paul M.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Sharp, Paul M.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland; [Rayner, Julian C.] Wellcome Trust Sanger Inst, Sanger Inst, Malaria Programme, Cambridge CB10 1SA, England	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Albany; Harvard University; Harvard Medical School; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Harvard University; University of New Mexico; University of Edinburgh; University of Edinburgh; Wellcome Trust Sanger Institute	Hahn, BH (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	bhahn@uab.edu	Sharp, Paul M/GPX-1497-2022; Learn, Jerry/E-3356-2012; Locatelli, Sabrina/I-5777-2019; Learn, Gerald H/B-6934-2011; Delaporte, Eric/J-5397-2018; Sharp, Paul M/F-5783-2010; Sharp, Paul/Y-3787-2019; Georgiev, Alexander/C-5061-2015	Sharp, Paul M/0000-0001-9771-543X; Locatelli, Sabrina/0000-0002-1133-0561; Learn, Gerald H/0000-0003-0434-7733; Delaporte, Eric/0000-0002-1822-9853; Sharp, Paul M/0000-0001-9771-543X; Rayner, Julian/0000-0002-9835-1014; Hahn, Beatrice/0000-0002-9400-9887; Georgiev, Alexander/0000-0001-5622-3826	National Institutes of Health [R01 AI50529, R01 AI58715, U19 AI 067854, R03 AI074778, T32 GM008111, T32 AI007245, P30 AI 27767]; BillAMP;Melinda Gates Foundation [37874]; National Science Foundation [0755823]; Agence Nationale de Recherche sur le Sida [12152/12182]; US Fish and Wildlife Service; Arthur L. Greene Fund; Wallace Global Fund; Bristol Myers Freedom to Discover Program; Wellcome Trust; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767, F32AI007767, U19AI067854, R37AI050529, T32AI007245, R01AI050529, R03AI074778, R01AI058715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BillAMP;Melinda Gates Foundation(CGIAR); National Science Foundation(National Science Foundation (NSF)); Agence Nationale de Recherche sur le Sida(ANRSFrench National Research Agency (ANR)); US Fish and Wildlife Service(US Fish & Wildlife Service); Arthur L. Greene Fund; Wallace Global Fund; Bristol Myers Freedom to Discover Program; Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Neel, S. Loul, A. Mebanga, B. Yangda and F. Liegeois for field work in Cameroon; the Cameroonian Ministries of Health, Forestry and Wildlife, and Research for permission to collect samples in Cameroon; the Water and Forest Ministry for permission to collect samples in the Central African Republic; the Ministries of Science and Technology and Forest Economy for permission to collect samples in the Republic of the Congo; the Ministry of Scientific Research and Technology and the Department of Ecology and Management of Plant and Animal Resources of the University of Kisangani for permission to collect samples in the Democratic Republic of the Congo; M. Ndunda, S. Coxe, A. Lokasola, A. Todd and the staff of the World Wildlife Fund in the Central African Republic for logistical support; R. Carter for helpful discussions; M. Salazar, Y. Chen and B. Cochran for technical assistance; and J. White for artwork and manuscript preparation. This work was supported by grants from the National Institutes of Health (R01 AI50529, R01 AI58715, U19 AI 067854, R03 AI074778, T32 GM008111, T32 AI007245, P30 AI 27767), the Bill&Melinda Gates Foundation(37874), the National Science Foundation (0755823), the Agence Nationale de Recherche sur le Sida (12152/12182), the Great Ape Conservation Fund of the US Fish and Wildlife Service, the Arthur L. Greene Fund, the Wallace Global Fund, the Bristol Myers Freedom to Discover Program and the Wellcome Trust. R. S. R. was supported by a Howard Hughes Medical Institute Med-into-Grad Fellowship.	BRAY RS, 1958, AM J TROP MED HYG, V7, P20, DOI 10.4269/ajtmh.1958.7.20; Brown WM, 2004, BIOCHEMISTRY-US, V43, P6219, DOI 10.1021/bi049892w; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Coluzzi M, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P277; Duval L, 2010, P NATL ACAD SCI USA, V107, P10561, DOI 10.1073/pnas.1005435107; Duval L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005520; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Kappe SHI, 2010, SCIENCE, V328, P862, DOI 10.1126/science.1184785; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li Y., 2010, P 17 C RETR OPP INF; Liu WM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000097; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Neel C, 2010, J VIROL, V84, P1464, DOI 10.1128/JVI.02129-09; Nwakanma DC, 2009, J INFECT DIS, V199, P1567, DOI 10.1086/598856; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Rich SM, 1998, P NATL ACAD SCI USA, V95, P4425, DOI 10.1073/pnas.95.8.4425; Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SIMMONDS P, 1990, J VIROL, V64, P864, DOI 10.1128/JVI.64.2.864-872.1990; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Su XZ, 2003, MICROBES INFECT, V5, P891, DOI 10.1016/S1286-4579(03)00173-4; Talman AM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-140; VAN HEUVERSWYN F, 2007, VIROLOGY, V368, P155	37	367	371	1	186	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					420	+		10.1038/nature09442	http://dx.doi.org/10.1038/nature09442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20864995	Green Accepted			2022-12-24	WOS:000282090200034
J	Zhang, FL; Saha, S; Shabalina, SA; Kashina, A				Zhang, Fangliang; Saha, Sougata; Shabalina, Svetlana A.; Kashina, Anna			Differential Arginylation of Actin Isoforms Is Regulated by Coding Sequence-Dependent Degradation	SCIENCE			English	Article							N-END RULE; RNA-PROTEIN TRANSFERASE; CELLS; IDENTIFICATION; TRANSLATION; RIBOSOME; PATHWAY	The mammalian cytoskeletal proteins beta- and gamma-actin are highly homologous, but only beta-actin is amino-terminally arginylated in vivo, which regulates its function. We examined the metabolic fate of exogenously expressed arginylated and nonarginylated actin isoforms. Arginylated gamma-actin, unlike beta-, was highly unstable and was selectively ubiquitinated and degraded in vivo. This instability was regulated by the differences in the nucleotide coding sequence between the two actin isoforms, which conferred different translation rates. gamma-actin was translated more slowly than beta-actin, and this slower processing resulted in the exposure of a normally hidden lysine residue for ubiquitination, leading to the preferential degradation of gamma-actin upon arginylation. This degradation mechanism, coupled to nucleotide coding sequence, may regulate protein arginylation in vivo.	[Zhang, Fangliang; Saha, Sougata; Kashina, Anna] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Shabalina, Svetlana A.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Kashina, A (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	akashina@vet.upenn.edu	Shabalina, Svetlana/N-8939-2013	Shabalina, Svetlana/0000-0003-2272-7473	NIH [5R01HL084419]; W. W. Smith Charitable Trust; Philip Morris Research Management Group; NIH, National Center for Biotechnology Information; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084419] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. W. Smith Charitable Trust; Philip Morris Research Management Group; NIH, National Center for Biotechnology Information(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank R. Dominguez for help with actin structure analysis and the preparation of fig. S15; D. Volgin for helpful suggestions on quantitative polymerase chain reaction; S. Fuchs, Y. Goldman, and J. M. Murray for helpful discussions; and S. Kurosaka for critical reading of the manuscript. This work was supported by NIH grant 5R01HL084419 and W. W. Smith Charitable Trust and Philip Morris Research Management Group awards to A. K. and by the Intramural Research Program of NIH, National Center for Biotechnology Information, to S.A.S.	BALZI E, 1990, J BIOL CHEM, V265, P7464; Condeelis J, 2005, BIOL CELL, V97, P97; ELIAS S, 1990, J BIOL CHEM, V265, P15511; FERBER S, 1987, NATURE, V326, P808, DOI 10.1038/326808a0; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GONDA DK, 1989, J BIOL CHEM, V264, P16700; GROLLMAN AP, 1967, J BIOL CHEM, V242, P3226; Hofer D, 1997, J CELL SCI, V110, P765; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kwon YT, 1999, MOL CELL BIOL, V19, P182; LOPO AC, 1989, BIOCHEM J, V258, P553, DOI 10.1042/bj2580553; OTEY CA, 1986, J CELL BIOL, V102, P1726, DOI 10.1083/jcb.102.5.1726; OTEY CA, 1987, J CELL BIOCHEM, V34, P113, DOI 10.1002/jcb.240340205; Rai R, 2005, P NATL ACAD SCI USA, V102, P10123, DOI 10.1073/pnas.0504500102; REDMAN KL, 1984, METHOD ENZYMOL, V106, P179; RUBENSTEIN PA, 1983, J BIOL CHEM, V258, P3961; VAN DEN ENT F, 2001, NATURE, V413, P39; VANDEKERCKHOVE J, 1978, ARCH INT PHYSIOL BIO, V86, P891; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; Wong CCL, 2007, PLOS BIOL, V5, P2231, DOI 10.1371/journal.pbio.0050258	22	139	141	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1534	1537		10.1126/science.1191701	http://dx.doi.org/10.1126/science.1191701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847274	Green Accepted			2022-12-24	WOS:000281869000045
J	Tian, BZ; Cohen-Karni, T; Qing, Q; Duan, XJ; Xie, P; Lieber, CM				Tian, Bozhi; Cohen-Karni, Tzahi; Qing, Quan; Duan, Xiaojie; Xie, Ping; Lieber, Charles M.			Three-Dimensional, Flexible Nanoscale Field-Effect Transistors as Localized Bioprobes	SCIENCE			English	Article							CELLS; ELECTROPHYSIOLOGY; CHEMISTRY; DYNAMICS; ARRAYS; FUSION	Nanoelectronic devices offer substantial potential for interrogating biological systems, although nearly all work has focused on planar device designs. We have overcome this limitation through synthetic integration of a nanoscale field-effect transistor (nanoFET) device at the tip of an acute-angle kinked silicon nanowire, where nanoscale connections are made by the arms of the kinked nanostructure, and remote multilayer interconnects allow three-dimensional (3D) probe presentation. The acute-angle probe geometry was designed and synthesized by controlling cis versus trans crystal conformations between adjacent kinks, and the nanoFET was localized through modulation doping. 3D nanoFET probes exhibited conductance and sensitivity in aqueous solution, independent of large mechanical deflections, and demonstrated high pH sensitivity. Additionally, 3D nanoprobes modified with phospholipid bilayers can enter single cells to allow robust recording of intracellular potentials.	[Tian, Bozhi; Qing, Quan; Duan, Xiaojie; Xie, Ping; Lieber, Charles M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Cohen-Karni, Tzahi; Lieber, Charles M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	cml@cmliris.harvard.edu	Cohen-Karni, Tzahi/CAG-1520-2022; Duan, Xiaojie/N-7667-2013; Qing, Quan/R-8411-2017	Cohen-Karni, Tzahi/0000-0001-5742-1007; Qing, Quan/0000-0002-4230-8244; Duan, xiaojie/0000-0001-7799-3897	NIH [5DP1OD003900]; National Security Science and Engineering Faculty Fellow (NSSEFF) [N00244-09-1-0078]; McKnight Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003900] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Security Science and Engineering Faculty Fellow (NSSEFF); McKnight Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Yellen, W. C. Claycomb, B. P. Bean, P. T. Ellinor, G. H. Yu, D. Casanova, B. P. Timko, and T. Dvir for help with experiments and data analysis. C. M. L. acknowledges support from a NIH Director's Pioneer Award (5DP1OD003900), a National Security Science and Engineering Faculty Fellow (NSSEFF) award (N00244-09-1-0078), and the McKnight Foundation Neuroscience award.	Almquist BD, 2010, P NATL ACAD SCI USA, V107, P5815, DOI 10.1073/pnas.0909250107; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cohen-Karni T, 2009, P NATL ACAD SCI USA, V106, P7309, DOI 10.1073/pnas.0902752106; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; Eschermann JF, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3194138; EWING AG, 1992, ACCOUNTS CHEM RES, V25, P440, DOI 10.1021/ar00022a002; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Heller I, 2009, SMALL, V5, P2528, DOI 10.1002/smll.200900823; Ieong Meikei, 2004, Science, V306, P2057, DOI 10.1126/science.1100731; Leong TG, 2009, P NATL ACAD SCI USA, V106, P703, DOI 10.1073/pnas.0807698106; Lu W, 2007, NAT MATER, V6, P841, DOI 10.1038/nmat2028; Misra N, 2009, P NATL ACAD SCI USA, V106, P13780, DOI 10.1073/pnas.0904850106; Molleman A., 2003, PATCH CLAMPING INTRO; PURVES RD, 1981, MICROELECTRODE METHO; Qing Q, 2010, P NATL ACAD SCI USA, V107, P1882, DOI 10.1073/pnas.0914737107; SAKMANN B, 1984, ANNU REV PHYSIOL, V46, P455, DOI 10.1146/annurev.ph.46.030184.002323; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schrlau MG, 2009, ACS NANO, V3, P563, DOI 10.1021/nn800851d; Tian BZ, 2009, NAT NANOTECHNOL, V4, P824, DOI [10.1038/nnano.2009.304, 10.1038/NNANO.2009.304]; Wightman RM, 2006, SCIENCE, V311, P1570, DOI 10.1126/science.1120027; Zhou XJ, 2007, NAT NANOTECHNOL, V2, P185, DOI 10.1038/nnano.2007.34; Zipes DP., 2018, CARDIAC ELECTROPHYSI, V7	27	619	653	6	427	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					830	834		10.1126/science.1192033	http://dx.doi.org/10.1126/science.1192033			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705858	Green Accepted			2022-12-24	WOS:000280809900048
J	Strachan, NJC; Forbes, KJ				Strachan, Norval J. C.; Forbes, Ken J.			The growing UK epidemic of human campylobacteriosis	LANCET			English	Editorial Material							GENERAL-PRACTICE; INFECTION		[Strachan, Norval J. C.] Univ Aberdeen, Sch Biol Sci, Inst Environm & Biol Sci, Aberdeen AB24 3UU, Scotland; [Forbes, Ken J.] Univ Aberdeen, Sch Med, Sect Immunol & Infect, Aberdeen AB24 3UU, Scotland	University of Aberdeen; University of Aberdeen	Strachan, NJC (corresponding author), Univ Aberdeen, Sch Biol Sci, Inst Environm & Biol Sci, Aberdeen AB24 3UU, Scotland.		Strachan, Norval J/D-4744-2009					Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Ethelberg S, 2005, AM J EPIDEMIOL, V162, P1008, DOI 10.1093/aje/kwi316; *FOOD STAND AG, 2009, Q PUBL ATT TRACK DEC; Food Standards Agency (FSA), 2009, FSA REP UK SURV CAMP; *FSA, 2010, CAMP EV PROGR; Gormley FJ, 2008, APPL ENVIRON MICROB, V74, P383, DOI 10.1128/AEM.01455-07; LOWMAN R, 2009, 15 INT C CAMP HEL RE; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; POLLOCK K, 2010, HPS WKLY REP, V44, P38; *POP ENV HLTH GROU, 2009, NOT OTH DIS NZ 2008; Samuel MC, 2004, CLIN INFECT DIS, V38, pS165, DOI 10.1086/381583; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Zia S, 2003, RHEUMATOLOGY, V42, P1083, DOI 10.1093/rheumatology/keg303; 2006, DOMINION POST   0710, pA5; 2005, EFSA J, V297, P1; 2010, HLTH PROTECTION REP, V4, P5	19	24	24	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2010	376	9742					665	667		10.1016/S0140-6736(10)60708-8	http://dx.doi.org/10.1016/S0140-6736(10)60708-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646YW	20663545				2022-12-24	WOS:000281582900008
J	Heiden, MGV; Locasale, JW; Swanson, KD; Sharfi, H; Heffron, GJ; Amador-Noguez, D; Christofk, HR; Wagner, G; Rabinowitz, JD; Asara, JM; Cantley, LC				Heiden, Matthew G. Vander; Locasale, Jason W.; Swanson, Kenneth D.; Sharfi, Hadar; Heffron, Greg J.; Amador-Noguez, Daniel; Christofk, Heather R.; Wagner, Gerhard; Rabinowitz, Joshua D.; Asara, John M.; Cantley, Lewis C.			Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells	SCIENCE			English	Article							PYRUVATE-KINASE M2; PHOSPHOTRANSFERASE SYSTEM; RABBIT MUSCLE; PHOSPHORYLATION; PROTEIN; METABOLISM; DEPHOSPHORYLATION; IDENTIFICATION; SINGLE; GROWTH	Proliferating cells, including cancer cells, require altered metabolism to efficiently incorporate nutrients such as glucose into biomass. The M2 isoform of pyruvate kinase (PKM2) promotes the metabolism of glucose by aerobic glycolysis and contributes to anabolic metabolism. Paradoxically, decreased pyruvate kinase enzyme activity accompanies the expression of PKM2 in rapidly dividing cancer cells and tissues. We demonstrate that phosphoenolpyruvate (PEP), the substrate for pyruvate kinase in cells, can act as a phosphate donor in mammalian cells because PEP participates in the phosphorylation of the glycolytic enzyme phosphoglycerate mutase (PGAM1) in PKM2-expressing cells. We used mass spectrometry to show that the phosphate from PEP is transferred to the catalytic histidine (His11) on human PGAM1. This reaction occurred at physiological concentrations of PEP and produced pyruvate in the absence of PKM2 activity. The presence of histidine-phosphorylated PGAM1 correlated with the expression of PKM2 in cancer cell lines and tumor tissues. Thus, decreased pyruvate kinase activity in PKM2-expressing cells allows PEP-dependent histidine phosphorylation of PGAM1 and may provide an alternate glycolytic pathway that decouples adenosine triphosphate production from PEP-mediated phosphotransfer, allowing for the high rate of glycolysis to support the anabolic metabolism observed in many proliferating cells.	[Heiden, Matthew G. Vander; Locasale, Jason W.; Swanson, Kenneth D.; Sharfi, Hadar; Christofk, Heather R.; Asara, John M.; Cantley, Lewis C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Heiden, Matthew G. Vander; Locasale, Jason W.; Swanson, Kenneth D.; Sharfi, Hadar; Christofk, Heather R.; Asara, John M.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Heiden, Matthew G. Vander] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Heiden, Matthew G. Vander; Locasale, Jason W.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Heffron, Greg J.; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Amador-Noguez, Daniel; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Amador-Noguez, Daniel; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Princeton University; Princeton University	Cantley, LC (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA.	lewis_cantley@hms.harvard.edu	Rabinowitz, Joshua/GPP-4019-2022; Cantley, Lewis C/D-1800-2014; Locasale, Jason W/ABE-6505-2020	Rabinowitz, Joshua/0000-0002-1247-4727; Cantley, Lewis C/0000-0002-1298-7653; Locasale, Jason W/0000-0002-7766-3502; Christofk, Heather/0000-0002-8662-4425	Damon Runyon Cancer Research Foundation; Burroughs Wellcome Fund; American Cancer Society; Dana-Farber/Harvard Cancer Center; NIH [1K08CA136983, 5P30CA006516-43, 5 T32 CA009361-28, R21/R33 DK070299, P01GM047467, R01 AI078063, R21 CA128620, R01-GM56302, P01CA089021, 1P01CA120964-01A]; NATIONAL CANCER INSTITUTE [K08CA136983, P01CA089021, P01CA120964, T32CA009361, R21CA128620, P30CA006516, T32CA009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK070299, R33DK070299] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203, P01GM047467] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Cancer Society(American Cancer Society); Dana-Farber/Harvard Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Carrecedo and P. P. Pandolfi for normal and neoplastic prostate tissue; L. Burga and G. Wulf for normal breast and breast tumor; G. Bellinger for assistance with mouse dissection; M. Sasaki for help generating constructs; V. Vyas, A. Subtelny, L. Freimark, X. Yang, L. Schmidt, and M. Balastik for technical assistance; M. Bayro and S. Hyberts for help with processing the NMR spectra; and A. Shaywitz, J. Hutti, C. Benes, D. Anastasiou, A. Couvillion, and A. Saci for helpful discussions. This work was partially supported by the Damon Runyon Cancer Research Foundation (M. V. H.), the Burroughs Wellcome Fund (M. V. H.), the American Cancer Society (J. W. L.), Dana-Farber/Harvard Cancer Center (J. M. A. and J. W. L.), and by grants from the NIH (1K08CA136983 to M. V. H., 5P30CA006516-43 to J. M. A., 5 T32 CA009361-28 to J. W. L., R21/R33 DK070299 and P01GM047467 to G. W., R01 AI078063 and R21 CA128620 to J. D. R., R01-GM56302 and P01CA089021 to L. C. C., and 1P01CA120964-01A to J. M. A. and L.C.C.).	AINSWORTH S, 1973, BIOCHEM J, V131, P223, DOI 10.1042/bj1310223; Besant PG, 2005, BBA-PROTEINS PROTEOM, V1754, P281, DOI 10.1016/j.bbapap.2005.07.026; BLATTLER WA, 1980, BIOCHEMISTRY-US, V19, P738; BURNELL JN, 1984, ARCH BIOCHEM BIOPHYS, V231, P175, DOI 10.1016/0003-9861(84)90375-8; BURNELL JN, 1986, ARCH BIOCHEM BIOPHYS, V245, P297, DOI 10.1016/0003-9861(86)90219-5; CHEUNG EC, CURR OPIN C IN PRESS; Cho J, 2008, P NATL ACAD SCI USA, V105, P5998, DOI 10.1073/pnas.0710980105; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Engel M, 2004, J BIOL CHEM, V279, P35803, DOI 10.1074/jbc.M402768200; Evans MJ, 2005, NAT BIOTECHNOL, V23, P1303, DOI 10.1038/nbt1149; FOTHERGILLGILMORE LA, 1989, ADV ENZYMOL RAMB, V62, P227; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hohenester UM, 2010, ANAL BIOANAL CHEM, V397, P3209, DOI 10.1007/s00216-009-3372-x; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kleinnijenhuis AJ, 2007, ANAL CHEM, V79, P7450, DOI 10.1021/ac0707838; Klumpp S, 2002, EUR J BIOCHEM, V269, P1067, DOI 10.1046/j.1432-1033.2002.02755.x; Kondoh H, 2005, CANCER RES, V65, P177; LAGUNAS R, 1983, EUR J BIOCHEM, V137, P479, DOI 10.1111/j.1432-1033.1983.tb07851.x; LEE ME, 1992, BIOCHEMISTRY-US, V31, P2172, DOI 10.1021/bi00122a039; Lehninger A., 1993, PRINCIPLES BIOCH; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Medzihradszky KF, 1997, PROTEIN SCI, V6, P1405, DOI 10.1002/pro.5560060704; MINAKAMI S, 1965, BIOCHEM BIOPH RES CO, V18, P345, DOI 10.1016/0006-291X(65)90711-4; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; RACKER E, 1976, J CELL PHYSIOL, V89, P697, DOI 10.1002/jcp.1040890429; SAIER MH, 1994, MOL MICROBIOL, V13, P755; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Zu XL, 2007, AMINO ACIDS, V32, P347, DOI 10.1007/s00726-007-0493-4	35	474	481	3	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1492	1499		10.1126/science.1188015	http://dx.doi.org/10.1126/science.1188015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20847263	Green Accepted, Green Submitted			2022-12-24	WOS:000281869000033
J	von Ungern-Sternberg, BS; Boda, K; Chambers, NA; Rebmann, C; Johnson, C; Sly, PD; Habre, W				von Ungern-Sternberg, Britta S.; Boda, Krisztina; Chambers, Neil A.; Rebmann, Claudia; Johnson, Chris; Sly, Peter D.; Habre, Walid			Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study	LANCET			English	Article							LARYNGEAL MASK AIRWAY; TRACT INFECTIONS; REFLEX BRONCHOCONSTRICTION; BRONCHIAL RESPONSIVENESS; INTRAVENOUS LIDOCAINE; TRACHEAL INTUBATION; ADVERSE EVENTS; LUNG-FUNCTION; CHILDREN; ASTHMA	Background Perioperative respiratory adverse events in children are one of the major causes of morbidity and mortality during paediatric anaesthesia. We aimed to identify associations between family history, anaesthesia management, and occurrence of perioperative respiratory adverse events. Methods We prospectively included all children who had general anaesthesia for surgical or medical interventions, elective or urgent procedures at Princess Margaret Hospital for Children, Perth, Australia, from Feb 1,2007, to Jan 31, 2008. On the day of surgery, anaesthetists in charge of paediatric patients completed an adapted version of the International Study Group for Asthma and Allergies in Childhood questionnaire. We collected data on family medical history of asthma, atopy, allergy, upper respiratory tract infection, and passive smoking. Anaesthesia management and all perioperative respiratory adverse events were recorded. Findings 9297 questionnaires were available for analysis. A positive respiratory history (nocturnal dry cough, wheezing during exercise, wheezing more than three times in the past 12 months, or a history of present or past eczema) was associated with an increased risk for bronchospasm (relative risk [RR] 8.46, 95% Cl 6.18-11.59; p<0.0001), laryngospasm (4.13, 3.37-5.08; p<0.0001), and perioperative cough, desaturation, or airway obstruction (3.05, 2.76-3.37; p<0.0001). Upper respiratory tract infection was associated with an increased risk for perioperative respiratory adverse events only when symptoms were present (RR 2.05, 95% CI 1.82-2.31; p<0.0001) or less than 2 weeks before the procedure (2.34, 2.07-2.66; p<0.0001), whereas symptoms of upper respiratory tract infection 2-4 weeks before the procedure significantly lowered the incidence of perioperative respiratory adverse events (0.66, 0.53-0.81; p<0.0001). A history of at least two family members having asthma, atopy, or smoking increased the risk for perioperative respiratory adverse events (all p<0.0001). Risk was lower with intravenous induction compared with inhalational induction (all p<0.0001), inhalational compared with intravenous maintenance of anaesthesia (all p<0.0001), airway management by a specialist paediatric anaesthetist compared with a registrar (all p<0.0001), and use of face mask compared with tracheal intubation (all p<0.0001). Interpretation Children at high risk for perioperative respiratory adverse events could be systematically identified at the preanaesthetic assessment and thus can benefit from a specifically targeted anaesthesia management.	[von Ungern-Sternberg, Britta S.; Chambers, Neil A.; Rebmann, Claudia; Johnson, Chris] Princess Margaret Hosp Children, Dept Anaesthesia, Perth, WA, Australia; [von Ungern-Sternberg, Britta S.; Sly, Peter D.] Univ Western Australia, Telethon Inst Child Hlth Res, Div Clin Sci, Perth, WA 6009, Australia; [von Ungern-Sternberg, Britta S.; Sly, Peter D.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [von Ungern-Sternberg, Britta S.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Boda, Krisztina] Univ Szeged, Dept Med Informat, Szeged, Hungary; [Habre, Walid] Univ Geneva, Geneva Childrens Hosp, Paediat Anaesthesia Unit, Geneva, Switzerland	University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; Szeged University; University of Geneva	von Ungern-Sternberg, BS (corresponding author), Princess Margaret Hosp Children, Dept Anaesthesia, Roberts Rd, Subiaco, WA 6008, Australia.	bvonungern@uhbs.ch	von Ungern-Sternberg, Britta/CAG-9904-2022; Sly, Peter D/F-1486-2010; von Ungern-Sternberg, Britta/S-5532-2019	von Ungern-Sternberg, Britta/0000-0002-8043-8541; Sly, Peter D/0000-0001-6305-2201; Boda, Krisztina/0000-0002-9937-0460	Department of Anaesthesia, Princess Margaret Hospital for Children; Swiss Foundation for Grants in Biology and Medicine; Swiss National Science Foundation; Voluntary Academic Society Basel, Switzerland	Department of Anaesthesia, Princess Margaret Hospital for Children; Swiss Foundation for Grants in Biology and Medicine; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Voluntary Academic Society Basel, Switzerland	This study was supported by the Department of Anaesthesia, Princess Margaret Hospital for Children, a grant of the Swiss Foundation for Grants in Biology and Medicine in cooperation with the Swiss National Science Foundation, and by the Voluntary Academic Society Basel, Switzerland. We thank all staff members of the Department of Anaesthesia and the nurses in postanaesthetic care unit, Princess Margaret Hospital for Children, Perth, Australia, for their tremendous support with this study.	Adamzik M, 2007, ANESTH ANALG, V104, P168, DOI 10.1213/01.ane.0000247884.94119.d5; Arshad SH, 2005, CHEST, V127, P502, DOI 10.1378/chest.127.2.502; Backlund AB, 2006, ALLERGY, V61, P549, DOI 10.1111/j.1398-9995.2006.01027.x; Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bhananker SM, 2007, ANESTH ANALG, V105, P344, DOI 10.1213/01.ane.0000268712.00756.dd; Bjerg A, 2007, PEDIATRICS, V120, P741, DOI 10.1542/peds.2006-3742; Bordet F, 2002, PAEDIATR ANAESTH, V12, P762, DOI 10.1046/j.1460-9592.2002.00987.x; BUCKNER CK, 1985, AM REV RESPIR DIS, V132, P305; Chang HYS, 2007, ANESTH ANALG, V104, P1109, DOI 10.1213/01.ane.0000260638.57139.87; COHEN MM, 1991, ANESTH ANALG, V72, P282; Forastiere F, 1996, AM J RESP CRIT CARE, V153, P1098, DOI 10.1164/ajrccm.153.3.8630551; Groeben H, 1996, ANESTHESIOLOGY, V84, P533, DOI 10.1097/00000542-199603000-00007; Groeben H, 1999, AM J RESP CRIT CARE, V159, P530, DOI 10.1164/ajrccm.159.2.9806102; Groeben H, 2000, CHEST, V118, P509, DOI 10.1378/chest.118.2.509; Habre W, 1996, BRIT J ANAESTH, V77, P739, DOI 10.1093/bja/77.6.739; Harnett M, 2000, CAN J ANAESTH, V47, P315, DOI 10.1007/BF03020944; Homer JR, 2007, PEDIATR ANESTH, V17, P154, DOI 10.1111/j.1460-9592.2006.02059.x; Jones DT, 2006, OTOLARYNG HEAD NECK, V135, P12, DOI 10.1016/j.otohns.2006.03.011; Joos GF, 2003, EUR RESPIR J, V21, P1050, DOI 10.1183/09031936.03.00008403; Joseph-Bowen J, 2004, AM J RESP CRIT CARE, V169, P850, DOI 10.1164/rccm.200304-556OC; Lakshmipathy N, 1996, ANESTH ANALG, V82, P724, DOI 10.1097/00000539-199604000-00008; Mamie C, 2004, PEDIATR ANESTH, V14, P218, DOI 10.1111/j.1460-9592.2004.01169.x; Murat I, 2004, PAEDIATR ANAESTH, V14, P158, DOI 10.1111/j.1460-9592.2004.01167.x; Parnis SJ, 2001, PAEDIATR ANAESTH, V11, P29, DOI 10.1046/j.1460-9592.2001.00607.x; Rooke GA, 1997, ANESTHESIOLOGY, V86, P1294, DOI 10.1097/00000542-199706000-00010; Schreiner MS, 1996, ANESTHESIOLOGY, V85, P475, DOI 10.1097/00000542-199609000-00005; Schutz N, 2004, BRIT J ANAESTH, V92, P254, DOI 10.1093/bja/aeh049; Skolnick ET, 1998, ANESTHESIOLOGY, V88, P1144, DOI 10.1097/00000542-199805000-00003; Tait AR, 1998, ANESTH ANALG, V86, P706, DOI 10.1097/00000539-199804000-00006; Tait AR, 2005, ANESTH ANALG, V100, P59, DOI 10.1213/01.ANE.0000139653.53618.91; Tait AR, 2001, ANESTHESIOLOGY, V95, P299, DOI 10.1097/00000542-200108000-00008; Tay CLM, 2001, PAEDIATR ANAESTH, V11, P711, DOI 10.1046/j.1460-9592.2001.00767.x; Varughese AM, 2006, PEDIATR ANESTH, V16, P723, DOI 10.1111/j.1460-9592.2006.01856.x; Von Ungern-Stemberg BS, 2007, ANESTHESIOLOGY, V107, P714, DOI 10.1097/01.anes.0000286925.25272.b5; von Ungern-Sternberg BS, 2008, ANESTHESIOLOGY, V108, P216, DOI 10.1097/01.anes.0000299430.90352.d5	35	286	292	1	32	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2010	376	9743					773	783		10.1016/S0140-6736(10)61193-2	http://dx.doi.org/10.1016/S0140-6736(10)61193-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	650EC	20816545				2022-12-24	WOS:000281831000028
J	Bieling, P; Telley, IA; Surrey, T				Bieling, Peter; Telley, Ivo A.; Surrey, Thomas			A Minimal Midzone Protein Module Controls Formation and Length of Antiparallel Microtubule Overlaps	CELL			English	Article							EGG EXTRACT SPINDLES; MITOTIC SPINDLE; FISSION YEAST; DYNAMIC INSTABILITY; ANAPHASE-B; PRC1; CYTOKINESIS; MOTORS; FORCE; ASE1P	During cell division, microtubules are arranged in a large bipolar structure, the mitotic spindle, to segregate the duplicated chromosomes. Antiparallel microtubule overlaps in the spindle center are essential for establishing bipolarity and maintaining spindle stability throughout mitosis. In anaphase, this antiparallel microtubule array is tightly bundled forming the midzone, which serves as a hub for the recruitment of proteins essential for late mitotic events. The molecular mechanism of midzone formation and the control of its size are not understood. Using an in vitro reconstitution approach, we show here that PRC1 autonomously bundles antiparallel microtubules and recruits Xklp1, a kinesin-4, selectively to overlapping antiparallel microtubules. The processive motor Xklp1 controls overlap size by overlap length-dependent microtubule growth inhibition. Our results mechanistically explain how the two conserved, essential midzone proteins PRC1 and Xklp1 cooperate to constitute a minimal protein module capable of dynamically organizing the core structure of the central anaphase spindle.	[Bieling, Peter; Telley, Ivo A.; Surrey, Thomas] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Surrey, T (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	surrey@embl.de	Surrey, Thomas/AAC-4608-2021; Telley, Ivo Andreas/D-2063-2011	Telley, Ivo Andreas/0000-0003-4444-1046; Bieling, Peter/0000-0002-7458-4358; Surrey, Thomas/0000-0001-9082-1870	DFG; HFSPO; European Commission; Swiss National Science Foundation	DFG(German Research Foundation (DFG)); HFSPO(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Vladimir Rybin for analytical ultracentrifugation, Jan Ellenberg, Elmar Schiebel, Johanna Roostalu, and Scott Hansen for critically reading the manuscript, and the DFG, HFSPO, the European Commission (STREP "Active Biomics''), and the Swiss National Science Foundation for financial support.	Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Bieling P, 2010, METHOD CELL BIOL, V95, P555, DOI 10.1016/S0091-679X(10)95028-0; Bieling P, 2010, CURR BIOL, V20, P763, DOI 10.1016/j.cub.2010.02.067; Bratman SV, 2007, DEV CELL, V13, P812, DOI 10.1016/j.devcel.2007.10.015; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Cheerambathur DK, 2007, J CELL BIOL, V177, P995, DOI 10.1083/jcb.200611113; Cottingham FR, 1999, J CELL BIOL, V147, P335, DOI 10.1083/jcb.147.2.335; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Khmelinskii A, 2008, CELL CYCLE, V7, P283, DOI 10.4161/cc.7.3.5349; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Khmelinskii A, 2009, DEV CELL, V17, P244, DOI 10.1016/j.devcel.2009.06.011; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Kwon M, 2004, MOL BIOL CELL, V15, P219, DOI 10.1091/mbc.E03-07-0489; Lee YM, 2004, EXP MOL MED, V36, P93, DOI 10.1038/emm.2004.13; Liu J, 2009, J BIOL CHEM, V284, P23059, DOI 10.1074/jbc.M109.009670; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Muller S, 2004, CURR BIOL, V14, P412, DOI 10.1016/j.cub.2004.02.032; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Pearson CG, 2006, MOL BIOL CELL, V17, P4069, DOI 10.1091/mbc.E06-04-0312; Powers J, 2004, J CELL BIOL, V166, P991, DOI 10.1083/jcb.200403036; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Sagolla MJ, 2003, J CELL SCI, V116, P4891, DOI 10.1242/jcs.00796; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Telley IA, 2009, BIOPHYS J, V96, P3341, DOI 10.1016/j.bpj.2009.01.015; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; TRANQUILLO RT, 1987, J MATH BIOL, V25, P229, DOI 10.1007/BF00276435; Uteng M, 2008, J CELL BIOL, V182, P715, DOI 10.1083/jcb.200801125; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Verbrugghe KJC, 2004, CURR BIOL, V14, P1755, DOI 10.1016/j.cub.2004.09.055; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	57	207	209	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					420	432		10.1016/j.cell.2010.06.033	http://dx.doi.org/10.1016/j.cell.2010.06.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691901	Bronze			2022-12-24	WOS:000280609100019
J	Kim, Y; Holland, AJ; Lan, W; Cleveland, DW				Kim, Yumi; Holland, Andrew J.; Lan, Weijie; Cleveland, Don W.			Aurora Kinases and Protein Phosphatase 1 Mediate Chromosome Congression through Regulation of CENP-E	CELL			English	Article							SMALL-MOLECULE INHIBITOR; MITOTIC CHECKPOINT; OUTER KINETOCHORE; KINESIN MOTOR; CELL-DIVISION; SPINDLE POLE; B KINASE; A KINASE; MICROTUBULE; ANEUPLOIDY	Opposing roles of Aurora kinases and protein phosphatase 1 (PP1) during mitosis have long been suggested. Here, we demonstrate that Aurora kinases A and B phosphorylate a conserved residue on the kinetochore motor CENP-E. PP1 binds CENP-E via a motif overlapping this phosphorylation site and binding is disrupted by Aurora phosphorylation. Phosphorylation of CENP-E by the Auroras is enriched at spindle poles, disrupting binding of PP1 and reducing CENP-E's affinity for individual microtubules. This phosphorylation is required for CENP-E-mediated towing of initially polar chromosomes toward the cell center. Kinetochores on such chromosomes cannot make subsequent stable attachment to spindle microtubules when dephosphorylation of CENP-E or rebinding of PP1 to CENP-E is blocked. Thus, an Aurora/PP1 phosphorylation switch modulates CENP-E motor activity as an essential feature of chromosome congression from poles and localized PP1 delivery by CENP-E to the outer kinetochore is necessary for stable microtubule capture by those chromosomes.	[Kim, Yumi; Holland, Andrew J.; Lan, Weijie; Cleveland, Don W.] Univ Calif Berkeley, Ludwig Inst Canc Res, Berkeley, CA 94720 USA; [Kim, Yumi] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif Berkeley, Ludwig Inst Canc Res, Berkeley, CA 94720 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	National Institutes of Health [GM29513]; Ludwig Institute for Cancer Research; European Molecular Biology Organization (EMBO); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029513, R37GM029513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Stephen Taylor, Patrick Eyers, Todd Stukenberg, and Arshad Desai for providing reagents. This work was supported by a grant (GM29513) from the National Institutes of Health to D. W.C., who receives salary support from the Ludwig Institute for Cancer Research. A.J.H. is supported by a European Molecular Biology Organization (EMBO) Long-Term Fellowship.	Akiyoshi B, 2009, GENE DEV, V23, P2887, DOI 10.1101/gad.1865909; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Emanuele MJ, 2008, J CELL BIOL, V181, P241, DOI 10.1083/jcb.200710019; Espeut J, 2008, MOL CELL, V29, P637, DOI 10.1016/j.molcel.2008.01.004; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; HUBBARD MJ, 1989, EUR J BIOCHEM, V186, P701, DOI 10.1111/j.1432-1033.1989.tb15263.x; HYMAN AA, 1991, NATURE, V351, P206, DOI 10.1038/351206a0; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; LIAO H, 1994, SCIENCE, V265, P394, DOI 10.1126/science.8023161; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Ovechkina Y, 2002, J CELL BIOL, V159, P557, DOI 10.1083/jcb.200205089; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yucel JK, 2000, J CELL BIOL, V150, P1, DOI 10.1083/jcb.150.1.1; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547	52	175	177	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					444	455		10.1016/j.cell.2010.06.039	http://dx.doi.org/10.1016/j.cell.2010.06.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691903	Green Accepted, Bronze			2022-12-24	WOS:000280609100021
J	de Galan, BE				de Galan, Bastiaan E.			Blood Pressure Control in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	de Galan, BE (corresponding author), Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	b.degalan@aig.umcn.nl	de Galan, Bastiaan E/H-3161-2015; Wetzels, Jack F.M./A-1720-2014; Krüger, Bernd/F-5781-2011	de Galan, Bastiaan E/0000-0002-1255-7741; Wetzels, Jack F.M./0000-0002-0650-6921; 				de Galan BE, 2002, DIABETES, V51, P790, DOI 10.2337/diabetes.51.3.790; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005	2	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					695	696						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TN	20701534				2022-12-24	WOS:000280764600022
J	Schrier, RW				Schrier, Robert W.			Blood Pressure Control in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									Univ Colorado Denver, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Schrier, RW (corresponding author), Univ Colorado Denver, Aurora, CO USA.	robert.schrier@ucdenver.edu	de Galan, Bastiaan E/H-3161-2015; Wetzels, Jack F.M./A-1720-2014; Krüger, Bernd/F-5781-2011	de Galan, Bastiaan E/0000-0002-1255-7741; Wetzels, Jack F.M./0000-0002-0650-6921; 				Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Schrier RW, 2007, NAT CLIN PRACT NEPHR, V3, P428, DOI 10.1038/ncpneph0559; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x	3	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					696	697						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TN	20701534				2022-12-24	WOS:000280764600024
J	Benck, U; Kruger, B; Kramer, BK				Benck, Urs; Krueger, Bernd; Kraemer, Bernhard K.			Blood Pressure Control in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Benck, Urs; Kraemer, Bernhard K.] Mannheim Univ Hosp, Mannheim, Germany; [Krueger, Bernd] Ruhr Univ Bochum, Bochum, Germany	Ruprecht Karls University Heidelberg; Ruhr University Bochum	Benck, U (corresponding author), Mannheim Univ Hosp, Mannheim, Germany.	bernhard.kraemer@umm.de	de Galan, Bastiaan E/H-3161-2015; Wetzels, Jack F.M./A-1720-2014; Krüger, Bernd/F-5781-2011	de Galan, Bastiaan E/0000-0002-1255-7741; Wetzels, Jack F.M./0000-0002-0650-6921; 					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					696	696						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TN	20701534				2022-12-24	WOS:000280764600023
J	Wetzels, JFM				Wetzels, Jack F. M.			Blood Pressure Control in Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							DISEASE		Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Wetzels, JFM (corresponding author), Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	j.wetzels@nier.umcn.nl	de Galan, Bastiaan E/H-3161-2015; Wetzels, Jack F.M./A-1720-2014; Krüger, Bernd/F-5781-2011	de Galan, Bastiaan E/0000-0002-1255-7741; Wetzels, Jack F.M./0000-0002-0650-6921; 				Bavry AA, 2010, HYPERTENSION, V55, P48, DOI 10.1161/HYPERTENSIONAHA.109.142240; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Protogerou AD, 2007, HYPERTENSION, V50, P172, DOI 10.1161/HYPERTENSIONAHA.107.089797	4	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					695	695						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TN	20701534				2022-12-24	WOS:000280764600021
